PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	McCarthy, KS; Kneavel, M; Ernst, W				McCarthy, Kevin S.; Kneavel, Meredith; Ernst, William			Psychometric properties of concussion knowledge and cognitive mediators of reporting measures	BRAIN INJURY			English	Article						Concussion education; measurement; theory of planned behavior; theory of reasoned action	TRAUMATIC BRAIN-INJURY; ATTITUDES; PROGRAM	Context: Concussion education and prevention programs require reliable and valid instruments to evaluate the theory, mechanisms, and outcome of these interventions Objective: To assess the psychometric properties of measures evaluating concussion education and prevention programsDesign: Descriptive epidemiological Setting: 10 NCAA-member universities Patients or Other Participants: 841 student-athletes in an RCT control group testing an ecological, peer-led concussion education program Main Outcome Measures: Instruments adapted for assessing concussion knowledge and Theory of Planned Behavior/Theory of Reasoned Action (TPB/TRA) cognitive mediators of reporting behavior (attitudes, subjective norms, perceived control, and intentions to report concussion). Participants completed measures at baseline, after one hour, and after one month Results: Internal consistency and test-retest reliability were moderate for both the concussion knowledge and cognitive mediator measures. TPB/TRA was supported subscale intercorrelation and item factor analysis in the cognitive mediator scale. Factor analysis of the concussion knowledge measure revealed subscales for physical/cognitive, psychological/affective, and non-symptoms. The intermediate TPB/TRA mediators of attitudes, norms, and perceived control predicted greater intention-to-report, which predicted increased likelihood of reporting concussion one month later.Conclusions: Measures of concussion knowledge and cognitive mediators of reporting adapted from the literature show adequate psychometric properties and support TPB/TRA application for concussion reporting behaviors.	[McCarthy, Kevin S.; Ernst, William] Chestnut Hill Coll, Philadelphia, PA USA; [McCarthy, Kevin S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kneavel, Meredith] La Salle Univ, Sch Nursing & Hlth Sci, Philadelphia, PA 19141 USA; [Kneavel, Meredith] Chestnut Hill Coll, Ctr Concuss Educ & Res, Philadelphia, PA USA		McCarthy, KS (corresponding author), Chestnut Hill Coll, Psychol, 9601 Germantown Ave, Philadelphia, PA 19118 USA.	mccarthyk1@chc.edu		Ernst, William/0000-0002-6774-4528; McCarthy, Kevin/0000-0002-1609-7340	NCAA-Department of Defense [Mind Matters Challenge]	This work was supported by the NCAA-Department of Defense [Mind Matters Challenge].	Albarracin D., 2007, PREDICTING CHANGING, P3; Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Centers for Disease Control National Center for Injury Prevention and Control, HEADS HLTH CAR PROV; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen, 1998, STAT POWER SOCIAL SC; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eichhorn B. R, 2014, COMMON METHOD VARIAN, P1; Ernst W, 2020, J ATHL TRAINING, V55, P448, DOI 10.4085/1062-6050-212-19; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hulley SB, 2013, DESIGNING CLIN RES E; Hunt TN., 2015, ATHLETIC TRAIN ED J, V10, P65, DOI [10.4085/100165, DOI 10.4085/100165]; Kneavel ME, 2020, J ATHL TRAINING, V55, P456, DOI 10.4085/1062-6050-0182.19; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Oluka OC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094419; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schmidt JD, IN PRESS; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Valovich TC, 2003, J ATHL TRAINING, V38, P51	35	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1210	1217		10.1080/02699052.2021.1959064		AUG 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000681118900001	34347541				2022-02-07	
J	Mele, C; Pagano, L; Franciotta, D; Caputo, M; Nardone, A; Aimaretti, G; Marzullo, P; Pingue, V				Mele, C.; Pagano, L.; Franciotta, D.; Caputo, M.; Nardone, A.; Aimaretti, G.; Marzullo, P.; Pingue, V.			Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Thyroid; Epilepsy; Traumatic brain injury; Outcome	III-IODOTHYRONINE DEIODINASE; HEAD-INJURY; EPILEPSY; HORMONE; BARRIER; SYSTEM; IMPAIRMENT; PREVALENCE; DISABILITY; NEURONS	Purpose That thyroid hormones exert pleiotropic effects and have a contributory role in triggering seizures in patients with traumatic brain injury (TBI) can be hypothesized. We aimed at investigating thyroid function tests as prognostic factors of the development of seizures and of functional outcome in TBI. Methods This retrospective study enrolled 243 adult patients with a diagnosis of mild-to-severe TBI, consecutively admitted to our rehabilitation unit for a 6-month neurorehabilitation program. Data on occurrence of seizures, brain imaging, injury characteristics, associated neurosurgical procedures, neurologic and functional assessments, and death during hospitalization were collected at baseline, during the workup and on discharge. Thyroid function tests (serum TSH, fT4, and fT3 levels) were performed upon admission to neurorehabilitation. Results Serum fT3 levels were positively associated with an increased risk of late post-traumatic seizures (LPTS) in post-TBI patients independent of age, sex and TBI severity (OR = 1.85, CI 95% 1.22-2.61, p < 0.01). Measured at admission, fT3 values higher than 2.76 pg/mL discriminated patients with late post-traumatic seizures from those without, with a sensitivity of 74.2% and a specificity of 60.9%. Independently from the presence of post-traumatic epilepsy and TBI severity, increasing TSH levels and decreasing fT3 levels were associated with worse neurological and functional outcome, as well as with higher risk of mortality within 6 months from the TBI event. Conclusions Serum fT3 levels assessed in the subacute phase post-TBI are associated with neurological and functional outcome as well as with the risk of seizure occurrence. Further studies are needed to investigate the mechanisms underlying these associations.	[Mele, C.; Nardone, A.] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy; [Pagano, L.] Univ Turin, Div Endocrinol Diabetol & Metab, Dept Med Sci, Turin, Italy; [Franciotta, D.] IRCCS Osped Policlin San Martino, Genoa, Italy; [Caputo, M.] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Nardone, A.; Pingue, V.] IRCCS, Inst Pavia, Neurorehabilitat & Spinal Unit, Ist Clin Sci Maugeri SPA SB, Pavia, Italy; [Aimaretti, G.; Marzullo, P.] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Marzullo, P.] Osped San Giuseppe, IRCCS Ist Auxol Italiano, Div Gen Med, Verbania, Italy		Mele, C (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.	chiara.mele1989@gmail.com	Nardone, Antonio/J-8733-2016; pingue, valeria/AAC-1833-2020; Caputo, Marina/AAC-6707-2022	Nardone, Antonio/0000-0002-9547-1774; pingue, valeria/0000-0001-9376-4699; 	Universita degli Studi di Pavia within the CRUI-CARE Agreement	Open access funding provided by Universita degli Studi di Pavia within the CRUI-CARE Agreement. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; CHIOLERO RL, 1988, ACTA ENDOCRINOL-COP, V117, P80, DOI 10.1530/acta.0.1170080; Cooper, 2013, WERNER INGBARS THYRO, P103; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Das K, 2004, NEUROCHEM RES, V29, P1755, DOI 10.1023/B:NERE.0000035812.58200.a9; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; Engelborghs S, 2000, ACTA NEUROL BELG, V100, P201; Farwell AP, 2013, CURR OPIN ENDOCRINOL, V20, P478, DOI 10.1097/01.med.0000433069.09294.e8; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gutteridge JMC., 2001, FREE RADICALS BIOL M; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffmann G, 2004, NEUROSCIENCE, V125, P369, DOI 10.1016/j.neuroscience.2004.01.047; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Koch L., 2010, NAT REV ENDOCRINOL, V6, P655, DOI [10.1038/nrendo.2010.182, DOI 10.1038/NRENDO.2010.182]; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mackintosh S, 2009, AUST J PHYSIOTHER, V55, P65, DOI 10.1016/S0004-9514(09)70066-2; Malekpour Babak, 2012, Acta Med Iran, V50, P113; Mara JR, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2020.106935; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Patel VB., 2015, DIET NUTR CRITICAL C, P91, DOI [10.1007/978-1-4614-7836-2_2, DOI 10.1007/978-1-4614-7836-2_2]; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pingue V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84203-y; Rippe, 2011, INTENS CARE MED, P1182; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Santini F, 2001, EUR J ENDOCRINOL, V144, P577, DOI 10.1530/eje.0.1440577; Schroeder AC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00040; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shulga A, 2009, MOL CELL NEUROSCI, V42, P408, DOI 10.1016/j.mcn.2009.09.002; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Song TJ, 2010, THYROID, V20, P955, DOI 10.1089/thy.2009.0276; Strazzer S, 2016, PEDIATR DRUGS, V18, P235, DOI 10.1007/s40272-016-0167-3; Tamijani SMS, 2015, SEIZURE-EUR J EPILEP, V31, P155, DOI 10.1016/j.seizure.2015.07.021; TEASDALE G, 1974, LANCET, V2, P81; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vezzani, 2019, BRAIN, V142, DOI 10.1093/brain/awz130; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Westerholz S, 2010, NEUROSCIENCE, V168, P573, DOI 10.1016/j.neuroscience.2010.03.039; WOOLF PD, 1988, AM J MED, V84, P201, DOI 10.1016/0002-9343(88)90414-7; Yuen AWC, 2011, MED HYPOTHESES, V77, P536, DOI 10.1016/j.mehy.2011.06.025; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zimmermann LL, 2017, CURR OPIN NEUROL, V30, P580, DOI 10.1097/WCO.0000000000000505	56	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	FEB	2022	45	2					379	389		10.1007/s40618-021-01656-8		AUG 2021	11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	YL0SR	WOS:000681570500001	34351610	hybrid			2022-02-07	
J	To, XV; Nasrallah, FA				To, Xuan Vinh; Nasrallah, Fatima A.			Multi-modal magnetic resonance imaging in a mouse model of concussion	SCIENTIFIC DATA			English	Article; Data Paper							TRAUMATIC BRAIN-INJURY; INDEPENDENT COMPONENT ANALYSIS; IN-DIFFUSION MR; TEMPORAL WINDOW; ORIENTATION DISPERSION; FMRI; VULNERABILITY; CLASSIFICATION; CONNECTIVITY; DISTORTION	This data collection contains Magnetic Resonance Imaging (MRI) data, including structural, diffusion, stimulus-evoked, and resting-state functional MRI and behavioural assessment results, including acute post-impact Loss-of-Righting Reflex time and acute, subacute, and longer-term Neural Severity Score, and Open Field Behaviour obtained from a mouse model of concussion. Four cohorts with 43 3-4 months old male mice in total were used: Sham (n = 14, n = 6 day 2, n = 3 day 7, n = 5 day 14), concussion day 2 (CON 2; n = 9), concussion day 7 (CON 7; n = 10), concussion day 14 (CON 14; n = 10). The data collection contains the aforementioned MRI data in compressed NIFTI format, data sheets on animal's backgrounds and behavioural outcomes and is made publicly available from a data repository. The available data are intended to facility cross-study comparisons, meta-analysis, and science reproducibility.	[To, Xuan Vinh; Nasrallah, Fatima A.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Nasrallah, Fatima A.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia		Nasrallah, FA (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.; Nasrallah, FA (corresponding author), Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia.	f.nasrallah@uq.edu.au			Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia [2014000857]; University of QueenslandUniversity of Queensland [CRM 200221-005374]	This research was supported by Motor Accident Insurance Commission (MAIC), The Queensland Government, Australia (grant number: 2014000857) and The University of Queensland (Promoting Women's fellowship: CRM 200221-005374). We acknowledge the supports from the Queensland NMR Network and the National Imaging Facility (a National Collaborative Research Infrastructure Strategy capability) for the operation of the 9.4T MRI and the computational facilities at the Centre for Advanced Imaging, the University of Queensland. We also acknowledged the support of the University of Queensland (UQ)'s Library and Information Technology Service for the design and implementation of the UQ Research Data Manager (UQRDM) which provided the online data repository used for the data collection described in this manuscript.	Anderson M, 2012, IEEE T SIGNAL PROCES, V60, P1672, DOI 10.1109/TSP.2011.2181836; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Andersson JLR, 2018, NEUROIMAGE, V171, P277, DOI 10.1016/j.neuroimage.2017.12.040; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashburner J., 2003, HUMAN BRAIN FUNCTION; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Bajic D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00685; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Dohmatob E, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00064; Du YH, 2013, NEUROIMAGE, V69, P157, DOI 10.1016/j.neuroimage.2012.11.008; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Hong X, 2015, MAGN RESON IMAGING, V33, P1098, DOI 10.1016/j.mri.2015.06.010; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Lee JH, 2008, NEUROIMAGE, V40, P86, DOI 10.1016/j.neuroimage.2007.11.019; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nasrallah FA, 2014, NEUROIMAGE, V86, P417, DOI 10.1016/j.neuroimage.2013.10.025; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; To XV, 2021, J NEUROTRAUM, V38, P967, DOI 10.1089/neu.2019.6944; To XV., 2021, MRI COLLECTION MOUSE, DOI [10.14264/aae348e, DOI 10.14264/AAE348E]; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; To XV, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01098-y; Zerbi V, 2015, NEUROIMAGE, V123, P11, DOI 10.1016/j.neuroimage.2015.07.090; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	51	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2052-4463		SCI DATA	Sci. Data	AUG 5	2021	8	1							207	10.1038/s41597-021-00985-w			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY6MC	WOS:000683895400002	34354090	Green Published, gold			2022-02-07	
J	Yu, TT; Liu, X; Sun, L; Wu, JP; Wang, Q				Yu, Tingting; Liu, Xiao; Sun, Lei; Wu, Jianping; Wang, Qun			Clinical characteristics of post-traumatic epilepsy and the factors affecting the latency of PTE	BMC NEUROLOGY			English	Article						Post-traumatic epilepsy; Traumatic brain injury; Clinical characteristics; Latency; Risk factors	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; ILAE COMMISSION; RISK-FACTORS; SEIZURES; EPIDEMIOLOGY; MULTICENTER; PREVENTION; DRUGS	Objectives To summarize the clinical characteristics of post-traumatic epilepsy (PTE), and to identify the factors affecting the latency of PTE after traumatic brain injury (TBI). Methods We conducted a retrospective clinical analysis in patients with PTE who visited the outpatient Department of Epilepsy, Beijing Tiantan Hospital from January 2013 to December 2018. The clinical characteristics, including gender, age distribution, seizure type, and latency were summarized. Factors affecting the latency of PTE were evaluated using Kaplan-Meier curves and Cox proportional hazard regression analysis. Results Complete clinical information was available for 2862 subjects, of which 78.48% were males. The mean age at TBI was 21.4 +/- 15.1 years and peaked in the 0 to 12-year-old and 15 to 27-year-old groups. Generalized onset seizure was the most frequent seizure type (72.82% of patients). Approximately 19.95% PTE patients developed drug-resistant epilepsy. The latency of PTE ranged from 8 days to 20 years, with a median of 24.0 (IQR, 5.0-84.0) months. The Kaplan-Meier curves demonstrated that gender, age at TBI, severity of TBI, multiple craniocerebral injuries, post-TBI treatments, acute seizures, and residual disability were associated with PTE latency. The Cox regression model indicated that age >= 18 years old, severe TBI with multiple surgical operations, acute seizures, and residual disability were risk factors for shorter PTE latency. Conclusions PTE is more common in males than females, and peaked in the 0 to 12-year-old and 15 to 27-year-old groups. Generalized onset seizure was the most common seizure type and 19.95% of participants developed drug-resistant epilepsy. Patients aged >= 18 years old, who suffered severe TBI followed by multiple surgical operations, experienced acute seizures, or with residual disabilities had shorter PTE latency.	[Yu, Tingting; Liu, Xiao; Sun, Lei; Wu, Jianping; Wang, Qun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100070, Peoples R China; [Yu, Tingting; Liu, Xiao; Sun, Lei; Wu, Jianping; Wang, Qun] China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China; [Wu, Jianping] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100070, Peoples R China; [Wang, Qun] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China		Wang, Q (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100070, Peoples R China.; Wang, Q (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China.; Wang, Q (corresponding author), Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	wangq@ccmu.edu.cn			National Key R&D Program of China [2017YFC1307500]; Capital Healthy Development Research Funding [2016-12011, 2020-1-2013]	This work was supported by National Key R&D Program of China 2017YFC1307500, Capital Healthy Development Research Funding 2016-12011 & 2020-1-2013.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Chen W, 2017, NEUROPSYCH DIS TREAT, V13, P2301, DOI 10.2147/NDT.S141486; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Ghadiri T, 2020, IRAN J BASIC MED SCI, V23, P63, DOI 10.22038/IJBMS.2019.37558.8932; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Ikonomidou C, 2010, EPILEPSY RES, V88, P11, DOI 10.1016/j.eplepsyres.2009.09.019; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Karlander M, 2021, J NEUROL NEUROSUR PS, V92, P617, DOI 10.1136/jnnp-2020-325382; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lin WJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040589; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Nass RD, 2017, SEIZURE-EUR J EPILEP, V47, P51, DOI 10.1016/j.seizure.2017.02.013; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	29	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	AUG 5	2021	21	1							301	10.1186/s12883-021-02273-x			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU8ZT	WOS:000681319800001	34348691	Green Published, gold			2022-02-07	
J	Lamoureux, E; Ishikawa, T; Yeates, KO; Brooks, BL; Beauchamp, MH; Craig, W; Gravel, J; Zemek, R; Doan, Q				Lamoureux, Erik; Ishikawa, Takuro; Yeates, Keith Owen; Brooks, Brian L.; Beauchamp, Miriam H.; Craig, William; Gravel, Jocelyn; Zemek, Roger; Doan, Quynh		Pediat Emergency Res Canada PERC A	Convergent Validity of Myheartsmap: A Pediatric Psychosocial Health Screening Tool	CHILD PSYCHIATRY & HUMAN DEVELOPMENT			English	Article; Early Access						Pediatric mental health; Psychosocial screening; Self-assessment; Proxy-assessment; Convergent validity	QUALITY-OF-LIFE; GENERIC CORE SCALES; DIFFICULTIES QUESTIONNAIRE SDQ; ALCOHOL-USE DISORDERS; EMERGENCY-DEPARTMENT; SUICIDE RISK; MENTAL-DISORDERS; ADOLESCENTS; RELIABILITY; PEDSQL(TM)	Recognition of pediatric mental health concerns often depends on assessment by parents, educators, and primary care professionals. Therefore, a psychosocial screening instrument suitable for routine use in schools and primary care is needed. The Pediatric Quality of Life (PedsQL) and the Strengths and Difficulties Questionnaire (SDQ) are widely used for screening but lack adolescent-specific mental health measures. MyHEARTSMAP is an instrument assessing aspects of youth psychosocial health via four domains: Psychiatry, Function, Social, and Youth Health. We evaluated MyHEARTSMAP convergent validity with PedsQL and SDQ among 122 child-parent dyads participating in a larger concussion study. Convergent validity was assessed via correlations: MyHEARTSMAP Psychiatry and Function domains correlated strongly (r >= 0.44) and Social domain correlated weakly (r <= 0.25) to corresponding PedsQL and SDQ subscales, while Youth Health domain correlated moderately (r >= 0.31) to the tools' total scales. In conclusion, MyHEARTSMAP converges with PedsQL and SDQ, and benefits from the inclusion of adolescent-specific psychosocial measures.	[Lamoureux, Erik; Ishikawa, Takuro; Doan, Quynh] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Craig, William] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Durgence Pediat, CHU St Justine, Montreal, PQ, Canada; [Zemek, Roger] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Doan, Quynh] Univ British Columbia, Div Pediat Emergency Med, Dept Pediat, Vancouver, BC, Canada; [Doan, Quynh] Univ British Columbia, Dept Pediat, Fac Med, 4480 Oak St, Vancouver, BC V6T 1Z3, Canada		Doan, Q (corresponding author), BC Childrens Hosp Res Inst, Vancouver, BC, Canada.; Doan, Q (corresponding author), Univ British Columbia, Div Pediat Emergency Med, Dept Pediat, Vancouver, BC, Canada.; Doan, Q (corresponding author), Univ British Columbia, Dept Pediat, Fac Med, 4480 Oak St, Vancouver, BC V6T 1Z3, Canada.	qdoan@bcchr.ca			Canada Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This study was supported by funding for the Advancing Concussion Assessment in Pediatrics (A-CAP) study from the Canada Institutes of Health Research (CIHR).	Bentley N, 2019, CLIN CHILD FAM PSYCH, V22, P225, DOI 10.1007/s10567-018-00273-x; Bialy L, 2018, PEDIATR EMERG CARE, V34, P138, DOI 10.1097/PEC.0000000000001360; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Deighton J, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-14; Doan Q, 2020, J PEDIATR-US, V219, P54, DOI 10.1016/j.jpeds.2019.12.046; Eccleston C, 1996, J PSYCHOSOM RES, V40, P551, DOI 10.1016/0022-3999(95)00555-2; FLANAGAN R, 1995, J SCHOOL PSYCHOL, V33, P177, DOI 10.1016/0022-4405(95)00003-5; Folse VN, 2006, J PSYCHOSOC NURS MEN, V44, P23, DOI 10.3928/02793695-20060301-08; Folse VN, 2009, CLIN NURS RES, V18, P253, DOI 10.1177/1054773809335296; Gipson PY, 2015, PEDIATR EMERG CARE, V31, P88, DOI 10.1097/PEC.0000000000000225; Goodman A, 2011, J CHILD PSYCHOL PSYC, V52, P100, DOI 10.1111/j.1469-7610.2010.02278.x; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Hernandez L, 2014, J SUBST ABUSE TREAT, V47, P239, DOI 10.1016/j.jsat.2014.05.010; Huang IC, 2009, VALUE HEALTH, V12, P773, DOI 10.1111/j.1524-4733.2008.00487.x; Kang Y, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0335-y; Kelly TM, 2001, J STUD ALCOHOL, V62, P838, DOI 10.15288/jsa.2001.62.838; Kelly TM, 2004, ALCOHOL CLIN EXP RES, V28, P746, DOI 10.1097/01.ALC.0000125346.37075.85; Kelly TM, 2002, ALCOHOL ALCOHOLISM, V37, P444, DOI 10.1093/alcalc/37.5.444; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Limbers CA, 2009, J AUTISM DEV DISORD, V39, P1529, DOI 10.1007/s10803-009-0777-5; Mental Health Commission of Canada, 2010, MAK CAS INV MENT HLT MAK CAS INV MENT HLT, P1; Newton AS., 2017, SYSTEMATIC REV INSTR, DOI [10.1111/acem.13162, DOI 10.1111/ACEM.13162]; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Porter SC, 1997, ANN EMERG MED, V29, P141, DOI 10.1016/S0196-0644(97)70320-2; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reinfjell T, 2008, NORD J PSYCHIAT, V62, P279, DOI 10.1080/08039480801983950; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Stevens MW, 2012, ARCH PEDIAT ADOL MED, V166, P74, DOI 10.1001/archpediatrics.2011.694; Varni JW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-26; Varni JW, 2002, ARTHRITIS RHEUM, V46, P714, DOI 10.1002/art.10095; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Virk P, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000493; Wright H., 2018, SCREENING MENTAL HLT; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Youthinmind, 2015, INF RES PROF STRENGT INF RES PROF STRENGT; Youthinmind, 2016, SCORING STRENGTHS DI	43	0	0	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0009-398X	1573-3327		CHILD PSYCHIAT HUM D	Child Psychiat. Hum. Dev.												10.1007/s10578-021-01221-7		AUG 2021	10	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	TU7BG	WOS:000681187200003	34350505				2022-02-07	
J	Torres-Espin, A; Almeida, CA; Chou, A; Huie, JR; Chiu, M; Vavrek, R; Sacramento, J; Orr, MB; Gensel, JC; Grethe, JS; Martone, ME; Fouad, K; Ferguson, AR				Torres-Espin, Abel; Almeida, Carlos A.; Chou, Austin; Huie, J. Russell; Chiu, Michael; Vavrek, Romana; Sacramento, Jeff; Orr, Michael B.; Gensel, John C.; Grethe, Jeffery S.; Martone, Maryann E.; Fouad, Karim; Ferguson, Adam R.		STREET FAIR Workshop Participants	Promoting FAIR Data Through Community-driven Agile Design: the Open Data Commons for Spinal Cord Injury (odc-sci.org)	NEUROINFORMATICS			English	Article; Early Access						Data sharing; FAIR; spinal cord injury; neurotrauma; data reuse; community repository	INCREASING VALUE; REPRODUCIBILITY; RECOVERY; STANDARD; SCALE; BIAS	The past decade has seen accelerating movement from data protectionism in publishing toward open data sharing to improve reproducibility and translation of biomedical research. Developing data sharing infrastructures to meet these new demands remains a challenge. One model for data sharing involves simply attaching data, irrespective of its type, to publisher websites or general use repositories. However, some argue this creates a 'data dump' that does not promote the goals of making data Findable, Accessible, Interoperable and Reusable (FAIR). Specialized data sharing communities offer an alternative model where data are curated by domain experts to make it both open and FAIR. We report on our experiences developing one such data-sharing ecosystem focusing on 'long-tail' preclinical data, the Open Data Commons for Spinal Cord Injury (odc-sci.org). ODC-SCI was developed with community-based agile design requirements directly pulled from a series of workshops with multiple stakeholders (researchers, consumers, non-profit funders, governmental agencies, journals, and industry members). ODC-SCI focuses on heterogeneous tabular data collected by preclinical researchers including bio-behaviour, histopathology findings and molecular endpoints. This has led to an example of a specialized neurocommons that is well-embraced by the community it aims to serve. In the present paper, we provide a review of the community-based design template and describe the adoption by the community including a high-level review of current data assets, publicly released datasets, and web analytics. Although odc-sci.org is in its late beta stage of development, it represents a successful example of a specialized data commons that may serve as a model for other fields.	[Torres-Espin, Abel; Almeida, Carlos A.; Chou, Austin; Huie, J. Russell; Sacramento, Jeff; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Chiu, Michael; Grethe, Jeffery S.; Martone, Maryann E.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Vavrek, Romana; Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Vavrek, Romana; Fouad, Karim] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Orr, Michael B.; Gensel, John C.] Univ Kentucky, Coll Med, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Ferguson, Adam R.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94143 USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Fouad, K (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.; Fouad, K (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.; Ferguson, AR (corresponding author), San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94143 USA.	kfouad@ualberta.ca; adam.ferguson@ucsf.edu		Torres Espin, Abel/0000-0002-9787-8738; Huie, J. Russell/0000-0001-5594-4277; Grethe, Jeffrey/0000-0001-5212-7052; Sacramento, Jeffrey/0000-0001-7118-3519; Chiu, Michael/0000-0002-8879-7469; , John/0000-0001-8980-108X; Morioka, Kazuhito/0000-0001-5407-8178; Vavrek, Romana/0000-0003-1966-1258; Chou, Austin/0000-0003-4328-5811; Maldonado-Lasuncion, Ines/0000-0003-0631-7079	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088475, NS106899]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01RX002245, I01RX002787]; Wings for Life; Craig H. Neilsen Foundation; International Neuroinformatics Coordinating Facility (INCF); Wings for Life, Craig H. Neilsen Foundation; International Spinal Research Trust	Supported by: National Institutes of Health (NS088475, NS106899 to A. R.F.), the US Department of Veterans Affairs (I01RX002245, I01RX002787 to A.R.F.), Wings for Life (to A.R.F.) and the Craig H. Neilsen Foundation (to A.R.F.). The STREET-FAIR workshop was supported by a workshop grant from the International Neuroinformatics Coordinating Facility (INCF)(to A.R.F.). ODCSCI.org development is supported by a multi-funder grant (Wings for Life, Craig H. Neilsen Foundation, in-kind support from International Spinal Research Trust)(to K.F.)	Aguilar RM, 2010, EXP NEUROL, V221, P38, DOI 10.1016/j.expneurol.2009.09.028; Almeida CA, 2021, NEUROINFORMATICS, DOI 10.1007/s12021-021-09512-z; Anderson KD, 2009, EXP NEUROL, V220, P23, DOI 10.1016/j.expneurol.2009.08.020; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Broman KW, 2018, AM STAT, V72, P2, DOI 10.1080/00031305.2017.1375989; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Callahan A, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw040; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Charlifue S, 2016, ARCH PHYS MED REHAB, V97, P1805, DOI 10.1016/j.apmr.2016.03.030; Chervitz SA, 2011, METHODS MOL BIOL, V719, P31, DOI 10.1007/978-1-61779-027-0_2; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; Ferguson AR, 2014, NAT NEUROSCI, V17, P1442, DOI 10.1038/nn.3838; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2018, OPEN DATA COMMON SPI, DOI [10.7295/W9T72FMZ, DOI 10.7295/W9T72FMZ]; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kennedy DN, 2012, NEUROINFORMATICS, V10, P223, DOI 10.1007/s12021-012-9154-1; Kyritsis N, 2021, J EXP MED, V218, DOI 10.1084/jem.20201795; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; Lammertse DP, 2013, SPINAL CORD, V51, P2, DOI 10.1038/sc.2012.137; Larson SD, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00018; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Liu Y., 2019, OPEN DATA COMMONS SP, DOI [10.7295/W9HQ3X20, DOI 10.7295/W9HQ3X20]; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Pronk TE, 2015, PEERJ, V3, DOI 10.7717/peerj.1242; Puko N., 2020, OPEN DATA COMMONS SP, DOI [10.34945/F5QP4H, DOI 10.34945/F5QP4H]; Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779; Roundtable on Environmental Health Sciences Practice R. B. on P. H. and Division P. H. H. and M. & National Academies of Sciences E., 2016, PRINCIPLES OBSTACLES; Rubel O., 2019, NWB 2 20 ACCESIBLE D, DOI [10.1101/523035, DOI 10.1101/523035]; Schmidt E., 2019, OPEN DATA COMMONS SP, DOI [10.7295/W97942VQ, DOI 10.7295/W97942VQ]; Schulz JB, 2016, J NEUROCHEM, V139, P253, DOI 10.1111/jnc.13844; Seyhan AA., 2019, TRANSL MED COMMUN, V4, P18, DOI [10.1186/s41231-019-0050-7, DOI 10.1186/S41231-019-0050-7]; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Teeters JL, 2015, NEURON, V88, P629, DOI 10.1016/j.neuron.2015.10.025; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Watzlawick R, 2019, NEUROLOGY, V93, pE40, DOI 10.1212/WNL.0000000000007718; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Whetzel PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136206; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Young W, 2002, PROG BRAIN RES, V137, P231	50	0	0	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics												10.1007/s12021-021-09533-8		AUG 2021	17	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	TU6KJ	WOS:000681142900001	34347243	hybrid			2022-02-07	
J	Ueda, R; Hara, H; Hata, J; Senoo, A				Ueda, Ryo; Hara, Hiroyoshi; Hata, Junichi; Senoo, Atsushi			White matter degeneration in diffuse axonal injury and mild traumatic brain injury observed with automatic tractography	NEUROREPORT			English	Article						diffuse axonal injury; diffusion tensor imaging; focal axonal injury; mild traumatic brain injury; TRACULA		A better understanding of white matter tract damage in patients with diffuse axonal injury (DAI) and mild traumatic brain injury (MTBI) is important to obtain an objective basis for sequelae. The purpose of this study was to clarify the characteristics of white matter tract degeneration in DAI and MTBI using automated tractography. T1-weighted and diffusion tensor imaging (DTI) was performed on seven DAI and seven MTBI patients as well as on nine healthy subjects. Automated probabilistic tractography analysis was performed using FreeSurfer and TRACULA (tracts constrained by underlying anatomy) for the reconstruction of major nerve fibers. We investigated the difference between DTI quantitative values in each white matter nerve fiber between groups and attempted to evaluate the classification accuracy of DAI and MTBI using receiver operator curve analysis. Both DAI and MTBI appeared to exhibit axonal degeneration along the nerve fiber tract in a scattered manner. The mean diffusivity of the ampulla of the corpus callosum was significantly higher in DAI than that in MTBI patients, suggesting axonal degeneration of the corpus callosum in DAI patients. Using mean diffusivity of the right cingulum-angular bundle, DAI and MTBI could be discriminated with an area under the curve of 94%. Both DAI and MTBI exhibited scattered axonal degeneration; however, DAI appeared to exhibit more pronounced axonal degeneration in the ampulla of the corpus callosum than MTBI. Our results suggest that DAI and MTBI can be accurately distinguished using DTI.	[Ueda, Ryo] Keio Univ Hosp, Off Radiat Technol, Tokyo, Japan; [Hara, Hiroyoshi] Ainomiyako Neurosurg Hosp, Neurorehabil Ctr, Osaka, Japan; [Hata, Junichi] Jikei Univ, Div Regenerat Med, Grad Sch Med, Tokyo, Japan; [Senoo, Atsushi] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan		Ueda, R (corresponding author), Keio Univ Hosp, Off Radiat Technol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	dyeorua@gmail.com					Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Ljungqvist J, 2017, BRAIN INJURY, V31, P344, DOI 10.1080/02699052.2016.1256500; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Shen H, 2013, NEUROBIOL DIS, V59, P69, DOI 10.1016/j.nbd.2013.07.007; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wisse LEM, 2015, J ALZHEIMERS DIS, V45, P1247, DOI 10.3233/JAD-142994; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	25	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 4	2021	32	11					936	941		10.1097/WNR.0000000000001688			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TE5FE	WOS:000670036000005	34132707				2022-02-07	
J	Wang, ZY; Li, J; Wang, AQ; Wang, ZY; Wang, JM; Yuan, JJ; Wei, X; Xing, F; Zhang, W; Xing, N				Wang, Zhongyu; Li, Juan; Wang, Anqi; Wang, Zhaoyang; Wang, Junmin; Yuan, Jingjing; Wei, Xin; Xing, Fei; Zhang, Wei; Xing, Na			Sevoflurane Inhibits Traumatic Brain Injury-Induced Neuron Apoptosis via EZH2-Downregulated KLF4/p38 Axis	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						sevoflurane; traumatic brain injury; enhancer of zeste homolog 2; Krappel-like factor 4; p38-mitogen-activated protein kinase pathway	P38 MAPK; CEREBRAL-ISCHEMIA; NEUROPROTECTION	Y Traumatic brain injury (TBI) is characterized by physical damage to the brain tissues, ensuing transitory or permanent neurological dysfunction featured with neuronal loss and subsequent brain damage. Sevoflurane, a widely used halogenated anesthetic in clinical settings, has been reported to alleviate neuron apoptosis in TBI. Nevertheless, the underlying mechanism behind this alleviation remains unknown, and thus was the focus of the current study. First, Feeney models were established to induce TBI in rats. Subsequently, evaluation of the modified neurological severity scores, measurement of brain water content, Nissl staining, and TUNEL assay were employed to investigate the neuroprotective effects of sevoflurane. Immunofluorescence and Western blot analysis were further applied to detect the expression patterns of apoptosis-related proteins as well as the activation of the p38-mitogen-activated protein kinase (MAPK) signaling pathway within the lesioned cortex. Additionally, a stretch injury model comprising cultured neurons was established, followed by neuron-specific enolase staining and Sholl analysis. Mechanistic analyses were performed using dual-luciferase reporter gene and chromatin immunoprecipitation assays. The results demonstrated sevoflurane treatment brought about a decrease blood-brain barrier (BBB) permeability, brain water content, brain injury and neuron apoptosis, to improve neurological function. The neuroprotective action of sevoflurane could be attenuated by inactivation of the p38-MAPK signaling pathway. Mechanistically, sevoflurane exerted an inhibitory effect on neuron apoptosis by up-regulating enhancer of zeste homolog 2 (EZH2), which targeted Krappel-like factor 4 (KLF4) and inhibited KLF4 transcription. Collectively, our findings indicate that sevoflurane suppresses neuron apoptosis induced by TBI through activation of the p38-MAPK signaling pathway via the EZH2/KLF4 axis, providing a novel mechanistic explanation for neuroprotection of sevoflurane in TBI.	[Wang, Zhongyu; Li, Juan; Wang, Anqi; Wang, Zhaoyang; Yuan, Jingjing; Wei, Xin; Xing, Fei; Zhang, Wei; Xing, Na] Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol & Perioperat Med, Zhengzhou, Peoples R China; [Wang, Junmin] Zhengzhou Univ, Basic Med Coll, Dept Human Anat, Zhengzhou, Peoples R China		Wang, ZY; Xing, N (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol & Perioperat Med, Zhengzhou, Peoples R China.	wzy781217@163.com; 16427485@qq.com					Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chen J, 2019, EUR J PHARMACOL, V857, DOI 10.1016/j.ejphar.2019.172452; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Kim HC, 2017, J NEUROSURG ANESTH, V29, P37, DOI 10.1097/ANA.0000000000000331; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Luo YJ, 2020, STROKE, V51, P3320, DOI 10.1161/STROKEAHA.120.029951; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Qi XT, 2019, ACTA PHARMACOL SIN, V40, P546, DOI 10.1038/s41401-018-0050-6; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Shao HJ, 2019, CANCER MANAG RES, V11, P8699, DOI 10.2147/CMAR.S208508; Shi CX, 2020, MOL MED REP, V21, P123, DOI 10.3892/mmr.2019.10832; Shi ZH, 2018, MED SCI MONITOR, V24, P1097, DOI 10.12659/MSM.909042; Song HG, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919600; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Wang HL, 2016, ACTA NEUROCHIR SUPPL, V121, P55, DOI 10.1007/978-3-319-18497-5_10; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Xue H, 2019, DRUG DES DEV THER, V13, P1691, DOI 10.2147/DDDT.S197325; Yamamoto H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236771; Ye Z, 2012, NEUROL SCI, V33, P239, DOI 10.1007/s10072-011-0665-6; Zhang XM, 2015, NEUROCHEM INT, V90, P1, DOI 10.1016/j.neuint.2015.06.010	25	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	AUG 4	2021	9								658720	10.3389/fcel.2021.658720			13	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	UA2DG	WOS:000684974100005					2022-02-07	
J	Wang, ZY; Li, J; Wang, AQ; Wang, ZY; Wang, JM; Yuan, JJ; Wei, X; Xing, F; Zhang, W; Xing, N				Wang, Zhongyu; Li, Juan; Wang, Anqi; Wang, Zhaoyang; Wang, Junmin; Yuan, Jingjing; Wei, Xin; Xing, Fei; Zhang, Wei; Xing, Na			Sevoflurane Inhibits Traumatic Brain Injury-Induced Neuron Apoptosis via EZH2-Downregulated KLF4/p38 Axis	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						sevoflurane; traumatic brain injury; enhancer of zeste homolog 2; Kruppel-like factor 4; p38-mitogen-activated protein kinase pathway	P38 MAPK; CEREBRAL-ISCHEMIA; NEUROPROTECTION	Traumatic brain injury (TBI) is characterized by physical damage to the brain tissues, ensuing transitory or permanent neurological dysfunction featured with neuronal loss and subsequent brain damage. Sevoflurane, a widely used halogenated anesthetic in clinical settings, has been reported to alleviate neuron apoptosis in TBI. Nevertheless, the underlying mechanism behind this alleviation remains unknown, and thus was the focus of the current study. First, Feeney models were established to induce TBI in rats. Subsequently, evaluation of the modified neurological severity scores, measurement of brain water content, Nissl staining, and TUNEL assay were employed to investigate the neuroprotective effects of sevoflurane. Immunofluorescence and Western blot analysis were further applied to detect the expression patterns of apoptosis-related proteins as well as the activation of the p38-mitogen-activated protein kinase (MAPK) signaling pathway within the lesioned cortex. Additionally, a stretch injury model comprising cultured neurons was established, followed by neuron-specific enolase staining and Sholl analysis. Mechanistic analyses were performed using dual-luciferase reporter gene and chromatin immunoprecipitation assays. The results demonstrated sevoflurane treatment brought about a decrease blood-brain barrier (BBB) permeability, brain water content, brain injury and neuron apoptosis, to improve neurological function. The neuroprotective action of sevoflurane could be attenuated by inactivation of the p38-MAPK signaling pathway. Mechanistically, sevoflurane exerted an inhibitory effect on neuron apoptosis by up-regulating enhancer of zeste homolog 2 (EZH2), which targeted Kruppel-like factor 4 (KLF4) and inhibited KLF4 transcription. Collectively, our findings indicate that sevoflurane suppresses neuron apoptosis induced by TBI through activation of the p38-MAPK signaling pathway via the EZH2/KLF4 axis, providing a novel mechanistic explanation for neuroprotection of sevoflurane in TBI.	[Wang, Zhongyu; Li, Juan; Wang, Anqi; Wang, Zhaoyang; Yuan, Jingjing; Wei, Xin; Xing, Fei; Zhang, Wei; Xing, Na] Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol & Perioperat Med, Zhengzhou, Peoples R China; [Wang, Junmin] Zhengzhou Univ, Basic Med Coll, Dept Human Anat, Zhengzhou, Peoples R China		Wang, ZY; Xing, N (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Anesthesiol & Perioperat Med, Zhengzhou, Peoples R China.	wzy781217@163.com; 16427485@qq.com					Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chen J, 2019, EUR J PHARMACOL, V857, DOI 10.1016/j.ejphar.2019.172452; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Kim HC, 2017, J NEUROSURG ANESTH, V29, P37, DOI 10.1097/ANA.0000000000000331; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Luo YJ, 2020, STROKE, V51, P3320, DOI 10.1161/STROKEAHA.120.029951; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Qi XT, 2019, ACTA PHARMACOL SIN, V40, P546, DOI 10.1038/s41401-018-0050-6; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Shao HJ, 2019, CANCER MANAG RES, V11, P8699, DOI 10.2147/CMAR.S208508; Shi CX, 2020, MOL MED REP, V21, P123, DOI 10.3892/mmr.2019.10832; Shi ZH, 2018, MED SCI MONITOR, V24, P1097, DOI 10.12659/MSM.909042; Song HG, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919600; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Wang HL, 2016, ACTA NEUROCHIR SUPPL, V121, P55, DOI 10.1007/978-3-319-18497-5_10; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Xue H, 2019, DRUG DES DEV THER, V13, P1691, DOI 10.2147/DDDT.S197325; Yamamoto H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236771; Ye Z, 2012, NEUROL SCI, V33, P239, DOI 10.1007/s10072-011-0665-6; Zhang XM, 2015, NEUROCHEM INT, V90, P1, DOI 10.1016/j.neuint.2015.06.010	25	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	AUG 4	2021	9								658720	10.3389/fcell.2021.658720			13	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	UD3WP	WOS:000687140700001	34422795	gold, Green Published			2022-02-07	
J	Abdelrahman, AS; Abbas, YA; Abdelwahab, SM; Khater, NH				Abdelrahman, Ahmed S.; Abbas, Yasser A.; Abdelwahab, Sarah M.; Khater, Nivan Hany			Potential role of susceptibility-weighted imaging in the diagnosis of non-neoplastic pediatric neurological diseases	EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE			English	Article						Pediatric; Non-neoplastic; Neurological diseases; SWI; MRI	ACUTE NECROTIZING ENCEPHALOPATHY; CLINICAL-APPLICATIONS; BRAIN	Background: This study aimed to assess the added value and current applications of SWI in the diagnosis of pediatric non-neoplastic neurological diseases, including its ability to characterize hemorrhage in various brain lesions and its important role in the evaluation of both arterial as well as venous ischemic brain lesions. Results: Forty pediatric patients with a median age of 9 years were included in our prospective study; 23 were males and 17 females. SWI had a significantly higher detection rate than conventional MRI for traumatic brain injury (TBI) lesions, hemorrhagic lesions in acute necrotizing encephalopathy (ANEC), and cavernoma lesions (p=0.005, p=0.038, and p=0.046, respectively). The sensitivity, specificity and accuracy of SWI for the detection of venous ischemic insult was 88.9%, 50%, and 76.9% respectively. SWI was significantly better than the conventional MRI (p=0.046) for the detection of chronic ischemic brain insults and ischemic lesions with added hemorrhagic components. Conclusion: SWI is a technique with reasonable acquisition time that could improve the diagnostic performance of MRI for the evaluation of various pediatric non-neoplastic neurological diseases.	[Abdelrahman, Ahmed S.; Abbas, Yasser A.; Abdelwahab, Sarah M.; Khater, Nivan Hany] Ain Shams Univ, Fac Med, Radiol Dept, Cairo, Egypt		Abdelrahman, AS (corresponding author), Ain Shams Univ, Fac Med, Radiol Dept, Cairo, Egypt.	dr_ahmedsamy@yahoo.com		S. Abdelrahman, Ahmed/0000-0003-3682-0062			Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2015, J NEUROTRAUM, V147, P235; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bosemani T, 2014, J MAGN RESON IMAGING, V40, P530, DOI 10.1002/jmri.24410; Bosemani T, 2014, J NEUROIMAGING, V24, P221, DOI 10.1111/jon.12051; Bosemani T, 2013, NEURORADIOL J, V26, P579, DOI 10.1177/197140091302600512; Chalian M, 2011, J NEURORADIOLOGY, V38, P187, DOI 10.1016/j.neurad.2010.12.006; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Duyn J, 2013, J MAGN RESON, V229, P198, DOI 10.1016/j.jmr.2012.11.013; El-Serougy LG, 2017, EGYPT J RADIOL NUC M, V48, P225, DOI 10.1016/j.ejrnm.2016.11.003; Gasparian GG, 2015, INT J STROKE, V10, P298, DOI 10.1111/ijs.12435; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hamdeh A, 2017, J NEUROTRAUM, V66, P37; Horie N, 2011, AM J NEURORADIOL, V32, P1697, DOI 10.3174/ajnr.A2568; Lawrence TP, 2017, NEUROSCI LETT, V655, P143, DOI 10.1016/j.neulet.2017.06.046; Manara R, 2006, CHILD NERV SYST, V22, P1231, DOI 10.1007/s00381-006-0076-9; Mittal Puneet, 2010, Indian J Radiol Imaging, V20, P250, DOI 10.4103/0971-3026.73530; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Ormitti F, 2010, AM J NEURORADIOL, V31, P396, DOI 10.3174/ajnr.A2058; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Robinson R, 2011, J NEUROIMAGING, V21, P309, DOI 10.1111/j.1552-6569.2010.00524.x; Sahin N, 2015, CLIN MED REV CASE RE, V2, P32, DOI [10.23937/2378-3656/1410032, DOI 10.23937/2378-3656/1410032]; Seo HE, 2010, J KOREAN MED SCI, V25, P449, DOI 10.3346/jkms.2010.25.3.449; Sinha V., 2017, IND J NEUROTRAUMA, V32, P312; Sorimachi T, 2011, NEUROL RES, V33, P314, DOI 10.1179/016164110X12644252260510; Sparcia G, 2016, J NEURORADIOLOGY, V29, P325; Sultan AYA, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00198-y; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Wu XJ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/792578	30	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES		2090-4762		EGYPT J RADIOL NUC M	Egypt. J. Radiol. Nucl. Med.	AUG 3	2021	52	1							188	10.1186/s43055-021-00572-4			12	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	TX8MS	WOS:000683341400002		gold			2022-02-07	
J	Chihi, M; Oppong, MD; Quesada, CM; Dinger, TF; Gembruch, O; Pierscianek, D; Ahmadipour, Y; Uerschels, AK; Wrede, KH; Sure, U; Jabbarli, R				Chihi, Mehdi; Oppong, Marvin Darkwah; Quesada, Carlos M.; Dinger, Thiemo Florin; Gembruch, Oliver; Pierscianek, Daniela; Ahmadipour, Yahya; Uerschels, Anne-Kathrin; Wrede, Karsten H.; Sure, Ulrich; Jabbarli, Ramazan			Role of Brain Natriuretic Peptide in the Prediction of Early Postoperative Seizures Following Surgery for Traumatic Acute Subdural Hematoma: A Prospective Study	NEUROLOGY AND THERAPY			English	Article						Brain natriuretic peptide; Early postoperative seizures; Posttraumatic seizures; Acute subdural hematoma; Biomarker; Antiepileptic drugs	RISK-FACTORS; ELECTROGRAPHIC SEIZURES; POSTTRAUMATIC SEIZURES; EPILEPTIC SEIZURES; INJURY; PROPHYLAXIS; EPIDEMIOLOGY; PHENYTOIN; MORBIDITY; MORTALITY	Introduction Brain natriuretic peptide (BNP) is a reliable biomarker in the acute phase of traumatic brain injury. However, the relationship between BNP and traumatic acute subdural hematoma (aSDH) has not yet been addressed. This study aimed to analyze BNP levels on admission in surgically treated patients and assess their relationship with early postoperative seizures (EPS) and functional outcomes. Methods Patients with unilateral traumatic aSDH who were surgically treated in our department between July 2017 and May 2020 were included in the study. BNP was preoperatively measured. Patients' neurologic condition, radiographic variables on initial cranial computed tomography, sodium serum levels on admission, and occurrence of EPS were prospectively assessed. Functional outcome was assessed using the modified Rankin Scale (mRS) at discharge and follow-up (at 2-3 months). A poor outcome was defined by a mRS score > 3. Results EPS occurred in 20 (19.6%) of 102 surgically treated patients in the final cohort on the median day 3. A significant association between EPS and a poor Glasgow Coma Scale score at the 7th postoperative day was found, which in turn independently predicted a poor functional outcome at discharge and follow-up. Nonetheless, EPS were not associated with poor functional outcomes. The multivariate analysis revealed BNP > 95.4 pg/ml (aOR = 5.7, p = 0.003), sodium < 137.5 mmol/l (aOR = 4.6, p = 0.009), and left-sided aSDH (aOR = 4.4, p = 0.020) as independent predictors of EPS. Conclusion In the early postoperative phase of traumatic aSDH, EPS were associated with worse neurologic conditions, which in turn independently predicted poor outcomes at discharge and follow-up. Although several EPS risk factors have already been elucidated, this study presents BNP as a novel reliable predictor of EPS. Further larger studies are needed to determine whether a more precise estimate of EPS risk using BNP levels can be reached.	[Chihi, Mehdi; Oppong, Marvin Darkwah; Dinger, Thiemo Florin; Gembruch, Oliver; Pierscianek, Daniela; Ahmadipour, Yahya; Uerschels, Anne-Kathrin; Wrede, Karsten H.; Sure, Ulrich; Jabbarli, Ramazan] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg & Spine Surg, Hufelandstr 55, D-45147 Essen, Germany; [Quesada, Carlos M.] Univ Duisburg Essen, Univ Hosp Essen, Ctr Epileptol, Dept Neurol, Essen, Germany		Chihi, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg & Spine Surg, Hufelandstr 55, D-45147 Essen, Germany.	mehdi.chihi@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Dinger, Thiemo/AAD-5619-2022	Wrede, Karsten/0000-0001-7076-3503; Dinger, Thiemo/0000-0002-7009-9099	Open Access Publication Fund of the University of Duisburg-Essen	We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen, which helped the authors to fund the journal's Rapid Service Fee.	Abdelalim EM, 2006, PEPTIDES, V27, P1886, DOI 10.1016/j.peptides.2006.01.001; Akbik OS, 2019, WORLD NEUROSURG, V126, pE1235, DOI 10.1016/j.wneu.2019.02.234; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Driver J, 2019, NEUROCRIT CARE, V30, P16, DOI 10.1007/s12028-018-0503-2; Dubinski D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204331; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Fugate Jennifer E, 2015, Continuum (Minneap Minn), V21, P1425, DOI 10.1212/CON.0000000000000227; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; JENNETT B, 1975, EPILEPSY NONMISSILE; JENNETT WB, 1969, LANCET, V1, P1023; JENNETT WB, 1965, BRIT MED J, V1, P1215, DOI 10.1136/bmj.1.5444.1215; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Manaka S, 2003, NEUROL MED-CHIR, V43, P589, DOI 10.2176/nmc.43.589; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Peri A, 2019, FRONT HORM RES, V52, P36, DOI 10.1159/000493235; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Porzionato A, 2010, INT REV CEL MOL BIO, V280, P1, DOI 10.1016/S1937-6448(10)80001-2; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Swadron SP, 2012, NEUROCRIT CARE, V17, P112, DOI 10.1007/s12028-012-9760-7; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Won SY, 2017, WORLD NEUROSURG, V101, P416, DOI 10.1016/j.wneu.2017.02.024; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; Young GB, 1996, NEUROLOGY, V47, P83	49	0	0	3	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	2193-8253	2193-6536		NEUROL THER	Neurol. Ther.	DEC	2021	10	2					847	863		10.1007/s40120-021-00269-w		AUG 2021	17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WS1UR	WOS:000680810700001	34342872	gold, Green Published			2022-02-07	
J	Miyajima, H; Itokazu, T; Tanabe, S; Yamashita, T				Miyajima, Hisao; Itokazu, Takahide; Tanabe, Shogo; Yamashita, Toshihide			Interleukin-17A regulates ependymal cell proliferation and functional recovery after spinal cord injury in mice	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; GLIAL SCAR; T-CELLS; EXPRESSION; DIFFERENTIATION; INHIBITION; IL-17	Ependymal cells have been suggested to act as neural stem cells and exert beneficial effects after spinal cord injury (SCI). However, the molecular mechanism underlying ependymal cell regulation after SCI remains unknown. To examine the possible effect of IL-17A on ependymal cell proliferation after SCI, we locally administrated IL-17A neutralizing antibody to the injured spinal cord of a contusion SCI mouse model, and revealed that IL-17A neutralization promoted ependymal cell proliferation, which was paralleled by functional recovery and axonal reorganization of both the corticospinal tract and the raphespinal tract. Further, to test whether ependymal cell-specific manipulation of IL-17A signaling is enough to affect the outcomes of SCI, we generated ependymal cell-specific conditional IL-17RA-knockout mice and analyzed their anatomical and functional response to SCI. As a result, conditional knockout of IL-17RA in ependymal cells enhanced both axonal growth and functional recovery, accompanied by an increase in mRNA expression of neurotrophic factors. Thus, Ependymal cells may enhance the regenerative process partially by secreting neurotrophic factors, and IL-17A stimulation negatively regulates this beneficial effect. Molecular manipulation of ependymal cells might be a viable strategy for improving functional recovery.	[Miyajima, Hisao; Yamashita, Toshihide] Osaka Univ, Grad Sch Frontier Biosci, Dept Mol Neurosci, Suita, Osaka, Japan; [Itokazu, Takahide; Tanabe, Shogo; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Itokazu, Takahide; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Neuromed Sci, Suita, Osaka, Japan; [Tanabe, Shogo; Yamashita, Toshihide] Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Mol Neurosci, Suita, Osaka, Japan		Yamashita, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Mol Neurosci, Suita, Osaka, Japan.; Itokazu, T; Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.; Itokazu, T; Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Neuromed Sci, Suita, Osaka, Japan.; Yamashita, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Mol Neurosci, Suita, Osaka, Japan.	t.itokazu@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp		Itokazu, Takahide/0000-0003-2977-7190; Yamashita, Toshihide/0000-0003-4559-7018	AMED-CREST [18gm1210005h0001]; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP21K07459]	We are grateful to Dr. Jonas Frisen (Karolinska Institute) for providing FoxJ1-CreER<SUP>T2</SUP>::R26R-tdTomato mice, and Dr. Masashi Fujitani (Shimane University) for helpful suggestions. This work was supported by AMED-CREST (18gm1210005h0001) to T.Y., and JSPS KAKENHI Grant number JP21K07459 to T.I.	Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Becker CG, 2018, PROG NEUROBIOL, V170, P67, DOI 10.1016/j.pneurobio.2018.04.002; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Duncan GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05473-1; Fischer I, 2020, NAT REV NEUROSCI, V21, P366, DOI 10.1038/s41583-020-0314-2; Gao L, 2020, NEURAL REGEN RES, V15, P1350, DOI 10.4103/1673-5374.272614; Griffin JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911505; Harvey AR, 2015, BRAIN RES, V1619, P36, DOI 10.1016/j.brainres.2014.10.049; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P432, DOI 10.1089/scd.2011.0242; Hill F, 2011, NEUROSCI LETT, V487, P363, DOI 10.1016/j.neulet.2010.10.057; Hill RL, 2009, J NEUROTRAUM, V26, P1, DOI 10.1089/neu.2008.0543; Ishii H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.106; Ito S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0303-18.2018; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lacroix S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085916; Lee CM, 2020, P NATL ACAD SCI USA, V117, P19578, DOI 10.1073/pnas.1918883117; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Li XF, 2016, EBIOMEDICINE, V13, P55, DOI 10.1016/j.ebiom.2016.10.035; Li ZC, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-20; Lilley E, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113273; Liu Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep07554; Llorens-Bobadilla E, 2020, SCIENCE, V370, P73, DOI 10.1126/science.abb8795; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Paniagua-Torija B, 2018, J PATHOL, V246, P415, DOI 10.1002/path.5151; Perrin FE, 2019, EXP NEUROL, V318, P174, DOI 10.1016/j.expneurol.2019.05.007; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Ren YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41122; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zhang QH, 2021, IMMUNOLOGY, V162, P179, DOI 10.1111/imm.13265; Zhang SX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0543-8; Zong SH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/786947	56	0	0	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 3	2021	12	8							766	10.1038/s41419-021-04064-1			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	TZ6YO	WOS:000684616900001	34344859	Green Published, gold			2022-02-07	
J	Yao, SHW; Chong, SL; James, V; Lee, KP; Ong, GYK				Yao, Sarah Hui Wen; Chong, Shu-Ling; James, Vigil; Lee, Khai Pin; Ong, Gene Yong-Kwang			Associations of initial haemodynamic profiles and neurological outcomes in children with traumatic brain injury: a secondary analysis	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						emergency care systems; emergency departments; paediatric emergency med; paediatrics; paediatric resuscitation; trauma; head	BLOOD-PRESSURE; SHOCK INDEX; MORTALITY; AGE; HYPOTENSION; MORBIDITY	Introduction Initial low systolic blood pressure (SBP) in paediatric traumatic brain injury (TBI) is associated with mortality. There is limited literature on how other haemodynamic parameters including heart rate (HR); diastolic blood pressure (DBP); mean arterial pressure (MAP); and shock index, paediatric age-adjusted (SIPA) affect not only mortality but also long-term neurological outcomes in paediatric TBI. We aimed to analyse the associations of these haemodynamic variables (HR, SBP, MAP, DBP and SIPA) with mortality and long-term neurological outcomes in isolated moderate-to-severe paediatric TBI. Methods This was a secondary analysis of our primary study that analysed the association of TBI-associated coagulopathy with mortality and neurological outcome in isolated, moderate-to-severe paediatric head injury. A trauma registry-based, retrospective study of children <18 years old who presented to the emergency department with isolated, moderate-to-severe TBI from January 2010 to December 2016 was conducted. The association between initial haemodynamic variables and less favourable outcomes using Glasgow Outcome Scale-Extended Paediatric) at 6 months post injury was analysed using logistic regression. Results Among 152 children analysed, initial systolic and diastolic hypotension (<5th percentile) (OR) for SBP 11.40, 95% CI 3.60 to 36.05, p<0.001; OR for DBP 15.75, 95% CI 3.09 to 80.21, p<0.001) and Glasgow Coma Scale scores <8 (OR 14.50, 95% CI 3.65 to 57.55, p<0.001) were associated with 'moderate-to-severe neurological disabilities', 'vegetative state' and 'death'. After adjusting for confounders, only SBP was significant (adjusted OR 5.68, 95% CI 1.40 to 23.08, p=0.015). Conclusions Initial systolic hypotension was independently associated with mortality and moderate-to-severe neurological deficits at 6 months post injury. Further work is required to understand if early correction of hypotension will improve long-term outcomes.	[Yao, Sarah Hui Wen; Chong, Shu-Ling; James, Vigil; Lee, Khai Pin; Ong, Gene Yong-Kwang] KK Womens & Childrens Hosp, Childrens Emergency, Singapore, Singapore; [Chong, Shu-Ling; Lee, Khai Pin; Ong, Gene Yong-Kwang] Duke NUS Med Sch, Dept Emergency Med, Singapore, Singapore		Yao, SHW (corresponding author), KK Womens & Childrens Hosp, Childrens Emergency, Singapore, Singapore.	sarahyaohuiwen@gmail.com	Ong, Gene/W-3154-2019	Ong, Gene/0000-0002-9879-0594			Acker SN, 2017, SURGERY, V161, P803, DOI 10.1016/j.surg.2016.08.050; Annoni F, 2018, RESUSCITATION, V130, P167, DOI 10.1016/j.resuscitation.2018.07.017; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Berg RA, 2018, CIRCULATION, V137, P1784, DOI 10.1161/CIRCULATIONAHA.117.032270; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Erickson SL, 2021, NEUROCRIT CARE, V34, P1017, DOI 10.1007/s12028-020-01121-z; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3035; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; James V, 2020, J NEUROSURG-PEDIATR, V25, P663, DOI 10.3171/2019.12.PEDS19531; Johnson MA, 2018, WEST J EMERG MED, V19, P452, DOI 10.5811/westjem.2018.2.36404; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; NICE, 2003, HEAD INJ TRIAG ASS I; Nordin A, 2018, J PEDIATR SURG, V53, P130, DOI 10.1016/j.jpedsurg.2017.10.023; Rosario BL, 2018, PEDIATR CRIT CARE ME, V19, P957, DOI 10.1097/PCC.0000000000001676; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Vandewalle RJ, 2018, J PEDIATR SURG, V53, P362, DOI 10.1016/j.jpedsurg.2017.10.045; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	24	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2020-210641		AUG 2021	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XF8FG	WOS:000724301700001	34344733				2022-02-07	
J	Faulkner, JW; Snell, DL; Theadom, A; Mahon, S; Barker-Collo, S; Skirrow, P				Faulkner, Josh W.; Snell, Deborah L.; Theadom, Alice; Mahon, Susan; Barker-Collo, Suzanne; Skirrow, Paul			Psychological flexibility in mild traumatic brain injury: an evaluation of measures	BRAIN INJURY			English	Article						Mild traumatic brain injury; psychological flexibility; psychometrics; post-concussion symptoms	FUNCTIONAL DIMENSIONAL APPROACH; EXPERIENTIAL AVOIDANCE; COMMITMENT THERAPY; ACCEPTANCE; DEPRESSION; ANXIETY; PSYCHOGENESIS; PHYSIOGENESIS; INFLEXIBILITY; MINDFULNESS	Primary objective: In this study, we examined the psychometric properties of measures of psychological flexibility in a mild traumatic brain injury (mTBI) sample. Method and Procedures: Adults who sustained a mTBI (n = 112) completed the Acceptance and Action Questionnaire - Acquired Brain Injury reactive avoidance subscale (AAQ-ABI (RA). Exploratory factor analysis and Rasch analysis were conducted to evaluate the facture structure, dimensionality, and differential item functioning. Construct validity was determined by correlating the AAQ-ABI (RA) with the Acceptance and Action Questionnaire-Revised (AAQ-II) and Fear Avoidance after Traumatic Brain Injury (FAB-TBI). Main outcome and Results: The AAQ-ABI (RA) was found to have strong internal consistency (Cronbach's alpha = 0.87). Consistent with previous findings, the AAQ-ABI (RA) had one distinct factor. Fit to the unidimensional Rasch model was adequate (chi(2) (18) = 22.5, p = .21) with no evidence of differential item functioning across person factors examined. The AAQ-ABI (RA) also had expected relationships with theoretically relevant constructs. Conclusions: The AAQ-ABI (RA) appears to be a psychometrically sound measure of psychological flexibility in mTBI.	[Faulkner, Josh W.] Massey Univ, Sch Psychol, Wellington, New Zealand; [Snell, Deborah L.] Univ Otago, Univ Otago Christchurch, Christchurch, New Zealand; [Theadom, Alice; Mahon, Susan] Auckland Univ Technol, TBI Network, Univ Technol, Auckland, New Zealand; [Barker-Collo, Suzanne] Auckland Univ, Auckland, New Zealand; [Skirrow, Paul] Univ Otago, Univ Otago Wellington, Wellington, New Zealand		Faulkner, JW (corresponding author), Massey Univ, Coll Humanities & Social Sci, Sch Psychol, Wellington 756, New Zealand.	j.faulkner1@massey.ac.nz		Snell, Deborah/0000-0003-1664-0603; Faulkner, Josh/0000-0001-9555-4628; Theadom, Alice/0000-0003-0351-6216	Health Research Council of New Zealand Foxley Clinical Fellowship [20/041]	The study was funded by a Health Research Council of New Zealand Foxley Clinical Fellowship (20/041)	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Andrich D, 2015, EDUC PSYCHOL MEAS, V75, P185, DOI 10.1177/0013164414534258; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bohlmeijer ET, 2011, BEHAV RES THER, V49, P62, DOI 10.1016/j.brat.2010.10.003; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Faulkner JW, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110141; Gloster AT, 2011, PSYCHOL ASSESSMENT, V23, P970, DOI 10.1037/a0024135; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes S.C., 2011, ACCEPTANCE COMMITMEN; Hayes S. C., 2009, ACCEPTANCE COMMITMEN; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hayes SC, 2019, BEHAV RES THER, V117, P40, DOI 10.1016/j.brat.2018.10.005; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Houghton DC, 2014, PSYCHIAT RES, V220, P356, DOI 10.1016/j.psychres.2014.08.003; IBM Corporation, 2016, BM SPSS STAT MAC VER; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kashdan TB, 2020, PSYCHOL ASSESSMENT, V32, P829, DOI 10.1037/pas0000834; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Leonidou C, 2019, J HEALTH PSYCHOL, V24, P175, DOI 10.1177/1359105316666657; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luo G, RUMM 2030; Luoma J, 2011, ADDICT RES THEORY, V19, P3, DOI 10.3109/16066359.2010.524956; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Mantua J, 2019, BRAIN INJURY, V33, P1467, DOI 10.1080/02699052.2019.1646434; Masuda A, 2012, J EVID-BASED INTEGR, V17, P66, DOI 10.1177/2156587211423400; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McWhorter J, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI [10.1080/23279095.2019, DOI 10.1080/23279095.2019]; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Mitchell-Parker K, 2018, AUST J PSYCHOL, V70, P258, DOI 10.1111/ajpy.12192; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Ong CW, 2019, J CONTEXT BEHAV SCI, V12, P329, DOI 10.1016/j.jcbs.2019.02.007; Ost LG, 2014, BEHAV RES THER, V61, P105, DOI 10.1016/j.brat.2014.07.018; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Rasch G, STUDIES MATH PSYCHOL; Rochefort C, 2018, BEHAV THER, V49, P435, DOI 10.1016/j.beth.2017.08.008; Rolffs JL, 2018, ASSESSMENT, V25, P458, DOI 10.1177/1073191116645905; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Streiner DL., 2020, GUIDE STAT PERPLEXED, P110; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sylvester M, 2011, ACCEPTANCE COMMITMEN; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tyndall I, 2019, J CONTEXT BEHAV SCI, V12, P278, DOI 10.1016/j.jcbs.2018.09.005; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Weiss DS, CROSS CULTURAL ASSES, P219; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wolgast M, 2014, BEHAV THER, V45, P831, DOI 10.1016/j.beth.2014.07.002; Yehene E, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI 10.1080/23279095.2019.1569523	66	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1103	1111		10.1080/02699052.2021.1959062		AUG 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000679854700001	34334064				2022-02-07	
J	Ghazi, K; Wu, SJ; Zhao, W; Ji, SB				Ghazi, Kianoosh; Wu, Shaoju; Zhao, Wei; Ji, Songbai			Effective Head Impact Kinematics to Preserve Brain Strain	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Traumatic brain injury; Convolutional neural network; Finite element model; Worcester Head Injury Model	INJURY; ACCELERATIONS; PREDICTORS; RESPONSES	Conventional kinematics-based brain injury metrics often approximate peak maximum principal strain (MPS) of the whole brain but ignore the anatomical location of occurrence. In this study, we develop effective impact kinematics consisting of peak rotational velocity and the associated rotational axis to preserve not only peak MPS but also spatially detailed MPS. A pre-computed brain response atlas (pcBRA) serves as a common reference. A training dataset (N = 3069) is used to develop a convolutional neural network (CNN) to automate impact simplification. When preserving peak MPS alone, the CNN-estimated effective peak rotational velocity achieves a coefficient of determination (R-2) of similar to 0.96 relative to the directly identified counterpart, far outperforming nominal peak velocity from the resultant profiles (R-2 of similar to 0.34). Impacts from a subset of data (N = 1900) are also successfully matched with pcBRA idealized impacts based on elementwise MPS, where their regression slope and Pearson correlation coefficient do not deviate from 1.0 (when identical) by more than 0.1. The CNN-estimated effective peak rotation velocity and rotational axis are sufficiently accurate for similar to 73.5% of the impacts. This is not possible for the nominal peak velocity or any other conventional injury metric. The performance may be further improved by expanding the pcBRA to include deceleration and focusing on region-wise strains. This study establishes a new avenue to reduce an arbitrary head impact into an idealized but actual ``impact mode'' characterized by triplets of basic kinematic variables. They retain specific physical interpretations of head impact and may be an advancement over state-of-the-art kinematics-based scalar metrics for more effective impact comparison in the future.	[Ghazi, Kianoosh; Wu, Shaoju; Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, 100 Inst Rd, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	WU, SHAOJU/S-1930-2019	Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]	Funding is provided by the NIH Grant R01 NS092853. The Titan X Pascal GPU used in this work was donated by the NVIDIA Corporation.	Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2021, TBI GET THE FACTS; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Huston, 1994, 20 DES AUT C P, V69, P569; Ji S, 2021, P INT RES C BIOM IMP; Ji S, 2019, P INT RES C BIOM IMP; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller LE, 2021, ANN BIOMED ENG, V49, P1083, DOI 10.1007/s10439-020-02685-9; Morfey, 2001, P 17 INT TECHN C ENH; National Operating Committee on Standards for Athletic Equipment, 2020, 02220 NOCSAE DOC ND; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Yang King H, 2006, Stapp Car Crash J, V50, P429; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	40	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2777	2790		10.1007/s10439-021-02840-w		AUG 2021	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000680348400002	34341899				2022-02-07	
J	Toro, C; Temkin, N; Barber, J; Manley, G; Jain, S; Ohnuma, T; Komisarow, J; Foreman, B; Korley, FK; Vavilala, MS; Laskowitz, DT; Mathew, JP; Hernandez, A; Sampson, J; James, ML; Goldstein, BA; Markowitz, AJ; Krishnamoorthy, V				Toro, Camilo; Temkin, Nancy; Barber, Jason; Manley, Geoffrey; Jain, Sonia; Ohnuma, Tetsu; Komisarow, Jordan; Foreman, Brandon; Korley, Frederick K.; Vavilala, Monica S.; Laskowitz, Daniel T.; Mathew, Joseph P.; Hernandez, Adrian; Sampson, John; James, Michael L.; Goldstein, Benjamin A.; Markowitz, Amy J.; Krishnamoorthy, Vijay		TRACK-TBI Investigators	Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Shock; Vasopressors	CEREBRAL-BLOOD-FLOW; NOREPINEPHRINE; OXYGENATION; MANAGEMENT; PRESSURE; CIRCULATION; HYPOTENSION; REACTIVITY; DOPAMINE; SCALE	Background Early hypotension following moderate to severe traumatic brain injury (TBI) is associated with increased mortality and poor long-term outcomes. Current guidelines suggest the use of intravenous vasopressors to support blood pressure following TBI; however, guidelines do not specify vasopressor type, resulting in variation in clinical practice. Minimal data are available to guide clinicians on optimal early vasopressor choice to support blood pressure following TBI. Therefore, we conducted a multicenter study to examine initial vasopressor choice for the support of blood pressure following TBI and its association with clinical and functional outcomes after injury. Methods We conducted a retrospective cohort study of patients enrolled in the transforming research and clinical knowledge in traumatic brain injury (TRACK-TBI) study, an 18-center prospective cohort study of patients with TBI evaluated in participating level I trauma centers. We examined adults with moderate to severe TBI (defined as Glasgow Coma Scale score < 13) who were admitted to the intensive care unit and received an intravenous vasopressor within 48 h of admission. The primary exposure was initial vasopressor choice (phenylephrine versus norepinephrine), and the primary outcome was 6-month Glasgow Outcomes Scale Extended (GOSE), with the following secondary outcomes: length of hospital stay, length of intensive care unit stay, in-hospital mortality, new requirement for dialysis, and 6-month Disability Rating Scale. Regression analysis was used to assess differences in outcomes between patients exposed to norepinephrine versus phenylephrine, with propensity weighting to address selection bias due to the nonrandom allocation of the treatment groups and patient dropout. Results The final study sample included 156 patients, of whom 79 (51%) received norepinephrine, 69 (44%) received phenylephrine, and 8 (5%) received an alternate drug as their initial vasopressor. 121 (77%) of patients were men, with a mean age of 43.1 years. Of patients receiving norepinephrine as their initial vasopressor, 32% had a favorable outcome (GOSE 5-8), whereas 40% of patients receiving phenylephrine as their initial vasopressor had a favorable outcome. Compared with phenylephrine, exposure to norepinephrine was not significantly associated with improved 6-month GOSE (weighted odds ratio 1.40, 95% confidence interval 0.66-2.96, p = 0.37) or any secondary outcome. Conclusions The majority of patients with moderate to severe TBI received either phenylephrine or norepinephrine as first-line agents for blood pressure support following brain injury. Initial choice of norepinephrine, compared with phenylephrine, was not associated with improved clinical or functional outcomes.	[Toro, Camilo; Ohnuma, Tetsu; James, Michael L.; Krishnamoorthy, Vijay] Duke Univ, Crit Care & Perioperat Populat Hlth Res Unit, Dept Anesthesiol, Durham, NC 27708 USA; [Toro, Camilo] Duke Univ, Sch Med, Durham, NC USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Temkin, Nancy; Barber, Jason] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Manley, Geoffrey; Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Jain, Sonia] Univ Calif San Francisco, Biostat Res Ctr, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, San Diego, CA 94143 USA; [Ohnuma, Tetsu; Laskowitz, Daniel T.; Mathew, Joseph P.; James, Michael L.; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA; [Komisarow, Jordan; Laskowitz, Daniel T.; Sampson, John] Duke Univ, Dept Neurosurg, Durham, NC USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabilitat Med, Cincinnati, OH USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC USA; [Goldstein, Benjamin A.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Krishnamoorthy, Vijay] Duke Univ, Dept Populat Hlth Sci, Durham, NC 27708 USA		Krishnamoorthy, V (corresponding author), Duke Univ, Crit Care & Perioperat Populat Hlth Res Unit, Dept Anesthesiol, Durham, NC 27708 USA.; Krishnamoorthy, V (corresponding author), Duke Univ, Dept Anesthesiol, Durham, NC 27708 USA.; Krishnamoorthy, V (corresponding author), Duke Univ, Dept Populat Hlth Sci, Durham, NC 27708 USA.	vijay.krishnamoorthy@duke.edu		Komisarow, Jordan/0000-0003-3919-7931; Ohnuma, Tetsu/0000-0002-2303-6802	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	Dr. Krishnamoorthy received support for this study from the National Institute of Neurological Disorders and Stroke.	Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; Brassard P, 2017, AUTON NEUROSCI-BASIC, V207, P37, DOI 10.1016/j.autneu.2017.05.003; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; Dhillon NK, 2020, AM J SURG, V220, P1498, DOI 10.1016/j.amjsurg.2020.09.016; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; ElMasry WS, 1996, SPINE, V21, P614, DOI 10.1097/00007632-199603010-00015; Froese L, 2021, NEUROCRIT CARE, V34, P325, DOI 10.1007/s12028-020-01003-4; Gamper G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub4; Howell MD, 2017, JAMA-J AM MED ASSOC, V317, P847, DOI 10.1001/jama.2017.0131; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Jentzer JC, 2015, J CARDIOVASC PHARM T, V20, P249, DOI 10.1177/1074248414559838; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kramer AH, 2019, NEUROCRIT CARE, V30, P51, DOI 10.1007/s12028-018-0570-4; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lloyd-Donald P, 2020, INJURY, V51, P2129, DOI 10.1016/j.injury.2020.07.054; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Pochard J, 2021, NEUROCRIT CARE, V34, P974, DOI 10.1007/s12028-020-01092-1; Prevention CfDC, 2019, SURV REP TRAUM BRAIN SURV REP TRAUM BRAIN; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; ter Laan M, 2013, BRIT J ANAESTH, V111, P361, DOI 10.1093/bja/aet122; Thorup L, 2020, J NEUROSURG ANESTH, V32, P18, DOI 10.1097/ANA.0000000000000596; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	41	0	0	2	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01280-7		AUG 2021	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TT4MO	WOS:000680324500001	34341913				2022-02-07	
J	Whiting, DL; Chuah, SL; Simpson, GK; Deane, FP; Reynolds, J				Whiting, Diane L.; Chuah, Sarah L.; Simpson, Grahame K.; Deane, Frank P.; Reynolds, Julia			Video-consulting to address mental health needs after traumatic brain injury: evaluation of a training workshop to build capacity among psychologists	BRAIN INJURY			English	Article						Clinician training; traumatic brain injury; misconceptions; telehealth; cognitive behavioral therapy; implementation	COGNITIVE-BEHAVIORAL THERAPY; COMMUNITY-DWELLING ADULTS; PREVALENCE; ACCESS; MISCONCEPTIONS; COMORBIDITIES; INDIVIDUALS; PERCEPTIONS; DEPRESSION; SURVIVORS	Background Traumatic brain injury (TBI) can lead to significant psychological distress, but few psychologists in Australia are trained in working with this complex clinical group. Despite government funding to provide video-consulting (VC) services in Australia, uptake before COVID-19 was limited. Objective This mixed methods study evaluated whether training in eHealth and evidence based TBI psychological therapies increased provider uptake of VC in clinical practice, and delivery of mental health services to individuals with TBI. Methods Mental health professionals completed a range of self-report measures before (n = 50), after (n = 48), and four months following (n = 30) a one-day workshop. Participants' TBI knowledge, client-base and levels of access, confidence, motivation and attitudes toward VC were assessed. Knowledge did not increase after training but participants had significant increases in their confidence and motivation to using VC at follow up. Significant reductions in pragmatic barriers to using VC were reported post training and at follow up, all barrier categories indicated significant reductions. There was no significant change in clinical practice of the participants. Conclusions Training to increase TBI knowledge requires specific assessment tools and although training appears to reduce barriers to using VC, uptake in clinical practice may require additional supervision and warrants further research.	[Whiting, Diane L.; Chuah, Sarah L.; Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, Australia; [Whiting, Diane L.; Deane, Frank P.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Sch Med, Sydney, NSW, Australia; [Reynolds, Julia] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia		Whiting, DL (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool, Australia.; Whiting, DL (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.	Diane.whiting@health.nsw.gov.au		Simpson, Grahame/0000-0001-8156-9060; Whiting, Diane/0000-0003-1912-6626; Chuah, Sarah/0000-0002-5446-3874; reynolds, julia/0000-0001-9910-0455	icare NSW, Australia	The project was funded by icare NSW, Australia	Adler G, 2014, TELEMED E-HEALTH, V20, P83, DOI 10.1089/tmj.2013.0085; Australian Government Services Australia, 2020, MED IT REP; Australian Institute of Health and Welfare, 2019, MENTAL HLTH SERVICES; Australian Psychological Society (APS), 2018, EVIDENCE BASED PSYCH, V4th; Australian Psychological Society (APS), 2020, TEL MEAS IMPR ACC PS; Bashshur RL, 2016, TELEMED E-HEALTH, V22, P87, DOI 10.1089/tmj.2015.0206; Bearman SK, 2013, ADM POLICY MENT HLTH, V40, P518, DOI 10.1007/s10488-013-0485-5; Becker EM, 2013, BEHAV THER, V44, P614, DOI 10.1016/j.beth.2013.05.002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bradford NK, 2016, RURAL REMOTE HEALTH, V16; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Bryant E, 2020, BRAIN INJURY, V34, P1150, DOI 10.1080/02699052.2020.1795721; Cipolletta S, 2018, PSYCHOTHER RES, V28, P909, DOI 10.1080/10503307.2016.1259533; Connolly SL, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12311; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Department of Health, 2020, COVID 19 TEMP MBS TE; Department of Health, 2019, BETT ACC TEL IN RUR; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Feijt MA, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9485; Fereday J., 2006, INT J QUAL METHODS, V5, P80, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]; Fletcher TL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0922-y; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gallagher M, 2019, NEUROPSYCHOL REHABIL, V29, P1, DOI 10.1080/09602011.2016.1258367; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Herschell AD, 2010, CLIN PSYCHOL REV, V30, P448, DOI 10.1016/j.cpr.2010.02.005; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jenkins-Guarnieri MA, 2015, TELEMED E-HEALTH, V21, P652, DOI 10.1089/tmj.2014.0165; Knott V, 2020, AUST PSYCHOL, V55, P606, DOI 10.1111/ap.12464; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Mahmoud H, 2019, PSYCHIAT ANN, V49, P82, DOI 10.3928/00485713-20181228-02; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Mckinlay A, 2019, DISABIL REHABIL, V41, P1419, DOI 10.1080/09638288.2018.1429500; Meadows GN, 2015, MED J AUSTRALIA, V202, P190, DOI 10.5694/mja14.00330; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Nickerson A, 2018, MENTAL HLTH REFUGEE, P373; Norwood C, 2018, CLIN PSYCHOL PSYCHOT, V25, P797, DOI 10.1002/cpp.2315; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; Ottman KE, 2020, BEHAV RES THER, V130, DOI 10.1016/j.brat.2019.103531; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2020, J INT NEUROPSYCH SOC, V26, P47, DOI 10.1017/S135561771900078X; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Perle JG, 2014, J TECHNOL HUMAN SERV, V32, P158, DOI 10.1080/15228835.2014.894488; Perry K, 2020, J CLIN PSYCHOL, V76, P1125, DOI 10.1002/jclp.22770; Pierce BS, 2020, J CLIN PSYCHOL, V76, P1135, DOI 10.1002/jclp.22851; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Renn BN, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0077-1; Reynolds J, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4200; Roundhill S. J., 2007, QUALITATIVE RES PSYC, V4, P241, DOI [DOI 10.1080/14780880701473540, 10.1080/14780880701473540]; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sandera AM, 2021, NEUROPSYCHOL REHABIL, V31, P1105, DOI 10.1080/09602011.2020.1762670; Scott SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-70; Shore JH, 2007, PSYCHIAT SERV, V58, P830, DOI 10.1176/appi.ps.58.6.830; Simms DC, 2011, CAN PSYCHOL, V52, P41, DOI 10.1037/a0022275; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Simpson S, 2014, AUST J RURAL HEALTH, V22, P306, DOI 10.1111/ajr.12103; Tate RL, 2020, BRAIN INJURY, V34, P991, DOI 10.1080/02699052.2020.1764101; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Wilson A, 2020, VALUE HEALTH REG ISS, V21, P69, DOI 10.1016/j.vhri.2019.07.007; Wong DN, 2020, INT J COGN THER, V13, P379, DOI 10.1007/s41811-020-00079-2	73	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1065	1074		10.1080/02699052.2021.1953594		AUG 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000679854200001	34334058				2022-02-07	
J	Adams, RS; Ketchum, JM; Nakase-Richardson, R; Katz, DI; Corrigan, JD				Adams, Rachel Sayko; Ketchum, Jessica M.; Nakase-Richardson, Risa; Katz, Douglas I.; Corrigan, John D.			Prevalence of Drinking Within Low-Risk Guidelines During the First 2 Years After Inpatient Rehabilitation for Moderate or Severe Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Alcohol Use; Rehabilitation	ALCOHOL-USE; SUBSTANCE-ABUSE; DRUG-USE; MODEL; OUTCOMES; HISTORY; CONSUMPTION; PATTERNS; HEALTH; ADULTS	The objective of this retrospective, longitudinal study was to investigate the prevalence of drinking within the recommended limits (i.e., low-risk drinking) after moderate/severe traumatic brain injury (TBI). Data were drawn from the National Institute on Disability, Independent Living, and Rehabilitation Research TBI Model Systems National Database, a longitudinal dataset closely representative of the US adult population requiring inpatient rehabilitation for TBI. The sample included 6348 adults with moderate or severe TBI (injured October 2006-May 2016) who received inpatient rehabilitation at a civilian TBI Model Systems center and completed the alcohol consumption items preinjury and 1 and 2 yrs postinjury. National Institute on Alcohol Abuse and Alcoholism guidelines define low-risk drinking as no more than 4 drinks per day for men or 3 drinks per day for women and no more than 14 drinks per week for men or no more than 7 drinks per week for women. Low-risk drinking was common both before and after TBI, with more than 30% drinking in the low-risk level preinjury and more than 25% at 1 and 2 yrs postinjury. Postinjury, most drinkers consumed alcohol in the low-risk level regardless of preinjury drinking level. Definitive research on the long-term outcomes of low-risk alcohol consumption after more severe TBI should be a high priority.	[Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02454 USA; [Adams, Rachel Sayko] Rocky Mt Mental Illness Res Educ & Clin Ctr, Vet Hlth Adm, Aurora, CO USA; [Ketchum, Jessica M.] Craig Hosp, Natl Data & Stat Ctr, Traumat Brain Injury Model Syst, Englewood, CO USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Traumat Brain Injury Ctr Excellence, Tampa, FL USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02454 USA.	radams@brandeis.edu; JKetchum@craighospital.org; Risa.Richardson@va.gov; dkatz@bu.edu; johncorrigan1@me.com			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [NIDILRR 90DPTB0001, 90DP0084]	Drs Corrigan and Ketchum's efforts on this project were funded in part by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR 90DPTB0001 and 90DP0084). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this report do not necessarily represent the policy of NIDILRR, ACL, or HHS and endorsement by the Federal Government should not be assumed.	Awan N, 2020, ARCH PHYS MED REHAB, V101, P797, DOI 10.1016/j.apmr.2019.10.189; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cahalan D., 1969, MONOGRAPHS RUTGERS C, V6, P260, DOI DOI 10.1093/SF/49.2; Chang HK, 2019, J AFFECT DISORDERS, V250, P21, DOI 10.1016/j.jad.2019.02.059; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1315; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; De Reuck J, 2011, CLIN NEUROL NEUROSUR, V113, P469, DOI 10.1016/j.clineuro.2011.02.004; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Engler PA, 2013, ACTA DIABETOL, V50, P93, DOI 10.1007/s00592-010-0200-x; Heymann D, 2016, CURR ALZHEIMER RES, V13, P1356, DOI 10.2174/1567205013666160603005035; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Iglesias K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244336; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T, V07; Northcote J, 2011, ALCOHOL ALCOHOLISM, V46, P709, DOI 10.1093/alcalc/agr138; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Pretz C, 2020, J HEAD TRAUMA REHAB, V35, P140, DOI 10.1097/HTR.0000000000000506; Puddey IB, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0984-1; Sherk A, 2020, J STUD ALCOHOL DRUGS, V81, P352, DOI 10.15288/jsad.2020.81.352; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X	33	0	0	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2021	100	8					815	819		10.1097/PHM.0000000000001753			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TD3VE	WOS:000669257600022	33782273				2022-02-07	
J	Alsaeedi, M; Alghamdi, H; Hayes, PE; Hogan, AM; Glennon, JD				Alsaeedi, Majidah; Alghamdi, Huda; Hayes, Phyllis E.; Hogan, Anna M.; Glennon, Jeremy D.			Efficient Sub-1 Minute Analysis of Selected Biomarker Catecholamines by Core-Shell Hydrophilic Interaction Liquid Chromatography (HILIC) with Nanomolar Detection at a Boron-Doped Diamond (BDD) Electrode	SEPARATIONS			English	Article						BDD electrode; catecholamines; core-shell particles; HILIC; rapid separation	SIMULTANEOUS ELECTROCHEMICAL DETECTION; HUMAN URINE; PARKINSONS-DISEASE; CIRCULATING CATECHOLAMINES; SILICA PARTICLES; ASCORBIC-ACID; THIN-FILMS; PERFORMANCE; HPLC; BRAIN	A rapid, sensitive method for the separation of catecholamine biomarkers (CAs), of importance in traumatic brain injury (TBI) and in Parkinson's disease (PD), has been successfully developed using hydrophilic interaction liquid chromatography (HILIC). Dopamine (DA), epinephrine (EPI), and norepinephrine (NE) are known to be three to fivefold elevated above normal in traumatic brain injury (TBI) patients. HILIC facilitates the rapid and efficient separation of these polar biomarkers, which can be poorly retained by reversed-phase liquid chromatography (RPLC), while electrochemical detection (ECD) at the boron-doped diamond (BDD) electrode provides enhanced nanomolar detection. Three HILIC columns were compared, namely the superficially porous (core-shell) Z-HILIC column and the Z-cHILIC and Z-HILIC fully porous columns. The core-shell Z-HILIC showed the highest efficiency with a rapid separation within 60 s. The HILIC method utilizing the core-shell Z-HILIC column was initially optimized for the simultaneous analysis of DA, EPI, and NE using UV detection. The advantages of using the BDD electrode over UV detection were explored, and the improved limits of detection (LODs, S/N = 3) measured were 40, 50, and 50 nM for DA, EPI, and NE, respectively. Method validation is reported in terms of the linearity, repeatability, reproducibility, and LODs. Furthermore, the proposed method was successfully applied to the real sample analysis of urinary CAs following phenylboronic acid (PBA) solid phase extraction (SPE) pretreatment.	[Alsaeedi, Majidah; Alghamdi, Huda; Hayes, Phyllis E.; Hogan, Anna M.; Glennon, Jeremy D.] Univ Coll Cork, Analyt & Biol Chem Res Facil ABCRF, Innovat Chromatog Grp, Irish Separat Sci Cluster ISSC Ireland,Sch Chem, Western Rd, Cork T12 YN60, Ireland		Glennon, JD (corresponding author), Univ Coll Cork, Analyt & Biol Chem Res Facil ABCRF, Innovat Chromatog Grp, Irish Separat Sci Cluster ISSC Ireland,Sch Chem, Western Rd, Cork T12 YN60, Ireland.	113220101@umail.ucc.ie; 113220126@umail.ucc.ie; 113222587@umail.ucc.ie; annamaria.hogan@ucc.ie; j.glennon@ucc.ie			Science Foundation IrelandScience Foundation IrelandEuropean Commission [08/SRC/B1412]; Saudi Ministry of Education and Cultural Bureau, Dublin, Ireland	This research was funded by Science Foundation Ireland, grant number (08/SRC/B1412), and the Saudi Ministry of Education and Cultural Bureau, Dublin, Ireland.	Adameova A, 2009, CAN J PHYSIOL PHARM, V87, P493, DOI [10.1139/Y09-042, 10.1139/y09-042]; Alvarez-Segura T, 2019, ANAL CHIM ACTA, V1050, P176, DOI 10.1016/j.aca.2018.11.021; Barman K, 2016, RSC ADV, V6, P99983, DOI 10.1039/c6ra19813a; Barron J, 2010, J CLIN PATHOL, V63, P669, DOI 10.1136/jcp.2009.071647; Benicka E, 2005, J LIQ CHROMATOGR R T, V28, P1453, DOI 10.1081/JLC-200058326; Bicker J, 2013, ANAL CHIM ACTA, V768, P12, DOI 10.1016/j.aca.2012.12.030; Bicker W, 2011, J CHROMATOGR A, V1218, P882, DOI 10.1016/j.chroma.2010.10.073; Birbeck JA, 2013, ANAL CHEM, V85, P7398, DOI 10.1021/ac4013144; Bouamrane P, 1996, J ELECTROANAL CHEM, V405, P95; Bouri M, 2012, TALANTA, V99, P897, DOI 10.1016/j.talanta.2012.07.053; Brycht M, 2021, BIOELECTROCHEMISTRY, V137, DOI 10.1016/j.bioelechem.2020.107646; Cabrera K, 2004, J SEP SCI, V27, P843, DOI 10.1002/jssc.200401827; Chekhonin VP, 2000, B EXP BIOL MED+, V130, P805, DOI 10.1007/BF02681952; CHOU D, 1984, JAMA-J AM MED ASSOC, V251, P2587, DOI 10.1001/jama.1984.03340430079046; Chung H, 2019, ANAL SCI, V35, P433, DOI 10.2116/analsci.18P494; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Colleran JJ, 2012, J ELECTROANAL CHEM, V667, P30, DOI 10.1016/j.jelechem.2011.12.020; DeClements R, 1997, J ELECTROCHEM SOC, V144, P856, DOI 10.1149/1.1837500; DeStefano JJ, 2012, J CHROMATOGR A, V1258, P76, DOI 10.1016/j.chroma.2012.08.036; EHRENSTROM F, 1985, LIFE SCI, V36, P867, DOI 10.1016/0024-3205(85)90211-5; Ferry Y, 2005, ELECTROANAL, V17, P113, DOI 10.1002/elan.200403069; Focke PJ, 2013, STRUCTURE, V21, P694, DOI 10.1016/j.str.2013.03.002; Fung MM, 2008, ACTA PHYSIOL, V192, P325, DOI 10.1111/j.1748-1716.2007.01809.x; Goldstein DS, 2012, BRAIN, V135, P1900, DOI 10.1093/brain/aws055; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Gosetti F., 2018, CURR CHROMATOGR, V5, P18, DOI [10.2174/2213240605666180226142319, DOI 10.2174/2213240605666180226142319]; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HAWLEY MD, 1967, J AM CHEM SOC, V89, P447, DOI 10.1021/ja00978a051; Hayes PE, 2020, J CHROMATOGR A, V1612, DOI 10.1016/j.chroma.2019.460649; Hayes R, 2014, J CHROMATOGR A, V1357, P36, DOI 10.1016/j.chroma.2014.05.010; Huang X, 2019, ARAB J CHEM, V12, P1159, DOI 10.1016/j.arabjc.2014.11.038; Ivandini TA, 2005, DIAM RELAT MATER, V14, P2133, DOI 10.1016/j.diamond.2005.08.022; Kim AR, 2019, ACTA NATURAE, V11, P99, DOI 10.32607/20758251-2019-11-4-99-103; Kirkland Joseph J, 2013, J Pharm Anal, V3, P303, DOI 10.1016/j.jpha.2013.02.005; Kobayashi H, 2006, ANAL SCI, V22, P491, DOI 10.2116/analsci.22.491; Konieczna L, 2016, J CHROMATOGR A, V1431, P111, DOI 10.1016/j.chroma.2015.12.062; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Kumar A, 2011, J CHROMATOGR A, V1218, P3854, DOI 10.1016/j.chroma.2011.04.034; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Langsi VK, 2017, J CHROMATOGR A, V1506, P37, DOI 10.1016/j.chroma.2017.05.004; LAVERTY R, 1978, DRUGS, V16, P418, DOI 10.2165/00003495-197816050-00003; Machida M, 2006, J CHROMATOGR B, V830, P249, DOI 10.1016/j.jchromb.2005.10.047; McCalley DV, 2007, J CHROMATOGR A, V1171, P46, DOI 10.1016/j.chroma.2007.09.047; McCalley DV, 2010, J CHROMATOGR A, V1217, P3408, DOI 10.1016/j.chroma.2010.03.011; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Miekus N, 2017, TRANSL NEUROSCI, V8, P70, DOI 10.1515/tnsci-2017-0012; Nikolajsen RPH, 2001, ANAL CHIM ACTA, V449, P1, DOI 10.1016/S0003-2670(01)01358-7; Olivares-Hernandez A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020254; Pan XF, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00184; Patel D, 2020, ANN SURG ONCOL, V27, P1329, DOI 10.1245/s10434-020-08220-3; Peitzsch M, 2013, CLIN CHIM ACTA, V418, P50, DOI 10.1016/j.cca.2012.12.031; Rao TN, 2000, J ELECTROANAL CHEM, V491, P175, DOI 10.1016/S0022-0728(00)00208-4; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Ruta J, 2010, J SEP SCI, V33, P2465, DOI 10.1002/jssc.201000023; Sarada BV, 2000, ANAL CHEM, V72, P1632, DOI 10.1021/ac9908748; Sawada H, 2013, DIAGNOSTICS, V3, P210, DOI 10.3390/diagnostics3020210; Shen Y., 2019, PARAGANGLIOMA MULTID; Sochr J, 2014, DIAM RELAT MATER, V43, P5, DOI 10.1016/j.diamond.2014.01.005; Song J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00065; SPEEK AJ, 1983, CLIN CHIM ACTA, V128, P103, DOI 10.1016/0009-8981(83)90060-8; Swain GM, 1998, MRS BULL, V23, P56, DOI 10.1557/S0883769400029389; Terashima C, 2002, ANAL CHEM, V74, P895, DOI 10.1021/ac010681w; Thomas DH, 2008, CLIN CHIM ACTA, V398, P63, DOI 10.1016/j.cca.2008.08.013; Trifonova OP, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050339; van Faassen M, 2020, ANAL CHEM, V92, P9072, DOI 10.1021/acs.analchem.0c01263; Vermeiren Y, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00595; Wagner BM, 2012, J CHROMATOGR A, V1264, P22, DOI 10.1016/j.chroma.2012.09.052; Wei M, 2008, ADV FUNCT MATER, V18, P1414, DOI 10.1002/adfm.200701099; Whiting MJ, 2009, ANN CLIN BIOCHEM, V46, P129, DOI 10.1258/acb.2008.008180; WU AHB, 1985, CLIN CHEM, V31, P298; Xu XD, 2012, ANAL BIOCHEM, V427, P10, DOI 10.1016/j.ab.2012.04.022; Zhang L, 2016, J PHARMACEUT BIOMED, V118, P41, DOI 10.1016/j.jpba.2015.10.020	72	0	0	9	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2297-8739		SEPARATIONS	Separations	AUG	2021	8	8							124	10.3390/separations8080124			15	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	UH7NF	WOS:000690111900001		gold			2022-02-07	
J	Alvarez, TL; Yaramothu, C; Scheiman, M; Goodman, A; Cotter, SA; Huang, K; Chen, AM; Grady, M; Mozel, AE; Podolak, OE; Koutures, CG; Master, CL				Alvarez, Tara L.; Yaramothu, Chang; Scheiman, Mitchell; Goodman, Arlene; Cotter, Susan A.; Huang, Kristine; Chen, Angela M.; Grady, Matthew; Mozel, Anne E.; Podolak, Olivia E.; Koutures, Chris G.; Master, Christina L.			Disparity vergence differences between typically occurring and concussion-related convergence insufficiency pediatric patients	VISION RESEARCH			English	Article						Convergence insufficiency; Persistence post-concussion symptoms; Eye movements; Vergence; Convergence; Near point of convergence; Amplitude of accommodation	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; SYMPTOM SURVEY; RELIABILITY; BIOMARKERS; FREQUENCY; RESPONSES; VALIDITY; POINT	This study sought to test the hypothesis that significant differences would be observed in clinical measures, symptoms, and objective assessments of vergence eye movements between children with typically developing convergence insufficiency (TYP-CI) and children with persistent post-concussion symptoms with convergence insufficiency (PPCS-CI). Data from age-matched binocularly normal controls (BNC) were used for comparison. Data from three groups of children 11 to 17 years of age are presented: BNC (N = 11), TYP-CI (N = 10), and PPCS-CI (N = 15). Clinical measures of vergence, accommodation, and symptom severity were collected. Symmetrical 4 degrees disparity vergence eye movements were quantified with an eye tracker integrated into a head-mounted display (Oculus DK2). Peak velocity and final response amplitude of convergence and divergence eye movement responses were assessed. The mean near point of convergence (break) was more receded (worse), the amplitude of accommodation more deficient, and convergent and divergent peak velocities slower in the PPCS-CI group compared with the TYP-CI and BNC groups. These results suggest that PPCS-CI may be a different clinical entity than TYP-CI. Hence, more research is warranted to determine whether the therapeutic interventions that are effective for TYP-CI can also be used for PPCS-CI populations.	[Alvarez, Tara L.; Yaramothu, Chang] New Jersey Inst Technol, Biomed Engn, 323 Martin Luther King Blvd, Newark, NJ 07102 USA; [Yaramothu, Chang] New Jersey Inst Technol, Sch Appl Engn & Technol, Newark, NJ 07102 USA; [Scheiman, Mitchell] Salus Univ, Penn Coll Optometry, Philadelphia, PA USA; [Goodman, Arlene] St Peters Univ Hosp, St Peters Sports Med Inst, Somerset, NJ USA; [Cotter, Susan A.; Huang, Kristine; Chen, Angela M.] Marshall B Ketchum Univ, Southern Calif Coll Optometry, Fullerton, CA USA; [Grady, Matthew; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Mozel, Anne E.; Podolak, Olivia E.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Koutures, Chris G.] ActiveKidMD, Anaheim, CA USA; [Master, Christina L.] Univ Penn, Sch Med, Perelman Sch Med, Philadelphia, PA 19104 USA		Alvarez, TL (corresponding author), New Jersey Inst Technol, Biomed Engn, 323 Martin Luther King Blvd, Newark, NJ 07102 USA.	tara.l.alvarez@njit.edu; chang.yaramothu@njit.edu; mscheiman@salus.edu; agoodman@saintpetersuh.com; scotter@ketchum.edu; khuang@ketchum.edu; angelachen@ketchum.edu; gradym@chop.edu; mozela@chop.edu; podolako@chop.cdu; podolako@chop.edu; chris@dockoutures.com			National Eye Institute of the National Institutes of Health NEI [R01EY023261]; National Institute of Neurologic Disease and Stroke NINDS [R01 NS097549]; Department of Health and Human Services, Bethesda, Maryland, USA; College of Optometrists in Vision Development Research Grant	Supported by the National Eye Institute of the National Institutes of Health NEI R01EY023261 to TLA, the National Institute of Neurologic Disease and Stroke NINDS R01 NS097549 to CLM, Department of Health and Human Services, Bethesda, Maryland, USA and the College of Optometrists in Vision Development Research Grant to AMC.	Alvarez T. L., 2020, OPTOMETRY VISION SCI; Alvarez TL, 2020, OPHTHAL EPIDEMIOL, V27, P52, DOI 10.1080/09286586.2019.1679192; Alvarez TL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00419; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 2010, VISION RES, V50, P2163, DOI 10.1016/j.visres.2010.08.018; Alvarez TL, 2000, VISION RES, V40, P341, DOI 10.1016/S0042-6989(99)00175-3; Alvarez TL, 2005, J VISION, V5, P640, DOI 10.1167/5.7.4; Alvarez TL, 2002, CAH PSYCHOL COGN, V21, P243; Alvarez TL, 1998, J NEUROPHYSIOL, V79, P37, DOI 10.1152/jn.1998.79.1.37; Alvarez TL, 1999, ANN BIOMED ENG, V27, P380, DOI 10.1114/1.162; Azadi P., 2021, J INJURY VIOLENCE RE, V13, DOI [10.5249/jivr.v13i1.1525, DOI 10.5249/JIVR.V13I1.1525]; BAHILL AT, 1982, BIOL CYBERN, V45, P1, DOI 10.1007/BF00387207; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; CITT-ART Investigator Grp, 2019, OPTOMETRY VISION SCI, V96, P825, DOI 10.1097/OPX.0000000000001443; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Convergence Insufficency Investigator Group, 2019, OPTOMETRY VISION SCI, V96, P836; Davis AL, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6963976; Ducic S, 1988, CAN J OPTOM, V50, P194; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Garcia-munoz A, 2016, CLIN EXP OPTOM, V99, P313, DOI 10.1111/cxo.12376; Guo Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2530; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Hussaindeen J. R., 2017, CLIN EXP OPTOM, V100, P642; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kumar AN, 2002, INVEST OPHTH VIS SCI, V43, P2626; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Master C. L., 2017, CLIN J SPORT MED, V28, P1, DOI [10.1097/JSM.0000000000000507, DOI 10.1097/JSM.0000000000000507]; Master CL, 2020, JAMA OPHTHALMOL, V138, P1135, DOI 10.1001/jamaophthalmol.2020.3466; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Munoz P, 1999, VISION RES, V39, P1695, DOI 10.1016/S0042-6989(98)00206-5; Ovenseri-Ogbomo Godwin O, 2016, J Optom, V9, P258, DOI 10.1016/j.optom.2016.01.004; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Rollett P., 2019, CANADIAN J OPTOMETRY, V81, DOI [10.15353/CJO.V81I4.1590, DOI 10.15353/CJO.V81I4.1590]; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Scheiman M, 2005, BRIT J OPHTHALMOL, V89, P1318, DOI 10.1136/bjo.2005.068197; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M., 2021, VISION RES; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Scheiman M, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006768.pub3; Scheiman M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006768.pub2; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Shaw R, 2020, CLIN MANAGEMENT BINO; Sheard, 1930, AM J OPTOM, V7, P9, DOI DOI 10.1097/00006324-193001000-00001; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Suleiman A, 2020, NEURO-OPHTHALMOLOGY, V44, P157, DOI 10.1080/01658107.2019.1653325; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wajuihian Samuel Otabor, 2016, J Optom, V9, P246, DOI 10.1016/j.optom.2015.10.006; Widmer DE, 2018, OPTOMETRY VISION SCI, V95, P505, DOI 10.1097/OPX.0000000000001221; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Yaramothu C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100257; Yaramothu C, 2019, J NEUROTRAUM, V36, P2200, DOI 10.1089/neu.2018.6075; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624	62	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	AUG	2021	185						58	67		10.1016/j.visres.2021.03.014			10	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	SR6ET	WOS:000661136600006	33895648				2022-02-07	
J	Apfeld, CJ; Crichton, GK; Minneci, CP; Puls, TH; Cooper, NJ				Apfeld, C. Jordan; Crichton, G. Kristin; Minneci, C. Peter; Puls, T. Henry; Cooper, N. Jennifer			Identification of physical abuse-related hospitalizations in young children: Impact of the transition to ICD-10-CM coding	CHILD ABUSE & NEGLECT			English	Article						Abusive head trauma; Child physical abuse; Clinical coding; Disparities; Interrupted time series analysis	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT VISITS; UNITED-STATES; HEALTH DISPARITIES; ETHNIC DISPARITIES; RACIAL-DIFFERENCES; PROTECTION REPORTS; HEAD TRAUMA; MALTREATMENT; INFANTS	Background: Administrative healthcare databases are frequently used for child physical abuse (CPA)-related research and surveillance. In October 2015, the United States transitioned to the International Classification of Diseases, Clinical Modification-10th Revision (ICD-10-CM) coding regimen. ICD-10-CM expands coding related to CPA, including codes to differentiate suspected from confirmed CPA. Objective: This study examined the impact of the transition to ICD-10-CM coding on population-level trends in rates of hospitalizations coded for CPA. Participants and settings: Hospitalizations coded as related to CPA in children <5 years-of-age from 2010 to 2017 were identified across 19 Statewide Inpatient Databases. Methods: Interrupted time series analyses were used to assess the impact of the coding transition on hospitalizations coded for CPA, overall and by child race/ethnicity. Results: Of 9715 hospitalizations coded for CPA, 2797 (29%) occurred after the coding transition, including 51% coded for suspected CPA and 49% coded for confirmed CPA. There was a marginally-significant increase in the trend in CPA-related hospitalization after the coding transition among all children (0.09 per 100,000 children-per-quarter, p = 0.06), a significant increase in the trend among white children (0.15 per 100,000 children-per-quarter, p = 0.01), and no change among Black or Hispanic children. After the coding transition, hospitalizations coded for suspected CPA increased significantly overall (0.10 per 100,000 children-per-quarter, p < 0.001), and in particular among white children (0.12 per 100,000 children-per-quarter, p = 0.01) but not among Black or Hispanic children. Conclusions: The transition to ICD-10-CM differentially impacted trends in hospitalizations coded for CPA by child race/ethnicity. Further research is necessary to discern the reasons for these discrepancies.	[Apfeld, C. Jordan; Minneci, C. Peter; Cooper, N. Jennifer] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Surg Outcomes Res, 700 Childrens Dr, Columbus, OH 43205 USA; [Apfeld, C. Jordan; Minneci, C. Peter; Cooper, N. Jennifer] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Innovat Pediat Practice, 700 Childrens Dr, Columbus, OH 43205 USA; [Crichton, G. Kristin] Nationwide Childrens Hosp, Div Child & Family Advocacy, 655 E Livingston Ave, Columbus, OH 43205 USA; [Minneci, C. Peter] Nationwide Childrens Hosp, Dept Surg, 700 Childrens Dr, Columbus, OH 43205 USA; [Puls, T. Henry] Univ Missouri Kansas City, Sch Med, Childrens Mercy Kansas City, Div Hosp Med,Dept Pediat, 2401 Gillham Rd, Kansas City, MO 64108 USA		Cooper, NJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Surg Outcomes Res, 700 Childrens Dr,FB Suite 3A-3, Columbus, OH 43205 USA.; Cooper, NJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, 700 Childrens Dr,FB Suite 3A-3, Columbus, OH 43205 USA.	jordan.apfeld@nationwidechildrens.org; kristin.crichton@nationwidechildrens.org; peter.minneci@nationwidechildrens.org; htpuls@cmh.edu; jennifer.cooper@nationwidechildrens.org			National Institute on Minority Health and Health Disparities of the National Institutes of Health [R01MD013881]	This work was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health, Award Number R01MD013881 (PI: Jennifer N. Cooper). This sponsor did not have a role in study design; collection, analysis, and/or interpretation of data; in writing of the report; and in the decision to submit this article for publication. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo-Garcia D, 2008, LATINAS/OS IN THE UNITED STATES: CHANGING THE FACE OF AMERICA, P101, DOI 10.1007/978-0-387-71943-6_7; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Anderson BL, 2014, J TRAUMA ACUTE CARE, V77, pS36, DOI 10.1097/TA.0000000000000321; Annest Joseph L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Balcazar AJ, 2015, PUBLIC HEALTH, V129, P691, DOI 10.1016/j.puhe.2015.04.007; Berger RP, 2019, J PEDIATR-US, V204, P16, DOI 10.1016/j.jpeds.2018.07.081; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Centers for Medicare and Medicaid Services (CMS) and National Center for Health Statistics (NCHS), 2020, ICD 10 CM OFF GUID C; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Cort NA, 2010, J PUBLIC HEALTH MAN, V16, P329, DOI 10.1097/PHH.0b013e3181c4d933; Crouch E, 2020, J RURAL HEALTH, V36, P55, DOI 10.1111/jrh.12366; Dakil SR, 2011, J NATL MED ASSOC, V103, P926, DOI 10.1016/S0027-9684(15)30449-1; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Drake B, 2011, PEDIATRICS, V127, P471, DOI 10.1542/peds.2010-1710; Fenton Susan H, 2014, Perspect Health Inf Manag, V11, p1g; Flaherty EG, 2006, CHILD ABUSE NEGLECT, V30, P789, DOI 10.1016/j.chiabu.2005.12.008; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Hamilton ER, 2011, DEMOGR RES, V25, P783, DOI 10.4054/DemRes.2011.25.25; Hedegaard Holly, 2016, Natl Health Stat Report, P1; Hooft AM, 2015, ACAD PEDIATR, V15, P444, DOI 10.1016/j.acap.2015.01.008; Hunter AA, 2021, INJURY PREV, V27, P251, DOI 10.1136/injuryprev-2019-043579; Hymel KP, 2018, J PEDIATR-US, V198, P137, DOI 10.1016/j.jpeds.2018.01.048; Imran S, 2019, J INVEST MED, V67, P346, DOI 10.1136/jim-2018-000858; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jud A, 2016, CHILD ADOL PSYCH MEN, V10, DOI 10.1186/s13034-016-0105-8; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Khera R, 2018, JAMA-J AM MED ASSOC, V320, P133, DOI 10.1001/jama.2018.6823; King AJ, 2015, CHILD MALTREATMENT, V20, P151, DOI 10.1177/1077559514567176; Kistin CJ, 2010, PEDIATRICS, V126, P94, DOI 10.1542/peds.2009-3446; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lariscy JT, 2015, DEMOGRAPHY, V52, P1, DOI 10.1007/s13524-014-0357-y; Lee C, 2012, J ADOLESCENT HEALTH, V50, P443, DOI 10.1016/j.jadohealth.2011.09.014; Lee JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037075; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Maguire-Jack K, 2021, TRAUMA VIOLENCE ABUS, V22, P1316, DOI 10.1177/1524838020915592; Narang SK, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0203; Palloni A, 2001, ANN NY ACAD SCI, V954, P140; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Puls HT, 2020, JAMA PEDIATR, V174, P91, DOI 10.1001/jamapediatrics.2019.3992; Puls HT, 2019, J PEDIATR-US, V205, P230, DOI 10.1016/j.jpeds.2018.09.071; Putnam-Hornstein E, 2013, CHILD ABUSE NEGLECT, V37, P33, DOI 10.1016/j.chiabu.2012.08.005; Rebbe R, 2019, J PEDIATR-US, V208, P141, DOI 10.1016/j.jpeds.2018.12.065; Rebbe R, 2019, CHILD ABUSE NEGLECT, V88, P28, DOI 10.1016/j.chiabu.2018.11.001; Reid L.D., 2020, HEALTHCARE COST UTIL; Schmeer KK, 2012, SOC SCI MED, V75, P1523, DOI 10.1016/j.socscimed.2012.05.031; Schuck AM, 2005, J MARRIAGE FAM, V67, P543, DOI 10.1111/j.1741-3737.2005.00152.x; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sheats KJ, 2018, AM J PREV MED, V55, P462, DOI 10.1016/j.amepre.2018.05.017; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Census Bureau American Community Survey (ACS), 2017, DET TABL; U.S. Census Bureau Current Population Survey, 2017, ANN SOC EC SUPPL CPS; United States Department of Health and Human Services (US DHHS), 2017, CTR DIS CONTR PREV C; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Xia X, 2012, INT J ENV RES PUB HE, V9, P4187, DOI 10.3390/ijerph9114187	60	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	AUG	2021	118								105159	10.1016/j.chiabu.2021.105159			13	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	TM3WY	WOS:000675484200019	34147940				2022-02-07	
J	Avedesian, JM; Covassin, T; Baez, S; Nash, J; Nagelhout, E; Dufek, JS				Avedesian, Jason M.; Covassin, Tracey; Baez, Shelby; Nash, Jennifer; Nagelhout, Ed; Dufek, Janet S.			Relationship Between Cognitive Performance and Lower Extremity Biomechanics: Implications for Sports-Related Concussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						reaction time; visual memory; multiple object tracking; musculoskeletal injury	ANTERIOR CRUCIATE LIGAMENT; TEST-RETEST RELIABILITY; INJURY RISK; NEUROCOGNITIVE PERFORMANCE; MUSCULOSKELETAL INJURY; NEUROMUSCULAR CONTROL; BALANCE CONTROL; REACTION-TIME; IMPACT; EPIDEMIOLOGY	Background: Collegiate athletes with prior sports-related concussion (SRC) are at increased risk for lower extremity (LE) injuries; however, the biomechanical and cognitive mechanisms underlying the SRC-LE injury relationship are not well understood. Purpose: To examine the association between cognitive performance and LE land-and-cut biomechanics among collegiate athletes with and without a history of SRC and to determine the association among multiple cognitive testing batteries in the same athlete cohort. Study Design: Controlled laboratory study. Methods: A cohort of 20 collegiate athletes with prior SRC (9 men, 11 women; mean +/- standard deviation [SD] age, 20.5 +/- 1.3 years; mean +/- SD time since last SRC, 461 +/- 263 days) and 20 matched controls (9 men, 11 women; mean +/- SD age, 19.8 +/- 1.3 years) completed land-and-cut tasks using the dominant and nondominant limbs. LE biomechanical variables and a functional visuomotor reaction time (FVMRT) were collected during each trial. Athletes also completed the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) and Senaptec Sensory Station assessments. Results: In the SRC cohort, Pearson correlation coefficients indicated slower FVMRT was moderately correlated with decreased dominant limb (r = -0.512) and nondominant limb (r = -0.500) knee flexion, while increased dominant limb knee abduction moment was moderately correlated with decreased ImPACT Visual Memory score (r = -0.539) and slower ImPACT Reaction Time (r = 0.515). Most computerized cognitive measures were not associated with FVMRT in either cohort (P > .05). Conclusion: Decreased reaction time and working memory performance were moderately correlated with decreased sagittal plane knee motion and increased frontal plane knee loading in collegiate athletes with a history of SRC. The present findings suggest a potential unique relationship between cognitive performance and LE neuromuscular control in athletes with a history of SRC injury. Last, we determined that computerized measures of cognitive performance often utilized for SRC management are dissimilar to sport-specific cognitive processes.	[Avedesian, Jason M.; Covassin, Tracey; Baez, Shelby; Nash, Jennifer; Nagelhout, Ed; Dufek, Janet S.] Michigan State Univ, E Lansing, MI 48824 USA; [Avedesian, Jason M.] Emory Sports Performance & Res Ctr, 4450 Falcon Pkwy, Flowery Branch, GA 30542 USA; [Avedesian, Jason M.; Dufek, Janet S.] Univ Nevada, Dept Kinesiol & Nutr Sci, Las Vegas, NV USA; [Covassin, Tracey; Baez, Shelby] Michigan State Univ, Dept Kinesiol, E Lansing, MI USA; [Nash, Jennifer] Univ Nevada, Dept Phys Therapy, Las Vegas, NV USA; [Nagelhout, Ed] Univ Nevada, Dept English, Las Vegas, NV USA		Avedesian, JM (corresponding author), Emory Sports Performance & Res Ctr, 4450 Falcon Pkwy, Flowery Branch, GA 30542 USA.	jason.avedesian@emory.edu			International Society of Biomechanics Matching Dissertation Grant program; AOSSM	This project received funding through the International Society of Biomechanics Matching Dissertation Grant program (to J.M.A.). AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Avedesian Jason M, 2020, Int J Exerc Sci, V13, P873; Avedesian JM, 2020, J APPL BIOMECH, V36, P313, DOI 10.1123/jab.2020-0034; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Burris K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18565-7; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Giesche F, 2020, J SCI MED SPORT, V23, P82, DOI 10.1016/j.jsams.2019.09.003; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lempke LB, 2020, MED SCI SPORT EXER, V52, P1650, DOI 10.1249/MSS.0000000000002300; Leppanen Mari, 2017, Orthop J Sports Med, V5, p2325967117745487, DOI 10.1177/2325967117745487; Leppanen M, 2017, AM J SPORT MED, V45, P386, DOI 10.1177/0363546516665810; Lisee C, 2019, CLIN BIOMECH, V70, P231, DOI 10.1016/j.clinbiomech.2019.10.012; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Lysenko-Martin MR, 2020, J NEUROTRAUM, V37, P1777, DOI 10.1089/neu.2019.6842; Markolf KL, 2004, AM J SPORT MED, V32, P1144, DOI 10.1177/0363546503262198; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald AA, 2019, J ATHL TRAINING, V54, P489, DOI 10.4085/1062-6050-152-17; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mok KM, 2018, SPORT BIOMECH, V17, P157, DOI 10.1080/14763141.2016.1260766; Monfort SM, 2019, AM J SPORT MED, V47, P1488, DOI 10.1177/0363546519834544; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Padua DA, 2009, SPORTS HEALTH, V1, P165, DOI 10.1177/1941738108330971; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; RENSTROM P, 1986, AM J SPORT MED, V14, P83, DOI 10.1177/036354658601400114; Shimokochi Y, 2009, J ATHL TRAINING, V44, P33, DOI 10.4085/1062-6050-44.1.33; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Swanik C, 2015, J ATHL TRAINING, V50, P1100, DOI 10.4085/1062-6050-50.10.08; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; WITZ K, 1990, J EDUC STAT, V15, P84; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	49	0	0	4	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG	2021	9	8							23259671211032246	10.1177/23259671211032246			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	UT2YL	WOS:000697986700001	34458386	gold, Green Published			2022-02-07	
J	Bagnato, S; D'Ippolito, ME; Boccagni, C; De Tanti, A; Lucca, LF; Nardone, A; Salucci, P; Fiorilla, T; Pingue, V; Gennaro, S; Ursino, M; Colombo, V; Barone, T; Rubino, F; Andriolo, M				Bagnato, Sergio; D'Ippolito, Maria Enza; Boccagni, Cristina; De Tanti, Antonio; Lucca, Lucia Francesca; Nardone, Antonio; Salucci, Pamela; Fiorilla, Teresa; Pingue, Valeria; Gennaro, Serena; Ursino, Maria; Colombo, Valentina; Barone, Teresa; Rubino, Francesca; Andriolo, Maria			Sustained Axonal Degeneration in Prolonged Disorders of Consciousness	BRAIN SCIENCES			English	Article						neurofilament light chain; traumatic brain injury; hypoxic-ischemic brain injury; unresponsive wakefulness syndrome; vegetative state; minimally conscious state; secondary brain injury; biomarkers of brain injury	NEUROFILAMENT LIGHT-CHAIN; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; NEURODEGENERATION; NEUROPATHOLOGY; INFLAMMATION; SCALE; STATE	(1) Background: Sustained axonal degeneration may play a critical role in prolonged disorder of consciousness (DOCs) pathophysiology. We evaluated levels of neurofilament light chain (NFL), an axonal injury marker, in patients with unresponsive wakefulness syndrome (UWS) and in the minimally conscious state (MCS) after traumatic brain injury (TBI) and hypoxic-ischemic brain injury (HIBI). (2) Methods: This prospective multicenter blinded study involved 70 patients with prolonged DOC and 70 sex-/age-matched healthy controls. Serum NFL levels were evaluated at 1-3 and 6 months post-injury and compared with those of controls. NFL levels were compared by DOC severity (UWS vs. MCS) and etiology (TBI vs. HIBI). (3) Results: Patients' serum NFL levels were significantly higher than those of controls at 1-3 and 6 months post-injury (medians, 1729 and 426 vs. 90 pg/mL; both p < 0.0001). NFL levels were higher in patients with UWS than in those in MCS at 1-3 months post-injury (p = 0.008) and in patients with HIBI than in those with TBI at 6 months post-injury (p = 0.037). (4) Conclusions: Patients with prolonged DOC present sustained axonal degeneration that is affected differently over time by brain injury severity and etiology.	[Bagnato, Sergio; Boccagni, Cristina; Fiorilla, Teresa; Rubino, Francesca] Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, Italy; [Bagnato, Sergio; Boccagni, Cristina; Fiorilla, Teresa; Rubino, Francesca] Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, Italy; [D'Ippolito, Maria Enza; Andriolo, Maria] Giuseppe Giglio Fdn, Mol Biol Lab, I-90015 Cefalu, Italy; [De Tanti, Antonio; Gennaro, Serena] Cardinal Ferrari Ctr, I-43012 Fontanellato, Italy; [Lucca, Lucia Francesca; Ursino, Maria] S Anna Inst, RAN Res Adv Neurorehabil, I-88900 Crotone, Italy; [Nardone, Antonio; Pingue, Valeria] Inst Pavia, Neurorehabil Unit, ICS Maugeri, I-27100 Pavia, Italy; [Nardone, Antonio; Pingue, Valeria] Inst Pavia, Spinal Unit, ICS Maugeri, I-27100 Pavia, Italy; [Salucci, Pamela; Colombo, Valentina] Montecatone Rehabil Inst, I-40026 Imola, Italy; [Barone, Teresa] Immunohematol & Transfus Serv, I-90015 Cefalu, Italy		Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, Italy.; Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, Italy.	sergiobagnato@gmail.com; astutapc@yahoo.it; cristina.boccagni@hsrgiglio.it; antonio.detanti@centrocardinalferrari.it; l.lucca@istitutosantanna.it; antonio.nardone@icsmaugeri.it; pamela.salucci@montecatone.com; terryfiorilla@yahoo.it; valeria.pingue@icsmaugeri.it; serena.gennaro@centrocardinalferrari.it; m.ursino@istitutosantanna.it; valentina.colombo@montecatone.com; barone.teresa@asppalermo.org; francesca.rubino@hsrgiglio.it; maria.andriolo@hsrgiglio.it	Lucca, Lucia Francesca/AAB-8558-2022; Nardone, Antonio/J-8733-2016; pingue, valeria/AAC-1833-2020; Bagnato, Sergio/H-6842-2013	Nardone, Antonio/0000-0002-9547-1774; pingue, valeria/0000-0001-9376-4699; Bagnato, Sergio/0000-0002-6289-1887; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Anesten B, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000300; Annen J, 2018, ANN NEUROL, V83, P842, DOI 10.1002/ana.25214; Bagnato S, 2020, NEURAL REGEN RES, V15, P1247, DOI 10.4103/1673-5374.272574; Bagnato S, 2020, J NEUROTRAUM, V37, P423, DOI 10.1089/neu.2019.6449; Bagnato S, 2018, BRAIN INJURY, V32, P1056, DOI 10.1080/02699052.2018.1479042; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Fyfe I, 2019, NAT REV NEUROL, V15, P557, DOI 10.1038/s41582-019-0265-2; Gafson AR, 2020, BRAIN, V143, P1975, DOI 10.1093/brain/awaa098; Gentil BJ, 2015, CELL TISSUE RES, V360, P609, DOI 10.1007/s00441-014-2082-7; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Graham NSN, 2020, BRAIN, V143, P3685, DOI 10.1093/brain/awaa316; Gunn Alistair J, 2019, Handb Clin Neurol, V162, P217, DOI 10.1016/B978-0-444-64029-1.00010-2; Hunziker S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03459-y; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lin YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35766-w; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Nielsen HH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00448; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Thouvenot E, 2020, EUR J NEUROL, V27, P251, DOI 10.1111/ene.14063; Uher T, 2021, MULT SCLER J, V27, P220, DOI 10.1177/1352458520912379; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667	44	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2021	11	8							1068	10.3390/brainsci11081068			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG0GO	WOS:000688942400001	34439687	Green Published, gold			2022-02-07	
J	Benko, N; Luke, E; Alsanea, Y; Coats, B				Benko, Nikolaus; Luke, Emma; Alsanea, Yousef; Coats, Brittany			Mechanical characterization of the human pia-arachnoid complex	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Pia-arachnoid complex; Traumatic brain injury; Brain-skull interface; Optical coherence tomography	TRAUMATIC BRAIN-INJURY; HEAD; STRAIN; IMPACT	Traumatic brain injury (TBI) is a significant problem in global health that affects a wide variety of patients. Mild forms of TBI, commonly referred to as concussion, are a result of rapid accelerations of the head from either direct or indirect impacts. Kinetic energy from the impact is transferred into deformation of the brain, leading to cellular disruption. This transfer of energy is in part mediated by the pia-arachnoid complex (PAC), a layer of anatomical structures that forms the physical connection between the brain and the skull. The importance of properly quantifying the mechanics of the PAC for use in computational models of TBI has been understood for some time, but data from human subjects has been unavailable. In this study, we quantify the normal traction modulus of the PAC in five post-mortem human subjects using hydrostatic fluid pressurization in combination with optical coherence tomography. Testing at multiple locations across each brain reveals that brain-skull stiffness is heterogeneously distributed. The material response to traction loading was linear, with a mean normal traction modulus of 12.6 +/- 4.8 kPa. Modulus was 21% greater in superior regions of the brain compared to inferior regions. Comparisons with regional microstructural data suggests a potential relationship between the volume fraction of arachnoid trabeculae and modulus. Comparisons to coincident measurements of microstructural properties showed a positive correlation between arachnoid membrane thickness and normal traction modulus. This study is the first to characterize the mechanics of the human pia-arachnoid complex and quantify material properties in situ. These findings suggest implementing a heterogeneous model of the brain-skull interface in computational models of TBI may lead to more realistic injury prediction.	[Benko, Nikolaus; Alsanea, Yousef; Coats, Brittany] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Luke, Emma] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA		Coats, B (corresponding author), Univ Utah, 1495 E 100 S,1550 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu	Coats, Brittany/A-4523-2009	Benko, Nikolaus/0000-0002-7852-8775	NSF Smart and Connected Health Award [1622741]	The authors would like to acknowledge the financial support of NSF Smart and Connected Health Award No. 1622741.	Alhilali L.M., 2015, STAPP CAR CRASH J, V16, P1, DOI [10.1148/radiol.2015142974, DOI 10.1148/RADIOL.2015142974]; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Fabris G, 2019, ACTA BIOMATER, V100, P29, DOI 10.1016/j.actbio.2019.09.044; Ghaffari M., 2014, INT J MOD ENG, V14, P54; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giannini S, 2008, INT ORTHOP, V32, P145, DOI 10.1007/s00264-006-0297-2; Haines D.E., 2002, FUNDAMENTAL NEUROSCI; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2014, ANN BIOMED ENG, V42, P812, DOI 10.1007/s10439-013-0948-6; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AH, 2017, ANN NY ACAD SCI, V1409, P85, DOI 10.1111/nyas.13460; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Margulies S., 2013, PEDIAT INJURY BIOMEC, DOI [10.1007/978-1-4614-4154-0_4, DOI 10.1007/978-1-4614-4154-0_4]; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Prange M., 2000, SAE TECHNICAL PAPERS, DOI [10.4271/2000-01-SC15, DOI 10.4271/2000-01-SC15]; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Szarko M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-231; Takhounts EG, 2008, STAPP CAR C, V52, P1; Yin ZY, 2018, MAGN RESON MED, V80, P2573, DOI 10.1002/mrm.27347; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao Wei, 2019, SUMM BIOM BIOENG BIO, P528; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	36	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	AUG	2021	120								104579	10.1016/j.jmbbm.2021.104579			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	SU4YV	WOS:000663145900007	34020233	hybrid			2022-02-07	
J	Borst, J; Godat, LN; Berndtson, AE; Kobayashi, L; Doucet, JJ; Costantini, TW				Borst, Johanna; Godat, Laura N.; Berndtson, Allison E.; Kobayashi, Leslie; Doucet, Jay J.; Costantini, Todd W.			Repeat head computed tomography for anticoagulated patients with an initial negative scan is not cost-effective	SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; DELAYED INTRACRANIAL HEMORRHAGE; MILD; RISK; MANAGEMENT; WARFARIN; THERAPY; UTILITY; TRENDS; CT	Background: Patients on antithrombotic medications presenting with blunt trauma are at risk for delayed intracranial hemorrhage. We hypothesized that clinically significant delayed intracranial hemorrhage is rare in patients presenting on antithrombotic medications and therefore routine, repeat head computed tomography imaging is not a cost-effective practice to monitor for delayed intracranial hemorrhage. Methods: Patients presenting to our institution on antithrombotic (anticoagulant and antiplatelet) medications during a 5-y period from January 2014 through March 2019 who underwent a head computed tomography for blunt trauma were identified in our trauma registry. Patients with an initial negative head computed tomography underwent repeat imaging 6 h after their initial head computed tomography. Patient demographics, antithrombotic medication, international normalized ratio, Glasgow Coma Score, clinical change in neurologic status, and need for neurosurgical intervention were collected. Results: Our institution evaluated 1,676 patients on antithrombotic therapy with blunt trauma. The initial head computed tomography was negative in 1,377 patients (82.0%). Of those with an initial negative head computed tomography, 12 patients (0.9%) developed an intracranial hemorrhage that was identified on the second head computed tomography. Delayed intracranial hemorrhage included 6 patients with intraventricular hemorrhage, 3 with subdural hematoma, 2 with subarachnoid hemorrhage, and 1 with an intraparenchymal hemorrhage. None of the patients with delayed intracranial hemorrhage developed a change in neurologic status, required an intracranial pressure monitor, or underwent neurosurgical intervention. The estimated total direct cost of the negative head computed tomography scans was $926,247. Conclusion: Clinically significant delayed intracranial hemorrhage is rare in trauma patients on antithrombotic therapy, with an initial negative head computed tomography. Routine repeat head computed tomography imaging in patients with a negative scan on admission is not cost-effective. (c) 2021 Elsevier Inc. All rights reserved.	[Borst, Johanna; Godat, Laura N.; Berndtson, Allison E.; Kobayashi, Leslie; Doucet, Jay J.; Costantini, Todd W.] UC San Diego Sch Med, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92182 USA		Costantini, TW (corresponding author), UC San Diego Sch Med, Surg, 200 W Arbor Dr,8896, San Francisco, CA 92103 USA.	tcostantini@health.ucsd.edu	; /O-3005-2018	Borst, Johanna/0000-0002-1838-0852; /0000-0001-9617-001X			ACS, 2015, TQIP BEST PRACT MAN TQIP BEST PRACT MAN; Adams SD, 2015, CURR OPIN CRIT CARE, V21, P520, DOI 10.1097/MCC.0000000000000246; [Anonymous], 2019, 2019 SURV HEAD INJ A 2019 SURV HEAD INJ A; Arias E, 2019, NATL VITAL STAT REPO, V68; Barmparas G, 2019, AM J SURG, V217, P1051, DOI 10.1016/j.amjsurg.2018.10.016; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Brooke BS, 2020, JAMA SURG, V155, P250, DOI 10.1001/jamasurg.2019.4392; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cocca AT, 2019, J EMERG MED, V57, P812, DOI 10.1016/j.jemermed.2019.09.011; Cohan CM, 2020, J TRAUMA ACUTE CARE, V89, P301, DOI 10.1097/TA.0000000000002760; Docimo S, 2014, AM SURGEON, V80, P610; Erickson P, 1995, Healthy People 2000 Stat Notes, P1; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; HCUP Cost-to-Charge Ratio Files (CCR), HEALTHC COST UTIL PR HEALTHC COST UTIL PR; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Joseph B, 2014, AM SURGEON, V80, P43; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kim B, 2018, AM J EMERG MED, V36, P271, DOI 10.1016/j.ajem.2017.08.009; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Marcia L, 2018, AM SURGEON, V84, P1626; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Robert-Ebadi H, 2009, CLIN INTERV AGING, V4, P165; Schultz CH, 2020, PREHOSP DISASTER MED, V35, P3, DOI 10.1017/S1049023X1900520X; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Valiuddin H, 2020, J EMERG MED, V58, P183, DOI 10.1016/j.jemermed.2020.01.003; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	39	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2021	170	2					623	627		10.1016/j.surg.2021.02.024			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TK8FV	WOS:000674390000038	33781587				2022-02-07	
J	Bretzin, AC; Zynda, AJ; Wiebe, DJ; Covassin, T				Bretzin, Abigail C.; Zynda, Aaron J.; Wiebe, Douglas J.; Covassin, Tracey			Time to Authorized Clearance From Sport-Related Concussion: The Influence of Health Care Provider and Medical Facility	JOURNAL OF ATHLETIC TRAINING			English	Article						head injuries; recovery; sports; health disparity	HIGH-SCHOOL; EMERGENCY-DEPARTMENT; POSITION STATEMENT; MANAGEMENT; RECOVERY; ASSOCIATION; CHILDREN; REST	Context: Return to play after sport-related concussion (SRC) requires authorized clearance from a health care provider (HCP). The variability in HCPs and facilities where athletes seek care may influence return time. Objective: To identify the initial examiner, HCPs who authorize clearance to return to play, and medical facilities that authorize clearance to return to play for high school studentathletes after SRC and compare authorized clearance time by HCPs and medical facilities. Design: Prospective cohort study. Setting: High school. Patients or Other Participants: Student-athletes (n = 16 001) with SRC participating in athletics sponsored by the Michigan High School Athletic Association. Main Outcome Measure(s): Frequencies of initial examiner and authorized clearance for each HCP (doctor of osteopathic medicine, medical doctor, nurse practitioner, physician assistant) and medical facility (neurologist's office; team physician, primary care physician or pediatrician's office [PCP]; hospital; urgent/ready care) for each case of SRC. We calculated KaplanMeier curves and Peto tests to evaluate differences in the median time to authorized clearance between HCPs and facilities. Only cases with a date on which clearance to return to play was authorized (80.3%; n = 12 856) were included in the authorized clearance and time-to-return analyses. Results: An athletic trainer was at least 1 of the initial examiners in 71.3% (n = 11 404) of SRC cases; 81.2% (n = 12 990) had only 1 initial examiner. We observed an association between the initial examiner and the medical facility providing clearance for athletic director (chi(2) = 52.6, P < .001, V = 06), athletic trainer (chi(2) = 172.0, P < .001, V = .12), coach (chi(2) = 161.5, P < .001, V = .11), doctor of osteopathic medicine (chi(2) = 59.4, P < .001, V = .07), and nurse practitioner (chi(2) = 10.0, P = .04, V = .12). Clearance was authorized most frequently by a medical doctor (63.9%, n = 8218) and at a PCP (70.8%, n = 9099). Median (interquartile range) time to authorized clearance varied by facility (urgent/ready care = 7 days [4-11 days], hospital = 9 days [6-14 days], PCP = 10 days [6-14 days], team physician = 12 days [8-16 days], neurologist's office = 13 days [9-20 days]; P < .001). An athletic trainer was the initial examiner more often for males (74.1%) than for females (65.8%). The medical facility where clearance to return to play was authorized also differed between males (PCP = 69.3%, team physician = 11.3%, neurologist's office = 8.4%) and females (PCP = 73.6%, team physician = 8.5%, neurologist's office = 8.3%). Conclusions: Clearance to return to play after SRC was frequently provided by a medical doctor and at a PCP. The median time to return to unrestricted participation after SRC varied by HCP and medical facility. Future researchers should elucidate the reasons for these differences and determine why athletes seek care at different types of medical facilities.	[Bretzin, Abigail C.; Wiebe, Douglas J.] Univ Penn, Penn Injury Sci Ctr, Blockley Hall Room 937,423 Guardian Dr, Philadelphia, PA 19104 USA; [Bretzin, Abigail C.; Wiebe, Douglas J.] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Zynda, Aaron J.; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Bretzin, AC (corresponding author), Univ Penn, Penn Injury Sci Ctr, Blockley Hall Room 937,423 Guardian Dr, Philadelphia, PA 19104 USA.	Abigail.Bretzin@Pennmedicine.upenn.edu		Bretzin, Abigail/0000-0003-3730-2849			[Anonymous], MHSAA protocol for implementation of national federation sports playing rules for concussions; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Covassin T, 2018, AM J SPORT MED, V46, P2270, DOI 10.1177/0363546518780225; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Gravetter FrederickJ., 2020, ESSENTIALS STAT BEHA, V10th; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Huggins RA, 2019, J ATHL TRAINING, V54, P1129, DOI 10.4085/1062-6050-12-19; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Lam KC, 2016, J ATHL TRAINING, V51, P435, DOI 10.4085/1062-6050-51.8.03; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McLeod TCV, 2019, CLIN J SPORT MED, V29, P298, DOI 10.1097/JSM.0000000000000530; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; O'Keefe KA, 2018, PEDIATR EMERG CARE, V34, P322, DOI 10.1097/PEC.0000000000001476; Post EG, 2019, J ATHL TRAINING, V54, P1074, DOI 10.4085/1062-6050-207-18; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sports, MICH HIGH SCH ATHL A MICH HIGH SCH ATHL A; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zamarripa A, 2017, J PEDIATR-US, V181, P229, DOI 10.1016/j.jpeds.2016.10.071; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	38	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2021	56	8					869	878		10.4085/JAT0159-20			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6NS	WOS:000684588100010	33351918	gold			2022-02-07	
J	Brooks, JS; Allison, W; Harriss, A; Bian, KW; Mao, HJ; Dickey, JP				Brooks, Jeffrey S.; Allison, Wayne; Harriss, Alexandra; Bian, Kewei; Mao, Haojie; Dickey, James P.			Purposeful Heading Performed by Female Youth Soccer Players Leads to Strain Development in Deep Brain Structures	NEUROTRAUMA REPORTS			English	Article						female youth soccer; finite element modeling; linear acceleration; rotational velocity; traumatic brain injury	MAXIMUM PRINCIPAL STRAIN; FINITE-ELEMENT-ANALYSIS; WHITE-MATTER INTEGRITY; CORPUS-CALLOSUM; ACCELERATION MEASUREMENT; SEX-DIFFERENCES; NECK STRENGTH; CONCUSSION; INJURIES; FOOTBALL	Head impacts in soccer have been associated with both short- and long-term neurological consequences. Youth players' brains are especially vulnerable given that their brains are still developing, and females are at an increased risk of traumatic brain injury (TBI) compared to males. Approximately 90% of head impacts in soccer occur from purposeful heading. Accordingly, this study assessed the relationship between kinematic variables and brain strain during purposeful headers in female youth soccer players. A convenience sample of 36 youth female soccer players (13.4 [0.9] years of age) from three elite youth soccer teams wore wireless sensors to quantify head impact magnitudes during games. Purposeful heading events were categorized by game scenario (e.g., throw-in, goal kick) for 60 regular season games (20 games per team). A total of 434 purposeful headers were identified. Finite element model simulations were performed to calculate average peak maximum principal strain (APMPS) in the corpus callosum, thalamus, and brainstem on a subset of 110 representative head impacts. Rotational velocity was strongly associated with APMPS in these three regions of the brain (r = 0.83-0.87). Linear acceleration was weakly associated with APMPS (r = 0.13-0.31). Game scenario did not predict APMPS during soccer games (p > 0.05). Results demonstrated considerable APMPS in the corpus callosum (mean = 0.102) and thalamus (mean = 0.083). In addition, the results support the notion that rotational velocity is a better predictor of brain strain than linear acceleration and may be a potential indicator of changes to the brain.	[Brooks, Jeffrey S.; Allison, Wayne; Dickey, James P.] Western Univ, Fac Hlth Sci, Sch Kinesiol, 1151 Richmond St, London, ON N6A 3K7, Canada; [Harriss, Alexandra] Western Univ, Fac Hlth Sci, Hlth & Rehabil Sci, London, ON, Canada; [Bian, Kewei; Mao, Haojie] Western Univ, Fac Engn, Dept Mech & Mat Engn, London, ON, Canada; [Mao, Haojie; Dickey, James P.] Western Univ, Sch Biomed Engn, London, ON, Canada		Dickey, JP (corresponding author), Western Univ, Fac Hlth Sci, Sch Kinesiol, 1151 Richmond St, London, ON N6A 3K7, Canada.	jdickey@uwo.ca	Dickey, James P/K-6776-2013; Brooks, Jeffrey/ABA-4226-2021	Dickey, James P/0000-0002-4101-835X; Brooks, Jeffrey/0000-0002-1842-4763	Canada Research Chairs programCanada Research Chairs [X2281B63]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05187, R5748A04]	This research received no external funding. Instrumentation was provided as an in-kind contribution from GForce Tracker. Haojie Mao acknowledges the Canada Research Chairs program (X2281B63) and NSERC (R5748A04) for support. James P. Dickey acknowledges NSERC (RGPIN-2016-05187) for support.	Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Gur RC, 1999, J NEUROSCI, V19, P4065; Gur RC, 2002, CEREB CORTEX, V12, P998, DOI 10.1093/cercor/12.9.998; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A., 2020, J CONCUSSION, V4; Harriss A, 2019, SCI MED FOOTBALL, V3, P109, DOI 10.1080/24733938.2018.1506591; Harriss A, 2019, MUSCULOSKEL SCI PRAC, V40, P53, DOI 10.1016/j.msksp.2019.01.009; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meyer T, 2018, SCI MED FOOTBALL, V2, P1, DOI 10.1080/24733938.2017.1416950; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Mukaka MM, 2012, MALAWI MED J, V24, P69; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Peek K, 2021, SCI MED FOOTBALL, V5, P195, DOI 10.1080/24733938.2021.1897657; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; R Core Team, 2020, R LANG ENV STAT COMP; Rajakumar, 2013, BARRS HUMAN NERVOUS; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor K, 2019, P I MECH ENG P-J SPO, V233, P503, DOI 10.1177/1754337119857434; Tiernan S, 2019, BRAIN INJURY, V33, P427, DOI 10.1080/02699052.2019.1566834; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	73	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2021	2	1					354	362		10.1089/neur.2021.0014			9	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TX8TZ	WOS:000683360400001	34901935	gold, Green Published			2022-02-07	
J	Bryant, AM; McCrea, MA; Nelson, LD				Bryant, Andrew M.; McCrea, Michael A.; Nelson, Lindsay D.			Contribution of Peripheral Injuries to the Symptom Experience of Patients with Mild Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						injury severity; mild traumatic brain injury; neurotrauma; peripheral injuries; polytrauma; outcomes	POST-CONCUSSION SYMPTOMS; EPIDEMIOLOGY; PREDICTORS; SEVERITY	Peripheral injuries are common in patients who experience mild traumatic brain injury (mTBI). However, the additive or interactive effects of polytrauma on psychosocial adjustment, functional limitations, and clinical outcomes after head injury remain relatively unexamined. Using a recently developed structured injury symptom interview, we assessed the perception and relative importance of peripheral injuries at 3 months post-injury in patients with mTBI as defined by the American Congress of Rehabilitation Medicine. Our sample of Level 1 trauma patients (n = 74) included individuals who were treated and released from the emergency department (n = 43) and those admitted to an inpatient unit (n = 31). Across the sample, 91% of patients with mTBI experienced additional non-head injuries known to commonly impact recovery following mTBI, a majority of whom ranked pain as their worst peripheral injury symptom. Forty-nine percent of the mTBI sample (54% of the subsample with concurrent mTBI and peripheral injuries) reported being more bothered by peripheral injury symptoms than mTBI. Differences between patients with mTBI with worse mTBI symptoms versus those with worse peripheral injury symptoms are described. Conventional measures of injury severity do not capture patients' perceptions of the totality of their injuries, which limits the development of patient-centered treatments. Future research should enroll patients with mTBI diverse in peripheral injury severity and develop standardized assessments to characterize peripheral symptoms, enabling better characterization of the relevance of concurrent injuries in recovery and outcomes of patients with mTBI.	[Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			Center for Patient Care and Outcomes Research (PCOR) at the Medical College of Wisconsin; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR001436]	This project was funded by the Center for Patient Care and Outcomes Research (PCOR) at the Medical College of Wisconsin, and by the National Institute of Neurological Disorders and Stroke (grant #R01 NS110856). The REDCap database used in this study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through grant #UL1TR001436. The contents of this project are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Emmert Natalie A, 1800, J Int Neuropsychol Soc, V28, P143, DOI [10.1017/S1355617721000564, 10.1017/S1355617721000278]; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Harfmann EJ, 2020, J NEUROTRAUM, V37, P1408, DOI 10.1089/neu.2019.6746; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Levin HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.3046; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vedantam A, 2021, J NEUROTRAUM, V38, P53, DOI 10.1089/neu.2019.6979; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yue JK, 2020, NEUROTRAUMA REP, V1, P32, DOI 10.1089/neur.2020.0004; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000	24	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2021	2	1					363	369		10.1089/neur.2021.0012			7	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TZ1QZ	WOS:000684251900001	34901936	gold, Green Published			2022-02-07	
J	Cenik, Y; Baydin, A; Cakmak, E; Fidan, M; Aydin, K; Tuncel, OOK; Aslan, K				Cenik, Yavuz; Baydin, Ahmet; Cakmak, Eser; Fidan, Murat; Aydin, Keramettin; Tuncel, O. Ozgur Korhan; Aslan, Kerim			The Effect of Biomarkers and Optic Nerve Sheath Diameter in Determining Mortality in non-Traumatic Subarachnoid Hemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Subarachnoid hemorrhage; S100B protein; Glial Fibrillary Acidic Protein; Optic Nerve Sheath Diameter	MULTISECTION CT ANGIOGRAPHY; FIBRILLARY ACIDIC PROTEIN; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; AGE	Aim: Although radiological methods are sufficient for the diagnosis of spontaneous subarachnoid hemorrhage (SAH), additional biomarkers are needed to predict prognosis. The aim of this study was to investigate the effects of serum S100B protein, Glial Fibrillary Acidic Protein (GFAP) levels and, Optic Nerve Sheath Diameter (ONSD) on mortality and clinical severity in patients with spontaneous SAH. Materials and methods: Fifty-six patients who were diagnosed with SAH after first evaluation in the emergency department (ED) were included in the study group; Forty-six patients who were admitted to the ED with headache of non-intracranial etiology, were included as the control group. Cerebral computed tomography (CT) images and peripheral blood samples were obtained from all patients; at the time of diagnosis and 24 h after diagnosis. Serum S100B protein and GFAP levels were measured from the blood samples and ONSD was measured on CT. Results: Serum S100B protein and GFAP levels and, ONSDs at the time of diagnosis and 24 h after diagnosis were significantly higher in the study group (p < 0.05). Both GFAP levels and ONSD at the time of diagnosis and 24 h after the diagnosis were found to be related with increased mortality (p < 0.05). A similar association was found for serum S100B protein levels 24 h after the diagnosis, but not at the time of diagnosis (p = 0.540). Conclusion: Serum S100B protein and GFAP levels and, ONSD were increased in patients with spontaneous SAH. All parameters were found to be associated with increased mortality.	[Cenik, Yavuz; Baydin, Ahmet] Ondokuz Mayis Univ, Dept Emergency Med, Fac Med, TR-55139 Kurupelit, Samsun, Turkey; [Cakmak, Eser; Tuncel, O. Ozgur Korhan] Ondokuz Mayis Univ, Dept Med Biochem, Fac Med, TR-55139 Samsun, Turkey; [Aydin, Keramettin] Ondokuz Mayis Univ, Dept Neurosurg, Fac Med, TR-55139 Samsun, Turkey; [Fidan, Murat; Aslan, Kerim] Ondokuz Mayis Univ, Dept Radiol, Fac Med, TR-55139 Samsun, Turkey		Baydin, A (corresponding author), Ondokuz Mayis Univ, Dept Emergency Med, Fac Med, TR-55139 Kurupelit, Samsun, Turkey.	ahmetbaydn@yahoo.com			Ondokuz Mays UniversityOndokuz Mayis University [PYO.Tp.1904.19.010]	This study was supported financially by Ondokuz Mays University; PYO.Tp.1904.19.010. The authors would like to thank Associate Professor Doctor Leman Tomak for providing statistical advice.	Basile A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012769; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BRUNO A, 1988, STROKE, V19, P135, DOI 10.1161/01.STR.19.10.1300; Lopez ZRD, 2015, CLIN CHEM LAB MED, V53, pE179, DOI 10.1515/cclm-2014-1189; De Bernardo M, 2020, ANN CLIN TRANSL NEUR, V7, P1459, DOI 10.1002/acn3.51116; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Lashkarivand A, 2020, ACTA NEUROCHIR, V162, P533, DOI 10.1007/s00701-019-04190-y; Lee S, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2360-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lubicz B, 2007, AM J NEURORADIOL, V28, P1949, DOI 10.3174/ajnr.A0699; Marotta G, 2020, NEUROCRIT CARE, V33, P855, DOI 10.1007/s12028-020-00999-z; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Ruiz-Sandoval JL, 2006, STROKE, V37, P2946, DOI 10.1161/01.STR.0000248766.22741.4b; SAVELAND H, 1986, J NEUROSURG, V64, P191, DOI 10.3171/jns.1986.64.2.0191; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Teksam M, 2004, AM J NEURORADIOL, V25, P1485; Turkin A M, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P81, DOI 10.17116/neiro201781681-88; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Yesilaras M, 2017, AM J EMERG MED, V35, P1408, DOI 10.1016/j.ajem.2017.04.022; Zali Ali Reza, 2012, Glob J Health Sci, V4, P179, DOI 10.5539/gjhs.v4n3p179; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zoerle T, 2020, NEUROCRIT CARE, V33, P491, DOI 10.1007/s12028-020-00970-y	29	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2021	207								106813	10.1016/j.clineuro.2021.106813			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WQ3CK	WOS:000713696800004	34311386				2022-02-07	
J	Cheever, K; Kay, M				Cheever, Kelly; Kay, Melissa			Certified Athletic Trainers' Use of Cervical Clinical Testing in the Diagnosis and Management of Sports-Related Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						differential diagnosis; cervical spine; manual therapy; persistent post-concussion symptoms	SYMPTOMS; BRAIN; DIZZINESS; KNOWLEDGE; SPINE; CARE	Context: Despite evidence implicating cervicogenic symptoms in the development of persistent postconcussion symptoms, factors that influence utilization of cervical clinical tests to identify cervicogenic symptoms following concussion are poorly understood. Objective: Explore barriers to the utilization of cervical clinical testing in multifaceted concussion evaluation. Design: Cross-sectional. Setting: Online survey. Patients or Other Participants: A total of 122 athletic trainers (AT) (age = 42.6 [6.4] y; female = 51.6%; 52% >10 y of clinical practice; 68% master's degree or greater; 35% treated a minimum of 15 concussions/y). Main Outcome Measure(s): Perceived importance, clinical experience, number of concussions treated, utilization of cervical clinical tests following nonspecific cervical pathology and following concussion, comfort with cervical treatment modalities following a concussion, and recommendation for cervical-specific therapy to treat persistent postconcussion symptoms. Results: Ordinal logistic regression revealed perceived importance had the strongest positive impact onAT's likelihood of high utilization of cervical clinical testing following concussion (95% CI, .17 to.99; P =.005), while clinical experience (95% CI, -.43 to.29; P =.71) and number of concussions treated/y (95% CI, -.21 to.31; P =.71) had no bearing. Moreover, low comfort with cervical treatments following a concussion (95% CI, -2.86 to -.26; P =.018) and low utilization of cervical clinical testing following nonspecific cervical pathology (95% CI, -7.01 to -3.39; P =.001) had a strong positive impact on high utilization of cervical clinical testing following concussion. Two logistic regression models demonstrated how recommendations for cervical-specific therapy in persistent post-concussion symptom patients could be predicted based on (1) cervical test utilization and (2) perceptions and clinical experience with 79% and 78%, respectively. Conclusions: Perceived importance played a major role in utilization of cervical clinical test following concussion. ATs who utilized common cervical treatments when dealing with non-concussive injuries were more likely to utilize those same treatments to treat comorbid cervical pathology following a concussion.	[Cheever, Kelly] Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Kinesiol, San Antonio, TX 78249 USA; [Kay, Melissa] Univ Southern Mississippi, Coll Nursing & Hlth Profess, Sch Hlth Profess, Hattiesburg, MS 39406 USA		Cheever, K (corresponding author), Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Kinesiol, San Antonio, TX 78249 USA.	kelly.cheever@utsa.edu		Cheever, Kelly/0000-0001-8381-3426			Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Carmichael JP, 2019, INT J SPORTS PHYS TH, V14, P334, DOI 10.26603/ijspt20190334; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Gergen DM, 2015, J CHIROPR MED, V14, P220, DOI 10.1016/j.jcm.2015.08.006; Hammerle M, 2019, J MANIP PHYSIOL THER, V42, P399, DOI 10.1016/j.jmpt.2018.12.002; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; King JA, 2020, ARCH PHYS MED REHAB, V101, P89, DOI 10.1016/j.apmr.2019.08.471; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Langelier DM, 2017, PHYS THER SPORT, V25, P84, DOI 10.1016/j.ptsp.2017.01.003; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moreau WJ, 2015, J CHIROPR MED, V14, P169, DOI 10.1016/j.jcm.2015.08.003; Mucha A, 2019, J ORTHOP SPORT PHYS, V49, P787, DOI 10.2519/jospt.2019.8855; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Paddack M, 2016, J ATHL TRAINING, V51, P82, DOI 10.4085/1062-6050-51.2.01; Rebbeck T, 2019, J ORTHOP SPORT PHYS, V49, P819, DOI 10.2519/jospt.2019.8946; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Simpson JR, 2011, J AM ACAD PSYCHIATRY, V39, P133; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Taylor DN, 2018, CHIROPR MAN THER, V26, DOI 10.1186/s12998-018-0186-y; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598	36	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2021	30	6					926	934		10.1123/jsr.2020-0394			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	TM8VK	WOS:000675824200013	33771946				2022-02-07	
J	Chen, LF; Jiang, HZ; Xing, GQ; Guan, B; Yang, Y; Ahmed, A; Ma, XD				Chen, Lifeng; Jiang, Hongzhen; Xing, Guoqiang; Guan, Bing; Yang, Yang; Ahmed, Anwar; Ma, Xiaodong			Effects of Yunanan Baiyao adjunct therapy on postoperative recovery and clinical prognosis of patients with traumatic brain injury: A randomized controlled trial	PHYTOMEDICINE			English	Article						Traumatic brain injury; Emergency craniotomy; Yunnan Baiyao; Clinical outcome; Serum S100B; Superoxide dismutase	SUPEROXIDE-DISMUTASE; YUNNAN BAIYAO; SERUM S100B; HEAD-INJURY; IDENTIFICATION; COMPLICATIONS; BARRIER; DAMAGE	Background: Effective therapies are needed to prevent the secondary injury and poor prognosis associated with emergency craniotomy of traumatic brain injury (TBI). Hypothesis/Purpose: The wound-healing medicine Yunnan Baiyao (YB) and Xingnaojing (XNJ) adjunct-therapy may improve the outcome of orthodox mono-therapy (OT). Study design: Randomized controlled trial. Methods: Eighty patients with moderate-to-severe TBI received emergency craniotomy (within 12 h after TBI) at the Chinese PLA General Hospital before being randomly assigned to 4 different treatments (n = 20) for 7 days: 1) OT; 2) OT+XNJ (i.v. 20 ml/daily); 3) OT+low dose-YB (oral, 1,000 mg/day); 4) OT+high dose-YB, 2,000 mg/day). Results: GCS score was improved more quickly and became significantly higher in XNJ, L-YB, h-YB groups than in OT group (p<0.01). Serum S100B peaked higher but declined more slowly in OT group than in other groups (p<0.01). On postoperative Day 7, S100B was 20% below baseline in YB and XNJ groups but remained 19% above baseline in OT group which also lost 38% of superoxide dismutase (SOD) activity on Day 3 and recovered 69% of SOD on Day 7 whereas the YB and XNJ groups lost 16%similar to 23% of SOD activity on Day 3 and recovered 92%similar to 99% of SOD on Day 7 (p<0.01). Clinical prognosis (Glasgow Outcome Scale and Karnofsky Performance Scale) were significantly better (25%similar to 30%) in the XNJ, L-YB and h-YB groups than in OT group 3 months post-surgery and were correlated with serum S100B and SOD. Conclusions: YB and XNJ adjunct therapies improved postoperative recovery and clinical prognosis in patients with moderate-to-severe TBI partly through divergent regulation of S100B and SOD pathways.	[Chen, Lifeng; Jiang, Hongzhen; Ma, Xiaodong] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Med Ctr 1, Beijing 100853, Peoples R China; [Xing, Guoqiang] North Sichuan Med Univ, Nanchong Cent Hosp, Affiliated Hosp, Nanchong 637000, Peoples R China; [Xing, Guoqiang] North Sichuan Med Univ, Nanchong Cent Hosp, Clin Med Coll 2, Nanchong 637000, Peoples R China; [Guan, Bing] Chinese Peoples Liberat Army Gen Hosp, Dept Hlth Econ, Med Ctr 1, Beijing 100853, Peoples R China; [Yang, Yang] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Med Ctr 2, Beijing, Peoples R China; [Ahmed, Anwar] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Xing, Guoqiang] Lotus Biotechcom LLC, Gaithersburg, MD 20878 USA		Ma, XD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Med Ctr 1, Beijing 100853, Peoples R China.; Xing, GQ (corresponding author), North Sichuan Med Univ, Nanchong Cent Hosp, Affiliated Hosp, Nanchong 637000, Peoples R China.; Xing, GQ (corresponding author), North Sichuan Med Univ, Nanchong Cent Hosp, Clin Med Coll 2, Nanchong 637000, Peoples R China.; Xing, GQ (corresponding author), Lotus Biotechcom LLC, Gaithersburg, MD 20878 USA.	gxing99@yahoo.com; bgbj@sina.com; anwar.ahmed.ctr@usuhs.edu; xiaodongm@hotmail.com					Alain-Pascal BBN, 2010, CHIN J TRAUMATOL, V13, P25, DOI 10.3760/cma.j.issn.1008-1275.2010.01.005; Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bokesch PM, 2002, ANESTH ANALG, V95, P889, DOI 10.1097/00000539-200210000-00018; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen RJY, 2011, ACTA PHARMACOL SIN, V32, P141, DOI 10.1038/aps.2010.197; Cheng YJ, 2018, INT J MOL MED, V42, P2120, DOI 10.3892/ijmm.2018.3755; Dai C, 2013, J SEP SCI, V36, P1935, DOI 10.1002/jssc.201300244; Einav S, 2006, CRIT CARE, V10, DOI 10.1186/cc5058; Glass NE, 2019, J SURG RES, V235, P615, DOI 10.1016/j.jss.2018.10.021; GUDEMAN SK, 1983, NEUROSURGERY, V12, P175, DOI 10.1227/00006123-198302000-00007; Guo YP, 2016, EMPIR SOFTW ENG, V21, P159, DOI [10.1007/s10664-014-9351-7, 10.1155/2014/346918]; HALLORAN LG, 1980, AM J SURG, V139, P44, DOI 10.1016/0002-9610(80)90228-7; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jones CMC, 2020, BRAIN INJURY, V34, P407, DOI 10.1080/02699052.2020.1725123; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Ladas EJ, 2012, SUPPORT CARE CANCER, V20, P3379, DOI 10.1007/s00520-012-1598-1; Lee B, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014145; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Li R, 2011, INT J CLIN EXP MED, V4, P309; Li ZM, 2010, MED PRIN PRACT, V19, P17, DOI 10.1159/000252829; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Lu GY, 2020, WORLD NEUROSURG, V133, pE135, DOI 10.1016/j.wneu.2019.08.184; Lucena Adson Freitas de, 2011, Rev Bras Ter Intensiva, V23, P96; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Muballe KD, 2019, J NEUROSURG, V131, P1648, DOI 10.3171/2018.4.JNS172185; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; MULLER P, 1988, CAN J NEUROL SCI, V15, P384, DOI 10.1017/S0317167100028092; Papa L., 2015, BRAIN NEUROTRAUMA MO; Peng WJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/210851; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Podolsky-Gondim GG, 2018, CHILD NERV SYST, V34, P2455, DOI 10.1007/s00381-018-3989-1; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Shim Hyuk Ki, 2018, Korean J Neurotrauma, V14, P99, DOI 10.13004/kjnt.2018.14.2.99; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Su TM, 2019, J CLIN NEUROSCI, V63, P62, DOI 10.1016/j.jocn.2019.02.006; Tang ZL, 2009, INT J ORAL MAX SURG, V38, P261, DOI 10.1016/j.ijom.2008.12.003; Tapper J., 2017, SURG NEUROL INT, V8; Vasquez AOR, 2018, CURR OPIN ANESTHESIO, V31, P61, DOI 10.1097/ACO.0000000000000551; Wang J.C., 2015, CHIN J PRACT NERV DI, V18, P50; Wang T., 2010, MED J IND ENTERPRISE, V23, P3; Wu LJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002875; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu CC, 2019, J ETHNOPHARMACOL, V236, P443, DOI 10.1016/j.jep.2019.02.035; Xu DY, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00274; Xu G., 2009, PRACT CLIN MED CN, V18, P353; Xu M, 2010, CHIN J TRAUMATOL, V13, P158, DOI 10.3760/cma.j.issn.1008-1275.2010.03.005; Xu YM, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012967, 10.1097/md.0000000000012967]; Yang B, 2014, INT J CLIN EXP MED, V7, P461; Yunoki M, 1997, J NEUROTRAUM, V14, P739, DOI 10.1089/neu.1997.14.739; Zaghloul N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108168; Zhou M, 2007, J NEUROCHEM, V103, P2212, DOI 10.1111/j.1471-4159.2007.04906.x	59	0	0	1	1	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0944-7113	1618-095X		PHYTOMEDICINE	Phytomedicine	AUG	2021	89								153593	10.1016/j.phymed.2021.153593			11	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	TR9NQ	WOS:000679285700006	34182194	hybrid			2022-02-07	
J	Chong, SL; Ong, GYK; Zheng, CQ; Dang, HX; Ming, MX; Mahmood, M; Chan, LCN; Chuah, SL; Lee, OPE; Qian, SY; Fan, LJ; Konoike, Y; Lee, JH				Chong, Shu-Ling; Ong, Gene Yong-Kwang; Zheng, Charles Qishi; Dang, Hongxing; Ming, Meixiu; Mahmood, Maznisah; Chan, Lawrence Chi Ngong; Chuah, Soo Lin; Lee, Olive Pei Ee; Qian, Suyun; Fan, Lijia; Konoike, Yoshihiko; Lee, Jan Hau		Pediat Acute Critical Care Med Asi	Early Coagulopathy in Pediatric Traumatic Brain Injury: A Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN) Retrospective Study	NEUROSURGERY			English	Article						Blood coagulation disorders; Brain injuries; Traumatic; Child; Mortality; Critical care outcomes	HEMORRHAGIC PROGRESSION; PLATELET DYSFUNCTION; REFERENCE INTERVALS; HEMOSTATIC SYSTEM; TISSUE FACTOR; HEAD-INJURY; FACTOR VIIA; HYPOPERFUSION; CHILDREN; PATHOGENESIS	BACKGROUND: Although early coagulopathy increases mortality in adults with traumatic brain injury (TBI), less is known about pediatric TBI. OBJECTIVE: To describe the prothrombin time (PT), activated partial thromboplastin time (APTT), and platelet levels of children with moderate to severe TBI to identify predictors of early coagulopathy and study the association with clinical outcomes. METHODS: Using the Pediatric Acute and Critical Care Medicine Asian Network (PACCMAN) TBI retrospective cohort, we identified patients <16 yr old with a Glasgow Coma Scale (GCS) <= 13. We compared PT, APTT, platelets, and outcomes between children with isolated TBI and multiple trauma with TBI. We performed logistic regressions to identify predictors of early coagulopathy and study the association with mortality and poor functional outcomes. RESULTS: Among 370 children analyzed, 53/370 (14.3%) died and 127/370 (34.3%) had poor functional outcomes. PT was commonly deranged in both isolated TBI (53/173, 30.6%) and multiple trauma (101/197, 51.3%). Predictors for early coagulopathy were young age (adjusted odds ratio [aOR] 0.94, 95% CI 0.88-0.99, P = .023), GCS < 8 (aOR 1.96, 95% CI 1.26-3.06, P = .003), and presence of multiple trauma (aOR 2.21, 95% confidence interval [CI] 1.37-3.60, P = .001). After adjusting for age, gender, GCS, multiple traumas, and presence of intracranial bleed, children with early coagulopathy were more likely to die (aOR 7.56, 95% CI 3.04-23.06, P < .001) and have poor functional outcomes (aOR 2.16, 95% CI 1.26-3.76, P = .006). CONCLUSION: Early coagulopathy is common and independently associated with death and poor functional outcomes among children with TBI.	[Chong, Shu-Ling; Ong, Gene Yong-Kwang] KK Womens & Childrens Hosp, Dept Emergency Med, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Chong, Shu-Ling; Ong, Gene Yong-Kwang; Lee, Jan Hau] Duke NUS Med Sch, Singapore, Singapore; [Zheng, Charles Qishi] Singapore Clin Res Inst, Singapore, Singapore; [Dang, Hongxing] Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China; [Ming, Meixiu] Fudan Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Shanghai, Peoples R China; [Mahmood, Maznisah] Inst Paediat, Dept Paediat, Kuala Lumpur, Malaysia; [Chan, Lawrence Chi Ngong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Peoples R China; [Chuah, Soo Lin] Univ Malaya, Dept Paediat, Kuala Lumpur, Malaysia; [Lee, Olive Pei Ee] Sarawak Gen Hosp, Dept Paediat, Sarawak, Malaysia; [Qian, Suyun] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Pediat Intens Care Unit, Beijing, Peoples R China; [Fan, Lijia] Natl Univ Singapore Hosp, Khoo Teck Puat Natl Univ Childrens Med Inst, Singapore, Singapore; [Fan, Lijia] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Konoike, Yoshihiko] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Crit Care Med, Kobe, Hyogo, Japan; [Lee, Jan Hau] KK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.	Chong.Shu-Ling@kkh.com.sg	Ong, Gene/W-3154-2019; Zheng, Qishi/R-9499-2016	Ong, Gene/0000-0002-9879-0594; Zheng, Qishi/0000-0003-3368-4843	SingHealth Foundation Research GrantSingHealth [SHF/FG670P/2017]	This study was funded by SingHealth Foundation Research Grant (Grant Number SHF/FG670P/2017).	Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Choi PM, 2014, CURR OPIN PEDIATR, V26, P343, DOI 10.1097/MOP.0000000000000086; Chong SL, 2021, PEDIATR CRIT CARE ME, V22, P401, DOI 10.1097/PCC.0000000000002575; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2017, CRIT CARE CLIN, V33, P101, DOI 10.1016/j.ccc.2016.08.003; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Dwivedi Ashish Kumar, 2018, Asian J Neurosurg, V13, P1123, DOI 10.4103/ajns.AJNS_16_17; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Flanders MM, 2006, J PEDIATR-US, V149, P275, DOI 10.1016/j.jpeds.2006.04.008; Flanders MM, 2005, CLIN CHEM, V51, P1738, DOI 10.1373/clinchem.2005.050211; Goh SSM, 2020, BMJ OPEN, V10, DOI DOI 10.1136/bmjopen-2019-035513; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; James V, 2020, J NEUROSURG-PEDIATR, V25, P663, DOI 10.3171/2019.12.PEDS19531; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Nair A, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2019-000382; Parmar N, 2006, CLIN LAB, V52, P115; R Core Team, 2020, R LANG ENV STAT COMP; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	39	0	0	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2021	89	2					283	290		10.1093/neuros/nyab157			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UA5OK	WOS:000685210900036	33913493				2022-02-07	
J	Clark, JMR; Twamley, EW; Krause, JS				Clark, Jillian M. R.; Twamley, Elizabeth W.; Krause, James S.			Mental Health, Pain, and Sleep Factors Associated With Subjective Cognitive Difficulties in Individuals With Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						spinal cord injuries; cognition; depression; sleep; pain	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; PREVALENCE; COMPLAINTS; POLYPHARMACY; DECLINE; MEMORY; DEPRESSION; COMMUNITY; COGSMART	Objective: We examined the relationships between self-reported demographic, mental health, physical health, and health behavior factors and subjective cognitive difficulties in a unique cohort of individuals with spinal cord injury (SCI) who averaged more than 30 years postinjury at assessment. Method: The study involved cross-sectional analyses of self-report assessment data collected during the most recent data-collection period (2018-2019) of a 45-year multicohort longitudinal study. Participants (n = 553) were identified from a specialty hospital in the southeastern United States and two midwestern university hospitals and were initially enrolled in the study in 1973-1974, 1984-1985, 1993-1994, or 2003-2004. The Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function-Short Form 8a v2.0 was the main outcome measure used to assess subjective cognitive difficulties. Results: Bivariate analyses indicated that greater subjective cognitive difficulties were associated with being female, elevated anxiety and depressive symptoms, sleep disturbance, cardiovascular disease, worse pain, polypharmacy, worse self-rated diet, and tobacco use. A hierarchical linear regression analysis including sociodemographic and SCI-related variables (Step 1) and physical, mental health, and health variables (added in Step 2) explained 33% of the variance in subjective cognitive difficulties, F(16, 421) = 13.45, p <= .001. Depressive, anxiety, and pain symptoms; sleep disturbance; and injury level remained significant predictors of variance in subjective cognitive symptoms when considering all variables simultaneously. Conclusion: Improving mental health symptoms, pain experiences, and sleep difficulties may be promising to improve subjective cognitive symptoms in individuals with SCI.	[Clark, Jillian M. R.; Krause, James S.] Med Univ South Carolina, Coll Hlth Profess, 151-B Rutledge Ave,MSC 962, Charleston, SC 29425 USA; [Clark, Jillian M. R.; Twamley, Elizabeth W.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Clark, JMR (corresponding author), Med Univ South Carolina, Coll Hlth Profess, 151-B Rutledge Ave,MSC 962, Charleston, SC 29425 USA.	jillian.clark2@va.gov		Twamley, Elizabeth/0000-0002-8693-8782	U.S. Department of Health and Human Services Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90IF0112]	The contents of this publication were developed under a grant from the U.S. Department of Health and Human Services Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Grant 90IF0112. However, those contents do not necessarily represent the policy of the U.S. Department of Health and Human Services, and you should not assume endorsement by the federal government.	Awofala AA, 2018, ALEX J MED, V54, P251, DOI 10.1016/j.ajme.2017.08.001; Bhushan A, 2018, EUR J EPIDEMIOL, V33, P223, DOI 10.1007/s10654-017-0330-3; Biering-Sorensen F, 2009, RESP PHYSIOL NEUROBI, V169, P165, DOI 10.1016/j.resp.2009.08.014; Buchholz AC, 2004, CURR OPIN CLIN NUTR, V7, P635, DOI 10.1097/00075197-200411000-00008; Centers for Disease Control and Prevention (CDC), 2010, BEH RISK FACT SURV S; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Fondell E, 2018, EUR J EPIDEMIOL, V33, P79, DOI 10.1007/s10654-017-0331-2; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Hill NL, 2017, INT PSYCHOGERIATR, V29, P1965, DOI 10.1017/S1041610217001636; Huang SW, 2017, J NEUROTRAUM, V34, P615, DOI 10.1089/neu.2016.4525; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Kielb S, 2017, ALZHEIMERS DEMENT, V13, P1337, DOI 10.1016/j.jalz.2017.04.008; Kitzman P, 2017, J SPINAL CORD MED, V40, P147, DOI 10.1179/2045772314Y.0000000235; Koppara Alexander, 2015, Alzheimers Dement (Amst), V1, P194, DOI 10.1016/j.dadm.2015.02.005; Krause James S, 2015, Top Spinal Cord Inj Rehabil, V21, P189, DOI 10.1309/sci2103-189; Krause JS, 2009, J SPINAL CORD MED, V32, P162, DOI 10.1080/10790268.2009.11760768; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Le J, 2016, SPINAL CORD, V54, P626, DOI 10.1038/sc.2016.69; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liew TM, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0527-7; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Mollayeva T, 2019, ALZH DEMENT-DADM, V11, P355, DOI 10.1016/j.dadm.2019.03.003; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; National Institutes of Health, 2012, PROMIS INSTRUMENT DE; National Spinal Cord Injury Statistical Center, 2020, SPIN CORD INJ FACTS; Nightingale TE, 2020, PHYSIOL BEHAV, V213, DOI 10.1016/j.physbeh.2019.112742; Paradise MB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-108; Perrotin A, 2017, ALZHEIMERS DEMENT, V13, P550, DOI 10.1016/j.jalz.2016.08.011; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Saunders LL, 2015, SPINAL CORD, V53, P641, DOI 10.1038/sc.2015.71; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Sperling SA, 2017, J GERIATR PSYCH NEUR, V30, P324, DOI 10.1177/0891988717732153; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Thelen JM, 2014, J PSYCHOSOM RES, V76, P400, DOI 10.1016/j.jpsychores.2014.02.013; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tsapanou A, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12759; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vaessen TJA, 2015, SLEEP MED REV, V19, P51, DOI 10.1016/j.smrv.2014.03.008; van Gorp S, 2015, EUR J PAIN, V19, P5, DOI 10.1002/ejp.522; Yuan CZ, 2019, NEUROLOGY, V92, pE63, DOI 10.1212/WNL.0000000000006684	51	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2021	66	3					248	256		10.1037/rep0000384			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	WV8LQ	WOS:000717482400002	34472923				2022-02-07	
J	Cucher, D; Harmon, L; Myer, B; Ngyuen, A; Rankin, T; Cook, A; Hu, C; Tesoriero, R; Scalea, T; Stein, D				Cucher, Daniel; Harmon, Laura; Myer, Brian; Ngyuen, Andrew; Rankin, Timothy; Cook, Alan; Hu, Charles; Tesoriero, Ronald; Scalea, Thomas; Stein, Deborah			Critical traumatic brain injury is associated with worse coagulopathy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Coagulopathy; TEG; TBI	DIRECTED HEMOSTATIC RESUSCITATION; FRESH-FROZEN PLASMA; HEMORRHAGIC-SHOCK; TISSUE FACTOR; PLATELET; TRANSFUSION; OUTCOMES	Objectives As thromboelastography (TEG) becomes the standard of care in patients with hemorrhagic shock (HS), an association between concomitant traumatic brain injury (TBI) and coagulopathy by TEG parameters is not well understood and is thus investigated. Methods Retrospective analysis of trauma registry data at a single level 1 trauma center of 772 patients admitted with head Abbreviated Injury Scale (AIS) score of 3 and TEG studies between 2014 and 2017. Patients were stratified to moderate-severe TBI by head AIS scores of 3 and 4 (435 patients) and critical TBI by head AIS score of 5 (328 patients). Hemorrhagic shock was defined by base deficit of 4 or shock index of 0.9. Statistical analysis with unpaired t tests compared patients with critical TBI with patients with moderate-severe TBI, and patients were grouped by presence or absence of HS. A comparison of TBI data with conventional coagulation studies was also evaluated. Results In the setting of HS, critical TBI versus moderate-severe TBI was associated with longer R time (p = 0.004), longer K time (p < 0.05), less acute angle (p = 0.001), and lower clot strength and stability (maximum amplitude [MA]) (p = 0.01). Worse TBI did not correlate with increased fibrinolysis by clot lysis measured by the percentage decrease in amplitude at 30 minutes after MA (p = 0.3). Prothrombin time and international normalized ratio failed to demonstrate more severe coagulopathy, while partial thromboplastin time was found to correlate with severity of TBI (p = 0.01). In patients with critical TBI, the presence of HS correlated with a statistically significant worsening of all parameters (p < 0.05) except for clot lysis measured by the percentage decrease in amplitude at 30 minutes after MA (LY-30). Conclusion Thromboelastography demonstrates that, with and without hemorrhagic shock, critical TBI correlates with a significant worsening of traumatic coagulopathy in comparison with moderate/severe TBI. In HS, critical TBI correlates with impaired clot initiation, impaired clot kinetics, and impaired platelet-associated clot strength and stability versus parameters found in moderate-severe TBI. Hemorrhagic shock correlates with worse traumatic coagulopathy in all evaluated patient groups with TBI. Conventional coagulation studies underestimate TBI-associated coagulopathy. Traumatic brain injury-associated coagulopathy is not associated with fibrinolysis.	[Cucher, Daniel; Cook, Alan; Hu, Charles] Chandler Reg Med Ctr, Div Trauma, Chandler, AZ 85224 USA; [Harmon, Laura] Univ Colorado, Anschutz Med Ctr, Sect Trauma Acute Care Surg Surg Crit Care & Burn, Aurora, CO USA; [Myer, Brian] Univ Minnesota Hlth, Div Crit Care & Acute Care Surg, St Paul, MN USA; [Ngyuen, Andrew] Riverside Univ Hlth Syst Med Ctr, Div Trauma Surg & Surg Crit Care, Riverside, CA USA; [Rankin, Timothy] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Tesoriero, Ronald; Scalea, Thomas; Stein, Deborah] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Program Trauma, Baltimore, MD 21201 USA		Cucher, D (corresponding author), Chandler Reg Med Ctr, 485 S Dobson Rd,Suite 110, Chandler, AZ 85224 USA.	daniel.cucher@commonspirit.org					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Daley MJ, 2017, EUR J TRAUMA EMERG S, V43, P105, DOI 10.1007/s00068-016-0643-z; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; FLECK RA, 1990, THROMB RES, V57, P765, DOI 10.1016/0049-3848(90)90034-A; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Moore EE, 2018, J TRAUMA ACUTE CARE, V84, pS35, DOI 10.1097/TA.0000000000001797; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Shenkman B, 2017, J TRAUMA ACUTE CARE, V82, P287, DOI 10.1097/TA.0000000000001282; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	20	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2021	91	2					331	335		10.1097/TA.0000000000003253			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TV2YO	WOS:000681591100017	34397954				2022-02-07	
J	Daia, C; Scheau, C; Spinu, A; Andone, I; Popescu, C; Toader, C; Bumbea, AM; Verenca, MC; Onose, G				Daia, Cristina; Scheau, Cristian; Spinu, Aura; Andone, Ioana; Popescu, Cristina; Toader, Corneliu; Bumbea, Ana Maria; Verenca, Madalina Codruta; Onose, Gelu			Modulated Neuroprotection in Unresponsive Wakefulness Syndrome after Severe Traumatic Brain Injury	BRAIN SCIENCES			English	Article						severe traumatic brain injury; unresponsive wakefulness syndrome; vegetative state; neurological assessment; neuroprotective treatment	MONTREAL COGNITIVE ASSESSMENT; MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; HEAD TRAUMA; COMA; SCALE	Background: We aimed to assess the effects of modulated neuroprotection with intermittent administration in patients with unresponsive wakefulness syndrome (UWS) after severe traumatic brain injury (TBI). Methods: Retrospective analysis of 60 patients divided into two groups, with and without neuroprotective treatment with Actovegin, Cerebrolysin, pyritinol, L-phosphothreonine, L-glutamine, hydroxocobalamin, alpha-lipoic acid, carotene, DL-alpha-tocopherol, ascorbic acid, thiamine, pyridoxine, cyanocobalamin, Q 10 coenzyme, and L-carnitine alongside standard treatment. Main outcome measures: Glasgow Coma Scale (GCS) after TBI, Extended Glasgow Coma Scale (GOS E), Disability Rankin Scale (DRS), Functional Independence Measurement (FIM), and Montreal Cognitive Assessment (MOCA), all assessed at 1, 3, 6, 12, and 24 months after TBI. Results: Patients receiving neuroprotective treatment recovered more rapidly from UWS than controls (p = 0.007) passing through a state of minimal consciousness and gradually progressing until the final evaluation (p = 0.000), towards a high cognitive level MOCA = 22 +/- 6 points, upper moderate disability GOS-E = 6 +/- 1, DRS = 6 +/- 4, and an assisted gait, FIM =101 +/- 25. The improvement in cognitive and physical functioning was strongly correlated with lower UWS duration (-0.8532) and higher GCS score (0.9803). Conclusion: Modulated long-term neuroprotection may be the therapeutic key for patients to overcome UWS after severe TBI.	[Daia, Cristina; Spinu, Aura; Andone, Ioana; Popescu, Cristina; Toader, Corneliu; Onose, Gelu] Carol Davila Univ Med & Pharm, Dept Med Rehabil, Bucharest 041914, Romania; [Daia, Cristina; Spinu, Aura; Andone, Ioana; Popescu, Cristina; Onose, Gelu] Clin Emergency Hosp Bagdasar Arseni, Neuromuscular Dept, Bucharest 041914, Romania; [Scheau, Cristian] Carol Davila Univ Med & Pharm, Dept Physiol, Bucharest 050474, Romania; [Toader, Corneliu] Natl Inst Cerebro Vasc Dis, Dept Neurosurg, Bucharest 041914, Romania; [Bumbea, Ana Maria] Univ Med & Pharm, Dept Med Rehabil, Craiova 200349, Romania; [Bumbea, Ana Maria] Clin Neuropsychiat Hosp, Neurorehabil Dept, Craiova 200473, Romania; [Verenca, Madalina Codruta] St John Emergency Hosp Children, Galati 800402, Romania		Scheau, C (corresponding author), Carol Davila Univ Med & Pharm, Dept Physiol, Bucharest 050474, Romania.	cristinaoctavianadaia@gmail.com; cristian.scheau@umfcd.ro; aura_ko@yahoo.com; ioanaandone11@yahoo.com; cristina_popescu_recuperare@yahoo.com; corneliutoader@gmail.com; anamariabumbea@yahoo.com; madverrec@gmail.com; geluonose@gmail.com	Onose, Gelu/AAC-6786-2021; Scheau, Cristian/AAC-3378-2021; Daia, Cristina/ABB-8725-2021; Toader, Corneliu/AAY-8825-2021; Daia, Cristina/R-6294-2018	Onose, Gelu/0000-0002-6346-8941; Scheau, Cristian/0000-0001-7676-6393; Daia, Cristina/0000-0002-9872-6496; Daia, Cristina/0000-0002-9872-6496; Spinu, Aura/0000-0002-0823-1511; Popescu, Cristina/0000-0002-5703-985X; Bumbea, Ana Maria/0000-0001-5132-2788			Allan Kaylee, 2019, JBI Database System Rev Implement Rep, V17, P1901, DOI 10.11124/JBISRIR-2017-003984; Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3; Bornstein NM, 2018, NEUROL SCI, V39, P629, DOI 10.1007/s10072-017-3214-0; Chen H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29430-6; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Firsching R, 2017, DTSCH ARZTEBL INT, V114, P313, DOI 10.3238/arztebl.2017.0313; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Huff J.S., 2021, STATPEARLS; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jain S., 2021, STATPEARLS; Jhala SS, 2011, NEUROCHEM INT, V58, P248, DOI 10.1016/j.neuint.2010.11.019; Kavusipur Somaye, 2013, Bull Emerg Trauma, V1, P86; Kim HJ, 2012, J KOREAN NEUROSURG S, V51, P24, DOI 10.3340/jkns.2012.51.1.24; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Mkrtchyan GV, 2018, BBA-BIOENERGETICS, V1859, P925, DOI 10.1016/j.bbabio.2018.05.005; Muresanu D., 2018, NEUROTRAUMA COMPREHE, P333, DOI [10.1093/med/9780190279431.003.0027, DOI 10.1093/MED/9780190279431.003.0027]; Muresanu DF, 2020, NEUROL SCI, V41, P1171, DOI 10.1007/s10072-019-04181-y; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Olaya J, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120990; Onose G, 2009, J Med Life, V2, P350; Onose G., 2011, ROMANIAN NEUROSURGER, V18, P11; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Wu FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00406	33	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2021	11	8							1044	10.3390/brainsci11081044			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG1PL	WOS:000689033100001	34439663	Green Published, gold			2022-02-07	
J	Dawod, AY; Phaphuangwittayakul, A				Dawod, Ahmad Yahya; Phaphuangwittayakul, Aniwat			Adaptive Image Segmentation for Traumatic Brain Haemorrhage	TEM JOURNAL-TECHNOLOGY EDUCATION MANAGEMENT INFORMATICS			English	Article						Traumatic Brain Injury; segmentation; DRLSE; Thresholding; Morphological	ALGORITHM	It is challenging to establish a significant solution with computer techniques to improve the speed and efficiency of Traumatic Brain Injury (TBI) diagnosis. Several segmentation methods involving diverse precision and a degree of effort have been proposed and detailed within the related literature. Segmentation of Brain image is one of the significant clinical diagnostics implements. This paper proposes a modified (MDRLSE) calculation for haemorrhage segmentation on Computed Tomography (CT) images. The image noise that abdicates the obscured edges is utilized to portray the precise boundary of the haemorrhage region. The proposed segmentation technique achieved an accuracy rate of 97.16%. The technique is implemented using an edge-based involved contour model for image segmentation, providing a simple narrowband to significantly reduce computational costs. The performance results show that it is effective for TBI image segmentation in brain images with various characteristics.	[Dawod, Ahmad Yahya; Phaphuangwittayakul, Aniwat] Chiang Mai Univ, Int Coll Digital Innovat, 239 Nimmanahaeminda Rd, Chiang Mai 50200, Thailand		Dawod, AY (corresponding author), Chiang Mai Univ, Int Coll Digital Innovat, 239 Nimmanahaeminda Rd, Chiang Mai 50200, Thailand.	ahmadyahyadawod.a@cmu.ac.th			international college of digital innovation Chiang Mai University; Faculty of Medicine Research Fund [143-2562]	The researchers wish to thank the international college of digital innovation Chiang Mai University and supported by the Faculty of Medicine Research Fund, grant no. 143-2562 to help our group to collect the datasets of haemorrhage CT scan images.	Phan AC, 2019, J INFORM TELECOMMUN, V3, P196, DOI 10.1080/24751839.2018.1547951; Aslam A, 2015, PROCEDIA COMPUT SCI, V58, P430, DOI 10.1016/j.procs.2015.08.057; Burduja M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20195611; Chang PD, 2018, AM J NEURORADIOL, V39, P1609, DOI 10.3174/ajnr.A5742; Chaudhary N, 2015, EXP NEUROL, V272, P88, DOI 10.1016/j.expneurol.2015.05.011; Chen H, 2018, NEUROIMAGE, V170, P446, DOI 10.1016/j.neuroimage.2017.04.041; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Danilov G, 2020, STUD HEALTH TECHNOL, V272, P370, DOI 10.3233/SHTI200572; Dawod A Y, 2010, 2010 International Conference on Computer Applications and Industrial Electronics (ICCAIE), P486, DOI 10.1109/ICCAIE.2010.5735129; Dhal KG, 2020, ARCH COMPUT METHOD E, V27, P855, DOI 10.1007/s11831-019-09334-y; Fauzdar P., 2018, HDB RES ADV CONCEPTS, P77, DOI [10.4018/978-1-5225-2848-7.ch004, DOI 10.4018/978-1-5225-2848-7.CH004]; Gautam A, 2018, BIOCYBERN BIOMED ENG, V38, P504, DOI 10.1016/j.bbe.2018.04.003; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; He W, 2013, CLIN IMAG, V37, P983, DOI 10.1016/j.clinimag.2013.08.001; Hssayeni MD, 2020, DATA, V5, DOI 10.3390/data5010014; Jayaraman T, 2020, VIS COMPUT IND BIOME, V3, DOI 10.1186/s42492-020-00064-8; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Ker J, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092167; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Li L, 2021, IEEE J BIOMED HEALTH, V25, P1646, DOI 10.1109/JBHI.2020.3028243; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Malathi M, 2019, Asian Pac J Cancer Prev, V20, P2095, DOI 10.31557/APJCP.2019.20.7.2095; Patel A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54491-6; Sage A, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10217577; Shahangian B, 2016, BIOCYBERN BIOMED ENG, V36, P217, DOI 10.1016/j.bbe.2015.12.001; Soltaninejad M., 2014, MIUA, P99; Thay S, 2018, 2018 INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION TECHNOLOGY (ICIIT 2018), P18, DOI 10.1145/3193063.3193073; Ye H, 2019, EUR RADIOL, V29, P6191, DOI 10.1007/s00330-019-06163-2; Zacks JM, 2016, CORTEX, V74, P233, DOI 10.1016/j.cortex.2015.11.002; Zhou ZW, 2018, LECT NOTES COMPUT SC, V11045, P3, DOI 10.1007/978-3-030-00889-5_1	31	0	0	0	0	ASSOC INFORMATION COMMUNICATION TECHNOLOGY EDUCATION & SCIENCE	NOVI PAZAR	HILMA ROZAJCA 15, NOVI PAZAR, 36300, SERBIA	2217-8309	2217-8333		TEM J	TEM J.	AUG	2021	10	3					1476	1487		10.18421/TEM103-61			12	Computer Science, Information Systems	Emerging Sources Citation Index (ESCI)	Computer Science	UK8EE	WOS:000692196800061		gold			2022-02-07	
J	Dong, XY; Ye, W; Tang, YL; Wang, J; Zhong, LY; Xiong, J; Liu, HP; Lu, GH; Feng, Z				Dong, Xiaoyang; Ye, Wen; Tang, Yunliang; Wang, Jun; Zhong, Linyang; Xiong, Jing; Liu, Haiping; Lu, Guohui; Feng, Zhen			Wakefulness-Promoting Effects of Lateral Hypothalamic Area-Deep Brain Stimulation in Traumatic Brain Injury-Induced Comatose Rats: Upregulation of alpha 1-Adrenoceptor Subtypes and Downregulation of Gamma-Aminobutyric Acid 13 Receptor Expression Via the Orexins Pathway	WORLD NEUROSURGERY			English	Article						alpha 1-Adrenoceptor subtypes; Deep brain stimulation; Gamma-aminobutyric acid beta receptor; Lateral hypothalamic area; Orexin receptor type 1; Traumatic brain injury; Wakefulness-promotion	NERVE-STIMULATION; SLEEP; MECHANISMS; DISORDERS; DISEASE	OBJECTIVE: Previous studies have shown that deep brain stimulation (DBS) can improve the level of consciousness of comatose patients with traumatic brain injuries (TBIs). However, the most suitable targets for DBS are unknown, and the mechanisms underlying recovery remain to be determined. The aim of the present study was to assess the effects of lateral hypothalamic area-DBS (LHA-DBS) in comatose rats with TBIs. METHODS: A total of 55 Sprague-Dawley rats were randomly assigned to 5 groups: the control group, TBI group, stimulated (TBI+LHA-DBS) group, antagonist (TBI+SB334867+LHA-DBS) group, and antagonist control (TBI+saline+LHA-DBS) group. The rats in the control group had undergone a sham operation and anesthesia, without coma induction. Coma was induced using a free fall drop method. The rats in the stimulated group received bilateral LHA stimulation (frequency, 200 Hz; voltage, 2-4 V; pulse width, 0.1 ms) for 1 hour, with 5 minute intervals between subsequent stimulations, which were applied alternately to the left and right sides of the lateral hypothalamus. The comatose rats in the antagonist group received an intracerebroventricular injection with an orexins receptor type 1 (OX1R) antagonist (SB334867) and then received LHA-DBS. A I -VI consciousness scale and electroencephalography were used to assess the level of consciousness in each group of rats after LHA-DBS. Western blotting and immunofluorescence were used to detect OX1R expression in the LHA and alpha 1-adrenoceptor (alpha 1-AR) subtype and gamma-aminobutyric acid b receptor (GABABR) expression in the prefrontal cortex. RESULTS: In the TBI, stimulated, antagonist, and antagonist control groups, 5, 10, 6, and 9 rats were awakened. The electroencephalographic readings indicated that the proportion of d waves was lower in the stimulated group than in the TBI and antagonist groups (P < 0.05). Western blotting and immunofluorescence analysis showed that OX1R expression was greater in the stimulated group than in the TBI group (P < 0.05). The expression of alpha 1-AR was also greater in the stimulated group than in the TBI and antagonist groups (P < 0.05). In contrast, the GABABR levels in the stimulated group were lower than those in the TBI and antagonist groups (P < 0.05). A statistically significant difference was found between the antagonist and antagonist control groups. CONCLUSIONS: Taken together, these results suggest that LHA-DBS promotes the recovery of consciousness in comatose rats with TBIs. Upregulation of alpha 1-AR expression and downregulation of GABABR expression in the prefrontal cortex via the orexins and OX1R pathways might be involved in the wakefulness-promoting effects of LHA-DBS.	[Dong, Xiaoyang; Ye, Wen; Tang, Yunliang; Wang, Jun; Zhong, Linyang; Xiong, Jing; Feng, Zhen] Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Liu, Haiping] Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Lu, Guohui] Nanchang Univ, Dept Neurosurg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	fengzhen@email.ncu.edu.cn					Assari S, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100703; Boss C, 2015, BIOORG MED CHEM LETT, V25, P2875, DOI 10.1016/j.bmcl.2015.05.012; Chijavadze E, 2013, Georgian Med News, P66; Chudy D, 2018, J NEUROSURG, V128, P1189; Cury RG, 2017, NEUROLOGY, V89, P1416, DOI 10.1212/WNL.0000000000004295; Dong XY, 2018, NEURAL REGEN RES, V13, P244, DOI 10.4103/1673-5374.226395; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng Z, 2016, NEURAL REGEN RES, V11, P951, DOI 10.4103/1673-5374.184494; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Gottshall JL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00020; Haddad AR, 2019, NEUROMODULATION, V22, P373, DOI 10.1111/ner.12944; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; HILAKIVI I, 1984, ACTA PHYSIOL SCAND, V120, P363, DOI 10.1111/j.1748-1716.1984.tb07396.x; Jang SH, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1607-9; Jia XJ, 2012, NEUROPHARMACOLOGY, V62, P775, DOI 10.1016/j.neuropharm.2011.08.047; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Khazipov R, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00161; Kundu B, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18168; Lemaire JJ, 2018, ANN CLIN TRANSL NEUR, V5, P1372, DOI 10.1002/acn3.648; Soto-Montenegro ML, 2014, MOL IMAGING BIOL, V16, P830, DOI 10.1007/s11307-014-0753-0; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martino A, 2020, FRONT SURG, V7, DOI 10.3389/fsurg.2020.00055; Mieda M, 2017, NEUROSCI RES, V118, P56, DOI 10.1016/j.neures.2017.03.015; Padilla R, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021022; Pigeon WR, 2010, SLEEP MED, V11, P816, DOI 10.1016/j.sleep.2010.06.002; Schwartz WJ, 2019, NEUROL CLIN, V37, P475, DOI 10.1016/j.ncl.2019.03.001; Shirasaka T, 2011, J ANESTH, V25, P65, DOI 10.1007/s00540-010-1071-6; Singh C, 2015, ELIFE, V4, DOI 10.7554/eLife.07000; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Dang TTH, 2019, MOV DISORD CLIN PRAC, V6, P348, DOI 10.1002/mdc3.12780; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Wang ZY, 2016, J PARKINSON DIS, V6, P317, DOI 10.3233/JPD-160817; Wu M, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/7089543; Wu X, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2045-x; Zhang X, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00386; Zhong YJ, 2015, MOL MED REP, V12, P4441, DOI 10.3892/mmr.2015.3898	37	0	0	6	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2021	152						E321	E331		10.1016/j.wneu.2021.05.089			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TS1ZH	WOS:000679455500001	34062300				2022-02-07	
J	Dunn, C; Sturdivant, N; Venier, S; Ali, S; Wolchok, J; Balachandran, K				Dunn, Celeste; Sturdivant, Nasya; Venier, Sara; Ali, Syed; Wolchok, Jeffery; Balachandran, Kartik			Blood-Brain Barrier Breakdown and Astrocyte Reactivity Evident in the Absence of Behavioral Changes after Repeated Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						blood-brain barrier breakdown; mild TBI; neuroinflammation; repeated TBI; traumatic brain injury (TBI)	PROFESSIONAL FOOTBALL; RISK; MODEL; S100B; MATRIX-METALLOPROTEINASE-9; TISSUE; EDEMA; NEUROINFLAMMATION; CONCUSSIONS; PERFORMANCE	Repeated traumatic brain injuries (TBIs) cause debilitating effects. Without understanding the acute effects of repeated TBIs, treatment options to halt further degeneration and damage cannot be developed. This study sought to examine the acute effects of blood-brain barrier (BBB) dysfunction, edema, inflammation and behavioral changes after either a single or double TBI using a C57BL/6 mouse model. We examined the effects of one or two TBIs, of either a mild or moderate severity. Double injuries were spaced 7 days apart, and all analysis was performed 24 h post-injury. To examine edema and inflammation, protein levels of glial fibrillary acidic protein (GFAP), S100 calcium-binding protein B, interleukin-6, and matrix metallopeptidase 9 (MMP9) were analyzed. Aquaporin-4 (AQP4) and zonula occludens-1 (ZO-1) were analyzed to observe BBB dysfunction. Ionized calcium-binding adapter molecule 1 (IBA1) was analyzed to observe microglial activation. Rotarod, beam walking, and grip strength tests were used to measure changes in physical behavior post-injury. A sample size of >= 5 was used for all analysis. Double injuries led to an increase in BBB breakdown, as indicated by altered MMP-9, AQP4, and ZO-1 protein expression. Single injuries showed an increase in microglial activation, astrocyte activation, and BBB breakdown. Behavioral tasks showed no significant differences between injured and control groups. Based on our findings, we suggest that behavioral studies should not be used as the sole clinical indicator on brain tissue recovery. Analysis of markers such as IBA1, GFAP, MMP-9, AQP4, and ZO-1 provide valuable insight on pathophysiological response to injury.	[Dunn, Celeste] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA; [Sturdivant, Nasya; Wolchok, Jeffery; Balachandran, Kartik] Univ Arkansas, Dept Biomed Engn, 122 John A White Jr Engn Hall, Fayetteville, AR 72701 USA; [Venier, Sara] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Ali, Syed] NCTR FDA, Neurochem Lab, Div Neurotoxicol, Jefferson, AR USA		Balachandran, K (corresponding author), Univ Arkansas, Dept Biomed Engn, 122 John A White Jr Engn Hall, Fayetteville, AR 72701 USA.	kbalacha@uark.edu			Arkansas Biosciences Institute; National Science FoundationNational Science Foundation (NSF) [CMMI-1404716, CMMI-1761071]	This project was funded by the Arkansas Biosciences Institute and the National Science Foundation under grant numbers CMMI-1404716 and CMMI-1761071.	Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schwaninger M, 1999, J NEUROCHEM, V73, P1461, DOI 10.1046/j.1471-4159.1999.0731461.x; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang Y., 2020, SCI ADV; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yardan T, 2011, J PAK MED ASSOC, V61, P276	54	0	0	6	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2021	2	1					399	410		10.1089/neur.2021.0017			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UL3AN	WOS:000692528100002	34901939	gold, Green Published			2022-02-07	
J	Estell, K				Estell, Krista			Acute Central Nervous System Trauma in the Field	VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE			English	Article						Spinal cord; Central nervous system; Trauma; Traumatic brain injury Traumatic spinal cord injury	CERVICAL VERTEBRAL FRACTURE; CREATINE-KINASE ACTIVITY; INTERNAL-FIXATION; BRAIN-INJURY; HORSES; RACEHORSES		[Estell, Krista] Virginia Techs, Marion duPont Scott Equine Med Ctr, 17690 Old Waterford Rd, Leesburg, VA 20176 USA		Estell, K (corresponding author), Virginia Techs, Marion duPont Scott Equine Med Ctr, 17690 Old Waterford Rd, Leesburg, VA 20176 USA.	bishopk@vt.edu					BARNES HG, 1995, J AM VET MED ASSOC, V206, P221; Bullock MR, 2007, GUIDELINES MANAGEMEN; Feary DJ, 2007, JAVMA-J AM VET MED A, V231, P259, DOI 10.2460/javma.231.2.259; Finno CJ, 2012, J VET INTERN MED, V26, P1251, DOI 10.1111/j.1939-1676.2012.00994.x; FURR MO, 1990, J AM VET MED ASSOC, V197, P245; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Gygax D, 2011, VET SURG, V40, P636, DOI 10.1111/j.1532-950X.2011.00842.x; Hoshide Reid, 2016, Surg Neurol Int, V7, P84, DOI 10.4103/2152-7806.190439; Jackson C, 1996, J VET INTERN MED, V10, P246, DOI 10.1111/j.1939-1676.1996.tb02057.x; JOHNSON BJ, 1994, EQUINE VET J, V26, P327, DOI 10.1111/j.2042-3306.1994.tb04395.x; Lischer CJ, 2005, EQUINE VET J, V37, P483, DOI 10.2746/042516405774480058; Lunn D. P., 1989, Equine Veterinary Education, V1, P94, DOI 10.1111/j.2042-3292.1989.tb01355.x; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mayhew IGJ, 2009, EQUINE VET EDUC, V21, P536, DOI 10.2746/095777309X461345; NIXON AJ, 1988, J AM VET MED ASSOC, V193, P677; Pinchbeck G, 2001, EQUINE VET EDUC, V13, P8, DOI 10.1111/j.2042-3292.2001.tb01874.x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rossignol F, 2016, VET SURG, V45, P104, DOI 10.1111/vsu.12425; Sarrafian TL, 2012, JAVMA-J AM VET MED A, V241, P935, DOI 10.2460/javma.241.7.935; Toth B, 2012, JAVMA-J AM VET MED A, V240, P580, DOI 10.2460/javma.240.5.580; Vaughan LC, 1976, CLIN PATHOLOGICAL ST; Vos P, 2015, TRAUMATIC BRAIN INJU; Winfield LS, 2014, EQUINE VET J, V46, P575, DOI 10.1111/evj.12147	23	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0739	1558-4224		VET CLIN N AM-EQUINE	Vet. Clin. N. Am.-Equine Pract.	AUG	2021	37	2					245	258		10.1016/j.cveq.2021.04.001			14	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	TF4HT	WOS:000670679800002	34119403				2022-02-07	
J	Firidin, MN				Firidin, Mustafa Nevzat			Effect of Resveratrol on the Changes in the Cerebellum in Traumatic Brain Injury	ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY			English	Article						ADAMTS-4; brain; cerebellum; GFAP; rat; resveratrol; traumatic brain injury	SPINAL-CORD-INJURY; RATS; PROTECTS; MODEL; ANTIOXIDANT; EXPRESSION; RECOVERY; ENZYME	OBJECTIVE: To study the effects of resveratrol in neuronal structures in traumatic brain injury (TBI). STUDY DESIGN: Thirty rats were categorized as (1) control group (n=10), saline solution administered i.p. for 14 days, (2) TBI group (n=10), trauma induced by weight-drop model on brain, and (3) TBI+ Resveratrol group (n=10), 15 minutes after injury the rats were given resveratrol (10 mu moL/kg/i.p.) for 14 days. At the end of the experiment the cerebellum was excised for routine paraffin tissue protocol. Blood samples were tested for serum biochemical markers (MDA, SOD, CAT, and GSH-x). RESULTS: SOD, GPx, and CAT values were lowest in the TBI group. MDA and histological scores of dilations in vessels, inflammation, degeneration in neurons, apoptosis in microglia, ADAMTS8, and GFAP expressions were highest in the TBI group. Sections of the control group showed normal cerebellar histology. The trauma group showed degenerated ganglion layer, pyknotic and apoptotic Purkinje cell nuclei. Vascular thrombus was seen in the substantia alba and substantia grisea. In the Trauma+ Resveratrol group, most pathologies observed in the TBI group were improved. In the control group, GFAP protein was expressed in granular cells, axons, dendrites, Purkinje cells, and microglia cells. In the trauma group, increased GFAP expression was observed in glial processes, neurons, and Purkinje cells. In the Trauma+ Resveratrol group, GFAP was expressed in molecular layer and glial processes. In the control group, ADAMTS-4 activity was observed in granulosa layer, glial cells, and Purkinje cells. In the trauma group, ADAMTS-4 expression was positive in Purkinje cells and glial cells. In the Trauma+ Resveratrol group, ADAMTS-4 was expressed in Purkinje cells, granular cells, and glial cells. CONCLUSION: GFAP and ADAMTS-4 proteins may be involved in regeneration of damaged astroglial cells and other glial cells, Purkinje cells, and synaptic extensions. We suggest that antioxidative drugs such as resveratrol may be alternative target agents in neurological disease.	[Firidin, Mustafa Nevzat] Siirt Univ, Fac Med, Dept Neurosurg, Gures St, TR-56100 Siirt, Turkey		Firidin, MN (corresponding author), Siirt Univ, Fac Med, Dept Neurosurg, Gures St, TR-56100 Siirt, Turkey.	firidin2828@gmail.com					AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Cetin A, 2019, FOLIA MORPHOL, V78, P221, DOI 10.5603/FM.a2018.0085; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farahnak A, 2013, IRAN J PARASITOL, V8, P167; Fu S, 2018, SAUDI J BIOL SCI, V25, P259, DOI 10.1016/j.sjbs.2016.10.019; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Guo ZB, 2013, BRAIN RES, V1532, P14, DOI 10.1016/j.brainres.2013.08.003; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Kaur C, 2014, BRAIN STRUCT FUNCT, V219, P151, DOI 10.1007/s00429-012-0491-5; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kong XY, 2017, J CELL MOL MED, V21, P941, DOI 10.1111/jcmm.13034; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Neelamkavil SV, 2016, S INDIAN J BIOL SCI, V2, P41; Noorudheen N, 2016, S INDIAN J BIOL SCI, V2, P95; Ozevren H, 2020, ACTA CIR BRAS, V35, DOI 10.1590/s0102-865020200040000006; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Peker N, 2020, ANAL QUANT CYTOPATHO, V42, P197; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schettler V, 1999, Ther Apher, V3, P219; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Valsan A, 2016, S INDIAN J BIOL SCI, V2, P75, DOI DOI 10.22205/SIJBS/2016/V2/I1/; Xing BZ, 2008, J NEUROCHEM, V105, P1737, DOI 10.1111/j.1471-4159.2008.05276.x; Xu BP, 2020, NEURAL REGEN RES, V15, P482, DOI 10.4103/1673-5374.266064; Zhang L, 2012, NEURAL REGEN RES, V7, P2882, DOI 10.3969/j.issn.1673-5374.2012.36.005; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027	29	0	0	1	1	SCI PRINTERS & PUBL INC	ST LOUIS	PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA	0884-6812			ANAL QUANT CYTOPATHO	Anal. Quant. Cytopathol. Histopathol.	AUG	2021	43	4					193	201					9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	WJ3HI	WOS:000708937900006					2022-02-07	
J	Fischer, PD; Hutchison, KA; Becker, JN; Monfort, SM				Fischer, Patrick D.; Hutchison, Keith A.; Becker, James N.; Monfort, Scott M.			Evaluating the Spectrum of Cognitive-Motor Relationships During Dual-Task Jump Landing	JOURNAL OF APPLIED BIOMECHANICS			English	Article						cognition; ACL; knee; sports biomechanics	CRUCIATE LIGAMENT INJURY; EXTREMITY MUSCULOSKELETAL INJURY; NEUROMUSCULAR CONTROL; ATTENTION CONTROL; WORKING-MEMORY; KNEE-JOINT; RISK; BIOMECHANICS; CONCUSSION; PERFORMANCE	Cognitive function plays a role in understanding noncontact anterior cruciate ligament injuries, but the research into how cognitive function influences sport-specific movements is underdeveloped. The purpose of this study was to determine how various cognitive tasks influenced dual-task jump-landing performance along with how individuals' baseline cognitive ability mediated these relationships. Forty female recreational soccer and basketball players completed baseline cognitive function assessments and dual-task jump landings. The baseline cognitive assessments quantified individual processing speed, multitasking, attentional control, and primary memory ability. Dual-task conditions for the jump landing included unanticipated and anticipated jump performance, with and without concurrent working memory and captured visual attention tasks. Knee kinematics and kinetics were acquired through motion capture and ground reaction force data. Jumping conditions that directed visual attention away from the landing, whether anticipated or unanticipated, were associated with decreased peak knee flexion angle (P < .001). No interactions between cognitive function measures and jump-landing conditions were observed for any of the biomechanical variables, suggesting that injury-relevant cognitive-motor relationships may be specific to secondary task demands and movement requirements. This work provides insight into group- and subject-specific effects of established anticipatory and novel working memory dual-task paradigms on the neuromuscular control of a sport-specific movement.	[Fischer, Patrick D.; Monfort, Scott M.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA; [Hutchison, Keith A.] Montana State Univ, Dept Psychol, Bozeman, MT 59717 USA; [Becker, James N.] Montana State Univ, Dept Hlth & Human Performance, Bozeman, MT 59717 USA		Fischer, PD (corresponding author), Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA.	patrick.fischer2@student.montana.edu					Almonroeder TG, 2018, J ORTHOP SPORT PHYS, V48, P381, DOI 10.2519/jospt.2018.7739; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brown TN, 2009, BRIT J SPORT MED, V43, P1049, DOI 10.1136/bjsm.2008.055954; Cortes N, 2011, SPORT BIOMECH, V10, P22, DOI 10.1080/14763141.2010.547591; Covassin T, 2010, OPEN ACCESS J SPORTS, V1, P55; Dai BY, 2018, SPORT BIOMECH, V17, P192, DOI 10.1080/14763141.2016.1265579; Deng HI., 1996, INVERSE METHODS, P320, DOI [10. 1007/BFb0011791, DOI 10.1007/BFB0011791]; EGETH H, 1975, AM J PSYCHOL, V88, P339, DOI 10.2307/1421603; Fischer R, 2010, INT J PSYCHOL RES, V3, P88, DOI 10.21500/20112084.852; Ford KR, 2005, J STRENGTH COND RES, V19, P394, DOI 10.1519/15834.1; Giesche F, 2020, J SCI MED SPORT, V23, P82, DOI 10.1016/j.jsams.2019.09.003; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Herzog MM., 2005, COST OUTPATIENT ARTH; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hutchison KA, 2007, J EXP PSYCHOL LEARN, V33, P645, DOI 10.1037/0278-7393.33.4.645; Kreidler SM, 2013, J STAT SOFTW, V54, P1, DOI 10.18637/jss.v054.i10; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Louw Q, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-22; Marquez G, 2017, J MUSCULOSKEL NEURON, V17, P409; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; Mok KM, 2017, SCAND J MED SCI SPOR, V27, P161, DOI 10.1111/sms.12640; Monfort SM, 2019, AM J SPORT MED, V47, P1488, DOI 10.1177/0363546519834544; POLLACK I, 1959, J EXP PSYCHOL, V57, P137, DOI 10.1037/h0046137; Redick TS, 2016, J EXP PSYCHOL GEN, V145, P1473, DOI 10.1037/xge0000219; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Shibata Satoshi, 2018, Phys Ther Res, V21, P44, DOI 10.1298/ptr.E9938; Shultz SJ, 2019, J ATHL TRAINING, V54, P970, DOI 10.4085/1062-6050-54.084; Simon D, 2015, ADV ORTHOP, V2015, DOI 10.1155/2015/928301; Stephenson ML, 2018, SPORT BIOMECH, V17, P67, DOI 10.1080/14763141.2017.1346141; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Taylor JB, 2017, J STRENGTH COND RES, V31, P3034, DOI 10.1519/JSC.0000000000001785; Thomas AC, 2013, J ATHL TRAINING, V48, P610, DOI 10.4085/1062-6050-48.3.23; Unsworth N, 2014, COGNITIVE PSYCHOL, V71, P1, DOI 10.1016/j.cogpsych.2014.01.003; Walden M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094573; Wiggins AJ, 2016, AM J SPORT MED, V44, P1861, DOI 10.1177/0363546515621554; Wilke J, 2021, BIOL SPORT, V38, P123, DOI 10.5114/biolsport.2020.97070; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4	47	0	0	7	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2021	37	4					388	395		10.1123/jab.2020-0388			8	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	TW6PI	WOS:000682518900014	34271547				2022-02-07	
J	Flowers, M; Leung, A; Schiehser, DM; Metzger-Smith, V; Delano-Wood, L; Sorg, S; Kunnel, A; Wong, A; Vaninetti, M; Golshan, S; Lee, R				Flowers, Matthew; Leung, Albert; Schiehser, Dawn M.; Metzger-Smith, Valerie; Delano-Wood, Lisa; Sorg, Scott; Kunnel, Alphonsa; Wong, Angeline; Vaninetti, Michael; Golshan, Shahrokh; Lee, Roland			Severities in persistent mild traumatic brain injury related headache is associated with changes in supraspinal pain modulatory functions	MOLECULAR PAIN			English	Article						MTBI; traumatic brain injury; chronic post-traumatic headache; pain modulation; functional magnetic resonance imaging; resting state functional activity	ALGORITHMS	Emerging evidence suggests mild traumatic brain injury related headache (MTBI-HA) is a form of neuropathic pain state. Previous supraspinal mechanistic studies indicate patients with MTBI-HA demonstrate a dissociative state with diminished levels of supraspinal prefrontal pain modulatory functions and enhanced supraspinal sensory response to pain in comparison to healthy controls. However, the relationship between supraspinal pain modulatory functional deficit and severity of MTBI-HA is largely unknown. Understanding this relationship may provide enhanced levels of insight about MTBI-HA and facilitate the development of treatments. This study assessed pain related supraspinal resting states among MTBI-HA patients with various headache intensity phenotypes with comparisons to controls via functional magnetic resonance imaging (fMRI). Resting state fMRI data was analyzed with self-organizing-group-independent-component-analysis in three MTBI-HA intensity groups (mild, moderate, and severe) and one control group (n = 16 per group) within a pre-defined supraspinal pain network based on prior studies. In the mild-headache group, significant increases in supraspinal function were observed in the right premotor cortex (T = 3.53, p < 0.001) and the left premotor cortex (T = 3.99, p < 0.0001) when compared to the control group. In the moderate-headache group, a significant (T = -3.05, p < 0.01) decrease in resting state activity was observed in the left superior parietal cortex when compared to the mild-headache group. In the severe-headache group, significant decreases in resting state supraspinal activities in the right insula (T = -3.46, p < 0.001), right premotor cortex (T = -3.30, p < 0.01), left premotor cortex (T = -3.84, p < 0.001), and left parietal cortex (T = -3.94, p < 0.0001), and an increase in activity in the right secondary somatosensory cortex (T = 4.05, p < 0.0001) were observed when compared to the moderate-headache group. The results of the study suggest that the increase in MTBI-HA severity may be associated with an imbalance in the supraspinal pain network with decline in supraspinal pain modulatory function and enhancement of sensory/pain decoding.	[Flowers, Matthew; Leung, Albert; Schiehser, Dawn M.; Metzger-Smith, Valerie; Delano-Wood, Lisa; Sorg, Scott; Kunnel, Alphonsa; Wong, Angeline; Vaninetti, Michael; Golshan, Shahrokh] Vet Affairs San Diego Healthcare Syst, Ctr Pain & Headache Res, San Diego, CA USA; [Leung, Albert; Vaninetti, Michael] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92161 USA; [Schiehser, Dawn M.; Delano-Wood, Lisa; Sorg, Scott] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Lee, Roland] Vet Affairs San Diego Healthcare Syst, Dept Radiol, San Diego, CA USA		Leung, A (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92161 USA.	ayleung@health.ucsd.edu			VA Rehabilitation and Research Development SPIRE [21RX001359, 21RX002366, IRX002506A, CDA-2-034-07F]; Schiehser [CDA-2-06510S]; Veterans Affairs Merit AwardUS Department of Veterans Affairs [CX000842-01A2]; Department of Defense Investigator-Initiated Research GrantUnited States Department of Defense [W81XWH-10-2-0169]; VA Clinical Science Research Development [IK2CX001508]; VA Clinical Science Research & Development Service	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the funding support from the VA Rehabilitation and Research Development SPIRE and Merit Awards to Dr. Leung (21RX001359, 21RX002366, IRX002506A), a Career Development Awards to Drs. Delano-Wood (CDA-2-034-07F) and Schiehser (CDA-2-06510S), a Veterans Affairs Merit Award to Dr. Delano-Wood (CX000842-01A2) as well as a Department of Defense Investigator-Initiated Research Grant awarded to Dr. Delano-Wood (W81XWH-10-2-0169). Dr. Sorg received salary support from a VA Clinical Science Research & Development funded Career Development Award (IK2CX001508) from the VA Clinical Science Research & Development Service.	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Defrin R., 2014, J NEUROTRAUM; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Formisano E., 2005, FUNDAMENTALS DATA AN, P479; Furukawa TA, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000088; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Leung A., 2006, NEUROIMAGE, V31, P504; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-18; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Shukla S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-45; Stilling J, 2020, J NEUROTRAUM, V37, P312, DOI 10.1089/neu.2019.6692; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Tracey Irene, 2007, Curr Opin Support Palliat Care, V1, P109, DOI 10.1097/SPC.0b013e3282efc58b	29	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		1744-8069		MOL PAIN	Mol. Pain	AUG	2021	17								17448069211037881	10.1177/17448069211037881			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ6DN	WOS:000709133600001	34365850	Green Published, gold			2022-02-07	
J	Freislederer, F; Bensler, S; Specht, T; Magerkurth, O; Eid, K				Freislederer, Florian; Bensler, Susanne; Specht, Thomas; Magerkurth, Olaf; Eid, Karim			Plate Fixation for Irreducible Proximal Humeral Fractures in Children and Adolescents-A Single-Center Case Series of Six Patients	CHILDREN-BASEL			English	Article						humerus fracture; proximal humeral fracture; children; plate fixation; ORIF; tissue entrapment; biceps	CONSTANT SCORE	Background: Recommended treatment for severely displaced proximal humeral fractures in children is the closed reduction and percutaneous fixation by K-wires or intramedullary nailing. Methods: From January 2016 to January 2017 6, 21 children/adolescents (range 8 to 16 years) with proximal humeral fractures were treated surgically for severe displacement. In these six patients, several attempts of closed reduction were unsuccessful, and an open reduction was performed. The humeral head was fixed with a 3.5 mm T-plate without affecting the growth plate. Plate removal was performed at a mean interval of 132 days after initial surgery. Two years after initial surgery, the clinical outcome was assessed by the Constant-Murley score and QuickDASH score (including sport/music and work) and the shoulder joint was evaluated with a standardized sonographic examination for the rotator cuff and the conjoint tendon. Results: In all six patients, dorsal displacement of the fracture was irreducible due to the interposition of tendinous or osseous structures. Intraoperatively, the interposed structures were the long biceps tendon in two, periosteal tissue in two, a bony fragment in one, and the long biceps tendon together with the conjoint tendon in one case. At mean follow-up of 26 months (range 22 months to 29 months), patients showed very good clinical results with an excellent mean Constant-Murley score of 97.5 (range 91 to 100) and mean QuickDASH score (including sport/music and work) of 5.5 (range 0-20.8). An X-ray follow-up 6 weeks after surgery demonstrated early consolidation and correct alignment in all patients. A sonographic evaluation at 2 years post injury showed that the biceps and the conjoined tendon were intact in all patients. Conclusions: If a proximal humeral fracture is not reducible by closed means, a tissue entrapment (most likely biceps tendon) should be considered. Treatment with an open reduction and plate fixation yields very good clinical and radiological results and preserves interposed structures as the biceps and conjoint tendon.	[Freislederer, Florian; Specht, Thomas; Eid, Karim] Kantonsspital Baden KSB, Dept Orthopaed & Traumatol, Ergel 1, CH-5404 Baden, Switzerland; [Bensler, Susanne] Kantonsspital Baden KSB, Unit Musculoskeletal Radiol, Dept Radiol, Ergel 1, CH-5404 Baden, Switzerland; [Magerkurth, Olaf] Kantonsspital Baden KSB, Unit Pediat Radiol, Dept Radiol, Ergel 1, CH-5404 Baden, Switzerland		Freislederer, F; Eid, K (corresponding author), Kantonsspital Baden KSB, Dept Orthopaed & Traumatol, Ergel 1, CH-5404 Baden, Switzerland.	freislederer.florian@gmail.com; susanne.bensler@ksb.ch; thomas.specht@ksb.ch; olaf.magerkurth@ksb.ch; karim.eid@ksb.ch					Bahrs C, 2009, J PEDIATR ORTHOPED, V29, P238, DOI 10.1097/BPO.0b013e31819bd9a7; Bankes MJK, 1998, J SHOULDER ELB SURG, V7, P116, DOI 10.1016/S1058-2746(98)90220-8; Beaty J H, 1992, Instr Course Lect, V41, P369; Binder H, 2011, INT ORTHOP, V35, P1497, DOI 10.1007/s00264-011-1277-8; Bishop JY, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000156004.01503.43; BOYDEN EM, 1991, ORTHOPEDICS, V14, P585; Chee Y, 2006, J PEDIATR ORTHOP B, V15, P45, DOI 10.1097/01202412-200601000-00010; DAMERON TB, 1969, J BONE JOINT SURG AM, VA 51, P289, DOI 10.2106/00004623-196951020-00008; Dobbs MB, 2003, J PEDIATR ORTHOPED, V23, P208, DOI 10.1097/00004694-200303000-00015; Fernandez FF, 2008, INJURY, V39, P1453, DOI 10.1016/j.injury.2008.04.001; Fialka C, 2005, INJURY, V36, P1159, DOI 10.1016/j.injury.2004.12.023; Kelly DM, 2016, J PEDIATR ORTHOPED, V36, pS49, DOI 10.1097/BPO.0000000000000755; Kinderchirurgie D.G.F, 2016, AWMF ONLINE, V4, P1; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Lefevre Y, 2014, ORTHOP TRAUMATOL-SUR, V100, pS149, DOI 10.1016/j.otsr.2013.06.010; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; Pahlavan S, 2011, J CHILD ORTHOP, V5, P187, DOI 10.1007/s11832-011-0328-4; Pandya NK, 2012, J CHILD ORTHOP, V6, P111, DOI [10.1007/s11832-012-0398-y, 10.1007/s11832-012-0397-z]; Peterson H.A., 2011, PHYSEAL INJURY OTHER; Quatman-Yates CC, 2013, J PEDIATR ORTHOPED, V33, P838, DOI 10.1097/BPO.0b013e3182a00688; Rajan RA, 2008, J CHILD ORTHOP, V2, P15, DOI 10.1007/s11832-007-0070-0; Schwendenwein E, 2004, EUR J PEDIATR SURG, V14, P51, DOI 10.1055/s-2004-815781; Shrader MW, 2007, HAND CLIN, V23, P431, DOI 10.1016/j.hcl.2007.09.002	23	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	AUG	2021	8	8							635	10.3390/children8080635			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	UF9RW	WOS:000688904200001	34438526	Green Published			2022-02-07	
J	Fujiwara, G; Okada, Y; Ishii, W; Iizuka, R; Murakami, M; Sakakibara, T; Yamaki, T; Hashimoto, N				Fujiwara, Gaku; Okada, Yohei; Ishii, Wataru; Iizuka, Ryoji; Murakami, Mamoru; Sakakibara, Takehiko; Yamaki, Tarumi; Hashimoto, Naoya			Association of skull fracture with in-hospital mortality in severe traumatic brain injury patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Skull fracture; Coagulopathy	HEAD TRAUMA; COAGULOPATHY; JAPAN	Introduction: To identify the association between skull fracture (SF) and in-hospital mortality in patients with se-vere traumatic brain injury (TBI). Materials and methods: This multicenter cohort study included a retrospective analysis of data from the Japan Trauma Data Bank (JTDB). JTDB isa nationwide, prospective, observational trauma registry with data from 235 hospitals. Adult patients with severe TBI (Glasgow Coma Scale <9, head Abbreviated Injury Scale (AIS) >= 3, and any other AIS < 3) who were registered in the JTDB between January 2004 and December 2017 were in-cluded in the study. Patients who (a) were < 16 years old, (b) developed cardiac arrest before or at hospital ar -rival, and (c) had burns and penetrating injuries were excluded from the study. In-hospital mortality was the primary outcome assessed. Multivariable logistic regression analyses were performed to calculate the adjusted odds ratios (ORs) of SF and their 95% confidence intervals (CIs) for in-hospital mortality. Results: A total of 9607 patients were enrolled [median age: 67 (interquartile range: 50-78) years] in the study. Among those patients, 3574 (37.2%) and 6033 (62.8%) were included in the SF and non-SF groups, respectively. The overall in-hospital mortality rate was 44.1% (4238/9607). A multivariate analysis of the association between SF and in-hospital mortality yielded a crude OR of 1.63 (95% CI: 1.47-1.80). A subgroup analysis of the association of skull vault fractures, skull base fractures, and both fractures together with in-hospital mortality yielded ad-justed ORs of 1.60 (95% CI: 1.42-1.98), 1.40 (95% CI: 1.16-1.70), and 2.14 (95% CI: 1.74-2.64), respectively, rel-ative to the non-SF group. Conclusions: This observational study showed that SF is associated with in-hospital mortality among patients with severe TBI. Furthermore, patients with both skull base and skull vault fractures were associated with higher in-hospital mortality than those with only one of these injuries. (c) 2021 Elsevier Inc. All rights reserved.	[Fujiwara, Gaku; Hashimoto, Naoya] Kyoto Prefectural Univ Med, Dept Neurosurg, Kyoto, Japan; [Fujiwara, Gaku; Murakami, Mamoru] Japanese Red Cross Soc, Kyoto Daini Hosp, Dept Neurosurg, Kyoto, Japan; [Okada, Yohei; Ishii, Wataru; Iizuka, Ryoji] Japanese Red Cross Soc, Kyoto Daini Hosp, Dept Emergency Med & Crit Care, Kyoto, Japan; [Okada, Yohei] Kyoto Univ, Sch Publ Hlth, Dept Prevent Serv, Kyoto, Japan; [Sakakibara, Takehiko; Yamaki, Tarumi] Kyoto Kujo Hosp, Dept Neurosurg, Kyoto, Japan		Fujiwara, G (corresponding author), 465 Kajii Cho,Kamigyo Ku, Kyoto, Kyoto 5650871, Japan.	gakufujiwara@hotmail.com; yokada-kyf@umin.ac.jp; wataruaug0804@lily.ocn.ne.jp; iizukar@kyoto2.jcr.or.jp; t-sakaki@msf.biglobe.ne.jp; ytaru@wf6.so-net.jp	OKADA, YOHEI/ABI-3017-2020	OKADA, YOHEI/0000-0002-2266-476X; Fujiwara, Gaku/0000-0002-2799-9243; Ishii, Wataru/0000-0002-4992-2255			[Anonymous], 2009, TRAUMA DATA BANK REP; Benson M, 1996, Prehosp Disaster Med, V11, P117; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Endo A, 2017, J AM COLL SURGEONS, V224, P191, DOI 10.1016/j.jamcollsurg.2016.10.051; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Faried A, 2019, CHIN J TRAUMATOL, V22, P286, DOI 10.1016/j.cjtee.2019.05.006; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Haut RC, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4034430; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kushimoto S, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0196-6; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Sahoo D, 2016, J MECH BEHAV BIOMED, V57, P24, DOI 10.1016/j.jmbbm.2015.11.014; Sahoo D, 2013, J MECH BEHAV BIOMED, V28, P340, DOI 10.1016/j.jmbbm.2013.08.010; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shibahashi K, 2020, J NEUROSURG, V133, P504, DOI 10.3171/2019.4.JNS182660; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; SIMPSON DA, 1989, J TRAUMA, V29, P1519, DOI 10.1097/00005373-198911000-00011; SmithSeemiller L, 1997, BRAIN INJURY, V11, P191; Sosin DM, 1996, BRAIN INJURY, V10, P47; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Tohira Hideo, 2011, Ann Adv Automot Med, V55, P255; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Vander Vorst Michael, 2003, Annu Proc Assoc Adv Automot Med, V47, P363; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weisenbach CA, 2018, MIL MED, V183, P287, DOI 10.1093/milmed/usx210; Yanagawa Y, 2000, NEUROL MED-CHIR, V40, P133, DOI 10.2176/nmc.40.133; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524	35	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2021	46						78	83		10.1016/j.ajem.2021.03.020			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TU8UX	WOS:000681307200015	33740570				2022-02-07	
J	Gagnon, A; Laroche, M; Williamson, D; Giroux, M; Giguere, JF; Bernard, F				Gagnon, Alexandrine; Laroche, Mathieu; Williamson, David; Giroux, Marc; Giguere, Jean-Francois; Bernard, Francis			Incidence and characteristics of cerebral hypoxia after craniectomy in brain-injured patients: a cohort study	JOURNAL OF NEUROSURGERY			English	Article						cerebral oxygenation; traumatic brain injury; multimodality monitoring; decompressive craniectomy; intracranial pressure; disease management	DECOMPRESSIVE CRANIECTOMY; OXYGEN DELIVERY; EPIDEMIOLOGY; MECHANISMS; DIFFUSION	OBJECTIVE After craniectomy, although intracranial pressure (ICP) is controlled, episodes of brain hypoxia might still occur. Cerebral hypoxia is an indicator of poor outcome independently of ICP and cerebral perfusion pressure. No study has systematically evaluated the incidence and characteristics of brain hypoxia after craniectomy. The authors' objective was to describe the incidence and characteristics of brain hypoxia after craniectomy. METHODS The authors included 25 consecutive patients who underwent a craniectomy after traumatic brain injury or intracerebral hemorrhage and who were monitored afterward with a brain tissue oxygen pressure monitor. RESULTS The frequency of hypoxic values after surgery was 14.6% despite ICP being controlled. Patients had a mean of 18 +/- 23 hypoxic episodes. Endotracheal (ET) secretions (17.4%), low cerebral perfusion pressure (10.3%), and mobilizing the patient (8.6%) were the most common causes identified. Elevated ICP was rarely identified as the cause of hypoxia (4%). No cause of cerebral hypoxia could be determined 31.2% of the time. Effective treatments that were mainly used included sedation/analgesia (20.8%), ET secretion suctioning (15.4%), and increase in fraction of inspired oxygen or positive end-expiratory pressure (14.1%). CONCLUSIONS Cerebral hypoxia is common after craniectomy, despite ICP being controlled. ET secretion and patient mobilization are common causes that are easily treatable and often not identified by standard monitoring. These results suggest that monitoring should be pursued even if ICP is controlled. The authors' findings might provide a hypothesis to explain the poor functional outcome in the recent randomized controlled trials on craniectomy after traumatic brain injury where in which brain tissue oxygen pressure was not measured.	[Gagnon, Alexandrine] Univ Montreal, Nursing Sch, Montreal, PQ, Canada; [Gagnon, Alexandrine; Laroche, Mathieu; Giroux, Marc; Giguere, Jean-Francois] Univ Montreal, Neurosurg Dept, Montreal, PQ, Canada; [Gagnon, Alexandrine; Laroche, Mathieu; Williamson, David; Giroux, Marc; Giguere, Jean-Francois] Univ Montreal, Pharm Dept, Montreal, PQ, Canada; [Gagnon, Alexandrine; Laroche, Mathieu; Williamson, David; Giroux, Marc; Giguere, Jean-Francois; Bernard, Francis] Univ Montreal, Med Dept, Montreal, PQ, Canada; [Gagnon, Alexandrine; Laroche, Mathieu; Williamson, David; Giroux, Marc; Giguere, Jean-Francois; Bernard, Francis] Hop Sacre Coeur Montreal, Ctr Integre Univ Sante & Serv Sociaux CIUSSS Nord, Montreal, PQ, Canada		Bernard, F (corresponding author), Hop Sacre Coeur Montreal, Montreal, PQ, Canada.	f.bernard@umontreal.ca					Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Freye E, 2003, ANASTH INTENSIV NOTF, V38, P14, DOI 10.1055/s-2003-36558; Ghajar J., 2006, NEUROSURGERY, V58, pI, DOI DOI 10.1093/NEUROSURGERY/58.SUPPL_3.S2-VI; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Habler OP, 1997, TRANSFUS SCI, V18, P425, DOI 10.1016/S0955-3886(97)00041-6; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Lubillo ST, 2018, J NEUROSURG, V128, P1538, DOI 10.3171/2017.1.JNS161840; Maggia Christophe, 2016, Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries. First International Workshop, Brainles 2015, held in conjunction with MICCAI 2015. Revised Selected Papers: LNCS 9556, P57, DOI 10.1007/978-3-319-30858-6_6; Marinkovic I, 2009, NEUROSURGERY, V65, P780, DOI 10.1227/01.NEU.0000351775.30702.A9; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Rahman M., 2018, JNINB, V3, P80; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zhang JW, 2017, MAGN RESON MED, V77, P1762, DOI 10.1002/mrm.26253	29	0	0	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					554	561		10.3171/2020.6.JNS20776			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800027	33157533				2022-02-07	
J	Gamble, ASD; Bigg, JL; Sick, S; Krolikowski, M; Patton, DA; Hagel, BE; Emery, CA				Gamble, Alexander S. D.; Bigg, Jessica L.; Sick, Stacy; Krolikowski, Maciek; Patton, Declan A.; Hagel, Brent E.; Emery, Carolyn A.			Helmet Fit Assessment and Concussion Risk in Youth Ice Hockey Players: A Nested Case-Control Study	JOURNAL OF ATHLETIC TRAINING			English	Article						adolescents; head injury; injury prevention; protective equipment	BODY CHECKING; INJURY; HEAD	Context: Injury surveillance has shown that concussions are the most common injury in youth ice hockey. Research examining the criteria for ensuring the correct fit of protective equipment and its potential relationship with concussion risk is very limited. Objective: To evaluate the association between helmet fit and the odds of experiencing a concussion among youth ice hockey players. Design: Nested case-control within a cohort study. Setting: Calgary, Alberta, Canada. Patients or Other Participants: Data were collected for 72 concussed, 41 nonconcussion-injured, and 62 uninjured ice hockey players aged 11 to 18 years. Main Outcome Measure(s): Helmet-fit assessments were conducted across players and encompassed helmet specifications, condition, certification, and criteria measuring helmet fit. Using a validated injury-surveillance system, we identified participants as players with suspected concussions or physician-diagnosed concussions or both. One control group comprised players who sustained nonconcussion injuries, and a second control group comprised uninjured players. Helmet-fit criteria (maximum score = 16) were assessed for the concussed players and compared with each of the 2 control groups. The primary outcome was dichotomous (>1 helmet-fit criteria missing versus 0 or 1 criterion missing). Logistic and conditional logistic regression were used to investigate the effect of helmet fit on the odds of concussion. Results: The primary analysis (54 pairs matched for age, sex, and level of play) suggested that inadequate helmet fit (>1 criterion missing) resulted in greater odds of sustaining a concussion when comparing concussed and uninjured players (odds ratio [OR] = 2.67 [95% CI = 1.04, 6.81], P = .040). However, a secondary unmatched analysis involving all participants indicated no significant association between helmet fit and the odds of sustaining a concussion when we compared concussed players with nonconcussion-injured players (OR = 0.98 [0.43, 2.24], P = .961) or uninjured players (OR = 1.66 [0.90, 3.05], P = .103). Conclusions: Inadequate helmet fit may affect the odds of sustaining a concussion in youth ice hockey players. Future investigators should continue to evaluate this relationship in larger samples to inform helmet-fit recommendations.	[Gamble, Alexander S. D.; Bigg, Jessica L.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Sick, Stacy; Krolikowski, Maciek; Patton, Declan A.; Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada		Gamble, ASD (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	agambl01@uoguelph.ca			International Olympic Committee; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Hotchkiss Brain Institute; Alberta Children's Hospital Foundation	The Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. We acknowledge the funding from Canadian Institutes of Health Research, Alberta Innovates Health Solutions, Hotchkiss Brain Institute, and Alberta Children's Hospital Foundation. We also recognize Hockey Canada, Hockey Calgary, and all of the involved coaches, players, and parents for their time and support in completing this research project.	ALLEY RH, 1964, JAMA-J AM MED ASSOC, V188, P418; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; DeMarco AL, 2017, ANN BIOMED ENG, V45, P1974, DOI 10.1007/s10439-017-1842-4; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Hagel BE, 2010, INJURY PREV, V16, P178, DOI 10.1136/ip.2009.023994; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Injury Prevention Centre, FITT HELM IC SPORTS; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Lee RS, 2009, INJURY PREV, V15, P125, DOI 10.1136/ip.2008.019695; McGuine T, 1997, AM SOC TEST MATER, V1305, P83, DOI 10.1520/STP11775S; McGuine TA, 1995, 41 M AM COLL SPORTS; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Mock HE, 1948, J SCHOOL HEALTH, V18, P121; Patton D, 2017, BR J SPORTS MED, V51, P372, DOI [10.1136/bjsports- 2016-097372.224, DOI 10.1136/BJSPORTS-2016-097372.224]; Pearsall DJ, 2016, P I MECH ENG P-J SPO, V230, P23, DOI 10.1177/1754337115598723; Pfister K, 2014, BR J SPORTS MED, V48, P652, DOI [10.1136/bjsports-2014-093494.245, DOI 10.1136/BJSPORTS-2014-093494.245]; RAWLINS JSP, 1956, LANCET, V271, P719; Rivara F P, 1999, Inj Prev, V5, P194; Romanow NR, 2014, CHRON DIS INJ CAN, V34, P1; Schneider KJ, 2021, CLIN J SPORT MED, V31, P70, DOI 10.1097/JSM.0000000000000673; Thom DR, 2000, 44 ANN M HUM FACT ER; USA Hockey, 2019 2020 SEAS FIN R; Williams R.M., 2014, ATHLETIC TRAINING SP, V6, P206, DOI [10.3928/19425864-20140916-05, DOI 10.3928/19425864-20140916-05]	29	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2021	56	8					845	850		10.4085/1062-6050-0294.20			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6NS	WOS:000684588100007	33238008	gold			2022-02-07	
J	Grima, NA; Rajaratnam, SMW; Mansfield, D; McKenzie, D; Ponsford, JL				Grima, Natalie A.; Rajaratnam, Shantha M. W.; Mansfield, Darren; McKenzie, Dean; Ponsford, Jennie L.			Poorer sleep quality predicts melatonin response in patients with traumatic brain injury: findings from a randomized controlled trial	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						sleep disturbance; insomnia; traumatic brain injury; acquired brain injury; melatonin	PROLONGED-RELEASE MELATONIN; POSTTRAUMATIC AMNESIA; HEAD-INJURY; DAYTIME SLEEPINESS; INSOMNIA; DISTURBANCES; DISORDERS; ASSOCIATION; MANAGEMENT; GUIDELINE	Study Objectives: A recent clinical trial demonstrated that melatonin treatment was effective in improving self-perceived sleep quality in patients with traumatic brain injury (TBI); however, it remains unclear which patients benefited from melatonin treatment. To that end, findings from the clinical trial were re-examined to identify possible predictors of treatment response. Methods: Hierarchical multiple regression was used to identify patient characteristics, TBI injury characteristics, and self-report measures assessing sleep, fatigue, mood, and anxiety symptomatology that may uniquely explain a change in self-reported sleep quality scores (follow-up minus baseline score) as assessed by the Pittsburgh Sleep Quality Index (PSQI). Results: After controlling for patient demographic and TBI injury-related variables, baseline self-report measures of sleep, fatigue, mood, and anxiety explained an additional 32% of the variance in change in PSQI scores. However, only baseline PSQI score made a unique and statistically significant contribution (beta = -0.56, P = .006). After controlling for patient and TBI characteristics, baseline PSQI scores further explained 27% of the variance in change in PSQI scores (R-2 change = .27, F-1,F-27 change = 11.79, P = .002). The standardized beta for baseline PSQI score revealed a statistically significant negative relationship with change in PSQI score (beta = -0.54, P = .002), revealing that higher PSQI score at baseline was associated with better sleep outcomes. Conclusions: In a sample comprising predominantly severe TBI and comorbid insomnia, participants who report poorer sleep quality have the most to gain from melatonin treatment irrespective of time since injury, demographics, fatigue, daytimes sleepiness, mood, and anxiety symptomology.	[Grima, Natalie A.; Ponsford, Jennie L.] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Grima, Natalie A.; Rajaratnam, Shantha M. W.; Mansfield, Darren; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, 18 Innovat Walk, Clayton, Vic 3800, Australia; [Mansfield, Darren] Monash Hlth, Monash Lung & Sleep, Clayton, Vic, Australia; [McKenzie, Dean] Epworth HealthCare, Richmond, Vic, Australia; [McKenzie, Dean] Monash Univ, Dept Epidemiol & Prevent Med, St Kilda, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, 18 Innovat Walk, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu		Rajaratnam, Shantha/0000-0001-7527-8558	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1028733]	All authors have seen and approved the manuscript. Work for this study was performed at Monash University. This study was funded by National Health and Medical Research Council Grant 1028733. The funder provided input into study design, although itwas not involvedin the collection, analysis, interpretation, writing,orapproval of themanuscript. N.A.G. was funded by an Australian Postgraduate Award. S.M.W.R. reports that he has, through his institution, served as a consultant to and received research funding fromVandaPharmaceuticals, Philips Respironics, Cephalon, Rio Tinto, BHP Billiton, and Shell, which are not related to this paper; has received equipment support and consultancy fees through his institution from Optalert, Compumedics, Teva Pharmaceuticals, and Circadian Therapeutics, which are not related to this paper; has served as an expertwitness/consultant in legal cases involving melatonin; has served as a consultant to Alertness CRC and Circadian Therapeutics; and is director of the Sleep Health Foundation. The other authors report no conflicts of interest.	Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V75, P447, DOI 10.1210/jc.75.2.447; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; GARFINKEL D, 1995, LANCET, V346, P541, DOI 10.1016/S0140-6736(95)91382-3; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lemoine P, 2007, J SLEEP RES, V16, P372, DOI 10.1111/j.1365-2869.2007.00613.x; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Magee M, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12684; Mallampalli MP, 2014, J WOMENS HEALTH, V23, P553, DOI 10.1089/jwh.2014.4816; Marseglia L, 2015, INT J MOL SCI, V16, P1209, DOI 10.3390/ijms16011209; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; Ree M, 2017, SLEEP MED, V36, pS43, DOI 10.1016/j.sleep.2017.03.017; REYNER A, 1995, SLEEP, V18, P127; Riemann D, 2017, J SLEEP RES, V26, P675, DOI 10.1111/jsr.12594; Rogers NL, 2003, SLEEP, V26, P1058; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shepherd D, 2020, QUAL LIFE RES, V29, P665, DOI 10.1007/s11136-019-02346-y; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Tabachnick BG., 2012, USING MULTIVARIATE S; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade AG, 2007, CURR MED RES OPIN, V23, P2597, DOI 10.1185/030079907X233098; Wade AG, 2011, CURR MED RES OPIN, V27, P87, DOI 10.1185/03007995.2010.537317; Wade AG, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-51; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	0	0	0	0	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	AUG 1	2021	17	8					1545	1551		10.5664/jcsm.9234			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XW5MY	WOS:000735664400005	33704046				2022-02-07	
J	Gupta, VS; Liras, IN; Allukian, M; Cotton, BA; Cox, CS; Harting, MT				Gupta, Vikas S.; Liras, Ioannis N.; Allukian, Myron; Cotton, Bryan A.; Cox, Charles S., Jr.; Harting, Matthew T.			Injury Severity, Arrival Physiology, Coagulopathy, and Outcomes Among the Youngest Trauma Patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Pediatrics; Trauma; Thrombelastography; Coagulopathy; TBI	BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; CHILDREN; IMPACT; AGE	Background: Although physiologic differences exist between younger and older children, pediatric trauma analyses are weighted toward older patients. Trauma-induced coagulopathy, determined by rapid thrombelastography (rTEG), is a predictor of outcome in trauma patients, but the significance of rTEG values among very young trauma patients remains un-known. Our objective was to identify the prehospital or physiologic factors, including rTEG values, that were associated with mortality in trauma patients younger than 5 y old. Materials and Methods: Patients younger than 5 y old that met the highest-level trauma activation criteria at an academic children's hospital from 2010-2016 were included. Data regarding demographics, pre-hospital management, laboratory values, injury severity, and outcome were queried. Univariate and multivariate analyses were performed comparing survivors and non-survivors. Results: A total of 356 patients were included. 60% were male, and the median age was 3 y (IQR 1-4). Overall mortality was 13% (n = 45); brain injury (91%) and hemorrhage (9%) were the causes of death. Compared to survivors, rTEG values in nonsurvivors showed longer activated clotting time and slower speed of clot formation. Clot strength was also decreased in nonsurvivors. On stepwise regression modeling, rTEG values were not significant predictors of mortality. Admission base deficit, arrival temperature, and head injury severity were identified as independent predictors of mortality. Conclusions: While rTEG identified coagulopathy in trauma patients < 5 y old, it was not an independent predictor of mortality. Our findings suggest that trauma providers should pay close attention to admission base deficit, arrival temperature, and head injury severity when managing the youngest trauma patients. (C) 2021 Elsevier Inc. All rights reserved.	[Gupta, Vikas S.; Allukian, Myron; Cox, Charles S., Jr.; Harting, Matthew T.] Dept Pediat Surg, Houston, TX USA; [Liras, Ioannis N.; Cotton, Bryan A.] Dept Surg, Houston, TX USA; [Liras, Ioannis N.; Cotton, Bryan A.] Ctr Translat Injury Res, Houston, TX USA; [Allukian, Myron; Cox, Charles S., Jr.; Harting, Matthew T.] Univ Texas Houston, McGovern Med Sch, Ctr Surg Trials & Evidence Based Practice, Houston, TX 77030 USA		Harting, MT (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St,MSB 5-233, Houston, TX 77030 USA.	matthew.t.harting@uth.tmc.edu		Gupta, Vikas/0000-0002-4625-7413			[Anonymous], 2020, 10 LEAD CAUS DEATH I; Appel IM, 2012, J THROMB HAEMOST, V10, P2254, DOI 10.1111/j.1538-7836.2012.04905.x; Borse NN, 2009, J SAFETY RES, V40, P71, DOI 10.1016/j.jsr.2009.01.002; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Committee On Pediatric Emergency Medicine COI Violence Poison Prevention SOCCSOOSOSSOTMPTS Society Of Trauma Nurses Pediatric C Management of Pediatric Trauma, 2016, PEDIATRICS, P138; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Liras IN, 2016, J TRAUMA ACUTE CARE, V80, P778, DOI 10.1097/TA.0000000000000985; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McFadyen J Grant, 2012, Int J Crit Illn Inj Sci, V2, P121, DOI 10.4103/2229-5151.100888; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Overly Frank L, 2014, R I Med J (2013), V97, P27; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Randolph LC, 2002, J TRAUMA, V53, P838, DOI 10.1097/00005373-200211000-00006; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	25	0	0	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2021	264						236	241		10.1016/j.jss.2021.02.007			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SV7XD	WOS:000664031200033	33838408				2022-02-07	
J	Haber, M; Amyot, F; Lynch, CE; Sandsmark, DK; Kenney, K; Werner, JK; Moore, C; Flesher, K; Woodson, S; Silverman, E; Chou, YY; Pham, D; Diaz-Arrastia, R				Haber, Margalit; Amyot, Franck; Lynch, Cillian E.; Sandsmark, Danielle K.; Kenney, Kimbra; Werner, John K.; Moore, Carol; Flesher, Kelley; Woodson, Sarah; Silverman, Erika; Chou, Yiyu; Pham, Dzung; Diaz-Arrastia, Ramon			Imaging biomarkers of vascular and axonal injury are spatially distinct in chronic traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Traumatic brain injury; cerebrovascular reactivity; cerebral blood flow; axonal injury; biomarker	PRINCIPAL EIGENVECTOR MEASUREMENTS; SURFACE-BASED ANALYSIS; CEREBRAL-BLOOD-FLOW; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; MODEL; DISRUPTION; ATROPHY; ARTERY; DAMAGE	Traumatic Brain Injury (TBI) is associated with both diffuse axonal injury (DAI) and diffuse vascular injury (DVI), which result from inertial shearing forces. These terms are often used interchangeably, but the spatial relationships between DAI and DVI have not been carefully studied. Multimodal magnetic resonance imaging (MRI) can help distinguish these injury mechanisms: diffusion tensor imaging (DTI) provides information about axonal integrity, while arterial spin labeling (ASL) can be used to measure cerebral blood flow (CBF), and the reactivity of the Blood Oxygen Level Dependent (BOLD) signal to a hypercapnia challenge reflects cerebrovascular reactivity (CVR). Subjects with chronic TBI (n = 27) and healthy controls (n = 14) were studied with multimodal MRI. Mean values of mean diffusivity (MD), fractional anisotropy (FA), CBF, and CVR were extracted for pre-determined regions of interest (ROIs). Normalized z-score maps were generated from the pool of healthy controls. Abnormal ROIs in one modality were not predictive of abnormalities in another. Approximately 9-10% of abnormal voxels for CVR and CBF also showed an abnormal voxel value for MD, while only 1% of abnormal CVR and CBF voxels show a concomitant abnormal FA value. These data indicate that DAI and DVI represent two distinct TBI endophenotypes that are spatially independent.	[Haber, Margalit; Lynch, Cillian E.; Sandsmark, Danielle K.; Woodson, Sarah; Silverman, Erika; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Amyot, Franck; Kenney, Kimbra] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Kenney, Kimbra; Werner, John K.; Moore, Carol; Flesher, Kelley] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Chou, Yiyu; Pham, Dzung] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Diaz-Arrastia, R (corresponding author), Penn Presbyterian Med Ctr, Andrew Mutch Bldg,Room 417,51 North 39th St, Philadelphia, PA 19104 USA.	ramon.diaz-arrastia@pennmedicine.upenn.edu			Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD; Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086090]; DoDUnited States Department of Defense [W81XWH-14-2-0176, W81XWH-19-2-0002]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health. This work was also funded by NINDS U01 NS086090, DoD W81XWH-14-2-0176 and W81XWH-19-2-0002.	Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andreasen SH, 2020, J NEUROTRAUM, V37, P581, DOI 10.1089/neu.2019.6608; Appelman APA, 2008, J CEREBR BLOOD F MET, V28, P633, DOI 10.1038/sj.jcbfm.9600563; Ban SY, 2019, EUR NEUROL, V81, P294, DOI 10.1159/000501612; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cherian L, 2011, J PHARMACOL EXP THER, V337, P451, DOI 10.1124/jpet.110.176602; Clarencon F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186641; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Duncan MA, 2000, BRIT J ANAESTH, V85, P476, DOI 10.1093/bja/85.3.476; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaiser C, 2008, FORENSIC SCI INT, V182, pE15, DOI 10.1016/j.forsciint.2008.10.001; Kansagara D., 2013, COMPLICATIONS MILD T; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kindelberger D, 2003, J FORENSIC SCI, V48, P1366; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lu H., 2014, J VIS EXP, V94, P52306; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mascalchi M, 2017, J NEUROIMAGING, V27, P85, DOI 10.1111/jon.12374; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Muller M, 2010, J HYPERTENS, V28, P1498, DOI 10.1097/HJH.0b013e32833951ef; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Navarro JC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00494; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797	72	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2021	41	8					1924	1938		10.1177/0271678X20985156			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	TS1GD	WOS:000679405000009	33444092	Green Published			2022-02-07	
J	Harada, A; Kawai, N; Ogawa, T; Hatakeyama, T; Tamiya, T				Harada, Akio; Kawai, Nobuyuki; Ogawa, Tomoya; Hatakeyama, Tetsuhiro; Tamiya, Takashi			Long-term Multidisciplinary Rehabilitation Efficacy in Older Patients After Traumatic Brain Injury: Assessed by the Functional Independence Measure	ACTA MEDICA OKAYAMA			English	Article						aging; Functional Independence Measure; physical and cognitive impairments; traumatic brain injury; rehabilitation	INPATIENT REHABILITATION; OUTCOMES; ADULTS; AGE; EPIDEMIOLOGY; LENGTH	Instances of traumatic brain injury (TBI) in the elderly have been increasing along with the aging of populations. In the present study, we examined the effect of aging on long-term multidisciplinary in-patient rehabilitation efficacy after TBI. Sixty-three patients with physical and cognitive impairments after TBI were enrolled in this study. Patients were divided into 4 age groups (<= 24, 25-44, 45-64, >= 65 years) and the clinical characteristics and rehabilitation efficacy of each age group were determined. Functional disability was evaluated using motor and cognitive Functional Independence Measure (FIM) scores. Rehabilitation efficacy was assessed by FIM gains during rehabilitation and compared among the groups. There were no statistically significant differences in motor and cognitive FIM gains among the age groups. However, cognitive FIM gain was limited in a subset of >= 65 patients, and initial cognitive measures could not predict cognitive FIM improvement. These results indicate that chronological age is insufficient to accurately predict rehabilitation efficacy in older TBI patients, and that such patients should be considered candidates for intensive rehabilitation programs based on these results. Accurate prognostication of rehabilitation efficacy with continuing data collection is important when using rehabilitation resources for older TBI patients.	[Harada, Akio; Ogawa, Tomoya; Hatakeyama, Tetsuhiro; Tamiya, Takashi] Kagawa Univ, Fac Med, Dept Neurol Surg, Miki, Kagawa 7610793, Japan; [Kawai, Nobuyuki] Kagawa Rehabil Hosp, Dept Neurol Surg, Takamatsu, Kagawa 7618057, Japan		Kawai, N (corresponding author), Kagawa Rehabil Hosp, Dept Neurol Surg, Takamatsu, Kagawa 7618057, Japan.	nobu@kagawa-reha.net					Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Pedersen AR, 2015, NEUROREHAB NEURAL RE, V29, P299, DOI 10.1177/1545968314545171; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	17	0	0	0	0	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	AUG	2021	75	4					479	486					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	WJ8IN	WOS:000709282300001	34511615				2022-02-07	
J	Hentig, J; Cloghessy, K; Lahne, M; Jung, YJ; Petersen, RA; Morris, AC; Hyde, DR				Hentig, James; Cloghessy, Kaylee; Lahne, Manuela; Jung, Yoo Jin; Petersen, Rebecca A.; Morris, Ann C.; Hyde, David R.			Zebrafish Blunt-Force TBI Induces Heterogenous Injury Pathologies That Mimic Human TBI and Responds with Sonic Hedgehog-Dependent Cell Proliferation across the Neuroaxis	BIOMEDICINES			English	Article						traumatic brain injury; blunt-force TBI; regeneration; zebrafish; cerebellum; proliferation; learning; memory	TRAUMATIC BRAIN-INJURY; ADULT ZEBRAFISH; RADIAL GLIA; HEAD-INJURY; RETINAL REGENERATION; COGNITIVE DEFICITS; STEM-CELLS; TNF-ALPHA; MODEL; MILD	Blunt-force traumatic brain injury (TBI) affects an increasing number of people world-wide as the range of injury severity and heterogeneity of injury pathologies have been recognized. Most current damage models utilize non-regenerative organisms, less common TBI mechanisms (penetrating, chemical, blast), and are limited in scalability of injury severity. We describe a scalable blunt-force TBI model that exhibits a wide range of human clinical pathologies and allows for the study of both injury pathology/progression and mechanisms of regenerative recovery. We modified the Marmarou weight drop model for adult zebrafish, which delivers a scalable injury spanning mild, moderate, and severe phenotypes. Following injury, zebrafish display a wide range of severity-dependent, injury-induced pathologies, including seizures, blood-brain barrier disruption, neuroinflammation, edema, vascular injury, decreased recovery rate, neuronal cell death, sensorimotor difficulties, and cognitive deficits. Injury-induced pathologies rapidly dissipate 4-7 days post-injury as robust cell proliferation is observed across the neuroaxis. In the cerebellum, proliferating nestin:GFP-positive cells originated from the cerebellar crest by 60 h post-injury, which then infiltrated into the granule cell layer and differentiated into neurons. Shh pathway genes increased in expression shortly following injury. Injection of the Shh agonist purmorphamine in undamaged fish induced a significant proliferative response, while the proliferative response was inhibited in injured fish treated with cyclopamine, a Shh antagonist. Collectively, these data demonstrate that a scalable blunt-force TBI to adult zebrafish results in many pathologies similar to human TBI, followed by recovery, and neuronal regeneration in a Shh-dependent manner.	[Hentig, James; Cloghessy, Kaylee; Lahne, Manuela; Jung, Yoo Jin; Hyde, David R.] Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Lahne, Manuela; Jung, Yoo Jin; Hyde, David R.] Univ Notre Dame, Ctr Zebrafish Res, South Bend, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Lahne, Manuela; Jung, Yoo Jin; Hyde, David R.] Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Galvin Life Sci Ctr, South Bend, IN 46556 USA; [Petersen, Rebecca A.; Morris, Ann C.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA		Hyde, DR (corresponding author), Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Zebrafish Res, South Bend, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Galvin Life Sci Ctr, South Bend, IN 46556 USA.	jhentig@nd.edu; kdoghes@nd.edu; mlahne@nd.edu; yjung1@nd.edu; Rebecca.petersen@uky.edu; ann.morris@uky.edu; dhyde@nd.edu		Hentig, James/0000-0002-5371-9049; Hyde, David/0000-0003-0198-4403	Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF) [DGE-1841556]; LTC Neil Hyland Fellowship of Notre Dame; Sentinels of Freedom Fellowship; Office of The Director of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD020067]; Center for Zebrafish Research at the University of Notre Dame; Center for Stem Cells and Regenerative Medicine at the University of Notre Dame; Pat Tillman Scholarship	This project was funded, in part, with support from the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health to DRH. Its contents are solely the responsibility of the providers and do not necessarily represent the official views of the Indiana State Department of Health. This work was also supported by grants from the National Science Foundation Graduate Research Fellowship Program #DGE-1841556 (JTH), LTC Neil Hyland Fellowship of Notre Dame (JTH), Sentinels of Freedom Fellowship (JTH), Pat Tillman Scholarship (JTH), the Office of The Director of the National Institutes of Health (NIH) under Award Number S10OD020067 (ACM), the Center for Zebrafish Research at the University of Notre Dame, and the Center for Stem Cells and Regenerative Medicine at the University of Notre Dame.	Alyenbaawi H, 2021, ELIFE, V10, DOI 10.7554/eLife.58744; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Campbell LJ, 2021, GLIA, V69, P546, DOI 10.1002/glia.23912; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chanin S., 2012, ZEBRAFISH PROTOCOLS, P287, DOI DOI 10.1007/978-1-61779-597-8; Chaplin N, 2010, J NEUROSCI, V30, P3048, DOI 10.1523/JNEUROSCI.6201-09.2010; Conner C, 2014, J NEUROSCI, V34, P14403, DOI 10.1523/JNEUROSCI.0498-14.2014; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eliceiri BP, 2011, METHODS MOL BIOL, V686, P371, DOI 10.1007/978-1-60761-938-3_18; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FLOOD NC, 1976, PHYSIOL BEHAV, V16, P783, DOI 10.1016/0031-9384(76)90251-1; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Hasegawa T, 2017, ELIFE, V6, DOI 10.7554/eLife.22716; Hentig J, 2021, JOVE-J VIS EXP, DOI 10.3791/62745; Hentig J, 2021, JOVE-J VIS EXP, DOI 10.3791/62709; Hentig JT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091445; Hoshi Y, 2018, J NEUROSCI, V38, P5700, DOI 10.1523/JNEUROSCI.2888-17.2018; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kaslin J, 2017, DEVELOPMENT, V144, P1462, DOI 10.1242/dev.144907; Kaslin J, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-9; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lahne M, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.617923; Lahne M, 2020, ANNU REV VIS SCI, V6, P171, DOI 10.1146/annurev-vision-121219-081808; Lahne M, 2015, J NEUROSCI, V35, P15612, DOI 10.1523/JNEUROSCI.5005-14.2015; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lindsey BW, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00750; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Matsuda K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10794-0; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; McFarland KA, 2008, DEV BIOL, V318, P162, DOI 10.1016/j.ydbio.2008.03.016; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Thomas JL, 2018, EXP EYE RES, V166, P106, DOI 10.1016/j.exer.2017.10.003; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Truong L, 2014, NEUROTOXICOLOGY, V43, P134, DOI 10.1016/j.neuro.2014.03.005; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; Ueda Y, 2018, J COMP NEUROL, V526, P2360, DOI 10.1002/cne.24489; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wullimann M., 1996, NEUROANATOMY ZEBRAFI, V1st ed., P1, DOI DOI 10.1007/978-3-0348-8979-7_1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu XJ, 2003, BEHAV NEUROSCI, V117, P548, DOI 10.1037/0735-7044.117.3.548; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	86	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	AUG	2021	9	8							861	10.3390/biomedicines9080861			34	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	UF9FY	WOS:000688873200001	34440066	Green Published			2022-02-07	
J	Holdnack, JA; Brennan, PF				Holdnack, James A.; Brennan, Patricia Flatley			Usability and Effectiveness of Immersive Virtual Grocery Shopping for Assessing Cognitive Fatigue in Healthy Controls: Protocol for a Randomized Controlled Trial	JMIR RESEARCH PROTOCOLS			English	Article						cognitive fatigue; immersive VR; user experience; virtual grocery shopping; instrumental activity of daily living	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; MENTAL FATIGUE; EYE-TRACKING; VISUAL FATIGUE; LIVING SKILL; OLDER-ADULTS; PERFORMANCE; REAL; ENVIRONMENT	Background: Cognitive fatigue (CF) is a human response to stimulation and stress and is a common comorbidity in many medical conditions that can result in serious consequences; however, studying CF under controlled conditions is difficult. Immersive virtual reality provides an experimental environment that enables the precise measurement of the response of an individual to complex stimuli in a controlled environment. Objective: We aim to examine the development of an immersive virtual shopping experience to measure subjective and objective indicators of CF induced by instrumental activities of daily living. Methods: We will recruit 84 healthy participants (aged 18-75 years) for a 2-phase study. Phase 1 is a user experience study for testing the software functionality, user interface, and realism of the virtual shopping environment. Phase 2 uses a 3-arm randomized controlled trial to determine the effect that the immersive environment has on fatigue. Participants will be randomized into 1 of 3 conditions exploring fatigue response during a typical human activity (grocery shopping). The level of cognitive and emotional challenges will change during each activity. The primary outcome of phase 1 is the experience of user interface difficulties. The primary outcome of phase 2 is self-reported CF. The core secondary phase 2 outcomes include subjective cognitive load, change in task performance behavior, and eye tracking. Phase 2 uses within-subject repeated measures analysis of variance to compare pre-and postfatigue measures under 3 conditions (control, cognitive challenge, and emotional challenge). Results: This study was approved by the scientific review committee of the National Institute of Nursing Research and was identified as an exempt study by the institutional review board of the National Institutes of Health. Data collection will begin in spring 2021. Conclusions: Immersive virtual reality may be a useful research platform for simulating the induction of CF associated with the cognitive and emotional challenges of instrumental activities of daily living.	[Holdnack, James A.; Brennan, Patricia Flatley] NINR, NIH, BG 10 RM 2N110A,10 Ctr Dr, Bethesda, MD 20892 USA		Holdnack, JA (corresponding author), NINR, NIH, BG 10 RM 2N110A,10 Ctr Dr, Bethesda, MD 20892 USA.	jim.holdnack@nih.gov		Brennan, Patricia/0000-0001-5989-9960; Holdnack, James/0000-0002-0898-7773	NIH, Division of Intramural ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH, NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [20-NR-0124]; Division of Intramural Research of the NINR/NIH Bethesda, Maryland, United States	The authors would like to acknowledge the contributions of John Ostuni, Donnie Bliss, Katelyn Snell, and Ross Tredinnick for the development of products, store design, and engineering contributions. They appreciate the collaboration with Tyson and Nestle USA, Inc, who shared product images that improved the overall quality and realism of the shopping environment. They also thank India Little, Sara Flash, and Denise Goldsmith for concepts that informed the design elements of the virtual grocery store. The authors appreciate the timely and carefully considered feedback from our external reviewers, Dr Vaugh-Cooke and Dr Persky, and the support of NINR leadership, particularly Dr Wingate and Dr Saligan, who provided them with ongoing support and direction. The authors thank their protocol navigator, Nada Saleh, and administrative team, Erica Vass, Demond Gibson, and La Rhonda Elliott for procuring the necessary equipment and advising on how to work through the NIH system. This study was funded by the NIH, Division of Intramural Research, and NINR (20-NR-0124) .; This protocol is funded by the Division of Intramural Research of the NINR/NIH Bethesda, Maryland, United States.	Adamczyk P.D., 2004, P SIGCHI C HUM FACT, P271, DOI [10.1145/1879831.1879833, DOI 10.1145/1879831.1879833]; Akerstedt T, 2000, J SLEEP RES, V9, P395; Allan JL, 2019, HEALTH PSYCHOL, V38, P318, DOI 10.1037/hea0000725; American Psychological Association, 2014, NEUROPSYCHOLOGY, V28, P319, DOI [10.1037/neu0000061, DOI 10.1037/NEU0000061]; Ames SL, 2005, OPTOMETRY VISION SCI, V82, P168, DOI 10.1097/01.OPX.0000156307.95086.6; Armougum A, 2019, J ENVIRON PSYCHOL, V65, DOI 10.1016/j.jenvp.2019.101338; Aubin G, 2018, NEUROPSYCHOL REHABIL, V28, P689, DOI 10.1080/09602011.2015.1074083; BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Behrens M, 2018, J GERONTOL A-BIOL, V73, P792, DOI 10.1093/gerona/glx210; Borragan G, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00378; Burke SE, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00327; Burton RL, 2018, ARCH CLIN NEUROPSYCH, V33, P795, DOI 10.1093/arclin/acx112; Busey T, 2015, FORENSIC SCI INT, V251, P202, DOI 10.1016/j.forsciint.2015.03.028; Campoe KR, 2017, HUM FACTORS, V59, P1204, DOI 10.1177/0018720817732605; Cehelyk EK, 2019, MULT SCLER RELAT DIS, V27, P269, DOI 10.1016/j.msard.2018.10.112; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chai R, 2015, IEEE ENG MED BIO, P7594, DOI 10.1109/EMBC.2015.7320150; Chen RG, 2015, IEEE ENG MED BIO, P5163, DOI 10.1109/EMBC.2015.7319554; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Costenoble A, 2021, GERONTOLOGIST, V61, pE12, DOI 10.1093/geront/gnz147; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Dawson D, 2012, SLEEP MED REV, V16, P167, DOI 10.1016/j.smrv.2011.05.004; Delliaux S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00565; Desmond PA, 1997, ACCIDENT ANAL PREV, V29, P515, DOI 10.1016/S0001-4575(97)00031-6; Dimitrakopoulos GN, 2018, IEEE T NEUR SYS REH, V26, P740, DOI 10.1109/TNSRE.2018.2791936; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Dorrian J, 2007, APPL ERGON, V38, P155, DOI 10.1016/j.apergo.2006.03.006; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Felnhofer A., 2012, P INT SOC PRES RES; Feng L, 2019, CANCER MED-US, V8, P5840, DOI 10.1002/cam4.2490; FISK AD, 1987, HUM FACTORS, V29, P653, DOI 10.1177/001872088702900605; Gartenberg D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01504; Gergelyfi M, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00176, 10.3389/fnbeh.2015,00176]; Glize B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02019; Glynn NW, 2015, J AM GERIATR SOC, V63, P130, DOI 10.1111/jgs.13191; Grasha AF, 2001, PERCEPT MOTOR SKILL, V92, P53, DOI 10.2466/PMS.92.1.53-71; Greenwood KE, 2016, SCHIZOPHR RES, V172, P206, DOI 10.1016/j.schres.2016.02.029; Grewe P, 2014, EPILEPSY BEHAV, V31, P57, DOI 10.1016/j.yebeh.2013.11.014; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; GUASTELLO SJ, 2014, P HUMAN FACTORS ERGO, V0058, P00908; Gunzelmann G, 2019, PROG BRAIN RES, V246, P177, DOI 10.1016/bs.pbr.2019.03.022; Guo ZZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198206; Guo ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163360; Hanna TN, 2018, J AM COLL RADIOL, V15, P1709, DOI 10.1016/j.jacr.2017.12.019; HART S G, 1988, P139; Hart SG., 2006, P HUM FACT ERG SOC A, V50, P904, DOI DOI 10.1177/154193120605000909; Haubert A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00237; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Hockey GR, 2011, MOTIVATIONAL CONTROL; Holtzer R, 2010, AGING NEUROPSYCHOL C, V18, P108, DOI 10.1080/13825585.2010.517826; Hopstaken JF, 2016, J EXP PSYCHOL HUMAN, V42, P878, DOI 10.1037/xhp0000189; Hopstaken JF, 2015, BIOL PSYCHOL, V110, P100, DOI 10.1016/j.biopsycho.2015.06.013; Iskander J, 2018, IEEE ACCESS, V6, P19345, DOI 10.1109/ACCESS.2018.2815663; John O, 2010, HDB PERSONALITY THEO, P102; Kandalaft MR, 2013, J AUTISM DEV DISORD, V43, P34, DOI 10.1007/s10803-012-1544-6; Klaassen EB, 2014, BIOL PSYCHOL, V96, P134, DOI 10.1016/j.biopsycho.2013.11.008; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Kluckow SW, 2016, CORTEX, V83, P167, DOI 10.1016/j.cortex.2016.07.018; Kluger BM, 2017, PARKINSONISM RELAT D, V37, P87, DOI 10.1016/j.parkreldis.2017.02.005; Kottwitz MU, 2013, SCAND J WORK ENV HEA, V39, P310, DOI 10.5271/sjweh.3334; Kourtesis P, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00342; Kwon OY, 2017, SEIZURE-EUR J EPILEP, V45, P151, DOI 10.1016/j.seizure.2016.11.006; Lavine RA, 2002, AVIAT SPACE ENVIR MD, V73, P367; Lee BC, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8101780; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Levy CE, 2019, AM J PHYS MED REHAB, V98, P191, DOI 10.1097/PHM.0000000000001041; Li J, 2019, AUTOMAT CONSTR, V105, DOI 10.1016/j.autcon.2019.102835; Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459; Makizako H, 2015, INT J ENV RES PUB HE, V12, P3002, DOI 10.3390/ijerph120303002; Mark G, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P107; Marquart G, 2015, PROCEDIA MANUF, V3, P2854, DOI 10.1016/j.promfg.2015.07.783; McGrath RP, 2019, J AM MED DIR ASSOC, V20, P730, DOI 10.1016/j.jamda.2018.10.014; Mollaoglu M, 2011, ARCH GERONTOL GERIAT, V53, pE93, DOI 10.1016/j.archger.2010.07.001; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Negut A, 2016, CLIN NEUROPSYCHOL, V30, P165, DOI 10.1080/13854046.2016.1144793; Nilsson T, 1997, ACCIDENT ANAL PREV, V29, P479, DOI 10.1016/S0001-4575(97)00027-4; Ouellet E, 2018, J NEUROSCI METH, V303, P126, DOI 10.1016/j.jneumeth.2018.03.010; Park S, 2019, APPL ERGON, V78, P26, DOI 10.1016/j.apergo.2019.01.014; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2017, J NEUROSCI METH, V291, P13, DOI 10.1016/j.jneumeth.2017.07.027; Parsons TD, 2017, J ALZHEIMERS DIS, V59, P1227, DOI 10.3233/JAD-170295; Peukert C, 2019, J MANAGE INFORM SYST, V36, P755, DOI 10.1080/07421222.2019.1628889; Pittion-Vouyovitch S, 2006, J NEUROL SCI, V243, P39, DOI 10.1016/j.jns.2005.11.025; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Rempfer MV, 2003, PSYCHIAT RES, V117, P103, DOI 10.1016/S0165-1781(02)00318-9; Ren P, 2019, AGING-US, V11, P2312, DOI 10.18632/aging.101915; Rogers AP, 2019, ANXIETY STRESS COPIN, V32, P312, DOI 10.1080/10615806.2019.1596671; Ross HA, 2014, EXP BRAIN RES, V232, P1729, DOI 10.1007/s00221-014-3865-5; Rossi R, 2011, PROCD SOC BEHV, V20, DOI 10.1016/j.sbspro.2011.08.074; Castro EDS, 2018, INT J NEUROSCI, V128, P530, DOI 10.1080/00207454.2017.1400970; Saligan LN, 2015, SUPPORT CARE CANCER, V23, P2461, DOI 10.1007/s00520-015-2763-0; Samuel IBH, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00012; Schwid SR, 2003, MULT SCLER, V9, P503, DOI 10.1191/1352458503ms946oa; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Sheppard AL, 2018, BMJ OPEN OPHTHALMOL, V3, DOI 10.1136/bmjophth-2018-000146; Shinar D, 2008, HUM FACTORS, V50, P380, DOI 10.1518/001872008X250647; Sorensen EE, 2014, J CLIN NURS, V23, P1274, DOI 10.1111/jocn.12329; Stussman B, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01025; Sutherland A, 2019, ARCH DIS CHILD, V104, P588, DOI 10.1136/archdischild-2018-315981; Thomas L, 2017, J NURS CARE QUAL, V32, P309, DOI 10.1097/NCQ.0000000000000256; Trujillo LT, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01292; Truschzinski M, 2018, APPL ERGON, V69, P1, DOI 10.1016/j.apergo.2017.12.019; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; Waite S, 2017, AM J ROENTGENOL, V208, P739, DOI 10.2214/AJR.16.16963; Walker LAS, 2012, J NEUROL SCI, V316, P86, DOI 10.1016/j.jns.2012.01.021; Wang C, 2016, J NEUROSCI, V36, P3919, DOI 10.1523/JNEUROSCI.3652-15.2016; Wang C, 2014, BRAIN COGNITION, V85, P251, DOI 10.1016/j.bandc.2014.01.004; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Weigl M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-433; Williamson A, 2011, ACCIDENT ANAL PREV, V43, P498, DOI 10.1016/j.aap.2009.11.011; Xu JL, 2018, HEALTHC TECHNOL LETT, V5, P54, DOI 10.1049/htl.2017.0020; Xu LW, 2017, NEUROSCI LETT, V640, P21, DOI 10.1016/j.neulet.2017.01.018; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	117	0	0	2	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	AUG	2021	10	8							e28073	10.2196/28073			16	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	UK8CS	WOS:000692193000026	34346898	gold, Green Published			2022-02-07	
J	Huang, PS; Tsai, PY; Yang, LY; Lecca, D; Luo, WM; Kim, DS; Hoffer, BJ; Chiang, YH; Greig, NH; Wang, JY				Huang, Pen-Sen; Tsai, Ping-Yen; Yang, Ling-Yu; Lecca, Daniela; Luo, Weiming; Kim, Dong Seok; Hoffer, Barry J.; Chiang, Yung-Hsiao; Greig, Nigel H.; Wang, Jia-Yi			3,6 '-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						3,6 '-dithiopomalidomide; pomalidomide; traumatic brain injury; neurodegeneration; cognitive deficits; neuroinflammation; microgliosis; astrogliosis; immunomodulatory imide drugs	CLOSED-HEAD INJURY; FUNCTIONAL OUTCOMES; GENE-EXPRESSION; PIFITHRIN-ALPHA; CORTICAL IMPACT; NEURONAL LOSS; TNF-ALPHA; NEUROINFLAMMATION; DEFICITS; ACTIVATION	Traumatic brain injury (TBI) is a leading cause of disability and mortality worldwide. It can instigate immediate cell death, followed by a time-dependent secondary injury that results from disproportionate microglial and astrocyte activation, excessive inflammation and oxidative stress in brain tissue, culminating in both short- and long-term cognitive dysfunction and behavioral deficits. Within the brain, the hippocampus is particularly vulnerable to a TBI. We studied a new pomalidomide (Pom) analog, namely, 3,6 '-dithioPom (DP), and Pom as immunomodulatory imide drugs (IMiD) for mitigating TBI-induced hippocampal neurodegeneration, microgliosis, astrogliosis and behavioral impairments in a controlled cortical impact (CCI) model of TBI in rats. Both agents were administered as a single intravenous dose (0.5 mg/kg) at 5 h post injury so that the efficacies could be compared. Pom and DP significantly reduced the contusion volume evaluated at 24 h and 7 days post injury. Both agents ameliorated short-term memory deficits and anxiety behavior at 7 days after a TBI. The number of degenerating neurons in the CA1 and dentate gyrus (DG) regions of the hippocampus after a TBI was reduced by Pom and DP. DP, but not Pom, significantly attenuated the TBI-induced microgliosis and DP was more efficacious than Pom at attenuating the TBI-induced astrogliosis in CA1 and DG at 7D after a TBI. In summary, a single intravenous injection of Pom or DP, given 5 h post TBI, significantly reduced hippocampal neurodegeneration and prevented cognitive deficits with a concomitant attenuation of the neuroinflammation in the hippocampus.	[Huang, Pen-Sen; Tsai, Ping-Yen; Yang, Ling-Yu; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Tsai, Ping-Yen] Taipei Med Univ, Coll Med, Sch Med, Taipei 110, Taiwan; [Lecca, Daniela; Luo, Weiming; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Kim, Dong Seok] Aevis Bio Inc, Daejeon 34141, South Korea; [Kim, Dong Seok] Aevis Bio Inc, Gaithersburg, MD 20878 USA; [Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Chiang, Yung-Hsiao; Wang, Jia-Yi] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiang, Yung-Hsiao; Wang, Jia-Yi] Taipei Med Univ, Neurosci Res Ctr, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei 110, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan.; Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.; Wang, JY (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Neurosci Res Ctr, Taipei 110, Taiwan.	benson342536@gmail.com; murphy7160@gmail.com; allison73323@gmail.com; daniela.lecca@nih.gov; luowe@grc.nia.nih.gov; dskim@aevisbio.com; bjh82@case.edu; ychiang@tmu.edu.tw; greign@grc.nia.nih.gov; jywang2010@tmu.edu.tw		Greig, Nigel/0000-0002-3032-1468; Tsai, Ping-Yen/0000-0001-8863-2966; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 110-2314-B-038-106, MOST 108-2321-B-038-008]; Sunny Brain Tumor and Brain Disease Research and Development Fund, Taipei Medical University, Taipei, Taiwan; Intramural Research Program, National Institute on Aging, National Institutes of Health, USA; National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56 AG057028]; Technology Development Program of MSS [S2782046]; National Research Foundation (NRF) - Korean GovernmentKorean Government [2021M3A9G2015889]	This research was supported in part by (i) grants from (a) the Ministry of Science and Technology, Taiwan (MOST 110-2314-B-038-106 and MOST 108-2321-B-038-008); (b) Sunny Brain Tumor and Brain Disease Research and Development Fund, Taipei Medical University, Taipei, Taiwan; (ii) The Intramural Research Program, National Institute on Aging, National Institutes of Health, USA; (iii) National Institutes of Health R56 AG057028, USA; and (iv) the Technology Development Program of MSS (S2782046) and the National Research Foundation (NRF) grant funded by the Korean Government (2021M3A9G2015889).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Castejon O J, 1995, J Neurosurg Sci, V39, P47; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Decourt B, 2020, OPEN ACCESS J CLIN T, V12, P1, DOI [10.2147/oajct.s221914, 10.2147/OAJCT.S221914]; Dell'Aquila M, 2021, HISTOL HISTOPATHOL, V36, P795, DOI 10.14670/HH-18-319; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Hsueh SC, 2021, ACS PHARMACOL TRANSL, V4, P980, DOI 10.1021/acsptsci.1c00042; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jamjoom AAB, 2021, BRAIN, V144, P18, DOI 10.1093/brain/awaa321; Jung YJ, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.656921; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Leconte C, 2020, J NEUROTRAUM, V37, P1342, DOI 10.1089/neu.2019.6679; Lin CT, 2020, ELIFE, V9, DOI 10.7554/eLife.54726; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Redell JB, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113372; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schober ME, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112971; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Subedi L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030764; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tadepalli SA, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112268; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wen ZJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4296075; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113135; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	81	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2021	22	15							8276	10.3390/ijms22158276			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	TV9EQ	WOS:000682017700001	34361041	gold, Green Published			2022-02-07	
J	Joaquim, AF; Schroeder, GD; Vaccaro, AR				Joaquim, Andrei Fernandes; Schroeder, Gregory D.; Vaccaro, Alexander R.			Traumatic Atlanto-Occipital Dislocation-A Comprehensive Analysis of All Case Series Found in the Spinal Trauma Literature	INTERNATIONAL JOURNAL OF SPINE SURGERY			English	Article						atlanto-occipital dislocation; occipito-cervical dislocation; craniocervical dislocation; traumatic; injury	CRANIOCERVICAL JUNCTION; COMPUTED-TOMOGRAPHY; DISSOCIATION; INJURIES; MANAGEMENT; DIAGNOSIS; SURVIVAL; INTERVAL; AXIS	Background: Traumatic atlanto-occipital dislocation (TAOD) is one of the most devastating traumatic injuries, generally associated with immediate death after high-energy trauma. The aim of this study was to perform a systematic literature review of all cases series of TAOD and present the current state of this entity. Methods: A systematic literature review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Only case series with at least 5 cases were included in the analysis. We focused on survival rates, diagnostic methods, delays in diagnosis, outcomes, and cases successfully treated nonoperatively. Results: A total of 17 articles were included (16 retrospective and 1 prospective study) with 341 patients. Six studies included pediatric patients only. The mean Glasgow Coma Scale at admission was <= 8 in all studies. Many different diagnostic criteria were used, but none of them had high accuracy. The overall mortality rate was 34.8%, but the studies' designs were heterogeneous (some included only survivors). A high rate of concomitant traumatic brain injury was documented in some studies. We found it interesting that some patients were treated with cervical immobilization (37/341; 10.8%), which was generally used in less unstable injuries; however, the majority of patients were managed with an occipito-cervical fusion (193/341; 56.5%). Conclusions: TAOD is a devastating traumatic injury, with a high mortality rate. An MRI may be recommended when there are subtle findings of TAOD and a normal computed tomography scan, such as subarachnoid hemorrhage in the posterior fossa, upper cervical injuries, or consistent neurological findings. Further studies are necessary to identify patients with mild MRI findings and TAOD that may be managed nonoperatively.	[Joaquim, Andrei Fernandes] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil; [Schroeder, Gregory D.; Vaccaro, Alexander R.] Thomas Jefferson Univ, Dept Orthopaed Surg & Neurosurg, Philadelphia, PA 19107 USA		Joaquim, AF (corresponding author), Univ Campinas UNICAMP, Dept Neurosurg, Sao Paulo, Brazil.	andjoaquim@yahoo.com					Abouelleil M, 2018, CUREUS, V10, DOI 10.7759/cureus.2486; AHUJA A, 1994, SURG NEUROL, V41, P112, DOI 10.1016/0090-3019(94)90107-4; Astur N, 2013, J BONE JOINT SURG AM, V95A, P2213, DOI 10.2106/JBJS.L.01295; Blackwood NJ, 1908, ANN SURG, V47, P654, DOI 10.1097/00000658-190805000-00003; BULAS DI, 1993, RADIOLOGY, V188, P155, DOI 10.1148/radiology.188.1.8511290; Chang DG, 2020, SPINE, V45, P884, DOI 10.1097/BRS.0000000000003423; Child Z, 2016, SPINE J, V16, P1116, DOI 10.1016/j.spinee.2016.03.057; COHEN A, 1991, Pediatric Emergency Care, V7, P24, DOI 10.1097/00006565-199102000-00007; Cooper Z, 2010, J SURG RES, V160, P3, DOI 10.1016/j.jss.2009.04.004; Corcoran B, 2016, AM J NEURORADIOL, V37, P958, DOI 10.3174/ajnr.A4641; Dahdaleh NS, 2016, GLOB SPINE J, V6, P529, DOI 10.1055/s-0035-1569058; DUBLIN AB, 1980, J NEUROSURG, V52, P541, DOI 10.3171/jns.1980.52.4.0541; Filiberto DM, 2018, SURGERY, V164, P500, DOI 10.1016/j.surg.2018.05.011; Formentin C, 2019, REV ASSOC MED BRAS, V65, P198, DOI 10.1590/1806-9282.65.2.198; Gire JD, 2013, SPINE J, V13, P510, DOI 10.1016/j.spinee.2013.01.023; Gregg S, 2005, J TRAUMA, V58, P168, DOI 10.1097/01.TA.0000151184.08273.82; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; Hazboun R, 2021, PEDIATR EMERG CARE, V37, pE602, DOI 10.1097/PEC.0000000000001721; Horn EM, 2007, J NEUROSURG-SPINE, V6, P113, DOI 10.3171/spi.2007.6.2.113; Hosalkar HS, 2005, J BONE JOINT SURG AM, V87A, P2480, DOI 10.2106/JBJS.D.01897; Joaquim AF, 2011, GLOB SPINE J, V1, P35, DOI 10.1055/s-0031-1296055; Joaquim AF, 2015, J CRANIOVERTEBRAL JU, V6, P16, DOI 10.4103/0974-8237.151585; Joaquim AF, 2020, GLOB SPINE J, V10, P647, DOI 10.1177/2192568219877878; Kaplan NB, 2015, GLOB SPINE J, V5, P505, DOI 10.1055/s-0035-1566290; Kasliwal MK, 2016, CURR REV MUSCULOSKE, V9, P247, DOI 10.1007/s12178-016-9347-6; Kenter K, 2001, J PEDIATR ORTHOPED, V21, P585, DOI 10.1097/00004694-200109000-00006; Kim Yeon-Joon, 2012, Korean J Spine, V9, P85, DOI 10.14245/kjs.2012.9.2.85; Klimo P, 2007, NEUROSURG CLIN N AM, V18, P599, DOI 10.1016/j.nec.2007.09.004; LEE C, 1987, AM J NEURORADIOL, V8, P19; Martinez-del-Campo E, 2016, J NEUROSURG-SPINE, V24, P535, DOI 10.3171/2015.6.SPINE15226; Menon K Venugopal, 2018, Eur J Orthop Surg Traumatol, V28, P381, DOI 10.1007/s00590-017-2053-2; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Mueller FJ, 2013, EUR SPINE J, V22, P65, DOI 10.1007/s00586-012-2543-1; OCEBM Levels of Evidence Working Group, OXFORD 2011 LEVELS E; Pang D, 2007, NEUROSURGERY, V61, P995, DOI 10.1227/01.neu.0000303196.87672.78; POWERS B, 1979, NEUROSURGERY, V4, P12, DOI 10.1097/00006123-197901000-00004; Przybylski GJ, 1996, SPINE, V21, P1761, DOI 10.1097/00007632-199608010-00009; Radcliff K, 2012, CLIN ORTHOP RELAT R, V470, P1602, DOI 10.1007/s11999-011-2151-0; Reis Abilio, 2010, Evid Based Spine Care J, V1, P69, DOI 10.1055/s-0028-1100920; Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; TEPPER SL, 1990, AM J FOREN MED PATH, V11, P193, DOI 10.1097/00000433-199009000-00003; Theodore N, 2013, NEUROSURGERY, V72, P114, DOI 10.1227/NEU.0b013e31827765e0; TRAYNELIS VC, 1986, J NEUROSURG, V65, P863, DOI 10.3171/jns.1986.65.6.0863; WHOLEY MH, 1958, RADIOLOGY, V71, P350, DOI 10.1148/71.3.350; Yelamarthy PKK, 2020, EUR SPINE J, V29, P1197, DOI 10.1007/s00586-019-06112-z; ZIVOT U, 1993, AM J FOREN MED PATH, V14, P185, DOI 10.1097/00000433-199309000-00002	47	0	0	0	0	INT SOC ADVANCEMENT SPINE SURGERY-ISASS	WHEATON	301 S COUNTY FARM RD, STE L, WHEATON, IL, UNITED STATES		2211-4599		INT J SPINE SURG	Int. J. Spine Surg.	AUG 1	2021	15	4					724	739		10.14444/8095			16	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	UC1YP	WOS:000686330200013	34289992	gold, Green Published			2022-02-07	
J	Kati, P; Matti, V; Sanna, K; Jon, P; Tiina, L; Laura, H				Kati, Peltonen; Matti, Vartiainen; Sanna, Koskinen; Jon, Pertab; Tiina, Laitala; Laura, Hokkanen			Post-Concussion Acute Signs and Reliable Cognitive Decline in a Finnish Youth Ice Hockey Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Practice effects; Reliable change; Assessment; Cross-cultural	TEST-RETEST RELIABILITY; DEMOGRAPHICALLY CORRECTED NORMS; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; SPANISH SPEAKERS; TEST-PERFORMANCE; ONLINE VERSION; IMPACT; RECOVERY; PREDICT	Objective In sports concussion research, the importance of an individualized approach incorporating neuropsychological assessment data has been emphasized. This study examined the impact of acute signs of concussion on post-injury cognitive functioning using reliable change methodology in a sample of Finnish, elite-level, youth ice hockey players. Methods From a sample of 1,823 players (all male, 14-20 years old) who completed preseason baseline testing with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT (R)) battery, two subgroups were identified. First, in total, 312 uninjured athletes, who completed baseline testing twice-1 year apart. The scores were contrasted to calculate reliable change indices (RCIs). Second, from a subsample of 570 athletes participating in an intensive follow-up arm of the project, the analysis included 32 concussed athletes. The RCIs were determined for the five ImPACT composite scores and used in identifying athletes with declined performance 3 days post-injury. Results Test-retest reliability ranged from .39 to .71. Athletes who had experienced an acute loss of consciousness, amnesia, or postural instability had increased odds for declines in two or more areas assessed by ImPACT (odds ratio = 7.67-8.00, p < .05). In contrast, acute disorientation or vacant look did not lead to cognitive change that met the reliable change threshold. Conclusions The reliability coefficients and RCIs differed from those published earlier emphasizing the importance of national reference values. The presence of acute loss of consciousness, amnesia, or postural instability may indicate a more severe injury and predict the need for more intensive cognitive follow-up.	[Kati, Peltonen; Matti, Vartiainen; Sanna, Koskinen; Laura, Hokkanen] Univ Helsinki, Dept Psychol & Logoped, Haartmaninkatu 3, Helsinki 00014, Finland; [Jon, Pertab] Intermt Med Ctr, Neurosci Inst, Murray, UT USA; [Tiina, Laitala] Univ Turku, Inst Biomed, Turku, Finland		Kati, P (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Haartmaninkatu 3, Helsinki 00014, Finland.	kati.peltonen@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084	Ministry of Social Affairs and Health Finland [201510103]; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science [00190810]	This work was supported by the Ministry of Social Affairs and Health Finland (grant number 201510103) and the Finnish Cultural Foundation (grant number 00190810).	Agranovich AV, 2007, ARCH CLIN NEUROPSYCH, V22, P273, DOI 10.1016/j.acn.2007.01.003; ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Bure-Reyes A, 2013, J CLIN EXP NEUROPSYC, V35, P404, DOI 10.1080/13803395.2013.778232; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P81, DOI 10.1017/S1355617713001288; Echemendia RJ, 2002, STUD NEUROPSYCHOL DE, P181; Echemendia RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P240, DOI 10.1093/arclin/acz077; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Iverson G. L., 2002, IMMEDIATE POSTCONCUS; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R, 2004, IMPACT VERSION 2 0 C; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; OECD, 2019, Health at a Glance 2019:�OECD Indicators, DOI 10.1787/4dd50c09-en; Peltonen K, 2020, TRANSL SPORTS MED, V3, P565, DOI 10.1002/tsm2.179; Peltonen K, 2019, CHILD NEUROPSYCHOL, V25, P336, DOI 10.1080/09297049.2018.1474865; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vartiainen MV, 2021, APPL NEUROPSYCH-ADUL, V28, P53, DOI 10.1080/23279095.2019.1592175; Zahra D., 2010, PSYCHOL POSTGRADUATE, V76, P14	52	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2021	36	5					757	766		10.1093/arclin/acaa108			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	WX1CC	WOS:000718340500010	33210122	Green Accepted			2022-02-07	
J	Knott, MV; Ngwenya, LB; Correll, EA; Bohnert, J; Ziemba, NJ; Allgire, E; Hopkins, T; McGuire, JL				Knott, Maxon, V; Ngwenya, Laura B.; Correll, Erika A.; Bohnert, Judy; Ziemba, Noah J.; Allgire, Emily; Hopkins, Tracy; McGuire, Jennifer L.			Lack of Glutamate Receptor Subunit Expression Changes in Hippocampal Dentate Gyrus after Experimental Traumatic Brain Injury in a Rodent Model of Depression	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						depression; hippocampus; traumatic brain injury; glutamate receptor; Wistar Kyoto	ANTIDEPRESSANT-LIKE ACTIVITY; WISTAR-KYOTO RATS; SPREADING DEPOLARIZATIONS; CELL-PROLIFERATION; GLUR2 ENDOCYTOSIS; SPATIAL MEMORY; PROTEIN; KETAMINE; STRESS; NEUROGENESIS	Traumatic brain injury (TBI) affects over 69 million people annually worldwide, and those with pre-existing depression have worse recovery. The molecular mechanisms that may contribute to poor recovery after TBI with co-morbid depression have not been established. TBI and depression have many commonalities including volume changes, myelin disruption, changes in proliferation, and changes in glutamatergic signaling. We used a well-established animal model of depression, the Wistar Kyoto (WKY) rat, to elucidate changes after TBI that may influence the recovery trajectory. We compared the histological and molecular outcomes in the hippocampal dentate gyrus after experimental TBI using the lateral fluid percussion injury (LFPI) in the WKY and the parent Wistar (WIS) strain. We showed that WKY had exaggerated myelin loss after LFPI and baseline deficits in proliferation. In addition, we showed that while after LFPI WIS rats exhibited glutamate receptor subunit changes, namely increased GluN2B, the WKY rats failed to show such injury-related changes. These differential responses to LFPI helped to elucidate the molecular characteristics that influence poor recovery after TBI in those with pre-existing depression and may lead to targets for future therapeutic interventions.	[Knott, Maxon, V] Univ Honors Program, Univ Cincinnati, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.; Correll, Erika A.; Bohnert, Judy; Ziemba, Noah J.; Hopkins, Tracy; McGuire, Jennifer L.] Univ Cincinnati, Dept Neurosurg, Coll Med, Cincinnati, OH 45267 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, Coll Med, Cincinnati, OH 45267 USA; [Allgire, Emily] Univ Cincinnati, Neurosci Grad Program, Cincinnati, OH 45267 USA; [Correll, Erika A.] Univ Massachusetts, Neurosci & Behav Grad Program, Amherst, MA 01003 USA; [Bohnert, Judy] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH 45229 USA; [Ziemba, Noah J.] Univ Pittsburgh, Swanson Sch Engn, Pittsburgh, PA 15260 USA		Ngwenya, LB (corresponding author), Univ Cincinnati, Dept Neurosurg, Coll Med, Cincinnati, OH 45267 USA.; Ngwenya, LB (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, Coll Med, Cincinnati, OH 45267 USA.	knottmv@mail.uc.edu; Laura.Ngwenya@uc.edu; erikacorrell@umass.edu; bohnerjy@ucmail.uc.edu; NOZ6@pitt.edu; johns4ey@mail.uc.edu; morttl@ucmail.uc.edu; kozioljl@ucmail.uc.edu		McGuire, Jennifer/0000-0003-3058-5241; Ngwenya, Laura/0000-0001-7103-971X	Local Initiative for Excellence (L.I.F.E.) Foundation - National Institutes of Health/National Institute of Neurological Disorders and Stroke [K08NS110988]	This research was funded by a research grant awarded by the Local Initiative for Excellence (L.I.F.E.) Foundation (L.B.N. and J.L.M.), and partially funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke grant K08NS110988 (L.B.N.).	Aan Het Rot M, 2012, BIOL PSYCHIAT, V72, P537, DOI 10.1016/j.biopsych.2012.05.003; aan het Rot M, 2009, CAN MED ASSOC J, V180, P305, DOI 10.1503/cmaj.080697; Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Aleksandrova LR, 2019, NEUROSCI BIOBEHAV R, V105, P1, DOI 10.1016/j.neubiorev.2019.07.007; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Ballachey EL, 1932, U CALIFORNIA PUBLICA, V6, P1; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Barhorst KA, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-01000-3; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Belovicova Kristina, 2017, Interdiscip Toxicol, V10, P40, DOI 10.1515/intox-2017-0006; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Boku S, 2018, PSYCHIAT CLIN NEUROS, V72, P3, DOI 10.1111/pcn.12604; Campbell S, 2006, CURR OPIN PSYCHIATR, V19, P25, DOI 10.1097/01.yco.0000194371.47685.f2; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Carr GV, 2010, NEUROPSYCHOPHARMACOL, V35, P752, DOI 10.1038/npp.2009.183; Castagne V, 2009, EUR J PHARMACOL, V616, P128, DOI 10.1016/j.ejphar.2009.06.018; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clements KM, 2006, BEHAV BRAIN RES, V167, P295, DOI 10.1016/j.bbr.2005.09.016; Cominski TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00273; Correll EA, 2021, IBRO NEUROSCI REP, V10, P31, DOI 10.1016/j.ibneur.2020.11.005; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Duman RS, 2019, NEURON, V102, P75, DOI 10.1016/j.neuron.2019.03.013; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gormley S, 2016, PHYSIOL BEHAV, V160, P66, DOI 10.1016/j.physbeh.2016.04.007; Gould NF, 2007, AM J PSYCHIAT, V164, P516, DOI 10.1176/appi.ajp.164.3.516; GRAUER E, 1993, BEHAV BRAIN RES, V59, P147, DOI 10.1016/0166-4328(93)90161-I; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hartings JA, 2019, J NEUROSURG, V130, P2095, DOI 10.3171/2018.6.JNS18235; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Kallarackal AJ, 2013, J NEUROSCI, V33, P15669, DOI 10.1523/JNEUROSCI.2588-13.2013; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kin K, 2017, BEHAV BRAIN RES, V329, P148, DOI 10.1016/j.bbr.2017.04.046; Kirshner ZZ, 2018, MOL CELL ENDOCRINOL, V473, P156, DOI 10.1016/j.mce.2018.01.015; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kronenberg G, 2007, DEV NEUROSCI-BASEL, V29, P124, DOI 10.1159/000096217; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lei Y, 2010, NEUROSCIENCE, V169, P125, DOI 10.1016/j.neuroscience.2010.05.003; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Malkesman O, 2007, PHYSIOL BEHAV, V90, P619, DOI 10.1016/j.physbeh.2006.11.014; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; McGuire JL, 2019, MOL NEUROBIOL, V56, P2908, DOI 10.1007/s12035-018-1276-5; McNally KJ, 1998, J HISTOCHEM CYTOCHEM, V46, P541, DOI 10.1177/002215549804600415; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Newcomer J W, 2000, Dialogues Clin Neurosci, V2, P219; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; O'Neil DA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00579; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; PARE WP, 1992, PHYSIOL BEHAV, V51, P1051, DOI 10.1016/0031-9384(92)90091-F; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; Sacchet MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02062-y; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P717, DOI 10.1177/38.5.1692056; Schreiber JA, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0645-6; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Shoval G, 2016, NEUROPSYCHOBIOLOGY, V73, P123, DOI 10.1159/000443890; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson SM, 2015, TRENDS NEUROSCI, V38, P279, DOI 10.1016/j.tins.2015.03.003; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Witherspoon JW, 2014, BIOTECH HISTOCHEM, V89, P355, DOI 10.3109/10520295.2013.872297; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	88	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2021	22	15							8086	10.3390/ijms22158086			18	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	TV7JR	WOS:000681895600001	34360865	gold, Green Published			2022-02-07	
J	Kostelnik, C; Lucki, I; Choi, KH; Browne, CA				Kostelnik, Claire; Lucki, Irwin; Choi, Kwang H.; Browne, Caroline A.			Translational relevance of fear conditioning in rodent models of mild traumatic brain injury	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article						Fear conditioning; Incubation of fear; Traumatic brain injury; Posttraumatic stress disorder; Mild traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MYELIN BASIC-PROTEIN; MENTAL-HEALTH PROBLEMS; BDNF VAL66MET; NEUROTROPHIC FACTOR; DELAYED-ONSET; POSTCONCUSSION SYMPTOMS; LIMBIC SYSTEM; RAT MODEL; EXTINCTION	Mild traumatic brain injury (mTBI) increases the risk of posttraumatic stress disorder (PTSD) in military populations. Utilizing translationally relevant animal models is imperative for establishing a platform to delineate neurobehavioral deficits common to clinical PTSD that emerge in the months to years following mTBI. Such platforms are required to facilitate preclinical development of novel therapeutics. First, this mini review provides an overview of the incidence of PTSD following mTBI in military service members. Secondly, the translational relevance of fear conditioning paradigms used in conjunction with mTBI in preclinical studies is evaluated. Next, this review addresses an important gap in the current preclinical literature; while incubation of fear has been studied in other areas of research, there are relatively few studies pertaining to the enhancement of cued and contextual fear memory over time following mTBI. Incubation of fear paradigms in conjunction with mTBI are proposed as a novel behavioral approach to advance this critical area of research. Lastly, this review discusses potential neurobiological substrates implicated in altered fear memory post mTBI.	[Kostelnik, Claire; Lucki, Irwin; Choi, Kwang H.; Browne, Caroline A.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Lucki, Irwin; Browne, Caroline A.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Lucki, Irwin; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Browne, CA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	kwang.choi@usuhs.edu; caroline.browne.ctr@usuhs.edu	Lucki, Irwin/AAX-6061-2021	Kostelnik, Claire/0000-0002-2415-8852	United States Public Health Service (USPHS) from the National Institute of Mental Health [R01 MH105623]; USUHS Transforming Technology for the Warfighter Program; Henry M Jackson foundation for the Advancement of Military Medicine; FEDERAL AGENCY AWARD [HU0001-20-2-0014]	The authors were supported by the United States Public Health Service (USPHS) grant R01 MH105623 from the National Institute of Mental Health and the USUHS Transforming Technology for the Warfighter Program, FEDERAL AGENCY AWARD NUMBER: HU0001-20-2-0014. Funds were administered by the Henry M Jackson foundation for the Advancement of Military Medicine. The funding sponsors were not involved in preparation or submission of the article for publication.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Angelucci F, 2014, BRAIN COGNITION, V84, P118, DOI 10.1016/j.bandc.2013.11.012; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; BARBARESE E, 1988, J NEUROCHEM, V51, P1737, DOI 10.1111/j.1471-4159.1988.tb01153.x; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Berninger A, 2010, AM J IND MED, V53, P1177, DOI 10.1002/ajim.20894; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buckley TC, 1996, J ABNORM PSYCHOL, V105, P617, DOI 10.1037/0021-843X.105.4.617; Chang Chun-hui, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0823s47; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ehlis AC, 2011, AM J MED GENET B, V156B, P291, DOI 10.1002/ajmg.b.31161; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Felmingham KL, 2018, PSYCHONEUROENDOCRINO, V91, P142, DOI 10.1016/j.psyneuen.2018.03.002; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Giarratana AO, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01175; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Glushakova OY, 2018, HDB NEUROEMERGENCY C, P139, DOI [10.1016/B978-0-12-804064-5.00008, DOI 10.1016/B978-0-12-804064-5.00008]; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; Gray MJ, 2004, J CONSULT CLIN PSYCH, V72, P909, DOI 10.1037/0022-006X.72.5.909; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; Hoffman AN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50312-y; Hoffman AN, 2019, BEHAV PHARMACOL, V30, P115, DOI 10.1097/FBP.0000000000000461; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Laskowitz D., 2016, TRANSLATIONAL RES TR; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Long RP, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8524560; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Ma QY, 2013, CNS NEUROL DISORD-DR, V12, P392, DOI 10.2174/1871527311312030012; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maeng Lisa Y, 2017, Chronic Stress (Thousand Oaks), V1, p2470547017713297, DOI 10.1177/2470547017713297; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Marschner L, 2019, BEHAV BRAIN RES, V365, P222, DOI 10.1016/j.bbr.2018.02.040; McAllister D.E., 1967, J EXPT RES PERSONAL J EXPT RES PERSONAL; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Morrow JD, 2015, BEHAV BRAIN RES, V276, P59, DOI 10.1016/j.bbr.2014.04.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Nonaka M, 2021, J NEUROTRAUM, V38, P1551, DOI 10.1089/neu.2020.7254; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Perez Garcia G., 2021, J NEUROTRAUM; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Pickens C.L., 2013, CURR PROTOC NEUROSCI, V64; Pickens CL, 2009, BIOL PSYCHIAT, V65, P881, DOI 10.1016/j.biopsych.2008.12.010; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Santhanam P, 2019, J NEUROTRAUM, V36, P1093, DOI 10.1089/neu.2017.5541; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Sumner JA, 2018, BRAIN BEHAV IMMUN, V69, P203, DOI 10.1016/j.bbi.2017.11.013; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Tucker LB, 2021, J NEUROTRAUM, V38, P1585, DOI 10.1089/neu.2021.0025; Vedantam A, 2021, J NEUROTRAUM, V38, P53, DOI 10.1089/neu.2019.6979; Wang Q, 2004, J TRAUMA, V56, P604, DOI 10.1097/01.TA.0000058122.57737.0E; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Weiss C, 2020, SHOCK, V53, P744, DOI 10.1097/SHK.0000000000001424; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wurtz H, 2016, NEUROSCIENCE, V321, P222, DOI 10.1016/j.neuroscience.2015.06.012; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332; Zhang L, 2014, MOL PSYCHIATR, V19, P8, DOI 10.1038/mp.2012.180; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	122	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	AUG	2021	127						365	376		10.1016/j.neubiorev.2021.04.037			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TP3GB	WOS:000677480800005	33961927				2022-02-07	
J	Lack, V; Fru, PN; van Rensburg, C; van Rensburg, K; Loveland, JA				Lack, V; Fru, P. N.; van Rensburg, C.; van Rensburg, K.; Loveland, J. A.			The epidemiology of traumatic brain injuries sustained by children under 10 years of age presenting to a tertiary hospital in Soweto, South Africa	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							HEAD-INJURY; OUTCOMES	Background. Traumatic brain injury (TBI) in the paediatric population is a significant contributor to death and disability worldwide. In sub-Saharan Africa, death and disability from TBI are still superseded by infectious disease. Mechanisms of injury differ by region and socioeconomics, but in general, falls, road traffic collisions (RTCs), being 'struck by/against objects' and non-accidental injuries (NAIs) are responsible for most cases. Objectives. To: (i) quantify the burden of TBI in terms of demographics, causes and severity; (ii) explore resource utilisation regarding length of stay, computed tomography (CT) brain scan use and multidisciplinary participation; (iii) interrogate possible temporal patterns of injury; and (iv) thus identify potential targets for community-based prevention strategies. Methods. In a 5-year retrospective review of all children aged <10 years admitted with TBI between September 2013 and August 2018, demographics, date of injury, mechanism of injury, severity of TBI based on the Glasgow Coma Scale, and requirement for a CT brain scan were collected for each patient. Outcomes were reported as discharge, transfer or death. Outcomes for children sustaining isolated TBI were compared with those for children sustaining TBI with polytrauma. Results. A total of 2 153 patients were included, with a mean (standard deviation) age of 4.6 (2.7) years and a male/female ratio of 1.7:1. RTCs were the most frequent cause of injury at 59% (80% of these were pedestrian-vehicle collisions), followed by falls at 24%. Mild TBIs accounted for 87% of admissions, moderate injuries for 6%, and severe injuries for 7%. Polytrauma was associated with increased severity of TBI. The cohort had a 2.3% mortality. NAIs accounted for 6% of injuries and carried a 4% mortality. The median (interquartile range) duration of hospitalisation was 1 (1 -3) days, ranging from <24 hours to 132 days. CT scans were performed on 43% of admitted patients, and 48% of patients had consultations with another medical or allied medical discipline. Injuries were more frequent during the summer months and over weekends. Infants aged <1 year were identified as a group particularly vulnerable to injury, specifically NAI. Conclusions. Paediatric TBI was demonstrated to be a resource-intensive public health concern. From the results, we identified potential primary prevention targets that could perhaps be incorporated into broader community-based intervention programmes. We also identified a need to study long-term consequences of mild TBI further in our paediatric population.	[Lack, V; Loveland, J. A.] Chris Hani Baragwanath Acad Hosp, Dept Paediat Surg, Johannesburg, South Africa; [Lack, V; Fru, P. N.; van Rensburg, C.; van Rensburg, K.; Loveland, J. A.] Univ Witwatersrand, Div Gen Surg, Sch Clin Med, Fac Hlth Sci, Johannesburg, South Africa		Lack, V (corresponding author), Chris Hani Baragwanath Acad Hosp, Dept Paediat Surg, Johannesburg, South Africa.; Lack, V (corresponding author), Univ Witwatersrand, Div Gen Surg, Sch Clin Med, Fac Hlth Sci, Johannesburg, South Africa.	veredlack@yahoo.com		(Fonteh) Fru, Pascaline/0000-0002-3631-1893			Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Buitendag JJP, 2017, SAMJ S AFR MED J, V107, P777, DOI [10.7196/SAMJ.2017.v107i9.12394, 10.7196/samj.2017.v107i9.12394]; Burrows P, 2015, ARCH DIS CHILD, V100, P1032, DOI 10.1136/archdischild-2014-307119; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Herbert HK, 2012, J TRAUMA ACUTE CARE, V73, P168, DOI 10.1097/TA.0b013e31824d67c3; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lack V, 2020, BURNS OPEN, V4, P53, DOI [10.1016/j.burnso.2020.01.001, DOI 10.1016/J.BURNSO.2020.01.001]; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Lalloo R, 2004, SAMJ S AFR MED J, V94, P544; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Morrongiello BA, 1998, J PEDIATR PSYCHOL, V23, P33, DOI 10.1093/jpepsy/23.1.33; Naidoo Dinesh, 2013, SAMJ, S. Afr. med. j., V103, P613, DOI 10.7196/samj.7325; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Robertson DB, 2013, J INJ VIOLENCE RES, V5, P51, DOI [10.5249/jivr.v5i1.205, DOI 10.5249/JIVR.V5I1.205]; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Statistics South Africa, 030109 STAT S AFR 030109 STAT S AFR; Stevenson M, 2015, AM J LIFESTYLE MED, V9, P442, DOI 10.1177/1559827615569699; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Weimann A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193608; World Health Organization, 2008, GLOB BURD DIS 2004 U, V146, DOI DOI 10.1038/NPP.2011.85; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	33	0	0	0	0	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	AUG	2021	111	8					789	795		10.7196/SAMJ.2021.v111i8.15553			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TX1CJ	WOS:000682827800023		gold			2022-02-07	
J	Lee, SE; Yang, H; Sung, Y; Kim, Y; Park, SA				Lee, Sung Eun; Yang, Haijie; Sung, Youngjun; Kim, Younghoon; Park, Sun Ah			Region-Specific Differences in the Apoe4-dependent Response to Focal Brain Injury	EXPERIMENTAL NEUROBIOLOGY			English	Article						Apolipoprotein E4; Neuroglia; Hippocampus; Inflammation; Brain injuries; Neurodegeneration	ALZHEIMERS-DISEASE; APOE; ALLELE; CORTEX	Apolipoprotein E (apoE) plays a role in various physiological functions including lipid transport, synaptic plasticity, and immune modulation. Epidemiological studies suggest that the apoE4 allele increases the risk of post-traumatic sequelae. This study was performed to investigate regionspecific effects of the apoE4 isoform on post-traumatic neurodegeneration. Two focal brain injuries were introduced separately in the motor cortex and hippocampus of apoE4 knock-in, apoE3 knock-in, apoE knockout, and wild-type (WT) mice. Western blotting showed that the expression levels of pre-synaptic and post-synaptic markers at the recovery stage were lower in the hippocampal injury core in apoE4 mice, compared with apoE3 and WT mice. Fast glial activation (determined by immunohistochemistry with glial fibrillary acidic protein, ionized calcium binding adaptor molecule 1, and cluster of differentiation 45 antibodies) was characteristic of apoE4 mice with hippocampal injury penumbra. apoE4-specific changes were not observed after cortical injury. The intensity of microglial activation in the hippocampus was inversely correlated with the volume of injury reduction on sequential magnetic resonance imaging examinations, when validated using matched samples. These findings indicate that the effects of the interaction between apoE4 and focal brain damage are specific to the hippocampus. Manipulation of inflammatory cell responses could be beneficial for reducing post-traumatic hippocampal neurodegeneration in apoE4 carriers.	[Lee, Sung Eun; Kim, Younghoon; Park, Sun Ah] Ajou Univ, Sch Med, Dept Anat, Lab Neurodegenerat Dementia, Suwon 16499, South Korea; [Lee, Sung Eun; Park, Sun Ah] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Neurosci Grad Program, Suwon 16499, South Korea; [Yang, Haijie] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 16499, South Korea; [Sung, Youngjun] Ajou Univ, Dept Biol Sci, Suwon 16499, South Korea; [Park, Sun Ah] Ajou Univ, Dept Neurol, Sch Med, Suwon 16499, South Korea		Park, SA (corresponding author), Ajou Univ, Sch Med, Dept Anat, Lab Neurodegenerat Dementia, Suwon 16499, South Korea.; Park, SA (corresponding author), Ajou Univ, Grad Sch Med, Dept Biomed Sci, Neurosci Grad Program, Suwon 16499, South Korea.; Park, SA (corresponding author), Ajou Univ, Dept Neurol, Sch Med, Suwon 16499, South Korea.	sap001@ajou.ac.kr			Basic Science Research Program of the National Research Foundation of Korea - Korean government, MSIT [NRF-2018R1A2B6009439, 2019R1A5A2026045]; Original Technology Research Program for Brain Science of the National Research Foundation of Korea - Korean government, MSIT [NRF-2018M3C7A1056293]	This work was supported by Basic Science Research Program (NRF-2018R1A2B6009439 and 2019R1A5A2026045) and the Original Technology Research Program for Brain Science (NRF-2018M3C7A1056293) of the National Research Foundation of Korea funded by the Korean government, MSIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2018, JAMA NEUROL, V75, P328, DOI 10.1001/jamaneurol.2017.4198; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ben-Moshe H, 2020, J MOL NEUROSCI, V70, P32, DOI 10.1007/s12031-019-01397-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Foley KE, 2020, APOEE3 E4 APOEE4 E4, DOI [10.1101/2020.10.28.359422, DOI 10.1101/2020.10.28.359422]; Giarratana AO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76849-x; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Lee E, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00042; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Roussarie JP, 2020, NEURON, V107, P821, DOI 10.1016/j.neuron.2020.06.010; Shi Y, 2019, J EXP MED, V216, P2546, DOI 10.1084/jem.20190980; Teter B, 2004, J MOL NEUROSCI, V23, P167, DOI 10.1385/JMN:23:3:167; Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003; Yang HJ, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00642-0; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289	29	0	0	0	0	KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE	SEOUL	EXPERIMENTAL NEUROBIOLOGY,  SEOUL NATL UNIV, RM 410, BLDG 152-1, SEOUL, 151-742, SOUTH KOREA	1226-2560	2093-8144		EXP NEUROBIOL	Exp. Neurobiol.	AUG	2021	30	4					285	293		10.5607/en21022			9	Medicine, Research & Experimental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	UR3AF	WOS:000696624200003	34376629	Green Published, gold			2022-02-07	
J	Lee, TY; Jo, HJ				Lee, Tae Young; Jo, Hang Joon			Differential diagnosis and comorbid physical illness of schizophrenia	JOURNAL OF THE KOREAN MEDICAL ASSOCIATION			Korean	Article						Schizophrenia; Psychosis; Differential diagnosis; Comorbidity; Physical illness	TRAUMATIC BRAIN-INJURY; SEXUAL DYSFUNCTION; PSYCHOTIC SYMPTOMS; DISORDERS; PREVALENCE; WEIGHT; METAANALYSIS; DEMENTIA; DISEASE; EPIDEMIOLOGY	Background: Schizophrenia is a neurodevelopmental disorder that generally develops during adolescence or early adulthood. However, differentiating it from psychosis caused by a physical illness is difficult due to the phenotype-based diagnostic system. In this review, differential diagnosis of schizophrenia and the comorbid physical illnesses of patients with schizophrenia will be discussed. Current Concepts: Psychotic symptoms can be caused by various physical illnesses, and patients with schizophrenia have many physical comorbidities. Symptoms of psychosis can also be expressed by physical illness including brain tumors, encephalitis, temporal lobe epilepsy, autoimmune disease, and genetic disease. For the differential diagnosis of other physical illnesses that can cause psychosis, biological tests are essential. Depending on the cause, antipsychotics and treatment of physical diseases are required. In addition, patients with schizophrenia have many comorbid medical conditions such as obesity, diabetes, cardiovascular disease, but the diagnosis rate is low, and the mortality is higher than that of the general population due to untreated medical diseases. Discussion and Conclusion: The differential diagnoses of schizophrenia and physical illness causing psychosis are important. To decrease the high mortality of patients with schizophrenia, periodic physical condition examinations and mental status examinations should be conducted.	[Lee, Tae Young] Pusan Natl Univ, Yangsan Hosp, Dept Psychiat, Yangsan, South Korea; [Jo, Hang Joon] Hanyang Univ, Coll Med, Dept Physiol, Seoul, South Korea		Jo, HJ (corresponding author), Hanyang Univ, Coll Med, Dept Physiol, Seoul, South Korea.	hang.jo@gmail.com		Lee, Tae Young/0000-0002-0238-8147	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2021R1A2C1006718]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2021R1A2C1006718).	ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Almeida OP, 2007, AUST NZ J PSYCHIAT, V41, P274, DOI 10.1080/00048670601172772; Ando N, 2004, NEUROPSYCHOPHARMACOL, V29, P1251, DOI 10.1038/sj.npp.1300427; Aronow WS, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.03.17; Baggaley M, 2008, HUM PSYCHOPHARM CLIN, V23, P201, DOI 10.1002/hup.924; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; CASTLE DJ, 1993, BRIT J PSYCHIAT, V162, P658, DOI 10.1192/bjp.162.5.658; Cullen AE, 2019, BIOL PSYCHIAT, V85, P35, DOI 10.1016/j.biopsych.2018.06.016; Cutler AJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00113-0; FILLEY CM, 1995, WESTERN J MED, V163, P19; GIBB WRG, 1987, BRAIN, V110, P1131, DOI 10.1093/brain/110.5.1131; GOLDSTEIN JM, 1989, PSYCHIAT RES, V28, P243, DOI 10.1016/0165-1781(89)90205-9; Green T, 2001, SEX TRANSM INFECT, V77, P214, DOI 10.1136/sti.77.3.214; HARE EH, 1959, J MENT SCI, V105, P594, DOI 10.1192/bjp.105.440.594; Heiberg IH, 2019, ACTA PSYCHIAT SCAND, V139, P558, DOI 10.1111/acps.13017; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hummer M, 1995, EUR NEUROPSYCHOPHARM, V5, P437, DOI 10.1016/0924-977X(95)00012-E; Jang YE, 2019, PSYCHIAT INVEST, V16, P109, DOI 10.30773/pi.2018.10.23; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Keshavan MS, 2013, WORLD PSYCHIATRY, V12, P4, DOI 10.1002/wps.20001; Kumral E, 2004, NEUROLOGY, V62, P110, DOI 10.1212/WNL.62.1.110; Lambert Timothy J R, 2003, Med J Aust, V178, pS67; Lee TY, 2010, PSYCHIAT INVEST, V7, P278, DOI 10.4306/pi.2010.7.4.278; Lennox BR, 2017, LANCET PSYCHIAT, V4, P42, DOI 10.1016/S2215-0366(16)30375-3; Lyoo IK, 1996, J NEUROPSYCH CLIN N, V8, P54; Madhusoodanan S, 2010, EXPERT REV NEUROTHER, V10, P1529, DOI [10.1586/ern.10.94, 10.1586/ERN.10.94]; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Nagahama Y, 2007, AM J GERIAT PSYCHIAT, V15, P961, DOI 10.1097/JGP.0b013e3180cc1fdf; National Collaborating Centre for Mental Health, 2014, PSYCH SCHIZ AD TREA; Osser DN, 1999, J CLIN PSYCHIAT, V60, P767, DOI 10.4088/JCP.v60n1109; OSULLIVAN DJ, 1977, J NEUROL NEUROSUR PS, V40, P853, DOI 10.1136/jnnp.40.9.853; Patten SB, 2005, NEUROLOGY, V65, P1123, DOI 10.1212/01.wnl.0000178998.95293.29; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pillinger T, 2017, JAMA PSYCHIAT, V74, P261, DOI 10.1001/jamapsychiatry.2016.3803; Ramankutty G, 2002, ACTA PSYCHIAT SCAND, V105, P235, DOI 10.1034/j.1600-0447.2002.2c257a.x; Richards M, 2019, AM J PSYCHIAT, V176, P269, DOI 10.1176/appi.ajp.2018.18040404; Ropacki SA, 2005, AM J PSYCHIAT, V162, P2022, DOI 10.1176/appi.ajp.162.11.2022; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Ruschena D, 1998, BRIT J PSYCHIAT, V172, P331, DOI 10.1192/bjp.172.4.331; Schneider M, 2016, WORLD PSYCHIATRY, V15, P259, DOI 10.1002/wps.20347; Scott JG, 2018, BJPSYCH OPEN, V4, P69, DOI 10.1192/bjo.2018.8; Sellgren C, 2014, SCHIZOPHRENIA BULL, V40, P1552, DOI 10.1093/schbul/sbu054; Solano JJR, 2000, SCHIZOPHR RES, V44, P137, DOI 10.1016/S0920-9964(99)00203-0; Stangeland H, 2018, J NEUROL NEUROSUR PS, V89, P879, DOI 10.1136/jnnp-2017-317327; Stubbs B, 2014, ACTA PSYCHIAT SCAND, V130, P470, DOI 10.1111/acps.12313; Torta R, 1999, EPILEPSIA, V40, pS2, DOI 10.1111/j.1528-1157.1999.tb00883.x; UMBRICHT DSG, 1994, J CLIN PSYCHIAT, V55, P157; Vohra J, 2020, HEART LUNG CIRC, V29, P1427, DOI 10.1016/j.hlc.2020.07.003; Waldo ML, 2015, INT PSYCHOGERIATR, V27, P531, DOI 10.1017/S1041610214002580	52	0	0	3	3	KOREAN MEDICAL ASSOC	SEOUL	302-75 INCHON-1 DONG, YONGSAN-GU, SEOUL, 140-721, SOUTH KOREA	1975-8456	2093-5951		J KOREAN MED ASSOC	J. Korean Med. Assoc.	AUG	2021	64	8					551	558		10.5124/jkma.2021.64.8.551			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UA0LM	WOS:000684857100007		gold			2022-02-07	
J	Lempke, LB; Johnson, RS; Le, RK; Anderson, MN; Schmidt, JD; Lynall, RC				Lempke, Landon B.; Johnson, Rachel S.; Le, Rachel K.; Anderson, Melissa N.; Schmidt, Julianne D.; Lynall, Robert C.			Head Impact Biomechanics in Youth Flag Football A Prospective Cohort Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						pediatric; repetitive head impact; concussion; subconcussive; sport safety; youth sport	LATER-LIFE; EXPOSURE; INJURIES; CONTACT; SYSTEMS; AGE	Background: Youth flag football participation has rapidly grown and is a potentially safer alternative to tackle football. However, limited research has quantitatively assessed youth flag football head impact biomechanics. Purpose: To describe head impact biomechanics outcomes in youth flag football and explore factors associated with head impact magnitudes. Study Design: Cross-sectional study; Level of evidence, 3. Methods: We monitored 52 player-seasons among 48 male flag football players (mean +/- SD; age, 9.4 +/- 1.1 years; height, 138.6 +/- 9.5 cm; mass, 34.7 +/- 9.2 kg) across 3 seasons using head impact sensors during practices and games. Sensors recorded head impact frequencies, peak linear (g) and rotational (rad/s(2)) acceleration, and estimated impact location. Impact rates (IRs) were calculated as 1 impact per 10 player-exposures; IR ratios (IRRs) were used to compare season, event type, and age group IRs; and 95% CIs were calculated for IRs and IRRs. Weekly and seasonal cumulative head impact frequencies and magnitudes were calculated. Mixed-model regression models examined the association between player characteristics, event type, and seasons and peak linear and rotational accelerations. Results: A total of 429 head impacts from 604 exposures occurred across the study period (IR, 7.10; 95% CI, 4.81-10.50). Weekly and seasonal cumulative median head impact frequencies were 1.00 (range, 0-2.63) and 7.50 (range, 0-21.00), respectively. The most frequent estimated head impact locations were the skull base (n = 96; 22.4%), top of the head (n = 74; 17.2%), and back of the head (n = 66; 15.4%). The combined event type IRs differed among the 3 seasons (IRR range, 1.45-2.68). Games produced greater IRs (IRR, 1.24; 95% CI, 1.01-1.53) and peak linear acceleration (mean difference, 5.69g; P = .008) than did practices. Older players demonstrated greater combined event-type IRs (IRR, 1.46; 95% CI, 1.12-1.90) and increased head impact magnitudes than did younger players, with every 1-year age increase associated with a 3.78g and 602.81-rad/s(2) increase in peak linear and rotational acceleration magnitude, respectively (P <= .005). Conclusion: Head IRs and magnitudes varied across seasons, thus highlighting multiple season and cohort data are valuable when providing estimates. Head IRs were relatively low across seasons, while linear and rotational acceleration magnitudes were relatively high.	[Lempke, Landon B.; Johnson, Rachel S.; Le, Rachel K.; Anderson, Melissa N.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lempke, Landon B.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Lempke, Landon B.] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Ramsey Student Ctr, 330 River Rd, Athens, GA 30602 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	National Operating Committee on Standards for Athletic Equipment (NOCSAE); AOSSM	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was supported by the National Operating Committee on Standards for Athletic Equipment (NOCSAE). AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Burnham BR, 2010, AM J PREV MED, V38, pS141, DOI 10.1016/j.amepre.2009.10.010; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Campbell KR, 2020, MED SCI SPORT EXER, V52, P2198, DOI 10.1249/MSS.0000000000002371; Cecchi NJ, 2020, J SCI MED SPORT, V23, P927, DOI 10.1016/j.jsams.2020.03.008; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; De Caro, YOUTH TACKLE FOOTBAL; Kaplan Y, 2013, CLIN J SPORT MED, V23, P39, DOI 10.1097/JSM.0b013e3182694870; Karton C, 2016, ISBS C P ARCH INT SO ISBS C P ARCH INT SO; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Association of Intercollegiate Athletics, WOM FLAG FOOTB WOM FLAG FOOTB; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; National Intramural-Recreational Sports Association, NIRSA FLAG FOOTB NIRSA FLAG FOOTB; Oeur RA, 2016, ISBS C P ARCH INT SO ISBS C P ARCH INT SO; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; R Core Team, 2020, R LANG ENV STAT COMP; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Savino AK, 2020, ANN BIOMED ENG, V48, P2763, DOI 10.1007/s10439-020-02548-3; Schlechter CR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5108-3; Schlechter CR, 2017, J SPORT SCI, V35, P22, DOI 10.1080/02640414.2016.1154593; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Solomon J, 2018, 10 CHARTS SHOW PROGR; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012	35	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2021	49	10					2817	2826		10.1177/03635465211026643			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TY5RC	WOS:000683840500030	34264780				2022-02-07	
J	Li, DD; Wang, Y; Kim, EL; Hong, J; Jung, JH				Li, Dan-dan; Wang, Ying; Kim, Eun La; Hong, Jongki; Jung, Jee H.			Neuroprotective Effect of Cyclo-(L-Pro-L-Phe) Isolated from the Jellyfish-Derived Fungus Aspergillus flavus	MARINE DRUGS			English	Article						PPAR; 2; 5-diketopiperazines; cyclo-(L-Pro-L-Phe); neuroprotection; oxidative stress	ACTIVATED RECEPTOR-GAMMA; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; PPAR-GAMMA; BIOLOGICAL-ACTIVITY; HYDROGEN-PEROXIDE; DIKETOPIPERAZINES; 2,5-DIKETOPIPERAZINES	Peroxisome proliferator-activated receptor (PPAR) expression has been implicated in pathological states such as cancer, inflammation, diabetes, and neurodegeneration. We isolated natural PPAR agonists-eight 2,5-diketopiperazines-from the jellyfish-derived fungus Aspergillus flavus. Cyclo-(L-Pro-L-Phe) was the most potent PPAR-gamma activator among the eight 2,5-DKPs identified. Cyclo-(L-Pro-L-Phe) activated PPAR-gamma in Ac2F rat liver cells and SH-SY5Y human neuroblastoma cells. The neuroprotective effect of this partial PPAR-gamma agonist was examined using the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, lactate dehydrogenase release, and the Hoechst 33342 staining assay in SH-SY5Y cells. Our findings revealed that cyclo-(L-Pro-L-Phe) reduced hydrogen peroxide-induced apoptosis as well as the generation of reactive oxygen species. Rhodamine 123 staining and western blotting revealed that cyclo-(L-Pro-L-Phe) prevented the loss of mitochondrial membrane potential and inhibited the activation of mitochondria-related apoptotic proteins, such as caspase 3 and poly (ADP-ribose) polymerase. Moreover, cyclo-(L-Pro-L-Phe) inhibited the activation and translocation of nuclear factor-kappa B. Thus, the partial PPAR-gamma agonist cyclo-(L-Pro-L-Phe) demonstrated potential neuroprotective activity against oxidative stress-induced neurodegeneration in SH-SY5Y cells.	[Li, Dan-dan; Wang, Ying; Kim, Eun La; Jung, Jee H.] Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea; [Hong, Jongki] Kyung Hee Univ, Coll Pharm, Seoul 02447, South Korea		Jung, JH (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.	leedany1992@gmail.com; wangrunhe829@gmail.com; eunlakim@gmail.com; jhong@khu.ac.kr; jhjung@pusan.ac.kr			National Research Foundation of Korea (NRF)National Research Foundation of Korea [201901920001]	This research was funded by the National Research Foundation of Korea (NRF) (201901920001).	Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; BANKS WA, 1993, AM J PHYSIOL, V264, pE723, DOI 10.1152/ajpendo.1993.264.5.E723; Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Biovia D.S., 2015, DISCOVERY STUDIO MOD; Borthwick AD, 2017, CRIT REV FOOD SCI, V57, P718, DOI 10.1080/10408398.2014.911142; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Bright JJ, 2008, PPAR RES, V2008, DOI 10.1155/2008/658520; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Carrieri R, 2020, J FUNGI, V6, DOI 10.3390/jof6020083; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Chiang MC, 2016, NEUROBIOL AGING, V40, P181, DOI 10.1016/j.neurobiolaging.2016.01.132; Choudhary NS, 2019, J CLIN EXP HEPATOL, V9, P731, DOI 10.1016/j.jceh.2019.06.004; Cornacchia C, 2012, MINI-REV MED CHEM, V12, P2, DOI 10.2174/138955712798868959; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Eom SH, 2016, MAR DRUGS, V14, DOI 10.3390/md14060112; Faden AI, 2005, ANN NY ACAD SCI, V1053, P472, DOI 10.1196/annals.1344.041; Faden AI, 2005, CHEM BIODIVERS, V2, P1564, DOI 10.1002/cbdv.200590127; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; Machado MMF, 2019, PHARMACOL REP, V71, P556, DOI 10.1016/j.pharep.2018.11.005; Furtado NAJC, 2005, J BRAZIL CHEM SOC, V16, P1448, DOI 10.1590/S0103-50532005000800026; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gos FMWR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01642; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Hadwan MH, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0097-5; Hall MG, 2008, PPAR RES, V2008, DOI 10.1155/2008/780452; Huang BX, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00281; Huang DY, 2021, NAT PROD RES, DOI 10.1080/14786419.2021.1878168; Huang RM, 2014, MAR DRUGS, V12, P6213, DOI 10.3390/md12126213; Huang RM, 2010, CHEM BIODIVERS, V7, P2809, DOI 10.1002/cbdv.200900211; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Huo HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154605; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Jayatilake GS, 1996, J NAT PROD, V59, P293, DOI 10.1021/np960095b; Kang H, 2016, BIOORG MED CHEM LETT, V26, P1873, DOI 10.1016/j.bmcl.2016.03.030; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lanzillotta A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00098; Lee S.K., 2003, OS, P418; Lee Y, 2019, BRAIN RES, V1704, P47, DOI 10.1016/j.brainres.2018.09.036; Li XH, 2016, INT J MOL MED, V38, P1152, DOI 10.3892/ijmm.2016.2701; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lin WX, 2020, NAT PROD RES, V34, P1461, DOI 10.1080/14786419.2018.1508148; Luo LuGuang, 2013, Curr Aging Sci, V6, P8; Luo RC, 2020, AUTOPHAGY, V16, P52, DOI 10.1080/15548627.2019.1596488; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Mandrekar-Colucci S, 2013, ASN NEURO, V5, DOI 10.1042/AN20130030; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; McCleland K, 2004, J PHARM PHARMACOL, V56, P1143, DOI 10.1211/0022357044139; Minelli A, 2008, AMINO ACIDS, V35, P283, DOI 10.1007/s00726-007-0629-6; Mollica A, 2014, FITOTERAPIA, V98, P91, DOI 10.1016/j.fitote.2014.07.010; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Ou YX, 2016, NAT PROD RES, V30, P1771, DOI 10.1080/14786419.2015.1137570; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash KRC, 2002, BIOORGAN MED CHEM, V10, P3043, DOI 10.1016/S0968-0896(02)00132-3; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Quintanilla RA, 2014, PPAR RES, V2014, DOI 10.1155/2014/768594; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Satyanarayanan SK, 2018, MOL NEUROBIOL, V55, P7271, DOI 10.1007/s12035-018-0899-x; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Seok H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40736-x; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stark T, 2005, J AGR FOOD CHEM, V53, P7222, DOI 10.1021/jf051313m; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Takahashi A, 2004, BRAIN RES BULL, V62, P497, DOI 10.1016/j.brainresbull.2003.07.009; Tang XM, 2020, NEUROCHEM RES, V45, P837, DOI 10.1007/s11064-020-02956-w; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tullberg M, 2006, TETRAHEDRON, V62, P7484, DOI 10.1016/j.tet.2006.05.010; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Vazquez-Rivera D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/197608; Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wagner N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9112367; Waku T, 2009, FEBS LETT, V583, P320, DOI 10.1016/j.febslet.2008.12.017; Wang GH, 2010, CHEM NAT COMPD+, V46, P583, DOI 10.1007/s10600-010-9680-8; Wang XJ, 1998, ONCOGENE, V17, P2819, DOI 10.1038/sj.onc.1202216; Wang Y, 2013, EXPERT OPIN THER PAT, V23, P1415, DOI 10.1517/13543776.2013.828036; Wojtowicz S, 2020, NEUROCHEM RES, V45, P972, DOI 10.1007/s11064-020-02993-5; Xiao B., 2021, BIOMOL THER, DOI [10.4062/biomolther.2021.008, DOI 10.4062/BIOMOLTHER.2021.008]; Xiao HB, 2016, CHEM SCI, V7, P6153, DOI 10.1039/c6sc01793b; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Younus H, 2018, INT J HEALTH SCI-IJH, V12, P88; Zhang Q, 2013, J AGR FOOD CHEM, V61, P11447, DOI 10.1021/jf403200g	92	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-3397		MAR DRUGS	Mar. Drugs	AUG	2021	19	8							417	10.3390/md19080417			18	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	UI5JO	WOS:000690643400001	34436256	gold, Green Published			2022-02-07	
J	Li, X; Pierre, K; Yang, ZH; Nguyen, L; Johnson, G; Venetucci, J; Torres, I; Lucke-Wold, B; Shi, Y; Boutte, A; Shear, D; Leung, LY; Wang, KKW				Li, Xue; Pierre, Kevin; Yang, Zhihui; Nguyen, Lynn; Johnson, Gabrielle; Venetucci, Juliana; Torres, Isabel; Lucke-Wold, Brandon; Shi, Yuan; Boutte, Angela; Shear, Deborah; Leung, Lai Yee; Wang, Kevin K. W.			Blood-Based Brain and Global Biomarker Changes after Combined Hypoxemia and Hemorrhagic Shock in a Rat Model of Penetrating Ballistic-Like Brain Injury	NEUROTRAUMA REPORTS			English	Article						biomarker; brain injury; global injury markers; organ injury	ALPHA-II-SPECTRIN; SUBUNIT NF-H; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; MICRORNA DYSREGULATION; PNF-H; SERUM; DAMAGE; HYPOXIA; HYPOTENSION	Penetrating traumatic brain injury (pTBI) often occurs with systemic insults such as hemorrhagic shock (HS) and hypoxemic (HX). This study examines rat models of penetrating ballistic-like brain injury (PBBI) and HX+HS to assess whether the blood levels of brain and systemic response biomarkers phosphorylated neurofilament-heavy protein (pNF-H), neurofilament-light protein (NF-L), alpha II-spectrin, heat shock protein (HSP70), and high mobility group box 1 protein (HMGB1) can distinguish pTBI from systemic insults and guide in pTBI diagnosis, prognosis, and monitoring. Thirty rats were randomly assigned to sham, PBBI, HS+HX, and PBBI+HS+HX groups. PBBI and sham groups underwent craniotomy with and without probe insertion and balloon expansion, respectively. HX and HS was then simulated by blood withdrawal and fraction of inspired oxygen (FIO2) reduction. Biomarker serum concentrations were determined at one (D1) and two (D2) days post-injury with enzyme-linked immunosorbent assay (ELISA) methods. Axonal injury-linked biomarkers pNF-H and NF-L serum levels in PBBI groups were higher than those in sham and HX+HS groups at D1 and D2 post-injury. The same was true for PBBI+HX+HS compared with sham (D2 only for pNF-H) and HX+HS groups. However, pNF-H and NF-L levels in PBBI+HX+HS groups were not different than their PBBI counterparts. At D1, alpha II-spectrin levels in the HX+HS and PBBI+HS+HX groups were higher than the sham groups. alpha II-spectrin levels in the HX+HS group were higher than the PBBI group. This suggests HX+HS as the common insult driving alpha II-spectrin elevations. In conclusion, pNF-H and NF-L may serve as specific serum biomarkers of pTBI in the presence or absence of systemic insults. alpha II-spectrin may be a sensitive acute biomarker in detecting systemic insults occurring alone or with pTBI.	[Li, Xue; Pierre, Kevin; Yang, Zhihui; Nguyen, Lynn; Johnson, Gabrielle; Venetucci, Juliana; Torres, Isabel; Lucke-Wold, Brandon; Shi, Yuan; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Pierre, Kevin] Univ Florida, Coll Med, Gainesville, FL 32611 USA; [Lucke-Wold, Brandon] Univ Florida, Dept Neurosurg, Gainesville, FL 32611 USA; [Li, Xue; Shi, Yuan] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Boutte, Angela; Shear, Deborah; Leung, Lai Yee] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect, Silver Spring, MD USA; [Wang, Kevin K. W.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Leung, Lai Yee] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarker Res NN, Room LG-128,1149 Newell Dr, Gainesville, FL 32611 USA.	kwang@ufl.edu			Center for Military Psychiatry and Neuroscience at the Walter Reed Army Institute of Research; Department of Emergency Medicine at the University of Florida	This work was supported by departmental funding from the Center for Military Psychiatry and Neuroscience at the Walter Reed Army Institute of Research and from the Department of Emergency Medicine at the University of Florida.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blanie A, 2012, J NEUROTRAUM, V29, P2782, DOI 10.1089/neu.2012.2381; Boutte AM, 2020, J NEUROTRAUM, V37, P1574, DOI 10.1089/neu.2019.6537; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; DAUTIGNY A, 1988, BIOCHEM BIOPH RES CO, V154, P1099, DOI 10.1016/0006-291X(88)90254-9; DeDominicis KE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00490; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gao WY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022363; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Inoue R, 2017, NEUROSCI LETT, V653, P39, DOI 10.1016/j.neulet.2017.05.023; Johnson D, 2017, J TRAUMA ACUTE CARE, V83, pS145, DOI 10.1097/TA.0000000000001475; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Lee Bruce, 2005, NeuroRx, V2, P372; Leung LY, 2016, J TRAUMA ACUTE CARE, V81, P860, DOI 10.1097/TA.0000000000001206; Leung Lai Yee, 2015, J Trauma Acute Care Surg, V79, pS130, DOI 10.1097/TA.0000000000000785; Leung LY, 2013, J NEUROTRAUM, V30, P1288, DOI 10.1089/neu.2012.2715; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Madathil SK, 2017, J TRAUMA ACUTE CARE, V83, pS16, DOI 10.1097/TA.0000000000001471; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raucci A, 2007, AUTOIMMUNITY, V40, P285, DOI 10.1080/08916930701356978; Rider P, 2017, J IMMUNOL, V198, P1395, DOI 10.4049/jimmunol.1601342; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Singh Ajai, 2017, Int J Crit Illn Inj Sci, V7, P212, DOI 10.4103/IJCIIS.IJCIIS_73_16; Skarupa DJ, 2019, AM J SURG, V218, P255, DOI 10.1016/j.amjsurg.2018.11.034; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Thangavelu B, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00915; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Zhang J, 2012, CHIN J TRAUMATOL, V15, P338, DOI 10.3760/cma.j.issn.1008-1275.2012.06.004; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	60	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2021	2	1					370	380		10.1089/neur.2021.0006			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UB0JV	WOS:000685540300001	34901937	gold, Green Published			2022-02-07	
J	Lotze, FP; Riess, ML				Lotze, Felicia P.; Riess, Matthias L.			Poloxamer 188 Exerts Direct Protective Effects on Mouse Brain Microvascular Endothelial Cells in an In Vitro Traumatic Brain Injury Model	BIOMEDICINES			English	Article						copolymer; hypoxia reoxygenation; ischemia reperfusion; neuroprotection; P188; stroke	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; MEMBRANE PERMEABILIZATION; SURFACTANT POLOXAMER-188; OXIDATIVE STRESS; BLOCK-COPOLYMER; BARRIER DAMAGE; MITOCHONDRIAL; RAT; MECHANISMS	Traumatic Brain Injury (TBI), the main contributor to morbidity and mortality worldwide, can disrupt the cell membrane integrity of the vascular endothelial system, endangering blood brain barrier function and threatening cellular subsistence. Protection of the vascular endothelial system might enhance clinical outcomes after TBI. Poloxamer 188 (P188) has been shown to improve neuronal function after ischemia/reperfusion (I/R) injury as well as after TBI. We aimed to establish an in vitro compression-type TBI model, comparing mild-to-moderate and severe injury, to observe the direct effects of P188 on Mouse Brain Microvascular Endothelial Cells (MBEC). Confluent MBEC were exposed to normoxic or hypoxic conditions for either 5 or 15 h (hours). 1 h compression was added, and P188 was administered during 2 h reoxygenation. A direct effect of P188 on MBEC was tested by assessing cell number/viability, cytotoxicity/membrane damage, metabolic activity, and total nitric oxide production (tNOp). While P188 enhanced cell number/viability, metabolic activity, and tNOp, an increase in cytotoxicity/membrane damage after mild-to-moderate injury was prevented. In severely injured MBEC, P188 improved metabolic activity only. P188, present during reoxygenation, influenced MBEC function directly in simulated I/R and compression-type TBI.	[Lotze, Felicia P.; Riess, Matthias L.] Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN 37232 USA; [Lotze, Felicia P.] Univ Med Greifswald, Dept Anesthesiol, D-17475 Greifswald, Germany; [Riess, Matthias L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Riess, Matthias L.] TVHS VA Med Ctr, Anesthesiol, Nashville, TN 37212 USA		Riess, ML (corresponding author), Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN 37232 USA.; Riess, ML (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Riess, ML (corresponding author), TVHS VA Med Ctr, Anesthesiol, Nashville, TN 37212 USA.	felicia.lotze@gmail.com; matthias.riess@vanderbilt.edu		Riess, Matthias/0000-0001-8748-5757	US Department of Veterans Affairs Biomedical Laboratory RD ServiceUS Department of Veterans Affairs [I01 BX003482]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01 HL123227]	This work was supported in part by the US Department of Veterans Affairs Biomedical Laboratory R&D Service (I01 BX003482), the National Institutes of Health (5R01 HL123227), and by institutional funds to M.L.R.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Adhikari U, 2016, J PHYS CHEM B, V120, P5823, DOI 10.1021/acs.jpcb.5b11448; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bartos Jason A, 2016, JACC Basic Transl Sci, V1, P224; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boulpaep E.L., 2017, MED PHYSL; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; COLBASSANI HJ, 1989, STROKE, V20, P1241, DOI 10.1161/01.STR.20.9.1241; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Datta D, 2020, JOVE-J VIS EXP, DOI 10.3791/60295; Ding WB, 2020, TOXICOLOGY, V436, DOI 10.1016/j.tox.2020.152437; Dong HL, 2019, NEUROCHEM INT, V126, P178, DOI 10.1016/j.neuint.2019.03.013; Douglas HF, 2017, FASEB J, V31; Faley SL, 2019, STEM CELL REP, V12, P474, DOI 10.1016/j.stemcr.2019.01.009; Follis F, 1996, J INVEST SURG, V9, P149, DOI 10.3109/08941939609012466; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Goliaei A, 2016, J PHYS CHEM B, V120, P8631, DOI 10.1021/acs.jpcb.6b03030; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Houang EM, 2017, MOL PHARMACEUT, V14, P2333, DOI 10.1021/acs.molpharmaceut.7b00197; Huang LM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-49; Igarashi J, 2008, BBA-MOL CELL BIOL L, V1781, P489, DOI 10.1016/j.bbalip.2008.06.008; Inyang E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59888-2; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Kanagaraj J, 2018, ANN BIOMED ENG, V46, P354, DOI 10.1007/s10439-017-1953-y; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kwiatkowski TA, 2020, AM J PHYSIOL-CELL PH, V318, pC253, DOI 10.1152/ajpcell.00321.2019; L Lin, 2016, Biochem Pharmacol (Los Angel), V5, DOI 10.4172/2167-0501.1000213; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Li Z, 2021, FASEB J, V35, DOI 10.1096/fasebj.2021.35.S1.03999; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lotze F.P., 2019, FASEB J, V33, p527.4, DOI [10.1096/fasebj.2019.33.1_supplement.527.4, DOI 10.1096/FASEBJ.2019.33.1_SUPPLEMENT.527.4]; Lotze FP, 2019, CIRCULATION, V140; Lucas Rudolf, 2014, Front Immunol, V5, P589, DOI 10.3389/fimmu.2014.00589; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2015, J MOL NEUROSCI, V56, P988, DOI 10.1007/s12031-015-0568-8; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Martindale JJ, 2014, J MOL CELL CARDIOL, V67, P26, DOI 10.1016/j.yjmcc.2013.12.008; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Maskarinec SA, 2005, ANN NY ACAD SCI, V1066, P310, DOI 10.1196/annals.1363.018; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Meyer LJ, 2021, LIFE-BASEL, V11, DOI 10.3390/life11040316; Misra A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016011; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moysidou CM, 2021, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.620962; Murphy AD, 2010, PLAST RECONSTR SURG, V125, P1651, DOI 10.1097/PRS.0b013e3181ccdbef; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Salzman M.M., 2015, FASEB J, V29, p1026.5, DOI [10.1096/fasebj.29.1_supplement.1026.5, DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.1026.5]; Salzman M.M., 2017, CIRCULATION, V136; Salzman MM, 2020, PHARMACOL RES PERSPE, V8, DOI 10.1002/prp2.639; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shelat PB, 2013, J NEUROSCI, V33, P12287, DOI 10.1523/JNEUROSCI.5731-12.2013; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sigma Aldrich, POLY ETHYLENE GLYCOL; Sigma-Aldrich, KOLL P 188; Song HW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69096-7; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Tskitishvili E, 2010, MOL HUM REPROD, V16, P188, DOI 10.1093/molehr/gap104; Tsukada Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80497-6; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang JC, 2017, NEUROCHEM INT, V109, P126, DOI 10.1016/j.neuint.2017.04.007; Wang T, 2015, J MOL NEUROSCI, V55, P240, DOI 10.1007/s12031-014-0313-8; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284; Zhao M, 2008, INVEST OPHTH VIS SCI, V49, P550, DOI 10.1167/iovs.07-1037	76	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	AUG	2021	9	8							1043	10.3390/biomedicines9081043			32	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	UF9BV	WOS:000688862500001	34440247	Green Published, gold			2022-02-07	
J	Ma'u, E; Cullum, S; Cheung, G; Livingston, G; Mukadam, N				Ma'u, Etuini; Cullum, Sarah; Cheung, Gary; Livingston, Gill; Mukadam, Naaheed			Differences in the potential for dementia prevention between major ethnic groups within one country: A cross sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand	LANCET REGIONAL HEALTH-WESTERN PACIFIC			English	Article							AIR-POLLUTION; PREVALENCE; HEALTH; INEQUALITIES; IMPAIRMENT; DISEASE; BURDEN	Background: Twelve potentially modifiable risk factors (less education, hypertension, obesity, alcohol, traumatic brain injury (TBI), hearing loss, smoking, depression, physical inactivity, social isolation, diabetes, air pollution) account for an estimated 40% of worldwide dementia cases. We aimed to calculate population attributable fractions (PAFs) for dementia for the four largest New Zealand ethnic groups (European, Maori, Asian, and Pacific peoples) to identify whether optimal dementia prevention targets differed by ethnicity. Methods: We calculated risk factor prevalence for 10 risk factors using the New Zealand Health Survey 2018/19 and published reports for hearing loss and TBI prevalences. We calculated the PAF for each risk factor using calculated prevalence and relative risk estimates from previous meta-analyses. To account for risk factor overlap, we calculated communality of risk factors and a weighted PAF. Findings: The weighted PAF for dementia was 47.7% overall in New Zealand, 47.6% for Europeans, 51.4% for Maori, 50.8% for Pacific peoples, and 40.8% for Asians. Highest PAFs for Europeans were hearing loss (8%) and social isolation (5.7%), and for Asians hearing loss (7.3%) and physical inactivity (5.5%). For Maori and Pacific peoples, highest PAFs were for obesity (7.3% and 8.9% respectively) and hearing loss (6.5% and 6.6%). Interpretation: New Zealand has higher dementia prevention potential than worldwide estimates with high prevalences of untreated hearing loss and obesity. The relative contribution of individual risk factors PAFs varies by ethnic group. Public health strategies for dementia prevention need to be tailored to these differences. (C) 2021 The Authors. Published by Elsevier Ltd.	[Livingston, Gill; Mukadam, Naaheed] UCL, Div Psychiat, London, England; [Livingston, Gill; Mukadam, Naaheed] Camden & Islington NHS Fdn Trust, St Pancras Hosp, London, England; [Ma'u, Etuini; Cullum, Sarah; Cheung, Gary] Univ Auckland, Dept Psychol Med, Auckland, New Zealand; [Ma'u, Etuini] Waikato Dist Hlth Board, Hamilton, New Zealand; [Cullum, Sarah] Counties Manukau Dist Hlth Board, Auckland, New Zealand; [Cheung, Gary] Auckland Dist Hlth Board, Auckland, New Zealand		Ma'u, E (corresponding author), Univ Auckland, Waikato Hosp, Peter Rothwell Acad Ctr, Dept Psychol Med, Private Bag 3200, Hamilton 3240, New Zealand.			Ma'u, Etuini/0000-0003-3989-8404; Livingston, Gill/0000-0001-6741-5516	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC:20/021]	Health Research Council of New Zealand (HRC:20/021).	Adelman S, 2011, BRIT J PSYCHIAT, V199, P119, DOI 10.1192/bjp.bp.110.086405; Ahmadi-Abhari S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2856; [Anonymous], 2017, DELOITTE ACCESS ECON; [Anonymous], 2019, 2018 19 NEW ZEALAND; [Anonymous], 2020, SPORT NZ ACTIVE NZ 2; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Browne MAO, 2006, AUST NZ J PSYCHIAT, V40, P865, DOI 10.1111/j.1440-1614.2006.01905.x; Chen H, 2017, ENVIRON INT, V108, P271, DOI 10.1016/j.envint.2017.08.020; Cullum S, 2020, NEW ZEAL MED J, V133, P119; Deloitte Access Economics, 2016, SOCIAL EC COSTS HEAR; Desai R, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101122; Digby J.E., 2019, DEAFNESS NOTIFICATIO; Dudley M, 2019, NEW ZEAL MED J, V132, P66; Exeter DJ, 2015, NEW ZEAL MED J, V128, P12; Gosling AL, 2015, ANN HUM GENET, V79, P470, DOI 10.1111/ahg.12132; Harris RB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196476; Lee CHJ, 2017, NEW ZEAL MED J, V130, P10; Lee HB, 2012, AGING MENT HEALTH, V16, P372, DOI 10.1080/13607863.2011.609533; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Livingston M, 2015, J STUD ALCOHOL DRUGS, V76, P158, DOI 10.15288/jsad.2015.76.158; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Mayeda ER, 2016, ALZHEIMERS DEMENT, V12, P216, DOI 10.1016/j.jalz.2015.12.007; Milne RJ, 2012, J PAEDIATR CHILD H, V48, P685, DOI 10.1111/j.1440-1754.2012.02447.x; Ministry for the Environment, NATL PM10 CONCENTRAT; Ministry of Health, 2020, ANN UPDATE KEY RESUL; Ministry of Health, 2004, TRACKING OBESITY EPI; Ministry of Health, 2018, HLTH INDEPENDENCE RE; Ministry of Health, SURVEYS; Ministry of Health, 2017, HISO 100012017 ETHNI; Mukadam N, 2020, LANCET HEALTH LONGEV, V1, pE13; Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9; NIWA PM2.5 in New Zealand, 2019, MODELLING CURRENT 20; OECD, EXPOSURE PM25 COUNTR; Paterson C., 2018, WORLD ALZHEIMER REPO; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince MJ, 2015, WORLD ALZHEIMER REPO; Richardson EA, 2011, HEALTH PLACE, V17, P1137, DOI 10.1016/j.healthplace.2011.05.007; Sommerlad A, 2018, J NEUROL NEUROSUR PS, V89, P231, DOI 10.1136/jnnp-2017-316274; Statistics New Zealand, NATL ETHNIC PROJECTI; Statistics New Zealand, 2013, 2013 NZ DISABILITY S; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Te Hiringa Hauora, FIND ALCOHOL STAT; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; World Health Organisation ICD-10, 2004, INT STAT CLASSIFICAT, V2nd; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051	47	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2666-6065		LANCET REG HEALTH-W	Lancet Reg. Health-W. Pac.	AUG	2021	13								100191	10.1016/j.lanwpc.2021.100191			9	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	UI1OD	WOS:000690384700008	34527984	Green Published, gold			2022-02-07	
J	Mader, MM; Boger, R; Appel, D; Schwedhelm, E; Haddad, M; Mohme, M; Lamszus, K; Westphal, M; Czorlich, P; Hannemann, J				Mader, Marius M.; Boeger, Rainer; Appel, Daniel; Schwedhelm, Edzard; Haddad, Munif; Mohme, Malte; Lamszus, Katrin; Westphal, Manfred; Czorlich, Patrick; Hannemann, Juliane			Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral hemorrhage; L-arginine; nitric oxide; dimethylarginine; humans	ASYMMETRIC DIMETHYLARGININE ADMA; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; MASS-SPECTROMETRIC DETERMINATION; CORTICAL IMPACT INJURY; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; NITROSATIVE STRESS; RISK MARKER; ARGINASE	Alterations in the concentration of nitric oxide (NO) and L-arginine metabolites have been associated with the pathophysiology of different vascular diseases. Here, we describe striking changes in L-arginine metabolism after hemorrhagic stroke. Blood and cerebrospinal fluid (CSF) samples of patients with intracerebral hemorrhage (ICH) and/or intraventricular hemorrhage were collected over a ten-day period. Liquid chromatography-tandem mass spectrometry was used to quantify key substrates and products of L-arginine metabolizing enzymes as well as asymmetric (ADMA) and symmetric dimethylarginine (SDMA). Changes in the plasma were limited to early reductions in L-ornithine, L-lysine, and L-citrulline concentrations. Intrathecally, we observed signs of early NO synthase (NOS) upregulation followed by a decrease back to baseline accompanied by a rise in the level of its endogenous NOS-inhibitor ADMA. SDMA demonstrated increased levels throughout the observation period. For arginase, a pattern of persistently elevated activity was measured and arginine:glycine amidinotransferase (AGAT) appeared to be reduced in its activity at later time points. An early reduction in CSF L-arginine concentration was an independent risk factor for poor outcome. Together, these findings further elucidate pathophysiological mechanisms after ICH potentially involved in secondary brain injury and may reveal novel therapeutic targets.	[Mader, Marius M.; Mohme, Malte; Lamszus, Katrin; Westphal, Manfred; Czorlich, Patrick] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany; [Mader, Marius M.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Boeger, Rainer; Schwedhelm, Edzard; Hannemann, Juliane] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Appel, Daniel] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany; [Haddad, Munif] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany		Mader, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	mader@uke.de		Mader, Marius/0000-0002-7467-9672			Ahn M, 2012, BRAIN RES, V1445, P11, DOI 10.1016/j.brainres.2012.01.045; Akar E, 2019, WORLD NEUROSURG, V132, pE443, DOI 10.1016/j.wneu.2019.08.119; Appel D, 2018, NEUROCRIT CARE, V29, P84, DOI 10.1007/s12028-018-0520-1; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Atzler D, 2011, J CHROMATOGR B, V879, P2294, DOI 10.1016/j.jchromb.2011.06.016; Barakat W, 2018, N-S ARCH PHARMACOL, V391, P603, DOI 10.1007/s00210-018-1489-1; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2000, J AM COLL CARDIOL, V36, P2287, DOI 10.1016/S0735-1097(00)01013-5; Brouns R, 2009, NEUROCHEM RES, V34, P1642, DOI 10.1007/s11064-009-9954-3; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Cheng J, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113214; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Choe CU, 2013, CIRCULATION, V128, P1451, DOI 10.1161/CIRCULATIONAHA.112.000580; Ckless K, 2007, AM J RESP CELL MOL, V36, P645, DOI 10.1165/rcmb.2006-0329SM; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Davids M, 2012, FEBS LETT, V586, P3653, DOI 10.1016/j.febslet.2012.08.020; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Jung CS, 2012, NEUROSCI LETT, V524, P20, DOI 10.1016/j.neulet.2012.06.076; Liddle L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224870; Lovasik BP, 2016, WORLD NEUROSURG, V94, P309, DOI 10.1016/j.wneu.2016.07.022; Luneburg N, 2012, CLIN SCI, V122, P105, DOI 10.1042/CS20110013; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Madan S, 2018, MOL GENET METAB, V125, P112, DOI 10.1016/j.ymgme.2018.07.007; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Morgan TC, 2013, STROKE, V44, P635, DOI 10.1161/STROKEAHA.112.670653; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Ochoa JB, 2000, SURGERY, V127, P419, DOI 10.1067/msy.2000.104745; Ochoa JB, 2001, ANN SURG, V233, P393, DOI 10.1097/00000658-200103000-00014; Rashid Parveen A, 2003, J Stroke Cerebrovasc Dis, V12, P82, DOI 10.1053/jscd.2003.9; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; TANAKA K, 1993, NEUROREPORT, V4, P267, DOI 10.1097/00001756-199303000-00010; TEASDALE G, 1974, LANCET, V2, P81; Terpolilli NA, 2016, J CEREBR BLOOD F MET, V36, P2096, DOI 10.1177/0271678X15605848; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-00018; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wanby P, 2006, ATHEROSCLEROSIS, V185, P271, DOI 10.1016/j.atherosclerosis.2005.06.033; Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM; Willmot M, 2005, NITRIC OXIDE-BIOL CH, V12, P141, DOI 10.1016/j.niox.2005.01.003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Worthmann H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1016-1; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770	54	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2021	41	8					1964	1977		10.1177/0271678X20983216			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	TS1GD	WOS:000679405000012	33461409	Green Published			2022-02-07	
J	Maki, Y; Kidokoro, H; Okumura, A; Yamamoto, H; Nakata, T; Fukasawa, T; Kubota, T; Kawaguchi, M; Suzuki, T; Tanaka, M; Okai, Y; Sakaguchi, Y; Ohno, A; Negoro, T; Takahashi, Y; Natsume, J				Maki, Yuki; Kidokoro, Hiroyuki; Okumura, Akihisa; Yamamoto, Hiroyuki; Nakata, Tomohiko; Fukasawa, Tatsuya; Kubota, Tetsuo; Kawaguchi, Masahiro; Suzuki, Takeshi; Tanaka, Masaharu; Okai, Yu; Sakaguchi, Yoko; Ohno, Atsuko; Negoro, Tamiko; Takahashi, Yoshiyuki; Natsume, Jun			Repetitive sleep starts: An important differential diagnosis of infantile spasms	EPILEPSY & BEHAVIOR			English	Article						Repetitive sleep start; Epileptic spasm; Sleep-related movement disorder; Propriospinal myoclonus; Video-electroencephalogram	PROPRIOSPINAL MYOCLONUS; INFANCY	Objective: Repetitive sleep starts (RSS) are clusters of nonepileptic, spasm-like movements occurring during sleep onset. However, their characteristics have yet to be defined. We conducted a clinicoelectroencephalographic study of children with RSS to clarify their detailed characteristics. Methods: To differentiate starts from epileptic spasms, we recruited children with brief "crescendo-de crescendo" muscle contractions that simultaneously involved the limbs and trunk without electroencephalogram changes, and that fulfilled the following criteria: (1) repeated occurrence (five or more) and (2) manifestation during sleep stage N1-N2. A total of nine children met these criteria. Their clinical information and video-electroencephalogram data were analyzed retrospectively. Results: The background conditions observed at onset of RSS were perinatal hypoxic-ischemic encephalopathy (n = 4), West syndrome of unknown etiology (n = 1), and traumatic brain injury (n = 1). The age at onset of RSS, the number of starts in a given RSS cluster, the interval between starts, and the duration of surface electromyogram activity were between 3 and 46 months, 5 and 547, <1 and 60 s, and 0.3 and 5.4 s, respectively. None of the median value of these parameters differed between children with and without corticospinal tract injury. During the median follow-up period of 33 months, RSS disappeared spontaneously in five. Conclusion: This is the largest case series of RSS clarifying their clinicoelectroencephalographic characteristics reported to date. To avoid unnecessary antiepileptic therapies, clinicians should be aware of RSS and distinguish it from other disorders involving involuntary movements or seizures, especially epileptic spasms. (c) 2021 Elsevier Inc. All rights reserved.	[Maki, Yuki; Kidokoro, Hiroyuki; Yamamoto, Hiroyuki; Nakata, Tomohiko; Kawaguchi, Masahiro; Suzuki, Takeshi; Tanaka, Masaharu; Okai, Yu; Sakaguchi, Yoko; Ohno, Atsuko; Negoro, Tamiko; Takahashi, Yoshiyuki; Natsume, Jun] Nagoya Univ, Dept Pediat, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Okumura, Akihisa] Aichi Med Univ, Dept Pediat, Nagakute, Aichi, Japan; [Fukasawa, Tatsuya; Kubota, Tetsuo] Anjo Kosei Hosp, Dept Pediat, Anjo, Aichi, Japan; [Natsume, Jun] Nagoya Univ, Dept Dev Disabil Med, Grad Sch Med, Nagoya, Aichi, Japan		Kidokoro, H (corresponding author), Nagoya Univ, Dept Pediat, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kidokoro@med.nagoya-u.ac.jp		Kawaguchi, Masahiro/0000-0001-9219-9173; Yamamoto, Hiroyuki/0000-0003-1109-5298; Kidokoro, Hiroyuki/0000-0002-7991-8580			American Academy of Sleep Medicine, 2017, AASM MANUAL SCORING; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Antelmi E, 2015, SLEEP MED REV, V22, P54, DOI 10.1016/j.smrv.2014.10.007; BROWN P, 1991, BRAIN, V114, P197; BROWN P, 1994, MOVEMENT DISORD, V9, P571, DOI 10.1002/mds.870090511; Caraballo RH, 2009, EPILEPSIA, V50, P1176, DOI 10.1111/j.1528-1167.2008.01994.x; CHOKROVERTY S, 1992, NEUROLOGY, V42, P1591, DOI 10.1212/WNL.42.8.1591; Chokroverty S., 1994, SLEEP DISORDERS MED, P381; Chokroverty S, 2013, J CLIN NEUROPHYSIOL, V30, P403, DOI 10.1097/WNP.0b013e31829dde98; Clouston PD, 1996, MOVEMENT DISORD, V11, P404, DOI 10.1002/mds.870110409; Dreissen YEM, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03709.x; Dreissen YEM, 2012, CLIN NEUROPHYSIOL, V123, P34, DOI 10.1016/j.clinph.2011.09.022; Fusco L, 2005, NEUROL SCI, V26, pS205, DOI 10.1007/s10072-005-0488-4; Fusco L, 1999, EPILEPTIC DISORD, V1, P63; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; Pavone P, 2014, BRAIN DEV-JPN, V36, P739, DOI 10.1016/j.braindev.2013.10.008; van der Salm SMA, 2014, NEUROLOGY, V83, P1862, DOI 10.1212/WNL.0000000000000982	17	0	0	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2021	121								108075	10.1016/j.yebeh.2021.108075			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	SY2TY	WOS:000665746200020	34077901				2022-02-07	
J	Mao, B; Wang, Y; Balasubramanian, T; Urioste, R; Wafa, T; Fitzgerald, TS; Haraczy, SJ; Edwards-Hollingsworth, K; Sayyid, ZN; Wilder, D; Sajja, VSSS; Wei, YL; Arun, P; Gist, I; Cheng, AG; Long, JB; Kelley, MW				Mao, Beatrice; Wang, Ying; Balasubramanian, Tara; Urioste, Rodrigo; Wafa, Talah; Fitzgerald, Tracy S.; Haraczy, Scott J.; Edwards-Hollingsworth, Kamren; Sayyid, Zahra N.; Wilder, Donna; Sajja, Venkata Siva Sai Sujith; Wei, Yanling; Arun, Peethambaran; Gist, Irene; Cheng, Alan G.; Long, Joseph B.; Kelley, Matthew W.			Assessment of auditory and vestibular damage in a mouse model after single and triple blast exposures	HEARING RESEARCH			English	Article						Blast exposure; Hearing loss; Synaptopathy; Tympanic membrane; Outer hair cells; Vestibular evoked potentials	HEARING-LOSS; COCHLEAR SYNAPTOPATHY; NOISE EXPOSURE; HAIR-CELLS; BRAIN; DEGENERATION; SECTION; MICE; ACCELERATION; REGENERATION	The use of explosive devices in war and terrorism has increased exposure to concussive blasts among both military personnel and civilians, which can cause permanent hearing and balance deficits that adversely affect survivors' quality of life. Significant knowledge gaps on the underlying etiology of blast induced hearing loss and balance disorders remain, especially with regard to the effect of blast exposure on the vestibular system, the impact of multiple blast exposures, and long-term recovery. To address this, we investigated the effects of blast exposure on the inner ear using a mouse model in conjunction with a high-fidelity blast simulator. Anesthetized animals were subjected to single or triple blast exposures, and physiological measurements and tissue were collected over the course of recovery for up to 180 days. Auditory brainstem responses (ABRs) indicated significantly elevated thresholds across multiple frequencies. Limited recovery was observed at low frequencies in single-blasted mice. Distortion Product Otoacoustic Emissions (DPOAEs) were initially absent in all blast-exposed mice, but low-amplitude DPOAEs could be detected at low frequencies in some single-blast mice by 30 days post-blast, and in some triple-blast mice at 180 days post-blast. All blast-exposed mice showed signs of Tympanic Membrane (TM) rupture immediately following exposure and loss of outer hair cells (OHCs) in the basal cochlear turn. In contrast, the number of Inner Hair Cells (IHCs) and spiral ganglion neurons was unchanged following blast-exposure. A significant reduction in IHC pre-synaptic puncta was observed in the upper turns of blast-exposed cochleae. Finally, we found no significant loss of utricular hair cells or changes in vestibular function as assessed by vestibular evoked potentials. Our results suggest that (1) blast exposure can cause severe, long-term hearing loss which may be partially due to slow TM healing or altered mechanical properties of healed TMs, (2) traumatic levels of sound can still reach the inner ear and cause basal OHC loss despite middle ear dysfunction caused by TM rupture, (3) blast exposure may result in synaptopathy in humans, and (4) balance deficits after blast exposure may be primarily due to traumatic brain injury, rather than damage to the peripheral vestibular system. (c) 2021 Elsevier B.V. All rights reserved.	[Mao, Beatrice; Balasubramanian, Tara; Haraczy, Scott J.; Edwards-Hollingsworth, Kamren; Kelley, Matthew W.] Natl Inst Deafness & Other Commun Disorders, Natl Inst Hlth, Sect Dev Neurosci, Bethesda, MD USA; [Wang, Ying; Urioste, Rodrigo; Wilder, Donna; Sajja, Venkata Siva Sai Sujith; Wei, Yanling; Arun, Peethambaran; Gist, Irene; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD USA; [Wafa, Talah; Fitzgerald, Tracy S.] Natl Inst Deafness & Other Commun Disorders, Natl Inst Hlth, Mouse Auditory Testing Core Facil, Bethesda, MD USA; [Sayyid, Zahra N.; Cheng, Alan G.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA		Mao, B (corresponding author), Natl Inst Deafness & Other Commun Disorders, Natl Inst Hlth, Sect Dev Neurosci, Bethesda, MD USA.; Wang, Y; Long, JB (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD USA.	beatrice.mao@nih.gov; ying.wang5.ctr@mail.mil; joseph.b.long.civ@mail.mil		Sajja, Sujith/0000-0002-1992-9501; Wafa, Talah/0000-0001-6943-2205; Sayyid, Zahra/0000-0001-6872-7028	United States Army Medical Research and Materiel Command Grant [W81XWH-15-2-0024]; NIDCD's Intramural Research Program [DC000059, DC000080]; NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC016919]	This project was funded by United States Army Medical Research and Materiel Command Grant W81XWH-15-2-0024 to J.B.L., Y.W. and M.W.K, the NIDCD's Intramural Research Program (DC000059 to M.W.K and DC000080 to the Mouse Auditory Testing Core), and NIDCD R01DC016919 toA.G.C.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Bucks SA, 2017, ELIFE, V6, DOI [10.7554/eLife.18128.001, 10.7554/eLife.18128]; Cai LL, 2019, HEARING RES, V384, DOI 10.1016/j.heares.2019.107813; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Dandy WE, 1934, B JOHNS HOPKINS HOSP, V55, P240; Dong W, 2019, HEARING RES, V378, P3, DOI 10.1016/j.heares.2019.01.015; Dror AA, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12635; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Fischer, 2019, RECENT TRENDS ACTIVE; Harrod CG, 2003, BRAIN RES, V972, P75, DOI 10.1016/S0006-8993(03)02505-8; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; Kallakuri S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193389; Kim J, 2018, P NATL ACAD SCI USA, V115, pE4853, DOI 10.1073/pnas.1720121115; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; LIBERMAN MC, 1978, ACTA OTO-LARYNGOL, P5; Lien S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00297; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Masri S, 2018, NEUROSCIENCE, V379, P428, DOI 10.1016/j.neuroscience.2018.03.041; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; MIKAELIAN DO, 1970, ARCHIV OTOLARYNGOL, V91, P371; Morozko EL, 2015, HUM MOL GENET, V24, P609, DOI 10.1093/hmg/ddu474; NEFF WD, 1947, J COMP PHYSIOL PSYCH, V40, P203, DOI 10.1037/h0056931; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Sajja VS, 2018, NEUROMETHODS, V139, P123, DOI 10.1007/978-1-4939-8564-7_8; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Sayyid ZN, 2019, CELL REP, V28, P312, DOI 10.1016/j.celrep.2019.06.028; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; SPOENDLIN H, 1975, ACTA OTO-LARYNGOL, V79, P266, DOI 10.3109/00016487509124683; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Tona R, 2019, HUM MOL GENET, V28, P1530, DOI 10.1093/hmg/ddy445; Wang Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67389-5; Yu Y, 2020, J OTOL, V15, P77, DOI 10.1016/j.joto.2020.01.003	46	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	AUG	2021	407								108292	10.1016/j.heares.2021.108292			11	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	TK8DR	WOS:000674384300005	34214947				2022-02-07	
J	Marin, JR; Rodean, J; Mannix, RC; Hall, M; Alpern, ER; Aronson, PL; Chaudhari, PP; Cohen, E; Freedman, SB; Morse, RB; Peltz, A; Samuels-Kalow, M; Shah, SS; Simon, HK; Neuman, MI				Marin, Jennifer R.; Rodean, Jonathan; Mannix, Rebekah C.; Hall, Matt; Alpern, Elizabeth R.; Aronson, Paul L.; Chaudhari, Pradip P.; Cohen, Eyal; Freedman, Stephen B.; Morse, Rustin B.; Peltz, Alon; Samuels-Kalow, Margaret; Shah, Samir S.; Simon, Harold K.; Neuman, Mark, I			Association of Clinical Guidelines and Decision Support with Computed Tomography Use in Pediatric Mild Traumatic Brain Injury	JOURNAL OF PEDIATRICS			English	Article							MINOR HEAD-INJURY; INCIDENTAL FINDINGS; CT SCANS; CHILDREN; SYSTEMS; IMPLEMENTATION; OUTCOMES; PATIENT; PECARN; VISITS	Objective To examine whether the presence of clinical guidelines and clinical decision support (CDS) for mild traumatic brain injury (mTBI) are associated with lower use of head computed tomography (CT). Study design We conducted a cross-sectional study of 45 pediatric emergency departments (EDs) in the Pediatric Hospital Information System from 2015 through 2019. We included children discharged with mTBI and surveyed ED clinical directors to ascertain the presence and implementation year of clinical guidelines and CDS. The association of clinical guidelines and CDS with CT use was assessed, adjusting for relevant confounders. As secondary outcomes, we evaluated ED length of stay and rates of 3-day ED revisits and admissions after revisits. Results There were 216 789 children discharged with mTBI, and CT was performed during 20.3% (44 114/216 789) of ED visits. Adjusted hospital-specific CT rates ranged from 11.8% to 34.7% (median 20.5%, IQR 17.3%, 24.3%). Of the 45 EDs, 17 (37.8%) had a clinical guideline, 9 (20.0%) had CDS, and 19 (42.2%) had neither. Compared with EDs with neither a clinical guideline nor CDS, visits to EDs with CDS (aOR 0.52 [0.47, 0.58]) or a clinical guideline (aOR 0.83 [0.78, 0.89]) had lower odds of including a CT for mTBI. ED length of stay and revisit rates did not differ based on the presence of a clinical guideline or CDS. Conclusions Clinical guidelines for mTBI, and particularly CDS, were associated with lower rates of head CT use without adverse clinical out-comes.	[Marin, Jennifer R.] UPMC, Div Pediat Emergency Med, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Rodean, Jonathan; Hall, Matt] Childrens Hosp Assoc, Lenexa, KS USA; [Mannix, Rebekah C.; Neuman, Mark, I] Harvard Med Sch, Div Emergency Med, Boston Childrens Hosp, Boston, MA 02115 USA; [Alpern, Elizabeth R.] Northwestern Univ, Feinberg Sch Med, Div Emergency Med, Dept Pediat,Ann & Robert H Lurie Childrens Hosp C, Chicago, IL 60611 USA; [Aronson, Paul L.] Yale Sch Med, Dept Pediat, Sect Pediat Emergency Med, New Haven, CT USA; [Chaudhari, Pradip P.] USC, Childrens Hosp Los Angeles, Div Emergency & Transport Med, Los Angeles, CA USA; [Chaudhari, Pradip P.] USC, Keck Sch Med, Los Angeles, CA USA; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Div Pediat Med & Child Hlth Evaluat Sci, Toronto, ON, Canada; [Cohen, Eyal] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Cohen, Eyal] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Dept Emergency Med, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Sect Pediat Emergency Med, Dept Pediat,Alberta Childrens Hosp,Alberta Childr, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Sect Gastroenterol, Dept Pediat,Alberta Childrens Hosp,Alberta Childr, Calgary, AB, Canada; [Morse, Rustin B.] Nationwide Childrens Hosp, Columbus, OH USA; [Peltz, Alon] Harvard Med Sch, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Samuels-Kalow, Margaret] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Div Hosp Med, Cincinnati, OH 45229 USA; [Simon, Harold K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Simon, Harold K.] Childrens Healthcare Atlanta, Atlanta, GA USA		Marin, JR (corresponding author), 4401 Penn Ave,AOB Suite 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu	Hall, Matt/AAT-1349-2021	Hall, Matt/0000-0001-7778-5887; Chaudhari, Pradip/0000-0002-7732-632X	National Football League Charitable foundation; Department of DefenseUnited States Department of Defense [DOD W81XWH1920011]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HL155425, U01NS096835, 1R01NS115942]; Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS026006]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness; Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL 1TR002541]; Harvard University; CDC-Concussion Management Grant [U01 CE002939]; HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [U03MC33155-01-00]; Georgia Clinical & Translational Science Alliance [NCATS UL1 TR002378]; Massachusetts Association of Health Plans	R.C.M. is supported by funding from the National Football League Charitable foundation, the Department of Defense (DOD W81XWH1920011), and the National Institutes of Health (U01NS096835, 1R01NS115942). P.L.A. is supported by the Agency for Healthcare Research and Quality (AHRQ) (K08HS026006). S.B.F. receives grant support from the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness. M.S.-K. was supported by the Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. H.K.S. is supported by CDC U01 CE002939-Concussion Management Grant, HRSA U03MC33155-01-00 (PECARN), and NCATS UL1 TR002378 Georgia Clinical & Translational Science Alliance. A.P. is supported by funding from the National Institutes of Health (K23HL155425) and the Massachusetts Association of Health Plans. The other authors declare no conflicts of interest.	Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Bennett P, 2017, J AM MED INFORM ASSN, V24, P655, DOI 10.1093/jamia/ocw151; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Devaraj S, 2014, J BUS ADM RES, P3; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Erly WK, 2003, AM J ROENTGENOL, V180, P1727, DOI 10.2214/ajr.180.6.1801727; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Institute of Medicine, 2009, RACE ETHNICITY LANGU; Institute of Medicine, 1990, CLIN PRACT GUID DIR; Jarman MP, 2018, JAMA SURG, V153, P535, DOI 10.1001/jamasurg.2017.6133; Kamat PP, 2019, J PEDIATR-US, V204, P285, DOI 10.1016/j.jpeds.2018.08.039; Kemp A, 2016, ARCH DIS CHILD, V101, P929, DOI 10.1136/archdischild-2015-309078; Khairat S, 2018, JMIR MED INF, V6, P25, DOI 10.2196/medinform.8912; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maher CO, 2015, PEDIATRICS, V135, pE1084, DOI 10.1542/peds.2015-0071; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Marin JR, 2015, J PEDIATR-US, V167, P897, DOI 10.1016/j.jpeds.2015.06.052; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rogers AJ, 2013, PEDIATRICS, V132, pE356, DOI 10.1542/peds.2013-0299; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tham E, 2016, APPL CLIN INFORM, V7, P534, DOI 10.4338/ACI-2015-10-CR-0144; Trivedi MH, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-6; Zerhouni EA, 2006, J INVEST MED, V54, P171, DOI 10.2310/6650.2006.X0016	40	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2021	235						178	+		10.1016/j.jpeds.2021.04.026			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	TN9WF	WOS:000676575200038	33894265				2022-02-07	
J	Matur, AV; Ngwenya, LB; Prestigiacomo, CJ				Matur, Abhijith V.; Ngwenya, Laura B.; Prestigiacomo, Charles J.			The surgical history of head injury in motor vehicle collision	JOURNAL OF NEUROSURGERY			English	Article						head injury; MVC; motor vehicle collision; TBI; traumatic brain injury; history; trauma	BRAIN-INJURY; SKULL; PREVENTION; MANAGEMENT; FRACTURE	Motor vehicle collisions (MVCs) are a significant cause of head injuries today, but efforts to manage and prevent these injuries extend as far back as the beginning of modern neurosurgery itself. Head trauma in MVCs occurred as far back as 1899, and the surgical literature of the time mentions several cases of children being struck by passing automobiles. By the 1930s, Dr. Claire L. Straith, a Detroit plastic surgeon, recommended changes to automobile design after seeing facial injuries and depressed skull fractures that resulted from automobile accidents. During World War II, Sir Hugh Cairns, a British neurosurgeon, demonstrated the efficacy of motorcycle helmets in preventing serious head injury. In the 1950s, Dr. Frank H. Mayfield, a Cincinnati neurosurgeon on the trauma committee of the American College of Surgeons, made several recommendations, such as adding padded dashboards and seatbelts, to make automobiles safer. Ford implemented the recommendations from Dr. Mayfield and others into a safety package for the 1956 models. Significant work has also been done to prevent head injury in motorsports. Efforts by surgeons, especially neurosurgeons, to prevent head injury in MVCs have saved countless lives, although it is a less frequently celebrated achievement.	[Matur, Abhijith V.; Ngwenya, Laura B.; Prestigiacomo, Charles J.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.; Prestigiacomo, Charles J.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45221 USA; [Ngwenya, Laura B.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA		Prestigiacomo, CJ (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.; Prestigiacomo, CJ (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45221 USA.	presticj@ucmail.uc.edu					[Anonymous], 1899, NEW YORK TIMES, P1; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Beekman F, 1928, ANN SURG, V87, P355, DOI 10.1097/00000658-192803000-00002; Boundy RG., 2020, TRANSPORTATION ENERG, V38th; CAIRNS H, 1946, BRIT MED J, V2, P322, DOI 10.1136/bmj.2.4470.322; Cairns H, 1943, BMJ-BRIT MED J, V1943, P591, DOI 10.1136/bmj.1.4297.591; Carter BN, 1926, ANN SURG, V83, P182, DOI 10.1097/00000658-192602000-00005; Ford Motor Company, 1955, FORD LIF DES; Frank H, MAYFIELD BIOGRAPHICA; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Greene A, 2002, INJ PREV, V8, P257, DOI 10.1136/ip.8.3.257; Hamlin O D, 1908, Cal State J Med, V6, P12; Hubbard RP, 1987, US patent, Patent No. [4,638,510, 4638510]; Hubbard RP., SAE TECHNICAL PAPER; Kaul A, 2016, J NEUROSURG-SPINE, V25, P756, DOI 10.3171/2015.10.SPINE15337; MAYFIELD FH, 1957, JAMA-J AM MED ASSOC, V163, P245, DOI 10.1001/jama.1957.02970390021009; Nader R., 1965, UNSAFE AT ANY SPEED; Newell ED, 1937, ANN SURG, V105, P662, DOI 10.1097/00000658-193705000-00004; NHTSA, TRAFF SAF FACTS; O'Neill B, 2009, TRAFFIC INJ PREV, V10, P113, DOI 10.1080/15389580802486225; Parry M, 2011, AM J PUBLIC HEALTH, V101, P257, DOI 10.2105/AJPH.2009.191163; PATTON H S, 1959, Plast Reconstr Surg Transplant Bull, V23, P200; Pendleton C, 2014, J NEUROL SURG PART B, V75, P27, DOI 10.1055/s-0033-1353361; Ransohoff J, 1910, ANN SURG, V51, P796, DOI 10.1097/00000658-191006000-00005; ROSS WD, 1959, AM J SURG, V98, P577, DOI 10.1016/0002-9610(59)90039-X; ROVIT R, 1988, SURG NEUROL, V29, P175, DOI 10.1016/0090-3019(88)90001-8; SHELDEN CH, 1955, JAMA-J AM MED ASSOC, V159, P981, DOI 10.1001/jama.1955.02960270001001; Stone JL, 2016, J NEUROSURG, V125, P1301, DOI 10.3171/2015.8.JNS142613; Straith CL, 1937, J AMER MED ASSOC, V109, P940, DOI 10.1001/jama.1937.92780380004007; Straith CL, 1951, US patent, Patent No. [2,560,009, 2560009]; TEW JM, 1982, SURG NEUROL, V17, P1, DOI 10.1016/0090-3019(82)90029-5; Vogrin B., 1994, LOS ANGELES TIMES; Watkins Eric S, 2006, Clin Neurosurg, V53, P145; Watkins S., 1996, LIFE LIMIT TRIUMPH T, V1st; Watts G, 2012, LANCET, V380, P1734, DOI 10.1016/S0140-6736(12)61979-5; Wilensky AO, 1919, ANN SURG, V70, P404, DOI 10.1097/00000658-191910000-00005; Youngers EH, 2017, NEUROSURGERY, V81, P416, DOI 10.1093/neuros/nyx053	37	0	0	4	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					594	600		10.3171/2020.7.JNS20941			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800031	33254132				2022-02-07	
J	McIntosh, AS; Patton, DA; McIntosh, AG				McIntosh, Andrew Stuart; Patton, Declan Alexander; McIntosh, Alexander G. D.			Managing head injury risks in competitive skateboarding: what do we know?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						skate board; helmet; olympics; concussion; injury prevention	HELMET USE; POPULATION; SKATEPARK; CHILDREN; TRAUMA; USERS	Objectives The broad objective of this paper is to inform policy, practice and research regarding the management of head injury risks in competitive skateboarding. The main motivation for the current study was the question of mandating helmet use in competitive skateboarding. The specific aims are to present current knowledge on (A) head injury risks in skateboarding, (B) preliminary biomechanical data on falls and head injury risks in a selection of competitive skateboarding events similar to those planned for the Summer Olympics, (C) standards for skateboard-styled helmets and (D) impact performance of helmets commonly used in skateboarding. Methods A narrative review of the published literature on head injuries in skateboarding was conducted. Videos of skateboarding competitions from Vans Park Professional League, Street League Skateboarding and Dew Tour were reviewed to describe crashes and falls. Standards databases including the International Organization for Standardization (ISO), British Standards Institution (BSI), Snell, United States Consumer Product Safety Commission (CPSC) and American Society for Testing and Materials (ASTM) were searched for skateboarding-styled helmet standards. A sample of helmets considered suitable for skateboarding was tested in standard impact tests. Results The majority of previous literature focused on the paediatric population in a recreational setting with little data from competitive skateboarding. Head injuries comprised up to 75% of all injuries and helmet use was less than 35%. Video analysis identified high rates of falls and crashes during competitive skateboarding, but also a capacity for the athletes to control falls and limit head impacts. Less than 5% of competitive skateboarders wore helmets. In addition to dedicated national skateboard helmet standards, there are several national standards for skateboard-styled helmets. All helmets, with the exception of one uncertified helmet, had similar impact attenuation performance; that is, at 0.8 m drop height, 114-148 g; at 1.5 m, 173-220 g; and at 2.0 m, 219-259 g. Impact performance in the second impact was degraded in all helmets tested. Conclusion Helmets styled for skateboarding are available 'off the shelf' that will offer protection to the head against skull fractures and intracranial injuries in competitive skateboarding. There is an urgent need to commence a programme of research and development to understanding and control head injury risks.	[McIntosh, Andrew Stuart] Edith Cowan Univ, Sch Engn & ACRISP, Joondalup, WA, Australia; [McIntosh, Andrew Stuart; McIntosh, Alexander G. D.] McIntosh Consultancy & Res, Sydney, NSW, Australia; [Patton, Declan Alexander] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Patton, Declan Alexander] Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada		McIntosh, AS (corresponding author), Edith Cowan Univ, Sch Engn, Joondalup, WA, Australia.	as.mcintosh@optusnet.com.au			International Olympic Committee (IOC) Medical and Science Commission; Centre for Road Safety, Transport for NSW	The projects summarised in this paper were funded in part by the International Olympic Committee (IOC) Medical and Science Commission and the Centre for Road Safety, Transport for NSW.	Bahr R., 2020, ORTHOP J SPORTS MED, V8, DOI [10.1136/bjsports-2019-101969, DOI 10.1136/BJSPORTS-2019-101969]; Bandzar S, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1253; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Brudvik C, 2006, PREV SCI, V7, P313, DOI 10.1007/s11121-006-0031-8; Capua J, 2012, J AM ORGAN NEUROL SU, V12, P75; Cassell E., 2014, PREVENTING SERIOUS F; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Dagget L., 2013, ANNIVERSARY DAY X GA; Everett WW, 2002, J EMERG MED, V23, P269, DOI 10.1016/S0736-4679(02)00528-0; Fabian LA, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/924381; Feletti F, 2018, RES SPORTS MED, V26, P129, DOI 10.1080/15438627.2018.1438285; Forjuoh SN, 2002, ARCH PEDIAT ADOL MED, V156, P656, DOI 10.1001/archpedi.156.7.656; Forsman L, 2001, BRIT J SPORT MED, V35, P325, DOI 10.1136/bjsm.35.5.325; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Kaddis M, 2016, J PAEDIATR CHILD H, V52, P30, DOI 10.1111/jpc.12986; Keays G, 2014, INJURY, V45, P1215, DOI 10.1016/j.injury.2014.03.010; Keilani M, 2010, PM&R, V2, P619, DOI 10.1016/j.pmrj.2010.04.022; Konkin DE, 2006, AM J SURG, V191, P615, DOI 10.1016/j.amjsurg.2006.02.012; Kyle SB, 2002, J TRAUMA, V53, P686, DOI 10.1097/00005373-200210000-00011; Lindsay H, 2014, CHRON DIS INJ CAN, V34, P74; Louison C., 2011, IMPOSSIBLE RODNEY MU; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Ma N, 2018, ANZ J SURG, V88, P337, DOI 10.1111/ans.14288; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McKenzie Lara B, 2016, Inj Epidemiol, V3, P10; O'Connor P, 2016, J SPORT SOC ISSUES, V40, P477, DOI 10.1177/0193723516673408; Page JL, 2012, INJURY PREV, V18, P94, DOI 10.1136/injuryprev-2011-040029; Patton DA, 2016, P I MECH ENG P-J SPO, V230, P29, DOI 10.1177/1754337115615482; Peachey AA, 2016, HEALTH EDUC J, V75, P565, DOI 10.1177/0017896915607912; Powell EC, 2004, AMBUL PEDIATR, V4, P495, DOI 10.1367/A04-074R1.1; Sadeghian Homa, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-161; Savage TN, 2017, J SPORT SCI, V35, P449, DOI 10.1080/02640414.2016.1172722; Schalamon J, 2003, J PEDIATR SURG, V38, P1612, DOI 10.1016/S0022-3468(03)00571-2; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Thakore S, 2009, PAED CHILD HEALT-CAN, V14, P509, DOI 10.1093/pch/14.8.509; Tominaga GT, 2015, BRAIN INJURY, V29, P1044, DOI 10.3109/02699052.2014.989404; Tominaga GT, 2013, INJURY, V44, P645, DOI 10.1016/j.injury.2012.01.022; Tuckel PS, 2019, CLIN PEDIATR, V58, P417, DOI 10.1177/0009922818821872; Usman J, 2015, J SCI MED SPORT, V18, P529, DOI 10.1016/j.jsams.2014.07.020; Vaca F, 2005, CLIN J SPORT MED, V15, P142, DOI 10.1097/01.jsm.0000164041.68916.f8	42	0	0	7	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2021	55	15					836	+		10.1136/bjsports-2020-102013			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TQ6RW	WOS:000678407700005	33032991				2022-02-07	
J	Modiano, YA; Karakas, C; Haneef, Z				Modiano, Yosefa A.; Karakas, Cemal; Haneef, Zulfi			Social determinants do not affect access to specialized epilepsy care in veterans	EPILEPSY & BEHAVIOR			English	Article						Health disparities; Healthcare access; Veterans; Epilepsy monitoring	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEIGHBORHOOD ENVIRONMENT; HEALTH-STATUS; SURGERY; DISPARITIES; AFGHANISTAN; ADULTS; IRAQ; LONG	Introduction: It is well established that sociodemographic and neighborhood determinants impact access to healthcare. Veterans with epilepsy (VWE) face unique challenges that may limit access to specialized epilepsy care, though institutional initiatives have aimed to minimize disparities. We assessed the extent to which surrogate markers of access to quality care in VWE were impacted by sociodemographic and neighborhood determinants. Methods: The sample included 180 VWE. Surrogate markers included time between initial diagnosis and admission to epilepsy monitoring unit (EMU) (time to referral, TTR), and the number of CT, MRI, and EEGs conducted prior to initial EMU evaluation. Sociodemographic and neighborhood determinants included age, sex, race, education, neighborhood advantage, rural status, distance from home to the nearest VAMC, and number of service connection (SC) conditions. Significant correlations across variables of interest were entered into a linear regression. Group differences between social factors were assessed for early and late TTR groups (based on 1st and 4th quartiles). Results: The mean TTR was 12 years (SD +/- 13.18). Longer TTR was correlated to older age (p < 0.001) and fewer SC conditions (p = 0.03). None of the other factors were significantly correlated to TTR. Older age significantly predicted longer TTR on regression. The earlier TTR group was younger, had more SC condi-tions, lived closer to a VAMC, and was more likely to be female. Greater geographic distance was corre-lated with fewer CT scans (p = 0.01). A greater number of MRIs was correlated with older age (p = 0.04). Younger age (p < 0.01) and greater education (p = 0.01) were correlated with more SC. Conclusion: Access to epilepsy care among VWE was largely unimpacted by social determinants, with the exception of older age leading to longer TTR. The TTR in VWE was considerably shorter than has been reported in the literature for civilian patients. The Veterans Health Administration model of care may har-bor certain advantages in epilepsy treatment. Published by Elsevier Inc.	[Modiano, Yosefa A.] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, 2002 Holcombe Blvd, Houston, TX 77030 USA; [Karakas, Cemal] Univ Louisville, Dept Neurol, Div Pediat Neurol, Norton Childrens Med Grp, 615 S Preston St,2nd Floor, Louisville, KY 40202 USA; [Haneef, Zulfi] Michael E DeBakey VA Med Ctr, Neurol Care Line, 2002 Holcombe Blvd, Houston, TX 77030 USA; [Haneef, Zulfi] Baylor Coll Med, Dept Neurol, 1 Baylor Plaza, Houston, TX 77030 USA		Haneef, Z (corresponding author), Michael E DeBakey VA Med Ctr, Neurol Care Line, 2002 Holcombe Blvd, Houston, TX 77030 USA.	yosefa.modiano@va.gov; cemal.karakas@louisville.edu; zulfi.haneef@bcm.edu		Modiano, Yosefa/0000-0001-6064-7082; Karakas, Cemal/0000-0002-9516-2285	FY21 MEDVAMC Seed and Bridge funding	Dr. Haneef's work was supported by the FY21 MEDVAMC Seed and Bridge funding. The other author(s) received no financial support for the research, authorship, or publication of this article.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; [Anonymous], Department of Veterans Affairs FY 2018-2024 Strategic Plan; [Anonymous], Us Department of Veterans Affairs>Locations>Interactive US Maps; [Anonymous], America's Veterans Thrive in Rural Communities; [Anonymous], About the ECoEs-Epilepsy Centers of Excellence (ECoE); [Anonymous], Health inequalities exist in access to health care as well as health outcomes; Begley CE, 2009, EPILEPSIA, V50, P1040, DOI 10.1111/j.1528-1167.2008.01898.x; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Berg AT, 2006, ANN NEUROL, V60, P73, DOI 10.1002/ana.20852; Breeze J, 2020, J NEUROL NEUROSUR PS, V91, P359, DOI 10.1136/jnnp-2019-321723; Burneo JG, 2009, EPILEPSIA, V50, P2285, DOI 10.1111/j.1528-1167.2009.02282.x; Cascino GD, 1996, EPILEPSIA, V37, P651, DOI 10.1111/j.1528-1157.1996.tb00629.x; Choi H, 2009, EPILEPSY RES, V86, P224, DOI 10.1016/j.eplepsyres.2009.05.014; Cihan E, 2020, NEUROLOGY, V94, pE2555, DOI 10.1212/WNL.0000000000009463; Davis LE, 2019, TELEMED E-HEALTH, V25, P274, DOI 10.1089/tmj.2018.0067; Desai M, 2010, J ROY SOC MED, V103, P283, DOI 10.1258/jrsm.2010.100126; Economic Research Service, US DEP AGR RUR POV W; Economic Research Service US Department of Agriculture, RUR URB COMM AR COD; Engel J, 2008, JAMA-J AM MED ASSOC, V300, P2548, DOI 10.1001/jama.2008.756; Griffin CL, 2015, WORK, V50, P49, DOI 10.3233/WOR-141929; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Haley J, UNINSURED VETERANS F; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Karakas C, 2021, EPILEPSY BEHAV, V117, DOI 10.1016/j.yebeh.2021.107811; Kharkar S, 2014, SEIZURE-EUR J EPILEP, V23, P290, DOI 10.1016/j.seizure.2014.01.002; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Kondo K, 2017, MED CARE, V55, pS9, DOI 10.1097/MLR.0000000000000756; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee HY, 2015, AM J MENS HEALTH, V9, P370, DOI 10.1177/1557988314545485; Microsoft>Bing Maps>REST Services>Locations, FIND LOCATION ADDRES; Nelson K, 2011, J GEN INTERN MED, V26, P862, DOI 10.1007/s11606-011-1710-0; Office of Rural Health, RUR VET HLTH BACKGR; Parikh RB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18318; Powell WR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.7559; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Rehman R, 2015, J REHABIL RES DEV, V52, P751, DOI 10.1682/JRRD.2014.10.0241; Samanta D, 2021, EPILEPSY BEHAV, V117, DOI 10.1016/j.yebeh.2021.107837; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Sen A, 2020, LANCET, V395, P735, DOI 10.1016/S0140-6736(19)33064-8; Shulkin David J, 2016, Fed Pract, V33, P9; United States Census Bureau, 2019 POV RAT US; University of Wisconsin School of Medicine Public Health, NEIGHBORHOOD ATLAS; US Department of Veteran Affairs>Health Care>South Central VA Health Care Network, S CENTRAL VA HLTH CA; US Department of Veterans Affairs, VET HLTH ADM; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Weeks WB, 2006, J RURAL HEALTH, V22, P204, DOI 10.1111/j.1748-0361.2006.00033.x; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022	50	0	0	2	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2021	121								108071	10.1016/j.yebeh.2021.108071			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	SY2TY	WOS:000665746200039	34052631				2022-02-07	
J	Moe, HK; Follestad, T; Andelic, N; Haberg, AK; Flusund, AMH; Kvistad, KA; Saksvoll, EH; Olsen, O; Abel-Gruner, S; Sandrod, O; Skandsen, T; Vik, A; Moen, KG				Moe, Hans Kristian; Follestad, Turid; Andelic, Nada; Haberg, Asta Kristine; Flusund, Anne-Mari Holte; Kvistad, Kjell Arne; Saksvoll, Elin Hildrum; Olsen, Oystein; Abel-Gruner, Sebastian; Sandrod, Oddrun; Skandsen, Toril; Vik, Anne; Moen, Kent Goran			Traumatic axonal injury on clinical MRI: association with the Glasgow Coma Scale score at scene of injury or at admission and prolonged posttraumatic amnesia	JOURNAL OF NEUROSURGERY			English	Article						craniocerebral trauma; diffuse axonal injury; consciousness disorders; posttraumatic amnesia; neuroimaging; traumatic brain injury	BRAIN-INJURY; HEAD-INJURY; DAMAGE; CLASSIFICATION; IMMEDIATE; RATHER; IMPACT; STEM	OBJECTIVE The aim in this study was to investigate if MRI findings of traumatic axonal injury (TAI) after traumatic brain injury (TBI) are related to the admission Glasgow Coma Scale (GCS) score and prolonged duration of posttraumatic amnesia (PTA). METHODS A total of 490 patients with mild to severe TBI underwent brain MRI within 6 weeks of injury (mild TBI: median 2 days; moderate to severe TBI: median 8 days). The location of TAI lesions and measures of total TAI lesion burden (number and volume of lesions on FLAIR and diffusion-weighted imaging and number of lesions on T2*-weighted gradient echo or susceptibility-weighted imaging) were quantified in a blinded manner for clinical information. The volume of contusions on FLAIR was likewise recorded. Associations between GCS score and the location and burden of TAI lesions were examined with multiple linear regression, adjusted for age, Marshall CT score (which includes compression of basal cisterns, midline shift, and mass lesions), and alcohol intoxication. The predictive value of TAI lesion location and burden for duration of PTA > 28 days was analyzed with multiple logistic regression, adjusted for age and Marshall CT score. Complete-case analyses of patients with TAI were used for the regression analyses of GCS scores (n = 268) and PTA (n = 252). RESULTS TAI lesions were observed in 58% of patients: in 7% of mild, 69% of moderate, and 93% of severe TBI cases. The TAI lesion location associated with the lowest GCS scores were bilateral lesions in the brainstem (mean difference in GCS score -2.5), followed by lesions bilaterally in the thalamus, unilaterally in the brainstem, and lesions in the splenium. The volume of TAI on FLAIR was the measure of total lesion burden most strongly associated with the GCS score. Bilateral TAI lesions in the thalamus had the largest predictive value for PTA > 28 days (OR 16.2, 95% CI 3.9-87.4). Of the measures of total TAI lesion burden, the FLAIR volume of TAI predicted PTA > 28 days the best. CONCLUSIONS Bilateral TAI lesions in the brainstem and thalamus, as well as the total volume of TAI lesions on FLAIR, had the strongest association with the GCS score and prolonged PTA. The current study proposes a first step toward a modified classification of TAI, with grades ranked according to their relation to these two measures of clinical TBI severity.	[Moe, Hans Kristian; Haberg, Asta Kristine; Flusund, Anne-Mari Holte; Skandsen, Toril; Vik, Anne; Moen, Kent Goran] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway; [Andelic, Nada] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Sweden; [Haberg, Asta Kristine; Kvistad, Kjell Arne; Abel-Gruner, Sebastian] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Sandrod, Oddrun] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Anesthesiol & Intens Care Med, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Flusund, Anne-Mari Holte] Molde Hosp, Dept Radiol, Molde, Norway; [Saksvoll, Elin Hildrum; Olsen, Oystein; Moen, Kent Goran] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Radiol, Levanger, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol NTNU, Trondheim, Norway.	kent.g.moen@ntnu.no			Norwegian University of Science and Technology (NTNU); ERA-NET NEURON; Research Council of Norway (TAI-MRI project)Research Council of Norway; liaison committee	H.K.M. and K.G.M. received funding from the Norwegian University of Science and Technology (NTNU), ERA-NET NEURON, and the Research Council of Norway (TAI-MRI project). T.S. received a research grant during the study period from the liaison committee between the Central Norway Regional Health Authority and NTNU.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; [Anonymous], 2012, J NEUROL NEUROSUR PS, V83, P1193; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; de Vet HCW, 2017, J CLIN EPIDEMIOL, V83, P85, DOI 10.1016/j.jclinepi.2016.12.007; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; GENTRY LR, 1994, RADIOLOGY, V191, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Griffanti L, 2018, NEUROIMAGE, V170, P174, DOI 10.1016/j.neuroimage.2017.03.024; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Mazwi NL, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000479; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Moe HK, 2020, J NEUROSURG, V133, P1559, DOI 10.3171/2019.6.JNS191040; Moen KG, LONGITUDINAL MRI; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	41	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					562	573		10.3171/2020.6.JNS20112			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800028		Bronze			2022-02-07	
J	Moscato, EL; Peugh, J; Taylor, HG; Stancin, T; Kirkwood, MW; Wade, SL				Moscato, Emily L.; Peugh, James; Taylor, H. Gerry; Stancin, Terry; Kirkwood, Michael W.; Wade, Shari L.			Bidirectional Effects of Behavior Problems and Parenting Behaviors Following Adolescent Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						parenting; externalizing; brain injury; bidirectional	CHILD EXTERNALIZING BEHAVIOR; AUTISM SPECTRUM DISORDER; OUTCOME 30 MONTHS; TRANSACTIONAL MODELS; COMPLICATED MILD; CONDUCT PROBLEMS; FIT INDEXES; FAMILY; PREDICTORS; TERM	Purpose/Objective: Existing evidence suggests that the relationship between adolescent behavior problems following traumatic brain injury (TBI) and injury-related family burden may be bidirectional, with increased child behavior problems contributing to greater family burden over the first year postinjury and vice versa. We extended existing evidence by prospectively examining reciprocal influences between parent-adolescent interactions and adolescent behavior problems over the initial 2 years postinjury. Research Method/Design: Participants included 117 adolescents ages 12-17 with moderate-tosevere TBIs and their parents who participated in a randomized controlled trial. At baseline, adolescent-parent dyads completed a videotaped problem-solving task that yielded composites of negativity, effective communication, and warmth. Parents also completed a structured interview and problem checklists. Families repeated assessments at 6, 12, and 18 months postbaseline. Bidirectional associations between observed parenting behavior and adolescent behavior were examined with autoregressive cross-lagged panel analyses collapsed across the trial arms. Results: One cross-lagged model was significant, with higher observed effective communication predicting fewer externalizing behavior problems at subsequent time points, and fewer externalizing behavior problems predicting more effective communication. Other models indicated that effects were unidirectional, with observed parenting behaviors predicting externalizing behavior and everyday functioning. Conclusions/Implications: The bidirectional relationship between effective communication and adolescent externalizing behavior suggests a transactional model in pediatric TBI in which effective communication leads to reduced adolescent behavior problems and reduced behavior problems lead to improved communication over time. Findings yielded stronger evidence for parenting effects as compared to adolescent behavior effects, providing further support for clinical interventions targeting parent-adolescent interactions following TBI.	[Moscato, Emily L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Moscato, Emily L.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Peugh, James] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Peugh, James; Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Dept Pediat Psychol & Psychiat, Cleveland, OH USA; [Stancin, Terry] MetroHlth Syst, Dept Psychiat, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Rehabil Psychol & Neuropsychol, Aurora, CO USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA		Moscato, EL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	emily.moscato@cchmc.org		Moscato, Emily/0000-0002-0207-0251	National Institute of Mental Health/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH073764]; Colorado Traumatic Brain Injury Trust Fund	This study was funded by R01 MH073764 from the National Institute of Mental Health/National Institutes of Health, awarded to Shari L. Wade, and partially funded by the Colorado Traumatic Brain Injury Trust Fund awarded to MichaelW. Kirkwood.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alfredsson EK, 2018, SCAND J PSYCHOL, V59, P378, DOI 10.1111/sjop.12446; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Baker JK, 2011, J ABNORM PSYCHOL, V120, P465, DOI 10.1037/a0021900; Boonen H, 2014, RES AUTISM SPECT DIS, V8, P716, DOI 10.1016/j.rasd.2014.03.008; Bryant FB, 2012, STRUCT EQU MODELING, V19, P372, DOI 10.1080/10705511.2012.687671; Burke JD, 2008, J ABNORM CHILD PSYCH, V36, P679, DOI 10.1007/s10802-008-9219-7; Celano M, 2008, FAM PROCESS, V47, P7, DOI 10.1111/j.1545-5300.2008.00236.x; DeLambo KE, 2004, J PEDIATR PSYCHOL, V29, P343, DOI 10.1093/jpepsy/jsh038; Dieleman LM, 2017, DEV PSYCHOPATHOL, V29, P1199, DOI 10.1017/S0954579416001243; Dunn MJ, 2011, J PEDIATR PSYCHOL, V36, P565, DOI 10.1093/jpepsy/jsq062; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gardner F, 2017, CURR OPIN PSYCHOL, V15, P99, DOI 10.1016/j.copsyc.2017.02.023; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Graham JW, 2003, STRUCT EQU MODELING, V10, P80, DOI 10.1207/S15328007SEM1001_4; Gruhn MA, 2016, HEALTH PSYCHOL, V35, P652, DOI 10.1037/hea0000349; Harris C, 2017, J RES ADOLESCENCE, V27, P201, DOI 10.1111/jora.12267; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hipwell A, 2008, J ABNORM CHILD PSYCH, V36, P663, DOI 10.1007/s10802-007-9206-4; Hodges K, 2000, J ABNORM CHILD PSYCH, V28, P287, DOI 10.1023/A:1005100521818; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Laird RD, 2003, CHILD DEV, V74, P752, DOI 10.1111/1467-8624.00566; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Marcoulides KM, 2017, STRUCT EQU MODELING, V24, P148, DOI 10.1080/10705511.2016.1225260; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Melby JN, 2001, FAMILY OBSERVATIONAL CODING SYSTEMS, P33; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Narad ME, 2019, ARCH PHYS MED REHAB, V100, P811, DOI 10.1016/j.apmr.2019.01.010; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Pardini DA, 2008, J ABNORM CHILD PSYCH, V36, P647, DOI 10.1007/s10802-007-9162-z; 홍세희, 2007, [Korean Journal of Educational Psychology, 교육심리연구], V21, P129; Patterson G.R., 1992, ANTISOCIAL BOYS, V4; Patterson GR, 1982, COERCIVE FAMILY PROC, V3; Pearl AM, 2014, J CHILD FAM STUD, V23, P177, DOI 10.1007/s10826-012-9692-z; Pettit GS, 2008, J ABNORM CHILD PSYCH, V36, P711, DOI 10.1007/s10802-008-9242-8; Pinquart M, 2017, DEV PSYCHOL, V53, P873, DOI 10.1037/dev0000295; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Sameroff AJ, 2003, DEV PSYCHOPATHOL, V15, P613, DOI 10.1017/S0954579403000312; Scaramella L., 1998, IOWA FAMILY INTERACT; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Serbin LA, 2015, DEV PSYCHOPATHOL, V27, P969, DOI 10.1017/S0954579415000632; Shaffer A, 2013, J ABNORM CHILD PSYCH, V41, P199, DOI 10.1007/s10802-012-9670-3; STEINBERG LD, 1981, DEV PSYCHOL, V17, P833, DOI 10.1037/0012-1649.17.6.833; STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037/0012-1649.31.2.322; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Van Ryzin MJ, 2016, FAMILY-BASED PREVENTION PROGRAMS FOR CHILDREN AND ADOLESCENTS: THEORY, RESEARCH, AND LARGE-SCALE DISSEMINATION, P1; Wade SL, 2020, J PSYCHOTHER INTEGR, V30, P332, DOI 10.1037/int0000215; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Weisz J.R., 2010, EVIDENCE BASED PSYCH; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zadeh ZY, 2010, INT J BEHAV DEV, V34, P218, DOI 10.1177/0165025409350953	78	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2021	66	3					273	285		10.1037/rep0000380			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	WV8LQ	WOS:000717482400005	34472926				2022-02-07	
J	Ord, AS; Shura, RD; Curtiss, G; Armistead-Jehle, P; Vanderploeg, RD; Bowles, AO; Kennedy, JE; Tate, DF; Cooper, DB				Ord, Anna S.; Shura, Robert D.; Curtiss, Glenn; Armistead-Jehle, Patrick; Vanderploeg, Rodney D.; Bowles, Amy O.; Kennedy, Jan E.; Tate, David F.; Cooper, Douglas B.			Number of Concussions Does Not Affect Treatment Response to Cognitive Rehabilitation Interventions Following Mild TBI in Military Service Members	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild TBI; Multiple concussions; Cognitive rehabilitation; SCORE	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER	Objective: The study objective was to determine whether number of concussions would affect symptom improvement following cognitive rehabilitation (CR) interventions. Method: Servicemembers (N = 126) with concussion history completed a 6-week randomized control trial of CR interventions. Participants were stratified based on self-reported lifetime concussion frequency. Outcome measures included the Paced Auditory Serial Addition Test (PASAT), the Global Severity Index (GSI) from the Symptom Checklist-90-Revised, and the Key Behaviors Change Inventory (KBCI). Results: Mixed-model analyses of variance revealed a significant main effect for time on cognitive, psychological, and neurobehavioral functioning. A significant main effect for the number of concussions was observed for GSI and KBCI, but not PASAT. Interactions between the number of concussions and time were not significant for any of the outcome variables. Conclusions: Over the 6-week interval, improvements were found for all participants across all outcome measures. Number of concussions did not affect improvements over time.	[Ord, Anna S.; Shura, Robert D.] Salisbury VA Healthcare Syst, MidAtlant VISN 6 Menial Illness Res Educ & Clin C, Salisbury, NC USA; [Ord, Anna S.; Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Curtiss, Glenn] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Neurol, San Antonio, TX USA; [Tate, David F.] Univ Utah, TBI & Concuss Ctr, Sch Med, Salt Lake City, UT USA; [Tate, David F.] George E Whalen VA Med Ctr, Salt Lake City, UT USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Rehabil Med, Dept Psychiat, San Antonio, TX 78229 USA; [Cooper, Douglas B.] San Antonio VA Polytrauma Rehabil Ctr, San Antonio, TX 78229 USA		Cooper, DB (corresponding author), San Antonio VA Polytrauma Rehabil Ctr, Fdn Adv Vet Hlth Res FAVHR, 7400 Merton Minter, San Antonio, TX 78229 USA.	b.cooper@gmail.com		Armistead-Jehle, Patrick/0000-0002-6784-1432	TATRC research grant (ERMS) [12286030]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment (MIRT)US Department of Veterans Affairs; Research & Academic Affairs Service Line, Salisbury VA Medical Center, Salisbury, North Carolina; Department of Veterans Affairs Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC)	Supported with resources and the use of the facilities at Brooke Army Medical Center (BAMC), Joint Base San Antonio. Research staff and resources were provided in part by the Defense and Veterans Brain Injury Center (DVBIC) and the Telemedicine and Advanced Technology Research Center. Data management was supported by TATRC research grant (ERMS#12286030) to DFT. Writing of this manuscript was also supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment (MIRT), the Research & Academic Affairs Service Line, Salisbury VA Medical Center, Salisbury, North Carolina, and the Department of Veterans Affairs Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC).	Belanger H. G., 2002, KEY BEHAV CHAN UNPUB; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Department of Defense & Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HEITJAN DF, 1991, J R STAT SOC C-APPL, V40, P13; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Merritt VC, 2020, ARCH CLIN NEUROPSYCH, V35, P491, DOI 10.1093/arclin/acaa006; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vanderploeg RD, 2018, REHABIL PSYCHOL, V63, P194, DOI 10.1037/rep0000215	24	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2021	36	5					850	856		10.1093/arclin/acaa119			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	WX1CC	WOS:000718340500018	33264387				2022-02-07	
J	Perea, LL; Morgan, ME; Bradburn, EH; Bresz, KE; Rogers, AT; Gaines, BA; Cook, AD; Rogers, FB				Perea, Lindsey L.; Morgan, Madison E.; Bradburn, Eric H.; Bresz, Kellie E.; Rogers, Amelia T.; Gaines, Barbara A.; Cook, Alan D.; Rogers, Frederick B.			An Evaluation of Pediatric Secondary Overtriage in the Pennsylvania Trauma System	JOURNAL OF SURGICAL RESEARCH			English	Article						Overtriage; Secondary overtriage; Pediatric trauma; Pediatric trauma center	TRANSFERS	Background: We sought to determine the secondary overtriage rate of pediatric trauma patients admitted to pediatric trauma centers. We hypothesized that pediatric secondary overtriage (POT) would constitute a large percentage of admissions to PTC. Materials and methods: The Pennsylvania Trauma Outcome Study database was retrospectively queried from 2003 to 2017 for pediatric (age = 18 y) trauma patients transferred to accredited pediatric trauma centers in Pennsylvania (n = 6). Patients were stratified based on discharge within (early) and beyond (late) 24 h following admission. POT was defined as patients transferred to a PTC with an early discharge. Multilevel mixed-effects logistic regression model controlling for demographic and injury severity covariates were utilized to determine the adjusted impact of injury patterns on early discharge. Results: A total of 37,653 patients met inclusion criteria. For transfers, POT compromised 18,752 (49.8%) patients. Compared to POT, non-POT were more severely injured (ISS: 10 versus 6;P < 0.001) and spent less time in the ED (Min: 181 versus 207;P < 0.001). In adjusted analysis, concussion, closed skull vault fractures, supracondylar humerus fractures, and consults to neurosurgery were associated with increased odds of POT. Overall, femur fracture, child abuse evaluation, and consults to plastic surgery, orthopedics, and ophthalmology were all associated with a decreased risk of being POT. Conclusions: POT comprises 49.8% of PTC transfer admissions in Pennsylvania's trauma system. Improving community resources for management of pediatric concussion and mild TBI could result in decreased rates of POT to PTCs. Developing better inter-facility transfer guidelines and increased education of adult TC and nontrauma center hospitals is needed to decrease POT. (C) 2021 Elsevier Inc. All rights reserved.	[Perea, Lindsey L.; Morgan, Madison E.; Bradburn, Eric H.; Bresz, Kellie E.; Rogers, Frederick B.] Penn Med Lancaster Gen Hlth, Trauma & Acute Care Surg, 555 N Duke St, Lancaster, PA 17602 USA; [Rogers, Amelia T.] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Gaines, Barbara A.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pediat Gen & Thorac Surg, Pittsburgh, PA USA; [Cook, Alan D.] Univ Texas Tyler, Hlth Sci Ctr Tyler, UT Hlth East Texas, Tyler, TX 75799 USA		Perea, LL (corresponding author), Penn Med Lancaster Gen Hlth, Trauma & Acute Care Surg, 555 N Duke St, Lancaster, PA 17602 USA.	lindsey.perea@pennmedicine.upenn.edu		Rogers, Frederick/0000-0002-3423-9488			American College of Surgeons, RESOURCES OPTIMAL CA; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Choi B, 2014, ANN EMERG MED, V64, pS104; Donaldson K, 2019, PEDIATR EMERG CARE, V35, P301, DOI 10.1097/PEC.0000000000001814; Engum SA, 2000, J PEDIATR SURG, V35, P82, DOI 10.1016/S0022-3468(00)80082-2; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Goldstein SD, 2015, J PEDIATR SURG, V50, P1028, DOI 10.1016/j.jpedsurg.2015.03.028; Hewes HA, 2017, J TRAUMA ACUTE CARE, V83, P662, DOI 10.1097/TA.0000000000001560; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Leung A, 2016, AM SURGEON, V82, P763; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Paci GM, 2018, J ORTHOP TRAUMA, V32, pE215, DOI 10.1097/BOT.0000000000001134; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Schwartz J, 2020, J SURG RES, V255, P106, DOI 10.1016/j.jss.2020.05.042; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Vorhies JS, 2019, J ORTHOP TRAUMA, V33, pE331, DOI 10.1097/BOT.0000000000001502	17	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2021	264						368	374		10.1016/j.jss.2021.02.032			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SV7XD	WOS:000664031200006	33848835				2022-02-07	
J	Maheshwarappa, RP; Valand, HA; Locke, T; Soni, N; Bathla, G				Pillenahalli Maheshwarappa, Ravishankar; Valand, Hardik A.; Locke, Thomas; Soni, Neetu; Bathla, Girish			Repeat Head CT for Neurologically Stable Patients With Mild Traumatic Subarachnoid Hemorrhage During Interfacility Transfer and Follow-Up Does Not Alter Patient Care	CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES			English	Article						mild tSAH; cost-effectiveness; radiation exposure; repeat head CT; interfacility transfer	COMPUTED TOMOGRAPHIC SCANS; BRAIN-INJURY; CLINICAL-SIGNIFICANCE; UNITED-STATES; LOW-RISK; UTILITY; DETERIORATION	Purpose: To evaluate the impact of repeat head computed tomography (CT) during (1) interfacility transfer and (2) inpatient and/or outpatient follow-up on management, cost-effectiveness, and radiation dose in neurologically stable patients with mild traumatic subarachnoid hemorrhage (tSAH). Material and Methods: This is a single-center retrospective study evaluating patients with mild tSAH presenting between January 2017 and July 2019. A total of 101 and 140 patients met the eligibility criteria for the first and second subgroups, respectively. Common inclusion criteria were isolated mild tSAH, Glasgow Coma Scale between 13 and 15, and neurological stability. Additional inclusion criteria for the first subgroup were availability of brain imaging at the outside institution prior to transfer and the second subgroup was the availability of follow-up imaging. Results: In the first subgroup, 76.20% of patients had stable SAH, 18.80% had reduced SAH, while 5% had an interval increase in SAH. None required any surgical intervention. Additional per-patient mean radiation exposure was 1.77 +/- 0.26 mSv. In the second subgroup, all 140 patients had complete resolution of tSAH. One patient had a new tiny subdural hemorrhage, which subsequently resolved on follow-up. The additional mean radiation exposure was 2.47 +/- 1.29 mSv. A total of 256 avoidable CT scans were performed resulting in excess health care costs of about US$531 696. Conclusion: In neurologically stable isolated tSAH patients, repeat brain imaging during interfacility transfer and inpatient and/or outpatient follow-up do not alter patient management despite increased health care costs and radiation burden.	[Pillenahalli Maheshwarappa, Ravishankar; Soni, Neetu] Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA; [Valand, Hardik A.] Amer Univ Integrat Sci, Tucker, GA USA; [Locke, Thomas] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Bathla, Girish] Univ Iowa Hosp & Clin, Dept Radiol, Div Neuroradiol, Iowa City, IA 52242 USA		Maheshwarappa, RP (corresponding author), Univ Iowa Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52246 USA.	ravishankar-pm@uiowa.edu	Maheshwarappa, Ravishankar Pillenahalli/R-8949-2019	Maheshwarappa, Ravishankar Pillenahalli/0000-0002-9602-612X; BATHLA, GIRISH/0000-0003-3170-242X			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Disease Control, 2016, UPD MILD TRAUM BRAIN UPD MILD TRAUM BRAIN; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Cooper SW, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000313; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Gupta R, 2010, J TRAUMA, V69, P253, DOI 10.1097/TA.0b013e3181e4d579; Haley Theodore, 2009, Am J Surg, V198, P858, DOI 10.1016/j.amjsurg.2009.05.030; Huynh T, 2006, AM SURGEON, V72, P1162; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; National Research Council Board on Radiation Effects Research, 1998, HLTH RISKS EXP LOW L HLTH RISKS EXP LOW L; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Rubino S, 2014, J NEUROSURG, V121, P944, DOI 10.3171/2014.6.JNS132204; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sung Jeffrey C, 2009, J Am Coll Radiol, V6, P626, DOI 10.1016/j.jacr.2009.04.010; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vernon Seth A, 2019, Kans J Med, V12, P7; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	35	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0846-5371	1488-2361		CAN ASSOC RADIOL J	Can. Assoc. Radiol. J.-J. Assoc. Can. Radiol.	AUG	2021	72	3					541	547		10.1177/0846537120941674			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	TR0WJ	WOS:000678693300029					2022-02-07	
J	Poon, CS; Rinehart, B; Langri, DS; Rambo, TM; Miller, AJ; Foreman, B; Sunar, U				Poon, Chien-Sing; Rinehart, Benjamin; Langri, Dharminder S.; Rambo, Timothy M.; Miller, Aaron J.; Foreman, Brandon; Sunar, Ulas			Noninvasive Optical Monitoring of Cerebral Blood Flow and EEG Spectral Responses after Severe Traumatic Brain Injury: A Case Report	BRAIN SCIENCES			English	Article						cerebral blood flow and oxygenation; diffuse correlation spectroscopy; EEG; traumatic brain injury; neurointensive care unit; neuromonitoring	DIFFUSE CORRELATION SPECTROSCOPY; ELECTROGRAPHIC SEIZURES; CARE	Survivors of severe brain injury may require care in a neurointensive care unit (neuro-ICU), where the brain is vulnerable to secondary brain injury. Thus, there is a need for noninvasive, bedside, continuous cerebral blood flow monitoring approaches in the neuro-ICU. Our goal is to address this need through combined measurements of EEG and functional optical spectroscopy (EEG-Optical) instrumentation and analysis to provide a complementary fusion of data about brain activity and function. We utilized the diffuse correlation spectroscopy method for assessing cerebral blood flow at the neuro-ICU in a patient with traumatic brain injury. The present case demonstrates the feasibility of continuous recording of noninvasive cerebral blood flow transients that correlated well with the gold-standard invasive measurements and with the frequency content changes in the EEG data.	[Poon, Chien-Sing; Rinehart, Benjamin; Langri, Dharminder S.; Sunar, Ulas] Wright State Univ, Dept Biomed Engn, Dayton, OH 45435 USA; [Rambo, Timothy M.; Miller, Aaron J.] Quantum Opus LLC, Novi, MI 48375 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA		Sunar, U (corresponding author), Wright State Univ, Dept Biomed Engn, Dayton, OH 45435 USA.	poon.4@wright.edu; rinehart.32@wright.edu; langri.2@wright.edu; tim@quantumopus.com; aaron@quantumopus.com; foremabo@ucmail.uc.edu; ulas.sunar@wright.edu	Sunar, Ulas/ABF-9866-2021	Rinehart, Benjamin/0000-0002-8212-6883; sunar, ulas/0000-0002-0623-7522; Foreman, Brandon/0000-0002-5418-674X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R03NS115022]; Ohio Third Frontier [667750]	This research was funded by NIH (5R03NS115022) and the Ohio Third Frontier to the Ohio Imaging Research and Innovation Network (OIRAIN, 667750).	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Baker WB, 2019, J CEREBR BLOOD F MET, V39, P1469, DOI 10.1177/0271678X19846657; Barud M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10132938; BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Buckley EM, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011009; Busch DR, 2019, NEUROCRIT CARE, V30, P72, DOI 10.1007/s12028-018-0573-1; Carp SA, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.9.097003; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Colombo L, 2020, OPT LETT, V45, P3377, DOI 10.1364/OL.392355; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Esnault P, 2015, MINERVA ANESTESIOL, V81, P876; Favilla CG, 2014, STROKE, V45, P1269, DOI 10.1161/STROKEAHA.113.004116; Foreman B, 2019, WORLD NEUROSURG, V124, P378, DOI 10.1016/j.wneu.2019.01.047; Foreman B, 2018, J CEREBR BLOOD F MET, V38, P506, DOI 10.1177/0271678X17700433; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Forti RM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00147; Forti RM, 2019, J STROKE CEREBROVASC, V28, P1483, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.019; Gagnon L, 2008, OPT EXPRESS, V16, P15514, DOI 10.1364/OE.16.015514; Kampfl A., 1997, BRAIN EDEMA X 1997; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim MN, 2014, NEUROCRIT CARE, V20, P443, DOI 10.1007/s12028-013-9849-7; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Li J, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700165; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; Mullen MT, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.07.010; Poon C, 2020, JOVE-J VIS EXP, DOI 10.3791/60765; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Rosenthal ES, 2018, ANN NEUROL, V83, P958, DOI 10.1002/ana.25232; Selb J, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.4.045005; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Topjian AA, 2015, PEDIATR CRIT CARE ME, V16, P461, DOI 10.1097/PCC.0000000000000352; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Yu G., 2011, HDB BIOMEDICAL OPTIC, P195; Zaninotto A.L.C., 2018, NEUROMETHODS	41	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2021	11	8							1093	10.3390/brainsci11081093			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UG0VE	WOS:000688980400001	34439712	Green Submitted, gold, Green Published			2022-02-07	
J	Prem, B; Mueller, CA				Prem, Bernhard; Mueller, Christian Albert			Smell loss as initial symptom of olfactory groove meningioma	BMJ CASE REPORTS			English	Article						ear; nose and throat; otolaryngology; medical management; neuroimaging; neurosurgery		Approximately 20% of the general population suffer from olfactory dysfunction (OD). Until today, olfactory function (OF) receives less attention than other human senses despite its significance for quality of life. The main causes of OD are upper respiratory tract infections, traumatic brain injuries and sinonasal diseases. Here, we report the case of a 28-year-old woman, who started to suffer from OD during pregnancy. Smell loss was attributed to pregnancy-induced rhinitis and initiated no further examinations. Nevertheless, OD persisted post partum and undulating headache occurred 1 year later. Only after visual impairment and one more year passing by, diagnosis of olfactory groove meningioma was made using MRI. With this case report, we want to highlight the importance of the symptom of smell loss. Patients reporting OD should undergo thorough anamnesis, endoscopy of the nasal cavity, psychophysical smell testing and radiographic imaging in unclear cases to determine diagnosis.	[Prem, Bernhard; Mueller, Christian Albert] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria		Mueller, CA (corresponding author), Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria.	christian.a.mueller@meduniwien.ac.at					Adappa ND, 2011, OTOLARYNG CLIN N AM, V44, P965, DOI 10.1016/j.otc.2011.06.001; Birkenbeuel JL, 2020, AM J RHINOL ALLERGY, V34, P297, DOI 10.1177/1945892419889325; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Brown GC., 2018, CLIN RES OPHTHALMOLO, V1, P1; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Claus EB, 2007, CANCER-AM CANCER SOC, V110, P471, DOI 10.1002/cncr.22783; Croy I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033365; Dedeciusova M, 2020, J NEUROL SURG PART A, V81, P310, DOI 10.1055/s-0040-1709165; Ellegard E, 2000, GYNECOL OBSTET INVES, V49, P98, DOI 10.1159/000010223; Hoekman PK, 2014, LARYNGOSCOPE, V124, P365, DOI 10.1002/lary.24248; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; MABRY RL, 1980, SOUTHERN MED J, V73, P1176, DOI 10.1097/00007611-198009000-00004; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Orban N, 2013, RHINOLOGY, V51, P111, DOI [10.4193/Rhino12.045, 10.4193/Rhin12.045]; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635	17	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	AUG	2021	14	8							e241013	10.1136/bcr-2020-241013			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UJ1JG	WOS:000691049900010	34426419				2022-02-07	
J	Qubty, D; Schreiber, S; Rubovitch, V; Boag, A; Pick, CG				Qubty, Doaa; Schreiber, Shaul; Rubovitch, Vardit; Boag, Amir; Pick, Chaim G.			No Significant Effects of Cellphone Electromagnetic Radiation on Mice Memory or Anxiety: Some Mixed Effects on Traumatic Brain Injured Mice	NEUROTRAUMA REPORTS			English	Article						cellphone; electromagnetic radiation; mice; traumatic brain injury	COGNITIVE DEFICITS; HEAD-INJURY; EXPOSURE; BEHAVIOR; DISEASE; MODELS; IMPACT; RISK; MTBI; RAT	Current literature details an array of contradictory results regarding the effect of radiofrequency electromagnetic radiation (RF-EMR) on health, both in humans and in animal models. The present study was designed to ascertain the conflicting data published regarding the possible impact of cellular exposure (radiation) on male and female mice as far as spatial memory, anxiety, and general well-being is concerned. To increase the likelihood of identifying possible "subtle" effects, we chose to test it in already cognitively impaired (following mild traumatic brain injury; mTBI) mice. Exposure to cellular radiation by itself had no significant impact on anxiety levels or spatial/visual memory in mice. When examining the dual impact of mTBI and cellular radiation on anxiety, no differences were found in the anxiety-like behavior as seen at the elevated plus maze (EPM). When exposed to both mTBI and cellular radiation, our results show improvement of visual memory impairment in both female and male mice, but worsening of the spatial memory of female mice. These results do not allow for a decisive conclusion regarding the possible hazards of cellular radiation on brain function in mice, and the mTBI did not facilitate identification of subtle effects by augmenting them.	[Qubty, Doaa; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Boag, Amir] Tel Aviv Univ, Sch Elect Engn, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Ctr Biol Addict Dis, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, 6 Weizmann St, IL-6423609 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sylvan Adams Sports Inst, Tel Aviv, Israel		Schreiber, S (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Psychiat, 6 Weizmann St, IL-6423609 Tel Aviv, Israel.	shaulsch@tlvmc.gov.il			Ari and Regine Aprijaskis Fund; Tel Aviv University	This research was supported in part by the Ari and Regine Aprijaskis Fund, and in part by internal fund of Tel Aviv University.	Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Aldad TS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00312; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belzung Catherine, 2001, Behavioural Brain Research, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Czyz J, 2004, BIOELECTROMAGNETICS, V25, P296, DOI 10.1002/bem.10199; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Elder JA, 2003, BIOELECTROMAGNETICS, pS101, DOI 10.1002/bem.10175; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fragopoulou A F, 2010, Pathophysiology, V17, P179, DOI 10.1016/j.pathophys.2009.11.002; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hardell Lennart, 2015, Pathophysiology, V22, P1, DOI 10.1016/j.pathophys.2014.10.001; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kesari KK, 2013, INDIAN J EXP BIOL, V51, P187; Kwon M.S., 2001, BIOELECTROMAGNETICS, V32, P353; Lakshmanan VK, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104020; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Little A, 2021, NEUROREHABILITATION, V48, P67, DOI 10.3233/NRE-201544; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Narayanan SN, 2019, ENVIRON SCI POLLUT R, V26, P30693, DOI 10.1007/s11356-019-06278-5; O'dea, 2020, NUMBER SMARTPHONE US; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Sage C., 2009, PATHOPHYSIOLOGY, V16, pB233; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Sienkiewicz Z, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091607; Tafakori S, 2020, BEHAV BRAIN RES, V391, DOI 10.1016/j.bbr.2020.112703; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Zhao TY, 2007, NEUROSCI LETT, V412, P34, DOI 10.1016/j.neulet.2006.09.092; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	41	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	AUG 1	2021	2	1					381	390		10.1089/neur.2021.0009			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	UB6RP	WOS:000685971300001	34723249	Green Published, gold			2022-02-07	
J	Raza, A; Saleem, HMK; Chaudhry, M; Khalid, MU				Raza, Ali; Saleem, Hafiz Muhammad Kashif; Chaudhry, Mariam; Khalid, Muhammad Usman			Radiological and Functional Outcome of Distal Radius Fracture treated conservatively (MUA Plaster of Paris) vs Percutaneous K-wire fixation	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						closed fracture; distal radius; back slab; K-wires	RANDOMIZED CONTROLLED-TRIAL; LOCKING-PLATE FIXATION; EXTRAARTICULAR FRACTURES; NONSURGICAL TREATMENT; OPERATIVE TREATMENT; KIRSCHNER WIRES; POPULATION; EPIDEMIOLOGY; CAST; END	Aim: To compare the radiological and functional result of conservatively treated distant radius fractures (manipulation under anesthesia and plaster of paris) versus percutaneous K- wire fixation Study design: Retrospective Duration and place of study: Department of Orthopedic Surgery, The Indus Hospital, Raiwind campus Lahore from July 2018 to August 2020. Methods: The sample size of 100 patients aged between 18-60 years, closed, isolated distal radius fracture were included, and patients with diabetes mellitus, ischemic heart disease, pathological fractures, chronic renal disease, head injury, chronic liver disease, whose Glasgow coma scale was <14, malignancy were excluded. Patients were randomized as A & B by lottery method. They managed with conservative treatment (manipulation under anesthesia (MUA) and plaster of paris (POP) cast) and K- wire fixation in groups A & B, respectively. Side of the fractured bone, infection, radiological union, and function outcome were recorded. Results: Amongst the total 100 patients in group-A, 32(63.8%) were males, and 18(36.2%) were females, and 35 (70.2%) were males, and 15 (29.8%) were females in Group-B. in group A patients mean age was 38.86.19 years, while patients mean age of the group B was 39.57.36 years. With the conservative method, 45(95.7%), the union rate was while with the K- wire fixation method, the union rate was 48(96%). In group-A, 35(70%) had excellent, 10 (20%) good, 03 (6%) had an average, and 2(4%) poor and in group-B, 40(80%) had excellent, 04 (08%) good, 04(08%) had an average, and 02 (4%) poor functional outcome. Conclusion: In terms of clinical and radiological evaluation, fixation of a distal radius fracture with K-wires has a better outcome than conservative treatment (MUA and POP cast) with a low infection rate and better union and result.	[Raza, Ali; Saleem, Hafiz Muhammad Kashif] Indus Hosp & Hlth Network, Karachi, Pakistan; [Chaudhry, Mariam; Khalid, Muhammad Usman] Mayo Hosp, Lahore, Pakistan		Saleem, HMK (corresponding author), Indus Hosp & Hlth Network, Karachi, Pakistan.	doctorkashifsaleem@gmail.com					Aktekin CN, 2010, J HAND SURG-AM, V35A, P736, DOI 10.1016/j.jhsa.2010.01.028; Alm-Paulsen PS, 2012, J PLAST SURG HAND SU, V46, P195, DOI 10.3109/2000656X.2012.685623; Armstrong KA, 2019, CAN J SURG, V62, P386, DOI 10.1503/cjs.016218; Arora R, 2011, J BONE JOINT SURG AM, V93A, P2146, DOI 10.2106/JBJS.J.01597; Azad A, 2019, J WRIST SURG, V8, P305, DOI 10.1055/s-0039-1685205; Azzopardi T, 2005, J BONE JOINT SURG BR, V87B, P837, DOI 10.1302/0301-620X.87B6.15608; Bagul RR, 2014, MED J DY PATIL U, V7, P590; BUHR AJ, 1959, LANCET, V1, P531; Corsino CB, 2019, STATPEARLS; Costa ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19170; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Das AK, 2011, INDIAN J ORTHOP, V45, P422, DOI 10.4103/0019-5413.83949; Egol KA, 2010, J BONE JOINT SURG AM, V92A, P1851, DOI 10.2106/JBJS.I.00968; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; Goehre F, 2014, J HAND SURG-EUR VOL, V39, P249, DOI 10.1177/1753193413489057; Handoll HG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858; Handoll HH, COCHRANE DB SYST REV; Hashmi IA, 2008, J SURG PAKISTAN INT, V13, P2; Ju JH, 2015, LANGENBECK ARCH SURG, V400, P767, DOI 10.1007/s00423-015-1324-9; Kilic A, 2009, ACTA ORTHOP TRAUMATO, V43, P229, DOI 10.3944/AOTT.2009.229; Kurup HV, 2005, EUR J ORTHOP SURG TR, V15, P135; LENOBLE E, 1995, J BONE JOINT SURG BR, V77B, P562, DOI 10.1302/0301-620X.77B4.7615598; LI J, 2001, CHIN J TRAUMATOL, V7; Lindau TR, 1999, ACTA ORTHOP SCAND, V70, P124, DOI 10.3109/17453679909011248; Lutz K, 2014, J HAND SURG-AM, V39, P1280, DOI 10.1016/j.jhsa.2014.04.018; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P357, DOI 10.1007/BF01622198; Malmin H, 1992, SCANDIA, V63, P552; Mauck BM, 2018, ORTHOP CLIN N AM, V49, P211, DOI 10.1016/j.ocl.2017.12.001; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P404, DOI 10.1302/0301-620X.78B3.0780404; Okamura A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2007-9; Sabir MN., 2018, J RAWALPINDI MED COL, P215; SCHECK M, 1962, J BONE JOINT SURG AM, V44, P337, DOI 10.2106/00004623-196244020-00010; Song J, 2015, INT J CLIN EXP MED, V8, P17023; Stirling ERB, 2018, J HAND SURG-EUR VOL, V43, P974, DOI 10.1177/1753193418786378; Venkatesh RB, 2016, J CLIN DIAGN RES, V10, pRC5, DOI 10.7860/JCDR/2016/18266.7220; Walton NP, 2001, INJURY, V32, P383, DOI 10.1016/S0020-1383(00)00251-5; Wong TC, 2010, J HAND SURG-EUR VOL, V35E, P202, DOI 10.1177/1753193409339941	37	0	0	0	0	LAHORE MEDICAL RESEARCH CENTER LLP	LAHORE	590, Karim Block, Allama Iqbal Town, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	AUG	2021	15	8					1842	1845		10.53350/pjmhs211581842			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XN0WN	WOS:000729235200026					2022-02-07	
J	Richard, P; Patel, N; Gedeon, D; Hyppolite, R; Younis, M				Richard, Patrick; Patel, Nilam; Gedeon, Daniel; Hyppolite, Regine; Younis, Mustafa			Common Symptoms of Mild Traumatic Brain Injury and Work Functioning of Active-Duty Service Members with a History of Deployment	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						work functioning; mild traumatic brain injury; active-duty service members; Military Health System	EMPLOYMENT STABILITY; PROPENSITY SCORE; VETERANS; OUTCOMES; RETURN; IRAQ; AFGHANISTAN; PREDICTORS; PAIN	This study used data from the Military Health System Data Repository to examine the association between mild traumatic brain injuries (mTBI) and work functioning such as work duty limitations, hospital emergency room visits and inpatient admissions for active-duty service members (ADSMs). Further, this study assessed the role that common symptoms of mTBI play in work functioning. Multivariate results showed that having a mTBI diagnosis is not a major factor that results in being "released with work duty limitations". However, findings from these regression models also showed that the interaction of mTBI with cognitive and linguistic symptoms resulted in odds of 3.63 (CI: 1.40-9.36, p < 0.01) for being "released with work duty limitations" and odds of 4.98 (CI: 1.16-21.39, p < 0.05) for having any emergency department visits compared to those with no diagnosis of mTBI and none of these symptoms. Additionally, the interaction of mTBI with sleep disturbance and chronic pain showed odds of 2.72 (CI: 1.31-5.65, p < 0.01) and odds of 11.56 (CI: 2.65-50.44, p < 0.01) for being "released with work duty limitations" compared to those with no diagnosis of TBI and none of these symptoms, respectively. Further research is needed to investigate the association between mTBI and duration of time off work to provide a comprehensive understanding of the effect of mTBI on work functioning in the Military Health System.	[Richard, Patrick] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Patel, Nilam; Gedeon, Daniel; Hyppolite, Regine] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20814 USA; [Younis, Mustafa] Jackson State Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Jackson, MS 39217 USA		Richard, P (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.	patrick.richard@usuhs.edu; nilam.patel.ctr@usuhs.edu; daniel.gedeon.ctr@usuhs.edu; regine.hyppolite.ctr@usuhs.edu; younis99@gmail.com		Younis, Mustafa/0000-0001-8448-808X	Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [W81XWH-15-2-0070]	This research was funded by the Congressionally Directed Medical Research Program (CDMRP) (Award #W81XWH-15-2-0070).	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9062007; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bauer M, 2018, ARCH PHYS MED REHAB, V99, P145, DOI [10.1016/j.apmr.2018.08.053, DOI 10.1016/J.APMR.2018.08.053]; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Cacialli P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041585; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Defense Health Agency (DHA), TRAUMATIC BRAIN INJU; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hart T, 2019, REHABIL PSYCHOL, V64, P435, DOI 10.1037/rep0000290; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Koenig KN, 2011, GERONTOL GERIATR EDU, V32, P396, DOI 10.1080/02701960.2011.611713; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larson MJ, 2018, J ALTERN COMPLEM MED, V24, P666, DOI 10.1089/acm.2017.0290; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McKeon AB, 2019, NEUROREHABILITATION, V45, P163, DOI 10.3233/NRE-192804; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Ord AS, 2021, REHABIL PSYCHOL, V66, P31, DOI 10.1037/rep0000333; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Routon PW, 2014, J LABOR RES, V35, P15, DOI 10.1007/s12122-013-9170-4; Rumery ZR, 2018, MIL MED, V183, pE241, DOI 10.1093/milmed/usx102; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sandqvist Jan L, 2004, Work, V23, P147; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633	49	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	AUG	2021	18	15							8079	10.3390/ijerph18158079			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	TV6BB	WOS:000681805600001	34360372	gold, Green Published			2022-02-07	
J	Rodgin, S; Suskauer, SJ; Chen, J; Katz, E; Davis, KC; Slomine, BS				Rodgin, Sandra; Suskauer, Stacy J.; Chen, Julia; Katz, Elana; Davis, Kimberly C.; Slomine, Beth S.			Very Long-Term Outcomes in Children Admitted in a Disorder of Consciousness After Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain Injuries; Child; Consciousness disorders; Rehabilitation	COMA RECOVERY SCALE; YOUNG-ADULTS; REHABILITATION; STATE; NEUROREHABILITATION	Objectives: To investigate functional outcomes and state of consciousness at 1 year and >2 years postinjury in children who sustained a traumatic brain injury and were in a disorder of consciousness (DOC), either vegetative state (VS) or minimally conscious state (MCS), upon admission to inpatient rehabilitation. Design: Retrospective chart review. Setting: Pediatric inpatient rehabilitation unit. Participants: Children aged 2-18 years (NZ37) who were admitted to inpatient rehabilitation with admission scores <30 on the Cognitive and Linguistic Scale (CALS). Interventions: Not applicable. Main Outcome Measures: Glasgow Outcome Scale-Extended, Pediatric Revision (GOS-E Peds), and state of consciousness based on previously established guidelines. Results: At admission, 16 children were in VS (43.2%) and 21 (56.8%) were in MCS. Children admitted in VS had a significantly longer time from injury to inpatient rehabilitation admission, lower CALS admission scores, were more likely to be in a DOC >28 days, and had greater disability at both follow-up time points. At the 1-year follow-up, 3 patients were in VS, 7 were in MCS, and 27 had emerged from MCS. By the time of the most recent follow-up (>2y), 2 more patients had emerged from MCS. Across the cohort, GOS-E Peds scores at 1 year ranged from VS (GOS-E Peds, 7) to upper moderate disability (GOS-E Peds, 3). Most patients were functioning in the lower severe disability category (GOS-E Peds, 6) at 1 year (43.2%) and at the time of the most recent follow-up (43.2%). Twenty-seven patients (73.0%) showed stable GOS-E Peds scores between the 2 time points, 6 (16.2%) improved, and 4 (10.8%) were deceased. Conclusions: Although a majority of patients emerged from a DOC by 1 year postinjury, most continued to demonstrate notable functional impairment at the 1-year follow-up that persisted to the most recent follow-up. A small subset demonstrated important improvements between 1 year and the most recent follow-up (2 patients emerged, 6 patients showed improvement in GOS-E Peds scores). Archives of Physical Medicine and Rehabilitation 2021;102:1507-13 (c) 2021 by the American Congress of Rehabilitation Medicine	[Rodgin, Sandra; Slomine, Beth S.] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Rodgin, Sandra; Slomine, Beth S.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD USA; [Suskauer, Stacy J.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, Dept Pediat Rehabil, Baltimore, MD USA; [Chen, Julia] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA USA; [Katz, Elana] Childrens Hosp Philadelphia, Div Rehabil Med, Dept Pediat, Philadelphia, PA USA; [Davis, Kimberly C.] Texas Childrens Hosp, Dept Psychol, Houston, TX USA; [Davis, Kimberly C.] Dept Pediat, Baylor Coll Med, Houston, TX USA		Rodgin, S (corresponding author), Johns Hopkins Univ, Kennedy Krieger Inst, Dept Neuropsychol, Sch Med, 1750 Fairmount Ave, Baltimore, MD 21231 USA.	rodgin@kennedykrieger.org			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50 HD103538] Funding Source: Medline		Alvarez G, 2019, ARCH PHYS MED REHAB, V100, P687, DOI 10.1016/j.apmr.2018.12.022; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Eilander HJ, 2016, BRAIN INJURY, V30, P1302, DOI 10.3109/02699052.2016.1170881; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Slomine BS, 2016, REHABIL PSYCHOL, V61, P328, DOI 10.1037/rep0000096; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	17	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2021	102	8					1507	1513		10.1016/j.apmr.2021.01.084			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	UL3LL	WOS:000692556700008	33609500				2022-02-07	
J	Rungruangsak, K; Poriswanish, N				Rungruangsak, Kodchakan; Poriswanish, Nitikorn			Pathology of fatal diffuse brain injury in severe non-penetrating head trauma	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Closed-head injury; DAI; Diffuse brain injury; Dynamic head injury; Non-penetrating head trauma; TBI	AXONAL INJURY; CLINICOPATHOLOGICAL ENTITY; CEREBRAL EDEMA; DEATHS; PATHOPHYSIOLOGY; DIAGNOSIS; SYSTEM	Traumatic brain injury (TBI) is recognised as a serious global public health problem that imposes a heavy socioeconomic burden on society. The vast majority of cases result from road traffic accidents and falls, and the injuries are mainly attributed to velocity-related mechanisms. Lethal cases are mostly found to suffer from severe diffuse brain injuries (DBI), comprising diffuse vascular injury, diffuse axonal injury (DAI), generalized cerebral edema and ischemic-hypoxic injury. Coup and contrecoup brain contusions may also occur. This study set out to describe the pathological findings of severe DBI in terms of survival times and Abbreviated Injury Scale (AIS) severity scores. The autopsy data from 2 recent years (2018 and 2019) were reviewed to recruit over 800 cases presenting with severe head injuries. Many demographic characteristics of TBI were identified (for example, causes, victim genders and victim ages). These were revealed to be like those previously reported in the literature, confirming that there are shared risk factors across the globe. The hallmarks of severe TBI-such as a unimodal survival distribution and a period for detecting DAI via conventional staining-were also evident, as per previous reports. However, it was noticed that the histopathological detection rates of DAI surged after 72 h, which might be because these injuries are mediated by secondary axotomy. This study also analysed real brain weights to identify the time period for the development of cerebral edema in humans; this period seems to have never been reported. The increment time of cerebral edema reached a peak in 12 h, after which the condition sustained for at least 72 h. This may be a golden period in clinical practice as well as a prognostic factor in forensic medicine.	[Rungruangsak, Kodchakan; Poriswanish, Nitikorn] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Forens Med, Bangkok, Thailand; [Rungruangsak, Kodchakan] Minist Publ Hlth, Hua Hin Hosp, Khiri Khan, Thailand		Poriswanish, N (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Forens Med, Bangkok, Thailand.	nitikorn.por@mahidol.ac.th		/0000-0001-9576-7818; Poriswanish, Nitikorn/0000-0002-2173-0008			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; COURVILLE C B, 1950, Bull Los Angel Neuro Soc, V15, P72; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Deng YY, 2016, MINI-REV MED CHEM, V16, P917, DOI 10.2174/1389557516666160304151233; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Govender S, 2018, INT J MORPHOL, V36, P915; HARTMANN P, 1994, PATHOLOGE, V15, P165, DOI 10.1007/s002920050040; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institute of Urban Disease Control, 2019, COLL RTI DAT INT ENH; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Marmarou A, 2003, ACT NEUR S, V86, P7; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; Mittal P., 2015, FORENSIC RES CRIMINO, V1, P157, DOI [10.15406/frcij.2015.01.00026, DOI 10.15406/FRCIJ.2015.01.00026]; O'Leary RA, 2018, J NEUROSURG SCI, V62, P542, DOI 10.23736/S0390-5616.18.04501-0; Okidi R, 2020, BJS OPEN, V4, P320, DOI 10.1002/bjs5.50243; Pfeifer R, 2017, WORLD J SURG, V41, P3111, DOI 10.1007/s00268-017-4122-4; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Prathep Sumidtra, 2017, Journal of the Medical Association of Thailand, V100, P843; Ruangwinitwong S, 2020, JFPAT, V14, P45, DOI [10.14456/jfpat.2020.5, DOI 10.14456/JFPAT.2020.5]; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Staal JA, 2009, J NEUROTRAUM, V26, P781, DOI 10.1089/neu.2008.0669	38	0	0	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	AUG	2021	82								102226	10.1016/j.jflm.2021.102226			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	WC6BD	WOS:000704340600012	34375839				2022-02-07	
J	Sekar, S; Viswas, RS; Mahabadi, HM; Alizadeh, E; Fonge, H; Taghibiglou, C				Sekar, Sathiya; Viswas, Raja Solomon; Mahabadi, Hajar Miranzadeh; Alizadeh, Elahe; Fonge, Humphrey; Taghibiglou, Changiz			Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cellular prion protein; flotillin-1; CAP; brain insulin resistance; mild traumatic brain injury; motor and cognitive functions	GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; BLAST EXPOSURE; PRION PROTEIN; RISK-FACTOR; QUANTIFICATION; NEUROPATHOLOGY; HYPERGLYCEMIA; F-18-FDG	Brain injury/concussion is a growing epidemic throughout the world. Although evidence supports association between traumatic brain injury (TBI) and disturbance in brain glucose metabolism, the underlying molecular mechanisms are not well established. Previously, we reported the release of cellular prion protein (PrPc) from the brain to circulation following TBI. The PrPc level was also found to be decreased in insulin-resistant rat brains. In the present study, we investigated the molecular link between PrPc and brain insulin resistance in a single and repeated mild TBI-induced mouse model. Mild TBI was induced in mice by dropping a weight (similar to 95 g at 1 m high) on the right side of the head. The procedure was performed once and thrice (once daily) for single (SI) and repeated induction (RI), respectively. Micro PET/CT imaging revealed that RI mice showed significant reduction in cortical, hippocampal and cerebellum glucose uptake compared to SI and control. Mice that received RI also showed significant motor and cognitive deficits. In co-immunoprecipitation, the interaction between PrPc, flotillin and Cbl-associated protein (CAP) observed in the control mice brains was disrupted by RI. Lipid raft isolation showed decreased levels of PrPc, flotillin and CAP in the RI mice brains. Based on observation, it is clear that PrPc has an interaction with CAP and the dislodgment of PrPc from cell membranes may lead to brain insulin resistance in a mild TBI mouse model. The present study generated a new insight into the pathogenesis of brain injury, which may result in the development of novel therapy.	[Sekar, Sathiya; Mahabadi, Hajar Miranzadeh; Taghibiglou, Changiz] Univ Saskatchewan, Coll Med, Dept Anat Physiol & Pharmacol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Viswas, Raja Solomon; Alizadeh, Elahe; Fonge, Humphrey] Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada; [Fonge, Humphrey] Royal Univ Hosp RUH, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada		Taghibiglou, C (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat Physiol & Pharmacol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.; Fonge, H (corresponding author), Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada.; Fonge, H (corresponding author), Royal Univ Hosp RUH, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada.	sathiya.sekar@usask.ca; rav137@mail.usask.ca; h.miranzadeh@usask.ca; elahe.alizadeh@usask.ca; humphrey.fonge@usask.ca; changiz.taghibiglou@usask.ca	Viswas, Raja Solomon/AAA-1020-2022	Fonge, Humphrey/0000-0001-9388-6872	Department of National Defense and the University of Saskatchewan, College of Medicine for the COMRAD research grant; Saskatchewan Health Research Foundation (SHRF)	The research was funded by Department of National Defense and the University of Saskatchewan, College of Medicine for the COMRAD research grant to C.T. and Saskatchewan Health Research Foundation (SHRF) postdoctoral fellowship to S.S.	Alf MF, 2013, J NUCL MED, V54, P132, DOI 10.2967/jnumed.112.107474; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Biessels GJ, 2006, J NEUROL NEUROSUR PS, V77, P304, DOI 10.1136/jnnp.2005.069583; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Czech MP, 2000, NATURE, V407, P147, DOI 10.1038/35025183; de la Monte SM, 2014, EUR NEUROPSYCHOPHARM, V24, P1954, DOI 10.1016/j.euroneuro.2014.06.008; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Franklin W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44635-z; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Kanzaki M, 2003, CURR BIOL, V13, pR574, DOI 10.1016/S0960-9822(03)00478-0; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Mahabadi HM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197058; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Persad A, 2021, BRAIN INJURY, V35, P734, DOI 10.1080/02699052.2021.1900602; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Salas R, 2003, J NEUROSCI, V23, P6255; Sathiya S, 2013, NEUROPHARMACOLOGY, V73, P98, DOI 10.1016/j.neuropharm.2013.05.025; Sato N, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3339/fnagi.2015,00199, 10.3389/fnagi.2015.00199]; Sekar S, 2019, J NEUROTRAUM, V36, P3103, DOI 10.1089/neu.2018.5918; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Taghibiglou C, 2000, J LIPID RES, V41, P499; Taghibiglou C, 2009, NEUROPHARMACOLOGY, V57, P268, DOI 10.1016/j.neuropharm.2009.05.013; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Vicente Miranda H, 2016, MOVEMENT DISORD, V31, P782, DOI 10.1002/mds.26566; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Xu XJ, 2021, CHIN J TRAUMATOL, V24, P5, DOI 10.1016/j.cjtee.2020.10.001; Yu AS, 2009, J NUCL MED, V50, P966, DOI 10.2967/jnumed.108.060533	51	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2021	22	16							9005	10.3390/ijms22169005			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	UG4HU	WOS:000689216400001	34445708	Green Published, gold			2022-02-07	
J	Shah, AA; Devana, SK; Lee, C; Bugarin, A; Lord, EL; Shamie, AN; Park, DY; van der Schaar, M; SooHoo, NF				Shah, Akash A.; Devana, Sai K.; Lee, Changhee; Bugarin, Amador; Lord, Elizabeth L.; Shamie, Arya N.; Park, Don Y.; van der Schaar, Mihaela; SooHoo, Nelson F.			Prediction of Major Complications and Readmission After Lumbar Spinal Fusion: A Machine Learning-Driven Approach	WORLD NEUROSURGERY			English	Article						Complications; Lumbar fusion; Machine learning; Outcomes; Readmission	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; COMPENSATION; OUTCOMES; MORTALITY; SURGERY; CLASSIFICATION; ILLNESS; BACK	BACKGROUND: Given the significant cost and morbidity of patients undergoing lumbar fusion, accurate preoperative risk-stratification would be of great utility. We aim to develop a machine learning model for prediction of major complications and readmission after lumbar fusion. We also aim to identify the factors most important to performance of each tested model. METHODS: We identified 38,788 adult patients who underwent lumbar fusion at any California hospital between 2015 and 2017. The primary outcome was major perioperative complication or readmission within 30 days. We build logistic regression and advanced machine learning models: XGBoost, AdaBoost, Gradient Boosting, and Random Forest. Discrimination and calibration were assessed using area under the receiver operating characteristic curve and Brier score, respectively. RESULTS: There were 4470 major complications (11.5%). The XGBoost algorithm demonstrates the highest discrimination of the machine learning models, outperforming regression. The variables most important to XGBoost performance include angina pectoris, metastatic cancer, teaching hospital status, history of concussion, comorbidity burden, and workers' compensation insurance. Teaching hospital status and concussion history were not found to be important for regression. CONCLUSIONS: We report a machine learning algorithm for prediction of major complications and readmission after lumbar fusion that outperforms logistic regression. Notably, the predictors most important for XGBoost differed from those for regression. The superior performance of XGBoost may be due to the ability of advanced machine learning methods to capture relationships between variables that regression is unable to detect. This tool may identify and address potentially modifiable risk factors, helping riskstratify patients and decrease complication rates.	[Shah, Akash A.; Devana, Sai K.; Bugarin, Amador; Lord, Elizabeth L.; Shamie, Arya N.; Park, Don Y.; SooHoo, Nelson F.] UCLA, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90024 USA; [Lee, Changhee; van der Schaar, Mihaela] Univ Calif Los Angeles, Dept Elect & Comp Engn, Los Angeles, CA USA; [van der Schaar, Mihaela] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England		Shah, AA (corresponding author), UCLA, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90024 USA.	aashah@mednet.ucla.edu		Lord, Elizabeth/0000-0003-2433-2475	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under the Ruth L. Kirschstein National Research Service Award [T32AR059033]	The research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under the Ruth L. Kirschstein National Research Service Award Number T32AR059033. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bohl DD, 2016, SPINE, V41, P1058, DOI 10.1097/BRS.0000000000001389; Bohl DD, 2015, SPINE, V40, P1785, DOI 10.1097/BRS.0000000000001003; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burns JE, 2017, RADIOLOGY, V284, P788, DOI 10.1148/radiol.2017162100; Cabitza F, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00075; Carreon LY, 2010, SPINE, V35, P1812, DOI 10.1097/BRS.0b013e3181c68b75; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Cheriyan T, 2015, SPINE J, V15, P2564, DOI 10.1016/j.spinee.2015.09.033; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Daniels AH, 2017, J AM ACAD ORTHOP SUR, V25, pE225, DOI 10.5435/JAAOS-D-16-00895; Di Capua J, 2017, SPINE, V42, P1347, DOI 10.1097/BRS.0000000000002090; Donnellan C, 2020, NEUROL SCI, V41, P509, DOI 10.1007/s10072-019-04150-5; Durand WM, 2018, SPINE J, V18, P626, DOI 10.1016/j.spinee.2017.08.256; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fingar KR, 2014, MOST FREQUENT OPERAT; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Golinvaux NS, 2014, SPINE, V39, P1809, DOI 10.1097/BRS.0000000000000506; Goyal A, 2019, J NEUROSURG-SPINE, V31, P568, DOI 10.3171/2019.3.SPINE181367; Goz V, 2013, SPINE, V38, P1970, DOI 10.1097/BRS.0b013e3182a62527; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gum JL, 2013, SPINE, V38, P443, DOI 10.1097/BRS.0b013e318278ebe8; Harris AHS, 2018, CLIN ORTHOP RELAT R, V476, P1869, DOI 10.1097/CORR.0000000000000377; Hashimoto DA, 2018, ANN SURG, V268, P70, DOI 10.1097/SLA.0000000000002693; Hopkins BS, 2020, CLIN NEUROL NEUROSUR, V192, DOI 10.1016/j.clineuro.2020.105718; Hopkins BS, 2020, J NEUROSURG-SPINE, V32, P399, DOI 10.3171/2019.9.SPINE19860; Ilyas H, 2019, J NEUROSURG-SPINE, V31, P20, DOI 10.3171/2019.1.SPINE18878; Jackson KL, 2020, GLOB SPINE J, V10, P929, DOI 10.1177/2192568219886595; Jain D, 2020, SPINE, V45, P1151, DOI 10.1097/BRS.0000000000003475; Jimenez-Almonte JH, 2020, SPINE J, V20, P1529, DOI 10.1016/j.spinee.2020.05.550; Karhade AV, 2019, SPINE J, V19, P1950, DOI 10.1016/j.spinee.2019.06.024; Karhade AV, 2019, NEUROSURGERY, V85, pE671, DOI 10.1093/neuros/nyz070; Karhade AV, 2019, NEUROSURGERY, V85, pE83, DOI 10.1093/neuros/nyy469; Kazim S, WORLD NEUROSURG, V148, P141; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Khormaee S, 2019, SPINE J, V19, P430, DOI 10.1016/j.spinee.2018.05.044; Kim JS, 2018, SPINE, V43, P853, DOI 10.1097/BRS.0000000000002442; Lee NJ, 2018, SPINE, V43, P41, DOI 10.1097/BRS.0000000000001586; Manning DW, 2016, J AM ACAD ORTHOP SUR, V24, P19, DOI 10.5435/JAAOS-D-15-00072; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Mummaneni PV, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS1450; Ogink PT, 2019, EUR SPINE J, V28, P1433, DOI 10.1007/s00586-019-05928-z; Ozenne B, 2015, J CLIN EPIDEMIOL, V68, P855, DOI 10.1016/j.jclinepi.2015.02.010; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Ratsch G, 2001, MACH LEARN, V42, P287, DOI 10.1023/A:1007618119488; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Schoenfeld AJ, 2013, SPINE J, V13, P1171, DOI 10.1016/j.spinee.2013.02.071; Shah AA, 2019, SPINE J, V19, P1657, DOI 10.1016/j.spinee.2019.04.022; Sivaganesan A, 2019, SPINE, V44, P588, DOI 10.1097/BRS.0000000000002883; Taree A, 2021, CLIN SPINE SURG, V34, pE216, DOI 10.1097/BSD.0000000000001095; Veeravagu A, 2017, J NEUROSURG-SPINE, V27, P81, DOI 10.3171/2016.12.SPINE16969; Yale New Haven Health Services Corporation/ Center for Outcomes Research & Evaluation, 2017, PROC SPEC MEAS UPD S; Zhang C, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2021.105688	56	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2021	152						E227	E234		10.1016/j.wneu.2021.05.080			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TS9LP	WOS:000679970700028	34058366				2022-02-07	
J	Shao, NN; Jiang, SY; Younger, D; Chen, T; Brown, M; Rao, KVR; Skotak, M; Gan, RZ; Chandra, N				Shao, Ningning; Jiang, Shangyuan; Younger, Daniel; Chen, Tao; Brown, Marcus; Rao, Kakulavarapu V. Rama; Skotak, Maciej; Gan, Rong Z.; Chandra, Namas			Central and peripheral auditory abnormalities in chinchilla animal model of blast-injury	HEARING RESEARCH			English	Article						Auditory abnormalities; Blast injury; Central nervous system; Hearing loss, Neurotransmitters; Tinnitus	TRAUMATIC BRAIN-INJURY; JUGULAR-VEIN COMPRESSION; INDUCED TINNITUS; HEARING-LOSS; SOUND-TRANSMISSION; RAT; SYSTEM; MECHANISMS; RECEPTORS; ACETYLCHOLINE	Exposure to blast overpressure or high-intensity sound can cause injuries to the auditory system, which leads to hearing loss or tinnitus. In this study, we examined the involvement of peripheral auditory system (PAS), and central auditory system (CAS) changes after exposure to blast overpressure (15-25 psi) on Day 1 and additionally during 7 days of post blast time period in chinchillas. Auditory brainstem response (ABR), distortion product otoacoustic emission (DPOAE), and cochlear hair cell changes were measured or identified in post-blast period within 7 days to detect injuries in the PAS. In the CAS, changes in NMDAR1 (excitatory receptor) and GABAA (inhibitory receptor) as well as changes in serotonin (5-HT2A) and acetylcholine (AChR) receptors were examined in different brain regions: auditory cortex (AC), geniculate body (GB), inferior colliculus (IC) and amygdala by immunofluorescence staining. We observed the PAS abnormalities of increased ABR threshold and decreased DPOAE response in animals after blast exposure with hearing protection devices (e.g., earplug). Blast exposure also caused a reduction in both NMDAR1 and GABA(A) receptor levels in acute condition (post-blast or Day 1) in AC and IC, while serotonin and acetylcholine receptor levels displayed a biphasic response at Day 1 and Day 7 post-exposure. Results demonstrate that the earplug can protect the tympanic membrane and middle ear against structural damage, but the hearing level, cochlear outer hair cell, and the central auditory system (levels of excitatory and inhibitory neurotransmitter receptors) were only partially protected at the tested blast overpressure level. The findings in this study indicate that blast exposure can cause both peripheral and central auditory dysfunctions, and the central auditory response is independent of peripheral auditory damage. The CAS dysfunction is likely mediated by direct transmission of shockwaves in all the regions of central nervous system (CNS), including nerves and surrounding tissues along the auditory pathways. Hence, targeting central auditory neurotransmitter abnormalities may have a therapeutic benefit to attenuate blast-induced hearing loss and tinnitus. (C) 2021 Published by Elsevier B.V.	[Shao, Ningning; Younger, Daniel; Rao, Kakulavarapu V. Rama; Skotak, Maciej; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA; [Jiang, Shangyuan; Chen, Tao; Brown, Marcus; Gan, Rong Z.] Univ Oklahoma, Sch Aerosp & Mech Engn, Norman, OK 73019 USA; [Chandra, Namas] Walter Reed Army Inst Res WRAIR, Ctr Mil Psychiat & Neurosci CMPN, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave,Bldg 503, Silver Spring, MD 20910 USA		Rao, KVR (corresponding author), Walter Reed Army Inst Res WRAIR, Ctr Mil Psychiat & Neurosci CMPN, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave,Bldg 503, Silver Spring, MD 20910 USA.; Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Biomed Engn, 111 Lock St, Newark, NJ 07102 USA.; Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, 111 Lock St, Newark, NJ 07102 USA.	sn467@njit.edu; Shangyuan.Jiang-1@ou.edu; dey2@njit.edu; Tao.Chen-1@ou.edu; marcus.brown@ou.edu; venkata.r.kakulavarapu.ctr@mail.mil; mskotak@gmail.com; rgan@ou.edu; namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294; Shao, Ningning/0000-0002-9916-8502	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-1-0303, W81XWH-14-0228]	This work was supported by grants received from the U.S. Army Medical Research and Materiel Command: 1) W81XWH-15-1-0303 (NC) and 2) W81XWH-14-0228 (RG).	Abdala C, 2003, VOLTA REV, V103, P281; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Campagna-Slater V, 2007, NEUROSCI LETT, V418, P28, DOI 10.1016/j.neulet.2007.02.091; Caspary DM, 2017, HEARING RES, V349, P197, DOI 10.1016/j.heares.2016.08.009; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chandra N., 2015, BRAIN NEUROTRAUMA MO; Chen T, 2019, HEARING RES, V378, P33, DOI 10.1016/j.heares.2019.01.010; Chen W, 2013, INT J CLIN EXP PATHO, V6, P375; Daniel SJ, 2007, LARYNGOSCOPE, V117, P2201, DOI 10.1097/MLG.0b013e318148b275; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fubara BM, 1996, J COMP NEUROL, V369, P83; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gan RZ, 2009, J ACOUST SOC AM, V126, P243, DOI 10.1121/1.3129129; Guan XY, 2011, HEARING RES, V277, P96, DOI 10.1016/j.heares.2011.03.003; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Han BI, 2009, J CLIN NEUROL, V5, P11, DOI 10.3988/jcn.2009.5.1.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Health, 2019, HLTH NIO QUICK STAT HLTH NIO QUICK STAT; HEFFNER RS, 1991, HEARING RES, V52, P13, DOI 10.1016/0378-5955(91)90183-A; Henry KS, 2016, J NEUROSCI, V36, P2227, DOI 10.1523/JNEUROSCI.3944-15.2016; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Jalilvand H, 2015, AUDIOL NEURO-OTOL, V20, P195, DOI 10.1159/000377617; Jiang SY, 2019, HEARING RES, V378, P43, DOI 10.1016/j.heares.2018.12.003; Kallakuri S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193389; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kim J, 2018, P NATL ACAD SCI USA, V115, pE4853, DOI 10.1073/pnas.1720121115; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Li Chao-jun, 2006, Chin J Traumatol, V9, P242; Liang JF, 2017, HEARING RES, V354, P48, DOI 10.1016/j.heares.2017.08.003; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Liu W, 1991, Zhonghua Er Bi Yan Hou Ke Za Zhi, V26, P67; LOPEZIBOR JJ, 1988, BRIT J PSYCHIAT, V153, P26, DOI 10.1192/S0007125000297262; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; MASTERTON RB, 1993, ORL J OTO-RHINO-LARY, V55, P159; Medicine, 2006, NOISE MILITARY SERVI; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Ouyang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04941-w; Race N, 2017, J NEUROPHYSIOL, V118, P782, DOI 10.1152/jn.00710.2016; Raju Ganesan, 2015, Indian J Occup Environ Med, V19, P138, DOI 10.4103/0019-5278.173993; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; Shin SS, 2015, NEURAL REGEN RES, V10, P1552, DOI 10.4103/1673-5374.165309; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Sindelar B, 2017, OTOL NEUROTOL, V38, P1205, DOI 10.1097/MAO.0000000000001500; Sindelar B, 2017, OTOL NEUROTOL, V38, P591, DOI 10.1097/MAO.0000000000001332; Smith KD, 2020, MIL MED, V185, P248, DOI 10.1093/milmed/usz309; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Wu JA, 2011, AM J OTOLARYNG, V32, P8, DOI 10.1016/j.amjoto.2009.08.012; Xu JH, 2010, CEREB CORTEX, V20, P804, DOI 10.1093/cercor/bhp143; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Zhang JS, 2019, J ACOUST SOC AM, V146, P3811, DOI 10.1121/1.5132551	63	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	AUG	2021	407								108273	10.1016/j.heares.2021.108273			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	TK8DR	WOS:000674384300001	34139381				2022-02-07	
J	Sicard, V; Hergert, DC; Reddy, SP; Robertson-Benta, CR; Dodd, AB; Shaff, NA; Stephenson, DD; Yeates, KO; Cromer, JA; Campbell, RA; Phillips, JP; Sapien, RE; Mayer, AR				Sicard, Veronik; Hergert, Danielle C.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Dodd, Andrew B.; Shaff, Nicholas A.; Stephenson, David D.; Yeates, Keith Owen; Cromer, Jason A.; Campbell, Richard A.; Phillips, John P.; Sapien, Robert E.; Mayer, Andrew R.			Severity of Ongoing Post-Concussive Symptoms as a Predictor of Cognitive Performance Following a Pediatric Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Executive function; Learning; Brain concussion; Neuropsychological tests; Adolescent; Child	DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; PREMORBID INTELLIGENCE; EMERGENCY-DEPARTMENT; PROTRACTED RECOVERY; CONSENSUS STATEMENT; BASE-LINE; CHILDREN; ATTENTION	Objective: This study aimed to examine the predictors of cognitive performance in patients with pediatric mild traumatic brain injury (pmTBI) and to determine whether group differences in cognitive performance on a computerized test battery could be observed between pmTBI patients and healthy controls (HC) in the sub-acute (SA) and the early chronic (EC) phases of injury. Method: 203 pmTBI patients recruited from emergency settings and 159 age- and sex-matched HC aged 8-18 rated their ongoing post-concussive symptoms (PCS) on the Post-Concussion Symptom Inventory and completed the Cogstate brief battery in the SA (1-11 days) phase of injury. A subset (156 pmTBI patients; 144 HC) completed testing in the EC (similar to 4 months) phase. Results: Within the SA phase, a group difference was only observed for the visual learning task (One-Card Learning), with pmTBI patients being less accurate relative to HC. Follow-up analyses indicated higher ongoing PCS and higher 5P clinical risk scores were significant predictors of lower One-Card Learning accuracy within SA phase, while premorbid variables (estimates of intellectual functioning, parental education, and presence of learning disabilities or attention-deficit/hyperactivity disorder) were not. Conclusions: The absence of group differences at EC phase is supportive of cognitive recovery by 4 months post-injury. While the severity of ongoing PCS and the 5P score were better overall predictors of cognitive performance on the Cogstate at SA relative to premorbid variables, the full regression model explained only 4.1% of the variance, highlighting the need for future work on predictors of cognitive outcomes.	[Sicard, Veronik; Hergert, Danielle C.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Dodd, Andrew B.; Shaff, Nicholas A.; Stephenson, David D.; Phillips, John P.; Mayer, Andrew R.] Lovelace Biomed Res Inst, Mind Res Network, Albuquerque, NM USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Cromer, Jason A.] Yale Univ, Child Study Ctr, New Haven, CT USA; [Cromer, Jason A.] Cogstate Ltd, New Haven, CT USA; [Campbell, Richard A.; Mayer, Andrew R.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM USA; [Phillips, John P.; Mayer, Andrew R.] Univ New Mexico, Dept Neurol, Albuquerque, NM USA; [Sapien, Robert E.] Univ New Mexico, Dept Emergency Med, Hlth Sci Ctr, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domen Hall,1101 Yale Ave NE, Albuquerque, NM 87106 USA.	amayer@mrn.org		Sicard, Veronik/0000-0003-2452-934X; Hergert, Danielle/0000-0003-0860-2674	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1, R01 NS098494-03S1A1]	This research was supported by grants from the National Institutes of Health to Andrew R. Mayer (grant numbers NIH 01 R01 NS098494-01A1, and R01 NS098494-03S1A1). The NIH had no role in study review, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cogstate, 2018, COGST PED AD NORM DA; Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Davis A.S., 2018, J PEDIATR NEUROPSYCH, V4, P49; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Doniger GM, 2008, APPL NEUROPSYCHOL, V15, P250, DOI 10.1080/09084280802325074; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Gardner AJ, 2020, BRAIN INJURY, V34, P224, DOI 10.1080/02699052.2019.1683894; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Grigorian A, 2019, J CHILD ADOL PS NURS, V32, P171, DOI 10.1111/jcap.12246; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; Mayer AR, 2020, NEUROLOGY, V94, pE241, DOI 10.1212/WNL.0000000000008488; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2019, BRAIN INJURY, V33, P291, DOI 10.1080/02699052.2018.1546408; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; OVERALL JE, 1977, MULTIVAR BEHAV RES, V12, P171, DOI 10.1207/s15327906mbr1202_5; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Takagi M, 2020, CHILD NEUROPSYCHOL, V26, P54, DOI 10.1080/09297049.2019.1639653; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	68	0	0	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2021	27	7					686	696	PII S1355617720001228	10.1017/S1355617720001228			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	TY5HL	WOS:000683815300004	33243310				2022-02-07	
J	Sporri, E; Halvachizadeh, S; Gamble, JG; Berk, T; Allemann, F; Pape, HC; Rauer, T				Spoerri, Emilian; Halvachizadeh, Sascha; Gamble, Jamison G.; Berk, Till; Allemann, Florin; Pape, Hans-Christoph; Rauer, Thomas			Comparison of Injury Patterns between Electric Bicycle, Bicycle and Motorcycle Accidents	JOURNAL OF CLINICAL MEDICINE			English	Article						E-bike injuries; polytrauma; outcome; injury pattern comparison	E-BIKE; TRAUMA; SEVERITY; CRASHES	Background: Electric bicycles (E-bikes) are an increasingly popular means of transport, and have been designed for a higher speed comparable to that of small motorcycles. Accident statistics show that E-bikes are increasingly involved in traffic accidents. To test the hypothesis of whether accidents involving E-bikes bear more resemblance to motorcycle accidents than conventional bicyclists, this study evaluates the injury pattern and severity of E-bike injuries in direct comparison to injuries involving motorcycle and bicycle accidents. Methods: In this retrospective cohort study, the data of 1796 patients who were treated at a Level I Trauma Center between 2009 and 2018 due to traffic accident, involving bicycles, E-bikes or motorcycles, were evaluated and compared with regard to injury patterns and injury severity. Accident victims treated as inpatients at least 16 years of age or older were included in this study. Pillion passengers and outpatients were excluded. Results: The following distribution was found in the individual groups: 67 E-bike, 1141 bicycle and 588 motorcycle accidents. The injury pattern of E-bikers resembled that of bicyclists much more than that of motorcyclists. The patients with E-bike accidents were almost 14 years older and had a higher incidence of moderate traumatic brain injuries than patients with bicycle accidents, in spite of the fact that E-bike riders were nearly twice as likely to wear a helmet as compared to bicycle riders. The rate of pelvic injuries in E-bike accidents was twice as high compared with bicycle accidents, whereas the rate of upper extremity injuries was higher following bicycle accidents. Conclusion: The overall E-bike injury pattern is similar to that of cyclists. The differences in the injury pattern to motorcycle accidents could be due to the higher speeds at the time of the accident, the different protection and vehicle architecture. What is striking, however, is the higher age and the increased craniocerebral trauma of the E-bikers involved in accidents compared to the cyclists. We speculate that older and untrained people who have a slower reaction time and less control over the E-bike could benefit from head protection or practical courses similar to motorcyclists.	[Spoerri, Emilian; Halvachizadeh, Sascha; Berk, Till; Allemann, Florin; Pape, Hans-Christoph; Rauer, Thomas] Univ Hosp Zurich, Dept Trauma Surg, CH-8091 Zurich, Switzerland; [Gamble, Jamison G.] St Georges Univ, Sch Med, St Georges, Grenada		Rauer, T (corresponding author), Univ Hosp Zurich, Dept Trauma Surg, CH-8091 Zurich, Switzerland.	emilian.spoerri@gmail.com; Sascha.Halvachizadeh@usz.ch; jg120gamble@gmail.com; till.berk@usz.ch; Florin.Allemann@usz.ch; hans-christoph.pape@usz.ch; thomas.rauer@usz.ch		Pape, Hans-Christoph/0000-0002-2059-4980; Berk, Till/0000-0001-9582-1810; Rauer, Thomas/0000-0003-4775-1103; Allemann, Florin/0000-0003-0479-2810; Halvachizadeh, Sascha/0000-0003-1393-3232			Baschera D, 2019, WORLD NEUROSURG, V126, pE1023, DOI 10.1016/j.wneu.2019.03.032; Bundesamt fur Statistik BFS, 2020, VER PERS NACH VERK 2; DiMaggio CJ, 2020, INJURY PREV, V26, P524, DOI 10.1136/injuryprev-2019-043418; Dozza M, 2016, TRANSPORT RES F-TRAF, V41, P217, DOI 10.1016/j.trf.2015.04.003; Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646; Fletcher C, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000326; Gross I, 2018, J EMERG MED, V54, P793, DOI 10.1016/j.jemermed.2017.12.012; Hertach P, 2018, ACCIDENT ANAL PREV, V117, P232, DOI 10.1016/j.aap.2018.04.021; Hu F, 2014, TRAFFIC INJ PREV, V15, P319, DOI 10.1080/15389588.2013.817669; MacArthur J, 2014, TRANSPORT RES REC, P123, DOI 10.3141/2468-14; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Papoutsi S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/850236; TEASDALE G, 1974, LANCET, V2, P81; Tenenbaum S, 2017, INJURY, V48, P2140, DOI 10.1016/j.injury.2017.08.020; Vlakveld WP, 2015, ACCIDENT ANAL PREV, V74, P97, DOI 10.1016/j.aap.2014.10.018; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weber T, 2014, ACCIDENT ANAL PREV, V73, P47, DOI 10.1016/j.aap.2014.07.020; Weiss R, 2018, Z ORTHOP UNFALLCHIR, V156, P78, DOI 10.1055/s-0043-120200; YELON JA, 1995, AM SURGEON, V61, P202; Zhang XJ, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1819, DOI 10.1177/1010539513496840; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y	21	0	0	7	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	AUG	2021	10	15							3359	10.3390/jcm10153359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TV9LF	WOS:000682034800001	34362145	Green Accepted, gold, Green Published			2022-02-07	
J	Stopa, BM; Harary, M; Jhun, R; Job, A; Izzy, S; Smith, TR; Gormley, WB				Stopa, Brittany M.; Harary, Maya; Jhun, Ray; Job, Arun; Izzy, Saef; Smith, Timothy R.; Gormley, William B.			Divergence in the epidemiological estimates of traumatic brain injury in the United States: comparison of two national databases	JOURNAL OF NEUROSURGERY			English	Article						head injury; traumatic brain injury; incidence; epidemiology; trauma	MANAGEMENT; GUIDELINES; DEATHS	OBJECTIVE Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in the US, but the true incidence of TBI is unknown. METHODS The National Trauma Data Bank National Sample Program (NTDB NSP) was queried for 2007 and 2013, and population-based weighted estimates of TBI-related emergency department (ED) visits, hospitalizations, and deaths were calculated. These data were compared to the 2017 Centers for Disease Control and Prevention (CDC) report on TBI, which used the Healthcare Cost and Utilization Project's National ("Nationwide" before 2012) Inpatient Sample and National Emergency Department Sample. RESULTS In the NTDB NSP the incidence of TBI-related ED visits was 59/100,000 in 2007 and 62/100,000 in 2013. However, in the CDC report there were 534/100,000 in 2007 and 787/100,000 in 2013. The CDC estimate for ED visits was 805% higher in 2007 and 1169% higher in 2013. In the NTDB NSP, the incidence of TBI-related deaths was 5/100,000 in 2007 and 4/100,000 in 2013. In the CDC report, the incidence was 18/100,000 in both years. The CDC estimate for deaths was 260% higher in 2007 and 325% higher in 2013. CONCLUSIONS The databases disagreed widely in their weighted estimates of TBI incidence: CDC estimates were consistently higher than NTDB NSP estimates, by an average of 448%. Although such a discrepancy may be intuitive, this is the first study to quantify the magnitude of disagreement between these databases. Given that research, funding, and policy decisions are made based on these estimates, there is a need for a more accurate estimate of the true national incidence of TBI.	[Stopa, Brittany M.; Harary, Maya; Jhun, Ray; Job, Arun; Smith, Timothy R.; Gormley, William B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Computat Neurosci Outcomes Ctr, Boston, MA 02115 USA; [Stopa, Brittany M.] Virginia Tech Caril, Sch Med, Roanoke, VA USA; [Harary, Maya] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Jhun, Ray; Job, Arun] Boston Univ, Sch Med, Boston, MA 02215 USA; [Izzy, Saef] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA		Gormley, WB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Computat Neurosci Outcomes Ctr, Boston, MA 02115 USA.	wgormley@bwh.harvard.edu	Smith, Timothy R/N-2481-2014	Smith, Timothy R/0000-0003-1976-0766			Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Alluri RK, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.49; American College of Surgeons, 2011, NAT SAMPL PROGR ARR; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Centers for Disease Control and Prevention, HEADS; Centers for Disease Control and Prevention, 2019, US CENS POP BRIDG RA; Coronado VG, 2014, J SAFETY RES, V48, P117, DOI 10.1016/j.jsr.2013.12.006; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Grimes DA, 2015, HUM REPROD, V30, P1749, DOI 10.1093/humrep/dev151; Karhade AV, 2018, NEUROSURGERY, V83, P333, DOI 10.1093/neuros/nyx408; Kegler SR, 2003, J HEAD TRAUMA REHAB, V18, P469, DOI 10.1097/00001199-200311000-00001; Leo P, 2016, TRANSLATIONAL RES TR; Levant Shaleah, 2016, Natl Health Stat Report, P1; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; National Institutes of Health, EST FUND VAR RES CON; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salmon, 1999, J MANAGE CARE PHARM, V5, P215, DOI DOI 10.18553/jmcp.1999.5.3.215; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Wilson MH, 2016, LANCET PUBLIC HEALTH, V1, pE44, DOI 10.1016/S2468-2667(16)30022-6	34	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					584	593		10.3171/2020.7.JNS201896			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800030	33254146				2022-02-07	
J	Sysoev, YI; Prikhodko, VA; Chernyakov, RT; Idiyatullin, RD; Musienko, PE; Okovityi, SV				Sysoev, Yuriy, I; Prikhodko, Veronika A.; Chernyakov, Roman T.; Idiyatullin, Ruslan D.; Musienko, Pavel E.; Okovityi, Sergey, V			Effects of Alpha-2 Adrenergic Agonist Mafedine on Brain Electrical Activity in Rats after Traumatic Brain Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; neuroprotection; electrocorticography; rat; mafedine; dexmedetomidine	DEXMEDETOMIDINE; CORTEX; MODEL	The search for and development of new neuroprotective (or cerebroprotective) drugs, as well as suitable methods for their preclinical efficacy evaluation, are priorities for current biomedical research. Alpha-2 adrenergic agonists, such as mafedine and dexmedetomidine, are a highly appealing group of drugs capable of reducing neurological deficits which result from brain trauma and vascular events in both experimental animals and human patients. Thus, our aim was to assess the effects of mafedine and dexmedetomidine on the brain's electrical activity in a controlled cortical-impact model of traumatic brain injury (TBI) in rats. The functional status of the animals was assessed by electrocorticography (ECoG), using ECoG electrodes which were chronically implanted in different cortical regions. The administration of intraperitoneal mafedine sodium at 2.5 mg.kg(-1) at 1 h after TBI induction, and daily for the following 6 days, restored interhemispheric connectivity in remote brain regions and intrahemispheric connections within the unaffected hemisphere at post-TBI day 7. Animals that had received mafedine sodium also demonstrated an improvement in cortical responses to photic and somatosensory stimulation. Dexmedetomidine at 25 mu g.kg(-1) did not affect the brain's electrical activity in brain-injured rats. Our results confirm the previously described neuroprotective effects of mafedine sodium and suggest that ECoG registration and analysis are a viable method evaluating drug efficacy in experimental animal models of TBI.	[Sysoev, Yuriy, I; Prikhodko, Veronika A.; Chernyakov, Roman T.; Idiyatullin, Ruslan D.; Okovityi, Sergey, V] St Petersburg State Chem & Pharmaceut Univ, Dept Pharmacol & Clin Pharmacol, St Petersburg 197022, Russia; [Sysoev, Yuriy, I; Musienko, Pavel E.] St Petersburg State Univ, Inst Translat Biomed, Lab Neuroprosthet, St Petersburg 199034, Russia; [Sysoev, Yuriy, I; Musienko, Pavel E.] RAS, Pavlov Inst Physiol, St Petersburg 199034, Russia; [Prikhodko, Veronika A.; Okovityi, Sergey, V] Russian Acad Sci, NP Bechtereva Inst Human Brain, St Petersburg 197376, Russia; [Musienko, Pavel E.] Sirius Natl Tech Univ, Neurosci Program, Soci 354340, Russia		Sysoev, YI (corresponding author), St Petersburg State Chem & Pharmaceut Univ, Dept Pharmacol & Clin Pharmacol, St Petersburg 197022, Russia.; Sysoev, YI (corresponding author), St Petersburg State Univ, Inst Translat Biomed, Lab Neuroprosthet, St Petersburg 199034, Russia.; Sysoev, YI (corresponding author), RAS, Pavlov Inst Physiol, St Petersburg 199034, Russia.	susoyev92@mail.ru; veronika.prihodko@pharminnotech.com; rom4ik19.06.2001@gmail.com; rusidi100@gmail.com; pol-spb@mail.ru; sergey.okovity@pharminnotech.com	Okovityy, Sergey/Q-5122-2018; Musienko, Pavel/L-6677-2015	Okovityy, Sergey/0000-0003-4294-5531; Musienko, Pavel/0000-0002-7324-9021	St. Petersburg State University, St. Petersburg, Russia [73025408]	This work was performed within project ID: 73025408 of the St. Petersburg State University, St. Petersburg, Russia.	Aliev O.A., 1999, B EXP BIOL MED+, VS1, P12; Bundy DT, 2019, STROKE, V50, P2626, DOI 10.1161/STROKEAHA.119.023550; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Casillas-Espinosa PM, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.04.011; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Del Vecchio M, 2019, BRAIN STRUCT FUNCT, V224, P9, DOI 10.1007/s00429-018-1754-6; Ding MY, 2019, EXP THER MED, V18, P2323, DOI 10.3892/etm.2019.7790; Gantsgorn E.V., 2015, J BIOMED OPT, V3, P87; Gantsgorn E.V., 2018, EXP CLIN PHARMACOL, V81, P52; Gao X, 2016, PSYCHIAT RES, V243, P446, DOI 10.1016/j.psychres.2016.07.020; Gerasimova M.M., 2004, NEUROL B, V36, P12; Jiang LX, 2017, J CLIN ANESTH, V40, P25, DOI 10.1016/j.jclinane.2017.04.003; Kalinina DS, 2016, J EVOL BIOCHEM PHYS+, V52, P352, DOI 10.1134/S0022093016050033; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Lychakov DV, 2007, J EVOL BIOCHEM PHYS+, V43, P509, DOI 10.1134/S002209300705009X; Mete M, 2021, INJURY, V52, P713, DOI 10.1016/j.injury.2021.02.055; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rajah GB, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.1.FOCUS16497; Rusinov V.S., 1987, BIOPOTENCIALS HUMAN; SAKATANI K, 1990, STROKE, V21, P124, DOI 10.1161/01.STR.21.1.124; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Sick T, 2017, J NEUROTRAUM, V34, P2467, DOI 10.1089/neu.2016.4826; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Sysoev Y., 2020, NEUROSCI BEHAV PHYSI, V50, P1216, DOI [10.1007/s11055-020-01023-9, DOI 10.1007/S11055-020-01023-9]; Sysoev Y.I., 2019, J BIOMED OPT, V4, P107, DOI [10.33647/2074-5982-15-4-107-120, DOI 10.33647/2074-5982-15-4-107-120]; Sysoev Y.I., 2019, J BIOMED OPT, V1, P62; [Сысоев Ю.И. Sysoev Yu. I.], 2020, [Биомедицина, Journal Biomed, Biomeditsina], V16, P68, DOI 10.33647/2074-5982-16-2-68-77; [Сысоев Ю.И. Sysoev Yu. I.], 2019, [Российский физиологический журнал им. И.М. Сеченова, Neuroscience and Behavioral Physiology - Sechenov Physiology Journal, Rossiiskii fiziologicheskii zhurnal im. I.M. Sechenova], V105, P749, DOI 10.1134/S0869813919060074; Sysoev YI, 2019, NEUROSCI LETT, V701, P234, DOI 10.1016/j.neulet.2019.03.001; Sysoev Yuriy Igorevich, 2019, J Exp Pharmacol, V11, P53, DOI 10.2147/JEP.S199464; Topcu I, 2013, TURK NEUROSURG, V23, P764, DOI 10.5137/1019-5149.JTN.7749-13.0; Volokhova G.A., 2008, INT NEUROL J, V2, P51; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Zhirmunskaya E.A., 1991, CLIN ENCEPHALOGRAPHY	37	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2021	11	8							981	10.3390/brainsci11080981			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UF8VE	WOS:000688845200001	34439602	Green Published			2022-02-07	
J	Tang, OY; Perla, KMR; Lim, RK; Yoon, JS; Weil, RJ; Toms, SA				Tang, Oliver Y.; Perla, Krissia M. Rivera; Lim, Rachel K.; Yoon, James S.; Weil, Robert J.; Toms, Steven A.			Interhospital competition and hospital charges and costs for patients undergoing cranial neurosurgery	JOURNAL OF NEUROSURGERY			English	Article						Herfindahl-Hirschman Index; HHI; healthcare economics; healthcare costs; health policy; perioperative; outcomes; National Inpatient Sample; NIS	UNITED-STATES; CONSOLIDATION IMPLICATIONS; OUTCOMES; CARE; CRANIOTOMY; QUALITY; SURGEON; VOLUME; TUMOR	OBJECTIVE Research has documented significant growth in neurosurgical expenditures and practice consolidation. The authors evaluated the relationship between interhospital competition and inpatient charges or costs in patients undergoing cranial neurosurgery. METHODS The authors identified all admissions in 2006 and 2009 from the National Inpatient Sample. Admissions were classified into 5 subspecialties: cerebrovascular, tumor, CSF diversion, neurotrauma, or functional. Hospital-specific interhospital competition levels were quantified using the Herfindahl-Hirschman Index (HHI), an economic metric ranging continuously from 0 (significant competition) to 1 (monopoly). Inpatient charges (hospital billing) were multiplied with reported cost-to-charge ratios to calculate costs (actual resource use). Multivariate regressions were used to assess the association between HHI and inpatient charges or costs separately, controlling for 17 patient, hospital, severity, and economic factors. The reported beta-coefficients reflect percentage changes in charges or costs (e.g., beta-coefficient = 1.06 denotes a +6% change). All results correspond to a standardized -0.1 change in HHI (increase in competition). RESULTS In total, 472,938 nationwide admissions for cranial neurosurgery treated at 896 unique hospitals met inclusion criteria. Hospital HHIs ranged from 0.099 to 0.724 (mean 0.298 +/- 0.105). Hospitals in more competitive markets had greater charge/cost markups (beta-coefficient = 1.10, p < 0.001) and area wage indices (beta- coefficient = 1.04, p < 0.001). Between 2006 and 2009, average neurosurgical charges and costs rose significantly ($62,098 to $77,812, p < 0.001; $21,385 to $22,389, p < 0.001, respectively). Increased interhospital competition was associated with greater charges for all admissions (beta-coefficient = 1.07, p < 0.001) as well as cerebrovascular (beta-coefficient = 1.08, p < 0.001), tumor (beta-coefficient = 1.05, p = 0.039), CSF diversion (beta- coefficient = 1.08, p < 0.001), neurotrauma (beta-coefficient = 1.07, p < 0.001), and functional neurosurgery (beta-coefficient = 1.11, p = 0.037) admissions. However, no significant associations were observed between HHI and costs, except for CSF diversion surgery (beta-coefficient = 1.03, p = 0.021). Increased competition was not associated with important clinical outcomes, such as inpatient mortality, favorable discharge disposition, or complication rates, except for lower mortality for brain tumors (OR 0.78, p = 0.026), but was related to greater length of stay for all admissions (beta-coefficient = 1.06, p < 0.001). For a sensitivity analysis adjusting for outcomes, all findings for charges and costs remained the same. CONCLUSIONS Hospitals in more competitive markets exhibited higher charges for admissions of patients undergoing an in-hospital cranial procedure. Despite this, interhospital competition was not associated with increased inpatient costs except for CSF diversion surgery. There was no corresponding improvement in outcomes with increased competition, with the exception of a potential survival benefit for brain tumor surgery.	[Tang, Oliver Y.; Perla, Krissia M. Rivera; Lim, Rachel K.; Toms, Steven A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Yoon, James S.] Yale Sch Med, New Haven, CT USA; [Weil, Robert J.; Toms, Steven A.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI USA		Toms, SA (corresponding author), Rhode Isl Hosp, Providence, RI 02903 USA.	steven.toms@lifespan.org					[Anonymous], Herfindahl-Hirschman Index; Bai G, 2015, HEALTH AFFAIR, V34, P922, DOI 10.1377/hlthaff.2014.1414; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Beaulieu ND, 2020, NEW ENGL J MED, V382, P51, DOI 10.1056/NEJMsa1901383; Cerullo M, 2019, ANN SURG, V270, P681, DOI 10.1097/SLA.0000000000003481; Chang DC, 2011, J AM COLL SURGEONS, V212, P12, DOI 10.1016/j.jamcollsurg.2010.09.014; Chang V, 2016, SURGERY, V160, P1155, DOI 10.1016/j.surg.2016.05.027; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Clyde AT, 2008, HEALTH AFFAIR, V27, P1632, DOI 10.1377/hlthaff.27.6.1632; Collins S, 2019, HLTH INSURANCE COVER; Connor RA., 1998, INT J ECON BUS, V5, P159, DOI [10.1080/13571519884495, DOI 10.1080/13571519884495]; Cost -to -charge ratio files, HEALTHC COST UT PROJ; Cowan John A Jr, 2007, Clin Neurosurg, V54, P209; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Davies JM, 2017, J NEUROSURG, V127, P69, DOI 10.3171/2016.7.JNS15925; Devers KJ, 2003, HEALTH SERV RES, V38, P447, DOI 10.1111/1475-6773.00124; Durand WM, 2018, SPINE J, V18, P626, DOI 10.1016/j.spinee.2017.08.256; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Goldman DP, 2010, NEW ENGL J MED, V363, P2185, DOI 10.1056/NEJMp1009501; Gourin CG, 2019, JAMA OTOLARYNGOL, V145, P939, DOI 10.1001/jamaoto.2019.2303; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Henke RM, 2013, AM J MANAG CARE, V19, pE238; Houchens R., 2015, MISSING DATA METHODS; Huppertz JW, 2017, HEALTH SERV RES, V52, P1590, DOI 10.1111/1475-6773.12549; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Kim DH, 2017, NEUROSURGERY, V80, pS4, DOI 10.1093/neuros/nyx008; Li HL, 2014, HEALTHCARE, V2, P152, DOI 10.1016/j.hjdsi.2013.10.002; Ly DP, 2018, J GEN INTERN MED, V33, P1020, DOI 10.1007/s11606-018-4347-4; Medicare Payment Advisory Committee, 2018, HOSP INP OUTP SERV A; Mooney MA, 2019, NEUROSURGERY, V84, P1280, DOI 10.1093/neuros/nyy185; Mukamel DB, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-10; Munoz E, 2010, ANN SURG, V251, P195, DOI 10.1097/SLA.0b013e3181cbcc9a; Overview of the National (Nationwide) Inpatient Sample (NIS), HEALTHC COST UT PROJ; Robinson JC, 2011, AM J MANAG CARE, V17, pE241; Sharma M, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13295; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Sun Y, 2019, TOOLS MORE ACCURATE; Washington CW, 2014, J NEUROSURG, V121, P482, DOI 10.3171/2014.4.JNS131100; Wright JD, 2016, JAMA SURG, V151, P612, DOI 10.1001/jamasurg.2015.5508; Wu VY, 2008, INQUIRY-J HEALTH CAR, V45, P280, DOI 10.5034/inquiryjrnl_45.03.280; Xu T, 2015, JAMA-J AM MED ASSOC, V314, P1337, DOI 10.1001/jama.2015.7492; Yoon JS, 2019, WORLD NEUROSURG, V129, pE791, DOI 10.1016/j.wneu.2019.06.034; Yoon O, 2019, 2019 AANS ANN SCI M; Zygourakis CC, 2017, NEUROSURGERY, V81, P972, DOI 10.1093/neuros/nyx133	45	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2021	135	2					361	372		10.3171/2020.6.JNS20732			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	UP9SW	WOS:000695714800005		Bronze			2022-02-07	
J	Tatro, HA; McMillen, JC; Hamilton, LA; Rowe, AS				Tatro, Hayley A.; McMillen, James C.; Hamilton, Leslie A.; Rowe, A. Shaun			23.4% Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure in Patients With Traumatic Brain Injury: A Single-Center Retrospective Cohort Study	ANNALS OF PHARMACOTHERAPY			English	Article						intracranial pressure; traumatic brain injury; hyperosmolar therapy; hypertonic saline; mannitol; intracranial hypertension		Background Intermittent doses of mannitol or hypertonic saline are recommended to treat elevated intracranial pressure (ICP). However, it is unclear if one agent is more effective than the other. Previous studies have compared mannitol and hypertonic saline in reduction of ICP, with conflicting results. However, no study thus far has compared 23.4% sodium chloride with mannitol. Objective The objective of this study was to determine the difference in absolute reduction of ICP 60 minutes after infusion of 23.4% sodium chloride versus mannitol. Methods This was a single-center retrospective cohort study that included patients at least 16 years old admitted to the trauma/surgical intensive care unit between August 8, 2016, and August 30, 2018, who received either 23.4% sodium chloride 30 mL and/or mannitol 0.5 g/kg and had an ICP monitor or external ventricular drain in place. The primary outcome was absolute reduction in ICP 60 minutes after infusion of hyperosmolar therapy. Results In all, 31 patients and 162 doses of hyperosmolar therapy were included in the analysis. There was no statistically significant difference in the primary end point of absolute reduction of ICP 60 minutes after infusion of hyperosmolar therapy comparing 23.4% sodium chloride 30 mL with 0.5 g/kg mannitol (P = 0.2929). There was no statistically significant difference found for any secondary end points. Conclusion and Relevance No difference was found for absolute reduction of ICP at 30, 60, and 120 minutes, respectively, after infusion of hyperosmolar agent or time to next elevated ICP. Patient-specific parameters should be used to guide the choice of hyperosmolar agent to be administered.	[Tatro, Hayley A.; McMillen, James C.] Univ Tennessee Med Ctr, Knoxville, TN USA; [Tatro, Hayley A.; McMillen, James C.; Hamilton, Leslie A.; Rowe, A. Shaun] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Knoxville, TN USA		Tatro, HA (corresponding author), Univ Tennessee Med Ctr, Dept Pharm, 1924 Alcoa Highway, Knoxville, TN 37920 USA.	htatro@wisc.edu		Rowe, Anthony/0000-0002-2533-9233			Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; American College of Surgeons Trauma Quality Improvement Program, BEST PRACT MAN TRAUM; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Mangat HS, 2020, NEUROSURGERY, V86, P221, DOI 10.1093/neuros/nyz046; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Patil H, 2019, WORLD NEUROSURG, V125, pE221, DOI 10.1016/j.wneu.2019.01.051; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1	17	0	0	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	AUG	2021	55	8					988	994		10.1177/1060028020982379			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	SU3AN	WOS:000663013100006	33345546				2022-02-07	
J	Theodorou, CM; Trappey, AF; Beyer, CA; Yamashiro, KJ; Hirose, S; Galante, JM; Beres, AL; Stephenson, JT				Theodorou, Christina M.; Trappey, A. Francois; Beyer, Carl A.; Yamashiro, Kaeli J.; Hirose, Shinjiro; Galante, Joseph M.; Beres, Alana L.; Stephenson, Jacob T.			Quantifying the need for pediatric REBOA: A gap analysis	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; REBOA; Resuscitative endovascular balloon occlusion of the aorta; Gap analysis; Pediatric REBOA	ENDOVASCULAR BALLOON OCCLUSION; TRAUMATIC BRAIN-INJURY; AORTA REBOA; SHOCK INDEX; RESUSCITATIVE THORACOTOMY; RISK-FACTORS; POPULATION; VALIDATION; HEMORRHAGE; MANAGEMENT	Background: Trauma is the leading cause of death in children. Resuscitative endovascular balloon occlusion of the aorta (REBOA) provides temporary hemorrhage control, but its potential benefit has not been assessed in children. We hypothesized that there are pediatric patients who may benefit from REBOA. Methods: Trauma patients <18 years old at a level 1 pediatric trauma center between 2009 and 2019 were queried for deaths, pre-hospital cardiac arrest, massive transfusion protocol activation, transfusion requirement, or hemorrhage control surgery. These patients defined the cohort of severely injured patients. From this cohort, patients with intraabdominal injuries for which REBOA may provide temporary hemorrhage control were iden-tified, including solid organ injury necessitating intervention, vascular injury, or pelvic hemorrhage. Results: There were 239 severely injured patients out of 6538 pediatric traumas. Of these, 38 had REBOA-amenable injuries (15.9%) with 34.2% mortality, accounting for 10.2% of all pediatric trauma deaths at one center. Eleven patients with REBOA-amenable injuries had TBI (28.9%). Patients with REBOA-amenable injuries repre-sented 0.6% of all pediatric traumas. Conclusion: Nearly 20% of severely injured pediatric patients could potentially benefit from REBOA. The overall proportion of pediatric patients with REBOA-amenable injuries is similar to adult studies. Type of Study: Retrospective comparative study. Level of Evidence: Level III. (c) 2020 Elsevier Inc. All rights reserved.	[Theodorou, Christina M.; Beyer, Carl A.; Yamashiro, Kaeli J.; Hirose, Shinjiro; Galante, Joseph M.; Beres, Alana L.; Stephenson, Jacob T.] Univ Calif Davis, Dept Surg, Med Ctr, 2335 Stockton Blvd,Room 5107, Sacramento, CA 95817 USA; [Trappey, A. Francois] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Stephenson, Jacob T.] Uniformed Serv Univ Hlth Sci, Dept Pediat Surg, Bethesda, MD 20814 USA		Theodorou, CM (corresponding author), Univ Calif Davis, Dept Surg, Med Ctr, 2335 Stockton Blvd,Room 5107, Sacramento, CA 95817 USA.	ctheodorou@ucdavis.edu		Beyer, Carl/0000-0002-9785-8526	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001860]	The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860 for author C.M.T. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Acker SN, 2017, SURGERY, V161, P803, DOI 10.1016/j.surg.2016.08.050; Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Alexander J, 2016, CATHETER CARDIO INTE, V88, P1098, DOI 10.1002/ccd.26702; Aoki M, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00757-2; Aso S, 2017, J TRAUMA ACUTE CARE, V82, P910, DOI 10.1097/TA.0000000000001345; Barnard EBG, 2015, EMERG MED J, V32, P926, DOI 10.1136/emermed-2015-205217; Beyer CA, 2019, J TRAUMA ACUTE CARE, V87, P590, DOI 10.1097/TA.0000000000002363; Biffl WL, 2015, J TRAUMA ACUTE CARE, V78, P1054, DOI 10.1097/TA.0000000000000609; Boatright DH, 2013, J AM COLL SURGEONS, V216, P1094, DOI 10.1016/j.jamcollsurg.2013.02.013; Brenner M, 2018, JAMA SURG, V153, P130, DOI 10.1001/jamasurg.2017.3549; Campagna GA, 2020, J PEDIATR SURG, V55, P2128, DOI 10.1016/j.jpedsurg.2020.01.052; Centers for Disease Control and Prevention, 2018, C THEM TRAUM BRAIN, DOI [10.1080/02699052.2017.1312145, DOI 10.1080/02699052.2017.1312145]; Centers for Disease Control Growth Chart, BOYS AG 2 20 YEARS; Centers for Disease Control Growth Chart, GIRLS AG 2 20 YEARS; Davidson AJ, 2018, J TRAUMA ACUTE CARE, V84, P192, DOI 10.1097/TA.0000000000001711; DeSoucy ES, 2019, J ENDOVASC RESUSC TR, V3, P97, DOI 10.26676/jevtm.v3i3.95; Drake SA, 2020, PEDIATR SURG INT, V36, P179, DOI 10.1007/s00383-019-04597-9; Dumas RP, 2019, J SURG RES, V233, P413, DOI 10.1016/j.jss.2018.08.031; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Flynn-O'Brien KT, 2016, J PEDIATR SURG, V51, P163, DOI 10.1016/j.jpedsurg.2015.10.034; Gale Hannah L, 2019, Crit Care Explor, V1, pe0062, DOI 10.1097/CCE.0000000000000062; Hatchimonji JS, 2020, J SURG RES, V256, P149, DOI 10.1016/j.jss.2020.06.034; Hilbert-Carius P, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00301-8; Hill SJ, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2009.12.016; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Joseph B, 2019, JAMA SURG, V154, P500, DOI 10.1001/jamasurg.2019.0096; Joseph B, 2016, J TRAUMA ACUTE CARE, V81, pS128, DOI 10.1097/TA.0000000000001104; Kobayashi T, 2010, NIHON KYUKYU IGAKUKA, V21, P343, DOI [10.3893/jjaam.21.343, DOI 10.3893/JJAAM.21.343]; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Manley JD., 2017, J SPEC OPER MED, V17, P1; Manzano-Nunez R, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0205-2; Matsumura Y, 2017, EMERG MED J, V34, P793, DOI 10.1136/emermed-2016-206383; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Moore HB, 2016, J PEDIATR SURG, V51, P315, DOI 10.1016/j.jpedsurg.2015.10.040; Morrison JJ, 2014, SHOCK, V41, P388, DOI 10.1097/SHK.0000000000000136; Morrison JJ, 2016, J TRAUMA ACUTE CARE, V80, P324, DOI 10.1097/TA.0000000000000913; Nicolson NG, 2015, AM J SURG, V210, P720, DOI 10.1016/j.amjsurg.2015.05.007; Nordin A, 2018, J PEDIATR SURG, V53, P130, DOI 10.1016/j.jpedsurg.2017.10.023; Norii T, 2017, J TRAUMA ACUTE CARE, V82, P915, DOI 10.1097/TA.0000000000001347; Ordoñez Carlos A., 2017, Rev. colomb. anestesiol., V45, P30; Petrone P, 2019, AM SURGEON, V85, P654; Russo RM, 2016, J AM COLL SURGEONS, V223, P359, DOI 10.1016/j.jamcollsurg.2016.04.037; Russo RM, 2016, J TRAUMA ACUTE CARE, V80, P372, DOI 10.1097/TA.0000000000000940; Sadeghi M, 2019, J ENDOVASC RESUSC TR, V3, P139, DOI 10.26676/jevtm.v3i3.99; Smith AD, 2020, J PEDIATR SURG, V55, P2732, DOI 10.1016/j.jpedsurg.2020.08.007; Stephens CQ, 2017, J PEDIATR SURG, V52, P2031, DOI 10.1016/j.jpedsurg.2017.08.039; Tibbits EM, 2018, J TRAUMA ACUTE CARE, V85, P101, DOI 10.1097/TA.0000000000001858; Villamaria CY, 2014, J PEDIATR SURG, V49, P428, DOI 10.1016/j.jpedsurg.2013.10.002; Yamashiro KJ, 2020, J PEDIATR SURG, V55, P346, DOI 10.1016/j.jpedsurg.2019.10.013	49	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	AUG	2021	56	8					1395	1400		10.1016/j.jpedsurg.2020.09.011			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	UA3EB	WOS:000685044000028	33046222				2022-02-07	
J	Tian, JS; Xu, XY; Tian, D				Tian, Jinsi; Xu, Xiaoya; Tian, Da			Forsythiaside-A Alleviates Traumatic Brain Injury by Regulating Toll-Like Receptor 4/Myeloid Differentiation Factor 88/Nuclear Factor-Kappa B Signaling Pathway	CURRENT TOPICS IN NUTRACEUTICAL RESEARCH			English	Article						Apoptosis; Forsythiaside A; Inflammation; TLR4/MyD88/NF-kappa B signaling pathway; Traumatic brain injury		Traumatic brain injury refers to brain injury caused by mechanical impact often leading to severe morbidity and mortality. Despite increasing awareness, there are no effective treatments strategies. Therefore, there is a need to develop new effective treatments for this injury. Forsythiaside A is a monomer of phenylethanolglucoside extracted from Forsythia, which has a wide range of pharmacological properties including protective effects on brain tissue. Herein, using a rat model of traumatic brain injury, we have shown that forsythiaside A can improve nerve function and brain tissue injury in rats with traumatic brain injury, and reduce brain inflammation and neuronal apoptosis. We have further shown that forsythiaside A regulates toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway. This opens the possibility of a potentially promising therapeutic drug for the treatment of traumatic brain injury.	[Tian, Jinsi] Lishui Hosp Tradit Chinese Med, Dept Surg, Lishui 323000, Zhejiang, Peoples R China; [Xu, Xiaoya; Tian, Da] Lishui Peoples Hosp, Dept Neurosurg, 15 Dazhong St, Lishui 323000, Zhejiang, Peoples R China		Xu, XY (corresponding author), Lishui Peoples Hosp, Dept Neurosurg, 15 Dazhong St, Lishui 323000, Zhejiang, Peoples R China.	xuxiaoya_666@163.com					Bittencourt-Villalpando M, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102534; Caplan HW, 2021, STEM CELLS, V39, P358, DOI 10.1002/stem.3320; Chen LQ, 2019, NEUROCHEM INT, V125, P57, DOI 10.1016/j.neuint.2019.02.008; Cheng GD, 2014, EXP THER MED, V7, P179, DOI 10.3892/etm.2013.1378; Cheng L, 2015, INT IMMUNOPHARMACOL, V28, P494, DOI 10.1016/j.intimp.2015.07.011; Gallagher Sean, 2008, J Vis Exp, DOI 10.3791/759; Ghawami H, 2020, ARCH IRAN MED, V23, P813, DOI 10.34172/aim.2020.108; Gong LH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01855-9; Huang CK, 2015, NEUROCHEM RES, V40, P27, DOI 10.1007/s11064-014-1461-5; Jerome KR, 2000, PATHOLOGY, V32, P186; Lee MT, 2019, ASIAN AUSTRAL J ANIM, V32, P309, DOI 10.5713/ajas.18.0538; Lesniak E, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1855588; Li HF, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0834-x; Li YX, 2012, EUR J DRUG METAB PH, V37, P179, DOI 10.1007/s13318-012-0088-7; Little A, 2021, NEUROREHABILITATION, V48, P67, DOI 10.3233/NRE-201544; Lu C, 2020, FRONT BIOSCI-LANDMRK, V25, P526, DOI 10.2741/4818; Ma T, 2019, MOL MED REP, V20, P1313, DOI 10.3892/mmr.2019.10312; Peters M, 2016, J IMMUNOL, V196, P1626, DOI 10.4049/jimmunol.1502178; Qian J, 2017, EUR J PHARMACOL, V812, P250, DOI 10.1016/j.ejphar.2017.07.033; Rashidian A, 2020, INFLAMMATION, V43, P1999, DOI 10.1007/s10753-020-01273-2; Shavit-Stein E, 2021, MOL CELL NEUROSCI, V111, DOI 10.1016/j.mcn.2020.103586; Wang WQ, 2017, MICROB PATHOGENESIS, V107, P12, DOI 10.1016/j.micpath.2017.03.011; Wang X, 2013, INTEGR BIOL-UK, V5, P351, DOI 10.1039/c2ib20204b; Wang Y, 2016, NEUROCHEM RES, V41, P659, DOI 10.1007/s11064-015-1731-x; Zhao EX, 2020, NEUROTOX RES, V38, P723, DOI 10.1007/s12640-020-00245-6; Zusso M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1538-9	26	0	0	1	8	NEW CENTURY HEALTH PUBLISHERS, LLC	COPPELL	PO BOX 175, COPPELL, TX 75019 USA	1540-7535	2641-452X		CURR TOP NUTRACEUT R	Curr. Top. Nutraceutical Res.	AUG	2021	19	3					326	332	15	10.37290/ctnr2641-452X.19:326-332			7	Nutrition & Dietetics; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics; Pharmacology & Pharmacy	RL5AQ	WOS:000638986300015					2022-02-07	
J	Toong, T; Wilson, KE; Hunt, AW; Scratch, S; DeMatteo, C; Reed, N				Toong, Tiffany; Wilson, Katherine E.; Hunt, Anne W.; Scratch, Shannon; DeMatteo, Carol; Reed, Nick			Sensitivity and Specificity of a Multimodal Approach for Concussion Assessment in Youth Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; pediatric; psychometric; balance; cognition; strength	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; ASSESSMENT TOOLS; MUSCLE STRENGTH; TEST BATTERIES; PERFORMANCE; RELIABILITY; RECOVERY; ADOLESCENTS; MANAGEMENT	Context: Current international consensus endorses amultimodal approach to concussion assessment. However, the psychometric evaluation of clinical measures used to identify postconcussion performance deficits once an athlete is asymptomatic remains limited, particularly in the pediatric population. Objective: To describe and compare the sensitivity and specificity of a multimodal assessment battery (balance, cognition, and upper and lower body strength) versus individual clinical measures at discriminating between concussed youth athletes and noninjured controls when asymptomatic. Design: Prospective cohort study. Setting: Hospital laboratory setting. Participants: A total of 32 youth athletes with a concussion and 32 matched (age and sex) noninjured control participants aged 10-18 years. Intervention(s): Participants were administered preinjury (baseline) assessments of cognition (Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT]), balance (BioSway), and upper and lower body strength (grip strength and standing long jump). Assessments were readministered when concussed participants reported symptom resolution (asymptomatic time point). Noninjured control participants were reassessed using the same time interval as their concussion matched pair. Sensitivity and specificity were calculated using standardized regression-based methods and receiver operating characteristic curves. Main Outcome Measures: Outcome measures included baseline and postinjury ImPACT, BioSway, grip strength, and standing long jump scores. Results: When asymptomatic, declines in performance on each individual clinical measure were seen in 3% to 22% of the concussion group (sensitivity = 3%- 22%) compared with 3% to 13% of the noninjured control group (specificity = 87%-97%) (90% confidence interval). The multimodal battery of all combined clinical measures yielded a sensitivity of 41% and a specificity of 77% (90% confidence interval). Based on discriminative analyses, the multimodal approach was statistically superior compared with an individual measures approach for balance and upper and lower body strength, but not for cognition. Conclusions: Results provide a foundation for understanding which domains of assessment (cognition, balance, and strength) may be sensitive and specific to deficits once symptoms resolve in youth athletes. More work is needed prior to clinical implementation of a preinjury (baseline) to postinjury multimodal approach to assessment following concussion in youth athletes.	[Toong, Tiffany; Hunt, Anne W.; Scratch, Shannon; Reed, Nick] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Toong, Tiffany; Wilson, Katherine E.; Hunt, Anne W.; Scratch, Shannon; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Hunt, Anne W.; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON, Canada; [Scratch, Shannon] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada		Reed, N (corresponding author), Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada.; Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.; Reed, N (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON, Canada.	nick.reed@utoronto.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [127048]; Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario government	This work was funded by the Canadian Institutes of Health Research (no. 127048), the Ontario Neurotrauma Foundation, and the Ontario Brain Institute. The Ontario Brain Institute is an independent nonprofit corporation, funded partially by the Ontario government. The opinions, results, and conclusions are those of the authors, and no endorsement by the Ontario Brain Institute is intended or should be inferred. We would also like to acknowledge the efforts of the members of the Canadian Institutes of Health Research (CIHR) "NeuroCare" Team and the members of the Concussion Centre (Bloorview Research Institute), specifically Talia Dick, James Murphy, Lee Verweel, and Katherine Mah. There is no conflict of interest to declare.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bianco A, 2015, INT J OCCUP MED ENV, V28, P445, DOI 10.13075/ijomeh.1896.00393; Biodex Medical Systems Inc, BIOSWAY PORT BAL SYS BIOSWAY PORT BAL SYS, V6339; Bressan S, 2016, J PAEDIATR CHILD H, V52, P151, DOI 10.1111/jpc.12967; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Evans Teresa M, 2014, Transl Proteom, V3, P10; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fernandez-Santos JR, 2015, J STRENGTH COND RES, V29, P2277, DOI 10.1519/JSC.0000000000000864; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1570, DOI 10.1212/01.CON.0000458973.71142.7d; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, CLIN J SPORT MED, P1; ImPACT Applications Inc, 2002, IMPACT VERS 2 1 CLIN IMPACT VERS 2 1 CLIN; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kriz PK, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117737307; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lemeshow S, 2000, APPL LOGISTIC REGRES; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nelson LD, 2015, J ATHL TRAINING, V50, P1319, DOI 10.4085/1062-6050-51.1.09; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; R Foundation for statistical computing, 2013, R LANG ENV STAT COMP; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reed N, 2016, INT J SPORTS MED, V37, P708, DOI 10.1055/s-0042-104199; Reed N, 2014, J VIS EXP, P1; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Servatius RJ, 2018, J NEUROTRAUM, V35, P1008, DOI 10.1089/neu.2017.5314; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	63	0	0	1	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	AUG	2021	30	6					850	859		10.1123/jsr.2020-0279			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TM8VK	WOS:000675824200003	33547256				2022-02-07	
J	Trbovich, AM; Howie, EK; Elbin, RJ; Ernst, N; Stephenson, K; Collins, MW; Kontos, AP				Trbovich, Alicia M.; Howie, Erin K.; Elbin, R. J.; Ernst, Nathan; Stephenson, Katie; Collins, Michael W.; Kontos, Anthony P.			The relationship between accelerometer-measured sleep and next day ecological momentary assessment symptom report during sport-related concussion recovery	SLEEP HEALTH			English	Article						Sport-related concussion; Actigraphy; Ecological momentary assessment; Sleep; Symptoms	PHYSICAL-ACTIVITY; BASE-LINE; ADOLESCENTS; PERFORMANCE; DISTURBANCE; PATTERNS; CHILDREN; DURATION; NEED	Objectives: Research examining sleep and concussion symptoms following sport-related concussion (SRC) is limited by retrospective self-report rather than objective data from wearable technology and real-time symptom report. The purpose of this study is to use actigraphy and ecological momentary assessment (EMA) to examine the relationship between sleep parameters and next day symptoms. Methods: Seventeen athletes (47.1%F) aged 12-19 (15.35+/-2.09) years (<72 hours post-SRC) wore Actigraph GT3x + to measure nighttime sleep and completed post-concussion symptom scales (PCSS) three times via mobile EMA, resulting in a range of 91-177 observations for each outcome. Generalized linear mixed models, utilizing independent variables of sleep efficiency (SE%: ratio of awake time to sleep time) and total sleep time (TST) examined the associations between nightly sleep and symptoms next-day and throughout recovery. Results: SE% (IRR .97, 95%CI: .95, .99, P= .009) and TST (IRR .91, 95%CI: .84, .999, P = .047) were negatively associated with next day night symptoms. The negative relationship between SE% and the cognitive-migraine-fatigue (CMF) factor was significant for next day/night symptoms (P = .01), while TST was associated with symptom severity for the affective symptom factor (P = .015). Sleep was negatively associated with total symptoms and afternoon symptoms in Week 1 and total, morning, afternoon, and night symptoms in Week 2 (ps=.001-.021) of recovery. Conclusion: Sleep was negatively associated with symptoms the next day, especially late in the day and among CMF and emotional symptoms. The relationship between sleep and symptom burden was strongest in the subacute stage of concussion recovery, highlighting the potential importance of sleep intervention post-injury. (c) 2021 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.	[Trbovich, Alicia M.; Ernst, Nathan; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthoped Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Howie, Erin K.; Elbin, R. J.; Stephenson, Katie] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR USA		Trbovich, AM (corresponding author), Univ Pittsburgh, 3200 S Water St, Pittsburgh, PA 15203 USA.	trbovicham@upmc.edu		Trbovich, Alicia/0000-0003-4539-7120; Stephenson, Katie/0000-0002-4590-8122	Steven Manners Faculty Develop-ment Award	This study was funded by the Steven Manners Faculty Develop-ment Award.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Aguggia M, 2011, NEUROL SCI, V32, pS51, DOI 10.1007/s10072-011-0524-5; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Conley S, 2019, SLEEP MED REV, V46, P151, DOI 10.1016/j.smrv.2019.05.001; Depp CA, 2010, J NERV MENT DIS, V198, P715, DOI 10.1097/NMD.0b013e3181f49ea3; Foundation NS, 2006, SLEEP AM POLL; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoffman NL, 2020, J NEUROTRAUM, V37, P1029, DOI 10.1089/neu.2019.6761; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Kasser SL, 2017, DISABIL HEALTH J, V10, P207, DOI 10.1016/j.dhjo.2016.10.006; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; MCCARLEY RW, 1982, AM J PSYCHIAT, V139, P565; Ozdalga E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1994; Paterson DH, 2007, APPL PHYSIOL NUTR ME, V32, pS69, DOI 10.1139/H07-111; Pires GN, 2016, SLEEP MED, V23, P109, DOI 10.1016/j.sleep.2016.07.019; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raven F, 2018, SLEEP MED REV, V39, P3, DOI 10.1016/j.smrv.2017.05.002; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Robbins ML, 2014, WILEY-BL HB BEHAV SC, P429; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sufrinko AM, 2019, J HEAD TRAUMA REHAB, V34, pE40, DOI 10.1097/HTR.0000000000000474; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Vgontzas A, 2018, HEADACHE, V58, P1030, DOI 10.1111/head.13358; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	41	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2352-7218	2352-7226		SLEEP HEALTH	Sleep Health	AUG	2021	7	4					519	525		10.1016/j.sleh.2021.03.006			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	UD0CL	WOS:000686885300018	33933377				2022-02-07	
J	Tutunjian, AM; Arabian, SS; Paolino, J; Wolfe, ES; Mahoney, EJ; Hojman, HM; Johnson, BP; Bugaev, N				Tutunjian, Alyssa M.; Arabian, Sandra S.; Paolino, Jacqueline; Wolfe, Elizabeth S.; Mahoney, Eric J.; Hojman, Horacio M.; Johnson, Benjamin P.; Bugaev, Nikolay			ABO blood groups do not predict progression of traumatic intracranial hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood group antigens; Von Willebrand factor; Intracranial hemorrhage; Traumatic; Brain injuries; Radiologic progression	INTRACEREBRAL HEMORRHAGE; RISK-FACTOR; POPULATION	ABO blood groups are associated with genetically predisposed variations in von Willebrand factor (VWF) resulting in higher risks of thrombotic events in non-O blood types and bleeding complications in blood type O. The role of ABO blood groups in progression of traumatic intracranial hemorrhage (TICH) is unknown. Given statistically lower VWF levels in blood type O in the general population, we hypothesized that blood type O patients have a higher risk of such progression. A retrospective review of adult trauma patients with isolated TICH admitted to a Level 1 trauma center over eight years was conducted. Patients were categorized with blood type O and non-O (types A, B, AB) delineation. The primary outcome was radiological progression of TICH during the first 24 h. Secondary outcomes included surgical intervention after follow-up computed tomography (CT), complications, days on mechanical ventilation (DMV), intensive care unit (ICU) length of stay (LOS), hospital LOS, and mortality. Of 949 patients, 432 (45.5%) had blood type O. When comparing O and non-O groups, no significant differences were found in gender, age, race, admission vital signs, Glasgow Coma Scale, coagulation profile, TICH type, or Injury Severity Score. No difference in TICH progression was found between O and non-O groups: 73 (17%) vs 80 (15%), respectively, p = 0.55. Blood type O mortality was 12 (3% vs. 23 (4%), p = 0.174). Rate of TICH surgical intervention after follow-up CT, DMV, complications, and ICU and hospital LOS did not differ. No association between ABO blood types and radiological progression of TICH was identified. (c) 2021 Elsevier Ltd. All rights reserved.	[Tutunjian, Alyssa M.] Tufts Univ, Sch Med, 145 Harrison Ave, Boston, MA 02111 USA; [Arabian, Sandra S.; Wolfe, Elizabeth S.; Mahoney, Eric J.; Hojman, Horacio M.; Johnson, Benjamin P.; Bugaev, Nikolay] Tufts Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 800 Washington St,4488, Boston, MA 02111 USA; [Paolino, Jacqueline] Tufts Med Ctr, Dept Surg, 800 Washington St, Boston, MA 02111 USA		Bugaev, N (corresponding author), Tufts Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 800 Washington St,4488, Boston, MA 02111 USA.	alyssa.tutunjian@tufts.edu; sarabian@tufts-medicalcenter.org; emahoney1@tuftsmedicalcenter.org; hhojman@tuftsmedicalcenter.org; bjohnson5@tuftsmedicalcenter.org; nbugaev@tuftsmedicalcenter.org	Bugaev, Nikolay/AAC-6963-2022		National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002544]	This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award UL1TR002544.	American College of Surgeons Committee on Trauma, 2014, ACS NTDB NAT TRAUM D; Bugaev N, 2014, NEUROCRIT CARE, V21, P58, DOI 10.1007/s12028-014-9957-z; Centers for Disease Control and Prevention National Center for Injury Prevention and Control., TBI REL EM DEP VIS H; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Dean L., 2005, BLOOD GROUPS RED CEL; Dentali F, 2013, J THROMB HAEMOST, V11, P187, DOI 10.1111/jth.12057; Dentali F, 2014, SEMIN THROMB HEMOST, V40, P49, DOI 10.1055/s-0033-1363460; Dentali F, 2013, SEMIN THROMB HEMOST, V39, P72, DOI 10.1055/s-0032-1329550; Dubinski D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204331; Franchini M, 2016, SEMIN THROMB HEMOST, V42, P112, DOI 10.1055/s-0035-1564832; Franchini Massimo, 2007, Thromb J, V5, P14; Hamsen U, 2019, ORTHOP REV, V11, P171, DOI 10.4081/or.2019.8214; He QG, 2019, J STROKE CEREBROVASC, V28, P2311, DOI 10.1016/j.jstrokecerebrovasdis.2019.05.022; Iturbe T, 1999, TRANSFUS SCI, V20, P17, DOI 10.1016/S0955-3886(98)00086-1; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Kahr MK, 2018, HAEMOPHILIA, V24, pE207, DOI 10.1111/hae.13537; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Muellner SK, 2011, THROMB HAEMOSTASIS, V105, P5, DOI 10.1160/TH10-08-0504; Ng I, 2019, J CLIN NEUROSCI, V60, P58, DOI 10.1016/j.jocn.2018.10.035; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; Powers AY, 2020, J NEUROSURG, V132, P552, DOI 10.3171/2018.11.JNS182199; Roh D, 2019, NEUROCRIT CARE, V31, P66, DOI 10.1007/s12028-018-0655-0; Schack A, 2019, TRANSFUSION, V59, P125, DOI 10.1111/trf.15067; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shpiner AC, 2019, J CLIN NEUROSCI, V59, P79, DOI 10.1016/j.jocn.2018.10.149; Sun GH, 2020, J CARDIOTHOR VASC AN, V34, P906, DOI 10.1053/j.jvca.2019.09.015; Takayama W, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2022-0	27	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2021	90						345	350		10.1016/j.jocn.2021.06.023			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XQ4VH	WOS:000731543700004	34275573				2022-02-07	
J	Tverdal, C; Andelic, N; Helseth, E; Brunborg, C; Ronning, P; Hellstrom, T; Roe, C; Aarhus, M				Tverdal, Cathrine; Andelic, Nada; Helseth, Eirik; Brunborg, Cathrine; Ronning, Pal; Hellstrom, Torgeir; Roe, Cecilie; Aarhus, Mads			In the Aftermath of Acute Hospitalization for Traumatic Brain Injury: Factors Associated with the Direct Pathway into Specialized Rehabilitation	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; rehabilitation; care pathway; predictors; trauma hospital	HEAD-INJURY; CONTINUOUS CHAIN; 1ST YEAR; OUTCOMES; CARE; AGE; EPIDEMIOLOGY; MULTICENTER; DISCHARGE; SCALE	Previous research has demonstrated that early initiation of rehabilitation and direct care pathways improve outcomes for patients with severe traumatic brain injury (TBI). Despite this knowledge, there is a concern that a number of patients are still not included in the direct care pathway. The study aim was to provide an updated overview of discharge to rehabilitation following acute care and identify factors associated with the direct pathway. We analyzed data from the Oslo TBI Registry-Neurosurgery over a five-year period (2015-2019) and included 1724 adults with intracranial injuries. We described the patient population and applied multivariable logistic regression to investigate factors associated with the probability of entering the direct pathway. In total, 289 patients followed the direct pathway. For patients with moderate-severe TBI, the proportion increased from 22% to 35% during the study period. Significant predictors were younger age, low preinjury comorbidities, moderate-severe TBI and disability due to TBI at the time of discharge. In patients aged 18-29 years, 53% followed the direct pathway, in contrast to 10% of patients aged 65-79 years (moderate-severe TBI). This study highlights the need for further emphasis on entering the direct pathway to rehabilitation, particularly for patients aged >64 years.	[Tverdal, Cathrine; Helseth, Eirik; Ronning, Pal; Aarhus, Mads] Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway; [Tverdal, Cathrine; Helseth, Eirik; Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, N-0318 Oslo, Norway; [Andelic, Nada; Hellstrom, Torgeir; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, N-0373 Oslo, Norway; [Brunborg, Cathrine] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, N-0317 Oslo, Norway		Tverdal, C (corresponding author), Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway.; Tverdal, C (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, N-0318 Oslo, Norway.; Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway.; Andelic, N (corresponding author), Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, N-0373 Oslo, Norway.	uxtvec@ous-hf.no; nadand@ous-hf.no; ehelseth@ous-hf.no; uxbruc@ous-hf.no; paroen@ous-hf.no; uxhetz@ous-hf.no; cecilie.roe@medisin.uio.no; madaar@ous-hf.no	Hellstrom, Torgeir/AAY-6043-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Tverdal, Cathrine/0000-0002-1094-3825			Andelic N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051035; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Borgen IMH, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.10.009; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Forslund MV, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010157; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hakkennes S, 2012, INT J REHABIL RES, V35, P323, DOI 10.1097/MRR.0b013e328355dd00; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jacob L, 2020, NEUROREHAB NEURAL RE, V34, P814, DOI 10.1177/1545968320946038; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Langhorne P, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub4; Longley V, 2019, CLIN REHABIL, V33, P304, DOI 10.1177/0269215518808000; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Norman A, 2020, HEALTH SOC CARE COMM, V28, P2037, DOI 10.1111/hsc.13015; Oyesanya TO, 2020, BRAIN INJURY, V34, P1222, DOI 10.1080/02699052.2020.1797172; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Skaansar O, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01943-6; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Tverdal C, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00269-8; Tverdal CB, 2018, J REHABIL MED, V50, P505, DOI 10.2340/16501977-2332; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403	41	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	AUG	2021	10	16							3577	10.3390/jcm10163577			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UG4FX	WOS:000689211500001	34441872	Green Published, gold			2022-02-07	
J	van Veelen, MJ; Maeder, MB				van Veelen, Michiel J.; Maeder, Monika Brodmann			Hypothermia in Trauma	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						hypothermia; trauma; hemorrhage; lethal triad; coagulation; traumatic brain injury; cardiac arrest; extracorporeal life support; ECLS; emergency preservation resuscitation	ACCIDENTAL HYPOTHERMIA; MODERATE HYPOTHERMIA; ENZYME-ACTIVITY; CARDIAC-ARREST; BRAIN-INJURY; COAGULOPATHY; BLOOD; RESUSCITATION; COAGULATION; PATIENT	Hypothermia in trauma patients is a common condition. It is aggravated by traumatic hemorrhage, which leads to hypovolemic shock. This hypovolemic shock results in a lethal triad of hypothermia, coagulopathy, and acidosis, leading to ongoing bleeding. Additionally, hypothermia in trauma patients can deepen through environmental exposure on the scene or during transport and medical procedures such as infusions and airway management. This vicious circle has a detrimental effect on the outcome of major trauma patients. This narrative review describes the main factors to consider in the co-existing condition of trauma and hypothermia from a prehospital and emergency medical perspective. Early prehospital recognition and staging of hypothermia are crucial to triage to proper care to improve survival. Treatment of hypothermia should start in an early stage, especially the prevention of further cooling in the prehospital setting and during the primary assessment. On the one hand, active rewarming is the treatment of choice of hypothermia-induced coagulation disorder in trauma patients; on the other hand, accidental or clinically induced hypothermia might improve outcomes by protecting against the effects of hypoperfusion and hypoxic injury in selected cases such as patients suffering from traumatic brain injury (TBI) or traumatic cardiac arrest.	[van Veelen, Michiel J.; Maeder, Monika Brodmann] Inst Mt Emergency Med, Eurac Res, I-39100 Bolzano, Italy; [Maeder, Monika Brodmann] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Maeder, Monika Brodmann] Bern Univ, CH-3010 Bern, Switzerland		van Veelen, MJ (corresponding author), Inst Mt Emergency Med, Eurac Res, I-39100 Bolzano, Italy.	michiel.vanveelen@eurac.edu; monika.brodmannmaeder@insel.ch					[Anonymous], 2014, CURR PROB SURG, V51, P417, DOI 10.1067/j.cpsurg.2014.07.004; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Blasco Marino R, 2021, INJURY, V26, pS0020; BOYAN CP, 1964, ANN SURG, V160, P282, DOI 10.1097/00000658-196408000-00016; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Darocha T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001086; Forristal C, 2020, PREHOSP EMERG CARE, V24, P15, DOI 10.1080/10903127.2019.1599474; Ireland S, 2011, RESUSCITATION, V82, P300, DOI 10.1016/j.resuscitation.2010.10.016; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kutcher ME, 2016, INT J SURG, V33, P209, DOI 10.1016/j.ijsu.2015.10.014; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Lehavi A, 2018, EMERG MED J, V35, P564, DOI 10.1136/emermed-2017-207112; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Lucchelli M., 2020, EMERG MED TRAUMA; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Maeder MB, 2018, CAN MED ASSOC J, V190, pE1263, DOI 10.1503/cmaj.70338; MAHAJAN SL, 1981, JAMA-J AM MED ASSOC, V245, P2517, DOI 10.1001/jama.245.24.2517; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Martini WZ, 2005, J TRAUMA, V58, P1002, DOI 10.1097/01.TA.0000156246.53383.9F; Mazur P, 2019, ANN CARDIOTHORAC SUR, V8, P137, DOI 10.21037/acs.2018.10.12; McCarty TR, 2021, PEDIATR EMERG CARE, V37, pE284, DOI 10.1097/PEC.0000000000001588; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Moffatt SE, 2013, EMERG MED J, V30, P989, DOI 10.1136/emermed-2012-201883; Mommsen P, 2013, INJURY, V44, P86, DOI 10.1016/j.injury.2011.10.013; Moore EE, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00264-3; Paal P, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0303-7; Paal P, 2013, INJURY, V44, P1665, DOI 10.1016/j.injury.2013.06.019; Pasquier M, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0636-0; Perlman R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1271-z; Ramaker AJDWR, 2009, BLOOD COAGUL FIBRIN, V20, P436, DOI 10.1097/MBC.0b013e32832dc327; REED RL, 1990, CIRC SHOCK, V32, P141; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rosli D, 2020, WORLD J SURG, V44, P4106, DOI 10.1007/s00268-020-05750-5; Rubiano AM, 2013, INJURY, V44, P1219, DOI 10.1016/j.injury.2012.11.026; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Soreide K, 2014, INJURY, V45, P647, DOI 10.1016/j.injury.2012.12.027; Spahn Donat R, 2004, Best Pract Res Clin Anaesthesiol, V18, P661, DOI 10.1016/j.bpa.2004.05.002; Strapazzon G, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0172-5; Strapazzon G, 2014, HIGH ALT MED BIOL, V15, P104, DOI 10.1089/ham.2014.1008; Sumann G, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00790-1; Ting DK, 2018, CAN MED ASSOC J, V190, pE718, DOI 10.1503/cmaj.180117; Trentzsch H, 2012, SHOCK, V37, P131, DOI 10.1097/SHK.0b013e318245f6b2; Tsuei BJ, 2004, INJURY, V35, P7, DOI 10.1016/S0020-1383(03)00309-7; Uleberg O, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0178-z; Wallner B, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00843; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wiles MD, 2017, ANAESTHESIA, V72, P1448, DOI 10.1111/anae.14042; Winkelmann M, 2019, EUR J TRAUMA EMERG S, V45, P255, DOI 10.1007/s00068-017-0897-0; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zafren K, 2014, WILD ENVIRON MED, V25, pS66, DOI 10.1016/j.wem.2014.10.010	60	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	AUG	2021	18	16							8719	10.3390/ijerph18168719			7	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	UI3UI	WOS:000690536200001	34444466	gold, Green Published			2022-02-07	
J	Walton, SR; Kranz, S; Malin, SK; Broshek, DK; Hertel, J; Resch, JE				Walton, Samuel Richard; Kranz, Sibylle; Malin, Steven Kenneth; Broshek, Donna K.; Hertel, Jay; Resch, Jacob Earl			Factors Associated With Energy Expenditure and Energy Balance in Acute Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; resting metabolic rate; sex differences; concussion history; symptom burden	NEUROCOGNITIVE PERFORMANCE; BRAIN INJURY; SYMPTOMS; CONSCIOUSNESS; METABOLISM; STATEMENT; RECOVERY	Context: Sport-related concussion (SRC) is characterized by a pathologic neurometabolic cascade that results in an increased intracranial energy demand and a decreased energy supply. Little is known about the whole-body energy-related effects of SRC. Objective: To examine factors associated with whole-body resting metabolic rate (RMR), total energy expenditure (TEE), energy consumption (EC), and energy balance (EBal) in student-athletes acutely after SRC and healthy matched control individuals. Design: Case-control study. Setting: University research laboratory. Patients or Other Participants: Student-athletes diagnosed with SRC (n = 28, 50% female, age = 18.4 +/- 1.8 years, body mass index [BMI] = 24.1 +/- 4.1 kg/m(2)) assessed -72 hours postinjury and a matched control group (n = 28, 50% female, age = 19.4 +/- 2.9 years, BMI = 24.7 +/- 4.78 kg/m(2)). Main Outcome Measure(s): Resting metabolic rate was measured via indirect calorimetry. Participants reported their physical activity and dietary intake for 3 days, which we used to estimate TEE and EC, respectively, and to calculate EBal (EC:TEE ratio). Resting metabolic rate, TEE, and EC were normalized to body mass. Group and group-by-sex comparisons were conducted for RMR.kg(-1), TEE.kg(-1), EC.kg(-1), and EBal using independent t tests with the a priori alpha = .05. Associations of age, sex, concussion history, BMI, and symptom burden with RMR.kg(-1) and EBal were explored with linear regression models. Results: Total energy expenditure.kg(-1) was lower (P < .01; mean difference 6 SD = -5.31 +/- 1.41 kcal.kg(-1)) and EBal was higher (P < .01; 0.28 +/- 0.10) in SRC participants than in control participants. Both sexes with SRC had lower TEE.kg(-1) than did the control participants (P values <= .04); females with SRC had higher EBal than controls (P = .01), but male groups did not differ. Higher RMR.kg(-1) was associated with history of concussion (adjusted R-2 = .10, beta = 0.65). Younger age (beta = -0.35), fewer concussions (beta = -0.35), lower BMI (beta = -0.32), greater symptom duration (beta = 1.50), and lower symptom severity (beta = -1.59) were associated with higher EBal (adjusted R-2 = .54). Conclusions: Total energy expenditure.kg(-1) and EBal appeared to be affected by acute SRC, despite no differences in RMR.kg(-1). Sex, concussion history, BMI, and symptom burden were associated with acute energy-related outcomes.	[Walton, Samuel Richard] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27516 USA; [Kranz, Sibylle; Hertel, Jay; Resch, Jacob Earl] Univ Virginia, Dept Kinesiol, Charlottesville, VA USA; [Malin, Steven Kenneth] Rutgers State Univ, New Brunswick, NJ USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Neurocognit Assessment Lab, Charlottesville, VA USA		Walton, SR (corresponding author), Univ N Carolina, 2207 Stallings Evans Sports Ctr,Campus Box 8700, Chapel Hill, NC 27516 USA.	srwalton@email.unc.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brooks GA., 2005, EXERCISE PHYSL HUMAN, V4th ed; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Capling L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121313; Cohen J, 1998, STAT POWER ANAL BEHA; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daniell B, 2020, TRANSL J AM COLL SPO, V5, DOI [10.1249/ TJX.0000000000000129, DOI 10.1249/TJX.0000000000000129]; ELIA M, 1992, ENERGY METABOLISM, P61; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Harris J.A., 1919, BIOMETRIC STUDY BASA; Heyward VH, 2010, ADV FITNESS ASSESSME, V6th, P231; Howell DR, 2019, CLIN J SPORT MED, V29, P391, DOI 10.1097/JSM.0000000000000629; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Mannino C, 2018, J NEUROSCI RES, V96, P696, DOI 10.1002/jnr.24097; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Morris RGM, 1999, BRAIN RES BULL, V50, P437, DOI 10.1016/S0361-9230(99)00182-3; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; TEASDALE G, 1974, LANCET, V2, P81; Teixeira V, 2018, NUTR DIET, V75, P219, DOI 10.1111/1747-0080.12401; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Walton SR, 2020, SPORTS HEALTH, V12, P382, DOI 10.1177/1941738120923869; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	33	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2021	56	8					860	868		10.4085/359-20			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TZ6NS	WOS:000684588100009	33150378	gold			2022-02-07	
J	Wang, G; Liang, XS; He, CJ; Zhou, YF; Chen, SH				Wang, Gang; Liang, Xiao-Song; He, Chen-Jun; Zhou, Yi-Fu; Chen, Si-Hua			Ability of serum annexin A1 to predict 6-month poor clinical outcome following aneurysmal subarachnoid hemorrhage	CLINICA CHIMICA ACTA			English	Article						Aneurysm; Subarachnoid hemorrhage; Annexin A1; Clinical outcome	EARLY BRAIN-INJURY; EXPRESSION; ISCHEMIA	Background: Annexin A1 might be neuroprotective and serum annexin A1 concentrations were markedly declined after severe traumatic brain injury. We determine dthe ability of serum annexin A1 to assess severity and predict prognosis after aneurysmal subarachnoid hemorrhage (aSAH). Methods: We included 157 aSAH patients and 157 healthy subjects. Serum annexin A1 measurements were measured. A poor outcome was designated as Glasgow outcome scale score of 1-3. Multivariate logistic regression analysis was applied to identify predictors of a poor 6-month outcome. Results: Serum annexin A1 concentrations were significantly lower in patients than in controls. Annexin A1 concentrations were strongly correlated with the World Federation of Neurological Surgeons scale (WFNS) score, Hunt-Hess score, Glasgow coma scale score and modified Fisher score. A total of 59 patients (37.6%) experienced a poor outcome. Serum annexin A1, WFNS score and modified Fisher score emerged as the 3 independent predictors for a poor outcome after aSAH. Under ROC curve analysis, serum annexin A1 had a fair accuracy to predict a poor outcome, AUC of serum annexin A1 concentration was equivalent to those of WFNS score and modified Fisher score and AUC of combination of the 3 factors significantly exceeded that of each one alone. Conclusions: Annexin A1 may be involved in the occurrence and progression of secondary brain injury after aSAH. Detection of serum annexin A1 may have certain ability for assessment of severity and prediction of long-term prognosis following aSAH.	[Wang, Gang] Zhejiang Univ, Sch Med, Shaoxing Hosp, Dept Neurosurg,Shaoxing Peoples Hosp, 568 North Zhongxing Rd, Shaoxing 312000, Zhejiang, Peoples R China; [Liang, Xiao-Song; He, Chen-Jun; Zhou, Yi-Fu; Chen, Si-Hua] Shaoxing Univ, Shaoxing Municipal Hosp, Dept Neurosurg, Affiliated Hosp, 999 South Zhongxing Rd, Shaoxing 312000, Zhejiang, Peoples R China		Liang, XS (corresponding author), Shaoxing Univ, Shaoxing Municipal Hosp, Dept Neurosurg, Affiliated Hosp, 999 South Zhongxing Rd, Shaoxing 312000, Zhejiang, Peoples R China.	lxsxzd@163.com					Aggarwal A, 2018, NEUROSURG REV, V41, P241, DOI 10.1007/s10143-017-0843-y; Al-Mufti F, 2017, WORLD NEUROSURG, V107, P148, DOI [10.1016/J.WNEU.2017.07.114, 10.1016/j.wneu.2017.07.114]; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Colamatteo A, 2019, J IMMUNOL, V203, P1753, DOI 10.4049/jimmunol.1801683; Coulibaly AP, 2020, NEUROTHERAPEUTICS, V17, P436, DOI 10.1007/s13311-019-00829-x; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Ding Y, 2020, J NEUROSCI RES, V98, P168, DOI 10.1002/jnr.24478; Fan W, CLIN CHIM ACTA, V517, P9; Fang YJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66160-0; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Gussenhoven R, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020137; JENNETT B, 1975, LANCET, V1, P480; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Luo ZZ, 2014, J NEUROIMMUNOL, V276, P24, DOI 10.1016/j.jneuroim.2014.07.013; McArthur S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0043-0; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petridis AK, 2017, DTSCH ARZTEBL INT, V114, P226, DOI 10.3238/arztebl.2017.0226; Rass V, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0990-3; Rouanet C, 2019, ARQ NEURO-PSIQUIAT, V77, P806, DOI [10.1590/0004-282X20190112, 10.1590/0004-282x20190112]; Wang Z, 2017, J CEREBR BLOOD F MET, V37, P2509, DOI 10.1177/0271678X16669513; Zhao JJ, 2020, EXP THER MED, V19, P1896, DOI 10.3892/etm.2019.8357	22	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2021	519						142	147		10.1016/j.cca.2021.04.020			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	SO8JO	WOS:000659221500022	33932407				2022-02-07	
J	Xie, QJ; Huang, W; Shen, L; Wang, MH; Liu, KF; Liu, F				Xie, Qi-Jun; Huang, Wu; Shen, Liang; Wang, Ming-Hai; Liu, Ke-Feng; Liu, Fang			Combination of Neutrophil-to-Lymphocyte Ratio and Admission Glasgow Coma Scale Score Is Independent Predictor of Clinical Outcome in Diffuse Axonal Injury	WORLD NEUROSURGERY			English	Article						6-Month outcome; Admission GCS score; Diffuse axonal injury; Inflammation; Neutrophil-to-lymphocyte ratio	PROGNOSTIC VALUE; MORTALITY; NEUROINFLAMMATION; GCS	BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is an independent predictor of clinical outcome of different diseases, such as acute ischemic stroke, intracerebral hemorrhage, malignant tumor, and traumatic brain injury. However, the prognostic value of NLR plus admission Glasgow Coma Scale score (NLR-GCS) is still unclear in patients with diffuse axonal injury (DAI). Therefore this study assessed the relationship between the NLR-GCS and 6-month outcome of DAI patients. METHODS: The clinical characteristics of DAI patients admitted to our department between January 2014 and January 2020 were retrospectively analyzed. The candidate risk factors were screened by using univariate analysis, and the independence of resultant risk factors was evaluated by the binary logistic regression analysis and least absolute shrinkage and selection operator regression analysis. The predictive value of NLR-GCS in an unfavorable outcome was assessed by the receiver operating characteristics curve analysis. RESULTS: A total of 93 DAI patients were included. Binary logistic regression analysis and least absolute shrinkage and selection operator regression analysis showed the level of NLR on admission was an independent risk factor of unfavorable outcomes in DAI patients. The ROC curve analysis showed that the predictive capacity of the combination of NLR and admission GCS score and combination of NLR and coma duration outperformed NLR, admission GCS score, and coma duration alone. CONCLUSIONS: The higher NLR level on admission is independently associated with unfavorable outcomes of DAI patients at 6 months. Furthermore, the combination of NLR and admission GCS score provides the superior predictive capacity to either NLR or GCS alone.	[Xie, Qi-Jun; Huang, Wu; Shen, Liang; Wang, Ming-Hai; Liu, Ke-Feng; Liu, Fang] Nanjing Med Univ, Dept Neurosurg, Affiliated Changzhou Peoples Hosp 2, Changzhou, Jiangsu, Peoples R China		Liu, F (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Changzhou Peoples Hosp 2, Changzhou, Jiangsu, Peoples R China.	czdoctorliu@hotmail.com			International Cooperation Program of Changzhou [CZ20200039]; Key Research and Development Program of Jiangsu Province [BE2019652]; 33300 Talent Project of Jiangsu Province [BRA2020151]	This work was supported by the International Cooperation Program of Changzhou (CZ20200039), the "33300 Talent Project of Jiangsu Province (BRA2020151) and the Key Research and Development Program of Jiangsu Province (BE2019652).	Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Vieira RDA, 2018, WORLD NEUROSURG, V109, P140, DOI 10.1016/j.wneu.2017.09.101; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Angkananard T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2703518; Berkovitch A, 2019, AM J CARDIOL, V123, P396, DOI 10.1016/j.amjcard.2018.10.036; Braun LH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102448; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; Engebretsen S, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0730-1; Faria SS, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.702; Vieira GFR, 2020, NEURORADIOLOGY, V62, P653, DOI 10.1007/s00234-020-02383-2; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frati A, 2017, INT J MOL SCI, P18; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Giede-Jeppe A, 2020, NEUROCRIT CARE, V33, P97, DOI 10.1007/s12028-019-00859-5; Giede-Jeppe A, 2017, CEREBROVASC DIS, V44, P26, DOI 10.1159/000468996; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Humble SS, 2018, J TRAUMA ACUTE CARE, V85, P155, DOI 10.1097/TA.0000000000001852; Iwai N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75745-8; Jang SH., 2020, DIAGNOSTICS BASEL, P10; JENNETT B, 1975, LANCET, V1, P480; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kimball R, 2020, CLIN NEUROL NEUROSUR, V193, DOI 10.1016/j.clineuro.2020.105772; Kochanek P.M., 2018, NAT REV NEUROL, V13, P171, DOI [10.1038/nrneurol.2017.13, DOI 10.1038/NRNEUROL.2017.13]; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Manda-Handzlik A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121477; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Munakomi S, 2020, ADV EXP MED BIOL, V1251, P19, DOI 10.1007/5584_2019_445; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Sabouri E, 2020, WORLD NEUROSURG, V140, P142, DOI 10.1016/j.wneu.2020.04.185; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Siwicka-Gieroba D, 2019, J CLIN MED, P8; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Soares HD, 1995, J NEUROSCI, V15, P8223; Tomita K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214381; Vaibhav K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8847; Vinal D, 2021, CLIN TRANSL ONCOL, V23, P1185, DOI 10.1007/s12094-020-02509-1; Wang F, 2018, NEUROTOX RES, V34, P347, DOI 10.1007/s12640-018-9890-6; Yu S, 2018, J NEUROL SCI, V387, P115, DOI 10.1016/j.jns.2018.02.002; Zhao JL, 2019, WORLD NEUROSURG; Zhong YH, 2021, NEUROCRIT CARE, V34, P465, DOI 10.1007/s12028-020-01043-w; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	53	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2021	152						E118	E127		10.1016/j.wneu.2021.05.060			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TS9LP	WOS:000679970700013	34033962	hybrid			2022-02-07	
J	Yang, LX; Wang, Y; Zhang, C; Chen, T; Cheng, HL				Yang, Lixiang; Wang, Yue; Zhang, Can; Chen, Tao; Cheng, Huilin			Perampanel, an AMPAR antagonist, alleviates experimental intracerebral hemorrhage-induced brain injury via necroptosis and neuroinflammation	MOLECULAR MEDICINE REPORTS			English	Article						perampanel; early brain injury; intracerebral hemorrhage; necroptosis; neuroinflammation	GLUTATHIONE DEPLETION; NEURONAL INJURY; PTEN; INFLAMMATION; PHOSPHATASE; CELLS; CHROMOSOME-10; ATORVASTATIN; ACTIVATION; MECHANISMS	Spontaneous intracerebral hemorrhage (ICH) is a subtype of stroke with high mortality and morbidity due to the lack of effective therapies. The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist perampanel has been reported to alleviate early brain injury following subarachnoid hemorrhage and traumatic brain injury by reducing reactive oxygen species, apoptosis, autophagy, and necroptosis. Necroptosis is a caspase-independent programmed cell death mechanism that serves a vital role in neuronal cell death following ICH. However, the precise role of necroptosis in perampanel-mediated neuroprotection following ICH has not been confirmed. The present study aimed to investigate the neuroprotective effects and potential molecular mechanisms of perampanel in ICH-induced early brain injury by regulating neural necroptosis in C57BL/6 mice and in a hemin-induced neuron damage cell culture model. Mortality, neurological score, brain water content, and neuronal death were evaluated. The results demonstrated that perampanel treatment increased the survival rate and neurological score, and increased neuron survival. In addition, perampanel treatment downregulated the protein expression levels of receptor interacting serine/threonine kinase (RIP) 1, RIP3, and mixed lineage kinase domain like pseudokinase, and of the cytokines IL-1 beta, IL-6, TNF-alpha, and NF-kappa B. These results indicated that perampanel-mediated inhibition of necroptosis and neuroinflammation ameliorated neuronal death in vitro and in vivo following ICH. The neuroprotective capacity of perampanel was partly dependent on the PTEN pathway. Taken together, the results of the present study demonstrated that perampanel improved neurological outcomes in mice and reduced neuronal death by protecting against neural necroptosis and neuroinflammation.	[Yang, Lixiang; Cheng, Huilin] Southeast Univ, Sch Med, Zhongda Hosp, Dept Neurosurg, 87 Dingjia Bridge Rd, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Yue; Chen, Tao] Anhui Med Univ, Wuxi Clin Coll, 904th Hosp Joint Logist Support Force PLA, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China; [Zhang, Can] Second Peoples Hosp Hefei, Dept Neurosurg, Hefei 230011, Anhui, Peoples R China		Cheng, HL (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Neurosurg, 87 Dingjia Bridge Rd, Nanjing 210009, Jiangsu, Peoples R China.	dnuchl123@163.com					Adeoye O, 2010, NAT REV NEUROL, V6, P593, DOI 10.1038/nrneurol.2010.146; Aida V, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113222; Bao WD, 2020, AGING CELL, V19, DOI 10.1111/acel.13235; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Chen AQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1716-9; Chen JH, 2020, NEURAL REGEN RES, V15, P1947, DOI 10.4103/1673-5374.280326; Chen JH, 2018, MOL MED REP, V17, P1651, DOI 10.3892/mmr.2017.8074; Chen JH, 2016, INT J MOL MED, V37, P1059, DOI 10.3892/ijmm.2016.2506; Chen JH, 2021, J CELL PHYSIOL, V236, P6920, DOI 10.1002/jcp.30351; Chen JH, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00110; Chen JH, 2019, J CELL MOL MED, V23, P2256, DOI 10.1111/jcmm.14105; Chen SP, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01853-x; Chen T., 2020, CNS NEUROL DISORD-DR; Chen T, 2021, CNS NEUROSCI THER, V27, P134, DOI 10.1111/cns.13580; Chen T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2198-5; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chu X, 2018, STROKE, V49, P2473, DOI 10.1161/STROKEAHA.117.019253; De Caro C, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.620221; Deng SX, 2020, NEUROTHERAPEUTICS, V17, P1940, DOI 10.1007/s13311-020-00908-4; Dohare P, 2016, J NEUROSCI, V36, P3363, DOI 10.1523/JNEUROSCI.4329-15.2016; Gao X, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2530-0; Gautam J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01788-3; Gross BA, 2019, JAMA-J AM MED ASSOC, V321, P1295, DOI 10.1001/jama.2019.2413; Guido C, 2012, CELL CYCLE, V11, P2911, DOI 10.4161/cc.21336; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Huang HJ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920522; Huang SY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0280-1; Karuppagounder SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac6008; Kim JE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165643; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Liao WP, 2021, CNS NEUROSCI THER, V27, P330, DOI 10.1111/cns.13458; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu LL, 2021, BIOL TRACE ELEM RES, V199, P1584, DOI 10.1007/s12011-020-02563-4; Liu XF, 2018, CANCER SCI, V109, P1147, DOI 10.1111/cas.13541; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lule S, 2021, J CEREBR BLOOD F MET, V41, P1623, DOI 10.1177/0271678X20973609; Mazzocchetti P, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104848; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mo YS, 2021, NANOSCALE, V13, P3827, DOI 10.1039/d0nr06249a; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Tian Q, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1295382; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang KJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8840590; Wang LQ, 2020, J HAZARD MATER, V398, DOI 10.1016/j.jhazmat.2020.122905; Wang M, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02015-9; Wang T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-017-1039-7; Wright SK, 2020, ANN CLIN TRANSL NEUR, V7, P883, DOI 10.1002/acn3.51030; Wu X, 2020, TRANSL STROKE RES, V11, P924, DOI 10.1007/s12975-019-00768-x; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Xue MZ, 2020, LANCET NEUROL, V19, P1023, DOI 10.1016/S1474-4422(20)30364-1; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zhang Y, 2020, TRANSL STROKE RES, V11, P267, DOI 10.1007/s12975-019-00711-0; Zhang Y, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02770-w; Zhang ZX, 2020, TRANSL STROKE RES, V11, P789, DOI 10.1007/s12975-019-00754-3; Zhao D, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00281; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	58	0	0	3	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2021	24	2							544	10.3892/mmr.2021.12183			12	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	SQ1AS	WOS:000660093000001	34080030	hybrid, Green Published			2022-02-07	
J	Yengo-Kahn, AM; Reynolds, RA; Bonfield, CM				Yengo-Kahn, Aaron M.; Reynolds, Rebecca A.; Bonfield, Christopher M.			Mild Traumatic Brain Injury in Children	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Pediatric; mTBI; Concussion; Sport-related concussion; Return-to-play; Return-to-learn	POST-CONCUSSION SYNDROME; EMERGENCY-DEPARTMENT VISITS; SPORTS-RELATED CONCUSSION; VESTIBULAR REHABILITATION; POSTCONCUSSION SYNDROME; NUTRITIONAL SUPPLEMENTS; RECOVERY TRAJECTORIES; UNITED-STATES; SYMPTOMS; DISORDERS		[Yengo-Kahn, Aaron M.; Reynolds, Rebecca A.; Bonfield, Christopher M.] Vanderbilt Univ, Dept Neurosurg, Med Ctr, Med Ctr North, Suite T-4224,1161 21st Ave South, Nashville, TN 37232 USA		Bonfield, CM (corresponding author), Vanderbilt Univ, Dept Neurosurg, Med Ctr, Med Ctr North, Suite T-4224,1161 21st Ave South, Nashville, TN 37232 USA.	chris.bonfield@vumc.org					Ahluwalia R, 2020, SPORT RELATED TRAUMA, V1st; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2019, PERCENT DISTRIBUTION; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Barlow KM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-2812; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Cushman DM, 2019, HEADACHE, V59, P371, DOI 10.1111/head.13451; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DeMatteo C, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000667; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Esquivel AO, 2017, ANN BIOMED ENG, V45, P1581, DOI 10.1007/s10439-017-1809-5; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Legarreta AD, 2019, OPEN ACCESS J SPORTS, V10, P115, DOI 10.2147/OAJSM.S171815; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McLeod TCV, 2019, CLIN J SPORT MED, V29, P298, DOI 10.1097/JSM.0000000000000530; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mulroy MH, 2012, FORENSIC SCI INT, V214, P167, DOI 10.1016/j.forsciint.2011.07.050; Mummareddy N, 2020, CLIN J SPORT MED, V30, P451, DOI 10.1097/JSM.0000000000000626; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Pan J, 2018, J NEUROSURG-PEDIATR, V22, P158, DOI 10.3171/2018.2.PEDS17523; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seifert T, 2018, HAND CLINIC, V158, P119, DOI 10.1016/B978-0-444-63954-7.00012-4; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2019, J NEUROTRAUM, V36, P142, DOI 10.1089/neu.2017.5443; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Trojian TH, 2017, CURR SPORT MED REP, V16, P247, DOI 10.1249/JSR.0000000000000387; Ungprasert P, 2016, STROKE, V47, P356, DOI 10.1161/STROKEAHA.115.011678; Waltzman D, 2020, MMWR-MORBID MORTAL W, V69, P870, DOI 10.15585/mmwr.mm6927a4; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Young JY, 2016, EMERG RADIOL, V23, P325, DOI 10.1007/s10140-016-1392-3; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0909-4	95	0	0	3	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	AUG	2021	68	4					857	874		10.1016/j.pcl.2021.04.011			18	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	TL2OZ	WOS:000674696400014	34247714				2022-02-07	
J	Zeng, SY; Huang, YB; Zhong, T; Huang, T; Dong, XN; Zhu, HD; Ouyang, FL				Zeng, Shuying; Huang, Yubo; Zhong, Tao; Huang, Tao; Dong, Xianyan; Zhu, Huadong; Ouyang, Fulian			The expression and clinical value of ubiquitin carboxyl-terminal hydrolase L1 in the blood of neonates with hypoxic ischemic encephalopathy	TRANSLATIONAL PEDIATRICS			English	Article						Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1); hypoxic ischemic encephalopathy (HIE); newborn; clinical value	TRAUMATIC BRAIN-INJURY; UCH-L1; GFAP	Background: Neonatal hypoxic ischemic encephalopathy (HIE) can result in mental retardation due to the associated brain damage. Early identification of brain injury is vital for the prevention and treatment of brain damage in neonates. This study investigated the expression levels of serum ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) in neonates with HIE and its correlation with brain damage. Methods: From January 2019 to December 2020, 56 cases of neonatal patients with HIE were selected as the observation group, and 60 cases of healthy newborns delivered in our hospital during the same period were selected as the control group. Blood samples were obtained from neonates and the serum expression of UCH-L1 was detected by enzyme-linked immunosorbent assays (ELISAs). The relationship between UCH-L1 and neonatal prognosis and clinical features was analyzed. Results: Compared with the healthy control group, the serum levels of UCH-L1 in the observation group was significantly higher (2.28 +/- 1.21 vs. 0.81 +/- 0.39 ng/mL, P=0.000). Furthermore, at 6 hours after birth, the serum levels of UCH-LI were significantly higher in neonates with moderate to severe HIE compared to patients with mild HIE (2.92 +/- 0.80 and 1.76 +/- 0.72 ng/mL, respectively, P=0.000). Pearson correlation analysis showed that the expression levels of UCH-L1 were negatively correlated with the development quotient (DQ), intelligence index (MI), and the Neonatal Behavioral Neurological Assessment (NBNA) score of HIE newborns (P<0.05). Conclusions: The level of UCH-L1 protein expression is elevated in the serum of newborns with HIE, and this may have a certain clinical value in predicting the intelligence of children.	[Zeng, Shuying; Huang, Yubo; Zhong, Tao; Huang, Tao; Dong, Xianyan; Zhu, Huadong; Ouyang, Fulian] Ganzhou Peoples Hosp, Dept Pediat, Ganzhou 341000, Peoples R China		Ouyang, FL (corresponding author), Ganzhou Peoples Hosp, Dept Pediat, Ganzhou 341000, Peoples R China.	ouyangfulian0705@sina.com					Anderson TN, 2020, RESUSCITATION, V154, P110, DOI 10.1016/j.resuscitation.2020.07.002; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Dominguez-Dieppa F, 2021, MEDICC REV, V23, P30, DOI 10.37757/MR2021.V23.N1.7; Dukhovny D, 2017, ACTA PAEDIATR, V106, P1200, DOI 10.1111/apa.13781; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178049; Mir IN, 2019, PEDIATR RES, V86, P500, DOI 10.1038/s41390-019-0439-z; Morris MC, 2019, J SURG RES, V244, P63, DOI 10.1016/j.jss.2019.06.023; Mrozek S, 2019, BIOMARK INSIGHTS, V14, DOI 10.1177/1177271919851515; Ogawa Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00397; Palsdottir Kolbrun, 2007, Laeknabladid, V93, P595; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Ramezani F, 2018, EMERGENCY, V6; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Richard M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043635; Shahjouei S, 2018, BRAIN INJURY, V32, P1, DOI 10.1080/02699052.2017.1382717; Thorngren-Jerneck K, 2001, PEDIATR RES, V49, P495, DOI 10.1203/00006450-200104000-00010; Umran RMR, 2016, AM J PERINAT, V33, P640, DOI 10.1055/s-0036-1571319; Zaigham M, 2016, J MATERN-FETAL NEO M, V29, P1822, DOI 10.3109/14767058.2015.1064108	20	0	0	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-4336	2224-4344		TRANSL PEDIATR	Transl. Pediatr.	AUG	2021	10	8					2063	2068		10.21037/tp-21-327		AUG 2021	6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	UM5ZQ	WOS:000687719300001	34584876	Green Published, gold			2022-02-07	
J	Zynda, AJ; Petit, KM; Anderson, M; Tomczyk, CP; Covassin, T				Zynda, Aaron J.; Petit, Kyle M.; Anderson, Morgan; Tomczyk, Christopher P.; Covassin, Tracey			Removal From Activity After Sports-Related Concussion in Sex-Comparable Sports From the Michigan High School Athletic Association	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; removal from activity; adolescent; sex differences	STATES HIGH-SCHOOL; POSITION STATEMENT; GENDER-DIFFERENCES; INJURY; RATES; EPIDEMIOLOGY; MANAGEMENT; KNOWLEDGE; RISK; AGE	Background: Research has demonstrated that female athletes are more likely to report their sports-related concussion (SRC) symptoms compared with male athletes; however, it is unknown if these reporting behaviors correspond to immediate removal from activity in sex-comparable sports. Purpose: To compare the incidence of high school student-athletes removed and not removed from activity after SRC in sex-comparable sports in Michigan. Study Design: Descriptive epidemiology study. Methods: Participants included student-athletes diagnosed with SRC participating in Michigan High School Athletic Association-sponsored athletic activities (22 sex-comparable sports) between 2016 and 2019. All SRCs were recorded in the association's Head Injury Reporting System (HIRS) by certified athletic trainers, administrators, or coaches. Removal from activity indicated that the student-athlete was removed from play at the time of an injury event. If the student-athlete reported that his or her suspected injury event occurred earlier during activity or if symptom onset was delayed, "not removed from activity'' was entered into the HIRS. Incidence proportions were calculated by dividing SRCs not removed by total SRCs in each sport. Risk ratios were calculated by dividing the incidence proportions of girls not removed by boys not removed in each sport. Results: A total of 4418 (2773 female, 1645 male) SRCs were reported, with the most occurring in female soccer players (n = 1023). Overall, 515 girls and 243 boys were not removed from activity, resulting in incidences of 0.19 (95% CI, 0.17-0.20) and 0.15 (95% CI, 0.13-0.17), respectively. Across all sports, girls were 1.26 (95% CI, 1.09-1.45) times as likely to not be removed from activity compared with boys. Of the sports with the most SRCs-soccer, basketball, baseball/softball, and lacrosse-girls had 1.37 (95% CI, 1.09-1.72), 1.15 (95% CI, 0.89-1.47), 1.19 (95% CI, 0.77-1.84), and 1.35 (95% CI, 0.94-1.95) times the risk of not being removed, respectively. Conclusion: Girls were at greater risk of not being removed from activity compared with boys in sex-comparable sports. Results from this study should be incorporated into SRC education in Michigan and potentially elsewhere to inform affiliated personnel of potential sex differences and protect female student-athletes from further harm.	[Zynda, Aaron J.; Anderson, Morgan; Tomczyk, Christopher P.; Covassin, Tracey] Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA; [Petit, Kyle M.] Univ Mary, Bismarck, ND USA		Zynda, AJ (corresponding author), Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA.	zyndaaar@msu.edu	; Zynda, Aaron/P-5353-2018	Tomczyk, Christopher/0000-0003-3790-2385; Zynda, Aaron/0000-0003-0663-7320	Michigan High School Athletic Association (MHSAA)	The authors declared that they have no conflicts of interest in the authorship and publication of this contribution. This project was supported by the Michigan High School Athletic Association (MHSAA). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of the MHSAA. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bey T, 2009, WEST J EMERG MED, V10, P6; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2018, AM J SPORT MED, V46, P2270, DOI 10.1177/0363546518780225; Derose KP, 2001, J GEN INTERN MED, V16, P218, DOI 10.1046/j.1525-1497.2001.016004218.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Drummond JL, 2007, J ATHL TRAINING, V42, P106; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Esposito G, 1996, J NUCL MED, V37, P559; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Kahanov L, 2011, J ATHL TRAINING, V46, P424; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Olson A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00220; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zynda Aaron J, 2020, Int J Exerc Sci, V13, P87	42	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2021	49	10					2810	2816		10.1177/03635465211020007			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TY5RC	WOS:000683840500029	34181487				2022-02-07	
J	Chaudhary, S; Garg, V; Mishra, D; Yasam, R; Barik, S; Sinha, SK; Singh, V				Chaudhary, Sunny; Garg, Varun; Mishra, Dipun; Yasam, Ramapriya; Barik, Sitanshu; Sinha, Sourabh K.; Singh, Vivek			Risk Factors for Avascular Necrosis of the Femoral Head in Pediatric Femoral Neck Fractures	CUREUS			English	Article						open reduction; internal fixation; ratliff; delbet classification; screw; k-wire	HIP-FRACTURES; INTERNAL-FIXATION; OPEN REDUCTION; CHILDREN OPEN; ADOLESCENTS; FEMUR; OSTEONECROSIS	Introduction A neck of femur fracture is a rare injury in the pediatric population and is of foremost importance, as it is associated with a high rate of complications. It usually occurs due to high-velocity trauma or a fall from a height. There is a scarcity of data on risk factors and their role in the prognostication of avascular necrosis. The purpose of the study was to retrospectively analyze the association of various risk factors with avascular necrosis (AVN) of the femoral head in patients with a neck of femur fracture in the pediatric age group. Material and methods The study included 21 (13 males and 8 females) pediatric patients with a neck of femur fracture treated at a university-level hospital. The patients were followed for a minimum of one year and the clinico-radiological outcome was analyzed using Ratliff criteria. The association of AVN with age, gender, side, fracture type, and injury with treatment delay, type of reduction, and type of internal fixation used was studied. Results The mean age of the treated patients was 11 (+/- 3.178) years (range=5-16 years). Avascular necrosis was seen in four patients and coxa vara occurred in two of them. A statistically significant association was seen between the Delbet fracture type and avascular necrosis, and three out of four cases of AVN were a Type I fracture (p-value=0.006). Three out of six patients having concomitant skeletal or other organ injuries developed AVN (p-value=0.022). The rate of AVN was higher in patients who were managed after 48 hours of initial injury but no statistically significant correlation was found (p-value=0.314). No statistically significant association with AVN was found between gender, age, type of reduction (closed/open), or the implant used (cannulated screws/k-wires). Conclusions Multiple independent factors may have a role in the development of AVN of the femoral head in children. Prognostication should not be based on a single factor. Statistically significant results in this study have shown that the type of fracture and concomitant skeletal or other organ injuries are important risk factors and should be kept in mind. All independent risk factors must be noted and should be considered while prognosticating the outcome of a child with a neck of femur fracture.	[Chaudhary, Sunny; Garg, Varun; Mishra, Dipun; Yasam, Ramapriya; Barik, Sitanshu; Sinha, Sourabh K.; Singh, Vivek] All India Inst Med Sci, Orthopaed, Rishikesh, India		Singh, V (corresponding author), All India Inst Med Sci, Orthopaed, Rishikesh, India.	singhvr27@gmail.com		YASAM, RAMA PRIYA/0000-0002-3677-8610			AlKhatib N, 2019, INT ORTHOP, V43, P677, DOI 10.1007/s00264-018-3998-4; Azam MQ, 2009, INDIAN J ORTHOP, V43, P253, DOI 10.4103/0019-5413.53455; Bagatur AE, 2002, J PEDIATR ORTHOP B, V11, P219; Bali K, 2011, CLIN ORTHOP SURG, V3, P302, DOI 10.4055/cios.2011.3.4.302; Baysal O, 2016, J PEDIATR ORTHOP B, V25, P228, DOI 10.1097/BPB.0000000000000263; Bimmel R, 2010, ACTA ORTHOP BELG, V76, P7; Bombaci Hasan, 2006, Acta Orthop Traumatol Turc, V40, P6; Bukva B, 2015, INJURY, V46, pS44, DOI 10.1016/j.injury.2015.10.059; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P338; Dai ZZ, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01587-9; Dial BL, 2018, J ORTHOP, V15, P529, DOI 10.1016/j.jor.2018.03.039; Eberl R, 2010, ACTA ORTHOP, V81, P442, DOI 10.3109/17453674.2010.501744; Ju L, 2016, J PEDIATR ORTHOP B, V25, P459, DOI 10.1097/BPB.0000000000000339; Kay S P, 1971, Clin Orthop Relat Res, V80, P53, DOI 10.1097/00003086-197110000-00009; Kuo Feng-Chih, 2011, Chang Gung Med J, V34, P512; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Norton B, 2012, CURR ORTHOP PRACT, V23, P429, DOI 10.1097/BCO.0b013e318268561e; Palocaren T, 2018, INDIAN J ORTHOP, V52, P501, DOI 10.4103/ortho.IJOrtho_404_17; Patterson JT, 2018, J AM ACAD ORTHOP SUR, V26, P411, DOI 10.5435/JAAOS-D-16-00362; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Sankar WN, 2019, J ORTHOP TRAUMA, V33, pS22, DOI 10.1097/BOT.0000000000001541; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; Song KS, 2010, J BONE JOINT SURG BR, V92B, P1148, DOI 10.1302/0301-620X.92B8.24482; Spence D, 2016, J PEDIATR ORTHOPED, V36, P111, DOI 10.1097/BPO.0000000000000424; Stone JD, 2015, ORTHOPEDICS, V38, pE983, DOI 10.3928/01477447-20151020-06; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161	30	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 31	2021	13	7							e16776	10.7759/cureus.16776			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UA3BO	WOS:000685037500006	34476143	Green Published, gold			2022-02-07	
J	Ilhan, C; Citirik, M; Uzel, MM; Bagli, S				Ilhan, Cagri; Citirik, Mehmet; Uzel, Mehmet M.; Bagli, Selim			Characteristics of work-related eye trauma in construction and manufacturing industries	CLINICAL AND EXPERIMENTAL OPTOMETRY			English	Article; Early Access						Construction; eye trauma; manufacturing; occupation; work	OCULAR TRAUMA; INJURIES; EPIDEMIOLOGY; POPULATION; REGION	Background The aim of this study was to compare demographic, epidemiological, and clinical characteristics of work-related eye trauma in workers in the construction and manufacturing industries. Methods Medical board disability reports of subjects who experienced work-related eye trauma were investigated in this retrospective comparative study. Subjects were separated into two groups - construction and manufacturing - and the demographic, epidemiologic, and clinical characteristics within the two groups were compared. Results The construction group included 138 eyes of 132 subjects and the manufacturing group included 82 eyes of 77 subjects. Demographic characteristics of the groups were similar (p > 0.05). The number of work-related eye trauma incidents was found as decreased during winter in construction (p < 0.001), but a similar trend was not found in manufacturing (p > 0.05). Head traumas as reason for work-related eye trauma (p < 0.001), and concomitant systemic diseases including bone fracture and traumatic brain injuries (p < 0.001 and p = 0.012) were significantly associated with eye trauma in manufacturing. Open globe injury was more common in construction (p = 0.046), and chemical injury was more common in manufacturing (p < 0.001). Retinal detachment was more prevalent in construction (p = 0.042). Hand motion or worse final visual acuity was more prevalent in manufacturing (p = 0.007) and the final visual acuity better than 6/60 was more prevalent in construction (p = 0.045). Conclusion Chemical injuries are more common in manufacturing, whereas open globe injuries and retinal detachments occur more frequently in construction. Permanent low vision and blindness are more commonly associated with work-related eye trauma in manufacturing.	[Ilhan, Cagri] Hatay Educ & Res Hosp, Dept Ophthalmol, 81 Adres Kodu, TR-20443644 Antakya, Turkey; [Citirik, Mehmet] Univ Hlth Sci, Ankara Ulucanlar Eye Educ & Res Hosp, Dept Ophthalmol, Ankara, Turkey; [Uzel, Mehmet M.] Balikesir Univ, Dept Ophthalmol, Balikesir, Turkey; [Bagli, Selim] Turkish Social Secur Inst, Ankara, Turkey		Ilhan, C (corresponding author), Hatay Educ & Res Hosp, Dept Ophthalmol, 81 Adres Kodu, TR-20443644 Antakya, Turkey.	cagriilhan@yahoo.com	UZEL, MEHMET MURAT/ABC-4549-2021; CITIRIK, Mehmet/A-1694-2018	UZEL, MEHMET MURAT/0000-0002-7420-8934; CITIRIK, Mehmet/0000-0002-0558-5576			AlMahmoud T, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016083; [Anonymous], REGULATION USE PERSO; Cai MM, 2015, INT J ENV RES PUB HE, V12, P9864, DOI 10.3390/ijerph120809864; Cakmak SS, 2004, PUBLIC HEALTH, V118, P570, DOI 10.1016/j.puhe.2003.12.018; Fiebai B, 2011, CLIN OPHTHALMOL, V5, P1261, DOI 10.2147/OPTH.S20297; Forrest KYZ, 2009, OPHTHAL EPIDEMIOL, V16, P156, DOI 10.1080/09286580902738175; Gordon JJ., 1993, EPIDEMIOLOGY EYE DIS, V1st, P278; Ho CK, 2007, KAOHSIUNG J MED SCI, V23, P463, DOI 10.1016/S1607-551X(08)70054-8; Ho CK, 2008, KAOHSIUNG J MED SCI, V24, P10, DOI 10.1016/S1607-551X(08)70067-6; Jovanovic N, 2016, INT J OCCUP ENV HEAL, V22, P325, DOI 10.1080/10773525.2016.1243081; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Lubis Rodiah Rahmawaty, 2018, Open Access Maced J Med Sci, V6, P2119, DOI 10.3889/oamjms.2018.441; Mansouri MR, 2010, EUR J OPHTHALMOL, V20, P770, DOI 10.1177/112067211002000420; Mansouri M, 2009, RETINA-J RET VIT DIS, V29, P1141, DOI 10.1097/IAE.0b013e3181a395ac; McCall BP, 2009, INJURY PREV, V15, P176, DOI 10.1136/ip.2008.020024; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; Negrel AD., 1997, J COMMUN EYE HLTH, V10, P49; Ngo CS, 2008, SINGAP MED J, V49, P280; Omar R, 2014, Malays Fam Physician, V9, P27; Peate WF, 2007, AM FAM PHYSICIAN, V75, P1017; Sahraravand A, 2017, ACTA OPHTHALMOL, V95, P288, DOI 10.1111/aos.13313; Serinken M, 2013, INDIAN J OPHTHALMOL, V61, P497, DOI 10.4103/0301-4738.119435; Stryjewski TP, 2014, OPHTHALMOLOGY, V121, P327, DOI 10.1016/j.ophtha.2013.06.045; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Vats S, 2008, INDIAN J OPHTHALMOL, V56, P313; Xiang HY, 2005, AM J IND MED, V48, P57, DOI 10.1002/ajim.20179; Yu TSI, 2004, OPHTHALMOLOGY, V111, P70, DOI 10.1016/j.ophtha.2003.05.018; Zhang X, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7694913	28	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0816-4622	1444-0938		CLIN EXP OPTOM	Clin. Exp. Optom.												10.1080/08164622.2021.1952842		JUL 2021	6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	TQ9WB	WOS:000678624800001	34320332				2022-02-07	
J	Walsh, HS; Fleming, J; Murillo, N				Walsh, Hayley S.; Fleming, Jennifer; Murillo, Narda			Cross-cultural adaptation, translation, and validation of a Spanish version of the Westmead Post-traumatic Amnesia Scale for use following a traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Memory; Learning; Behaviour; Orientation; Cognition	MENTAL STATUS QUESTIONNAIRE; MODERATE HEAD-INJURY; REHABILITATION; AGITATION; COGNITION; DURATION	Health professionals need linguistically and culturally correct tools with proven validity to effectively assess people in their native language. This study aimed to translate and validate the Westmead Post-traumatic Amnesia Scale (WPTAS) into a Spanish version to measure the progression and duration of post-traumatic amnesia (PTA) in Spanish-speaking populations. Seven native Spanish and English translators, 11 therapists and 15 people with a traumatic brain injury (TBI) and nine people with non-traumatic acquired brain injury participated in the forward-backward translation method to adapt the WPTAS. Participants with a TBI in PTA (n = 20), out of PTA (n = 21), and controls without cognitive impairment (n = 21) participated in the validation test phase by completing the WPTAS, Selective Reminding Test, Short Portable Metal Status Questionnaire, Digit Span, and Agitated Behaviour Scale. The translated version of the WPTAS produced consistent responses and appropriate errors (2%) among all pre-test participants. Results from the validation phase showed that participants in PTA scored significantly lower in all tests (p < .05) when compared with those out of PTA and controls. The Spanish version of the WPTAS created and tested in this study is culturally and linguistically appropriate as well as valid for use with Spanish speakers.	[Walsh, Hayley S.; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Murillo, Narda] Univ Autonoma Barcelona, Fundacio Inst Guttmann, Neurorehabil Univ Inst, Barcelona, Spain		Walsh, HS (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	hayley.walsh@uq.net.au		Fleming, Jennifer/0000-0002-5603-2410	National Health and Medical Research Council, Moving Ahead Centre of Research Excellence in Brain Recovery, Australia	Hayley Walsh was supported by a seed grant from the National Health and Medical Research Council, Moving Ahead Centre of Research Excellence in Brain Recovery, Australia.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; de la Iglesia JM, 2001, MED CLIN-BARCELONA, V117, P129; Fleming J, 1999, BRAIN INJURY, V13, P417; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Kiernan R.J., 2006, NEUROBEHAVIORAL COGN; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Moin P, 2011, INT J PREVENTIVE MED, V2, P82; Morales M, 2010, ARCH CLIN NEUROPSYCH, V25, P745, DOI 10.1093/arclin/acq076; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Ponsford J., 2018, NEUROPSYCHOL REHABIL, V30, P1; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silva Silvia Cristina Fürbringer e, 2007, Acta paul. enferm., V20, P24, DOI 10.1590/S0103-21002007000100005; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Uysal-Bozkir O, 2013, J CLIN EPIDEMIOL, V66, P608, DOI 10.1016/j.jclinepi.2012.12.004; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684	29	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1959351		JUL 2021	16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TS3XX	WOS:000679587400001	34325605				2022-02-07	
J	Aguiar, OMG; Radivojevic, O; Potvin, BM; Vakili, O; Robinovitch, SN				Aguiar, Olivia M. G.; Radivojevic, Olga; Potvin, Brigitte M.; Vakili, Omid; Robinovitch, Stephen N.			Effective stiffness, damping and mass of the body during laboratory simulations of shoulder checks in ice hockey	SPORTS BIOMECHANICS			English	Article; Early Access						Impact biomechanics; shoulder; stiffness; mass; sport; ice hockey	SYSTEMATIC VIDEO ANALYSIS; LEAGUE NHL; PAD DESIGN; IMPACT; INJURY; MENS; CONCUSSIONS; BIOMECHANICS; FORCES; RISK	Ice hockey is a fast-paced sport with a high incidence of collisions between players. Shoulder checks are especially common, accounting for a large portion of injuries including concussions. The forces generated during these collisions depend on the inertial and viscoelastic characteristics of the impacting bodies. Furthermore, the effect of shoulder pads in reducing peak force depends on the baseline (unpadded) properties of the shoulder. We conducted experiments with nine men's ice hockey players (aged 19-26) to measure their effective shoulder stiffness, damping and mass during the impact stage of a shoulder check. Participants delivered a style of check commonly observed in men's university ice hockey, involving lateral impact to the deltoid region, with the shoulder brought stationary by the collision. The effective stiffness and damping coefficient of the shoulder averaged 12.8 kN/m and 377 N-s/m at 550 N, and the effective mass averaged 47% of total body mass. The damping coefficient and stiffness increased with increasing force, but there was no significant difference in the damping coefficient above 350 N. Our results provide new evidence on the dynamics of shoulder checks in ice hockey, as a starting point for designing test systems for evaluating and improving the protective value of shoulder pads.	[Aguiar, Olivia M. G.; Radivojevic, Olga; Potvin, Brigitte M.; Vakili, Omid; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada		Aguiar, OMG (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	oaguiar@sfu.ca		Aguiar, Olivia/0000-0001-9131-9049; Robinovitch, Stephen/0000-0003-3881-6227	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [643549, RGPIN/04065]; Undergraduate Student Research Award; Simon Fraser University under the Dean's Graduate Entrance Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) under Grant 643549 to OMGA, Grant RGPIN/04065 to SNR, and an Undergraduate Student Research Award to OR. OMGA was also supported by Simon Fraser University under the Dean's Graduate Entrance Scholarship.	Agel J, 2010, CAN J SURG, V53, P319; Aguiar OMG, 2020, J BIOMECH, V108, DOI 10.1016/j.jbiomech.2020.109882; BENNETT MB, 1990, J ANAT, V171, P131; Bolte J H 4th, 2000, Stapp Car Crash J, V44, P261; Compigne Sabine, 2004, Stapp Car Crash J, V48, P89; Davidson PL, 2005, J APPL BIOMECH, V21, P115, DOI 10.1123/jab.21.2.115; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Hughes A., 2020, DEV SILICONE ELASTOM, V49, P77, DOI [10.3390/proceedings2020049077, DOI 10.3390/PROCEEDINGS2020049077]; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M, 2014, AM SOC TEST MATER, V1552, P142, DOI 10.1520/STP155220120150; Lynall RC, 2018, J ATHL TRAINING, V53, P938, DOI 10.4085/1062-6050-173-17; Melvin PR, 2018, AM J SPORT MED, V46, P2521, DOI 10.1177/0363546518781338; Mertz H.J., 1984, SAE TECHNICAL PAPER, DOI [10.4271/840884, DOI 10.4271/840884]; Nikooyan AA, 2011, P I MECH ENG H, V225, P1121, DOI 10.1177/0954411911424210; Ono K., 2005, INT RES COUNCIL BIOM; Pauelsen M, 2017, CLIN J SPORT MED, V27, P283, DOI 10.1097/JSM.0000000000000347; Payne T, 2014, PROCEDIA ENGINEER, V72, P533, DOI 10.1016/j.proeng.2014.06.092; Payne Thomas, 2013, Critical Reviews in Biomedical Engineering, V41, P51; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Potvin BM, 2019, J BIOMECH, V91, P43, DOI 10.1016/j.jbiomech.2019.05.002; Richards D, 2016, SPORT BIOMECH, V15, P385, DOI 10.1080/14763141.2016.1163414; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Robinovitch SN, 1997, ANN BIOMED ENG, V25, P499, DOI 10.1007/BF02684190; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Seminati E, 2017, SPORT BIOMECH, V16, P58, DOI 10.1080/14763141.2016.1194453; Tator CH, 2016, CLIN J SPORT MED, V26, P232, DOI 10.1097/JSM.0000000000000232; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Virani S, 2017, MED SCI SPORT EXER, V49, P573, DOI 10.1249/MSS.0000000000001136	32	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2021.1951828		JUL 2021	12	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	TQ6RD	WOS:000678405600001	34319214				2022-02-07	
J	Cai, GX; Zhang, XN; Ou, QT; Zhou, Y; Huang, LQ; Chen, SL; Zeng, HK; Jiang, WQ; Wen, MY				Cai, Gengxin; Zhang, Xiunong; Ou, Qitian; Zhou, Yuan; Huang, Linqiang; Chen, Shenglong; Zeng, Hongke; Jiang, Wenqiang; Wen, Miaoyun			Optimal Targets of the First 24-h Partial Pressure of Carbon Dioxide in Patients with Cerebral Injury: Data from the MIMIC-III and IV Database	NEUROCRITICAL CARE			English	Article; Early Access						PaCO2; Craniocerebral diseases; Subarachnoid hemorrhage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; CARDIAC-ARREST; HYPERVENTILATION; HYPERCAPNIA; ASSOCIATION; VENTILATION; HYPOCAPNIA; ACIDOSIS; OUTCOMES	Background It is generally believed that hypercapnia and hypocapnia will cause secondary injury to patients with craniocerebral diseases, but a small number of studies have shown that they may have potential benefits. We assessed the impact of partial pressure of arterial carbon dioxide (PaCO2) on in-hospital mortality of patients with craniocerebral diseases. The hypothesis of this research was that there is a nonlinear correlation between PaCO2 and in-hospital mortality in patients with craniocerebral diseases and that mortality rate is the lowest when PaCO2 is in a normal range. Methods We identified patients with craniocerebral diseases from Medical Information Mart for Intensive Care third and fourth edition databases. Cox regression analysis and restricted cubic splines were used to examine the association between PaCO2 and in-hospital mortality. Results Nine thousand six hundred and sixty patients were identified. A U-shaped association was found between the first 24-h PaCO2 and in-hospital mortality in all participants. The nadir for in-hospital mortality risk was estimated to be at 39.5 mm Hg (p for nonlinearity < 0.001). In the subsequent subgroup analysis, similar results were found in patients with traumatic brain injury, metabolic or toxic encephalopathy, subarachnoid hemorrhage, cerebral infarction, and other encephalopathies. Besides, the mortality risk reached a nadir at PaCO2 in the range of 35-45 mm Hg. The restricted cubic splines showed a U-shaped association between the first 24-h PaCO2 and in-hospital mortality in patients with other intracerebral hemorrhage and cerebral tumor. Nonetheless, nonlinearity tests were not statistically significant. In addition, Cox regression analysis showed that PaCO2 ranging 35-45 mm Hg had the lowest death risk in most patients. For patients with hypoxic-ischemic encephalopathy and intracranial infections, the first 24-h PaCO2 and in-hospital mortality did not seem to be correlated. Conclusions Both hypercapnia and hypocapnia are harmful to most patients with craniocerebral diseases. Keeping the first 24-h PaCO2 in the normal range (35-45 mm Hg) is associated with lower death risk.	[Cai, Gengxin; Wen, Miaoyun] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Xiunong; Ou, Qitian; Huang, Linqiang; Chen, Shenglong; Zeng, Hongke; Jiang, Wenqiang; Wen, Miaoyun] Guangdong Acad Med, Guangdong Prov Peoples Hosp, Dept Emergency & Crit Care Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Yuan] Southern Med Univ, Clin Med Coll 2, Guangzhou, Guangdong, Peoples R China; [Wen, Miaoyun] Southern Med Univ, Guangzhou, Peoples R China		Wen, MY (corresponding author), South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China.; Jiang, WQ; Wen, MY (corresponding author), Guangdong Acad Med, Guangdong Prov Peoples Hosp, Dept Emergency & Crit Care Med, Guangzhou, Guangdong, Peoples R China.; Wen, MY (corresponding author), Southern Med Univ, Guangzhou, Peoples R China.	wenjian8046@163.com; wenmiaoyun041105@163.com			GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province [KJ012019452]; Science and Technology Project of Guangzhou [201804010379]	This work was supported by GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province (KJ012019452) and the Science and Technology Project of Guangzhou (201804010379).	Godoy DA, 2021, J CRIT CARE, V61, P207, DOI 10.1016/j.jcrc.2020.10.028; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Dodds C, 1999, BRIT J ANAESTH, V82, P813, DOI 10.1093/bja/82.5.813; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Feigin VL, 2020, LANCET NEUROL, V19, P255, DOI 10.1016/S1474-4422(19)30411-9; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Gelb AW, 2008, ANESTH ANALG, V106, P585, DOI 10.1213/01.ane.0000295804.41688.8a; Godoy DA, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.573237; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; HARPER AM, 1965, J NEUROL NEUROSUR PS, V28, P449, DOI 10.1136/jnnp.28.5.449; Hextrum S, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117139; Hoiland RL, 2019, COMPR PHYSIOL, V9, P1101, DOI 10.1002/cphy.c180021; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Kilgannon JH, 2019, RESUSCITATION, V135, P212, DOI 10.1016/j.resuscitation.2018.11.015; Kofke WA, 2020, J NEUROSURG ANESTH, V32, P120, DOI 10.1097/ANA.0000000000000609; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marhong J, 2014, RESP CARE, V59, P1597, DOI 10.4187/respcare.03405; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; PALJARVI L, 1982, ACTA NEUROPATHOL, V58, P87, DOI 10.1007/BF00691646; Reiff T, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1603-0; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; Tiruvoipati R, 2018, JAMA NEUROL, V75, P818, DOI 10.1001/jamaneurol.2018.0123; van Hulst RA, 2002, INTENS CARE MED, V28, P68, DOI 10.1007/s00134-001-1157-6; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Westermaier T, 2016, NEUROCRIT CARE, V25, P205, DOI 10.1007/s12028-016-0246-x	34	0	0	6	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01312-2		JUL 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TS4VG	WOS:000679648100002	34331211				2022-02-07	
J	Sessoms, PH; Fraser, JJ; Bodell, DM; Haluch, KS; Markham, AE; Brookfield, JS; Jameson, J; Gottshall, KR				Sessoms, Pinata H.; Fraser, John J.; Bodell, Dawn M.; Haluch, Kathrine S.; Markham, Amanda E.; Brookfield, Jacob S.; Jameson, Jason; Gottshall, Kim R.			Clinical effectiveness of virtual reality versus conventional clinic-based vestibular physical therapy on balance and function in active duty service members. A pilot randomized controlled trial	VIRTUAL REALITY			English	Article; Early Access						Therapeutics; Data display; Craniocerebral trauma; Physical therapy modalities; Sensation disorders	REHABILITATION; DIZZINESS; PERFORMANCE; DEFICITS; INJURY; GAIT; INDIVIDUALS; CONCUSSION	Virtual reality (VR) may be useful during rehabilitation of service members with persistent vestibular impairment following concussion. Thirty-eight active duty US military service members with persistent balance impairment resulting from concussion were randomized into three groups [Conventional Vestibular Physical Therapy (CVPT, n = 13), Virtual Reality Vestibular Physical Therapy (VRVPT, n = 12), and Hybrid Virtual Reality and Conventional Vestibular Physical Therapy (HybridVPT, n = 13)] and were treated twice weekly for 6 weeks. Changes in clinical measures such as Activities-specific Balance Confidence (ABC) Scale, Dizziness Handicap Inventory (DHI), Functional Gait Assessment (FGA), and Sensory Organization Test (SOT) were assessed from pre-, mid-, and post-treatment scores. A significant main time effect was observed demonstrating clinical improvement over time (ABC: p < .001, eta(2)(p) = .54; DHI: p < .001, eta(2)(p) = .57; FGA: p < .001, eta(2)(p) = .74; SOT: p < .001, eta(2)(p) = .35). Both CVPT and HybridVPT groups demonstrated significant improvements in patient-reported confidence and function earlier in the treatment course (p < .005). FGA significantly and incrementally improved at each assessment time point in all treatment groups. The SOT significantly improved early in treatment in the CVPT group only and pre-to-post-treatment in the CVPT and VRVPT groups only. The HybridVPT group did not demonstrate any significant improvement with time in the instrumented SOT measure. In the comparison of pre-to-post-effects of VRVPT and HybridVPT effects compared to CVPT, there was no clear superiority or inferiority observed in either of the experimental treatments. This preliminary work shows initial efficacy of using VR-based therapy for concussed individuals allowing future work to personalize treatment that may improve adherence and engagement to therapy.	[Sessoms, Pinata H.; Fraser, John J.; Bodell, Dawn M.; Haluch, Kathrine S.; Markham, Amanda E.; Brookfield, Jacob S.; Jameson, Jason] Naval Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Fraser, John J.; Bodell, Dawn M.] Navy Med Readiness & Training Command, Phys Therapy Dept, 34800 Bob Wilson Dr, San Diego, CA 92134 USA; [Bodell, Dawn M.; Markham, Amanda E.; Brookfield, Jacob S.; Jameson, Jason; Gottshall, Kim R.] Leidos Inc, 4161 Campus Point Court, San Diego, CA 92121 USA; [Gottshall, Kim R.] Florida Ear & Balance Ctr, 410 Celebration Pl, Kissimmee, FL 34747 USA; [Haluch, Kathrine S.] Eagle Appl Sci, 1826 N Loop 1604 E 350, San Antonio, TX 78248 USA		Sessoms, PH (corresponding author), Naval Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	Pinata.H.Sessoms.civ@mail.mil	Fraser, John J./H-6714-2016	Fraser, John J./0000-0001-9697-3795	U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured Program [60818, N1703]	The authors are military members and employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C. 105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. 101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. This work was supported by the U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured Program under work unit no. 60818 and N1703. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol number NHRC.2011.0027.	Alahmari KA, 2014, IEEE T NEUR SYS REH, V22, P389, DOI 10.1109/TNSRE.2013.2294904; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Badke MB, 2005, ANN OTO RHINOL LARYN, V114, P48, DOI 10.1177/000348940511400109; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bergeron Mathieu, 2015, Adv Med, V2015, P916735, DOI 10.1155/2015/916735; Cawthorne T., 1944, J CHARTERED SOC PHYS, V3, P106; Chong SF, 2011, PROC SINGAP HEALTHC, V20, P236, DOI 10.1177/201010581102000314; Covassin T, 2015, CLIN SPORT MED, V34, P199, DOI 10.1016/j.csm.2014.12.004; Cuthbert JP, 2014, BRAIN INJURY, V28, P181, DOI 10.3109/02699052.2013.860475; Defense and Veterans Brain Injury Center, 2019, DOD NUMB TRAUM BRAIN; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Gerlanc D, 2015, BOOTES BOOTSTRAP EFF; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall Kim, 2005, Work, V24, P381; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00106; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Haluch K, 2020, FIGSHARE J CONTRIB, DOI [10.6084/m9.figshare.12456683.v1, DOI 10.6084/M9.FIGSHARE.12456683.V1]; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2003, OTOL NEUROTOL, V24, P633, DOI 10.1097/00129492-200307000-00017; HORAK FB, 1992, OTOLARYNG HEAD NECK, V106, P175, DOI 10.1177/019459989210600220; Howard MC, 2017, COMPUT HUM BEHAV, V70, P317, DOI 10.1016/j.chb.2017.01.013; Johnson CM, 2014, OTOLARYNG HEAD NECK, V150, P437, DOI 10.1177/0194599813515184; Kassambara Alboukadel, 2021, CRAN; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Newman Craig W., 1993, Seminars in Hearing, V14, P363, DOI 10.1055/s-0028-1085134; Pape MM, 2020, MIL MED, V185, P428, DOI 10.1093/milmed/usz265; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; R Core Team, 2020, R LANG ENV STAT COMP; R-Core, 2020, CRAN; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; SHEPARD NT, 1993, ANN OTO RHINOL LARYN, V102, P198, DOI 10.1177/000348949310200306; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Torchiano Marco, 2020, CRAN; Whitney SL, 2006, CYBERPSYCHOL BEHAV, V9, P152, DOI 10.1089/cpb.2006.9.152; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Whitney SL, 2015, CURR OPIN NEUROL, V28, P61, DOI 10.1097/WCO.0000000000000162; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	43	0	0	3	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1359-4338	1434-9957		VIRTUAL REAL-LONDON	Virtual Real.												10.1007/s10055-021-00546-x		JUL 2021	14	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Imaging Science & Photographic Technology	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Imaging Science & Photographic Technology	TS4YD	WOS:000679655600001		hybrid			2022-02-07	
J	Shapiro, JS; Takagi, M; Silk, T; Anderson, N; Clarke, C; Davis, GA; Hearps, SJC; Ignjatovic, V; Rausa, V; Seal, ML; Babl, FE; Anderson, V				Shapiro, Jesse S.; Takagi, Michael; Silk, Tim; Anderson, Nicholas; Clarke, Cathriona; Davis, Gavin A.; Hearps, Stephen J. C.; Ignjatovic, Vera; Rausa, Vanessa; Seal, Marc L.; Babl, Franz E.; Anderson, Vicki			No Evidence of a Difference in Susceptibility-Weighted Imaging Lesion Burden or Functional Network Connectivity between Children with Typical and Delayed Recovery Two Weeks Post-Concussion	JOURNAL OF NEUROTRAUMA			English	Article						mild traumatic brain injury; pediatric concussion; pediatric neuroimaging; persisting post-concussion symptoms; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; HEAD-INJURY; EPIDEMIOLOGY; SYMPTOMS; MRI	Susceptibility weighted imaging (SWI) and resting state functional magnetic resonance imaging have been highlighted as two novel neuroimaging modalities that have been underutilized when attempting to predict whether a child with concussion will recover normally or have a delayed recovery course. This study aimed to investigate whether there was a difference between children who recover normally from a concussion and children with delayed recovery in terms of SWI lesion burden and resting state network makeup. Forty-one children who presented to the emergency department of a tertiary level pediatric hospital with concussion participated in this study as a part of a larger prospective, longitudinal observational cohort study into concussion assessment and recovery. Children underwent neuroimaging 2 weeks post-injury and were classified as either normally recovering (n = 27), or delayed recovering (n = 14) based on their post-concussion symptoms at 2 weeks post-injury. No participants showed lesions detected using SWI; therefore, no group differences could be assessed. No between-group resting state network differences were uncovered using dual regression analysis. These findings, alongside previously published work, suggest that potential causes of delayed recovery from concussion may not be found using current neuroimaging paradigms.	[Shapiro, Jesse S.; Takagi, Michael; Silk, Tim; Anderson, Nicholas; Clarke, Cathriona; Davis, Gavin A.; Hearps, Stephen J. C.; Ignjatovic, Vera; Rausa, Vanessa; Seal, Marc L.; Babl, Franz E.; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Shapiro, Jesse S.; Takagi, Michael; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Silk, Tim; Ignjatovic, Vera; Seal, Marc L.; Babl, Franz E.; Anderson, Vicki] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Shapiro, Jesse S.; Takagi, Michael] Monash Univ, Monash Sch Psychol Sci, Melbourne, Vic, Australia; [Silk, Tim] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Takagi, M (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	michael.takagi@mcri.edu.au	Silk, Tim/K-4295-2019	Takagi, Michael/0000-0003-2903-7598; Silk, Tim/0000-0002-7290-512X	Royal Children's Hospital Foundation, Melbourne, Australia [2014370]; Clinical Sciences Theme, MCRI; Victorian Government's Operational Infrastructure Support Program; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; Royal Children's Hospital Research Foundation; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Melbourne Campus Clinician Scientist Fellowship; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	The study is funded by a project grant from Royal Children's Hospital Foundation, Melbourne, Australia (2014370). Near miss funding from the Clinical Sciences Theme, MCRI. Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant; Babl was funded by the Royal Children's Hospital Research Foundation, an NHMRC Practitioner Fellowship, and a Melbourne Campus Clinician Scientist Fellowship; and Anderson by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Choi JI, 2014, CHILD NERV SYST, V30, P1011, DOI 10.1007/s00381-013-2349-4; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Holmes SA, 2019, BRAIN INJURY, V33, P383, DOI 10.1080/02699052.2018.1552023; Iyer KK, 2020, J NEUROTRAUM, V37, P2647, DOI 10.1089/neu.2020.7200; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Khetani A, 2019, J NEUROTRAUM, V36, P3274, DOI 10.1089/neu.2018.6117; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morrison MA, 2018, NEUROIMAGE-CLIN, V20, P498, DOI 10.1016/j.nicl.2018.08.002; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rausa VC, 2020, NEUROSCI BIOBEHAV R, V118, P643, DOI 10.1016/j.neubiorev.2020.08.017; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Shapiro JS, 2020, J NEUROTRAUM, V37, P1300, DOI 10.1089/neu.2019.6768; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Takagi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022098; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	35	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2384	2390		10.1089/neu.2021.0069		JUL 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000680091700001	33823646				2022-02-07	
J	Youn, DH; Tran, NM; Kim, BJ; Kim, Y; Jeon, JP; Yoo, H				Youn, Dong Hyuk; Tran, Ngoc Minh; Kim, Bong Jun; Kim, Youngmi; Jeon, Jin Pyeong; Yoo, Hyojong			Shape effect of cerium oxide nanoparticles on mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							ENHANCED CATALYTIC-ACTIVITY; OXIDATIVE STRESS; CEO2 NANORODS; PROTECT; DISEASE	The catalytic performance and therapeutic effect of nanoparticles varies with shape. Here, we investigated and compared the therapeutic outcomes of ceria nanospheres (Ceria NSs) and ceria nanorods (Ceria NRs) in an in vivo study of mild traumatic brain injury (mTBI). In vivo TBI was induced in a mouse model of open head injury using a stereotaxic impactor. Outcomes including cytoprotective effects, cognitive function, and cerebral edema were investigated after retro-orbital injection of 11.6 mM of ceria nanoparticles. Ceria nanoparticles significantly reduced fluoro-jade B (FJB)-positive cells and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells, and restored mRNA levels of superoxide dismutase 1 (SOD1) and SOD2. They also decreased the cyclooxygenase-2 (COX-2) expression compared with the untreated control group. Comparing the two nanomaterials, Ceria NRs showed less stable and high-energy (100) and (110) planes, which increased the number of active sites. The Ce3+/Ce4+ molar ratio of Ceria NRs (0.40) was greater than that of Ceria NSs (0.27). Ceria NRs (0.059 +/- 0.021) appeared to exhibit better anti-inflammatory effect than Ceria NSs (0.133 +/- 0.024), but the effect was statistically insignificant (p=0.190). Ceria nanoparticles also improved cognitive impairment following mTBI compared with the control group, but the effect did not differ significantly according to the nanoshape. However, Ceria NRs (70.1 +/- 0.5%) significantly decreased brain water content compared with Ceria NSs (73.7 +/- 0.4%; p=0.0015), indicating a more effective reduction in brain edema (p=0.0015). Compared with Ceria NSs, the Ceria NRs are more effective in alleviating cerebral edema following in vivo mTBI.	[Youn, Dong Hyuk; Kim, Bong Jun; Kim, Youngmi; Jeon, Jin Pyeong] Hallym Univ, Inst New Frontier Res, Coll Med, Chunchon, South Korea; [Tran, Ngoc Minh; Yoo, Hyojong] Hanyang Univ, Dept Mat Sci & Chem Engn, Ansan 15588, Gyeonggi Do, South Korea; [Jeon, Jin Pyeong] Genet & Res Inc, Chunchon, South Korea; [Jeon, Jin Pyeong] Hallym Univ, Coll Med, Dept Neurosurg, 77 Sakju Ro, Chunchon 24253, South Korea		Jeon, JP (corresponding author), Hallym Univ, Inst New Frontier Res, Coll Med, Chunchon, South Korea.; Yoo, H (corresponding author), Hanyang Univ, Dept Mat Sci & Chem Engn, Ansan 15588, Gyeonggi Do, South Korea.; Jeon, JP (corresponding author), Genet & Res Inc, Chunchon, South Korea.; Jeon, JP (corresponding author), Hallym Univ, Coll Med, Dept Neurosurg, 77 Sakju Ro, Chunchon 24253, South Korea.	jjs6553@daum.net; hjhaha73@hanyang.ac.kr		Tran, Ngoc Minh/0000-0003-2116-6707	National Research Foundation of Korea - Ministry of Education [2020R1l1A3070726]; Hallym Research Fund; Ministry of Science and ICT, MSICT [NRF-2020R1A2C1004006]	This research was supported by the National Research Foundation of Korea funded by the Ministry of Education (2020R1l1A3070726), Hallym Research Fund, and the Ministry of Science and ICT, MSICT (NRF-2020R1A2C1004006).	Bae YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1180-y; Bailey ZS, 2020, J NEUROTRAUM, V37, P1452, DOI 10.1089/neu.2016.4644; Carlson K, 2009, ASSESSMENT TREATMENT; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Das S, 2013, NANOMEDICINE-UK, V8, P1483, DOI [10.2217/NNM.13.133, 10.2217/nnm.13.133]; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dowding JM, 2014, CELL DEATH DIFFER, V21, P1622, DOI 10.1038/cdd.2014.72; Dowding JM, 2013, ACS NANO, V7, P4855, DOI 10.1021/nn305872d; Fiorani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140387; Flynn Frederick G, 2010, Continuum (Minneap Minn), V16, P79, DOI 10.1212/01.CON.0000391454.15052.e4; Gao W, 2015, NANOSCALE, V7, P11686, DOI 10.1039/c5nr01846c; Heckman KL, 2013, ACS NANO, V7, P10582, DOI 10.1021/nn403743b; Kang T, 2020, COORDIN CHEM REV, V403, DOI 10.1016/j.ccr.2019.213092; Keep RF, 2012, TRANSL STROKE RES, V3, P263, DOI 10.1007/s12975-012-0152-2; Kim CK, 2012, ANGEW CHEM INT EDIT, V51, P11039, DOI 10.1002/anie.201203780; Li Y, 2015, NANOSCALE, V7, P16631, DOI 10.1039/c5nr02970h; Liu XW, 2009, J AM CHEM SOC, V131, P3140, DOI 10.1021/ja808433d; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Montini T, 2016, CHEM REV, V116, P5987, DOI 10.1021/acs.chemrev.5b00603; Pan CS, 2008, EUR J INORG CHEM, P2429, DOI 10.1002/ejic.200800047; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Rajeshkumar S., 2018, Biotechnology Reports, V17, P1, DOI 10.1016/j.btre.2017.11.008; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Riddle DR., 2007, BRAIN AGING MODELS M, DOI [10.1201/9781420005523, DOI 10.1201/9781420005523]; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rzigalinski BA, 2006, NANOMEDICINE-UK, V1, P399, DOI 10.2217/17435889.1.4.399; Rzigalinski BA, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1444; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Singh N, 2007, ANN NY ACAD SCI, V1122, P219, DOI 10.1196/annals.1403.015; Sun CW, 2012, ENERG ENVIRON SCI, V5, P8475, DOI 10.1039/c2ee22310d; Tana, 2009, CATAL TODAY, V148, P179, DOI 10.1016/j.cattod.2009.02.016; Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f; Torrente-Murciano L, 2013, APPL CATAL B-ENVIRON, V132, P116, DOI 10.1016/j.apcatb.2012.10.030; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Xie XW, 2009, NATURE, V458, P746, DOI 10.1038/nature07877; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhao YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03834-2; Zhou KB, 2005, J CATAL, V229, P206, DOI 10.1016/j.jcat.2004.11.004; Zhou KB, 2012, ANGEW CHEM INT EDIT, V51, P602, DOI 10.1002/anie.201102619	41	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 30	2021	11	1							15571	10.1038/s41598-021-95057-9			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX8GU	WOS:000683325900019	34330990	gold, Green Published			2022-02-07	
J	Brickell, TA; French, LM; Sullivan, JK; Varbedian, NV; Wright, MM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Wright, Megan M.; Lange, Rael T.			Unhealthy Family Functioning Is Associated With Health-Related Quality of Life Among Military Spouse Caregivers	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article; Early Access						military caregiver; family functioning; health-related quality of life; service member veteran; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; VETERANS; CHILDREN; MEMBERS; RISK	Clinical Impact Statement Close to one in two spouse caregivers assisting service members and veterans (SMVs) following traumatic brain injury reported unhealthy family functioning. Unhealthy family functioning was related to worse caregiver health-related quality of life (HRQOL), whereas healthy family functioning was associated with factors that may mitigate poor HRQOL. Despite increasing evidence of the burden of caregiving, military policy continues to mandate that family services may only be provided in support of the SMV treatment plan. Money spent on caregiver and family-focused programs might improve outcomes for military families and could be achieved at a relatively modest cost with focused goals. Objective: The current study examines health-related quality of life (HRQOL) and family functioning in a sample of spouse caregivers assisting post-9/11 service members and veterans (SMV) following traumatic brain injury (TBI). Method: Participants were 316 spouse (and partner) caregivers of SMVs following a mild, moderate, severe, or penetrating TBI. Caregivers completed the Family Assessment Device General Functioning subscale, 24 HRQOL questionnaires, and the Mayo-Portland Adaptability Inventory (4th ed.; MPAI-4). The sample was divided into two family functioning groups: Healthy Family Functioning (HFF; n = 162) and Unhealthy Family Functioning (UFF; n = 154). Scores on HRQOL measures that generate T scores using normative data were classified as "clinically elevated," using a cutoff of >60T. Results: Compared with the HFF group, caregivers in the UFF group reported worse scores on all HRQOL measures and worse SMV functional ability on the MPAI-4 Adjustment Index and Anxiety, Depression, and Irritability/Anger/Aggression items (all ps < .001, ds = .41-1.36). A significantly higher proportion of the UFF group had clinically elevated HRQOL scores compared with the HFF group on the majority of measures (Hs = .24-.75). When examining all HRQOL measures simultaneously, the UFF group consistently had a significantly higher cumulative percentage of clinically elevated scores compared with the HFF group (e.g., >= 5 clinically elevated scores: UFF = 53.9% vs. HFF = 22.2%; H = .68). Conclusions: Caring for a SMV following TBI with comorbid mental health problems may have negative implications for their family functioning and the caregiver's HRQOL. Family-centered interventions could be beneficial for military families experiencing distress following SMV TBI and mental health comorbidity.	[Brickell, Tracey A.; French, Louis M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Wright, Megan M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Traumat Brain Injury Ctr Excellence, Res Dept, Bethesda, MD 20889 USA; [Brickell, Tracey A.; Lange, Rael T.] Ctr Excellence Posttraumat Stress Disorder, Res Dept, Ottawa, ON, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Traumat Brain Injury Ctr Excellence, Gen Dynam Informat Technol, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@gdit.com		french, louis/0000-0002-9451-0604	Traumatic Brain Injury Center of Excellence, Walter Reed National Military Medical Center, Bethesda, Maryland, United States	This work is supported by the Traumatic Brain Injury Center of Excellence, Walter Reed National Military Medical Center, Bethesda, Maryland, United States.	Beks T, 2016, QUAL REP, V21, P645; Brickell TA, 2020, MIL PSYCHOL, V32, P341, DOI 10.1080/08995605.2020.1754149; Brickell TA, 2020, QUAL LIFE RES, V29, P2781, DOI 10.1007/s11136-020-02529-y; Brickell TA, 2020, REHABIL PSYCHOL, V65, P377, DOI 10.1037/rep0000306; Brickell TA, 2019, REHABIL PSYCHOL, V64, P366, DOI 10.1037/rep0000270; Campbell SB, 2018, CLIN PSYCHOL REV, V65, P152, DOI 10.1016/j.cpr.2018.08.003; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P323, DOI 10.1037/rep0000295; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cozza SJ, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P259, DOI 10.1007/978-1-4419-7064-0_13; Creech S.K., 2017, MILITARY BEHAV HLTH, V5, P374, DOI [10.1080/21635781.2017.1333062, DOI 10.1080/21635781.2017.1333062]; Department of Defense, 2019, 2018 DEM PROF MIL CO; Dursun S., 2016, ROLE MILITARY FAMILY, DOI [10.1007/978-3-319-21488-7_14, DOI 10.1007/978-3-319-21488-7_14]; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; HealthMeasures, 2020, PROMIS GEN LIF SAT C; Laifer LM, 2019, J CHILD FAM STUD, V28, P1843, DOI 10.1007/s10826-019-01405-9; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Madruga M, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010054; Makhija NJ, 2019, FAM J, V27, P404, DOI 10.1177/1066480719868700; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Peterson K., 2014, CARE MILITARY SERVIC, P225, DOI [10.1176/appi.books.9781585625161.sc12, DOI 10.1176/APPI.BOOKS.9781585625161.SC12]; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Ramchand R., 2014, HIDDEN HEROES AM MIL; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Smith VA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00122; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU, V2, DOI [10.1682/JRRD.2009.06.0076, DOI 10.1682/JRRD.2009.06.0076]; Wadsworth SM, 2016, AM J COMMUN PSYCHOL, V57, P190, DOI 10.1002/ajcp.12025; Winter L, 2017, BRAIN INJURY, V31, P493, DOI 10.1080/02699052.2017.1283534; Yambo TW, 2016, J NURS SCHOLARSHIP, V48, P543, DOI 10.1111/jnu.12237	40	0	0	2	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma												10.1037/tra0001055		JUL 2021	11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	XS7QH	WOS:000733098000001	34323566				2022-02-07	
J	Everitt, A; Root, B; Calnan, D; Manwaring, P; Bauer, D; Halter, R				Everitt, Alicia; Root, Brandon; Calnan, Daniel; Manwaring, Preston; Bauer, David; Halter, Ryan			A bioimpedance-based monitor for real-time detection and identification of secondary brain injury	SCIENTIFIC REPORTS			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; ISCHEMIC-STROKE; INTRACRANIAL HYPERTENSION; MANAGEMENT; HEMORRHAGE; PRESSURE; MODEL; EPIDEMIOLOGY; PREVENTION; DIAGNOSIS	Secondary brain injury impacts patient prognosis and can lead to long-term morbidity and mortality in cases of trauma. Continuous monitoring of secondary injury in acute clinical settings is primarily limited to intracranial pressure (ICP); however, ICP is unable to identify essential underlying etiologies of injury needed to guide treatment (e.g. immediate surgical intervention vs medical management). Here we show that a novel intracranial bioimpedance monitor (BIM) can detect onset of secondary injury, differentiate focal (e.g. hemorrhage) from global (e.g. edema) events, identify underlying etiology and provide localization of an intracranial mass effect. We found in an in vivo porcine model that the BIM detected changes in intracranial volume down to 0.38 mL, differentiated high impedance (e.g. ischemic) from low impedance (e.g. hemorrhagic) injuries (p<0.001), separated focal from global events (p<0.001) and provided coarse 'imaging' through localization of the mass effect. This work presents for the first time the full design, development, characterization and successful implementation of an intracranial bioimpedance monitor. This BIM technology could be further translated to clinical pathologies including but not limited to traumatic brain injury, intracerebral hemorrhage, stroke, hydrocephalus and post-surgical monitoring.	[Everitt, Alicia; Halter, Ryan] Dartmouth Coll, Thayer Sch Engn, HB 8000,14 Engn Dr, Hanover, NH 03755 USA; [Root, Brandon; Calnan, Daniel; Bauer, David; Halter, Ryan] Dartmouth Hitchcock Med Ctr, Neurol Surg, Lebanon, NH 03766 USA; [Manwaring, Preston] Rytek Med Inc, 16 Cavendish Ct, Lebanon, NH 03766 USA		Everitt, A (corresponding author), Dartmouth Coll, Thayer Sch Engn, HB 8000,14 Engn Dr, Hanover, NH 03755 USA.	alicia.c.everitt.th@dartmouth.edu			NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R41NS100313-01]; NHIRC-Granite State Technology Innovation Grant;  [NIBIB-T32 EB021966]	We would like to thank our veterinary staff Karen Moodie and Margaret Meacham for their invaluable contribution to this work and impeccable care of the animals. We would also like to acknowledge Michaela Whitty, Michael Pearl, Robert Ferranti Jr., Theresa Haron and Amy Cotterill for their expert assistance in image acquisition and integration with the surgical suite. Lastly, we would like to acknowledge Joseph Skinner for his assistance in circuit design, Arati Gangadharan for her work in blood tracking and Erin D'Agostino for her work in segmentation of brain volumes. Special thanks to the Center for Surgical Innovation and Dartmouth College. Thank you to our funding sources NIH (NINDS)-1R41NS100313-01, NHIRC-Granite State Technology Innovation Grant and NIBIB-T32 EB021966 Training in Surgical Innovation.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; APUZZO MLJ, 1983, NEUROSURGERY, V12, P277, DOI 10.1227/00006123-198303000-00005; Bailey RD, 2001, NEUROLOGY, V56, P773, DOI 10.1212/WNL.56.6.773; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bertemes-Filho P., 2018, BIOIMPEDANCE BIOMEDI, DOI [10.1007/978-3-319-74388-2, DOI 10.1007/978-3-319-74388-2]; Bodenstein M, 2009, CRIT CARE MED, V37, P713, DOI 10.1097/CCM.0b013e3181958d2f; Bouchaala D, 2016, MEASUREMENT, V79, P339, DOI 10.1016/j.measurement.2015.07.054; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; Coutts Shelagh B, 2017, Continuum (Minneap Minn), V23, P82, DOI 10.1212/CON.0000000000000424; Deinsberger W, 1996, NEUROL RES, V18, P475; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Dowrick T, 2016, PHYSIOL MEAS, V37, P765, DOI 10.1088/0967-3334/37/6/765; Fabrizi L, 2006, PHYSIOL MEAS, V27, pS163, DOI 10.1088/0967-3334/27/5/S14; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Fu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113202; Fukushima U, 2000, J VET MED SCI, V62, P353, DOI 10.1292/jvms.62.353; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gupta S, 2020, J NEUROSURG, V132, P289, DOI 10.3171/2018.8.JNS182182; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; Hawthorne C, 2018, ACTA NEUROCHIR SUPPL, V126, P89, DOI 10.1007/978-3-319-65798-1_19; Heuer JF, 2012, J NEUROL SURG PART A, V73, P289, DOI 10.1055/s-0032-1304813; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janda M, 2012, LAB ANIM-UK, V46, P258, DOI 10.1258/la.2011.011149; Jones SP, 2007, J ADV NURS, V60, P577, DOI 10.1111/j.1365-2648.2007.04510.x; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Khalil SF, 2014, SENSORS-BASEL, V14, P10895, DOI 10.3390/s140610895; KIMURA S, 1994, CHEST, V105, P1679, DOI 10.1378/chest.105.6.1679; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Le Roux P, 2016, INTRACRANIAL PRESSUR; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Lobo B, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.06; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P9, DOI 10.1007/978-3-7091-0693-8_2; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; Martin M, 2017, NEUROCRIT CARE, V26, P87, DOI 10.1007/s12028-016-0291-5; Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035; Mulasi U, 2015, NUTR CLIN PRACT, V30, P180, DOI 10.1177/0884533614568155; Murphy EK, 2017, PHYSIOL MEAS, V38, P1242, DOI 10.1088/1361-6579/aa660e; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Perez JJ, 2004, PHYS MED BIOL, V49, P4383, DOI 10.1088/0031-9155/49/18/013; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Seoane F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/613247; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Sheth SA, 2015, ANN NEUROL, V78, P584, DOI 10.1002/ana.24474; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; SMITH RWM, 1992, MEAS SCI TECHNOL, V3, P1054, DOI 10.1088/0957-0233/3/11/006; Squire L. R., 2009, ENCY NEUROSCIENCE; Strand-Amundsen RJ, 2016, PHYSIOL MEAS, V37, P257, DOI 10.1088/0967-3334/37/2/257; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Trofimov A, 2016, ACTA NEUROCHIR SUPPL, V122, P125, DOI 10.1007/978-3-319-22533-3_25; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642	63	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 29	2021	11	1							15454	10.1038/s41598-021-94600-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TU5GY	WOS:000681066000045	34326387	Green Published, gold			2022-02-07	
J	French, JA; Bebin, M; Dichter, MA; Engel, J; Hartman, AL; Jozwiak, S; Klein, P; McNamara, J; Twyman, R; Vespa, P				French, Jacqueline A.; Bebin, Martina; Dichter, Marc A.; Engel, Jerome, Jr.; Hartman, Adam L.; Jozwiak, Sergiusz; Klein, Pavel; McNamara, James, Sr.; Twyman, Roy; Vespa, Paul			Antiepileptogenesis and disease modification: Clinical and regulatory issues	EPILEPSIA OPEN			English	Article						antiepileptogenesis; clinical trials; disease modification	LATE POSTTRAUMATIC SEIZURES; TUBEROUS SCLEROSIS COMPLEX; RISK-FACTORS; UNITED-STATES; EPILEPSY; INFANTS; ONSET; EPILEPTOGENESIS; THERAPY; INJURY	This is a summary report of clinical and regulatory issues discussed at the 2018 NINDS workshop, entitled "Accelerating Therapies for Antiepileptogenesis and Disease Modification." The intent of the workshop was to optimize and accelerate development of therapies for antiepileptogenesis (AEG) and disease modification in the epilepsies. The working group discussed nomenclature for antiepileptogenic therapies, subdividing them into "antiepileptogenic therapies" and "disease modifying therapies," both of which are urgently needed. We use the example of traumatic brain injury to explain issues and complexities in designing a trial for disease-preventing antiepileptogenic therapies, including identifying timing of intervention, selecting the appropriate dose, and the need for biomarkers. We discuss the recent trials of vigabatrin to prevent onset and modify epilepsy outcome in children with tuberous sclerosis (Epistop and PreVeNT). We describe a potential approach to a disease modification trial in adults, using patients with temporal lobe epilepsy. Finally, we discuss regulatory hurdles for antiepileptogenesis and disease-modifying trials.	[French, Jacqueline A.] NYU Grossman, Sch Med, New York, NY USA; [French, Jacqueline A.] NYU Langone Hlth, New York, NY USA; [Bebin, Martina] UAB Sch Med, Birmingham, AL USA; UAB Epilepsy Ctr, Birmingham, AL USA; [Dichter, Marc A.] Univ Penn, Philadelphia, PA 19104 USA; [Engel, Jerome, Jr.] UCLA, David Geffen Sch Med, Los Angeles, CA USA; [Engel, Jerome, Jr.] Brain Res Inst, Los Angeles, CA USA; [Hartman, Adam L.] NINDS, Div Clin Res, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Jozwiak, Sergiusz] Med Univ Warsaw, Dept Child Neurol, Warsaw, Poland; [Klein, Pavel] Mid Atlantic Epilepsy & Sleep Ctr, Bethesda, MD USA; [McNamara, James, Sr.] Duke Univ, Dept Neurobiol, Sch Med, Durham, NC USA; [Twyman, Roy] Amron Neurosci LLC, Darby, MT USA; [Vespa, Paul] UCLA, Dept Neurol, David Geffen Sch Med, Los Angeles, CA USA; [Vespa, Paul] UCLA, Dept Neurosurg, David Geffen Sch Med, Los Angeles, CA USA		French, JA (corresponding author), NYU Comprehens Epilepsy Ctr, 223 East 34th St, New York, NY 10016 USA.	jacqueline.french@nyulangone.org	; French, Jacqueline/G-6795-2013	Peters, Jurriaan/0000-0002-6725-2814; French, Jacqueline/0000-0003-2242-8027; Hartman, Adam/0000-0001-5672-3409; Twyman, Roy/0000-0002-4208-6645; Bickley, Martina/0000-0003-1264-3428; Klein, Pavel/0000-0001-7244-3722	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS056217, NS097717, NS111708, NS033310, NS100064]	Engel, JJr, is supported by NIH grants NS033310 and NS100064. J McNaamara is supported by NIH grants NS056217, NS097717, NS111708. The authors would like to thank O. Potnis for help in formatting the manuscript.	Angriman F, 2019, STROKE, V50, P1095, DOI 10.1161/STROKEAHA.118.024380; [Anonymous], 2014, TRANSFORMING RES CLI; [Anonymous], 2021, CTR TBI; [Anonymous], 2007, EV PACK INS; [Anonymous], 2020, DELOITTE ACCESS EC; Bakr A, 2018, BRIT J NEUROSURG, V32, P237, DOI 10.1080/02688697.2018.1464118; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; Benova B, 2018, EUR J PAEDIATR NEURO, V22, P632, DOI 10.1016/j.ejpn.2018.03.001; Bovis F, 2018, ANN NEUROL, V84, P621, DOI 10.1002/ana.25323; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Canevini MP, 2018, AM J MED GENET C, V178, P299, DOI 10.1002/ajmg.c.31652; Capal JK, 2017, EPILEPSY BEHAV, V70, P245, DOI 10.1016/j.yebeh.2017.02.007; Chung CWT, 2017, PEDIATR NEUROL, V76, P20, DOI 10.1016/j.pediatrneurol.2017.05.014; Clement EV, 2020, PEDIATR DRUGS, V22, P73, DOI 10.1007/s40272-019-00376-0; Clossen BL, 2017, BBA-MOL BASIS DIS, V1863, P1519, DOI 10.1016/j.bbadis.2017.02.003; Curatolo P, 2018, EUR J PAEDIATR NEURO, V22, P738, DOI 10.1016/j.ejpn.2018.05.006; Domanska-Pakiela D, 2014, EUR J PAEDIATR NEURO, V18, P458, DOI 10.1016/j.ejpn.2013.12.006; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; French JA, 2016, LANCET, V388, P2153, DOI 10.1016/S0140-6736(16)31419-2; Galanopoulou AS, 2021, EPILEPSIA OPEN, V6, P276, DOI 10.1002/epi4.12490; Ghaiyoumi A, 2019, EPILEPSY; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Greenhalgh J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007286.pub4; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hogan P., 2019, EC BURDEN FUTURE IMP; Jozwiak S, 2019, PEDIATR NEUROL, V101, P18, DOI 10.1016/j.pediatrneurol.2019.07.008; Jozwiak S, 2011, EUR J PAEDIATR NEURO, V15, P424, DOI 10.1016/j.ejpn.2011.03.010; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kotulska K, 2021, ANN NEUROL, V89, P304, DOI 10.1002/ana.25956; Kotulska K, 2014, EUR J PAEDIATR NEURO, V18, P714, DOI 10.1016/j.ejpn.2014.06.009; Lutkenhoff ES, 2020, J NEUROL NEUROSUR PS, V91, P1154, DOI 10.1136/jnnp-2020-322780; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Nirwan N, 2018, REV NEUROSCIENCE, V29, P757, DOI 10.1515/revneuro-2017-0086; Pinto Anna, 2016, F1000Res, V5, DOI 10.12688/f1000research.7605.1; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Shorvon S., 2009, TREATMENT EPILEPSY, P249; Simonato M, 2021, NAT REV NEUROL, V17, P231, DOI 10.1038/s41582-021-00461-4; Slowinska M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0764-z; Trinka E, 2014, CURR OPIN NEUROL, V27, P227, DOI 10.1097/WCO.0000000000000067; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vergeer M, 2019, EPILEPSIA OPEN, V4, P581, DOI 10.1002/epi4.12365; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wang H, 2018, NEUROBIOL DIS, V116, P53, DOI 10.1016/j.nbd.2018.04.015; Wat R, 2019, WORLD NEUROSURG, V122, P433, DOI 10.1016/j.wneu.2018.11.076; Whitney R, 2017, PEDIATR NEUROL, V72, P76, DOI 10.1016/j.pediatrneurol.2017.04.009; Wong M, 2019, J NEURODEV DISORD, V11, DOI 10.1186/s11689-019-9289-6; Wu JY, 2019, EPILEPSIA, V60, P2428, DOI 10.1111/epi.16379; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2470-9239		EPILEPSIA OPEN	Epilepsia Open	SEP	2021	6	3					483	492	e12526	10.1002/epi4.12526		JUL 2021	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UJ8NS	WOS:000680437500001	34270884	gold, Green Published			2022-02-07	
J	Fure, SCR; Howe, EI; Spjelkavik, O; Roe, C; Rike, PO; Olsen, A; Ponsford, J; Andelic, N; Lovstad, M				Fure, Silje Christine Reistad; Howe, Emilie Isager; Spjelkavik, Oystein; Roe, Cecilie; Rike, Per-Ola; Olsen, Alexander; Ponsford, Jennie; Andelic, Nada; Lovstad, Marianne			Post-concussion symptoms three months after mild-to-moderate TBI: characteristics of sick-listed patients referred to specialized treatment and consequences of intracranial injury	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; persistent post-concussion symptoms; post-concussive symptoms; the rivermead post-concussion symptom questionnaire	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; HEAD-INJURY; PREDICTORS; RETURN; RISK; QUESTIONNAIRE; EPIDEMIOLOGY; POPULATION; PREVALENCE	Objective: To present pre-injury, injury-related, work-related and post-injury characteristics, and to compare patients with and without traumatic intracranial abnormalities, in a treatment-seeking sample with persistent post-concussion symptoms (PPCS) after mild-to-moderate TBI. Methods: Cross-sectional design in the context of a specialized TBI outpatient clinic. Eligible patients were aged 18-60 years, employed >= 50% at time of injury, and sick listed >= 50% at inclusion due to PPCS. Data were collected 8-12 weeks after injury through review of medical records, semi-structured interviews, questionnaires, and neuropsychological screening. Results: The study included 116 patients, of whom 60% were women, and predominantly white-collar workers in full-time positions. Ninety-four percent had a mild TBI, and 23% had intracranial abnormalities. The full sample reported high somatic, emotional, and cognitive symptom burden, and decreased health-related quality of life. Patients with normal CT/MRI results reported higher overall symptom burden, while patients with intracranial abnormalities had worse memory function. Conclusion: Injury severity and traumatic intracranial radiological findings should not be the sole ground for planning of rehabilitation service provision in patients with PPCS, as subjective complaints do not necessarily co-vary with these variables.	[Fure, Silje Christine Reistad; Howe, Emilie Isager; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Fure, Silje Christine Reistad; Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Howe, Emilie Isager; Roe, Cecilie] Oslo Univ Hosp, Fac Med, Inst Clin Med, Oslo, Norway; [Spjelkavik, Oystein] Oslo Metropolitan Univ, Work Res Inst, Oslo, Norway; [Rike, Per-Ola; Lovstad, Marianne] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Olsen, Alexander] Norwegian Univ Technol & Sci, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, Dept Phys Med & Rehabil, St Olavs Hosp, Trondheim, Norway; [Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Fure, SCR (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway.	scfure@uio.no	; Ponsford, Jennie/H-8341-2014; Lovstad, Marianne/A-4321-2019	Spjelkavik, Oystein/0000-0003-1151-1263; Ponsford, Jennie/0000-0003-0430-125X; Fure, Silje Christine Reistad/0000-0001-7926-6298; Olsen, Alexander/0000-0001-8691-3860; Lovstad, Marianne/0000-0002-8738-8401; Andelic, Nada/0000-0002-3719-4406	Research Council of NorwayResearch Council of Norway [256689/H10]	The Research Council of Norway (256689/H10) provided funding	ACRM Mild Traumatic , 1993, DEFINITION MILD TRAU, V8, P86; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corp. I. IBM SPSS, 2020, STAT WIND; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Howe EI, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2218-7; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kringlen E, 2001, AM J PSYCHIAT, V158, P1091, DOI 10.1176/appi.ajp.158.7.1091; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lerdal A, 2011, DISABIL REHABIL, V33, P334, DOI 10.3109/09638288.2010.490867; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Oslo Uo, 2019, BALANSEKUNST MAN VRE; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Perrine K, 2016, CUREUS, V8, DOI 10.7759/cureus.743; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Pozzato I, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034494; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Saksvik SB, 2020, J NEUROTRAUM, V37, P2528, DOI 10.1089/neu.2019.6898; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherman A., 2021, POSTCONCUSSIVE SYNDR; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; StataCorp, 2019, STATA STAT SOFTWARE; Statistisk sentralbyr?, 2020, S ED ATT POP; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Szende A, 2014, SELF REPORTED POPULA; TEASDALE G, 1974, LANCET, V2, P81; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Watkin C, 2020, BRAIN INJURY, V34, P68, DOI 10.1080/02699052.2019.1681512; Wechsler Adult DW., 2008, INTELLIGENCE SCALE; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zargar F, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.4(2)2015.20977	70	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1054	1064		10.1080/02699052.2021.1953593		JUL 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000678020300001	34314269	Green Published, hybrid			2022-02-07	
J	Garrett, ME; Qin, XJ; Mehta, D; Dennis, MF; Manc, CE; Grant, GA; Stein, MB; Kimbrel, NA; Beckharn, JC; Hauser, MA; Ashley-Koch, AE				Garrett, Melanie E.; Qin, Xue Jun; Mehta, Divya; Dennis, Michelle F.; Manc, Christine E.; Grant, Gerald A.; Stein, Murray B.; Kimbrel, Nathan A.; Beckharn, Jean C.; Hauser, Michael A.; Ashley-Koch, Allison E.		VA Mid-Atlantic Mirecc Workgrp; PTSD Initiative; Injury Traumatic Stress INTRuST; Psychiat Genomics Consortium PTSD	Gene Expression Analysis in Three Posttraumatic Stress Disorder Cohorts Implicates Inflammation and Innate Immunity Pathways and Uncovers Shared Genetic Risk With Major Depressive Disorder	FRONTIERS IN NEUROSCIENCE			English	Article						posttraumatic stress disorder; gene expression; major depressive disorder; quantitative trait loci; multi-ethnic; meta-analysis	GENOME-WIDE ASSOCIATION; INTEGRIN-LINKED KINASE; GLUCOCORTICOID-RECEPTOR PATHWAY; SUBSTANCE USE DISORDERS; DSM-IV; HIPPOCAMPAL NEUROGENESIS; AFGHANISTAN VETERANS; TRAUMATIC EVENTS; BIPOLAR DISORDER; DNA METHYLATION	Posttraumatic stress disorder (PTSD) is a complex psychiatric disorder that can develop following exposure to traumatic events. The Psychiatric Genomics Consortium PTSD group (PGC-PTSD) has collected over 20,000 multi-ethnic PTSD cases and controls and has identified both genetic and epigenetic factors associated with PTSD risk. To further investigate biological correlates of PTSD risk, we examined three PGC-PTSD cohorts comprising 977 subjects to identify differentially expressed genes among PTSD cases and controls. Whole blood gene expression was quantified with the HumanHT-12 v4 Expression BeadChip for 726 OEF/OIF veterans from the Veterans Affairs (VA) Mental Illness Research Education and Clinical Center (MIRECC), 155 samples from the Injury and Traumatic Stress (INTRuST) Clinical Consortium, and 96 Australian Vietnam War veterans. Differential gene expression analysis was performed in each cohort separately followed by meta-analysis. In the largest cohort, we performed co-expression analysis to identify modules of genes that are associated with PTSD and MDD. We then conducted expression quantitative trait loci (eQTL) analysis and assessed the presence of eQTL interactions involving PTSD and major depressive disorder (MDD). Finally, we utilized PTSD and MDD GWAS summary statistics to identify regions that colocalize with eQTLs. Although not surpassing correction for multiple testing, the most differentially expressed genes in meta-analysis were interleukin-1 beta (IL1B), a pro-inflammatory cytokine previously associated with PTSD, and integrin-linked kinase (ILK), which is highly expressed in brain and can rescue dysregulated hippocampal neurogenesis and memory deficits. Pathway analysis revealed enrichment of toll-like receptor (TLR) and interleukin-1 receptor genes, which are integral to cellular innate immune response. Co-expression analysis identified four modules of genes associated with PTSD, two of which are also associated with MDD, demonstrating common biological pathways underlying the two conditions. Lastly, we identified four genes (UBA7, HLA-F, HSPA1B, and RERE) with high probability of a shared causal eQTL variant with PTSD and/or MDD GWAS variants, thereby providing a potential mechanism by which the GWAS variant contributes to disease risk. In summary, we provide additional evidence for genes and pathways previously reported and identified plausible novel candidates for PTSD. These data provide further insight into genetic factors and pathways involved in PTSD, as well as potential regions of pleiotropy between PTSD and MDD.	[Garrett, Melanie E.; Qin, Xue Jun; Hauser, Michael A.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Mehta, Divya] Queensland Univ Technol, Ctr Genom & Personalised Hlth, Inst Hlth & Biomed Innovat Kelvin Grove, Fac Hlth, Kelvin Grove, Qld, Australia; [Dennis, Michelle F.; Manc, Christine E.; Kimbrel, Nathan A.; Beckharn, Jean C.] Durham Vet Affairs Hlth Care Syst, Durham, NC USA; [Dennis, Michelle F.; Manc, Christine E.; Kimbrel, Nathan A.; Beckharn, Jean C.; VA Mid-Atlantic Mirecc Workgrp] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Dennis, Michelle F.; Manc, Christine E.; Kimbrel, Nathan A.; Beckharn, Jean C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Grant, Gerald A.] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA USA; Gallipoli Med Res Fdn, Greenslopes Private Hosp, Greenslopes, Qld, Australia; [PTSD Initiative] Queensland Univ Technol, Fac Hlth, Kelvin Grove, Qld, Australia; [Stein, Murray B.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA		Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA.	allison.ashleykoch@duke.edu	Mehta, Divya/ABD-4551-2021	Mehta, Divya Deepak/0000-0002-7359-348X	Biomedical and Laboratory Research and Development (BLR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD)US Department of Veterans Affairs [I01BX002577]; CSRD [11S-RCS-009]; Queensland Branch of the Returned and Services League of Australia (RSL QLD), Australia; Faculty of Health QUT; QUT; CDMRPUnited States Department of Defense [W81XWH-08-2-0159]; VA Office of Academic Affairs; US Department of Veteran Affairs (CSRD)US Department of Veterans Affairs [CX00160001A1]; IHBI	Work utilizing the MIRECC/Duke cohort was supported by grant #I01BX002577 from the Biomedical and Laboratory Research and Development (BLR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD). In addition, JB was supported by a Research Career Scientist Award (#11S-RCS-009) from CSR&D. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the VA or the US government. The PTSD Initiative was funded by the Queensland Branch of the Returned and Services League of Australia (RSL QLD), Australia. The Gallipoli Medical Research Foundation wishes to thank the RSL QLD for their generous donation, and Sullivan Nicolaides Pathology and Queensland X-Ray for their in-kind support. The authors thank the Faculty of Health QUT, and IHBI for financial and administrative support. DM was funded via the QUT Vice Chancellors Research Fellowship. Research using the INTRuST cohort was supported by the CDMRP award W81XWH-08-2-0159 (MS), the VA Office of Academic Affairs (J. Bomyea) and a Career Development Award from the US Department of Veteran Affairs (CSR&D CX00160001A1; J. Bomyea).	Akosile W, 2018, AUSTRALAS PSYCHIATRY, V26, P60, DOI 10.1177/1039856217734738; Ali T, 2014, AM J GASTROENTEROL, V109, P604, DOI 10.1038/ajg.2013.416; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashley-Koch AE, 2015, J AFFECT DISORDERS, V184, P225, DOI 10.1016/j.jad.2015.03.049; Ben Barnes J, 2018, PSYCHIAT RES, V259, P442, DOI 10.1016/j.psychres.2017.10.045; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Bhattacharya D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135700; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanco C, 2013, DRUG ALCOHOL DEPEN, V132, P630, DOI 10.1016/j.drugalcdep.2013.04.016; Bomyea J, 2020, J PSYCHIATR RES, V121, P108, DOI 10.1016/j.jpsychires.2019.11.012; Bomyea J, 2019, PSYCHIAT RES, V272, P531, DOI 10.1016/j.psychres.2018.12.021; Bookwalter DB, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2432-9; Borsini A, 2018, INT J NEUROPSYCHOPH, V21, P187, DOI 10.1093/ijnp/pyx083; Breen MS, 2015, MOL PSYCHIATR, V20, P1538, DOI 10.1038/mp.2015.9; Breen MS, 2018, NEUROPSYCHOPHARMACOL, V43, P469, DOI 10.1038/npp.2017.220; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bryois J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05379-y; Cerimele JM, 2017, J CLIN PSYCHIAT, V78, pE506, DOI 10.4088/JCP.16r10897; Cougle JR, 2010, J ANXIETY DISORD, V24, P183, DOI 10.1016/j.janxdis.2009.10.006; Crews FT, 2017, NEUROPHARMACOLOGY, V122, P56, DOI 10.1016/j.neuropharm.2017.01.031; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Department of Veterans Affairs Office of Mental Health Suicide Prevention, 2020, 2020 NAT VET SUC PRE; Desmarais P, 2020, AM J GERIAT PSYCHIAT, V28, P48, DOI 10.1016/j.jagp.2019.08.006; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Duncan LE, 2018, MOL PSYCHIATR, V23, P666, DOI 10.1038/mp.2017.77; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; First M.B., 1994, STRUCTURED CLIN INTE; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Girgenti MJ, 2021, NAT NEUROSCI, V24, P24, DOI 10.1038/s41593-020-00748-7; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Guardado P, 2016, J ANXIETY DISORD, V38, P9, DOI 10.1016/j.janxdis.2015.12.004; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huckins LM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107716; Huckins LM, 2019, NAT GENET, V51, P659, DOI 10.1038/s41588-019-0364-4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Koenen KC, 2017, PSYCHOL MED, V47, P209, DOI [10.1017/S0033291716002294, 10.1017/s0033291716002294]; Kong F, 2013, ARCH BIOCHEM BIOPHYS, V533, P11, DOI 10.1016/j.abb.2013.02.014; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuan PF, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0050-1; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Li M, 2012, BEHAV BRAIN RES, V231, P146, DOI 10.1016/j.bbr.2012.03.010; Lind MJ, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz257; Liu H, 2017, JAMA PSYCHIAT, V74, P270, DOI 10.1001/jamapsychiatry.2016.3783; Liu RJ, 2009, INT J BIOCHEM CELL B, V41, P1371, DOI 10.1016/j.biocel.2008.12.002; Livingston WS, 2020, J AFFECT DISORDERS, V274, P1184, DOI 10.1016/j.jad.2020.05.024; Logue MW, 2015, PSYCHONEUROENDOCRINO, V57, P1, DOI 10.1016/j.psyneuen.2015.03.016; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444; Matzaraki V, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1207-1; McLeay SC, 2017, MED J AUSTRALIA, V206, P251, DOI 10.5694/mja16.00935; Mehta D, 2017, ACTA PSYCHIAT SCAND, V136, P493, DOI 10.1111/acps.12778; Mehta D, 2018, BRAIN BEHAV IMMUN, V74, P133, DOI 10.1016/j.bbi.2018.08.014; Mehta D, 2011, ARCH GEN PSYCHIAT, V68, P901, DOI 10.1001/archgenpsychiatry.2011.50; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Miller MW, 2018, HARVARD REV PSYCHIAT, V26, P57, DOI 10.1097/HRP.0000000000000167; Mills J, 2003, J NEUROSCI, V23, P1638; Morrison FG, 2019, NEUROSCI LETT, V692, P204, DOI 10.1016/j.neulet.2018.10.027; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Nievergelt CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12576-w; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Patel RR, 2019, BRAIN BEHAV IMMUN, V75, P208, DOI 10.1016/j.bbi.2018.10.009; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Pollard HB, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00087; Ratanatharathorn A, 2017, AM J MED GENET B, V174, P619, DOI 10.1002/ajmg.b.32568; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Rusch HL, 2019, BRAIN BEHAV IMMUN, V80, P904, DOI 10.1016/j.bbi.2019.04.039; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Sarapas C, 2011, DIS MARKERS, V30, P101, DOI [10.1155/2011/328054, 10.3233/DMA-2011-0764]; Sartor CE, 2012, ARCH GEN PSYCHIAT, V69, P293, DOI 10.1001/archgenpsychiatry.2011.1385; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Segman R. H., 2005, MOL PSYCHIATR, V10, P425, DOI DOI 10.1038/SJ.MP.4001676; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith AK, 2011, AM J MED GENET B, V156B, P700, DOI 10.1002/ajmg.b.31212; Song H, 2018, JAMA-J AM MED ASSOC, V319, P2388, DOI 10.1001/jama.2018.7028; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Stein MB, 2021, NAT GENET, V53, P174, DOI 10.1038/s41588-020-00767-x; Stein MB, 2017, ALCOHOL CLIN EXP RES, V41, P139, DOI 10.1111/acer.13269; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teeters JB, 2017, SUBST ABUSE REHABIL, V8, P69, DOI 10.2147/SAR.S116720; Thomson CA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-73; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Tursich M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.56; Uddin M, 2010, P NATL ACAD SCI USA, V107, P9470, DOI 10.1073/pnas.0910794107; Ursano RJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19935; van Iterson M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1131-9; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Weathers F.W., 1993, ANN M INT SOC TRAUM; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wolf EJ, 2014, PSYCHOL MED, V44, P1499, DOI 10.1017/S0033291713002286; Wray NR, 2018, NAT GENET, V50, P668, DOI 10.1038/s41588-018-0090-3; Xu XF, 2018, BRAIN RES, V1695, P65, DOI 10.1016/j.brainres.2018.05.024; Xu XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11456; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Yehuda R, 2001, J PSYCHIAT RES, V35, P261, DOI 10.1016/S0022-3956(01)00032-2; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zieker J, 2007, MOL PSYCHIATR, V12, P116, DOI 10.1038/sj.mp.4001905	119	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 29	2021	15								678548	10.3389/fnins.2021.678548			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UJ5IB	WOS:000691317500001	34393704	gold, Green Published			2022-02-07	
J	Rubiano, AM; Griswold, DP; Adelson, PD; Echeverri, RA; Khan, AA; Morales, S; Sanchez, DM; Amorim, R; Soto, AR; Paiva, W; Paranhos, J; Carreno, JN; Monteiro, R; Kolias, A; Hutchinson, PJ				Rubiano, Andres M.; Griswold, Dylan P.; Adelson, P. David; Echeverri, Raul A.; Khan, Ahsan A.; Morales, Santiago; Sanchez, Diana M.; Amorim, Robson; Soto, Alvaro R.; Paiva, Wellingson; Paranhos, Jorge; Carreno, Jose N.; Monteiro, Ruy; Kolias, Angelos; Hutchinson, Peter J.			International Neurotrauma Training Based on North-South Collaborations: Results of an Inter-institutional Program in the Era of Global Neurosurgery	FRONTIERS IN SURGERY			English	Article						neurosurgery; neurotrauma; fellowship; global neurosurgery; education	TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; INCOME; COUNTRIES; NIHILISM; SYSTEMS; ACCESS; DRAIN	Objective: Shortage of general neurosurgery and specialized neurotrauma care in low resource settings is a critical setback in the national surgical plans of low and middle-income countries (LMIC). Neurotrauma fellowship programs typically exist in high-income countries (HIC), where surgeons who fulfill the requirements for positions regularly stay to practice. Due to this issue, neurosurgery residents and medical students from LMICs do not have regular access to this kind of specialized training and knowledge-hubs. The objective of this paper is to present the results of a recently established neurotrauma fellowship program for neurosurgeons of LMICs in the framework of global neurosurgery collaborations, including the involvement of specialized parallel education for neurosurgery residents and medical students. Methods: The Global Neurotrauma Fellowship (GNTF) program was inaugurated in 2015 by a multi-institutional collaboration between a HIC and an LMIC. The course organizers designed it to be a 12-month program based on adapted neurotrauma international competencies with the academic support of the Barrow Neurological Institute at Phoenix Children's Hospital and Meditech Foundation in Colombia. Since 2018, additional support from the UK, National Institute of Health Research (NIHR) Global Health Research in Neurotrauma Project from the University of Cambridge enhanced the infrastructure of the program, adding a research component in global neurosurgery and system science. Results: Eight fellows from Brazil, Venezuela, Cuba, Pakistan, and Colombia have been trained and certified via the fellowship program. The integration of international competencies and exposure to different systems of care in high-income and low-income environments creates a unique environment for training within a global neurosurgery framework. Additionally, 18 residents (Venezuela, Colombia, Ecuador, Peru, Cuba, Germany, Spain, and the USA), and ten medical students (the United Kingdom, USA, Australia, and Colombia) have also participated in elective rotations of neurotrauma and critical care during the time of the fellowship program, as well as in research projects as part of an established global surgery initiative. Conclusion: We have shown that it is possible to establish a neurotrauma fellowship program in an LMIC based on the structure of HIC formal training programs. Adaptation of the international competencies focusing on neurotrauma care in low resource settings and maintaining international mentoring and academic support will allow the participants to return to practice in their home-based countries.	[Rubiano, Andres M.] Univ El Bosque, Neurosci Inst, INUB Meditech Res Grp, Bogota, Colombia; [Rubiano, Andres M.; Echeverri, Raul A.; Morales, Santiago] Meditech Fdn, Valle Salud IPS Clin Network, Cali, Colombia; [Rubiano, Andres M.; Griswold, Dylan P.; Kolias, Angelos; Hutchinson, Peter J.] Univ Cambridge, Global Hlth Res Grp Neurotrauma, Natl Inst Hlth Res NIHR, Div Neurosurg, Cambridge, England; [Rubiano, Andres M.; Echeverri, Raul A.; Khan, Ahsan A.; Morales, Santiago; Sanchez, Diana M.; Amorim, Robson; Soto, Alvaro R.; Paiva, Wellingson; Paranhos, Jorge; Carreno, Jose N.; Monteiro, Ruy] Meditech Fdn, Neurotrauma & Global Surg Fellowship Program, Cali, Colombia; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Khan, Ahsan A.] Aga Khan Univ, Neurol Surg Serv, Karachi, Pakistan; [Sanchez, Diana M.] Univ Ciencias Med, Neurosurg Training Program, Havana, Cuba; [Amorim, Robson] Univ Fed Amazonas, Neurosurg Program, Manaus, Amazonas, Brazil; [Soto, Alvaro R.] UROS Clin, Neurosurg Serv, Neiva, Colombia; [Paiva, Wellingson] Univ Sao Paulo, Med Sch, Neurosurg Serv, Sao Paulo, Brazil; [Paranhos, Jorge] Hosp Santa Casa, Neurosurg Serv, Sao Joao Del Rei, Brazil; [Carreno, Jose N.] Santa Fe Fdn Hosp, Neurosurg Serv, Bogota, Colombia; [Monteiro, Ruy] Hosp Miguel Couto, Neurosurg Serv, Rio De Janeiro, Brazil		Rubiano, AM (corresponding author), Univ El Bosque, Neurosci Inst, INUB Meditech Res Grp, Bogota, Colombia.; Rubiano, AM (corresponding author), Meditech Fdn, Valle Salud IPS Clin Network, Cali, Colombia.; Rubiano, AM (corresponding author), Univ Cambridge, Global Hlth Res Grp Neurotrauma, Natl Inst Hlth Res NIHR, Div Neurosurg, Cambridge, England.; Rubiano, AM (corresponding author), Meditech Fdn, Neurotrauma & Global Surg Fellowship Program, Cali, Colombia.	andresrubiano@aol.com	Paiva, Wellingson S/G-5517-2013; Griswold, Dylan/ABC-7890-2021	Paiva, Wellingson S/0000-0002-5165-7040; Sanchez Parra, Diana Marcela/0000-0002-8928-0613; Griswold, Dylan/0000-0003-0291-8360	NIHR Global Health Research Group on Neurotrauma; United Kingdom Government [16/137/105]; Gates Cambridge Trust; European Union Seventh Framework Programme grant (CENTERTBI) [602,150]; Royal College of Surgeons of England; Clinical Lectureship from the School of Clinical Medicine, University of Cambridge; NIHRNational Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR)	This work was supported by the NIHR Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using United Kingdom aid from the United Kingdom Government (project 16/137/105) . PH was the Chief Investigator of the RESCUEicp and RESCUE-ASDH randomized trials. DG was supported by the Gates Cambridge Trust. PH was supported by a Research Professorship from the NIHR, the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Programme grant (CENTERTBI; grant no. 602,150) , and the Royal College of Surgeons of England. AK was supported by a Clinical Lectureship from the School of Clinical Medicine, University of Cambridge, and the Royal College of Surgeons of England.	Adam T, 2012, HEALTH POLICY PLANN, V27, P9, DOI 10.1093/heapol/czs086; Africa Ao, 2016, AOSPINE S AFR LONG T; Clark D, 2019, INT J SURG PROTOC, V15, P13, DOI [10.1016/j.isjp.2019.03.007, DOI 10.1016/J.ISJP.2019.03.007]; Clavijo A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00112; Cohn SM, 2007, J TRAUMA, V62, P951, DOI 10.1097/01.ta.0000260131.79063.50; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Grenier ML, 2015, INT J MIGR HEALTH SO, V11, P218, DOI 10.1108/IJMHSC-08-2014-0031; Griswold D, 2021, JMIR RES PROTOC, V10, DOI 10.2196/25207; Griswold DP, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045598; Griswold DP, 2020, NEUROSURGERY, V87, P476, DOI 10.1093/neuros/nyaa049; HCUP Statistical Briefs By Topic, 2021, HEALTHC COST UT PROJ; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; Hughes JD, 2018, WORLD NEUROSURG, V115, P430, DOI 10.1016/j.wneu.2018.03.220; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1853, DOI 10.1001/jama.298.16.1853; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Medicasur, 2018, CURS ALT ESP ENF VAS; Michael DB, 2016, AANS NEUROSURGEON; Moscote LR, 2014, PANAM J TRAUMA CRIT, V3, P23, DOI [10.5005/jp-journals-10030-1081, DOI 10.5005/JP-JOURNALS-10030-1081]; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; Ouma PO, 2018, LANCET GLOB HEALTH, V6, pE342, DOI 10.1016/S2214-109X(17)30488-6; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Ravindra VM, 2018, GLOB SPINE J, V8, P784, DOI 10.1177/2192568218770769; Roberts DJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000229; Rosseau G, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18295; Rubiano AM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01063; Rubiano AM, 2019, WORLD NEUROSURG, V125, pE82, DOI 10.1016/j.wneu.2019.01.005; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Sekhon MS, 2017, CAN J NEUROL SCI, V44, P350, DOI 10.1017/cjn.2017.25; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Surgeon CLC, 2013, B ROYAL COLL SURG EN, V95, P324, DOI [10.1308/003588413X13643054409586, DOI 10.1308/003588413X13643054409586]; Timmons S., 2016, AANS NEUROSURGEON; World Health Organization, 2019, WORLD HLTH ASS; Zaidi AA, 2019, AFR J EMERG MED, V9, pS14, DOI 10.1016/j.afjem.2019.01.007	43	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	JUL 29	2021	8								633774	10.3389/fsurg.2021.633774			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UA4GO	WOS:000685119500001	34395505	Green Published, gold			2022-02-07	
J	Hognon, L; Heraud, N; Varray, A; Torre, K				Hognon, Louis; Heraud, Nelly; Varray, Alain; Torre, Kjerstin			Adaptive Capacities and Complexity of Heart Rate Variability in Patients With Chronic Obstructive Pulmonary Disease Throughout Pulmonary Rehabilitation	FRONTIERS IN PHYSIOLOGY			English	Article						fractal; exercise capacities; 6-minute walking test; perturbation; chronic disease; resilience	6-MIN WALK TEST; DETRENDED FLUCTUATION ANALYSIS; KNEE EXTENSOR TORQUE; POSTURAL CONTROL; CEREBRAL CONCUSSION; NONLINEAR DYNAMICS; BLOOD-PRESSURE; OXYGEN-UPTAKE; EXERCISE; MORTALITY	Introduction: The complexity of bio-signals, like R-R intervals, is considered a reflection of the organism's capacity to adapt. However, this association still remains to be consolidated. We investigated whether the complexity of R-R intervals at rest and during perturbation [6-minute walking test (6MWT)], yielded information regarding adaptive capacities in Chronic Obstructive Pulmonary Disease (COPD) patients during pulmonary rehabilitation (PR). Methods: In total, 23 COPD patients (64 +/- 8 years, with forced expiratory volume in 1 s of 55 +/- 19% predicted) were tested three times at the start (T1), middle (T2), and end (T3) of 4 weeks PR. Each time, R-R intervals were measured at rest and during 6MWT. The complexity of R-R intervals was assessed by evenly spaced Detrended Fluctuations Analysis and evaluated by the fractal exponent alpha and deviation from maximal complexity vertical bar 1-alpha vertical bar. Results: The 6MWT distance was significantly increased at T2 and T3 compared to T1. Neither alpha nor vertical bar 1-alpha vertical bar at rest and during perturbation significantly changed throughout PR, nor were they consistently associated with 6MWT distances at each time. Throughout the PR program, complexity during the 6MWT was significantly lower compared to the rest. The level of alpha during 6MWT at T1 was positively correlated with the improvement of the 6MWT distance throughout the PR program. Discussion: Reduced complexity in COPD patients during acute perturbation at the beginning of PR supports a decreased improvement of the 6MWT distance throughout PR. This result seems consistent with the notion that the complexity reflects the patients' adaptive capacities and could therefore become a clinical indicator in an applied perspective.	[Hognon, Louis; Varray, Alain; Torre, Kjerstin] Univ Montpellier, IMT Mines Ales, EuroMov Digital Hlth Mot, Montpellier, France; [Heraud, Nelly] GCS CIPS, Direct Rech & Innovat Sante Korian, Lodeve, France		Hognon, L (corresponding author), Univ Montpellier, IMT Mines Ales, EuroMov Digital Hlth Mot, Montpellier, France.	louishognon@outlook.fr					Ahn AC, 2006, PLOS MED, V3, P709, DOI 10.1371/journal.pmed.0030208; Albentosa Marina, 1994, Aquaculture, V126, P315; Almurad ZMH, 2016, PHYSICA A, V451, P63, DOI 10.1016/j.physa.2015.12.155; Amagoh F., 2008, INNOV J, V13, P1; Ambrosino N, 2015, EUR RESPIR J, V46, P1538, DOI 10.1183/13993003.01125-2015; Arsac LM, 2018, ADV PHYSIOL EDUC, V42, P493, DOI 10.1152/advan.00181.2017; Batchinsky AL, 2007, J TRAUMA, V63, P512, DOI 10.1097/TA.0b013e318142d2f0; Bodduluri S, 2018, J CLIN INVEST, V128, P5374, DOI 10.1172/JCI120693; Borghi-Silva A, 2015, EUR J PHYS REHAB MED, V51, P211; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Caminal P, 2018, EUR J APPL PHYSIOL, V118, P669, DOI 10.1007/s00421-018-3808-0; Carvalho TD, 2011, INT J CHRONIC OBSTR, V6, P23, DOI 10.2147/COPD.S15099; CASADEI B, 1995, ACTA PHYSIOL SCAND, V153, P125, DOI 10.1111/j.1748-1716.1995.tb09843.x; Castiglioni P, 2011, J PHYSIOL-LONDON, V589, P355, DOI 10.1113/jphysiol.2010.196428; Castles JF, 2006, INT J SPORTS MED, V27, P780, DOI 10.1055/s-2005-872968; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Celli BR, 2010, RESP MED, V104, P773, DOI 10.1016/j.rmed.2009.12.017; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; CONRAD M, 1977, B MATH BIOL, V39, P139; Correa FR, 2013, INT J SPORTS MED, V34, P111, DOI 10.1055/s-0032-1321888; Cote CG, 2007, CHEST, V132, P1778, DOI 10.1378/chest.07-2050; Dames KK, 2014, RESP PHYSIOL NEUROBI, V192, P39, DOI 10.1016/j.resp.2013.12.004; Delignieres Didier, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P435; Diniz A, 2011, HUM MOVEMENT SCI, V30, P889, DOI 10.1016/j.humov.2010.07.006; Ducharme SW, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01318; Fang FC, 2011, INFECT IMMUN, V79, P1401, DOI 10.1128/IAI.01343-10; Moreira MAF, 2014, J BRAS PNEUMOL, V40, P222, DOI 10.1590/S1806-37132014000300004; Gentile S, 2003, EUR J CANCER CARE, V12, P58, DOI 10.1046/j.1365-2354.2003.00295.x; Gijzel SMW, 2019, J AM GERIATR SOC, V67, P2650, DOI 10.1111/jgs.16149; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; GLASS L, 1987, PROC R SOC LON SER-A, V413, P9, DOI 10.1098/rspa.1987.0097; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBERGER AL, 1987, YALE J BIOL MED, V60, P421; GOLDBERGER AL, 1991, NEWS PHYSIOL SCI, V6, P87, DOI 10.1152/physiologyonline.1991.6.2.87; Gronwald T, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.550572; Gronwald T, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00999; Gronwald T, 2019, RES SPORTS MED, V27, P88, DOI 10.1080/15438627.2018.1502182; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Hautala AJ, 2003, CLIN PHYSIOL FUNCT I, V23, P215, DOI 10.1046/j.1475-097X.2003.00499.x; Heffernan KS, 2007, AM J PHYSIOL-HEART C, V293, pH3180, DOI 10.1152/ajpheart.00648.2007; Heylighen F., 1999, ENCY LIFE SUPPORT SY, P253; Huber M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4163; Iberall A.S., 1968, IFAC P VOL, V2, P39, DOI [10.1016/S1474-6670(17)68837-2, DOI 10.1016/S1474-6670(17)68837-2]; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Korolj A, 2019, BIOMATERIALS, V219, DOI 10.1016/j.biomaterials.2019.119363; Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8; Li P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax1977; Li P, 2019, NEUROBIOL AGING, V83, P21, DOI 10.1016/j.neurobiolaging.2019.08.023; Liddy JJ, 2018, PHYSICA A, V491, P233, DOI 10.1016/j.physa.2017.08.099; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Macklem PT, 2008, J APPL PHYSIOL, V104, P1844, DOI 10.1152/japplphysiol.00942.2007; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; Malara A, 2018, ADV HLTH BEHAV, V1, P1, DOI [10.25082/AHB.2018.01.001, DOI 10.25082/AHB.2018.01.001]; Malliani A, 1999, NEWS PHYSIOL SCI, V14, P111, DOI 10.1152/physiologyonline.1999.14.3.111; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; Manor B, 2013, PROG NEURO-PSYCHOPH, V45, P287, DOI 10.1016/j.pnpbp.2012.08.020; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Marengoni A, 2018, CHEST, V154, P21, DOI 10.1016/j.chest.2018.02.014; Marmelat V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00208; Martinez CAG, 2017, USE R, P1, DOI 10.1007/978-3-319-65355-6; Mazzuco A, 2015, INT J CHRONIC OBSTR, V10, P1651, DOI 10.2147/COPD.S81736; Millar PJ, 2013, SCAND J MED SCI SPOR, V23, P620, DOI 10.1111/j.1600-0838.2011.01435.x; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Pethick J, 2016, AM J PHYSIOL-REG I, V310, pR1144, DOI 10.1152/ajpregu.00019.2016; Pethick J, 2015, J PHYSIOL-LONDON, V593, P2085, DOI 10.1113/jphysiol.2015.284380; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Polkey MI, 2013, AM J RESP CRIT CARE, V187, P382, DOI 10.1164/rccm.201209-1596OC; Porta A, 2017, IEEE T BIO-MED ENG, V64, P1287, DOI 10.1109/TBME.2016.2600160; Raichlen DA, 2019, J GERONTOL A-BIOL, V74, P1461, DOI 10.1093/gerona/gly247; Rejbi Imen Ben Cheikh, 2010, Int J Chron Obstruct Pulmon Dis, V5, P209; Ribeiro GD, 2018, BRAZ J PHYS THER, V22, P383, DOI [10.1016/j.bjpt.2018.03.008, 10.1016/j.bjpt.2018.3.008]; Richardson MJ, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P253; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seely AJE, 2012, CHAOS, V22, DOI 10.1063/1.3675622; Sen J, 2018, CHAOS, V28, DOI 10.1063/1.5038818; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Soares-Miranda L, 2011, J SPORT SCI, V29, P1011, DOI 10.1080/02640414.2011.568513; Spruit MA, 2015, EUR RESPIR J, V46, P1625, DOI 10.1183/13993003.00350-2015; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Sturmberg JP, 2015, FRONT PHYSIOL, V6, DOI [10.3389/fphys.7015.00169, 10.3389/fphys.2015.00169]; Sturmberg JP, 2014, J EVAL CLIN PRACT, V20, P508, DOI 10.1111/jep.12126; Tang SC, 2015, J NEUROL NEUROSUR PS, V86, P95, DOI 10.1136/jnnp-2014-308389; Troosters T, 2001, J Cardiopulm Rehabil, V21, P10, DOI 10.1097/00008483-200101000-00004; Troosters T, 2002, EUR RESPIR J, V20, P564, DOI 10.1183/09031936.02.02092001; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Gestel Arnoldus J R, 2010, J Thorac Dis, V2, P215, DOI 10.3978/j.issn.2072-1439.2010.02.04.5; Van Orden GC, 2011, HBK PHILOS SCI, V10, P629; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Vonbank K, 2020, RESPIRATION, V99, P225, DOI 10.1159/000505856; Whitacre JM, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-6; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Yentes JM, 2020, COPD, V17, P245, DOI 10.1080/15412555.2020.1750578; Zhou JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03422-4; Zupanic E, 2014, COPD, V11, P659, DOI 10.3109/15412555.2014.898046	104	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-042X		FRONT PHYSIOL	Front. Physiol.	JUL 28	2021	12								669722	10.3389/fphys.2021.669722			14	Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physiology	TY5SE	WOS:000683843300001	34393810	Green Published, gold			2022-02-07	
J	Kunadia, A; Aughtman, S; Hoffmann, M; Rossi, F				Kunadia, Anuj; Aughtman, Shelby; Hoffmann, Michael; Rossi, Fabian			Superlative Artistic Abilities in a Patient With Post-traumatic Brain Injury	CUREUS			English	Article						diaschisis; superlative abilities post-traumatic brain injury; tbi compensatory ability; neurology; post traumatic brain injury	SENSORIMOTOR CORTEX; MOTOR CORTEX; RECOVERY; REORGANIZATION; PLASTICITY; DIASCHISIS; STROKE	This case describes a patient who exhibits newfound superlative abilities in painting, music, philosophy, culinary, and performing arts after a traumatic brain injury (TBI) involving the frontal and temporal lobes. Such a dramatic change in de novo artistic behavior after brain injury is rare but has been reported in other patients with frontotemporal dementia, as well as other neurological diseases. Previous studies have shown that mild frontal cortical dysfunction likely plays a role in facilitating creative endeavors and that artistic circuitry is distributed throughout the brain. The neuronal reorganization which occurs after injuries enhances synapse formation and neural plasticity, which may contribute to the acceleration of artistic output after brain injury. This is likely an underdiagnosed phenomenon and a deeper understanding is required to allow clinicians to more effectively recognize and nurture newfound creativity in the setting of brain damage.	[Kunadia, Anuj; Aughtman, Shelby] Univ Cent Florida, Coll Med, Internal Med, Orlando, FL 32816 USA; [Hoffmann, Michael] Univ Cent Florida, Coll Med, Internal Med & Neurol, Orlando, FL 32816 USA; [Rossi, Fabian] Orlando Vet Affairs Med Ctr, Clin Neurophysiol Lab, Orlando, FL USA		Hoffmann, M (corresponding author), Univ Cent Florida, Coll Med, Internal Med & Neurol, Orlando, FL 32816 USA.	mhoffmann4@me.com					Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; BEAR D, 1982, J NEUROL NEUROSUR PS, V45, P481, DOI 10.1136/jnnp.45.6.481; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Bogousslavsky J, 2007, NEUROLOGICAL DISORDE, DOI [10.1159/isbn.978-3-318-01450-1, DOI 10.1159/ISBN.978-3-318-01450-1]; Boutoleau-Bretonniere C, 2015, DEMENT GER COGN D EX, V5, P503, DOI 10.1159/000440859; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Jones TA, 1999, J COMP NEUROL, V414, P57; Le Prieult F, 2017, J NEUROTRAUM, V34, P1097, DOI 10.1089/neu.2016.4575; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Midorikawa A, 2015, NEUROCASE, V21, P90, DOI 10.1080/13554794.2013.873058; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Trimble MR, 1997, J NEUROPSYCH CLIN N, V9, P429; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Zaidel DW, 2017, BEHAV SCI, V7, DOI 10.3390/bs7030056	20	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 28	2021	13	7							e16697	10.7759/cureus.16697			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	UE2HC	WOS:000687714100009	34462704	gold, Green Published			2022-02-07	
J	Peterson, A; Webster, F; Gonzalez-Lara, LE; Munce, S; Owen, AM; Weijer, C				Peterson, Andrew; Webster, Fiona; Gonzalez-Lara, Laura Elizabeth; Munce, Sarah; Owen, Adrian M.; Weijer, Charles			Caregiver reactions to neuroimaging evidence of covert consciousness in patients with severe brain injury: a qualitative interview study	BMC MEDICAL ETHICS			English	Article						Vegetative state; Minimally conscious state; Neuroimaging; Caregiver; Ethics; Research ethics; Traumatic brain injury	DETECTING AWARENESS; DISORDERS; STATE	Background Severe brain injury is a leading cause of death and disability. Diagnosis and prognostication are difficult, and errors occur often. Novel neuroimaging methods can improve diagnostic and prognostic accuracy, especially in patients with prolonged disorders of consciousness (PDoC). Yet it is currently unknown how family caregivers understand this information, raising ethical concerns that disclosure of neuroimaging results could result in therapeutic misconception or false hope. Methods To examine these ethical concerns, we conducted semi-structured interviews with caregivers of patients with PDoC who were enrolled in a concurrent neuroimaging research program designed to detect covert consciousness following severe brain injury. Caregivers held surrogate decision-making status for a patient. Interviews were conducted at two time points for each caregiver. The first interview occurred before the disclosure of neuroimaging results. The second occurred after disclosure. Descriptive analysis was applied to the data of four interview topics: (1) expectations for neuroimaging; (2) reactions to evidence of preserved cognition; (3) reactions to null results; and (4) understanding of the results and study. Results Twelve caregivers participated in the study; two caregivers shared surrogate decision-making status for one patient with PDoC. Twenty-one interviews were completed; one caregiver declined to participate in the post-disclosure interview. Three patients with PDoC associated with the study displayed evidence of covert consciousness. Overall, caregivers understood the neuroimaging research and results. Caregivers who received results of covert consciousness were generally pleased. However, there was some variation in expectations and reactions to these data and null results. Conclusion This study, for the first time, reveals caregiver expectations for and reactions to neuroimaging evidence of covert consciousness in patients with PDoC. Caregivers understood the neuroimaging research and results, casting doubt on speculative ethical concerns regarding therapeutic misconception and false hope. However, disclosure of neuroimaging result could be improved. Pre-disclosure consultations might assist professionals in shaping caregiver expectations. Standardization of disclosure might also improve comprehension of the results.	[Peterson, Andrew] George Mason Univ, Inst Philosophy & Publ Policy, Fairfax, VA 22030 USA; [Webster, Fiona] Western Univ, Arthur Labatt Family Sch Nursing, London, ON, Canada; [Gonzalez-Lara, Laura Elizabeth; Owen, Adrian M.] Western Univ, Brain & Mind Inst, London, ON, Canada; [Munce, Sarah] Univ Hlth Network, Toronto Rehabil Inst, Toronoto, ON, Canada; [Weijer, Charles] Western Univ, Dept Med, London, ON, Canada; [Weijer, Charles] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Weijer, Charles] Western Univ, Dept Philosophy, London, ON, Canada		Peterson, A (corresponding author), George Mason Univ, Inst Philosophy & Publ Policy, Fairfax, VA 22030 USA.	apeter31@gmu.edu	Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074; Webster, Fiona/0000-0002-7318-7713	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-133705]; Greenwall Foundation Faculty Scholars program; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AG069805]	This research was supported by an operating grant from the Canadian Institutes of Health Research MOP-133705. AP is currently supported by the Greenwall Foundation Faculty Scholars program and NIH R21AG069805.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Beukema S, 2016, NEUROIMAGE-CLIN, V12, P359, DOI 10.1016/j.nicl.2016.08.003; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Comanducci A, 2020, CLIN NEUROPHYSIOL, V131, P2736, DOI 10.1016/j.clinph.2020.07.015; Denzin N.K., 2017, DISCOVERY GROUNDED T, P105, DOI [10.4324/9781315129945-10, DOI 10.4324/9780203793206]; Edgar A, 2015, J EVAL CLIN PRACT, V21, P374, DOI 10.1111/jep.12220; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2018, CURR BIOL, V28, pR1345, DOI 10.1016/j.cub.2018.10.022; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2016, ANN NEUROL, V80, P412, DOI 10.1002/ana.24726; Gonzalez-Lara LE, 2021, BRAIN INJURY, V35, P200, DOI 10.1080/02699052.2020.1865565; Graham M, 2015, J MED ETHICS, V41, P534, DOI 10.1136/medethics-2014-102078; Harkins K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0112-7; JENNETT B, 1972, LANCET, V1, P734; Kitzinger C, 2014, CLIN REHABIL, V28, P627, DOI 10.1177/0269215514527844; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Munce SEP, 2021, BRAIN INJURY, V35, P8, DOI 10.1080/02699052.2020.1858494; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Peterson A., 2020, NEUROETHICS-NETH, V4, P1; Peterson A, 2020, JAMA NEUROL, V77, P541, DOI 10.1001/jamaneurol.2020.0232; Peterson A, 2020, BRAIN INJURY, V34, P390, DOI 10.1080/02699052.2019.1706000; Peterson A, 2019, EMERG TOP LIFE SCI, V3, P707, DOI 10.1042/ETLS20190115; Peterson A, 2020, BIOETHICS, V34, P295, DOI 10.1111/bioe.12678; Posner JB, 2019, PLUM POSNERS DIAGNOS, DOI [10.1093/med/9780190208875.001.0001, DOI 10.1093/MED/9780190208875.001.0001]; Schembs L, 2020, NEUROETHICS-NETH, P1, DOI [10.1007/s12152-019-09425, DOI 10.1007/S12152-019-09425]; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Weijer C, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-41	36	0	0	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6939			BMC MED ETHICS	BMC Med. Ethics	JUL 28	2021	22	1							105	10.1186/s12910-021-00674-8			13	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	TT5VB	WOS:000680414500003	34320966	gold, Green Published			2022-02-07	
J	Steimer, M; Kaiser, S; Ulbrich, F; Kalbhenn, J; Burkle, H; Schallner, N				Steimer, Matti; Kaiser, Sandra; Ulbrich, Felix; Kalbhenn, Johannes; Buerkle, Hartmut; Schallner, Nils			Expression of HO1 and PER2 can predict the incidence of delirium in trauma patients with concomitant brain injury	SCIENTIFIC REPORTS			English	Article							INTENSIVE-CARE-UNIT; HEME OXYGENASE-1; CIRCADIAN-RHYTHM; GENE; KIDNEY; CLOCK; INDUCTION; MELATONIN; PROTECTS; AKI	Intensive care unit (ICU)-acquired delirium is associated with adverse outcome in trauma patients with concomitant traumatic brain injury (TBI), but diagnosis remains challenging. Quantifying circadian disruption by analyzing expression of the circadian gene period circadian regulator 2 (PER2) and heme oxygenase 1 (HO1), which determines heme turnover, may prove to be potential diagnostic tools. Expression of PER2 and HO1 was quantified using qPCR from blood samples 1 day and 7 days after trauma. Association analysis was performed comparing mRNA expression levels with parameters of trauma (ISS-injury severity score), delirium, acute kidney injury (AKI) and length of ICU stay. 48 polytraumatized patients were included (equal distribution of TBI versus non-TBI) corrected for ISS, age and gender using a matched pairs approach. Expression levels of PER2 and HO1 were independent of age (PER2: P=0.935; HO1: P=0.988), while expression levels were significantly correlated with trauma severity (PER2: P=0.009; HO1: P<0.001) and longer ICU length of stay (PER2: P=0.018; HO1: P<0.001). High expression levels increased the odds of delirium occurrence (PER2: OR=4.32 [1.14-13.87]; HO1: OR=4.50 [1.23-14.42]). Patients with TBI showed a trend towards elevated PER2 (OR=3.00 [0.84-9.33], P=0.125), but not towards delirium occurrence (P=0.556). TBI patients were less likely to develop AKI compared to non-TBI (P=0.022). Expression levels of PER2 and HO1 correlate with the incidence of delirium in an age-independent manner and may potentially improve diagnostic algorithms when used as delirium biomarkers.Trial registration: German Clinical Trials Register (Trial-ID DRKS00008981; Universal Trial Number U1111-1172-6077; Jan. 18, 2018).	[Steimer, Matti; Kaiser, Sandra; Ulbrich, Felix; Kalbhenn, Johannes; Buerkle, Hartmut; Schallner, Nils] Univ Freiburg, Fac Med, Med Ctr, Dept Anesthesiol & Crit Care Med, Hugstetter Str 55, D-79106 Freiburg, Germany; [Steimer, Matti; Kaiser, Sandra; Ulbrich, Felix; Kalbhenn, Johannes; Buerkle, Hartmut; Schallner, Nils] Univ Freiburg, Fac Med, Freiburg, Germany		Schallner, N (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Anesthesiol & Crit Care Med, Hugstetter Str 55, D-79106 Freiburg, Germany.; Schallner, N (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	nils.schallner@uniklinik-freiburg.de		Schallner, Nils/0000-0003-2120-788X	German Research Foundation (DFG)German Research Foundation (DFG) [SCHA 1838/4-1]; Berta-Ottenstein-Programme for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg; University of Freiburg; Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. German Research Foundation (DFG) Grant to NS: SCHA 1838/4-1. NS is funded by the Berta-Ottenstein-Programme for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg. The article processing charge is funded by the University of Freiburg in the funding program "Open Access Publishing".	AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Bian ZH, 2015, MOL MED REP, V11, P3188, DOI 10.3892/mmr.2014.3108; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Bolisetty S, 2017, AM J KIDNEY DIS, V69, P531, DOI 10.1053/j.ajkd.2016.10.037; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Coiffard B, 2019, SHOCK, V52, P29, DOI 10.1097/SHK.0000000000001241; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Correa-Costa M, 2018, P NATL ACAD SCI USA, V115, pE2302, DOI 10.1073/pnas.1716747115; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fitzgerald JM, 2013, MED HYPOTHESES, V81, P568, DOI 10.1016/j.mehy.2013.06.032; Gile J, 2018, CRIT CARE MED, V46, pE600, DOI 10.1097/CCM.0000000000003077; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Hall RJ, 2018, INT J GERIATR PSYCH, V33, P1479, DOI 10.1002/gps.4720; Harrois A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2265-9; Ho KH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82800-5; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Kaiser S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100496; Khan BA, 2011, J AM GERIATR SOC, V59, pS256, DOI 10.1111/j.1532-5415.2011.03702.x; Kotfis K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071075; Leaf DE, 2016, J AM SOC NEPHROL, V27, P3291, DOI 10.1681/ASN.2016010038; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Li CX, 2013, MOL MED REP, V7, P1117, DOI 10.3892/mmr.2013.1331; Luetz A, 2010, CRIT CARE MED, V38, P409, DOI 10.1097/CCM.0b013e3181cabb42; Nagasawa Y, 2019, INTERNAL MED, V58, P1531, DOI 10.2169/internalmedicine.2323-18; Olaoye OA, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1156-z; Rowley-Conwy G, 2018, INTENS CRIT CARE NUR, V44, P99, DOI 10.1016/j.iccn.2017.09.001; Schallner N, 2017, STROKE, V48, P2565, DOI 10.1161/STROKEAHA.116.016165; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Telias I, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2366-0; Toft K, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0548-1; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Von Rueden KT, 2017, CRIT CARE NURSE, V37, P40, DOI 10.4037/ccn2017373; Wiebking N, 2013, CURR NEUROVASC RES, V10, P112, DOI 10.2174/1567202611310020004; Xiao J, 2017, PEERJ, V5, DOI 10.7717/peerj.3726; Zaal IJ, 2015, CRIT CARE MED, V43, P40, DOI 10.1097/CCM.0000000000000625	40	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 28	2021	11	1							15388	10.1038/s41598-021-94773-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TX8RJ	WOS:000683353600049	34321570	Green Published, gold			2022-02-07	
J	Brockamp, T; Bohmer, A; Lefering, R; Bouillon, B; Wafaisade, A; Mutschler, M; Kappel, P; Frohlich, M				Brockamp, Thomas; Boehmer, Andreas; Lefering, Rolf; Bouillon, Bertil; Wafaisade, Arasch; Mutschler, Manuel; Kappel, Paola; Frohlich, Matthias		German Trauma Soc DGU	Alcohol and trauma: the influence of blood alcohol levels on the severity of injuries and outcome of trauma patients-a retrospective analysis of 6268 patients of the TraumaRegister DGU(R)	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Blood alcohol; Traumatic brain injury; Outcome; Youth	SERUM ETHANOL LEVELS; BRAIN-INJURY; INTOXICATION; MODERATE; ASSOCIATION; CONSUMPTION; PREVALENCE; MORTALITY	Background Blood alcohol level (BAL) has previously been considered as a factor influencing the outcome of injured patients. Despite the well-known positive correlation between alcohol-influenced traffic participation and the risk of accidents, there is still no clear evidence of a positive correlation between blood alcohol levels and severity of injury. The aim of the study was to analyze data of the TraumaRegister DGU(R) (TR-DGU), to find out whether the blood alcohol level has an influence on the type and severity of injuries as well as on the outcome of multiple-trauma patients. Methods Datasets from 11,842 trauma patients of the TR-DGU from the years 2015 and 2016 were analyzed retrospectively and 6268 patients with a full dataset and an AIS >= 3 could be used for evaluation. Two groups were formed for data analysis. A control group with a BAL = 0 parts per thousand (BAL negative) was compared to an alcohol group with a BAL of >= 0.3 parts per thousand to < 4.0 parts per thousand (BAL positive). Patients with a BAL > 0 parts per thousand and < 0.3 parts per thousand were excluded. They were compared with regard to various preclinical, clinical and physiological parameters. Additionally, a subgroup analysis with a focus on patients with a traumatic brain injury (TBI) was performed. A total of 5271 cases were assigned to the control group and 832 cases to the BAL positive group. 70.3% (3704) of the patients in the control group were male. The collective of the control group was on average 5.7 years older than the patients in the BAL positive group (p < .001). The control group showed a mean ISS of 20.3 and the alcohol group of 18.9 (p = .007). In terms of the injury severity of head, the BAL positive group was significantly higher on average than the control group (p < 0.001), whereas the control group showed a higher AIS to thorax and extremities (p < 0.001). The mean Glasgow Coma Scale (GCS) was 10.8 in the BAL positive group and 12.0 in the control group (p < 0.001). Physiological parameters such as base excess (BE) and International Normalized Ratio (INR) showed reduced values for the BAL positive group. However, neither the 24-h mortality nor the overall mortality showed a significant difference in either group (p = 0.19, p = 0.14). In a subgroup analysis, we found that patients with a relevant head injury (AIS: Abbreviated Injury Scale head >= 3) and positive BAL displayed a higher survival rate compared to patients in the control group with isolated TBI (p < 0.001). Conclusions This retrospective study analyzed the influence of the blood alcohol level in severely injured patients in a large national dataset. BAL positive patients showed worse results with regard to head injuries, the GCS and to some other physiological parameters. Finally, neither the 24-h mortality nor the overall mortality showed a significant difference in either group. Only in a subgroup analysis the mortality rate in BAL negative patients with TBI was significantly higher than the mortality rate of BAL positive patients with TBI. This mechanism is not yet fully understood and is discussed controversially in the literature.	[Brockamp, Thomas; Bouillon, Bertil; Wafaisade, Arasch; Mutschler, Manuel; Kappel, Paola; Frohlich, Matthias] Univ Witten Herdecke, Dept Trauma & Orthopaed Surg, Cologne Merheim Med Ctr, Ostmerheimer St 200, D-51109 Cologne, Germany; [Boehmer, Andreas] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Anaesthesiol & Surg Intens Care Med, Ostmerheimer St 200, D-51109 Cologne, Germany; [Lefering, Rolf; German Trauma Soc DGU] Univ Witten Herdecke, Inst Res Operat Med IFOM, Ostmerheimer St 200, D-51109 Cologne, Germany; [Brockamp, Thomas] German Trauma Soc DGU, Working Grp Injury Prevent German Trauma Soc, Str 17 Juni 106-108, D-10623 Berlin, Germany		Brockamp, T (corresponding author), Univ Witten Herdecke, Dept Trauma & Orthopaed Surg, Cologne Merheim Med Ctr, Ostmerheimer St 200, D-51109 Cologne, Germany.; Brockamp, T (corresponding author), German Trauma Soc DGU, Working Grp Injury Prevent German Trauma Soc, Str 17 Juni 106-108, D-10623 Berlin, Germany.	tbrockamp@gmail.com			Projekt DEAL	Not applicable". Open Access funding enabled and organized by Projekt DEAL.	ANDERSEN JA, 1990, J TRAUMA, V30, P415, DOI 10.1097/00005373-199030040-00007; Asmaro K, 2013, CURR DRUG TARGETS, V14, P74, DOI 10.2174/138945013804806505; Berry C, 2010, AM SURGEON, V76, P1067; Borges G, 2004, SOC SCI MED, V58, P1191, DOI 10.1016/S0277-9536(03)00290-9; Bundesamt S., 2019, UNFALLE 18 BIS 24 JA UNFALLE 18 BIS 24 JA; Cornwell EE, 1998, AM SURGEON, V64, P461; de Gaetano G, 2016, NUTR METAB CARDIOVAS, V26, P443, DOI 10.1016/j.numecd.2016.03.007; Dunne JR, 2005, J TRAUMA, V58, P959, DOI 10.1097/01.TA.0000158508.84009.49; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Imam I, 2010, BRIT J HOSP MED, V71, P635, DOI 10.12968/hmed.2010.71.11.79653; Majchrowicz E, 1975, Adv Exp Med Biol, V56, P111; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Porter RS, 2000, PEDIATR EMERG CARE, V16, P316, DOI 10.1097/00006565-200010000-00003; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Scheyerer MJ, 2014, EMERG MED J, V31, P813, DOI 10.1136/emermed-2013-202804; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Statistisches Bundesamt, 2019, UNF EINFL ALK AND BE UNF EINFL ALK AND BE; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; Yaghoubian A, 2009, AM SURGEON, V75, P950	30	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUL 27	2021	29	1							101	10.1186/s13049-021-00916-z			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TQ1KG	WOS:000678045800001	34315518	gold, Green Published			2022-02-07	
J	D'Silva, LJ; Chalise, P; Obaidat, S; Rippee, M; Devos, H				D'Silva, Linda J.; Chalise, Prabhakar; Obaidat, Sakher; Rippee, Michael; Devos, Hannes			Oculomotor Deficits and Symptom Severity Are Associated With Poorer Dynamic Mobility in Chronic Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						baseline visual acuity; post-concussion symptom scale; dizziness handicap inventory; functional gait assessment; chronic mild traumatic brain injury	QUALITY-OF-LIFE; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENTS; VISUOSPATIAL ABILITY; VESTIBULAR FUNCTION; GAZE STABILIZATION; FUNCTIONAL STATUS; OLDER-ADULTS; BALANCE; CONCUSSION	Oculomotor deficits, vestibular impairments, and persistent symptoms are common after a mild traumatic brain injury (mTBI); however, the relationship between visual-vestibular deficits, symptom severity, and dynamic mobility tasks is unclear. Twenty-three individuals (mean age 55.7 +/- 9.3 years) with persistent symptoms after mTBI, who were between 3 months to 2 years post-injury were compared with 23 age and sex-matched controls. Oculomotor deficits [depth perception, near-point convergence, baseline visual acuity (BLVA), perception time], vestibular deficits (dynamic visual acuity in the pitch and yaw planes), dynamic mobility measured by the Functional Gait Assessment (FGA), and symptoms measured by the Post-Concussion Symptom Scale (PCSS) and Dizziness Handicap Inventory (DHI) were compared between groups. Participants with mTBI had poorer performance on the FGA (p < 0.001), higher symptom severity on the PCSS (p < 0.001), and higher DHI scores (p < 0.001) compared to controls. Significant differences were seen on specific items of the FGA between individuals with mTBI and controls during walking with horizontal head turns (p = 0.002), walking with vertical head tilts (p < 0.001), walking with eyes closed (p = 0.003), and stair climbing (p = 0.001). FGA performance was correlated with weeks since concussion (r = -0.67, p < 0.001), depth perception (r = -0.5348, p < 0.001), near point convergence (r = -0.4717, p = 0.001), baseline visual acuity (r = -0.4435, p = 0.002); as well as with symptoms on the PCSS (r = -0.668, p < 0.001), and DHI (r = -0.811, p < 0.001). Dynamic balance deficits persist in chronic mTBI and may be addressed using multifaceted rehabilitation strategies to address oculomotor dysfunction, post-concussion symptoms, and perception of handicap due to dizziness.	[D'Silva, Linda J.; Obaidat, Sakher; Devos, Hannes] Univ Kansas, Dept Phys Therapy Rehabil Sci & Athlet Training, Med Ctr, Kansas City, MO 66045 USA; [Chalise, Prabhakar] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, MO USA; [Rippee, Michael] Univ Kansas Hlth Syst, Dept Neurol, Kansas City, MO USA		D'Silva, LJ (corresponding author), Univ Kansas, Dept Phys Therapy Rehabil Sci & Athlet Training, Med Ctr, Kansas City, MO 66045 USA.	ldsilva@kumc.edu			Department of Physical Therapy and Rehabilitation Science at the University of Kansas Medical Center; School of Health Professions at the University of Kansas Medical Center; NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); University of Kansas (KU) One University Open Access Author Fund by the KU; University of Kansas (KU) One University Open Access Author Fund by the KUMC	This work was supported by internal grants fromthe Department of Physical Therapy and Rehabilitation Science and the School of Health Professions at the University of Kansas Medical Center. REDCap at University of Kansas Medical Center is supported by CTSA grant from NCRR and NCATS awarded to the University of Kansas Medical Center for Frontiers: University of Kansas Clinical and Translational Science Institute. The article processing charges related to the publication of this article were supported by the University of Kansas (KU) One University Open Access Author Fund sponsored jointly by the KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research, andmanaged jointly by the Libraries at the Medical Center and KU-Lawrence.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Baydan M, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110785; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bigelow RT, 2015, J AM GERIATR SOC, V63, P1837, DOI 10.1111/jgs.13609; Bigelow RT, 2015, J VESTIBUL RES-EQUIL, V25, P73, DOI 10.3233/VES-150544; Bramley H, 2016, SPORTS MED ARTHROSC, V24, P123, DOI 10.1097/JSA.0000000000000111; Brandt T, 2020, CURR OPIN NEUROL, V33, P136, DOI 10.1097/WCO.0000000000000771; Buhagiar F, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.598208; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2012, OPTOMETRY, V83, P10; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; D'Silva L, 2021, BRAIN INJURY, V35, P59, DOI 10.1080/02699052.2020.1857839; D'Silva LJ, 2020, J VESTIBUL RES-EQUIL, V30, P259, DOI 10.3233/VES-200706; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dunlap Pamela M, 2018, J Am Acad Audiol, DOI 10.3766/jaaa.18015; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Haber YO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168803; Hagovska M, 2016, GERIATR GERONTOL INT, V16, P1043, DOI 10.1111/ggi.12593; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hile ES, 2010, PHYS THER, V90, P1649, DOI 10.2522/ptj.20090405; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Jacobson G P, 2000, J Am Acad Audiol, V11, P76; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kim SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192705; King JE, 2018, MIL MED, V183, P237, DOI 10.1093/milmed/usx170; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kovacs E, 2013, EUR J PHYS REHAB MED, V49, P639; Li KZH, 2010, J GERONTOL A-BIOL, V65, P1344, DOI 10.1093/gerona/glq151; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Martini DN, 2021, J NEUROTRAUM, V38, P218, DOI 10.1089/neu.2020.6986; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Narciso FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151609; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Pilkar R, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00836; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Quintana C, 2020, J VESTIBUL RES-EQUIL, V30, P249, DOI 10.3233/VES-200710; Row J, 2019, J NEUROTRAUM, V36, P2435, DOI 10.1089/neu.2018.5755; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Semenov YR, 2016, J GERONTOL A-BIOL, V71, P243, DOI 10.1093/gerona/glv069; Skora W, 2018, ANN AGR ENV MED, V25, P665, DOI 10.26444/aaem/81138; Sremakaew M, 2018, J ORAL FACIAL PAIN H, V32, P321, DOI 10.11607/ofph.2029; Starobova H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00174; Stika MM, 2021, J HEAD TRAUMA REHAB, V36, P44, DOI 10.1097/HTR.0000000000000611; Tarakci E, 2013, CLIN REHABIL, V27, P813, DOI 10.1177/0269215513481047; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Tramontano M, 2018, RESTOR NEUROL NEUROS, V36, P709, DOI 10.3233/RNN-180850; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; Van Bloemendaal M, 2019, CLIN REHABIL, V33, P94, DOI 10.1177/0269215518791000; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Waitman Lemuel R, 2011, AMIA Annu Symp Proc, V2011, P1454; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; Ward BK, 2010, OTOL NEUROTOL, V31, P168, DOI 10.1097/MAO.0b013e3181c4c3e2; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Xie YJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00173	93	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 26	2021	12								642457	10.3389/fneur.2021.642457			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TX1ZT	WOS:000682890600001	34381408	Green Published, gold			2022-02-07	
J	Hosomi, S; Kitamura, T; Sobue, T; Ogura, H; Shimazu, T				Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka; Ogura, Hiroshi; Shimazu, Takeshi			Survival outcomes after traumatic brain injury during national academic meeting days in Japan	SCIENTIFIC REPORTS			English	Article							MORTALITY; CARE; WEEKEND; EPIDEMIOLOGY; COMMITMENT	Surgeons and medical staff attend academic meetings several times a year. However, there is insufficient evidence on the influence of the "meeting effect" on traumatic brain injury (TBI) treatments and outcomes. Using the Japan Trauma Data Bank, we analyzed the data of TBI patients admitted to the hospital from 2004 to 2018 during the national academic meeting days of the Japanese Association for Acute Medicine, the Japanese Society of Intensive Care Medicine, the Japanese Association for the surgery of trauma, the Japan Society of Neurotraumatology and the Japan Neurosurgical Society. The data of these patients were compared with those of TBI patients admitted 1 week before and after the meetings. The primary outcome was in-hospital death. We included 7320 patients in our analyses, with 5139 and 2181 patients admitted during the non-meeting and meeting days, respectively; their in-hospital mortality rates were 15.7% and 14.5%, respectively. No significant differences in in-hospital mortality were found (adjusted odds ratio, 0.93; 95% confidence interval, 0.78-1.11). In addition, there were no significant differences in in-hospital mortality during the meeting and non-meeting days by the type of national meeting. In Japan, it is acceptable for medical professionals involved in TBI treatments to attend national academic meetings without impacting the outcomes of TBI patients.	[Hosomi, Sanae; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, 215 Yamadaoka, Suita, Osaka 5650871, Japan; [Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka] Osaka Univ, Div Environm Med & Populat Sci, Dept Social & Environm Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka, Japan		Hosomi, S (corresponding author), Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, 215 Yamadaoka, Suita, Osaka 5650871, Japan.; Hosomi, S (corresponding author), Osaka Univ, Div Environm Med & Populat Sci, Dept Social & Environm Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp	Kitamura, Tetsuhisa/AAA-2555-2020; Sobue, Tomotaka/ABE-4739-2021	Kitamura, Tetsuhisa/0000-0003-0107-0580; 	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K08886]; Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives)	This study was funded by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant Number: 18K08886), and a Grant from Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) awarded to S.H. The funders had no role in the study design, collection, analysis, interpretation of data, and manuscript writing. The authors thank the emergency medical service personnel, nurses, neurosurgeons, and emergency medicine physicians who participated in the JTDB. We also thank our colleagues from the Osaka University Center of Medical Data Science, Advanced Clinical Epidemiology Investigator's Research Project for providing insight and expertise in the research.	Association for the Advancement of Automatic Medicine, 2001, ABBREVIATED INJURY S; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; Carteron L, 2017, MINERVA ANESTESIOL, V83, P412, DOI 10.23736/S0375-9393.16.11696-7; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davis KA, 2008, J TRAUMA, V65, P1236, DOI 10.1097/TA.0b013e31818ba311; Gallo V, 2011, J CLIN EPIDEMIOL, V64, P1350, DOI 10.1016/j.jclinepi.2011.07.010; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hirose T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018687; Japan Trauma Care and Research, 2019, JAP TRAUM DAT ANN RE JAP TRAUM DAT ANN RE; Japan Trauma Care and Research, 2019, JAP TRAUM DAT BANK A; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Jenkins PC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214020; Katayama Y, 2021, EUR J TRAUMA EMERG S, V47, P515, DOI 10.1007/s00068-019-01154-w; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; Ono Y, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0095-1; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sado Junya, 2019, Circ Rep, V1, P212, DOI 10.1253/circrep.CR-18-0030; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Schneider EB, 2012, J SURG RES, V177, P295, DOI 10.1016/j.jss.2012.06.022; Sise CB, 2011, J TRAUMA, V70, P560, DOI 10.1097/TA.0b013e31820c7b79; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Yumoto T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207049	29	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 26	2021	11	1							15206	10.1038/s41598-021-94759-4			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TU2LR	WOS:000680872900005	34312458	Green Published, gold			2022-02-07	
J	Wu, XH; Xu, W; Zhang, TF; Bao, WX				Wu, Xiaohong; Xu, Wen; Zhang, Tianfang; Bao, Wangxiao			Peripheral inflammatory markers in patients with prolonged disorder of consciousness after severe traumatic brain injury	ANNALS OF PALLIATIVE MEDICINE			English	Article						Severe traumatic brain injury (sTBI); prolonged disorder of consciousness (prolonged DoC); inflammation; recovery		Background: Inflammatory processes are known to be the key secondary effects of severe traumatic brain injury (sTBI). The aim of the present study was to assess the value of peripheral inflammatory markers in the chronic unconscious phase after sTBI. Methods: This was a prospective cohort study. A total of 101 patients with prolonged disorder of consciousness (DoC) and 22 healthy controls (HC) were enrolled in the study. Serum levels of interleukin (IL)-1 ,-4,-6,-10,-13, and tumor necrosis factor-(TNF-) were investigated in patients with prolonged DoC after sTBI. In addition, the Coma Recovery Scale-revised (CRS-R) was used to quantify the consciousness level, and clinical outcomes at 12 months were determined using the Glasgow Outcome Scale (GOS). Predictive logistic model was built based on the demographic characteristics and cytokine levels. Results: At baseline, IL-6,-10,-13, and TNF-levels were significantly higher in patients with prolonged DoC compared with controls, while no differences in cytokine levels were observed between patients in a vegetative state (VS) and those in a minimally conscious state (MCS). IL-13 and TNF-were found to be correlated with behavioral scores in patients with prolonged DoC, and were associated with recovery 12 months later. Conclusions: The results of the study provide information about long-term inflammatory responses in the chronic unconscious phase after brain trauma. Further larger studies are required to validate the value of these inflammatory markers.	[Wu, Xiaohong; Xu, Wen; Zhang, Tianfang; Bao, Wangxiao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Rehabil Med, 79 Qingchun Rd, Hangzhou, Peoples R China		Bao, WX (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Rehabil Med, 79 Qingchun Rd, Hangzhou, Peoples R China.	baowangxiao@zju.edu.cn			General Project of Health Department of Zhejiang Province [2020370189]	This work was supported by the General Project of Health Department of Zhejiang Province (No. 2020370189).	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bao WX, 2018, EXPERT REV MOL DIAGN, V18, P761, DOI 10.1080/14737159.2018.1471985; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Casault C, 2019, NEUROCRIT CARE, V30, P22, DOI 10.1007/s12028-018-0522-z; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Deepika A, 2018, J NEUROTRAUM, V35, P1124, DOI 10.1089/neu.2017.5151; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; JENNETT B, 1975, LANCET, V1, P480; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majetschak M, 2000, J TRAUMA, V48, P832, DOI 10.1097/00005373-200005000-00006; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Savarraj J, 2018, NEUROCRIT CARE, V28, P203, DOI 10.1007/s12028-017-0471-y	27	0	0	2	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	AUG	2021	10	8					9114	9121		10.21037/apm-21-1852		JUL 2021	8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	UJ3RA	WOS:000683790000001	34488397	gold			2022-02-07	
J	Zhang, B; Yang, MS; Yan, QY; Xu, XJ; Niu, F; Dong, JQ; Zhuang, Y; Lu, SH; Ge, QQ; Liu, BY				Zhang, Bin; Yang, Mengshi; Yan, Qiongyu; Xu, Xiaojian; Niu, Fei; Dong, Jinqian; Zhuang, Yuan; Lu, Shenghua; Ge, Qianqian; Liu, Baiyun			The Dual Dose-Dependent Effects of Corticosterone on Hippocampal Cell Apoptosis After Traumatic Brain Injury Depend on the Activation Ratio of Mineralocorticoid Receptors to Glucocorticoid Receptors	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; corticosterone; mineralocorticoid receptor; glucocorticoid receptor; apoptosis	SEVERE HEAD-INJURY; COGNITIVE DEFICITS; CHRONIC STRESS; DEATH; MECHANISMS; PHOSPHORYLATION; INHIBITION; PREVENTION; BALANCE	In our recent studies, we reported that mineralocorticoid receptor (MR) had the opposite effects of glucocorticoid receptor (GR) on neural cell survival after traumatic brain injury (TBI). However, whether short-term use of high-dose natural glucocorticoids, which are mixed agonists of both MR and GR, leads to neurotoxic effects by inducing excessive GR activation is unclear, as is the threshold GR activation level and the possible signaling pathways remain unclear. In this study, we examined the dual dose-dependent effects of corticosterone (CORT) on spatial memory, hippocampal cell survival and receptor-mediated downstream signaling pathways after TBI. We found that different doses of CORT exhibited dual effects on hippocampal cell survival and rat spatial memory. Low doses of CORT (0.3 and 3 mg/kg) significantly increased MR activation, upregulated Akt/CREB/Bad phosphorylation and Bcl-2 concentration, reduced the number of apoptotic neural cells, and subsequently improved rat spatial memory. In contrast, a high dose of CORT (30 mg/kg) exerted the opposite effects by overactivating GR, upregulating P53/Bax levels, and inhibiting Erk/CREB activity. The results suggest that the neuroprotective and neurotoxic effects of endogenous GC depend on a threshold level and that a higher dose of GC, even for short-term use, should be avoided after TBI.	[Zhang, Bin; Yang, Mengshi; Dong, Jinqian; Zhuang, Yuan; Lu, Shenghua; Ge, Qianqian] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Yan, Qiongyu] Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China; [Xu, Xiaojian; Niu, Fei] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Baiyun] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Baiyun] Beijing Tiantan Hosp, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China		Liu, BY (corresponding author), Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.	liubaiyun1212@163.com			Beijing municipal health commission; PXM [2020_026280_000002]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]; China Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2021-M692251]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2021-ZZ-018]	This work was supported by research grants from the Beijing municipal health commission (No. PXM 2020_026280_000002), National Natural Science Foundation of China (Grant No. 81771327). China Postdoctoral Research Foundation (Grant No. 2021-M692251), and Beijing Postdoctoral Research Foundation (Grant No. 2021-ZZ-018).	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Arango-Lievano M, 2015, P NATL ACAD SCI USA, V112, P15737, DOI 10.1073/pnas.1509045112; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; Bratton S.L., 2007, J NEUROTRAUM, V24, pS, DOI [10.1089/neu.2007.9981, DOI 10.1089/NEU.2007.9981]; Burkhardt T, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.8.FOCUS15324; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; de Kloet ER, 2014, ENDOCRINOLOGY, V155, P2754, DOI 10.1210/en.2014-1048; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Fardet L, 2012, AM J PSYCHIAT, V169, P491, DOI 10.1176/appi.ajp.2011.11071009; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Judd LL, 2014, AM J PSYCHIAT, V171, P1045, DOI 10.1176/appi.ajp.2014.13091264; Kahles T, 2013, CRIT CARE MED, V41, P1378, DOI 10.1097/CCM.0b013e318283ceb4; Kowalski EA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1605-2; Krugers Harmen J, 2010, Front Synaptic Neurosci, V2, P24, DOI 10.3389/fnsyn.2010.00024; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; Laugesen K, 2021, WORLD PSYCHIATRY, V20, P142, DOI 10.1002/wps.20831; Liang H, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02087-1; Licznerski P, 2018, P NATL ACAD SCI USA, V115, P3742, DOI 10.1073/pnas.1803645115; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sadeghi MA, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01153-2; Sarabdjitsingh RA, 2009, BRAIN RES, V1249, P43, DOI 10.1016/j.brainres.2008.10.048; Schreiber R, 2020, CURR NEUROPHARMACOL, V18, P188, DOI 10.2174/1570159X17666191010103044; Sheline YI, 2019, BIOL PSYCHIAT, V85, P436, DOI 10.1016/j.biopsych.2019.01.011; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Vandewalle J, 2018, TRENDS ENDOCRIN MET, V29, P42, DOI 10.1016/j.tem.2017.10.010; Wu CH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0543-8; Zhang B, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02000-2; Zhang B, 2020, NEUROSCIENCE, V424, P1, DOI 10.1016/j.neuroscience.2019.10.026; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zuo DY, 2016, NEUROTOX RES, V30, P159, DOI 10.1007/s12640-016-9611-y	49	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	JUL 26	2021	12								713715	10.3389/fphar.2021.713715			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TX2GK	WOS:000682908400001	34381366	gold, Green Published			2022-02-07	
J	Zhang, RY; Wang, JM; Huang, L; Wang, TJ; Huang, YR; Li, ZF; He, JX; Sun, C; Wang, J; Chen, XM; Wang, J				Zhang, Ruoyu; Wang, Junming; Huang, Leo; Wang, Tom J.; Huang, Yinrou; Li, Zefu; He, Jinxin; Sun, Chen; Wang, Jing; Chen, Xuemei; Wang, Jian			The pros and cons of motor, memory, and emotion-related behavioral tests in the mouse traumatic brain injury model	NEUROLOGICAL RESEARCH			English	Article						Animal models; behavior; biomarker; mice; translational; traumatic brain injury	CONTROLLED CORTICAL IMPACT; TAIL SUSPENSION TEST; FORCED SWIM TEST; INTRACEREBRAL HEMORRHAGE; ANIMAL-MODELS; BARRIER DISRUPTION; SENSORIMOTOR FUNCTION; COGNITIVE FUNCTION; ENHANCES RECOVERY; OXIDATIVE STRESS	Traumatic brain injury (TBI) is a medical emergency with high morbidity and mortality. Motor, memory, and emotion-related deficits are common symptoms following TBI, yet treatment is very limited. To develop new drugs and find new therapeutic avenues, a wide variety of TBI models have been established to mimic the heterogeneity of TBI. In this regard, along with histologic measures, behavioral functional outcomes provide valuable insight into the underlying neuropathology and guide neurorehabilitation efforts for neuropsychiatric impairment after TBI. Development, characterization, and application of behavioral tests that can assess functional neurologic deficits are essential to the development of translational therapies. This comprehensive review aims to summarize 19 common behavioral tests from three aspects (motor, memory, and emotion-related) that are associated with TBI pathology. Discussion covers the apparatus, the test steps, the evaluation indexes, data collection and analysis, animal performance and applications, advantages and disadvantages as well as precautions to eliminate bias wherever possible. We discussed recent studies on TBI-related preconditioning, biomarkers, and optimized behavioral protocols. The neuropsychologic tests employed in clinics were correlated with those used in mouse TBI models. In summary, this review provides a comprehensive, up-to-date reference for TBI researchers to choose the right neurobehavioral protocol according to the research objectives of their translational investigation.	[Zhang, Ruoyu; Wang, Junming; Huang, Yinrou; Li, Zefu; He, Jinxin; Sun, Chen; Wang, Jing; Chen, Xuemei; Wang, Jian] Zhengzhou Univ, Coll Basic Med Sci, Dept Human Anat, Zhengzhou 450001, Peoples R China; [Huang, Leo] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Wang, Tom J.] Winston Churchill High Sch, Potomac, MD USA		Wang, J (corresponding author), Zhengzhou Univ, Coll Basic Med Sci, Dept Human Anat, Zhengzhou 450001, Peoples R China.	jianwang2020@outlook.com	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1704166]	This work was supported by the National Natural Science Foundation of China [U1704166].	Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Alkhlaif Y, 2017, PHARMACOL BIOCHEM BE, V161, P47, DOI 10.1016/j.pbb.2017.08.013; Amani M, 2013, NEUROPHARMACOLOGY, V73, P87, DOI 10.1016/j.neuropharm.2013.04.056; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Barbosa EH, 2016, J MOTOR BEHAV, V48, P5, DOI 10.1080/00222895.2015.1024824; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bentzer P, 2017, NEUROCRIT CARE, V26, P450, DOI 10.1007/s12028-016-0348-5; Bin Abdullah MFIL, 2018, ASIAN J PSYCHIATR, V37, P67, DOI 10.1016/j.ajp.2018.08.017; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Boettinger S, 2017, BEHAV BRAIN RES, V323, P154, DOI 10.1016/j.bbr.2017.02.004; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Calabrese EJ, 2019, TRENDS PHARMACOL SCI, V40, P8, DOI 10.1016/j.tips.2018.10.010; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Catlin J, 2020, CNS NEUROSCI THER, V26, P628, DOI 10.1111/cns.13228; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Ciftci E, 2020, BEHAV BRAIN RES, V392, DOI 10.1016/j.bbr.2020.112719; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Commons KG, 2017, ACS CHEM NEUROSCI, V8, P955, DOI 10.1021/acschemneuro.7b00042; Constantino LC, 2015, BEHAV BRAIN RES, V282, P103, DOI 10.1016/j.bbr.2014.12.056; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Darnall BD, 2017, J PAIN, V18, P1139, DOI 10.1016/j.jpain.2017.05.003; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dobrachinski F, 2019, MOL NEUROBIOL, V56, P3145, DOI 10.1007/s12035-018-1296-1; Domingues CD, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0171-8; Driskell LD, 2016, REHABIL PSYCHOL, V61, P112, DOI 10.1037/rep0000079; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hennessy MJ, 2020, J CLIN NEUROSCI, V81, P37, DOI 10.1016/j.jocn.2020.09.030; Huang SX, 2018, NEUROCHEM RES, V43, P1814, DOI 10.1007/s11064-018-2597-5; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; Jadavji NM, 2015, NEUROSCIENCE, V300, P1, DOI 10.1016/j.neuroscience.2015.04.067; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JP, 2018, J NEUROSCI METH, V307, P95, DOI 10.1016/j.jneumeth.2018.06.025; Joo H, 2019, PLANTA MED, V85, P231, DOI 10.1055/a-0753-0400; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kennedy JE, 2019, BRAIN INJURY, V33, P932, DOI 10.1080/02699052.2019.1610191; Khalin I, 2016, DRUG DELIV, V23, P3520, DOI 10.1080/10717544.2016.1199609; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kim ST, 2010, BRAIN RES, V1306, P176, DOI 10.1016/j.brainres.2009.09.103; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Krafft PR, 2014, BEHAV BRAIN RES, V264, P151, DOI 10.1016/j.bbr.2014.01.052; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Leconte C, 2020, J NEUROTRAUM, V37, P1342, DOI 10.1089/neu.2019.6679; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lesniak A, 2021, NEUROSCIENCE, V458, P1, DOI 10.1016/j.neuroscience.2021.01.013; Li XH, 2019, CHEMOSPHERE, V215, P454, DOI 10.1016/j.chemosphere.2018.10.070; Litofsky NS, 2018, BRAIN INJURY, V32, P342, DOI 10.1080/02699052.2018.1425913; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mangas A, 2018, EUR J HISTOCHEM, V62, P278, DOI 10.4081/ejh.2018.2985; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Mattei TA, 2020, WORLD NEUROSURG, V134, P311, DOI 10.1016/j.wneu.2019.10.193; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Nanegrungsunk D, 2021, NEUROL RES, V43, P239, DOI 10.1080/01616412.2020.1841481; Naugle KM, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01207-1; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; Nye KS, 2017, ANN BIOMED ENG, V45, P1101, DOI 10.1007/s10439-016-1741-0; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Ouyang W, 2018, J NEUROSCI RES, V96, P1412, DOI 10.1002/jnr.24261; Pappacena S, 2019, MINERVA ANESTESIOL, V85, P830, DOI 10.23736/S0375-9393.19.13307-X; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pinkernell S, 2016, LAB ANIM-UK, V50, P442, DOI 10.1177/0023677216675010; Piscitelli F, 2020, ACS CHEM NEUROSCI, V11, P1117, DOI 10.1021/acschemneuro.9b00633; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Qiu XZ, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.903040; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Raj R, 2015, INJURY, V46, P86, DOI 10.1016/j.injury.2014.08.026; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Roome RB, 2015, JOVE-J VIS EXP, DOI 10.3791/52701; Rossi JL, 2015, J NEUROTRAUM, V32, P1101, DOI 10.1089/neu.2014.3611; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Samuelson KW, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.569005; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Sclafani A, 2017, PHYSIOL BEHAV, V173, P188, DOI 10.1016/j.physbeh.2017.02.008; Sebastiani A, 2018, J NEUROCHEM, V147, P190, DOI 10.1111/jnc.14551; Selvaraj P, 2019, J NEUROTRAUM, V36, P1655, DOI 10.1089/neu.2018.6226; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Stukalin Y, 2020, NEUROSCI BIOBEHAV R, V112, P39, DOI 10.1016/j.neubiorev.2020.01.034; Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323; Tan XL, 2020, BRAIN INJURY, V34, P131, DOI 10.1080/02699052.2019.1667539; Tchantchou F, 2018, J NEUROTRAUM, V35, P1192, DOI 10.1089/neu.2017.5401; Toma W, 2017, NEUROPHARMACOLOGY, V117, P305, DOI 10.1016/j.neuropharm.2017.02.020; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00013; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vuralli D, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0963-6; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang JP, 2017, BEHAV BRAIN RES, V316, P145, DOI 10.1016/j.bbr.2016.09.007; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Waqas M, 2018, WORLD NEUROSURG, V116, pE783, DOI 10.1016/j.wneu.2018.05.092; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Witkowski ED, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00166; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu K, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1428-1; Wu P, 2019, INT J NANOMED, V14, P4059, DOI 10.2147/IJN.S202353; Wu XB, 2019, J NEUROTRAUM, V36, P460, DOI 10.1089/neu.2018.5756; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yan HC, 2010, NEUROSCI BULL, V26, P327, DOI 10.1007/s12264-010-0323-7; Yankelevitch-Yahav R., 2015, JOVE-J VIS EXP, V97, DOI [10.3791/52587, DOI 10.3791/52587]; Yokobori S, 2013, TRANSL STROKE RES, V4, P25, DOI 10.1007/s12975-012-0226-1; Yoneyama-Sarnecky T, 2010, DEV NEUROSCI-BASEL, V32, P81, DOI 10.1159/000258700; Yu J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020299; Zan JY, 2017, MOL MED REP, V16, P6958, DOI 10.3892/mmr.2017.7468; Zhang H, 2017, J CEREBR BLOOD F MET, V37, P3422, DOI 10.1177/0271678X17690165; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang XS, 2018, FREE RADICAL BIO MED, V124, P504, DOI 10.1016/j.freeradbiomed.2018.06.035; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhang Z, 2019, J NEUROTRAUM, V36, P74, DOI 10.1089/neu.2017.5450; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701; Zhao D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1007-2; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004; Zhu W, 2017, NEUROSCIENCE, V343, P77, DOI 10.1016/j.neuroscience.2016.11.037; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423	176	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN 2	2022	44	1					65	89		10.1080/01616412.2021.1956290		JUL 2021	25	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI3AF	WOS:000678945800001	34308784				2022-02-07	
J	Chien, SC; Tu, PH; Liu, ZH; Chen, CC; Liao, CH; Hsieh, CH; Fu, CY				Chien, Shou-Chi; Tu, Po-Hsun; Liu, Zhuo-Hao; Chen, Ching-Chang; Liao, Chien-Hung; Hsieh, Chi-Hsun; Fu, Chih-Yuan			Neurological deteriorations in mild brain injuries: the strategy of evaluation and management	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Mild head injury; Deterioration; Computed tomography scan; Muscular weakness	CT HEAD RULE; HEMORRHAGE; COMA	Purpose Most mild traumatic brain injuries (TBIs) can be treated conservatively. However, some patients deteriorate during observation. Therefore, we tried to evaluate the characteristics of deterioration and requirement for further management in mild TBI patients. Methods From 1/1/2017 to 12/31/2017, patients with mild TBI and positive results on CT scans of the brain were retrospectively studied. Patients with and without neurological deteriorations were compared. The characteristics of mild TBI patients with further neurological deterioration or the requirement for interventions were delineated. Results One hundred ninety-two patients were enrolled. Twenty-three (12.0%) had neurological deteriorations. The proportions of deterioration occurring within 24 h, 48 h and 72 h were 23.5, 41.2 and 58%, respectively. Deteriorated patients were significantly older than those without neurological deteriorations (69.7 vs. 60.2; p = 0.020). More associated extracranial injuries were observed in deteriorated patients [injury severity score (ISS): 20.2 vs. 15.9; p = 0.005). Significantly higher proportions of intraventricular hemorrhage (8.7 vs. 1.2%; p = 0.018) and multiple lesions (78.3 vs. 53.8%; p = 0.027) were observed on the CT scans of patients with neurological deteriorations. Subset analysis showed that deteriorated patients who required neurosurgical interventions (N = 7) had significantly more initial GCS defects (13 or 14) (71.4 vs. 12.5%; p = 0.005) and more initial decreased muscle power of extremities (85.7 vs. 18.8%; p = 0.002). Conclusion More attention should be given to mild TBI patients with older age, GCS defects, decreased muscle power of the extremities, multiple lesions on CT scans and other systemic injuries (high ISS). Most deteriorations occur within 72 h after trauma.	[Chien, Shou-Chi; Tu, Po-Hsun; Liu, Zhuo-Hao; Chen, Ching-Chang] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Neurosurg, Linkou Med Ctr, 5 Fu Hsing St, Taoyuan, Taiwan; [Liao, Chien-Hung; Hsieh, Chi-Hsun; Fu, Chih-Yuan] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, Linkou Med Ctr, 5 Fu Hsing St, Taoyuan, Taiwan		Fu, CY (corresponding author), Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Trauma & Emergency Surg, Linkou Med Ctr, 5 Fu Hsing St, Taoyuan, Taiwan.	mp1886@cgmh.org.tw; d12096@cgmh.org.tw; liuch@cgmh.org.tw; 8702047@cgmh.org.tw; m7077@cgmh.org.tw; hsiehchihsun@yahoo.com.tw; fucy@cgmh.org.tw		Fu, Chih-Yuan/0000-0003-1536-1549			Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Baratloo A, 2017, ADV J EMERG MED, V1, DOI [10.22114/AJEM.v1i1.1, 10.22114/ajem.v1i1.1]; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; BULLOCK R, 1982, SURG NEUROL, V18, P300, DOI 10.1016/0090-3019(82)90353-6; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Fournier N, 2019, EMERG MED J, V36, P617, DOI 10.1136/emermed-2018-208153; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; IUVARABOMMELI A, 1991, SCHWEIZ MED WSCHR, V121, P646; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Radulovic Danilo, 2005, Vojnosanit Pregl, V62, P679, DOI 10.2298/VSP0509679R; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Seno S, 2019, J CLIN NEUROSCI, V67, P124, DOI 10.1016/j.jocn.2019.06.007; Shah Jayun M, 2017, Asian J Neurosurg, V12, P412, DOI 10.4103/1793-5482.180968; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shibahashi K, 2018, WORLD NEUROSURG, V114, pE350, DOI 10.1016/j.wneu.2018.02.183; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Shpiner AC, 2019, J CLIN NEUROSCI, V59, P79, DOI 10.1016/j.jocn.2018.10.149; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; TEASDALE G, 1974, LANCET, V2, P81; The Committee on Trauma, 2018, ATLS ADV TRAUM LIF S; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	38	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01753-6		JUL 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TO9RP	WOS:000677239200002	34302502				2022-02-07	
J	Liu, QM; Wu, XF; Tong, NC				Liu, Qiming; Wu, Xingfu; Tong, Nichen			Assessment and prediction of acute subdural hematomas in vehicle collision accidents	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article; Early Access						Acute subdural hematoma; injury criteria; biomechanical metrics; prediction model; vehicle collision accident	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; ACCELERATION; MODEL; BIOMECHANICS	Acute subdural hematomas (ASDHs) caused by vehicle collisions are common brain injuries that suffers prone to disability and death. However, there is currently no commonly accepted evaluation index for ASDHs, such as the head injury criterion (HIC) for evaluating skull injuries and the brain injury criteria (BrIC, BRIC) for evaluating diffuse axonal injuries. Therefore, we established a set of ASDH indexes (ASDHIs) based on the genetic algorithm for different biomechanical metrics and developed an ASDH prediction model based on an artificial neural network learning (ANN-L). First, simulation models were built using 218 sets of crash test data and the simulated injury monitor model (SIMon). We calculated the correlation coefficients between the kinematic parameters, such as the translational and rotational acceleration, and the biomechanical metrics, such as the intracranial pressure and strain of the bridging vein. The effect of some outlier data is removed using a combination of K-Nearest Neighbor and quadratic regression. We screened some parameters with strong correlations and calculated their weight factors based on the genetic algorithm to establish a set of evaluation indexes for ASDHs. Comparing with 19 existed injury criteria, the results show that each established ASDHI has a higher correlation than these traditional criteria, and also indicate that the evaluation performance of each established ASDHI is advantageous. Finally, on the basis of these established ASDHIs, we built an accurate prediction model of ASDHs using ANN-L, which makes it possible to realize the prediction of ASDHs by only depending on kinematic responses.	[Liu, Qiming; Tong, Nichen] Hebei Univ Technol, Sch Mech Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China; [Wu, Xingfu] Hunan Univ, Coll Mech & Vehicle Engn, State Key Lab Adv Design & Mfg Vehicle Body, Changsha, Peoples R China		Liu, QM (corresponding author), Hebei Univ Technol, Sch Mech Engn, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China.	logemen@hebut.edu.cn			Natural Science Foundation of Hebei Province of ChinaNatural Science Foundation of Hebei Province [A2019202171]; Independent Research Project of State Key Laboratory of Reliability and Intelligence Electrical Equipment, Hebei University of Technology, PR China [EERIPD2018002]; Open Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body, PR China [31915004]	This work is supported by the Natural Science Foundation of Hebei Province of China (Grant No. A2019202171), Independent Research Project of State Key Laboratory of Reliability and Intelligence Electrical Equipment, Hebei University of Technology, PR China (No. EERIPD2018002), the Open Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body, PR China (Grant No. 31915004).	Antona-Makoshi J., 2012, P 2012 INT IRCOBI C P 2012 INT IRCOBI C, V2012; Antona-Makoshi J., 2016, IJAE, V7, P69; Cui ZY, 2017, COMPUT METHOD BIOMEC, V20, P530, DOI 10.1080/10255842.2016.1255942; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gadd C., 1966, SAE TECHNICAL PAPER; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Han IS, 2014, INT J PRECIS ENG MAN, V15, P2405, DOI 10.1007/s12541-014-0607-3; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S., 2002, THESIS KTH ROYAL I T THESIS KTH ROYAL I T; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Liu QM, 2020, J MECH DESIGN, V142, DOI 10.1115/1.4044328; Liu QM, 2019, STRUCT MULTIDISCIP O, V60, P1491, DOI 10.1007/s00158-019-02277-9; Liu QM, 2019, MED BIOL ENG COMPUT, V57, P1109, DOI 10.1007/s11517-018-1944-7; Liu SX, 2013, APPL MECH MATER, V387, P55, DOI 10.4028/www.scientific.net/AMM.387.55; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Mao HJ, 2018, J BIOMECH, V77, P228, DOI 10.1016/j.jbiomech.2018.07.004; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; Newman J.A., 2000, STAPP CAR CRASH J; Newman J.A., 1986, P INT IRCOBI C ZUR S; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Takahashi, 2015, SAE TECHNICAL PAPER; Takhounts E. G., 2011, PAPER; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Versace J, 1971, SAE TECHNICAL PAPER; Wong GKC, 2010, ACTA NEUROCHIR SUPPL, V106, P235, DOI 10.1007/978-3-211-98811-4_44; World Health Organization, 2014, GLOBAL STATUS REPORT, P67; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	42	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness												10.1080/13588265.2021.1959169		JUL 2021	16	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	TX7BY	WOS:000683245000001					2022-02-07	
J	Brenner, LA; Grassmeyer, RP; Biffl, S; Kinney, AR; Dise-Lewis, JE; Betthauser, LM; Forster, JE				Brenner, Lisa A.; Grassmeyer, Riley P.; Biffl, Susan; Kinney, Adam R.; Dise-Lewis, Jeanne E.; Betthauser, Lisa M.; Forster, Jeri E.			Met and unmet rehabilitative needs among pediatric patients with moderate to severe TBI	BRAIN INJURY			English	Article						Traumatic brain injury; pediatric rehabilitation; health services research; rehabilitation	TRAUMATIC BRAIN-INJURY; FAMILY BURDEN; HEALTH-CARE; CHILDREN; SERVICES; RECOVERY; OUTCOMES; RETURN	Objective Estimate the probability of met and unmet post-acute rehabilitative needs among pediatric patients with moderate to severe traumatic brain injury (TBI). Participants One hundred and thirty children who received acute and post-acute rehabilitative services at a hospital for children. Methods Prospective, observational study. Recommended service needs (1. Medical, 2. Psychological, 3. Cognitive/Educational, 4. Medically Based Therapies, 5. Community/Caregiver/Family Support) were collected at discharge and 1, 6, 12, and 18 months post-injury. Probabilities were estimated using nonlinear logistic regression models. The impact of age at discharge was also assessed. Results Over time, the estimated probability of need for Medical, Medically Based Therapies, and Cognitive/Educational services were consistently high. Whereas unmet need for Medical and Medically Based Therapies were low, unmet need for Cognitive/Educational services were relatively high. Need for Psychological and Community/Caregiver/Family Support services increased in the months post-discharge, as did the probability of unmet need. Older age at discharge was associated with need for Psychological and Community/Caregiver Family Support services. Conclusions Findings support the long-term monitoring of need for Psychological and Community/Caregiver/Family Support services among children with moderate to severe TBI. Future research to explore the etiology of unmet needs is warranted.	[Brenner, Lisa A.; Kinney, Adam R.; Betthauser, Lisa M.; Forster, Jeri E.] Vet Hlth Adm Rocky Mt Mental Illness Res Educ & C, Aurora, CO USA; [Brenner, Lisa A.; Grassmeyer, Riley P.; Kinney, Adam R.; Dise-Lewis, Jeanne E.; Betthauser, Lisa M.; Forster, Jeri E.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA; [Brenner, Lisa A.; Dise-Lewis, Jeanne E.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO 80045 USA; [Biffl, Susan] Univ Calif San Diego, Rady Childrens Hosp, Dept Orthoped Phys Med & Rehabil, San Diego, CA 92103 USA		Brenner, LA (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO 80045 USA.; Brenner, LA (corresponding author), Univ Colorado, Anschutz Med Campus,Mail Stop F493 Acad Off 1, Aurora, CO 80045 USA.	lisa.brenner@va.gov			Centers for Disease Control and Prevention NCIPC [R49 CE000394-03]; VHA Rocky Mountain Mental Illness Research Education and Clinical Center; University of Colorado, Anschutz Medical Campus, Department of Physical Medicine and Rehabilitation	This study was funded by the Centers for Disease Control and Prevention NCIPC, [R49 CE000394-03] and supported by the VHA Rocky Mountain Mental Illness Research Education and Clinical Center, and the University of Colorado, Anschutz Medical Campus, Department of Physical Medicine and Rehabilitation.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Glang A, 2008, NEUROREHABILITATION, V23, P477; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Katia S., 2014, OPEN J THERAPY REHAB, V2, P11, DOI [10.4236/ojtr.2014.21009, DOI 10.4236/OJTR.2014.21009]; Keenan HT, 2020, J HEAD TRAUMA REHAB, V35, pE67, DOI 10.1097/HTR.0000000000000499; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Lantagne A, 2018, J PEDIATR PSYCHOL, V43, P703, DOI 10.1093/jpepsy/jsy020; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Sirois K, 2019, NEUROPSYCHOL REHABIL, V29, P1383, DOI 10.1080/09602011.2017.1413987; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wade SL, 2018, REHABIL PSYCHOL, V63, P327, DOI 10.1037/rep0000187; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110	29	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1162	1167		10.1080/02699052.2021.1953146		JUL 2021	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000698741500001	34554040				2022-02-07	
J	Choi, AR; Feller, ER				Choi, Ariel R.; Feller, Edward R.			Misrepresentation of mild traumatic brain injury research in press releases	PM&R			English	Article; Early Access							JOURNALISM; SPIN; CANCER; CONCUSSION; KNOWLEDGE; EDUCATION; TRIALS; POLICY; GUIDE; MEDIA	Background Press releases from academic medical centers often form the basis for health and science news stories. Press release coverage of mild traumatic brain injury (mTBI) research has not been formally appraised in the literature. Objective To perform a systematic content analysis of mTBI-based press releases. Design Retrospective database study. Setting EurekAlert! (), the main distribution engine for scientific press releases. Participants Press releases indexed between January 1, 2012 and December 31, 2019 containing a minimum of 150 words. Interventions Preestablished, investigator-generated criteria delineating aspects of misinformation. Main Outcome Measurements Press releases were evaluated for manifestations of "spin," including misleading title, misleading reporting, misleading claims, and inappropriate extrapolation. Results Our database search yielded 125 entries within the specified time period. Of these, 66 met inclusion criteria. Fifty-five of 66 (83%) press releases exhibited at least one manifestation of spin. We identified 38 (58%) with misleading titles, 49 (74%) with misleading reporting, 44 (67%) with misleading claims, and 38 (58%) with inappropriate extrapolation. Conclusions Our analysis revealed a high degree of spin in recent press releases dedicated to mTBI research. The reports often overstated the strengths and practical impact of the study, publicize substandard research without clinical relevance, while downplaying or failing to report limitations and caveats. Misrepresentation in press releases can affect real-life medical decisions and outcomes.	[Choi, Ariel R.] Warren Alpert Med Sch, Program Liberal Med Educ, Providence, RI USA; [Feller, Edward R.] Brown Univ, Warren Alpert Med Sch, Dept Community Hlth, 222 Richmond St,Box G-M 264, Providence, RI 02912 USA		Feller, ER (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Community Hlth, 222 Richmond St,Box G-M 264, Providence, RI 02912 USA.	edward_feller@brown.edu					Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8; [Anonymous], HEALTHNEWSREVIEW; Apuke O, 2016, NEW MEDIA MASS COMMU, V53, P83, DOI [10.29333/ojcmt/2614, DOI 10.29333/OJCMT/2614]; Atarodi A., 2021, LIB PHILOS PRACT, V4848, P1; Autzen C, 2014, JCOM-J SCI COMMUN, V13; Boutron I, 2014, J CLIN ONCOL, V32, P4120, DOI 10.1200/JCO.2014.56.7503; Bratton Luke, 2019, Wellcome Open Res, V4, P148, DOI 10.12688/wellcomeopenres.15486.2; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Bussell CA, 2019, J INT NEUROPSYCH SOC, V25, P90, DOI 10.1017/S1355617718000760; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Caulfield T, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0064-2; Chiu K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002173; Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001; Fung AYH., 2020, PRIMARY CARE REVISIT, P67; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Grilli R., 2002, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858, 10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Haneef Romana, 2017, Res Integr Peer Rev, V2, P9, DOI 10.1186/s41073-017-0033-z; Haneef R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140889; Igic R, 2012, SCR MED-BRNO, V43, P78; Jain T, 2021, NAT REV GASTRO HEPAT, V18, P99, DOI 10.1038/s41575-020-00410-4; Jaques H, 2011, BMJ-BRIT MED J, V342, pC6921, DOI [10.1136/bmj.c6921, DOI 10.1136/BMJ.C6921]; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Lazarus C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0079-x; Lewis J, 2008, JOURNALISM STUD, V9, P1, DOI 10.1080/14616700701767974; Lin YL, 2020, J MED INTERNET RES, V22, DOI 10.2196/19982; MACNAMARA J, 2014, JOURNALISM PR UNPACK; Master CL, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-3-201402040-01002; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Morgan SE., 2020, HDB APPL COMMUNICATI, P897; Nguyen A., 2006, INF RES INT ELECT J, V11, pN3; Ohiagu OP, 2011, KIABARA J HUMANITIES, V16, P225; Peters C, 2010, JOURNALISM STUD, V11, P832, DOI 10.1080/14616701003658390; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Picard RG, 2014, DIGIT JOURNAL, V2, P273, DOI 10.1080/21670811.2014.895531; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Schafer MS., 2017, OXFORD HDB SCI SCI C, V51, P57; Schroeder JC, 2010, ENVIRON HEALTH PERSP, V118, pA58, DOI 10.1289/ehp.1001913; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Schwitzer G, 2014, JAMA INTERN MED, V174, P1183, DOI 10.1001/jamainternmed.2014.1359; Sellers P, 2009, CYCLES SPIN STRATEGI; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Stack ML, 2010, INT J LEADERSH EDUC, V13, P107, DOI 10.1080/13603120903121721; Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102; Sumner P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168217; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vera-Badillo FE, 2013, ANN ONCOL, V24, P1238, DOI 10.1093/annonc/mds636; Wang MTM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145294; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Wu SR, 2014, AM J GASTROENTEROL, V109, pS636, DOI 10.14309/00000434-201410002-02193; Wulfemeyer KT., 1985, J MASS MEDIA ETHICS, V1, P57; Yadamsuren B., 2010, P AM SOC INFORM SCI, V47, P1; Yavchitz A, 2016, J CLIN EPIDEMIOL, V75, P56, DOI 10.1016/j.jclinepi.2016.01.020; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308; Yousaf M., 2020, GLOBAL MEDIA J PAK E GLOBAL MEDIA J PAK E, V13, P36	61	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12656		JUL 2021	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	TN2ZL	WOS:000676108300001	34156765				2022-02-07	
J	Jones, KM; Starkey, N; Barker-Collo, S; Ameratunga, S; Theadom, A; Pocock, K; Borotkanics, R; Feigin, VL				Jones, Kelly M.; Starkey, Nicola; Barker-Collo, Suzanne; Ameratunga, Shanthi; Theadom, Alice; Pocock, Katy; Borotkanics, Robert; Feigin, Valery L.		BIONIC Study Grp	Parent and Teacher-Reported Child Outcomes Seven Years After Mild Traumatic Brain Injury: A Nested Case Control Study	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; quality of life; behavior; emotional adjustment; social participation (MeSH); executive function; children	QUALITY-OF-LIFE; EXECUTIVE FUNCTION; ADOLESCENT SCALE; HOSPITAL ANXIETY; HEALTH; PARTICIPATION; RELIABILITY; ATTENTION; VALIDITY; PEDSQL(TM)-4.0	Background: Increasing evidence suggests potential lifetime effects following mild traumatic brain injury (TBI) in childhood. Few studies have examined medium-term outcomes among hospitalized and non-hospitalized samples. Study aims were to describe children's behavioral and emotional adjustment, executive function (EF), quality of life, and participation at 7-years following mild TBI using parents' and teachers' reports. Methods: Nested case control study of 86 children (68% male, mean age at assessment = 11.27 years; range 7-17 years) who sustained a mild TBI 7-years previously, identified from a prospective, population-based study. They were compared to 69 children free from TBI (61% male, mean age at assessment = 11.12 years; range 5-17 years). In addition to parent-reported socio-demographic details, parents (mild TBI n = 86, non-TBI n = 69) completed age-appropriate standardized questionnaires about children's health-related quality of life, behavioral and emotional adjustment, EF, and social participation. Parents own mood was assessed using the Hospital Anxiety and Depression Scale. Teachers (mild TBI n = 53, non-TBI n = 42) completed questionnaires about children's behavioral and emotional adjustment, and EF. Results: Parent reports showed median group-level scores for cases were statistically significantly greater than controls for emotional symptoms, conduct problems, hyperactivity/inattention, total behavioral difficulties, inhibitory control, shifting, planning/organizing, and Global Executive Composite (total) EF difficulties (p-values 0.001-0.029). Parent reports of child quality of life and social participation were similar, as were teacher reports of child behavioral and emotional adjustment, and EF (p > 0.05). When examining clinical cut-offs, compared to controls, cases had a higher risk of parent-reported total EF difficulties (odds ratio = 3.00) and, to a lesser extent, total behavior problems (odds ratio = 2.51). Conclusions: As a group, children with a history of mild TBI may be at elevated risk for clinically significant everyday EF difficulties in the medium-term compared to non-TBI controls, as judged by their parents. Further multi-informant longitudinal research is required, following larger samples. Aspects requiring particular attention include pre-injury characteristics, such as sleep disturbances and comorbidities (e.g., headaches), that may act as potential confounders influencing the association between mild TBI and child behavioral problems.	[Jones, Kelly M.; Theadom, Alice; Pocock, Katy; Feigin, Valery L.] Auckland Univ Technol, Sch Clin Sci, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Div Arts Law Psychol & Social Sci, Hamilton, New Zealand; [Barker-Collo, Suzanne; Ameratunga, Shanthi] Univ Auckland, Fac Sci, Sch Psychol, Auckland, New Zealand; [Ameratunga, Shanthi] UCL, UCL Res Dept Epidemiol & Publ Hlth, London, England; [Borotkanics, Robert] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand		Jones, KM (corresponding author), Auckland Univ Technol, Sch Clin Sci, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	kelly.jones@aut.ac.nz			Waikato Medical Research Foundation [272]; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A, 11/192]	This research was supported by the Waikato Medical Research Foundation under Grant number WMRF 2016 #272. The original BIONIC study was funded by the Health Research Council of New Zealand under Grant numbers HRC 09/063A and 11/192.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chavez-Arana C, 2018, J PEDIATR PSYCHOL, V43, P928, DOI 10.1093/jpepsy/jsy013; Delobel-Ayoub M, 2006, PEDIATRICS, V117, P1996, DOI 10.1542/peds.2005-2310; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Golos A, 2016, NEUROREHABILITATION, V38, P311, DOI 10.3233/NRE-161322; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Ibm C., 2017, IBM SPSS STAT WINDOW; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lonigan CJ, 2009, J ABNORM CHILD PSYCH, V37, P387, DOI 10.1007/s10802-008-9284-y; Mahone EM, 2007, CLIN NEUROPSYCHOL, V21, P569, DOI 10.1080/13854040600762724; Matza LS, 2004, VALUE HEALTH, V7, P79, DOI 10.1111/j.1524-4733.2004.71273.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mellor D, 2004, PSYCHOL ASSESSMENT, V16, P396, DOI 10.1037/1040-3590.16.4.396; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Olsson CA, 2013, J HAPPINESS STUD, V14, P1069, DOI 10.1007/s10902-012-9369-8; PARKER S, 1988, PEDIATR CLIN N AM, V35, P1227; Perez-Edgar K, 2005, J COGN DEV, V6, P89, DOI 10.1207/s15327647jcd0601_6; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rothbart MK, 2003, J PERS, V71, P1113, DOI 10.1111/1467-6494.7106009; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Selvin S, 2015, BIOSTATISTICS TOOLBO, V1st, P578; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, J CLIN OUTCOMES MANA, V6, P33; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; World Health Organisation,, 2007, INT CLASS FUNCT DIS; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 23	2021	12								683661	10.3389/fneur.2021.683661			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TY4CB	WOS:000683730300001	34367050	Green Published, gold			2022-02-07	
J	Broggi, M; Ready, RE				Broggi, Michael; Ready, Rebecca E.			Academic skills, self-perceptions, and grades in university students with a history of multiple concussions: the mediating roles of processing speed and psychological symptoms	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; US HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; COLLEGE-STUDENTS; WORKING-MEMORY; RUGBY UNION; CHILDREN; IMPACT; DEPRESSION; OUTCOMES	Objective: This study determined if university students with a history of multiple concussions may be at risk for academic difficulties and poor academic performance. We investigated if executive functioning, processing speed, and/or psychological symptoms might partially account for differences in academic performance of students with and without a history of multiple concussions. Method: University students with a history of three or more concussions (n = 58), one concussion (n = 57), or no concussion (n = 57) completed academic, cognitive, and psychological assessments. Results: Students with a history of multiple concussions read fewer words per minute and reported more learning difficulties than the no concussion group. Processing speed mediated the association between concussion status and reading rate. Psychological symptoms mediated the association between concussion status and self-reported learning difficulties. Conclusion: University students with a history of multiple concussions may be at risk for poor academic outcomes due, at least in part, to slower processing speed and psychological symptoms.Treatment of psychological symptoms, cognitive rehabilitation to augment processing speed, and academic accommodations might improve academic outcomes for students with a history of three or more concussions.	[Broggi, Michael; Ready, Rebecca E.] Univ Massachusetts Amherst, Dept Psychol & Brain Sci, Tobin Hall 135 Hicks Way, Amherst, MA 01003 USA		Broggi, M (corresponding author), Univ Massachusetts Amherst, Dept Psychol & Brain Sci, Tobin Hall 135 Hicks Way, Amherst, MA 01003 USA.	mbroggi@umass.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Army Individual Tests Battery, 1944, MAN DIR SCOR; Ashcraft MH, 2007, PSYCHON B REV, V14, P243, DOI 10.3758/BF03194059; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Barkley R.A., 2011, BARKLEY ADULT ADHD R; Baskin TW, 2010, J COUNS PSYCHOL, V57, P290, DOI 10.1037/a0019652; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Breck J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17626; Broggi M, 2019, DYSLEXIA, V25, P256, DOI 10.1002/dys.1625; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown J, 1993, NELSON DENNY READING; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chapell MS, 2005, J EDUC PSYCHOL, V97, P268, DOI 10.1037/0022-0663.97.2.268; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; de Lijster JM, 2018, J AFFECT DISORDERS, V230, P108, DOI 10.1016/j.jad.2018.01.008; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeRoma V., 2009, COLL STUD J, V43, P325; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg D, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.2191; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gaultney JF, 2010, J AM COLL HEALTH, V59, P91, DOI 10.1080/07448481.2010.483708; Georgiou GK, 2015, J LEARN DISABIL-US, V48, P535, DOI 10.1177/0022219413513924; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes A, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00057; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P209, DOI 10.1080/09297049.2010.532204; Kane ST, 2011, J LEARN DISABIL-US, V44, P533, DOI 10.1177/0022219410392045; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Klassen RM, 2008, CONTEMP EDUC PSYCHOL, V33, P915, DOI 10.1016/j.cedpsych.2007.07.001; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lewandowski LJ, 2003, J PSYCHOEDUC ASSESS, V21, P134, DOI 10.1177/073428290302100202; Liebel SW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239097; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Mather N, 2014, TECHNICAL MANUAL WOO; Molfese DL, 2015, DEV NEUROPSYCHOL, V40, P1, DOI 10.1080/87565641.2015.1006479; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rieger B, 2019, J INT NEUROPSYCH SOC, V25, P777, DOI 10.1017/S1355617719000468; Rose LT, 2012, MIND BRAIN EDUC, V6, P1, DOI 10.1111/j.1751-228X.2011.01135.x; Savage R, 2005, BRAIN LANG, V93, P152, DOI 10.1016/j.bandl.2004.09.005; Schatschneider C, 2004, J EDUC PSYCHOL, V96, P265, DOI 10.1037/0022-0663.96.2.265; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stoodley CJ, 2006, NEUROSCI LETT, V399, P264, DOI 10.1016/j.neulet.2006.02.004; Stringaris A, 2012, J CHILD PSYCHOL PSYC, V53, P1109, DOI 10.1111/j.1469-7610.2012.02561.x; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wimmer H, 2010, DYSLEXIA, V16, P283, DOI 10.1002/dys.411; Zukerman G, 2019, AUTISM RES, V12, P1376, DOI 10.1002/aur.2129	76	0	0	2	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1958924		JUL 2021	17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UB4EU	WOS:000685801900001	34402398				2022-02-07	
J	Chan, ST; Ordway, C; Calvanio, RJ; Buonanno, FS; Rosen, BR; Kwong, KK				Chan, Suk-Tak; Ordway, Cora; Calvanio, Ronald J.; Buonanno, Ferdinando S.; Rosen, Bruce R.; Kwong, Kenneth K.			Cerebrovascular Responses to O-2-CO2 Exchange Ratio under Brief Breath-Hold Challenge in Patients with Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						breath-hold challenge; functional magnetic resonance imaging; mild traumatic brain injury; O-2-CO2 exchange ratio	CAROTID-ARTERY OCCLUSION; SURFACE-BASED ANALYSIS; REACTIVITY; VARIANCE	Breath-by-breath oxygen-carbon dioxide (O-2-CO2) exchange ratio (bER) is a respiratory gas exchange (RGE) metric, which is the ratio of the changes in the partial pressure of O-2 (Delta PO2) to CO2 (Delta PCO2) between end-inspiration and end-expiration, has been demonstrated to characterize the cerebrovascular responses to breath-hold challenge in healthy individuals. We aimed to explore whether bER could characterize cerebrovascular responses in patients with chronic mild traumatic brain injury (mTBI) under breath-hold challenge. We also investigated the correlation between bER and the severity of post-concussion symptoms. Blood-oxygenation-level-dependent (BOLD) images were acquired using functional magnetic resonance imaging (fMRI) on 10 patients with chronic mTBI and 10 controls without brain injury history when performing a breath-hold task. Time series of RGE metrics of Delta PO2, Delta PCO2, and bER were computed, and their cross-correlation with regional change in BOLD (Delta BOLD) was calculated. Symptom burden was assessed using the Rivermead Post Concussion Questionnaire (RPQ), and its correlation with RGE changes was also measured. Compared with controls, a diffuse decrease in the correlation between regional Delta BOLD and bER was found in the brain of patients with mTBI (p(fdr) < 0.05). No significant difference was found between patients and controls for the correlation of regional Delta BOLD with Delta PO2 and Delta PCO2. Symptom severity indicated by RPQ scores increased with a decrease in the averaged changes of bER (rho = 0.79, p = 0.01) and Delta PO2 (rho = 0.70, p = 0.03) in breath-hold epochs. Our imaging and symptom severity findings suggest that bER can be used to characterize cerebrovascular responses to breath hold in patients with mTBI. The RGE may contribute to the post-concussive symptom severity.	[Chan, Suk-Tak; Ordway, Cora; Rosen, Bruce R.; Kwong, Kenneth K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Calvanio, Ronald J.; Buonanno, Ferdinando S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Chan, ST (corresponding author), Athinoula A Martinos Ctr Biomed Imaging, Bldg 149,Thirteenth St,Room 2301, Charlestown, MA 02129 USA.	stchan@mgh.harvard.edu			National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896]; National Center for Complementary and Integrative Health (NCCIH) [R21AT010955];  [S10RR023043]	This research was performed in whole at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896, a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, as well as the Shared Instrumentation Grant S10RR023043. This study was also supported, in part, by National Center for Complementary and Integrative Health (NCCIH) grant (R21AT010955).	Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Chan ST, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225915; Cox RW, 2019, BRAIN CONNECT, V9, P529, DOI 10.1089/brain.2019.0666; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dodd AB, 2020, J CEREBR BLOOD F MET, V40, P2491, DOI 10.1177/0271678X19896883; DUBOIS AB, 1952, J APPL PHYSIOL, V5, P1; FERRIS EB, 1946, J CLIN INVEST, V25, P734, DOI 10.1172/JCI101757; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; HONG SK, 1971, J APPL PHYSIOL, V30, P540, DOI 10.1152/jappl.1971.30.4.540; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kansagara D., 2013, COMPLICATIONS MILD T; Kastrup A, 1999, AM J NEURORADIOL, V20, P1233; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Lindholm P, 2006, UNDERSEA HYPERBAR M, V33, P463; Lindholm P, 2002, EUR J APPL PHYSIOL, V86, P487, DOI 10.1007/s00421-002-0581-9; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; OTIS AB, 1948, AM J PHYSIOL, V152, P674, DOI 10.1152/ajplegacy.1948.152.3.674; Pillai JJ, 2015, AM J NEURORADIOL, V36, P7, DOI 10.3174/ajnr.A3941; Ratnatunga C, 1990, Eur J Vasc Surg, V4, P519, DOI 10.1016/S0950-821X(05)80795-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saad ZS, 2003, NEUROIMAGE, V18, P494, DOI 10.1016/S1053-8119(02)00024-1; Silvestrini M, 1999, ACTA NEUROL SCAND, V99, P187, DOI 10.1111/j.1600-0404.1999.tb07342.x; TALAIRACH J, 1988, COPLANAR STEREOTAXIC, P1988; Tancredi FB, 2013, J CEREBR BLOOD F MET, V33, P1066, DOI 10.1038/jcbfm.2013.48; Thomason ME, 2007, HUM BRAIN MAPP, V28, P59, DOI 10.1002/hbm.20241; Thomason ME, 2008, NEUROIMAGE, V39, P206, DOI 10.1016/j.neuroimage.2007.08.014; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	36	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2021	38	20					2851	2861		10.1089/neu.2021.0166		JUL 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WL5LP	WOS:000676013800001	34210158	Green Submitted			2022-02-07	
J	Coris, EE; Moran, B; Sneed, K; Del Rossi, G; Bindas, B; Mehta, S; Narducci, D				Coris, Eric E.; Moran, Byron; Sneed, Kevin; Del Rossi, Gianluca; Bindas, Bradford; Mehta, Shaan; Narducci, Dusty			Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article; Early Access						neurocognitive impairment; mild traumatic brain injury (mTBI); attention deficit; hyperactivity disorder (ADHD); stimulant medication	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; SICKLE-CELL-DISEASE; POSTCONCUSSION SYNDROME; HYPERACTIVITY DISORDER; VITAL SIGNS; METHYLPHENIDATE; CHILDREN; SYMPTOMS; ADHD	Context: There are 3.8 million mild traumatic brain injuries (mTBIs) that occur each year in the United States. Many are left with prolonged life-altering neurocognitive deficits, including difficulties in attention, concentration, mental fatigue, and distractibility. With extensive data on the safety and efficacy of stimulant medications in treating attention deficit, concentration difficulties and distractibility seen with attention deficit disorder, it is not surprising that interest continues regarding the application of stimulant medications for the persistent neurocognitive deficits in some mTBIs. Evidence Acquisition: Studies were extracted from PubMed based on the topics of neurocognitive impairment, mTBI, stimulant use in mTBI, stimulants, and the association between attention deficit/hyperactivity disorder and mTBI. The search criteria included a date range of 1999 to 2020 in the English language. Study Design: Literature review. Results: Currently, there is very limited literature, and no guidelines for evaluating the use of stimulant medication for the treatment of prolonged neurocognitive impairments due to mTBI. However, a limited number of studies have demonstrated efficacy and safety of stimulants in the treatment of neurocognitive sequelae of mTBI in the adult, pediatric, military, and athletic populations. Conclusion: There is limited evidence to suggest stimulant medication may be beneficial in patients with mTBI with persistent neurocognitive symtpoms. The decision to utilize stimulant medication for mTBI patients remains physician and patient preference dependent. Given the limited encouraging data currently available, physicians may consider stimulant medication in appropriate patients to facilitate the recovery of prolonged neurocognitive deficits, while remaining cognizant of potential adverse effects.	[Coris, Eric E.; Moran, Byron; Bindas, Bradford; Mehta, Shaan; Narducci, Dusty] USF Morsani Coll Med, Dept Family Med, Tampa, FL USA; [Coris, Eric E.; Moran, Byron; Del Rossi, Gianluca; Narducci, Dusty] USF Morsani Coll Med, Dept Orthoped & Sports Med, Tampa, FL USA; [Sneed, Kevin] USF Coll Pharm, Tampa, FL USA		Coris, EE (corresponding author), USF Morsani Coll Med, Dept Orthoped & Sports Med, Dept Family Med, 13330 Laurel Dr, Tampa, FL 33612 USA.	ecoris@usf.edu					Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; [Anonymous], 2013, DIAGN STAT MAN MENT; Arciniegas DB., BEHAV NEUROLOGY NEUR, V2013, P511; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bass Christopher, 2019, Pract Neurol, V19, P96, DOI 10.1136/practneurol-2018-001950; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Becquemont L, 2009, PHARMACOGENOMICS, V10, P961, DOI [10.2217/pgs.09.37, 10.2217/PGS.09.37]; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Childress AC, 2009, J CHILD ADOL PSYCHOP, V19, P351, DOI 10.1089/cap.2009.0007; Clendenin Aaron A, 2005, J Atten Disord, V8, P79, DOI 10.1177/1087054705277166; Conklin HM, 2009, PEDIATRICS, V124, P226, DOI 10.1542/peds.2008-1855; Cook NE, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.606879; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Daly B, 2012, J DEV BEHAV PEDIATR, V33, P244, DOI 10.1097/DBP.0b013e31824ba1b5; Daly BP, 2007, J PEDIATR PSYCHOL, V32, P1111, DOI 10.1093/jpepsy/jsm012; Diav-Citrin O, 2011, REPROD TOXICOL, V31, P540, DOI 10.1016/j.reprotox.2011.02.008; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrari R, 2005, ACAD EMERG MED, V12, P699, DOI 10.1197/j.aem.2005.03.531; Habel LA, 2011, JAMA-J AM MED ASSOC, V306, P2673, DOI 10.1001/jama.2011.1830; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Iaccarino MA, 2020, J ATTEN DISORD, V24, P309, DOI 10.1177/1087054718759752; International Olympic Committee, 2012, INT OLYMPIC COMMITTE; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jensen PS, 2001, J DEV BEHAV PEDIATR, V22, P60, DOI 10.1097/00004703-200102000-00008; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Nicholls E, 2012, POSTGRAD MED, V124, P78, DOI 10.3810/pgm.2012.09.2596; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Pare G, 2015, INFORM MANAGE-AMSTER, V52, P183, DOI 10.1016/j.im.2014.08.008; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Rapport MD, 2002, CLIN PSYCHOL REV, V22, P1107, DOI 10.1016/S0272-7358(02)00129-0; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Thompson SJ, 2001, J CLIN ONCOL, V19, P1802, DOI 10.1200/JCO.2001.19.6.1802; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; US Department of Health and Human Resources US Food and Drug Administration, FDA DRUG FACTS STIM FDA DRUG FACTS STIM; Veliz P, 2013, J STUD ALCOHOL DRUGS, V74, P714, DOI 10.15288/jsad.2013.74.714; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Webster J, 2002, MIS QUART, V26, pXIII; WHO, 1992, INT STAT CLASS DIS R; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P700, DOI 10.1097/CHI.0b013e31816bffdf; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000421; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960	82	0	0	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health											19417381211031842	10.1177/19417381211031842		JUL 2021	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TO4LT	WOS:000676886000001	34292098				2022-02-07	
J	Ferguson, L; Giza, CC; Serpa, RO; Greco, T; Robert, H; Folkerts, M; Prins, ML				Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Robert, Hannah; Folkerts, Michael; Prins, Mayumi L.			Sex Differences in Neurophysiological Changes Following Voluntary Exercise in Adolescent Rats	FRONTIERS IN NEUROLOGY			English	Article						adolescence; exercise; sex differences; BDNF; estrous cycle	TRAUMATIC BRAIN-INJURY; FOLLICLE-STIMULATING-HORMONE; RELATIVE ENERGY DEFICIENCY; FEMALE ATHLETE TRIAD; NEUROTROPHIC FACTOR; MENSTRUAL DISTURBANCES; REPRODUCTIVE HORMONES; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; HIPPOCAMPAL BDNF	Background: Adolescence is a period of time characterized by the onset of puberty and is marked by cognitive and social developments and gross physical changes that can play a role in athletic performance. Sex differences are present with differences in body size, height, physiology and behavior which contribute to differences in athletic performance as well. Pre-clinical studies representing this active group are lacking. Methods: Acute and chronic effects of exercise were evaluated. Male and female adolescent rats were given voluntary access to a running wheel for 10 consecutive days. Running behavior (males and females) and estrous cycling (females only) were analyzed daily. A second group was given 10 days of voluntary access to a running wheel, then rested for 10 days to determine the long-term effects of exercise on the adolescent brain. Brain and muscle tissue were harvested at 10 and 20 day time points to understand exercise-dependent changes in mitochondrial activity and neuroplasticity. Animal cohorts were carried out at two different sites: University of California Los Angeles and Pepperdine University. Results: On average, running distance, intensity of run, and length of running bout increased for both male and female rats across the 10 days measured. Females ran significantly further and for longer intervals compared to males. Cortical and muscle expression of PGC1 alpha showed similar levels at 10 days regardless of sex and exercise. There was a significant increase in expression at 20 days in all groups correlating with body size (p's < 0.05). Cortical and hippocampal levels of BDNF were similar across all groups, however, BDNF was significantly higher in exercised females at the acute compared to long-term time point. Discussion: Adolescent rats allowed 10 days of exercise show changes in physiologic function. There are sex differences in running behavior not impacted by sex hormones. These results are important to further our understanding of how exercise impacts the adolescent brain.	[Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Ferguson, Lindsay; Giza, Christopher C.; Serpa, Rebecka O.; Greco, Tiffany; Prins, Mayumi L.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Robert, Hannah; Folkerts, Michael] Pepperdine Univ, Dept Psychol, Seaver Coll, Malibu, CA USA		Ferguson, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.; Ferguson, L (corresponding author), Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA.	lmferguson@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021		National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS110757]; Easton Labs for Brain Injury; Steve Tisch BrainSPORT program at the University of California Los Angeles; Brain injury Research Center at the University of California Los Angeles	The work of the current project was in collaboration with the Social Science Division at Pepperdine University. It was supported in part by the National Institute of Health (NS110757, MP), Easton Labs for Brain Injury, and the Brain injury Research Center and Steve Tisch BrainSPORT program at the University of California Los Angeles.	Agarwal A, 2009, J PEDIATR ADOL GYNEC, V22, P365, DOI 10.1016/j.jpag.2009.02.005; [Anonymous], 2007, MED SCI SPORT EXER, V39, P1867, DOI 10.1249/mss.0b013e318149f111; Anto-Ocrah M, 2019, BRAIN INJURY, V33, P1449, DOI 10.1080/02699052.2019.1644377; ATTIE KM, 1990, J CLIN ENDOCR METAB, V71, P975, DOI 10.1210/jcem-71-4-975; BAGATELL CJ, 1990, FERTIL STERIL, V53, P688, DOI 10.1016/s0015-0282(16)53465-7; BAILEY DA, 1989, J BONE JOINT SURG AM, V71A, P1225, DOI 10.2106/00004623-198971080-00016; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Becu-Villalobos D, 1997, CELL MOL NEUROBIOL, V17, P699, DOI 10.1023/A:1022542221535; Bordini B, 2011, PEDIATR REV, V32, P223, DOI 10.1542/pir.32-6-223; Brook EM, 2019, SCAND J MED SCI SPOR, V29, P678, DOI 10.1111/sms.13385; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; Clark R., 2013, IMPULSE, P1; CUMMING DC, 1990, SEMIN REPROD ENDOCR, V8, P15, DOI 10.1055/s-2007-1021419; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; CUTLER GB, 1978, ENDOCRINOLOGY, V103, P2112, DOI 10.1210/endo-103-6-2112; DALE E, 1979, OBSTET GYNECOL, V54, P47, DOI 10.1097/00006250-197907000-00013; De Souza MJ, 2004, J CLIN ENDOCR METAB, V89, P3536, DOI 10.1210/jc.2003-032007; De Souza MJ, 2003, MED SCI SPORT EXER, V35, P1553, DOI 10.1249/01.MSS.0000084530.31478.DF; DESOUZA MJ, 1990, MED SCI SPORT EXER, V22, P575, DOI 10.1249/00005768-199010000-00006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; DING JH, 1988, ANN INTERN MED, V108, P530, DOI 10.7326/0003-4819-108-4-530; Dipla K, 2021, HORM-INT J ENDOCRINO, V20, P35, DOI 10.1007/s42000-020-00214-w; Elliott-Sale KJ, 2018, INT J SPORT NUTR EXE, V28, P335, DOI 10.1123/ijsnem.2018-0127; FEICHT CB, 1978, LANCET, V2, P1145; Ferguson L, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.616661; FitzGerald LZ, 2012, EUR J APPL PHYSIOL, V112, P3765, DOI 10.1007/s00421-012-2356-2; Fontoura-Andrade JL, 2017, ACTA CIR BRAS, V32, P251, DOI [10.1590/S0102-865020170030000010, 10.1590/s0102-865020170030000010]; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Gallego X, 2015, PHYSIOL BEHAV, V138, P28, DOI 10.1016/j.physbeh.2014.10.008; GERALL AA, 1973, PHYSIOL BEHAV, V10, P225, DOI 10.1016/0031-9384(73)90302-8; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gorzek JF, 2007, MED SCI SPORT EXER, V39, P248, DOI 10.1249/01.mss.0000241649.15006.b8; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hakimi O, 2017, SPORTS MED, V47, P1555, DOI 10.1007/s40279-016-0669-8; HAKKINEN K, 1991, EUR J APPL PHYSIOL O, V63, P194, DOI 10.1007/BF00233847; Hillen TIJ, 1999, J ADOLESCENT HEALTH, V25, P40, DOI 10.1016/S1054-139X(98)00147-5; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Joy E, 2014, CURR SPORT MED REP, V13, P219, DOI 10.1249/JSR.0000000000000077; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Kight KE, 2017, J NEUROSCI RES, V95, P345, DOI 10.1002/jnr.23920; Kim Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160245; Koehler K, 2016, J SPORT SCI, V34, P1921, DOI 10.1080/02640414.2016.1142109; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Leidy HJ, 2007, OBESITY, V15, P446, DOI 10.1038/oby.2007.542; Lightfoot JT, 2008, INT J BIOL SCI, V4, P126; Lou SJ, 2008, BRAIN RES, V1210, P48, DOI 10.1016/j.brainres.2008.02.080; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Maughan RJ., 1997, NUTR IN SPORT, P17; Mckay D, 2016, PEDIATR EXERC SCI, V28, P488, DOI 10.1123/pes.2016-0021; Miranda M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00363; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Negi Priyanka, 2018, J Family Med Prim Care, V7, P804, DOI 10.4103/jfmpc.jfmpc_159_17; PIRKE KM, 1990, CLIN ENDOCRINOL, V33, P345, DOI 10.1111/j.1365-2265.1990.tb00499.x; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Rocha PiedadeS., 2019, SPORTS MED PHYS; Romeo RD, 2013, CURR DIR PSYCHOL SCI, V22, P140, DOI 10.1177/0963721413475445; ROY EJ, 1975, J COMP PHYSIOL PSYCH, V89, P573, DOI 10.1037/h0077436; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; SCHWARTZ B, 1981, AM J OBSTET GYNECOL, V141, P662, DOI 10.1016/S0002-9378(15)33308-1; Scott KM., 2021, BRAD PHYS MED REHABI, V6, P431; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; SHANGOLD M, 1990, JAMA-J AM MED ASSOC, V263, P1665, DOI 10.1001/jama.263.12.1665; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spear LP, 2004, ANN NY ACAD SCI, V1021, P23, DOI 10.1196/annals.1308.002; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; VELDHUIS JD, 1987, J CLIN ENDOCR METAB, V65, P929, DOI 10.1210/jcem-65-5-929; Verma PB., 2011, NATL J INTEGR RES ME, V2, P38; Wagner G, 2015, J CEREBR BLOOD F MET, V35, P1570, DOI 10.1038/jcbfm.2015.125; WHEELER GD, 1984, JAMA-J AM MED ASSOC, V252, P514, DOI 10.1001/jama.252.4.514; Wiksten-Almstromer M, 2007, ACTA OBSTET GYN SCAN, V86, P65, DOI 10.1080/00016340601034970; Wilmore JH, 2003, PHYSICIAN SPORTSMED, V31, P45, DOI 10.3810/psm.2003.05.367; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yang B, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.95	78	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 22	2021	12								685822	10.3389/fneur.2021.685822			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UF2QK	WOS:000688423300001	34367052	gold, Green Published			2022-02-07	
J	Rashid, H; Mishra, S; Dobbin, N				Rashid, Haroon; Mishra, Smarak; Dobbin, Nick			Management of sport-related concussion in emergency departments in England: a multi-center study	BRAIN INJURY			English	Article						Traumatic brain injury; emergency medicine; survey	TRAUMATIC BRAIN-INJURY; STATEMENT	Objective: To establish the current knowledge of sport-related concussion (SRC) management of clinicians in emergency departments in the North West of England. Methods: A cross-sectional, multi-center study design was used and included emergency department clinicians (EDCs) across 15 centers in the North West of England. A 22-question survey was issued with questions focused on the 5th International Conference on Concussion Consensus Statement. Absolute and percentages were presented, and comparisons in knowledge of guidelines and confidence between EDCs were made using the Kruskal-Wallis test. Results: Of an estimated 300 EDCs, 111 (37%) responded. Thirty (27%) were aware of the guidelines, whilst 63 (57%) had heard of a graduated return-to-sport protocol. Physical rest was advised by 106 (95%) respondents, with 68 (61%) advising cognitive rest and 47 (42%) providing written advice. There was no difference (p > .05) in awareness of SRC guidelines or confidence between clinician grade, with most receiving no SRC training. Conclusions: There is a lack of knowledge amongst EDCs in the North West of England in managing and providing discharge advice to patients with SRC. This is likely due to the limited awareness of guidelines and training, and therefore further education delivery on SRC management guidelines is required.	[Rashid, Haroon] Manchester Royal Infirm, Dept Emergency Med, Manchester, Lancs, England; [Rashid, Haroon; Mishra, Smarak; Dobbin, Nick] Manchester Metropolitan Univ, Dept Hlth Profess, Manchester, Lancs, England		Rashid, H (corresponding author), Manchester Royal Infirm, Dept Med, Manchester, Lancs, England.	haroons@doctors.org.uk	Rashid, Haroon/AAW-4684-2021				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Carson JD, 2016, CAN FAM PHYSICIAN, V62, P494; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; DeMatteo C, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000667; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; Duignan M, 2016, INT EMERG NURS, V26, P47, DOI 10.1016/j.ienj.2015.11.005; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Headway, 2013, MILD BRAIN INJ GUID; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kipps C, 2017, BRIT J SPORT MED, V51, pA21, DOI [10.1136/bjsports-2016-097270.53, DOI 10.1136/BJSPORTS-2016-097270.53]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; National Institute for Health and Care Excellence, 2021, HEAD INJ ASS EARL MA; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Phillips T., 2017, BRIT J SPORT MED, V51, pA49.1, DOI [10.1136/bjsports-2016-097270.126, DOI 10.1136/BJSPORTS-2016-097270.126]; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; The Royal College of Emergency Medicine, 2016, CURR ASS SYST TRAIN; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	30	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1035	1042		10.1080/02699052.2021.1945146		JUL 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000675287300001	34288793	hybrid			2022-02-07	
J	Cameron, B; Burma, JS; Jasinovic, T; Lun, V; van Rassel, CR; Sutter, B; Wiley, JP; Schneider, KJ				Cameron, Ben; Burma, Joel S.; Jasinovic, Tin; Lun, Victor; van Rassel, Cody R.; Sutter, Bonnie; Wiley, J. Preston; Schneider, Kathryn J.			One-year stability of preseason Sport Concussion Assessment Tool 5 (SCAT5) values in university level collision and combative sport athletes	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Sport concussion assessment tool 5; sport-related concussion; sideline testing; standardized assessment of concussion; neurocognitive testing; balance assessment	BASE-LINE VALUES; HIGH-SCHOOL; ICE HOCKEY; RELIABILITY; EPIDEMIOLOGY	Objectives To determine the stability of the Sport Concussion Assessment Tool (SCAT) 5 between consecutive seasons in uninjured collision and combative varsity athletes. Methods Thirty-six athletes (19 females) were recruited to participate (wrestling [n = 12], rugby [n = 14], and hockey [n = 10]). The SCAT5 was administration at the start of the 2017 and 2018 seasons. Median baseline demographics for 2017 were as follows: age (19 years [range: 17-24 years]), height (174 cm [range: 149-195 cm]), and weight (76 kg [range: 57-118 kg]). Outcome metrics included subcomponents of the SCAT5: symptom reporting, standardized assessment of concussion (SAC), neurological screening, and balance performance measured with the modified balance error scoring system (mBESS). Wilcoxon signed-rank tests and Cronbach's alpha (alpha) values were calculated to determine the stability between consecutive years for the SCAT5 variables in the same cohort of athletes. Bonferroni corrections were applied for Wilcoxon signed-rank tests, where alpha = 0.006 (0.05/9). Results Between the 2017 and 2018 seasons, no differences were noted in symptom reporting (p = 0.14), SAC (p = 0.32), neurological screening (p = 0.98), and balance performance on the mBESS (p = 0.01). The Cronbach's alpha displayed unacceptable to questionable levels of within-subject stability (range: alpha = 0.34-0.70) for all subcomponents, except months in reverse order (alpha = 0.92). Conclusions While no statistical differences were present for all SCAT5 subcomponent metrics between 2017 and 2018 baselines, all but one displayed unacceptable to questionable stability (alpha <= 0.70) when retested one year later. Further research is needed to understand the appropriate time duration baseline SCAT5 values can reliably be utilized within longitudinal studies; as well as the normal variation of SCAT5 reporting/scoring.	[Cameron, Ben; Jasinovic, Tin; Lun, Victor; Wiley, J. Preston] Univ Calgary, Cumming Sch Med, Dept Family Med, Calgary, AB, Canada; [Cameron, Ben; Lun, Victor; Sutter, Bonnie; Wiley, J. Preston; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada; [Burma, Joel S.; van Rassel, Cody R.; Wiley, J. Preston; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Burma, Joel S.; Schneider, Kathryn J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn J.] Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB, Canada		Schneider, KJ (corresponding author), Sport Injury Prevent Res Ctr, Fac Kinesiol, KNB 3300D,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca		Burma, Joel/0000-0001-9756-5793	Canadian Academy for Sport and Exercise Medicine	The authors received unrestricted financial support of this study from the Canadian Academy for Sport and Exercise Medicine.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bunt SC, 2021, CLIN J SPORT MED, V31, pE229, DOI 10.1097/JSM.0000000000000788; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; CHRISTENSEN L, 1986, BEHAV THER, V17, P305, DOI 10.1016/S0005-7894(86)80060-0; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Dubas RL, 2021, J SPORT REHABIL, V30, P90, DOI 10.1123/jsr.2019-0307; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Jackson WT, 2019, MED CLIN N AM, V103, P251, DOI 10.1016/j.mcna.2018.10.005; Jasinovic T, 2021, PHYS THER SPORT, V51, P36, DOI 10.1016/j.ptsp.2021.06.008; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; NESSELROADE JR, 1986, PSYCHOL BEITR, V28, P255; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pierpoint LA, 2021, CLIN SPORT MED, V40, P1, DOI 10.1016/j.csm.2020.08.013; R Core Team, 2020, R LANG ENV STAT COMP; Romano J., 2006, ANN M FLOR ASS I RES; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Spencer FH, 2003, J CHILD NEUROL, V18, P5, DOI 10.1177/08830738030180010901; StataCorp, 2017, STATA STAT SOFTWARE; StataCorp, 2013, STATA STAT SOFTW REL; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Wise EA, 2004, J PERS ASSESS, V82, P50, DOI 10.1207/s15327752jpa8201_10; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	0	0	4	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1955225		JUL 2021	8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	TL8FQ	WOS:000675091800001	34283687				2022-02-07	
J	Hollin, G				Hollin, Gregory			"Learning to Listen to Them and Ask the Right Questions." Bennet Omalu, Scientific Objectivities, and the Witnessing of a Concussion Crisis	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						autobiography; chronic traumatic encephalopathy; scientific objectivity; neuropathology; science and technology studies; standpoint theories	CONFLICTS-OF-INTEREST; TRAUMATIC ENCEPHALOPATHY; REGULATORY OBJECTIVITY; MODE 2; SCIENCE; FOOTBALL; NEUROSCIENCE; MEDICINE; BEHAVIOR; INJURY	The death of American Football player Mike Webster has become foundational to narratives of sport's twenty-first century concussion crisis. Bennet Omalu, the neuropathologist who conducted Webster's autopsy and subsequently diagnosed Webster with Chronic Traumatic Encephalopathy (CTE), has, likewise, become a central figure in the concussion crisis. Indeed, it is frequently argued that there is something about Omalu in particular that made it possible for him to "witness " CTE when the disease entity had hitherto remained invisible to a great many medics and scientists. In this article, and drawing upon auto/biographies, I consider Omalu's self-described mode of scientific witnessing which purportedly allowed him to (re)discover CTE. I find Omalu's described objectivity to be shaped by three factors: First, the importance of "trained judgment " within which Omalu's scientific training is emphasized. Second, the infusion of religiosity within scientific practice. Third, a self-described position as an "outsider " to both football and American culture. Throughout this analysis, I pay attention not only to the ways in which Omalu's narratives depart from conventional depictions of scientific objectivity; I also note the similarities with particular bodies of social scientific work, most notably within a feminist "turn to care " in Science and Technology Studies (STS) and related standpoint epistemologies. Following these analyses, I argue that, first, Omalu's writing affords the dead a "response-ability " that is often absent within analyses of the concussion crisis and, second, that a focus upon diverse forms of objectivity, such as those described in Omalu's work, complements existing work into concussion science that has foregrounded scientific conflict of interest.	[Hollin, Gregory] Univ Leeds, Sch Sociol & Social Policy, Leeds, W Yorkshire, England		Hollin, G (corresponding author), Univ Leeds, Sch Sociol & Social Policy, Leeds, W Yorkshire, England.	g.hollin@leeds.ac.uk			Wellcome Trust Research Fellowship in Humanities and Social Science [212694/Z/18/Z]	This research was undertaken as part of a larger project entitled Hard Knock Life: Negotiating concussion and dementia in sport. This project has been made possible by the award of a Wellcome Trust Research Fellowship in Humanities and Social Science (212694/Z/18/Z).	ABIRAM PG, 1991, ISIS, V82, P326, DOI 10.1086/355756; Almond S., 2014, FOOTBALL ONE FANS RE; Bachynski K.E., 2019, STUDIES SOCIAL MED, DOI [10.5149/northcarolina/9781469653709.001.0001, DOI 10.5149/NORTHCAROLINA/9781469653709.001.0001]; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Baugh CM, 2020, J LAW MED ETHICS, V48, P307, DOI 10.1177/1073110520935342; Belson K., 2015, NEW YORK TIMES, P4; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; Cambrosio A, 2006, SOC SCI MED, V63, P189, DOI 10.1016/j.socscimed.2005.12.007; Cambrosio A, 2009, SOC STUD SCI, V39, P651, DOI 10.1177/0306312709334640; Candea M, 2013, THEOR CULT SOC, V30, P105, DOI 10.1177/0263276413501204; Casper ST, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112688; Casper ST, 2019, LANCET NEUROL, V18, P522, DOI 10.1016/S1474-4422(19)30158-9; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Casper ST, 2018, CAN MED ASSOC J, V190, pE140, DOI 10.1503/cmaj.171204; Cetina K.K, 1999, EPISTEMIC CULTURES S; Daston L., 2010, OBJECTIVITY PAPERBAC; de la Bellacasa MP, 2011, SOC STUD SCI, V41, P85, DOI 10.1177/0306312710380301; Desilets S., 2019, YEARS WORK STUDIES F, P198, DOI [10.2307/j.ctvr7f74x.13, DOI 10.2307/J.CTVR7F74X.13]; Despret V., 2016, WHAT WOULD ANIMALS S; Dotson-Pierson C., 2019, STUDIES HLTH COMMUNI; Doward J., 2020, GUARDIAN; Dumit J., 2012, DRUGS LIFE PHARM CO; Endedijk B., 2020, EVIDENCE BRAIN DAMAG; Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Fitzgerald D., 2017, IN VIVO CULTURAL MED; Foucault M., 2005, HERMENEUTICS SUBJECT; Foucault M., 1984, USE PLEASURE HIST SE, V2; Foucault M., 1977, LANGUAGE COUNTER MEM, P139; Grano DA, 2020, COMMUN CRIT-CULT STU, V17, P339, DOI 10.1080/14791420.2020.1820058; Greenhough B, 2011, ENVIRON PLANN D, V29, P47, DOI 10.1068/d17109; Haraway, 2019, AUTOBIOGRAPHY STUDIE, V34, P565, DOI DOI 10.1080/08989575.2019.1664163; HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066; Haraway D., 2008, SPECIES MEET; Haraway D.J., 1997, MODEST WITNESS 2 MIL; Haraway Donna., 2016, STAYING TROUBLE MAKI; Haraway Donna, 1992, PRIMATE VISIONS GEND; Harding S., 1991, WHOSE SCI WHOSE KNOW; Harding S., 1993, FEMINIST EPISTEMOLOG, P49; Harding S, 2015, INT SOC HIST PHIL SO; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Henne K, 2020, CRIME MEDIA CULT, V16, P395, DOI 10.1177/1741659019879888; Hobson W., 2020, WASH POST; Huff C, 2019, AUTOBIOGRAP STUD, V34, P375, DOI [10.1080/08989575.2019.1664167, DOI 10.1080/08989575.2019.1664167]; Keller E.F., 1984, FEELING ORGANISM 10; Kelly M.G., 2013, COMPANION FOUCAULT, P510, DOI [10.1002/9781118324905.ch26, DOI 10.1002/9781118324905.CH26]; Kohn E, 2013, FORESTS THINK ANTHR, DOI [10.1525/9780520956865, DOI 10.1525/9780520956865]; Kristeva Julia, 1982, POWERS HORROR ESSAY; Landesman P., 2015, CONCUSSION; Laskas J.M., 2015, CONCUSSION; Leavy J., 2012, WOMAN WHO WOULD SAVE; Malcolm D., 2020, CONCUSSION CRISIS SP, DOI [10.4324/9780429292408, DOI 10.4324/9780429292408]; Martin A, 2020, BIOSOCIETIES, DOI 10.1057/s41292-020-00209-1; MARTIN E, 1991, SIGNS, V16, P485, DOI 10.1086/494680; McKay RA, 2017, PATIENT ZERO MAKING, DOI [10.7208/chicago/9780226064000.001.0001, DOI 10.7208/CHICAGO/9780226064000.001.0001]; McKee A., 2019, NEUR DIAGN CHRON TRA; Murphy M., 2006, SICK BUILDING SYNDRO, DOI [10.1215/9780822387831, DOI 10.1215/9780822387831]; Murphy M., 2012, SEIZING MEANS REPROD, DOI [10.2307/j.ctv125jmpm, DOI 10.2307/J.CTV125JMPM]; Nowinski C., 2007, HEAD GAMES FOOTBALLS; Nowotny H, 2003, MINERVA, V41, P179, DOI 10.1023/A:1025505528250; O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; Omalu B., 2017, TRUTH DOESNT HAVE SI; Omalu B., 2008, PLAY HARD YOUNG FOOT; Omalu B., 2020, WE ARE BECOMING NATI; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oreskes N, 2010, NATURE, V465, P686, DOI 10.1038/465686a; Outram D., 1996, TELLING LIVES SCI ES, P85, DOI [10.1017/CBO9780511525292.004, DOI 10.1017/CBO9780511525292.004]; Pandian A., 2019, POSSIBLE ANTHR METHO, DOI [10.1215/9781478004370, DOI 10.1215/9781478004370]; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Puig de la Bellacasa M., 2017, MATTERS CARE SPECULA, DOI [10.5406/illinois/9780252037573.003.0011, DOI 10.5406/ILLINOIS/9780252037573.003.0011]; Rees T., 2016, PLASTIC REASON ANTHR, DOI [10.1525/california/9780520288126.001.0001, DOI 10.1525/CALIFORNIA/9780520288126.001.0001]; Roosth S., 2017, SYNTHETIC LIFE GOT M, DOI [10.7208/chicago/9780226440637.001.0001, DOI 10.7208/CHICAGO/9780226440637.001.0001]; Roy D., 2018, MOL FEMINISMS BIOL B; Sandel E., 2020, SHAKEN BRAIN SCI CAR, DOI [10.4159/9780674246324, DOI 10.4159/9780674246324]; SHAPIN S., 1985, LEVIATHAN AIR PUMP H; Shoemaker D., 2014, SQUARED CIRCLE LIFE; Shortland M., 1988, SCI PUBL POL, V15, P170; Shortland M., 1996, TELLING LIVES SCI ES, P1; Soderqvist Thomas, 2002, J Hist Neurosci, V11, P38, DOI 10.1076/jhin.11.1.38.9099; Squire L.R., 2011, HIST NEUROSCIENCE AU, V7; Stengers I., 1997, POWER INVENTION SITU; Van Dooren T., 2014, FLIGHT WAYS LIFE LOS, DOI [10.7312/vand16618, DOI 10.7312/VAND16618]; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Willey A, 2016, SCI TECHNOL HUM VAL, V41, P991, DOI 10.1177/0162243916658707; Wylie S., 2018, FRACTIVISM CORPORATE	87	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUL 21	2021	3								672749	10.3389/fspor.2021.672749			12	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TU5CS	WOS:000681055000001	34368758	gold, Green Published			2022-02-07	
J	Howland, J; Campbell, J; Thomas, R; Smyth, S; Chaneco, A; Torres, A; Olshaker, J				Howland, Jonathan; Campbell, Julia; Thomas, Rebekah; Smyth, Steven; Chaneco, Aynsley; Torres, Alcy; Olshaker, Jonathan			An Evaluation of Post-Concussion Return to School Guidelines: A Survey of Massachusetts School Nurses	JOURNAL OF SCHOOL NURSING			English	Article; Early Access						mild traumatic brain injury; concussion; school nursing; return to school; policy; traumatic brain injury; return to learn	CHILDREN; SYMPTOMS	Although all states have legislation pertaining to youth sports concussion, most of these laws focus on return-to-play procedures; only a few address return-to-learn (RTL) accommodations for students who have experienced a concussion. To address this gap in the legislation, some states and nongovernmental organizations have developed RTL guidelines to advise school personnel, parents, and health care providers on best practices for accommodating students' postconcussion reintegration into academic activity. In 2018, the Massachusetts Department of Public Health (MDPH) developed RTL guidelines which were disseminated to school nurses (SNs) at all public and nonpublic middle and high schools in the state. In 2020, the MDPH engaged the Injury Prevention Center at Boston Medical Center to survey Massachusetts SNs to assess the usefulness of the guidelines. The response rate was 63%; 92% found the booklet extremely useful or moderately useful; and 70% endorsed that the booklet fostered collaboration among stakeholders.	[Howland, Jonathan; Campbell, Julia; Olshaker, Jonathan] Boston Med Ctr, Dept Emergency Med, 800 Harrison Ave,BCD Bldg,2nd Floor, Boston, MA 02118 USA; [Howland, Jonathan; Olshaker, Jonathan] Boston Univ, Sch Med, Dept Emergency Med, Boston, MA 02118 USA; [Howland, Jonathan; Campbell, Julia; Torres, Alcy; Olshaker, Jonathan] Boston Med Ctr, Injury Prevent Ctr, Boston, MA USA; [Thomas, Rebekah; Smyth, Steven; Chaneco, Aynsley] Massachusetts Dept Publ Hlth, Boston, MA USA; [Torres, Alcy] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Torres, Alcy] Boston Med Ctr, Dept Neurol, Boston, MA USA		Howland, J (corresponding author), Boston Med Ctr, Dept Emergency Med, 800 Harrison Ave,BCD Bldg,2nd Floor, Boston, MA 02118 USA.	jhowl@bu.edu		Campbell, Julia/0000-0002-2674-1830	Massachusetts Department of Public Health through CDC [NU17CE924835]	This research was made possible through funding from the Massachusetts Department of Public Health through CDC grant NU17CE924835. The thoughts and opinions in this report do not necessarily reflect the opinions of the Massachusetts Department of Public Health.	Breiding M.J, 2014, SURVEILLANCE REPORT, P24; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Halstead ME, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-3194; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanson Holly R, 2019, Inj Epidemiol, V6, P23, DOI 10.1186/s40621-019-0207-x; Howland J, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000959; Howland J, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00240-7; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Kriz PK, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117737307; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; Massachusetts Department of Public Health, 2018, GUID MASS SCH; McAvoy K, 2020, J SCHOOL HEALTH, V90, P849, DOI 10.1111/josh.12949; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Newton A, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00283-w; O'Hara K, 2020, CUREUS, V12, DOI 10.7759/cureus.7691; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	23	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.											10598405211032210	10.1177/10598405211032210		JUL 2021	9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	TO4UX	WOS:000676909800001	34287070				2022-02-07	
J	Kennedy, E; Chapple, C; Quinn, D; Tumilty, S				Kennedy, Ewan; Chapple, Cathy; Quinn, Dusty; Tumilty, Steve			Can the neck contribute to persistent symptoms post concussion? Long-term follow up from a prospective descriptive case series	JOURNAL OF MANUAL & MANIPULATIVE THERAPY			English	Article						Brain concussion; cervical spine; physiotherapy	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; MANUAL THERAPY; CERVICOGENIC DIZZINESS; PHYSICAL-THERAPY; POPULATION; REHABILITATION; EPIDEMIOLOGY; RELIABILITY; DISORDERS	Objective: To describe individual long-term outcomes of people with persistent symptoms following a concussion who received neck treatment as part of multidisciplinary concussion care. A secondary objective is to report on how participants describe the outcomes of neck treatmentMethods: Long-term follow-up for a subgroup of participants in a prospective case series (n = 11). Data were collected at initial assessment, completion of neck treatment, 6 and 12 months including standard questionnaires (Rivermead post-concussion symptoms questionnaire, neck disability index, dizziness handicap inventory); patient-reported measures of headache, dizziness and neck pain and participant descriptions of the effects of neck treatmentResults: Grouped measures of post-concussion symptoms were further improved or sustained at 6 and 12 months. Ten of the 11 participants reported neck treatment as a beneficial part of their care and described the effects on the neck, multiple symptoms and their overall recovery. However, seven participants experienced recurrent headache, neck pain or dizziness at 6- or 12-month follow-up.Conclusion: Long-term follow-up of individuals receiving neck treatment shows improvement across a range of patient reported outcomes, yet highlights frequent recurrence of symptoms. Neck treatment can play a valuable role in people's recovery that extends beyond local effects on the neck.	[Kennedy, Ewan; Chapple, Cathy; Tumilty, Steve] Univ Otago, Sch Physiotherapy, Div Hlth Sci, Dunedin, New Zealand; [Quinn, Dusty] Back Mot Ltd, Dunedin, New Zealand		Kennedy, E (corresponding author), Univ Otago, Sch Physiotherapy, Dunedin, New Zealand.	ewan.kennedy@otago.ac.nz		Kennedy, Ewan/0000-0002-7341-5309; Chapple, Cathy/0000-0001-5141-8376	Postdoctoral Fellowship in Orthopaedic Manual Therapy at the School of Physiotherapy, University of Otago, New Zealand	This research was supported by a Postdoctoral Fellowship in Orthopaedic Manual Therapy at the School of Physiotherapy, University of Otago, New Zealand and held by Dr Ewan Kennedy. This Postdoctoral position was enabled by a generous bequest from the Alumni of the University of Otago in America, Inc. The authors affirm that they have no financial affiliation (including research funding) or involvement with any commercial organization that has a direct financial interest in any matter included in this manuscript.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bialosky Joel E, 2018, J Orthop Sports Phys Ther, V48, P8, DOI 10.2519/jospt.2018.7476; Borrell-Carrio F, 2004, ANN FAM MED, V2, P576, DOI 10.1370/afm.245; Carey TS, 2003, SPINE, V28, P1631, DOI 10.1097/00007632-200308010-00001; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Gunter KB, 2018, J ORTHOP SPORT PHYS, V48, P934, DOI 10.2519/jospt.2018.8214; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kennedy Ewan, 2019, J Orthop Sports Phys Ther, V49, P845, DOI 10.2519/jospt.2019.8547; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Kovanur-Sampath K, 2017, MUSCULOSKEL SCI PRAC, V29, P120, DOI 10.1016/j.msksp.2017.04.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Reid SA, 2015, MANUAL THER, V20, P148, DOI 10.1016/j.math.2014.08.003; Reid SA, 2014, ARCH PHYS MED REHAB, V95, P1603, DOI 10.1016/j.apmr.2014.04.009; Sampath KK, 2015, MED HYPOTHESES, V85, P819, DOI 10.1016/j.mehy.2015.10.003; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P140, DOI 10.1016/j.msksp.2019.05.007; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P151, DOI 10.1016/j.msksp.2019.01.006; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; van der Walt K, 2019, MUSCULOSKEL SCI PRAC, V39, P130, DOI 10.1016/j.msksp.2018.12.004; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	39	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1066-9817	2042-6186		J MAN MANIP THER	J. Man. Manip Ther.	SEP 3	2021	29	5					318	331		10.1080/10669817.2021.1920276		JUL 2021	14	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	UZ3LP	WOS:000674805600001	34279185				2022-02-07	
J	Merz, ZC; Lichtenstein, JD; Lace, JW				Merz, Zachary C.; Lichtenstein, Jonathan D.; Lace, John W.			Methodological considerations of assessing meaningful/reliable change in computerized neurocognitive testing following sport-related concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						ImPACT; regression to the mean; reliable change index; regression-based metrics; sport-related concussion	TEST-RETEST RELIABILITY; NORMATIVE DATA; IMPACT; MANAGEMENT; ASSESSMENTS; REGRESSION; RECOVERY; POSITION	Objective Traditional reliable change index (RCI) methods may be psychometrically limited due to their inability to account for particularly high or low baseline performance and regression to the mean following serial testing. The current study sought to examine differences between RCI and standardized regression-based (RBz) methods in a cohort of adolescent athletes engaged in sport-related concussion recovery. Methods Consultation records and results of computerized testing data via the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery were retrospectively reviewed among 240 adolescent athletes involved in return-to-play protocols following a sport-related concussion. Results High concordance rates were found between RCI and RBz metrics across ImPACT composites, consistent with previous literature. However, especially for those with lower baseline performance, RBz scores tended to suggest cognitive performance not meeting or exceeding baseline scores despite RCI metrics being appropriate across speed-based ImPACT composites. In contrast, results revealed high rates of RCI scores suggesting continued cognitive difficulties despite RBz metrics being within normal limits, especially for adolescents with higher baseline performance. Conclusions Results suggest value in interpreting RBz values in addition to RCI values as these allow for clinical interpretation more sensitive to statistical confounds, including baseline performance and regression to the mean.	[Merz, Zachary C.] Moses Cone Mem Hosp, LeBauer Dept Neurol, Greensboro, NC USA; [Lichtenstein, Jonathan D.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Dept Psychiat, Lebanon, NH 03756 USA; [Lichtenstein, Jonathan D.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Dept Pediat, Lebanon, NH 03756 USA; [Lichtenstein, Jonathan D.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, One Med Ctr Dr, Lebanon, NH 03756 USA; [Lace, John W.] Cleveland Clin, Sect Neuropsychol, Neurol Inst, Cleveland, OH 44106 USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, One Med Ctr Dr, Lebanon, NH 03756 USA.; Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Dept Psychiat, Pediat, One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@dartmouth.edu		Lichtenstein, Jonathan/0000-0002-9658-5992			Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barr William B, 2002, CNS Spectr, V7, P300; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Elbin RJ, 2019, J CLIN NEUROSCI, V62, P138, DOI 10.1016/j.jocn.2018.11.041; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P146, DOI 10.1007/s12207-019-09350-0; Lichtenstein JD, 2018, APPL NEUROPSYCH-CHIL, V7, P334, DOI 10.1080/21622965.2017.1340158; Lovell M.R., 2011, IMPACT TECHNICAL MAN, V2013; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P69, DOI 10.1080/87565641.2015.1014089; Maerlender AC, 2016, J CLIN EXP NEUROPSYC, V38, P869, DOI 10.1080/13803395.2016.1168781; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M., 2000, SCORING INTERPRETATI, V2nd; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; Messa I, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1866676; O'Brien AM, 2018, APPL NEUROPSYCH-CHIL, V7, P208, DOI 10.1080/21622965.2017.1290529; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066	43	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1952413		JUL 2021	9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TN1WB	WOS:000676031900001	34293970				2022-02-07	
J	Shore, O; Chen, P; Korah, T				Shore, Oliver; Chen, Pauline; Korah, Tessy			Electroconvulsive Therapy Trauma-Related Nightmares: A Case Report and Commentary	CUREUS			English	Article						trauma-focused psychological therapy; trauma-related nightmares; post-traumatic stress disorder; electroconvulsive therapy; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; SEXUAL ASSAULT SURVIVORS; SLEEP DISTURBANCES; EFFICACY	Trauma-related nightmares (TRN), one of the most reported symptoms of posttraumatic stress disorder (PTSD), may not always respond to current pharmacologic and therapeutic treatments. Validity of electroconvulsive therapy (ECT), which is used worldwide in clinical treatment for a broad range of neuropsychiatric conditions, is investigated as a potential therapeutic option for TRN in this report. A case of a 39-year-old male with a history of severe combat-related PTSD, major depressive disorder, history of traumatic brain injury, suicidal ideations, and persistent TRN is discussed here. Successful treatment outcome of this case with six sessions of right unilateral ECT is presented. On initial presentation, the patient had a Patient Health Questionnaire-9 (PHQ-9) score of 27 and a Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) score of 77. After six sessions of ECT, the patient had a PHQ-9 score of 3 and a PCL-5 score of 45. Furthermore, the rationale and potential mechanisms of action underlying the ECT treatment for treatment-resistant PTSD and TRN are also reviewed in this report.	[Shore, Oliver; Chen, Pauline; Korah, Tessy] Univ Florida, Psychiat, Gainesville, FL 32611 USA		Korah, T (corresponding author), Univ Florida, Psychiat, Gainesville, FL 32611 USA.	korah@ufl.edu					Ahmadi N, 2016, DEPRESS ANXIETY, V33, P640, DOI 10.1002/da.22451; Akkaoui MA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123990; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andrade C, 2016, EXPERT REV NEUROTHER, V16, P749, DOI 10.1080/14737175.2016.1179114; Balliett N. E., 2014, MILITARY BEHAV HLTH, V2, P337, DOI [10.1080/21635781.2014.963763, DOI 10.1080/21635781.2014.963763]; Dukart J, 2014, P NATL ACAD SCI USA, V111, P1156, DOI 10.1073/pnas.1321399111; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Fosse Roar, 2013, Front Psychiatry, V4, P94, DOI 10.3389/fpsyt.2013.00094; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Krakow B, 2001, J TRAUMA STRESS, V14, P647, DOI 10.1023/A:1013029819358; Lavie P, 2001, NEW ENGL J MED, V345, P1825, DOI 10.1056/NEJMra012893; Leiknes KA, 2012, BRAIN BEHAV, V2, P283, DOI 10.1002/brb3.37; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nielsen TA, 2005, NATURE, V437, P1286, DOI 10.1038/nature04288; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Pompili M, 2013, SCHIZOPHR RES, V146, P1, DOI 10.1016/j.schres.2013.02.005; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Takano H, 2007, BRIT J PSYCHIAT, V190, P63, DOI 10.1192/bjp.bp.106.023036; Tendolkar I, 2013, PSYCHIAT RES-NEUROIM, V214, P197, DOI 10.1016/j.pscychresns.2013.09.004; Youssef NA, 2017, ANN CLIN PSYCHIATRY, V29, P62	21	0	0	2	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 21	2021	13	7							e16546	10.7759/cureus.16546			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS9OY	WOS:000679981500020	34430153	gold, Green Published			2022-02-07	
J	Vallat-Azouvi, C; Swaenepoel, M; Ruet, A; Bayen, E; Ghout, I; Nelson, G; Pradat-Diehl, P; Meaude, L; Aegerter, P; Charanton, J; Jourdan, C; Azouvi, P				Vallat-Azouvi, Claire; Swaenepoel, Marie; Ruet, Alexis; Bayen, Eleonore; Ghout, Idir; Nelson, Gaelle; Pradat-Diehl, Pascale; Meaude, Layide; Aegerter, Philippe; Charanton, James; Jourdan, Claire; Azouvi, Philippe			Relationships between neuropsychological impairments and functional outcome eight years after severe traumatic brain injury: Results from the PariS-TBI study	BRAIN INJURY			English	Article						Traumatic brain injury; disability; outcome; cognition; neuropsychology	QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; ECOLOGICAL VALIDITY; DISABILITY; SCALE; REHABILITATION; MODERATE	Background/objectives The objective was to assess the relationships between neuropsychological impairments, functional outcome and life satisfaction in a longitudinal study of patients after a severe traumatic brain injury (TBI) (PariS-TBI study). Patients Out of 243 survivors, 86 were evaluated 8 years post-injury. They did not significantly differ from patients lost-to-follow up except for the latter being more frequently students or unemployed before the injury. Methods Outcome measures included the Glasgow Outcome Scale-Extended (GOS-E), a functional independence questionnaire, employment, mood, fatigue and satisfaction with life. Neuropsychological outcome was assessed by two ways: performance-based outcome measures, using neuropsychological tests and patient and relative-based measures. Results Neuropsychological measures were not significantly related to initial injury severity nor to gender, but were significantly related to age and education. After statistical correction for multiple comparisons, cognitive testing and cognitive questionnaires were significantly correlated with most outcome measures. By contrast, satisfaction with life was only related with patient-rated questionnaires. A regression analysis showed that the Trail-Making-Test-A was the best predictor of functional outcome, in addition to education duration. Conclusions Cognitive measures, particularly slowed information processing speed, were significant indicators of functional outcome at a long-term post-injury, beyond and above demographics or injury severity measures.	[Vallat-Azouvi, Claire] Univ Paris 8 St Denis, UR Fonctionnement & Dysfonctionnement Cognitifs A, St Denis, France; [Vallat-Azouvi, Claire; Swaenepoel, Marie] Hop Raymond Poincare, Antenne UEROS UGECAM IDF, Garches, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Paris Saclay, Team DevPsy, CESP, INSERM,UVSQ, Villejuif, France; [Ruet, Alexis] CHU Caen, Serv Med Phys & Readaptat, Caen, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Paris Sorbonne Univ, Paris, France; [Ghout, Idir; Meaude, Layide; Aegerter, Philippe] Hop Ambroise Pare, AP HP, Unite Rech Clin URC, Boulogne, France; [Nelson, Gaelle; Charanton, James] Ctr Ressources Francilien Traumatisme Cranien CRF, Paris, France; [Jourdan, Claire] CHU Montpellier, Serv Med Phys & Readaptat, Montpellier, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France		Vallat-Azouvi, C (corresponding author), Univ Paris 8 St Denis, UR Fonctionnement & Dysfonctionnement Cognitifs A, St Denis, France.	claire.vallat-azouvi@univ-paris8.fr	AEGERTER, Philippe/AAY-6003-2021; RUET, Alexis/L-8726-2015	AEGERTER, Philippe/0000-0002-9156-5028; RUET, Alexis/0000-0002-5080-5734	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement) - Institut de recherche en sante publique (IRESP)	The authors thank all members of the CRFTC Steering Committee (Centre Ressource Francilien du Traumatisme Cranien) for their valuable help. The first part of this study and the eight-year evaluation was funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004 and 2012, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study was funded by a grant from the Institut de recherche en sante publique (IRESP).	Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Azerad, 2017, CLIN REHABIL, V1; Azerad S., 2015, J HEAD TRAUMA REHAB, V19; Azerad S., 2014, NEUROPSYCHOL REHABIL, V18, P1; Azerad S., 2017, J HEAD TRAUMA REHAB, V5; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Delis DC, 1987, CALIFORNIA VERBAL LE; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2021, ARCH PHYS MED REHAB, V102, P371, DOI 10.1016/j.apmr.2020.09.387; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruet A, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.07.005; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Sakai S., 2018, BRAIN INJURY, V23, P1; Sigurdardottir S, 2020, J INT NEUROPSYCH SOC, V26, P654, DOI 10.1017/S1355617720000193; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stamatakis EA., 2020, J NEUROL NEUROSUR PS, V2; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wechsler D., 2011, WAIS 4; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	48	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1001	1010		10.1080/02699052.2021.1933180		JUL 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000675139100001	34283665				2022-02-07	
J	Balakrishnan, B; VanDongen-Trimmer, H; Kim, I; Hanson, SJ; Zhang, LY; Simpson, PM; Farias-Moeller, R				Balakrishnan, Binod; VanDongen-Trimmer, Heather; Kim, Irene; Hanson, Sheila J.; Zhang, Liyun; Simpson, Pippa M.; Farias-Moeller, Raquel			GCS-Pupil Score Has a Stronger Association with Mortality and Poor Functional Outcome than GCS Alone in Pediatric Severe Traumatic Brain Injury	PEDIATRIC NEUROSURGERY			English	Article						Outcomes; Pediatric study; Traumatic brain injury; Glasgow Coma Scale; Glasgow Coma Scale-Pupil; Fixed pupils	GLASGOW COMA SCALE; PROGNOSTIC VALUE; CHILDREN; PREDICTION; REACTIVITY; IMPACT	Background: The Glasgow Coma Scale (GCS), used to classify the severity of traumatic brain injury (TBI), is associated with mortality and functional outcomes. However, GCS can be affected by sedation and neuromuscular blockade. GCS-Pupil (GCS-P) score, calculated as GCS minus Pupil Reactivity Score (PRS), was shown to better predict outcomes in a retrospective cohort of adult TBI patients. We evaluated the applicability of GCS-P to a large retrospective pediatric severe TBI (sTBI) cohort. Methods: Admissions to pediatric intensive care units in the Virtual Pediatric Systems (VPS, LLC) database from 2010 to 2015 with sTBI were included. We collected GCS, PRS (number of nonreactive pupils), cardiac arrest, abusive head trauma status, illness severity scores, pediatric cerebral performance category (PCPC) score, and mortality. GCS-P was calculated as GCS minus PRS. chi(2) or Fisher's exact test and Mann-Whitney U test compared categorical and continuous variables, respectively. Classification and regression tree analysis identified thresholds of GCS-P and GCS along with other independent factors which were further examined using multivariable regression analysis to identify factors independently associated with mortality and unfavorable PCPC at PICU discharge. Results: Among the 2,682 patients included in the study, mortality was 23%, increasing from 4.7% for PRS = 0 to 80% for PRS = 2. GCS-P identified more severely injured patients with GCS-P scores 1 and 2 who had worse outcomes. GCS-P <= 2 had higher odds for mortality, OR = 68.4 (95% CI = 50.6-92.4) and unfavorable PCPC, OR = 17.3 (8.1, 37.0) compared to GCS <= 5. GCS-P <= 2 also had higher specificity and positive predictive value for both mortality and unfavorable PCPC compared to GCS <= 5. Conclusions: GCS-P, by incorporating pupil reactivity to GCS scoring, is more strongly associated with mortality and poor functional outcome at PICU discharge in children with sTBI.	[Balakrishnan, Binod; Hanson, Sheila J.; Farias-Moeller, Raquel] Childrens Hosp Wisconsin, Sect Crit Care, Milwaukee, WI 53201 USA; [Balakrishnan, Binod; Hanson, Sheila J.; Zhang, Liyun; Simpson, Pippa M.; Farias-Moeller, Raquel] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [VanDongen-Trimmer, Heather; Farias-Moeller, Raquel] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [VanDongen-Trimmer, Heather; Farias-Moeller, Raquel] Childrens Hosp Wisconsin, Div Child Neurol, Milwaukee, WI 53201 USA; [Kim, Irene] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Kim, Irene] Childrens Hosp Wisconsin, Div Pediat Neurosurg, Milwaukee, WI 53201 USA; [Zhang, Liyun; Simpson, Pippa M.] Med Coll Wisconsin, Sect Quantitat Hlth Sci, Milwaukee, WI 53226 USA		Balakrishnan, B (corresponding author), Childrens Hosp Wisconsin, Sect Crit Care, Milwaukee, WI 53201 USA.; Balakrishnan, B (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbalakris@mcw.edu					Almojuela A, 2019, J CHILD NEUROL, V34, P189, DOI 10.1177/0883073818822359; Balakrishnan B, 2018, PEDIATR NEUROSURG, V53, P379, DOI 10.1159/000494028; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Sadaka F, 2018, AM J EMERG MED, V36, P1624, DOI 10.1016/j.ajem.2018.01.051; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; STEINBERG D, 1997, CART CLASSIFICATION; TEASDALE G, 1974, LANCET, V2, P81; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Williamson T, 2020, JAMA SURG, V155, P723, DOI 10.1001/jamasurg.2020.1790	30	0	0	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	SEP	2021	56	5					432	439		10.1159/000517330		JUL 2021	8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	UN5CK	WOS:000675445500001	34284393				2022-02-07	
J	Desai, A; Chen, HZ; Kevala, K; Kim, HY				Desai, Abhishek; Chen, Huazhen; Kevala, Karl; Kim, Hee-Yong			Higher n-3 Polyunsaturated Fatty Acid Diet Improves Long-Term Neuropathological and Functional Outcome after Repeated Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						CHIMERA; DHA; ERG; gliosis; n-3 PUFA; repeated mild TBI; VEP	WHITE-MATTER INJURY; DOCOSAHEXAENOIC ACID; SUPPLEMENTATION; MODEL; OMEGA-3-FATTY-ACIDS; NEUROINFLAMMATION; IMPAIRMENTS; DAMAGE; MICE; RAT	Repeated mild traumatic brain injury (TBI) can cause persistent neuropathological effects and is a major risk factor for chronic traumatic encephalopathy. PUFAs (n-3 polyunsaturated fatty acids) were shown to improve acute TBI outcomes in single-injury models in most cases. In this study, we demonstrate positive effects of dietary n-3 PUFA on long-term neuropathological and functional outcome in a clinically relevant model of repeated mild TBI using the Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA). Adult mice, reared on n-3 PUFA adequate (higher n-3 PUFA) or deficient (lower n-3 PUFA) diets, were given a mild CHIMERA daily for 3 consecutive days. At 2 months after injury, visual function and spatial memory were evaluated. Glia cell activation was assessed by immunostaining using antibodies of ionized calcium-binding adaptor molecule 1 and glial fibrillary acidic protein, and axonal damage was examined using silver staining. Repeated CHIMERA (rCHIMERA)-induced gliosis was significantly suppressed in the optic tract, corpus callosum, and hippocampus of mice fed the n-3 PUFA adequate diet compared to the deficient diet group. Considerable axonal damage was detected in the optic tract after rCHIMERA, but the adequate diet group displayed less axonal damage compared to the deficient diet group. rCHIMERA induced a drastic reduction in N1 amplitude of the visual evoked potential in both diet groups and the a-wave amplitude of the electroretinogram in the deficient diet group. However, reduction of N1 and a-wave amplitude were less severe in the adequate diet group. The Morris water maze probe test indicated a significant decrease in the number of platform crossings in the deficient diet group compared to the adequate group. In summary, dietary n-3 PUFA can attenuate persistent glial cell activation and axonal damage and improve deficits in visual function and spatial memory after repeated mild TBI. These data support the neuroprotective potential of a higher n-3 PUFA diet in ameliorating the adverse outcome of repeated mild TBI.	[Desai, Abhishek; Chen, Huazhen; Kevala, Karl; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Bethesda, MD 20852 USA; [Chen, Huazhen; Kim, Hee-Yong] Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Bethesda, MD 20852 USA.	hykim@nih.gov			National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Center for Neuroscience and Regenerative Medicine/Henry M. Jackson Foundation for the Advancement of Military Medicine	This research was supported by the intramural program of the National Institute on Alcohol Abuse and Alcoholism and Center for Neuroscience and Regenerative Medicine/Henry M. Jackson Foundation for the Advancement of Military Medicine. The funding agencies did not have any role in the design and implementation of this study.	Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Benchorin G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2218; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Coltman R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.09.005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Figueiredo TH, 2018, MOL NEUROBIOL, V55, P187, DOI 10.1007/s12035-017-0732-y; Guest J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-79; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Hamazaki K, 2010, J PSYCHIATR RES, V44, P688, DOI 10.1016/j.jpsychires.2009.11.017; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kevala K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228768; Kim HY, 2018, MOL ASPECTS MED, V64, P34, DOI 10.1016/j.mam.2018.03.004; Kuda O, 2017, BIOCHIMIE, V136, P12, DOI 10.1016/j.biochi.2017.01.002; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Ma JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-33; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Mallick R, 2019, INT J DEV NEUROSCI, V79, P21, DOI 10.1016/j.ijdevneu.2019.10.004; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; PERLMAN I, 1983, BRIT J OPHTHALMOL, V67, P443, DOI 10.1136/bjo.67.7.443; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Reyes LD, 2020, J NEUROSCI RES, V98, P2232, DOI 10.1002/jnr.24705; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Ward GR, 1998, J NUTR, V128, P2473; Witte TR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-31; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007	56	0	0	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2622	2632		10.1089/neu.2021.0096		JUL 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000675019400001	33913741				2022-02-07	
J	Giese, H; Antritter, J; Unterberg, A; Beynon, C				Giese, Henrik; Antritter, Jennifer; Unterberg, Andreas; Beynon, Christopher			Long-Term Results of Neurological Outcome, Quality of Life, and Cosmetic Outcome After Cranioplastic Surgery: A Single Center Study of 202 Patients	FRONTIERS IN NEUROLOGY			English	Article						cranioplasty; decompressive craniecotmy; quality of life; cosmetic result; neurorehabilitation	COMPLICATIONS FOLLOWING CRANIOPLASTY; DECOMPRESSIVE CRANIECTOMY; AUTOLOGOUS BONE; EXPERIENCE	Objective: An increased interest in the surgical procedures of decompressive craniectomy (DC) and subsequent cranioplasty (CP) has emerged during the last decades with specific focus on mortality and complication rates. The aim of the present study was to evaluate long-term neurological and cosmetic outcomes as well as Quality of Life (QoL) after CP surgery. Methods: We retrospectively reviewed the medical records of CP patients treated at our institution between 2004 and 2014 and performed a follow-up examination, with evaluation of neurological outcome using the modified Rankin Scale (mRS) and the Glasgow outcome scale (GOS), QoL (SF-36 and EQ-5D-3L). Furthermore, the cosmetic results after CP were analyzed. Results: A total of 202 CP-patients were included in the present study. The main indications for DC and subsequent CP were space-occupying cerebral ischemia (32%), traumatic brain injury (TBI, 26%), intracerebral or subarachnoid hemorrhage (32%) and infection (10%). During a mean follow-up period of 91.9 months 46/42.6% of patients had a favorable neurological outcome (mRS <= 3/GOS >= 4). Patients with ischemia had a significant worse outcome (mRS 4.3 +/-& nbsp;1.5) compared with patients after TBI (3.1 +/- 2.3) and infectious diseases requiring CP (2.4 +/- 2.3). The QoL analysis showed that < 1/3rd of patients (31.2%) had a good QoL (SF-36) with a mean EQ-5D-VAS of 59 +/- 26. Statistical analysis confirmed a significant worse QoL of ischemia patients compared to other groups whereas multivariate regression analysis showed no other factors which may had an impact on the QoL. The majority (86.5%) of patients were satisfied with the cosmetic result after CP and regression analysis showed no significant factors associated with unfavorable outcomes. Conclusion: Long-term outcome and QoL after CP were significantly influenced by the medical condition requiring DC. Early detection and evaluation of QoL after CP may improve the patient's outcome due to an immediate initiation of targeted therapies (e.g., occupational- or physiotherapy).	[Giese, Henrik; Antritter, Jennifer; Unterberg, Andreas; Beynon, Christopher] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany		Giese, H (corresponding author), Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany.	henrik.giese@med.uni-heidelberg.de			Open Access Publishing Fund of Ruprecht-Karls-Universitat Heidelberg	We acknowledge financial support by the Open Access Publishing Fund of Ruprecht-Karls-Universitat Heidelberg.	Baumann M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-92; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Champeaux C, 2020, NEUROCRIT CARE, V32, P522, DOI 10.1007/s12028-019-00774-9; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Fischer CM, 2012, NEUROL RES, V34, P281, DOI 10.1179/1743132812Y.0000000007; Giese H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009273; Goedemans T, 2017, WORLD NEUROSURG, V105, P765, DOI 10.1016/j.wneu.2017.06.069; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Henker C, 2018, J NEUROTRAUM, V35, P1030, DOI 10.1089/neu.2017.5512; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Huang YH, 2013, INT J SURG, V11, P886, DOI 10.1016/j.ijsu.2013.07.013; Kaushal Ashutosh, 2019, Asian J Neurosurg, V14, P52, DOI 10.4103/ajns.AJNS_147_17; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Kosinski M., 1993, SF 36 HLTH SURVEY MA; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Satapathy D, 2019, WORLD NEUROSURG, V129, pE81, DOI 10.1016/j.wneu.2019.05.027; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Urbach David R, 2005, Surg Innov, V12, P161, DOI 10.1177/155335060501200216; van Middelaar T, 2015, INT J STROKE, V10, P170, DOI 10.1111/ijs.12329; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Worm PV, 2019, J CRANIO MAXILL SURG, V47, P715, DOI 10.1016/j.jcms.2019.01.040	33	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 20	2021	12								702339	10.3389/fneur.2021.702339			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TT5PH	WOS:000680399300001	34354667	gold, Green Published			2022-02-07	
J	Han, F; Yan, Z; Wu, Q; Hu, YS; Li, JQ; Du, F; Tan, YJ				Han, Feng; Yan, Zhi; Wu, Qiong; Hu, Yushi; Li, Jiaqing; Du, Fei; Tan, Yajun			Different dimension ZnO nano materials in the rehabilitation of patients with limb fracture and injury	FERROELECTRICS			English	Article						Nano zinc oxide; limb fracture; infection rate; exercise rehabilitation	TRAUMATIC BRAIN-INJURY; NANOMATERIALS	With the rapid development of industry and transportation in China, the incidence rate of open fracture caused by high energy injuries such as traffic accidents and falling height is increasing year by year. Based on the above background, the purpose of this paper is to study the application of ZnO nano materials with different dimensions in the rehabilitation of patients with limb fracture injury. In order to further solve the problem of limb fracture rehabilitation, zinc oxide nanomaterials are applied to fracture rehabilitation in this paper. The application of zinc oxide nanomaterials in fracture rehabilitation is realized by its strong antibacterial, high-efficiency stability and rich and colorful structure. In this paper, we propose to use the unique physical and chemical properties of ZnO nanomaterials to prepare artificial bone, bone cement, external fixation with good osteogenic performance and antibacterial performance, and carry antibiotics for the treatment of open fracture infection and bone defect. During the experiment, compared with other materials, the infection rate of external fixation was only 63%, and the inflammation index of artificial bone was only 2 mg/dl, which was far less than other materials. Moreover, using the excellent plasticity of ZnO nanomaterials, the oriented ZnO nanotube films were prepared, and the effect of inhibiting scar formation was confirmed through experimental research. In this paper, the unique physical, chemical and biological characteristics of zinc oxide nanomaterials were used to creatively introduce them into the treatment of infectious bone defect and injury rehabilitation caused by limb fracture. Through a series of in vitro and animal in vivo experiments, it was proved that zinc oxide nanomaterials can be used as ideal materials for the treatment of infectious bone defect, which provides new zinc oxide nanomaterials to solve clinical problems A new way of thinking.	[Han, Feng; Yan, Zhi; Wu, Qiong; Li, Jiaqing; Du, Fei] Dalian Port Hosp, Orthopaed, Dalian, Liaoning, Peoples R China; [Yan, Zhi; Hu, Yushi] Chengdu Sport Univ, Dept Sports Med & Hlth, Chengdu, Sichuan, Peoples R China; [Tan, Yajun] Chengdu Sport Univ, Sport Hosp, Chengdu, Sichuan, Peoples R China		Tan, YJ (corresponding author), Chengdu Sport Univ, Sport Hosp, Chengdu, Sichuan, Peoples R China.	1131389799@qq.com			National key research and development plan of china [2019YFF0301805]; Liaoning natural science fund [2019-ZD-1000, 2019-ZD-1001, 20170540056]	This work was supported by The National key research and development plan of china: 2019YFF0301805; Liaoning natural science fund: 20170540056; Liaoning natural science fund: 2019-ZD-1001; Liaoning natural science fund: 2019-ZD-1000.	Amirifar N, 2015, J APPL PHYS, V118, DOI 10.1063/1.4936167; Baca V, 2018, CENT EUR J PUBL HEAL, V26, P298, DOI 10.21101/cejph.a5161; Chaudhary S, 2018, MATERIALS, V11, DOI 10.3390/ma11020287; Daou I., 2017, WATER SCI TECHNOL, V77; Gao B, 2019, MATER LETT, V237, P180, DOI 10.1016/j.matlet.2018.11.054; Glavan G, 2017, ARCH ENVIRON CON TOX, V72, P471, DOI 10.1007/s00244-017-0385-x; Grigorian A, 2019, VASCULAR, V27, P252, DOI 10.1177/1708538118811231; James N., 2015, NIHON KYOBU SHIKKAN NIHON KYOBU SHIKKAN, V19, P470; Jayabharathi J, 2015, RSC ADV, V5, P9518, DOI 10.1039/c4ra15957h; Jodoin M, 2017, INJURY, V48, P1927, DOI 10.1016/j.injury.2017.06.025; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; Khan F, 2017, TURK J PH MED REHAB, V63, P193, DOI 10.5606/tftrd.2017.417; Kumar R, 2017, CERAM INT, V43, P3940, DOI 10.1016/j.ceramint.2016.12.062; Lei Z, 2020, J CLEAN PROD, V249, DOI 10.1016/j.jclepro.2019.119307; Li CG, 2016, IEEE T VEH TECHNOL, V65, P6765, DOI 10.1109/TVT.2015.2472456; Li Zhao-Hui, 2018, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V34, P115, DOI 10.12047/j.cjap.5558.2018.028; Libo Z., 2019, J INTELLIGENT FUZZY, V37, P1; [刘霖 Liu Lin], 2015, [中国脑血管病杂志, Chinese Journal of Cerebrovascular Diseases], V12, P306; Liu WF, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9365291; Liu XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep38474; Lv z, 2020, IEEE T INTELL TRANSP; Medina-Velo IA, 2017, J HAZARD MATER, V332, P214, DOI 10.1016/j.jhazmat.2017.03.008; Niikura T, 2015, J ORTHOP SURG-HONG K, V23, P37, DOI 10.1177/230949901502300109; North K, 2017, CURR ORTHOP PRACT, V28, P223, DOI 10.1097/BCO.0000000000000469; [努尔加依·沙黑窝拉 Nuerjiayi Shaheiwola], 2017, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V32, P1000; Pan SR, 2020, IEEE T CYBERNETICS, V50, P2475, DOI 10.1109/TCYB.2019.2932096; Penn-Barwell JG, 2015, INJURY, V46, P288, DOI 10.1016/j.injury.2014.12.004; Perumal Ramesh, 2016, J Orthop Case Rep, V6, P47, DOI 10.13107/jocr.2250-0685.626; Ramirez-Fernandez C, 2017, METHOD INFORM MED, V56, P145, DOI 10.3414/ME16-02-0017; Rizk-Allah RM, 2018, COMPUT ELECTR ENG, V69, P705, DOI 10.1016/j.compeleceng.2018.02.024; Sheng J, 2018, J NANOELECTRON OPTOE, V13, P637, DOI 10.1166/jno.2018.2322; Tang YC, 2019, ROBOT CIM-INT MANUF, V59, P36, DOI 10.1016/j.rcim.2019.03.001; Wang JX, 2017, MATER DESIGN, V121, P69, DOI 10.1016/j.matdes.2017.02.048; Yin H, 2015, CHEMOSPHERE, V124, P116, DOI 10.1016/j.chemosphere.2014.11.076	34	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0015-0193	1563-5112		FERROELECTRICS	Ferroelectrics	JUL 20	2021	578	1					95	107		10.1080/00150193.2021.1902766			13	Materials Science, Multidisciplinary; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	TZ1SL	WOS:000684256000009					2022-02-07	
J	Liu, ZH; Li, H; Ma, WC; Pan, SY				Liu, Zhuohang; Li, Hang; Ma, Wenchao; Pan, Shuyi			Network pharmacology to investigate the pharmacological mechanisms of muscone in Xingnaojing injections for the treatment of severe traumatic brain injury	PEERJ			English	Article						XNJI; Muscone; Protein targets; Network analysis; Traumatic brain injury	TRADITIONAL CHINESE MEDICINE; ISCHEMIA/REPERFUSION INJURY; SYSTEMS PHARMACOLOGY; STROKE; NEUROINFLAMMATION; NEURODEGENERATION; NEUROPROTECTION; DISRUPTION; PATHWAYS	Background. Xingnaojing injections (XNJI) are widely used in Chinese medicine to mitigate brain injuries. An increasing number of studies have shown that XNJI may improve neurological function. However, XNJI's active ingredients and molecular mechanisms when treating traumatic brain injury (TBI) are unknown. Methods. XNJI's chemical composition was acquisited from literature and the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database. We used the ``absorption, distribution, metabolism, and excretion'' (ADME) parameter-based virtual algorithm to further identify the bioactive components. We then screened data and obtained target information regarding TBI and treatment compounds from public databases. Using a Venn diagram, we intersected the information to determine the hub targets. Cytoscape was used to construct and visualize the network. In accordance with the hub proteins, we then created a protein-protein interaction (PPI) network using STRING 11.0. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were analyzed according to the DAVID bioinformatics resource database (ver. 6.8). We validated the predicted compound's efficacy using the experimental rat chronic constriction injury (CCI) model. The neuronal apoptosis was located using the TUNEL assay and the related pathways' hub proteins were determined by PCR, Western blot, and immunohistochemical staining. Results. We identified 173 targets and 35 potential compounds belonging to XNJI. STRING analysis was used to illustrate the protein-protein interactions and show that muscone played a fundamental role in XNJI's efficacy. Enrichment analysis revealed critical signaling pathways in these components' potential protein targets, including PI3K/AKT1, NF-kB, and p53. Moreover, the hub proteins CASP3, BCL2L1, and CASP8 were also involved in apoptosis and were associated with PI3K/AKT, NF-kB, and p53 signaling pathways. We showed that muscone and XNJI were similarly effective 168 h after CCI, demonstrating that the muscone in XNJI significantly attenuated neuronal apoptosis through the PI3K/Akt1/NF-kB/P53 pathway. Conclusion. We verified the neuroprotective mechanism in muscone for the first time in TBI. Network pharmacology offers a new approach for identifying the potential active ingredients in XNJI.	[Liu, Zhuohang; Ma, Wenchao; Pan, Shuyi] Anhui Med Univ, Clin Med Coll 5, Beijing, Peoples R China; [Liu, Zhuohang; Li, Hang; Pan, Shuyi] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hyperbar Oxygen, Beijing, Peoples R China; [Ma, Wenchao] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Neurol, Beijing, Peoples R China		Pan, SY (corresponding author), Anhui Med Univ, Clin Med Coll 5, Beijing, Peoples R China.; Pan, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hyperbar Oxygen, Beijing, Peoples R China.	psy9992011@163.com			Research Fund of Chinese PLA General HospitalSixth Medical Center [CXPY201816]; Beijing Nova ProgramBeijing Municipal Science & Technology Commission [Z171100001117092]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81500669]; National Nature Science Foundation of Beijing [7154241]	This research received support from the Research Fund of Chinese PLA General HospitalSixth Medical Center (CXPY201816), the Beijing Nova Program (Z171100001117092), the National Nature Science Foundation of China (81500669) and the National Nature Science Foundation of Beijing (7154241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Ali FEM, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117760; Amin FU, 2016, NEUROCHEM INT, V96, P1, DOI 10.1016/j.neuint.2016.04.001; Chen YH, 2018, J PHARMACOL SCI, V136, P16, DOI 10.1016/j.jphs.2017.11.005; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Du SB, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/7219740; Fu SL, 2018, MOLECULES, V23, DOI 10.3390/molecules23113039; Ge XH, 2017, PHYSIOL BEHAV, V170, P115, DOI 10.1016/j.physbeh.2016.12.021; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Gutjahr JC, 2021, HAEMATOLOGICA, V106, P2102, DOI 10.3324/haematol.2019.231944; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.1016/S1875-5364(13)60037-0, 10.3724/SP.J.1009.2013.00110]; Li XQ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1271-9; Li Y, 2015, J ETHNOPHARMACOL, V174, P45, DOI 10.1016/j.jep.2015.07.043; Liu JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19809; Liu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21146; Loo LSW, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2589-7; Ma X, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019648; Mehrafza S, 2019, IRAN J BASIC MED SCI, V22, P856, DOI 10.22038/ijbms.2019.30855.7442; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Qu XY, 2019, CHIN J NAT MEDICINES, V17, P498, DOI 10.1016/S1875-5364(19)30071-8; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Schwulst SJ, 2019, JOVE-J VIS EXP, DOI 10.3791/60027; Shamekhi S, 2020, PROBIOTICS ANTIMICRO, V12, P311, DOI 10.1007/s12602-019-09528-7; Slavoaca D, 2020, NEUROL SCI, V41, P2033, DOI 10.1007/s10072-019-04238-y; Song HJ, 2018, FRONT MED-PRC, V12, P334, DOI 10.1007/s11684-017-0539-2; Sun WC, 2016, J NEUROCHEM, V138, P233, DOI 10.1111/jnc.13647; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takada S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1709-8; Wang L, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116647; Wang MX, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1610; Wei G, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0882-2; Wei G, 2012, NAT PROD COMMUN, V7, P1069; Xu HY, 2019, NUCLEIC ACIDS RES, V47, pD976, DOI 10.1093/nar/gky987; Xu P, 2014, J ETHNOPHARMACOL, V152, P302, DOI 10.1016/j.jep.2013.12.046; Yan Z., 2011, CHINESE J PRACTICAL, V14, P75, DOI [10.3969/j.issn.1673-5110.2011.21.042, DOI 10.3969/J.ISSN.1673-5110.2011.21.042]; Yang ZJ, 2015, MOL MED REP, V11, P1615, DOI 10.3892/mmr.2014.2934; Yuan JW, 2020, CELL MOL NEUROBIOL, V40, P511, DOI 10.1007/s10571-019-00749-6; Zhang YM, 2020, PHARM BIOL, V58, P16, DOI 10.1080/13880209.2019.1698619; Zhang YM, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2361046; Zhou F, 2020, J ETHNOPHARMACOL, V259, DOI 10.1016/j.jep.2020.112940; Zhu QQ, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1211-8	47	0	0	4	6	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	JUL 20	2021	9								e11696	10.7717/peerj.11696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TM2VS	WOS:000675410100003	34322321	Green Published, gold			2022-02-07	
J	Nelson, LD; Magnus, BE; Temkin, NR; Dikmen, S; Balsis, S				Nelson, Lindsay D.; Magnus, Brooke E.; Temkin, Nancy R.; Dikmen, Sureyya; Balsis, Steve			Functional Status Examination Yields Higher Measurement Precision than the Glasgow Outcome Scale-Extended after Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; assessment tools; clinical trial; human studies; outcome measures	CRITERIA	A limited evidence base supports the Functional Status Examination (FSE) as superior to the more commonly used Glasgow Outcome Scale-Extended (GOSE) for precisely characterizing injury-related functional limitations. The aim of this study was to use modern psychometric tools to test the hypothesis that the FSE is more precise than the GOSE in characterizing individual differences in functional limitations after moderate-to-severe traumatic brain injury (TBI). Secondarily, we sought to confirm that the type of interviewee (patient, significant other) does not affect the test performance of the FSE. Using data from 357 individuals with TBI who participated in the Magnesium Sulfate clinical trial and had six-month outcome data, we performed item response theory (IRT) analyses comparing the FSE and GOSE at six months post-injury. Results showed that the FSE yielded higher measurement precision (IRT test information) than the GOSE across most of the disability severity spectrum. The GOSE yielded more information than the FSE at a very high level of disability, because of the GOSE's assignment of a unique score for individuals who are in a vegetative state. Finally, the FSE showed no evidence of differential item functioning by interviewee, indicating it is appropriate to interview either persons with TBI or significant others and combine data across respondents as is typically done. The findings support the FSE as a viable and oftentimes advantageous substitute for the GOSE in clinical trials and translational studies of TBI.	[Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Magnus, Brooke E.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA; [Magnus, Brooke E.] Boston Coll, Dept Neurosci, Chestnut Hill, MA 02167 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Balsis, Steve] Univ Massachusetts Lowell, Dept Psychol, Lowell, MA USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu			National Institutes of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643]	This secondary analysis project was funded by National Institutes of Neurological Disorders and Stroke (NINDS) grant #R01 NS110856. The clinical trial was funded by NINDS grant #R01 NS19643.	Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Machamer J, 2018, J NEUROTRAUM, V35, P1132, DOI 10.1089/neu.2017.5460; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelson LD, 2020, J NEUROTRAUM, V37, P675, DOI 10.1089/neu.2019.6719; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Slocum-Gori SL, 2011, SOC INDIC RES, V102, P443, DOI 10.1007/s11205-010-9682-8; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2021, J NEUROTRAUM, V38, P2435, DOI 10.1089/neu.2020.7527; Zahniser E, 2019, ARCH CLIN NEUROPSYCH, V34, P1165, DOI 10.1093/arclin/acy103	21	0	0	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3288	3294		10.1089/neu.2021.0152		JUL 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000675020800001	34114492				2022-02-07	
J	Pattnaik, S; Panda, BB; Swain, SC				Pattnaik, Shradha; Panda, Bijnya B.; Swain, Suresh C.			Spectrum of Ocular Findings in Closed Head Injuries, Correlation With Severity of Neurological Involvement, and Treatment Outcome: A Hospital-Based Cross-Sectional Study	CUREUS			English	Article						closed head injury; glasgow coma scale; relative afferent pupillary defect; traumatic optic neuropathy; ocular trauma	MANIFESTATIONS	Purpose: To study the various ocular findings in patients with closed head injuries, to find any association with the degree of neurological involvement, and to analyze the treatment outcome after the necessary intervention. Setting: Tertiary referral hospital in Eastern India. Design: Prospective observational study. Methods: Patients with closed head injuries attending our Outpatient department as well as referred from the Neurosurgery department for ophthalmic evaluation between October 2017 and September 2019 were recruited for the study. All patients meeting the inclusion criteria were examined by an experienced ophthalmologist. The Glasgow coma scale (GCS) was applied to grade the neurological involvement by the neurosurgery team. Ocular findings were recorded and necessary imaging was requested. Appropriate neurosurgery consultations were done in patients with neurological findings. All ocular injuries were managed as per institutional protocol. Descriptive statistics were used for analysis with p< 0.05 taken as statistically significant. Results: A total of 207 patients (414 eyes) were included in the study. The mean age was 33.82 years, with the prevalence of male patients (82.12%). The most common cause of head injury was RTA (57.01%) followed by assault (11.59%). The majority of patients (53.14%) were classified as having moderate, 46.37% patients with mild, and 0.48% with severe neurological involvement as per GCS scoring. Isolated ocular findings were seen in 70.04% of patients while 29.95% of patients had both neurological and ophthalmic features. Ocular adnexal involvement was observed in 38.6%, anterior segment involvement in 86%, neuro-ophthalmic manifestations in 33.3%, and posterior segment involvement in 38.6% of patients. Ocular signs were resolved over due course of lime in 48.8% of patients, completely resolved in 28%, while there was no improvement in 6.28% of patients. The final best-corrected visual acuity of >6/18 was achieved in 51.69% of patients. Statistical significance was observed in the correlation between the GCS scoring and general ocular findings (p= 0.02) as well as a relative afferent pupillary defect (p=0.003). The association between age > 50 years and neuro-ophthalmic features was not found to be statistically significant ( p=0.56). Conclusion: Poor visual acuity at presentation, optic canal fractures, the presence of multiple fractures of orbital walls, no improvement in vision within 48 hours of starting intravenous corticosteroids, were indicators of a poor visual prognosis in this study. The GCS, neuro-deficit, and ocular signs contribute significantly to the prediction of outcomes. Prompt treatment and referral can lead to a good resolution of symptoms and signs.	[Pattnaik, Shradha] Sriram Chandra Bhanja Med Coll & Hosp, Ophthalmol, Cuttack, India; [Panda, Bijnya B.; Swain, Suresh C.] Sriram Chandra Bhanja Med Coll, Ophthalmol, Cuttack, India		Swain, SC (corresponding author), Sriram Chandra Bhanja Med Coll, Ophthalmol, Cuttack, India.	drsureshswain@gmail.com					Bhattacharjee H, 2008, INDIAN J OPHTHALMOL, V56, P475, DOI 10.4103/0301-4738.43367; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; D'Oria F, 2020, INT OPHTHALMOL, V40, P2291, DOI 10.1007/s10792-020-01413-5; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Emery JM, 1971, T OPHTHALMOL OTOLARY, V75, P801; JANDA AM, 1991, POSTGRAD MED, V90, P51; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Malik A, 2016, SUDANESE J OPHTHALMO, V8, P46, DOI [10.4103/1858-540X.198536, DOI 10.4103/1858-540X.198536]; Masila F, 2014, J OPHTHALMOL E CENT, V18, P83; Nehra A, 2012, ACT NERV SUPER, V54, P139, DOI [10.1007/BF03379592, DOI 10.1007/BF03379592]; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; Rajiniganth MG, 2003, ARCH OTOLARYNGOL, V129, P1203, DOI 10.1001/archotol.129.11.1203; Raju N S, 1983, Indian J Ophthalmol, V31, P789; Sharma B, 2014, INT OPHTHALMOL, V34, P893, DOI 10.1007/s10792-014-9898-8	14	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 20	2021	13	7							e16515	10.7759/cureus.16515			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS9ZS	WOS:000680012000016	34295601	gold, Green Published			2022-02-07	
J	Rabinowitz, AR; Kumar, RG; Sima, A; Venkatesan, UM; Juengst, SB; O'Neil-Pirozzi, TM; Watanabe, TK; Goldin, Y; Hammond, FM; Dreer, LE				Rabinowitz, Amanda R.; Kumar, Raj G.; Sima, Adam; Venkatesan, Umesh M.; Juengst, Shannon B.; O'Neil-Pirozzi, Therese M.; Watanabe, Thomas K.; Goldin, Yelena; Hammond, Flora M.; Dreer, Laura E.			Aging with Traumatic Brain Injury: Deleterious Effects of Injury Chronicity Are Most Pronounced in Later Life	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						adult brain injury; age; head trauma; rehabilitation; traumatic brain injury	SYSTEMS NATIONAL DATABASE; COGNITIVE FUNCTION; AGE; REHABILITATION; DISABILITY; OUTCOMES; SCALE; EPIDEMIOLOGY; ORIENTATION; PREDICTION	Understanding the effects of age on longitudinal traumatic brain injury (TBI) outcomes requires attention to both chronic and evolving TBI effects and age-related changes in health and function. The present study examines the independent and interactive effects of aging and chronicity on functional outcomes after TBI. We leveraged a well-defined cohort of individuals who sustained a moderate/severe TBI and received acute inpatient rehabilitation at specialized centers with high follow up rate as part of their involvement in the TBI Model Systems longitudinal study. We selected individuals at one of two levels of TBI chronicity (either 2 or 10 years post-injury) and used an exact matching procedure to obtain balanced chronicity groups based on age and other characteristics (N = 1993). We found that both older age and greater injury chronicity were related to greater disability, reduced functional independence, and less community participation. There was a significant age by chronicity interaction, indicating that the adverse effects of greater time post-injury were most pronounced among survivors who were age 75 or older. The inflection point at roughly 75 years of age was corroborated by post hoc analyses, dividing the sample by age at 75 years and examining the interaction between age group and chronicity. These findings point to a need for provision of rehabilitation services in the chronic injury period, particularly for those who are over 75 years old. Future work should investigate the underlying mechanisms of this interaction towards the goal of developing interventions and models of care to promote healthy aging with TBI.	[Rabinowitz, Amanda R.; Venkatesan, Umesh M.; Watanabe, Thomas K.] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Kumar, Raj G.] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY USA; [Sima, Adam] Corrona LLC, Waltham, MA USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr, Dept Appl Clin Res, Dallas, TX USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Charlestown, MA USA; [Goldin, Yelena] Hackensack Meridian JFK Univ Med Ctr, Dept Cognit Rehabil, Edison, NJ USA; [Goldin, Yelena] Rutgers Robert Wood Johnson Med Sch, Dept Phys Med & Rehabil, New Brunswick, NJ USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indiana, PA USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu			National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0004, 90DP0038, 90DPTB0009, 90DPTB0013, 90DPTB0014, 90DPTB0011, 90DRTB0002]	This work was supported by the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) grant numbers: 90DPTB0004, 90DP0038, 90DPTB0009, 90DPTB0013, 90DPTB0014, 90DPTB0011, 90DRTB0002.	Aarsland D, 2011, MOVEMENT DISORD, V26, P334, DOI 10.1002/mds.23416; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bagnato S, 2020, NEURAL REGEN RES, V15, P1247, DOI 10.4103/1673-5374.272574; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bouzat P, 2019, J NEUROTRAUM, V36, P2506, DOI 10.1089/neu.2019.6432; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng C, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12208; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Erler KS, 2020, INT REV PSYCHIATR, V32, P12, DOI 10.1080/09540261.2019.1656175; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; McDowell I., 2006, MEASURING HLTH GUIDE, P765; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Moretti R, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P393, DOI 10.1016/B978-0-12-803196-4.00021-7; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2020, J HEAD TRAUMA REHAB, V35, P324, DOI 10.1097/HTR.0000000000000606; Walker W., 2018, BRAIN INJURY, V32, P1; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Ziebell JM, 2016, BRAIN INJURY, V30, P217, DOI 10.3109/02699052.2015.1090012	47	0	0	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0038		JUL 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TL7EQ	WOS:000675021600001	34082606				2022-02-07	
J	Vijayakumari, AA; Parker, D; Osmanlioglu, Y; Alappatt, JA; Whyte, J; Diaz-Arrastia, R; Kim, JJ; Verma, R				Vijayakumari, Anupa Ambili; Parker, Drew; Osmanlioglu, Yusuf; Alappatt, Jacob Antony; Whyte, John; Diaz-Arrastia, Ramon; Kim, Junghoon J.; Verma, Ragini			Free Water Volume Fraction: An Imaging Biomarker to Characterize Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						diffusion tensor imaging; free water volume fraction; traumatic brain injury	1ST-EPISODE PSYCHOSIS; AXONAL INJURY; REGISTRATION; MECHANISMS; DIAGNOSIS	Traumatic brain injury (TBI) is a major clinical and public health problem with few therapeutic interventions successfully translated to the clinic. Identifying imaging-based biomarkers characterizing injury severity and predicting long-term functional and cognitive outcomes in TBI patients is crucial for treatment. TBI results in white matter (WM) injuries, which can be detected using diffusion tensor imaging (DTI). Trauma-induced pathologies lead to accumulation of free water (FW) in brain tissue, and standard DTI is susceptible to the confounding effects of FW. In this study, we applied FW DTI to estimate free water volume fraction (FW-VF) in patients with moderate-to-severe TBI and demonstrated its association with injury severity and long-term outcomes. DTI scans and neuropsychological assessments were obtained longitudinally at 3, 6, and 12 months post-injury for 34 patients and once in 35 matched healthy controls. We observed significantly elevated FW-VF in 85 of 90 WM regions in patients compared to healthy controls (p < 0.05). We then presented a patient-specific summary score of WM regions derived using Mahalanobis distance. We observed that M-VF at 3 months significantly predicted functional outcome (p = 0.008), executive function (p = 0.005), and processing speed (p = 0.01) measured at 12 months and was significantly correlated with injury severity (p < 0.001). Our findings are an important step toward implementing M-VF as a biomarker for personalized therapy and rehabilitation planning for TBI patients.	[Vijayakumari, Anupa Ambili; Parker, Drew; Osmanlioglu, Yusuf; Alappatt, Jacob Antony; Verma, Ragini] Univ Penn, Perelman Sch Med, Dept Radiol, DiCIPHR Diffus & Connect Precis Hlthcare Rese Lab, Philadelphia, PA 19104 USA; [Whyte, John] Einstein Med Ctr Elkins Pk, TBI Rehabil Res Lab, Moss Rehabil Res Inst, Philadelphia, PA USA; [Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Kim, Junghoon J.] CUNY City Coll, Sch Med, Dept Mol Cellular & Biomed Sci, Harris Hall,Off 203F, New York, NY 10031 USA; [Kim, Junghoon J.; Verma, Ragini] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Verma, Ragini] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Verma, Ragini] Univ Penn, Dept Radiol, Perelman Sch Med, Diffus & Connect Precis Hlthcare Res Lab, Richards Bldg,7th Floor,3700 Hamilton Walk, Philadelphia, PA 19104 USA		Kim, JJ (corresponding author), CUNY City Coll, Sch Med, Dept Mol Cellular & Biomed Sci, Harris Hall,Off 203F, New York, NY 10031 USA.; Verma, R (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Diffus & Connect Precis Hlthcare Res Lab, Richards Bldg,7th Floor,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	jkim@med.cuny.edu; Ragini@pennmedicine.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01NS065980]	This work was supported by the National Institutes of Health (NINDS R01NS065980; PI: Junghoon J. Kim).	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton L. A., 1994, CONTROLLED ORAL WORD; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Doshi J, 2016, NEUROIMAGE, V127, P186, DOI 10.1016/j.neuroimage.2015.11.073; Dumont M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00270; Edde M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242696; Fortin JP, 2017, NEUROIMAGE, V161, P149, DOI 10.1016/j.neuroimage.2017.08.047; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gullett JM, 2020, NEUROIMAGE, V219, DOI 10.1016/j.neuroimage.2020.117040; Guo JY, 2021, PSYCHOL MED, V51, P1001, DOI 10.1017/S0033291719003969; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Ji F, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0292-4; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lyall AE, 2018, MOL PSYCHIATR, V23, P701, DOI 10.1038/mp.2017.43; Mahalanobis PC, 2018, SANKHYA SER A, V80, P1, DOI 10.1007/s13171-019-00164-5; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Ofori E, 2015, NEUROBIOL AGING, V36, P1097, DOI 10.1016/j.neurobiolaging.2014.10.029; Oishi K., 2010, JHU MNI SS ATLAS; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Parker D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233645; Pasternak O, 2016, SCHIZOPHR RES, V173, P200, DOI 10.1016/j.schres.2015.05.034; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Reitan R., 1985, HALSTEAD REITAN NEUR; Rodriguez-Grande B, 2017, AAPS J, V19, P1615, DOI 10.1208/s12248-017-0123-3; Seabold S., 2010, P 9 PYTHON SCI C; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Taylor PN, 2020, NEUROLOGY, V94, pE1021, DOI [10.1212/WNL.0000000000009053, 10.1212/WNL.0000000000008902]; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003	58	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0057		JUL 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TL7DN	WOS:000675018700001	33913750				2022-02-07	
J	Yeung, E; Miller, M; Wung, C; Behm, R; Cagir, B; Granet, P				Yeung, Enoch; Miller, Matthew; Wung, Cynthia; Behm, Robert; Cagir, Burt; Granet, Paul			Possible Predictive Factor of Acute Respiratory Distress Syndrome Development After Mild Traumatic Brain Injury: A Single Rural Trauma Center Preliminary Study	CUREUS			English	Article						ards; mild tbi; predictive risk factors; mortality; morbidity	ACUTE LUNG INJURY; MECHANICAL VENTILATION; ORGAN FAILURE; RISK; MORTALITY; SEPSIS; PLASMA; IMPACT; WORSE	Introduction Acute respiratory distress syndrome (ARDS) after mild traumatic brain injury (TBI) can be associated with significant morbidity and mortality. This study aimed to evaluate the potential predictive factors of ARDS development following mild TBI in trauma patients. Methods A retrospective chart review was done for adult trauma patients with mild TBI (GCS 13-15) requiring admission at our center from 2012 to 2020. Linear regression analysis and chi-square test were utilized to identify independent predictors of the association with ARDS in adults with mild TBI. Results A total of 784 mild Till patients were admitted during the lime of interest; 34 patients developed ARDS during their index hospitalization. Patients who had ARDS were more likely to have acute kidney injury (AKI; p < 0.0001), sepsis (p < 0.01), rib fractures (p < 0.05), use of anticoagulants (p < 0.001), deep vein thrombosis (p < 0.001), transfusion during the first 4 four hours upon admission (p = 0.01), intravenous fluid (IVF) resuscitation during the first four hours (p <0.05), the first eight hours (p = 0.01), the first 12 hours (p = 0.03), and intubation upon the admission (p < 0.0001). ARDS associated with mild TBI demonstrated a statistically significant increase in mortality during the index hospitalization (p < 0.0001). Conclusion ARDS after mild TBI can be associated with significant morbidity and mortality. Key risk factors identified include AKI, sepsis, anticoagulant use, deep vein thrombosis (DVT), transfusion in the first four hours, IVF resuscitation in the first four, eight, and 12 hours, and intubation upon admission.	[Yeung, Enoch; Miller, Matthew; Wung, Cynthia] Guthrie Robert Packer Hosp, Surg, Sayre, PA 18840 USA; [Behm, Robert] Guthrie Robert Packer Hosp, Trauma Crit Care, Sayre, PA USA; [Cagir, Burt] Guthrie Robert Packer Hosp, Colorectal Surg, Sayre, PA USA; [Granet, Paul] Guthrie Robert Packer Hosp, Trauma Surg Crit Care, Sayre, PA USA		Yeung, E (corresponding author), Guthrie Robert Packer Hosp, Surg, Sayre, PA 18840 USA.	enotyoung@gmail.com					Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; ANNAT G, 1983, ANESTHESIOLOGY, V58, P136, DOI 10.1097/00000542-198302000-00006; [Anonymous], 2015, TRAUMATIC BRAIN INJU; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; Eggimann P, 2003, AM J RESP CRIT CARE, V167, P1210, DOI 10.1164/rccm.200210-1196OC; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Hendrickson CM, 2015, J TRAUMA ACUTE CARE, V79, P417, DOI 10.1097/TA.0000000000000760; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583; Iriyama H, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-0426-9; Kangelaris KN, 2016, CRIT CARE MED, V44, P120, DOI 10.1097/CCM.0000000000001359; Kuiper JW, 2005, CRIT CARE MED, V33, P1408, DOI 10.1097/01.CCM.0000165808.30416.EF; Larsen AM, 2015, TRANSFUSION MED, V25, P174, DOI 10.1111/tme.12209; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Mascia L, 1998, INTENS CARE MED, V24, P1115, DOI 10.1007/s001340050727; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ramesh GH, 2019, INT J EMERG MED, V12, DOI 10.1186/s12245-019-0253-8; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rocha PN, 2005, AM J TRANSPLANT, V5, P1469, DOI 10.1111/j.1600-6143.2005.00867.x; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Tignanelli CJ, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000249; van den Akker JPC, 2013, CRIT CARE, V17, DOI 10.1186/cc12743; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957	30	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 20	2021	13	7							e16508	10.7759/cureus.16508			12	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS9ZS	WOS:000680012000009	34430122	gold, Green Published			2022-02-07	
J	Kabi, A; Tandon, S; Kandy, PT				Kabi, Ankita; Tandon, Shipra; Kandy, Priya T.			Extradural Anesthesia in a Case of Mild Head Injury	CUREUS			English	Article						polytrauma; epidural anaesthesia; mild head injury; intracranial pressure; pain management	PRESSURE; ANALGESIA; SURGERY	We experienced a case posted for bilateral lower limb surgery in a patient having mild traumatic brain injury (TBI), where administration of graded epidural anesthesia led to agitation, probably resulting from the transient elevation of intracranial pressure (ICP). Due to the wide range of benefits provided by regional anesthesia, an anesthetist should be aware of the possible options for perioperative management to best handle such polytrauma cases. In this case, agitation was managed with a bolus of benzodiazepine and maintenance infusion of dexmedetomidine while the six-hour-long surgery continued with epidural anesthesia. This patient was a smoker who had bronchospasm and underlying pneumonia precluding a high risk for postoperative ventilatory support if only general anesthesia was administered. Post-surgery the patient was conscious, oriented, and pain-free leading to early mobilization and discharge from the hospital. The patient did not report any neurological deterioration in a follow-up period of one month.	[Kabi, Ankita; Tandon, Shipra; Kandy, Priya T.] All India Inst Med Sci, Anesthesiol, Rishikesh, India; [Kabi, Ankita] All India Inst Med Sci, Emergency Med, Rishikesh, India		Kabi, A (corresponding author), All India Inst Med Sci, Anesthesiol, Rishikesh, India.; Kabi, A (corresponding author), All India Inst Med Sci, Emergency Med, Rishikesh, India.	ankitakabi@yahoo.com		Kabi, Ankita/0000-0001-5958-3966; T K, PRIYA/0000-0002-3647-0229			Abcejo AS, 2017, MAYO CLIN PROC, V92, P1042, DOI 10.1016/j.mayocp.2017.03.012; BENGIS RG, 1977, AM J PHYSIOL, V232, pH255, DOI 10.1152/ajpheart.1977.232.3.H255; Buchchloz HW, 1951, CHIRWRG, V22, P11; BURN JM, 1973, BRIT J ANAESTH, V45, P338, DOI 10.1093/bja/45.4.338; Chen SH, 2005, EUR J ANAESTH, V22, P634, DOI 10.1017/S0265021505211067; Greene NM, 1981, PHYSL SPINAL ANESTHE, P272; Khandelwal A, 2019, J ANAESTH CLIN PHARM, V35, P302, DOI 10.4103/joacp.JOACP_278_18; Moraca RJ, 2003, ANN SURG, V238, P663, DOI 10.1097/01.sla.0000094300.36689.ad; PAUL DL, 1989, BRIT J ANAESTH, V62, P368, DOI 10.1093/bja/62.4.368; Wang LP, 2008, ANESTH ANALG, V107, P193, DOI 10.1213/ane.0b013e31816c8888; Zabolotskikh I, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0056-2	11	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 19	2021	13	7							e16475	10.7759/cureus.16475			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS0VG	WOS:000679374800004	34422500	gold, Green Published			2022-02-07	
J	Sung, DS; Smith, JL; Yarabarla, S; Prasad, O; Owusu-Ansah, M; Ekici, S; Allen, JW; Mines, B; Fleischer, CC				Sung, Dongsuk; Smith, Jeremy L.; Yarabarla, Suma; Prasad, Ojaswa; Owusu-Ansah, Maame; Ekici, Selin; Allen, Jason W.; Mines, Brandon; Fleischer, Candace C.			Changes in brain metabolites and resting-state connectivity in collegiate basketball players as a function of play time	JOURNAL OF NEUROIMAGING			English	Article						brain metabolites; magnetic resonance spectroscopy; resting-state MRI; sports-related brain injury	MR SPECTROSCOPY; DIFFUSION-TENSOR; GLOBAL SIGNAL; INJURY; BOLD	Background and Purpose Magnetic resonance (MR) biomarkers are emerging for sports-related traumatic brain injury (TBI), but the effect of play time has not been characterized. Our goal was to characterize brain and inflammatory marker changes as a function of play time. Methods Nine male players (21 +/- 2 years old) from a single collegiate basketball team were included. MR imaging (MRI), MR spectroscopy, and plasma were collected pre, mid, and postseason. Game time played was calculated for each subject. Changes in brain volume, diffusion tensor imaging (DTI), metabolites (normalized to total creatine, tCr), temperature, structural and functional connectivity, and inflammatory markers were quantified. Results Myo-inositol/tCr in the left frontal white matter and brain temperature in the left frontal lobe varied significantly between time points. Glutamate (Glu/tCr) in the right frontal white matter and N-acetylaspartate in the posterior cingulate cortex (PCC) were negatively associated with minutes played. Midseason play time was associated with stronger blood-oxygen-level-dependent correlations between PCC and occipital areas, and weaker correlations between PCC and superior frontal connectivity. PCC Glu/tCr was positively associated with connectivity between the PCC and posterior supramarginal gyrus at preseason and with connectivity across time points among several right hemisphere regions. Volume, DTI, and inflammatory markers did not vary significantly. Conclusion Given that MR parameters vary with game play time in the absence of diagnosed injury, play time should be considered as a factor in sports-related TBI research.	[Sung, Dongsuk; Allen, Jason W.; Fleischer, Candace C.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Sung, Dongsuk; Allen, Jason W.; Fleischer, Candace C.] Emory Univ, Atlanta, GA 30322 USA; [Smith, Jeremy L.; Owusu-Ansah, Maame; Ekici, Selin; Allen, Jason W.; Fleischer, Candace C.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Yarabarla, Suma] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Prasad, Ojaswa] Philadelphia Coll Osteopath Med, Dept Med, Suwanee, GA USA; [Mines, Brandon] Emory Univ, Sch Med, Dept Orthoped, Atlanta, GA USA		Fleischer, CC (corresponding author), Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA.	candace.fleischer@emory.edu		Smith, Jeremy/0000-0003-0841-5297; Allen, Jason/0000-0002-5274-1105; Fleischer, Candace/0000-0003-3265-2276	Emory University Department of Radiology and Imaging Sciences	Emory University Department of Radiology and Imaging Sciences	Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Biegon A, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.576366; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Childs C, 2013, CRIT CARE, V17, DOI 10.1186/cc11892; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Churchill NW, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102258; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Fox MD, 2005, NEUROIMAGE, V25, P771, DOI 10.1016/j.neuroimage.2004.12.025; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Huang HY, 2018, BRAIN STRUCT FUNCT, V223, P131, DOI 10.1007/s00429-017-1479-y; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim YJ, 2015, PSYCHIAT INVEST, V12, P335, DOI 10.4306/pi.2015.12.3.335; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2017, J NEUROIMAGING, V27, P562, DOI 10.1111/jon.12463; Mazaika P., 2009, ANN M ORG HUM BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nakano K, 2000, BRAIN DEV-JPN, V22, pS5; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Voss MW, 2020, MED SCI SPORT EXER, V52, P131, DOI 10.1249/MSS.0000000000002115; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028	48	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV	2021	31	6					1146	1155		10.1111/jon.12909		JUL 2021	10	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	XK3BE	WOS:000674379700001	34288203				2022-02-07	
J	Wright, DR				Wright, David R.			Ketamine in Modern Neuroanesthesia Practice	CURRENT ANESTHESIOLOGY REPORTS			English	Article						Ketamine; Cerebral blood flow; Intracranial pressure; Acute brain injury; Traumatic brain injury; Subarachnoid hemorrhage; Neuroprotection; Spreading depolarization; Epilepsy; Electoconvulsive therapy; Analgesia; Depression; Pre-hospital care	CEREBRAL-BLOOD-FLOW; INTRAOPERATIVE KETAMINE; INTRACRANIAL-PRESSURE; MAJOR SURGERY; OLDER-ADULTS; DOUBLE-BLIND; ANESTHESIA; SEDATION; MULTICENTER; PREVENTION	Purpose of Review Ketamine has a number of clinical uses and properties that suggest a role for the drug in neuroanestheisa practice. "Dogma" and "myths" persist with regard to its effects on cerebral hemodynamics and intracranial pressure which have limited its use in Neuroanesthesia and care of the critically ill brain-injured patient. This review aims to educate the clinician on the possible role of ketamine in modern neuroanesthesia practice. Recent Findings A number of systemic reviews support the use of ketamine in patients with acute brain injury and raised intracranial pressure (ICP). Pre-clinical work suggests that ketamine may have mechanisms of action compatible with neuroprotection including modifying glutamate excitatory-driven mechanisms of brain injury. There is emerging clinical evidence to suggest that ketamine may inhibit spreading depolarizations (SDs), a cortical electrical phenomenon associated with brain injury. Ketamine is no longer contraindicated in the care of the brain-injured patient, and its properties of potent analgesia, dissociative anesthesia, and minimal effects on both the hemodynamic and respiratory system are being utilized in the pre-hospital and emergency room setting. Good grade data on meaningful clinical outcomes is presently lacking to support the use of ketamine as a drug with neuroprotection properties but is an area of ongoing interest.	[Wright, David R.] Univ Washington, Harborview Med Ctr, Anesthesiol & Pain Med & Neurol Surg, 325 9th Ave, Seattle, WA 98104 USA		Wright, DR (corresponding author), Univ Washington, Harborview Med Ctr, Anesthesiol & Pain Med & Neurol Surg, 325 9th Ave, Seattle, WA 98104 USA.	wrigh048@uw.edu					Alkhachroum A, 2020, NEUROLOGY, V95, pE2286, DOI 10.1212/WNL.0000000000010611; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Avidan MS, 2017, LANCET, V390, P267, DOI 10.1016/S0140-6736(17)31467-8; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bell JD, 2017, ANESTH ANALG, V124, P1237, DOI 10.1213/ANE.0000000000001856; Bhardwaj Ajit, 2020, Asian J Neurosurg, V15, P608, DOI 10.4103/ajns.AJNS_346_19; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Carspecken CW, 2018, J NEUROSURG ANESTH, V30, P305, DOI 10.1097/ANA.0000000000000511; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Dagal A, 2019, SPINE, V44, P959, DOI 10.1097/BRS.0000000000002968; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Eikermann M, 2012, ANESTHESIOLOGY, V116, P35, DOI 10.1097/ALN.0b013e31823d010a; Gamble JJ, 2018, CAN J ANESTH, V65, P636, DOI 10.1007/s12630-018-1088-0; Godoy DA, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03452-x; GREEN SM, 1990, ANN EMERG MED, V19, P1033, DOI 10.1016/S0196-0644(05)82569-7; Gregers MCT, 2020, NEUROCRIT CARE, V33, P273, DOI 10.1007/s12028-020-00975-7; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hudetz JA, 2009, J CARDIOTHOR VASC AN, V23, P651, DOI 10.1053/j.jvca.2008.12.021; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Loflin R, 2015, ANN EMERG MED, V65, P55, DOI 10.1016/j.annemergmed.2014.08.017; Loftus RW, 2010, ANESTHESIOLOGY, V113, P639, DOI 10.1097/ALN.0b013e3181e90914; Maheshwari K, 2020, ANESTHESIOLOGY, V132, P992, DOI 10.1097/ALN.0000000000003143; Mashour GA, 2018, BRIT J ANAESTH, V121, P1075, DOI 10.1016/j.bja.2018.03.030; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Morgan MM, 2021, PREHOSP EMERG CARE, V25, P588, DOI 10.1080/10903127.2020.1801920; Telles JPM, 2021, NEUROPHYSIOL CLIN, V51, P145, DOI 10.1016/j.neucli.2021.01.004; Rascon-Martinez DM, 2016, ANESTH ANALG, V122, P969, DOI 10.1213/ANE.0000000000001153; SARI A, 1972, ANESTH ANAL CURR RES, V51, P560; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; Torres AC, 2020, CUREUS, V12, DOI 10.7759/cureus.9248; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zeiler FA, 2014, NEUROCRIT CARE, V20, P502, DOI 10.1007/s12028-013-9939-6; Zeiler FA, 2016, J NEUROSURG ANESTH, V28, P123, DOI 10.1097/ANA.0000000000000234; Zhang ML, 2018, J AFFECT DISORDERS, V227, P372, DOI 10.1016/j.jad.2017.11.034; Zietlow J, 2019, MIL MED, V184, P542, DOI 10.1093/milmed/usy422	38	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-6275		CURR ANESTHESIOL REP	Curr. Anesthesiol. Rep.	SEP	2021	11	3					189	194		10.1007/s40140-021-00465-2		JUL 2021	6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	UL2GF	WOS:000675891400001					2022-02-07	
J	Adams, SA; Richards, H; Sproule, J; Hutchinson, PJ; Turner, AP				Adams, Stephanie A.; Richards, Hugh; Sproule, John; Hutchinson, Peter J.; Turner, Anthony P.			A Concussion Education Programme for Motorsport Drivers: A Field-Based Exploratory Pilot Study	BRAIN INJURY			English	Article						Traumatic brain injury; need for cognition; health education; knowledge; attitudes	INDIVIDUAL-DIFFERENCES; HEALTH MESSAGES; NEED; COGNITION; PREVENTION; MOTIVATION; KNOWLEDGE; ATTITUDES; BEHAVIORS; PLAYERS	Objective Concussion education strategies that improve knowledge and attitudes long term are needed. This exploratory study piloted an interactive concussion education program, adopting concepts from the learning sciences and attitude change literature, for the underserved and high-risk population of motorsports. Method Forty UK motorsport drivers (ages 16-20 years) participated. The workshop group received a two-phased workshop-based program. The comparison group received a concussion leaflet. Participants completed an adapted version of the Rosenbaum Concussion Knowledge and Attitudes Survey (RoCKAS-ST) at pre-, post- and 2-month follow-up. Within-group analysis for the workshop group explored the differential effect of the individual difference variable, Need for Cognition (NfC), and effectiveness was explored through post-workshop questionnaires and interviews. Results Unlike the comparison group, the workshop group showed a significant improvement in knowledge over time (F(2,58) = 45.49, p < .001, (eta 2)p = .61). Qualitative data indicated workshop-program participants developed safer attitudes toward concussion following programming. Preliminary evidence suggested individuals' responses to concussion education aligned with differences in NfC. Conclusion This study piloted the first concussion education program for motorsport drivers and explored whether aligning educational provision with the NfC construct may help to improve program effectiveness. Findings are relevant to addressing the public health issue of concussion through educational approaches.	[Adams, Stephanie A.; Richards, Hugh; Sproule, John; Turner, Anthony P.] Univ Edinburgh, Inst Sport PE & Hlth Sci, Moray House Sch Educ, Edinburgh, Midlothian, Scotland; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Acad Div Neurosurg, Cambridge, England		Adams, SA (corresponding author), Univ Edinburgh, Inst Sport PE & Hlth Sci, Moray House Sch Educ, Edinburgh, Midlothian, Scotland.	stephanie.adams@ed.ac.uk		Turner, Tony/0000-0003-1202-6649; Hutchinson, Peter/0000-0002-2796-1835			Adams SA, 2020, CLIN J SPORT MED, V30, P568, DOI 10.1097/JSM.0000000000000647; An D, 2017, PERS INDIV DIFFER, V116, P410, DOI 10.1016/j.paid.2017.04.050; Bakker AB, 1999, AIDS EDUC PREV, V11, P150; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown A, 2011, EDUC PSYCHOL MEAS, V71, P460, DOI 10.1177/0013164410375112; Cacioppo JT, 2018, SOC NEUROSCI-UK, V13, P129, DOI 10.1080/17470919.2016.1273851; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carvalho PF, 2020, NPJ SCI LEARN, V5, DOI 10.1038/s41539-020-0061-1; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; CIALDINI RB, 1981, ANNU REV PSYCHOL, V32, P357, DOI 10.1146/annurev.ps.32.020181.002041; Conner M, 2011, PSYCHOL HEALTH, V26, P133, DOI 10.1080/08870446.2011.531570; Cortese J, 2012, J AM SOC INF SCI TEC, V63, P1567, DOI 10.1002/asi.22700; Craig P, 2013, INT J NURS STUD, V50, P585, DOI 10.1016/j.ijnurstu.2012.09.009; Deakin ND, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000879; Deakin Naomi D, 2017, Concussion, V2, pCNC43, DOI 10.2217/cnc-2017-0004; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Ebbinghaus H, 2013, ANN NEUROSCI, V20, P155, DOI 10.5214/ans.0972.7531.200408; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fontaine D., 2019, COMMUNICATION SPORT, V9, P527; Fremont P, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000700; Gerrard Meg, 1999, Journal of the National Cancer Institute Monographs, P94; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Grass J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220282; Haug S, 2010, HEALTH PSYCHOL, V29, P367, DOI 10.1037/a0019450; Horcajo J, 2019, J SPORT SCI, V37, P2835, DOI 10.1080/02640414.2019.1665876; Howard-Jones PA, 2014, NAT REV NEUROSCI, V15, P817, DOI 10.1038/nrn3817; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Husmann PR, 2019, ANAT SCI EDUC, V12, P6, DOI 10.1002/ase.1777; Jebb AT, 2016, SPRINGER SER HUM EXC, P115, DOI 10.1007/978-3-319-28606-8_5; Karlsson P, 2015, ADDICTION, V110, P420, DOI 10.1111/add.12799; Kramer AW, 2021, COGNITIVE DEV, V57, DOI 10.1016/j.cogdev.2020.100978; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Latimer AE, 2005, J HEALTH COMMUN, V10, P137, DOI 10.1080/10810730500263364; Luttrell A, 2017, J EXP SOC PSYCHOL, V69, P178, DOI 10.1016/j.jesp.2016.09.006; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMath BF, 2005, J APPL SOC PSYCHOL, V35, P621, DOI 10.1111/j.1559-1816.2005.tb02138.x; Nancekivell SE, 2020, J EDUC PSYCHOL, V112, P221, DOI 10.1037/edu0000366; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Olvey S., 2015, INT J MOTOR SPORT ME, P36; Orbell S, 2004, HEALTH PSYCHOL, V23, P388, DOI 10.1037/0278-6133.23.4.388; Pashler Harold, 2008, Psychol Sci Public Interest, V9, P105, DOI 10.1111/j.1539-6053.2009.01038.x; Patton MQ., 2002, QUALITATIVE RES EVAL; Petty R. E., 1986, COMMUN PERSUATION, P141, DOI [DOI 10.1007/978-1-4612-4964-1_6, 10.1007/978-1-4612-4964-1_6]; Potkanowicz ES, 2013, SPORTS MED, V43, P565, DOI 10.1007/s40279-013-0040-2; Rhodes MG, 2020, GUIDE EFFECTIVE STUD; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Sherman, 2020, PRACTICAL GUIDE IMPL; SportScotland, DOUBT SIT THEM OUT; SportScotland, 2015, DOUBT SIT THEM OUT; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; Williams-Piehota P, 2003, HEALTH COMMUN, V15, P375, DOI 10.1207/S15327027HC1504_01	65	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1011	1021		10.1080/02699052.2021.1944669		JUL 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000673817500001	34264789	Green Published, hybrid			2022-02-07	
J	Bamer, AM; McMullen, K; Deutsch, A; Sevigny, M; Mroz, T; Wiechman, SA; Schneider, JC; Amtmann, D				Bamer, Alyssa M.; McMullen, Kara; Deutsch, Anne; Sevigny, Mitch; Mroz, Tracy; Wiechman, Shelly A.; Schneider, Jeffrey C.; Amtmann, Dagmar			Linking scores on the 4-and 5-item versions of the Satisfaction with Life Scale in people with traumatic brain, spinal cord, or burn injury: a National Institute on Disability, Independent Living, and Rehabilitation Research Model System study	JOURNAL OF PATIENT-REPORTED OUTCOMES			English	Article								Background The Satisfaction with Life Scale (SWLS) is a widely used measure of subjective well-being. Recent evidence indicates the fifth item of the scale reduces the reliability of the scale and is inappropriate for use in traumatic injury populations. The purpose of this study was to develop a linking procedure between the five-item version of the SWLS and a modified four-item version, which removes the problematic item, for use in Spinal Cord (SCI), Traumatic Brain (TBI), and Burn Injury populations. Methods Proration (i.e. adding the mean of the four items to their total) was identified as a potential linking solution that could be easily implemented in clinical or research settings. The validity of the proration approach was evaluated by examining mean differences, cross group classification by SWLS category, score correlations, the intraclass correlation coefficient, and visual inspection of Bland-Altman plots in a large sample of SCI, TBI, and Burn Injury survivors who were participants in the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Model Systems' National Databases. Results A total of 17,897 (SCI n = 8566, TBI n = 7941, and Burn n = 1390) participants were included in this study. SWLS scores ranged from 5 to 35, and the average score difference between directly derived and prorated scores was 0.39 points. A large majority of the sample (93%) had score differences of < 4 points (i.e. approximately 0.5 SD). The correlation between the prorated and directly derived scores was very high (r = 0.97) and the ICC value indicated excellent reliability (ICC = 0.97). Conclusions This study provides a valid scoring approach for researchers or clinicians who don't want to lose continuity with previously collected data but prefer to switch to the modified four-item version of the SWLS. Clear guidance is provided for traumatic injury researchers or clinicians on how to implement the proration scoring approach.	[Bamer, Alyssa M.; McMullen, Kara; Amtmann, Dagmar] Univ Washington, Ctr Outcomes Res Rehabil, Dept Rehabil Med, 12360 Lake City Way,Suite 502, Seattle, WA 98125 USA; [Deutsch, Anne] Shirley Ryan AbilityLab, 355 E Erie St, Chicago, IL 60611 USA; [Deutsch, Anne] Northwestern Univ, 355 E Erie St, Chicago, IL 60611 USA; [Deutsch, Anne] RTI Int, 230 W Monroe St, Chicago, IL 60606 USA; [Sevigny, Mitch] Craig Hosp, Spinal Cord Injury Model Syst, 3425 S Clarkson St, Englewood, CO 80113 USA; [Mroz, Tracy] Univ Washington, Dept Rehabil Med, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA; [Wiechman, Shelly A.] Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA; [Schneider, Jeffrey C.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Res Inst, Dept Phys Med & Rehabil, 300 1st Ave, Boston, MA 02129 USA		Amtmann, D (corresponding author), Univ Washington, Ctr Outcomes Res Rehabil, Dept Rehabil Med, 12360 Lake City Way,Suite 502, Seattle, WA 98125 USA.	dagmara@uw.edu	Deutsch, Anne/B-7530-2017	Deutsch, Anne/0000-0003-2290-7757	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPGE0004]; NIDILRRUnited States Department of Health & Human Services	The contents of this manuscript were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DPGE0004). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The TBI, Burn, and SCI Model Systems National Databases are multicenter studies of the TBI, Burn, and SCI Model Systems Centers Programs, and are supported by NIDILRR. However, these contents do not necessarily reflect the opinions or views of the TBI, Burn, or SCI Model Systems Centers, NIDILRR, ACL or HHS.	Amtmann D, 2020, ARCH PHYS MED REHAB, V101, pS5, DOI 10.1016/j.apmr.2017.09.109; Amtmann D, 2019, ASSESSMENT, V26, P695, DOI 10.1177/1073191117693921; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1797, DOI 10.1016/j.apmr.2016.02.027; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dorans NJ, 2007, QUAL LIFE RES, V16, P85, DOI 10.1007/s11136-006-9155-3; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mazza GL, 2015, MULTIVAR BEHAV RES, V50, P504, DOI 10.1080/00273171.2015.1068157; Mukaka MM, 2012, MALAWI MED J, V24, P69; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024	13	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2509-8020		J PATIENT-REP OUTCOM	J. Patient-Rep. Outcomes	JUL 17	2021	5	1							59	10.1186/s41687-021-00335-9			6	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	TL5ZT	WOS:000674939700001	34273011	gold, Green Published			2022-02-07	
J	Chen, HZ; Kevala, K; Aflaki, E; Marugan, J; Kim, HY				Chen, Huazhen; Kevala, Karl; Aflaki, Elma; Marugan, Juan; Kim, Hee-Yong			GPR110 ligands reduce chronic optic tract gliosis and visual deficit following repetitive mild traumatic brain injury in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Synaptamide; A8 (4Z; 7Z; 10Z; 13Z; 16Z; 19Z)-N-(2-hydroxy-2-methylpropyl) docosa-4; 7; 10; 13; 16; 19-hexaenamide (dimethylsynaptamide); repetitive CHIMERA; GPR110; Histopathology; Optic tract; Visual deficit; VEP; mTBI	PROTEIN-COUPLED RECEPTORS; WHITE-MATTER; DIFFUSION TENSOR; ADHESION-GPCRS; NEUROPROTECTION; CONCUSSION; ACTIVATION; ROLES	BackgroundRepetitive mild traumatic brain injury (mTBI) can result in chronic visual dysfunction. G-protein receptor 110 (GPR110, ADGRF1) is the target receptor of N-docosahexaenoylethanolamine (synaptamide) mediating the anti-neuroinflammatory function of synaptamide. In this study, we evaluated the effect of an endogenous and a synthetic ligand of GPR110, synaptamide and (4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-hydroxy-2-methylpropyl) docosa-4,7,10,13,16,19-hexaenamide (dimethylsynaptamide, A8), on the mTBI-induced long-term optic tract histopathology and visual dysfunction using Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA), a clinically relevant model of mTBI.MethodsThe brain injury in wild-type (WT) and GPR110 knockout (KO) mice was induced by CHIMERA applied daily for 3 days, and GPR110 ligands were intraperitoneally injected immediately following each impact. The expression of GPR110 and proinflammatory mediator tumor necrosis factor (TNF) in the brain was measured by using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) in an acute phase. Chronic inflammatory responses in the optic tract and visual dysfunction were assessed by immunostaining for Iba-1 and GFAP and visual evoked potential (VEP), respectively. The effect of GPR110 ligands in vitro was evaluated by the cyclic adenosine monophosphate (cAMP) production in primary microglia isolated from adult WT or KO mouse brains.ResultsCHIMERA injury acutely upregulated the GPR110 and TNF gene level in mouse brain. Repetitive CHIMERA (rCHIMERA) increased the GFAP and Iba-1 immunostaining of glia cells and silver staining of degenerating axons in the optic tract with significant reduction of N1 amplitude of visual evoked potential at up to 3.5 months after injury. Both GPR110 ligands dose- and GPR110-dependently increased cAMP in cultured primary microglia with A8, a ligand with improved stability, being more effective than synaptamide. Intraperitoneal injection of A8 at 1 mg/kg or synaptamide at 5 mg/kg significantly reduced the acute expression of TNF mRNA in the brain and ameliorated chronic optic tract microgliosis, astrogliosis, and axonal degeneration as well as visual deficit caused by injury in WT but not in GPR110 KO mice.ConclusionOur data demonstrate that ligand-induced activation of the GPR110/cAMP system upregulated after injury ameliorates the long-term optic tract histopathology and visual impairment caused by rCHIMERA. Based on the anti-inflammatory nature of GPR110 activation, we suggest that GPR110 ligands may have therapeutic potential for chronic visual dysfunction associated with mTBI.	[Chen, Huazhen; Kevala, Karl; Aflaki, Elma; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Rockville, MD 20852 USA; [Chen, Huazhen; Kim, Hee-Yong] Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20817 USA; [Marugan, Juan] NIH, Div Preclin Innovat, NCATS, Rockville, MD 20817 USA		Kim, HY (corresponding author), NIAAA, Lab Mol Signaling, NIH, 5625 Fishers Lane, Rockville, MD 20852 USA.; Kim, HY (corresponding author), Henry M Jackson Fdn, Ctr Neurosci & Regenerat Med, Bethesda, MD 20817 USA.	hykim@nih.gov			National Institute of Alcohol Abuse and Alcoholism (NIAAA) in National Institutes of Health (NIH); Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense; Henry M. Jackson Foundation for the Advancement of Military Medicine; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This research was supported by the intramural program of National Institute of Alcohol Abuse and Alcoholism (NIAAA) in National Institutes of Health (NIH) and Center for Neuroscience and Regenerative Medicine (CNRM) with Henry M. Jackson Foundation for the Advancement of Military Medicine. The funding agencies did not have any role in the design and implementation of this study. Open Access funding provided by the National Institutes of Health (NIH).	Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Benchorin G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2218; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Huang BX, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0831-6; Kim HY, 2018, MOL ASPECTS MED, V64, P34, DOI 10.1016/j.mam.2018.03.004; Kwon H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073386; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lum AM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-40; Ma BT, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-3146; Ma BT, 2017, AM J CANCER RES, V7, P433; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Park T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1621-2; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Ponomarenko AI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80818-9; Purcell RH, 2018, ANNU REV PHARMACOL, V58, P429, DOI 10.1146/annurev-pharmtox-010617-052933; Raker VK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00123; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tyrtyshnaia A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249703; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	43	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUL 17	2021	18	1							157	10.1186/s12974-021-02195-y			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	TM0IJ	WOS:000675238500001	34273979	gold, Green Published			2022-02-07	
J	Khaki, D; Hietanen, V; Corell, A; Herges, HO; Ljungqvist, J				Khaki, Djino; Hietanen, Virpi; Corell, Alba; Herges, Helena Odenstedt; Ljungqvist, Johan			Selection of CT variables and prognostic models for outcome prediction in patients with traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; IMPACT score; CRASH score; Stockholm CT score; Marshall classification; Rotterdam scoring system; Helsinki CT score	PERFUSION-CT; CLASSIFICATION; IMPACT; GUIDELINES	Background Traumatic brain injuries (TBI) are associated with high risk of morbidity and mortality. Early outcome prediction in patients with TBI require reliable data input and stable prognostic models. The aim of this investigation was to analyze different CT classification systems and prognostic calculators in a representative population of TBI-patients, with known outcomes, in a neurointensive care unit (NICU), to identify the most suitable CT scoring system for continued research. Materials and methods We retrospectively included 158 consecutive patients with TBI admitted to the NICU at a level 1 trauma center in Sweden from 2012 to 2016. Baseline data on admission was recorded, CT scans were reviewed, and patient outcome one year after trauma was assessed according to Glasgow Outcome Scale (GOS). The Marshall classification, Rotterdam scoring system, Helsinki CT score and Stockholm CT score were tested, in addition to the IMPACT and CRASH prognostic calculators. The results were then compared with the actual outcomes. Results Glasgow Coma Scale score on admission was 3-8 in 38%, 9-13 in 27.2%, and 14-15 in 34.8% of the patients. GOS after one year showed good recovery in 15.8%, moderate disability in 27.2%, severe disability in 24.7%, vegetative state in 1.3% and death in 29.7%. When adding the variables from the IMPACT base model to the CT scoring systems, the Stockholm CT score yielded the strongest relationship to actual outcome. The results from the prognostic calculators IMPACT and CRASH were divided into two subgroups of mortality (percentages); <= 50% (favorable outcome) and > 50% (unfavorable outcome). This yielded favorable IMPACT and CRASH scores in 54.4 and 38.0% respectively. Conclusion The Stockholm CT score and the Helsinki score yielded the closest relationship between the models and the actual outcomes in this consecutive patient series, representative of a NICU TBI-population. Furthermore, the Stockholm CT score yielded the strongest overall relationship when adding variables from the IMPACT base model and would be our method of choice for continued research when using any of the current available CT score models.	[Khaki, Djino; Corell, Alba; Ljungqvist, Johan] Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden; [Khaki, Djino; Corell, Alba; Ljungqvist, Johan] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Hietanen, Virpi; Herges, Helena Odenstedt] Sahlgrens Univ Hosp, Dept Anesthesia & Intens Care, Gothenburg, Sweden; [Herges, Helena Odenstedt] Univ Gothenburg, Sahlgrenska Acad, Inst Anesthesiol & Intens Care Med, Gothenburg, Sweden		Khaki, D; Ljungqvist, J (corresponding author), Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden.; Khaki, D; Ljungqvist, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	djino.khaki@vgregion.se; johan.liungqvist@vgregion.se		Corell, Alba/0000-0002-6329-2392	Gothenburg Society of Medicine; ALF; University of Gothenburg	AC received financial support from The Gothenburg Society of Medicine. Funding was received from ALF, the Swedish national contract between the state and region in cooperation with the university and the hospital in purpose to fund education and clinical research to advance development in medicine and health care. Open Access funding provided by University of Gothenburg.	Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Bilgi K., 2020, WORLD NEUROSURGERY WORLD NEUROSURGERY; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2019, NEUROL NEUROCHIR POL, V53, P55, DOI 10.5603/PJNNS.a2018.0003; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dijkland SA, 2021, J NEUROTRAUM, V38, P1377, DOI 10.1089/neu.2020.7300; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Ljungqvist J, 2017, BRAIN INJURY, V31, P344, DOI 10.1080/02699052.2016.1256500; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maeda Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221791; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Modi NJ, 2016, NEUROL INDIA, V64, P8, DOI 10.4103/0028-3886.178030; Murray GD, 2018, J NEUROSURG, V128, P1621, DOI 10.3171/2017.12.JNS172782; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Stalnacke BM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9216931; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Wiklund E, 2016, ACTA RADIOL, V57, P750, DOI 10.1177/0284185115597718; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Wongchareon K, 2020, INJURY PREV, V26, P546, DOI 10.1136/injuryprev-2019-043466	32	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUL 17	2021	29	1							94	10.1186/s13049-021-00901-6			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TJ8OG	WOS:000673733300001	34274009	Green Published, gold			2022-02-07	
J	Sullivan, KA; Bennett, D				Sullivan, Karen A.; Bennett, Darcy			An Experimental Study of the Effects of Biased Responding on the Modified Rivermead Post-concussion Symptoms Questionnaire and Validity Indicators	PSYCHOLOGICAL INJURY & LAW			English	Article						Minor head injury; Concussion; Forensic neuropsychology; Assessment; Malingering	TRAUMATIC BRAIN-INJURY; RECOGNITION MEMORY TEST; POSTCONCUSSION SYNDROME; PERFORMANCE VALIDITY; CLINICAL UTILITY; HEAD-INJURY; MILD; SCALE; EXAGGERATION; PTSD	The identification and management of persistent post-concussion symptoms (PPCS) is reliant on the accurate and valid reporting of symptoms. To assist with the evaluation of validity, symptom validity indicators (SVIs) are used. This study explored the utility of the newly developed modified Rivermead Post-concussion Symptoms Questionnaire (RPQ), which embeds an SVI into the RPQ (mRPQ). Ninety-four participants completed the mRPQ; two existing SVIs (the Validity-10 [Val-10] and the Mild Brain Injury Atypical Symptoms [mBIAS] scale); two performance validity tests (the Test of Memory Malingering [TOMM] and Warrington's Memory Recognition Test [WMRT]); and, a post-experimental questionnaire. This study utilized a simulation design, with participants randomly allocated to one of two conditions: mTBI Simulator (MS, n = 47) or Biased mTBI Simulator (BMS, n = 47). The BMS group received an additional biasing instruction to motivate distorted responding for a forensic assessment context. The validity measures were highly intercorrelated, as were the PPCS scores (p < 0.05). There were significant group differences on all measures (p < 0.05). The BMS group reported more PPCS than the MS group, and showed more signs of invalidity. Although relatively new and requiring further analysis, this study shows the mRPQ has the potential to aid clinical assessment as an indicator of symptom invalidity.	[Sullivan, Karen A.] Queensland Univ Technol, Fac Hlth, Sch Psychol & Counselling, Kelvin Grove Campus,O Block B Wing Victoria Pk Rd, Brisbane, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Australian Ctr Hlth Law Res, Brisbane, Qld, Australia; [Bennett, Darcy] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Psychol & Counselling, Kelvin Grove Campus,O Block B Wing Victoria Pk Rd, Brisbane, Qld 4059, Australia.; Sullivan, KA (corresponding author), Queensland Univ Technol, Australian Ctr Hlth Law Res, Brisbane, Qld, Australia.	karen.sullivan@qut.edu.au			QUT School of Psychology and Counselling	The QUT School of Psychology and Counselling funded the gift cards for this project.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Bodapati AS, 2019, CLIN NEUROPSYCHOL, V33, P539, DOI 10.1080/13854046.2018.1482003; Bush, 2013, MILD TRAUMATIC BRAIN, P1; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cartwright A, 2019, J FORENSIC PSYCHI PS, V30, P89, DOI 10.1080/14789949.2018.1502338; Cato MA, 2002, CLIN NEUROPSYCHOL, V16, P524, DOI 10.1076/clin.16.4.524.13901; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DONALDSON TS, 1968, J AM STAT ASSOC, V63, P660, DOI 10.2307/2284037; Donders J, 2021, ARCH CLIN NEUROPSYCH, V36, P394, DOI 10.1093/arclin/acz057; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HEILBRUN K, 1990, BEHAV SCI LAW, V0008, P00045, DOI DOI 10.1002/BSL.2370080106; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Jurick SM, 2020, J INT NEUROPSYCH SOC, V26, P108, DOI 10.1017/S1355617719000997; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menatti ARR, 2020, J HEAD TRAUMA REHAB, V35, pE36, DOI 10.1097/HTR.0000000000000467; Merckelbach H, 2019, CURR DIR PSYCHOL SCI, V28, P321, DOI 10.1177/0963721419837681; Millis SR, 2009, J NEUROTRAUM, V26, P2409, DOI 10.1089/neu.2008.0530; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Rickards TA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1748032; Rogers R., 2018, CLIN ASSESSMENT MALI; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schenk K, 2010, J CLIN EXP NEUROPSYC, V32, P752, DOI 10.1080/13803390903512678; Sherer M, 2020, J INT NEUROPSYCH SOC, V26, P932, DOI 10.1017/S1355617720000351; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sreenivasan S, 2003, J AM ACAD PSYCHIATRY, V31, P220; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sullivan K., 2006, J FORENSIC NEUROPSYC, V4, P49, DOI [10.1300/J151v04n04_04, DOI 10.1300/J151V04N04_04]; Sullivan K. A., CLIN NEUROPSYCHOL; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Sweet J. J., CLIN NEUROPSYCHOL, P1; Szogi EG, 2018, PSYCHOL INJ LAW, V11, P351, DOI 10.1007/s12207-018-9315-0; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vikane E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00639; Voormolen DC, 2020, BRAIN INJURY, V34, P1001, DOI 10.1080/02699052.2020.1761563; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Windle K, 2021, APPL NEUROPSYCH-ADUL, V28, P512, DOI 10.1080/23279095.2019.1660880; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	68	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	SEP	2021	14	3			SI		161	170		10.1007/s12207-021-09419-9		JUL 2021	10	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	WB9GE	WOS:000673682500001					2022-02-07	
J	Alhammoud, A; Moghamis, I; Abdelrahman, H; Ghouri, SI; Asim, M; Babikir, E; Al-Thani, H; El-Menyar, A				Alhammoud, Abduljabbar; Moghamis, Isam; Abdelrahman, Husham; Ghouri, Syed Imran; Asim, Mohammad; Babikir, Elhadi; Al-Thani, Hassan; El-Menyar, Ayman			Clinical characteristics, injury pattern and management of pediatric pelvic fracture: An observational retrospective study from a level I trauma center	BMC MUSCULOSKELETAL DISORDERS			English	Article						Pediatric pelvic fracture; Fracture classification; Pelvic ring injury; Polytrauma	RING FRACTURES; CLASSIFICATION; CHILDREN	Background Pediatric pelvic fractures (PPF) are uncommon among children requiring hospitalization after blunt trauma. The present study explored our experience for the prevalence, patients demographics, clinical characteristics, injury pattern and management of pediatric pelvic fractures in a level I trauma center. Methods This is a retrospective review of prospectively collected data obtained from trauma registry database for all pediatrics trauma patients of age <= 18 years. Data were analyzed according to different aspects relevant to the clinical applications such as Torode classification for pelvic ring fracture (Type I-IV), open versus closed triradiate cartilage, and surgical versus non-surgical management. Results During the study period (3 and half years), a total of 119 PPF cases were admitted at the trauma center (11% of total pediatric admissions); the majority had pelvic ring fractures (91.6%) and 8.4% had an acetabular fracture. The mean age of patients was 11.5 +/- 5.7, and the majority were males (78.2%). One hundred and four fractures were classified as type I (5.8%), type II (13.5%), type III (68.3%) and type IV (12.5%). Patients in the surgical group were more likely to have higher pelvis AIS (p = 0.001), type IV fractures, acetabular fractures and closed triradiate cartilage as compared to the conservative group. Type III fractures and open triradiate cartilage were significantly higher in the conservative group (p < 0.05). Patients with closed triradiate cartilage frequently sustained spine, head injuries, acetabular fracture and had higher mean ISS and pelvis AIS (p < 0.01) than the open group. However, the rate of in-hospital complications and mortality were comparable among different groups. The overall mortality rate was 2.5%. Conclusion PPF are uncommon and mainly caused by high-impact trauma associated with multisystem injuries. The majority of PPF are stable, despite the underlying high-energy mechanism. Management of PPF depends on the severity of fracture as patients with higher grade fractures require surgical intervention. Furthermore, larger prospective study is needed to understand the age-related pattern and management of PPF.	[Alhammoud, Abduljabbar; Moghamis, Isam; Ghouri, Syed Imran; Babikir, Elhadi] Hamad Gen Hosp, Dept Surg Orthoped Surg, Doha, Qatar; [Abdelrahman, Husham; Al-Thani, Hassan] Hamad Gen Hosp, Dept Surg Trauma Surg, Doha, Qatar; [Asim, Mohammad; El-Menyar, Ayman] Hamad Gen Hosp, HMC, Clin Res Trauma & Vasc Surg, Dept Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Sch, Dept Clin Med, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, HMC, Clin Res Trauma & Vasc Surg, Dept Surg, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Sch, Dept Clin Med, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Abdelrahman H, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01772-w; Banerjee S, 2009, INJURY, V40, P410, DOI 10.1016/j.injury.2008.10.019; Bent MA, 2017, J ORTHOP TRAUMA, V31, pE200, DOI 10.1097/BOT.0000000000000866; Chia JPY, 2004, J TRAUMA, V56, P83, DOI 10.1097/01.TA.0000084518.09928.CA; de la Calva C, 2020, PEDIATR EMERG CARE, V36, P519, DOI 10.1097/PEC.0000000000001411; Desai AA, 2015, J PEDIATR INTENSIVE, V4, P40, DOI 10.1055/s-0035-1554988; Dimeglio A, 2013, J CHILD ORTHOP, V7, P43, DOI 10.1007/s11832-012-0463-6; Gansslen Axel, 2013, Eur J Orthop Surg Traumatol, V23, P847, DOI 10.1007/s00590-012-1102-0; Grisoni N, 2002, J ORTHOP TRAUMA, V16, P458, DOI 10.1097/00005131-200208000-00003; Hauschild O, 2008, J TRAUMA, V64, P449, DOI 10.1097/TA.0b013e31815982b1; Hermans E, 2017, J CHILD ORTHOP, V11, P49, DOI 10.1302/1863-2548-11-160138; Holden CP, 2007, J AM ACAD ORTHOP SUR, V15, P172, DOI 10.5435/00124635-200703000-00007; Ismail N, 1996, J PEDIATR SURG, V31, P82, DOI 10.1016/S0022-3468(96)90324-3; Leonard M, 2011, INJURY, V42, P1027, DOI 10.1016/j.injury.2010.08.005; Niedzielski Kryspin Ryszard, 2013, Ortop Traumatol Rehabil, V15, P41, DOI 10.5604/15093492.1032796; Oransky M, 2010, INJURY, V41, P1140, DOI 10.1016/j.injury.2010.08.002; Pascarella R, 2013, Musculoskelet Surg, V97, P217, DOI 10.1007/s12306-013-0288-6; Schwarz N, 1998, INJURY, V29, P431, DOI 10.1016/S0020-1383(98)00074-6; Shore BJ, 2012, J PEDIATR ORTHOPED, V32, P162, DOI 10.1097/BPO.0b013e3182408be6; Silber JS, 2002, J PEDIATR ORTHOPED, V22, P22; Silber JS, 2001, J PEDIATR ORTHOPED, V21, P148, DOI 10.1097/00004694-200103000-00002; Silber JS, 2001, J PEDIATR ORTHOPED, V21, P446, DOI 10.1097/00004694-200107000-00006; Spiguel L, 2006, AM SURGEON, V72, P481; TORODE I, 1985, J PEDIATR ORTHOPED, V5, P76, DOI 10.1097/01241398-198501000-00014; Tosounidis Theodoros H, 2015, Open Orthop J, V9, P303, DOI 10.2174/1874325001509010303; Tuovinen H, 2012, EUR J TRAUMA EMERG S, V38, P163, DOI 10.1007/s00068-011-0140-3; Guerra MRV, 2016, ACTA ORTOP BRAS, V24, DOI 10.1590/1413-785220162403157540; Vitale MG, 2005, J PEDIATR ORTHOPED, V25, P581, DOI 10.1097/01.bpo.0000175112.91122.41; Zwingmann J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011955	29	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2474		BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	JUL 16	2021	22	1							626	10.1186/s12891-021-04448-6			11	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	TM2GE	WOS:000675369000001	34271915	Green Published, gold			2022-02-07	
J	Gould, SJ; Cochrane, GD; Johnson, J; Hebson, CL; Kazamel, M				Gould, Sara J.; Cochrane, Graham D.; Johnson, Jarvis; Hebson, Camden L.; Kazamel, Mohamed			Orthostatic intolerance in post-concussion patients	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Concussion; fludrocortisone; orthostatic intolerance; postural orthostatic tachycardia syndrome; tilt table test	VASOVAGAL SYNCOPE; TACHYCARDIA; ADOLESCENTS; OUTCOMES	Orthostatic intolerance (OI) following pediatric concussion is not well understood. Assessing the prevalence of concussion-related OI and how it compares to non-concussion-related OI will improve care for patients suffering with these symptoms. OBJECTIVE: We set out to describe concussion-related OI in adolescence, with particular emphasis on time to recovery and differences from non-concussion-related OI (including male vs. female prevalence). Retrospective chart reviews were completed on post-concussion patients endorsing symptoms of OI. The patients' sex, sport history, previous concussions, time since injury, and recovery time were analyzed and compared between males and females as well as against general OI statistics. Thirty-nine pediatric patients, representing 8.7% of all new patients referred to a specialized concussion clinic over a 13-month interval, were included in the chart review. Mean age of onset was 15.0 +/- 2.5 years and 18 (46%) were males. The median times from evaluation to symptom resolution were 120 days. Of 18 patients who completed head-up tilt table testing, 17 (94%) had orthostatic tachycardic response (>40 bpm heart rate increment). Post-concussive OI differs from other orthostatic intolerance etiologies, lacking a strong female predominance and exhibiting a shorter time course to recovery compared to other etiologies of OI (but longer recovery time compared to concussion patients in general). Clinical orthostatic vital signs may not be sensitive for diagnosing orthostatic intolerance in athletes, likely due to higher vagal tone and more efficient skeletal muscle pump.	[Gould, Sara J.] Univ Alabama Birmingham, Dept Orthoped Surg, Birmingham, AL USA; [Gould, Sara J.; Hebson, Camden L.] Childrens Alabama, Sports Med, Birmingham, AL USA; [Cochrane, Graham D.] UAB, Dept Phys Therapy, Birmingham, AL 35294 USA; [Johnson, Jarvis] UAB, Sch Med, Birmingham, AL USA; [Hebson, Camden L.] UAB, Div Pediat Cardiol, Dept Pediat, Birmingham, AL USA; [Kazamel, Mohamed] UAB, Dept Neurol, Birmingham, AL USA		Cochrane, GD (corresponding author), UAB, Dept Phys Therapy, Birmingham, AL 35294 USA.	gcoch@uab.edu		Gould, Sara/0000-0002-0713-1156			Bhatia R, 2016, J PEDIATR-US, V173, P149, DOI 10.1016/j.jpeds.2016.02.035; Boris JR, 2018, CARDIOL YOUNG, V28, P668, DOI 10.1017/S1047951117002888; Bruce BK, 2016, CLIN PEDIATR, V55, P1300, DOI 10.1177/0009922816638663; Bryarly M, 2019, J AM COLL CARDIOL, V73, P1207, DOI 10.1016/j.jacc.2018.11.059; Christou GA, 2016, EUR J PREV CARDIOL, V23, P1003, DOI 10.1177/2047487315600168; Convertino VA, 2007, AM J MED SCI, V334, P72, DOI 10.1097/MAJ.0b013e318063c6e4; Coote JH, 2015, J PHYSIOL-LONDON, V593, P1745, DOI 10.1113/jphysiol.2014.284364; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Haider MN, 2021, BRAIN INJURY, V35, P226, DOI 10.1080/02699052.2021.1871951; Hebson CL, 2019, CONGENIT HEART DIS, V14, P156, DOI 10.1111/chd.12720; Hernandez JP, 2005, J APPL PHYSIOL, V99, P1070, DOI 10.1152/japplphysiol.01169.2004; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Kanjwal K, 2010, CARDIOL J, V17, P482; Kokorelis C, 2020, CLIN PEDIATR, V59, P75, DOI 10.1177/0009922819885656; Lai CC, 2009, PACE, V32, P234, DOI 10.1111/j.1540-8159.2008.02207.x; Martinelli FS, 2005, BRAZ J MED BIOL RES, V38, P639, DOI 10.1590/S0100-879X2005000400019; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Olshansky B, 2020, PROG CARDIOVASC DIS, V63, P263, DOI 10.1016/j.pcad.2020.03.010; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Robertson D, 1999, AM J MED SCI, V317, P75, DOI 10.1097/00000441-199902000-00001; Sheldon R, 2016, J AM COLL CARDIOL, V68, P1, DOI 10.1016/j.jacc.2016.04.030; Singer W, 2012, J PEDIATR-US, V160, P222, DOI 10.1016/j.jpeds.2011.08.054; Sousa A, 2012, CLIN AUTON RES, V22, P151, DOI 10.1007/s10286-011-0155-1; Staples A, 2020, J CHILD NEUROL, V35, P526, DOI 10.1177/0883073820916260; Stewart JM, 2004, J PEDIATR-US, V145, P725, DOI 10.1016/j.jpeds.2004.06.084; Stewart JM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1673; van Dijk N, 2006, J AM COLL CARDIOL, V48, P1652, DOI 10.1016/j.jacc.2006.06.059; van Lieshout JJ, 2001, STROKE, V32, P1546, DOI 10.1161/01.STR.32.7.1546	29	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1953357		JUL 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	TJ9XB	WOS:000673823800001	34236936				2022-02-07	
J	Palmer, GA; Palmer, DG				Palmer, Glen A.; Palmer, Daniel G.			Anxiety Screening in Polytrauma Patients by Use of Single-Item Reporting With the Neurobehavioral Symptom Inventory: How Brief Is Too Brief?	PSYCHOLOGICAL REPORTS			English	Article; Early Access						Traumatic brain injury; veterans; polytrauma; anxiety; BAI	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; VETERANS	Purpose/Objective: This study examined the clinical utility of a single item for anxiety from the Neurobehavioral Symptom Inventory (NSI) in determining the need for mental health referral for veterans with traumatic brain injury (TBI). Research Method/Design: Three hundred eighty veterans referred for TBI evaluation were administered the NSI and a common anxiety screening measure (Beck Anxiety Inventory; BAI). Receiver Operating Characteristic (ROC) curve analyses were conducted to determine ideal BAI total cutoff scores for a single item of the NSI pertaining to anxiety (i.e., "anxious or tense"). Results Using multiclass ROC curve analyses, NSI scores of 3 and 4 for the sample were comparable to scores of 11 and 22 on the BAI, respectively. Post hoc ROC curve analyses were then conducted on the sample after removal of potentially invalid NSI protocols (i.e., Validity-10 scores greater than 22), and NSI scores 3 and 4 corresponded with scores of 11 and 20, respectively. Conclusion/Implications A minimum score of 3 (severe) on the NSI item was deemed sufficient to indicate the need for further mental health referral without warranting additional screening for anxiety. Further analyses also revealed that removal of positive Validity-10 protocols did not significantly change ROC curve findings, suggesting that the particular NSI item for anxiety can still be used for clinical purposes despite an otherwise invalid protocol. Implications for treatment and recommendations pertaining to when additional screening might be required are discussed.	[Palmer, Glen A.; Palmer, Daniel G.] St Cloud VA Hlth Care Syst, Dept Psychol, St Cloud, MN USA		Palmer, GA (corresponding author), St Cloud VA Hlth Care Syst, 4801 Vet Dr,MH-116A, St Cloud, MN 56303 USA.	Glen.Palmer@va.gov		Palmer, Glen/0000-0001-8043-3487; Palmer, Daniel/0000-0001-9260-8782			Bardhoshi G, 2016, J COUNS DEV, V94, P356, DOI 10.1002/jcad.12090; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cronbach L.J., 1984, ESSENTIALS PSYCHOL T, V4th Edn; Department of Veterans Affairs, 2009, POL TRAUM BRAIN INJ; Department of Veterans Affairs, 2013, POL SYST CAR VHA HDB; Department of Veterans Affairs, 2017, SCREEN EV TRAUM BRAI; Flaherty JM, 2018, J CLIN PSYCHOL, V74, P1281, DOI 10.1002/jclp.22595; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Oehlert ME, 2020, PSYCHOL SERV, V17, P372, DOI 10.1037/ser0000372; Palmer GA, 2016, MIL PSYCHOL, V28, P296, DOI 10.1037/mil0000117; Palmer GA, 2016, J LOSS TRAUMA, V21, P99, DOI 10.1080/15325024.2015.1072009; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; R Core Team, 2020, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shackelford T., 2017, ENCY PERSONALITY IND, DOI [10.1007/978-3-319-28099-8_5-1, DOI 10.1007/978-3-319-28099-8_5-1]; Steer, 1993, MANUAL BECK ANXIETY; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wandishin MS, 2009, WEATHER FORECAST, V24, P530, DOI 10.1175/2008WAF2222119.1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01	24	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-2941	1558-691X		PSYCHOL REP	Psychol. Rep.											00332941211031789	10.1177/00332941211031789		JUL 2021	14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TT8KW	WOS:000680593300001	34266335				2022-02-07	
J	Connolly, LJ; Rajaratnam, SMW; Spitz, G; Lockley, SW; Ponsford, JL				Connolly, Laura J.; Rajaratnam, Shantha M. W.; Spitz, Gershon; Lockley, Steven W.; Ponsford, Jennie L.			Factors Associated With Response to Pilot Home-Based Light Therapy for Fatigue Following Traumatic Brain Injury and Stroke	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; stroke; light therapy; fatigue; sleep disturbance; sleepiness	EXCESSIVE DAYTIME SLEEPINESS; PREDICTORS; DEPRESSION; DISORDERS; MODAFINIL; SEVERITY; QUALITY; TRIAL; AGE	Background: Fatigue and sleep disturbance are common and debilitating problems after brain injury. Light therapy shows promise as a potential treatment. We conducted a trial of in-home light therapy to alleviate fatigue and sleep disturbance. The aim of the current study was to identify factors moderating treatment response. Methods: Participants were 24 individuals with traumatic brain injury (TBI) (n = 19) or stroke (n = 5) reporting clinically significant fatigue. Outcomes included fatigue on Brief Fatigue Inventory (primary outcome), sleep disturbance on Pittsburgh Sleep Quality Index, reaction time (RT) on Psychomotor Vigilance Task and time spent in productive activity. Interactions of demographic and clinical variables with these outcomes were examined in linear mixed-model analyses. Results: Whilst there were no variables found to be significantly associated with change in our primary outcome of fatigue, some variables revealed medium or large effect sizes, including chronotype, eye color, injury severity as measured by PTA, and baseline depressive symptoms. Chronotype significantly moderated sleep quality, with evening chronotype being associated with greater improvement during treatment. Injury type significantly predicted mean RT, with stroke participants exhibiting greater post-treatment reduction than TBI. Age significantly predicted productive activity during Treatment, with younger participants showing stronger Treatment effect. Conclusion: Light therapy may have a greater impact on sleep in younger individuals and those with an evening chronotype. Older individuals may need higher treatment dose to achieve benefit.	[Connolly, Laura J.; Spitz, Gershon; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Connolly, Laura J.; Rajaratnam, Shantha M. W.; Spitz, Gershon; Lockley, Steven W.; Ponsford, Jennie L.] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Brigham & Womens Hosp, Dept Neurol, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Rajaratnam, Shantha M. W.; Lockley, Steven W.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA		Ponsford, JL (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.; Ponsford, JL (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia.	jennie.ponsford@monash.edu	; Spitz, Gershon/H-7755-2014	Rajaratnam, Shantha/0000-0001-7527-8558; Spitz, Gershon/0000-0002-7810-1480	National Health and Research Council Early Career Fellowship [APP1104692]	This work was supported by funding from The Summer Foundation; Epworth HealthCare; and a National Health and Research Council Early Career Fellowship (APP1104692 to GS).	Bajaj S., 2019, SLEEP, V42, pA378, DOI [10.1093/sleep/zsz067.939, DOI 10.1093/SLEEP/ZSZ067.939]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chellappa SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13973-1; Chellappa SL, 2013, J SLEEP RES, V22, P573, DOI 10.1111/jsr.12050; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Cohen J., 2013, STAT POWER ANAL BEHA; Connolly LJ, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02292-8; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Dallaspezia S, 2018, CHRONOBIOL INT, V35, P1319, DOI 10.1080/07420528.2018.1469034; Danielsson K, 2018, BEHAV SLEEP MED, V16, P325, DOI 10.1080/15402002.2016.1210150; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duncan F, 2014, J PSYCHOSOM RES, V77, P368, DOI 10.1016/j.jpsychores.2014.06.013; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; IJSPEERT JK, 1990, VISION RES, V30, P699, DOI 10.1016/0042-6989(90)90096-4; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Kragh M, 2018, CHRONOBIOL INT, V35, P1209, DOI 10.1080/07420528.2018.1468341; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LAM RW, 1994, ACTA PSYCHIAT SCAND, V89, P97, DOI 10.1111/j.1600-0447.1994.tb01494.x; Leppamaki S, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-22; Leppavuori A, 2002, CEREBROVASC DIS, V14, P90, DOI 10.1159/000064737; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McGlashan EM, 2019, J AFFECT DISORDERS, V256, P386, DOI 10.1016/j.jad.2019.05.076; McGlashan EM, 2018, PSYCHOPHARMACOLOGY, V235, P3201, DOI 10.1007/s00213-018-5019-0; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085837; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Phillips AJK, 2019, P NATL ACAD SCI USA, V116, P12019, DOI 10.1073/pnas.1901824116; Ponchel A, 2015, STROKE RES TREAT, V2015, DOI 10.1155/2015/347920; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Rahman SA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89494; Raikes AC, 2020, J HEAD TRAUMA REHAB, V35, pE405, DOI 10.1097/HTR.0000000000000579; ReichbornKjennerud T, 1996, J AFFECT DISORDERS, V41, P101, DOI 10.1016/S0165-0327(96)00076-6; RStudio T., 2020, RSTUDIO INT DEV ENV; Ruger M, 2013, J PHYSIOL-LONDON, V591, P353, DOI 10.1113/jphysiol.2012.239046; Salva MAQ, 2020, J HEAD TRAUMA REHAB, V35, pE78, DOI 10.1097/HTR.0000000000000500; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sletten TL, 2009, J BIOL RHYTHM, V24, P73, DOI 10.1177/0748730408328973; Terman M, 1996, AM J PSYCHIAT, V153, P1423; Terzoudi A, 2009, EUR NEUROL, V61, P16, DOI 10.1159/000165344; van Maanen A, 2016, SLEEP MED REV, V29, P52, DOI 10.1016/j.smrv.2015.08.009; West A, 2017, CHRONOBIOL INT, V34, P687, DOI 10.1080/07420528.2017.1314300; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 15	2021	12								651392	10.3389/fneur.2021.651392			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TQ8WK	WOS:000678558100001	34335435	gold, Green Published			2022-02-07	
J	Lempke, LB; Johnson, RS; Le, RK; Anderson, MN; Schmidt, JD; Lynall, RC				Lempke, Landon B.; Johnson, Rachel S.; Le, Rachel K.; Anderson, Melissa N.; Schmidt, Julianne D.; Lynall, Robert C.			Head Impact Biomechanics in Youth Flag Football: A Prospective Cohort Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						pediatric; repetitive head impact; concussion; subconcussive; sport safety; youth sport	LATER-LIFE; EXPOSURE; INJURIES; CONTACT; SYSTEMS; AGE	Background: Youth flag football participation has rapidly grown and is a potentially safer alternative to tackle football. However, limited research has quantitatively assessed youth flag football head impact biomechanics. Purpose: To describe head impact biomechanics outcomes in youth flag football and explore factors associated with head impact magnitudes. Study Design: Cross-sectional study; Level of evidence, 3. Methods: We monitored 52 player-seasons among 48 male flag football players (mean +/- SD; age, 9.4 +/- 1.1 years; height, 138.6 +/- 9.5 cm; mass, 34.7 +/- 9.2 kg) across 3 seasons using head impact sensors during practices and games. Sensors recorded head impact frequencies, peak linear (g) and rotational (rad/s(2)) acceleration, and estimated impact location. Impact rates (IRs) were calculated as 1 impact per 10 player-exposures; IR ratios (IRRs) were used to compare season, event type, and age group IRs; and 95% CIs were calculated for IRs and IRRs. Weekly and seasonal cumulative head impact frequencies and magnitudes were calculated. Mixed-model regression models examined the association between player characteristics, event type, and seasons and peak linear and rotational accelerations. Results: A total of 429 head impacts from 604 exposures occurred across the study period (IR, 7.10; 95% CI, 4.81-10.50). Weekly and seasonal cumulative median head impact frequencies were 1.00 (range, 0-2.63) and 7.50 (range, 0-21.00), respectively. The most frequent estimated head impact locations were the skull base (n = 96; 22.4%), top of the head (n = 74; 17.2%), and back of the head (n = 66; 15.4%). The combined event type IRs differed among the 3 seasons (IRR range, 1.45-2.68). Games produced greater IRs (IRR, 1.24; 95% CI, 1.01-1.53) and peak linear acceleration (mean difference, 5.69g; P = .008) than did practices. Older players demonstrated greater combined event-type IRs (IRR, 1.46; 95% CI, 1.12-1.90) and increased head impact magnitudes than did younger players, with every 1-year age increase associated with a 3.78g and 602.81-rad/s(2) increase in peak linear and rotational acceleration magnitude, respectively (P <= .005). Conclusion: Head IRs and magnitudes varied across seasons, thus highlighting multiple season and cohort data are valuable when providing estimates. Head IRs were relatively low across seasons, while linear and rotational acceleration magnitudes were relatively high.	[Lempke, Landon B.; Johnson, Rachel S.; Le, Rachel K.; Anderson, Melissa N.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lempke, Landon B.; Johnson, Rachel S.; Le, Rachel K.; Anderson, Melissa N.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lempke, Landon B.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Lempke, Landon B.] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA		Lynall, RC (corresponding author), Univ Georgia, Ramsey Student Ctr, Dept Kinesiol, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Burnham BR, 2010, AM J PREV MED, V38, pS141, DOI 10.1016/j.amepre.2009.10.010; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Campbell KR, 2020, MED SCI SPORT EXER, V52, P2198, DOI 10.1249/MSS.0000000000002371; Cecchi NJ, 2020, J SCI MED SPORT, V23, P927, DOI 10.1016/j.jsams.2020.03.008; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; De Caro Kaplen LLP, YOUTH TACKL FOOTB LE YOUTH TACKL FOOTB LE; Kaplan Y, 2013, CLIN J SPORT MED, V23, P39, DOI 10.1097/JSM.0b013e3182694870; Karton C, 2016, ISBS C P ARCH INT SO ISBS C P ARCH INT SO; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Association of Intercollegiate Athletics, WOM FLAG FOOTB WOM FLAG FOOTB; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; National Intramural-Recreational Sports Association, NIRSA FLAG FOOTB NIRSA FLAG FOOTB; Oeur RA, 2016, ISBS C P ARCH INT SO ISBS C P ARCH INT SO; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; R Core Team, R LANG ENV STAT COMP; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Savino AK, 2020, ANN BIOMED ENG, V48, P2763, DOI 10.1007/s10439-020-02548-3; Schlechter CR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5108-3; Schlechter CR, 2017, J SPORT SCI, V35, P22, DOI 10.1080/02640414.2016.1154593; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Solomon J, 2018, 10 CHARTS SHOW PROGR; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012	35	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.											03635465211026643	10.1177/03635465211026643		JUL 2021	10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TV1QA	WOS:000681500500001	34264780				2022-02-07	
J	Ousta, A; Piao, L; Fang, YH; Vera, A; Nallamothu, T; Garcia, AJ; Sharp, WW				Ousta, Alaa; Piao, Lin; Fang, Yong Hu; Vera, Adrianna; Nallamothu, Thara; Garcia, Alfredo J.; Sharp, Willard W.			Microglial Activation and Neurological Outcomes in a Murine Model of Cardiac Arrest	NEUROCRITICAL CARE			English	Article; Early Access						Ischemia reperfusion injury; Cardiopulmonary resuscitation; Microglia; Brain injuries	NEURONAL DEATH; BRAIN-INJURY; REMOVAL TEST; NEUROINFLAMMATION; CARDIOPULMONARY; PATHOPHYSIOLOGY; RESUSCITATION; INHIBITION; HYPOTHERMIA; ISCHEMIA	Background Neurological injury following successful resuscitation from sudden cardiac arrest (CA) is common. The pathophysiological basis of this injury remains poorly understood, and treatment options are limited. Microglial activation and neuroinflammation are established contributors to many neuropathologies, such as Alzheimer disease and traumatic brain injury, but their potential role in post-CA injury has only recently been recognized. Here, we hypothesize that microglial activation that occurs following brief asystolic CA is associated with neurological injury and represents a potential therapeutic target. Methods Adult C57BL/6 male and female mice were randomly assigned to 12-min, KCl-induced asystolic CA, under anesthesia and ventilation, followed by successful cardiopulmonary resuscitation (n = 19) or sham intervention (n = 11). Neurological assessments of mice were performed using standardized neurological scoring, video motion tracking, and sensory/motor testing. Mice were killed at 72 h for histological studies; neuronal degeneration was assessed using Fluoro-Jade C staining. Microglial characteristics were assessed by immunohistochemistry using the marker of ionized calcium binding adaptor molecule 1, followed by ImageJ analyses for cell integrity density and skeletal analyses. Results Neurological injury in post-cardiopulmonary-resuscitation mice vs. sham mice was evident by poorer neurological scores (difference of 3.626 +/- 0.4921, 95% confidence interval 2.618-4.634), sensory and motor functions (worsened by sixfold and sevenfold, respectively, compared with baseline), and locomotion (75% slower with a 76% decrease in total distance traveled). Post-CA brains demonstrated evidence of neurodegeneration and neuroinflammatory microglial activation. Conclusions Extensive microglial activation and neurodegeneration in the CA1 region and the dentate gyrus of the hippocampus are evident following brief asystolic CA and are associated with severe neurological injury.	[Ousta, Alaa; Piao, Lin; Fang, Yong Hu; Vera, Adrianna; Nallamothu, Thara; Garcia, Alfredo J.; Sharp, Willard W.] Univ Chicago, Dept Med, Sect Emergency Med, 5841 S Maryland Ave, Chicago, IL 60637 USA		Sharp, WW (corresponding author), Univ Chicago, Dept Med, Sect Emergency Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	wsharp@medicine.bsd.uchicago.edu	Garcia, Alfredo/ABG-6952-2021	Sharp, Willard W./0000-0002-7175-3523	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1HL133675]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HL007381, R01NS10742101]	The study was supported, in part, by the National Institutes of Health (NIH) Grant RO1HL133675 given to WWS, by the NIH training Grant T32HL007381 given to AO, and by the NIH Grants R01NS10742101 and R01NS10742101 given to AJG.	Albertsmeier M, 2007, RESUSCITATION, V74, P552, DOI 10.1016/j.resuscitation.2007.01.040; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Arriaga M, 2017, J NEUROSCI, V37, P9222, DOI 10.1523/JNEUROSCI.1076-17.2017; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Benjamin, 2018, CIRCULATION, V137, pE493, DOI 10.1161/CIR.0000000000000573; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Drabek T, 2009, ANESTH ANALG, V109, P914, DOI 10.1213/ane.0b013e3181b0511e; Ettl F, 2018, SHOCK, V50, P219, DOI 10.1097/SHK.0000000000001004; Fonken LK, 2019, EXP NEUROL, V317, P100, DOI 10.1016/j.expneurol.2019.02.008; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Geri G, 2014, ANN FR ANESTH, V33, P98, DOI 10.1016/j.annfar.2013.11.003; Huang KB, 2018, NEUROCRIT CARE, V29, P128, DOI 10.1007/s12028-018-0505-0; Kapoor M, 2019, MOL BIOL REP, V46, P6215, DOI 10.1007/s11033-019-05060-7; Khuu MA, 2019, J NEUROSCI, V39, P1320, DOI 10.1523/JNEUROSCI.1359-18.2018; Makinde HM, 2020, J SURG RES, V246, P113, DOI 10.1016/j.jss.2019.08.024; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nieradko-Lwanicka B, 2008, PHARMACOL REP, V60, P699; Ocak U, 2020, SHOCK, V54, P539, DOI 10.1097/SHK.0000000000001516; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Piao L, 2020, CRIT CARE MED, V48, pE133, DOI 10.1097/CCM.0000000000004095; Piao L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185046; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sangani S, 2015, PROG BRAIN RES, V218, P313, DOI 10.1016/bs.pbr.2014.12.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shi X, 2017, NEUROSCIENCE, V360, P128, DOI 10.1016/j.neuroscience.2017.07.052; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Taguchi N, 2016, NEUROSCI RES, V111, P56, DOI 10.1016/j.neures.2016.05.002; Tahsili-Fahadan P, 2018, BRAIN CIRC, V4, P1, DOI [10.4103/bc.bc_4_18, 10.4103/bc.BC_4_18]; Wang QY, 2015, J HUAZHONG U SCI-MED, V35, P225, DOI 10.1007/s11596-015-1415-4; Wang W, 2015, J NEUROCHEM, V134, P892, DOI 10.1111/jnc.13179; Xiong W, 2011, SEMIN NEUROL, V31, P216, DOI 10.1055/s-0031-1277991; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Zanier ER., 2015, INTENSIVE CARE MED E, V3, P1, DOI [10.1186/s40635-015-0039-0, DOI 10.1186/S40635-015-0039-0]; Zhang HJ, 2021, NEUROCRIT CARE, V34, P64, DOI 10.1007/s12028-020-00984-6; Zhao DH, 2008, RESUSCITATION, V77, P242, DOI 10.1016/j.resuscitation.2007.10.015	40	0	0	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01253-w		JUL 2021	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TK0LX	WOS:000673862400002	34268646	hybrid			2022-02-07	
J	Quick, BL; Glowacki, EM; Kriss, LA; Hartman, DE				Quick, Brian L.; Glowacki, Elizabeth M.; Kriss, Lauren A.; Hartman, Daniel E.			Raising Concussion Awareness among Amateur Athletes: An Examination of the Centers for Disease Control and Prevention's (CDC) Heads Up Campaign	HEALTH COMMUNICATION			English	Article; Early Access							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HEALTH BELIEF MODEL; KNOWLEDGE; COACHES; STUDENT; RISK; COMMUNICATION; EPIDEMIOLOGY; PERSPECTIVES	Attention to concussion prevention and management has grown in recent years due to the potentially long-term, debilitating effects a head injury can have on an individual. Although multiple campaigns have been designed to target this issue, there remains a need to evaluate the persuasive principles used to advocate for safety measures and protocols, specifically within youth sports. With this in mind, we applied the health belief model (HBM) in our content analysis of the Centers for Disease Control and Prevention's (CDC) Heads Up concussion awareness campaign. Campaign videos (N = 35) were coded for threat severity, threat susceptibility, benefits, barriers, self-efficacy, and cues to action. The majority of videos communicated the seriousness of concussions and attempts to communicate concussion susceptibility were driven by personal stories, rather than facts and statistics demonstrating concussion prevalence. Less than half of the videos communicated the benefits of following concussion protocols and only a third of the messages described barriers to following recommended protocols. The majority of videos aimed to elevate self-efficacy among athletes and parents, but not coaches, by focusing on identifying symptoms and concussion avoidance. The implications for concussion prevention and management among athletes, parents, and coaches are discussed.	[Quick, Brian L.; Hartman, Daniel E.] Univ Illinois, Carle Illinois Coll Med, Dept Commun, Champaign, IL 61820 USA; [Glowacki, Elizabeth M.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Hlth Sci, Madison, WI USA; [Kriss, Lauren A.] Univ Wisconsin, Sch Journalism & Mass Commun, Madison, WI USA		Quick, BL (corresponding author), Univ Illinois, Carle Illinois Coll Med, Dept Commun, Champaign, IL 61820 USA.	bquick@illinois.edu					Adame BJ, 2019, HEALTH COMMUN, V34, P1673, DOI 10.1080/10410236.2018.1517707; Agarwal N., SPORTS RELATED HEAD; Appel M, 2007, MEDIA PSYCHOL, V10, P113; Bandura A., 1977, SOCIAL LEARNING THEO; BECKER MH, 1987, HEALTH SERV RES, V22, P537; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bruinvels G, 2017, BRIT J SPORT MED, V51, P487, DOI 10.1136/bjsports-2016-096279; Cao ZJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-26; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Centers for Disease Control and Prevention, 2020, YRBSS DAT DOC; Centers for Disease Control and Prevention, 2019, TBI GET FACTS; Centers for Disease Control and Prevention, 2020, HEADS; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Corman S.R., 2019, CHANGING CULTURE CON, DOI [10.3886/E109184V1, DOI 10.3886/E109184V1]; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Daugherty J, 2019, HEALTH EDUC J, V78, P784, DOI 10.1177/0017896919846185; de Graaf A, 2014, HUM COMMUN RES, V40, P73, DOI 10.1111/hcre.12015; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Duke JC, 2019, AM J PREV MED, V57, P645, DOI 10.1016/j.amepre.2019.06.011; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Green MC, 2004, DISCOURSE PROCESS, V38, P247, DOI 10.1207/s15326950dp3802_5; Green MC, 2006, J COMMUN, V56, pS163, DOI 10.1111/j.1460-2466.2006.00288.x; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Keegan R, 2010, J APPL SPORT PSYCHOL, V22, P87, DOI 10.1080/10413200903421267; Kilinc E, 2020, INT J NURS PRACT, V26, DOI 10.1111/ijn.12861; Krippendorff K., 2018, CONTENT ANAL INTRO I; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Mayo Clinic, 2020, CONCUSSION; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Patel SJ, 2017, J APPL BIOBEHAV RES, V22, DOI 10.1111/jabr.12098; Perez CC., 2019, INVISIBLE WOMEN EXPO; Pinkleton BE, 2010, HEALTH COMMUN, V25, P258, DOI 10.1080/10410231003698937; Rice T, 2019, J SAFETY RES, V69, P85, DOI 10.1016/j.jsr.2019.02.007; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sarmiento K, 2020, J SCH NURS, DOI 10.1177/1059840520945389; Sarmiento Kelly, 2019, J Concussion, V3, DOI 10.1177/2059700219861863; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Skinner CS, 2015, HLTH BEHAV HLTH ED T, V5th, P75; Sleet DA, 2010, AM J LIFESTYLE MED, V4, P25, DOI 10.1177/1559827609349573; Smoll FL, 2007, J YOUTH DEV, V2, P20; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Stead TS, 2016, CUREUS, V8, DOI 10.7759/cureus.755; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Wang WL, 2014, KAOHSIUNG J MED SCI, V30, P422, DOI 10.1016/j.kjms.2014.04.007; Woolsey C, 2010, J APPL SPORT PSYCHOL, V22, P65, DOI 10.1080/10413200903403224; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Youth Risk Behavior Survey (YRBS), 2020, CTR DIS CONTR PREV; Zanin AC, 2020, SMALL GR RES, V51, P342, DOI 10.1177/1046496419883948; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	64	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.												10.1080/10410236.2021.1950295		JUL 2021	12	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	TM0WF	WOS:000675275200001	34289773				2022-02-07	
J	Suntai, Z; Smith, NL; Chipalo, E; Kubanga, K; Won, C				Suntai, Zainab; Smith, Natasha L.; Chipalo, Edson; Kubanga, Kefentse; Won, Claudia			Effectiveness of Support Groups for Caregivers of Traumatic Brain Injury Survivors	JOURNAL OF EVIDENCE-BASED SOCIAL WORK			English	Article						Traumatic brain injury; TBI; support groups; caregiver burden	FAMILY CAREGIVERS; SOCIAL SUPPORT; BURDEN; DEMENTIA; LIFE; VETERANS; THERAPY; CARE; INTERVENTIONS; DEPRESSION	Purpose: Caregiver burden refers to the collective adverse outcomes of caregiving and its prevalence amongst caregivers of people with traumatic brain injury (TBI) is amplified by the suddenness of brain injury. This systematic review aimed to determine the effectiveness of support groups for this population. Methods: Studies were retrieved from the following databases: PsycINFO, PubMed, Science Direct, Web of Science, Academic Search Premier, CINAHL, JSTOR and the Cochrane Central Register of Controlled Trials. Results: Only two articles were found to meet the inclusion criteria and both studies showed reduced caregiver burden at the end of the support group interventions. Both studies employed online/remote support groups. Discussion and Conclusion: Social workers should consider the integration of technological advances to address barriers to support group access for caregivers of TBI survivors. More empirical studies are needed to determine the effectiveness of support groups for this population.	[Suntai, Zainab; Smith, Natasha L.; Chipalo, Edson; Kubanga, Kefentse; Won, Claudia] Univ Alabama, Sch Social Work, Tuscaloosa, AL 35487 USA		Suntai, Z (corresponding author), Univ Alabama, Sch Social Work, Tuscaloosa, AL 35487 USA.	zsuntai@crimson.ua.edu					Albright DL, 2016, J PAIN SYMPTOM MANAG, V51, P213, DOI 10.1016/j.jpainsymman.2015.09.005; Anderson LN, 2013, J COMMUNITY PSYCHOL, V41, P709, DOI 10.1002/jcop.21566; ANTONUCCI TC, 1987, J GERONTOL, V42, P519, DOI 10.1093/geronj/42.5.519; ANTONUCCI TC, 1985, HDB AGING SOCIAL SCI, P00094; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bosch SJ, 2019, J ENVIRON PSYCHOL, V62, P74, DOI 10.1016/j.jenvp.2019.02.002; Brain Injury Association, BRAIN INJ ASS AM; BrainLine, 2019, CAT CAR; BrainLine, 2019, CHOOS RIGHT CAR SUPP; Brim O., 1980, LIFE-SPAN DEV BEHAV, V3, P253; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Carlbring P, 2018, COGN BEHAV THERAPY, V47, P1, DOI 10.1080/16506073.2017.1401115; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Chiao CY, 2015, INT NURS REV, V62, P340, DOI 10.1111/inr.12194; Clinic M., 2019, TRAUMATIC BRAIN INJU; Cutler S., 2018, MEDSURG NURSING, V27, P359, DOI [10.1007/s11606-017-4265-x, DOI 10.1007/S11606-017-4265-X]; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; DeAngelis, 2010, CLOS GAP PRACT RES; Donnelly KZ, 2020, DISABIL REHABIL, V42, P2482, DOI 10.1080/09638288.2018.1563638; Drebing CE, 2018, PSYCHOL SERV, V15, P135, DOI 10.1037/ser0000178; Family Caregiver Alliance, 2013, TRAUMATIC BRAIN INJU; Galiatsatos P, 2017, J RELIG HEALTH, V56, P946, DOI 10.1007/s10943-017-0367-3; Given BA, 2017, GENERATIONS, V41, P50; Gorawara-Bhat R, 2019, SAGE OPEN NURS, V5, DOI 10.1177/2377960819844670; Greenfield JC, 2018, J GERONTOL SOC WORK, V61, P849, DOI 10.1080/01634372.2018.1487895; Harding R, 2015, J PAIN SYMPTOM MANAG, V50, P445, DOI 10.1016/j.jpainsymman.2015.04.005; Holloway M, 2016, BRIT J SOC WORK, V46, P1301, DOI 10.1093/bjsw/bcv039; Huber J, 2018, J CANCER SURVIV, V12, P1, DOI 10.1007/s11764-017-0633-0; Ibarra, 2012, BRAIN INJURY COPING; Inauen J, 2017, APPL PSYCHOL-HLTH WE, V9, P303, DOI 10.1111/aphw.12093; Inci FH, 2016, APPL NURS RES, V32, P233, DOI 10.1016/j.apnr.2016.08.002; Joling KJ, 2010, AM J GERIAT PSYCHIAT, V18, P146, DOI 10.1097/JGP.0b013e3181bf9f0f; Khanna AK, 2015, INDIAN J PEDIATR, V82, P1006, DOI 10.1007/s12098-015-1762-y; Kirst-Ashman K. K., 2015, UNDERSTANDING GEN PR; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; LIN N, 1979, J HEALTH SOC BEHAV, V20, P108, DOI 10.2307/2136433; Madiba Sphiwe, 2012, Glob J Health Sci, V4, P119, DOI 10.5539/gjhs.v4n6p119; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Miyawaki A, 2019, SOC SCI MED, V223, P24, DOI 10.1016/j.socscimed.2019.01.034; Montgomery RJV, 2009, GENERATIONS, V33, P47; Narad ME, 2019, ARCH PHYS MED REHAB, V100, P811, DOI 10.1016/j.apmr.2019.01.010; National Cancer Institute, NCI DICT CANC TERMS; OCathain A, 2018, MIXED METHODS APPRAI; Paradise M, 2015, AGING MENT HEALTH, V19, P72, DOI 10.1080/13607863.2014.915922; Perrin A., 2019, DIGITAL GAP RURAL NO; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Rural Health Information Hub, 2018, BARR TRANSP RUR AR; Sabella SA, 2019, J HEAD TRAUMA REHAB, V34, P233, DOI 10.1097/HTR.0000000000000471; Schaie, 2019, CAREGIVING SYSTEMS I; Shapiro JR, 2010, INT J EAT DISORDER, V43, P513, DOI 10.1002/eat.20744; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Simpson G, 2016, J SOC WORK DISABIL R, V15, P213, DOI 10.1080/1536710X.2016.1220888; Slone, 2011, RUR TRANSP NEEDS; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suntai Z, 2021, AM J HOSP PALLIAT ME, V38, P494, DOI 10.1177/1049909120959634; Tracy K, 2016, SUBST ABUSE REHABIL, V7, P143, DOI 10.2147/SAR.S81535; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P933, DOI 10.1080/13548506.2015.1009380; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Waller, 2020, TRAUMATOLOGY, V26, P344, DOI [10.1037/trm0000245, DOI 10.1037/TRM0000245]; Weiss ME, 2015, J NURS ADMIN, V45, P606, DOI 10.1097/NNA.0000000000000273; Worrall H, 2018, MENT HEALTH SOC INCL, V22, P85, DOI 10.1108/MHSI-12-2017-0055; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260; Zia N, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000259	68	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2640-8066	2640-8074		J EVID-BASED SOC WOR	J. Evid.-Based Soc. Work	NOV 2	2021	18	6					636	649		10.1080/26408066.2021.1925613		JUL 2021	14	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	XC5CK	WOS:000674785300001					2022-02-07	
J	Townsend, S				Townsend, Stephen			"'The Tragedy of the Punch Drunk': Reading Concussion in Australian Sporting Newspapers, 1843-1954"	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						sports related concussion; history; Australia; newspapers; media analysis; concussion; brain injury - traumatic; distant reading and close reading	INJURY	Australian cultural attitudes toward sports related concussion (SRC) are understudied. Australia has a long history of valorising combat, collision, and contact sports, in which SRC is a common occurrence. It is therefore vital to understand how sociocultural and historical factors shape Australian attitudes toward SRC, in order to more critically evaluate the decisions made by athletes, parents, coaches, and others with regards to risk and brain injury in sport. This paper analyzed historical representations of SRC in Australian sporting newspapers between 1803 and 1954. Using distant reading, this analysis revealed four distinct periods of increased press discourse about "concussion, " which were subject to interrogation via close reading. Close reading revealed that concussion was being reported in the Australian sporting press as early as 1859. Further analysis revealed critical and scientifically informed discussions about the delayed effects of concussion in 1901, systemic critiques of sporting organizations' response to concussion in 1906, and evidence of a limited concussion crisis in Australian boxing during the early 1930s. The findings of this research show that concussion was not only being reported in Australian newspapers throughout the late nineteenth and early twentieth centuries but it was subject to critical and informed commentary that has striking similarities with current debates about SRC. Despite this, widespread systematic changes to Australian sport did not occur until recently. This raises important questions about the political and institutional factors that prevented a major concussion crisis from developing in Australia during the early twentieth century, and prompts us to further consider the distinguishing features that facilitated the development of the current crisis.	[Townsend, Stephen] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia		Townsend, S (corresponding author), Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia.	s.townsend@uq.edu.au		Townsend, Stephen/0000-0002-8750-0504			Bode K, 2018, DIGIT HUMAN, P1, DOI 10.3998/mpub.8784777; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Coakley J., 2017, SPORTS SOC ISSUES CO, V12th; Crotty M, 2003, INT J HIST SPORT, V20, P1, DOI [10.1080/09523360412331305753, DOI 10.1080/09523360412331305753]; Eadie M.J., 2000, FLOWERING WARATAH HI; Elkington L., 2019, CONCUSSION SPORT AUS, P4; Fowler X, 2019, INT J HIST SPORT, V36, P1035, DOI 10.1080/09523367.2019.1687449; Goot M, 1979, MEDIA CTR PAPERS, V11, P1; Gunasekaran P, 2020, PHYSICIAN SPORTSMED, V48, P1, DOI 10.1080/00913847.2019.1624656; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Horton P, 2015, INT J HIST SPORT, V32, P1238, DOI 10.1080/09523367.2015.1072309; James D., 2020, MODERNISM CLOSE READ, DOI [10.1093/oso/9780198749967.001.0001, DOI 10.1093/OSO/9780198749967.001.0001]; Longworth T, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000860; Macnaughton J, 2016, EDINBURGH COMPANION TO THE CRITICAL MEDICAL HUMANITIES, P294; Malcolm D., 2020, CONCUSSION CRISIS SP, DOI [10.4324/9780429292408, DOI 10.4324/9780429292408]; Mayer H, 1964, PRESS AUSTR; Moretti Franco, 2013, DISTANT READING; Osmond G, 2015, INT J HIST SPORT, V32, P1578, DOI 10.1080/09523367.2015.1086343; Phillips M.G., 1994, INT J HIST SPORT, V11, P102, DOI 10.1080/09523369408713850; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Stone James L, 2014, Neurosurgery, V75 Suppl 4, pS3, DOI 10.1227/NEU.0000000000000488; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Townsend S., 2019, J SPORT HIST, V46, P380, DOI 10.5406/jsporthistory.46.3.0380; Townsend S, 2018, INT J HIST SPORT, V35, P1149, DOI 10.1080/09523367.2018.1523146; Townsend S, 2018, SPORT HIST, V38, P267, DOI 10.1080/17460263.2018.1474129; Underwood T., 2019, DISTANT HORIZONS DIG, DOI [10.7208/chicago/9780226612973.001.0001, DOI 10.7208/CHICAGO/9780226612973.001.0001]; Unterharnscheidt F., 2003, BOXING MEDICAL ASPEC; Ventresca M., 2020, SOCIOCULTURAL EXAMIN, DOI [10.4324/9780429028175, DOI 10.4324/9780429028175]; Willmot D, 1994, LATROBE J, V53, P39	30	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUL 15	2021	3								676463	10.3389/fspor.2021.676463			14	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TS0HY	WOS:000679338700001	34337402	Green Published, gold			2022-02-07	
J	Zaninotto, AL; Grassi, DC; Duarte, D; Rodrigues, PA; Cardoso, E; Feltrin, FS; Guirado, VMD; Macruz, FBD; Otaduy, MCG; Leite, CD; Paiva, WS; Andrade, CS				Zaninotto, Ana Luiza; Grassi, Daphine Centola; Duarte, Dante; Rodrigues, Priscila Aparecida; Cardoso, Ellison; Feltrin, Fabricio Stewan; de Paula Guirado, Vinicius Monteiro; de Carvalho Macruz, Fabiola Bezerra; Garcia Otaduy, Maria Concepcion; Leite, Claudia da Costa; Paiva, Wellingson Silva; Andrade, Celi Santos			DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores	NEUROLOGICAL SCIENCES			English	Article						Brain injury; White matter; Diffusion tensor imaging; Depression; Anxiety	DIFFUSE AXONAL INJURY; CORPUS-CALLOSUM; HEAD-INJURY; DEPRESSION; MILD; PERFORMANCE; INVENTORY; INTEGRITY; RECOVERY; METRICS	Background and aim Diffusion tensor imaging (DTI) parameters in the corpus callosum have been suggested to be a biomarker for prognostic outcomes in individuals with diffuse axonal injury (DAI). However, differences between the DTI parameters on moderate and severe trauma in DAI over time are still unclear. A secondary goal was to study the association between the changes in the DTI parameters, anxiety, and depressive scores in DAI over time. Methods Twenty subjects were recruited from a neurological outpatient clinic and evaluated at 2, 6, and 12 months after the brain injury and compared to matched age and sex healthy controls regarding the DTI parameters in the corpus callosum. State-Trace Anxiety Inventory and Beck Depression Inventory were used to assess psychiatric outcomes in the TBI group over time. Results Differences were observed in the fractional anisotropy and mean diffusivity of the genu, body, and splenium of the corpus callosum between DAI and controls (p < 0.02). Differences in both parameters in the genu of the corpus callosum were also detected between patients with moderate and severe DAI (p < 0.05). There was an increase in the mean diffusivity values and the fractional anisotropy decrease in the DAI group over time (p < 0.02). There was no significant correlation between changes in the fractional anisotropy and mean diffusivity across the study and psychiatric outcomes in DAI. Conclusion DTI parameters, specifically the mean diffusivity in the corpus callosum, may provide reliable characterization and quantification of differences determined by the brain injury severity. No correlation was observed with DAI parameters and the psychiatric outcome scores.	[Zaninotto, Ana Luiza] MGH Inst Hlth Profess MGHIHP, Speech & Feeding Disorders Lab, Boston, MA 02129 USA; [Zaninotto, Ana Luiza; Rodrigues, Priscila Aparecida; de Paula Guirado, Vinicius Monteiro; Paiva, Wellingson Silva] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, SP, Brazil; [Grassi, Daphine Centola; Cardoso, Ellison; Feltrin, Fabricio Stewan; de Carvalho Macruz, Fabiola Bezerra; Garcia Otaduy, Maria Concepcion; Leite, Claudia da Costa; Andrade, Celi Santos] Univ Sao Paulo, Lab Med Invest, Hosp Clin, Fac Med, Sao Paulo, Brazil; [Grassi, Daphine Centola; Cardoso, Ellison; Feltrin, Fabricio Stewan; de Carvalho Macruz, Fabiola Bezerra; Garcia Otaduy, Maria Concepcion; Leite, Claudia da Costa; Andrade, Celi Santos] Univ Sao Paulo, Dept Radiol, Fac Med, LIM 44,HCFMUSP, Sao Paulo, Brazil; [Duarte, Dante] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Feltrin, Fabricio Stewan] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA		Zaninotto, AL (corresponding author), MGH Inst Hlth Profess MGHIHP, Speech & Feeding Disorders Lab, Boston, MA 02129 USA.; Zaninotto, AL (corresponding author), Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, SP, Brazil.	acostazaninotto@mghihp.edu	Paiva, Wellingson S/G-5517-2013; Rodrigues, Priscila/N-9326-2014; Guirado, Vinicius Monteiro de Paula/AAG-7299-2019; Costa Zaninotto, Ana Luiza/I-4095-2016; Cardoso, Ellison/I-2263-2013	Paiva, Wellingson S/0000-0002-5165-7040; Rodrigues, Priscila/0000-0001-6105-1061; Guirado, Vinicius Monteiro de Paula/0000-0002-7782-3609; Grassi, Daphine/0000-0001-5003-7619; Feltrin, Fabricio Stewan/0000-0001-6783-7655; Costa Zaninotto, Ana Luiza/0000-0003-0639-0612; Cardoso, Ellison/0000-0002-5542-4527			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Andrade L., 1998, REV PSIQUIATRIA CLIN, V25, P245; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Cyprien F, 2014, J AFFECT DISORDERS, V165, P16, DOI 10.1016/j.jad.2014.04.040; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Dillon DG, 2018, DEPRESS ANXIETY, V35, P440, DOI 10.1002/da.22734; Feltrin FS, 2018, BRAIN INJURY, V32, P1208, DOI 10.1080/02699052.2018.1494852; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Grassi DC, 2021, BRAIN INJURY, V35, P275, DOI 10.1080/02699052.2020.1859615; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on the Review of the Department of Veterans Affairs Examinations for Traumatic Brain Injury, 2019, EV DIS DET PROC TRAU; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Roland JL, 2017, P NATL ACAD SCI USA, V114, P13278, DOI 10.1073/pnas.1707050114; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; TEASDALE G, 1974, LANCET, V2, P81; Ubukata S, 2019, J NEUROTRAUM, V36, P1106, DOI 10.1089/neu.2018.5823; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Ware AL, 2020, BRAIN IMAGING BEHAV, V14, P772, DOI 10.1007/s11682-018-0018-7; Yiannakkaras C, 2019, J INTEGR NEUROSCI, V18, P95, DOI 10.31083/j.jin.2019.02.144	42	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2022	43	2					1343	1350		10.1007/s10072-021-05455-0		JUL 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YQ4IP	WOS:000673927100001	34264413				2022-02-07	
J	[Anonymous]				[Anonymous]			38th Annual National Neurotrauma Symposium Jul 11-14, 2021 (Virtual) Abstracts	JOURNAL OF NEUROTRAUMA			English	Article																		0	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					A2	A132					131	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000669061100015					2022-02-07	
J	Adachi, R; Yang, C				Adachi, Ryan; Yang, Chong			Electroconvulsive Therapy for Traumatic Brain Injury and Schizoaffective Disorder	CUREUS			English	Article						electroconvulsive therapy; ect; traumatic brain injury; tbi; psychosis; schizoaffective disorder	ECT	Traumatic brain injury (TBI) is a source of disability and mortality with high rates of psychiatric disorders. Patients with comorbid TBI and psychiatric disorders may be safely treated with electroconvulsive therapy (ECT). In this case report, we present a 34-year-old man with the diagnosis of major neurocognitive disorder due to traumatic brain injury and schizoaffective disorder, bipolar type. He received an index course of 19 ECT treatments with clinical improvements in his psychosis, mood, and cognition. This case may support the utilization of ECT for patients with comorbid TBI and schizoaffective disorder.	[Adachi, Ryan] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA 94592 USA; [Yang, Chong] Calif Dept State Hosp, Psychiat, Napa, CA USA		Adachi, R (corresponding author), Touro Univ Calif, Coll Osteopath Med, Vallejo, CA 94592 USA.	ryan.adachi@tu.edu					Abrams R, 1997, CONVULSIVE THER, V13, P125; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson JCS, 2017, AUST NZ J PSYCHIAT, V51, P942, DOI 10.1177/0004867417698235; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Kellner CH, 2016, ACTA PSYCHIAT SCAND, V134, P459, DOI 10.1111/acps.12658; Koola Maju Mathew, 2018, Prim Care Companion CNS Disord, V20, DOI 10.4088/PCC.17nr02235; Kramer BA, 1999, J ECT, V15, P245; Krystal AD, 1997, J NEUROPSYCH CLIN N, V9, P283; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Sanghani SN, 2018, CURR OPIN PSYCHIATR, V31, P213, DOI 10.1097/YCO.0000000000000418; Srienc Anja, 2018, Innov Clin Neurosci, V15, P43	14	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 14	2021	13	7							e16390	10.7759/cureus.16390			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TM6CI	WOS:000675638100012	34408943	gold, Green Published			2022-02-07	
J	Di Gregorio, F; La Porta, F; Lullini, G; Casanova, E; Petrone, V; Simoncini, L; Ferrucci, E; Piperno, R				Di Gregorio, Francesco; La Porta, Fabio; Lullini, Giada; Casanova, Emanuela; Petrone, Valeria; Simoncini, Loredana; Ferrucci, Enrico; Piperno, Roberto			Efficacy of Repetitive Transcranial Magnetic Stimulation Combined With Visual Scanning Treatment on Cognitive-Behavioral Symptoms of Unilateral Spatial Neglect in Patients With Traumatic Brain Injury: Study Protocol for a Randomized Controlled Trial	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; rehabilitation methods; transcranial magnetic stimulation (repetitive); randomized controlled trial; brain physiology	THETA-BURST STIMULATION; VISUOSPATIAL ATTENTION; HEMISPATIAL NEGLECT; REHABILITATION; RECOVERY; STROKE; ANCOVA; TIME; BIAS	Left hemispatial neglect (LHSN) is a frequent and disabling condition affecting patients who suffered from traumatic brain injury (TBI). LHSN is a neuropsychological syndrome characterized clinically by difficulties in attending, responding, and consciously representing the right side of space. Despite its frequency, scientific evidence on effective treatments for this condition in TBI patients is still low. According to existing literature, we hypothesize that in TBI, LHSN is caused by an imbalance in inter-hemispheric activity due to hyperactivity of the left hemisphere, as observed in LHSN after right strokes. Thus, by inhibiting this left hyperactivity, repetitive Transcranial Magnetic Stimulation (rTMS) would have a rebalancing effect, reducing LHSN symptoms in TBI patients. We plan to test this hypothesis within a single-blind, randomized SHAM controlled trial in which TBI patients will receive inhibitory i-rTMS followed by cognitive treatment for 15 days. Neurophysiological and clinical measures will be collected before, afterward, and in the follow-up. This study will give the first empirical evidence about the efficacy of a novel approach to treating LHSN in TBI patients.	[Di Gregorio, Francesco; Simoncini, Loredana; Ferrucci, Enrico] Azienda Unita Sanit Locale, UO Med Riabilitat & Neuroriabilitaz, Bologna, Italy; [La Porta, Fabio; Lullini, Giada; Casanova, Emanuela; Petrone, Valeria; Piperno, Roberto] IRCCS, Ist Sci Neurol Bologna, UO Med Riabilitat & Neuroriabilitaz, Bologna, Italy		La Porta, F (corresponding author), IRCCS, Ist Sci Neurol Bologna, UO Med Riabilitat & Neuroriabilitaz, Bologna, Italy.	fabiolaporta@mail.com	Lullini, Giada/AAC-3745-2022; Casanova, Emanuela/AAD-3643-2022; Simoncini, Laura/AAB-9410-2022	Lullini, Giada/0000-0002-0669-298X; Casanova, Emanuela/0000-0002-5727-3769; Simoncini, Laura/0000-0002-8853-1791	Italian Ministry of HealthMinistry of Health, Italy [SG-2018-12367527]	This study was supported by the Italian Ministry of Health, Ricerca Finalizzata SG-2018-12367527.	Azouvi P, 2017, ANN PHYS REHABIL MED, V60, P191, DOI 10.1016/j.rehab.2016.10.006; Bonni S, 2013, NEUROL SCI, V34, P2053, DOI 10.1007/s10072-013-1412-y; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; BROWN WS, 1994, NEUROPSYCHOLOGIA, V32, P439, DOI 10.1016/0028-3932(94)90089-2; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; CERMAK S A, 1989, Physical and Occupational Therapy in Geriatrics, V7, P43; Chen P, 2016, NEUROREHAB NEURAL RE, V30, P451, DOI 10.1177/1545968315604397; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Conti R. P., 2016, INT J NEUROSCIENCE B, V4, DOI [https://doi.org/10.13189/ijnbs.2016.040101, DOI 10.13189/IJNBS.2016.040101]; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Di Gregorio F, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04943-6; Di Monaco M, 2011, ARCH PHYS MED REHAB, V92, P1250, DOI 10.1016/j.apmr.2011.03.018; Di Russo F, 2017, NEUROSCI BIOBEHAV R, V78, P57, DOI 10.1016/j.neubiorev.2017.04.019; Di Russo F, 2008, BRAIN, V131, P842, DOI 10.1093/brain/awm281; Di Russo F, 2013, CORTEX, V49, P931, DOI 10.1016/j.cortex.2012.04.017; Dietz MJ, 2014, J NEUROSCI, V34, P5003, DOI 10.1523/JNEUROSCI.3765-13.2014; Fasotti L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00780; Hill-Jarrett TG, 2015, BRAIN INJURY, V29, P1617, DOI 10.3109/02699052.2015.1075155; Jacquin-Courtois S, 2015, ANN PHYS REHABIL MED, V58, P251, DOI 10.1016/j.rehab.2015.07.388; Johnson TR, 2016, QUANT METH PSYCHOL, V12, P253, DOI 10.20982/tqmp.12.3.p253; Kavcic V, 2015, NEUROPSYCHOLOGIA, V68, P82, DOI 10.1016/j.neuropsychologia.2015.01.003; Kim BR, 2013, ARCH PHYS MED REHAB, V94, P803, DOI 10.1016/j.apmr.2012.12.016; Kim JS., 2016, J KOREAN ACAD REHABI, V34, P397, DOI [10.1007/s00221-014-4112-9, DOI 10.1007/S00221-014-4112-9]; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; LADAVAS E, 1989, NEUROPSYCHOLOGIA, V27, P353, DOI 10.1016/0028-3932(89)90024-9; Lim JY, 2010, J REHABIL MED, V42, P447, DOI 10.2340/16501977-0553; Lisa LP, 2013, NEUROREHABILITATION, V33, P611, DOI 10.3233/NRE-130986; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mancuso M, 2015, NEUROL SCI, V36, P1233, DOI 10.1007/s10072-015-2088-2; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Oliveri M, 2001, NEUROLOGY, V57, P1338, DOI 10.1212/WNL.57.7.1338; Oliveri M, 2011, RESTOR NEUROL NEUROS, V29, P421, DOI 10.3233/RNN-2011-0613; PIZZAMIGLIO L, 1992, J CLIN EXP NEUROPSYC, V14, P901, DOI 10.1080/01688639208402543; Ptak R, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00248, 10.3389/fnhum.2013.00254]; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Verleger R, 1996, ELECTROEN CLIN NEURO, V99, P444, DOI 10.1016/S0013-4694(96)95645-X; Winkens B, 2007, CONTEMP CLIN TRIALS, V28, P713, DOI 10.1016/j.cct.2007.04.002; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	40	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 14	2021	12								702649	10.3389/fneur.2021.702649			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TS9ZH	WOS:000680010800001	34335455	Green Published, gold			2022-02-07	
J	Martin, S; Mooruth, D; Guerdoux-Ninot, E; Mazzocco, C; Brouillet, D; Taconnat, L; Trouillet, R				Martin, Sophie; Mooruth, Draushika; Guerdoux-Ninot, Estelle; Mazzocco, Clemence; Brouillet, Denis; Taconnat, Laurence; Trouillet, Raphael			Demographic Characteristics, Motivation and Perception of Change as Determinants of Memory Compensation Self-Reports After Acquired Brain Injury	FRONTIERS IN PSYCHOLOGY			English	Article						memory compensation strategies; self-report; brain injury; motivation; change; rehabilitation	COGNITIVE REHABILITATION; QUESTIONNAIRE MCQ; STRATEGY USE; ADULTS; MILD; PEOPLE; HEALTH; DEPRESSION; SYMPTOMS; BELIEFS	Introduction Individuals with brain injuries experience cognitive and emotional changes that have long-lasting impacts on everyday life. In the context of rehabilitation, surveys have stressed the importance of compensating for memory disturbances to ease the impact of disorders on day-to-day autonomy. Despite extensive research on the nature of neurocognitive impairments following brain injury, few studies have looked at patients' perceptions of these day-to-day compensations. This study examines these perceptions; in particular, what brain-injured people believe they do to compensate for memory deficiencies in everyday life. It also investigates the determinants of reported compensation strategies (age, gender, perceived stress, change awareness and motivation to succeed). Methods Eighty patients and 80 controls completed the French Memory Compensation Questionnaire, a self-report measure of everyday memory compensation. Five forms of compensation were investigated: External and Internal strategies, Reliance on social help, and investments in Time and Effort, along with two general factors: the degree of importance attached to Success (motivation) and perceptions of Change. Participants also completed measures of demographic and emotional aspects that may affect everyday compensation perceptions. Results The brain-injured group reported significantly more frequent use of memory compensation strategies than controls, with the exception of External aids. Large effects were observed for Reliance and Effort. Demographic, motivation and perception of change determinants were found to have different effects depending on the compensation strategy, and mediated the direct effect of brain injury on reported compensation. Conclusion Clinical and rehabilitation neuropsychologists often seek to have a better sense of how their patients perceive their compensatory behaviors. In practice, such an understanding is needed to help select appropriate methods and improve the long-term impact of rehabilitation programs: memory rehabilitation will fail if neuropsychologists do not deal, first and foremost, with the emotional and metacognitive issues surrounding traumatic brain injury (TBI), rather than focusing on cognitive efficiency.	[Martin, Sophie; Mooruth, Draushika; Mazzocco, Clemence; Brouillet, Denis; Trouillet, Raphael] Paul Valery Univ Montpellier 3, Lab EPSYLON EA 4556, Montpellier, France; [Martin, Sophie; Mooruth, Draushika; Brouillet, Denis] COMUE Languedoc Roussillon Univ, Cogithon Participat Innovat Platform Promoting Hu, Maison Sci Homme Sci Unies Autre Dev, FR CNRS 2005, Montpellier, France; [Guerdoux-Ninot, Estelle] Montpellier Canc Inst ICM, Unit Psychooncol, Dept Support Care, Montpellier, France; [Guerdoux-Ninot, Estelle] Univ Montpellier, INSERM, UMR Inst Desbrest Epidemiol & Publ Hlth 1302, Montpellier, France; [Taconnat, Laurence] Univ Poitiers, Univ Tours, UMR Ctr Rech Cognit & Apprentissage 7295, Poitiers, France		Martin, S (corresponding author), Paul Valery Univ Montpellier 3, Lab EPSYLON EA 4556, Montpellier, France.; Martin, S (corresponding author), COMUE Languedoc Roussillon Univ, Cogithon Participat Innovat Platform Promoting Hu, Maison Sci Homme Sci Unies Autre Dev, FR CNRS 2005, Montpellier, France.	Sophie.martin@univ-montp3.fr					American Psychiatric Association (APA), 1994, DIAGNOSTIC STAT MANU, V4th; APA, 2000, DIAGNOSTIC STAT MANU; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; BACHYRITA P, 1990, ARCH PHYS MED REHAB, V71, P1084; BACKMAN L, 1992, PSYCHOL BULL, V112, P259, DOI 10.1037/0033-2909.112.2.259; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borkowski J.G., 1986, HDB COGNITIVE SOCIAL, P147; Brewer-Mixon K.K., 2013, Neuropsychological Rehabilitation, P1; BUSCHKE H, 1984, J CLIN NEUROPSYCHOL, V6, P433, DOI 10.1080/01688638408401233; Melendez JC, 2013, ARCH GERONTOL GERIAT, V56, P32, DOI 10.1016/j.archger.2012.06.018; Christopher E, 2019, CUREUS, V11, DOI 10.7759/cureus.5120; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J, 1998, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; de Frias CM, 2005, PSYCHOL ASSESSMENT, V17, P168, DOI 10.1037/1040-3590.17.2.168; de Frias CM, 2003, J GERONTOL B-PSYCHOL, V58, pP12, DOI 10.1093/geronb/58.1.P12; Dixon RA, 2001, J CLIN EXP NEUROPSYC, V23, P650, DOI 10.1076/jcen.23.5.650.1242; Dixon RA, 2008, COGNITIVE NEUROREHAB, P22; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Farace E, 2000, Neurosurg Focus, V8, pe6; Finset A, 2000, BRAIN INJURY, V14, P887; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fluharty George, 1993, Brain Injury, V7, P85, DOI 10.3109/02699059309008160; Freund AM, 1998, PSYCHOL AGING, V13, P531, DOI 10.1037/0882-7974.13.4.531; Garrett DD, 2010, PSYCHOL AGING, V25, P74, DOI 10.1037/a0017726; Goldstein F.C., 1996, HDB MEMORY DISORDER, P187; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang J, 2014, NEUROPSYCHOL REHABIL, V24, P61, DOI 10.1080/09602011.2013.854723; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; Lewis M., 2000, HDB EMOTIONS, P623, DOI DOI 10.1002/0470013494.CH26; Louda J., 2007, Z NEUROPSYCHOL, V18, P91, DOI [10.1080/09602010600831004, DOI 10.1080/09602010600831004]; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Maronna R.A., 2006, ROBUST METHODS S PLU; Martin S., 2013, PSYCHOL CLIN VIEILLI PSYCHOL CLIN VIEILLI; Martin S, 2015, ARCH GERONTOL GERIAT, V60, P28, DOI 10.1016/j.archger.2014.10.013; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mazzocco C., 2015, REV NEUROPSYCHOL, V2, P135, DOI [10.1684/nrp.2015.0340, DOI 10.1684/NRP.2015.0340]; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Oberski D, 2014, J STAT SOFTW, V57, P1; Paganini-Hill A, 2001, J AM GERIATR SOC, V49, P941, DOI 10.1046/j.1532-5415.2001.49185.x; Paganini-Hill A, 2007, DEMENT GERIATR COGN, V23, P74, DOI 10.1159/000097097; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2003, NEUROREHABILITATION, V18, P47; Quintard B., 1994, INSTRODUCTION PSYCHO; R Core Team, 2020, R LANG ENV STAT COMP; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Ryan R.M., 1991, ADV MOTIVATION ACHIE, V7, P115; Ryan RM, 1997, DEV PSYCHOPATHOL, V9, P701, DOI 10.1017/S0954579497001405; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; SKINNER EA, 1990, J EDUC PSYCHOL, V82, P22, DOI 10.1037/0022-0663.82.1.22; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thone A.I.T., 2001, Z NEUROPSYCHOL Z NEUROPSYCHOL, V12, P102; Trexler L.E., 2000, INT HDB NEUROPSYCHOL; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turner LA, 1998, AM J MENT RETARD, V103, P162, DOI 10.1352/0895-8017(1998)103<0162:ROABTM>2.0.CO;2; Van der Elst W, 2011, ASSESSMENT, V18, P517, DOI 10.1177/1073191110370116; vandenHeuvel N, 1996, J AFFECT DISORDERS, V41, P229, DOI 10.1016/S0165-0327(96)00088-2; Walsh RS, 2020, NEUROREHABILITATION, V47, P11, DOI 10.3233/NRE-203079; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Zahodne LB, 2018, BRAIN IMAGING BEHAV, V12, P1112, DOI 10.1007/s11682-017-9776-x; ZIFF MA, 1995, HEALTH EDUC QUART, V22, P127, DOI 10.1177/109019819502200111	78	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JUL 14	2021	12								607035	10.3389/fpsyg.2021.607035			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TS0EA	WOS:000679328400001	34335350	Green Published, gold			2022-02-07	
J	Pirruccio, K; Parisien, RL; Kelly, JD				Pirruccio, Kevin; Parisien, Robert L.; Kelly, John D.			Sports-related concussions in high school females: an epidemiologic analysis of twenty-year national trends	RESEARCH IN SPORTS MEDICINE			English	Article						Closed head injury; recreation; organized sports; emergency department; traumatic brain injury	SEX-DIFFERENCES	The epidemiology of sports-related concussions (SRCs) and closed head injuries (CHIs) in high school females remains undefined at the national level, especially for unorganized sports and recreational activities. This study examines 1,176,092 national weighted estimates of SRCs or CHIs in female patients 14-18 years of age presenting to United States (US) emergency departments (EDs) between 2000 and 2019 in the National Electronic Injury Surveillance System (NEISS). The national weighted estimate of female patients in our study increased significantly (p < 0.001) between 2000 (9,835; 95% Confidence Interval [CI] 7,105-12,566) and 2019 (31,751; CI 26,392-37,110). The top five ranked sports and recreational activities most commonly associated with concussions and CHIs in female patients 14-18 years of age were: soccer (20.6%; CI 17.6%-23.6%); basketball (18.5%; CI 16.9%-20.1%); cheerleading (10.4%; CI 8.9%-11.9%); softball (10.1%; CI 9.0%-11.3%); volleyball (6.5%; CI 5.7%-7.2%). Simple univariate regression models showed that an increase of 10,000 annual female participants across all high school sports and recreational activities was associated with 308.7 (SE = 20.8, p < 0.001, R2 = 0.92) additional annual SRCs and CHIs presenting to US EDs. The promotion of concussion awareness and educational programs may help minimize SRCs and CHIs.	[Pirruccio, Kevin] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Parisien, Robert L.] Harvard Med Sch, Boston, MA 02115 USA; [Kelly, John D.] Univ Penn, Perelman Sch Med, Clin Orthopaed Surg, Philadelphia, PA USA		Pirruccio, K (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.	Kevin.Pirruccio@yale.edu					Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; CPSC U. S., 2000, NEISS NAT EL JUR SUR; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeCastro, 2020, CONCUSSION STATPEARL; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Federation of State High School Associations, 2019, HIGH SCH PART SURV A; Pirruccio K, 2019, JAMA SURG, V154, P458, DOI 10.1001/jamasurg.2019.0061; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; StataCorp L. P., 2018, STATA IC 151 WIND; Stoneback JW, 2012, J BONE JOINT SURG AM, V94A, P240, DOI 10.2106/JBJS.J.01663; US Consumer Product Safety Commission, 2017, NAT EL INJ SURV SYST; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	21	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	NOV 2	2021	29	6					526	535		10.1080/15438627.2021.1954514		JUL 2021	10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UY1VP	WOS:000673003900001	34254551				2022-02-07	
J	Ye, ZQ; Li, XL; Zheng, DL; Pei, SL; Cheng, P; Zhang, LS; Zhu, L				Ye, Zhiqiang; Li, Xiaoli; Zheng, Dongliang; Pei, Shuaili; Cheng, Pei; Zhang, Lishu; Zhu, Lin			Intravitreally Injected Methylene Blue Protects Retina against Acute Ocular Hypertension in Rats	CURRENT EYE RESEARCH			English	Article						Retinal ganglion cell; methylene blue; Nrf2; BACE1; acute ocular hypertension	TRAUMATIC BRAIN-INJURY; GANGLION-CELL SURVIVAL; A-BETA; ISCHEMIA/REPERFUSION INJURY; SIGNIFICANTLY IMPROVES; GLAUCOMA; DISEASES; DAMAGE; NEUROPROTECTION; EXPRESSION	Purpose: To assess the neuroprotective effects of methylene blue (MB) in a rat model of acute ocular hypertension (AOH) and explore its possible mechanisms. Methods: Our AOH rat model was obtained with anterior chamber perfusion for 60 min. After that, 100 mu M MB was injected into the vitreous cavity immediately after injury. Electroretinogram, fundus photography, optical coherence tomography (OCT) and retina morphology examination were utilized to quantify retinal damage before surgery, as well as 7, 14 and 28 days after. The average number of surviving retinal ganglion cells (RGCs) was counted after fluorescent retrograde labelling with 4% DiI. And TUNEL assay was used to investigate retinal cell apoptosis at 24 hours after AOH. Nrf2 and BACE1 in the retina were determined by RT-qPCR analysis. Results: AOH did produce a severe degeneration effect on the whole retinal layer. Intravitreally injected MB maintained certain retinal thickness after AOH, reduced the destruction of electroretinograms, and enhanced RGCs survival. The average number of TUNEL-labelled cells statistically reduced in the MB-treated retina tissue compared with retina treated with normal saline. The relative mRNA level of Nrf2 was also much higher in the MB-treated retinas after AOH, and the expression of BACE1 had a decline in the AOH + MB group. Conclusions: MB can protect the retina from AOH injury and the possible mechanism might involve the inhibition of BACE1 expression and the activation of Nrf2 antioxidant pathway.	[Ye, Zhiqiang; Li, Xiaoli; Zheng, Dongliang; Pei, Shuaili; Cheng, Pei; Zhang, Lishu; Zhu, Lin] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Inst Adv Mat Nanobio Applicat, 270 Xueyuan Xi Rd, Wenzhou 325027, Zhejiang, Peoples R China; [Li, Xiaoli] Zhengzhou Univ, Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Li, Xiaoli] Zhengzhou Univ, Henan Eye Inst, Peoples Hosp, Zhengzhou, Henan, Peoples R China		Zhu, L (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Inst Adv Mat Nanobio Applicat, 270 Xueyuan Xi Rd, Wenzhou 325027, Zhejiang, Peoples R China.	linzhudai123@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81900827]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LQ18H180004]	This work was financially supported by the National Natural Science Foundation of China (81900827) and the Natural Science Foundation of Zhejiang Province (LQ18H180004).	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Chauhan BC, 2004, INVEST OPHTH VIS SCI, V45, P144, DOI 10.1167/iovs.03-0687; Chen ZW, 2017, MOL NEUROBIOL, V54, P2209, DOI 10.1007/s12035-016-9818-1; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cheung W, 2008, OPTOMETRY VISION SCI, V85, P406, DOI 10.1097/OPX.0b013e31817841e5; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; Cort A, 2010, REGUL TOXICOL PHARM, V58, P121, DOI 10.1016/j.yrtph.2010.05.001; Daudt DR, 2012, INVEST OPHTH VIS SCI, V53, P4657, DOI 10.1167/iovs.12-9734; Deliyanti D, 2018, INVEST OPHTH VIS SCI, V59, P815, DOI 10.1167/iovs.17-22920; Di Marco E, 2015, CLIN SCI, V129, P199, DOI 10.1042/CS20150093; Dogan S, 2011, EXP EYE RES, V93, P387, DOI 10.1016/j.exer.2011.05.008; Dreixler JC, 2011, EXP EYE RES, V92, P521, DOI 10.1016/j.exer.2011.03.015; El Sayed NS, 2019, ARCH TOXICOL, V93, P2927, DOI 10.1007/s00204-019-02548-w; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gobel K, 2014, KLIN MONATSBL AUGENH, V231, P130, DOI 10.1055/s-0033-1360316; Grozdanic SD, 2003, INVEST OPHTH VIS SCI, V44, P2597, DOI 10.1167/iovs.02-0600; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Hao JF, 2019, OCUL IMMUNOL INFLAMM, V27, P836, DOI 10.1080/09273948.2018.1450516; Huang Y, 2008, NEUROSCIENCE, V153, P214, DOI 10.1016/j.neuroscience.2008.02.007; Huang Y, 2007, EXP EYE RES, V85, P684, DOI 10.1016/j.exer.2007.08.003; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Johnson TV, 2010, BRAIN RES BULL, V81, P349, DOI 10.1016/j.brainresbull.2009.04.004; Ko ML, 2011, EXP EYE RES, V93, P580, DOI 10.1016/j.exer.2011.07.003; Liu HH, 2017, INVEST OPHTH VIS SCI, V58, P5129, DOI 10.1167/iovs.17-22200; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Mancino R, 2018, CURR NEUROPHARMACOL, V16, P971, DOI 10.2174/1570159X16666171206144045; Mathew B, 2017, GRAEF ARCH CLIN EXP, V255, P1581, DOI 10.1007/s00417-017-3690-1; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Mekala NK, 2019, REDOX BIOL, V20, P107, DOI 10.1016/j.redox.2018.09.023; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Nucci C, 2015, PROG BRAIN RES, V221, P49, DOI 10.1016/bs.pbr.2015.04.010; Pakavathkumar P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13730; Pardue MT, 2018, PROG RETIN EYE RES, V65, P50, DOI 10.1016/j.preteyeres.2018.02.002; Rey-Funes M, 2016, AM J PHYSIOL-REG I, V310, pR1011, DOI 10.1152/ajpregu.00266.2015; Rojas JC, 2009, NEUROTOX RES, V15, P260, DOI 10.1007/s12640-009-9027-z; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Siegfried CJ, 2019, AM J OPHTHALMOL, V203, P12, DOI 10.1016/j.ajo.2019.02.008; Stack C, 2014, HUM MOL GENET, V23, P3716, DOI 10.1093/hmg/ddu080; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Varga B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101782; Watson, 1986, RAT BRAIN STEREOTAXI; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wilcock GK, 2018, J ALZHEIMERS DIS, V61, P435, DOI 10.3233/JAD-170560; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Wischik CM, 2015, J ALZHEIMERS DIS, V44, P705, DOI 10.3233/JAD-142874; Yang SH, 2017, PROG NEUROBIOL, V157, P273, DOI 10.1016/j.pneurobio.2015.10.005; Zakaria A, 2016, MOL NEUROBIOL, V53, P1220, DOI 10.1007/s12035-014-9088-8; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307; Zhang XY, 2013, INVEST OPHTH VIS SCI, V54, P3912, DOI 10.1167/iovs.13-11614; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551; Zhou L, 2019, EXP EYE RES, V180, P77, DOI 10.1016/j.exer.2018.12.006	59	0	0	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	JAN 2	2022	47	1					91	101		10.1080/02713683.2021.1948062		JUL 2021	11	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	YL5RN	WOS:000677912500001	34165383				2022-02-07	
J	Jaekel, C; Oezel, L; Bieler, D; Grassmann, JP; Rang, C; Lefering, R; Windolf, J; Thelen, S				Jaekel, C.; Oezel, L.; Bieler, D.; Grassmann, J. P.; Rang, C.; Lefering, R.; Windolf, J.; Thelen, S.		DGU	Implications of prehospital estimation of trauma patients for the treatment pathway-An evaluation of the TraumaRegister DGU (R)	ANAESTHESIST			German	Article; Early Access						Emergency medical services; Severely injured; Prehospital; Emergency physician; Shock room	SEVERELY INJURED PATIENTS; MULTIPLE TRAUMA; LIFE SUPPORT(R); CARE; INTERVENTIONS; MANAGEMENT; DIAGNOSIS; MORTALITY; SEVERITY; TIMES	Background In the prehospital acute treatment phase of severely injured patients, the stabilization of the vital parameters is paramount. The rapid and precise assessment of the injuries by the emergency physician is crucial for the initial treatment and the selection of the receiving hospital. Objective The aim of this study was to determine whether the prehospital emergency medical assessment has an influence on prehospital and emergency room treatment. Material and methods Data from the TraumaRegister DGU (R) between 2015 and 2019 in Germany were evaluated. The prehospital emergency medical assessment of the injury pattern and severity was recorded using the emergency physician protocol and compared with the in-hospital documented diagnoses using the abbreviated injury scale. Results A total of 47,838 patients with an average injury severity score (ISS) of 18,7 points (SD 12.3) were included. In summary, 127,739 injured body regions were documented in the hospitals. Of these, a total of 87,921 were correctly suspected by the emergency physician Thus, 39,818 injured body regions were not properly documented. In 42,530 cases a region of the body was suspected to be injured without the suspicion being confirmed in the hospital. Traumatic brain injuries and facial injuries were mostly overdiagnosed (13.5% and 14.7%, respectively documented by an emergency physician while the diagnosis was not confirmed in-hospital). Chest injuries were underdocumented (17.3% missed by an emergency physician while the diagnosis was finally confirmed in-hospital). The total mortality of all groups was very close to the expected mortality calculated with the revised injury severity classification II(RISC II)-score (12.0% vs. 11.3%). Conclusion In the prehospital care of severely injured patients, the overall injury severity is often correctly recorded by the emergency physician and correlates well with the derived treatment, the selection of the receiving hospital as well as the clinical course and the patient outcome; however, the assessment of injuries of individual body regions seems to be challenging in the prehospital setting.	[Jaekel, C.; Oezel, L.; Bieler, D.; Grassmann, J. P.; Rang, C.; Windolf, J.; Thelen, S.] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Klin Orthopadie & Unfallchirurg, Med Fak, Moorenstr 5, D-40225 Dusseldorf, Germany; [Bieler, D.] Bundeswehrzentralkrankenhaus Koblenz, Klin Unfallchirurg & Orthopadie Wiederherstellung, Verbrennungsmed, Koblenz, Germany; [Lefering, R.] Univ Witten Herdecke, Inst Forsch Operativen Med IFOM, Cologne, Germany		Oezel, L (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Klin Orthopadie & Unfallchirurg, Med Fak, Moorenstr 5, D-40225 Dusseldorf, Germany.	Lisa.Oezel@med.uni-duesseldorf.de			Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Ali J, 1997, J TRAUMA, V42, P786, DOI 10.1097/00005373-199705000-00006; Andruszkow H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146897; Aufmkolk M, 2003, UNFALLCHIRURG, V106, P746, DOI 10.1007/s00113-003-0640-7; Beuran M, 2012, CHIRURGIA-BUCHAREST, V107, P564; Bieler D, 2017, INJURY, V48, P32, DOI 10.1016/j.injury.2016.08.015; Biewener A, 2000, UNFALLCHIRURG, V103, P137, DOI 10.1007/s001130050025; Chrysou K, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0384-y; Craxford S, 2016, BONE JOINT J, V98B, P825, DOI 10.1302/0301-620X.98B6.37435; Esmer E, 2017, UNFALLCHIRURG, V120, P409, DOI 10.1007/s00113-015-0127-3; Giannakopoulos GF, 2012, INJURY, V43, P1517, DOI 10.1016/j.injury.2011.07.012; Grubmuller M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0469-7; Helm M, 2007, ANAESTHESIST, V56, P1142, DOI 10.1007/s00101-007-1253-2; Lecky FE, 2010, DAMAGE CONTROL MANAGEMENT IN THE POLYTRAUMA PATIENT, P13, DOI 10.1007/978-0-387-89508-6_2; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McCoy CE, 2013, ANN EMERG MED, V61, P167, DOI 10.1016/j.annemergmed.2012.08.026; Muhm M, 2011, ANAESTHESIST, V60, P534, DOI 10.1007/s00101-010-1846-z; O'Dochartaigh D, 2015, INJURY, V46, P2093, DOI 10.1016/j.injury.2015.07.007; Pandrich MJ, 2020, NEUROSURG REV, V43, P69, DOI 10.1007/s10143-018-0988-3; Pehle B, 2006, UNFALLCHIRURG, V109, P964, DOI 10.1007/s00113-006-1161-y; Ruchholtz S, 1997, UNFALLCHIRURG, V100, P859, DOI 10.1007/s001130050205; SCHWEIBERER L, 1987, UNFALLCHIRURG, V90, P529; Seamon MJ, 2013, INJURY, V44, P634, DOI 10.1016/j.injury.2012.12.020; Staub LJ, 2018, INJURY, V49, P457, DOI 10.1016/j.injury.2018.01.033; Swaroop Mamta, 2013, J Emerg Trauma Shock, V6, P16, DOI 10.4103/0974-2700.106320; Teuben M, 2020, EUR J TRAUMA EMERG S, V46, P1321, DOI 10.1007/s00068-019-01141-1; Timm A, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.08.017; Waydhas C, 2018, WORLD J SURG, V42, P2800, DOI 10.1007/s00268-018-4553-6; Weinlich M, 2019, INJURY, V50, P1028, DOI 10.1016/j.injury.2018.12.018; Wolfl CG, 2009, UNFALLCHIRURG, V112, P846, DOI 10.1007/s00113-009-1685-z	30	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist												10.1007/s00101-021-01001-x		JUL 2021	10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	TI7JY	WOS:000672977400001	34255101	hybrid			2022-02-07	
J	Cheng, CJ; Wang, XS; Jiang, YH; Li, YD; Liao, ZB; Li, WL; Yu, ZY; Whalen, MJ; Lok, J; Dumont, AS; Liu, N; Wang, XY				Cheng, Chongjie; Wang, Xiaoshu; Jiang, Yinghua; Li, Yadan; Liao, Zhengbu; Li, Wenlu; Yu, Zhanyang; Whalen, Michael J.; Lok, Josephine; Dumont, Aaron S.; Liu, Ning; Wang, Xiaoying			Recombinant Annexin A2 Administration Improves Neurological Outcomes After Traumatic Brain Injury in Mice	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; Annexin A2; blood-brain barrier; cerebrovascular remodeling; angiogenesis; neurological outcomes	ANGIOGENESIS; NEUROGENESIS; MECHANISMS; EXPRESSION; INDUCTION; RECOVERY; THERAPY; SYSTEM	Microvascular failure is one of the key pathogenic factors in the dynamic pathological evolution after traumatic brain injury (TBI). Our laboratory and others previously reported that Annexin A2 functions in blood-brain barrier (BBB) development and cerebral angiogenesis, and recombinant human Annexin A2 (rA2) protected against hypoxia plus IL-1 beta-induced cerebral trans-endothelial permeability in vitro, and cerebral angiogenesis impairment of AXNA2 knock-out mice in vivo. We thereby hypothesized that ANXA2 might be a cerebrovascular therapy candidate that targets early BBB integrity disruption, and subacute/delayed cerebrovascular remodeling after TBI, ultimately improve neurological outcomes. In a controlled cortex impact (CCI) mice model, we found rA2 treatment (1 mg/kg) significantly reduced early BBB disruption at 24 h after TBI; and rA2 daily treatment for 7 days augmented TBI-induced mRNA levels of pro-angiogenic and endothelial-derived trophic factors in cerebral microvessels. In cultured human brain microvascular endothelial cells (HBMEC), through MAPKs array, we identified that rA2 significantly activated Akt, ERK, and CREB, and the activated CREB might be responsible for the rA2-induced VEGF and BDNF expression. Moreover, rA2 administration significantly increased cerebral angiogenesis examined at 14 days and vessel density at 28 days after TBI in mice. Consistently, our results validated that rA2 significantly induced angiogenesis in vitro, evidenced by tube formation and scratched migration assays in HBMEC. Lastly, we demonstrated that rA2 improved long-term sensorimotor and cognitive function, and reduced brain tissue loss at 28 days after TBI. Our findings suggest that rA2 might be a novel vascular targeting approach for treating TBI.	[Cheng, Chongjie; Wang, Xiaoshu; Liao, Zhengbu] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China; [Cheng, Chongjie; Wang, Xiaoshu; Liao, Zhengbu; Li, Wenlu; Yu, Zhanyang; Lok, Josephine] Massachusetts Gen Hosp, Neuroprotect Res Lab, Charlestown, MA USA; [Cheng, Chongjie; Wang, Xiaoshu; Liao, Zhengbu; Li, Wenlu; Yu, Zhanyang; Lok, Josephine] Harvard Med Sch, Charlestown, MA USA; [Jiang, Yinghua; Li, Yadan; Dumont, Aaron S.; Liu, Ning; Wang, Xiaoying] Tulane Univ, Sch Med, Dept Neurosurg & Neurol, Clin Neurosci Res Ctr, New Orleans, LA 70118 USA; [Whalen, Michael J.; Lok, Josephine] Massachusetts Gen Hosp, Dept Pediat, Pediat Crit Care Med, Boston, MA 02114 USA; [Whalen, Michael J.; Lok, Josephine] Harvard Med Sch, Boston, MA 02115 USA		Liu, N; Wang, XY (corresponding author), Tulane Univ, Sch Med, Dept Neurosurg & Neurol, Clin Neurosci Res Ctr, New Orleans, LA 70118 USA.	Nliu3@tulane.edu; xwang51@tulane.edu	liao, ZB/ABF-8804-2021	liao, ZB/0000-0003-4591-9689; Liu, Ning/0000-0002-5632-0359	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS092085]	The authors disclosed receipt of the followingfinancial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (NIH) grants (RO1 NS092085 to XW)	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Andre C, 2014, BRAIN BEHAV IMMUN, V41, P10, DOI 10.1016/j.bbi.2014.03.012; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Carmen-Orozco RP, 2019, J NEUROSCI RES, V97, P137, DOI 10.1002/jnr.24335; Chen J, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.590669; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; Dallacasagrande V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061499; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Fang MR, 2011, NEUROSIGNALS, V19, P16, DOI 10.1159/000324272; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; Hayes MJ, 2009, BBA-MOL CELL RES, V1793, P1086, DOI 10.1016/j.bbamcr.2008.10.007; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Jacovina AT, 2009, J CLIN INVEST, V119, P3384, DOI 10.1172/JCI39591; Kant S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11982-4; Laskowitz D., 2016, FRONT NEUROSCI-SWITZ; Lee DBN, 2004, AM J PHYSIOL-RENAL, V287, pF481, DOI 10.1152/ajprenal.00175.2003; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Li WL, 2019, J CEREBR BLOOD F MET, V39, P2048, DOI 10.1177/0271678X18777916; Liu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246125; Liu W, 2016, BIOL CHEM, V397, P1005, DOI 10.1515/hsz-2016-0166; Lo EH, 2008, BRIT J PHARMACOL, V153, pS396, DOI 10.1038/sj.bjp.0707626; Luo M., 2017, J EXP MED; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Nilsen J, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0903-7; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Segarra M, 2021, TRENDS NEUROSCI, V44, P393, DOI 10.1016/j.tins.2020.12.002; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Sirbulescu RF, 2019, J NEUROTRAUM, V36, P2579, DOI 10.1089/neu.2018.6368; Song M, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00595-w; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xing CH, 2009, J NEUROSCI RES, V87, P2571, DOI 10.1002/jnr.22076; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zhu HH, 2010, J CEREBR BLOOD F MET, V30, P1137, DOI 10.1038/jcbfm.2009.279	51	0	0	6	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	JUL 12	2021	12								708469	10.3389/fphar.2021.708469			14	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TQ2GI	WOS:000678103500001	34400908	Green Published, gold			2022-02-07	
J	Mladek, A; Gerla, V; Seba, P; Kolar, V; Skalicky, P; Whitley, H; Lhotska, L; Benes, V; Bradac, O				Mladek, Arnost; Gerla, Vaclav; Seba, Petr; Kolar, Vladimir; Skalicky, Petr; Whitley, Helen; Lhotska, Lenka; Benes, Vladimir; Bradac, Ondrej			From head micro-motions towards CSF dynamics and non-invasive intracranial pressure monitoring	SCIENTIFIC REPORTS			English	Article							NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; FLOW; MANAGEMENT; ARTERIES; EMISSIONS; WAVES	Continuous monitoring of the intracranial pressure (ICP) is essential in neurocritical care. There are a variety of ICP monitoring systems currently available, with the intraventricular fluid filled catheter transducer currently representing the "gold standard". As the placement of catheters is associated with the attendant risk of infection, hematoma formation, and seizures, there is a need for a reliable, non-invasive alternative. In the present study we suggest a unique theoretical framework based on differential geometry invariants of cranial micro-motions with the potential for continuous non-invasive ICP monitoring in conservative traumatic brain injury (TBI) treatment. As a proof of this concept, we have developed a pillow with embedded mechanical sensors and collected an extensive dataset (>550 h on 24 TBI coma patients) of cranial micro-motions and the reference intraparenchymal ICP. From the multidimensional pulsatile curve we calculated the first Cartan curvature and constructed a "fingerprint" image (Cartan map) associated with the cerebrospinal fluid (CSF) dynamics. The Cartan map features maxima bands corresponding to a pressure wave reflection corresponding to a detectable skull tremble. We give evidence for a statistically significant and patient-independent correlation between skull micro-motions and ICP time derivative. Our unique differential geometry-based method yields a broader and global perspective on intracranial CSF dynamics compared to rather local catheter-based measurement and has the potential for wider applications.	[Mladek, Arnost; Skalicky, Petr; Whitley, Helen; Benes, Vladimir; Bradac, Ondrej] Charles Univ Prague, Fac Med 1, Dept Neurosurg & Neurooncol, Prague, Czech Republic; [Mladek, Arnost; Skalicky, Petr; Whitley, Helen; Benes, Vladimir; Bradac, Ondrej] Mil Univ Hosp, Prague, Czech Republic; [Mladek, Arnost; Gerla, Vaclav; Lhotska, Lenka] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, Dept Cognit Syst & Neurosci, Prague, Czech Republic; [Seba, Petr] Univ Hradec Kralove, Dept Phys, Hradec Kralove, Czech Republic; [Kolar, Vladimir] LINET Spol SRO, Dept Tech Dev, Slany, Czech Republic; [Skalicky, Petr; Bradac, Ondrej] Charles Univ Prague, Fac Med 2, Dept Neurosurg, Prague, Czech Republic; [Skalicky, Petr; Bradac, Ondrej] Motol Univ Hosp, Prague, Czech Republic; [Lhotska, Lenka] Czech Tech Univ, Fac Biomed Engn, Dept Nat Sci, Prague, Czech Republic		Bradac, O (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurosurg & Neurooncol, Prague, Czech Republic.; Bradac, O (corresponding author), Mil Univ Hosp, Prague, Czech Republic.; Bradac, O (corresponding author), Charles Univ Prague, Fac Med 2, Dept Neurosurg, Prague, Czech Republic.; Bradac, O (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	ondrej.bradac@uvn.cz		whitley, helen/0000-0002-2798-296X			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aggarwal P, 2014, J EVOL MED DENT SCI-, V3, P14270, DOI 10.14260/jemds/2014/3914; Amantini A, 2012, MINERVA ANESTESIOL, V78, P1067; Andersson L, 2012, ACTA NEUROCHIR, V154, P121, DOI 10.1007/s00701-011-1152-9; Behrens A, 2010, NEUROSURGERY, V66, P1050, DOI 10.1227/01.NEU.0000369519.35932.F2; Bershad EM, 2016, WORLD NEUROSURG, V89, P647, DOI 10.1016/j.wneu.2015.11.102; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Canac N, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00201-8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2012, CAN J NEUROL SCI, V39, P483, DOI 10.1017/S0317167100013998; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Firsching R, 2011, J NEUROSURG, V115, P371, DOI 10.3171/2011.3.JNS101275; Freeman W David, 2015, Continuum (Minneap Minn), V21, P1299, DOI 10.1212/CON.0000000000000235; Geeraerts T, 2008, CRIT CARE, V12, DOI [10.1186/cc6893, 10.1186/cc7006]; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Golan S, 2013, CLIN OPHTHALMOL, V7, P1083, DOI 10.2147/OPTH.S38910; Khan Marium Naveed, 2017, Surg Neurol Int, V8, P51, DOI 10.4103/sni.sni_403_16; Kim YI, 2008, J KOREAN NEUROSURG S, V44, P141, DOI 10.3340/jkns.2008.44.3.141; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KLINGELHOFER J, 1987, KLIN WOCHENSCHR, V65, P542, DOI 10.1007/BF01727619; Koenig Matthew A, 2018, Continuum (Minneap Minn), V24, P1588, DOI 10.1212/CON.0000000000000665; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Li Z, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-66; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; Michaeli D, 2002, J NEUROSURG, V96, P1132, DOI 10.3171/jns.2002.96.6.1132; Nag DS, 2019, WORLD J CLIN CASES, V7, P1535, DOI 10.12998/wjcc.v7.i13.1535; OROURKE MF, 1967, J APPL PHYSIOL, V23, P139, DOI 10.1152/jappl.1967.23.2.139; Ragauskas A, 2005, ACT NEUR S, V95, P357; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Roldan M, 2020, J NEUROTRAUM, V37, P2445, DOI 10.1089/neu.2020.7266; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Sacco TL, 2019, DIMENS CRIT CARE NUR, V38, P61, DOI 10.1097/DCC.0000000000000341; Sacco TL, 2018, DIMENS CRIT CARE NUR, V37, P120, DOI 10.1097/DCC.0000000000000293; Sajjadi SA, 2006, ANN NEUROL, V59, P867, DOI 10.1002/ana.20856; Sallam A, 2021, ANESTH ANALG, V132, P686, DOI 10.1213/ANE.0000000000005189; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; Stettin E, 2011, J CLIN MONIT COMPUT, V25, P203, DOI 10.1007/s10877-011-9297-x; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Voss SE, 2006, NEUROCRIT CARE, V4, P251, DOI 10.1385/NCC:4:3:251; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Wu J, 2013, MED DEVICES-EVID RES, V6, P123, DOI 10.2147/MDER.S47725	44	0	0	3	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 12	2021	11	1							14349	10.1038/s41598-021-93740-5			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TP3LG	WOS:000677494600022	34253803	Green Published, gold			2022-02-07	
J	Reith, W; Kettner, M; Yilmaz, U				Reith, W.; Kettner, M.; Yilmaz, U.			Nonaccidental traumatic brain injury in infants and children	RADIOLOGE			German	Article						Brain trauma; Child abuse; Shaking trauma; Subdural hemorrhage; Death	SHAKEN BABY SYNDROME; HEAD-INJURY	Violent traumatic brain injury (TBI) can cause brain dysfunction and injury. Accidental and nonaccidental trauma are still the leading cause of childhood death worldwide. It is assumed that about 20% of TBI in children under 2 years of age are nonaccidentally caused. In all cases, nonaccidental TBI is caused by the violent impact on the brain and spinal cord by the massive shaking of the child held by the upper arms or body. This can lead to a rupture of blood vessels, especially bridge veins, as well as axonal shear injuries to the nerve connections and brain swelling. Involvement of the brain stem can lead to initial short-term respiratory arrest. The resulting clinical symptoms include poor drinking, drowsiness, apathy, cerebral seizures, breathing disorders, temperature disorders, and vomiting as a result of increased intracranial pressure. Long-term disorders can include neurological and neuropsychological disorders, hearing disorders, visual disorders up to blindness, and poor school performance. In addition, there are metaphyseal fractures and rib fractures of various forms, also of different ages. Since shaking trauma has a poor prognosis, preventive measures are useful: education!	[Reith, W.; Kettner, M.; Yilmaz, U.] Univ Klinikum Saarlandes, Klin Diagnost & Intervent Neuroradiol, Kirrberger Str, D-66424 Homburg, Germany		Reith, W (corresponding author), Univ Klinikum Saarlandes, Klin Diagnost & Intervent Neuroradiol, Kirrberger Str, D-66424 Homburg, Germany.	Wolfgang.Reith@uniklinikum-saarland.de					AWMF, 2019, S3 LEITL KIND MISSBR, P027; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Benz B., 2002, BMFT; Blumenthal I, 2002, POSTGRAD MED J, V78, P732, DOI 10.1136/pmj.78.926.732; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Dubowitz H, 2007, LANCET, V369, P1891, DOI 10.1016/S0140-6736(07)60856-3; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Herrmann B, 2008, RECHTSMEDIZIN, V18, P9, DOI 10.1007/s00194-007-0482-7; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Matschke J, 2008, RECHTSMEDIZIN, V18, P29, DOI 10.1007/s00194-007-0487-2; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Reith W, 2016, RADIOLOGE, V56, P424, DOI 10.1007/s00117-016-0106-x; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]; Yilmaz U, 2015, CLIN NEURORADIOL, V25, P181, DOI 10.1007/s00062-014-0283-9	18	0	0	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0033-832X	1432-2102		RADIOLOGE	Radiologe	AUG	2021	61	8			SI		742	747		10.1007/s00117-021-00885-5		JUL 2021	6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	TT8HS	WOS:000672286600001	34251479				2022-02-07	
J	Wu, ZT; Ma, JK; Zhou, XL; Ma, XM				Wu, Zongtao; Ma, Jingku; Zhou, Xiaolong; Ma, Xiumei			Self-Adaptive Particle Swarm Optimization of CT Images for Diagnosis of Severe Traumatic Brain Injury	SCIENTIFIC PROGRAMMING			English	Article								This paper aimed to explore the application values of computed tomography (CT) imaging in the treatment of patients with severe traumatic brain injury (STBI), to provide help in the treatment of STBI. In this study, 86 patients with STBI were selected as the research objects and examined by CT based on a self-adaptive particle swarm algorithm (APSO). Besides, patients were treated with hyperbaric oxygen, high-dose hormone shock, and naloxone hydrochloride. The results showed that there was a locally low-density brain contusion and laceration injury area, spot-like high-density hemorrhage, and subarachnoid hemorrhage in the images of CT examination. The ventricles of diffuse brain injury were compressed and reduced, and the white matter indicated that the ventricles and cisterns became smaller. Asymmetric hemorrhage and subarachnoid hemorrhage were scattered at the white matter junction. In short, subarachnoid hemorrhage, spot-like high-density hemorrhage at the injury site, and diminished ventricles were typical CT imaging manifestations of STBI. Naloxone hydrochloride method could effectively alleviate the matrix metalloproteinase-9 (MMP-9) (23.47 +/- 3.45) and S100 calcium-binding protein B (S100B) (0.16 +/- 0.06) of patients, which had reliable guiding significance for the later CT examination clinically.	[Wu, Zongtao] Ankang Chinese Med Hosp, Dept Neurosurg, Ankang 725000, Shaanxi, Peoples R China; [Ma, Jingku] Shaanxi Prov Nucl Ind 215th Hosp, Dept Neurosurg, Xianyang 712000, Shaanxi, Peoples R China; [Zhou, Xiaolong] Baoji Cent Hosp, Dept Neurosurg, Baoji 721008, Peoples R China; [Ma, Xiumei] First Hosp Yulin City, Dept Imaging, Yulin 719000, Shaanxi, Peoples R China		Ma, XM (corresponding author), First Hosp Yulin City, Dept Imaging, Yulin 719000, Shaanxi, Peoples R China.	0116007@yzpc.edu.cn					Abdel-Basset M, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0846-9; Dunne RB, 2018, PAIN MANAG, V8, P197, DOI 10.2217/pmt-2017-0065; Firsching R, 2017, J NEUROL SURG PART A, V78, P478, DOI 10.1055/s-0037-1599239; Gorich J, 2019, DTSCH ARZTEBL INT, V116, P460, DOI 10.3238/arztebl.2019.0460a; Gorse KM, 2018, J NEUROTRAUM, V35, P1694, DOI 10.1089/neu.2017.5275; Guo SK, 2019, INT J SOFTW ENG KNOW, V29, P139, DOI 10.1142/S0218194019500074; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Kumar KS, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/4909846; Majidi S, 2016, J NEUROIMAGING, V26, P346, DOI 10.1111/jon.12306; Useche JN, 2018, NEUROIMAG CLIN N AM, V28, P15, DOI 10.1016/j.nic.2017.09.006; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Shi Y, 2019, ARTIF INTELL MED, V100, DOI 10.1016/j.artmed.2019.101709; Sierink JC, 2016, LANCET, V388, P673, DOI 10.1016/S0140-6736(16)30932-1; Stoneback JW, 2018, RES SPORTS MED, V26, P114, DOI 10.1080/15438627.2018.1439034; Taguchi K, 2017, RADIOL PHYS TECHNOL, V10, P8, DOI 10.1007/s12194-017-0390-9; Yamada A, 2016, IEEE ENG MED BIO, P6437, DOI 10.1109/EMBC.2016.7592202	17	0	0	2	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1058-9244	1875-919X		SCI PROGRAMMING-NETH	Sci. Program.	JUL 12	2021	2021								9891663	10.1155/2021/9891663			9	Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	TU2FV	WOS:000680856400003		gold			2022-02-07	
J	Yang, K; Zhao, M; Sun, J; Nie, XL				Yang, Ke; Zhao, Meng; Sun, Jing; Nie, Xiuli			Accuracy of PECARN decision rule in minor blunt head trauma in pediatric emergency department: A meta-analysis	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							PREDICTION RULES; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; UNITED-STATES; BRAIN-INJURY; CT; CHILDREN; VALIDATION; CANCER; VISITS	Background Paediatric Emergency Care Applied Research Network (PECARN) is a useful Clinical Decision Support Tool (CDST) to identify traumatic brain injuries and reduce the use of head computed tomography (CT) scans among paediatric patients. The present Meta-analysis aims to evaluate the diagnostic accuracy of the PECARN rule from 2009 to 2020 in children with a very low risk of blunt head trauma. Methods A detailed search was conducted from the databases of Medline (via PubMed), Cinahl (via Ebsco), Scopus, Web of Sciences, from 2009 till the end of December 2020 using the keywords like decreased use of CT scan, blunt head trauma (BHT) combined with accuracy, PECARN OR CDST. Studies showing the diagnostic accuracy of the PECARN rule in children younger than 18 years of age with minor BHT were included. Results Thirteen studies were included in the present analysis. Pooled sensitivity of 0.08, (95% confidence interval of 0.074-0.087), pooled specificity of 0.20 (95% CI of 0.196-0.213) and diagnostic odds ratio of 0.004 (95% CI of 0.000-0.1666) was in <2 years of age. The overall sensitivity of 0.07, specificity of 0.66, and the diagnostic odds ratio of 0.54 (95% CI of 0.10-2.78) were seen in >= 2 years of age. Overall sensitivity of 0.13 (95% CI 0.12-0.14), specificity of 0.81 (95% CI 0.80-0.82) and diagnostic odds ratio of 0.79 (95% CI of 0.08-7.71) was in 0-18 years of age. Conclusion The present analysis indicates the PECARN decision tool as an accurate CDST in low-risk minor BHT cases in children below two years of age and can become a valuable tool in reducing Head CT scan overuse in paediatric emergency departments.	[Yang, Ke] First Peoples Hosp Tianmen City, Dept CT & MRI, Tianmen, Peoples R China; [Zhao, Meng] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Peoples R China; [Sun, Jing; Nie, Xiuli] Shandong Univ, Jinan Cent Hosp, Dept Radiol, Jinan 250013, Shandong, Peoples R China		Nie, XL (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Radiol, Jinan 250013, Shandong, Peoples R China.	niexiuli1987@gmail.com		Plante, Patrick/0000-0002-0860-5798; , Xiuli/0000-0002-4917-3370			Ahmadi S, 2017, INT J PEDIATR-MASSHA, V5, P6285, DOI 10.22038/ijp.2017.26693.2299; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl Franz E, 2015, Evid Based Med, V20, P33, DOI 10.1136/ebmed-2014-110090; Barrett J., 2016, USE CLIN DECISION RU; Bozan O, 2019, EUR J TRAUMA EMERG S, V45, P849, DOI 10.1007/s00068-017-0865-8; Bregstein JS, 2014, CURR OPIN PEDIATR, V26, P272, DOI 10.1097/MOP.0000000000000096; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Fuller G, 2011, EMERG MED J, V28, pA2; Gariepy M, 2020, PAED CHILD HEALT-CAN, V25, P26, DOI 10.1093/pch/pxy180; Gizli G, 2020, HONG KONG J EMERG ME, DOI 10.1177/1024907920930510; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Khalifa M, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0940-7; Kobe IO, 2017, CHILD NERV SYST, V33, P2147, DOI 10.1007/s00381-017-3577-9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McGraw M, 2019, CAN J EMERG MED, V21, P120, DOI 10.1017/cem.2018.444; Mihindu E, 2014, AM SURGEON, V80, P841; Mueller DL, 2011, J TRAUMA, V70, P724, DOI 10.1097/TA.0b013e3182092ff8; Nakhjavan-Shahraki B, 2017, EUR J TRAUMA EMERG S, V43, P755, DOI 10.1007/s00068-017-0811-9; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	32	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	NOV	2021	75	11							e14586	10.1111/ijcp.14586		JUL 2021	10	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	WJ4KY	WOS:000671884200001	34191372	Green Submitted			2022-02-07	
J	Gagnon, MA; Berube, M; Mercier, E; Yanchar, N; Cameron, P; Stelfox, T; Gabbe, B; Bourgeois, G; Lauzier, F; Turgeon, A; Belcaid, A; Moore, L				Gagnon, Marc-Aurele; Berube, Melanie; Mercier, Eric; Yanchar, Natalie; Cameron, Peter; Stelfox, Thomas; Gabbe, Belinda; Bourgeois, Gilles; Lauzier, Francois; Turgeon, Alexis; Belcaid, Amina; Moore, Lynne			Low-value injury admissions in an integrated Canadian trauma system: A multicentre cohort study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article; Early Access							PEDIATRIC-PATIENTS; HOSPITAL QUALITY; SKULL FRACTURE; OLDER PATIENTS; BLUNT TRAUMA; MANAGEMENT; CHILDREN; CARE; GUIDELINES	Background Injury represents 260 000 hospitalisations and $27 billion in healthcare costs each year in Canada. Evidence suggests that there is significant variation in the prevalence of hospital admissions among emergency department presentations between countries and providers, but we lack data specific to injury admissions. We aimed to estimate the prevalence of potentially low-value injury admissions following injury in a Canadian provincial trauma system, identify diagnostic groups contributing most to low-value admissions and assess inter-hospital variation. Methods We conducted a retrospective multicentre cohort study based on all injury admissions in the Quebec trauma system (2013-2018). Using literature and expert consultation, we developed criteria to identify potentially low-value injury admissions. We used a multilevel logistic regression model to evaluate inter-hospital variation in the prevalence of low-value injury admissions with intraclass correlation coefficients (ICC). We stratified our analyses by age (1-15; 16-64; 65-74; 75+ years). Results The prevalence of low-value injury admissions was 16% (n = 19 163) among all patients, 26% (2136) in children, 11% (4695) in young adults and 19% (12 345) in older adults. Diagnostic groups contributing most to low-value admissions were mild traumatic brain injury in children (48% of low-value paediatric injury admissions; n = 922), superficial injuries (14%, n = 660) or minor spinal injuries (14%, n = 634) in adults aged 16-64 and superficial injuries in adults aged 65+ (22%, n = 2771). We observed strong inter-hospital variation in the prevalence of low-value injury admissions (ICC = 37%). Conclusion One out of six hospital admissions following injury may be of low value. Children with mild traumatic brain injury and adults with superficial injuries could be good targets for future research efforts seeking to reduce healthcare services overuse. Inter-hospital variation indicates there may be an opportunity to reduce low-value injury admissions with appropriate interventions targeting modifications in care processes.	[Gagnon, Marc-Aurele; Turgeon, Alexis; Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Gagnon, Marc-Aurele; Berube, Melanie; Mercier, Eric; Lauzier, Francois; Turgeon, Alexis; Moore, Lynne] Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Ctr Rech,CHU Quebec,Hop Enfant Jesus, 1401 18eme Rue,Local Z-201, Quebec City, PQ G1J 1Z4, Canada; [Berube, Melanie] Univ Laval, Fac Sci Infirmieres, Quebec City, PQ, Canada; [Yanchar, Natalie] Dalhousie Univ, Dept Surg, Halifax, NS, Canada; [Cameron, Peter] Monash Univ, Alfred Hosp, Melbourne, Vic, Australia; [Stelfox, Thomas] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Thomas] Alberta Hlth Serv, Calgary, AB, Canada; [Gabbe, Belinda] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Bourgeois, Gilles] Urgences Sante, Montreal, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med Interne, Quebec City, PQ, Canada; [Turgeon, Alexis] Univ Laval, Dept Anesthesiol & Soins Intensifs, Quebec City, PQ, Canada; [Belcaid, Amina] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada		Gagnon, MA (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Ctr Rech,CHU Quebec,Hop Enfant Jesus, 1401 18eme Rue,Local Z-201, Quebec City, PQ G1J 1Z4, Canada.	marc-aurele.gagnon.2@ulaval.ca		Gagnon, Marc-Aurele/0000-0002-7974-3389	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [353374]	Canadian Institutes of Health Research, Grant/Award Number: 353374	Admi H, 2015, RAMBAM MAIMONIDES ME, V6, DOI DOI 10.5041/RMMJ.10201; Age UK, 2016, AGE UK BRIEF DISCH O; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Biffl WL, 2015, WORLD J SURG, V39, P1373, DOI 10.1007/s00268-014-2793-7; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bond Kenneth, 2007, Healthc Q, V10, P32; Bracken ME, 2007, ANN EMERG MED, V49, P45, DOI 10.1016/j.annemergmed.2006.04.013; Brown Cynthia J., 2004, Journal of the American Geriatrics Society, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Canadian Institute for Health Information, 2017, UNN CAR CAN TECHN RE; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chaudhry SI, 2013, J AM COLL CARDIOL, V61, P635, DOI 10.1016/j.jacc.2012.11.027; Coon ER, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2797; Fall CL, 2008, ANNU REV NURS RES, V24, P39; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Goodman TR, 2019, PEDIATR RADIOL, V49, P469, DOI 10.1007/s00247-018-4281-y; Graf C, 2006, AM J NURS, V106, P58, DOI 10.1097/00000446-200601000-00032; Halfon P, 2017, INT J QUAL HEALTH C, V29, P527, DOI 10.1093/intqhc/mzx061; Hoffman JR, 1998, ANN EMERG MED, V32, P461, DOI 10.1016/S0196-0644(98)70176-3; Institut national d'excellence en sante et services sociaux, 2015, CONT SERV TRAUM; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Kevric J, 2016, EUR J TRAUMA EMERG S, V42, P671, DOI 10.1007/s00068-015-0605-x; Krogstad U, 2005, QUAL SAF HEALTH CARE, V14, P438, DOI 10.1136/qshc.2005.014233; Landefeld CS, 2006, J HOSP MED, V1, P42, DOI 10.1002/jhm.11; Manderbacka K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029592; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moore L, 2019, J TRAUMA ACUTE CARE, V86, P983, DOI 10.1097/TA.0000000000002246; Moore Lynne, 2013, J Emerg Trauma Shock, V6, P95, DOI 10.4103/0974-2700.110754; OECD, 2014, GEOGRAPHIC VARIATION; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parachute Canada, 2015, COST INJ CAN; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Purdy S, 2013, J ROY COLL PHYS EDIN, V43, P340, DOI 10.4997/JRCPE.2013.415; Rafter N, 2015, QJM-INT J MED, V108, P273, DOI 10.1093/qjmed/hcu145; Reuveni-Salzman A, 2016, CHILD NERV SYST, V32, P1669, DOI 10.1007/s00381-016-3175-2; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Saragiotto BT., 2018, COCHRANE DB SYST REV, V4; Schonfeld D, 2012, CURR OPIN PEDIATR, V24, P314, DOI 10.1097/MOP.0b013e328352de97; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Stuke LE, 2013, AM SURGEON, V79, P1149; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; van Vliet M, 2017, J AM GERIATR SOC, V65, P1214, DOI 10.1111/jgs.14767; Victor CR, 2000, HEALTH SOC CARE COMM, V8, P443, DOI 10.1046/j.1365-2524.2000.00270.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7	49	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.											e14473	10.1111/ijcp.14473		JUL 2021	9	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pharmacology & Pharmacy	TG9UT	WOS:000671741900001	34107144				2022-02-07	
J	Lokineni, S; Tirthani, E; Wuest, J; Ayyad, R				Lokineni, Sravani; Tirthani, Ekta; Wuest, Julia; Ayyad, Rania			Paroxysmal Sympathetic Hyperactivity in a 73-Year-Old Female With Acute Myeloid Leukemia	CUREUS			English	Article						paroxysmal sympathetic hyperactivity; acute myeloid leukemia (aml); traumatic brain injury; sympathetic response; recurrence		Paroxysmal Sympathetic Hyperactivity (PSH) is a syndrome of recurrent exaggerated sympathetic responses in combination with motor features typically observed in the setting of traumatic brain injury and rarely seen without it. Here, we present a case of PSH in a 73-year-old female with acute myeloid leukemia (AML) without any brain injuries presenting with recurrent intermittent episodes of tachycardia, tachypnea, hypertension, fever, dystonia. These episodes resolved with clonidine and clonazepam thus confirming the diagnosis of PSH. PSH is an unusual and rare presentation in AML and not much literature has been reported.	[Lokineni, Sravani; Tirthani, Ekta; Ayyad, Rania] Rochester Reg Hlth, Internal Med, Rochester, NY 14608 USA; [Wuest, Julia] Rochester Reg Hlth, Oncol, Rochester, NY USA		Lokineni, S (corresponding author), Rochester Reg Hlth, Internal Med, Rochester, NY 14608 USA.	sravani.lokineni@gmail.com		Tirthani, Ekta/0000-0002-0372-187X			Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Feyissa AM, 2014, CLIN NEUROPHYSIOL, V125, P1069, DOI 10.1016/j.clinph.2013.09.023; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Morinaga Y, 2020, INTRACTABLE RARE DIS, V9, P119, DOI 10.5582/irdr.2020.01021; O'Keefe LM, 2020, NEUROLOGIST, V25, P24, DOI 10.1097/NRL.0000000000000258; Zheng RZ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00081	6	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 10	2021	13	7							e16293	10.7759/cureus.16293			2	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TM1KT	WOS:000675313000004	34381652	gold, Green Published			2022-02-07	
J	Nabavizadeh, B; Hakam, N; Holler, JT; Namiri, NK; Sadighian, MJ; Rios, N; Enriquez, A; Amend, GM; Breyer, BN				Nabavizadeh, Behnam; Hakam, Nizar; Holler, Jordan T.; Namiri, Nikan K.; Sadighian, Michael J.; Rios, Natalie; Enriquez, Anthony; Amend, Gregory M.; Breyer, Benjamin N.			Epidemiology of child playground equipment-related injuries in the USA: Emergency department visits, 1995-2019	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article; Early Access						children; fracture; injuries; play; plaything		Aim To analyse the most recent trends and characteristics of playground equipment-related injuries in children. Methods We used the National Electronic Injury Surveillance System database to acquire cases of playground equipment-related injuries in children <= 17 years old between 1995 and 2019. A total of 184 580 unweighted cases met our study inclusion criteria. Results A total of 5 356 703 (95% confidence interval 4 235 530-6 477 876) emergency department visits for playground-related injuries in the USA were estimated during the study period which was equal to an average of 29.4 annual injuries per 10 000 US population <= 17 years. The mean age was 6.5 (standard error 0.049) years. School-aged (42.7%) and pre-school children (35.3%) accounted for most playground injuries. More than half of the injuries were reported in males (53.6%). Most injuries occurred with climbing apparatuses (36%), followed by swings (25.9%) and slides (20.9%). Overall number of injuries ( increment - 22.3%, P = 0.01) and incidence ( increment - 21.6%, P = 0.01) had a declining trend after 2012. However, reported concussion injuries showed an increasing trend during the study ( increment + 28.3%, P < 0.001). A marked seasonal variation in number of injuries existed with most injuries in May and September. Conclusions Although injuries arising from playground equipment have decreased during the past 8 years, there was an increase in number of reported concussions. The outcomes of this study suggested that further efforts should be directed towards such serious injuries.	[Nabavizadeh, Behnam; Hakam, Nizar; Holler, Jordan T.; Namiri, Nikan K.; Sadighian, Michael J.; Rios, Natalie; Enriquez, Anthony; Amend, Gregory M.; Breyer, Benjamin N.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA; [Breyer, Benjamin N.] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94110 USA		Nabavizadeh, B (corresponding author), Univ Calif San Francisco, Dept Urol, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, 1001 Potrero Suite 3A, San Francisco, CA 94110 USA.	behnam.nabavizadeh@ucsf.edu	Nabavizadeh, Behnam/R-3113-2018; Namiri, Nikan/AAW-6616-2021	Nabavizadeh, Behnam/0000-0003-4378-9243; 			Adelson SL, 2018, CLIN PEDIATR, V57, P584, DOI 10.1177/0009922817732144; ASTM, 2018, F129218E1 ASTM INT F129218E1 ASTM INT; ASTM, 2017, F148717 ASTM INT F148717 ASTM INT; Bernardo L M, 2001, J Soc Pediatr Nurs, V6, P11; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Elm EV., 2007, PLOS MED, V4, pE296, DOI DOI 10.1371/journal.pmed.0040296; Fahlstedt M, 2019, J BIOMECH, V89, P1, DOI 10.1016/j.jbiomech.2019.03.038; Laforest S, 2000, J EPIDEMIOL COMMUN H, V54, P475, DOI 10.1136/jech.54.6.475; Loder RT, 2011, INJURY, V42, P945, DOI 10.1016/j.injury.2010.02.009; Migneault D, 2018, CUREUS, V10, DOI 10.7759/cureus.3548; Milteer RM, 2012, PEDIATRICS, V129, pE204, DOI 10.1542/peds.2011-2953; Richmond SA, 2018, CAN J PUBLIC HEALTH, V109, P134, DOI 10.17269/s41997-018-0035-8; Rideout VJ., 2010, GENERATION M 2 MEDIA; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Suh D, 2018, MEDICINE, V97, DOI [10.1097/md.0000000000013705, 10.1097/MD.0000000000013705]; Teitelbaum MP, 2020, CUREUS, V12, DOI 10.7759/cureus.6534; Traumatic Brain Injury Legislation, NAT C STAT LEG NAT C STAT LEG; Tuckel P, 2018, CLIN PEDIATR, V57, P563, DOI 10.1177/0009922817732618; US Census Bureau, ANN EST RES POP SING ANN EST RES POP SING; US Census Bureau, USEST00INT US CENS B USEST00INT US CENS B; US Census Bureau, USEST90INT07 US CENS USEST90INT07 US CENS; US Consumer Product Safety Commission, 2008, PUBL PLAYGR SAF HDB PUBL PLAYGR SAF HDB; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health												10.1111/jpc.15644		JUL 2021	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	TG7LM	WOS:000671581600001	34245468				2022-02-07	
J	Garcia-Bardon, A; Kamuf, J; Ziebart, A; Liu, TH; Krebs, N; Dunges, B; Kelm, RF; Morsbach, S; Mohr, K; Heimann, A; Hartmann, EK; Thal, SC				Garcia-Bardon, Andreas; Kamuf, Jens; Ziebart, Alexander; Liu, Tanghua; Krebs, Nadia; Duenges, Bastian; Kelm, Robert F.; Morsbach, Svenja; Mohr, Kristin; Heimann, Axel; Hartmann, Erik K.; Thal, Serge C.			Levosimendan increases brain tissue oxygen levels after cardiopulmonary resuscitation independent of cardiac function and cerebral perfusion	SCIENTIFIC REPORTS			English	Article							BLOOD-FLOW; MICROCIRCULATION; PROTECTION; IMPROVES; INJURY; MODEL	Prompt reperfusion is important to rescue ischemic tissue; however, the process itself presents a key pathomechanism that contributes to a poor outcome following cardiac arrest. Experimental data have suggested the use of levosimendan to limit ischemia-reperfusion injury by improving cerebral microcirculation. However, recent studies have questioned this effect. The present study aimed to investigate the influence on hemodynamic parameters, cerebral perfusion and oxygenation following cardiac arrest by ventricular fibrillation in juvenile male pigs. Following the return of spontaneous circulation (ROSC), animals were randomly assigned to levosimendan (12 mu g/kg, followed by 0.3 mu g/kg/min) or vehicle treatment for 6 h. Levosimendan-treated animals showed significantly higher brain PbtO(2) levels. This effect was not accompanied by changes in cardiac output, preload and afterload, arterial blood pressure, or cerebral microcirculation indicating a local effect. Cerebral oxygenation is key to minimizing damage, and thus, current concepts are aimed at improving impaired cardiac output or cerebral perfusion. In the present study, we showed that NIRS does not reliably detect low PbtO(2) levels and that levosimendan increases brain oxygen content. Thus, levosimendan may present a promising therapeutic approach to rescue brain tissue at risk following cardiac arrest or ischemic events such as stroke or traumatic brain injury.	[Garcia-Bardon, Andreas; Kamuf, Jens; Ziebart, Alexander; Liu, Tanghua; Krebs, Nadia; Duenges, Bastian; Kelm, Robert F.; Hartmann, Erik K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Morsbach, Svenja; Mohr, Kristin] Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany; [Heimann, Axel] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany; [Thal, Serge C.] Witten Herdecke Univ, HELIOS Univ Hosp Wuppertal, Dept Anesthesiol, Heusnerstr 40, D-42283 Wuppertal, Germany		Garcia-Bardon, A; Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.; Thal, SC (corresponding author), Witten Herdecke Univ, HELIOS Univ Hosp Wuppertal, Dept Anesthesiol, Heusnerstr 40, D-42283 Wuppertal, Germany.	a.garciabardon@uni-mainz.de; serge@thal.de		Thal, Serge/0000-0002-1222-8729	Johannes Gutenberg-University Mainz; Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. This work was supported by a grant from the Johannes Gutenberg-University Mainz (Stage 1 grant, RFK).	Ashana DC, 2019, CRIT CARE MED, V47, P1591, DOI 10.1097/CCM.0000000000003969; Berger R, 2007, EUR J HEART FAIL, V9, P202, DOI 10.1016/j.ejheart.2006.06.001; Fries M, 2008, CRIT CARE MED, V36, P1886, DOI 10.1097/CCM.0b013e31817cede9; Grossini E, 2012, J PHARMACOL EXP THER, V342, P376, DOI 10.1124/jpet.112.193961; Hein M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-106; Huang L, 2005, CRIT CARE MED, V33, P487, DOI 10.1097/01.ccm.0000156241.55872.15; Kelm RF, 2014, CRIT CARE MED, V42, pE410, DOI 10.1097/CCM.0000000000000308; Klein KU, 2013, BRIT J ANAESTH, V110, P266, DOI 10.1093/bja/aes376; Klein KU, 2011, J NEUROSURG ANESTH, V23, P341, DOI 10.1097/ANA.0b013e31822cf893; Klein KU, 2010, J NEUROSURG ANESTH, V22, P38, DOI 10.1097/ANA.0b013e3181bea439; Kopustinskiene DM, 2001, EUR J PHARMACOL, V428, P311, DOI 10.1016/S0014-2999(01)01350-4; Koudouna E, 2007, ACTA ANAESTH SCAND, V51, P1123, DOI 10.1111/j.1399-6576.2007.01383.x; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Morsbach S, 2018, J CHROMATOGR B, V1072, P34, DOI 10.1016/j.jchromb.2017.11.012; Nolan Jerry P, 2009, Int Emerg Nurs, V17, P203, DOI 10.1016/j.ienj.2009.01.001; Oldner A, 2001, CRIT CARE MED, V29, P2185, DOI 10.1097/00003246-200111000-00022; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073758; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; Sommer S, 2016, EUR J CARDIO-THORAC, V49, pe54, DOI 10.1093/ejcts/ezv397; Varvarousi G, 2014, EUR J PHARMACOL, V740, P596, DOI 10.1016/j.ejphar.2014.06.024; Wang CH, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016139; Wu BJ, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0309-3	24	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 9	2021	11	1							14220	10.1038/s41598-021-93621-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TK9QY	WOS:000674491000002	34244561	Green Published, gold			2022-02-07	
J	Hakansson, S; Karlander, M; Larsson, D; Mahamud, Z; Garcia-Ptacek, S; Zelezniak, A; Zelano, J				Hakansson, Samuel; Karlander, Markus; Larsson, David; Mahamud, Zamzam; Garcia-Ptacek, Sara; Zelezniak, Aleksej; Zelano, Johan			Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis	EPILEPSIA			English	Article						big data; comorbidity; epidemiology; personalized medicine	POSTSTROKE SEIZURES; ANTIEPILEPTIC DRUGS; MULTIPLE-SCLEROSIS; EPILEPSY; CARBAMAZEPINE; MEDICINE; LAMOTRIGINE	Objective The first antiseizure medication (ASM) is ineffective or intolerable in 50% of epilepsy cases. Selection between more than 25 available ASMs is guided by epilepsy factors, but also age and comorbidities. Randomized evidence for particular patient subgroups is seldom available. We asked whether register data could be used for retention rate calculations based on demographics, comorbidities, and ASM history, and quantified the potential improvement in retention rates of the first ASM in several large epilepsy cohorts. We also describe retention rates in patients with epilepsy after traumatic brain injury and dementia, patient groups with little available evidence. Methods We used medical, demographic, and drug prescription data from epilepsy cohorts from comprehensive Swedish registers, containing 6380 observations. By analyzing 381 840 prescriptions, we studied retention rates of first- and second-line ASMs for patients with epilepsy in multiple sclerosis (MS), brain infection, dementia, traumatic brain injury, or stroke. The rank of retention rates of ASMs was validated by comparison to published randomized control trials. We identified the optimal stratification for each brain disease, and quantified the potential improvement if all patients had received the optimal ASM. Results Using optimal stratification for each brain disease, the potential improvement in retention rate (percentage points) was MS, 20%; brain infection, 21%; dementia, 14%; trauma, 21%; and stroke, 14%. In epilepsy after trauma, levetiracetam had the highest retention rate at 80% (95% confidence interval [CI] = 65-89), exceeding that of the most commonly prescribed ASM, carbamazepine (p = .04). In epilepsy after dementia, lamotrigine (77%, 95% CI = 68-84) and levetiracetam (74%, 95% CI = 68-79) had higher retention rates than carbamazepine (p = .006 and p = .01, respectively). Significance We conclude that personalized ASM selection could improve retention rates and that national registers have potential as big data sources for personalized medicine in epilepsy.	[Hakansson, Samuel; Larsson, David; Mahamud, Zamzam; Zelano, Johan] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden; [Hakansson, Samuel; Karlander, Markus; Larsson, David; Mahamud, Zamzam; Zelano, Johan] Gothenburg Univ, Sahlgrenska Acad, Dept Clin Neurosci, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hakansson, Samuel; Larsson, David; Mahamud, Zamzam; Zelano, Johan] Gothenburg Univ, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Karlander, Markus] Sodra Alvsborg Hosp, Dept Neurol, Boras, Sweden; [Karlander, Markus] Sodra Alvsborg Hosp, Reg Vastra Gotaland, Dept Res Educ & Innovat, Boras, Sweden; [Garcia-Ptacek, Sara] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden; [Garcia-Ptacek, Sara] Karolinska Univ Hosp, Cognit Clin, Inflammat & Aging Theme, Stockholm, Sweden; [Zelezniak, Aleksej] Chalmers Univ Technol, Div Syst & Synthet Biol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Zelezniak, Aleksej] Sci Life Lab, Stockholm, Sweden		Zelano, J (corresponding author), Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden.	johan.zelano@neuro.gu.se		Zelano, Johan/0000-0001-9445-4545; Hakansson, Samuel/0000-0002-8681-0113; Larsson, David/0000-0002-8334-951X	Swedish Society of Medicine [SLS-881501]; Swedish Society of Medical Research [S18-0040]; Linnea and Josef Carlsson foundation [90_20180321_048]; Promobilia Foundation [18012]; Gothenburg Medical Society [GLS-780651]; Magnus Bergvall Foundation [2017-01990]; Swedish government [ALFGBG-932515]; Swedish county councils, the ALF agreement [ALFGBG-932515]	Swedish Society of Medicine (SLS-881501), Swedish Society of Medical Research (S18-0040), Linnea and Josef Carlsson foundation (90_20180321_048), the Promobilia Foundation (18012), the Gothenburg Medical Society (GLS-780651), the Magnus Bergvall Foundation (2017-01990), and grants from the Swedish state under an agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-932515).	Asadi-Pooya AA, 2020, EPILEPSIA, V61, P1668, DOI 10.1111/epi.16610; Beniczky S, 2021, EPILEPSIA, V62, P220, DOI 10.1111/epi.16763; Bluhmki T, 2017, J CLIN EPIDEMIOL, V82, P103, DOI 10.1016/j.jclinepi.2016.11.001; Brigo F, 2018, SEIZURE-EUR J EPILEP, V61, P57, DOI 10.1016/j.seizure.2018.08.001; Brigo F, 2013, EPILEPSY BEHAV, V27, P439, DOI 10.1016/j.yebeh.2013.03.010; Burman J, 2017, NEUROLOGY, V89, P2462, DOI 10.1212/WNL.0000000000004740; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Consoli D, 2012, CEREBROVASC DIS, V34, P282, DOI 10.1159/000342669; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Devinsky O, 2016, EPILEPSY BEHAV, V56, P32, DOI 10.1016/j.yebeh.2015.12.039; Gao LL, 2020, SELECTIVE INFERENCE; Gilad R, 2007, CLIN NEUROPHARMACOL, V30, P189, DOI 10.1097/WNF.0B013E3180333069; Gleichgerrcht E, 2017, EXPERT REV PRECIS ME, V2, P229, DOI 10.1080/23808993.2017.1364133; Hampel H, 2018, BRAIN, V141, P1917, DOI 10.1093/brain/awy132; Janusinfo, 2020, VID REC; Johansson FD., 2020, NEURIPS, V33, P1333; Karlander M, 2021, J NEUROL NEUROSUR PS, V92, P617, DOI 10.1136/jnnp-2020-325382; Klein JP, 2007, STAT MED, V26, P4505, DOI 10.1002/sim.2864; Larsson D, 2019, SEIZURE-EUR J EPILEP, V64, P29, DOI 10.1016/j.seizure.2018.11.013; MacLehose RF, 2005, EPIDEMIOLOGY, V16, P548, DOI 10.1097/01.ede.0000166500.23446.53; Mahamud Z, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2021.108034; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Mbizvo GK, 2020, EPILEPSIA, V61, P1319, DOI 10.1111/epi.16547; Naimo GD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153717; Perucca Emilio, 2016, Epilepsia Open, V1, P9, DOI 10.1002/epi4.3; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Sisodiya SM, 2021, EPILEPSIA, V62, pS90, DOI 10.1111/epi.16539; Stajduhar I, 2012, EXPERT SYST APPL, V39, P7226, DOI 10.1016/j.eswa.2012.01.054; Striano P., 2018, J TRANSL GENET GENOM, V2, P1; Sveinsson O, 2017, NEUROLOGY, V89, P170, DOI 10.1212/WNL.0000000000004094; Torabian P, 2019, ARCH IRAN MED, V22, P516; Walker LE, 2015, J INTERN MED, V277, P218, DOI 10.1111/joim.12322; Wang P, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3214306; Zelano J, 2020, EUR J NEUROL, V27, P129, DOI 10.1111/ene.14043; Zelano J, 2020, NEUROLOGY, V95, pE3213, DOI 10.1212/WNL.0000000000010954; Zelano J, 2016, EUR STROKE J, V1, P272, DOI 10.1177/2396987316669000	37	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2021	62	9					2123	2132		10.1111/epi.16987		JUL 2021	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UI1MW	WOS:000671478300001	34245010	Green Published, hybrid			2022-02-07	
J	Hoffman, H; Otite, FO; Chin, LS				Hoffman, Haydn; Otite, Fadar O.; Chin, Lawrence S.			Venous Injury in Patients with Blunt Traumatic Brain Injury: Retrospective Analysis of a National Cohort	NEUROCRITICAL CARE			English	Article; Early Access						Sinus thrombosis (intracranial); Brain injuries (traumatic); Trauma (nervous system); Wounds; Nonpenetrating	DEPRESSED SKULL FRACTURE; SUPERIOR SAGITTAL SINUS; INTRACRANIAL HYPERTENSION; HEAD TRAUMA; THROMBOSIS; DIAGNOSIS; OCCLUSION; STENOSIS	Background Cerebral venous injury (CVI) includes injury to a dural venous sinus or major vein and leads to poorer outcomes for patients with blunt traumatic brain injury (TBI). We sought to identify the incidence, associated factors, and outcomes associated with CVI in a large national cohort. Methods Adult patients with blunt TBI were identified from the National Trauma Databank (2013-2017). Outcomes included inpatient mortality, discharge disposition, stroke, length of stay (LOS), intensive care unit LOS, and duration of mechanical ventilation. Multivariate regression models were used to identify the association between exposure variables and CVI, as well as each outcome. Results There were 619,659 patients with blunt TBI who met the inclusion criteria. CVI occurred in 1792 (0.3%) patients. Mixed intracranial injury type had the strongest association with CVI (odds ratio [OR] 2.89, 95% confidence interval [CI] 2.38-3.50), followed by isolated TBI (OR 1.76, 95% CI 1.54-2.02) and skull fracture (OR 1.72, 95% CI 1.55-1.91). CVI was associated with increased odds of mortality (OR 1.38, 95% CI 1.19-1.60), nonroutine discharge (OR 1.26, 95% CI 1.12-1.40), and stroke (OR 1.95, 95% CI 1.33-2.86). It was also associated with longer LOS (beta 2.02, 95% CI 1.55-2.50) and intensive care unit LOS (beta 0.14, 95% CI 0.13-0.16). Among locations of venous injury, superior sagittal sinus injury had significant associations with mortality (OR 2.93, 95% CI 1.62-5.30) and nonroutine discharge disposition (OR 1.94, 95% CI 1.12-3.35), whereas the others did not. Conclusions We identified a 0.3% incidence of CVI in all-comers with blunt TBI as well as several injury-related variables that may be used to guide investigation for dural venous sinus injury. CVI was associated with poorer outcomes, with superior sagittal sinus injury having the strongest association.	[Hoffman, Haydn; Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA; [Otite, Fadar O.] SUNY Upstate Med Univ, Dept Neurol, Syracuse, NY 13210 USA		Hoffman, H (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.	hoffman@upstate.edu		Hoffman, Haydn/0000-0002-2967-6528			Adepoju A, 2017, J NEUROSURG-PEDIATR, V20, P598, DOI 10.3171/2017.6.PEDS16702; Afshari FT, 2018, J CLIN NEUROSCI, V57, P169, DOI 10.1016/j.jocn.2018.08.047; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Benifla M, 2016, J NEUROSURG-PEDIATR, V18, P253, DOI 10.3171/2016.3.PEDS15690; Bokhari R, 2020, WORLD NEUROSURG, V142, P495, DOI 10.1016/j.wneu.2020.06.117; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; Ferro JM, 2017, EUR STROKE J, V2, P195, DOI 10.1177/2396987317719364; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Li HJ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.597623; Li J, 2015, NEUROL INDIA, V63, P881, DOI 10.4103/0028-3886.170067; Lindvall P, 2013, CASE REP NEUROL, V5, P168, DOI 10.1159/000355394; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; MEIER U, 1992, ACTA NEUROCHIR, V119, P91, DOI 10.1007/BF01541788; Qureshi Adnan I, 2020, J Vasc Interv Neurol, V11, P27; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Sheng HS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007055; Vender JR, 2005, J NEUROSURG, V103, P458, DOI 10.3171/ped.2005.103.5.0458; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	21	0	0	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01265-6		JUL 2021	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TG6GD	WOS:000671500100002	34244919				2022-02-07	
J	Nguyen, A; Chow, DSL; Wu, L; Teng, YA; Sarkar, M; Toups, EG; Harrop, JS; Schmitt, KM; Johnson, MM; Guest, JD; Aarabi, B; Shaffrey, CI; Boakye, M; Frankowski, RF; Fehlings, MG; Grossman, RG				Nguyen, Ashley; Chow, Diana S-L; Wu, Lei; Teng, Yang Angela; Sarkar, Mahua; Toups, Elizabeth G.; Harrop, James S.; Schmitt, Karl M.; Johnson, Michele M.; Guest, James D.; Aarabi, Bizhan; Shaffrey, Christopher, I; Boakye, Maxwell; Frankowski, Ralph F.; Fehlings, Michael G.; Grossman, Robert G.			Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						pharmacokinetics; population modeling; riluzole; spinal cord injury	TIME-VARYING CLEARANCE; P-GLYCOPROTEIN; POPULATION PHARMACOKINETICS; ENDOTHELIAL-CELLS; DISPOSITION; MICROCIRCULATION; PHARMACOLOGY; RESISTANCE; BRAIN; MODEL	Riluzole, a benzothiazole sodium channel blocker that received US Food and Drug Administration approval to attenuate neurodegeneration in amyotrophic lateral sclerosis in 1995, was found to be safe and potentially efficacious in a spinal cord injury (SCI) population, as evident in a phase I clinical trial. The acute and progressive nature of traumatic SCI and the complexity of secondary injury processes can alter the pharmacokinetics of therapeutics. A 1-compartment with first-order elimination population pharmacokinetic model for riluzole incorporating time-dependent clearance and volume of distribution was developed from combined data of the phase 1 and the ongoing phase 2/3 trials. This change in therapeutic exposure may lead to a biased estimate of the exposure-response relationship when evaluating therapeutic effects. With the developed model, a rational, optimal dosing scheme can be designed with time-dependent modification that preserves the required therapeutic exposure of riluzole.	[Nguyen, Ashley; Chow, Diana S-L; Wu, Lei; Teng, Yang Angela; Sarkar, Mahua] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth Bldg 2,Room 7051, Houston, TX 77204 USA; [Teng, Yang Angela] Covance, Madison, WI USA; [Toups, Elizabeth G.; Grossman, Robert G.] Houston Methodist Res Inst, Dept Neurosurg, Houston, TX USA; [Harrop, James S.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA USA; [Schmitt, Karl M.; Johnson, Michele M.] Univ Texas Houston, Hlth Sci Ctr, Dept Neurosurg, Houston, TX USA; [Johnson, Michele M.] Atlanta Brain & Spine Care, Atlanta, GA USA; [Guest, James D.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL USA; [Aarabi, Bizhan] Univ Maryland, Dept Neurosurg, Baltimore, MD USA; [Shaffrey, Christopher, I] Univ Virginia, Dept Neurosurg, Hlth Syst, Charlottesville, VA USA; [Shaffrey, Christopher, I] Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC USA; [Boakye, Maxwell] Univ Louisville, Dept Neurosurg, Louisville, KY USA; [Frankowski, Ralph F.] Univ Texas Houston, Div Biostat, Sch Publ Hlth, Houston, TX USA; [Fehlings, Michael G.] Univ Toronto, Toronto Western Hosp, Div Neurosurg & Spine Program, Toronto, ON, Canada		Nguyen, A (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, 4849 Calhoun Rd,Hlth Bldg 2,Room 7051, Houston, TX 77204 USA.	nguyenashley89@gmail.com			US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY [W81XWH-16-C-0031]	This study was supported by US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY under Contract No. W81XWH-16-C-0031.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; An GH, 2020, J CLIN PHARMACOL, V60, P149, DOI 10.1002/jcph.1545; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bruno R, 1997, CLIN PHARMACOL THER, V62, P518, DOI 10.1016/S0009-9236(97)90047-3; Chow DSL, 2012, J NEUROSURG-SPINE, V17, P129, DOI 10.3171/2012.5.AOSPINE12112; Cruz-Antonio L, 2006, J NEUROTRAUM, V23, P75, DOI 10.1089/neu.2006.23.75; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Dulin JN, 2013, J NEUROTRAUM, V30, P211, DOI 10.1089/neu.2012.2587; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; Fehlings MG, 2016, SPINAL CORD, V54, P8, DOI 10.1038/sc.2015.95; Fuentes-Lara G, 1999, J PHARMACOL TOX MET, V42, P93, DOI 10.1016/S1056-8719(00)00048-4; Furlan JC, 2009, SPINE, V34, P501, DOI 10.1097/BRS.0b013e31819712f5; Garcia-Lopez P, 2007, SPINAL CORD, V45, P603, DOI 10.1038/sj.sc.3102001; Gibiansky E, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.42; Guizar-Sahagun G, 2004, J NEUROTRAUM, V21, P1614, DOI 10.1089/0897715042441765; Hijazi Y, 2003, BRIT J ANAESTH, V90, P155, DOI 10.1093/bja/aeg028; Holmes GM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.113009; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lavezo L A, 1995, J Spinal Cord Med, V18, P233; LeLiboux A, 1997, J CLIN PHARMACOL, V37, P820; Liu C, 2017, CLIN PHARMACOL THER, V101, P657, DOI 10.1002/cpt.656; Mestre H, 2011, SPINAL CORD, V49, P955, DOI 10.1038/sc.2011.58; Milane A, 2010, NEUROSCI LETT, V472, P166, DOI 10.1016/j.neulet.2010.01.078; National Spinal Cord Injury Statistical Center, 2020, FACTS FIG GLANC; Qosa H, 2016, GLIA, V64, P1298, DOI 10.1002/glia.23003; Sarkar M, 2017, J PHARMACEUT BIOMED, V146, P334, DOI 10.1016/j.jpba.2017.08.045; SEGAL JL, 1991, J CLIN PHARMACOL, V31, P651, DOI 10.1002/j.1552-4604.1991.tb03751.x; Segal JL, 1997, ARCH PHYS MED REHAB, V78, P44, DOI 10.1016/S0003-9993(97)90008-3; Segal JL, 1998, PHARMACOTHERAPY, V18, P16; SEIFERT J, 1979, PARAPLEGIA, V17, P436, DOI 10.1038/sc.1979.85; Taylor JA, 2018, AUTON NEUROSCI-BASIC, V209, P1, DOI 10.1016/j.autneu.2017.09.015; Vertiz-Hernandez A, 2007, J NEUROTRAUM, V24, P1855, DOI 10.1089/neu.2007.0375; Wilkins JJ, 2019, CPT-PHARMACOMET SYST, V8, P415, DOI 10.1002/psp4.12406; Wurthwein G, 2017, EUR J DRUG METAB PH, V42, P955, DOI 10.1007/s13318-017-0410-5; Young F, 2011, AM J HEALTH-SYST PH, V68, P1607, DOI 10.2146/ajhp100473; Zloza A, 2014, J INTERF CYTOK RES, V34, P915, DOI 10.1089/jir.2013.0155	37	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0091-2700	1552-4604		J CLIN PHARMACOL	J. Clin. Pharmacol.	SEP	2021	61	9					1232	1242		10.1002/jcph.1876		JUL 2021	11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TY6KQ	WOS:000671402900001	33908635	hybrid, Green Published			2022-02-07	
J	Tiba, MH; McCracken, BM; Leander, DC; Mahmood, CIC; Greer, NL; Picton, P; Williamson, CA; Ward, KR				Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Mahmood, Carmen I. Colmenero; Greer, Nicholas L.; Picton, Paul; Williamson, Craig A.; Ward, Kevin R.			Trans-Ocular Brain Impedance Indices Predict Pressure Reactivity Index Changes in a Porcine Model of Hypotension and Cerebral Autoregulation Perturbation	NEUROCRITICAL CARE			English	Article; Early Access						Cerebral autoregulation; Bioimpedance; Pressure reactivity index; Traumatic brain injury	PERFUSION-PRESSURE; CEREBROVASCULAR AUTOREGULATION; BLOOD-FLOW	Background Cerebrovascular autoregulation (CA) is a protective mechanism that enables the cerebral vasculature to automodulate tone in response to changes in cerebral perfusion pressure to ensure constant levels of cerebral blood flow (CBF) and oxygen delivery. CA can be impaired after neurological injury and contributes to secondary brain injury. In this study, we report novel impedance indices using trans-ocular brain impedance (TOBI) during controlled systemic hemorrhage and hypotension to assess CA in comparison with pressure reactivity index (PRx). Methods Yorkshire swine were instrumented to record intracranial pressure (ICP), mean arterial pressure (MAP), and CBF. TOBI was recorded using electrocardiographic electrodes placed on the closed eyelids. Impedance changes (dz) were recorded in response to introducing an alternating current (0.4 mA) through the electrodes. MAP, ICP, and CBF were also measured. Animals were subjected to a controlled hemorrhage to remove 30-40% of each animal's total blood volume over 25-35 min. Hemorrhage was titrated to reach an MAP of approximately 35 mm Hg and end-tidal carbon dioxide above 28 mm Hg. PRx was calculated as a moving Pearson correlation between MAP and ICP. TOBI indices were calculated as the amplitude of the respiratory-induced changes in dz. DZx was calculated as a moving Pearson correlation between dz and MAP. TOBI indices (dz and DZx) were compared with hemodynamic indicators and PRx. Results dz was shown to be highly correlated with MAP, ICP, cerebral perfusion pressure, and CBF (r = - 0.823, - 0.723, - 0.813, and - 0.726), respectively (p < 0.0001). During hemorrhage, cerebral perfusion pressure and CBF had a mean percent decrease (standard deviation) from baseline of - 54.2% (12.5%) and - 28.3% (14.7%), respectively, whereas dz increased by 277% (268%). Receiver operator characteristics and precision-recall curves demonstrated high predictive performance of DZx when compared with PRx with an area under the curve above 0.82 and 0.89 for receiver operator characteristic and precision-recall curves, respectively, with high sensitivity and positive predictive power. Conclusions TOBI indices appear to track changes in PRx and hemodynamics that affect CA during hemorrhage-induced hypotension. TOBI may offer a suitable, less invasive surrogate to PRx for monitoring and assessing CA.	[Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Mahmood, Carmen I. Colmenero; Greer, Nicholas L.; Ward, Kevin R.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Tiba, Mohamad H.; McCracken, Brendan M.; Leander, Danielle C.; Mahmood, Carmen I. Colmenero; Greer, Nicholas L.; Picton, Paul; Williamson, Craig A.; Ward, Kevin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care MCIRCC, Ann Arbor, MI 48109 USA; [Picton, Paul] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol Surg, Ann Arbor, MI USA; [Williamson, Craig A.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Ward, Kevin R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI USA		Tiba, MH (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Tiba, MH (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care MCIRCC, Ann Arbor, MI 48109 USA.	tibam@med.umich.edu		Tiba, Mohamad/0000-0002-6789-7532	Department of DefenseUnited States Department of Defense [W81XWH-18-1-0005]	This study was supported by a grant from the Department of Defense (#W81XWH-18-1-0005).	Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Animals NRCUCftUotGftCaUoL, 2011, GUIDE CARE USE LAB A; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Atkins ER, 2010, CEREBROVASC DIS, V29, P228, DOI 10.1159/000267845; Babu J P, 1990, J Postgrad Med, V36, P57; Bernstein D. P., 2010, J ELECT BIOMP, V1, P2, DOI [10.5617/jeb.51, DOI 10.5617/JEB.51]; Bhuta A C, 1990, J Postgrad Med, V36, P64; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Caldas JR, 2018, INTERACT CARDIOV TH, V26, P494, DOI 10.1093/icvts/ivx357; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Choi S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024259; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Davis J., 2006, PROC 23 INT C MACH L, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Sekhon MS, 2019, CRIT CARE MED, V47, P960, DOI 10.1097/CCM.0000000000003745; Steppan J, 2014, BEST PRACT RES-CLIN, V28, P429, DOI 10.1016/j.bpa.2014.09.002; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Tiba MH, 2021, J CLIN MONIT COMPUT, V35, P1007, DOI 10.1007/s10877-020-00556-1; Tiba MH, 2017, J NEUROTRAUM, V34, P3089, DOI 10.1089/neu.2017.5090; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; van den Brule JMD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4143636; VISSER KR, 1989, ANN BIOMED ENG, V17, P463, DOI 10.1007/BF02368066; Vranken Nousjka P A, 2017, J Extra Corpor Technol, V49, P182	38	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01272-7		JUL 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TG6GD	WOS:000671500100001	34244920				2022-02-07	
J	Bressan, S; Eapen, N; Phillips, N; Gilhotra, Y; Kochar, A; Dalton, S; Cheek, JA; Furyk, J; Neutze, J; Williams, A; Hearps, S; Donath, S; Oakley, E; Singh, S; Dalziel, SR; Borland, ML; Babl, FE				Bressan, Silvia; Eapen, Nitaa; Phillips, Natalie; Gilhotra, Yuri; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Furyk, Jeremy; Neutze, Jocelyn; Williams, Amanda; Hearps, Stephen; Donath, Susan; Oakley, Ed; Singh, Sonia; Dalziel, Stuart R.; Borland, Meredith L.; Babl, Franz E.		Paediat Res Emergency Dept Int Col	PECARN algorithms for minor head trauma: Risk stratification estimates from a prospective PREDICT cohort study	ACADEMIC EMERGENCY MEDICINE			English	Article						child; clinical decision rule; PECARN; traumatic brain injury	COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; RADIATION-EXPOSURE; UNITED-STATES; CHILDREN; ASSOCIATION; CANCER; CT	Background: The Pediatric Emergency Care Applied Research Network (PECARN) head trauma clinical decision rules informed the development of algorithms that risk stratify the management of children based on their risk of clinically important traumatic brain injury (ciTBI). We aimed to determine the rate of ciTBI for each PECARN algorithm risk group in an external cohort of patients and that of ciTBI associated with different combinations of high- or intermediate-risk predictors. Methods: This study was a secondary analysis of a large multicenter prospective data set, including patients with Glasgow Coma Scale scores of 14 or 15 conducted in Australia and New Zealand. We calculated ciTBI rates with 95% confidence intervals (as) for each PECARN risk category and combinations of related predictor variables. Results: Of the 15,163 included children, 4,011 (25.5%) were aged <2 years. The frequency of ciTBI was 8.5% (95% CI = 6.0%41.6%), 0.2% (95% CI = 0.0%-0.6%), and 0.0% (95% CI = 0.0%-0.2%) in the high-, intermediate-, and very-low-risk groups, respectively, for children <2 years and 5.7% (95% CI = 4.4%-7.2%), 0.7% (95% Cl = 0.5%1.0%), and 0.0% (95% CI = 0.0%-0.1%) in older children. The isolated high-risk predictor with the highest risk of ciTBI was "signs of palpable skull fracture" for younger children (11.4%, 95% CI = 5.3%-20.5%) and "signs of basilar skull fracture" in children >= 2 years (11.1%, 95% CI = 3.7%-24.1%). For older children in the intermediate-risk category, the presence of all four predictors had the highest risk of ciTBI (25.0%, 95% CI = 0.6%-80.6%) followed by the combination of "severe mechanism of injury" and "severe headache" (7.7%, 95% CI = 0.2%-36.0%). The very few children <2 years at intermediate risk with ciTBI precluded further analysis. Conclusions: The risk estimates of ciTBI for each of the PECARN algorithms risk group were consistent with the original PECARN study. The risk estimates of ciTBI within the high- and intermediate-risk predictors will help further refine clinical judgment and decision making on neuroimaging.	[Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Bressan, Silvia; Eapen, Nitaa; Cheek, John A.; Williams, Amanda; Hearps, Stephen; Donath, Susan; Oakley, Ed; Singh, Sonia; Babl, Franz E.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Eapen, Nitaa; Cheek, John A.; Donath, Susan; Oakley, Ed; Singh, Sonia; Babl, Franz E.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Eapen, Nitaa; Cheek, John A.; Donath, Susan; Oakley, Ed; Singh, Sonia; Babl, Franz E.] Univ Melbourne, Ctr Integrated Crit Care, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Phillips, Natalie; Gilhotra, Yuri] Queensland Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.; Oakley, Ed; Singh, Sonia; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Melbourne, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Furyk, Jeremy] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Furyk, Jeremy] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Singh, Sonia] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Child & Youth Hlth, Auckland, New Zealand; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Res, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au		Hearps, Stephen/0000-0003-2984-1172	National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1771228]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Melbourne Campus Clinician Scientist fellowship, Melbourne, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]; Cure Kids New Zealand	This study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1771228), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by an NHMRC Practitioner Fellowship, Canberra, Australia and a Melbourne Campus Clinician Scientist fellowship, Melbourne, Australia. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556) and Cure Kids New Zealand.	Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Borland ML, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3123; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bressan S, 2019, ARCH DIS CHILD, V104, P664, DOI 10.1136/archdischild-2018-316066; Centers for Disease Control and Prevention website, 2014, TRAUMATIC BRAIN INJU; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Homme JL, 2018, EMERG MED CLIN N AM, V36, P287, DOI 10.1016/j.emc.2017.12.015; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Wilson CL, 2020, EMERG MED J, V37, P686, DOI 10.1136/emermed-2020-209719	25	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2021	28	10					1124	1133		10.1111/acem.14308		JUL 2021	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WM1WO	WOS:000673610700001	34236116				2022-02-07	
J	Dagod, G; Roustan, JP; Bringuier-Branchereau, S; Ridolfo, JM; Martinez, O; Capdevila, X; Charbit, J				Dagod, Geoffrey; Roustan, Jean-Paul; Bringuier-Branchereau, Sophie; Ridolfo, Jerome; Martinez, Orianne; Capdevila, Xavier; Charbit, Jonathan			Effect of a temporary lying position on cerebral hemodynamic and cerebral oxygenation parameters in patients with severe brain trauma	ACTA NEUROCHIRURGICA			English	Article						Brain trauma injury; Lying position; Cerebral oxygenation; Cerebral hemodynamics; Cerebral autoregulation; Cerebral ischemia	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; BLOOD-FLOW; BODY POSITION; REACTIVITY; AUTOREGULATION; EPIDEMIOLOGY; MANAGEMENT; ELEVATION	Background Temporary transition from the half-seated position (HSP) to the lying position (LyP) is often associated with an increase in intracranial pressure (ICP) during management of patients with severe traumatic brain injury (TBI). This study was designed to assess the impact of the temporary LyP on cerebral perfusion and oxygenation in cases of severe TBI. Method Patients with a severe blunt TBI with indication of ICP monitoring were prospectively included. Patients underwent standardized management according to the international guidelines to minimize secondary insults. For each patient, a maneuver to a LyP for 30 min was performed daily during the first 7 days of hospitalization. ICP, cerebral perfusion pressure (CPP), mean velocity (V-m), pulsatility index (PI), regional cerebral oxygen saturation (rScO(2)), jugular venous oxygen saturation (SvjO(2))) were compared in the HSP and the LyP. Results Twenty-four 24 patients were included. The median Glasgow coma scale score was 6 (interquartile range (IQR), 3-8), the median injury severity score was 32 (IQR, 25-48), and the mean age was 39 +/- 16 years. On day 1, ICP (+ 6 mmHg (IQR, 4-7 mmHg)) and CPP (+ 10 mmHg (IQR, 5-14 mmHg) were significantly increased in the LyP compared with the HSP. V-m increased significantly in the LyP on the mainly injured side (+ 6 cm/s (IQR, + 0-11 cm/s); P = 0.01) and on the less injured side (+ 4 cm/s (IQR, + 1-8 cm/s); P < 0.01). rScO(2) behaved similarly (+ 2 points (IQR, + 2-4 points) and + 3 points (IQR, + 2-5 points), respectively; P < 0.001). Mixed models highlighted the significant association between the position and CPP, V-m, rScO(2), with more favorable conditions in the lying position. Conclusions Within the first week of management, the temporary LyP in cases of severe TBI was associated with a moderate increase in CPP, V-m, and rScO(2)despite a moderate increase in ICP.	[Dagod, Geoffrey; Roustan, Jean-Paul; Bringuier-Branchereau, Sophie; Ridolfo, Jerome; Martinez, Orianne; Capdevila, Xavier; Charbit, Jonathan] Lapeyronie Univ Hosp, Trauma Intens & Crit Care Unit, 371 Ave Doyen G Giraud, F-34295 Montpellier, France; [Dagod, Geoffrey; Roustan, Jean-Paul; Martinez, Orianne; Capdevila, Xavier; Charbit, Jonathan] OcciTRAUMA Network, Reg Network Med Org & Management Severe Trauma Oc, Montpellier, France		Dagod, G (corresponding author), Lapeyronie Univ Hosp, Trauma Intens & Crit Care Unit, 371 Ave Doyen G Giraud, F-34295 Montpellier, France.; Dagod, G (corresponding author), OcciTRAUMA Network, Reg Network Med Org & Management Severe Trauma Oc, Montpellier, France.	g-dagod@chu-montpellier.fr					Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BUTLER GC, 1990, AVIAT SPACE ENVIR MD, V61, P240; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; deDeyne C, 1996, ACTA NEUROCHIR, V138, P1409, DOI 10.1007/BF01411119; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Juhler M, 2020, CHANGES INTRACRANIAL; KENNING JA, 1981, SURG NEUROL, V15, P148, DOI 10.1016/0090-3019(81)90037-9; Kosty JA, 2013, ANESTH ANALG, V117, P694, DOI 10.1213/ANE.0b013e31829cc765; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; MIYAMOTO Y, 1982, JPN J PHYSIOL, V32, P245; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Olavarria VV, 2014, CEREBROVASC DIS, V37, P401, DOI 10.1159/000362533; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Reinstrup P, 2019, ACTA NEUROCHIR, V161, P635, DOI 10.1007/s00701-019-03856-x; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Winkelman C, 2000, Am J Crit Care, V9, P373	37	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2021	163	9					2595	2602		10.1007/s00701-021-04851-x		JUL 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TZ1IL	WOS:000672409700003	34236525				2022-02-07	
J	Mills, GN; Raskin, SA; DiMario, FJ				Mills, Ginger N.; Raskin, Sarah A.; DiMario, Francis J.			Remembering to remember: prospective memory in children with epilepsy	CHILD NEUROPSYCHOLOGY			English	Article						Neuropsychology; epilepsy; prospective memory; assessment	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; COGNITIVE-DEVELOPMENT; NEW-ONSET; SCHOOLCHILDREN; DISORDERS; ATTENTION	Prospective memory, the ability to remember to perform an intended act in the future, is a complex process that involves several stages and cognitive domains. This study sought to investigate prospective memory functioning in children with idiopathic epilepsy using tasks from the Rivermead Behavioral Memory Test for Children (RBMT-C) and the Memory for Intentions Screening Test for Youth (MISTY). Performances on prospective memory task characteristics of the MISTY (i.e., cue-type, length of time delay, and response type) were also compared between and across participant groups. Healthy children (N = 26) were found to have higher overall IQ and verbal IQ scores when compared to children with epilepsy (N = 19). Group differences in prospective memory functioning were found in subtests of the RBMT-C but not on the MISTY. Lastly, while there was no significant interaction effect between the groups and MISTY task characteristics, main effects were found across participant groups; all participants performed better on event-based tasks when compared to time-based tasks and on two-minute when compared to 10-minute time delays. Overall, findings suggest potential differences in cognitive functioning, particularly in IQ and prospective memory, in children with idiopathic epilepsy, though due to differences in findings across prospective memory tasks, further research is warranted to more definitively ascertain the extent, if any, of prospective memory deficits in children with epilepsy.	[Mills, Ginger N.] Univ Hartford, Dept Psychol, Hartford, CT 06117 USA; [Raskin, Sarah A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Raskin, Sarah A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [DiMario, Francis J.] Connecticut Childrens Med Ctr, Dept Neurol, Hartford, CT USA		Mills, GN (corresponding author), Univ Hartford, Dept Psychol, Hartford, CT 06117 USA.	ginger.mills@hhchealth.org		Raskin, Sarah/0000-0002-4310-4278			Aldenkamp A, 2016, EPILEPTIC DISORD, V18, pS55, DOI 10.1684/epd.2016.0817; Aldrich, 1991, RIVERMEADBEHAVIOURAL; Bhise VV, 2010, DEV MED CHILD NEUROL, V52, P22, DOI 10.1111/j.1469-8749.2009.03404.x; Bosa, 2015, PSYCHOL NEUROSCI, V8, P211, DOI [10.1037/h0101059, DOI 10.1037/H0101059]; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; de Lima AB, 2014, ARQ NEURO-PSIQUIAT, V72, P954, DOI 10.1590/0004-282X20140191; Einstein, 2008, PROSPECTIVE MEMORY C, P283; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Fastenau PS, 2008, J LEARN DISABIL-US, V41, P195, DOI 10.1177/0022219408317548; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Henkin Y, 2005, DEV MED CHILD NEUROL, V47, P126, DOI 10.1017/S0012162205000228; Holmes GL, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.00504.x; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Kellermann TS, 2015, CORTEX, V66, P1, DOI 10.1016/j.cortex.2015.02.001; Kliegel M, 2013, J EXP CHILD PSYCHOL, V116, P792, DOI 10.1016/j.jecp.2013.07.012; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; Mills GN, 2021, CLIN NEUROPSYCHOL, V35, P643, DOI 10.1080/13854046.2019.1711198; NAUGLE RI, 1993, PSYCHOL ASSESS, V5, DOI DOI 10.1037/1040-3590.5.2.182; Northcott E, 2005, EPILEPSIA, V46, P924, DOI 10.1111/j.1528-1167.2005.62304.x; O'Muircheartaigh J, 2012, CORTEX, V48, P144, DOI 10.1016/j.cortex.2011.11.012; PARKER LD, 1993, MEAS EVAL COUNS DEV, V26, P152; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Raskin S., 2010, MEMORY INTENTIONS TE; Rathouz PJ, 2014, DEV MED CHILD NEUROL, V56, P635, DOI 10.1111/dmcn.12432; Sheppard DP, 2018, CLIN NEUROPSYCHOL, V32, P748, DOI 10.1080/13854046.2018.1435823; Talbot KDS, 2018, CLIN NEUROPSYCHOL, V32, P783, DOI 10.1080/13854046.2017.1393563; Tang ZH, 2014, EPILEPSY BEHAV, V31, P15, DOI 10.1016/j.yebeh.2013.10.028; Voigt B, 2011, Z PSYCHOL, V219, P92, DOI 10.1027/2151-2604/a000053; Wandschneider B, 2012, EPILEPSIA, V53, P2091, DOI 10.1111/epi.12003; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; WILSON BA, 1993, J CLIN EXP NEUROPSYC, V15, P474, DOI 10.1080/01688639308402572; Yang TX, 2011, NEUROPSYCHOLOGY, V25, P342, DOI 10.1037/a0022239; Zilli T, 2015, J CLIN EXP NEUROPSYC, V37, P1036, DOI 10.1080/13803395.2015.1076380	36	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2022	28	1					14	29		10.1080/09297049.2021.1944615		JUL 2021	16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XJ1QK	WOS:000670820800001	34236944				2022-02-07	
J	Wei, WF; Rasu, RS; Hernandez-Munoz, JJ; Flores, RJ; Rianon, NJ; Hernandez-Vizcarrondo, GA; Brown, AT				Wei, Wenfei; Rasu, Rafia S.; Hernandez-Munoz, Jose J.; Flores, Renee J.; Rianon, Nahid J.; Hernandez-Vizcarrondo, Genesis A.; Brown, Adam T.			Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis	DRUGS & AGING			English	Article							TRAUMATIC BRAIN-INJURY; VITAMIN-K ANTAGONISM; LOW-DOSE ASPIRIN; ELDERLY-PATIENTS; INTRACRANIAL HEMORRHAGE; STROKE PREVENTION; COST-EFFECTIVENESS; ANTITHROMBOTIC THERAPY; SUBGROUP ANALYSIS; ISCHEMIC-STROKE	Background and Objective The decision to initiate anticoagulation in older adults with atrial fibrillation is complicated by the benefit of ischemic stroke prevention vs the risk of falls resulting in major bleeds. The objective of this study was to assess the impact of different treatments including direct oral anticoagulants on quality-adjusted life-years (QALYs) in patients aged 75 years and older with atrial fibrillation in the context of falls. Methods A Markov decision process was constructed for older patients with atrial fibrillation taking no anti-thrombotic, aspirin, warfarin, rivaroxaban, and apixaban. Input probabilities for clinical events were estimated from the available literature. One-way and two-way sensitivity analyses were performed by measuring the impact of varying input probabilities of clinical events on QALY outcomes. Results The base-case scenario estimated that older adults treated with no anti-thrombotic, aspirin, warfarin, rivaroxaban, and apixaban had QALYs of 8.03, 8.69, 10.38, 11.02, and 11.56, respectively. The sensitivity analysis estimated that an older adult would need to fall over 45 (rivaroxaban) and 458 (apixaban) times per year for the QALY of a direct oral anticoagulant to be lower than that of aspirin. Conclusions Older adults with atrial fibrillation benefit from stroke protection of anticoagulants, especially direct oral anticoagulants, even if they are at high risk of falls. Clinicians should not consider fall risk as a deciding factor for withholding anticoagulation in this population of patients.	[Wei, Wenfei; Hernandez-Munoz, Jose J.; Brown, Adam T.] Texas A&M Univ, Coll Pharm, College Stn, TX 77843 USA; [Rasu, Rafia S.] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Coll Pharm, Ft Worth, TX USA; [Hernandez-Munoz, Jose J.] Texas A&M Univ, Dept Pharmaceut Sci, College Stn, TX USA; [Flores, Renee J.; Rianon, Nahid J.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Geriatr & Palliat Med, Houston, TX 77030 USA; [Rianon, Nahid J.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Family & Community Med, Houston, TX 77030 USA; [Hernandez-Vizcarrondo, Genesis A.] Texas A&M Univ, College Stn, TX USA; [Brown, Adam T.] Texas A&M Univ, Dept Pharm Practice, College Stn, TX USA		Wei, WF (corresponding author), Texas A&M Univ, Coll Pharm, College Stn, TX 77843 USA.	wenfeiwei@gmail.com	Munoz, Jose J Hernandez/L-9879-2018	Munoz, Jose J Hernandez/0000-0002-2553-3159; Wei, Wenfei/0000-0003-3518-0171	Texas A&M University College of Pharmacy	Texas A&M University College of Pharmacy provided the analytic software (500). No sources of funding were received for the conduct of this study or the preparation of this article.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Anderson LK, 2020, APPL NURS RES, V51, DOI 10.1016/j.apnr.2019.151190; Bahri O, 2015, J AM GERIATR SOC, V63, P71, DOI 10.1111/jgs.13200; Chan YH, 2019, CHEST, V156, P529, DOI 10.1016/j.chest.2019.04.108; Close JCT, 2003, EMERG MED J, V20, P421, DOI 10.1136/emj.20.5.421; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; de Wit K, 2020, J AM GERIATR SOC, V68, P970, DOI 10.1111/jgs.16338; Donze J, 2012, AM J MED, V125, P773, DOI 10.1016/j.amjmed.2012.01.033; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Ekerstad N, 2018, CLIN INTERV AGING, V13, P749, DOI 10.2147/CIA.S159373; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fang MC, 2012, STROKE, V43, P1795, DOI 10.1161/STROKEAHA.111.630731; Franklin M, 2020, AGE AGEING, V49, P57, DOI 10.1093/ageing/afz125; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Garwood CL, 2008, ANN PHARMACOTHER, V42, P523, DOI 10.1345/aph.1K498; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gross CP, 2003, CLIN THER, V25, P1750, DOI 10.1016/S0149-2918(03)80167-4; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Janakiraman B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221875; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Johansson C, 2014, SCAND J PRIM HEALTH, V32, P226, DOI 10.3109/02813432.2014.984952; Kalula SZ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0212-7; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; Luderitz B, 2000, ARCH INTERN MED, V160, P1749, DOI 10.1001/archinte.160.12.1749; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Ng KH, 2016, AGE AGEING, V45, P77, DOI 10.1093/ageing/afv156; O'Brien CL, 2005, JAMA-J AM MED ASSOC, V293, P699, DOI 10.1001/jama.293.6.699; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng SY, 2018, CURR MED RES OPIN, V34, P55, DOI 10.1080/03007995.2017.1375470; Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097; Puymirat E, 2013, PRESSE MED, V42, P1432, DOI 10.1016/j.lpm.2013.04.010; Rangaraju S, 2017, INTERV NEUROL, V6, P36, DOI 10.1159/000452634; Rao MP, 2018, AM J MED, V131, P269, DOI 10.1016/j.amjmed.2017.10.036; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Seelig J, 2020, THROMB J, V18, DOI 10.1186/s12959-020-00218-x; Sellers MB, 2011, AM HEART J, V161, P241, DOI 10.1016/j.ahj.2010.11.002; Shah SJ, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.006212; Sherwood MW, 2015, J AM COLL CARDIOL, V66, P2271, DOI 10.1016/j.jacc.2015.09.024; Smith AD, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.0671.2754; Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107; Stephen S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4634-8; Sullivan PW, 2006, PHARMACOECONOMICS, V24, P1021, DOI 10.2165/00019053-200624100-00009; Thein PM, 2019, INTERN MED J, V49, P969, DOI 10.1111/imj.14236; Zhao YJ, 2016, INT J CARDIOL, V220, P794, DOI 10.1016/j.ijcard.2016.06.087	60	0	0	1	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1170-229X	1179-1969		DRUG AGING	Drugs Aging	AUG	2021	38	8					713	723		10.1007/s40266-021-00870-6		JUL 2021	11	Geriatrics & Gerontology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Pharmacology & Pharmacy	TV5CY	WOS:000670730500001	34235644				2022-02-07	
J	Yang, H; Ye, CY; Liu, XC; Sun, LX; Wang, AQ; Wang, J; Hu, NT; Hu, XH; Gosseries, O; Laureys, S; Di, HB; Fang, JQ				Yang, Hao; Ye, Chengyin; Liu, Xiaochen; Sun, Lingxiu; Wang, Anqi; Wang, Jing; Hu, Nantu; Hu, Xiaohua; Gosseries, Olivia; Laureys, Steven; Di, Haibo; Fang, Jiqian			Estimating the Minimal Number of Repeated Examinations for Random Responsiveness With the Coma Recovery Scale-Revised as an Example	FRONTIERS IN INTEGRATIVE NEUROSCIENCE			English	Article						repeated examinations; random responsiveness; diagnosis; Coma Recovery Scale-Revised; disorders of consciousness; minimally conscious state	CONSCIOUSNESS; DISORDERS	Objective: The aim of this study was to develop a general method to estimate the minimal number of repeated examinations needed to detect patients with random responsiveness, given a limited rate of missed diagnosis. Methods: Basic statistical theory was applied to develop the method. As an application, 100 patients with disorders of consciousness (DOC) were assessed with the Coma Recovery Scale-Revised (CRS-R). DOC patients were supposed to be examined for 13 times over 20 days, while anyone who was diagnosed as a minimally conscious state (MCS) in a round would no longer be examined in the subsequent rounds. To test the validation of this method, a series of the stochastic simulation was completed by computer software under all the conditions of possible combinations of three kinds of distributions for p, five values of p, and four sizes of the sample and repeated for 100 times. Results: A series of formula was developed to estimate the probability of a positive response to a single examination given by a patient and the minimal number of successive examinations needed based on the numbers of patients detected in the first i (i =1, 2,.) rounds of repeated examinations. As applied to the DOC patients assessed with the CRS-R, with a rate of missed diagnosis < 0.0001, the estimate of the minimal number of examinations was six in traumatic brain injury patients and five in non-traumatic brain injury patients. The outcome of the simulation showed that this method performed well under various conditions possibly occurring in practice. Interpretation: The method developed in this paper holds in theory and works well in application and stochastic simulation. It could be applied to any other kind of examinations for random responsiveness, not limited to CRS-R for detecting MCS; this should be validated in further research.	[Yang, Hao; Liu, Xiaochen; Sun, Lingxiu; Wang, Anqi; Wang, Jing; Hu, Nantu; Di, Haibo] Hangzhou Normal Univ, Int Unrespons Wakefulness Syndrome & Consciousnes, Hangzhou, Zhejiang, Peoples R China; [Ye, Chengyin] Hangzhou Normal Univ, Sch Publ Hlth, Dept Hlth Management, Hangzhou, Zhejiang, Peoples R China; [Hu, Xiaohua] Hangzhou Wujing Hosp, Hangzhou, Zhejiang, Peoples R China; [Gosseries, Olivia; Laureys, Steven] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Gosseries, Olivia; Laureys, Steven] Univ Liege, Ctr Cerveau, Liege, Belgium; [Gosseries, Olivia; Laureys, Steven] Univ Hosp Liege, Liege, Belgium; [Fang, Jiqian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China		Di, HB (corresponding author), Hangzhou Normal Univ, Int Unrespons Wakefulness Syndrome & Consciousnes, Hangzhou, Zhejiang, Peoples R China.; Fang, JQ (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	dihaibo19@aliyun.com; fangjq@mail.sysu.edu.cn		Wang, Jing/0000-0003-2445-4966	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81920108023]; Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; Generet fund & King Baudouin Foundation; European UnionEuropean Commission [945539]	This study was supported by the National Natural Science Foundation of China (81920108023), the Belgian National Funds for Scientific Research (FRS-FNRS), the Generet fund & King Baudouin Foundation, and the European Union's Horizon 2020 Framework Programme for Research and Innovation [Grant agreement No. 945539 (Human Brain Project SGA3)]. OG was research associate and SL was research director at FRS-FNRS.	Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; SAZBON L, 1991, ACTA NEUROCHIR, V112, P110, DOI 10.1007/BF01405137; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wang FY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0330-7; Wang J, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01924-9; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	15	0	0	3	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5145			FRONT INTEGR NEUROSC	Front. Integr. Neurosci.	JUL 8	2021	15								685627	10.3389/fnint.2021.685627			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TM4YD	WOS:000675555600001	34305542	gold, Green Published			2022-02-07	
J	Baud, C; Crulli, B; Evain, JN; Isola, C; Wroblewski, I; Bouzat, P; Mortamet, G				Baud, Caroline; Crulli, Benjamin; Evain, Jean-Noel; Isola, Clement; Wroblewski, Isabelle; Bouzat, Pierre; Mortamet, Guillaume			Traumatic brain injury in children with thoracic injury: clinical significance and impact on ventilatory management	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Chest trauma; Mechanical ventilation; Pulmonary contusion; Traumatic brain injury; Children	CHEST TRAUMA; SEVERITY; SCORE	Purpose This study aims to describe the epidemiology and management of chest trauma in our center, and to compare patterns of mechanical ventilation in patients with or without associated moderate-to-severe traumatic brain injury (TBI). Methods All children admitted to our level-1 trauma center from February 2012 to December 2018 following chest trauma were included in this retrospective study. Results A total of 75 patients with a median age of 11 [6-13] years, with thoracic injuries were included. Most patients also had extra-thoracic injuries (n = 71, 95%) and 59 (79%) had TBI. A total of 52 patients (69%) were admitted to intensive care and 31 (41%) were mechanically ventilated. In patients requiring mechanical ventilation, there was no difference in tidal volume or positive end-expiratory pressure in patients with moderate-to-severe TBI when compared with those with no-or-mild TBI. Only one patient developed Acute Respiratory Distress Syndrome. A total of 6 patients (8%) died and all had moderate-to-severe TBI. Conclusion In this small retrospective series, most patients requiring mechanical ventilation following chest trauma had associated moderate-to-severe TBI. Mechanical ventilation to manage TBI does not seem to be associated with more acute respiratory distress syndrome occurrence.	[Baud, Caroline; Isola, Clement; Wroblewski, Isabelle; Mortamet, Guillaume] Grenoble Alpes Univ Hosp, Pediat Intens Care Unit, La Tronche, France; [Crulli, Benjamin] Great Ormond St Hosp Sick Children, Pediat Intens Care Unit, London, England; [Evain, Jean-Noel; Bouzat, Pierre] Grenoble Alps Univ Hosp, Dept Anesthesiol & Crit Care, La Tronche, France		Mortamet, G (corresponding author), Grenoble Alpes Univ Hosp, Pediat Intens Care Unit, La Tronche, France.	gmortamet@chu-grenoble.fr					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Black TL, 1996, SOUTHERN MED J, V89, P494, DOI 10.1097/00007611-199605000-00009; Bliss D, 2002, CRIT CARE MED, V30, pS409, DOI 10.1097/00003246-200211001-00005; Bouzat P, 2017, ANAESTH CRIT CARE PA, V36, P135, DOI 10.1016/j.accpm.2017.01.003; Cooper N K, 1994, J R Coll Surg Edinb, V39, P133; de Roulet A, 2019, J PEDIATR SURG, V54, P1405, DOI 10.1016/j.jpedsurg.2018.07.005; de Roulet Amory, 2017, J Trauma Acute Care Surg, V82, P781, DOI [10.1097/TA.0000000000001358, 10.1097/ta.0000000000001358]; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Killien EY, 2020, CRIT CARE MED, V48, pE26, DOI 10.1097/CCM.0000000000004075; Killien EY, 2019, J TRAUMA ACUTE CARE, V86, P844, DOI 10.1097/TA.0000000000002202; Medar SS, 2021, J INTENSIVE CARE MED, V36, P107, DOI 10.1177/0885066619887666; Mollberg NM, 2014, J TRAUMA ACUTE CARE, V76, P273, DOI 10.1097/TA.0000000000000090; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Pearson EG, 2017, SEMIN PEDIATR SURG, V26, P36, DOI 10.1053/j.sempedsurg.2017.01.007; PECLET MH, 1990, J PEDIATR SURG, V25, P961, DOI 10.1016/0022-3468(90)90238-5; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Skinner DL, 2015, SAMJ S AFR MED J, V105, P47, DOI 10.7196/SAMJ.8499; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Tovar JA, 2013, PAEDIATR RESPIR REV, V14, P86, DOI 10.1016/j.prrv.2013.02.011; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI [10.2471/BLT.07.045120, 10.1371/journal.pmed.0040296]; Weerdenburg KD, 2019, PEDIATR EMERG CARE, V35, P330, DOI 10.1097/PEC.0000000000001129; World Health Organization, 2004, WORLD REPORT CHILD I	25	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	OCT	2021	37	10					1421	1428		10.1007/s00383-021-04959-2		JUL 2021	8	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	UL1BH	WOS:000671915000001	34232362	Bronze, Green Published			2022-02-07	
J	Daneva, E; Makris, K; Korompeli, A; Muurlink, O; Kaklamanos, I; Fildissis, G; Vlachos, K; Myrianthefs, P				Daneva, Eleni; Makris, Konstantinos; Korompeli, Anna; Muurlink, Olav; Kaklamanos, Ioannis; Fildissis, George; Vlachos, Konstantinos; Myrianthefs, Pavlos			Saliva cortisol levels and physiological parameter fluctuations in mild traumatic brain injury patients compared to controls	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Early Access						Body temperature; blood pressure; fluctuations; heart rate; saliva cortisol levels; traumatic brain injury	CIRCADIAN-RHYTHM; SERUM; DISTURBANCE; CARE	Background: Evidence suggests that fluctuations of cortisol and physiological parameters can emerge during the course of mild Traumatic Brain Injury (mTBI). Objective: To investigate fluctuations of cortisol and physiological parametersduring the acute phase of mTBI in hospitalized patients. Methods: 30 participants (19 patients with mTBI and 11 controls) were examined for saliva cortisol dynamics, heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP) and body temperature (BT) fluctuations for four consecutive days. Also, the participants completed the Athens Insomnia Scale and Epworth Sleepiness Scales, in order to check for sleep problems. Results: Patients showed elevated levels of cortisol relative to controls (peak at 8 am and lowest levels at 12 am), as well as for most physiological parameters. MAP was significantly higher for patients throughout the measurement period, and BT was elevated for patients relative to controls at almost all measurements of the first and second day. Mean HR tended to track at non-significantly higher levels for the mTBI group. Patients' sleepiness and insomnia values (ESS and AIS) were initially significantly higher relative to controls but the difference dissipated by day 4. Conclusion: The increase in absolute values of cortisol and physiological parameters measurements, indicates that in the acute phase of mTBI, a stressful process is activated which may affect sleep quality as well. Supplemental data for this article is available online at at doi: 10.1080/00207454.2021.1951264.	[Daneva, Eleni; Vlachos, Konstantinos] KAT Gen Hosp, Athens, Greece; [Makris, Konstantinos] KAT Gen Hosp, Clin Biochem Dept, Athens, Greece; [Korompeli, Anna; Kaklamanos, Ioannis; Fildissis, George; Myrianthefs, Pavlos] Natl & Kapodistrian Univ Athens, AgioiAnargyroi Gen Hosp, Sch Hlth Sci, Dept Nursing, Athens, Greece; [Korompeli, Anna; Kaklamanos, Ioannis; Fildissis, George; Myrianthefs, Pavlos] Noufaron & Timiou Stavrou, Athens, Greece; [Muurlink, Olav] Cent Queensland Univ, Griffith Inst Educ Res, Brisbane, Qld, Australia		Korompeli, A (corresponding author), Notou 12, Athens 15342, Greece.	akorompe@nurs.uoa.gr	Makris, Konstantinos/E-6946-2013	Makris, Konstantinos/0000-0002-7896-9028; Korompeli, Anna/0000-0002-4963-9409; Muurlink, Olav/0000-0002-8251-9521; Vlachos, Konstantinos/0000-0003-2794-1065			Analytics M Analytics FM Number AC., 2017, CORTISOL 2, P1; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Bensalah M, 2018, CLIN ENDOCRINOL, V88, P627, DOI 10.1111/cen.13562; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; El-Farhan N, 2017, ANN CLIN BIOCHEM, V54, P308, DOI 10.1177/0004563216687335; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Korompeli A, 2019, NURS CRIT CARE, V24, P320, DOI 10.1111/nicc.12433; Kyrou I., 2000, ENDOTEXT; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MOTOHASHI Y, 1987, ERGONOMICS, V30, P1235, DOI 10.1080/00140138708966019; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pattoneri Paolo, 1800, J Clin Hypertens (Greenwich), V7, P734, DOI 10.1111/j.1524-6175.2005.04780.x; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Poll EM, 2007, CLIN CHIM ACTA, V382, P15, DOI 10.1016/j.cca.2007.03.009; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; St Korompeli A, 2016, CHRONOBIOL INT, V33, P124, DOI 10.3109/07420528.2015.1113985; Turpeinen U, 2013, BEST PRACT RES CL EN, V27, P795, DOI 10.1016/j.beem.2013.10.008; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Yaneva M, 2009, CENT EUR J MED, V4, P59, DOI 10.2478/s11536-009-0004-y; Zhanfeng Niu, 2019, World Neurosurg, V130, pe475, DOI 10.1016/j.wneu.2019.06.122	29	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.												10.1080/00207454.2021.1951264		JUL 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL8DX	WOS:000675087300001	34228947				2022-02-07	
J	Foreman, B; Lee, H; Mizrahi, MA; Hartings, JA; Ngwenya, LB; Privitera, M; Tortella, FC; Zhang, NH; Kramer, JH				Foreman, Brandon; Lee, Hyunjo; Mizrahi, Moshe A.; Hartings, Jed A.; Ngwenya, Laura B.; Privitera, Michael; Tortella, Frank C.; Zhang, Nanhua; Kramer, Joel H.			Seizures and Cognitive Outcome After Traumatic Brain Injury: A Post Hoc Analysis	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Continuous electroencephalography; Neurocritical care; Cognition; Outcome	NONCONVULSIVE SEIZURES; IMPAIRMENT; HEMORRHAGE; GUIDELINES; TERMINOLOGY; PERFORMANCE; MANAGEMENT; PHENYTOIN; DAMAGE; RBANS	Introduction Seizures and abnormal periodic or rhythmic patterns are observed on continuous electroencephalography monitoring (cEEG) in up to half of patients hospitalized with moderate to severe traumatic brain injury (TBI). We aimed to determine the impact of seizures and abnormal periodic or rhythmic patterns on cognitive outcome 3 months following moderate to severe TBI. Methods This was a post hoc analysis of the multicenter randomized controlled phase 2 INTREPID2566 clinical trial conducted from 2010 to 2016 across 20 United States Level I trauma centers. Patients with nonpenetrating TBI and postresuscitation Glasgow Coma Scale scores 4-12 were included. Bedside cEEG was initiated per protocol on admission to intensive care, and the burden of ictal-interictal continuum (IIC) patterns, including seizures, was quantified. A summary global cognition score at 3 months following injury was used as the primary outcome. Results 142 patients (age mean + / - standard deviation 32 + / - 13 years; 131 [92%] men) survived with a mean global cognition score of 81 + / - 15; nearly one third were considered to have poor functional outcome. 89 of 142 (63%) patients underwent cEEG, of whom 13 of 89 (15%) had severe IIC patterns. The quantitative burden of IIC patterns correlated inversely with the global cognition score (r = - 0.57; p = 0.04). In multiple variable analysis, the log-transformed burden of severe IIC patterns was independently associated with the global cognition score after controlling for demographics, premorbid estimated intelligence, injury severity, sedatives, and antiepileptic drugs (odds ratio 0.73, 95% confidence interval 0.60-0.88; p = 0.002). Conclusions The burden of seizures and abnormal periodic or rhythmic patterns was independently associated with worse cognition at 3 months following TBI. Their impact on longer-term cognitive endpoints and the potential benefits of seizure detection and treatment in this population warrant prospective study.	[Foreman, Brandon; Lee, Hyunjo; Mizrahi, Moshe A.; Ngwenya, Laura B.; Privitera, Michael] Univ Cincinnati, Gardner Neurosci Inst, Dept Neurol & Rehabil Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Foreman, Brandon; Lee, Hyunjo; Hartings, Jed A.; Ngwenya, Laura B.] Univ Cincinnati, Collaborat Res Acute Neurol Injuries, Cincinnati, OH 45267 USA; [Foreman, Brandon; Hartings, Jed A.; Ngwenya, Laura B.] Univ Cincinnati, Gardner Neurosci Inst, Dept Neurosurg, Cincinnati, OH 45267 USA; [Tortella, Frank C.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kramer, Joel H.] Univ Calif San Francisco, San Francisco Memory & Aging Ctr, San Francisco, CA 94143 USA		Foreman, B (corresponding author), Univ Cincinnati, Gardner Neurosci Inst, Dept Neurol & Rehabil Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.; Foreman, B (corresponding author), Univ Cincinnati, Collaborat Res Acute Neurol Injuries, Cincinnati, OH 45267 USA.; Foreman, B (corresponding author), Univ Cincinnati, Gardner Neurosci Inst, Dept Neurosurg, Cincinnati, OH 45267 USA.	brandon.foreman@uc.edu			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Neuren Pharmaceuticals Limited; Institutional Clinical and Translational Science Award [NIH/NCATS 1UL1TR001425]; National Institute Of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101123]	The -INTREPID2566 trial was supported in part by grants from the U.S. Army Medical Research and Materiel Command (FT) and by Neuren Pharmaceuticals Limited. A preliminary version of this work was completed in partial fulfillment of the Master of Science degree in Clinical and Translational Research in the Division of Epidemiology, University of Cincinnati College of Medicine made possible through an Institutional Clinical and Translational Science Award (NIH/NCATS 1UL1TR001425). Author BF is supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health (K23NS101123). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Defense or the National Institutes of Health.	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Holmes GL, 2015, EPILEPTIC DISORD, V17, P101, DOI 10.1684/epd.2015.0739; Howell KB, 2016, EPILEPSIA, V57, P343, DOI 10.1111/epi.13306; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Khor D, 2018, WORLD J SURG, V42, P1727, DOI 10.1007/s00268-017-4373-0; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lee H, 2019, CRIT CARE MED, V47, P574, DOI 10.1097/CCM.0000000000003639; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2018, CRIT CARE MED, V46, P1480, DOI 10.1097/CCM.0000000000003272; Naidech AM, 2017, NEUROLOGY, V88, P52, DOI 10.1212/WNL.0000000000003461; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Peterson AB, 2014, SURVEILLANCE REPORT; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Team RS, 2015, RSTUDIO INT DEV R; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325	37	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01267-4		JUL 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TH6XY	WOS:000672231500001	34232458				2022-02-07	
J	Hou, Y; Li, MF; Jin, YCA; Xu, FB; Liang, SH; Xue, C; Wang, KL; Zhao, W				Hou, Yun; Li, Meifeng; Jin, Yinchuan; Xu, Feibo; Liang, Shaohua; Xue, Chen; Wang, Kaili; Zhao, Wei			Protective effects of tetramethylpyrazine on dysfunction of the locus coeruleus in rats exposed to single prolonged stress by anti-ER stress mechanism	PSYCHOPHARMACOLOGY			English	Article						Post-traumatic stress disorder; Locus coeruleus; Endoplasmic reticulum stress; Single prolonged stress; Tetramethylpyrazine	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-DEATH; INDUCED APOPTOSIS; PATHWAY; INJURY; SENSOR; ATF6; IRE1; PTSD	Post-traumatic stress disorder (PTSD) is a serious stress-related neuropsychiatric disorder caused by major traumatic events. Abnormal activity of the locus coeruleus (LC)-noradrenergic system is related to the development of PTSD-like symptoms. Our previous studies have indicated that endoplasmic reticulum (ER) stress induced neuronal apoptosis of LC in rats with PTSD. The purpose of this study was to further investigate the role of ER stress pathways in LC neuronal dysfunction and elucidate the effect of the bioactive component tetramethylpyrazine (TMP) against ER stress response. We used an acute exposure to single prolonged stress (SPS) to model PTSD in rats. There were higher norepinephrine (NE) levels in the brain, increased tyrosine hydroxylase expression in LC, and enhanced anxiety-like behaviors in rats exposed to SPS, which were observed by enzyme-linked immunosorbent assay, western blot analysis and elevated plus maze test, respectively. In addition, the three major pathways of ER stress were activated by SPS exposure, which may be involved in the dysregulation of the LC-noradrenergic system of rats with PTSD. Furthermore, we found that TMP administration significantly suppressed the increased responsiveness of LC-noradrenergic system, effectively reduced the anxiety response of SPS rats, and selectively attenuated the activation of pro-apoptotic ER stress pathways. The results suggest that TMP was efficient in improving the LC-NE dysfunction induced by excessive ER stress. TMP exhibited a significant neuroprotective effect and potential therapeutics on PTSD-like symptoms.	[Hou, Yun; Xu, Feibo; Zhao, Wei] Binzhou Med Univ, Dept Histol & Embryol, 346 Guanhai Rd, Yantai 264003, Shandong, Peoples R China; [Li, Meifeng] Qingdao Univ, Dept Intens Care Unit, Yantai Yuhuangding Hosp, Yantai 264000, Shandong, Peoples R China; [Jin, Yinchuan] Fourth Mil Med Univ, Dept Med Psychol, 169 West Changle Rd, Xian 710032, Peoples R China; [Liang, Shaohua] Binzhou Med Univ, Dept Anat, 346 Guanhai Rd, Yantai 264003, Shandong, Peoples R China; [Xue, Chen; Wang, Kaili] Binzhou Med Univ, Clin Med Coll, 346 Guanhai Rd, Yantai 264003, Shandong, Peoples R China		Zhao, W (corresponding author), Binzhou Med Univ, Dept Histol & Embryol, 346 Guanhai Rd, Yantai 264003, Shandong, Peoples R China.	zhaowei_cathy@163.com			Natural Science Foundation of Shaanxi Province, ChinaNatural Science Foundation of Shaanxi Province [2020JM-328]; key Research and Development Program of Shandong Province, China [2018GSF118129]; Science and Technology Development Plan of Chinese Medicine of Shandong Province, China [2017-234]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701301]; Natural Science Foundation of Shandong Province, ChinaNatural Science Foundation of Shandong Province [ZR2018PH017]; 2019 National Undergraduate Innovation and Entrepreneurship Training Program, China [201910440007]; 2018 Binzhou Medical University Undergraduate Innovation and Entrepreneurship Training Program, China [201810440136]	This work was supported by the financial grants from the Natural Science Foundation of Shaanxi Province, China (2020JM-328); the key Research and Development Program of Shandong Province, China (2018GSF118129); the Science and Technology Development Plan of Chinese Medicine of Shandong Province, China (2017-234); the National Natural Science Foundation of China (81701301); the Natural Science Foundation of Shandong Province, China (ZR2018PH017); the 2019 National Undergraduate Innovation and Entrepreneurship Training Program, China (201910440007), and the 2018 Binzhou Medical University Undergraduate Innovation and Entrepreneurship Training Program, China (201810440136).	American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Bangasser DA, 2016, BRAIN RES, V1641, P177, DOI 10.1016/j.brainres.2015.11.021; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Clark EM, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.041426; Fu SN, 2019, PSYCHOPHARMACOLOGY, V236, P2173, DOI 10.1007/s00213-019-05210-6; George SA, 2013, EUR J NEUROSCI, V37, P901, DOI 10.1111/ejn.12095; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Glembotski CC, 2019, TRENDS MOL MED, V25, P538, DOI 10.1016/j.molmed.2019.03.005; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105944; Grillon C, 1996, MOL PSYCHIATR, V1, P278; Hansen N, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/2727602; He M, 2019, PSYCHONEUROENDOCRINO, V104, P286, DOI 10.1016/j.psyneuen.2019.03.017; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang SJ, 2019, J BIOL CHEM, V294, P18726, DOI 10.1074/jbc.REV119.007036; Kalin NH, 2020, AM J PSYCHIAT, V177, P187, DOI 10.1176/appi.ajp.2020.20010057; Karam EG, 2014, DEPRESS ANXIETY, V31, P130, DOI 10.1002/da.22169; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Li L, 2018, CURR BIOL, V28, P859, DOI 10.1016/j.cub.2018.02.005; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liu M, 2016, PSYCHOSOM MED, V78, P888, DOI 10.1097/PSY.0000000000000353; Liu WS, 2018, MED SCI MONITOR, V24, P1225, DOI 10.12659/MSM.908616; Lv L, 2012, CLIN EXP PHARMACOL P, V39, P20, DOI 10.1111/j.1440-1681.2011.05628.x; Maeyashiki C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57657-9; Mak SK, 2017, TOXICOL APPL PHARM, V336, P84, DOI 10.1016/j.taap.2017.10.016; Mapanao R, 2018, FISH SHELLFISH IMMUN, V72, P519, DOI 10.1016/j.fsi.2017.11.035; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Naegeli C, 2018, BIOL PSYCHIAT, V83, P254, DOI 10.1016/j.biopsych.2017.08.021; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Rai U, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172763; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rohde C, 2019, EMERG MICROBES INFEC, V8, P1300, DOI 10.1080/22221751.2019.1659552; Roy A, 2019, CANCERS, V11, DOI 10.3390/cancers11121929; Sabban EL, 2015, J NEUROCHEM, V135, P975, DOI 10.1111/jnc.13347; Schwarz LA, 2015, CURR BIOL, V25, pR1051, DOI 10.1016/j.cub.2015.09.039; Seligowski AV, 2020, J PSYCHIATR RES, V124, P85, DOI 10.1016/j.jpsychires.2020.02.024; Senthilkumaran M, 2016, NEUROCHEM RES, V41, P1612, DOI 10.1007/s11064-016-1875-3; Serova LI, 2013, NEUROSCIENCE, V236, P298, DOI 10.1016/j.neuroscience.2013.01.040; Sharma M, 2019, MOL CELL BIOCHEM, V451, P185, DOI 10.1007/s11010-018-3405-x; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Van Bockstaele EJ, 2013, ADV PHARMACOL, V68, P405, DOI 10.1016/B978-0-12-411512-5.00019-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang K, 2017, EXP CELL RES, V359, P120, DOI 10.1016/j.yexcr.2017.08.002; Watson c, 2004, RAT BRAIN STEREOTAXI, P112; Wu XP, 2014, INT J CANCER, V135, P61, DOI 10.1002/ijc.28649; Yin JJ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272313; Zeng T, 2015, BIOCHEM BIOPH RES CO, V460, P530, DOI 10.1016/j.bbrc.2015.03.064; Zhang JX, 2016, BIOMED PHARMACOTHER, V82, P281, DOI 10.1016/j.biopha.2016.04.050; Zhao W, 2016, PROG NEURO-PSYCHOPH, V69, P11, DOI 10.1016/j.pnpbp.2016.03.008; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	OCT	2021	238	10					2923	2936		10.1007/s00213-021-05908-6		JUL 2021	14	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	UT9SI	WOS:000670217400001	34231002				2022-02-07	
J	Leadbeater, B; Contreras, A; Rajabali, F; Zheng, A; Beaulieu, E; Pike, I				Leadbeater, Bonnie; Contreras, Alejandra; Rajabali, Fahra; Zheng, Alex; Beaulieu, Emilie; Pike, Ian			Longitudinal cohort study of injury type, settings, treatment and costs in British Columbia youth, 2003-2013	INJURY PREVENTION			English	Article; Early Access						costs; youth; adolescent; sports; leisure facility	ADOLESCENCE	Background In 2010 in British Columbia (BC), Canada, total injury costs per capita were higher among youth aged 15-24 years than in any other age group. Injury prevention efforts have targeted injuries with high mortality (transportation injuries) or morbidity (concussions). However, the profile and health costs of common youth injuries (types, locations, treatment choices and prevention strategies) and how these change from adolescence to young adulthood is not known. Methods Participants (n=662) were a randomly recruited cohort of BC youth, aged 12-18, in 2003. They were followed biennially across a decade (six assessments). Results Serious injuries (defined as serious enough to limit normal daily activities) in the last year were reported by 27%-41% of participants at each assessment. Most common injuries were sprains or strains, broken bones, cuts, punctures or animal bites, and severe bruises. Most occurred when playing a sport or from falling. Estimated total direct cost of treatment per injury was approximately $2500. In addition, 25% experienced serious injuries at three or more assessments, indicating possible differences that warrents further investigation. Conclusions The occurence and health cost of common injuries to youth and young adults are underestimated in this study but are nevertheless substantial. Ongoing surveillence, awareness raising, and prevention efforts may be needed to reduce these costs.	[Leadbeater, Bonnie; Contreras, Alejandra] Univ Victoria, Psychol, Victoria, BC V8W 2Y2, Canada; [Rajabali, Fahra; Zheng, Alex; Beaulieu, Emilie; Pike, Ian] BC Injury Res & Prevent Unit, Vancouver, BC, Canada; [Pike, Ian] Univ British Columbia, Pediat, Vancouver, BC, Canada		Leadbeater, B (corresponding author), Univ Victoria, Psychol, Victoria, BC V8W 2Y2, Canada.	bleadbea@uvic.ca		Pike, Ian/0000-0002-6860-7760	Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR) [88476, 79917, 192583, 130500, SHI-155410]	The Victoria Healthy Youth Survey study and this research were supported by grants from the Canadian Institute for Health Research (88476; 79917; 192583; 130500; SHI-155410).	Ames ME, 2020, INT J PSYCHOL, V55, P1, DOI 10.1002/ijop.12549; Ames ME, 2018, HEALTH PSYCHOL, V37, P103, DOI 10.1037/hea0000560; Ames ME, 2016, PSYCHOL HEALTH, V31, P976, DOI 10.1080/08870446.2016.1163360; Banz BC, 2019, YALE J BIOL MED, V92, P725; BC Emergency Health Services, 2012, ANN REP 2012 2013; Belton K., 2015, COST INJURY CANADA; Brubacher JR, 2019, ADDICTION, V114, P1616, DOI 10.1111/add.14663; Canada TPHA of, 2017, EC BURD ILLN CAN 201; CIHI, 2013, COST STAND HOSP STAY; CIHI, 2013, NAT PHYS DAT UT TABL; Health M of, 2013, NAT AMB CAR REP SYST; Karlsson MK, 2013, SCAND J PUBLIC HEALT, V41, P442, DOI 10.1177/1403494813483215; Leadbeater B, 2012, J CLIN CHILD ADOLESC, V41, P719, DOI 10.1080/15374416.2012.694608; Leadbeater B, 2010, INT J INJ CONTROL SA, V17, P119, DOI 10.1080/17457300903564561; Miller T.R., 2012, INJURY PREVENTION CH, P21; Rajabali F., 2015, EC BURDEN INJURY BRI; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Statistic Canada, 2017, BRIT COL CAN CENS PR	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.												10.1136/injuryprev-2021-044168		JUL 2021	7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XK5HY	WOS:000727497700001	34244327				2022-02-07	
J	Marquardt, CA; Pokorny, VJ; Disner, SG; Nelson, NW; McGuire, KA; Sponheim, SR				Marquardt, Craig A.; Pokorny, Victor J.; Disner, Seth G.; Nelson, Nathaniel W.; McGuire, Kathryn A.; Sponheim, Scott R.			Inefficient Attentional Control Explains Verbal-Memory Deficits Among Military Veterans With Posttraumatic Reexperiencing Symptoms	CLINICAL PSYCHOLOGICAL SCIENCE			English	Article; Early Access						posttraumatic stress disorder; PTSD; brain injury; verbal memory; implicit priming; attention; encoding	TRAUMATIC BRAIN-INJURY; CONFIRMATORY FACTOR-ANALYSIS; BLAST-RELATED CONCUSSION; EDITION CVLT-II; STRESS-DISORDER; AUTOBIOGRAPHICAL MEMORY; PTSD; COMORBIDITY; PSYCHOTHERAPY; SUBTHRESHOLD	Among individuals with posttraumatic stress disorder (PTSD), verbal learning and memory are areas of weakness compared with other cognitive domains (e.g., visuospatial memory). In this study, previously deployed military veterans completed clinical assessments of word memory and vocabulary (n = 243) and a laboratory task measuring encoding, free recall, repetition priming, and recognition of words (n = 147). Impaired verbal memory was selectively related to reexperiencing symptoms of PTSD but was not associated with other symptom groupings or blast-induced traumatic brain injury. Implicit priming of response times following word repetition was also unrelated to clinical symptoms. Instead, slowed response times during encoding explained associations between reexperiencing and memory performance. These findings are consistent with alterations in attentional control explaining PTSD-related verbal-memory deficits. Such findings have implications for understanding trauma-focused psychotherapy and recovery, which may depend on efficient attentional processing of words to alter posttraumatic reexperiencing symptoms.	[Marquardt, Craig A.; Disner, Seth G.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55455 USA; [Marquardt, Craig A.; Pokorny, Victor J.; Disner, Seth G.; McGuire, Kathryn A.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Pokorny, Victor J.; Sponheim, Scott R.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA; [Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, St Paul, MN USA		Sponheim, SR (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.	sponh001@umn.edu		Pokorny, Victor/0000-0002-1003-0196	Department of Veterans Affairs Rehabilitation RD ProgramUS Department of Veterans Affairs [I01RX000622]; Congressionally Directed Medical Research ProgramUnited States Department of Defense; Department of DefenseUnited States Department of Defense [PT074550]; Minnesota Veterans Research Institute	The Department of Veterans Affairs Rehabilitation R&D Program (S. R. Sponheim; I01RX000622), the Congressionally Directed Medical Research Program (S. R. Sponheim), the Department of Defense (S. R. Sponheim; PT074550), and the Minnesota Veterans Research Institute (N. W. -Nelson) provided funds for this work. Funding sources were not involved in the choice of topics, study design, data analysis or interpretation, or preparation/submission of this manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs or the Department of Defense.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ashley V, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-86; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bora E, 2013, PSYCHOL MED, V43, P2017, DOI 10.1017/S0033291712002085; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Brewin C. R., 2003, POSTTRAUMATIC STRESS; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2014, PSYCHOL BULL, V140, P69, DOI 10.1037/a0033722; Chin JM, 2008, EUR J COGN PSYCHOL, V20, P396, DOI 10.1080/09541440701728623; Cukor J, 2010, J ANXIETY DISORD, V24, P918, DOI 10.1016/j.janxdis.2010.06.017; Cuthbert BN, 2005, J ABNORM PSYCHOL, V114, P565, DOI 10.1037/0021-843X.114.4.565; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Disner SG, 2018, HUM BRAIN MAPP, V39, P837, DOI 10.1002/hbm.23886; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Ecker B., 2012, UNLOCKING EMOTIONAL; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Etkin A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aal3236; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gilmore CS, 2018, BEHAV BRAIN RES, V340, P174, DOI 10.1016/j.bbr.2016.12.002; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GROVE WM, 1991, PSYCHOL REP, V69, P3; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobs U, 2001, PROF PSYCHOL-RES PR, V32, P458, DOI 10.1037/0735-7028.32.5.458; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnsen GE, 2009, PSYCHIAT RES, V165, P68, DOI 10.1016/j.psychres.2008.01.001; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Knowlton B.J., 2000, NEW COGNITIVE NEUROS, V2, P756; Lieberman L, 2017, J PSYCHIATR RES, V92, P55, DOI 10.1016/j.jpsychires.2017.04.002; Longenecker JM, 2018, ARCH CLIN NEUROPSYCH, V33, P477, DOI 10.1093/arclin/acx082; Marquardt C.A., J ABNORM PSYCHOL; Marquardt CA, 2018, J TRAUMA STRESS, V31, P114, DOI 10.1002/jts.22259; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Marsolek C.J., 2003, RETHINKING IMPLICIT, P41; MCNALLY RJ, 1995, BEHAV RES THER, V33, P619, DOI 10.1016/0005-7967(95)00007-K; MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946; Neimeyer Robert A, 2002, J Palliat Med, V5, P935, DOI 10.1089/10966210260499177; Nelson N.W., 2015, BRAIN NEUROTRAUMA MO, P451; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; Park CL, 2006, J LOSS TRAUMA, V11, P389, DOI 10.1080/15325020600685295; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rasmussen A, 2007, J ABNORM PSYCHOL, V116, P734, DOI 10.1037/0021-843X.116.4.734; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scheiner DL, 2014, J TRAUMA STRESS, V27, P291, DOI 10.1002/jts.21921; Schnyder U, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.28186; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sponheim SR, 2004, SCHIZOPHR RES, V71, P339, DOI 10.1016/j.schres.2004.04.008; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Steger MF., 2012, INTEGRATED APPROACH, P171, DOI DOI 10.1037/13746-008; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wagner A.D., 2002, PRIMING ENCY HUMAN B, V4, P27; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WechslerD, 2001, WECHSLER TEST ADULT; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900	81	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-7026	2167-7034		CLIN PSYCHOL SCI	Clin. Psychol. Sci.											21677026211025018	10.1177/21677026211025018		JUL 2021	15	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	TI6GV	WOS:000672901600001					2022-02-07	
J	Subramaniam, S; Prabhakar, P; Kanagaraj, U; Baby, P				Subramaniam, Sivakami; Prabhakar, Preetham; Kanagaraj, Umadevi; Baby, Priya			Effect of an Educational Intervention on the Knowledge about Traumatic Brain Injury Guidelines among Clinical Nurses	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						traumatic brain injury; clinical guidelines; nurses; knowledge; educational intervention	CARE	Objective Traumatic brain injury (TBI) is a major cause of death and disability throughout the world including developing countries like India. Adherence to guideline based TBI management has proven to decrease death rate and improve neurological outcomes. This study aimed to assess the knowledge of TBI guidelines among clinical nurses caring for TBI patients, and to determine the effect of an educational intervention on their knowledge. Methods Preexperimental, one group pretest and posttest design was used. A purposive sample of 60 nurses was included in the study. A structured questionnaire was prepared to assess the knowledge of nurses. Educational intervention was given in the form of a planned teaching program that was prepared based on the national TBI guidelines. Results There was a significant gain in the knowledge scores of the nurses after the educational intervention when compared with the knowledge scores before the intervention (p = 0.001) Nurses who were experienced more than 10 years were found to have significantly higher knowledge score than others with lesser years of experience. Discussion This study demonstrates important knowledge gap about TBI guidelines among clinical nurses. Educational interventions can be effectively used to improve the knowledge about TBI guidelines among nurses.	[Subramaniam, Sivakami] Natl Inst Mental Hlth & Neurosci, Bengaluru, Karnataka, India; [Prabhakar, Preetham; Kanagaraj, Umadevi] Kempegowda Inst Nursing Sci, Bengaluru, Karnataka, India; [Baby, Priya] Natl Inst Mental Hlth & Neurosci, Coll Nursing, Bengaluru 560011, Karnataka, India		Baby, P (corresponding author), Natl Inst Mental Hlth & Neurosci, Coll Nursing, Bengaluru 560011, Karnataka, India.	priam19@gmail.com					Bimal S, 2009, NURSING MIDWIFERY RE, V5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cook RS, 2013, J NEUROSCI NURS, V45, P108, DOI 10.1097/JNN.0b013e318282906e; Ghoneim NIA., 2012, J AM SCI, V8, P649; Gururaj G, 2005, TRAUMATIC BRAIN INJU, V61; Herzer G, 2016, WIEN KLIN WOCHENSCHR, V128, P649, DOI 10.1007/s00508-016-1027-4; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Neurotrauma Society of India, 2014, TRAUMATIC BRAIN INJU; Oyesanya TO, 2018, J SPEC PEDIATR NURS, V23, DOI 10.1111/jspn.12209; Oyesanya TO, 2018, J CLIN NURS, V27, P1408, DOI 10.1111/jocn.14298; Shehab M., 2018, INT J CARING SCI, V11, P1104; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6	16	0	0	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1729140		JUL 2021	5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TF0FE	WOS:000670382400002		hybrid			2022-02-07	
J	Zhou, H; Hu, LB; Li, JR; Ruan, W; Cao, Y; Zhuang, JF; Xu, HZ; Peng, YC; Zhang, ZY; Xu, CR; Yu, Q; Li, Y; Dou, ZQ; Hu, JW; Wu, XY; Yu, XB; Gu, C; Cao, SL; Yan, F; Chen, G				Zhou, Hang; Hu, Libin; Li, Jianru; Ruan, Wu; Cao, Yang; Zhuang, Jianfeng; Xu, Hangzhe; Peng, Yucong; Zhang, Zhongyuan; Xu, Chaoran; Yu, Qian; Li, Yin; Dou, Zhangqi; Hu, Junwen; Wu, Xinyan; Yu, Xiaobo; Gu, Chi; Cao, Shenglong; Yan, Feng; Chen, Gao			AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						AXL kinase; Reactive astrocytes; Phagocytosis; Traumatic brain injury	IN-VITRO; ACTIVATION; MICROGLIA; NEURONS; CELLS; MICE; NEUROINFLAMMATION; RECEPTORS; APOPTOSIS; DEFICITS	Background Complex changes in the brain microenvironment following traumatic brain injury (TBI) can cause neurological impairments for which there are few efficacious therapeutic interventions. The reactivity of astrocytes is one of the keys to microenvironmental changes, such as neuroinflammation, but its role and the molecular mechanisms that underpin it remain unclear. Methods Male C57BL/6J mice were subjected to the controlled cortical impact (CCI) to develop a TBI model. The specific ligand of AXL receptor tyrosine kinase (AXL), recombinant mouse growth arrest-specific 6 (rmGas6) was intracerebroventricularly administered, and selective AXL antagonist R428 was intraperitoneally applied at 30 min post-modeling separately. Post-TBI assessments included neurobehavioral assessments, transmission electron microscopy, immunohistochemistry, and western blotting. Real-time polymerase chain reaction (RT-PCR), siRNA transfection, and flow cytometry were performed for mechanism assessments in primary cultured astrocytes. Results AXL is upregulated mainly in astrocytes after TBI and promotes astrocytes switching to a phenotype that exhibits the capability of ingesting degenerated neurons or debris. As a result, this astrocytic transformation promotes the limitation of neuroinflammation and recovery of neurological dysfunction. Pharmacological inhibition of AXL in astrocytes significantly decreased astrocytic phagocytosis both in vivo and in primary astrocyte cultures, in contrast to the effect of treatment with the rmGas6. AXL activates the signal transducer and activator of the transcription 1 (STAT1) pathway thereby further upregulating ATP-binding cassette transporter 1 (ABCA1). Moreover, the supernatant from GAS6-depleted BV2 cells induced limited enhancement of astrocytic phagocytosis in vitro. Conclusion Our work establishes the role of AXL in the transformation of astrocytes to a phagocytic phenotype via the AXL/STAT1/ABCA1 pathway which contributes to the separation of healthy brain tissue from injury-induced cell debris, further ameliorating neuroinflammation and neurological impairments after TBI. Collectively, our findings provide a potential therapeutic target for TBI.	[Zhou, Hang; Hu, Libin; Li, Jianru; Cao, Yang; Zhuang, Jianfeng; Xu, Hangzhe; Peng, Yucong; Xu, Chaoran; Yu, Qian; Li, Yin; Dou, Zhangqi; Hu, Junwen; Wu, Xinyan; Yu, Xiaobo; Gu, Chi; Cao, Shenglong; Yan, Feng; Chen, Gao] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Jiefang Road88th, Hangzhou 310016, Peoples R China; [Ruan, Wu] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Burn & Plast Surg, 3333 Binsheng Rd, Hangzhou 310052, Zhejiang, Peoples R China; [Zhang, Zhongyuan] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurosurg, 3333 Binsheng Rd, Hangzhou 310052, Zhejiang, Peoples R China		Yan, F; Chen, G (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Jiefang Road88th, Hangzhou 310016, Peoples R China.	fengyanzju@zju.edu.cn; d-chengao@zju.edu.cn		yan, feng/0000-0001-8663-6859; , caoyang/0000-0002-3431-8231	Foundation for National Key R&D Program of China [2018YFC1312600, 2018YFC1312603]; Key Research and Development Project of Zhejiang Province [2018C03011]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971099, 81870908, 81870910]; Zhejiang Province Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ20H090015]	This work was supported by the Foundation for National Key R&D Program of China (2018YFC1312600, 2018YFC1312603); the Key Research and Development Project of Zhejiang Province (No.2018C03011); the National Natural Science Foundation of China (No. 81971099, 81870908, 81870910); and the Zhejiang Province Natural Science Foundation (LQ20H090015).	Akopian A, 2014, J NEUROSCI, V34, P10582, DOI 10.1523/JNEUROSCI.1912-14.2014; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Barth ND, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01708; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; CHENG HW, 1994, NEUROSCIENCE, V62, P425, DOI 10.1016/0306-4522(94)90377-8; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124; Herzog C, 2019, DEVELOPMENT, P146; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kim SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29673; Kim SK, 2016, J CLIN INVEST, V126, P1983, DOI 10.1172/JCI82859; Lemke G, 2019, NAT REV IMMUNOL, V19, P539, DOI 10.1038/s41577-019-0167-y; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li JR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0959-6; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Morioka S, 2018, NATURE, V563, P714, DOI 10.1038/s41586-018-0735-5; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ray AK, 2017, GLIA, V65, P2051, DOI 10.1002/glia.23214; Rodriguez-Zas SL, 2018, PSYCHONEUROENDOCRINO, V97, P47, DOI 10.1016/j.psyneuen.2018.06.024; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Shen Y, 2016, J CELL BIOL, V215, P719, DOI 10.1083/jcb.201605046; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Thau-Zuchman O, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6420; Tong LS, 2017, J CEREBR BLOOD F MET, V37, P1971, DOI 10.1177/0271678X16658490; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wu GY, 2018, NEUROBIOL DIS, V110, P59, DOI 10.1016/j.nbd.2017.11.009; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu XM, 2017, REDOX BIOL, V13, P20, DOI 10.1016/j.redox.2017.05.010; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang M, 2018, THERANOSTICS, V8, P4262, DOI 10.7150/thno.26164	53	0	0	3	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUL 7	2021	18	1							154	10.1186/s12974-021-02201-3			17	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	TG3UR	WOS:000671333400001	34233703	gold, Green Published			2022-02-07	
J	Barros, CS; Bossing, T				Barros, Claudia S.; Bossing, Torsten			Microtubule disruption upon CNS damage triggers mitotic entry via TNF signaling activation	CELL REPORTS			English	Article							CELL-CYCLE ACTIVATION; ALZHEIMERS-DISEASE; NEUROFIBRILLARY DEGENERATION; REGENERATIVE RESPONSE; DEPENDENT KINASE; DROSOPHILA; TAU; PROTEINS; NEURONS; EXPRESSION	Repair after traumatic injury often starts with mitotic activation around the lesion edges. Early midline cells in the Drosophila embryonic CNS can enter into division following the traumatic disruption of microtubules. We demonstrate that microtubule disruption activates non-canonical TNF signaling by phosphorylation of TGF-beta activated kinase 1 (Tak1) and its target IkappaB kinase (Ik2), culminating in Dorsal/NfkappaB nuclear translocation and Jra/Jun expression. Tak1 and Ik2 are necessary for the damaged-induced divisions. Microtubule disruption caused by Tau accumulation is also reported in Alzheimer's disease (AD). Human Tau expression in Drosophila midline cells is sufficient to induce Tak1 phosphorylation, Dorsal and Jra/Jun expression, and entry into mitosis. Interestingly, activation of Tak1 and Tank binding kinase 1 (Tbk1), the human Ik2 ortholog, and NfkappaB upregulation are observed in AD brains.	[Barros, Claudia S.; Bossing, Torsten] Univ Plymouth, Fac Hlth, Peninsula Med Sch, John Bull Bldg,16 Res Way, Plymouth PL6 8BU, Devon, England		Bossing, T (corresponding author), Univ Plymouth, Fac Hlth, Peninsula Med Sch, John Bull Bldg,16 Res Way, Plymouth PL6 8BU, Devon, England.	torsten.bossing@plymouth.ac.uk			School of Biomedical Sciences; Peninsula Medical School, University of Plymouth, U.K	We would like to thank the South West Dementia Brain Bank (SWDBB) for providing brain tissue for this study. For the supply of antisera, we are grateful to S.A. Wasserman, S. Hiyashi, S. Crews, and the Developmental Studies Hybridoma Bank (DSHB) at the University of Iowa. The project was funded by the School of Biomedical Sciences (T.B.) and the Peninsula Medical School (T.B. and C.B.), University of Plymouth, U.K.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Bejjani F, 2019, BBA-REV CANCER, V1872, P11, DOI 10.1016/j.bbcan.2019.04.003; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; Bossing T, 2006, DEVELOPMENT, V133, P1001, DOI 10.1242/dev.02288; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Bossing T, 2012, DEV CELL, V23, P433, DOI 10.1016/j.devcel.2012.06.002; Busser J, 1998, J NEUROSCI, V18, P2801; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chopra A, 2014, J BIOL CHEM, V289, P2978, DOI 10.1074/jbc.M113.499319; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Evans T, 2018, BRAIN RES, V1681, P1, DOI 10.1016/j.brainres.2017.12.026; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herrup Karl, 2012, Front Biosci (Elite Ed), V4, P2101; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Huang L, 2005, DEV BIOL, V280, P407, DOI 10.1016/j.ydbio.2005.02.006; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Iqbal K, 2006, J ALZHEIMERS DIS, V9, P219; Jackman RW, 2009, EXP CELL RES, V315, P3242, DOI 10.1016/j.yexcr.2009.08.020; Kato K, 2018, DEV DYNAM, V247, P85, DOI 10.1002/dvdy.24565; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Lin T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005642; Marlier Q, 2020, CELL MOL LIFE SCI, V77, P4553, DOI 10.1007/s00018-020-03548-1; Martin R, 2018, INT J DEV BIOL, V62, P507, DOI 10.1387/ijdb.170326gm; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Nakamura M, 2020, J NEUROPATH EXP NEUR, V79, P22, DOI 10.1093/jnen/nlz107; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Orti-Casan N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00049; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Otani T, 2011, DEV CELL, V20, P219, DOI 10.1016/j.devcel.2011.02.001; Panayidou S, 2013, PATHOGENS, V2, P209, DOI 10.3390/pathogens2020209; Park KHJ, 2007, J NEUROSCI, V27, P2969, DOI 10.1523/JNEUROSCI.0186-07.2007; Pei JJ, 2002, ACTA NEUROPATHOL, V104, P369, DOI 10.1007/s00401-002-0565-1; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072; Ricci L, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.321; ROBERTSON HM, 1988, GENETICS, V118, P461; Ruddy RM, 2018, CELL TISSUE RES, V371, P125, DOI 10.1007/s00441-017-2658-0; Sankaranarayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125614; SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111; Scholz H, 1997, MECH DEVELOP, V62, P79, DOI 10.1016/S0925-4773(96)00652-1; Sealey MA, 2017, NEUROBIOL DIS, V105, P74, DOI 10.1016/j.nbd.2017.05.003; Shah N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04121-y; Shen BH, 2001, P NATL ACAD SCI USA, V98, P8596, DOI 10.1073/pnas.141235698; Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; van der Zee J, 2017, HUM MUTAT, V38, P297, DOI 10.1002/humu.23161; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597	70	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	JUL 6	2021	36	1							109325	10.1016/j.celrep.2021.109325			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	TE7KZ	WOS:000670188500025	34233183	gold, Green Published			2022-02-07	
J	Bernick, C; Shan, GG; Bennett, L; Alberts, J; Cummings, J				Bernick, Charles; Shan, Guogen; Bennett, Lauren; Alberts, Jay; Cummings, Jeffrey			Assessing Clinical Change in Individuals Exposed to Repetitive Head Impacts: The Repetitive Head Impact Composite Index	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; chronic traumatic encephalopathy; composite index; cognition; composite index	COGNITIVE IMPAIRMENT; END-POINTS; VALIDITY; RELIABILITY; UPDRS	Background: There is a current lack of any composite measure for the effective tracking and monitoring of clinical change in individuals exposed to repetitive head impacts (RHI). The aim of this study is to create a composite instrument for the purposes of detecting change over time in cognitive and behavioral function in individuals exposed to RHI. Methods: The data to derive the composite instrument came from the Professional Fighters Brain Health Study (PFBHS), a longitudinal study of active and retired professional fighters [boxers and mixed martial arts (MMA) fighters] and healthy controls. Participants in the PFBHS underwent assessment on an annual basis that included computerized cognitive testing and behavioral questionnaires. Multivariate logistic regression models were employed to compare active fighters (n = 117) with controls (n = 22), and retired fighters (n = 26) with controls to identify the predictors that could be used to differentiate the groups over time. In a second step, linear discriminant analysis was performed to derive the linear discriminant coefficients for the three groups by using the predictors from the two separate logistic regression models. Results: The composite scale is a weighted linear value of 12 standardized scores consisting of both current and yearly change scores in domains including: processing speed, choice reaction time, semantic fluency, letter fluency, and Barrett Impulsiveness Scale. Because the weighting of values differed between active and retired fighters, two versions emerged. The mean and standard deviation ratio (MSDR) showed that the new index had better sensitivity compared to the individual measures, with the ratio of MSDR of the new index to that of the existing measures of at least 1.84. Conclusion: With the increasing need for tools to follow individuals exposed to RHI and the potential of clinical trials on the horizon for CTE, the RHICI is poised to serve as an initial approach to a composite clinical measure.	[Bernick, Charles; Bennett, Lauren; Cummings, Jeffrey] Cleveland Clin, Neurol Inst, Las Vegas, NV 89106 USA; [Bernick, Charles] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Shan, Guogen] Univ Nevada, Dept Epidemiol & Biostat, Las Vegas, NV 89154 USA; [Alberts, Jay] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Cummings, Jeffrey] Univ Nevada, Ctr Transformat Neurosci, Las Vegas, NV 89154 USA		Bernick, C (corresponding author), Cleveland Clin, Neurol Inst, Las Vegas, NV 89106 USA.; Bernick, C (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	Bernick@uw.edu			Professional Fighters Brain Health Study from: Ultimate Fighters Championship, Top Rank Promotions, Haymon Boxing, Bellator/Spike TV	This study was made possible by financial support of the Professional Fighters Brain Health Study from: Ultimate Fighters Championship, Top Rank Promotions, Haymon Boxing, Bellator/Spike TV. None of these funders had any role in the design of the study or collection, analysis, and interpretation of data, nor writing of the manuscript.	[Anonymous], 1999, STAT MED, V18, P1905; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bernick C, 2020, NEUROLOGY, V94, pE232, DOI 10.1212/WNL.0000000000008817; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; European Medicines Agency, 2018, GUID CLIN INV MED TR; Food and Drug Administration, 2018, EARL ALZH DIS DEV DR; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Goldberg R, 2014, AM J MED, V127, P379, DOI 10.1016/j.amjmed.2014.01.011; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee B, 2019, HEAD TRAUMA REHABIL, V34, pE29, DOI [10.1097/HTR.0000000000000495, DOI 10.1097/HTR.0000000000000495]; Mccoy CE, 2018, WEST J EMERG MED, V19, P631, DOI 10.5811/westjem.2018.4.38383; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Potts GF, 2006, NEUROSCI LETT, V397, P130, DOI 10.1016/j.neulet.2005.12.003; Schaffert J, 2020, INT REV PSYCHIATR, V32, P71, DOI 10.1080/09540261.2019.1658572; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tharmaratnam T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00445; Wang JP, 2016, J NEUROL NEUROSUR PS, V87, P993, DOI 10.1136/jnnp-2015-312383; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001	30	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 6	2021	12								605318	10.3389/fneur.2021.605318			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL3AH	WOS:000674727300001	34295295	Green Submitted, Green Published, gold			2022-02-07	
J	Greenhow, A; Doherty, A				Greenhow, Annette; Doherty, Alison			Two Sports, Two Systems, One Goal: A Comparative Study of Concussion Policies and Practices of the Australian Football League and Hockey Canada	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						concussion; brain injury; sport governance; regulation; national sporting organisation; Australian Football League; Hockey Canada	GOVERNANCE; INJURY; CRISIS	Concussion in sport is today regarded as both a public health issue and high profile injury concern in many contact and collision sports. This paper undertakes a comparative review of the current policies and practices of two high profile national sporting organisations of such sports-the Australian Football League (AFL) and Hockey Canada (HC)-in governing the issue as a regulatory concern. By examining the policies and practices of the AFL and HC, this study aims to identify common themes, divergent practices, and nuanced sport-specific approaches to develop understandings on the regulation and governance of this high profile sports injury. The paper aims to contribute to understanding concussion as a regulatory concern, while at the same time recognising the heterogeneity of sport and reinforcing nuanced understandings that align to specific social and cultural settings. We make recommendations based on regulatory and cultural legitimacy. The paper concludes that these NSOs are institutional actors with historical and cultural roots who assert regulatory legitimacy by steering and influencing behaviour and directing the regulatory agenda to manage and mitigate the harm associated with concussion.	[Greenhow, Annette] Bond Univ, Fac Law, Gold Coast, Qld, Australia; [Doherty, Alison] Western Univ, Sch Kinesiol, London, ON, Canada		Greenhow, A (corresponding author), Bond Univ, Fac Law, Gold Coast, Qld, Australia.	agreenho@bond.edu.au		Greenhow, Annette/0000-0003-2167-2634			AFL Queensland, 2020, AFL QUEENSL SEN COMM; [Anonymous], 2015, MANDATE LETT PRIME M; ANSELL D, 2016, HDB THEORIES GOVERNA, P1; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Australian Football League, 1997, ANN REP FIL; Australian Football League, 2020, LAWS GAM FIL; Australian Football League, 2011, AFL RES BOARD; Australian Football League, 2007, ANN REP FIL; Australian Football League, 2021, AFL ED; Australian Football League, 2019, 28 ANN INJ REP 2019; Australian Football League, 1995, ANN REP FIL; Australian Football League, 2020, AFL STAT AM AFL TRIB; Australian Football League, 2017, AFL COMM 2017 AFL CO; Australian Football League, 2013, MEMB PROT POL; Australian Football League, 2018, CONST; Australian Football League, 2008, ANN REP FIL; Australian Football League, 1996, ANN REP FIL; Australian Football League, 2009, ANN REP FIL; Australian Football League, 2012, AFL RESP APPR CONC A; Australian Football League ( 2021b ), 2021, STAT GUID CONC MAN C; Australian Football League Australian Football League Players' Association, 2018, COLL BARG AGR 2017 2; Bachynski K., 2019, GAME BOYS PLAY HIST, DOI [10.5149/northcarolina/9781469653709.001.0001, DOI 10.5149/NORTHCAROLINA/9781469653709.001.0001]; Bachynski KE, 2020, SPORT HIST REV, V51, P25, DOI 10.1123/shr.2019-0026; Bachynski KE, 2019, J HIST MED ALL SCI, V74, P167, DOI 10.1093/jhmas/jry042; Batuev M, 2019, SPORT SOC, V22, P1674, DOI 10.1080/17430437.2018.1440998; Black J., 2002, AUSTR J LEGAL PHILOS, V27, P1; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Chapman P., 1985, AUST J SCI MED SPORT, P23; Collins B., 2018, AFL NEWS; Commonwealth Australian Institute of Health Welfare, 1997, NAT HLTH PRIOR AR RE, P1; Crawford D., 1993, AFL ADM STRUCTURE RE; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Cuskelly G., 2013, COMP SPORT DEV SYSTE, P225, DOI [10.1007/978-1-4614-8905-4_17, DOI 10.1007/978-1-4614-8905-4_17]; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Doherty A, 2013, J SPORT MANAGE, V27, P1, DOI 10.1123/jsm.27.1.1; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fiss P. C, 2008, SAGE HDB ORG I; Freiberg A., 2017, REGULATION AUSTR; Gleeson M., 2021, AGE; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Gostin LO, 2016, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT, 3RD EDITION; Grabosky P, 2013, REGUL GOV, V7, P114, DOI 10.1111/j.1748-5991.2012.01147.x; Greenhow A., 2018, THESIS; Greenhow A, 2015, NEUROETHICS-NETH, V8, P65, DOI 10.1007/s12152-014-9216-1; Hall T., 2018, CONCUSSIONS SPORT WE; Hancher L., 1989, CAPITALISM CULTURE E, P271; Hanlon P., 2010, AGE; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Hockey Canada, 2019, BYLAWS REG HIST; Hockey Canada, 2018, CONC POL; Independent Sports Panel, 2009, FUTURE SPORT AUSTR; International Ice Hockey Federation, 2019, OFF RUL BOOK 2018 20; Knill C., 2012, PUBLIC POLICY NEW IN; Koop C, 2017, REGUL GOV, V11, P95, DOI 10.1111/rego.12094; Lane S., 2011, AGE; Levi-Faur D., 2012, OXFORD HDB GOVERNANC, P3; Lodge, 2012, UNDERSTANDING REGULA, DOI [https://doi.org/10.1093/acprof:osobl/9780199576081.001.0001, DOI 10.1093/ACPROF:OSOBL/9780199576081.001.0001]; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Macdonald RD, 2016, HARVARD J SPORTS ENT, V7, P53, DOI DOI 10.2139/SSRN.2502662; Maddocks T., 2021, ABC NEWS; Makdissi M., 2016, BRIT J SPORT MED, V51, pA79, DOI DOI 10.1136/BJSPORTS-2016-097270.205; Malcolm D., 2020, CONCUSSION CRISIS SP, DOI [10.4324/9780429292408, DOI 10.4324/9780429292408]; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Mick H., 2012, GLOBE MAIL; Murdoch Children's Research Institute, 2018, MCRI AFL TEAM TACKL; National Health and Medical Research Council, 1994, FOOTB INJ HEAD NECK; O'Boyle I, 2020, ROUT INT HANDB, P94; O'Boyle I, 2016, MANAG SPORT LEIS, V21, P353, DOI 10.1080/23750472.2017.1289339; Patricios JS, 2014, BRIT J SPORT MED, V48, P71, DOI 10.1136/bjsports-2013-093285; Peters B.G., 2020, HDB RES METHODS APPL, P20, DOI DOI 10.4337/9781788111195.00007; Peters G. B., 2016, HDB THEORIES GOVERNA, P308, DOI 10.4337/9781782548508.00037; Petry Karen, 2013, COMP SPORT DEV SYSTE, P323, DOI DOI 10.1007/978-1-4614-8905-4_24; Pomfret R, 2011, AGENDA-J POLICY ANAL, V18, P85; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Ryan P., 2017, INJURY SURVEY GAMES; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Sport Canada, 2015, FED PROV TERR SPORT; Thompson M., 2014, AFL TV 14 MAY 2014 I; Tworney C., 2021, AFL DOUBLES MANDATOR; Vamplew W., 1991, SPORTS VIOLENCE AUST; Weatherill S., 2017, PRINCIPLES PRACTICE; Windholz E., 2018, GOVERNING REGULATION GOVERNING REGULATION, DOI DOI 10.4324/9781315677286; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	93	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUL 6	2021	3								672895	10.3389/fspor.2021.672895			16	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TM5SU	WOS:000675612300001	34296080	Green Published, gold			2022-02-07	
J	Williamson, JR; Sturim, D; Vian, T; Lacirignola, J; Shenk, TE; Yuditskaya, S; Rao, HM; Talavage, TM; Heaton, KJ; Quatieri, TF				Williamson, James R.; Sturim, Doug; Vian, Trina; Lacirignola, Joseph; Shenk, Trey E.; Yuditskaya, Sophia; Rao, Hrishikesh M.; Talavage, Thomas M.; Heaton, Kristin J.; Quatieri, Thomas F.			Using Dynamics of Eye Movements, Speech Articulation and Brain Activity to Predict and Track mTBI Screening Outcomes	FRONTIERS IN NEUROLOGY			English	Article						neurocognitive testing; eye tracking; speech; fMRI; fine motor coordination; resting state brain activity	DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; CONCUSSION; SPECTRUM; COORDINATION; SPECIFICITY; PERFORMANCE; SYMPTOMS; CHILDREN; INJURY	Repeated subconcussive blows to the head during sports or other contact activities may have a cumulative and long lasting effect on cognitive functioning. Unobtrusive measurement and tracking of cognitive functioning is needed to enable preventative interventions for people at elevated risk of concussive injury. The focus of the present study is to investigate the potential for using passive measurements of fine motor movements (smooth pursuit eye tracking and read speech) and resting state brain activity (measured using fMRI) to complement existing diagnostic tools, such as the Immediate Post-concussion Assessment and Cognitive Testing (ImPACT), that are used for this purpose. Thirty-one high school American football and soccer athletes were tracked through the course of a sports season. Hypotheses were that (1) measures of complexity of fine motor coordination and of resting state brain activity are predictive of cognitive functioning measured by the ImPACT test, and (2) within-subject changes in these measures over the course of a sports season are predictive of changes in ImPACT scores. The first principal component of the six ImPACT composite scores was used as a latent factor that represents cognitive functioning. This latent factor was positively correlated with four of the ImPACT composites: verbal memory, visual memory, visual motor speed and reaction speed. Strong correlations, ranging between r = 0.26 and r = 0.49, were found between this latent factor and complexity features derived from each sensor modality. Based on a regression model, the complexity features were combined across sensor modalities and used to predict the latent factor on out-of-sample subjects. The predictions correlated with the true latent factor with r = 0.71. Within-subject changes over time were predicted with r = 0.34. These results indicate the potential to predict cognitive performance from passive monitoring of fine motor movements and brain activity, offering initial support for future application in detection of performance deficits associated with subconcussive events.	[Williamson, James R.; Sturim, Doug; Yuditskaya, Sophia; Rao, Hrishikesh M.; Quatieri, Thomas F.] MIT, Lincoln Lab, Human Hlth & Performance Syst, 244 Wood St, Lexington, MA 02173 USA; [Vian, Trina; Lacirignola, Joseph] MIT, Lincoln Lab, Counter WMD Syst, 244 Wood St, Lexington, MA 02173 USA; [Shenk, Trey E.] MIT, Lincoln Lab, Adv RF Tech & Syst, 244 Wood St, Lexington, MA 02173 USA; [Talavage, Thomas M.] Purdue Univ, Elect & Comp Engn Biomed Engn, W Lafayette, IN 47907 USA; [Heaton, Kristin J.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA USA		Williamson, JR; Sturim, D (corresponding author), MIT, Lincoln Lab, Human Hlth & Performance Syst, 244 Wood St, Lexington, MA 02173 USA.	jrw@ll.mit.edu; sturim@ll.mit.edu		Talavage, Thomas/0000-0003-4977-6398	Department of the Army under Air Force [FA8702-15-D-0001]	This material is based upon work supported by the Department of the Army under Air Force Contract No. FA8702-15-D-0001.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Ahmadlou M, 2014, CLIN NEUROPHYSIOL, V125, P694, DOI 10.1016/j.clinph.2013.08.033; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Bueno APA, 2019, NEUROPSYCHOLOGIA, V133, DOI 10.1016/j.neuropsychologia.2019.107191; Caccese JB, 2018, NEUROLOGY, V91, DOI 10.1212/01.wnl.0000550684.23716.bb; Casson AJ, 2019, BIOMED ENG LETT, V9, P53, DOI 10.1007/s13534-018-00093-6; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; [Dataset] ImPACT Applications I, BAS POST TEST CONC C BAS POST TEST CONC C; Daudet L, 2017, IEEE J BIOMED HEALTH, V21, P496, DOI 10.1109/JBHI.2016.2633509; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Falcone M, 2013, INT CONF ACOUST SPEE, P7577, DOI 10.1109/ICASSP.2013.6639136; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gibaldi A, 2017, BEHAV RES METHODS, V49, P923, DOI 10.3758/s13428-016-0762-9; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Grace N, 2018, DEV NEUROPSYCHOL, V43, P581, DOI 10.1080/87565641.2018.1504948; Grafton ST, 2004, CURR OPIN NEUROBIOL, V14, P715, DOI 10.1016/j.conb.2004.10.010; Helfer BS, 2014, INTERSPEECH, P485; Helfer BS., 2016, ARXIV PREPRINT ARXIV; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kim S, 2009, J NEUROPHYSIOL, V102, P2910, DOI 10.1152/jn.00206.2009; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lammert AC, 2020, J SPEECH LANG HEAR R, V63, P917, DOI 10.1044/2020_JSLHR-19-00001; Lammert AC, 2017, INT CONF AFFECT, P105, DOI 10.1109/ACII.2017.8273586; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Lovell MR., 2007, IMPACT CLIN INT MAN IMPACT CLIN INT MAN; Ma S., 2014, 2014 48 AS C SIGN SY 2014 48 AS C SIGN SY; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Mehta DD, 2012, J ACOUST SOC AM, V132, P1732, DOI 10.1121/1.4739462; Neubauer AC, 2009, INTELLIGENCE, V37, P223, DOI 10.1016/j.intell.2008.10.008; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Quatieri TF., 2016, MIT LINCOLN LAB TECH MIT LINCOLN LAB TECH; Quatieri TF., 2017, ROLE TECHNOLOGY CLIN, P409, DOI 10.1093/oso/9780190234737.003.0021; Ritchie S., 2015, INTELLIGENCE ALL MAT; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Stauffer JM, 2001, PSYCHOMETRIKA, V66, P63, DOI 10.1007/BF02295732; Stuart S, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.00005; Talkar T., 2020, P INTERSPEECH 2020 S, V2020, P135, DOI [10.21437/Interspeech.2020-2651, DOI 10.21437/INTERSPEECH.2020-2651]; Talkar T, 2020, IEEE ACCESS, V8, P127535, DOI 10.1109/ACCESS.2020.3007348; Thompson B ., 1984, CANONICAL CORRELATIO, V47; Thorndike R.L., 1949, PERSONNEL SELECTION; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Williamson JR, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21062047; Williamson JR, 2012, EPILEPSY BEHAV, V25, P230, DOI 10.1016/j.yebeh.2012.07.007; Williamson JR, 2011, INT CONF ACOUST SPEE, P665	53	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 6	2021	12								665338	10.3389/fneur.2021.665338			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TK9IJ	WOS:000674467900001	34295299	gold, Green Published			2022-02-07	
J	Ewing-Cobbs, L; Montroy, JJ; Clark, AE; Holubkov, R; Cox, CS; Keenan, HT				Ewing-Cobbs, Linda; Montroy, Janelle J.; Clark, Amy E.; Holubkov, Richard; Cox, Charles S., Jr.; Keenan, Heather T.			As Time Goes by: Understanding Child and Family Factors Shaping Behavioral Outcomes After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; behavioral symptoms; psychological adjustment; emotional symptoms; conduct problems; executive functions; long-term outcome; pediatric	LONG-TERM OUTCOMES; RECOVERY TRAJECTORIES; EXECUTIVE FUNCTION; EXTERNALIZING BEHAVIOR; MEASUREMENT INVARIANCE; PSYCHIATRIC-DISORDERS; SOCIAL COMPETENCE; SELF-REGULATION; HEAD-INJURY; MILD	Objective: To model pre-injury child and family factors associated with the trajectory of internalizing and externalizing behavior problems across the first 3 years in children with pediatric traumatic brain injury (TBI) relative to children with orthopedic injuries (OI). Parent-reported emotional symptoms and conduct problems were expected to have unique and shared predictors. We hypothesized that TBI, female sex, greater pre-injury executive dysfunction, adjustment problems, lower income, and family dysfunction would be associated with less favorable outcomes. Methods: In a prospective longitudinal cohort study, we examined the level of behavior problems at 12 months after injury and rate of change from pre-injury to 12 months and from 12 to 36 months in children ages 4-15 years with mild to severe TBI relative to children with OI. A structural equation model framework incorporated injury characteristics, child demographic variables, as well as pre-injury child reserve and family attributes. Internalizing and externalizing behavior problems were indexed using the parent-rated Emotional Symptoms and Conduct Problems scales from the Strengths and Difficulties questionnaire. Results: The analysis cohort of 534 children [64% boys, M (SD) 8.8 (4.3) years of age] included 395 with mild to severe TBI and 139 with OI. Behavior ratings were higher after TBI than OI but did not differ by TBI severity. TBI, higher pre-injury executive dysfunction, and lower income predicted the level and trajectory of both Emotional Symptoms and Conduct Problems at 12 months. Female sex and poorer family functioning were vulnerability factors associated with greater increase and change in Emotional Symptoms by 12 months after injury; unique predictors of Conduct Problems included younger age and prior emotional/behavioral problems. Across the long-term follow-up from 12 to 36 months, Emotional Symptoms increased significantly and Conduct Problems stabilized. TBI was not a significant predictor of change during the chronic stage of recovery. Conclusions: After TBI, Emotional Symptoms and Conduct Problem scores were elevated, had different trajectories of change, increased or stayed elevated from 12 to 36 months after TBI, and did not return to pre-injury levels across the 3 year follow-up. These findings highlight the importance of addressing behavioral problems after TBI across an extended time frame.	[Ewing-Cobbs, Linda; Montroy, Janelle J.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda; Montroy, Janelle J.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA; [Clark, Amy E.; Holubkov, Richard; Keenan, Heather T.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA.; Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Childrens Learning Inst, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; Nicole and Evan Katz Neurodevelopmental Fund	This study was supported by the Centers for Disease Control under Cooperative Agreement U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease COntrol and PRevention. This study was also supported by the National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development K24HD072984. Neither the CDC nor the NICHD played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional funding was provided by the Nicole and Evan Katz Neurodevelopmental Fund.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; [Anonymous], 1990, ABBREVIATED INJURY S; [Anonymous], 2003, NAT CTR INJ PREV CON; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bongers IL, 2004, CHILD DEV, V75, P1523, DOI 10.1111/j.1467-8624.2004.00755.x; Byrne B., 2001, STRUCTURAL EQUATION; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chavez-Arana C, 2019, CHILD NEUROPSYCHOL, V25, P1125, DOI 10.1080/09297049.2019.1589442; Cicchetti D, 2010, WORLD PSYCHIATRY, V9, P145, DOI 10.1002/j.2051-5545.2010.tb00297.x; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Durbeej N, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0326-8; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Fisher ER, 2021, J NEUROTRAUM, V38, P2600, DOI 10.1089/neu.2020.7541; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gorman S, 2017, DEV NEUROPSYCHOL, V42, P127, DOI 10.1080/87565641.2017.1315581; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Gutman LM, 2020, J ABNORM CHILD PSYCH, V48, P703, DOI 10.1007/s10802-020-00623-w; Hair J. F., 2010, MULTIVARIATE DATA AN; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Hendry K, 2020, CHILD NEUROPSYCHOL, V26, P1005, DOI 10.1080/09297049.2020.1750577; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Jones KM, 2021, BRAIN INJURY, V35, P416, DOI 10.1080/02699052.2021.1878553; Keenan HT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.2624; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Landgraf JM., 2014, ENCY QUALITY LIFE WE, P698, DOI DOI 10.1007/978-94-007-0753-5_324; Le Fur C, 2020, ANN PHYS REHABIL MED, V63, P270, DOI 10.1016/j.rehab.2019.09.003; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCormick BF, 2021, CHILD PSYCHIAT HUM D, V52, P166, DOI 10.1007/s10578-020-00992-9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLaughlin KA, 2017, CURR OPIN PSYCHOL, V14, P29, DOI 10.1016/j.copsyc.2016.10.004; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Montroy JJ, 2016, DEV PSYCHOL, V52, P1744, DOI 10.1037/dev0000159; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; MUTHEN BO, 2006, MPLUS USERS GUIDE; Narad ME, 2020, J HEAD TRAUMA REHAB, V35, pE271, DOI 10.1097/HTR.0000000000000550; Narad ME, 2019, ARCH PHYS MED REHAB, V100, P811, DOI 10.1016/j.apmr.2019.01.010; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Pastore V, 2018, BRAIN INJURY, V32, P1011, DOI 10.1080/02699052.2018.1469041; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Petranovich CL, 2020, J HEAD TRAUMA REHAB, V35, P226, DOI 10.1097/HTR.0000000000000555; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sulik MJ, 2010, J PSYCHOPATHOL BEHAV, V32, P8, DOI 10.1007/s10862-009-9164-y; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Toll SWM, 2011, J LEARN DISABIL-US, V44, P521, DOI 10.1177/0022219410387302; Wade SL, 2020, J HEAD TRAUMA REHAB, V35, pE393, DOI 10.1097/HTR.0000000000000567; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P418, DOI 10.1037/a0025779; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zelazo PD, 2020, ANNU REV CLIN PSYCHO, V16, P431, DOI 10.1146/annurev-clinpsy-072319-024242	82	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 5	2021	12								687740	10.3389/fneur.2021.687740			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TK6LW	WOS:000674268600001	34290664	Green Published, gold			2022-02-07	
J	Hosomi, S; Kitamura, T; Sobue, T; Ogura, H; Shimazu, T				Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka; Ogura, Hiroshi; Shimazu, Takeshi			Sex and age differences in isolated traumatic brain injury: a retrospective observational study	BMC NEUROLOGY			English	Article						Mortality; Traumatic brain injury; Sex; Epidemiology; In-hospital complications	ACUTE LUNG INJURY; OLDER-ADULTS; INTRACRANIAL-PRESSURE; HEAD-INJURY; GENDER; OUTCOMES; EPIDEMIOLOGY; MORTALITY; IMPACT; COMPLICATIONS	BackgroundAmong the many factors that may influence traumatic brain injury (TBI) progression, sex is one of the most controversial. The objective of this study was to investigate sex differences in TBI-associated morbidity and mortality using data from the largest trauma registry in Japan.MethodsThis retrospective, population-based observational study included patients with isolated TBI, who were registered in a nationwide database between 2004 and 2018. We excluded patients with extracranial injury (Abbreviated Injury Scale score >= 3) and removed potential confounding factors, such as non-neurological causes of mortality. Patients were stratified by age and mortality and post-injury complications were compared between males and females.ResultsA total of 51,726 patients with isolated TBI were included (16,901 females and 34,825 males). Mortality across all ages was documented in 12.01% (2030/16901) and 12.76% (4445/34825) of males and females, respectively. The adjusted odds ratio (OR) of TBI mortality for males compared to females was 1.32 (95% confidence interval [CI], 1.22-1.42]. Males aged 10-19 years and >= 60 years had a significantly higher mortality than females in the same age groups (10-19 years: adjusted OR, 1.97 [95% CI, 1.08-3.61]; 60-69 years: adjusted OR, 1.24 [95% CI, 1.02-1.50]; 70-79 years: adjusted OR, 1.20 [95% CI, 1.03-1.40]; 80-89 years: adjusted OR, 1.50 [95% CI, 1.31-1.73], and 90-99 years: adjusted OR, 1.72 [95% CI, 1.28-2.32]). In terms of the incidence of post-TBI neurologic and non-neurologic complications, the crude ORs were 1.29 (95% CI, 1.19-1.39) and 1.14 (95% CI, 1.07-1.22), respectively, for males versus females. This difference was especially evident among elderly patients (neurologic complications: OR, 1.27 [95% CI, 1.14-1.41]; non-neurologic complications: OR, 1.29 [95% CI, 1.19-1.39]).ConclusionsIn a nationwide sample of patients with TBI in Japan, males had a higher mortality than females. This disparity was particularly evident among younger and older generations. Furthermore, elderly males experienced more TBI complications than females of the same age.	[Hosomi, Sanae; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 215 Yamada Oka, Suita, Osaka, Japan; [Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Div Environm Med & Populat Sci, 215 Yamada Oka, Suita, Osaka, Japan		Hosomi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 215 Yamada Oka, Suita, Osaka, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp	Sobue, Tomotaka/ABE-4739-2021; Kitamura, Tetsuhisa/AAA-2555-2020	Kitamura, Tetsuhisa/0000-0003-0107-0580	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K08886]; Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives)	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (18K08886) and a grant from Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adediran T, 2019, J SURG RES, V243, P427, DOI 10.1016/j.jss.2019.05.053; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; [Anonymous], 2001, ABBREVIATED INJURY S; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2019, TBI DAT STAT TBI DAT STAT; Civiletti F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42147-4; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Gallo V, 2011, J CLIN EPIDEMIOL, V64, P1350, DOI 10.1016/j.jclinepi.2011.07.010; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Japan Trauma Care and Research, 2019, JAP TRAUM DAT BANK A; Katayama Y, 2021, EUR J TRAUMA EMERG S, V47, P515, DOI 10.1007/s00068-019-01154-w; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Scheetz LJ, 2015, INT EMERG NURS, V23, P162, DOI 10.1016/j.ienj.2014.09.003; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tachino J, 2021, J TRAUMA ACUTE CARE, V90, P185, DOI 10.1097/TA.0000000000002969; Tanaka T, 2005, J JPN PEDIAT SOC, V109, P1232; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	45	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 5	2021	21	1							261	10.1186/s12883-021-02305-6			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI0JC	WOS:000672466400001	34225691	gold, Green Published			2022-02-07	
J	Sicard, V; Harrison, AT; Moore, RD				Sicard, V.; Harrison, A. T.; Moore, R. D.			Psycho-affective health, cognition, and neurophysiological functioning following sports-related concussion in symptomatic and asymptomatic athletes, and control athletes	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-TO-HEAD; WORKING-MEMORY; INTERNATIONAL-CONFERENCE; PERSISTENT INFLUENCE; CONSENSUS STATEMENT; MILD; ATTENTION; DYSFUNCTION; ACTIVATION	Little is known about the neuropsychiatric and neurophysiological differences that characterize abnormal recovery following a concussion. The present study aimed to investigate the psycho-affective, cognitive, and neurophysiological profiles of symptomatic, slow-to-recover, concussed athletes, asymptomatic concussed athletes, and control athletes. Seventy-eight athletes (26 symptomatic, 26 asymptomatic, 26 control) completed the Beck Depression Inventory-II, Profile of Mood States, and 2-Back task. Additionally, event-related brain potentials were recorded during an experimental three-stimulus visual Oddball paradigm. Compared to asymptomatic and control groups, the symptomatic group reported greater depression symptoms and negatively altered mood states. Symptomatic athletes also exhibited poorer cognitive performance on the 2-Back task, indicated by more errors and slower reaction time. ERP analyses indicated prolonged P3b latency for both symptomatic and asymptomatic groups, but symptomatic athletes also exhibited reduced P3b amplitude compared to both asymptomatic and control groups. For the asymptomatic group, correlations were observed between time since last concussion and functioning, but no relations were observed within the symptomatic group for any measure. The current findings provide valuable information regarding the psycho-affective, cognitive, and neurophysiological profiles of athletes with and without persistent symptoms following a concussion and highlight the need to assess and treat symptomatic, slow-to-recover athletes from a multidimensional and integrative perspective.	[Sicard, V.] Lovelace Biomed Res Ctr, Mind Res Network, 1101 Yale Ave, Albuquerque, NM 87106 USA; [Harrison, A. T.; Moore, R. D.] Univ South Carolina, Arnold Sch Publ Hlth, 91 Assembly St, Columbia, SC 29208 USA		Sicard, V (corresponding author), Lovelace Biomed Res Ctr, Mind Res Network, 1101 Yale Ave, Albuquerque, NM 87106 USA.	veronik.sicard@gmail.com		Sicard, Veronik/0000-0003-2452-934X			Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT., 1996, BECK DEPRESSION INVE, pB9; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cantu R., 2012, CONCUSSIONS OUR KIDS; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cogstate, 2016, COGST BRIEF BATT COGST BRIEF BATT; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Czerniak LL, 2021, SPORTS MED, V51, P351, DOI 10.1007/s40279-020-01393-7; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Furger R. E., 2016, CONCUSSION, V1, pCNC11; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grove J., 1990, ANN M AUSTR SPORTS M; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnston LH, 1998, J SPORT REHABIL, V7, P206, DOI 10.1123/jsr.7.3.206; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McNair DM, 1971, PROFILE MOOD STATES; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Neuroscience E., 2021, SCI BEHID EVOX; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Quackenbush N., 1994, Journal of Sport Behavior, V17, P178; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Wood H, 2015, NAT REV NEUROL, V11, P607, DOI [10.1038/nrneurol.2015.37, 10.1038/nrneurol.2015.148, 10.1038/nrneurol.2015.9, 10.1038/nrneurol.2015.105, 10.1038/nrneurol.2015.40, 10.1038/nrneurol.2015.204, 10.1038/nrneurol.2015.149, 10.1038/nrneurol.2015.205]; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	63	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 5	2021	11	1							13838	10.1038/s41598-021-93218-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TI2JN	WOS:000672616000008	34226626	Green Published, gold			2022-02-07	
J	Ouellet, V; Boucher, V; Beauchamp, F; Neveu, X; Archambault, P; Berthelot, S; Chauny, JM; De Guise, E; Emond, M; Frenette, J; Lang, E; Lee, J; Mercier; Moore, L; Ouellet, MC; Perry, J; Le Sage, N				Ouellet, V; Boucher, V; Beauchamp, F.; Neveu, X.; Archambault, P.; Berthelot, S.; Chauny, J. M.; De Guise, E.; Emond, M.; Frenette, J.; Lang, E.; Lee, J.; Mercier; Moore, L.; Ouellet, M. C.; Perry, J.; Le Sage, N.			Influence of concomitant injuries on post-concussion symptoms after a mild traumatic brain injury - a prospective multicentre cohort study	BRAIN INJURY			English	Article						Brain injuries; concomitant injuries; post-concussion symptoms; rivermead post-concussion symptoms questionnaire	QUALITY-OF-LIFE; HEAD-INJURY; RISK-FACTORS; QUESTIONNAIRE; EPIDEMIOLOGY; FRACTURE; OUTCOMES; PAIN; TBI	Objectives: To compare post-concussion symptoms (PCS) and return to normal activities between mild Traumatic Brain Injury (mTBI) patients with or without concomitant injuries at 7-and 90 days post-mTBI.Methods: Design: Sub-analysis of a multicentre prospective cohort study. Participants and setting: patients with mTBI from 7 Canadian Emergency Departments. Procedure: Research assistants conducted telephone follow-ups using the Rivermead Postconcussion Symptoms Questionnaire (RPQ) at 7-, 30- and 90 days post-mTBI. Main outcome: Presence of PCS (RPQ: >= 3 symptoms) at 90 days. Secondary outcomes: RPQ score >= 21, prevalence of individual RPQ symptoms and patients' return to normal activities, at 7- and 90-days. Adjusted risk ratios (RR) were calculated.Results: 1725 mTBI patients were included and 1055 (61.1%) had concomitant injuries. Patients with concomitant injuries were at higher risk of having >= 3 symptoms on the RPQ (RR:1.26 [95% CI 1.01-1.58]) at 90 days. They were also at higher risk of experiencing specific symptoms (dizziness, fatigue, headaches and taking longer to think) and of non-return to their normal activities (RR:2.11 [95% CI 1.30-3.45]).Conclusion: Patients with concomitant injuries have slightly more PCS and seemed to be at higher risk of non-return to their normal activities 90 days, compared to patients without concomitant injuries.	[Ouellet, V; Boucher, V; Beauchamp, F.; Neveu, X.; Berthelot, S.; Emond, M.; Mercier; Le Sage, N.] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Ouellet, V; Boucher, V; Beauchamp, F.; Neveu, X.; Berthelot, S.; Emond, M.; Frenette, J.; Mercier; Le Sage, N.] Univ Laval CERSSPL UL, Ctr Rech Sur Les Soins & Les Serv Premiere Ligne, Quebec City, PQ, Canada; [Ouellet, V; Beauchamp, F.; Archambault, P.; Berthelot, S.; Emond, M.; Mercier; Le Sage, N.] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Archambault, P.] Univ Hotel Dieu Levis, Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Ctr Hosp, Levis, PQ, Canada; [Chauny, J. M.; De Guise, E.] Univ Montreal, Montreal, PQ, Canada; [De Guise, E.] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [De Guise, E.] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lang, E.] Univ Calgary, Calgary, AB, Canada; [Lee, J.] Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Moore, L.] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Ouellet, M. C.] Univ Laval, Dept Psychol, Quebec City, PQ, Canada; [Ouellet, M. C.] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Perry, J.] Univ Ottawa, Ottawa Hosp, Dept Emergency Med, Res Inst, Ottawa, ON, Canada		Le Sage, N (corresponding author), Univ Laval CERSSPL UL, VITAM Ctr Rech Sante Durable, Ctr Integre Univ Sante & Serv Sociaux CIUSSS, Ctr Rech Sur Les Soins & Les Serv Premiere Ligne, Quebec City, PQ, Canada.	natalie.lesage@fmed.ulaval.ca		Archambault, Patrick/0000-0002-5090-6439	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was funded by the Canadian Institutes of Health Research.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, Vxxvii; BELLAMY RF, 1986, ANN EMERG MED, V15, P1384, DOI 10.1016/S0196-0644(86)80920-9; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Bottari C, 2017, NEUROPSYCHOL REHABIL, V27, P871, DOI 10.1080/09602011.2015.1110528; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Deb S, 1999, AM J PSYCHIAT, V156, P374; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gordon KE, 2018, BRAIN INJURY, V32, P41, DOI 10.1080/02699052.2017.1403046; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jodoin M, 2018, PROG NEURO-PSYCHOPH, V87, P322, DOI 10.1016/j.pnpbp.2017.07.005; Jodoin M, 2017, INJURY, V48, P1927, DOI 10.1016/j.injury.2017.06.025; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Lee JS, 2009, ARCH ORTHOP TRAUM SU, V129, P711, DOI 10.1007/s00402-008-0632-8; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Public Health Agency of Canada, 2020, INJ REV 2020 ED SPOT; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Russell K, 2019, J NEUROSURG-PEDIATR, V23, P455, DOI 10.3171/2018.8.PEDS18356; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sherman A., 2019, STATPEARLS; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Sosin DM, 1996, BRAIN INJURY, V10, P47; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; World Health Organization, 1992, ICD10 WHO, V67, P227; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	48	0	0	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2021	35	9					1028	1034		10.1080/02699052.2021.1945145		JUL 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UN1JX	WOS:000669726500001	34224275				2022-02-07	
J	Sicard, V; Caron, G; Moore, RD; Ellemberg, D				Sicard, Veronik; Caron, Gabriel; Moore, Robert Davis; Ellemberg, Dave			Post-exercise cognitive testing to assess persisting alterations in athletes with a history of concussion	BRAIN INJURY			English	Article						Long term; exercise; higher cognition; persistent; executive functions; physical effort	TRAUMATIC BRAIN-INJURY; EXTREMITY MUSCULOSKELETAL INJURY; CEREBRAL-BLOOD-FLOW; SPORTS-RELATED CONCUSSION; DEFAULT-MODE NETWORK; ACUTE EXERCISE; NEUROTROPHIC FACTOR; RECOVERY; FATIGUE; RISK	Primary Objective: To determine whether a physical exercise protocol could reveal persistent cognitive alterations in university athletes with a history of concussion (HOC). Thirty-four HOC and 34 controls participated in this study. Research Design: Cross-sectional. Methods and Procedures: The exercise protocol consisted of a 20-min bout on a stationary bike at 80% of the theoretical maximal heart rate. Before and after the exercise, participants performed a computerized switch task designed specifically to recruit executive functions. Group x Condition (pre- and post-exercise) repeated measures of ANCOVAs for accuracy, reaction time, and inverse efficiency score on the switch task were conducted. Chi-square tests were run to determine if the proportion of HOC and controls who underperformed (at least 2SD lower than the control group's average score) at rest and post-exercise were similar. Whilst no interaction or main effects were found with ANCOVAs, significantly more HOC athletes (21%) underperformed following exercise than at rest (3%) on the switch task, p = .02. The current results indicate that an acute bout of exercise can reveal persistent alterations that are not present at rest in the protracted phase of concussion. They also highlight the importance of considering inter-individual differences in recovery trajectories.	[Sicard, Veronik; Caron, Gabriel; Ellemberg, Dave] Univ Montreal, Sch Kinesiol & Exercise Sci, 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [Sicard, Veronik; Caron, Gabriel; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, 90 Rue Vincent Indy, Montreal, PQ, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA		Sicard, V (corresponding author), Univ Montreal, Sch Kinesiol & Exercise Sci, 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	veronik.sicard@gmail.com			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR MOP-102608]	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-102608) to Dave Ellemberg.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bahdur K, 2016, INT ORTHOP, V3, P503, DOI [10.17554/j..2311-5106.2016.03.154, DOI 10.17554/J..2311-5106.2016.03.154]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Boecker H., 2012, FUNCTIONAL NEUROIMAG, P25, DOI DOI 10.1007/978-1-4614-3293-7_2; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dietrich A, 2006, PSYCHIAT RES, V145, P79, DOI 10.1016/j.psychres.2005.07.033; Ellemberg D., 2020, TRANSLATIONAL J AM C, V5, P1, DOI DOI 10.1249/TJX.0000000000000130; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Han DY, 2018, APPL NEUROPSYCH-CHIL, V8, P1; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; LeMonda BC, 2017, DEV NEUROPSYCHOL, V42, P113, DOI 10.1080/87565641.2016.1274315; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Marshall CM, 2019, PHYSICIAN SPORTSMED, V47, P158, DOI 10.1080/00913847.2018.1542258; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McGowan AL, 2019, NEUROPSYCHOLOGIA, V131, P223, DOI 10.1016/j.neuropsychologia.2019.05.026; McGowan AL, 2018, NEUROPSYCHOLOGY, V32, P564, DOI 10.1037/neu0000475; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McIntyre M, 2020, AM J PHYS MED REHAB, V99, P257, DOI 10.1097/PHM.0000000000001340; McPherson A, 2018, MED SCI SPORT EXER, V50, P2; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Petushek EJ, 2015, J SPORT EXERCISE PSY, V37, P291, DOI 10.1123/jsep.2014-0315; Sicard V, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1842410; Sicard V, 2020, J CLIN EXP NEUROPSYC, V42, P965, DOI 10.1080/13803395.2020.1828836; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Strauss R, 1984, CLIN EXERCISE TRAINI; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	66	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					978	985		10.1080/02699052.2021.1944668		JUL 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000669728100001	34223775				2022-02-07	
J	Harris, L; Townsend, D; Ingleton, R; Kershberg, A; Uff, C; O'Halloran, PJ; Offiah, C; McKenna, GS				Harris, Lauren; Townsend, Dominic; Ingleton, Rose; Kershberg, Alice; Uff, Chris; O'Halloran, Philip J.; Offiah, Curtis; McKenna, Grainne S.			Venous sinus thrombosis in traumatic brain injury: a major trauma centre experience	ACTA NEUROCHIRURGICA			English	Article						Venous sinus thrombosis; Traumatic brain injury; Cerebral venography; Anticoagulation	HEAD TRAUMA; RISK; MANAGEMENT; FRACTURE	Background This study explores the presentation, management and outcomes of traumatic venous sinus thrombosis (VST) and identifies risk factors associated with poor outcomes. Methods This study is a retrospective review of all patients with VST secondary to trauma who presented to a major trauma centre, between April 2015 and January 2020. VST was confirmed by CT venogram and a consultant neuroradiologist. Results Forty-six patients were identified (38 male), mean age of 43 (range 12-78) and median follow-up 10.2 months (range 0.7-39.1). Fifty-two percent presented as a severe traumatic brain injury, and all had an associated skull fractures overlying the sinus. Ninety-six percent had cerebral contusions, 96% had an intracranial haematoma, 91% had traumatic subarachnoid haemorrhage (tSAH) and 22% had acute cerebral infarction. Thirty-seven percent of the VSTs were occlusive. Fifty-eight percent had sustained, unprovoked intracranial pressure (ICP) spikes (> 20 mmHg). Fifty percent underwent surgical intervention-20% external ventricular drain and 46% craniotomy/craniectomy. Nine percent were treated with anticoagulation and 4% with antiplatelets, at a median of 13.5 days and 9.5 days post-injury, with no additional complications. Age > 60 was associated with poor outcome (GOS of 3-5) (p = 0.0098). On follow-up CT, 52% of the VSTs remained unchanged, 29% re-canalised, 14% improved and 5% worsened, independent of treatment. Conclusions This study demonstrated a higher incidence of VST in severe TBI and strong associations with skull fractures, cerebral contusions, tSAH, raised ICP and surgical intervention. Management was inconsistent, with no difference in outcome with or without anticoagulation. Larger, prospective cohort studies are needed to better understand this condition and establish evidence-based guidelines.	[Harris, Lauren; Townsend, Dominic; Ingleton, Rose; Kershberg, Alice; Uff, Chris; O'Halloran, Philip J.; McKenna, Grainne S.] Royal London Hosp, Dept Neurosurg, Whitechapel Rd, London E1 1FR, England; [O'Halloran, Philip J.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; [Offiah, Curtis] Royal London Hosp, Dept Radiol, Whitechapel Rd, London E1 1FR, England		Townsend, D (corresponding author), Royal London Hosp, Dept Neurosurg, Whitechapel Rd, London E1 1FR, England.	dominiccharles.townsend@nhs.net		Townsend, Dominic/0000-0002-0242-3213			Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Bergui M, 1999, NEURORADIOLOGY, V41, P419, DOI 10.1007/s002340050775; Bhatoe HS, 2015, NEUROL INDIA, V63, P832, DOI 10.4103/0028-3886.170063; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; Daligic A, 2008, TURK NEUROSURG, V18, P70; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Foreman PM, 2017, CEREBROVASC DIS EXTR, V7, P72, DOI 10.1159/000455391; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Ghuman Mandeep Singh, 2016, J Emerg Trauma Shock, V9, P37, DOI 10.4103/0974-2700.173865; Grangeon L, 2017, REV NEUROL-FRANCE, V173, P411, DOI 10.1016/j.neurol.2017.03.025; Hsu PJ, 2014, NEUROLOGY, V83, pE135, DOI 10.1212/WNL.0000000000000836; KRISTENSEN B, 1992, J NEUROL NEUROSUR PS, V55, P287, DOI 10.1136/jnnp.55.4.287; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Lindvall P, 2013, CASE REP NEUROL, V5, P168, DOI 10.1159/000355394; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Park JH, 2008, MED HYPOTHESES, V70, P143, DOI 10.1016/j.mehy.2007.03.036; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; San Juan GZ, 2019, NEUROCIRUGIA, V30, P243, DOI 10.1016/j.neucir.2018.10.002; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; Wang WH, 2013, J CLIN NEUROL, V9, P259, DOI 10.3988/jcn.2013.9.4.259; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	31	0	0	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2021	163	9					2615	2622		10.1007/s00701-021-04916-x		JUL 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TZ1IL	WOS:000669278700001	34218332				2022-02-07	
J	Khaliq, A; Ali, M; Azam, F; Gul, N; Chaurasia, B				Khaliq, Adnan; Ali, Mumtaz; Azam, Farooq; Gul, Nayab; Chaurasia, Bipin			Contusion Index is an Important Tool for the Management of Traumatic Intracerebral Hematoma	INDIAN JOURNAL OF NEUROTRAUMA			English	Article; Early Access						contusion index; Glasgow Coma Scale; head injury; intracerebral contusions	COMPUTED-TOMOGRAPHY; HEAD-INJURY	Objective This article evaluates outcome of traumatic intracerebral hematomas in terms of Glasgow Coma Scale (GCS) after medical or surgical management according to contusion index. Materials and Methods This descriptive study was conducted in the Department of Neurosurgery, Lady Reading Hospital, Peshawar, Pakistan from January 2017 to December 2018. Total number of patients with traumatic intracerebral contusions included in this study was 60 with age between 5 and 75 years. Both male and female were included. Patients with other coexisting traumatic intracranial hematomas like extradural hematoma, subdural hematoma, and polytrauma were excluded from this study. Contusion index of patients were calculated by noncontrast-enhanced computed tomography brain. On arrival patient GCS was documented. The management protocol, that is, conservative or surgical, was provided to individual patient according to contusion index as calculated. Outcome of management was assessed in terms of GCS. Results Patients with contusion index of 0 to 4 were managed conservatively. Patients with contusion index of 6 were offered surgical management. Patients with contusion index of 9 had poor outcome with both conservative and surgical management. Conclusion Contusion index can be used reliably as a tool for management of isolated traumatic intracerebral hematomas	[Khaliq, Adnan] Saidu Teaching Hosp, Saidu Med Coll, Dept Neurosurg, Swat, Pakistan; [Ali, Mumtaz] Prime Teaching Hosp, Peshawar Med Coll, Peshawar, Pakistan; [Azam, Farooq] Lady Reading Hosp Peshawar, Peshawar, Pakistan; [Gul, Nayab] Rehman Med Inst, Peshawar, Pakistan; [Chaurasia, Bipin] Neurosurg Clin, Birgunj, Nepal		Khaliq, A (corresponding author), Saidu Teaching Hosp, Saidu Med Coll, Swat, Pakistan.	dradnankhaliq@gmail.com					ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; BOOM WH, 1985, REV INFECT DIS, V7, P189; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; Illingworth RD, GREENSBERG HDB NEURO, V8, P270; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kraus JF, 1987, HEAD INJURY, V2, P1; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801	13	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma												10.1055/s-0041-1727293		JUL 2021	4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TD3UZ	WOS:000669257100001		hybrid			2022-02-07	
J	Raman, S; Schibler, A; Le Marsney, R; Trnka, P; Kennedy, M; Mattke, A; Gibbons, K; Schlapbach, LJ				Raman, Sainath; Schibler, Andreas; Marsney, Renate Le; Trnka, Peter; Kennedy, Melanie; Mattke, Adrian; Gibbons, Kristen; Schlapbach, Luregn J.			0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial	TRIALS			English	Article						Balanced solutions; Bolus; Child; Critical care; Intravenous fluid therapy	CRITICALLY-ILL CHILDREN; INTENSIVE-CARE-UNIT; BALANCED CRYSTALLOIDS; SERUM CREATININE; SALINE; OUTCOMES; SEPSIS	Background: Intravenous fluid therapy represents the most common intervention critically ill patients are exposed to. Hyperchloremia and metabolic acidosis associated with 0.9% sodium chloride have been observed to lead to worse outcomes, including mortality. Balanced solutions, such as Plasma-Lyte 148 and Compound Sodium Lactate, represent potential alternatives but the evidence on optimal fluid choices in critically ill children remains scarce. This study aims to demonstrate whether balanced solutions, when used as intravenous fluid therapy, are able to reduce the incidence of a rise in serum chloride level compared to 0.9% sodium chloride in critically ill children. Methods: This is a single-centre, open-label randomized controlled trial with parallel 1:1:1 assignment into three groups: 0.9% sodium chloride, Plasma-Lyte 148, and Compound Sodium Lactate solutions for intravenous fluid therapy. The intervention includes both maintenance and bolus fluid therapy. Children aged < 16 years admitted to intensive care and receiving intravenous fluid therapy during the first 4 h of admission are eligible. The primary outcome measure is a >= 5mmol/L increase in serum chloride level within 48 h post-randomization. The enrolment target is 480 patients. The main analyses will be intention-to-treat. Discussion: This study tests three types of intravenous fluid therapy in order to compare the risk of hyperchloremia associated with normal saline versus balanced solutions. This pragmatic study is thereby assessing the most common intervention in paediatric critical care. This is a single-centre open-label study with no blinding at the level of delivery of the intervention. Certain paediatric intensive care unit (PICU) patient groups such as those admitted with a cardiac condition or following a traumatic brain injury are excluded from this study.	[Raman, Sainath; Schibler, Andreas; Marsney, Renate Le; Kennedy, Melanie; Mattke, Adrian; Gibbons, Kristen; Schlapbach, Luregn J.] Univ Queensland, Child Hlth Res Ctr, Paediat Crit Care Res Grp, 62 Graham St, South Brisbane, Qld 4101, Australia; [Raman, Sainath; Schibler, Andreas; Kennedy, Melanie; Mattke, Adrian; Schlapbach, Luregn J.] Queensland Childrens Hosp, Paediat Intens Care Unit, South Brisbane, Australia; [Trnka, Peter] Queensland Childrens Hosp, Paediat Nephrol, South Brisbane, Australia; [Schlapbach, Luregn J.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Dept Intens Care & Neonatol, Zurich, Switzerland		Raman, S (corresponding author), Univ Queensland, Child Hlth Res Ctr, Paediat Crit Care Res Grp, 62 Graham St, South Brisbane, Qld 4101, Australia.; Raman, S (corresponding author), Queensland Childrens Hosp, Paediat Intens Care Unit, South Brisbane, Australia.	sainath.raman@uq.edu.au	Trnka, Peter/I-7700-2016	Trnka, Peter/0000-0002-5584-2622; Raman, Sainath/0000-0002-0152-9980	Study, Education and Research Trust Account funding scheme 2019, Children's Health Queensland, Brisbane, Australia; NHMRCNational Health and Medical Research Council of Australia; Children's Hospital Foundation Brisbane, Australia	The study was supported by a grant from the Study, Education and Research Trust Account funding scheme 2019, Children's Health Queensland, Brisbane, Australia. LJS has been supported by a grant from the NHMRC, and the Children's Hospital Foundation Brisbane, Australia. The funding sources had no involvement in study design, analyses, nor interpretation of the results.	Allen CH, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0652-4; Alobaidi R, 2018, JAMA PEDIATR, V172, P257, DOI 10.1001/jamapediatrics.2017.4540; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Balamuth F, 2019, ACAD EMERG MED, DOI 10.1111/acem.13815; Barhight MF, 2018, INTENS CARE MED, V44, P2183, DOI 10.1007/s00134-018-5424-1; Boer DP, 2010, PEDIATR NEPHROL, V25, P2107, DOI 10.1007/s00467-010-1533-y; Bulfon A, 2019, J PEDIATR INTENSIVE, V8, P218, DOI 10.1055/s-0039-1692413; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; Cortes DO, 2014, BRIT J ANAESTH, V112, P968, DOI 10.1093/bja/aeu047; Feld LG, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3083; Finfer S, 2018, NAT REV NEPHROL, V14, P541, DOI 10.1038/s41581-018-0044-0; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huber JL, 2019, PEDIAT EMERGENCY CAR, V00, P1; Kartha GB, 2017, J PEDIATR GASTR NUTR, V65, P621, DOI 10.1097/MPG.0000000000001609; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Leteurtre S, 2013, CRIT CARE MED, V41, P1761, DOI 10.1097/CCM.0b013e31828a2bbd; Levin M, 2019, LANCET RESP MED, V7, P581, DOI 10.1016/S2213-2600(19)30114-6; Lima MF, 2019, J NEUROSURG ANESTH, V31, P30, DOI 10.1097/ANA.0000000000000515; Morgan TJ, 2005, CRIT CARE, V9, P204, DOI 10.1186/cc2946; Schlapbach LJ, 2015, LANCET INFECT DIS, V15, P46, DOI 10.1016/S1473-3099(14)71003-5; Self WH, 2018, NEW ENGL J MED, V378, P819, DOI 10.1056/NEJMoa1711586; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Severs D, 2015, NEPHROL DIAL TRANSPL, V30, P178, DOI 10.1093/ndt/gfu005; Varrier M, 2015, CRIT CARE CLIN, V31, P823, DOI 10.1016/j.ccc.2015.06.014; Weiss SL, 2017, J PEDIATR-US, V182, P304, DOI 10.1016/j.jpeds.2016.11.075; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334	27	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 3	2021	22	1							427	10.1186/s13063-021-05376-5			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	TD4LK	WOS:000669299800001	34217337	gold, Green Accepted, Green Published			2022-02-07	
J	Andrew, AS; Anderson, FL; Lee, SL; Von Herrmann, KM; Havrda, MC				Andrew, Angeline S.; Anderson, Faith L.; Lee, Stephen L.; Von Herrmann, Katharine M.; Havrda, Matthew C.			Lifestyle Factors and Parkinson's Disease Risk in a Rural New England Case-Control Study	PARKINSONS DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; GENE-ENVIRONMENT INTERACTIONS; PESTICIDE EXPOSURE; OCCUPATIONAL-EXPOSURE; LEAD-EXPOSURE; HEAD-INJURY; WELL WATER; ASSOCIATION; HEALTH; METAANALYSIS	Introduction. Parkinson's disease (PD) is an age-related neurodegenerative disease likely caused by complex interactions between genetic and environmental risk factors. Exposure to pesticides, toxic metals, solvents, and history of traumatic brain injury have been implicated as environmental risk factors for PD, underscoring the importance of identifying risk factors associated with PD across different communities. Methods. We conducted a questionnaire-based case-control study in a rural area on the New Hampshire/Vermont border, enrolling PD patients and age- and sex-matched controls from the general population between 2017 and 2020. We assessed frequent participation in a variety of recreational and occupational activities and surveyed potential chemical exposures. Results. Suffering from "head trauma or a concussion" prior to diagnosis was associated with a fourfold increased risk of PD. Adjustment for head trauma negated any risk of participation in "strenuous athletic activities." We observed a 2.7-fold increased risk of PD associated with activities involving lead (adjusted p=0.038). Conclusion. Implicating these factors in PD risk favors public health efforts in exposure mitigation while also motivating future work mechanisms and intervention opportunities.	[Andrew, Angeline S.; Anderson, Faith L.; Lee, Stephen L.; Von Herrmann, Katharine M.; Havrda, Matthew C.] Geisel Sch Med Dartmouth, Rubin Bldg, Lebanon, NH 03756 USA		Andrew, AS (corresponding author), Geisel Sch Med Dartmouth, Rubin Bldg, Lebanon, NH 03756 USA.	angeline.andrew@dartmouth.edu; matthew.havrda@dartmouth.edu			Michael J. Fox Foundation (MJFF); NIH/NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [1R01ES024745]; CDC/ATSDR [R01TS000288]	The authors would like to thank the research staff and study participants who made this work possible. The authors thank Dr. Diane Sherman and the members of the Aging Resource Center at DHMC. This research was supported by the Michael J. Fox Foundation (MJFF), NIH/NIEHS 1R01ES024745, and CDC/ATSDR R01TS000288.	Anderson FL, 2018, TOXICOL SCI, V166, P3, DOI 10.1093/toxsci/kfy219; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Bihaqi S.W., 2018, CURR ALZHEIMER RES, V36; Bjorklund G, 2018, CURR MED CHEM, V25, P2198, DOI 10.2174/0929867325666171129124616; Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702; Cagac A, 2020, NEUROSCIENCES, V25, P129, DOI 10.17712/nsj.2020.2.20190104; Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025; Chen HL, 2018, J PARKINSON DIS, V8, pS9, DOI 10.3233/JPD-181493; Coon S, 2006, ENVIRON HEALTH PERSP, V114, P1872, DOI 10.1289/ehp.9102; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Driscoll TR, 2016, ANN OCCUP HYG, V60, P113, DOI 10.1093/annhyg/mev056; Edwards M, 2014, ENVIRON SCI TECHNOL, V48, P739, DOI 10.1021/es4034952; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91; Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009; Furlong M, 2015, ENVIRON INT, V75, P144, DOI 10.1016/j.envint.2014.11.002; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2012, ANN NEUROL, V71, P776, DOI 10.1002/ana.22629; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Jacobs BM, 2020, J NEUROL NEUROSUR PS, V91, P1046, DOI 10.1136/jnnp-2020-323646; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kuhn W, 1998, NEUROLOGY, V50, P1885, DOI 10.1212/WNL.50.6.1885; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Liew Z, 2014, ARCH ENVIRON OCCUP H, V69, P241, DOI 10.1080/19338244.2013.778808; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Neal AP, 2013, TOXICOL RES-UK, V2, P99, DOI 10.1039/c2tx20064c; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Petrovitch H, 2002, ARCH NEUROL-CHICAGO, V59, P1787, DOI 10.1001/archneur.59.11.1787; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Pouchieu C, 2018, INT J EPIDEMIOL, V47, P299, DOI 10.1093/ije/dyx225; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Racette BA, 2012, NEUROTOXICOLOGY, V33, P1356, DOI 10.1016/j.neuro.2012.08.011; Ruckart PZ, 2019, J PUBLIC HEALTH MAN, V25, pS84, DOI 10.1097/PHH.0000000000000871; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shrestha S, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110186; Simon DK, 2020, CLIN GERIATR MED, V36, P1, DOI 10.1016/j.cger.2019.08.002; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Tansey MG, 2019, EUR J NEUROSCI, V49, P364, DOI 10.1111/ejn.14290; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Weisskopf MG, 2010, ENVIRON HEALTH PERSP, V118, P1609, DOI 10.1289/ehp.1002339; Willis AW, 2010, AM J EPIDEMIOL, V172, P1357, DOI 10.1093/aje/kwq303; Willis AW, 2010, PARKINSONISM RELAT D, V16, P163, DOI 10.1016/j.parkreldis.2009.09.002; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491; Winkel R, 1995, J NEURAL TRANSM-SUPP, P183; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Zhang JB, 2012, INT J BIOL SCI, V8, P935, DOI 10.7150/ijbs.4499	55	0	0	3	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-8083	2042-0080		PARKINSONS DIS-US	Parkinsons Dis.	JUL 2	2021	2021								5541760	10.1155/2021/5541760			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL2AS	WOS:000674656700002	34306610	gold, Green Published			2022-02-07	
J	Brooks, KJL; Sullivan, KA				Brooks, Kelly Jack Lee; Sullivan, Karen A.			Validating the modified Rivermead Post-concussion Symptoms Questionnaire (mRPQ)	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Mild traumatic brain injury; minor head injury; concussion; postconcussive syndrome; symptom validity; response bias; symptom exaggeration; invalid responding	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; UTILITY; SCALE; EPIDEMIOLOGY; EXAGGERATION; INVENTORY; VALIDITY-10; MULTICENTER	Objective: Response distortions in the reporting of postconcussion symptoms can occur for many reasons. The Rivermead Post-concussion Symptoms Questionnaire (RPQ) was recently modified to include an embedded symptom validity indicator to test for atypical symptoms. The present study used a simulation design to investigate the psychometric properties of the modified RPQ (mRPQ). Method: 298 adult volunteers were randomised into three groups: honest responding (Controls, C) who reported actual, current symptoms; mild traumatic brain injury (mTBI) simulators (MS) who role played being injured, and; biased mTBI simulators (BMS) who role played being injured and were asked to bias (exaggerate) their response. The MS and BMS participants received instructions to support the simulation. All participants completed the mRPQ and a modified Neurobehavioral Symptom Inventory (mNSI). Results: A 2 x 3 mixed ANOVA with one within-group variable (Symptom type: Standard or Atypical) and one between-group variable (Instruction type: C, MS, BMS) found a significant two-way interaction (p < .05, eta p2 = .08). Conclusions: The BMS group had score elevations for both standard and atypical postconcussion symptoms; therefore, both symptom types should be considered when evaluating for biased responding. The mRPQ has promising psychometric properties and should be further developed.	[Brooks, Kelly Jack Lee; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.autel			QUT School of Psychology and Counselling	This project was approved by the QUT Human Research Ethics Committee (HREC approval number: 1900001173). The risk assessment for this project was approved by the QUT (approval number: 1331). The QUT School of Psychology and Counselling funded the gift cards for this project.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Ashendorf L, 2019, J CLIN EXP NEUROPSYC, V41, P432, DOI 10.1080/13803395.2019.1567693; Balalla S, 2020, NEUROTRAUMA REP, V1, P63, DOI 10.1089/neur.2020.0017; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Boone K, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P551, DOI 10.1007/978-0-387-76978-3_18; Bowman LL, 2003, TEACH PSYCHOL, V30, P102, DOI 10.1207/S15328023TOP3002_03; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DeVellis R.F, 2016, SCALE DEV THEORY APP; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DONALDSON TS, 1968, J AM STAT ASSOC, V63, P660, DOI 10.2307/2284037; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P1029, DOI 10.1080/13854046.2017.1323119; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; George D., 2003, USING SPSS WINDOWS S; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C; Harp J.P., 2017, THESIS, P121, DOI [https://doi.org/10.13023/ETD.2017.341, DOI 10.13023/ETD.2017.341]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jelicic, 2020, PSYCHOL CONSCIOUS, DOI [10.1037/cns0000224, DOI 10.1037/CNS0000224]; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lace JW, 2021, CLIN NEUROPSYCHOL, V35, P572, DOI 10.1080/13854046.2019.1694703; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Maher JM, 2013, CBE-LIFE SCI EDUC, V12, P345, DOI 10.1187/cbe.13-04-0082; Martelli M.F., 2007, BRAIN INJURY MED PRI, P1183; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson N.W., 2013, MILD TRAUMATIC BRAIN, P119; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rogers R., 2019, CLIN ASSESSMENT MALI, V4th; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherman EMS, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P873, DOI 10.1007/978-0-387-76978-3_30; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Vosa L, 2019, BRAIN INJURY, V33, P1165, DOI 10.1080/02699052.2019.1637024; Windle K, 2021, APPL NEUROPSYCH-ADUL, V28, P512, DOI 10.1080/23279095.2019.1660880; Wisdom NM, 2010, ARCH CLIN NEUROPSYCH, V25, P118, DOI 10.1093/arclin/acp110; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	69	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1942555		JUL 2021	20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TU7HS	WOS:000681204100001	34348079				2022-02-07	
J	Chatterton, Z; Mendelev, N; Chen, SA; Carr, W; Kamimori, GH; Ge, YC; Dwork, AJ; Haghighi, F				Chatterton, Zac; Mendelev, Natalia; Chen, Sean; Carr, Walter; Kamimori, Gary H.; Ge, Yongchao; Dwork, Andrew J.; Haghighi, Fatemeh			Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						cfDNA; diagnostic; epigenetic; neuron; glia; neurotrauma	FETAL DNA; MATERNAL PLASMA; MUTANT-DNA; TURNOVER; KINETICS; SERUM	Sampling the live brain is difficult and dangerous, and withdrawing cerebrospinal fluid is uncomfortable and frightening to the subject, so new sources of real-time analysis are constantly sought. Cell-free DNA (cfDNA) derived from glia and neurons offers the potential for wide-ranging neurological disease diagnosis and monitoring. However, new laboratory and bioinformatic strategies are needed. DNA methylation patterns on individual cfDNA fragments can be used to ascribe their cell-of-origin. Here we describe bisulfite sequencing assays and bioinformatic processing methods to identify cfDNA derived from glia and neurons. In proof-of-concept experiments, we describe the presence of both glia- and neuron-cfDNA in the blood plasma of human subjects following mild trauma. This detection of glia- and neuron-cfDNA represents a significant step forward in the translation of liquid biopsies for neurological diseases.	[Chatterton, Zac; Mendelev, Natalia; Chen, Sean; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Chatterton, Zac; Mendelev, Natalia; Chen, Sean; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Chatterton, Zac; Mendelev, Natalia; Chen, Sean; Ge, Yongchao; Haghighi, Fatemeh] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Chatterton, Zac; Mendelev, Natalia; Chen, Sean; Haghighi, Fatemeh] James J Peters VA Med Ctr, Med Epigenet, New York, NY 10468 USA; [Chatterton, Zac] Univ Sydney, Fac Med & Hlth, Brain & Mind Ctr, Sch Med Sci, Sydney, NSW, Australia; [Carr, Walter; Kamimori, Gary H.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Dwork, Andrew J.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Dwork, Andrew J.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dwork, Andrew J.] New York State Psychiat Inst & Hosp, Mol Imaging & Neuropathol Div, New York, NY 10032 USA		Chatterton, Z (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Chatterton, Z (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Chatterton, Z (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Chatterton, Z (corresponding author), James J Peters VA Med Ctr, Med Epigenet, New York, NY 10468 USA.; Chatterton, Z (corresponding author), Univ Sydney, Fac Med & Hlth, Brain & Mind Ctr, Sch Med Sci, Sydney, NSW, Australia.	zac.chatterton@sydney.edu.au			NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); VA Merit grants [CX001728, CX001395, BX003794, RX001705]; VA CSR&D Research Career Scientist Award [CX002074]; Broad Agency Announcement Award [W81XWH16-2-0001]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH64168, R01 MH098786ORK]; Fogarty International Center at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)	This study was supported by a postdoctoral fellowship to ZC from the NIDA T32 postdoctoral training program in Interdisciplinary Training in Drug Abuse Research, and VA Merit grants CX001728, CX001395, BX003794, and RX001705 to FH at the James J. Peters VA Medical Center. Also, FH is a recipient of the VA CSR&D Research Career Scientist Award (CX002074). Sample collections (GK) were supported by Broad Agency Announcement Award No. W81XWH16-2-0001. This research was supported in part by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USAMRMC. Acquisition and sampling of postmortem brain was supported by grants R01 MH64168 and R01 MH098786ORK from the National Institute of Mental Health and the Fogarty International Center at the National Institutes of Health. This work was also supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai.	Anker P, 1997, GASTROENTEROLOGY, V112, P1114, DOI 10.1016/S0016-5085(97)70121-5; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barry DM, 2007, EXP CELL RES, V313, P2110, DOI 10.1016/j.yexcr.2007.03.011; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Breitwieser FP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1568-0; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Combaret V, 2002, CANCER RES, V62, P3646; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gauthier VJ, 1996, J IMMUNOL, V156, P1151; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lunnon K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0871-x; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Matevossian Anouch, 2008, J Vis Exp, DOI 10.3791/914; Moody LR, 2017, J BIOL CHEM, V292, P5814, DOI 10.1074/jbc.M116.772020; Moss J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07466-6; Naeem H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-51; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Rosoklija G, 2013, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V34, P95; Salkeni MA, 2013, J NEURO-ONCOL, V115, P27, DOI 10.1007/s11060-013-1209-0; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Smyth GK, 2005, BIOINFORMATICS COMPU, V2005, P2005; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; VANDENBROEK J, 1995, BIOMETRICS, V51, P738, DOI 10.2307/2532959; Ye ZM, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcaa235	38	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUL 2	2021	14								672614	10.3389/fnmol.2021.672614			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TK1SU	WOS:000673947900001	34276305	Green Published, gold			2022-02-07	
J	Chowdhary, K; Enam, N				Chowdhary, Kuntal; Enam, Nabela			Post-traumatic Headaches After Traumatic Brain Injury: Current Clinical Approaches	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Post-traumatic headache; Traumatic brain injury; Rehabilitation; Secondary headache disorders; Head trauma; Prognosis	TENSION-TYPE HEADACHE; CLUSTER HEADACHE; NATURAL-HISTORY; SYMPTOMS; MIGRAINE; PATHOPHYSIOLOGY; PAIN; DEPRESSION; MANAGEMENT; DISORDERS	Purpose of Review The purpose of this review is to provide up-to-date literature on post-traumatic headache (PTH) and define a clear nomenclature for variable clinical presentations. This review discusses an evidence-based approach to the prognostication and treatment of PTH, which are further described in two clinical cases. Recent Findings As significant morbidity is associated with PTH, recent literature has focused on improved identification. Accurate diagnosis has led to targeted treatment that incorporates a multi-modal approach including pharmacological and nonpharmacological interventions. A detailed history and physical exam are key in recognizing the presenting phenotype of this secondary headache, which may be migrainous, tension-type, trigeminal autonomic cephalalgia, cervicogenic, or another PTH classification. Clinicians should clearly define the headache phenotype to provide effective management with a multi-modal approach targeting the namesake primary headache. This is crucial for successful recovery. Further research is needed to establish best practice guidelines for prognosis, as presentation, treatment and outcomes continue to vary.	[Chowdhary, Kuntal; Enam, Nabela] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, 1400 Locust St,Bldg E,Room 11522, Pittsburgh, PA 15219 USA		Enam, N (corresponding author), Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, 1400 Locust St,Bldg E,Room 11522, Pittsburgh, PA 15219 USA.	chowdharyk@upmc.edu; enamn@upmc.edu		Chowdhary, Kuntal/0000-0003-3676-0565; Enam, Nabela/0000-0001-6430-8176			Alstadhaug KB, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000612; Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Ashina H, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01202-6; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina S, 2015, CEPHALALGIA, V35, P211, DOI 10.1177/0333102414535110; Bartnik-Olson BL, 2021, BRAIN IMAGING BEHAV, V15, P504, DOI 10.1007/s11682-020-00330-6; Bohman T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-264; Bomyea J, 2016, HEADACHE, V56, P699, DOI 10.1111/head.12799; Burish MJ, 2019, NEUROL CLIN, V37, P847, DOI 10.1016/j.ncl.2019.07.001; Cancelliere C, 2020, ACCIDENT ANAL PREV, V142, DOI 10.1016/j.aap.2020.105580; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chan TLH, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1080-2; Coppola G, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0997-9; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Dwyer B, 2020, NEUROREHABILITATION, V47, P327, DOI 10.3233/NRE-208006; Etheredge, 2015, PAIN PRACT SUMMER, V25, P19; Evans RW, 2014, NEUROL CLIN, V32, P283, DOI 10.1016/j.ncl.2013.11.010; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fraser F, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0624-x; Grangeon L, 2020, J NEUROL NEUROSUR PS, V91, P572, DOI 10.1136/jnnp-2019-322725; Hassani-Mahmooei B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1386-6; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; JENSEN OK, 1990, CEPHALALGIA, V10, P295, DOI 10.1046/j.1468-2982.1990.1006295.x; Kane AW, 2019, SEMIN SPEECH LANG, V40, P36, DOI 10.1055/s-0038-1676652; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Ko Hak-Cheol, 2018, Asian J Neurosurg, V13, P1229, DOI 10.4103/ajns.AJNS_197_17; Kristoffersen ES, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0894-7; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Lambru G, 2010, CEPHALALGIA, V30, P1502, DOI 10.1177/0333102409359710; Langdon R, 2018, PEDIATR ANN, V47, pE61, DOI 10.3928/19382359-20180131-01; Leone M, 2009, LANCET NEUROL, V8, P755, DOI 10.1016/S1474-4422(09)70133-4; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; May A, 2018, DTSCH ARZTEBL INT, V115, P299, DOI 10.3238/arztebl.2018.0299; McMurtray AM, 2013, INT J PSYCHIAT MED, V45, P227, DOI 10.2190/PM.45.3.b; Merkley, NEUROPSYCHOL REV, V2021; Messlinger Karl, 2011, Keio Journal of Medicine, V60, P82; Minen M, 2019, HEADACHE, V59, P151, DOI 10.1111/head.13455; Moseley GL, 2015, J PAIN, V16, P807, DOI 10.1016/j.jpain.2015.05.005; Murphy PB., 2021, CERVICOGENIC HEADACH; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Rau JC, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0719-z; Register-Mihalik JK, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0724-2; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Schueler M, 2013, PAIN, V154, P1622, DOI 10.1016/j.pain.2013.04.040; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Starling AJ, 2018, MAYO CLIN PROC, V93, P252, DOI 10.1016/j.mayocp.2017.12.002; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Do TP, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0913-8; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; WAN Q, 2017, BIOMED RES INT, V2017, DOI DOI 10.1155/2017/4654803; Watson DH, 2016, HEADACHE, V56, P961, DOI 10.1111/head.12805; WHO, 2011, INT STAT CLASS DIS R; Wu BS, 2019, PAIN MED, V20, P1219, DOI 10.1093/pm/pny227; Zafonte, BRAIN INJURY MED 3 E, V2021	67	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	SEP	2021	9	3					100	107		10.1007/s40141-021-00314-7		JUL 2021	8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	UM0OZ	WOS:000681283500001					2022-02-07	
J	Rollet-Cohen, V; Sachs, P; Leger, PL; Merchaoui, Z; Rambaud, J; Berteloot, L; Kossorotoff, M; Mortamet, G; Dauger, S; Tissieres, P; Renolleau, S; Oualha, M				Rollet-Cohen, Virginie; Sachs, Philippe; Leger, Pierre-Louis; Merchaoui, Zied; Rambaud, Jerome; Berteloot, Laureline; Kossorotoff, Manoelle; Mortamet, Guillaume; Dauger, Stephane; Tissieres, Pierre; Renolleau, Sylvain; Oualha, Mehdi			Transcranial Doppler Use in Non-traumatic Critically Ill Children: A Multicentre Descriptive Study	FRONTIERS IN PEDIATRICS			English	Article						doppler ultrasonography; transcranial; pediatric intensive care unit; critically ill children; nervous system diseases; neuro monitoring	BLOOD-FLOW VELOCITY; PEDIATRIC INTENSIVE-CARE; EXTRACORPOREAL MEMBRANE-OXYGENATION; NERVOUS-SYSTEM INFECTIONS; BRAIN-DEATH; CEREBRAL AUTOREGULATION; DIABETIC-KETOACIDOSIS; NEUROCRITICAL CARE; GENDER-DIFFERENCES; PULSATILITY INDEX	Background: The use and perceived value of transcranial Doppler (TCD) scope in paediatric critical care medicine has not been extensively documented. Objective: To describe the use of TCD to assess non-traumatic brain injury in patients admitted to four paediatric intensive care units (PICUs) in France. Methods: We prospectively included all children (aged under 18) assessed with inpatient TCD between November 2014 and October 2015 at one of the four PICUs. The physicians completed a questionnaire within 4 h of performing TCD. Results: 152 children were included. The primary diagnosis was neurological disease in 106 patients (70%), including post ischemic-anoxic brain insult (n = 42, 28%), status epilepticus (n = 19, 13%), and central nervous system infection/inflammation (n = 15, 10%). TCD was the first-line neuromonitoring assessment in 110 patients (72%) and was performed within 24 h of admission in 112 patients (74%). The most common indications for TCD were the routine monitoring of neurological disorders (n = 85, 56%) and the detection of asymptomatic neurological disorders (n = 37, 24). Concordance between the operator's interpretation of TCD and the published normative values was observed for 21 of the 75 (28%) TCD abnormal findings according to the published normative values. The physicians considered that TCD was of value for the ongoing clinical management of 131 (86%) of the 152 patients. Conclusion: TCD is commonly used in French PICUs and tends to be performed early after admission on patients with a broad range of diseases. The physicians reported that the TCD findings often helped their clinical decision making. In view of the subjectivity of bedside interpretation, true TCD contribution to clinical care remains to be determined. Objective studies of the impact of TCD on patient management and clinical outcomes are therefore warranted.	[Rollet-Cohen, Virginie; Renolleau, Sylvain; Oualha, Mehdi] Necker Enfants Malad Univ Hosp, Assistance Publ Hop Paris, Paediat Intens Care Unit, Paris, France; [Sachs, Philippe; Dauger, Stephane] Robert Debre Univ Hosp, Assistance Publ Hop Paris, Paediat Intens Care Unit, Paris, France; [Leger, Pierre-Louis; Rambaud, Jerome] Trousseau Univ Hosp, Assistance Publ Hop Paris, Paediat & Neonatal Intens Care Unit, Paris, France; [Merchaoui, Zied; Tissieres, Pierre] Paris South Univ Hosp, Assistance Publ Hop Paris, Pediat Intens Care, Paris, France; [Berteloot, Laureline] Necker Enfants Malad Univ Hosp, Assistance Publ Hop Paris, Paediat Radiol Dept, Paris, France; [Kossorotoff, Manoelle] Necker Enfants Malad Univ Hosp, Assistance Publ Hop Paris, French Ctr Paediat Stroke, Paediat Neurol Dept, Paris, France; [Mortamet, Guillaume] Grenoble Univ Hosp, Paediat Intens Care Unit, Grenoble, France		Rollet-Cohen, V (corresponding author), Necker Enfants Malad Univ Hosp, Assistance Publ Hop Paris, Paediat Intens Care Unit, Paris, France.	virginierollet11@gmail.com	Dauger, Stephane/AAX-9669-2021; Oualha, Mehdi/AAW-7706-2021				Abdo A, 2015, TRANSPL P, V47, P2647, DOI 10.1016/j.transproceed.2015.10.006; Abecasis F, 2018, CHILD NERV SYST, V34, P1465, DOI 10.1007/s00381-018-3877-8; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Albers JM, 2012, CEREBROVASC DIS, V33, P403, DOI 10.1159/000335826; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BODE H, 1988, ARCH DIS CHILD, V63, P1474, DOI 10.1136/adc.63.12.1474; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Chen KS, 2003, J ULTRAS MED, V22, P1061, DOI 10.7863/jum.2003.22.10.1061; Ducharme-Crevier L, 2016, PEDIATR NEUROL, V65, P52, DOI 10.1016/j.pediatrneurol.2016.08.027; Fullerton HJ, 2011, J CHILD NEUROL, V26, P1101, DOI 10.1177/0883073811408089; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hindy-Francois C, 2009, TRANSPLANTATION, V87, P616, DOI 10.1097/TP.0b013e3181963d91; Horvat CM, 2016, SEMIN NEUROL, V36, P492, DOI 10.1055/s-0036-1592107; Kennedy BC, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13405; Killic T, 2002, CHILD NERV SYST, V18, P142, DOI 10.1007/s00381-002-0571-6; Klein M, 2011, CRIT CARE, V15, DOI 10.1186/cc10565; LaRovere KL, 2020, PEDIATR CRIT CARE ME, V21, P67, DOI 10.1097/PCC.0000000000002118; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; LaRovere KL, 2015, CURR OPIN PEDIATR, V27, P712, DOI 10.1097/MOP.0000000000000282; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Lowe LH, 2005, AM J NEURORADIOL, V26, P1698; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; Ma L, 2014, PEDIATR CRIT CARE ME, V15, P742, DOI 10.1097/PCC.0000000000000197; Mayo PH, 2009, CHEST, V135, P1050, DOI 10.1378/chest.08-2305; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Muller M, 1996, ULTRASOUND MED BIOL, V22, P173, DOI 10.1016/0301-5629(95)02029-2; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; O'Brien NF, 2019, PEDIATR CRIT CARE ME, V20, P178, DOI 10.1097/PCC.0000000000001778; O'Brien NF, 2013, PEDIATR CRIT CARE ME, V14, pE126, DOI 10.1097/PCC.0b013e3182712d62; O'Brien NF, 2018, J PEDIATR-US, V203, P116, DOI 10.1016/j.jpeds.2018.07.075; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; Qian S. Y., 1998, SMJ, V39, P247; Rilinger JF, 2017, J STROKE CEREBROVASC, V26, P2336, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.022; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Strauss G, 1997, HEPATOLOGY, V25, P837, DOI 10.1002/hep.510250409; SWAANENBURG JCJM, 1987, AM J CLIN PATHOL, V88, P182, DOI 10.1093/ajcp/88.2.182; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; van Toorn R, 2014, CHILD NERV SYST, V30, P1711, DOI 10.1007/s00381-014-2435-2; Vavilala MS, 2019, PEDIATR CRIT CARE ME, V20, P200, DOI 10.1097/PCC.0000000000001833; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Zieleskiewicz L, 2015, INTENS CARE MED, V41, P1638, DOI 10.1007/s00134-015-3952-5; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X	48	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	JUL 2	2021	9								609175	10.3389/fped.2021.609175			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	TK1MV	WOS:000673932400001	34277513	Green Published, gold			2022-02-07	
J	Zhu, S; Cheng, C; Zhao, DJ; Zhao, YL; Liu, XZ; Zhang, J				Zhu, Sha; Cheng, Chao; Zhao, Dianjiang; Zhao, Yuanli; Liu, Xianzeng; Zhang, Jun			The clinical and prognostic values of optic nerve sheath diameter and optic nerve sheath diameter/eyeball transverse diameter ratio in comatose patients with supratentorial lesions	BMC NEUROLOGY			English	Article						Optic nerve sheath diameter; Eyeball transverse diameter; Coma; Intracranial pressure; Prognosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; COMPUTED-TOMOGRAPHY; ARCHITECTURE; PREDICTION	Background The optic nerve sheath diameter (ONSD) and ONSD/eyeball transverse diameter (ETD) ratio have been proven to be correlated with intracranial pressure. This study aimed to evaluate the prognostic roles of ONSD and the ONSD/ETD ratio in comatose patients with supratentorial lesions and to determine the relationship of these two indices with the prognosis of such patients. Methods A total of 54 comatose patients with supratentorial lesions and 50 healthy controls were retrospectively included in this study. ONSD and ETD were measured by unenhanced computed tomography (CT). The differences in ONSD and the ONSD/ETD ratio between the two groups were compared. The prognosis of comatose patients was scored using the Glasgow Outcome Scale (GOS) at the 3-month follow-up, and these patients were classified into good (GOS score >= 3) and poor (GOS score < 3) prognosis groups. The differences in ONSD and the ONSD/ETD ratio were compared between comatose patients with good prognoses and those with poor prognoses. Results The ONSD and ONSD/ETD ratios in the comatose patients were 6.30 +/- 0.60 mm and 0.27 +/- 0.03, respectively, and both were significantly greater than those in the healthy controls (5.10 +/- 0.47 mm, t = 11.426, P < 0.0001; 0.22 +/- 0.02, t = 11.468, P < 0.0001; respectively). ONSD in patients with poor prognosis was significantly greater than that in patients with good prognosis (6.40 +/- 0.56 vs. 6.03 +/- 0.61 mm, t = 2.197, P = 0.032). The ONSD/ETD ratio in patients with poor prognosis was significantly greater than that in patients with good prognosis (0.28 +/- 0.02 vs. 0.26 +/- 0.03, t = 2.622, P = 0.011). The area under the receiver operating characteristic (ROC) curve, used to predict the prognosis of comatose patients, was 0.650 (95% confidence interval (CI): 0.486-0.815, P = 0.078) for ONSD and 0.711 (95% CI: 0.548-0.874, P = 0.014) for the ONSD/ETD ratio. Conclusions The ONSD and ONSD/ETD ratios were elevated in comatose patients. The ONSD/ETD ratio might be more valuable than ONSD in predicting the prognoses of comatose patients with supratentorial lesions.	[Zhu, Sha; Zhang, Jun] Peking Univ, Dept Neurol, Peoples Hosp, 11 South Ave, Beijing 100044, Peoples R China; [Cheng, Chao; Zhao, Dianjiang] Peking Univ, Dept Radiol, Int Hosp, Beijing, Peoples R China; [Zhao, Yuanli] Peking Univ, Dept Neurosurg, Int Hosp, Beijing, Peoples R China; [Zhao, Yuanli] Beijing TianTan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Xianzeng] Peking Univ, Dept Neurol, Int Hosp, 1 Life Sci Pk Life Rd, Beijing 102206, Peoples R China		Zhang, J (corresponding author), Peking Univ, Dept Neurol, Peoples Hosp, 11 South Ave, Beijing 100044, Peoples R China.; Liu, XZ (corresponding author), Peking Univ, Dept Neurol, Int Hosp, 1 Life Sci Pk Life Rd, Beijing 102206, Peoples R China.	liuxianzeng@pkuih.edu.cn; who626@163.com		Liu, xianzeng/0000-0003-3568-5401			Albert AF, 2017, J STROKE CEREBROVASC, V26, P2671, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.041; Bartsikhovsky T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216812; Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Chelly J, 2016, RESUSCITATION, V103, P7, DOI 10.1016/j.resuscitation.2016.03.006; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Du J, 2020, NEUROCRIT CARE, V32, P478, DOI 10.1007/s12028-019-00762-z; Gao YZ, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1202-5; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Haimann MCJ, 1998, J ANAT, V192, P99; Kavi T, 2018, CUREUS, V10, DOI 10.7759/cureus.3546; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kim DH, 2018, J CLIN NEUROL, V14, P345, DOI 10.3988/jcn.2018.14.3.345; Kim DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16173-z; Kim YH, 2014, ACAD EMERG MED, V21, P1121, DOI 10.1111/acem.12477; Lee S, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2360-6; Lee SJ, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01931-w; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Legros V, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105500; MIKELBERG FS, 1991, OPHTHALMOLOGY, V98, P60; Naldi A, 2020, NEUROL SCI, V41, P329, DOI 10.1007/s10072-019-04076-y; Rabinstein Alejandro A, 2018, Continuum (Minneap Minn), V24, P1708, DOI 10.1212/CON.0000000000000666; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; Vaiman M, 2016, J CLIN NEUROSCI, V34, P177, DOI 10.1016/j.jocn.2016.06.008; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; Waheed S, 2018, J PAK MED ASSOC, V68, P268	28	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 2	2021	21	1							259	10.1186/s12883-021-02285-7			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TH1EV	WOS:000671838300002	34215217	gold, Green Published			2022-02-07	
J	Abecasis, F; Dias, C; Zakrzewska, A; Oliveira, V; Czosnyka, M				Abecasis, Francisco; Dias, Celeste; Zakrzewska, Agnieszka; Oliveira, Vitor; Czosnyka, Marek			Monitoring cerebrovascular reactivity in pediatric traumatic brain injury: comparison of three methods	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatrics; Cerebrovascular circulation; Intracranial pressure; Cerebral perfusion pressure	CEREBRAL PERFUSION-PRESSURE; AUTOREGULATION; FLOW; THRESHOLDS; MANAGEMENT; CHILDREN	Purpose To study three different methods of monitoring cerebral autoregulation in children with severe traumatic brain injury. Methods Prospective cohort study of all children admitted to the pediatric intensive care unit at a university-affiliated hospital with severe TBI over a 4-year period to study three different methods of monitoring cerebral autoregulation: pressure-reactivity index (PRx), transcranial Doppler derived mean flow velocity index (Mx), and near-infrared spectroscopy derived cerebral oximetry index (COx). Results Twelve patients were included in the study, aged 5 months to 17 years old. An empirical regression analyzing dependence of PRx on cerebral perfusion pressure (CPP) displayed the classic U-shaped distribution, with low PRx values (< 0.3) reflecting intact auto-regulation, within the CPP range of 50-100 mmHg. The optimal CPP was 75-80 mmHg for PRx and COx. The correlation coefficients between the three indices were as follows: PRx vs Mx, r = 0.56; p < 0.0001; PRx vs COx, r = 0.16; p < 0.0001; and COx vs Mx, r = 0.15; p = 0.022. The mean PRx with a cutoff value of 0.3 predicted correctly long-term outcome (p = 0.015). Conclusions PRx seems to be the most robust index to access cerebrovascular reactivity in children with TBI and has promising prognostic value. Optimal CPP calculation is feasible with PRx and COx.	[Abecasis, Francisco] Univ Lisbon, Ctr Hosp Univ Lisboa Norte, Fac Med, Pediat Intens Care Unit, Lisbon, Portugal; [Dias, Celeste] Ctr Hosp Univ Sao Joao, Intens Care Dept, Neurocrit Care Unit, Porto, Portugal; [Zakrzewska, Agnieszka; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England; [Oliveira, Vitor] Univ Lisbon, Ctr Hosp Univ Lisboa Norte, Fac Med, Neurol Dept,Lab Cerebral Ultrasound, Lisbon, Portugal; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Abecasis, F (corresponding author), Univ Lisbon, Ctr Hosp Univ Lisboa Norte, Fac Med, Pediat Intens Care Unit, Lisbon, Portugal.	francisco.abecasis@chln.min-saude.pt	Dias, Celeste/AAV-3820-2020; Abecasis, Francisco/M-1875-2013	Dias, Celeste/0000-0003-0340-9808; Abecasis, Francisco/0000-0002-1883-050X	NIHR Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR)	MC is supported by NIHR Biomedical Research Centre, Cambridge.	Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Andropoulos DB, 2003, J THORAC CARDIOV SUR, V125, P491, DOI 10.1067/mtc.2003.159; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hahn GH, 2011, PEDIATR RES, V70, P166, DOI 10.1203/PDR.0b013e3182231d9e; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Young AMH, 2018, PEDIATR RES, V83, P41, DOI 10.1038/pr.2017.215; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	28	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2021	37	10					3057	3065		10.1007/s00381-021-05263-z		JUL 2021	9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	WG1YZ	WOS:000668826400002	34212250				2022-02-07	
J	Ali, H; Mushtaq, M; ul Haq, N; Ullah, MA; Ali, S; Shah, A				Ali, Haider; Mushtaq, Mohammad; ul Haq, Naeem; Ullah, Muhammad Anwar; Ali, Saqib; Shah, Anwar			Surgical management and Outcomes of Depressed Skull Fractures	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Depressed skull fracture; Non-missile injuries; Compund skull fracture; conservative management	HEAD-INJURY; REPLACEMENT; INFECTION	Objective: To determine the outcomes of surgical management in patients presented with depressed skull fractures. Study Design:Prospective Study Place and Duration of Study: Conducted at Neurosurgery department of Mardan Medical Complex/ Bacha Khan Medical College, Mardan during the period from 16th January 2019 to 15thJanuary 2020. Methodology: 65patients of both genders with ages were 10 to 60 year were included in this study. Patients were aged between 12-70 years of age. After taking informed written consent from all patient's/parent/guardians, detailed demographics age, gender,body mass index cause of fracture, type of fracture and site of fracture wererecorded. CT scan was performed on all patients.Depressed fracture of more than 5 mm, cosmetically disfiguring fractures and fracture over the sinuses were operated. Patients were held under examination for 12-weeks.Glasgow Coma Scale (GCS) was used for final outcome. Data was analyzed by SPSS 27.0. Results:Out of all the patients, male patients were 45(69.23%) and female patients were 20 (30.76%). 35(53.85%) with ages <30, 20(30.76%) with ages 30 to 50 and 10(15.38%) with ages >50 were reordered in study. Mean body mass index was 20.04 +/- 3.14 kg/m(2).The most common cause of the injury was road traffic accident 45(69.23%) followed by fall from the height 20 (30.76%). 40(61.53%)were compound fracture and 25 (38.46%) were closed fracture. 55 (87.5%) cases were treated surgically and 10 (12.5%) patients were treated conservatively. 45(69.23%) patients were completely recovered, 10 (12.5%) were moderately disabled and 7(10.77%) were severely disabled and 3(4.61%) were died. Conclusion:If treated promptly most of the cases of compound depress skull fracture revealed good results but outcomes of the depress skull fracture revealed contingent severity of injury and absence or presence of intracranial lesion.	[Ali, Haider] Lady Reading Hosp, Neurosurg Dept, Peshawar, Pakistan; [Mushtaq, Mohammad] Frontier Med & Dent Coll, Neurosurg Dept, Abbottabad, Pakistan; [ul Haq, Naeem] Bacha Khan Med Coll, Mardan Med Complex, Neurosurg Dept, Mardan, Pakistan; [Ullah, Muhammad Anwar] DHQ Teaching Hosp, Timergara, Pakistan; [Ali, Saqib] Univ Agr Faisalabad, Dept Comp Sci, Faisalabad, Pakistan; [Shah, Anwar] Khalifa Gul Nawaz Hosp Bannu, Neurosurg, Bannu, Pakistan		ul Haq, N (corresponding author), Bacha Khan Med Coll, Mardan Med Complex, Neurosurg Dept, Mardan, Pakistan.	brainsurgeon1978@yahoo.com					Ahmad S, 2018, PAK J MED SCI, V34, P130, DOI 10.12669/pjms.341.13184; Al-Derazi T, 2008, PAN ARAB J NEUROSURG, V12, P80; Ali L, 2021, J SAIDU MED COLL SWA, V11, P30; Ali M, 2003, JPMI, V17, P23; Asif Muhammad, 2017, PAK J NEUROL SURG, V21; BLANKENSHIP JB, 1991, PEDIATR NEUROSURG, V16, P297; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Fitzsimmons-Francis C, 2001, SURGINT, V52, P25; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan AH, 2004, THESIS PUNJAB U LAHO; Mendelow A D, 1983, J R Coll Surg Edinb, V28, P80; Mushtaq Muhammad Junaid, 2013, PAK J NEUROL SURG, V17; Nnadi M O N, 2014, Niger Postgrad Med J, V21, P311; Parker R, 2000, SURGINT, V51, P209; Rehman L, 2007, JCPSP-J COLL PHYSICI, V17, P140; Ren LH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072392; Rolekar Nikita G, 2014, IJMHS, V3, DOI [10.5455/ijmsph.2014.271020141, DOI 10.5455/IJMSPH.2014.271020141]; Satardey Ritesh S, 2018, Asian J Neurosurg, V13, P341, DOI 10.4103/ajns.AJNS_117_16; Tamimi A, 2005, PEDIATR NEUROSURG, V41, P237, DOI 10.1159/000087480; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Wylen EL, 1999, SURG NEUROL, V51, P452, DOI 10.1016/S0090-3019(98)00040-8	21	0	0	0	0	LAHORE MEDICAL RESEARCH CENTER LLP	LAHORE	590, Karim Block, Allama Iqbal Town, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	JUL	2021	15	7					2327	2329		10.53350/pjmhs211572327			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	WK8AR	WOS:000709944600108					2022-02-07	
J	Ali, M; Asghar, N; Li, A; Hannah, T; Spiera, Z; Marayati, NF; Dreher, N; Durbin, J; Gometz, A; Lovell, M; Choudhri, T				Ali, Muhammad; Asghar, Nek; Li, Adam; Hannah, Theodore; Spiera, Zachary; Marayati, Naoum Fares; Dreher, Nickolas; Durbin, John; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir			Incidence of concussion and recovery of neurocognitive dysfunction on ImPACT assessment among youth athletes with premorbid depression or anxiety taking antidepressants	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						antidepressants; anxiety; concussion; depression; ImPACT; trauma	SPORT; CHILDREN; FLUOXETINE; SYMPTOMS; PATTERNS; PLACEBO	OBJECTIVE Concussions in youth sports comprise an estimated 1.6-3.8 million annual injuries in the US. Sex, age, and attention-deficit hyperactivity disorder (ADHD) have been identified as salient risk factors for concussion. This study seeks to evaluate the role of premorbid depression or anxiety (DA), with or without antidepressant use, on the incidence of concussion and the recovery of symptoms and neurocognitive dysfunction after concussion. METHODS Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) was administered to 7453 youth athletes at baseline. Throughout the season, concussions were examined by physicians and athletic trainers, followed by readministration of ImPACT postinjury (PI) and again at follow-up, a median of 7 days PI. Individuals were divided into three categories: 1) unmedicated athletes with DA (DA-only, n = 315), athletes taking antidepressants (DA-meds, n = 81), and those without DA or antidepressant use (non-DA, n = 7039). Concussion incidence was calculated as the total number of concussions per total number of patient-years. The recovery of neurocognitive measures PI was calculated as standardized deviations from baseline to PI and then follow-up in the 5 composite ImPACT scores: symptom score, verbal memory, visual memory, visual motor skills, and reaction time. Univariate results were confirmed with multivariate analysis. RESULTS There was no difference in concussion incidence between the DA-only cohort and the non-DA group. How-ever, the DA-meds group had a significantly greater incidence of concussion than both the DA-only group (OR 2.67, 95% CI 1.88-7.18, p = 0.0001) and the non-DA group (OR 2.19, 95% CI 1.16-4.12, p = 0.02). Deviation from baseline in PI symptom scores was greater among the DA-meds group as compared to the non-DA group (OR 1.14, 95% CI 1.01-1.28, p = 0.03). At follow-up, the deviation from baseline in symptom scores remained elevated among the DA-meds group as compared to the non-DA group (OR 1.62, 95% CI 1.20-2.20, p = 0.002) and the DA-only group (OR 1.87, 95% CI 1.12-3.10, p = 0.02). Deviation from baseline in follow-up verbal memory was also greater among the DA-meds group as compared to both the non-DA group (OR 1.57, 95% CI 1.08-2.27, p = 0.02) and the DA-only group (OR 1.66, 95% CI 1.03-2.69, p = 0.04). CONCLUSIONS Premorbid DA itself does not seem to affect the incidence of concussion or the recovery of symptoms and neurocognitive dysfunction PI. However, antidepressant use for DA is associated with 1) increased concussion inci- dence and 2) elevated symptom scores and verbal memory scores up to 7 days after concussion, suggesting impaired symptomatic and neurocognitive recovery on ImPACT.	[Ali, Muhammad; Asghar, Nek; Li, Adam; Hannah, Theodore; Spiera, Zachary; Marayati, Naoum Fares; Dreher, Nickolas; Durbin, John; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY USA; [Gometz, Alex] Concuss Management New York, New York, NY USA; [Lovell, Mark] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA		Ali, M (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	muhammad.ali@icahn.mssm.edu	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Hannah, Theodore/0000-0001-6527-9725			[Anonymous], 2011, PRINC EP PUBL HLTH P PRINC EP PUBL HLTH P; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; Children's Mental Health, 2020, DAT STAT; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; HEILIGENSTEIN JH, 1994, PSYCHIAT RES, V52, P327, DOI 10.1016/0165-1781(94)90078-7; HEILIGENSTEIN JH, 1994, J AFFECT DISORDERS, V30, P163, DOI 10.1016/0165-0327(94)90077-9; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kroshus E, 2019, J CLIN SPORT PSYCHOL, V13, P390, DOI 10.1123/jcsp.2018-0004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lariviere K, 2019, J SPORTS MED HINDAWI; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Oberlander TF, 2011, PAED CHILD HEALT-CAN, V16, P549, DOI 10.1093/pch/16.9.549; Pluhar E, 2019, J SPORT SCI MED, V18, P490; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	23	0	0	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2021	28	1					69	75		10.3171/2020.11.PEDS20821			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TH0TW	WOS:000671808900004	33962383				2022-02-07	
J	Amelot, A; Nataloni, A; Francois, P; Cook, AR; Lejeune, JP; Baroncini, M; Henaux, PL; Toussaint, P; Peltier, J; Buffenoir, K; Hamel, O; Hieu, PD; Chibbaro, S; Kehrli, P; Lahlou, MA; Menei, P; Lonjon, M; Mottolese, C; Peruzzi, P; Mahla, K; Scarvada, D; Le Guerinel, C; Caillaud, P; Nuti, C; Pommier, B; Faillot, T; Iakovlev, G; Goutagny, S; Lonjon, N; Cornu, P; Bousquet, P; Sabatier, P; Debono, B; Lescure, JP; Vicaut, E; Froelich, S				Amelot, A.; Nataloni, A.; Francois, P.; Cook, A-R; Lejeune, J-P; Baroncini, M.; Henaux, P-L; Toussaint, P.; Peltier, J.; Buffenoir, K.; Hamel, O.; Dam Hieu, P.; Chibbaro, S.; Kehrli, P.; Lahlou, M. A.; Menei, P.; Lonjon, M.; Mottolese, C.; Peruzzi, P.; Mahla, K.; Scarvada, D.; Le Guerinel, C.; Caillaud, P.; Nuti, C.; Pommier, B.; Faillot, T.; Iakovlev, G.; Goutagny, S.; Lonjon, N.; Cornu, P.; Bousquet, P.; Sabatier, P.; Debono, B.; Lescure, J-P; Vicaut, E.; Froelich, S.			Security and reliability of CUSTOMBONE cranioplasties: A prospective multicentric study	NEUROCHIRURGIE			English	Article							TRAUMATIC BRAIN-INJURY; AUTOLOGOUS BONE FLAP; DECOMPRESSIVE CRANIECTOMY; TITANIUM CRANIOPLASTY; MADE HYDROXYAPATITE; CRANIAL DEFECTS; COMPLICATIONS; RECONSTRUCTION; IMPLANTS; PROSTHESIS	Background. - Repairing bone defects generated by craniectomy is a major therapeutic challenge in terms of bone consolidation as well as functional and cognitive recovery. Furthermore, these surgical procedures are often grafted with complications such as infections, breaches, displacements and rejections leading to failure and thus explantation of the prosthesis. Objective. - To evaluate cumulative explantation and infection rates following the implantation of a tailored cranioplasty CUSTOMBONE prosthesis made of porous hydroxyapatite. One hundred and ten consecutive patients requiring cranial reconstruction for a bone defect were prospectively included in a multicenter study constituted of 21 centres between December 2012 and July 2014. Follow-up lasted 2 years. Results. - Mean age of patients included in the study was 42 I 15 years old (y.o), composed mainly by men (57.27%). Explantations of the CUSTOMBONE prosthesis were performed in 13/110 (11.8%) patients, significantly due to infections: 9/13 (69.2%) (p<0.0001), with 2 (15.4%) implant fracture, 1 (7.7%) skin defect and 1 (7.7%) following the mobilization of the implant. Cumulative explantation rates were successively 4.6% (SD 2.0), 7.4% (SD 2.5), 9.4% (SD 2.8) and 11.8% (SD 2.9%) at 2, 6, 12 and 24 months. Infections were identified in 16/110 (14.5%): 8/16 (50%) superficial and 8/16 (50%) deep. None of the following elements, whether demographic characteristics, indications, size, location of the implant, redo surgery, co -morbidities or medical history, were statistically identified as risk factors for prosthesis explantation or infection. Conclusion. - Our study provides relevant clinical evidence on the performance and safety of CUSTOMBONE prosthesis in cranial procedures. Complications that are difficulty incompressible mainly occur during the first 6 months, but can appear at a later stage (>1 year). Thus assiduous, regular and long-term surveillances are necessary. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Amelot, A.; Francois, P.; Cook, A-R] Hop Bretonneau, Neurosurg Dept, Tours, France; [Nataloni, A.] Finceram Faenza SpA, Clin Res Dept, Ravenna, Italy; [Lejeune, J-P; Baroncini, M.] CHRU Lille, Neurosurg Dept, Lille, France; [Henaux, P-L] CHU Rennes, Neurosurg Dept, Rennes, France; [Toussaint, P.; Peltier, J.] CHU Amiens, Neurosurg Dept, Amiens, France; [Buffenoir, K.; Hamel, O.] CHU Nantes, Neurosurg Dept, Nantes, France; [Dam Hieu, P.] CHU Brest, Neurosurg Dept, Brest, France; [Chibbaro, S.; Lahlou, M. A.] CHU Strasbourg, Neurosurg Dept, Strasbourg, France; [Kehrli, P.; Menei, P.] CHU Angers, Neurosurg Dept, Angers, France; [Lonjon, M.] CHU Nice, Neurosurg Dept, Nice, France; [Mottolese, C.] CHU Neurol Lyon, Neurosurg Dept, Lyon, France; [Peruzzi, P.] CHU Maison Blanche, Neurosurg Dept, Reims, France; [Mahla, K.] Clin Tonkin, Neurosurg Dept, Villeurbanne, France; [Scarvada, D.] CHU Timone, Neurosurg Dept, Marseille, France; [Le Guerinel, C.] CHU Henri Mondor, Neurosurg Dept, Creteil, France; [Caillaud, P.] CH Cote Basque, Neurosurg Dept, Bayonne, France; [Nuti, C.; Pommier, B.] CHU St Etienne, Neurosurg Dept, St Etienne, France; [Faillot, T.; Iakovlev, G.; Goutagny, S.] CHU Hop Beaujon, Neurosurg Dept, Clichy, France; [Lonjon, N.] CHU Gui Chauliac, Neurosurg Dept, Montpellier, France; [Cornu, P.] CHU Pitie Salpetriere, Neurosurg Dept, Paris, France; [Bousquet, P.; Sabatier, P.; Debono, B.; Lescure, J-P] Clin Cedres, Neurosurg Dept, Cornebarrieu, France; [Vicaut, E.] Hop Lariboisiere, AP HP, Clin Res Unit URC, Paris, France; [Froelich, S.] Hop Lariboisiere, AP HP, Neurosurg Dept, Paris, France		Amelot, A (corresponding author), CHU Tours, Hop Bretonneau, Neurosurg Dept, 2 Blvd Tonnelle, F-37044 Tours 9, France.	aymmed@hotmail.fr			CODMAN Specialty Surgical, adivision of Integra LifeSciences Corporation	This work has been supported by CODMAN Specialty Surgical, adivision of Integra LifeSciences Corporation.	Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Bruneau M, 2015, OPER NEUROSURG, V11, P484, DOI 10.1227/NEU.0000000000000971; Carloni R, 2016, WORLD NEUROSURG, V95, DOI 10.1016/j.wneu.2016.08.116; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Fricia M, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.03.027; Gilardino MS, 2015, J CRANIOFAC SURG, V26, P117, DOI 10.1097/SCS.0000000000001305; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Huang GJ, 2015, J CRANIOFAC SURG, V26, P68, DOI 10.1097/SCS.0000000000001315; Iaccarino C, 2018, J NEUROSURG SCI, V62, P765, DOI 10.23736/S0390-5616.16.03721-8; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Lee JH, 2019, YONSEI MED J, V60, P1067, DOI 10.3349/ymj.2019.60.11.1067; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Lethaus B, 2014, J CRANIO MAXILL SURG, V42, P1948, DOI 10.1016/j.jcms.2014.08.006; Li A, 2017, WORLD NEUROSURG, V102, P209, DOI 10.1016/j.wneu.2017.03.022; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Maduri R, 2017, PEDIATR NEUROSURG, V52, P351, DOI 10.1159/000479329; Malcolm JG, 2018, WORLD NEUROSURG, V116, P60, DOI 10.1016/j.wneu.2018.05.009; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Moles A, 2018, WORLD NEUROSURG, V111, pE388, DOI 10.1016/j.wneu.2017.12.082; Morice A, 2017, J NEUROSURG-PEDIATR, V19, P51, DOI 10.3171/2016.8.PEDS1653; Morselli C, 2019, J NEUROSURG SCI, V63, P723, DOI 10.23736/S0390-5616.19.04779-9; Nasi Davide, 2020, Surg Neurol Int, V11, P94, DOI 10.25259/SNI_120_2020; Pallesen LP, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01119; Rashidi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228009; Reddy S, 2014, PLAST RECONSTR SURG, V133, P864, DOI 10.1097/PRS.0000000000000013; Rosenthal G, 2014, NEUROSURGERY, V75, P523, DOI 10.1227/NEU.0000000000000477; Sprio S, 2016, J APPL BIOMATER FUNC, V14, pE470, DOI 10.5301/jabfm.5000293; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini R, 2015, J APPL BIOMATER FUNC, V13, pE136, DOI 10.5301/jabfm.5000211; Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Williams LR, 2015, INT J ORAL MAX SURG, V44, P599, DOI 10.1016/j.ijom.2014.09.006; Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021; Yang NR, 2018, WORLD NEUROSURG, V110, pE160, DOI 10.1016/j.wneu.2017.10.117; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	51	0	0	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	JUL	2021	67	4					301	309		10.1016/j.neuchi.2021.02.007			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SL4XN	WOS:000656922600002	33667533				2022-02-07	
J	Anyaeji, CI; Cabral, J; Silbersweig, D				Anyaeji, Chinedu, I; Cabral, Joana; Silbersweig, David			On a Quantitative Approach to Clinical Neuroscience in Psychiatry: Lessons from the Kuramoto Model	HARVARD REVIEW OF PSYCHIATRY			English	Article						biologic psychiatry; computational biology; cortical synchronization; information networks; neuromodulators	RANDOM NOISE STIMULATION; MAJOR DEPRESSIVE DISORDER; FUNCTIONAL CONNECTIVITY; FREQUENCY-ANALYSIS; PREFRONTAL CORTEX; BRAIN NETWORKS; METASTABILITY; DYNAMICS; SYMPTOMS; SEIZURES	The human brain is a complex system comprising subregions that dynamically exchange information between its various parts through synchronization. These dynamic, complex interactions ultimately play a role in perception, emotion, cognition, and behavior, as well as in various maladaptive neurologic and psychiatric processes. It is therefore important to understand how brain dynamics might be implicated in these processes. Over the past few years, network neuroscience and computational neuroscience have highlighted the importance of measures such as metastability (a property whereby members of an oscillating system tend to linger at the edge of synchronicity without permanently becoming synchronized) in quantifying brain dynamics. Altered metastability has been implicated in various psychiatric illnesses, such as traumatic brain injury and Alzheimer's disease. Computational models, which range in complexity, have been used to assess how various parameters affect metastability, synchronization, and functional connectivity. These models, though limited, can act as heuristics in understanding brain dynamics. This article (aimed at the clinical psychiatrist who might not possess an extensive mathematical background) is intended to provide a brief and qualitative summary of studies that have used a specific, highly simplified computational model of coupled oscillators (Kuramoto model) for understanding brain dynamics-which might bear some relevance to clinical psychiatry.	[Anyaeji, Chinedu, I; Silbersweig, David] Harvard Med Sch, Boston, MA 02115 USA; [Anyaeji, Chinedu, I; Silbersweig, David] Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA; [Cabral, Joana] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal		Anyaeji, CI (corresponding author), 221 Longwood Ave, Boston, MA 02115 USA.	canyaeji@partners.org	Cabral, Joana/T-5118-2018	Cabral, Joana/0000-0002-6715-0826			Abe T, 2019, NEUROSCI LETT, V705, P138, DOI 10.1016/j.neulet.2019.04.049; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Alderson TH, 2018, NEUROIMAGE, V183, P438, DOI 10.1016/j.neuroimage.2018.08.033; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boes AD, 2015, BRAIN, V138, P3061, DOI 10.1093/brain/awv228; Bogousslavsky J., 2000, BEHAV MOOD DISORDERS; Boonstra TW, 2007, NEUROIMAGE, V36, P370, DOI 10.1016/j.neuroimage.2007.03.012; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; BRESSLER SL, 1980, ELECTROEN CLIN NEURO, V50, P19, DOI 10.1016/0013-4694(80)90319-3; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Cabral J, 2012, PHARMACOPSYCHIATRY, V45, pS57, DOI 10.1055/s-0032-1309001; Cabral J, 2017, NEUROIMAGE, V160, P84, DOI 10.1016/j.neuroimage.2017.03.045; Cabral J, 2014, NEUROIMAGE, V90, P423, DOI 10.1016/j.neuroimage.2013.11.047; Cabral J, 2012, NEUROIMAGE, V62, P1342, DOI 10.1016/j.neuroimage.2012.06.007; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Childs LM, 2008, CHAOS, V18, DOI 10.1063/1.3049136; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; Cohen MX., 2015, CYCLES MIND BRAIN RH; Contemori G, 2019, NEUROPSYCHOLOGIA, V125, P129, DOI 10.1016/j.neuropsychologia.2019.02.001; Contreras Joey A, 2015, Curr Behav Neurosci Rep, V2, P234; Damasio H., 1989, LESION ANAL NEUROPSY; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deco G, 2019, P NATL ACAD SCI USA, V116, P18088, DOI 10.1073/pnas.1905534116; Deco G, 2016, TRENDS NEUROSCI, V39, P432, DOI 10.1016/j.tins.2016.04.006; Deco G, 2014, NEURON, V84, P892, DOI 10.1016/j.neuron.2014.08.034; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Dong DB, 2018, SCHIZOPHRENIA BULL, V44, P168, DOI 10.1093/schbul/sbx034; Erra RG, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00098; Ferguson MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11353-z; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2018, NEW ENGL J MED, V379, P2237, DOI 10.1056/NEJMra1706158; Fox MD, 2013, NEUROIMAGE, V66, P151, DOI 10.1016/j.neuroimage.2012.10.082; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Gollo LL, 2017, NEUROIMAGE, V160, P97, DOI 10.1016/j.neuroimage.2017.01.057; Gollo LL, 2015, PHILOS T R SOC B, V370, P54, DOI 10.1098/rstb.2014.0165; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Houweling S, 2010, CEREB CORTEX, V20, P2605, DOI 10.1093/cercor/bhq008; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jooss A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00161; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kim NY, 2021, MOL PSYCHIATR, V26, P1299, DOI 10.1038/s41380-019-0565-3; Kringelbach ML, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00008; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16789-1; Li SY, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00482; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mammarella N, 2017, CORTEX, V91, P186, DOI 10.1016/j.cortex.2016.11.005; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Murphy OW, 2020, BRAIN STIMUL, V13, P1370, DOI 10.1016/j.brs.2020.07.001; Nikolin S, 2020, INT J NEUROPSYCHOPH, V23, P146, DOI 10.1093/ijnp/pyz072; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004100; Popescu T, 2016, NEUROPSYCHOLOGIA, V81, P255, DOI 10.1016/j.neuropsychologia.2015.12.028; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rufener KS, 2018, EUR J NEUROSCI, V48, P2301, DOI 10.1111/ejn.14128; Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156; Schmidt R, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0193-z; Shanahan M, 2010, CHAOS, V20, DOI 10.1063/1.3305451; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Snider SB, 2020, HUM BRAIN MAPP, V41, P1520, DOI 10.1002/hbm.24892; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Strogatz S., 2003, SYNC EMERGING SCI SP; Syan SK, 2018, J PSYCHIATR NEUROSCI, V43, P298, DOI 10.1503/jpn.170175; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Tyler SC, 2018, J COGNITIVE NEUROSCI, V30, P656, DOI 10.1162/jocn_a_01235; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vasa F, 2015, NEUROIMAGE, V118, P456, DOI 10.1016/j.neuroimage.2015.05.042; Villegas P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05990; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang YL, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102742; Xu J, 2019, NEUROSCI BIOBEHAV R, V96, P21, DOI 10.1016/j.neubiorev.2018.11.005	85	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-3229	1465-7309		HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	JUL-AUG	2021	29	4					318	326		10.1097/HRP.0000000000000301			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	TM5GD	WOS:000675577100006	34049338				2022-02-07	
J	Arora, R; Shukla, M; McQuillen, E; Sethuraman, U				Arora, Rajan; Shukla, Meghna; McQuillen, Elizabeth; Sethuraman, Usha			Pediatric minor head injury related return visits to the emergency department and their outcome	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Minor head injury; Children; Return visit; Emergency department	EPIDURAL HEMATOMAS; CHILDREN	Background: Minor head injury (MHI) in children is a common emergency department (ED) presentation. It is well established that majority of these patients don't require imaging and can be safely discharged. What is less known is how often these children come back to the ED and the outcome of their revisits? The objective of this study was to describe the frequency and outcome of unscheduled return visits (RVs) for MHI in a pediatric ED. Methods: A retrospective chart review of emergency department RV's database was conducted from August 2016 to July 2019. MHI patients <18 years of age who came back to the ED within 72 h of their index visit -for head injury related complaints -were eligible for inclusion. Results: Return visit rate for MHI was around 1% (61/6225). Of these, 55.7% (34/61) were female and 85.5% (53/ 61) were in the age group 2-17 years. Three-fourths of the revisits were for concussion-related symptoms. Nearly two-thirds of the patients required one or more interventions upon revisit. Missed clinically important traumatic brain injury was rare. Only one patient required operative intervention upon revisit. Though largely unpreventable, 5% (3/61) of the revisits were deemed potentially avoidable. Conclusion(s): RVs secondary to MHI in children remain low and are associated with good outcomes. (c) 2021 Published by Elsevier Inc.	[Arora, Rajan; Sethuraman, Usha] Cent Michigan Univ, Div Pediat Emergency Med, Dept Pediat, Childrens Hosp Michigan, Detroit, MI USA; [Shukla, Meghna] Wayne State Univ, Childrens Hosp Michigan, Div Pediat Emergency Med, Detroit, MI USA; [McQuillen, Elizabeth] Wayne State Univ, Coll Nursing, Off Fac Affairs, Detroit, MI 48202 USA		Arora, R (corresponding author), Childrens Hosp Michigan, Detroit, MI 48201 USA.	rarora@dmc.org; Av6363@wayne.edu; Elizabeth.McQuillen@wayne.edu; usethura@dmc.org					Arora R, 2018, PEDIATR EMERG CARE, V34, P422, DOI 10.1097/PEC.0000000000001510; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Bressan S, 2021, CHILD NERV SYST, V37, P55, DOI 10.1007/s00381-020-04660-0; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Cremonini C, 2020, J PEDIATR SURG, V55, P1773, DOI 10.1016/j.jpedsurg.2020.05.011; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Hsia RY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227981; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kocher KE, 2020, ANN EMERG MED, V75, P192, DOI 10.1016/j.annemergmed.2019.04.033; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Liberman DB, 2019, EMERG RADIOL, V26, P381, DOI 10.1007/s10140-019-01681-4; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Puffenbarger MS, 2019, ACAD EMERG MED, V26, P784, DOI 10.1111/acem.13666; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Sencer A, 2012, J NEUROSURG-PEDIATR, V9, P139, DOI 10.3171/2011.11.PEDS11177; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15	17	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45						71	74		10.1016/j.ajem.2021.01.036			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XN7FF	WOS:000729665500013	33676078				2022-02-07	
J	Asadi-Pooya, AA; Farazdaghi, M				Asadi-Pooya, Ali A.; Farazdaghi, Mohsen			Is severe head injury associated with functional (psychogenic) seizures?	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Dissociative; Head injury; Psychogenic; Seizure; PNES	TRAUMATIC BRAIN-INJURY; NONEPILEPTIC SEIZURES; RISK-FACTORS; EPILEPSY	Objectives: The aim of the current study was to compare the frequency of significant head injuries in three groups of people with seizures [idiopathic generalized epilepsies (IGE) vs. temporal lobe epilepsy (TLE) vs. functional seizures (FS)]. Methods: This was a retrospective study. All patients with a diagnosis of IGE, TLE, or FS were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, Shiraz, Iran, from 2008 until 2020. Results: One thousand and four hundred ninety-two patients were studied (559 patients with IGE, 646 people with TLE, and 287 persons with FS). Overall, 77 (5.2%) individuals of the studied people reported experiencing severe head injuries before the onset of their seizures [9 patients (1.6%) with IGE, 56 people (8.7%) with TLE, and 12 persons (4.2%) with FS; p = 0.0001]. Compared to people with IGE, the odds ratio of having a premorbid history of severe head injury in the FS group was 2.67 [95% Confidence Interval (CI): 1.11-6.40; p = 0.0280]. Compared to people with TLE, the odds ratio of having a premorbid history of severe head injury in the FS group was 0.46 (95% CI: 0.24-0.87; p = 0.0170). Conclusion: Severe head injury is significantly associated with FS. However, since head injury is also a significant risk factor for focal epilepsies, it may be necessary to ascertain the diagnosis of post-traumatic seizures by obtaing a detailed clinical history and also by performing video-EEG monitoring in order to adopt an appropriate treatment strategy in these patients.	[Asadi-Pooya, Ali A.; Farazdaghi, Mohsen] Shiraz Univ Med Sci, Epilepsy Res Ctr, Shiraz, Iran; [Asadi-Pooya, Ali A.] Thomas Jefferson Univ, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA		Asadi-Pooya, AA (corresponding author), Shiraz Univ Med Sci, Epilepsy Res Ctr, Shiraz, Iran.	aliasadipooya@yahoo.com			Shiraz University of Medical Sciences	Shiraz University of Medical Sciences supported this study.	Asadi-Pooya AA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106895; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Popkirov S, 2019, EPILEPTIC DISORD, V21, P529, DOI 10.1684/epd.2019.1107; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Prasad DKV, 2013, NEUROL INDIA, V61, P572, DOI 10.4103/0028-3886.125240; Rinne-Albers MA, 2017, EUR NEUROPSYCHOPHARM, V27, P1163, DOI 10.1016/j.euroneuro.2017.08.432; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026	12	0	0	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JUL	2021	89						38	40		10.1016/j.seizure.2021.04.018			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC2JZ	WOS:000668469100008	33979742				2022-02-07	
J	Audrit, H; Beauchamp, MH; Tinawi, S; Lague-Beauvais, M; Saluja, R; de Guise, E				Audrit, Helene; Beauchamp, Miriam H.; Tinawi, Simon; Lague-Beauvais, Maude; Saluja, Rajeet; de Guise, Elaine			Multidimensional Psychoeducative and Counseling Intervention (SAAM) for Symptomatic Patients With Mild Traumatic Brain Injury: A Pilot Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						counseling; intervention; mild traumatic brain injury; postconcussion symptoms; psychoeducation; randomized controlled trial	HEAD-INJURY; COMMUNITY INTEGRATION; CONCUSSION; FATIGUE; SLEEP; QUESTIONNAIRE; INSTRUMENT; THERAPY	Objective: To estimate feasibility and explore the treatment effect of a psychoeducative and counseling intervention program targeting 4 postconcussion symptoms (SAAM: Sleep/fatigue, Attention, Anxiety/mood, Memory). Setting: Level 1 trauma center. Participants: Twenty-five patients with postconcussion symptoms enrolled 1 to 3 months post-accident. Design: Parallel-group (experimental and wait-list control), randomized controlled trial, with masked outcome assessment the week following the last intervention session. The Experimental group received the SAAM intervention (1 session/week during 4 weeks); care as usual was maintained for both groups. Main Measure: Rivermead Post-concussion Symptoms Questionnaire (RPQ). Secondary Measures: Hospital Anxiety and Depression Scale (HADS-A/-D); Pittsburgh Sleep Quality Index (PSQI); Multidimensional Fatigue Inventory (MFI); attention and memory neuropsychological battery; Community Integration Questionnaire (CIQ). Tolerability Measure: A 10-item satisfaction questionnaire for the experimental group. Results: 15.67% of the participants evaluated for eligibility were randomized and completed the evaluation at T0. High rates of satisfaction regarding the SAAM intervention were found in the experimental group (n = 10). One participant (experimental group) withdrew after T0. Exploratory results showed that the group x time interaction was not significant, but had a large effect size for the RPQ (P = .051, eta(2) = .16) and HADS-D (P = .052, eta(2) = 0.17), and a significant interaction was found with a large effect size for the PSQI (P = .017, eta(2) = .24) and MFI (P = .041, eta(2) = .18). Post-hoc analyses revealed a significant reduction of these variables post-intervention. No significant group x time interaction was observed for cognitive measures and CIQ. Conclusion: The pilot study demonstrates the feasibility and tolerability of the SAAM intervention. Preliminary data suggest that SAAM intervention delivered post-acutely might reduce postconcussion symptoms, depression symptoms, fatigue, and sleep difficulties. A larger scale randomized control trial is warranted to confirm these promising results.	[Audrit, Helene; Beauchamp, Miriam H.; de Guise, Elaine] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Audrit, Helene; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Tinawi, Simon; Lague-Beauvais, Maude; Saluja, Rajeet] McGill Univ Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [Saluja, Rajeet; de Guise, Elaine] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca			Fonds de Recherche du Quebec-Sante (FRQS)-Strategic Innovative Projects Programme [302541]; Centre de Recherche Interdisciplinaire en Readaptation du Montreal Metropolitain (CRIR)/Laboratoire Vivant en Readaptation [301444]	The principal investigator, Dr de Guise, provided operational funds for this study from the Fonds de Recherche du Quebec-Sante (FRQS)-Strategic Innovative Projects Programme (grant number: 302541) and the Centre de Recherche Interdisciplinaire en Readaptation du Montreal Metropolitain (CRIR)/Laboratoire Vivant en Readaptation (grant number: 301444).	Auclair-Pilote J, 2021, DISABIL REHABIL, V43, P507, DOI 10.1080/09638288.2019.1630858; Audrit H, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.07.007; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cohen J, 1998, STAT POWER ANAL BEHA; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Lukens E.P., 2004, BRIEF TREATMENT CRIS, V4, P205, DOI [DOI 10.1093/BRIEF-TREATMENT/MHH019, https://doi.org/10.1093/brief-treatment/mhh019]; Marshall S., 2018, GUIDELINE CONCUSSION, V3rd; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mollayeva T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0432-z; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; RUFF RM, 1986, PERCEPT MOTOR SKILL, V62, P407, DOI 10.2466/pms.1986.62.2.407; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Schmidt M., 1996, REY AUDITORY VERBAL; Silver JM., 2013, MANAGEMENT ADULTS TR, P475; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL., 2016, J BEHAV BRAIN SCI, V6, P227, DOI [10.4236/jbbs.2016.66023, DOI 10.4236/JBBS.2016.66023]; Stallard N, 2012, STAT MED, V31, P1031, DOI 10.1002/sim.4357; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; van Gils A, 2020, PRACT NEUROL, V20, P213, DOI 10.1136/practneurol-2018-002087; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	0	0	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E249	E261		10.1097/HTR.0000000000000653			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100010	33656475				2022-02-07	
J	Awan, NM; Mat, A; Canavan, R				Awan, Nusrat Mehmood; Mat, Arimin; Canavan, Ronan			Retracing the tracks for SIAD: hyponatraemia due to post-traumatic brain injury hypopituitarism	BMJ CASE REPORTS			English	Article						pituitary disorders; adrenal disorders; thyroid disease	PITUITARY DYSFUNCTION; HYPOGLYCEMIA; MANAGEMENT; ADULTS	Hyponatraemia is common in hospital practice, with the syndrome of inappropriate antidiuresis (SIAD) being the most common underlying aetiology. A relatively less frequent but important cause is adrenal insufficiency (AI). We describe the case of a 63-year-old man who presented with symptomatic hyponatraemia and hypoglycaemia associated with abnormal body movements (ballism). The recent commencement of levothyroxine for newly diagnosed hypothyroidism, followed by fluid restriction for presumed SIAD, led to the worsening of a previously undiagnosed AI. His investigations confirmed central AI in association with thyroid and growth hormone deficiencies. The underlying cause of hypopituitarism, in this case, was a traumatic brain injury He responded well to steroid replacement and fluids. This case highlights that SIAD remains a diagnosis of exclusion, and other causes of hyponatraemia, including AI, should always be considered. Second, levothyroxine treatment without steroid replacement can lead to an adrenal crisis in patients with underlying AI.	[Awan, Nusrat Mehmood; Canavan, Ronan] St Vincents Univ Hosp, Endocrinol & Diabet, Dublin, Ireland; [Mat, Arimin; Canavan, Ronan] St Columcilles Hosp, Endocrinol & Diabet, Dublin, Ireland		Awan, NM (corresponding author), St Vincents Univ Hosp, Endocrinol & Diabet, Dublin, Ireland.	nusratawan28@gmail.com		Mat, Arimin/0000-0001-9066-7957			Biswas M, 2007, POSTGRAD MED J, V83, P373, DOI 10.1136/pgmj.2006.056515; Crowley RK, 2014, J CLIN ENDOCR METAB, V99, P4027, DOI 10.1210/jc.2014-2476; Fiordoliva I, 2017, THER ADV MED ONCOL, V9, P711, DOI 10.1177/1758834017736210; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Garrahy A, 2019, FRONT HORM RES, V52, P80, DOI 10.1159/000493239; Gupta M, 2011, ANN INDIAN ACAD NEUR, V14, P313, DOI 10.4103/0972-2327.91965; Kenny C, 2014, PRIM CARE DIABETES, V8, P3, DOI 10.1016/j.pcd.2013.09.002; Liamis G, 2017, EUR J ENDOCRINOL, V176, pR15, DOI 10.1530/EJE-16-0493; Lu HR, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00512; Martin-Grace J, 2020, CLIN CHIM ACTA, V505, P78, DOI 10.1016/j.cca.2020.01.029; Quinkler M, 2013, DTSCH ARZTEBL INT, V110, P882, DOI 10.3238/arztebl.2013.0882; Ross DS., 2021, UPTODATE; Takahashi Shusuke, 2006, Rinsho Shinkeigaku, V46, P278; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JUL	2021	14	7							e242764	10.1136/bcr-2021-242764			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TP3RD	WOS:000677510100019	34285022				2022-02-07	
J	Ayari, R; Fendri, O; Bouaziz, A; Amine, C; Kacem, MS; Khalil, A				Ayari, Rabie; Fendri, Omar; Bouaziz, Anis; Amine, Chabchoub; Kacem, Mohamed Samih; Khalil, Amri			Closed reduction of volar distal radio-ulnar joint dislocation	ARCHIVES OF TRAUMA RESEARCH			English	Article						Dislocation; distal radio-ulnar joint; volar		Volar dislocation of the distal radio-ulnar joint (DRUJ) is a rare occurrence in the literature, with only a few cases reported. Dorsal dislocation is more common than a volar dislocation. It can be easily missed due to the lack of a specific clinical presentation. They can be treated by closed reduction or more commonly by open reduction internal fixation. We present a case of volar dislocation of the DRUJ with an ulnar head fracture reduced by closed reduction. We report the case of a right-handed 35-year-old patient with no medical history who presented to our emergency department after sustaining a fall on his left hand. The trauma dated of 1 day and X-ray was initially judged normal in the emergency department. Due to the persistence of the pain and the functional impotence, the patient presented again to our department. The investigation showed that the patient's hand was in a supine position when the fall occurred. On physical examination, the forearm was locked in supination, with no passive or active pronation elicited. There was a loss of the dorsal ulnar prominence with a palpable deformity on the volar aspect of the wrist. There was no skin lesion and the neurovascular status of the hand was normal. Initial radiographs were made. Anteroposterior and lateral radiographs of the forearm and wrist showed a volar dislocation of the DRUJ with an associated ulnar head fracture. A closed reduction attempt in the emergency department was unsuccessful. The patient was admitted and under general anesthesia, the dislocation was reduced by pronating the forearm and applying direct pressure over the distal ulna. The wrist was tested after the reduction and the DRUJ was stable. Above-elbow cast was applied in a pronation position for a period of 5 weeks. Upon cast removal, the result was excellent. The patient regained full range of motion of the wrist and elbow, there was no instability nor pain or tenderness. Grip force was conserved. A radiographic assessment confirmed the reduction. Volar locked dislocation of DRUJ is a rare injury. A high index of clinical suspicion and proper X-ray is required for prompt detection. Computed tomography scanning can be useful if the diagnosis is not certain. If the reduction of the joint is stable, there is no need for fixation. Early diagnosis and appropriate treatment are the keys for a good outcome.	[Ayari, Rabie; Fendri, Omar; Bouaziz, Anis; Amine, Chabchoub; Kacem, Mohamed Samih; Khalil, Amri] Med Univ Tunis Manar, Kassab Orthoped Inst, Dept Orthoped, Tunis, Tunisia; [Ayari, Rabie; Fendri, Omar; Bouaziz, Anis; Amine, Chabchoub; Kacem, Mohamed Samih; Khalil, Amri] Med Univ Tunis Manar, Mil Hosp Instruct, Dept Orthoped, Tunis, Tunisia		Ayari, R (corresponding author), Med Univ Tunis Manar, Kassab Orthoped Inst, Dept Orthoped, Tunis, Tunisia.; Ayari, R (corresponding author), Med Univ Tunis Manar, Mil Hosp Instruct, Dept Orthoped, Tunis, Tunisia.						Adams JE, 2017, J HAND SURG-AM, V42, P47, DOI 10.1016/j.jhsa.2016.10.017; Bouri F, 2016, INT J SURG CASE REP, V22, P12, DOI 10.1016/j.ijscr.2016.03.012; Dukan Ruben, 2020, J Orthop Case Rep, V10, P97, DOI 10.13107/jocr.2020.v10.i02.1716; Kumar A, 1999, J EMERG MED, V17, P873, DOI 10.1016/S0736-4679(99)00098-0; Larrivee S, 2018, CASE REP ORTHOP, V2018; Mittal R, 2004, EUR J EMERG MED, V11, P113, DOI 10.1097/00063110-200404000-00012; Slattery David, 2013, Eur J Orthop Surg Traumatol, V23 Suppl 2, pS203, DOI 10.1007/s00590-012-1157-y; Szabo RM, 2006, J BONE JOINT SURG AM, V88A, P884, DOI 10.2106/00004623-200604000-00027; Werthel JD, 2014, CHIR MAIN, V33, P364, DOI 10.1016/j.main.2014.06.001; WESELEY MS, 1972, J TRAUMA, V12, P1083, DOI 10.1097/00005373-197212000-00009	10	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	JUL-SEP	2021	10	3					176	179		10.4103/atr.atr_94_20			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	XC1EQ	WOS:000721765300010		gold			2022-02-07	
J	Barot, J; Saxena, B				Barot, Jeetprakash; Saxena, Bhagawati			Therapeutic effects of eugenol in a rat model of traumatic brain injury: A behavioral, biochemical, and histological study	JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE			English	Article						Traumatic brain injury; Eugenol; Blood-brain barrier permeability; Brain edema; Neuroprotection	ANIMAL-MODELS; LIPID-PEROXIDATION; PATHOPHYSIOLOGY; RECOVERY; DEFICITS; MILD	Background and aim: Traumatic brain injury (TBI) results in death or long term functional disabilities. Eugenol is demonstrated to be beneficial in a range of experimental models of neurological disorders via its anti-inflammatory and antioxidant properties. Thus, the present study was designed to investigate the neuroprotective effects of eugenol in a weight-drop induced rat model of TBI. Experimental procedure: Rats were assigned into five groups; control and TBI groups pretreated with vehicle, and three TBI groups pretreated with different doses of eugenol (25, 50, and 100 mg/kg/day, p.o., seven consecutive days). Except for the control, all other groups were subjected to TBI using Marmarou's weight-drop method. 24 h after TBI, locomotor functions and short term memory were evaluated. Lastly animals were scarified and the estimation of lipid peroxidation in brain tissue, blood-brain barrier (BBB) integrity, brain water content (brain edema) and histopathology of the brain tissue were performed. Results: Weight-drop induced TBI caused functional disabilities in the rats as indicated by impairment in locomotor activities and short term memory. The TBI also resulted in augmented neuronal cell death designated by chromatolysis. The results also showed disruption in the BBB integrity, increased edema, and lipid peroxidation in the brain of the rats exposed to trauma. Pretreatment with eugenol (100 mg/kg) ameliorated histopathological, neurochemical, and behavioral consequences of trauma. Conclusion: For the first time this study revealed that eugenol can be considered as a potential candidate for managing the functional disabilities associated with TBI because of its antioxidant activities. (C) 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.	[Barot, Jeetprakash; Saxena, Bhagawati] Nirma Univ, Inst Pharm, Dept Pharmacol, SG Highway, Ahmadabad 382481, Gujarat, India		Saxena, B (corresponding author), Nirma Univ, Inst Pharm, Dept Pharmacol, SG Highway, Ahmadabad 382481, Gujarat, India.	bhagawati.saxena@nirmauni.ac.in		Saxena, Bhagawati/0000-0001-8346-5679	Institute of Pharmacy, Nirma University, Ahmedabad, India	Authors acknowledge the Institute of Pharmacy, Nirma University, Ahmedabad, India for financial support.	Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chavali VD, 2020, J MOL NEUROSCI, V70, P836, DOI 10.1007/s12031-020-01489-9; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; de Sa PL, 2016, PHYTOMEDICINE, V23, P725, DOI 10.1016/j.phymed.2016.03.014; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; DEWS PB, 1953, BRIT J PHARM CHEMOTH, V8, P46, DOI 10.1111/j.1476-5381.1953.tb00749.x; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Garabadu D, 2019, NEUROTOX RES, V35, P848, DOI 10.1007/s12640-019-0008-6; Garabadu D, 2011, STRESS, V14, P145, DOI 10.3109/10253890.2010.521602; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Goldstein LB, 2003, ILAR J, V44, P125, DOI 10.1093/ilar.44.2.125; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Honeybul Stephen, 2017, Evid Based Med, V22, P61, DOI 10.1136/ebmed-2016-110616; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kabuto H, 2007, BIOL PHARM BULL, V30, P423, DOI 10.1248/bpb.30.423; KATAYAMA S, 1978, MICROBIOL IMMUNOL, V22, P89, DOI 10.1111/j.1348-0421.1978.tb00352.x; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Lad KA, 2019, DRUG DISCOV THER, V13, P189, DOI 10.5582/ddt.2019.01056; Ma LL, 2018, RESTOR NEUROL NEUROS, V36, P659, DOI 10.3233/RNN-180826; Maier NRF, 1935, J COMP NEUROL, V61, P395, DOI 10.1002/cne.900610209; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Manikandan P, 2011, INVEST NEW DRUG, V29, P110, DOI 10.1007/s10637-009-9345-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mesole SB, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8425643; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Toxicology Program, 1983, Natl Toxicol Program Tech Rep Ser, V223, P1; Pezzoli M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06825; Prasad SN, 2013, NEUROCHEM RES, V38, P330, DOI 10.1007/s11064-012-0924-9; Said MM, 2017, ARH HIG RADA TOKSIKO, V68, P27, DOI 10.1515/aiht-2017-68-2878; Said MM, 2011, FUND CLIN PHARMACOL, V25, P708, DOI 10.1111/j.1472-8206.2010.00900.x; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singh V, 2014, MOL CELL BIOCHEM, V388, P61, DOI 10.1007/s11010-013-1899-9; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Won MH, 1998, NEUROSCI LETT, V254, P101, DOI 10.1016/S0304-3940(98)00664-8; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang LL, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1353356	50	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2225-4110			J TRADIT COMPL MED	J. Tradit. Complement. Med.	JUL	2021	11	4					318	327		10.1016/j.jtcme.2021.01.003			10	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	SW8KP	WOS:000664763600004	34195026	gold, Green Published			2022-02-07	
J	Boltz, AJ; Nedimyer, AK; Chandran, A; Robison, HJ; Collins, CL; Morris, SN				Boltz, Adrian J.; Nedimyer, Aliza K.; Chandran, Avinash; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.			Epidemiology of Injuries in National Collegiate Athletic Association Men's Ice Hockey: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						college; sport-related; injury surveillance	SHOULDER PAD DESIGN; SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; CONCUSSION; EDUCATION; 7-YEAR	Context: The National Collegiate Athletic Association has supported men's ice hockey, a distinct sport that mandates high-velocity gamesmanship, since 1974. Background: Injury surveillance systems are designed to identify evolving injury trends and their temporal qualities. Continual monitoring of collegiate men's ice hockey athletes remains essential. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program from 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios (IRR) were used to examine differential injury rates. Results: The overall injury rate was 7.65 per 1000 athleteexposures. Injuries from competition occurred at a rate nearly 7 times that from practice injuries (IRR = 6.54, 95% CI = 6.08, 7.04). The most common specific injury diagnoses were concussions (9.6%), acromioclavicular sprains (7.3%), and medial collateral ligament tears (3.7%). Summary: Injury rates by event type and season segment were higher than previously reported. Contusions accounted for nearly a quarter of all injuries, and acromioclavicular sprain rates increased notably across the study period.	[Boltz, Adrian J.; Chandran, Avinash; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117,Suite 500, Indianapolis, IN 46202 USA; [Nedimyer, Aliza K.] Univ N Carolina, Dept Exercise & Sport Sci, Human Movement Sci Curriculum & Matthew Gfeller, Chapel Hill, NC 27515 USA; [Nedimyer, Aliza K.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117,Suite 500, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Anderson GR, 2019, SPORTS HEALTH, V11, P514, DOI 10.1177/1941738119849105; Black AM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038166; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Campbell-McGovern C, 2018, INJURY PREV, V24, P319, DOI 10.1136/injuryprev-2018-042831; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Dick R, 2007, J ATHL TRAINING, V42, P173; Donskov AS, 2019, SPORTS, V7, DOI 10.3390/sports7110227; Grant JA, 2013, SPORTS HEALTH, V5, P270, DOI 10.1177/1941738112473053; Hibberd EE, 2016, AM J SPORT MED, V44, P2667, DOI 10.1177/0363546516643721; Kendall M, 2014, AM SOC TEST MATER, V1552, P142, DOI 10.1520/STP155220120150; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kluczynski MA, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116646534; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; LaPrade RF, 2009, BRIT J SPORT MED, V43, P1000, DOI 10.1136/bjsm.2009.067884; Lynall RC, 2018, J ATHL TRAINING, V53, P1129, DOI 10.4085/1062-6050-176-17; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Melvin PR, 2018, AM J SPORT MED, V46, P2521, DOI 10.1177/0363546518781338; Miyamoto RG, 2009, J AM ACAD ORTHOP SUR, V17, P152, DOI 10.5435/00124635-200903000-00004; National Collegiate Athletic Association website, NCAA IC HOCK 2016 17 NCAA IC HOCK 2016 17; National Collegiate Athletic Association website, NCAA IC HOCK 2014 15 NCAA IC HOCK 2014 15; National Collegiate Athletic Association website, NCAA IC HOCK 2018 19 NCAA IC HOCK 2018 19; National Collegiate Athletic Association website, 2020, NCAA SPORTS SPONS PA NCAA SPORTS SPONS PA; Popkin Charles A, 2017, Am J Orthop (Belle Mead NJ), V46, P123; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Richards D, 2016, SPORT BIOMECH, V15, P385, DOI 10.1080/14763141.2016.1163414; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Tegner Y, 1991, Br J Sports Med, V25, P159; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; US Bureau of Labor Statistics website, OCCUPATIONAL OUTLOOK; USA Hockey website, US HOCK ANN REP 2018 US HOCK ANN REP 2018; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wolfinger CR, 2016, INT J SPORTS PHYS TH, V11, P482; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	42	0	0	3	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					703	710		10.4085/1062-6050-611-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700016	34280280	gold			2022-02-07	
J	Brady, RD; Bird, S; Sun, MJ; Yamakawa, GR; Major, BP; Mychasiuk, R; O'Brien, TJ; McDonald, SJ; Shultz, SR				Brady, Rhys D.; Bird, Stefanie; Sun, Mujun; Yamakawa, Glenn R.; Major, Brendan P.; Mychasiuk, Richelle; O'Brien, Terence J.; McDonald, Stuart J.; Shultz, Sandy R.			Activation of the Protein Kinase R-Like Endoplasmic Reticulum Kinase (PERK) Pathway of the Unfolded Protein Response after Experimental Traumatic Brain Injury and Treatment with a PERK Inhibitor	NEUROTRAUMA REPORTS			English	Article						eukaryotic translation initiation factor alpha; fluid percussion injury; GSK2606414; misfolded proteins; neurodegeneration; protein kinase RNA-like ER kinase	HYPERPHOSPHORYLATED TAU; SODIUM SELENATE; OUTCOMES; MODEL; RATS	Neurodegeneration after traumatic brain injury (TBI) is increasingly recognized as a key factor contributing to poor chronic outcomes. Activation (i.e., phosphorylation) of the protein kinase R-like endoplasmic reticulum kinase (PERK) pathway has been implicated in neurodegenerative conditions with pathological similarities to TBI and may be a potential target to improve TBI outcomes. Here, we aimed to determine whether a moderate TBI would induce activation of the PERK pathway and whether treatment with the PERK inhibitor, GSK2606414, would improve TBI recovery. Male mice were administered a lateral fluid percussion injury (FPI) or sham injury and were euthanized at either 2 h, 24 h, or 1 week post-injury (n = 5 per injury group and time point) to assess changes in the PERK pathway. In the injured cortex, there was increased phosphorylated-PERK at 2 h post-FPI and increased phosphorylation of eukaryotic translation initiation factor alpha at 24 h post-FPI. We next examined the effect of acute treatment with GSK2606414 on pathological and behavioral outcomes at 4 weeks post-injury. Thus, there were a total of four groups: sham + VEH (n = 9); sham + GSK4606414 (n = 10); FPI + VEH (n = 9); and FPI + GSK2606414 (n = 9). GSK2606414 (50 mg/kg) or vehicle treatment was delivered by oral gavage beginning at 30 min post-injury, followed by two further treatments at 12-h increments. There were no significant effects of GSK2606414 on any of the outcomes assessed, which could be attributable to several reasons. For example, activation of PERK may not be a significant contributor to the neurological consequences 4 weeks post-FPI in mice. Further research is required to elucidate the role of the PERK pathway in TBI and whether interventions that target this pathway are beneficial.	[Brady, Rhys D.; Sun, Mujun; Yamakawa, Glenn R.; Major, Brendan P.; Mychasiuk, Richelle; O'Brien, Terence J.; McDonald, Stuart J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Brady, Rhys D.; Bird, Stefanie; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179	MND Research Institute of Australia; Mick Rodger and Benalla Act	This study was funded by a grant to S.R.S. from the MND Research Institute of Australia and Mick Rodger and Benalla Act to d'feet MND.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bell MC, 2016, CURR ALZHEIMER RES, V13, P150, DOI 10.2174/1567205013666151218145431; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Khodaie B, 2015, BEHAV BRAIN RES, V278, P55, DOI 10.1016/j.bbr.2014.09.034; Kokiko-Cochran ON, 2018, J NEUROTRAUM, V35, P73, DOI 10.1089/neu.2017.5203; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Meng CJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00111; Minter MR, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0341-4; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Newell EA, 2020, J NEUROTRAUM, V37, P635, DOI 10.1089/neu.2019.6675; Radford H, 2015, ACTA NEUROPATHOL, V130, P633, DOI 10.1007/s00401-015-1487-z; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tan XL, 2020, BRAIN INJURY, V34, P131, DOI 10.1080/02699052.2019.1667539; Tan XL, 2019, J NEUROTRAUM, V36, P87, DOI 10.1089/neu.2017.5491; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weitzner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52706; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Yan F, 2017, MOL NEUROBIOL, V54, P1808, DOI 10.1007/s12035-016-9790-9; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9	36	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUL 1	2021	2	1					330	342		10.1089/neur.2021.0001			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TH0KD	WOS:000671782700001	34318301	Green Submitted, Green Published, gold			2022-02-07	
J	Brett, BL; Meier, TB; Savitz, J; Guskiewicz, KM; McCrea, MA				Brett, Benjamin L.; Meier, Timothy B.; Savitz, Jonathan; Guskiewicz, Kevin M.; McCrea, Michael A.			Research Letter: Sleep Mediates the Association Between Prior Concussion and Depressive Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; contact sport; depression; mediation; sleep; TBI	INFLAMMATION; METAANALYSIS; RELIABILITY; INSOMNIA; HISTORY; RISK	Objective: To test sleep quality as one mechanistic pathway through which repeated concussion increases risk of depression later in life among former contact sport athletes. Setting: Multicenter study enrolled former American collegiate football players from 16 different National Collegiate Athletic Association member institutions. Participants: Fifty-eight former American collegiate football players approximately 15 years following sport discontinuation. Design: Participants completed in-person evaluations including comprehensive semistructured interviews with detailed concussion history and sport history, as well as self-reported measures of depression symptom severity (Beck Depression Inventory-II) and sleep quality (Pittsburgh Sleep Quality Index). Years of football participation were included as a covariate. Mediation modeling examined the degree to which sleep quality accounted for the association between repeated concussion and depression symptoms. Results: Within the mediation model, concussion history significantly predicted sleep quality (B = 1.03; 95% CI, 0.37 to 1.65; P = .002) and sleep quality significantly predicted depressive symptom severity (controlling for the effects of concussion history; B = 0.15; 95% CI, 0.06 to 0.24; P = .001). The association between prior concussion and depressive symptom severity was fully mediated by sleep quality. With inclusion of the indirect effects, concussion history did not predict depressive symptom severity (direct effect: B = 0.14; 95% CI, -0.09 to 0.41; P = .249; indirect effect: 0.15; 95% CI, 0.03 to 0.29; P = .016). Conclusions: Current findings raise the possibility that the greater risk of depression reported in those with a history of mTBI/concussion is mediated by sleep quality, a common sequela of mTBI. These findings highlight potential opportunities for prophylactic sleep-related intervention among individuals with multiple prior concussions to mitigate the risk of depression.	[Brett, Benjamin L.; Meier, Timothy B.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Oxley Coll Hlth Sci, Tulsa, OK USA; [Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu	Savitz, Jonathan/C-3088-2009	Savitz, Jonathan/0000-0001-8143-182X	National Collegiate Athletic Association; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225, R21NS099789, L30 NS113158-01]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH113871]	This research was supported through funding from the National Collegiate Athletic Association and institutional support from the University of North Carolina at Chapel Hill and Medical College of Wisconsin. The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, award no. UL1TR001436. B.L.B. acknowledges support from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, under award no. L30 NS113158-01. T.M. acknowledges the support of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (R01NS102225; R21NS099789). J.S. acknowledges the support of the National Institute of General Medical Sciences (P20GM121312) and the National Institute of Mental Health (R21MH113871).	Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Christensen H, 2016, LANCET PSYCHIAT, V3, P333, DOI 10.1016/S2215-0366(15)00536-2; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Jaussent I, 2011, SLEEP, V34, P1103, DOI 10.5665/SLEEP.1170; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Lovato N, 2014, SLEEP MED REV, V18, P521, DOI 10.1016/j.smrv.2014.03.006; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412	15	0	0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E284	E288		10.1097/HTR.0000000000000663			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100016	33656485	Green Accepted			2022-02-07	
J	Bretzin, AC; D'Alonzo, BA; Chandran, A; Boltz, AJ; Robison, HJ; Collins, CL; Morris, SN				Bretzin, Abigail C.; D'Alonzo, Bernadette A.; Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Lacrosse: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate sports; descriptive epidemiology; injury surveillance		Context: Lacrosse is an increasingly popular sport; the number of teams participating in collegiate women's lacrosse has increased by 21.4% in the past 5 years. Background: The growth of National Collegiate Athletic Association women's lacrosse, coupled with the ongoing discussions surrounding protective equipment, necessitates further epidemiologic studies in this population. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program during 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios with 95% CIs were used to examine differential injury rates. Results: The overall injury rate was 4.99 per 1000 athlete exposures. Less than 30% of injuries were time-loss injuries; injuries were most commonly attributed to noncontact (26.6%) and overuse (25.2%) mechanisms. The most commonly reported specific injuries were lateral ligament complex tears (ankle sprains; 9.1%), concussions (7.2%), and hamstring tears (3.8%). Summary: Findings from this study were consistent with the existing epidemiologic evidence in previous studies. Injury incidence in practices, in preseason, and as a result of player contact warrant further attention in this population.	[Bretzin, Abigail C.; D'Alonzo, Bernadette A.] Univ Penn, Penn Injury Sci Ctr, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Bretzin, Abigail/0000-0003-3730-2849	NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes.	[Anonymous], 2016 and 2017 NCAA Women's lacrosse rules; [Anonymous], 2018, US LACR PART REP 201 US LACR PART REP 201; [Anonymous], 2014 and 2015 NCAA Women's lacrosse rules changes; [Anonymous], 2018 and 2019 NCAA Women's lacrosse rules; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2020, J ATHL TRAINING, V55, P580, DOI 10.4085/1062-6050-0517.19; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Clark JM, 2018, J MECH BEHAV BIOMED, V80, P20, DOI 10.1016/j.jmbbm.2018.01.020; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Comstock RD, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00242-5; Danielsson A, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03658-8; Dick R, 2007, J ATHL TRAINING, V42, P173; Drew MK, 2016, BRIT J SPORT MED, V50, P1423, DOI 10.1136/bjsports-2015-095543; Foss KDB, 2018, CLIN J SPORT MED, V28, P406, DOI 10.1097/JSM.0000000000000458; Kerr ZY, 2018, MED SCI SPORT EXER, V50, P284, DOI 10.1249/MSS.0000000000001422; Kerr ZY, 2018, J SPORT REHABIL, V27, P118, DOI 10.1123/jsr.2016-0124; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Pierpoint LA, 2019, J ATHL TRAINING, V54, P42, DOI 10.4085/1062-6050-201-17; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; van der Merwe Carla, 2020, Foot (Edinb), V45, P101745, DOI 10.1016/j.foot.2020.101745; Windt J, 2017, BRIT J SPORT MED, V51, P428, DOI 10.1136/bjsports-2016-096040; Zabriskie HA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020470	25	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					750	757		10.4085/1062-6050-613-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700022	34280267	gold			2022-02-07	
J	Campbell, AM; Elbogen, EB; Johnson, JL; Hamer, RM; Belger, A				Campbell, Alana M.; Elbogen, Eric B.; Johnson, Jacqueline L.; Hamer, Robert M.; Belger, Aysenil			Event related potentials indexing the influence of emotion on cognitive processing in veterans with comorbid post-traumatic stress disorder and traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						ERP; P3b; N2; PTSD; TBI; Emotion; Oddball	CLOSED-HEAD INJURY; WORKING-MEMORY; EXECUTIVE FUNCTIONS; NEURAL CIRCUITRY; COMBAT VETERANS; PTSD; ATTENTION; THREAT; METAANALYSIS; PERFORMANCE	Objective: Emotion regulation and cognitive executive control are significantly impaired in both post traumatic stress disorder (PTSD) and traumatic brain injury (TBI). These illnesses are increasingly common in veterans and their co-occurrence may exacerbate symptoms and recovery. The current study sought to investigate neural correlates of these impairments via event-related potentials (ERPs) and examined the association of PTSD symptom severity and impulsivity with these correlates. Methods: Electroencephalographic data from seventy-nine veterans with PTSD and TBI and 17 control participants were recorded during a visual emotional oddball task and analyzed for the N2 and P3b ERPs. Results: Results revealed that veterans showed a reduced P3b ERP in response to both target images and standard images. However, for standard images that followed a negative emotional distractor, the veterans showed a heightened N2 amplitude while the controls did not. In addition, impulsivity predicted modulation of the P3b across stimulus conditions, with a greater P3b amplitude associated with an increase in impulsivity. Conclusions: These findings suggest that veterans showed hyper-responsivity to background information and reduced ERPs to task-relevant information. Significance: These findings may reflect heightened internal states that create neural noise and a reduced ability to modulate relevant responses. (c) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved. Objective: Emotion regulation and cognitive executive control are significantly impaired in both posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI). These illnesses are increasingly common in veterans and their co-occurrence may exacerbate symptoms and recovery. The current study sought to investigate neural correlates of these impairments via event-related potentials (ERPs) and examined the association of PTSD symptom severity and impulsivity with these correlates. Methods: Electroencephalographic data from seventy-nine veterans with PTSD and TBI and 17 control participants were recorded during a visual emotional oddball task and analyzed for the N2 and P3b ERPs. Results: Results revealed that veterans showed a reduced P3b ERP in response to both target images and standard images. However, for standard images that followed a negative emotional distractor, the veterans showed a heightened N2 amplitude while the controls did not. In addition, impulsivity predicted modulation of the P3b across stimulus conditions, with a greater P3b amplitude associated with an increase in impulsivity. Conclusions: These findings suggest that veterans showed hyper-responsivity to background information and reduced ERPs to task-relevant information. Significance: These findings may reflect heightened internal states that create neural noise and a reduced ability to modulate relevant responses.	[Campbell, Alana M.; Hamer, Robert M.; Belger, Aysenil] Univ N Carolina, Chapel Hill, NC 27515 USA; [Elbogen, Eric B.] Duke Univ, Durham, NC 27706 USA; [Elbogen, Eric B.] Durham VA Med Ctr, Durham, NC USA; [Johnson, Jacqueline L.] Rho Inc, Durham, NC USA		Campbell, AM (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	alana_campbell@med.unc.edu					Attias J, 1996, BIOL PSYCHIAT, V40, P373, DOI 10.1016/0006-3223(95)00419-X; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bardeen JR, 2011, J ANXIETY DISORD, V25, P1008, DOI 10.1016/j.janxdis.2011.06.009; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Ehlers CL, 2006, ANN NY ACAD SCI, V1071, P125, DOI 10.1196/annals.1364.011; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Falconer Erin M., 2008, Journal of Integrative Neuroscience, V7, P439, DOI 10.1142/S0219635208001873; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frewen PA, 2012, PSYCHOL TRAUMA-US, V4, P152, DOI 10.1037/a0023114; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gilmore CS, 2018, BEHAV BRAIN RES, V340, P174, DOI 10.1016/j.bbr.2016.12.002; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenwald M., 1997, INT AFFECTIVE PICTUR; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Hart T, 2017, BRAIN INJURY, V31, P297, DOI 10.1080/02699052.2016.1251612; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacNamara A, 2013, BIOL PSYCHOL, V94, P441, DOI 10.1016/j.biopsycho.2013.08.009; MacNamara A, 2011, COGN AFFECT BEHAV NE, V11, P321, DOI 10.3758/s13415-011-0036-z; McPherson WB, 1997, INTEGR PHYS BEH SCI, V32, P31, DOI 10.1007/BF02688611; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nutt DJ, 2004, J CLIN PSYCHIAT, V65, P11; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Shin L., 2005, STRUCTURAL FUNCTIONA; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Sippel LM, 2016, PSYCHIAT RES, V243, P421, DOI 10.1016/j.psychres.2016.06.040; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Stanford MS, 2001, PSYCHIAT RES, V102, P125, DOI 10.1016/S0165-1781(01)00236-0; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Van Dillen LF, 2012, EMOTION, V12, P1340, DOI 10.1037/a0028624; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Veltmeyer Melinda D., 2005, Journal of Integrative Neuroscience, V4, P145, DOI 10.1142/S0219635205000719; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Zuj DV, 2017, BRAIN COGNITION, V118, P19, DOI 10.1016/j.bandc.2017.07.001	55	0	0	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JUL	2021	132	7					1389	1397		10.1016/j.clinph.2021.03.017			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SP2VG	WOS:000659531600002	34023623				2022-02-07	
J	Canty, KW; Shiroishi, MS; Zada, G; Sharma, S; Jimenez, MA				Canty, Katherine W.; Shiroishi, Mark S.; Zada, Gabriel; Sharma, Supriya; Jimenez, Melissa A.			Bilateral arachnoid cyst-associated subdural fluid collections in an infant following TBI	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Congenital arachnoid cyst; Abusive head trauma; Subdural fluid collection; Infant; Traumatic brain injury	SPONTANEOUS RUPTURE; NATURAL-HISTORY; HYGROMA; PREVALENCE; HEMATOMAS	Introduction: arachnoid cyst-associated subdural fluid collections have been documented in children and adults following traumatic brain injury (TBI). However, this phenomenon has not been previously demonstrated in infants less than 12 months of age. We present a case of an infant with bilateral arachnoid cyst-associated subdural fluid collections identified after TBI. Case presentation: a 9-month-old female infant with profound macrocephaly presented to medical care with altered mental status following a witnessed fall down steps while unsecured in a stroller. Neuroimaging revealed bilateral subdural fluid collections, in addition to a hyperdense subdural hematoma, that raised concern for abusive head trauma (AHT) among the pediatric inpatient team and the hospital's Suspected Child Abuse and Neglect (SCAN) Team was consulted. After excluding occult abusive injuries as well as testing for underlying medical conditions, the infant's bilateral subdural fluid collections were attributed to rupture of a pre-existing left middle cranial fossa arachnoid cyst with evidence of prior macrocephaly. Conclusion: In infants and toddlers, the identification of subdural fluid collections on neuroimaging warrants inclusion of AHT in the differential diagnosis. However, in infants with a history of congenital macrocephaly, and an otherwise negative AHT workup, an accidental mechanism for the formation of subdural collections should be considered, especially when co-occurring with an arachnoid cyst.	[Canty, Katherine W.; Sharma, Supriya; Jimenez, Melissa A.] Harbor UCLA Med Ctr, Dept Pediat, 1000 W Carson St, Torrance, CA 90502 USA; [Shiroishi, Mark S.] LAC USC Med Ctr, Dept Radiol, Los Angeles, CA USA; [Zada, Gabriel] Univ Southern Calif, Dept Neurol Surg, Keck Sch Med, Los Angeles, CA 90007 USA		Canty, KW (corresponding author), Harbor UCLA Med Ctr, Dept Pediat, 1000 W Carson St, Torrance, CA 90502 USA.	kcanty@dhs.lacounty.gov		Sharma, Supriya/0000-0003-2248-4598			Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548; Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Albuquerque FC, 1997, NEUROSURGERY, V41, P951, DOI 10.1097/00006123-199710000-00036; Cayli SR, 2000, BRIT J NEUROSURG, V14, P568, DOI 10.1080/02688690050206738; Choong CT, 1998, BRAIN DEV-JPN, V20, P319, DOI 10.1016/S0387-7604(98)00039-4; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Christian CW, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1411; CULLIS PA, 1983, J NEUROL NEUROSUR PS, V46, P454, DOI 10.1136/jnnp.46.5.454; Donaldson JW, 2000, PEDIATR NEUROSURG, V32, P137, DOI 10.1159/000028918; Ergun R, 1997, ACTA NEUROCHIR, V139, P692, DOI 10.1007/BF01412007; Gelabert-Gonzalez M, 2002, CHILD NERV SYST, V18, P609, DOI 10.1007/s00381-002-0651-7; Jafrani Ryan, 2019, Surg Neurol Int, V10, P15, DOI 10.4103/sni.sni_320_18; Khilji Muhammad Faisal, 2016, Case Rep Emerg Med, V2016, P6964713, DOI 10.1155/2016/6964713; Maher CO, 2013, J NEUROSURG-PEDIATR, V12, P434, DOI 10.3171/2013.8.PEDS13206; Narang SK, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0203; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; RAKIER A, 1995, J NEUROSURG, V83, P1085, DOI 10.3171/jns.1995.83.6.1085; Sener RN, 1997, COMPUT MED IMAG GRAP, V21, P341; Tinois J, 2020, CHILD NERV SYST, V36, P2073, DOI 10.1007/s00381-020-04538-1; Vester MEM, 2015, FORENSIC SCI MED PAT, V11, P405, DOI 10.1007/s12024-015-9698-0; Wittschieber D, 2019, AM J NEURORADIOL, V40, P388, DOI 10.3174/ajnr.A5855; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; Wu XX, 2018, WORLD NEUROSURG, V109, pE118, DOI 10.1016/j.wneu.2017.09.115; YAMANOUCHI Y, 1986, CHILD NERV SYST, V2, P40, DOI 10.1007/BF00274033; Zada Gabriel, 2007, Neurosurg Focus, V22, pE1	25	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	JUL	2021	81								102189	10.1016/j.jflm.2021.102189			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	UA7RB	WOS:000685354100007	34052774				2022-02-07	
J	Castella, A; Attanasio, L; Schuind, S; Peluso, L; Annoni, F; Vincent, JL; Creteur, J; Taccone, FS; Bogossian, EG				Castella, Alberto; Attanasio, Laila; Schuind, Sophie; Peluso, Lorenzo; Annoni, Filippo; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio; Bogossian, Elisa Gouvea			Association of anemia and transfusions with outcome after subarachnoid hemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Blood products; hemotherapy; Acute cerebrovascular diseases; Hemorrhagic stroke; Disability	BLOOD-CELL TRANSFUSION; CEREBRAL OXYGEN DELIVERY; HEMOGLOBIN CONCENTRATIONS; CRITICALLY-ILL; BRAIN-INJURY; VASOSPASM; INCREASES; MORTALITY; COMPLICATIONS; THRESHOLDS	Introduction: The benefits of correcting anemia using red blood cell transfusion (RBCT) after subarachnoid hemorrhage (SAH) are controversial. We aimed to evaluate the role of anemia and RBCT on neurological outcome after SAH using a restrictive transfusion policy. Objective: We reviewed our institutional database of adult patients admitted to the Department of Intensive Care (ICU) after non-traumatic SAH over a 5-year period. We recorded hemoglobin (Hb) levels daily for a maximum of 20 days, as well as the use of RBCT. Unfavorable neurological outcome (UO) was defined as a Glasgow Outcome Score of 1-3 at 3 months. Results: Among 270 eligible patients, UO was observed in 40% of them. Patients with UO had lower Hb over time and received RBCT more frequently than others (15/109, 14% vs. 6/161, 4% - p < 0.01). Pre-RBCT median Hb values were similar in UO and FO patients (6.9 [6.6-7.1] vs. 7.3 [6.3-8.1] g/dL - p = 0.21). The optimal discriminative Hb threshold for UO was 9 g/dL. In a multivariable analysis, neither anemia nor RBCT were independently associated with UO. Conclusion: In this retrospective single center study using a restrictive strategy of RBCT in SAH patients was not associated with worse outcome in 3 months.	[Castella, Alberto; Attanasio, Laila; Peluso, Lorenzo; Annoni, Filippo; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio; Bogossian, Elisa Gouvea] Univ Libre Bruxelles, Dept Intens Care, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium; [Schuind, Sophie] Univ Libre Bruxelles, Dept Neurosurg, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium		Bogossian, EG (corresponding author), Univ Libre Bruxelles, Dept Intens Care, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium.	elisagobog@gmail.com	bogossian, elisa/AAY-9516-2021; Peluso, Lorenzo/AAC-5224-2019	Peluso, Lorenzo/0000-0001-6885-5353; Gouvea Bogossian, Elisa/0000-0002-2062-465X			Attanasio L., 2020, J NEUROSURG ANESTH; Ayling OGS, 2018, STROKE, V49, P1859, DOI 10.1161/STROKEAHA.117.020260; Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Broessner G, 2009, CRIT CARE MED, V37, P1886, DOI 10.1097/CCM.0b013e31819ffd7f; Bruder N, 1998, ANESTH ANALG, V86, P320, DOI 10.1097/00000539-199802000-00020; Carr KR, 2016, NEUROCRIT CARE, V25, P185, DOI 10.1007/s12028-016-0273-7; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; DRAKE CG, 1988, J NEUROSURG, V68, P985; Da Silva IRF, 2017, J CRIT CARE, V37, P126, DOI 10.1016/j.jcrc.2016.09.011; Festic E, 2013, NEUROCRIT CARE, V18, P209, DOI 10.1007/s12028-012-9777-y; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Kim E, 2015, WORLD NEUROSURG, V84, P1877, DOI 10.1016/j.wneu.2015.08.024; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2009, NEUROCRIT CARE, V10, P157, DOI 10.1007/s12028-008-9171-y; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Kurtz P, 2010, NEUROCRIT CARE, V13, P10, DOI 10.1007/s12028-010-9357-y; Lee EJ, 2001, J NEUROL SCI, V190, P3, DOI 10.1016/S0022-510X(01)00567-6; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; McLaren AT, 2009, CAN J ANAESTH, V56, P502, DOI 10.1007/s12630-009-9104-z; Mueller MM, 2019, JAMA-J AM MED ASSOC, V321, P983, DOI 10.1001/jama.2019.0554; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; RAMAEKERS VT, 1992, EARLY HUM DEV, V30, P211, DOI 10.1016/0378-3782(92)90070-W; Sampson TR, 2010, NEUROCRIT CARE, V12, P4, DOI 10.1007/s12028-009-9273-1; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Springer MV, 2009, NEUROSURGERY, V65, P1043, DOI 10.1227/01.NEU.0000359317.15269.20; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Taccone FS, 2014, NEUROCRIT CARE, V21, P38, DOI 10.1007/s12028-014-0033-5; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023	41	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2021	206								106676	10.1016/j.clineuro.2021.106676			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SP7JJ	WOS:000659840900011	34010752				2022-02-07	
J	Chan, AS; Lee, TL; Hamblin, MR; Cheung, MC				Chan, Agnes S.; Lee, Tsz-lok; Hamblin, Michael R.; Cheung, Mei-chun			Photoneuromodulation makes a difficult cognitive task less arduous	SCIENTIFIC REPORTS			English	Article							TRANSCRANIAL LASER THERAPY; TRAUMATIC BRAIN-INJURY; NEUROTHERA EFFECTIVENESS; SAFETY; INVENTORY; MEMORY; STROKE; LIGHT; FMRI	A positive effect of photoneuromodulation (PNM) has been found on cognitive and emotional functions in healthy populations. However, the hemodynamic changes associated with improved cognitive functions (i.e., memory and executive functions) are unexplored. Therefore, the present study investigated the hemodynamic changes associated with PNM using functional near-infrared spectroscopy (fNIRS). In this experiment, 33 young healthy adults were recruited and randomly assigned to control and experimental groups. A single PNM stimulation was applied to the forehead in the experimental group, while a sham stimulation (same procedure without machine activation) was performed for the control group. Before and after the stimulation, all participants performed an n-back task with 0-and 3-back conditions to assess their working memory function, and their hemodynamic responses during the tasks were measured by fNIRS. A significant group (experimental vs. control) x time (before vs. after PNM) interaction in memory-related frontal activation was found. Specifically, only the experimental group had a significant reduction in frontal hemodynamic levels during the difficult task. Additionally, the memory-related frontal activation was significantly correlated with the immediate and delayed recall of the Rey-Osterrieth Complex Figure Test assessed at baseline. Therefore, PNM may reduce the cognitive efforts needed to complete tasks with high memory loads.	[Chan, Agnes S.; Lee, Tsz-lok] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Chan, Agnes S.] Chinese Univ Hong Kong, Res Ctr Neuropsychol Well Being, Hong Kong, Peoples R China; [Hamblin, Michael R.] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa; [Hamblin, Michael R.] Iran Univ Med Sci, Radiat Biol Res Ctr, Tehran, Iran; [Cheung, Mei-chun] Chinese Univ Hong Kong, Dept Social Work, Hong Kong, Peoples R China		Chan, AS (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.; Chan, AS (corresponding author), Chinese Univ Hong Kong, Res Ctr Neuropsychol Well Being, Hong Kong, Peoples R China.	aschan@cuhk.edu.hk	Hamblin, Michael R/H-2758-2019; Cheung, Mei Chun/A-1261-2014	Hamblin, Michael R/0000-0001-6431-4605; Chan, Agnes/0000-0002-3321-182X; Cheung, Mei Chun/0000-0002-0210-0772	General Research Fund of the Research Grants Council in Hong Kong [14606519]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875, R21AI121700]	This study is supported by funding from the General Research Fund of the Research Grants Council in Hong Kong granted to the Chinese University of Hong Kong (ASC, 14606519). MRH was supported by US NIH Grants R01AI050875 and R21AI121700.	Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Blanco NJ, 2017, NEUROBIOL LEARN MEM, V139, P69, DOI 10.1016/j.nlm.2016.12.016; Boonswang N Ab, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.08.2011.4689; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Causse M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05378-x; Chan A.S., 2006, HONG KONG LIST LEARN; Chan AS, 2021, J ALZHEIMERS DIS, V83, P1471, DOI 10.3233/JAD-201600; Chan AS, 2019, INT J GERIATR PSYCH, V34, P369, DOI 10.1002/gps.5039; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Disner SG, 2016, BRAIN STIMUL, V9, P780, DOI 10.1016/j.brs.2016.05.009; FIRBANK M, 1993, PHYS MED BIOL, V38, P503, DOI 10.1088/0031-9155/38/4/002; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hesse S., 2015, INT ARCH MED, DOI [10.3823/1743, DOI 10.3823/1743]; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Maksimovich IV, 2015, WORLD J NEUROSCI, V5, P189; Meyers JE., 1995, REY COMPLEX FIGURE T; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	32	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUL 1	2021	11	1							13688	10.1038/s41598-021-93228-2			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UD6GF	WOS:000687302800063	34211101	gold, Green Published			2022-02-07	
J	Chandran, A; Morris, SN; Powell, JR; Boltz, AJ; Robison, HJ; Collins, CL				Chandran, Avinash; Morris, Sarah N.; Powell, Jacob R.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Men's Football: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate; descriptive epidemiology; injury surveillance	SURVEILLANCE SYSTEM; HIGH-SCHOOL; SPRAINS; RATES	Context: Football is among the most popular collegiate sports in the United States, and participation in National Collegiate Athletic Association (NCAA) football has risen in recent years. Background: Continued monitoring of football injuries is important for capturing the evolving burden of injuries in NCAA football. The purpose of this study was to describe the epidemiology of football-related injuries among men's NCAA football players during the 2014-2015 through 2018-2019 academic years. Methods: Exposure and injury data collected in the NCAA Injury Surveillance Program were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 9.31 per 1000 athlete-exposures. Most injuries occurred during general play (17.5%), blocking (15.8%), and tackling (14.0%). Concussions (7.5%), lateral ligament complex tears (6.9%), and hamstring tears (4.7%) were the most commonly reported injuries. Conclusions: Results of this study were generally consistent with previous findings, though changes over time in rates of commonly reported injuries warrant attention. Continued monitoring of injury incidence is needed to appraise the effectiveness of recently implemented rules changes.	[Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA; [Powell, Jacob R.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Powell, Jacob R.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Powell, Jacob/0000-0002-3899-9433	NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	ALBRIGHT JP, 1994, AM J SPORT MED, V22, P12, DOI 10.1177/036354659402200103; [Anonymous], 2020, EST PRO COMP COLL AT EST PRO COMP COLL AT; [Anonymous], 2019, STUD ATHL PART 2019 STUD ATHL PART 2019; Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Baugh CM, 2017, J LAW MED ETHICS, V45, P231, DOI 10.1177/1073110517720652; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2020, J QUANT ANAL SPORTS, V16, P221, DOI 10.1515/jqas-2019-0030; Clifton DR, 2017, AM J SPORT MED, V45, P417, DOI 10.1177/0363546516667914; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Heck JF, 2004, J ATHL TRAINING, V39, P101; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; McGuine TA, 2012, AM J SPORT MED, V40, P49, DOI 10.1177/0363546511422332; National Collegiate Athletic Association, 2019, 2019 FOOTB RUL REG 2019 FOOTB RUL REG; National Collegiate Athletic Association, 2018, 2018 FOOTBL RUL REG 2018 FOOTBL RUL REG; National Collegiate Athletic Association, 2017, FOOTB RUL REG 2016 2 FOOTB RUL REG 2016 2; Pontillo M, 2014, SPORTS HEALTH, V6, P497, DOI 10.1177/1941738114523239; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	21	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					643	650		10.4085/1062-6050-447-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700008	34280281	gold			2022-02-07	
J	Chandran, A; Morris, SN; Boltz, AJ; Robison, HJ; Collins, CL				Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Soccer: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate; sport-related; surveillance	ANKLE SPRAINS; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; TRAINING-PROGRAM; CONCUSSION; PREVENTION; SEX; VOLLEYBALL	Context: The National Collegiate Athletic Association held the first women's soccer championship in 1982; sponsorship and participation have greatly increased since. Background: Routine examinations of athlete injuries are important for identifying emerging temporal patterns. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program during the 2014-2015 through 2018-2019 seasons were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 8.33 per 1000 athlete-exposures. Lateral ligament complex tears (ankle sprains) (8.6%), concussions (8.3%), and quadriceps tears (5.0%) were the most commonly reported injuries. Rates of lateral ligament complex tears followed an increasing trajectory during the study period, whereas quadriceps tear rates fluctuated during the early years, and concussion rates decreased then increased. Summary: The findings of this study were mostly consistent with existing evidence; notable temporal patterns were observed with regard to lateral ligament complex tears and concussions.	[Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Allmers S, 2009, EAST ECON J, V35, P500, DOI 10.1057/eej.2009.30; [Anonymous], Sports sponsorship and participation rates database-studentathletes; [Anonymous], A tournament that broke all records.; [Anonymous], World Football Report; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P173; DiStefano LJ, 2018, J ATHL TRAINING, V53, P880, DOI 10.4085/1062-6050-156-17; Eils E, 2010, MED SCI SPORT EXER, V42, P2098, DOI 10.1249/MSS.0b013e3181e03667; Janssen K, 2017, J ATHL TRAINING, V52, P730, DOI 10.4085/1062-2050-52.4.06; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kaminski TW, 2019, J ATHL TRAINING, V54, P650, DOI 10.4085/1062-6050-487-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; Miller G, WOMENS SOCCER US SOC; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					651	658		10.4085/1062-6050-372-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700009	34280264	gold			2022-02-07	
J	Chandran, A; Morris, SN; Boltz, AJ; Robison, HJ; Collins, CL				Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Men's Soccer: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						surveillance; collegiate; sport-related	SURVEILLANCE SYSTEM; ANKLE SPRAINS; DESCRIPTIVE EPIDEMIOLOGY; TRAINING-PROGRAM; PREVENTION; SEVERITY	Context: The National Collegiate Athletic Association has sponsored men's soccer programs since 1959, and the popularity of the sport has grown over time. Background: Routine examinations of athlete injuries are important for identifying emerging temporal patterns. Methods: Exposure and injury data collected in the National Collegiate Athletic Association Injury Surveillance Program from 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 8.51 per 1000 athlete exposures. Lateral ligament complex tears (ankle sprains) (9.2%), hamstring tears (7.0%), and concussions (5.2%) were the most commonly reported injuries. Rates of lateral ligament complex tears remained stable from 2014-2015 through 2018-2019, whereas hamstring tear rates decreased and concussion rates increased. Summary: The findings of this study were in line with the existing epidemiological evidence, although notable temporal patterns were observed. Incidence trajectories of commonly observed injuries warrant particular attention in the future.	[Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Agel J, 2007, J ATHL TRAINING, V42, P270; [Anonymous], FIFA Activity Report 2018; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bahr R, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902908; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Chandran A, 2016, AM J SPORT MED, V44, P3237, DOI 10.1177/0363546516659879; Dick R, 2007, J ATHL TRAINING, V42, P173; Eils E, 2010, MED SCI SPORT EXER, V42, P2098, DOI 10.1249/MSS.0b013e3181e03667; Ekstrand J, 2020, AM J SPORT MED, V48, P723, DOI 10.1177/0363546519899359; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; Kaminski TW, 2019, J ATHL TRAINING, V54, P650, DOI 10.4085/1062-6050-487-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P893, DOI 10.4085/1062-6050-166-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; Turner AN, 2014, STRENGTH COND J, V36, P10, DOI 10.1519/SSC.0000000000000076; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Woods C, 2002, BRIT J SPORT MED, V36, P436, DOI 10.1136/bjsm.36.6.436	19	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					659	665		10.4085/1062-6050-370-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700010	34280266	gold			2022-02-07	
J	Chandran, A; Morris, SN; Lempke, LB; Boltz, AJ; Robison, HJ; Collins, CL				Chandran, Avinash; Morris, Sarah N.; Lempke, Landon B.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Volleyball: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate sports; descriptive epidemiology; injury surveillance	SURVEILLANCE SYSTEM; ANKLE SPRAINS; DESCRIPTIVE EPIDEMIOLOGY; TRAINING-PROGRAM; PREVENTION; OVERUSE	Context: Women's volleyball is a globally popular sport with widespread participation at the National Collegiate Athletic Association (NCAA) level. Background: Routine examinations of NCAA women's volleyball injuries are important for recognizing emerging injury-related patterns in this population. Methods: Exposure and injury data collected in the NCAA Injury Surveillance Program during the 2014-2015 through 2018-2019 athletic years were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differences in injury rates. Results: The overall injury rate was 6.73 per 1000 athlete-exposures. Knee (14.6%) and ankle (13.8%) injuries accounted for the largest proportion of all reported injuries, and most injuries were attributed to overuse (26.1%) or non-contact (22.7%) mechanisms. Lateral ankle ligament complex tears (11.1%) and concussions (7.3%) were the most commonly reported specific injury. Summary: Results indicate an increasing burden of practice-related injuries and the need to further examine overuse injuries. Lower-extremity injury prevention strategies and mechanisms of concussion also warrant further attention.	[Chandran, Avinash; Morris, Sarah N.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA; [Lempke, Landon B.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, Athens, GA USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Agel J, 2007, J ATHL TRAINING, V42, P295; [Anonymous], 2020, THIS IS VOLL VOLL THIS IS VOLL VOLL; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Biese KM, 2020, PHYS THER SPORT, V45, P86, DOI 10.1016/j.ptsp.2020.06.005; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Cools AM, 2005, J ATHL TRAINING, V40, P104; Dick R, 2007, J ATHL TRAINING, V42, P173; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Eils E, 2010, MED SCI SPORT EXER, V42, P2098, DOI 10.1249/MSS.0b013e3181e03667; Forthomme B, 2005, AM J SPORT MED, V33, P1513, DOI 10.1177/0363546505274935; Gouttebarge V, 2020, J SPORT SCI, V38, P612, DOI 10.1080/02640414.2020.1721255; Kaminski TW, 2019, J ATHL TRAINING, V54, P650, DOI 10.4085/1062-6050-487-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P926, DOI 10.4085/1062-6050-162-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2020, BRIT J SPORT MED, V54, P1314, DOI 10.1136/bjsports-2020-102185; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; National Collegiate Athletic Association, NCAA SPORTS SPONS PA; National Collegiate Athletic Association, 2016 WOM VOLL RUL CH 2016 WOM VOLL RUL CH; National Federation of State High School Associations, 2018 19 HIGH SCH ATH, DOI [1020412/2018-19_participation_survey.pdf, DOI 1020412/2018-19_PARTICIPATION_SURVEY.PDF]; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Seminati E, 2013, EUR J SPORT SCI, V13, P732, DOI 10.1080/17461391.2013.773090; Shih YF, 2019, J ATHL TRAINING, V54, P90, DOI 10.4085/1062-6050-216-17; Timoteo TF, 2021, J STRENGTH COND RES, V35, P791, DOI 10.1519/JSC.0000000000002754; Verhagen E, 2004, AM J SPORT MED, V32, P1385, DOI 10.1177/0363546503262177; Wolfe H, 2019, INT J SPORTS PHYS TH, V14, P88, DOI 10.26603/ijspt20190088	28	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					666	673		10.4085/1062-6050-679-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700011	34280268	gold			2022-02-07	
J	Chandran, A; Roby, PR; Boltz, AJ; Robison, HJ; Morris, SN; Collins, CL				Chandran, Avinash; Roby, Patricia R.; Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Gymnastics: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate sports; descriptive epidemiology; injury surveillance	SURVEILLANCE SYSTEM; SPORTS	Context: Women's gymnastics athletes in the National Collegiate Athletic Association (NCAA) constitute a unique population of NCAA athletes given the nature and dynamics of the sport. Background: Routine examination of women's gymnastics injuries is important for identifying the evolving burden of injuries in this sport. Methods: Exposure and injury data collected in the NCAA Injury Surveillance Program during 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics; injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 8.00 per 1000 athlete-exposures; injury incidence was greater in competitions than in practices (injury rate ratio = 1.84; 95% CI = 1.48, 2.29), though practice injury rates increased during 2015-2016 through 2018-2019. Most injuries were classified as strains (16.5%), sprains (16.4%), and inflammatory conditions (12.3%), with overuse injuries prevalent among practice injuries (22.5%). Concussions (8.4%) were the most commonly reported specific injury. Summary: The increasing trend in practice injury incidence is noteworthy although competition injury rates were higher overall. Findings also suggest that the etiologies of overuse injuries and inflammatory conditions as well as the biomechanical aspects of concussions warrant further attention.	[Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA; [Roby, Patricia R.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; [Anonymous], Women's gymnastics rules modification document and meet procedures; [Anonymous], 2018 & 2019 NCAA women's gymnastics rules modifications and meet procedures; [Anonymous], Student-athlete participation 1981-82-2018-19. NCAA sports sponsorship and participation rates report; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; CAINE D, 1989, AM J SPORT MED, V17, P811, DOI 10.1177/036354658901700616; Caine D., 2006, SPORTS MED TRAINING, V16, P501, DOI [10. 1080/15438629509512053, DOI 10.1080/15438629509512053]; Caine DJ, 2009, EPIDEMIOLOGY INJURY, V16, DOI [10.1002/9781444316872, DOI 10.1002/9781444316872]; Campbell R, 2019, BRIT J SPORT MED, V53, P1056, DOI 10.1136/bjsports-2018-099547; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Dick R, 2007, J ATHL TRAINING, V42, P173; Green H, 2020, SPORT J, V41; Jakse B, 2021, J NUTR METAB, V2021, DOI 10.1155/2021/8810548; Kerr G, 2006, J APPL SPORT PSYCHOL, V18, P28, DOI 10.1080/10413200500471301; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kolt GS, 1999, BRIT J SPORT MED, V33, P312, DOI 10.1136/bjsm.33.5.312; Lenka, 2016, INT J SPORT NUTR EXE, V26, P240, DOI 10.1123/ijsnem.2015-0166; Marshall SW, 2007, J ATHL TRAINING, V42, P234; Meng K, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-00344-x; Pasulka J, 2017, PHYSICIAN SPORTSMED, V45, P344, DOI 10.1080/00913847.2017.1313077; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Rizzone KH, 2017, J ATHL TRAINING, V52, P966, DOI 10.4085/1062-6050-52.8.01; Sands W, 2003, SCI ASPECTS WOMENS G, DOI [10.1159/isbn.978-3-318- 00894-4, DOI 10.1159/ISBN.978-3-318-00894-4]; Slater A, 2015, SPORT BIOMECH, V14, P45, DOI 10.1080/14763141.2015.1029514; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Westermann RW, 2015, SPORTS HEALTH, V7, P161, DOI 10.1177/1941738114559705	29	0	0	4	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					688	694		10.4085/1062-6050-635-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700014	34280287	gold			2022-02-07	
J	Chandran, A; Nedimyer, AK; Boltz, AJ; Robison, HJ; Collins, CL; Morris, SN				Chandran, Avinash; Nedimyer, Aliza K.; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Ice Hockey: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate sports; descriptive epidemiology; injury surveillance	SPORTS-RELATED INJURIES; DESCRIPTIVE EPIDEMIOLOGY; MENS; MECHANISMS; PREVENTION; FOOTBALL; EXERCISE	Context: The National Collegiate Athletic Association (NCAA) has sponsored women's ice hockey championships since 2001, and sponsorship has grown over time. Background: Routine examinations of injuries sustained by athletes are important for identifying and understanding patterns that can be used to inform sport safety practices. Methods: Exposure and injury data collected in the NCAA Injury Surveillance Program from 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios were used to examine differential injury rates. Results: The overall injury rate was 5.89 per 1000 athlete-exposures; preseason injury incidence rose sharply during 2016-2017 through 2018-2019. Head/face injuries (15.2%), knee injuries (13.2%), and shoulder injuries (12.9%) were the most commonly injured body parts, and injuries were most often classified as contusions (18.9%), strains (18.7%), and sprains (15.5%). Concussion (11.9%) was the most commonly reported specific injury, and concussion rates notably increased during 2017-2018 through 2018-2019. Summary: Study findings were generally consistent with the existing epidemiological evidence. Injury incidence in preseason and the etiology of strains warrant further attention in this population.	[Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA; [Nedimyer, Aliza K.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Nedimyer, Aliza K.] Univ N Carolina, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Sch Med, Chapel Hill, NC USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Ackery AD, 2012, CLIN J SPORT MED, V22, P86, DOI 10.1097/JSM.0b013e3182342b69; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Aman M, 2019, KNEE SURG SPORT TR A, V27, P1000, DOI 10.1007/s00167-018-5225-7; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; [Anonymous], NCAA student-athlete participation: 1981-82-2018-19. NCAA sports sponsorship and participation rates report; [Anonymous], Annual report 2018/2019; Ayeni OR, 2014, OPEN ACCESS J SPORTS, V5, P143, DOI 10.2147/OAJSM.S58985; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Blake Tracy, 2012, Clin J Sport Med, V22, P377, DOI 10.1097/JSM.0b013e31826038e0; Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Brughelli M, 2007, SPORTS MED, V37, P807, DOI 10.2165/00007256-200737090-00004; Buckeridge E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127324; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2020, J QUANT ANAL SPORTS, V16, P221, DOI 10.1515/jqas-2019-0030; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Dalton SL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116632692; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Faude O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00791; Ishoi L, 2016, SCAND J MED SCI SPOR, V26, P1334, DOI 10.1111/sms.12585; Kinnunen JV, 2019, J STRENGTH COND RES, V33, P479, DOI 10.1519/JSC.0000000000001881; Lerebours F, 2016, AM J SPORT MED, V44, P1024, DOI 10.1177/0363546515624671; Lynall RC, 2018, J ATHL TRAINING, V53, P1129, DOI 10.4085/1062-6050-176-17; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mihalik JP, 2020, ANN BIOMED ENG, V48, P104, DOI 10.1007/s10439-019-02343-9; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Popkin CA, 2016, OPEN ACCESS J SPORTS, V7, P167, DOI 10.2147/OAJSM.S118595; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Ryynanen J, 2013, BRIT J SPORT MED, V47, P986, DOI 10.1136/bjsports-2013-092676; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	33	0	0	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					695	702		10.4085/1062-6050-546-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700015	34280277	gold			2022-02-07	
J	Chen, HG; Dong, BB; Shi, Y; Yu, YH; Xie, KL				Chen, Hongguang; Dong, Beibei; Shi, Yuan; Yu, Yonghao; Xie, Keliang			Hydrogen Alleviates Neuronal Injury and Neuroinflammation Induced by Microglial Activation via the Nuclear Factor Erythroid 2-related Factor 2 Pathway in Sepsis-associated Encephalopathy	NEUROSCIENCE			English	Article						hydrogen; neuroinflammation; microglial activation; Nrf2	TRAUMATIC BRAIN-INJURY; MOLECULAR-HYDROGEN; POLYMICROBIAL SEPSIS; OXIDATIVE STRESS; LUNG INJURY; GAS; INFLAMMATION; PROTECTS; NRF2; NEUROPROTECTION	Sepsis-associated encephalopathy (SAE) is characterized by diffuse cerebral and central nervous system (CNS) dysfunction. Microglia play a vital role in protecting the brain from neuronal damage, which is closely related to inflammatory responses. The nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway has an impact on microglial and neuronal injury. Here, we mainly explored the molecular mechanism by which Hydrogen (H-2) regulates neuroinflammation in SAE and the role of Nrf2 in this process. An in vivo model of SAE was generated by cecal ligation and puncture (CLP). Primary microglia and neurons were cultured to establish an in vitro model. Microglia, neurons and brain tissue were obtained to detect Nrf2 expression, inflammation, cell injury, apoptosis, and microglial polarization. Escape latency, the number of platform crossings and the time spent in the target quadrant were measured to assess cognitive function. H-2 attenuated microglial polarization from the M1 to the M2 phenotype, cytokine release and TLR/NF-kappa b activation and protected neurons from lipopolysaccharide (LPS)-activated microglia-induced injury via the Nrf2 pathway. SAE activated Nrf2 expression, and H-2 further improved Nrf2 expression in SAE mice. H-2 alleviated microglial polarization from the M1 to the M2 phenotype and cytokine release in the cerebral cortex and improved neuronal injury or cognitive dysfunction in SAE mice and wild-type mice but not in Nrf2-/- mice. H-2 exerts antineuroinflammatory effects associated with TLR4/NF-kappa B signaling activation and neuroprotective effects by inhibiting the excessive release of proinflammatory cytokines, neuronal loss and apoptosis in vitro and in vivo through the Nrf2 pathway. (C) 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chen, Hongguang; Dong, Beibei; Shi, Yuan; Yu, Yonghao; Xie, Keliang] Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin 300052, Peoples R China; [Chen, Hongguang; Dong, Beibei; Shi, Yuan; Yu, Yonghao; Xie, Keliang] Tianjin Res Inst Anesthesiol, Tianjin 300052, Peoples R China		Yu, YH; Xie, KL (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Res Inst tute Anesthesiol, Dept Anesthesiol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	yyu@tmu.edu.cn; mzk2011@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601667, 81671888, 81772043]; Natural Science Foundation of Tianjin CityNatural Science Foundation of Tianjin [18JCYBJC93700]	This study was supported by a grant from the National Natural Science Foundation of China (Nos. 81601667 to Hongguang Chen; 81671888 to Yonghao Yu; 81772043 to Keliang Xie) and Natural Science Foundation of Tianjin City (18JCYBJC93700) .	Andonegui G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99364; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Cai ZY, 2017, EUR REV MED PHARMACO, V21, P1924; Chen CH, 2010, NEUROSCIENCE, V169, P402, DOI 10.1016/j.neuroscience.2010.04.043; Chen HG, 2018, INT J MOL MED, V42, P2009, DOI 10.3892/ijmm.2018.3763; Chen HG, 2015, INT IMMUNOPHARMACOL, V28, P643, DOI 10.1016/j.intimp.2015.07.034; Cheng Q, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.09.07; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dong AL, 2018, INT IMMUNOPHARMACOL, V65, P366, DOI 10.1016/j.intimp.2018.10.012; [董艾莉 Dong Aili], 2017, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V37, P632; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Fan H, 2017, MED SCI MONITOR, V23, P5599, DOI 10.12659/MSM.907530; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Gangula PR, 2018, AM J PHYSIOL-GASTR L, V315, pG980, DOI 10.1152/ajpgi.00152.2018; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Iketani M, 2017, CURR NEUROPHARMACOL, V15, P324, DOI 10.2174/1570159X14666160607205417; Imai K, 2016, FREE RADICAL BIO MED, V91, P154, DOI 10.1016/j.freeradbiomed.2015.12.015; Kitaoka Y, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13998; Lee DS, 2014, EUR J PHARMACOL, V728, P1, DOI 10.1016/j.ejphar.2013.12.041; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Mazeraud A, 2020, NEUROTHERAPEUTICS, V17, P392, DOI 10.1007/s13311-020-00862-1; Michels M, 2017, J NEUROIMMUNOL, V303, P90, DOI 10.1016/j.jneuroim.2016.12.015; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Qiao YY, 2016, WORLD J GASTROENTERO, V22, P5023, DOI 10.3748/wjg.v22.i21.5023; Rehman SU, 2019, MOL NEUROBIOL, V56, P2774, DOI 10.1007/s12035-018-1280-9; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Trzeciak A, 2019, J IMMUNOL, V203, P2979, DOI [10.4049/jimmunol.1900317, 10.4049/jimmunol.19900317]; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Xie KL, 2020, INFLAMM RES, V69, P697, DOI 10.1007/s00011-020-01347-9; Xie KL, 2010, SHOCK, V34, P495, DOI 10.1097/SHK.0b013e3181def9aa; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Yang L, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104814; Yang T, 2018, REDOX BIOL, V17, P323, DOI 10.1016/j.redox.2018.05.001; Yu Y, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106585; Zhang TY, 2019, EXP NEUROL, V317, P1, DOI 10.1016/j.expneurol.2019.02.009; Zhang W, 2017, NEUROSCIENCE, V366, P95, DOI 10.1016/j.neuroscience.2017.09.035; Zhong J, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116822; Zhou YL, 2020, ACTA PHARMACOL SIN, V41, P10, DOI 10.1038/s41401-019-0261-5; Zhuang XQ, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106287	48	0	0	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 1	2021	466						87	100		10.1016/j.neuroscience.2021.05.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SR9ZH	WOS:000661401900008	33992722				2022-02-07	
J	Chung, P; Khan, F; Judson, R				Chung, Pearl; Khan, Fary; Judson, Rodney			VALIDATION OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH CORE SETS FOR TRAUMATIC BRAIN INJURY FROM AUSTRALIAN COMMUNITY PATIENT PERSPECTIVES	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injury; traumatic; rehabilitation; qualitative research; focus groups; self -report		Objective: To examine the validity of the Comprehensive and Brief International Classification of Func tioning, Disability and Health (ICF) Core Sets for Traumatic Brain Injury for patients with traumat- ic brain injury living in the community in Australia. Design: Qualitative methodology using focus groups and individual interviews. Patients: Community -dwelling adult persons with traumatic brain injury. Methods: Patients sustaining traumatic brain injury with post -traumatic amnesia between September 2009 and August 2013, selected from the Royal Melbourne Hospital Trauma Registry, were invited to participate in the study. Participants were asked structured questions based on the ICF framework. Digital recordings of the discussions were transcrib- ed in full for linking to the ICF categories. Results: Saturation of data was reached after 5 groups involving 21 participants. Participants identified as relevant 77.7% (n = 108/139) and 100% (n = 23/23) of the Comprehensive and Brief ICF Core Sets for traumatic brain injury, respectively. Additional ICF categories identified in 2 or more groups were: b180 "experience of self and time functions"; b250 "taste function"; b265 "touch function"; b530 "weight maintenance function"; b780 "sensation related to muscles and movement"; and d650 "car- ing for household objects". Conclusion: The study found additional ICF categories to consider and supports the use of the ICF Core Sets for traumatic brain injury in Australian adults in the community.	[Chung, Pearl] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Khan, Fary; Judson, Rodney] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic, Australia		Chung, P (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	Pearl.Chung@Sydney.edu.au					AIHW A., 2008, AUSTR HLTH 2008 AUSTR HLTH 2008; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bickenbach J, 2012, ICF CORE SETS MANUAL; Chung P, 2016, BRAIN INJURY, V30, P481; Chung P., 2016, REHABILITATION TRAUM; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Coenen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1956; COTRELL V, 1993, GERONTOLOGIST, V33, P205, DOI 10.1093/geront/33.2.205; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Glassel A, 2012, DISABIL REHABIL, V34, P157, DOI 10.3109/09638288.2011.593680; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hieblinger R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2696; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Patton M.Q., 1990, QUALITATIVE EVALUATI; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Schofield P, 2019, HAND CLINIC, V164, P409, DOI 10.1016/B978-0-444-63855-7.00023-X; Stier-Jarmer M, 2011, J REHABIL MED, V43, P113, DOI [10.2340/16501977-0617, 10.2340/16501977-0659]; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; World Health Organization, 2007, INT CLASS FUNCT DIS	24	0	0	1	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUL	2021	53	7							jrm00218	10.2340/16501977-2860			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TY1FY	WOS:000683530800003	34240223	gold			2022-02-07	
J	Claassen, J; Akbari, Y; Alexander, S; Bader, MK; Bell, K; Bleck, TP; Boly, M; Brown, J; Chou, SHY; Diringer, MN; Edlow, BL; Foreman, B; Giacino, JT; Gosseries, O; Green, T; Greer, DM; Hanley, DF; Hartings, JA; Helbok, R; Hemphill, JC; Hinson, HE; Hirsch, K; Human, T; James, ML; Ko, N; Kondziella, D; Livesay, S; Madden, LK; Mainali, S; Mayer, SA; McCredie, V; McNett, MM; Meyfroidt, G; Monti, MM; Muehlschlegel, S; Murthy, S; Nyquist, P; Olson, DM; Provencio, JJ; Rosenthal, E; Silva, GS; Sarasso, S; Schiff, ND; Sharshar, T; Shutter, L; Stevens, RD; Vespa, P; Videtta, W; Wagner, A; Ziai, W; Whyte, J; Zink, E; Suarez, JI				Claassen, Jan; Akbari, Yama; Alexander, Sheila; Bader, Mary Kay; Bell, Kathleen; Bleck, Thomas P.; Boly, Melanie; Brown, Jeremy; Chou, Sherry H-Y; Diringer, Michael N.; Edlow, Brian L.; Foreman, Brandon; Giacino, Joseph T.; Gosseries, Olivia; Green, Theresa; Greer, David M.; Hanley, Daniel F.; Hartings, Jed A.; Helbok, Raimund; Hemphill, J. Claude; Hinson, H. E.; Hirsch, Karen; Human, Theresa; James, Michael L.; Ko, Nerissa; Kondziella, Daniel; Livesay, Sarah; Madden, Lori K.; Mainali, Shraddha; Mayer, Stephan A.; McCredie, Victoria; McNett, Molly M.; Meyfroidt, Geert; Monti, Martin M.; Muehlschlegel, Susanne; Murthy, Santosh; Nyquist, Paul; Olson, DaiWai M.; Provencio, J. Javier; Rosenthal, Eric; Silva, Gisele Sampaio; Sarasso, Simone; Schiff, Nicholas D.; Sharshar, Tarek; Shutter, Lori; Stevens, Robert D.; Vespa, Paul; Videtta, Walter; Wagner, Amy; Ziai, Wendy; Whyte, John; Zink, Elizabeth; Suarez, Jose, I		Curing Coma Campaign	Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness	NEUROCRITICAL CARE			English	Article						Coma; Consciousness; Electrophysiology; Magnetic resonance imaging; Biomarkers	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; NEUROTRAUMA EFFECTIVENESS RESEARCH; PLACEBO-CONTROLLED TRIAL; LIFE-SUSTAINING THERAPY; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; VEGETATIVE STATE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE	Coma and disorders of consciousness (DoC) are highly prevalent and constitute a burden for patients, families, and society worldwide. As part of the Curing Coma Campaign, the Neurocritical Care Society partnered with the National Institutes of Health to organize a symposium bringing together experts from all over the world to develop research targets for DoC. The conference was structured along six domains: (1) defining endotype/phenotypes, (2) biomarkers, (3) proof-of-concept clinical trials, (4) neuroprognostication, (5) long-term recovery, and (6) large datasets. This proceedings paper presents actionable research targets based on the presentations and discussions that occurred at the conference. We summarize the background, main research gaps, overall goals, the panel discussion of the approach, limitations and challenges, and deliverables that were identified.	[Claassen, Jan] Columbia Univ, Dept Neurol, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA; [Claassen, Jan] NewYork Presbyterian Hosp, Dept Neurol, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA; [Akbari, Yama] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Akbari, Yama] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA; [Akbari, Yama] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Akbari, Yama] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Alexander, Sheila] Univ Pittsburgh, Sch Med, Sch Nursing & Crit Care Med, Acute & Tertiary Care, Pittsburgh, PA USA; [Bader, Mary Kay] Mission Hosp, Mission Viejo, CA USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Bleck, Thomas P.] Northwestern Univ, Davee Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Boly, Melanie] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brown, Jeremy] NINDS, Off Emergency Care Res, Div Clin Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Chou, Sherry H-Y; Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Chou, Sherry H-Y; Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Chou, Sherry H-Y; Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Diringer, Michael N.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Edlow, Brian L.] Harvard Univ, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02115 USA; [Edlow, Brian L.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Rehabil Med, Cincinnati, OH USA; [Giacino, Joseph T.] Harvard Univ, Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Gosseries, Olivia] Univ Liege, GIGA Consciousness Coma Sci Grp, Liege, Belgium; [Green, Theresa] Queensland Univ Technol, Sch Nursing, Kelvin Grove, Qld, Australia; [Greer, David M.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hanley, Daniel F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Brain Injury Outcomes, Baltimore, MD 21205 USA; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Innsbruck, Austria; [Hemphill, J. Claude; Ko, Nerissa] Univ Calif San Francisco, Sch Med, Dept Neurol, Weill Inst Neurosci, San Francisco, CA USA; [Hinson, H. E.] Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; [Hirsch, Karen] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Human, Theresa] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA; [James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Kondziella, Daniel] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Livesay, Sarah] Rush Univ, Coll Nursing, Chicago, IL 60612 USA; [Madden, Lori K.] Univ Calif Davis, Ctr Nursing Sci, Sacramento, CA 95817 USA; [Mainali, Shraddha] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Mayer, Stephan A.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA; [McCredie, Victoria] Univ Toronto, Dept Respirol, Interdept Div Crit Care, Toronto, ON, Canada; [McNett, Molly M.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Meyfroidt, Geert] Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium; [Meyfroidt, Geert] Univ Leuven, Leuven, Belgium; [Monti, Martin M.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Brain Injury Res Ctr, Los Angeles, CA USA; [Muehlschlegel, Susanne] Univ Massachusetts, Dept Neurol, Med Sch, Worcester, MA 01605 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Dept Anesthesiol Crit Care, Med Sch, Worcester, MA 01605 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Dept Surg, Med Sch, Worcester, MA 01605 USA; [Murthy, Santosh] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Nyquist, Paul; Stevens, Robert D.; Ziai, Wendy; Suarez, Jose, I] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Nyquist, Paul; Stevens, Robert D.; Ziai, Wendy; Zink, Elizabeth; Suarez, Jose, I] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurol, Baltimore, MD USA; [Nyquist, Paul; Stevens, Robert D.; Ziai, Wendy; Suarez, Jose, I] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, Dept Neurosurg, Baltimore, MD USA; [Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX USA; [Provencio, J. Javier] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Provencio, J. Javier] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Rosenthal, Eric] Harvard Univ, Dept Neurol, Harvard Med Sch, Boston, MA 02115 USA; [Silva, Gisele Sampaio] Albert Einstein Israelite Hosp, Dept Neurol, Sao Paulo, Brazil; [Silva, Gisele Sampaio] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Sarasso, Simone] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Schiff, Nicholas D.] Cornell Univ, Weill Cornell Med, Dept Neurol, New York, NY 10021 USA; [Schiff, Nicholas D.] Cornell Univ, Weill Cornell Med, Brain Mind Res Inst, New York, NY USA; [Sharshar, Tarek] Paris Descartes Univ, Dept Intens Care, Paris, France; [Vespa, Paul] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Vespa, Paul] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Videtta, Walter] Natl Hosp Alejandro Posadas, Buenos Aires, DF, Argentina; [Wagner, Amy] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA		Claassen, J (corresponding author), Columbia Univ, Dept Neurol, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA.; Claassen, J (corresponding author), NewYork Presbyterian Hosp, Dept Neurol, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA.	jc1439@columbia.edu	Shutter, Lori A/G-2957-2013; Giacino, Joseph/AAF-1952-2021; Hinson, Holly/Q-2268-2019; Madden, Lori K/K-3749-2012; Hemphill, Claude/AAY-5630-2021; Sharshar, Tarek/ABF-4117-2021; Sarasso, Simone/C-7817-2012	Giacino, Joseph/0000-0002-7916-9698; Hinson, Holly/0000-0003-1598-9782; Madden, Lori K/0000-0001-9179-4202; Hemphill, Claude/0000-0003-4019-7525; Sarasso, Simone/0000-0001-9984-4710; Hanley, Daniel/0000-0002-9536-4258	NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Neurocritical Care Society; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS106014, R03 NS112760]	NINDS, NIH; Neurocritical Care Society. JC is supported by grant funding from the NIH R01 NS106014 and R03 NS112760.	Adhikari Neill K J, 2020, Wellcome Open Res, V5, P182, DOI [10.12688/wellcomeopenres.16152.2, 10.12688/wellcomeopenres.16152.1]; Agostoe DV, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00047; Albaeni A, 2014, RESUSCITATION, V85, P1455, DOI 10.1016/j.resuscitation.2014.08.030; Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Au SS, 2021, J EVAL CLIN PRACT, V27, P1066, DOI 10.1111/jep.13517; Bautista CA, 2019, J NEUROSCI NURS, V51, P158, DOI 10.1097/JNN.0000000000000438; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Biankin AV, 2015, NATURE, V526, P361, DOI 10.1038/nature15819; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Braiman C, 2018, CURR BIOL, V28, P3833, DOI 10.1016/j.cub.2018.10.057; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Chatelle C, 2020, NEUROCRIT CARE, V33, P449, DOI 10.1007/s12028-019-00904-3; Cho SM, 2019, ANN NEUROL, V86, P473, DOI 10.1002/ana.25539; Chou SHY, 2019, NEUROCRIT CARE, V30, P46, DOI 10.1007/s12028-019-00725-4; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Claassen J, 2016, ANN NEUROL, V80, P541, DOI 10.1002/ana.24752; Colantuoni E, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5748; Comanducci A, 2020, CLIN NEUROPHYSIOL, V131, P2736, DOI 10.1016/j.clinph.2020.07.015; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; Comolatti R, 2019, BRAIN STIMUL, V12, P1280, DOI 10.1016/j.brs.2019.05.013; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; des Ordons ALR, 2020, J PASTOR CARE COUNS, V74, P12, DOI 10.1177/1542305019890120; Dew MA, 2018, J HEART LUNG TRANSPL, V37, P803, DOI 10.1016/j.healun.2018.03.005; Dhand A, 2016, NAT REV NEUROL, V12, P605, DOI 10.1038/nrneurol.2016.119; Dijkland SA, 2020, J NEUROSURG, V133, P1132, DOI 10.3171/2019.5.JNS19483; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Donovan AL, 2018, CRIT CARE MED, V46, P980, DOI 10.1097/CCM.0000000000003067; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2020, NEUROCRIT CARE, V33, P364, DOI 10.1007/s12028-020-01062-7; Edlow BL, 2018, J HEAD TRAUMA REHAB, V33, P424, DOI 10.1097/HTR.0000000000000448; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edwards BA, 2019, AM J RESP CRIT CARE, V200, P691, DOI 10.1164/rccm.201901-0014TR; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Foreman B, 2020, NEUROTHERAPEUTICS, V17, P593, DOI 10.1007/s13311-020-00846-1; Forgacs PB, 2020, ANN NEUROL, V87, P618, DOI 10.1002/ana.25690; Forgacs PB, 2017, ANN CLIN TRANSL NEUR, V4, P119, DOI 10.1002/acn3.385; Fridman EA, 2019, BRAIN, V142, P1887, DOI 10.1093/brain/awz118; Froese L, 2020, NEUROTRAUMA REP, V1, P157, DOI 10.1089/neur.2020.0028; Froese L, 2020, ACTA NEUROCHIR, V162, P2683, DOI 10.1007/s00701-020-04579-0; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Gravesteijn BY, 2020, J NEUROTRAUM, V37, P1002, DOI 10.1089/neu.2019.6764; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; He FP, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5036184; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hermann B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61180-2; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang WS, 2017, BRAIN STIMUL, V10, P718, DOI 10.1016/j.brs.2017.02.001; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jain A, 2013, NEUROCRIT CARE, V19, P342, DOI 10.1007/s12028-013-9878-2; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Johnston SC, 2000, MUSCLE NERVE, V23, P839, DOI 10.1002/(SICI)1097-4598(200006)23:6<839::AID-MUS1>3.3.CO;2-M; Katzan IL, 2018, NEUROLOGY, V91, pE2182, DOI 10.1212/WNL.0000000000006626; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Kondziella D, 2017, NEUROCRIT CARE, V27, P401, DOI 10.1007/s12028-017-0407-6; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Kucuksezer UC, 2018, ARCH IMMUNOL THER EX, V66, P431, DOI 10.1007/s00005-018-0526-6; Kulkarni SS, 2021, ANN SURG, V274, P1081, DOI 10.1097/SLA.0000000000003669; Kumar A, 2019, NEUROCRIT CARE, V31, P321, DOI 10.1007/s12028-019-00679-7; Lauer Sebastian, 2013, EJIFCC, V24, P113; Lazaridis C, 2019, NEUROCRIT CARE, V30, P33, DOI 10.1007/s12028-018-0595-8; Legostaeva L, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050103; Liu P, 2016, EUR NEUROL, V76, P1, DOI 10.1159/000447325; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Machado C, 2014, CURR PHARM DESIGN, V20, P4185; Mancuso M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00524; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Martens G, 2018, BRAIN STIMUL, V11, P982, DOI 10.1016/j.brs.2018.04.021; McCracken DJ, 2019, NEUROSURGERY, V84, P741, DOI 10.1093/neuros/nyy193; McNett M, 2020, NEUROCRIT CARE, V33, P793, DOI 10.1007/s12028-020-01100-4; Menon DK, 2017, BRIT J ANAESTH, V119, P1062, DOI 10.1093/bja/aex374; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Micheel C.M., 2012, EVOLUTION TRANSLATIO; Mitchell P, 2018, MIND, V127, P1003, DOI 10.1093/mind/fzy020; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moore HM, 2011, J PROTEOME RES, V10, P3429, DOI 10.1021/pr200021n; Mori S, 2016, COMPUT SCI ENG, V18, P21, DOI 10.1109/MCSE.2016.93; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Multi -Society Task Force on PVS, 1995, NEW ENGL J MED, V333, P130; Muluk NB, 2019, AM J RHINOL ALLERGY, V33, P83, DOI 10.1177/1945892418807590; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakashima T, 2019, LANCET, V394, P2255, DOI 10.1016/S0140-6736(19)32488-2; Naro A, 2015, NEUROREHAB NEURAL RE, V29, P603, DOI 10.1177/1545968314562114; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Olson DM, 2019, J NEUROSCI NURS, V51, P43, DOI 10.1097/JNN.0000000000000426; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pan JH, 2020, BRAIN, V143, P1177, DOI 10.1093/brain/awaa026; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Pape TLB, 2014, BRAIN STIMUL, V7, P620, DOI 10.1016/j.brs.2014.03.007; Pisani LR, 2015, CONSCIOUS COGN, V38, P1, DOI 10.1016/j.concog.2015.09.012; Provencio JJ, 2020, NEUROCRIT CARE, V33, P1, DOI 10.1007/s12028-020-01028-9; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rao CPV, 2020, NEUROCRIT CARE, V32, P88, DOI 10.1007/s12028-019-00835-z; Rosenthal ES, 2018, ANN NEUROL, V83, P958, DOI 10.1002/ana.25232; Rubin DB, 2020, BRAIN, V143, P1143, DOI 10.1093/brain/awaa069; Rubin M, 2017, CURR OPIN CRIT CARE, V23, P134, DOI 10.1097/MCC.0000000000000396; Ruffner MA, 2020, ANN ALLERG ASTHMA IM, V124, P233, DOI 10.1016/j.anai.2019.12.011; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schlichter E, 2020, CRIT CARE NURSE, V40, pE1, DOI 10.4037/ccn2020681; Schmidt-Pogoda A, 2020, ANN NEUROL, V87, P40, DOI 10.1002/ana.25643; Schoettler N, 2020, CHEST, V157, P516, DOI 10.1016/j.chest.2019.10.009; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Sharrief AZ, 2017, J STROKE CEREBROVASC, V26, P2686, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.039; Siafakas N, 2017, COPD, V14, P367, DOI 10.1080/15412555.2017.1303041; Sokoliuk R, 2021, ANN NEUROL, V89, P646, DOI 10.1002/ana.25995; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Suarez JI, 2020, NEUROCRIT CARE, V32, P172, DOI 10.1007/s12028-019-00750-3; Suarez JI, 2019, NEUROCRIT CARE, V30, P1, DOI 10.1007/s12028-019-00751-2; Taran S, 2020, NEUROCRIT CARE, V32, P858, DOI 10.1007/s12028-019-00867-5; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Thibaut A, 2018, BRAIN STIMUL, V11, P642, DOI 10.1016/j.brs.2018.02.002; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tononi G, 2016, NAT REV NEUROSCI, V17, P450, DOI 10.1038/nrn.2016.44; Turgeon AF, 2019, CAN MED ASSOC J, V191, pE652, DOI 10.1503/cmaj.190154; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; Vaccarino AL, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00028; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Wang J, 2017, WORLD NEUROSURG, V98, P308, DOI 10.1016/j.wneu.2016.10.099; Wartenberg KE, 2019, NEUROCRIT CARE, V31, P231, DOI 10.1007/s12028-019-00769-6; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weppner JL, 2019, PMR, V11; White DB, 2010, CRIT CARE MED, V38, P743, DOI 10.1097/CCM.0b013e3181c58842; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Williamson T, 2020, JAMA SURG, V155, P723, DOI 10.1001/jamasurg.2020.1790; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Yeatts SD, 2020, J NEUROTRAUM, V37, P2674, DOI 10.1089/neu.2019.6969; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhao HC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00685; Zier LS, 2008, CRIT CARE MED, V36, P2341, DOI 10.1097/CCM.0b013e318180ddf9	169	0	0	6	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUL	2021	35	SUPPL 1		1	SI		4	23		10.1007/s12028-021-01260-x			20	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TG3ZR	WOS:000671346400002	34236619	Green Published, hybrid			2022-02-07	
J	Corne, R; Besson, V; Slimane, SAS; Coutan, M; Palhas, MLC; Shen, FX; Marchand-Leroux, C; Ogier, M; Mongeau, R				Corne, Remi; Besson, Valerie; Slimane, Sofiane Ait Si; Coutan, Mathieu; Palhas, Marta L. C.; Shen, Fang Xue; Marchand-Leroux, Catherine; Ogier, Michael; Mongeau, Raymond			Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress	NEUROSCIENCE			English	Article						traumatic brain injury; controlled cortical impact; fear conditioning; post-traumatic stress disorder; insulin-like growth factors	IGF-BINDING-PROTEINS; FACTOR-I; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MESSENGER-RNA; RAT-BRAIN; DISORDER; MILD; LOCALIZATION	growth factors (IGF) are potent neurotrophic and neurorepair factors that were recently proposed as biomarkers of traumatic brain injury (TBI) and associated psychiatric comorbidities, in particular posttraumatic stress disorder (PSTD). We tested the hypothesis that the IGF system is differentially deregulated in the acute and early chronic stages of TBI, and under acute stress. Plasma and brain IGF1 and IGF2 levels were evaluated in mice 3 weeks and 3 days after a controlled cortical impact (CCI)-induced mild-to-moderate TBI. The effects of conditioned fear on IGF levels and its interaction with TBI (TBI followed, 3 weeks later, by fearinducing procedures) were also evaluated. In the plasma, IGF1 decreased 3 weeks post-TBI only (-9%), whereas IGF2 remained unaffected. In the brain, IGF1 increased only in the cortex and hippocampus at 3 weeks post-TBI (up to +650%). At 3 days, surpringly, this increase was more diffuse and more important in sham (craniotomized) animals. Additionally, IGF2 immunostaining in brain ventricles was reorganized in TBI animals at both post-TBI stages. Conditioned fear exposure did not influence the effects of early chronic TBI on plasma IGF1 levels, but reduced plasma IGF2 (-6%) levels. It also dampened the effects of TBI on brain IGF systems, but brain IGF1 level and IGF2 tissue distribution remained statistically different from controls under these conditions. In co-exposed animals, DNA methylation increased at the hippocampal Igf1 gene promoter. These results show that blood IGF1 and IGF2 are most reduced in the early chronic phase of TBI and after exposure to a stressful event, and that the brain IGF system is up-regulated after TBI, and more so in the acute phase. (c) 2021 IBRO. Published by Elsevier Ltd. All rights reserved.	[Corne, Remi; Besson, Valerie; Slimane, Sofiane Ait Si; Palhas, Marta L. C.; Shen, Fang Xue; Marchand-Leroux, Catherine; Mongeau, Raymond] Univ Paris 05, EA4475 Pharmacol Circulat Cerebrale, 4 Ave Observ, F-75006 Paris, France; [Besson, Valerie; Marchand-Leroux, Catherine] Univ Paris 05, UMR S1144 Optimisat Therapeut Neuropsychopharmaco, 4 Ave Observ, F-75006 Paris, France; [Coutan, Mathieu; Ogier, Michael] Inst Rech Biomed Armees, 1 Pl Gen Valerie Andre, F-91223 Bretigny Sur Orge, France; [Mongeau, Raymond] Univ Paris 05, CNRS, UMR S Addict Pharmacol & Therapy 1124, ERL 3649,T3S 1124, 45 Rue St Peres, F-75006 Paris, France		Mongeau, R (corresponding author), Univ Paris 05, UMR S Addict Pharmacol & Therapy 1124, T3S 1124, 45 Rue St Peres, F-75270 Paris 06, France.	raymond.mongeau@parisdescartes.fr	BESSON, VALERIE/AAZ-9989-2020	BESSON, VALERIE/0000-0002-1491-2380	French Ministry for Armed Forces (Direction Generale de l'Armement -BioMedef Program); Fondation des Gueules Cassees	This work was supported by a grant from the French Ministry for Armed Forces (Direction Generale de l'Armement -BioMedef Program, to MO), and from the Fondation des Gueules Cassees (noFGC-11-2017 to VB and CM-L).	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Alani Behrang, 2013, Adv Biomed Res, V2, P42, DOI 10.4103/2277-9175.109757; AYERLELIEVRE C, 1991, DEVELOPMENT, V111, P105; Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burgdorf J, 2017, INT J NEUROPSYCHOPH, V20, P476, DOI 10.1093/ijnp/pyx007; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; de Oliveira JF, 2018, PSYCHIAT RES, V260, P111, DOI 10.1016/j.psychres.2017.11.061; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; Fan J, 1996, AM J PHYSIOL-REG I, V270, pR621, DOI 10.1152/ajpregu.1996.270.3.R621; Gautam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117092; Ghosh S, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12397; Giannakopoulou M, 2000, NEUROPATH APPL NEURO, V26, P513, DOI 10.1046/j.0305-1846.2000.00286.x; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Li H, 2013, BRAIN RES BULL, V90, P25, DOI 10.1016/j.brainresbull.2012.09.011; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lima BB, 2019, BRAIN BEHAV IMMUN, V78, P204, DOI 10.1016/j.bbi.2019.03.019; LOGAN A, 1994, ENDOCRINOLOGY, V135, P2255, DOI 10.1210/en.135.5.2255; Madathil SK, 2017, J TRAUMA ACUTE CARE, V83, pS16, DOI 10.1097/TA.0000000000001471; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; McCusker RH, 2006, J NEUROIMMUNOL, V179, P186, DOI 10.1016/j.jneuroim.2006.06.014; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Ogundele OM, 2017, NEUROSCIENCE, V353, P147, DOI 10.1016/j.neuroscience.2017.04.008; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Piskunov A, 2016, METAB BRAIN DIS, V31, P445, DOI 10.1007/s11011-015-9785-7; Prabhakaran J, 2017, BIOORG MED CHEM LETT, V27, P941, DOI 10.1016/j.bmcl.2016.12.086; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rusch HL, 2015, J CLIN SLEEP MED, V11, P615, DOI 10.5664/jcsm.4770; Santi A, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0196-5; Santi A, 2018, CEREB CORTEX, V28, P2007, DOI 10.1093/cercor/bhx106; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Stern SA, 2014, LEARN MEMORY, V21, P556, DOI 10.1101/lm.029348.112; Stern SA, 2014, NEUROPSYCHOPHARMACOL, V39, P2179, DOI 10.1038/npp.2014.69; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; UHDE TW, 1992, PHARMACOL BIOCHEM BE, V43, P263, DOI 10.1016/0091-3057(92)90667-5; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Waheed A, 2018, J INTERF CYTOK RES, V38, P1, DOI 10.1089/jir.2017.0088; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	59	0	0	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 1	2021	466						205	221		10.1016/j.neuroscience.2021.04.013			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SS0TR	WOS:000661455700002	33895341				2022-02-07	
J	Costine-Bartell, B; Price, G; Shen, J; McGuone, D; Staley, K; Duhaime, AC				Costine-Bartell, Beth; Price, George; Shen, John; McGuone, Declan; Staley, Kevin; Duhaime, Ann-Christine			A perfect storm: The distribution of tissue damage depends on seizure duration, hemorrhage, and developmental stage in a gyrencephalic, multi-factorial, severe traumatic brain injury model	NEUROBIOLOGY OF DISEASE			English	Article						Severe traumatic brain injury; Hemispheric hypodensity; Gyrencephalic; Abusive head trauma; Traumatic seizures; Subdural hemorrhage; Subarachnoid hemorrhage; Hypoxic ischemia	NONACCIDENTAL HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; MATRIX METALLO-PROTEINASE-9; HEMISPHERIC HYPODENSITY; AXONAL INJURY; PIGLET BRAIN; MATURATION; INFANTS; IMPACT; NEUROPATHOLOGY	The pathophysiology of extensive cortical tissue destruction observed in hemispheric hypodensity, a severe type of brain injury observed in young children, is unknown. Here, we utilize our unique, large animal model of hemispheric hypodensity with multifactorial injuries and insults to understand the pathophysiology of this severe type of traumatic brain injury, testing the effect of different stages of development. Piglets developmentally similar to human infants (1 week old, ?infants?) and toddlers (1 month old, ?toddlers?) underwent injuries and insults scaled to brain volume: cortical impact, creation of mass effect, placement of a subdural hematoma, seizure induction, apnea, and hypoventilation or a sham injury while anesthetized with a seizure-permissive regimen. Piglets receiving model injuries required overnight intensive care. Hemispheres were evaluated for damage via histopathology. The pattern of damage was related to seizure duration and hemorrhage pattern in ?toddlers? resulting in a unilateral hemispheric pattern of damage ipsilateral to the injuries with sparing of the deep brain regions and the contralateral hemisphere. While ?infants? had the equivalent duration of seizures as ?toddlers?, damage was less than ?toddlers?, not correlated to seizure duration, and was bilateral and patchy as is often observed in human infants. Subdural hemorrhagewas associate with adjacent focal subarachnoid hemorrhage. The percentage of the hemisphere covered with subarachnoid hemorrhage was positively correlated with damage in both developmental stages. In ?infants?, hemorrhage over the cortex was associated with damage to the cortex with sparing of the deep gray matter regions; without hemorrhage, damage was directed to the hippocampus and the cortex was spared. ?Infants? had lower neurologic scores than ?toddlers?. This multifactorial model of severe brain injury caused unilateral, wide-spread destruction of the cortex in piglets developmentally similar to toddlers where both seizure duration and hemorrhage covering the brain were positively correlated to tissue destruction. Inherent developmental differences may affect how the brain responds to seizure, and thus, affects the extent and pattern of damage. Study into specifically how the ?infant? brain is resistant to the effects of seizure is currently underway and may identify potential therapeutic targets that may reduce evolution of tissue damage after severe traumatic brain injury.	[Costine-Bartell, Beth; Price, George; Shen, John; Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Charlestown, MA USA; [Costine-Bartell, Beth; Duhaime, Ann-Christine] Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA; [McGuone, Declan] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Staley, Kevin] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Staley, Kevin] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA		Costine-Bartell, B (corresponding author), Bldg 149 13th St,Room 3-405, Charlestown, MA 02129 USA.	bcostinebartell@mgh.harvard.edu			NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD083759, R01HD099397]	This work is supported by NICHD grant K01HD083759 and R01HD099397 to BCB. The authors express their gratitude to Eleanor Crawford, Andrew Bourque, Kyle Vynorious, Jacqueline Andrews, Madeline Perlewitz, Zoe Silsby, Scott Henderson, Natalie Escobar, Carla Fortes-Monteiro, Madeline Karsten, Luis Fernando Martinez Ramirez, and Anna Akkara for their assistance with animal surgeries, tissue sectioning, and map analysis.	Berger RP, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0429; Bjorkman ST, 2010, NEUROSCIENCE, V166, P157, DOI 10.1016/j.neuroscience.2009.11.067; Boon P, 2015, SEIZURE-EUR J EPILEP, V32, P52, DOI 10.1016/j.seizure.2015.08.011; CLANCY RR, 1988, EPILEPSIA, V29, P256, DOI 10.1111/j.1528-1157.1988.tb03715.x; Coats B, 2017, J NEUROTRAUM, V34, P235, DOI 10.1089/neu.2015.4352; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; Costine-Bartell BA, 2019, J NEUROTRAUM, V36, P815, DOI 10.1089/neu.2018.5736; Cudna A, 2017, EPILEPSY RES, V129, P33, DOI 10.1016/j.eplepsyres.2016.11.006; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Dubey D, 2017, EPILEPSY RES, V132, P50, DOI 10.1016/j.eplepsyres.2017.02.021; Duhaime A.C., 1993, J NEUROTRAUM, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Durham SR, 2000, PEDIATR NEUROSURG, V33, P76, DOI 10.1159/000028980; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Foster KA, 2014, J NEUROTRAUM, V31, P1625, DOI 10.1089/neu.2014.3372; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giardano A., 1997, PRACTICAL GUIDE EVAL; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Glykys J, 2017, TRENDS NEUROSCI, V40, P276, DOI 10.1016/j.tins.2017.03.006; Goasdoue K, 2019, DEV NEUROSCI-BASEL, V40, P560, DOI 10.1159/000499365; Hampel KG, 2015, SEIZURE-EUR J EPILEP, V26, P81, DOI 10.1016/j.seizure.2015.02.004; Hefter D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00022; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Josephson CB, 2015, EPILEPSIA, V56, P143; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Khan NR, 2017, J NEUROSURG-PEDIATR, V20, P183, DOI 10.3171/2017.4.PEDS16650; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; Price G, 2019, J NEUROTRAUM, V36, pA97; Price G, 2018, J NEUROTRAUM, V35, pA91; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Takahashi T, 1999, AM J NEURORADIOL, V20, P917; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; Wirrell EC, 2001, PEDIATR RES, V50, P445, DOI 10.1203/00006450-200110000-00005	45	0	0	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2021	154								105334	10.1016/j.nbd.2021.105334			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA9RY	WOS:000649641600001	33753291	Green Accepted, gold			2022-02-07	
J	D'Alonzo, BA; Bretzin, AC; Chandran, A; Boltz, AJ; Robison, HJ; Collins, CL; Morris, SN				D'Alonzo, Bernadette A.; Bretzin, Abigail C.; Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.			Epidemiology of Injuries in National Collegiate Athletic Association Men's Lacrosse: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate; descriptive epidemiology; injury surveillance	DESCRIPTIVE EPIDEMIOLOGY; SPORTS; RECOMMENDATIONS; STRAINS	Context: The popularity of National Collegiate Athletic Association (NCAA) men's lacrosse has been steadily increasing since the early 1980s. Background: Injury surveillance is an important tool to aid in identifying emerging patterns of sport-related injury in NCAA men's lacrosse. Methods: Injury data collected from a sample of men's lacrosse teams through the NCAA Injury Surveillance Program for the academic years 2014-2015 through 2018-2019 were analyzed. Athlete exposures were estimated and computed based on collected exposure data. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios (IRRs) with 95% confidence intervals (CIs) were calculated to estimate differences in injury rates. Results: The overall injury rate was 4.90 per 1000 athlete exposures (AEs), and the competition injury rate was higher than the practice injury rate (IRR = 2.59; 95% CI = 2.35, 2.84). The overall preseason injury rate was higher than the regular and postseason injury rates. The most reported injuries were concussions (8.0%), ankle sprains (7.7%), and hamstring tears (6.9%). Conclusions: Study findings were comparable with existing epidemiological evidence. The overall burden of concussions and lower extremity injuries warrant further attention in this population.	[D'Alonzo, Bernadette A.; Bretzin, Abigail C.] Univ Penn, Penn Injury Sci Ctr, Philadelphia, PA 19104 USA; [Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Bretzin, Abigail/0000-0003-3730-2849	NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes.	[Anonymous], 2018 19 HIGH SCH ATH; [Anonymous], NCAA MENS LACROSSE 2; [Anonymous], US LACROSSE PARTICIP; [Anonymous], NCAA SPORTS SPONSORS; [Anonymous], 2020 21 NCAA DIVISIO; Askling CM, 2008, AM J SPORT MED, V36, P1799, DOI 10.1177/0363546508315892; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2020, J ATHL TRAINING, V55, P580, DOI 10.4085/1062-6050-0517.19; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2020, J QUANT ANAL SPORTS, V16, P221, DOI 10.1515/jqas-2019-0030; Chumanov ES, 2011, MED SCI SPORT EXER, V43, P525, DOI 10.1249/MSS.0b013e3181f23fe8; Dick R, 2007, J ATHL TRAINING, V42, P255; Elliott MCCW, 2011, AM J SPORT MED, V39, P843, DOI 10.1177/0363546510394647; Foss KDB, 2017, PHYSICIAN SPORTSMED, V45, P224, DOI 10.1080/00913847.2017.1355209; Hauer R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093329; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Irick E., NCAA SPORTS SPONSORS; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Kerr ZY, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3482; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kiernan D, 2018, J BIOMECH, V73, P201, DOI 10.1016/j.jbiomech.2018.04.001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; McDonald AA, 2019, J ATHL TRAINING, V54, P489, DOI 10.4085/1062-6050-152-17; Mokha M, 2016, J ATHL TRAINING, V51, P276, DOI 10.4085/1062-6050-51.2.07; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pierpoint LA, 2019, J ATHL TRAINING, V54, P30, DOI 10.4085/1062-6050-200-17; Reneker JC, 2019, PHYS THER SPORT, V40, P184, DOI 10.1016/j.ptsp.2019.09.012; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Sell KM, 2018, J STRENGTH COND RES, V32, P3160, DOI 10.1519/JSC.0000000000002830; Shultz SJ, 2016, HUMAN KINETICS, V4th, P688; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Steiner ME, 2016, SPORTS HEALTH, V8, P217, DOI 10.1177/1941738115626689; Wasserman E, 2017, BR J SPORTS MED, V51, pA67, DOI [10.1136/bjsports-2016-097270.174, DOI 10.1136/BJSPORTS-2016-097270.174]; Windt J, 2017, BRIT J SPORT MED, V51, P428, DOI 10.1136/bjsports-2016-096040	36	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					758	765		10.4085/1062-6050-612-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700023	34280286	gold			2022-02-07	
J	Dakay, KB; Azher, I; Mahta, A; Furie, K; Yaghi, S; Cutting, SM				Dakay, Katarina B.; Azher, Idrees; Mahta, Ali; Furie, Karen; Yaghi, Shadi; Cutting, Shawna M.			Multifocal Atraumatic Convexity Subarachnoid Hemorrhage	CUREUS			English	Article						subarachnoid hemorrhage; convexity subarachnoid hemorrhage; mri- magnetic resonance imaging; reversible cerebral vasoconstriction syndrome; cerebral amyloid angiopathy	CLINICAL PRESENTATION	Background Multi focal convexity subarachnoid hemorrhage (cSAH) has generally been described in the setting of traumatic brain injury, however, it has also been reported in the absence of trauma in conditions such as with reversible cerebral vasoconstriction syndrome. We describe the clinical and radiographic characteristics of multi focal cSAH in an academic center. Methods We analyzed our single-center retrospective database of nontraumatic convexity subarachnoid hemorrhage from January 2015-January 2018. Convexity subarachnoid hemorrhage was defined as blood in one or more cortical sulci in the absence of trauma; patients with blood in the cisterns or Sylvian fissure were excluded. Multifocal location was defined as at least two distinct foci of hemorrhage occurring in two or more lobes. Clinical and neuroimaging data were collected. Results Out of 70 total patients with convexity subarachnoid hemorrhage, 13 cases were of multifocal convexity subarachnoid hemorrhage, occurring in 18.6% of all cases. The mean age was 58 years (SD = 14.7). Eleven patients were female. Seven patients had reversible cerebral vasoconstriction syndrome (RCVS)/posterior reversible encephalopathy syndrome (PRES), two had cerebral amyloid angiopathy (CAA), three had intrinsic coagulopathy, and one patient had endocarditis as the etiology of multifocal cSAH. Headache was the most common complaint, in eight. (61.5%) patients. Conclusion Multifocal cSAH occurs in approximately 18.6% of all cSAH and can occur in the absence of trauma. In our larger cohort of all cSAH, CAA was the most common cause; however, multifocal cSAH is more commonly caused by RCVS/PRES spectrum. Clinicians should be aware that multifocal cSAH can occur in the absence of trauma, and may be a harbinger of RCVS/PRES, particularly in young patients with thunderclap headaches.	[Dakay, Katarina B.] Westchester Med Ctr, Neurosurg, Valhalla, NY 10595 USA; [Azher, Idrees] Univ Texas Hlth Sci Ctr Houston, Neurol, Houston, TX 77030 USA; [Mahta, Ali; Furie, Karen; Yaghi, Shadi; Cutting, Shawna M.] Brown Univ, Rhode Isl Hosp, Neurol, Providence, RI 02903 USA		Dakay, KB (corresponding author), Westchester Med Ctr, Neurosurg, Valhalla, NY 10595 USA.	katarina.dakay@gmail.com	Mahta, Ali/ABA-7340-2021				Bruno VA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0338-3; Beitzke M, 2011, STROKE, V42, P3055, DOI 10.1161/STROKEAHA.111.621847; Cuvinciuc V, 2010, AM J NEURORADIOL, V31, P1355, DOI 10.3174/ajnr.A1986; Dakay K, 2019, J NEUROINTERV SURG, V11, P1222, DOI 10.1136/neurintsurg-2019-014781; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Kumar S, 2010, NEUROLOGY, V74, P893, DOI 10.1212/WNL.0b013e3181d55efa; Mangla R, 2015, EMERG RADIOL, V22, P181, DOI 10.1007/s10140-014-1251-z; Refai D, 2008, J NEUROSURG, V109, P1034, DOI 10.3171/JNS.2008.109.12.1034; Rocha EA, 2019, NEUROLOGY, V92, pe639, DOI 10.1212/WNL.0000000000006917; Spitzer C, 2005, NEURORADIOLOGY, V47, P525, DOI 10.1007/s00234-005-1384-6	12	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL 1	2021	13	7							e16091	10.7759/cureus.16091			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TP3UX	WOS:000677521000008	34345565	Green Published, gold			2022-02-07	
J	Denny, JW; Dickinson, AS; Langdon, GS				Denny, J. W.; Dickinson, A. S.; Langdon, G. S.			Defining blast loading 'zones of relevance' for primary blast injury research: A consensus of injury criteria for idealised explosive scenarios	MEDICAL ENGINEERING & PHYSICS			English	Article						Blast injury criteria; Primary blast injury; Traumatic brain injury; Shock tube; Animal models; Injury mechanisms; Military; Civilian	TYMPANIC MEMBRANE; RISK-ASSESSMENT; BRAIN-INJURIES; EXPOSURE; IRAQ	Blast injuries remain a serious threat to defence and civilian populations around the world. 'Primary' blast injuries (PBIs) are caused by direct blast wave interaction with the human body, particularly affecting aircontaining organs. Work to define blast loading conditions for injury research has received relatively little attention, though with a continued experimental focus on PBIs and idealised explosion assumptions, meaningful test outcomes and subsequent clinical applications, rely on appropriate simulated conditions. This paper critically evaluates and combines existing PBI criteria (grouped into those affecting the auditory system, pulmonary injuries and brain trauma) as a function of idealised blast wave parameters. For clinical blast injury researchers, analysis of the multi-injury criteria indicates zones of appropriate loading conditions for human-scale test items and demonstrates the importance of simulating blast conditions that are both realistic and relevant to the injury type. For certain explosive scenarios, spatial interpretation of the 'zones of relevance' could support emergency response and hazard preparedness by informing triage, patient management and resource allocation, thus leading to improved health outcomes. This work will prove useful to clinical blast injury researchers, blast protection engineers and clinical practitioners involved in the triage, diagnosis, and treatment of PBIs.	[Denny, J. W.; Dickinson, A. S.] Univ Southampton, Dept Mech Engn, Southampton SO17 1BJ, Hants, England; [Langdon, G. S.] Univ Sheffield, Dept Civil & Struct Engn, Mappin St, Sheffield S1 3JD, S Yorkshire, England; [Langdon, G. S.] Univ Cape Town, Dept Mech Engn, Cape Town, South Africa		Denny, JW (corresponding author), Univ Southampton, Dept Mech Engn, Southampton SO17 1BJ, Hants, England.	Jack.Denny@soton.ac.uk	Dickinson, Alexander/D-2693-2012	Dickinson, Alexander/0000-0002-9647-1944; /0000-0003-3181-4747	RAEng Frontiers of Development Seed Funding; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Royal Academy of Engineering (RAEng)Royal Academy of Engineering - UK [RF/130]	RAEng Frontiers of Development Seed Funding. EPSRC Doctoral Prize. The Royal Academy of Engineering (RAEng) (award no. RF/130)	Action on Armed Violence (AOAV), 2020, EXPL VIOL 2019; ZUCKERMAN S., 1941, Proceedings of the Royal Society of Medicine, V31, P171; Axelsson H, 1996, J TRAUMA, V40, pS31, DOI 10.1097/00005373-199603001-00006; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Batchelor J, 2019, 4 INT WASH DC FOR BL, P2019; Beveridge, 1998, FORENSIC INVESTIGATI, DOI [10.1201/b11938, DOI 10.1201/B11938]; BRETT DO, 2008, J TRAUMA, V64, P295, DOI DOI 10.1097/TA.0B013-318163B875; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; Brode HL, 1954, RM1363AEC; Bulmash G., 1984, ARBRLTR02555; Cernak I., 2017, UNDERSTANDING BLAST, P2; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; ConWep Hyde DW, 1992, CONV WEAP EFF APPL T; Cranz C., 1926, LEHRBUCH BALLISTIK; Department of Defense, 1983, REP DOD COMM BEIR IN; Dickinson AS, 2020, BMJ MILITARY HEALTH, DOI [10.1136/bmjmilitary-2020001655, DOI 10.1136/BMJMILITARY-2020001655]; Divani AA, 2015, J NEUROTRAUM, V32, P1109, DOI 10.1089/neu.2014.3686; Dutch Safety Board, 2017, MORT ACC MAL; FEMA, 2005, RISK ASS GUID MIT PO; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P344, DOI 10.1098/rspa.1946.0047; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Goumtcha AA, 2014, INT J NUMER METH BIO, V30, P1667, DOI 10.1002/cnm.2694; Harrison CD, 2009, J TRAUMA, V67, P210, DOI 10.1097/TA.0b013e3181a5f1db; HILL JF, 1979, ANN ROY COLL SURG, V61, P4; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; Hopkinson B., 1915, BRIT ORDNANCE BOARD; Igarashi Y, 2015, BIOMED REP, V3, P468, DOI 10.3892/br.2015.454; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Jenzen-Jones NR, SUBMUNITIONS SYRIA A; Josey T, 2008, 20 S MIL ASP BLAST S; Josey T, 2019, J ROY ARMY MED CORPS, V165, P10, DOI 10.1136/jramc-2018-000954; Leggieri MJ, 2019, J ROY ARMY MED CORPS, V165, P7, DOI 10.1136/jramc-2018-000963; Mahoney, 2016, BLAST INJURY SCI EN; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owen-Smith M S, 1981, J R Army Med Corps, V127, P31; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Rafaels KA, 2010, J TRAUMA, V69, P368, DOI 10.1097/TA.0b013e3181e88122; Richmond DR., 1968, ESTIMATE MANS TOLERA; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; STAPCZYNSKI JS, 1982, ANN EMERG MED, V11, P687, DOI 10.1016/S0196-0644(82)80268-0; Teland, 2012, REV BLAST INJURY PRE; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU, DOI [10.1682/JRRD.2009.06.0076, DOI 10.1682/JRRD.2009.06.0076]; Nguyen TT, 2019, J ROY ARMY MED CORPS, V165, P33, DOI 10.1136/jramc-2018-000966; Toshikatsu, 2016, BRAIN MONIT, VXV, P122, DOI [10.1007/978-3-319-22533-3, DOI 10.1007/978-3-319-22533-3]; Trimble K, 2001, J R Army Med Corps, V147, P73; US Department of Defense (DoD), 2008, 334002 DOD UFC; US Department of Defense (DoD), 2006, DOD DIR 6025 21E MED; van der Voort MM, 2016, J LOSS PREVENT PROC, V40, P396, DOI 10.1016/j.jlp.2016.01.014	58	0	0	4	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	JUL	2021	93						83	92		10.1016/j.medengphy.2021.05.014			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	SV5BC	WOS:000663834800010	34154779	Green Submitted			2022-02-07	
J	DiBlasio, CA; Novack, TA; Cook, EW; Dams-O'Connor, K; Kennedy, RE				DiBlasio, Christina A.; Novack, Thomas A.; Cook, Edwin W.; Dams-O'Connor, Kristen; Kennedy, Richard E.			Convergent Validity of In-Person Assessment of Inpatients With Traumatic Brain Injury Using the Brief Test of Adult Cognition by Telephone (BTACT)	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; traumatic brain injury; cognition; inpatients; neuropsychological tests; psychometrics; telephone	RECOVERY	Objective: To examine convergent validity of the Brief Test of Adult Cognition by Telephone (BTACT) by determining correlation with established neuropsychological tests, administered an average of 4.4 days apart, in an inpatient traumatic brain injury (TBI) population. Setting: Acute inpatient rehabilitation hospital. Participants: Fifty-five patients receiving inpatient rehabilitation for new-onset TBI (69.1% male; mean age = 37 years, SD = 14 years). Design: Cross-sectional, secondary data analysis. Main Measures: BTACT; California Verbal Learning Test-second edition (CVLT-2); Wechsler Adult Intelligence Scale-IV (WAIS-IV) Digit Span; Trail Making Test; semantic fluency; phonemic fluency; Symbol Digit Modalities Test; Wisconsin Card Sorting Test. Results: The BTACT was significantly associated with established neuropsychological tests across composite scores of overall cognition (r = 0.64, P < .001), episodic verbal memory (r = 0.66, P < .001), and executive function (r = 0.56, P < .001). For BTACT subtests, Word List Immediate Recall and Word List Delayed Recall were correlated with CVLT-2 learning trials total score (r = 0.57, P < .01) and long delay free recall (r = 0.60, P < .001), respectively. BTACT Digits Backward correlated with WAIS-IV Digit Span (r = 0.51, P < .01). BTACT Animal Fluency was associated with semantic fluency (r = 0.65, P < .01), phonemic fluency (r = 0.60, P < .01), and Trail Making Test Part B (r = 0.39, P < .01). Conclusion: BTACT composite scores of overall cognition, verbal memory, and executive function demonstrate initial convergent validity in a TBI inpatient population. Future research should examine validity in a larger sample of individuals with TBI.	[DiBlasio, Christina A.; Cook, Edwin W.] Univ Alabama Birmingham, Dept Psychol, 933 19th St S, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; [Kennedy, Richard E.] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		DiBlasio, CA (corresponding author), Univ Alabama Birmingham, Dept Psychol, 933 19th St S, Birmingham, AL 35294 USA.	diblasio@mab.edu	Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0015, 90DPTB0009]; National Institutes of Health National Institute on Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1NS115268-01]	Thomas A. Novack is currently receiving a grant (#90DPTB0015) from the National Institute on Disability, Independent Living, and Rehabilitation Research. Kristen Dams-O'Connor is currently receiving a grant (#90DPTB0009) from the National Institute on Disability, Independent Living, and Rehabilitation Research and a grant (RF1NS115268-01) from theNational Institutes ofHealthNational Institute onNeurological Disorders and Stroke.	Brim OG, 2004, MAC FDN MEN, P1; Centers for Disease Control and Prevention, 2017, SEV TBI TRAUM BRAIN SEV TBI TRAUM BRAIN; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Davidson C.D, 2018, MIDLIFE US MIDUS REF; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis D.C., 2017, CALIFORNIA VERBAL LE, V3rd; Faul M, 2010, TRAUMATIC BRAIN INJU; Hantke NC, 2020, J AM GERIATR SOC, V68, P1387, DOI 10.1111/jgs.16514; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HOLM S, 1979, SCAND J STAT, V6, P65; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack, 2004, COGNITIVE LOG; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Reitan R, 1985, HALSTEAD REITAN NEUR; Ryff CD., 2017, MIDLIFE US MIDUS 2 C; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Smith A., 1982, SYMBOL DIGIT MODALIT; Tun PA., 2005, BRIEF TEST ADULT COG, P1; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Venton AL., 1983, MULTILINGUAL APHASIA; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E226	E232		10.1097/HTR.0000000000000677			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100006	33656489	Green Accepted			2022-02-07	
J	DiBlasio, CA; Sima, A; Kumar, RG; Kennedy, RE; Retnam, R; Lachman, ME; Novack, TA; Dams-O'Connor, K				DiBlasio, Christina A.; Sima, Adam; Kumar, Raj G.; Kennedy, Richard E.; Retnam, Reuben; Lachman, Margie E.; Novack, Thomas A.; Dams-O'Connor, Kristen			Research Letter: Performance of the Brief Test of Adult Cognition by Telephone in a National Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; traumatic brain injury; cognition; data analysis; neuropsychology; rehabilitation; telephone		Objective: To create a larger, more representative community comparison sample of the Brief Test of Adult Cognition by Telephone (BTACT) data to facilitate assessment of cognitive function in research studies. Setting: National US community-based survey. Participants: In total, 6747 healthy adults aged 23 to 84 years (53% female; mean age = 55 years, SD = 13). Design: Secondary data analysis of BTACT data collected from the National Survey of Midlife Development in the United States (MIDUS) II and MIDUS Refresher cohorts. Main Measures: The BTACT, a brief (15-20 minute) measure of global cognitive function validated for telephone administration. Results: This article provides BTACT community comparison sample data based on age, sex, and education from a national sample. Similar to other cognitive measures, BTACT scores decreased with age and increased with education. Conclusions: The BTACT community comparison sample will facilitate investigation of cognitive functioning in large-scale traumatic brain injury research studies and will support secondary analysis of existing BTACT data gathered through the MIDUS study.	[DiBlasio, Christina A.] Univ Alabama Birmingham, Dept Psychol, Coll Arts & Sci, 933 19th St S, Birmingham, AL 35294 USA; [Kennedy, Richard E.] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Dept Med, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Sch Med, Birmingham, AL 35294 USA; [Sima, Adam; Retnam, Reuben] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Lachman, Margie E.] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA		DiBlasio, CA (corresponding author), Univ Alabama Birmingham, Dept Psychol, Coll Arts & Sci, 933 19th St S, Birmingham, AL 35294 USA.	diblasio@uab.edu	Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X; Lachman, Margie/0000-0003-3027-8735	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DTPB0015, 90DPTB0009]; National Institutes of Health National Institute on Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1NS115268-01]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01-AG020166, U19-AG051426]	Thomas A. Novack is currently receiving a grant (#90DTPB0015) from the National Institute on Disability, Independent Living, and Rehabilitation Research. Kristen Dams-O'Connor is currently receiving a grant (#90DPTB0009) from the National Institute on Disability, Independent Living, and Rehabilitation Research and a grant (RF1NS115268-01) from the National Institutes of Health National Institute on Neurological Disorders and Stroke. Margie E. Lachman acknowledges support from grants (P01-AG020166 and U19-AG051426) from the National Institute on Aging.	Brim OG, 2004, MAC FDN MEN, P1; Brim OG., DESCRIPTION MIDUS SA; Brim Orville Gilbert, 1999, ICPSR, DOI 10.3886/ICPSR02760; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Davidson C.D, 2018, MIDLIFE US MIDUS REF; Hughes ML, 2018, J INT NEUROPSYCH SOC, V24, P805, DOI 10.1017/S1355617718000425; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; RADLER BT, 2014, OPEN HLTH DATA, V0002; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ryff C., 2017, MIDLIFE US MIDUS 2 2 MIDLIFE US MIDUS 2 2 MIDLIFE US MIDUS 2 2 MIDLIFE US MIDUS 2 2 MIDLIFE US MIDUS 2 2; Ryff C., 2017, MIDLIFE US MIDUS REF; Ryff CD., 2017, MIDLIFE US MIDUS 2 C; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Wechsler, 1997, WECHSLER ADULT INTEL	14	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E233	E239		10.1097/HTR.0000000000000664			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100007	33656486	Green Accepted			2022-02-07	
J	Drake, SA; Yang, YJ; Gao, S; Mora, S; Garza, R; Moore, L; Todd, SR; Wilson, C; Wolf, DA				Drake, Stacy A.; Yang, Yijiong; Gao, Si; Mora, Stephen; Garza, Robin; Moore, Laura; Todd, S. Rob; Wilson, Chad; Wolf, Dwayne A.			Fatal and Nonfatal Injury Patterns of Stranded Motorists	JOURNAL OF FORENSIC NURSING			English	Article						Fatal roadway injuries; forensic nursing; highway injury pattern; stranded motorist	DEATHS	Because nonfatal and fatal incidents for stranded motorists are not separated from vehicular accidents, little data are available on incident characteristics. To close this gap, data fields were inserted into databases at a medical examiner's office and two trauma centers to collect injury-related information. Forensic nurses and pathologists aided in forming a collaboration among the agencies involved and supported data collection efforts. Data collected over a 5-year period were examined for injury patterns to determine risk factors affecting these patterns. Of the total sample (N = 219), 24.7% had spinal injuries resulting in fatal injuries for 46 of 54 individuals. The odds were stranded motorists with spine-related injuries (C1-C7) had 9.13 times higher risk for a fatal outcome compared with those without spine-related injuries. Severe injuries (Abbreviated Injury Scale scores >= 4) noted for head/neck (29.7%) and chest (24.2%) were significantly associated with fatality. Of the 219 cases, 22.8% were inside of a stopped vehicle, and 77.2% were outside a vehicle at the time of injury. Outcomes illustrated the success of the interprofessional collaboration between trauma centers and a medicolegal death investigation agency that resulted in data useful for forensic nurses and pathologists documenting evidence, emergency and trauma responding personnel in patient priority stabilization, and injury prevention specialists for highway safety programs.	[Drake, Stacy A.] Texas A&M Univ, 2121 W Holcombe Blvd 1011A, Houston, TX 77030 USA; [Yang, Yijiong] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Gao, Si; Wolf, Dwayne A.] Univ Texas Houston, McGovern Med Sch, Harris Cty Inst Forens Sci, Houston, TX USA; [Mora, Stephen] Univ Texas Houston, McGovern Med Sch, Harris Hlth, Houston, TX USA; [Garza, Robin; Todd, S. Rob] Univ Texas Houston, McGovern Med Sch, Grady Hlth Syst, Houston, TX USA; [Moore, Laura] Univ Texas Houston, McGovern Med Sch, Houston, TX USA; [Wilson, Chad] Baylor Coll Med, Houston, TX 77030 USA		Drake, SA (corresponding author), Texas A&M Univ, 2121 W Holcombe Blvd 1011A, Houston, TX 77030 USA.	sadrake@tamu.edu					Attergrim J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199754; Delwiche LD, 2003, LITTLE SAS BOOK PRIM; Drake SA, 2015, J FORENSIC NURS, V11, P174, DOI 10.1097/JFN.0000000000000078; Elgin LB, 2019, J TRAUMA NURS, V26, P199, DOI 10.1097/JTN.0000000000000449; Hall GC, 2015, WORLD J ORTHOP, V6, P236, DOI 10.5312/wjo.v6.i2.236; Kalkwarf KJ, 2020, J TRAUMA ACUTE CARE, V89, P716, DOI 10.1097/TA.0000000000002833; Mitic I, 2021, US CAR SALES STAT FI; Roden-Foreman JW, 2019, J TRAUMA ACUTE CARE, V87, P658, DOI 10.1097/TA.0000000000002402; Santos AT, 2019, J TRAUMA NURS, V26, P93, DOI 10.1097/JTN.0000000000000428	9	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-3693	1939-3938		J FORENSIC NURS	J. Forensic Nurs.	JUL-SEP	2021	17	3					154	162		10.1097/JFN.0000000000000329			9	Criminology & Penology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Criminology & Penology; Nursing	UK8CV	WOS:000692193300007	33929400				2022-02-07	
J	Eastman, DK; Spilman, SK; Tang, K; Sidwell, RA; Pelaez, CA				Eastman, Darla K.; Spilman, Sarah K.; Tang, Kelly; Sidwell, Richard A.; Pelaez, Carlos A.			Platelet Reactivity Testing for Aspirin Patients Who Sustain Traumatic Intracranial Hemorrhage	JOURNAL OF SURGICAL RESEARCH			English	Article						Antiplatelets; Platelet transfusion; Intracranial hemorrhage; Aspirin antiplatelet reversal; Platelet reactivity testing; Medication reconciliation	ANTIPLATELET AGENTS; EMERGENCY REVERSAL; OLDER PATIENTS; BRAIN-INJURY; TRANSFUSION; GUIDELINE; MANAGEMENT; DRUGS; ANTICOAGULATION; RESISTANCE	Background: Patients who take aspirin and sustain traumatic intracranial hemorrhage (tICH) are often transfused platelets in an effort to prevent bleeding progression. The efficacy of platelet transfusion is questionable, however, and some medical societies recommend that platelet reactivity testing (PRT) should guide transfusion decisions. The study hypothesis was that utilization of PRT to guide platelet transfusion for tICH patients suspected of taking aspirin would safely identify patients who did not require platelet transfusion. Methods: This was a retrospective study of patients with blunt tICH who received PRT for known or suspected aspirin use between June 2014 and December 2017 at a level I trauma center. Chart abstraction was conducted to determine home aspirin status, and PRT values were used to classify patients as therapeutic or nontherapeutic on aspirin. Differences were assessed with Kruskal-Wallis and chi-square tests. Results: 157 patients met study inclusion criteria, and 118 (75%) patients had documented prior aspirin use. PRT results were available approximately 1.7 h (IQR: 0.9, 3.2) after arrival. Upon initial PRT, 70% of patients were considered inhibited and 88% of those patients had aspirin documented as a home medication. Conversely, 18% of patients with home aspirin use had normal platelet reactivity. Clinically significant worsening of the tICH did not significantly differ when comparing those who received platelet transfusion with those who did not (8% versus 7%, P = 0.87). Conclusions: Platelet reactivity testing can detect platelet inhibition related to aspirin and should guide transfusion decisions for head injured patients in the initial hours after trauma. (C) 2021 Elsevier Inc. All rights reserved.	[Eastman, Darla K.] Drake Univ, Coll Pharm & Hlth Sci, 2507 Univ Ave, Des Moines, IA 50311 USA; [Spilman, Sarah K.; Sidwell, Richard A.; Pelaez, Carlos A.] UnityPoint Hlth, Trauma Serv, Des Moines, IA USA; [Tang, Kelly] Des Moines Univ, Osteopath Med Program, Des Moines, IA USA; [Sidwell, Richard A.; Pelaez, Carlos A.] Iowa Clin, Trauma Surg, Des Moines, IA USA		Eastman, DK (corresponding author), Drake Univ, Coll Pharm & Hlth Sci, 2507 Univ Ave, Des Moines, IA 50311 USA.	darla.eastman@drake.edu					Accumetrics, ACCUMETRICS VERIFYNO; Airee A, 2008, PHARMACOTHERAPY, V28, P999, DOI 10.1592/phco.28.8.999; Alvikas J, 2020, J TRAUMA ACUTE CARE, V88, P847, DOI 10.1097/TA.0000000000002640; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Bosch-Lenders D, 2016, AGE AGEING, V45, P402, DOI 10.1093/ageing/afw045; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connelly CR, 2017, J SURG RES, V212, P260, DOI 10.1016/j.jss.2017.01.008; Diagnostics A, 2016, VERIFYNOW R REFERENC; Diagnostics A, 2015, VERIFYNOW SYSTEM REF; Eke O, 2018, CAN J EMERG MED, V20, pS78, DOI 10.1017/cem.2017.438; Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; James RF, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1328; Jones G, 2015, DRUG AGING, V32, P329, DOI 10.1007/s40266-015-0255-z; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Martin CP, 2005, PHARMACOTHERAPY, V25, P942, DOI 10.1592/phco.2005.25.7.942; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ogunlade J, 2018, CLIN NEUROL NEUROSUR, V174, P163, DOI 10.1016/j.clineuro.2018.09.021; Patel CH, 2016, ANN PHARMACOTHER, V50, P534, DOI 10.1177/1060028016647067; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pelaez CA, 2019, INJURY, V50, P73, DOI 10.1016/j.injury.2018.08.020; Vargas BR, 2016, INT J CLIN PHARM-NET, V38, P1164, DOI 10.1007/s11096-016-0348-8; Salem Ahmed M., 2019, Journal of Neurocritical Care, V12, P9, DOI 10.18700/jnc.190086; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Yassin AS, 2018, AM J THER	34	0	0	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2021	263						186	192		10.1016/j.jss.2021.01.039			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SL6WK	WOS:000657055800026	33677146				2022-02-07	
J	ElSaadani, M; Ahmed, SM; Jacovides, C; Lopez, A; Johnson, VE; Kaplan, LJ; Smith, DH; Pascual, JL				ElSaadani, Mohamed; Ahmed, Syed M.; Jacovides, Christina; Lopez, Alfonso; Johnson, Victoria E.; Kaplan, Lewis J.; Smith, Douglas H.; Pascual, Jose L.			Post-traumatic brain injury antithrombin III recovers Morris water maze cognitive performance, improving cued and spatial learning	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Antithrombin III; traumatic brain injury; cognitive recovery; learning; mice	PULMONARY VASCULAR INJURY; NEUTROPHIL ACTIVATION; LEUKOCYTE RECRUITMENT; MODEL; INFLAMMATION; PREVENTS; SODIUM; RATS	BACKGROUND Neuroinflammation and cerebral edema development following severe traumatic brain injury (TBI) affect subsequent cognitive recovery. Independent of its anticoagulant effects, antithrombin III (AT-III) has been shown to block neurovascular inflammation after severe TBI, reduce cerebral endothelial-leukocyte interactions, and decrease blood-brain barrier permeability. We hypothesized that AT-III administration after TBI would improve post-TBI cognitive recovery, specifically enhancing learning, and memory. METHODS Fifteen CD1 male mice were randomized to undergo severe TBI (controlled cortical impact [CCI]: velocity, 6 m/s; depth, 1 mm; diameter, 3 mm) or sham craniotomy and received either intravenous AT-III (250 IU/kg) or vehicle (VEH/saline) 15 minutes and 24 hours post-TBI. Animals underwent Morris water maze testing from 6 to 14 days postinjury consisting of cued learning trials (platform visible), spatial learning trials (platform invisible, spatial cues present), and probe (memory) trials (platform removed, spatial cues present). Intergroup differences were assessed by the Kruskal-Wallis test (p < 0.05). RESULTS Morris water maze testing demonstrated that cumulative cued learning (overall mean time in seconds to reach the platform on days 6-8) was worst in CCI-VEH animals (26.1 +/- 2.4 seconds) compared with CCI-AT-III counterparts (20.3 +/- 2.1 seconds, p < 0.01). Cumulative noncued spatial learning was also worst in the CCI-VEH group (23.4 +/- 1.8 seconds) but improved with AT-III (17.6 +/- 1.5 seconds, p < 0.01). In probe trials, AT-III failed to significantly improve memory ability. Animals that underwent sham craniotomy demonstrated preserved learning and memory compared with all CCI counterparts (p < 0.05). CONCLUSION Antithrombin III improves neurocognitive recovery weeks after TBI. This improvement is particularly related to improvement in learning but not memory function. Pharmacologic support of enhanced learning may support new skill acquisition or relearning to improve outcomes after TBI.	[ElSaadani, Mohamed; Ahmed, Syed M.; Jacovides, Christina; Lopez, Alfonso; Kaplan, Lewis J.; Pascual, Jose L.] Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, 51 N 39th St,Med Off Bldg,1st Floor,Suite 120, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA		Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, 51 N 39th St,Med Off Bldg,1st Floor,Suite 120, Philadelphia, PA 19104 USA.	Mu.elsaadani@gmail.com; Moiz1491@gmail.com; Christina.Jacovides@pennmedicine.upenn.edu; Alfonso.Lopez@pennmedicine.upenn.edu; Vje@pennmedicine.upenn.edu; Lewis.Kaplan@pennmedicine.upenn.edu; Amy.Carthy@pennmedicine.upenn.edu; Jose.Pascual@pennmedicine.upenn.edu		Ahmed, Syed Moiz/0000-0003-3922-5525	Grifols S.A. International	This work was supported in part by an investigator-sponsored research grant from Grifols S.A. International.	Allingstrup M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub3; Arai M, 2004, SPINE, V29, P405, DOI 10.1097/01.BRS.0000090887.50981.8E; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Campbell-Sills L, 2020, J HEAD TRAUMA REHAB, V35, P14, DOI 10.1097/HTR.0000000000000516; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; ElSaadani M, 2021, J TRAUMA ACUTE CARE, V90, P274, DOI 10.1097/TA.0000000000003000; Gardner AJ., 2016, HDB CLIN NEUROLOGY; Hagiwara S, 2008, INTENS CARE MED, V34, P361, DOI 10.1007/s00134-007-0887-5; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hoffmann JN, 2002, CRIT CARE MED, V30, P218, DOI 10.1097/00003246-200201000-00031; Iba T, 2005, INTENS CARE MED, V31, P1101, DOI 10.1007/s00134-005-2707-0; Iba T, 2018, THROMB RES, V171, P1, DOI 10.1016/j.thromres.2018.09.042; Jacovides CL, 2019, J TRAUMA ACUTE CARE, V87, P552, DOI 10.1097/TA.0000000000002403; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Maeda A, 2011, PEDIATR INT, V53, P747, DOI 10.1111/j.1442-200X.2011.03350.x; Mizutani A, 2003, BLOOD, V101, P3029, DOI 10.1182/blood-2002-08-2406; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neviere R, 2001, SHOCK, V15, P220, DOI 10.1097/00024382-200115030-00010; Ostrovsky L, 1997, CIRCULATION, V96, P2302; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Rehberg S, 2013, CRIT CARE MED, V41, pE439, DOI 10.1097/CCM.0b013e318298ad3a; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Uchiba M, 1997, SEMIN THROMB HEMOST, V23, P583, DOI 10.1055/s-2007-996140; Uchiba M, 1996, AM J PHYSIOL-LUNG C, V270, pL921, DOI 10.1152/ajplung.1996.270.6.L921; Uchiba M, 1998, THROMB RES, V89, P233, DOI 10.1016/S0049-3848(98)00012-7; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiedermann CJ, 2002, ACTA MED AUST, V29, P89, DOI 10.1046/j.1563-2571.2002.02012.x; Wu F, 2020, SHOCK, V53, P575, DOI 10.1097/SHK.0000000000001378	41	0	0	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2021	91	1					108	113		10.1097/TA.0000000000003112			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TC9ZM	WOS:000668996000031	33605694	Green Accepted			2022-02-07	
J	Esterov, D; Thomas, A; Weiss, K				Esterov, Dmitry; Thomas, Alphonsa; Weiss, Kyle			Osteopathic manipulative medicine in the management of headaches associated with postconcussion syndrome	JOURNAL OF OSTEOPATHIC MEDICINE			English	Article						concussion; neurorehabilitation; physical medicine and rehabilitation; postconcussion syndrome; posttraumatic headache; osteopathic manipulative treatment; rehabilitation; traumatic brain injury	PHYSICAL-THERAPY; SYMPTOMS; IMPACT; PAIN	Context: Previous studies have demonstrated the effectiveness of osteopathic manipulative treatment (OMT) for various headache types, with limited evidence of its use for headaches related to mild traumatic brain injury (MTBI). No studies prior studies were found regarding OMT for headaches in patients with postconcussion syndrome (PCS), defined as symptom persistence for longer than 3 months after MTBI. Objectives: To evaluate OMT for headaches in patients with PCS. Methods: A controlled pilot study was conducted of patients with PCS who presented to an outpatient interdisciplinary rehabilitation clinic; patients with symptoms lasting longer than 3 months were enrolled and randomly assigned to an OMT treatment group or a control group. Primary outcome measures were immediate change in headache scores according to a Visual Analog Scale (VAS) and change in the six item Headache Impact Test (HIT-6) between baseline and follow up visits. The participants in the control group completed the HIT-6 between baseline and follow up visits but did not receive OMT and did not complete the VAS. Mean immediate VAS score change for the treatment group and mean improvement in HIT-6 scores for both groups between baseline and follow up were analyzed for statistical significance. Results: A total of 26 patients were included in this study: 13 (50%) in the treatment group and 13 (50%) in the control group. Six patients (23.1%), three from each group, did not complete the study, so 10 subjects in each group were included in the final analysis. Statistically significant improvement in VAS scores was seen immediately after OMT in the treatment group (mean change, 2.1;p=0.002). Mean HIT-6 scores showed improvement in the treatment group compared with the control group, although the change was not statistically significant (p=0.15) from baseline to follow up visit. No adverse effects from treatments were noted. Conclusions: Patients with headaches secondary to PCS showed immediate benefit in headache pain intensity after OMT. However, no sustained benefit was found on the follow up visit compared with the control group.	[Esterov, Dmitry] Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA; [Thomas, Alphonsa] Shore Rehabil Inst, Dept Phys Med & Rehabil, Hackensack Meridian Hlth, Brick Township, NJ USA; [Weiss, Kyle] St Lukes Spine & Pain Med Associates, Easton, PA USA		Esterov, D (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	esterov.dmitry@mayo.edu			National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002377]	The data analysis of this research was supported by Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS). The contents of the study are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funder did not have any involvement in the decision to submit the manuscript for publication.	Association American Osteopathy, 2010, FDN OSTEOPATHIC MED; Ault B, 2015, J AM OSTEOPATH ASSOC, V115, P132, DOI 10.7556/jaoa.2015.026; Baltazar GA, 2020, CUREUS, V12, DOI 10.7759/cureus.7317; Castillo I, 2016, J AM OSTEOPATH ASSOC, V116, P178, DOI 10.7556/jaoa.2016.034; Cerritelli F, 2017, J PAIN RES, V10, P601, DOI 10.2147/JPR.S130501; Channell MK, 2009, J AM OSTEOPATH ASSOC, V109, P509; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Chow SC, 2010, SAMPLE SIZE CALCULAT, V3rd; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; Degenhardt BF, 2018, J AM OSTEOPATH ASSOC, V118, P141, DOI 10.7556/jaoa.2018.033; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gallagher RM, 2005, J AM OSTEOPATH ASSOC, V105, pS7; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Patel KG, 2018, J AM OSTEOPATH ASSOC, V118, P403, DOI 10.7556/jaoa.2018.061; Rolle G, 2014, J AM OSTEOPATH ASSOC, V114, P678, DOI 10.7556/jaoa.2014.136; Schwartzberg L, 2020, J AM OSTEOPATH ASSOC, V120, P601, DOI 10.7556/jaoa.2020.098; Schwerla F, 2013, J ALTERN COMPLEM MED, V19, P543, DOI 10.1089/acm.2012.0354; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Smith AD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-313; Tapia RN, 2019, NEUROSENSORY DISORDERS IN MILD TRAUMATIC BRAIN INJURY, P11, DOI 10.1016/B978-0-12-812344-7.00002-9; Warren C, 2018, J AM OSTEOPATH ASSOC, V118, pE41, DOI 10.7556/jaoa.2018.088; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890; Yao SC, 2020, J AM OSTEOPATH ASSOC, V120, P607, DOI 10.7556/jaoa.2020.099; Zwibel H, 2018, J AM OSTEOPATH ASSOC, V118, P655, DOI 10.7556/jaoa.2018.144	35	0	0	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY		2702-3648		J OSTEOPATH MED	J. Osteopath. Med.	JUL	2021	121	7					651	656		10.1515/jom-2020-0035			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TZ3LF	WOS:000684375800007	33831981	hybrid			2022-02-07	
J	Follette, C; Halimeh, B; Chaparro, A; Shi, A; Winfield, R				Follette, Craig; Halimeh, Bachar; Chaparro, Annelise; Shi, Alan; Winfield, Robert			Futile trauma transfers: An infrequent but costly component of regionalized trauma care	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Futility; trauma transfer; cost of transfer; futile transfer	INTERHOSPITAL TRANSFER; HIGHER-LEVEL; EXPERIENCES; CENTERS; BENEFIT	BACKGROUND Appropriate interfacility transfers are a key component of highly functioning trauma systems but transfer of unsalvageable patients can overburden the resources of higher-level centers. We sought to identify the occurrence and associated reasons for futile transfers within our trauma system. METHODS Using prospectively collected data from our system database, a retrospective cohort study was conducted to identify patients who underwent interfacility transfer to our American College of Surgeons level I center. Adult patients from June 2017 to June 2019 who died, had comfort measures implemented, were discharged, or went to hospice care within 48 hours of admission without significant operation, procedure, or radiologic intervention were examined. Futility was defined as resulting in death or hospice discharge within 48 hours of transfer without major operative, endoscopic, or radiologic intervention. RESULTS A total of 1,241 patients transferred to our facility during the study period. Four hundred seven patients had a length of stay less than or equal to 48 hours. Eighteen (1.5%) met the criteria for futility. The most common reason for transfer in the futile population was traumatic brain injury (56%) and need for neurosurgical capabilities (62%). Futile patients had a median age and Injury Severity Score of 75 and 21. The main transportation method was ground 9 (50%) with 8 (44.4%) being transported by helicopter and 1 (5.6%) being transported by both. Combining transport costs with hospital charges, each futile transfer was estimated to cost US $56,396 (interquartile range, 41,889-106,393) with a total cost exceeding US $1.7 million. With an estimated 33,000 interfacility transfers annually for trauma in the United States, the cost of futile transfers to the American trauma system would exceed 27 million dollars each year. CONCLUSION Futile transfers represent a small but costly portion transfer volume. Identification of patients whose conditions preclude the benefit of transfer due to futility and development of appropriate support for referral will significantly improve appropriate allocation of health care resources.	[Follette, Craig; Halimeh, Bachar; Chaparro, Annelise; Shi, Alan; Winfield, Robert] Univ Kansas, Med Ctr, Dept Surg, 4000 Cambridge St, Kansas City, KS 66160 USA		Follette, C (corresponding author), Univ Kansas, Med Ctr, Dept Surg, 4000 Cambridge St, Kansas City, KS 66160 USA.	cfollette@kumc.edu; bhalimeh@kumc.edu; achaparro@kumc.edu; ashi@kumc.edu; rwinfield@kumc.edu					Adzemovic T, 2019, J TRAUMA ACUTE CARE, V86, P952, DOI 10.1097/TA.0000000000002248; [Anonymous], 2016, NATL TRAUMA DATA BAN; Arthur KR, 2013, AM SURGEON, V79, P909; Broman KK., 2016, AAS SUS AC SURG C FE; Broman KK, 2017, AM SURGEON, V83, P866; Broman KK, 2016, AM J SURG, V212, P823, DOI 10.1016/j.amjsurg.2016.03.004; Cauley CE, 2016, J PALLIAT MED, V19, P529, DOI 10.1089/jpm.2015.0450; Cullinane JP, 2013, NURS CRIT CARE, V18, P289, DOI 10.1111/nicc.12047; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Mackie B, 2014, AUST CRIT CARE, V27, P177, DOI 10.1016/j.aucc.2014.04.004; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Stewart BA, 2010, J AM MED INFORM ASSN, V17, P341, DOI 10.1136/jamia.2009.001750; Young AJ, 2012, AM SURGEON, V78, P675	15	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2021	91	1					72	76		10.1097/TA.0000000000003139			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TC9ZM	WOS:000668996000026	34144558				2022-02-07	
J	Geddes, RI; Kapoor, A; Hayashi, K; Rauh, R; Wehber, M; Bongers, Q; Jansen, AD; Anderson, IM; Farquhar, G; Vadakkadath-Meethal, S; Ziegler, TE; Atwood, CS				Geddes, Rastafa I.; Kapoor, Amita; Hayashi, Kentaro; Rauh, Ryan; Wehber, Marlyse; Bongers, Quinn; Jansen, Alex D.; Anderson, Icelle M.; Farquhar, Gabrielle; Vadakkadath-Meethal, Sivan; Ziegler, Toni E.; Atwood, Craig S.			Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI-induced hypogonadism?	ENDOCRINOLOGY DIABETES & METABOLISM			English	Article						human chorionic gonadotropin; hypoadrenalism; hypogonadism; RU-486; testosterone; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; STEM-CELL PROLIFERATION; LUTEINIZING-HORMONE; DOWN-REGULATION; ALZHEIMERS-DISEASE; PITUITARY DYSFUNCTION; ESTROGEN REPLACEMENT; SPATIAL MEMORY; SPINAL-CORD; HYPOGONADOTROPIC HYPOGONADISM	Introduction Hypogonadotropic hypogonadism (HH) is an almost universal, yet underappreciated, endocrinological complication of traumatic brain injury (TBI). The goal of this study was to determine whether the developmental hormone human chorionic gonadotropin (hCG) treatment could reverse HH induced by a TBI. Methods Plasma samples were collected at post-surgery/post-injury (PSD/PID) days -10, 1, 11, 19 and 29 from male Sprague-Dawley rats (5- to 6-month-old) that had undergone a Sham surgery (craniectomy alone) or CCI injury (craniectomy + bilateral moderate-to-severe CCI injury) and treatment with saline or hCG (400 IU/kg; i.m.) every other day. Results Both Sham and CCI injury significantly decreased circulating testosterone (T), 11-deoxycorticosterone (11-DOC) and corticosterone concentrations to a similar extent (79.1% vs. 80.0%; 46.6% vs. 48.4%; 56.2% vs. 32.5%; respectively) by PSD/PID 1. hCG treatment returned circulating T to baseline concentrations by PSD/PID 1 (8.9 +/- 1.5 ng/ml and 8.3 +/- 1.9 ng/ml; respectively) and was maintained through PSD/PID 29. hCG treatment significantly, but transiently, increased circulating progesterone (P-4) similar to 3-fold (30.2 +/- 10.5 ng/ml and 24.2 +/- 5.8 ng/ml) above that of baseline concentrations on PSD 1 and PID 1, respectively. hCG treatment did not reverse hypoadrenalism following either procedure. Conclusions Together, these data indicate that (1) craniectomy is sufficient to induce persistent hypogonadism and hypoadrenalism, (2) hCG can reverse hypogonadism induced by a craniectomy or craniectomy +CCI injury, suggesting that (3) craniectomy and CCI injury induce a persistent hypogonadism by decreasing hypothalamic and/or pituitary function rather than testicular function in male rats. The potential role of hCG as a cheap, safe and readily available treatment for reversing surgery or TBI-induced hypogonadism is discussed.	[Geddes, Rastafa I.; Hayashi, Kentaro; Rauh, Ryan; Wehber, Marlyse; Bongers, Quinn; Jansen, Alex D.; Anderson, Icelle M.; Farquhar, Gabrielle; Vadakkadath-Meethal, Sivan; Atwood, Craig S.] Univ Wisconsin, Sch Med & Publ Hlth, Div Geriatr & Gerontol, Dept Med, Madison, WI USA; [Kapoor, Amita; Ziegler, Toni E.] Univ Wisconsin, Assay Serv Unit, Natl Primate Res Ctr, Madison, WI USA; [Kapoor, Amita; Ziegler, Toni E.] Univ Wisconsin, Inst Clin & Translat Res Core Lab, Natl Primate Res Ctr, Madison, WI USA; [Atwood, Craig S.] Vet Adm Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, Australia		Atwood, CS (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, William S Middleton Mem VA Hosp GRECC 11G, 2500 Overlook Terrace, Madison, WI 53705 USA.	csa@medicine.wisc.edu	, Craig/AAB-3963-2022		National Institute on Aging T32 training	This study was funded by VA Merit Review grant #1I21RX001371 (CSA). RIG was funded by the National Institute on Aging T32 training grant #5T32AG00213. This material is the result of work supported with resources at the William S. Middleton Memorial Veterans Hospital, Madison, WI. The opinions expressed herein are those of the authors. The contents do not represent the views of the Department of Veterans Affairs or the U.S. government. This article is Geriatrics Research, Education and Clinical Center VA paper 005-2021. The Institute for Clinical and Translational Research, UW-Madison, NIH UL1T000427, provided support for the steroid assays.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Atwood CS, 2017, GEROSCIENCE, V39, P103, DOI 10.1007/s11357-016-9955-5; Atwood CS, 2015, HORM BEHAV, V76, P63, DOI 10.1016/j.yhbeh.2015.06.021; Atwood CS, 2015, J ALZHEIMERS DIS, V47, P33, DOI 10.3233/JAD-143210; Atwood CS, 2011, EXP GERONTOL, V46, P100, DOI 10.1016/j.exger.2010.09.007; Atwood CS, 2011, EMBRYONIC STEM CELLS, P251; Auer M, 2013, DEUT MED WOCHENSCHR, V138, P831, DOI 10.1055/s-0033-1343099; Babahajian A, 2019, CURR STEM CELL RES T, V14, P177, DOI 10.2174/1574888X13666180918093822; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Barton DJ, 2016, J HEAD TRAUMA REHAB, V31, P277, DOI 10.1097/HTR.0000000000000188; Bauman WA, 2016, SPINAL CORD, V54, P961, DOI 10.1038/sc.2016.50; Belayev L, 2009, BRAIN RES, V1280, P117, DOI 10.1016/j.brainres.2009.05.030; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Berry A, 2008, HORM BEHAV, V54, P143, DOI 10.1016/j.yhbeh.2008.02.006; Bertagna X, 1997, PSYCHONEUROENDOCRINO, V22, pS51, DOI 10.1016/S0306-4530(97)00006-1; Blair JA, 2019, NEUROBIOL AGING, V78, P111, DOI 10.1016/j.neurobiolaging.2019.02.002; Blair JA, 2016, HORM BEHAV, V78, P60, DOI 10.1016/j.yhbeh.2015.10.013; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Bohm-Levine N, 2020, HORM BEHAV, V118, DOI 10.1016/j.yhbeh.2019.104590; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bowen RL, 2015, J ALZHEIMERS DIS, V44, P549, DOI 10.3233/JAD-141626; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Burnham V, 2017, HORM BEHAV, V89, P55, DOI 10.1016/j.yhbeh.2016.11.007; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Casadesus G, 2007, MOL CELL ENDOCRINOL, V269, P107, DOI 10.1016/j.mce.2006.06.013; Centers for Disease Control, 2009, WHAT IS TRAUMATIC BR; Cepicky P, 1993, Cesk Gynekol, V58, P288; CHASALOW F, 1979, J BIOL CHEM, V254, P5613; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dong YY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0051643, 10.1371/journal.pone.0039386]; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Erasso DM, 2013, BRAIN RES, V1530, P1, DOI 10.1016/j.brainres.2013.07.035; FERNANDEZCASTANER M, 1982, ANN ENDOCRINOL-PARIS, V43, P213; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; Fru KN, 2006, BIOL REPROD, V75, P568, DOI 10.1095/biolreprod.106.053470; GAILLARD RC, 1984, P NATL ACAD SCI-BIOL, V81, P3879, DOI 10.1073/pnas.81.12.3879; Gallagher S, 2008, ARCHIVES OF PHYSICAL, V89, pe26; Gallego MJ, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt28; Gallego MJ, 2009, STEM CELLS DEV, V18, P737, DOI 10.1089/scd.2008.0190; Geddes R, 2015, SOC NEUROSCI J, VJ38; Geddes RI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169494; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Hara Y, 2015, PHYSIOL REV, V95, P785, DOI 10.1152/physrev.00036.2014; HEALY DL, 1983, J CLIN ENDOCR METAB, V57, P863, DOI 10.1210/jcem-57-4-863; HOFFMAN YM, 1991, ENDOCRINOLOGY, V128, P388, DOI 10.1210/endo-128-1-388; Hohl A, 2014, BRAIN INJURY, V28, P1262, DOI 10.3109/02699052.2014.915986; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P989, DOI 10.1590/S0004-27302009000800013; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Kalyani RR, 2007, ENDOCRIN METAB CLIN, V36, P333, DOI 10.1016/j.ecl.2007.03.014; Kelly B, 2014, HORM BEHAV, V66, P731, DOI 10.1016/j.yhbeh.2014.08.016; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kenealy BP, 2016, ENDOCRINOLOGY, V157, P70, DOI 10.1210/en.2015-1770; Kenealy BP, 2013, J NEUROSCI, V33, P19051, DOI 10.1523/JNEUROSCI.3878-13.2013; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kolb BA, 2000, FERTIL STERIL, V74, P234, DOI 10.1016/S0015-0282(00)00641-5; Kuhla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068778; LEE SC, 1994, BRAIN INJURY, V8, P571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LINES JG, 1971, BRIT J ANAESTH, V43, P1136, DOI 10.1093/bja/43.12.1136; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mariani MM, 2020, HORM BEHAV, V119, DOI 10.1016/j.yhbeh.2019.104631; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; McConnell SEA, 2012, HORM BEHAV, V61, P479, DOI 10.1016/j.yhbeh.2012.01.003; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; MILLER AE, 1978, J GERONTOL, V33, P197, DOI 10.1093/geronj/33.2.197; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; MIYASAKI K, 1972, ACTA PATHOL JAPON, V22, P779; Movsas TZ, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00232; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; OBrien D, 1993, PAPER PRESENTED AT T; Palm R, 2014, J NEUROCHEM, V130, P115, DOI 10.1111/jnc.12706; PATIL A, 1987, ACTA NEUROCHIR, V87, P76, DOI 10.1007/BF02076021; PATIL AA, 1990, INT SURG, V75, P54; PATIL AA, 1983, ACTA NEUROCHIR, V69, P205, DOI 10.1007/BF01401807; Porayette P, 2007, BIOCHEM BIOPH RES CO, V364, P522, DOI 10.1016/j.bbrc.2007.10.021; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Reddy RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129521; Renner CIE, 2015, J CLIN MED, V4, P1815, DOI 10.3390/jcm4091815; Riordan AJ, 2018, PSYCHONEUROENDOCRINO, V91, P86, DOI 10.1016/j.psyneuen.2018.02.024; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Ruggeri RM, 2010, HORM-INT J ENDOCRINO, V9, P332, DOI 10.14310/horm.2002.1285; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; SMALL DH, 1994, J NEUROSCI, V14, P2117; Surampudi P, 2014, EXPERT OPIN PHARMACO, V15, P1247, DOI 10.1517/14656566.2014.913022; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TRAPP BD, 1994, J NEUROSCI RES, V37, P538, DOI 10.1002/jnr.490370413; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wang Hui, 2012, Ann Fr Anesth Reanim, V31, pe61, DOI 10.1016/j.annfar.2011.02.005; WANG JD, 1994, CONTRACEPTION, V49, P245, DOI 10.1016/0010-7824(94)90042-6; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Woodman DD, 1997, LAB ANIMAL ENDOCRINO; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Wu Hui-Bing Katie, 2008, Ethn Dis, V18, pS2; Xu XL, 2012, ENVIRON TOXICOL PHAR, V34, P688, DOI 10.1016/j.etap.2012.09.020; Ziegler SG, 2010, HORM BEHAV, V58, P705, DOI 10.1016/j.yhbeh.2010.07.002	110	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2398-9238		ENDOCRIN DIAB METAB	Endocrinol. Diabetes Metab.	JUL	2021	4	3							e00239	10.1002/edm2.239			11	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	TM5QH	WOS:000675605300041	34277964	gold, Green Published			2022-02-07	
J	Gill, SD; Stella, J; Lowry, N; Kloot, K; Reade, T; Baker, T; Hayden, G; Ryan, M; Seward, H; Page, RS				Gill, Stephen D.; Stella, Julian; Lowry, Nicole; Kloot, Kate; Reade, Tom; Baker, Tim; Hayden, Georgina; Ryan, Matthew; Seward, Hugh; Page, Richard S.			Gender differences in female and male Australian Football injuries-A prospective observational study of emergency department presentations	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sports-Related injury; Emergency medical services; Epidemiology; Trauma	UNITED-STATES; RUGBY; EPIDEMIOLOGY; METAANALYSIS; DISLOCATION; SPORTS; RISK; SEX	Objectives: To compare injury-profiles of females and males presenting to Emergency Departments (EDs) with an Australian Football injury. Design: Prospective observational study. Methods: All patients presenting to one of 10 EDs in Victoria, Australia, with an Australian Football injury were included in the study. Data were prospectively collected over a 10 month period, coinciding with a complete Australian Football season, including pre-season training and practice matches. Relevant information was extracted from patient medical records regarding injury-type, body part injured, investigations and treatments required. Female and male data were compared with chi-squared and Fisher's exact tests. Results: 1635 patients were included, of whom 242 (14.8%) were female. Females had a higher proportion of hand/finger injuries (34.3% v 23.4%), neck injuries (6.6% v 2.5%) and patella dislocations (2.9% v 0.6%). Males had a higher proportion of shoulder injuries (11.5% v 5.8%), skin lacerations (8.0% v 1.7%), and thorax/abdominal/pelvic injuries (5.7% v 2.1%). Concussion rates were similar between the genders, occurring in 14.1% of all patients. Anterior cruciate ligament injuries were infrequent (1.0%) and not significantly different between genders. Females received more imaging investigations (83.1% v 74.7%) and analgesia (62.4% v 48.5%). A higher proportion of males required admission to hospital (5.0% v 2.1%), usually for surgery. Conclusion: Australian Football injury profiles differed between females and males. Gender-specific injury prevention and management programs would be indicated based on the study findings. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Gill, Stephen D.; Page, Richard S.] Deakin Univ, Sch Med, Barwon Ctr Orthopaed Res & Educ B CORE, Geelong, Vic, Australia; [Gill, Stephen D.; Page, Richard S.] St John God Hosp, Subiaco, WA, Australia; [Stella, Julian; Lowry, Nicole; Reade, Tom] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Kloot, Kate; Baker, Tim] Deakin Univ, Ctr Rural Emergency Med, Sch Med, Geelong, Vic, Australia; [Hayden, Georgina] St John God Hosp Geelong, Geelong, Vic, Australia; [Ryan, Matthew] Epworth Hosp Geelong, Geelong, Vic, Australia; [Seward, Hugh] Newtown Med Ctr, Newtown, Vic, Australia		Gill, SD (corresponding author), Deakin Univ, Sch Med, Barwon Ctr Orthopaed Res & Educ B CORE, Geelong, Vic, Australia.; Gill, SD (corresponding author), St John God Hosp, Subiaco, WA, Australia.	Stephen.gill2@deakin.edu.au	Page, Richard/K-6327-2015	Page, Richard/0000-0002-2225-7144; Kloot, Kate/0000-0003-2889-9639; Gill, Stephen/0000-0001-8722-0572	Australian Football League Research Board	The Australian Football League Research Board provided funding to assist with the study.	Anderson H, 2019, J SPORTS MED DOPING, V9; [Anonymous], PREP TO PLAY; Australian Football League, 2019, AFLW INJ REP; Australian Football League, 2019, ANN REPORT; Bowe SJ, 2017, J SCI MED SPORT; Brisbine BR, 2020, SCI MED FOOTBALL, V4, P148, DOI 10.1080/24733938.2019.1682184; Chen EH, 2008, ACAD EMERG MED, V15, P414, DOI 10.1111/j.1553-2712.2008.00100.x; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Crossley KM, 2020, BRIT J SPORT MED, V54, P1089, DOI 10.1136/bjsports-2019-101587; Ekegren CL, 2015, J SCI MED SPORT, V18, P651, DOI 10.1016/j.jsams.2014.11.390; Ekegren CL, 2015, CLIN J SPORT MED, V25, P162, DOI 10.1097/JSM.0000000000000108; Fernando DT, 2018, MED J AUSTRALIA, V208, P255, DOI 10.5694/mja17.00872; Finch CF, 2016, BMJ OPEN SPORT EXERC, V2; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Fortington LV, 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015-000101, DOI 10.1136/BMJSEM-2015-000101]; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hay K, 2019, LANCET, V393, P2535, DOI 10.1016/S0140-6736(19)30648-8; Huntington LS, 2020, AM J SPORT MED, V48, P2552, DOI 10.1177/0363546519888467; Kavaja L, 2018, BRIT J SPORT MED, V52, P1498, DOI 10.1136/bjsports-2017-098539; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; La Fountaine MF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00691; Lathlean TJH, 2018, J SCI MED SPORT, V21, P1013, DOI 10.1016/j.jsams.2018.03.002; Lewallen L, 2015, J KNEE SURG, V28, P303, DOI 10.1055/s-0034-1398373; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McNeel C, 2020, J SCI MED SPORT, V23, P125, DOI 10.1016/j.jsams.2019.10.010; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Montalvo AM, 2019, J ATHL TRAINING, V54, P472, DOI 10.4085/1062-6050-407-16; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; RAFTERY KA, 1995, ANN EMERG MED, V26, P414, DOI 10.1016/S0196-0644(95)70107-9; Reyes J, 2020, AM J SPORT MED, V48, P1485, DOI 10.1177/0363546520912416; Sabesan V, 2016, OPEN ACCESS J SPORTS, V7, P135, DOI 10.2147/OAJSM.S114019; Silvers-Granelli HJ, 2017, CLIN ORTHOP RELAT R, V475, P2447, DOI 10.1007/s11999-017-5342-5; Smith TO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008106.pub3; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Uri O, 2015, EMERG MED J, V32, P149, DOI 10.1136/emermed-2013-202716; Waterman BR, 2012, J KNEE SURG, V25, P51, DOI 10.1055/s-0031-1286199; Xing XW, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01634-5	39	0	0	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2021	24	7					670	676		10.1016/j.jsams.2021.02.011			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SL1PO	WOS:000656691600011	33707157				2022-02-07	
J	Glossmann, K; Baumgartner, C; Koren, JP; Riederer, F				Gloessmann, Kerstin; Baumgartner, Christoph; Koren, Johannes Peter; Riederer, Franz			Recurrent migraine aura-like symptoms in an elderly woman: symptomatic cortical spreading depression?	BMJ CASE REPORTS			English	Article						headache (including migraines); stroke; pain (neurology)	CONVEXITY SUBARACHNOID HEMORRHAGE; CLINICAL PRESENTATION; DEPOLARIZATION; MECHANISMS; CORRELATE; ETIOLOGY; ATTACKS	Cortical spreading depression (CSD) has been directly observed in humans with malignant stroke, traumatic brain injury and subarachnoid haemorrhage and is also considered to be the correlate of migraine aura. We report on a 76-year-old woman with new-onset episodes of headache, paraesthesia, hemiparesis and dysarthria, in whom a small cortical subarachnoid haemorrhage was diagnosed with MRI. Repeated diffusion-weighted MRI scans shortly after transient focal neurological episodes as well as diagnostic workup were normal, which makes recurrent transient ischaemic attacks unlikely. Ictal electroencephalogram recordings showed no epileptic activity. Long-term follow-up revealed a diagnosis of probable cerebral amyloid angiopathy. We propose that CSD could be a pathophysiological correlate of transient focal neurological deficits in patients with cortical bleeding.	[Gloessmann, Kerstin; Baumgartner, Christoph; Koren, Johannes Peter; Riederer, Franz] Clin Hietzing, Dept Neurol, Vienna, Austria; [Baumgartner, Christoph; Koren, Johannes Peter] Karl Landsteiner Inst Clin Epilepsy Res & Cognit, Vienna, Austria; [Baumgartner, Christoph] Sigmund Freud Private Univ, Vienna, Austria; [Riederer, Franz] Univ Zurich, Zurich, Switzerland		Riederer, F (corresponding author), Clin Hietzing, Dept Neurol, Vienna, Austria.; Riederer, F (corresponding author), Univ Zurich, Zurich, Switzerland.	franz.riederer@uzh.ch	Koren, Johannes/D-4049-2018	Koren, Johannes/0000-0002-5290-2837; Riederer, Franz/0000-0002-9722-9754			Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Beitzke M, 2011, STROKE, V42, P3055, DOI 10.1161/STROKEAHA.111.621847; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Cuvinciuc V, 2010, AM J NEURORADIOL, V31, P1355, DOI 10.3174/ajnr.A1986; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Field DK, 2011, CEPHALALGIA, V31, P368, DOI 10.1177/0333102410384885; Graff-Radford J, 2016, EUR J NEUROL, V23, P839, DOI 10.1111/ene.12926; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Khurram A, 2014, STROKE, V45, P1151, DOI 10.1161/STROKEAHA.113.004298; Kleinig TJ, 2008, CEPHALALGIA, V28, P658, DOI 10.1111/j.1468-2982.2008.01570.x; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Kumar S, 2010, NEUROLOGY, V74, P893, DOI 10.1212/WNL.0b013e3181d55efa; Lampl C, 2005, J NEUROL NEUROSUR PS, V76, P1730, DOI 10.1136/jnnp.2005.063750; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Major S, 2020, GEROSCIENCE, V42, P57, DOI 10.1007/s11357-019-00142-7; Margineanu DG, 2009, SEIZURE-EUR J EPILEP, V18, P453, DOI 10.1016/j.seizure.2009.01.002; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; OLESEN J, 1992, PATHOL BIOL, V40, P318; Pavlovic AM, 2010, J CLIN NEUROSCI, V17, P1105, DOI 10.1016/j.jocn.2010.01.011; Richter F, 2008, SCHMERZ, V22, P544, DOI 10.1007/s00482-008-0653-9; Rico M, 2014, HEADACHE, V54, P545, DOI 10.1111/head.12197; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021	27	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JUL	2021	14	7							e241479	10.1136/bcr-2020-241479			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TH1OV	WOS:000671865100008	34226251	Bronze			2022-02-07	
J	Glorion, M; Sarsam, M; de Wolf, J; Sage, E				Glorion, Matthieu; Sarsam, Matthieu; de Wolf, Julien; Sage, Edouard			Successful management of donor-acquired fat embolism after lung transplantation	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Lung transplantation; Primary graft dysfunction fat embolism; Extracorporeal membrane oxygenation		Fat embolism is a serious complication in patients with multiple traumatic injuries. It is often asymptomatic during the first hours of resuscitation, thus remains underdiagnosed in patients who progress to brain death. Lung transplantation issued from such grafts can lead to severe lung primary graft dysfunction, the management of which is deemed difficult. Herein, we report a successful management of donor-acquired fat embolism syndrome after lung transplant in a 22 years old woman for cystic fibrosis. Fat embolism was suspected because of the donor's traumatic injuries and confirmed by histopathological analysis. An immediate postoperative primary graft dysfunction was successfully managed with veno-arterial extracorporeal membrane oxygenation. The patient is alive 31 months after surgery.	[Glorion, Matthieu; Sarsam, Matthieu; de Wolf, Julien; Sage, Edouard] Foch Hosp, Dept Thorac Surg & Lung Transplantat, 40 Rue Worth, F-92150 Suresnes, France; [Sage, Edouard] Univ Versailles St Quentin En Yvelines, Montigny Le Bretonneux, France		Glorion, M (corresponding author), Foch Hosp, Dept Thorac Surg & Lung Transplantat, 40 Rue Worth, F-92150 Suresnes, France.	m.glorion@hopital-foch.com		Sarsam, Matthieu/0000-0002-5853-0288			George Jacob, 2013, Lung India, V30, P47, DOI 10.4103/0970-2113.106133; Hoetzenecker K, 2018, J THORAC CARDIOV SUR, V155, P2193, DOI 10.1016/j.jtcvs.2017.10.144; Jacob S, 2016, EUR J CARDIO-THORAC, V49, P1344, DOI 10.1093/ejcts/ezv347; Padilla J, 2007, ANN THORAC SURG, V84, pE4, DOI 10.1016/j.athoracsur.2007.04.035; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033	5	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	JUL	2021	33	1					158	160		10.1093/icvts/ivab051			3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	TF8JC	WOS:000670960600027	33582794	Bronze			2022-02-07	
J	Guo, YJ; Abdoulaye, IA; Liu, F; Wang, JM; Tian, XX; Yu, DF; Le, K				Guo, Yijing; Abdoulaye, Idriss Ali; Liu, Fei; Wang, Jiamin; Tian, Xiuxiu; Yu, Dafan; Le, Kai			N-Butylphthalide vs. Human Urinary Kallidinogenase for the Treatment of Acute Ischemic Stroke: Functional Outcome and Impact on Serum VEGF and TNF-alpha Expressions	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						dl-3-n-Butylphthalide; tumor necrosis factor alpha; vascular endothelial growth factor; ischemic stroke; human urinary kallidinogenase	FOCAL CEREBRAL-ISCHEMIA; HUMAN TISSUE KALLIKREIN; TRAUMATIC BRAIN-INJURY; DL-3-N-BUTYLPHTHALIDE; ANGIOGENESIS; ACTIVATION; L-3-N-BUTYLPHTHALIDE; EXERCISE; NEUROPROTECTION; TRANSACTIVATION	Objective. To compare the efficacy and functional outcomes of dl-3-n-Butylphthalide (NBP) and human urinary kallidinogenase (HUK) on ischemic stroke patients and to determine their effects on serum tumor necrosis factor-alpha (TNF-alpha) and vascular endothelial growth factor (VEGF). Methods. A prospective study was conducted on 57 ischemic stroke patients. Functional outcomes were assessed by the National Institute Health Stroke Scale (NIHSS), the modified Rankin Scale (mRS), and the activities of daily living score (ADL), whereas TNF-alpha and VEGF expressions were measured by enzyme-linked immunosorbent assay (ELISA). Results. TNF-alpha was significantly down-regulated in the NBP group and upregulated in the control group two weeks after treatment (p=0.017 and p=0.047, respectively). A significant difference in VEGF expressions was observed between the two groups (330.25 +/- 120.64 vs. 437.15 +/- 137.68, p=0.041) two weeks after treatment. Both groups showed significant improvement in NIHSS and ADL scores three months after treatment (p<0.001), with the NBP group exhibiting improvement in NIHSS scores as early as two weeks after treatment (p=0.008). The three-month NIHSS scores of the two groups were significantly lower than those of the control group (p=0.010 and p=0.008, respectively). Both the NBP and HUK groups showed a significant decline in mRS scores two weeks and three months after treatment (p<0.05). Conclusions. Both treatments are effective and can significantly promote recovery in stroke patients. Additionally, both options have similar effects in promoting long-term recovery, with NBP exerting a greater impact on serum VEGF and TNF-alpha expressions.	[Guo, Yijing; Abdoulaye, Idriss Ali; Liu, Fei; Wang, Jiamin; Tian, Xiuxiu; Yu, Dafan; Le, Kai] Southeast Univ, Affiliated Zhongda Hosp, Sch Med, Dept Neurol, 87 Dingjiaqiao, Nanjing, Jiangsu, Peoples R China		Guo, YJ (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Sch Med, Dept Neurol, 87 Dingjiaqiao, Nanjing, Jiangsu, Peoples R China.	101010270@seu.edu.cn	Abdoulaye, Idriss Ali/W-4028-2017	Abdoulaye, Idriss Ali/0000-0002-0576-7679	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471187]; Southeast University Medical Ethics Committee [2015ZDSYLL043.0]	This study was supported by the National Natural Science Foundation of China (No.81471187) . This research was approved by the Southeast University Medical Ethics Committee (2015ZDSYLL043.0) .	Abdoulaye IA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5012341; Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bi MJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00394; Chen ZB, 2010, J CEREBR BLOOD F MET, V30, P1356, DOI 10.1038/jcbfm.2010.19; Chong ZZ, 1999, ACTA PHARMACOL SIN, V20, P696; Cui LY, 2013, CHINESE MED J-PEKING, V126, P3405, DOI 10.3760/cma.j.issn.0366-6999.20123240; [崔丽英 Cui Liying], 2005, [中华神经科杂志, Chinese Journal of Neurology], V38, P251; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Ding YH, 2004, CURR NEUROVASC RES, V1, P411, DOI 10.2174/1567202043361875; Emanueli C, 2004, CIRCULATION, V110, P1638, DOI 10.1161/01.CIR.0000142051.36244.83; Emanueli C, 2003, CURR PHARM DESIGN, V9, P589, DOI 10.2174/1381612033391315; Emanueli C, 2001, CIRCULATION, V103, P125; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fan YY, 2011, J CEREBR BLOOD F MET, V31, P305, DOI 10.1038/jcbfm.2010.94; Han D, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1033; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Li J, 2015, CELL BIOCHEM BIOPHYS, V71, P315, DOI 10.1007/s12013-014-0200-5; Li JW, 2015, J STROKE CEREBROVASC, V24, P1730, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.032; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Liao SJ, 2009, BRAIN RES, V1289, P69, DOI 10.1016/j.brainres.2009.06.018; Ling L, 2008, BRAIN RES, V1206, P89, DOI 10.1016/j.brainres.2008.01.099; Liu X. G., 1995, Yaoxue Xuebao, V30, P896; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Miura S, 2003, HYPERTENSION, V41, P1118, DOI 10.1161/01.HYP.0000064345.33807.57; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Sardar P, 2015, EUR HEART J, V36, P2373, DOI 10.1093/eurheartj/ehv270; Seidl Stacey E, 2011, Front Neurol, V2, P68, DOI 10.3389/fneur.2011.00068; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Song JX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00084; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Sun B, 2012, NEUROSCI LETT, V516, P247, DOI 10.1016/j.neulet.2012.04.003; Sun YF, 2017, BEHAV BRAIN RES, V329, P67, DOI 10.1016/j.bbr.2017.04.039; Tang SC, 2017, EUR REV MED PHARMACO, V21, P4431; Thuringer D, 2002, J BIOL CHEM, V277, P2028, DOI 10.1074/jbc.M109493200; Wade D T, 1988, Int Disabil Stud, V10, P64; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Wang XL, 2013, BIOORG MED CHEM LETT, V23, P1985, DOI 10.1016/j.bmcl.2013.02.035; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Wu DH, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.752; Yan HQ, 2017, NEUROL RES, V39, P337, DOI 10.1080/01616412.2016.1268775; Zhang Canfei, 2012, J Evid Based Med, V5, P31, DOI 10.1111/j.1756-5391.2012.01167.x; Zhang XN, 2017, INT J NEUROSCI, V127, P1059, DOI 10.1080/00207454.2017.1310727; Zhao CY, 2016, J ASIAN NAT PROD RES, V18, P289, DOI 10.1080/10286020.2015.1099524; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	51	0	0	3	3	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	JUL-AUG	2021	51	4					503	511					9	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	UJ9RK	WOS:000691614600006	34452888				2022-02-07	
J	Hammond, FM; Sevigny, M; Backhaus, S; Neumann, D; Corrigan, JD; Charles, S; Gazett, H				Hammond, Flora M.; Sevigny, Mitch; Backhaus, Samantha; Neumann, Dawn; Corrigan, John D.; Charles, SherylKatta; Gazett, Hannah			Marital Stability Over 10 Years Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; couples; divorce; marriage; outcomes; relationship stability	SPINAL-CORD-INJURY; HEAD-INJURY; ADJUSTMENT; PREDICTORS; IMPACT	Objective: To examine the stability of marriage from the time of traumatic brain injury (TBI) to 10 years postinjury. Design: Retrospective cohort. Setting: TBI Model Systems centers. Participants: In total, 1423 participants in the TBI Model Systems National Database who experienced TBI 10 years prior and were married at the time of injury. Interventions: Not applicable. Main Outcome Measure: Remaining married to the same partner from the time of injury to 10-year follow-up. Results: At 10 years, 66% (938) remained married to the same person. Significant associations were found with age at injury (P < .0001), sex (P = .0028), and preinjury problematic substance use (P = .0092). Marital stability over the 10-year period was higher for those who were older, were female, and had no problematic substance use history. Marital instability was greatest in the first year postinjury. Conclusions: Most married adults who received inpatient rehabilitation for TBI remained married to the same individual 10 years later. Those who were younger, were male, and had a history of problematic substance use were at a highest risk for relationship dissolution. Findings have implications for content, timing, and delivery of marital interventions. Substance use education and prevention appear to be important aspects of marital support.	[Hammond, Flora M.; Backhaus, Samantha; Neumann, Dawn; Charles, SherylKatta] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.; Backhaus, Samantha; Neumann, Dawn; Charles, SherylKatta] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Sevigny, Mitch; Gazett, Hannah] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Sevigny, Mitch; Gazett, Hannah] Craig Hosp, Res Dept, Englewood, CO USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA		Hammond, FM (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com					Anderson-Parente JK., 1990, COGN REHABIL, V8, P22; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cherlin AJ, 2010, J MARRIAGE FAM, V72, P403, DOI 10.1111/j.1741-3737.2010.00710.x; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DEVIVO MJ, 1985, ARCH PHYS MED REHAB, V66, P501; DEVIVO MJ, 1995, ARCH PHYS MED REHAB, V76, P130, DOI 10.1016/S0003-9993(95)80022-0; Edwards AC, 2018, AM J EPIDEMIOL, V187, P1010, DOI 10.1093/aje/kwx321; Fallesen P, 2016, DEMOGRAPHY, V53, P1377, DOI 10.1007/s13524-016-0498-2; Fals-Stewart W, 1999, J ABNORM PSYCHOL, V108, P11, DOI 10.1037/0021-843X.108.1.11; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gottman J., 1993, J FAM PSYCHOL, V7, P57, DOI [DOI 10.1037/0893-3200.7.1.57, 10.1037/0893-3200.7.1.57]; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Karimi R, 2019, EPIDEMIOL HEALTH, V41, DOI 10.4178/epih.e2019023; KARNEY BR, 1995, PSYCHOL BULL, V118, P3, DOI 10.1037/0033-2909.118.1.3; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Miller A, 2013, MONIT PSYCHOL, V44, P46; Panting A, 1972, REHABILITATION, V38, P33; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Stevenson B., 2000, TRENDS MARITAL STABI; Substance Abuse and Mental Health Services Administration, 2018, NAT HOUS SURV DRUG A NAT HOUS SURV DRUG A; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; US Census Bureau, 2020, NUMBER TIMING DURATI; US Census Bureau, SEL SOC CHAR US 2010 SEL SOC CHAR US 2010; US Census Bureau, 2020, MAR EV AM 2009 AUG 2 MAR EV AM 2009 AUG 2; US Census Bureau, SEL SOC CHAR US 2018 SEL SOC CHAR US 2018; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	38	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E199	E208		10.1097/HTR.0000000000000674			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100001	34197359	Bronze			2022-02-07	
J	Hannah, TC; Spiera, Z; Li, AY; Durbin, J; Dreher, N; Ali, M; Marayati, NF; Gometz, A; Lovell, M; Choudhri, T				Hannah, Theodore C.; Spiera, Zachary; Li, Adam Y.; Durbin, John; Dreher, Nickolas; Ali, Muhammad; Marayati, Naoum Fares; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir			Effects of Recurrent Mild Traumatic Brain Injuries on Incidence, Severity, and Recovery of Concussion in Young Student-Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; mTBI; Severity Index; student-athletes	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RISK-FACTORS; IMPACT; EPIDEMIOLOGY; PREDICTORS; STATEMENT	Objective: To examine the effects of recurrent concussions on the incidence, severity, and recovery of significant neurocognitive dysfunction (SND) in young athletes. Setting: Various US youth sports organizations that utilize Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) for baseline and postinjury concussion testing. Participants: Data from 11 563 ImPACT baseline evaluations of US student-athletes aged 12 to 22 years were separated into 2 cohorts: subjects reporting 2 or more previous concussions (PC; n = 976 baseline evaluations) at baseline and a control group reporting zero previous concussions (CT; n = 7743 baseline evaluations). Subjects reporting 1 prior concussion were excluded. Design: Retrospective cohort. Main Measures: Differences in SND incidence, severity, and recovery between the 2 cohorts were assessed using chi-squared tests, t tests, survival analyses, and multivariate regressions. Results: The PC cohort had a higher incidence of head injury leading to ImPACT (436.7 per 1000 person-years vs 194.4 per 1000 person-years, P < .0001) and a higher incidence of SND (140.4 vs 71.8, P < .0001) than controls. However, the Severity Index (SI) demonstrated that SND severity was lower in the PC group (7.55 vs 8.59, P = .04). Adjusted analyses similarly demonstrated that the PC cohort had increased SND incidence (odds ratio = 1.93; 95% CI, 1.61 to 2.31; P < .0001), decreased SI (beta = -1.37; 95% CI, -2.40 to -0.34; P = .009), and equivalent recovery (hazard ratio = 0.98; 95% CI, 0.76 to 1.72; P = .90). Conclusion: Participants with a history of concussion have a higher incidence of SND but present with lower severity SND, which may be a result of increased concussion education or symptom awareness. Recurrent concussion has no significant impact on acute neurocognitive recovery. Together, these results provide evidence against the supposition that a history of concussion increases the severity of future SND.	[Hannah, Theodore C.; Spiera, Zachary; Li, Adam Y.; Durbin, John; Dreher, Nickolas; Ali, Muhammad; Marayati, Naoum Fares; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, Dept Neurosurg, Annenberg Bldg,Floor 8,Room 88,1468 Madison Ave, New York, NY 10029 USA; [Gometz, Alex] Concuss Management New York, Phys Med & Rehabil, New York, NY USA; [Lovell, Mark] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Hannah, TC (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, Annenberg Bldg,Floor 8,Room 88,1468 Madison Ave, New York, NY 10029 USA.	theodore.hannah@icahn.mssm.edu	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Hannah, Theodore/0000-0001-6527-9725			Barker Trevor, 2017, BMC Psychol, V5, P14, DOI 10.1186/s40359-017-0184-1; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, PRINC EP PUBL HLTH P; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Graham R., 2014, SPORTS RELATED CONCU, P203; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt Jane, 2017, Concussion, V2, pCNC26, DOI 10.2217/cnc-2016-0020; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Schallmo MS., 2017, ORTHOP J SPORTS MED, V5, DOI [10.1177/2325967117S00439, DOI 10.1177/2325967117S00439]; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Walter A, 2019, J NEUROTRAUM, V36, P1115, DOI 10.1089/neu.2017.5622; Waltzman D, 2020, BRAIN INJURY, V34, P1193, DOI 10.1080/02699052.2020.1793388; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	41	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		293	301		10.1097/HTR.0000000000000676			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100017	33656488				2022-02-07	
J	Hinson, HE; Jacobs, J; McWeeney, S; Wachana, A; Shi, TJ; Martin, K; Rodland, K				Hinson, H. E.; Jacobs, Jon; McWeeney, Shannon; Wachana, Ann; Shi, Tujin; Martin, Kendall; Rodland, Karin			Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma	NEUROTRAUMA REPORTS			English	Article						biomarkers; blood-brain barrier dysfunction; endothelial activation; mass spectrometry; proteomics	BRAIN-INJURY; BIOMARKERS; SERUM	Antibody mediated strategies for protein biomarker detection are common, but may limit discovery. We hypothesized that the use of antibody-free proteomics is feasible for detecting protein biomarkers in plasma of patients sustaining major trauma. A subset of subjects with major trauma from a prospective observational trial were analyzed. Patients were assigned to one of four groups based on their presenting Abbreviated Injury Severity Score (AIS). Sensitive, antibody-free selective reaction monitoring (SRM) mass spectrometry (MS), with spiked-in isotopically labeled synthetic peptides, was used for targeted protein quantification of a panel of 10 prospective targets. An overall tiered sensitivity analytical approach was used for peptide detection and quantification based upon plasma immunoaffinity depletion and PRISM fractionation. Forty-four patients were included in the analysis, of which 82% were men with a mean age of 50 (+/- 19) years. Half had isolated head injury (n = 22), with the remaining patients experiencing multiple injuries or polytrauma (n = 14), isolated body injury (n = 2), or minor injury (n = 6). Peptides from 3 proteins (vascular adhesion molecule 1 [VCAM1], intercellular adhesion molecule 1 [ICAM1], and matrix metalloproteinase 9 [MMP9]) were detected and quantified in non-depleted processed plasma. Peptides from 2 proteins (angiopoietin 2 [Ang2] and plasminogen activator inhibitor-1 [PAI1]) were detected and quantification in depleted plasma, whereas the remaining 5 of the 10 prospective targets were undetected. VCAM1 (p = 0.02) and MMP9 (p = 0.03) were significantly upregulated in in the major trauma groups (1-3) versus mild injury group (4), whereas the others were not. There were no differences in protein expression between patients with traumatic brain injury (TBI; groups 1 and 2) versus those without TBI (groups 3 and 4). We detected non-specific upregulation of proteins reflecting blood-brain barrier breakdown in severely injured patients, indicating label-free MS techniques are feasible and may be informative.	[Hinson, H. E.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Jacobs, Jon; Shi, Tujin; Martin, Kendall; Rodland, Karin] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Wachana, Ann] Pacific Northwest Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA; [Rodland, Karin] Portland State Univ, Portland, OR 97207 USA		Hinson, HE (corresponding author), Oregon Hlth & Sci Univ, Neurocrit Care Program, 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.	hinson@ohsu.edu	Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782	Medical Research Foundation of Oregon;  [K23NS110828];  [UL1TR002369]	This work was supported by K23NS110828 (H.E.H.) and the Medical Research Foundation of Oregon. This project utilized REDCap, made possible by grant support (UL1TR002369).	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Condron M, 2018, J TRAUMA ACUTE CARE, V85, P888, DOI 10.1097/TA.0000000000002040; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Edsberg LE, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0567-2; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fair KA, 2021, J NEUROTRAUM, V38, P960, DOI 10.1089/neu.2018.6234; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hinson HE, 2018, J TRAUMA ACUTE CARE, V84, P19, DOI 10.1097/TA.0000000000001627; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Nielson CM, 2016, J CLIN ENDOCR METAB, V101, P2226, DOI 10.1210/jc.2016-1104; O'Connell GC, 2020, P NATL ACAD SCI USA, V117, P20764, DOI 10.1073/pnas.2007719117; Osier N, 2018, MOL NEUROBIOL, V55, P9280, DOI 10.1007/s12035-018-1054-4; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Shi TJ, 2016, PROTEOMICS, V16, P2160, DOI 10.1002/pmic.201500449; Shi TJ, 2012, P NATL ACAD SCI USA, V109, P15395, DOI 10.1073/pnas.1204366109; Xu LB, 2021, J NEUROTRAUM, V38, P918, DOI 10.1089/neu.2020.7177; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	20	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUL 1	2021	2	1					322	329		10.1089/neur.2021.0007			8	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TF3IQ	WOS:000670608800001	34318300	gold, Green Published			2022-02-07	
J	Holmqvist, A; Bartfai, A; Markovic, G; Moller, MC				Holmqvist, Anna; Bartfai, Aniko; Markovic, Gabriela; Moller, Marika C.			Does Intensive Training of Attention Influence Cognitive Fatigability in Patients With Acquired Brain Injury?	FRONTIERS IN NEUROSCIENCE			English	Article						acquired brain injury; attention; cognitive fatigability; paced auditory serial addition test (PASAT); intraindividual variability	LONG-TERM TREATMENT; MULTIPLE-SCLEROSIS; OLDER-ADULTS; FATIGUE; VARIABILITY; STROKE	Research Objectives Impairments in attention and the speed of information processing are central to the experience of cognitive fatigue in patients with acquired brain injury (ABI). Attention may be improved through intensive training in a rehabilitation setting. The aim of the study was to investigate the feasibility of reducing cognitive fatigability (CF) using attention training and to explore the effect of two different approaches to attention training. Design Randomised controlled study in a rehabilitation setting. Participants 59 patients (age 19-59 years) with mild to moderate stroke or traumatic brain injury in the early (<4 month) phase. Interventions Patients were randomly assigned to intensive specific training with Attention Process Training (APT) or Activity-Based Attention Training (ABAT) for 3-5 days per week for a period of 5-6 weeks with a total of 20 h, in addition to traditional interdisciplinary rehabilitation. Main Outcome Measure CF was conceptualised as performance decline in terms of an increased number of incorrect responses between the first and the last quintiles of the Paced Auditory Serial Addition Test (PASAT). A negative result was defined as fatigability. The evaluator of fatigability was blinded to treatment. Results At baseline, there were no differences between the groups in age, education, reasoning, anxiety or depression. After training, a significant treatment effect was found (p = 0.020), as the APT-group, but not the ABAT-group, had improved. However, after controlling for baseline differences regarding CF on the PASAT-f, the difference was no longer significant. Conclusion The results indicate that cognitive training might be a feasible method for reducing CF through attention training and that patients with high levels of CF benefit most from attention training. The type of intervention provided, whether specific or activity-based attention training, appears to be of less importance, as there was no treatment effect after controlling for the baseline level of CF. Future studies are required to confirm the validity of the findings.	[Holmqvist, Anna; Bartfai, Aniko; Markovic, Gabriela; Moller, Marika C.] Danderyd Hosp, Dept Rehabil, Stockholm, Sweden; [Holmqvist, Anna; Bartfai, Aniko; Markovic, Gabriela; Moller, Marika C.] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden		Holmqvist, A (corresponding author), Danderyd Hosp, Dept Rehabil, Stockholm, Sweden.; Holmqvist, A (corresponding author), Karolinska Inst, Dept Clin Sci, Stockholm, Sweden.	anna.holmqvist@ki.se	Moller, Marika/N-8782-2016	Moller, Marika/0000-0001-8700-5186	Stiftelsen Promobilia	This study was funded by the Stiftelsen Promobilia.	Arnold LM, 2008, PSYCHOSOMATICS, V49, P185, DOI 10.1176/appi.psy.49.3.185; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bartfai A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-102; Berard JA, 2020, BRAIN IMAGING BEHAV, V14, P2417, DOI 10.1007/s11682-019-00192-7; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bruce JM, 2010, NEUROPSYCHOLOGY, V24, P77, DOI 10.1037/a0015046; Cantor F, 2010, PM&R, V2, P399, DOI 10.1016/j.pmrj.2010.04.012; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; DeLuca J, 2005, ISS CLIN COGN NEUROP, P37; Fairchild JK, 2013, INT PSYCHOGERIATR, V25, P607, DOI 10.1017/S1041610212002049; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Holtzer R, 2010, AGING NEUROPSYCHOL C, V18, P108, DOI 10.1080/13825585.2010.517826; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Markovic G., 2017, THESIS KAROLINSKA I THESIS KAROLINSKA I; Markovic G, 2017, BRAIN INJURY, V31, P9, DOI 10.1080/02699052.2016.1206213; McKitrick L A, 1999, Int Psychogeriatr, V11, P289, DOI 10.1017/S1041610299005852; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Moller MC, 2014, J CLIN EXP NEUROPSYC, V36, P716, DOI 10.1080/13803395.2014.933779; Morrow SA, 2015, COGN BEHAV NEUROL, V28, P27, DOI 10.1097/WNN.0000000000000050; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Raz Amir, 2004, Anatomical Record Part B:The New Anatomist, V281, P21, DOI 10.1002/ar.b.20035; Roheger M, 2019, COGN BEHAV NEUROL, V32, P76, DOI 10.1097/WNN.0000000000000195; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Schwid SR, 2003, MULT SCLER, V9, P503, DOI 10.1191/1352458503ms946oa; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Walker LAS, 2012, J NEUROL SCI, V316, P86, DOI 10.1016/j.jns.2012.01.021; Walker LAS, 2019, NEUROL THER, V8, P251, DOI 10.1007/s40120-019-00158-3; Wang C, 2014, BRAIN COGNITION, V85, P251, DOI 10.1016/j.bandc.2014.01.004; Wechsler D., 2003, WAIS 3 SVENSK VERSIO; Wu SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub3; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	0	0	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 1	2021	15								656876	10.3389/fnins.2021.656876			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TJ6QH	WOS:000673603200001	34276283	Green Published, gold			2022-02-07	
J	Jimenez, N; Fuentes, M; Virtue, A; Alonso-Gonzalez, L; Lopez, E; Zhou, CA; Crawley, D; Apkon, S; Johnston, B; Rivara, F				Jimenez, Nathalia; Fuentes, Molly; Virtue, Alyssa; Alonso-Gonzalez, Laura; Lopez, Edgar; Zhou, Chuan; Crawley, Deborah; Apkon, Susan; Johnston, Brian; Rivara, Frederick			Feasibility and Acceptability of a Telephone-Based Intervention for Hispanic Children to Promote Treatment Adherence After Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						care transitions; Hispanic children; navigation; traumatic brain injury	OUTPATIENT REHABILITATION SERVICES; INSURANCE; FAMILIES; SCHOOL; RETURN; TRIAL; SCALE	Objective: To assess the feasibility and acceptability of a telephone-based education and navigation program for Hispanic parents of children hospitalized with traumatic brain injury (TBI). Setting: Level I trauma hospital and pediatric inpatient rehabilitation unit in the Northwestern United States. Participants: Fourteen Hispanic parent-child dyads. Parents were 85% female, with a mean age of 35 years. Children were 58% male, with a mean age of 9.7 years, and had been hospitalized for complicated mild/moderate (n = 5) or severe (n = 9) TBI. Design: Pilot prospective cohort design. Main Measures: Feasibility measures include recruitment, retention, and intervention adherence rates. Acceptability of intervention was measured by parents' use of educational materials and satisfaction with navigation program. We also evaluated study processes, including completion of baseline, 3, 6, and 12 months functional assessments of the child; assessment of parental health literacy and self-efficacy; and adherence to follow-up rehabilitation appointments. Results: Eighty-two percent of approached potential participants were recruited into the study. One hundred percent of participants completed the intervention, and 85% had 1-year follow-up. Intervention acceptability was high: 90% reported satisfaction with navigator, and 92% used the educational manual. Assessments demonstrated significant improvement in parents' TBI caregiving and community self-efficacy; 92% attendance to follow-up rehabilitation appointments; and improvement in the child's functional measures, except communication skills. Conclusions: Findings support feasibility and acceptability of a culturally relevant program to facilitate transitions of care for Hispanic children with TBI. A future randomized trial is warranted to determine the efficacy of the intervention on long-term treatment adherence and the child's post-TBI function.	[Jimenez, Nathalia] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Fuentes, Molly; Apkon, Susan] Univ Washington, Dept Rehabil Med, Seattle, WA 98121 USA; [Johnston, Brian; Rivara, Frederick] Univ Washington, Dept Pediat, Seattle, WA 98121 USA; [Rivara, Frederick] Univ Washington, Dept Epidemiol, Seattle, WA 98121 USA; [Jimenez, Nathalia; Fuentes, Molly; Virtue, Alyssa; Lopez, Edgar; Rivara, Frederick] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98121 USA; [Crawley, Deborah] Brain Injury Alliance Washington, Seattle, WA USA; [Jimenez, Nathalia; Fuentes, Molly; Alonso-Gonzalez, Laura; Zhou, Chuan; Rivara, Frederick] Seattle Childrens Res Ctr, Ctr Child Hlth Behav & Dev, Seattle, WA USA		Jimenez, N (corresponding author), Univ Washington, Seattle Childrens Res Inst, 2001 8th Ave, Seattle, WA 98121 USA.	nathalia.jimenez@seattlechildrens.org			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453-05]; Seattle Children's Center for Diversity and Health Equity Pilot Research Program; Seattle Children's Center for Child Health, Behavior, and Development (CHBD) Research Bridge Fund	This work was supported by the National Institute of Child Health and Human Development (grant no. K23HD078453-05 to Dr Jimenez), Seattle Children's Center for Diversity and Health Equity Pilot Research Program and Seattle Children's Center for Child Health, Behavior, and Development (CHBD) Research Bridge Funding (to Dr Jimenez).	Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Black Lindsey I, 2018, NCHS Data Brief, P1; Centers for Disease Control and Prevention, 1999, REP C TRAUM BRAIN IN REP C TRAUM BRAIN IN; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Falbe J, 2015, ACAD PEDIATR, V15, P386, DOI 10.1016/j.acap.2015.02.004; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gidengil C, 2017, ACAD PEDIATR, V17, P863, DOI 10.1016/j.acap.2017.03.012; Harrison PL., 2013, ADAPTIVE BEHAV ASSES; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HealthMeasures, 2018, HLTH MEAS PROMIS HLTH MEAS PROMIS; Jimenez Nathalia, 2020, Hosp Pediatr, V10, P509, DOI 10.1542/hpeds.2019-0304; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Lopez L, 2016, J DIABETES COMPLICAT, V30, P554, DOI 10.1016/j.jdiacomp.2015.12.003; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; MARIN G, 1987, HISPANIC J BEHAV SCI, V9, P183, DOI 10.1177/07399863870092005; Marr A., 2004, CENTRAL NERVOUS SYST; Matiz LA, 2014, J PRIM CARE COMMUNIT, V5, P271, DOI 10.1177/2150131914540694; Medina, 2020, DEMOGRAPHIC TURNING; Moore M, 2018, J HEAD TRAUMA REHAB, V33, P177, DOI 10.1097/HTR.0000000000000348; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; National Center for Excellence in Primary Care Research, CARE COORDINATION ME; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sarkar U, 2011, J GEN INTERN MED, V26, P265, DOI 10.1007/s11606-010-1552-1; Seid M, 2010, J PEDIATR PSYCHOL, V35, P1133, DOI 10.1093/jpepsy/jsp133; US Census Bureau, CURR POP SURV; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Walrath CM, 2004, J PSYCHOEDUC ASSESS, V22, P209, DOI 10.1177/073428290402200302; Yun L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1833-z	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		274	281		10.1097/HTR.0000000000000658			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100014	33656480	Green Accepted			2022-02-07	
J	Johns, TJ; Fabico-Dulin, J; Montgomery, A; Dulin, JF; Ashley, DW				Johns, Tracy J.; Fabico-Dulin, Josephine; Montgomery, Anne; Dulin, Janelle F.; Ashley, Dennis W.			Comprehensive Initiative to Decrease Trauma Venous Thromboembolism	JOURNAL OF TRAUMA NURSING			English	Article						Chemoprophylaxis; Data validation; Performance improvement; Prophylaxis; Pulmonary embolus; TQIP; Trauma; Venous thromboembolism	PROPHYLAXIS; TABLES; RISK	Background: Our trauma center was a high outlier for pulmonary embolism on a 2017 American College of Surgeons Trauma Quality Improvement Program (TQIP) report. The odds ratio for developing a pulmonary embolus was 1.76 and was in the 10th decile (worst results). Of the patients who received chemoprophylaxis, only 69% of patients received the "gold standard" low-molecular-weight heparin. Objective: The purpose of this study was to describe and evaluate a multicomponent performance improvement project to prevent pulmonary embolus incidence. Methods: This descriptive study was a before-and-after time-series analysis of adult trauma patients. Ongoing data validation, concurrent monitoring, and analysis on incidence of venous thrombolytic events identified barriers to evidence-based chemoprophylaxis administration. Results: There were a total of 4,711 trauma patients in the analysis. Compared with preintervention (fall 2017), the fall 2019 TQIP report indicated the pulmonary embolus odds ratio dropped to 0.56, lowering the benchmark decile from 10 (worst) to 1 (best). The proportion of patients receiving no chemoprophylaxis decreased to 23% and was lower than all hospitals (32%). The rate of low-molecular-weight heparin use increased to 80% for patients receiving chemoprophylaxis, and unfractionated heparin use plummeted to 14%. The proportion of patients with no chemoprophylaxis in the severe traumatic brain injury cohort fell to 21%. Conclusions: The high pulmonary embolus rate was driven by inaccurate data, infrequent monitoring, suboptimal ordering, and administration of chemoprophylaxis. A sustained decrease in the pulmonary embolus incidence was achieved through collaboration, updated guidelines, expanded education, concurrent validation, monitoring, and frequent reporting.	[Johns, Tracy J.; Fabico-Dulin, Josephine; Dulin, Janelle F.; Ashley, Dennis W.] Atrium Hlth Navicent, Trauma Serv Dept, Macon, GA USA; [Montgomery, Anne] Mercer Univ, Sch Med, Dept Community Hlth, Macon, GA 31207 USA		Johns, TJ (corresponding author), Atrium Hlth Navicent, Trauma Serv, 777 Hemlock St,MSC 103, Macon, GA 31201 USA.	johns.tracy@navicenthealth.org; josephine.fabico-dulin@atriumhealth.org; montgomery_a@mercer.edu; janelledulin@yahoo.com; dennis.ashley@atriumhealth.org	Montgomery, Anne/ABC-7887-2020	Montgomery, Anne/0000-0003-0084-7976			American College of Surgeons (ACS) Trauma Quality Improvement Program (TQIP), BEST PRACT MAN TRAUM BEST PRACT MAN TRAUM; Bickford A, 2013, AM J SURG, V206, P847, DOI 10.1016/j.amjsurg.2013.07.020; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Hlaing T, 2006, J TRAUMA, V61, P1400, DOI 10.1097/01.ta.0000195732.64475.87; Jacobs BN, 2017, J TRAUMA ACUTE CARE, V83, P151, DOI 10.1097/TA.0000000000001494; Lassiter RL, 2017, AM SURGEON, V83, P1283; Lau BD, 2014, BMJ QUAL SAF, V23, P187, DOI 10.1136/bmjqs-2012-001782; Ley EJ, 2020, J TRAUMA ACUTE CARE, V89, P971, DOI 10.1097/TA.0000000000002830; Maynard G, 2010, J THROMB THROMBOLYS, V29, P159, DOI 10.1007/s11239-009-0405-4; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Prabhakaran K, 2020, J SURG RES, V254, P327, DOI 10.1016/j.jss.2020.05.008; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Selby LV, 2016, J AM COLL SURGEONS, V222, P129, DOI 10.1016/j.jamcollsurg.2015.11.011; Wang TF, 2014, THROMB HAEMOSTASIS, V111, P88, DOI 10.1160/TH13-01-0042	17	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JUL-AUG	2021	28	4					250	257		10.1097/JTN.0000000000000593			8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	TJ6TK	WOS:000673611300009	34210945				2022-02-07	
J	Kaur, S; Rattan, A; Kumar, H; Rao, S; Kant, R; Misra, MC				Kaur, Shivpreet; Rattan, Amulya; Kumar, Hemant; Rao, Shalinee; Kant, Ravi; Misra, Mahesh C.			Advanced Trauma Care for Nurses (ATCN): A Single-Center Analysis of Trauma Nurses Knowledge Gaps	JOURNAL OF TRAUMA NURSING			English	Article						Advanced Trauma Care for Nurses; Advanced Trauma Life Support; ATCN; ATLS; Continuing medical education; Curriculum; Educational measurement; Program evaluation; Trauma training		Background: Trauma is a global cause of death and disability, and trauma systems are not well developed in low- and middle-income countries. Training of nurses in trauma care is of utmost importance to improve the organization and delivery of trauma care. Objective: This study aimed to identify common knowledge gaps and develop study aids to improve nurses' performance taking the Advanced Trauma Care for Nurses (ATCN) course. Methods: This is a descriptive, single-center study of the multiple-choice final examinations of the ATCN course conducted over 1 year in the All India Institute of Medical Sciences, Rishikesh, Level I trauma center. The questions missed by candidates were compiled, and the wrong options were tabulated. The most commonly missed questions were identified, and the most commonly marked wrong option was analyzed vis-a-vis the correct answer. Each error was classified into either a theoretical error or a practice-based error. Results: Ninety-six nurses attended 6 courses from June 2019 to June 2020. Of the theoretical-based questions, the top 3 categories of most missed questions were geriatric trauma (n = 13; 81.2%), massive transfusion (n = 35; 72.9%), and traumatic brain injury (n = 35; 72.9%). Of the practice-based questions, the top 3 categories of most missed questions were dislocated extremity management (n = 54; 79.4%), basic airway (n = 31; 64.5%), and shock management (n = 30; 62.5%). Conclusions: Periodic identification and categorization of the ATCN course examination's most frequent knowledge gaps allow instructors to develop teaching aids to enhance instructor teaching and improve trauma nurses' knowledge.	[Kaur, Shivpreet; Rattan, Amulya; Kumar, Hemant; Rao, Shalinee; Kant, Ravi] AIIMS Rishikesh, Rishikesh, Uttarakhand, India; [Misra, Mahesh C.] ATLS India, Indian Soc Trauma & Acute Care, New Delhi, India		Rattan, A (corresponding author), AIIMS Rishikesh, MCh Trauma Surg, Virbhadra Rd, Rishikesh 249203, Uttarakhand, India.	shivpreetkaur777@gmail.com; amulya.rattan@gmail.com; hemantharni@gmail.com; drshalineerao@gmail.com; ravibina@gmail.com; mcmisra@gmail.com					Abu-Zidan Fikri M, 2016, World J Crit Care Med, V5, P12, DOI 10.5492/wjccm.v5.i1.12; Advanced Centre for Continuous Professional Development, AIIMS RISH AIIMS RISH; American College of Surgeons (ACS), ADV TRAUM LIF SUPP ADV TRAUM LIF SUPP; Azam M.Q., 2020, DISASTER MED PUBLIC, P1, DOI [10.1017/dmp.2020.38, DOI 10.1017/DMP.2020.38]; Dandona R, 2020, LANCET PUBLIC HEALTH, V5, pE86, DOI 10.1016/S2468-2667(19)30246-4; Ding M, 2016, NURS EDUC TODAY, V44, P33, DOI 10.1016/j.nedt.2016.05.002; Hu QLN, 2020, J AM COLL SURGEONS, V231, P557, DOI 10.1016/j.jamcollsurg.2020.08.758; Ireland S, 2017, AUSTRALAS EMERG NURS, V20, P131, DOI 10.1016/j.aenj.2017.05.002; Jayaraman S, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004173.pub3, 10.1002/14651858.CD004173.pub4]; Juillard CJ, 2009, WORLD J SURG, V33, P1075, DOI 10.1007/s00268-009-9959-8; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mobily M, 2015, AM J SURG, V210, P942, DOI 10.1016/j.amjsurg.2015.03.007; Mohammad A, 2014, WORLD J SURG, V38, P322, DOI 10.1007/s00268-013-2294-0; Moore L, 2015, J TRAUMA ACUTE CARE, V78, P1168, DOI 10.1097/TA.0000000000000663; Radjou Angeline N, 2013, J Emerg Trauma Shock, V6, P164, DOI 10.4103/0974-2700.115324; Society of Trauma Nurses (STN), ADV TRAUM CAR NURS ADV TRAUM CAR NURS; WHO, 2020, ROAD TRAFF INJ; Wilson LN, 2013, J TRAUMA NURS, V20, P51, DOI 10.1097/JTN.0b013e31828661e9	18	0	0	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JUL-AUG	2021	28	4					258	264		10.1097/JTN.0000000000000594			7	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	TJ6TK	WOS:000673611300010	34210946				2022-02-07	
J	Kerr, ZY; Prim, J; DeFreese, JD; Thomas, LC; Simon, JE; Carneiro, KA; Marshall, SW; Guskiewicz, KM				Kerr, Zachary Y.; Prim, Julianna; DeFreese, J. D.; Thomas, Leah C.; Simon, Janet E.; Carneiro, Kevin A.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Musculoskeletal Injury History Is Associated With Lower Physical and Mental Health in a Historical Cohort of Former National Football League Players	JOURNAL OF SPORT REHABILITATION			English	Article						epidemiology; health-related quality of life; career-ending injury	QUALITY-OF-LIFE; RECURRENT CONCUSSION; KNEE INJURY; DEPRESSION; DIAGNOSIS; ACCURACY; OUTCOMES; RISK; PAIN	Context: Little research has examined health-related quality of life in former National Football League (NFL) players. Objective: Examine the association of musculoskeletal injury history and current self-reported physical and mental health in former NFL players. Setting: Cross-sectional questionnaire. Patients or Other Participants: Historical cohort of 2,103 former NFL players that played at least one season between 1940 and 2001. Intervention: Players were grouped by self-reported professional career musculoskeletal injury history and whether injuries affected current health: (1) no musculoskeletal injury history; (2) musculoskeletal injury history, currently affected by injuries; and (3) musculoskeletal injury history, not currently affected by injuries. Main Outcome Measure: The Short Form 36 Measurement Model for Functional Assessment of Health and Well-Being (SF-36) yielded physical and mental health composite scores (PCS and MCS, respectively); higher scores indicated better health. Multivariable linear regression computed mean differences (MD) among injury groups. Covariates included demographics, playing history characteristics, surgical intervention for musculoskeletal injuries, and whether injury resulted in premature end to career. MD with 95% CI excluding 0.00 were deemed significant. Results: Overall, 90.3% reported at least one musculoskeletal injury during their professional football careers, of which 74.8% reported being affected by their injuries at time of survey completion. Adjusting for covariates, mean PCS in the "injury and affected" group was lower than the "no injury" (MD = -3.2; 95% CI: -4.8, -1.7) and "injury and not affected" groups (MD = -4.3; 95% CI: -5.4, -3.3); mean MCS did not differ. Conclusion: Many players reported musculoskeletal injuries, highlighting the need for developing and evaluating injury management interventions.	[Kerr, Zachary Y.; DeFreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; DeFreese, J. D.; Carneiro, Kevin A.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; DeFreese, J. D.; Carneiro, Kevin A.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Prim, Julianna] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC 27515 USA; [Thomas, Leah C.] Duke Canc Inst, Durham, NC USA; [Simon, Janet E.] Ohio Univ, Sch Appl Hlth Sci & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Carneiro, Kevin A.] Univ N Carolina, Sch Med Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.; Kerr, ZY (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA.; Kerr, ZY (corresponding author), Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27515 USA.	zkerr@email.unc.edu					[Anonymous], 2006, MED SCI SPORT EXER, V38, P2030, DOI 10.1249/MSS.0b013e31802b37a6; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P985; Bauman J, 2005, CLIN J SPORT MED, V15, P432, DOI 10.1097/01.jsm.0000186682.21040.82; Bodkin SG, 2020, KNEE SURG SPORT TR A, V28, P790, DOI 10.1007/s00167-019-05461-y; Carey JL, 2006, AM J SPORT MED, V34, P1911, DOI 10.1177/0363546506290186; Clancy CM, 1998, SCIENCE, V282, P245, DOI 10.1126/science.282.5387.245; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Cowee K, 2019, J ATHL TRAINING, V54, P64, DOI 10.4085/1062-6050-377-17; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Filbay S, 2019, SPORTS MED, V49, P1723, DOI 10.1007/s40279-019-01163-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hair JF, 1995, MULTIVARIATE DATA AN; Halchin L., 2008, CRS REPORT C FORMER; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lam KC, 2017, J ATHL TRAINING, V52, P534, DOI 10.4085/1062-6050-50.5.01; Lie MM, 2019, BRIT J SPORT MED, V53, P1162, DOI 10.1136/bjsports-2018-099751; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; McAllister DR, 2001, AM J SPORT MED, V29, P806, DOI 10.1177/03635465010290062201; McGuine TA, 2012, CLIN J SPORT MED, V22, P334, DOI 10.1097/JSM.0b013e318257a40b; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Selden MA, 2009, AM J MED, V122, P811, DOI 10.1016/j.amjmed.2009.03.027; Shah VM, 2010, AM J SPORT MED, V38, P2233, DOI 10.1177/0363546510372798; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Stodden DF, 2010, J STRENGTH COND RES, V24, P2300, DOI 10.1519/JSC.0b013e3181dc4255; Straus SE, 2002, J GEN INTERN MED, V17, P684, DOI 10.1046/j.1525-1497.2002.20102.x; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494	36	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JUL	2021	30	5					760	767		10.1123/jsr.2020-0231			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SU0XU	WOS:000662866100010	33494044				2022-02-07	
J	Kratz, SV; Kratz, DJ				Kratz, Susan Vaughan; Kratz, Daniel J.			Effects of CranioSacral therapy upon symptoms of post-acute concussion and Post-Concussion Syndrome: A pilot study	JOURNAL OF BODYWORK AND MOVEMENT THERAPIES			English	Article						Concussion symptoms; Post-concussion syndrome; Mild TBI; CranioSacral therapy; craniosacral system	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HEART-RATE-VARIABILITY; POSTCONCUSSION SYNDROME; HIGH-SCHOOL; SENSORIMOTOR FUNCTION; PERSISTENT SYMPTOMS; NERVOUS-SYSTEM; RECOVERY-TIME; REHABILITATION	Objective: The purpose of this study was to investigate the utilization of CranioSacral Therapy (CST) in patients with Post-Concussion Syndrome (PCS) and capture patient-reported perceptions of clinical outcomes of lived treatment experiences. Design: Two-part, longitudinal study conducted through a chart review of target group, followed by a Patient-reported Treatment Outcome Survey (PTOS). Participants: A convenience sample of 212 patients with a historical incidence of head trauma not requiring hospitalization was obtained through medical records department dating back ten years. Inclusion criteria for further chart review (n = 67) was determined by identifying patients with a confirmed concussion directly correlated with presenting symptoms and for which CST was specifically sought as a treatment option. Demographics and patient-determined treatment duration data were analyzed by comparison groups extensively suggested in existing literature: Recovery time since injury as either Post-acute concussion (<6 months) or Post-Concussion Syndrome (PCS) (>6 months); Athletes (A) or Non-athletes (NA); and traditional gender. Final PTOS group criteria was determined by eliminating confounding issues reporting (n = 47): (A, n = 24 and NA, n = 23). Results: Quantitative data was analyzed via Numerical Analysis, and qualitative data was analyzed via Inductive Content Analysis. Symptoms reported in all charts as well as in the PTOS were consistent with identified PCS subtypes. Utilization of CST revealed that most patients determined the treatment effect upon concussion symptoms within 1-3 sessions. Nearly twice as many sessions were attended in the PCS than post-acute groups. Referral sources, studied for a perspective on local concussion after-care discharge planning, ranged from professional to personal recommendation or self-discovery. A majority of patients met goals of reducing post-acute or PCS as reasons cited by self-determined change-in status or discharge from service. Patients were asked to indicate on the PTOS which pre-and posttreatment symptoms were helped or not helped by this particular intervention. Conclusions: Patient-reported changes of PCS symptoms is critical when evaluating treatment options. CST is an experiential treatment that addresses subjective levels of dysfunction, thus it is the patient deciding the value of an intervention. A sizable portion of patients in all groups reported a positive effect upon their symptoms by CST. Patients indicated personal meaning to CST through their utilization of multiple sessions. A high percentage indicated the likelihood of referring others with PCS for CST. Of the 212 patient charts first studied, the 145 not meeting inclusion criteria suggest some chronic conditions may present as long-term effects of older head injuries. CST is a low-risk, conservative treatment option for PCS sub-types worthy of further clinical study. (C) 2021 Elsevier Ltd. All rights reserved.	[Kratz, Susan Vaughan] Special Therapies Inc, Occupat Therapy Dept, 1720 Dolphin Dr,Unit B, Waukesha, WI 53186 USA; [Kratz, Daniel J.] West Texas A&M Univ, Dept Psychol, 2501 4th Ave, Canyon, TX 79015 USA		Kratz, SV (corresponding author), Special Therapies Inc, Occupat Therapy Dept, 1720 Dolphin Dr,Unit B, Waukesha, WI 53186 USA.	info@specialtherapies.com; dkratz123@yahoo.com					Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Breman G.M., 2020, TOUCH BETTER 2 THERA, P201; Chaitow L., 2005, CRANIAL MANIPULATION; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis C.M., 2009, COMPLEMENTARY THERAP; Davis L, 2016, J BODYW MOV THER, V20, P42, DOI 10.1016/j.jbmt.2015.03.006; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Ernst E., 2012, FACT, V17, P197; Faco S.G., 2016, REV PESQUISA FISIOTE, V6, P341; Gagnon I., 2017, SPORTS CONCUSSIONS C; Garcia JD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00040; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Girsberger W, 2014, J INTEGR MED-JIM, V12, P156, DOI 10.1016/S2095-4964(14)60021-2; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Haller H, 2015, J ALTERN COMPLEM MED, V21, P110, DOI 10.1089/acm.2013.0283; Haller H, 2014, COMPLEMENT THER MED, V22, P1053, DOI 10.1016/j.ctim.2014.09.007; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harrison RE, 2011, J ALTERN COMPLEM MED, V17, P13, DOI 10.1089/acm.2009.0644; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jakel A, 2012, COMPLEMENT THER MED, V20, P456, DOI 10.1016/j.ctim.2012.07.009; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King ML, 1997, BRAIN INJURY, V11, P445; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kratz S.V., 2016, J PAIN, V1, P5; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leskowitz E, 2016, MED ACUPUNCT, V28, P181, DOI 10.1089/acu.2016.1168; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01034; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Passatore M, 2006, EUR J APPL PHYSIOL, V98, P423, DOI 10.1007/s00421-006-0312-8; Phillips MM, 2016, PHYS MED REH CLIN N, V27, P455, DOI 10.1016/j.pmr.2015.12.005; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rao K., 2017, MOJ YOGA PHYS THER, V2; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Seffinger M.A., 2017, J AM OSTEOPATH ASSOC, V117; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stecco A, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0352-9; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Teale C, 2013, J AUST TRADIT-MED SO, V19, P168; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Upledger J.E., 1983, CRANIOSACRAL THERAPY; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12; Wedel A., 2017, ALTERNATE THERAPIES, P149; Wetzler G, 2017, MED ACUPUNCT, V29, P239, DOI 10.1089/acu.2017.1222; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zasler ND, 2013, PHYS MED REH CLIN N, V24, P445, DOI 10.1016/j.pmr.2013.03.009	78	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1360-8592	1532-9283		J BODYW MOV THER	J. Bodyw. Mov. Ther.	JUL	2021	27						667	675		10.1016/j.jbmt.2021.05.010			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	TZ5UA	WOS:000684536100048	34391304				2022-02-07	
J	Kuo, LT; Lu, HY; Huang, APH				Kuo, Lu-Ting; Lu, Hsueh-Yi; Huang, Abel Po-Hao			Prognostic Value of Circadian Rhythm of Brain Temperature in Traumatic Brain Injury	JOURNAL OF PERSONALIZED MEDICINE			English	Article						organ temperature; traumatic brain injury; postoperative care; hypothermia; circadian rhythm; prognosis	BODY CORE TEMPERATURE; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; HYPOTHALAMIC INSTABILITY; HYPOTHERMIA; HEMORRHAGE; LIFE	Hypothermia has been used in postoperative management of traumatic brain injury (TBI); however, the rhythmic variation and prognostic value of brain temperature after TBI have never been studied. This study describes diurnal brain temperature patterns in comatose patients with TBI. Mesors of brain temperature, amplitude, and acrophase were estimated from recorded temperature measurements using cosinor analysis. The association of these patterns with clinical parameters, mortality, and functional outcomes in a 12-month follow-up was examined. According to the cosinor analysis, 59.3% of patients presented with circadian rhythms of brain temperature in the first 72 h postoperatively. The rhythm-adjusted mesor of brain temperature was 37.39 +/- 1.21 degrees C, with a diminished mean amplitude of 0.28 (+/- 0.25) degrees C; a shift of temperature acrophase was also observed. Multivariate logistic regression analysis revealed that initial Glasgow coma scale score, age, elevated blood glucose level, and circadian rhythm of brain temperature seemed to be predictive and prognostic factors of patients' functional outcomes. For the prediction of survival status, younger patients or those patients with mesor within the middle 50% of brain temperature were more likely to survive. The analysis of brain temperature rhythms in patients with moderate and severe TBI provided additional predictive information related to mortality and functional outcomes.	[Kuo, Lu-Ting; Huang, Abel Po-Hao] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, 7 Chung San South Rd, Taipei 100, Taiwan; [Lu, Hsueh-Yi] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Touliu 64002, Yunlin, Taiwan; [Huang, Abel Po-Hao] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 100, Taiwan		Huang, APH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, 7 Chung San South Rd, Taipei 100, Taiwan.; Huang, APH (corresponding author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 100, Taiwan.	kuoluting@gmail.com; hylu@yuntech.edu.tw; how.how0622@gmail.com	Kuo, Lu-Ting/AAU-3205-2021	HUANG, ABEL PO-HAO/0000-0002-5689-6761; Kuo, Lu-Ting/0000-0002-1405-8700	National Taiwan University Hospital, Yun-Lin branch [NTUHYL103.X005]; Ministry of Science and Technology [101-2314-B-002-040]	This research was funded by grants from the National Taiwan University Hospital, Yun-Lin branch (NTUHYL103.X005) and the Ministry of Science and Technology (101-2314-B-002-040).	Addis A, 2021, J CEREBR BLOOD F MET, V41, P359, DOI 10.1177/0271678X20910405; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Attia J, 1998, CRIT CARE CLIN, V14, P497, DOI 10.1016/S0749-0704(05)70013-0; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Childs C, 2013, CRIT CARE, V17, DOI 10.1186/cc11892; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; De Tanti A, 2005, BRAIN INJURY, V19, P1277, DOI 10.1080/02699050500309270; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Duclos C, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz191; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Gleason JD, 2019, BIOMED SIGNAL PROCES, V54, DOI 10.1016/j.bspc.2019.101610; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Guan JW, 2009, BRAIN RES, V1258, P78, DOI 10.1016/j.brainres.2008.11.106; Gubin Denis G, 2016, Curr Aging Sci, V9, P14; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Karamouzis I, 2016, ENDOCRINE, V52, P441, DOI 10.1007/s12020-015-0796-2; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Lee H, 2019, CRIT CARE MED, V47, P574, DOI 10.1097/CCM.0000000000003639; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Livingston DH, 2011, CAN MED ASSOC J, V183, P1570, DOI 10.1503/cmaj.110974; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Pizza F, 2011, SLEEP MED, V12, P1044, DOI 10.1016/j.sleep.2011.06.013; Rauen K, 2020, CRIT CARE MED, V48, P1157, DOI 10.1097/CCM.0000000000004387; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rzechorzek N.M., 2021, DIURNAL BRAIN TEMPER, DOI [10.1101/2021.01.23.21250327, DOI 10.1101/2021.01.23.21250327]; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Shemilt M, 2019, CRIT CARE MED, V47, pE522, DOI 10.1097/CCM.0000000000003728; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Tan HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04008-w; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Weinert D, 2005, CHRONOBIOL INT, V22, P179, DOI 10.1081/CBI-200053473; Yablonskiy DA, 2000, P NATL ACAD SCI USA, V97, P7603, DOI 10.1073/pnas.97.13.7603; Yang Y, 2020, MAR BIOTECHNOL, V22, P153, DOI 10.1007/s10126-019-09940-8; Zalai Dora M, 2020, CMAJ Open, V8, pE142, DOI 10.9778/cmajo.20190137	46	0	0	4	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	JUL	2021	11	7							620	10.3390/jpm11070620			12	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	TN8QX	WOS:000676493800001	34208924	gold, Green Published			2022-02-07	
J	Lamba, I; Luthra, A; Shinde, V; Daniel, SS				Lamba, Ishan; Luthra, Avinav; Shinde, Varsha; Daniel, S. S.			Using Canadian CT head rule in a developing nation: Validation and comparing utilisation by emergency physicians and neurosurgeons	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Canadian CT head rule; CCHR; TBI; Head injury in India; Head trauma	TRAUMATIC BRAIN-INJURY; STRATEGIES; MANAGEMENT; RADIATION	Objective: The objective of this study was to test the validity of the Canadian CT Head rule (CCHR) in cases of minor traumatic brain injury (TBI) in an Indian emergency department (ED). A secondary objective was to compare of the patterns of neuroradiology references between the emergency physician (EP) and the neurosurgeon. Methods: The study was prospectively conducted between July 2019 and July 2020. Patients satisfying the inclusion criteria were subjected to CCHR and the result was documented. The neurosurgeon was consulted for the final decision. In case of disagreement between the neurosurgeon and the EP, the decision of neuro-radiology was taken by the neurosurgeon. Results: A total of 101 patients satisfied the inclusion criteria. 62 subjects fulfilled the CCHR. Out of 62 subjects who fulfilled the CCHR criteria, 46 (74.1%) were reported to have normal CT scans, while 16 had either haemorrhages (n = 12) or contusions (n = 4). All the subjects who didn't fulfil the CCHR (n = 39), were reported to have normal CT scans. The EPs used CCHR in all cases of mild TBI while the neurosurgeons chose to get CT brains in all the subjects based of clinical gestalt. CCHR had an observed sensitivity of 100% and specificity of 45.8%. Conclusion: The CCHR has 100% sensitivity as a screening tool for patients requiring CT brains in case of TBI though the specificity is found to be rather low (45.8%). EPs show a higher level of awareness and inclination to use CDRs in cases of minor TBI to direct the decision for neuro-radiology, in comparison to neurosurgeons. ED residents reported comfort in mobile application based usage of the rule. (c) 2021 Elsevier Inc. All rights reserved.	[Lamba, Ishan; Luthra, Avinav; Shinde, Varsha; Daniel, S. S.] DY Patil Vidyapeeth Pune, Dept Emergency Med, Dr DY Patil Med Coll, Pune, Maharashtra, India		Lamba, I (corresponding author), DY Patil Vidyapeeth Pune, Dept Emergency Med, Dr DY Patil Med Coll, Pune, Maharashtra, India.	drishanlamba@yahoo.com; varsha.shinde@dpu.edu.in; swarupmasih.daniel@dpu.edu.in	Lamba, Ishan/AAG-2049-2021	Lamba, Ishan/0000-0002-8748-8517			Babhulkar S, 2019, OTA INT, V2; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Chan TM, 2020, ACAD MED, V95, P1230, DOI 10.1097/ACM.0000000000003098; Davey K, 2015, ANN EMERG MED, V4, pS95; Devi BI, 2019, WORLD NEUROSURG, V123, pE588, DOI 10.1016/j.wneu.2018.11.227; Jasperse N, 2020, SURG-J R COLL SURG E, V18, P12, DOI 10.1016/j.surge.2019.04.001; Lab Advisor, MED TESTS IND; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Ozan E, 2018, ULUS TRAVMA ACIL CER, V24, P121, DOI 10.5505/tjtes.2017.56884; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Quan AML, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/15503; Ramachandran R, 2017, J NEUROL SCI, V381, P256, DOI 10.1016/j.jns.2017.08.3258; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2000, CAN MED ASSOC J, V163, P1465; Tintinalli J, 2020, TINTINALLIS EMERGENC, V9th, P1687; Verdun FR, 2008, RADIOGRAPHICS, V28, P1807, DOI 10.1148/rg.287085042; Yavasi O, 2011, EUR J EMERG MED, V18, P238, DOI 10.1097/MEJ.0b013e3283449119; Zakhari R, 2016, J AM ASSOC NURSE PRA, V28, P659, DOI 10.1002/2327-6924.12402	21	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45						112	116		10.1016/j.ajem.2021.02.064			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XN7FF	WOS:000729665500020	33684867				2022-02-07	
J	Lara, M; Moll, A; Mas, A; Picado, MJ; Gassent, C; Pomar, J; Llompart-Pou, JA; Brell, M; Ibanez, J; Perez-Barcena, J				Lara, Monica; Moll, Apolonia; Mas, Antonio; Jose Picado, Maria; Gassent, Carmen; Pomar, Jaume; Antonio Llompart-Pou, Juan; Brell, Marta; Ibanez, Javier; Perez-Barcena, Jon			Use of diffusion tensor imaging to assess the vasogenic edema in traumatic pericontusional tissue	NEUROCIRUGIA			English	Article						Traumatic brain injury; Brain contusion; Pericontusional edema; Vasogenic edema; Diffusion tensor imaging	BRAIN-INJURY; CEREBRAL EDEMA	Background and objective: Cerebral edema is a frequent and serious complication of traumatic brain injury (TBI). Diffusion tensor imaging (DTI) is considered a useful technique to assess white matter integrity after TBI. The objective of this prospective, observational study was to assess the characteristics of the vasogenic edema in the traumatic pericontusional tissue and compare it to the vasogenic edema found in brain tumors. We also included a control group. Methods: Using DTI, the Apparent diffusion coefficient (ADC) and Fractional anisotropy (FA) were measured in the area of vasogenic edema in both TBI and tumor patients. The measurements in the control group were done in the gray and white matter. We included 15 TBI patients, 18 tumor patients and 15 controls. Results: ADC and FA showed no differences between TBI and tumor patients (p = 0.27 for AF; p = 0.79 for ADC). Compared to healthy controls, TBI and tumor patients presented higher ADC values and lower FA values. The differences between TBI and controls were statistically significant (p <0.05). Conclusions: In this prospective observational study using DTI-MRI in a selected group of mild and moderate TBI patients with vasogenic pericontusional edema we have shown that there were no significant differences of the ADC and FA values compared to brain tumor patients. Furthermore, healthy controls showed significant lower ADC values and higher FA values compared to TBI and tumor patients. Future studies, using DTI-MRI, should address whether any therapy has a favorable impact on the vasogenic edema of TBI patients with brain contusions. (C) 2020 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Lara, Monica; Brell, Marta; Ibanez, Javier] Son Espases Univ Hosp, Neurosurg Dept, Palma De Mallorca, Spain; [Moll, Apolonia; Mas, Antonio; Jose Picado, Maria; Gassent, Carmen] Son Espases Univ Hosp, Radiol Dept, Palma De Mallorca, Spain; [Pomar, Jaume] Res Inst Hlth IDISBA, Neuropsychol & Cognit Res Grp, Palma De Mallorca, Spain; [Pomar, Jaume] IUNICS UIB, Palma De Mallorca, Spain; [Antonio Llompart-Pou, Juan; Perez-Barcena, Jon] Son Espases Univ Hosp, Intens Care Dept, Palma De Mallorca, Spain		Perez-Barcena, J (corresponding author), Son Espases Univ Hosp, Intens Care Dept, Palma De Mallorca, Spain.	juan.perez@ssib.es		Ibanez, Javier/0000-0003-3735-8332			Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons Joint Section on Neurotrauma and Critical Care AANS/CNS, J NEUROTRAUM, V24, pS91; Casta  no-Leon AM, 2020, NEUROCIRUGIA ASTUR; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Castano-Leon AM, 2020, NEUROCIRUGIA, V31, P132, DOI 10.1016/j.neucir.2019.11.005; Castano-Leon AM, 2019, J NEUROTRAUM, V36, P2785, DOI 10.1089/neu.2018.5978; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Edwards P, 2005, LANCET, V365, P1957; Emich S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-6; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kolias AG, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3050-4; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Reynolds JEF, 1996, MARTINDALE EXTRA PHA, V31st, P1017; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sinha S, 2004, J NEUROL NEUROSUR PS, V75, P1632, DOI 10.1136/jnnp.2003.028647; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	31	0	0	1	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JUL-AUG	2021	32	4					161	169		10.1016/j.neucir.2020.05.002			9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TD7NR	WOS:000669509300002	34218876				2022-02-07	
J	Lempke, LB; Chandran, A; Boltz, AJ; Robison, HJ; Collins, CL; Morris, SN				Lempke, Landon B.; Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.			Epidemiology of Injuries in National Collegiate Athletic Association Women's Basketball: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						descriptive; sport-related; surveillance	DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; SOCCER	Context: Frequent inspection of sports-related injury epidemiology among National Collegiate Athletic Association (NCAA) women's basketball student-athletes is valuable for identifying injury-related patterns. Background: Emerging patterns in epidemiology of NCAA women's basketball injuries are unknown though general sports medicine practices, and playing rules and regulations have evolved in recent years. Methods: Athlete exposures (AEs) and injury incidence data were reported to the NCAA Injury Surveillance Program between 2014-2015 and 2018-2019. Injury counts, rates, and proportions were used to examine injury characteristics, and injury rate ratios (IRRs) were used to assess injury rate differences. Results: Practice and competition injury rates were 5.93 and 10.35 per 1000 AEs, respectively. Preseason injury rates were higher than regular (IRR = 1.41; 95% CI = 1.31, 1.53) and postseason (IRR = 3.12; 95% CI = 2.39, 4.07). Ankle sprains (14.3%), concussions (7.5%), and anterior cruciate ligament tears (2.5%) were the most commonly reported injuries. Summary: Higher rates of practice and competition injuries, as well as ankle sprains, were observed relative to previous reports; continuous monitoring is necessary to identify potential contributing factors to these trends.	[Lempke, Landon B.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA USA; [Chandran, Avinash; Boltz, Adrian J.; Robison, Hannah J.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org			NCAA	The National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes.	Agel J, 2007, J ATHL TRAINING, V42, P202; [Anonymous], High school participation survey archive; [Anonymous], NCAA SPORTS SPONSORS; [Anonymous], 2015 16 2016 17 WOME; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2020, J ATHL TRAINING, V55, P580, DOI 10.4085/1062-6050-0517.19; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2020, J QUANT ANAL SPORTS, V16, P221, DOI 10.1515/jqas-2019-0030; Clifton DR, 2018, J ATHL TRAINING, V53, P1037, DOI 10.4085/1062-6050-150-17; Doherty C, 2016, AM J SPORT MED, V44, P995, DOI 10.1177/0363546516628870; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Emery CA, 2007, CLIN J SPORT MED, V17, P17, DOI 10.1097/JSM.0b013e31802e9c05; Kaminski TW, 2019, J ATHL TRAINING, V54, P650, DOI 10.4085/1062-6050-487-17; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Poulsen E, 2019, BRIT J SPORT MED, V53, P1454, DOI 10.1136/bjsports-2018-100022	18	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					674	680		10.4085/1062-6050-466-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700012	34280270	gold			2022-02-07	
J	Levy, B; Luong, D; Bayley, MT; Sweet, SN; Voth, J; Kastner, M; Nelson, MLA; Jaglal, SB; Salbach, NM; Wilcock, R; Thoms, C; Shepherd, J; Munce, SEP				Levy, Ben B.; Luong, Dorothy; Bayley, Mark T.; Sweet, Shane N.; Voth, Jennifer; Kastner, Monika; Nelson, Michelle L. A.; Jaglal, Susan B.; Salbach, Nancy M.; Wilcock, Ruth; Thoms, Carla; Shepherd, John; Munce, Sarah E. P.			A Pilot Feasibility Randomized Controlled Trial on the Ontario Brain Injury Association Peer Support Program	JOURNAL OF CLINICAL MEDICINE			English	Article						peer support; traumatic brain injury; randomized controlled trial; mixed methods; joint display	SPINAL-CORD-INJURY; LONG-TERM ADJUSTMENT; SELF-EFFICACY; COMMUNITY INTEGRATION; CANCER-PATIENTS; INTERVENTIONS; VALIDITY; REHABILITATION; INDIVIDUALS; PEOPLE	Background: The long-term consequences of traumatic brain injury can create major barriers to community integration. Peer support represents a sustainable model of support across this transition. The objective of the current study was to determine the feasibility of conducting a randomized controlled trial on the Ontario Brain Injury Association Peer Support Program and the preliminary effectiveness of the program on community integration, mood, health-related quality of life, and self-efficacy; Methods: A pilot feasibility randomized controlled trial with an embedded qualitative component was conducted. Mentees with moderate-to-severe traumatic brain injury (n = 13) were randomized to a weekly intervention or waitlist control group. Interviews were conducted with a subset of mentees and peer mentors (n = 10). Integration of the quantitative and qualitative data was completed using a joint display approach; Results: No statistically significant results were found for community integration, mood, or self-efficacy; however, changes in these outcomes were accompanied by moderate-to-large effect sizes. Within health-related quality of life, the mean pain score of the intervention group was significantly lower than that of the control group at the two-month timepoint but not at completion. Interviews revealed proximal improvements in knowledge, skills, and goals, and identified two domains related to trial acceptability: (1) environmental context and resources, and (2) reinforcement; Conclusions: Given the conceivable importance of proximal improvements in domains such as knowledge, skills, and/or goals for the attainment of more distal outcomes, modifications to the existing Peer Support Program may be warranted. The introduction of program recommendations which promote discussion around particular domains may help facilitate long-term improvements in health outcomes.	[Levy, Ben B.] Univ Toronto, Temerty Fac Med, Toronto, ON M5S 1A8, Canada; [Levy, Ben B.; Luong, Dorothy; Bayley, Mark T.; Salbach, Nancy M.; Munce, Sarah E. P.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Bayley, Mark T.; Nelson, Michelle L. A.; Jaglal, Susan B.; Munce, Sarah E. P.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Bayley, Mark T.; Jaglal, Susan B.; Salbach, Nancy M.; Shepherd, John] Univ Toronto, Rehabil Sci Inst, Toronto, ON M5G 1V7, Canada; [Sweet, Shane N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada; [Sweet, Shane N.] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ H3S 1M9, Canada; [Voth, Jennifer] Hotel Dieu Grace Healthcare, Windsor, ON N9C 3Z4, Canada; [Kastner, Monika] North York Gen Hosp, Toronto, ON M2K 1E1, Canada; [Nelson, Michelle L. A.] Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Jaglal, Susan B.; Salbach, Nancy M.] Univ Toronto, Dept Phys Therapy, Toronto, ON M5G 1V7, Canada; [Wilcock, Ruth; Thoms, Carla] Ontario Brain Injury Assoc, St Catharines, ON L2V 4Y6, Canada; [Munce, Sarah E. P.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada		Munce, SEP (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada.; Munce, SEP (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada.; Munce, SEP (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada.	ben.levy@mail.utoronto.ca; dorothy.luong@uhn.ca; mark.bayley@uhn.ca; shane.sweet@mcgill.ca; jennifer.voth@hdgh.org; monika.kastner@nygh.on.ca; michelle.nelson@sinaihealthsystem.ca; susan.jaglal@utoronto.ca; nancy.salbach@utoronto.ca; rwilcock@obia.on.ca; cthoms@obia.on.ca; john.shepherd@mail.utoronto.ca; sarah.munce@uhn.ca		Levy, Ben/0000-0002-3391-6387	Ontario Neurotrauma Foundation [2017ABI-OBIA-1036]	This research was funded by the Ontario Neurotrauma Foundation, grant number 2017ABI-OBIA-1036.	Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Bagnall AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1584-x; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bartone PT, 2019, OMEGA-J DEATH DYING, V80, P137, DOI 10.1177/0030222817728204; Boschen K., 2012, ONTARIO BRAIN INJURY; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Bradt J, 2015, SUPPORT CARE CANCER, V23, P1261, DOI 10.1007/s00520-014-2478-7; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bray G. M., 2014, MAPPING CONNECTIONS; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; De Vinney DJ, 2000, EFFECTS PEER MENTORI; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Eldridge SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150205; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Ford P, 2013, INT J ENV RES PUB HE, V10, P5507, DOI 10.3390/ijerph10115507; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Guetterman TC, 2015, ANN FAM MED, V13, P554, DOI 10.1370/afm.1865; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Harrison PL, 2008, PRACT RESOUR MENT, P37, DOI 10.1016/B978-012373586-7.00003-5; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Heisler M., 2007, DIABETES SPECTR, V20, P214; Hughes R, 2020, BRAIN INJURY, V34, P847, DOI 10.1080/02699052.2020.1762002; Kelly EH, 2007, REHABIL PSYCHOL, V52, P226, DOI 10.1037/0090-5550.52.2.226; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lenhard W, 2016, COMPUTATION EFFECT S; Levy B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4110-5; Ljungberg I, 2011, J CLIN NURS, V20, P351, DOI 10.1111/j.1365-2702.2010.03432.x; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; Munce S., 2019, BRAIN INJURY, V33, P1, DOI [10.1080/02699052.2019.1608749, DOI 10.1080/02699052.2019.1608749]; Munce SEP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023367; Newby TA, 2015, PSYCHO-ONCOLOGY, V24, P1686, DOI 10.1002/pon.3781; O'Cathain A., 2018, INTEGRATING QUALITAT; Ontario Brain Injury Association, 2017, GET CONN PEER SUPP; Ontario Brain Injury Association, 2017, ONT BRAIN INJ ASS PE; Patil SJ, 2016, ANN FAM MED, V14, P540, DOI 10.1370/afm.1982; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Sokol R., 2016, AM J PUBLIC HEALTH, V106, P1308, DOI [10.2105/AJPH.2016.303180a, DOI 10.2105/AJPH.2016.303180A]; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TEASDALE G, 1974, LANCET, V2, P81; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160; Young J M, 1999, Healthc Manage Forum, V12, P51	53	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUL	2021	10	13							2913	10.3390/jcm10132913			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG0ED	WOS:000671085300001	34210061	Green Published, gold			2022-02-07	
J	Lexell, J; Loven, G; Fagher, K				Lexell, Jan; Loven, Gustav; Fagher, Kristina			Incidence of sports-related concussion in elite para athletes - a 52-week prospective study	BRAIN INJURY			English	Article						Athletic injuries; brain concussion; epidemiology; para-athletes; sports for persons with disabilities	PROSPECTIVE COHORT; PARALYMPIC GAMES; EPIDEMIOLOGY; INJURY; RISK	Objective: To assess the 52-week incidence proportion and incidence rate of sports-related concussion (SRC) among elite Para athletes, and to analyze the injury mechanisms. Method: In total, 70 male and 37 female Swedish elite Para athletes (median age 29 years) with vision, physical and intellectual impairment, weekly self-reported sports-related injuries including concussion in an eHealth application adapted to Para athletes. Descriptive statistics were used to assess the incidence rate and incidence proportion. Chi-square statistics were used to analyze differences in the proportion of SRC. Results: A total of 13 SRC were reported: three athletes each sustained two SRC. The incidence proportion was 9.3% (95% CI 4.8-16.7), and the incidence rate 0.5 SRC/1000 hours (95% CI 0.3-0.9) of sports exposure. Athletes with vision impairment and female athletes reported a significantly higher proportion of SRC. A majority of the injuries (n = 9; 69%) occurred during sport-specific training. The injury mechanisms were collision with object (n = 7; 54%), collision with person (n = 4; 31%), and poor playing field conditions (n = 2; 16%). Conclusion: The incidence of concussion among elite Paralympic athletes is comparable to sports for able-bodied athletes. Athletes with vision impairment and female athletes reported a significantly higher incidence of SRC, and collisions were the most common injury mechanism. These results can form the basis for future preventive research studies.	[Lexell, Jan; Loven, Gustav; Fagher, Kristina] Lund Univ, Dept Hlth Sci, Rehabil Med Res Grp, POB 157, S-22100 Lund, Sweden; [Lexell, Jan] Skane Univ Hosp, Dept Rehabil Med, Lund, Sweden		Lexell, J (corresponding author), Lund Univ, Dept Hlth Sci, Rehabil Med Res Grp, POB 157, S-22100 Lund, Sweden.	jan.lexell@med.lu.se		Lexell, Jan/0000-0001-5294-3332	Swedish Research Council for Sport Science [FO20190010, P2020128]	This work was supported by The The Swedish Research Council for Sport Science (Grant Number: FO20190010 and P2020128).	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Barth JT, 2015, BRAIN INJURY, V29, P127, DOI 10.3109/02699052.2014.977350; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Derman W, 2016, BRIT J SPORT MED, V50, P1069, DOI 10.1136/bjsports-2016-096214; Derman W, 2019, BRIT J SPORT MED, V53, P1099, DOI 10.1136/bjsports-2018-100096; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Fagher K, 2014, SCAND J MED SCI SPOR, V24, pE320, DOI 10.1111/sms.12175; Fagher K, 2020, SCAND J MED SCI SPOR, V30, P1457, DOI 10.1111/sms.13687; Fagher K, 2020, PM&R, V12, P271, DOI 10.1002/pmrj.12211; Fagher Kristina, 2017, JMIR Hum Factors, V4, pe30, DOI 10.2196/humanfactors.8117; Fagher K, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0053-x; Griffin S, 2017, BR J SPORTS MED, V51, P325, DOI [10.1136/bjsports-2016-097372.106, DOI 10.1136/BJSPORTS-2016-097372.106]; Kissick J, 2018, PHYS MED REH CLIN N, V29, P299, DOI 10.1016/j.pmr.2018.01.002; Langelaan M, 2007, OPHTHAL EPIDEMIOL, V14, P119, DOI 10.1080/09286580601139212; Lexell J., 2021, BRIT J SPORT MED, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Ptito, 2017, COMPLETE GUIDE RECOV; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Vanlandewijck Y.C., 2016, TRAINING COACHING PA; Webborn N, 2018, BRIT J SPORT MED, V52, P1157, DOI 10.1136/bjsports-2016-097236; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; West LR, 2017, BRIT J SPORT MED, V51, P1050, DOI 10.1136/bjsports-2016-096767; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					971	977		10.1080/02699052.2021.1942551		JUL 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000668007700001	34185611	hybrid			2022-02-07	
J	Lim, CC; Saniasiaya, J; Kulasegarah, J				Lim, Chee Chean; Saniasiaya, Jeyasakthy; Kulasegarah, Jeyanthi			Postauricular swelling secondary to salmonella extradural abscess in a toddler: a near miss condition	BMJ CASE REPORTS			English	Article						ear; nose and throat; otolaryngology; paediatrics	HEAD; INFANTS; INJURY	Postauricular swelling is usually encountered in an emergency setting in otorhinolaryngology, resulting from complication of acute or chronic suppurative otitis media. Besides that, postauricular swelling may occur secondary to various other conditions including infectious disease, tumour, vascular malformation, granulomatous condition and even trauma. Children less than 2 years old are prone to fall and up to 10% sustain traumatic brain injury without any obvious signs of neurological deficit. We describe a rare case of a postauricular swelling in a toddler which turned out to be salmonella extradural abscess from an infected traumatic haematoma. The importance of high clinical suspicion especially in a child with a history of fall cannot be emphasised more because a missed brain abscess could lead to potentially life-threatening problems. We would like to highlight that meticulous history taking along with prompt assessment and intervention is prudent for a better prognosis and recovery.	[Lim, Chee Chean; Saniasiaya, Jeyasakthy; Kulasegarah, Jeyanthi] Univ Malaya, Fac Med, Otorhinolaryngol, Kuala Lumpur, Malaysia		Saniasiaya, J (corresponding author), Univ Malaya, Fac Med, Otorhinolaryngol, Kuala Lumpur, Malaysia.	shakthy_18@yahoo.com	Saniasiaya, Jeyasakthy/AAC-4950-2021	Saniasiaya, Jeyasakthy/0000-0003-1974-4379; Kulasegarah, Jeyanthi/0000-0001-8021-7864			Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Freni F, 2019, ACTA MEDICA MEDITERR, V35, P405, DOI 10.19193/0393-6384_2019_1_66; Heyman R, 2005, NEUROSURGERY, V57, P924, DOI 10.1227/01.NEU.0000180026.73246.bf; Intan HI, 2008, SINGAP MED J, V49, pE186; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuruvath S, 2008, INT J INFECT DIS, V12, P298, DOI 10.1016/j.ijid.2007.02.004; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ponnambath DK., 2019, J ACAD CLIN MICROBIO, V21, P85; Schutzman SA, 2021, ACAD EMERG MED, V28, P92, DOI 10.1111/acem.14087; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sudhaharan S, 2014, J INFECT DEV COUNTR, V8, P831, DOI 10.3855/jidc.3731; Yen M H, 1999, J Microbiol Immunol Infect, V32, P289	15	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JUL	2021	14	7							e243412	10.1136/bcr-2021-243412			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TH1GE	WOS:000671841900010	34210704				2022-02-07	
J	Lindstrom, MR; Chavez, MB; Gross-Sable, EA; Hayden, EY; Teplow, DB				Lindstrom, Michael R.; Chavez, Manuel B.; Gross-Sable, Elijah A.; Hayden, Eric Y.; Teplow, David B.			From reaction kinetics to dementia: A simple dimer model of Alzheimer's disease etiology	PLOS COMPUTATIONAL BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; DOWN-SYNDROME; ENCEPHALOPATHY; A-BETA(1-42); OLIGOMERS; RISK; AGE	Author summary Oligomeric assemblies of A beta are hypothesized to be seminal pathologic agents in Alzheimer's disease (AD). Mechanistic studies of oligomerization and neurotoxicity in humans are currently impossible, yet such studies promise to advance efforts toward target identification and drug development. To overcome this hurdle, we developed a simple, mathematical model parameterized using experimental data extant. The model couples the kinetics of oligomerization with oligomer toxicity and enables determination of age-related changes in AD risk and hippocampal volume, the effects of traumatic brain injury on lifetime AD risk, gene dosage effects, and the effects of spatial variation in A beta monomer concentrations on millimeter scales. The model is easily interpretable and provides a foundation for development of more comprehensive models of AD development and progression. Oligomers of the amyloid beta-protein (A beta) have been implicated in the pathogenesis of Alzheimer's disease (AD) through their toxicity towards neurons. Understanding the process of oligomerization may contribute to the development of therapeutic agents, but this has been difficult due to the complexity of oligomerization and the metastability of the oligomers thus formed. To understand the kinetics of oligomer formation, and how that relates to the progression of AD, we developed models of the oligomerization process. Here, we use experimental data from cell viability assays and proxies for rate constants involved in monomer-dimer-trimer kinetics to develop a simple mathematical model linking A beta assembly to oligomer-induced neuronal degeneration. This model recapitulates the rapid growth of disease incidence with age. It does so through incorporation of age-dependent changes in rates of A beta monomer production and elimination. The model also describes clinical progression in genetic forms of AD (e.g., Down's syndrome), changes in hippocampal volume, AD risk after traumatic brain injury, and spatial spreading of the disease due to foci in which A beta production is elevated. Continued incorporation of clinical and basic science data into the current model will make it an increasingly relevant model system for doing theoretical calculations that are not feasible in biological systems. In addition, terms in the model that have particularly large effects are likely to be especially useful therapeutic targets.	[Lindstrom, Michael R.; Chavez, Manuel B.; Gross-Sable, Elijah A.] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Hayden, Eric Y.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Lindstrom, MR (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA.	mikel@math.ucla.edu		Hayden, Eric/0000-0001-6977-5056; Teplow, David/0000-0002-2389-3417			[Anonymous], 2019, Alzheimer's Disease Fact Sheet; Bernstein M. A., 2006, REGIONAL DIFFERENCES; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P981, DOI 10.1016/j.jalz.2018.03.005; Calvo-Rodriguez M, 2016, J ALZHEIMERS DIS, V54, P207, DOI 10.3233/JAD-151189; Chen XQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00659; Cheon MS, 2008, AMINO ACIDS, V35, P339, DOI 10.1007/s00726-007-0618-9; Chuang E, 2018, J CELL SCI, V131, DOI 10.1242/jcs.189928; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; Cummings J, 2019, ALZH DEMENT-TRCI, V5, P272, DOI 10.1016/j.trci.2019.05.008; Dear AJ, 2020, P NATL ACAD SCI USA, V117, P12087, DOI 10.1073/pnas.1922267117; Del Ferraro G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04718-3; Desikan RS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002258; Doherty Benjamin M, 2015, Alzheimers Dement (Amst), V1, P160; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fitzpatrick AL, 2005, J NEUROL SCI, V229, P43, DOI 10.1016/j.jns.2004.11.022; Franko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071354; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; Gordon BA, 2016, JAMA NEUROL, V73, P1192, DOI 10.1001/jamaneurol.2016.2642; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hansson O, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0485-0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasecke F, 2018, CHEM SCI, V9, P5937, DOI 10.1039/c8sc01479e; Hayden EY, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt226; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Meriaux S, 2018, FRONT PHYS-LAUSANNE, V6, DOI 10.3389/fphy.2018.00038; Michaels TC., 2020, NAT CHEM, P1; Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Nistor A, 2007, NEUROBIOL AGING, V28, P1493, DOI 10.1016/j.neurobiolaging.2006.06.023; NORDEN RH, 1972, INT STAT REV, V40, P329, DOI 10.2307/1402471; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; OYAMA F, 1994, J NEUROCHEM, V62, P1062; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Pistollato F, 2016, ADV NUTR, V7, P679, DOI 10.3945/an.115.011775; Raskatov JA, 2019, CHEMBIOCHEM, V20, P1725, DOI 10.1002/cbic.201900097; Rinne H., 2014, HAZARD RATE THEORY I; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith AJ, 2018, FASEB J, V32, P543, DOI 10.1096/fj.201700999; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Sturm KT, 2003, HEAT KERNELS ANAL MA, V338, P357; The World Bank, 2019, LIF EXP; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yamazaki Y, 2019, NAT REV NEUROL, V15, P501, DOI 10.1038/s41582-019-0228-7; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	66	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	JUL	2021	17	7							e1009114	10.1371/journal.pcbi.1009114			24	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	TP6NL	WOS:000677714200006	34280181	gold, Green Published			2022-02-07	
J	Liu, CH; Sung, PS; Li, YR; Huang, WK; Lee, TW; Huang, CC; Lee, TH; Chen, TH; Wei, YC				Liu, Chi-Hung; Sung, Pi-Shan; Li, Yan-Rong; Huang, Wen-Kuan; Lee, Tay-Wey; Huang, Chin-Chang; Lee, Tsong-Hai; Chen, Tien-Hsing; Wei, Yi-Chia			Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study	PLOS MEDICINE			English	Article							BLOOD-PRESSURE VARIABILITY; ACTIVATED RECEPTOR-GAMMA; COGNITIVE PERFORMANCE; PREVENTING DEMENTIA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; NATIONAL-HEALTH; ISCHEMIC-STROKE; LATE-LIFE; PIOGLITAZONE	Author summary Why was this study done? The drug of choice for antihypertensive treatment, and its association with dementia in patients with both type 2 diabetes mellitus (T2DM) and hypertension, is a valid question worthy of further investigations. Angiotensin receptor blockers (ARBs) modulate the renin-angiotensin-aldosterone system and potentially associate with cognitive preservation, but internal comparisons of the cognitive protective effects of different ARBs have not previously been performed. Telmisartan is the only ARB that, at a clinical dose, has agonistic effects on peroxisome proliferator-activated receptor gamma (PPAR-gamma), which maintains insulin sensitivity, reduces insulin resistance, and potentially has a protective impact on dementia. What did the researchers do and find? Using the electronic health records of the National Health Insurance Research Database of Taiwan between 1997 and 2013, we studied whether telmisartan was associated with a lower incidence of dementia compared to other ARBs in patients with T2DM and hypertension. Using telmisartan was associated with a lower risk of dementia diagnosis compared to using non-telmisartan ARBs (2.19% versus 3.20%). What do these findings mean? Telmisartan use in hypertensive T2DM patients may be associated with a lower risk of dementia and any ischemic stroke events in an East-Asian population. Further work will be needed to investigate the observed association, owing to the limitations inherent in this observational study. Background Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN). However, whether telmisartan, an ARB with peroxisome proliferator-activated receptor gamma (PPAR-gamma)-modulating effects, has additional benefits compared to other ARBs remains unclear. Methods and findings Between 1997 and 2013, 2,166,944 type 2 diabetes mellitus (T2DM) patients were identified from the National Health Insurance Research Database of Taiwan. Patients with HTN using ARBs were included in the study. Patients with a history of stroke, traumatic brain injury, or dementia were excluded. Finally, 65,511 eligible patients were divided into 2 groups: the telmisartan group and the non-telmisartan ARB group. Propensity score matching (1:4) was used to balance the distribution of baseline characteristics and medications. The primary outcome was the diagnosis of dementia. The secondary outcomes included the diagnosis of Alzheimer disease and occurrence of symptomatic ischemic stroke (IS), any IS, and all-cause mortality. The risks between groups were compared using a Cox proportional hazard model. Statistical significance was set at p < 0.05. There were 2,280 and 9,120 patients in the telmisartan and non-telmisartan ARB groups, respectively. Patients in the telmisartan group had a lower risk of dementia diagnosis (telmisartan versus non-telmisartan ARBs: 2.19% versus 3.20%; HR, 0.72; 95% CI, 0.53 to 0.97; p = 0.030). They also had lower risk of dementia diagnosis with IS as a competing risk (subdistribution HR, 0.70; 95% CI, 0.51 to 0.95; p = 0.022) and with all-cause mortality as a competing risk (subdistribution HR, 0.71; 95% CI, 0.53 to 0.97; p = 0.029). In addition, the telmisartan users had a lower risk of any IS (6.84% versus 8.57%; HR, 0.79; 95% CI, 0.67 to 0.94; p = 0.008) during long-term follow-up. Study limitations included potential residual confounding by indication, interpretation of causal effects in an observational study, and bias caused by using diagnostic and medication codes to represent real clinical data. Conclusions The current study suggests that telmisartan use in hypertensive T2DM patients may be associated with a lower risk of dementia and any IS events in an East-Asian population.	[Liu, Chi-Hung; Huang, Chin-Chang; Lee, Tsong-Hai] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Liu, Chi-Hung; Li, Yan-Rong; Huang, Wen-Kuan; Huang, Chin-Chang; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Sung, Pi-Shan] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan; [Li, Yan-Rong] Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Taoyuan, Taiwan; [Huang, Wen-Kuan] Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taoyuan, Taiwan; [Lee, Tay-Wey] Keelung Chang Gung Mem Hosp, Biostat Consultat Ctr, Keelung, Taiwan; [Chen, Tien-Hsing] Chang Gung Univ, Keelung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol,Coll Med, Keelung, Taiwan; [Wei, Yi-Chia] Keelung Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan; [Wei, Yi-Chia] Natl Yang Ming Chiao Tung Univ, Inst Neurosci, Taipei, Taiwan; [Wei, Yi-Chia] Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan		Chen, TH (corresponding author), Chang Gung Univ, Keelung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol,Coll Med, Keelung, Taiwan.; Wei, YC (corresponding author), Keelung Chang Gung Mem Hosp, Dept Neurol, Keelung, Taiwan.; Wei, YC (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Neurosci, Taipei, Taiwan.; Wei, YC (corresponding author), Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	skyheart0826@gmail.com; yichiawei@gmail.com		Sung, Pi-shan/0000-0003-2505-7583; Huang, Wen-Kuan/0000-0001-7789-8347; Wei, Yi-Chia/0000-0001-6085-3134	Ministry of Science and Technology [MOST 108-2314-B-182A-050 -MY1-3]; Chang Gung Memorial Hospital Research Project (CMRP) grant [CMRPG3F, CFRPG3L0011, BMRPF99]; CMRP grant [CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, CLRPG2G0081]	CHL was supported by the Ministry of Science and Technology grant MOST 108-2314-B182A-050 -MY1-3 and the Chang Gung Memorial Hospital Research Project (CMRP) grant CMRPG3F, CFRPG3L0011, and BMRPF99. THC and the Maintenance Project at the Biostatistical Consultation Center at Chang Gung Memorial Hospital were supported by the CMRP grant CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, and CLRPG2G0081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Abhari S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2856; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Beam CR, 2018, J ALZHEIMERS DIS, V64, P1077, DOI [10.3233/JAD-180141, 10.3233/jad-180141]; Beeri MS, 2004, NEUROLOGY, V63, P1902, DOI 10.1212/01.WNL.0000144278.79488.DD; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chen TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175475; Chou PS, 2017, J DIABETES COMPLICAT, V31, P1053, DOI 10.1016/j.jdiacomp.2017.01.006; de Menezes ST, 2021, HYPERTENSION, V77, P672, DOI 10.1161/HYPERTENSIONAHA.120.16080; Deng XL, 2017, METAB BRAIN DIS, V32, P1323, DOI 10.1007/s11011-017-0050-0; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diener HC, 2009, J HYPERTENS, V27, pS31, DOI 10.1097/01.hjh.0000357906.60778.7f; Ding J, 2020, LANCET NEUROL, V19, P61, DOI 10.1016/S1474-4422(19)30393-X; Drew DA, 2019, AM J KIDNEY DIS, V74, P782, DOI 10.1053/j.ajkd.2019.05.017; Ernsberger P, 2007, CURR OPIN PHARMACOL, V7, P140, DOI 10.1016/j.coph.2006.11.008; Evans CE, 2020, ACTA NEUROPATHOL, V139, P485, DOI 10.1007/s00401-019-02098-6; Fabia MJ, 2007, J HYPERTENS, V25, P1327, DOI 10.1097/HJH.0b013e3280825625; Fang T, 2018, BIOCHEM BIOPH RES CO, V503, P3044, DOI 10.1016/j.bbrc.2018.08.091; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Frosch OH, 2017, NEUROLOGY, V89, P249, DOI 10.1212/WNL.0000000000004110; Gairolla J, 2017, REV NEUROSCIENCE, V28, P295, DOI 10.1515/revneuro-2016-0055; Galimberti D, 2017, EXPERT OPIN INV DRUG, V26, P97, DOI 10.1080/13543784.2017.1265504; Galzerano D, 2010, VASC HEALTH RISK MAN, V6, P113; Gao Y, 2018, J STROKE CEREBROVASC, V27, P277, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.025; George MG, 2020, STROKE, V51, P729, DOI 10.1161/STROKEAHA.119.024156; Gerstein HC, 2016, DIABETES CARE, V39, P701, DOI 10.2337/dc15-2283; Hachinski V, 2019, ALZHEIMERS DEMENT, V15, P961, DOI 10.1016/j.jalz.2019.06.001; Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0019; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang WK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15189; Hughes D, 2020, JAMA-J AM MED ASSOC, V323, P1934, DOI 10.1001/jama.2020.4249; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Kaundal RK, 2010, DRUG NEWS PERSPECT, V23, P241, DOI 10.1358/dnp.2010.23.4.1437710; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Khan MA, 2019, CURR NEUROPHARMACOL, V17, P232, DOI 10.2174/1570159X16666180828100002; Kishi T, 2012, J CARDIOL, V60, P489, DOI 10.1016/j.jjcc.2012.08.004; Lane CA, 2019, LANCET NEUROL, V18, P942, DOI 10.1016/S1474-4422(19)30228-5; Lee M, 2017, STROKE, V48, P388, DOI 10.1161/STROKEAHA.116.013977; Lee TL, 2020, J ALZHEIMERS DIS, V73, P297, DOI 10.3233/JAD-190762; Leung LY, 2017, ARTERIOSCL THROM VAS, V37, P1579, DOI 10.1161/ATVBAHA.117.309298; Liu CH, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-019-0979-x; Liu CH, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418802688; Liu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010693.pub4; Ma Y, 2020, J AM COLL CARDIOL, V75, P2387, DOI 10.1016/j.jacc.2020.03.043; McGrath ER, 2017, NEUROLOGY, V89, P2447, DOI 10.1212/WNL.0000000000004741; Mori D, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0829-x; O'Caoimha R, 2014, J ALZHEIMERS DIS, V42, pS575, DOI 10.3233/JAD-141284; Ohishi M, 2018, HYPERTENS RES, V41, P389, DOI 10.1038/s41440-018-0034-4; Oishi E, 2017, CIRCULATION, V136, P516, DOI [10.1161/CIRCULATIONAHA.116.025667, 10.1161/circulationaha.116.025667]; Ormazabal V, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0762-4; Pantoni L, 2019, JAMA NEUROL, V76, P521, DOI 10.1001/jamaneurol.2018.4406; Petek B, 2018, J INTERN MED, V284, P620, DOI 10.1111/joim.12838; Peters R, 2020, NEUROLOGY, V94, pE267, DOI 10.1212/WNL.0000000000008732; Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005; Rajan KB, 2018, ANN NEUROL, V83, P935, DOI 10.1002/ana.25228; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Sogunuru GP, 2019, J CLIN HYPERTENS, V21, P324, DOI 10.1111/jch.13451; Spence JD, 2020, STROKE, V51, P3770, DOI 10.1161/STROKEAHA.120.031707; Spence JD, 2004, HYPERTENSION, V44, P20, DOI 10.1161/01.HYP.0000132374.90924.2a; Sueta D, 2014, AM J HYPERTENS, V27, P1464, DOI 10.1093/ajh/hpu076; Suhr JA, 2004, PSYCHOSOM MED, V66, P291, DOI 10.1097/01.psy.0000127870.64234.9f; Sutherland GT, 2017, J ALZHEIMERS DIS, V59, P393, DOI 10.3233/JAD-161194; Takagi H, 2014, J AM SOC HYPERTENS, V8, P578, DOI 10.1016/j.jash.2014.05.006; Towfighi A, 2008, CEREBROVASC DIS, V26, P106, DOI 10.1159/000139656; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; van Middelaar T, 2018, J HYPERTENS, V36, P1780, DOI 10.1097/HJH.0000000000001829; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wago T, 2010, HYPERTENS RES, V33, P796, DOI 10.1038/hr.2010.107; Wang Y, 2018, AM J THER, V25, pE642, DOI 10.1097/MJT.0000000000000733; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Yaffe K, 2014, CIRCULATION, V129, P1560, DOI 10.1161/CIRCULATIONAHA.113.004798; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	78	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	JUL	2021	18	7							e1003707	10.1371/journal.pmed.1003707			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TK9KF	WOS:000674473000001	34280191	Green Published, gold			2022-02-07	
J	Lo-Cao, E; Hall, S; Parsell, R; Dandie, G; Fahlstrom, A				Lo-Cao, Edward; Hall, Samuel; Parsell, Ruth; Dandie, Gordon; Fahlstroem, Andreas			Neurogenic pulmonary edema	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							END-EXPIRATORY PRESSURE	Aim: We report a case of neurogenic pulmonary edema in a patient who sustained a severe traumatic brain injury in a motorbike accident and review the current literature with regards to the management of neurogenic pulmonary edema (NPE). Methods: A 17 year old male was involved in a motorbike collision into a tree. Copious amounts of pink frothy sputum was noted on scene. Rapid sequence intubation was performed on scene and video laryngoscopy demonstrated profuse frothy secretions welling up from the larynx. Results: The patient underwent emergency external ventricular drain insertion for intracranial pressure (ICP) monitoring. Intracranial pressures remained refractorily high and a decompressive bifrontal craniectomy was performed on the subsequent day. He was tracheostomised on admission day 24 and discharged from ICU on day 34. Discussion: Neurogenic pulmonary edema is defined as acute respiratory distress triggered by severe sympathetic discharge from acute compromise in the central nervous system. Rapid intervention with intubation is often necessary to protect the airways and facilitate diagnostic evaluation. Reduction of ICP and supportive mechanical ventilation to improve oxygenation is necessary. Positive end-expiratory pressure should be carefully applied to balance recruitment of alveoli and minimisation of ICP. Although NPE is estimated to resolve within 72 h in more than half of patients, prognosis is generally poor due to the severity of the underlying brain injury, with estimated mortality rates of between 60 and 100%. Conclusion: Neurogenic pulmonary edema is a potentially life-threatening complication of severe brain injury and should be recognised early to facilitate management. (C) 2020 Elsevier Inc. All rights reserved.	[Lo-Cao, Edward; Hall, Samuel; Dandie, Gordon; Fahlstroem, Andreas] Westmead Hosp, Dept Neurosurg, Hawkesbury Rd, Westmead, NSW 2145, Australia; [Lo-Cao, Edward] Univ Sydney, Camperdown, NSW 2006, Australia; [Parsell, Ruth] Nepean Hosp, Emergency Dept, Derby St, Kingswood, NSW 2747, Australia; [Parsell, Ruth] CareFlight Rapid Response Helicopter, Redbank Rd, Northmead, NSW 2152, Australia; [Fahlstroem, Andreas] Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci, Neurosurg, S-75185 Uppsala, Sweden		Lo-Cao, E (corresponding author), Westmead Hosp, Dept Neurosurg, Hawkesbury Rd, Westmead, NSW 2145, Australia.	eloc9697@uni.sydney.edu.au	Fahlstrom, Andreas/ABA-6675-2021	Fahlstrom, Andreas/0000-0002-0298-8775; Hall, Samuel/0000-0003-3677-4182			Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Finsterer J, 2019, EUR NEUROL, V81, P94, DOI 10.1159/000500139; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; Hall Sean RR, 2002, ANESTH ANALG, V94; Hegde A, 2017, BRAIN INJURY, V31, P127, DOI 10.1080/02699052.2016.1219388; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Inamasu J, 2012, NEUROL MED-CHIR, V52, P49, DOI 10.2176/nmc.52.49; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; Muroi C, 2008, J NEUROSURG ANESTH, V20; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; van Bussel B, 2018, BMJ CASE REP, V2018	14	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45								678.e3	10.1016/j.ajem.2020.11.052			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TM2UG	WOS:000675406300018	33308892				2022-02-07	
J	Lopez-Caperuchipi, S; Kurzinger, L; Hopp-Kramer, S; Albert-Weissenberger, C; Paul, MM; Siren, AL; Stetter, C				Lopez-Caperuchipi, Simon; Kuerzinger, Lydia; Hopp-Kraemer, Sarah; Albert-Weissenberger, Christiane; Paul, Mila M.; Siren, Anna-Leena; Stetter, Christian			Posttraumatic learning deficits correlate with initial trauma severity and chronic cellular reactions after closed head injury in male mice	EXPERIMENTAL NEUROLOGY			English	Article						Neuroinflammation; TBI; IBA-1; GFAP; Weight drop; IntelliCage; Memory and learning; Handedness	BRAIN-INJURY; SEX-DIFFERENCES; INHERITANCE; HANDEDNESS; MODEL	Traumatic brain injury (TBI) is often associated with sustained attention and memory deficits. As persisting neuroinflammation and neurodegeneration may contribute to posttraumatic psychomotor dysfunction, we studied the relationship of brain cellular reactions three months after a weight-drop closed head injury in male mice with posttraumatic learning and memory using automated home-cage monitoring of socially housed mice in IntelliCages as well as tests for locomotor activity, anxiety and forepaw fine motor skills. One month after TBI, deficits in place learning and cognitive flexibility in reverse learning were clearly detectable in IntelliCages and these memory deficits correlated with the initial trauma severity on the functional neuroscore. While sucrose preference or its extinction were not influenced by TBI, traumatized mice performed significantly worse in a complex episodic memory learning task. In consecutive locomotor and forepaw skilled use tests, posttraumatic hyperactivity and impairment of contralateral paw use were evident. Analysis of cellular reactions to TBI three months after injury in selected defined regions of interest in the immediate lesion, ipsi- and contralateral frontoparietal cortex and hippocampus revealed a persistent microgliosis and astrogliosis which were accompanied by iron-containing macrophages and myelin degradation in the lesion area as well as with axonal damage in the neighboring cortical regions. Microglial and astroglial reactions in cortex showed a positive correlation with the initial trauma severity and a negative correlation with the spatial and episodic memory indicating a role of brain inflammatory reactions in posttraumatic memory deficits.	[Lopez-Caperuchipi, Simon; Kuerzinger, Lydia; Hopp-Kraemer, Sarah; Albert-Weissenberger, Christiane; Paul, Mila M.; Siren, Anna-Leena; Stetter, Christian] Univ Hosp Wurzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Kuerzinger, Lydia; Albert-Weissenberger, Christiane; Paul, Mila M.] Julius Maximilians Univ, Inst Physiol, Dept Neurophysiol, Rontgenring 9, D-97070 Wurzburg, Germany; [Paul, Mila M.] Univ Hosp Wurzburg, Dept Trauma Hand Plast & Reconstruct Surg, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany; [Albert-Weissenberger, Christiane] Helmholtz Inst RNA Based Infect Res, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany		Siren, AL (corresponding author), Univ Hosp Wurzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	lydia.kuerzinger@uni-wuerzburg.de; hopp_c@ukw.de; christiane.albert-weissenberger@uni-wuerzburg.de; Paul_M1@ukw.de; siren_a@ukw.de; stetter_c@ukw.de	Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081	German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EW1502B]; Interdisciplinary Clinical Research Center (IZKF) Wurzburg [E313, Z3/69]	Funding statement This work was supported by the German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame (BMBF 01EW1502B) and the Interdisciplinary Clinical Research Center (IZKF) Wurzburg (E313, Z3/69) .	Albert-Weissenberger C., 2012, EXP TRANSL STROKE ME, V4; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; COLLINS RL, 1969, J HERED, V60, P117, DOI 10.1093/oxfordjournals.jhered.a107951; COLLINS RL, 1968, J HERED, V59, P9, DOI 10.1093/oxfordjournals.jhered.a107656; Dere E, 2018, NEUROBIOL LEARN MEM, V150, P136, DOI 10.1016/j.nlm.2018.02.023; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kiryk A, 2020, BEHAV BRAIN RES, V388, DOI 10.1016/j.bbr.2020.112620; Lenhard W, 2016, COMPUTATION EFFECT S; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Vogel A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71879-x; Vu PA, 2021, BRAIN RES, V1750, DOI 10.1016/j.brainres.2020.147147; Wilhelmsson U, 2019, BIOL CHEM, V400, P1147, DOI 10.1515/hsz-2019-0199; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	25	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2021	341								113721	10.1016/j.expneurol.2021.113721			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SU9BX	WOS:000663426200004	33852877				2022-02-07	
J	MacGregor, AJ; Dougherty, AL; McCabe, CT; Watrous, JR				MacGregor, Andrew J.; Dougherty, Amber L.; McCabe, Cameron T.; Watrous, Jessica R.			Trajectory of self-rated health after combat-related injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Combat-related injury; Self-rated health; Military	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MILITARY PERSONNEL; VETERANS; IRAQ; RESILIENCE; DEPLOYMENT; BATTLE	Background: The U.S. military conflicts in Iraq and Afghanistan yielded the most combat casualties since Vietnam. With more service members than ever surviving their wounds, prospective research on factors related to long-term, patient-reported outcomes, including self-rated health (SRH), has increased importance. This study's objective was to use preinjury and postinjury SRH measures to identify trajectories and predictors of SRH after combat-related injury. Methods: The Wounded Warrior Recovery Project was queried for U.S. military personnel with combat-related injuries from Iraq or Afghanistan between 2004 and 2011. A single-item measure was used to assess SRH once prior to injury and twice after injury, and responses included excellent, very good, good, fair, or poor. Only those with good or better preinjury SRH levels were included. SRH trajectories were identified and defined. Multinomial logistic regression examined the association between injury-specific characteristics, post-traumatic stress disorder (PTSD), and SRH trajectory. Results: The study sample included 1,093 military personnel. Overall, 4 SRH trajectories were identified: (1) 56.7% resilient (preinjury SRH level was maintained throughout follow-up), (2) 9.4% recovered (SRH declined on first postinjury measure then returned to preinjury level), (3) 22.9% delayed (SRH declined only on second postinjury measure), and (4) 11.0% chronic (SRH declined on first postinjury measure and did not return to preinjury level). In multinomial logistic regression and relative to the resilient group, screening PTSD positive, serious-severe injury severity, and lower extremity injury predicted membership in the recovered and chronic groups, whereas back injury predicted membership in the chronic group only. Conclusion: This is the first study to examine long-term SRH trajectory following combat-related injury, finding that a majority of military personnel remain at their preinjury health levels of good or better. Decreases in postinjury SRH were associated with physical and psychological factors, which reinforces the need for a multidisciplinary approach to care. (C) 2021 Published by Elsevier Ltd.	[MacGregor, Andrew J.; Dougherty, Amber L.; McCabe, Cameron T.; Watrous, Jessica R.] Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA; [Dougherty, Amber L.; McCabe, Cameron T.; Watrous, Jessica R.] Leidos Inc, 140 Sylvester Rd, San Diego, CA 92106 USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	andrewmacgregor@protonmail.com; amber.l.dougherty.ctr@mail.mil; cameron.t.mccabe.ctr@mail.mil; jessica.r.watrous.ctr@mail.mil		MacGregor, Andrew/0000-0003-1020-7390; McCabe, Cameron/0000-0001-8395-9142	U.S. Navy Bureau of Medicine and Surgery [60808]; Department of Medical Modeling, Simulation and Mission Support at Naval Health Research Center	This report was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. 60808. We also acknowledge the research support from the Department of Medical Modeling, Simulation and Mission Support at Naval Health Research Center	Alghnam S, 2014, QUAL LIFE RES, V23, P119, DOI 10.1007/s11136-013-0444-3; Benyamini Y, 2009, PSYCHOSOM MED, V71, P345, DOI 10.1097/PSY.0b013e31819ccd10; Bilmes L, 2007, SOLDIERS RETURNING I; Bombak Andrea E, 2013, Front Public Health, V1, P15, DOI 10.3389/fpubh.2013.00015; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Britt, 2013, BUILDING PSYCHOL RES; Brooks SK, 2018, J MENT HEALTH, V27, P80, DOI 10.1080/09638237.2016.1276536; Clark Leslie L, 2015, MSMR, V22, P8; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Haddock CK, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-57; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Institute of Medicine, 2009, GULF WAR HLTH, V7; Isaacs K, 2017, J PSYCHIATR RES, V84, P301, DOI 10.1016/j.jpsychires.2016.10.017; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; MacGregor AJ, 2012, MIL MED, V177, P845, DOI 10.7205/MILMED-D-12-00021; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; Meredith L, 2011, PROMOTING PSYCHOL RE; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nindl BC, 2018, J SCI MED SPORT, V21, P1116, DOI 10.1016/j.jsams.2018.05.005; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Pons-Villanueva J, 2011, J TRAUMA, V70, P1072, DOI 10.1097/TA.0b013e3181eaad92; Porter B, 2019, AM J PREV MED, V57, P637, DOI 10.1016/j.amepre.2019.06.015; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Scholten AC, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0127-3; Trump DH, 2006, MIL MED, V171, P662, DOI 10.7205/MILMED.171.7.662; Watrous JR, 2020, HEALTH PSYCHOL, V39, P549, DOI 10.1037/hea0000850; Watrous JR, 2019, MIL MED, V184, P84, DOI 10.1093/milmed/usy243; Woodruff SI, 2018, QUAL LIFE RES, V27, P1393, DOI 10.1007/s11136-018-1806-7; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]	41	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2021	52	7					1721	1726		10.1016/j.injury.2021.04.026			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	SV7WM	WOS:000664029400014	34024636				2022-02-07	
J	MacGregor, AJ; Zouris, JM; Dougherty, AL; Dye, JL				MacGregor, Andrew J.; Zouris, James M.; Dougherty, Amber L.; Dye, Judy L.			Health Profiles of Military Women and the Impact of Combat-Related Injury	WOMENS HEALTH ISSUES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; VETERANS; BLAST; AFGHANISTAN; SOLDIERS; RISK; IRAQ	Purpose: The role of women in the United States military is expanding. Women are now authorized to serve in all military occupations, including special operations and frontline combat units, which places them at increased risk of combat exposure and injury. Little is known regarding the impact of these injuries on the health of military women. Methods: We conducted a retrospective matched cohort study of women service members who were injured during combat operations in Iraq and Afghanistan. Injured women were individually matched to non-injured controls at a 1:4 ratio. Medical diagnostic codes were abstracted from outpatient encounters in electronic health records, and hierarchical clustering was conducted to identify clusters of diagnostic codes, termed "health profiles." Conditional logistic regression was used to determine whether combat-related injury predicted membership in the profiles. Results: The study sample included 590 injured women and 2360 non-injured controls. Cluster analysis identified six post-deployment health profiles: low morbidity, anxiety/headache, joint disorders, mixed musculoskeletal, pregnancy related, and multimorbidity. Combat-related injury predicted membership in the anxiety/headache (odds ratio, 1.73; 95% confidence interval, 1.38-2.16) and multimorbidity (odds ratio, 3.43; 95% confidence interval, 2.65-4.43) profiles. Conclusions: Combat-related injury is associated with adverse post-deployment health profiles among military women, and women with these profiles may experience increased health care burden. As future conflicts will likely see a greater number of women with combat exposure and injury, health outcomes research among military women is paramount for the purposes of medical planning and resource allocation. (c) 2021 Published by Elsevier Inc. on behalf of Jacobs Institute of Women's Health.	[MacGregor, Andrew J.; Zouris, James M.; Dougherty, Amber L.; Dye, Judy L.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Dougherty, Amber L.; Dye, Judy L.] Leidos Inc, San Diego, CA USA		MacGregor, AJ (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	andrewmacgregor@protonmail.com		MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under work unit no. 60808. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center, Institutional Review Board protocol number NHRC.2003.0025.	Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Barry B, 2013, SURVIVAL, V55, P19, DOI 10.1080/00396338.2013.784461; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Blashfield R.K., 1984, CLUSTER ANAL; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Burnes T., 2008, CONTRIBUTIONS WOMEN; Commission on Professional Hospital Activities:, 1977, INT CLASSIFICATION D; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Department of Defense, 2019, DEF CAS AN SYST; Department of Defense, 2012, OFF SECR DEF PERS RE; Department of Defense (DoD), 2013, DEF DEP RESC DIR COM; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Dye JL, 2016, MIL MED, V181, P92, DOI 10.7205/MILMED-D-15-00237; Fraser J. J, BMC PUBLIC HLTH, V20, P578; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gwini SM, 2016, J OCCUP ENVIRON MED, V58, P659, DOI 10.1097/JOM.0000000000000755; Harding, 2012, WOMEN COMBAT ROLES C; Heathcare Cost and Utilization Project (HCUP), 2017, CLIN CLASSIFICATIONS; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; Joseph AR, 2018, AM J EPIDEMIOL, V187, P7, DOI 10.1093/aje/kwx199; Kamarck K. N, 2016, WOMEN COMBAT ISSUES; Katon JG, 2013, J REHABIL RES DEV, V50, P173, DOI 10.1682/JRRD.2012.01.0007; King A, 2013, RUSI J, V158, P4, DOI 10.1080/03071847.2013.774634; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulas JF, 2018, MIL MED, V183, pE114, DOI 10.1093/milmed/usx050; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2020, WOMEN HEALTH ISS, V30, P470, DOI 10.1016/j.whi.2020.08.004; MacGregor AJ, 2017, J WOMENS HEALTH, V26, P338, DOI 10.1089/jwh.2014.5130; MacGregor AJ, 2013, INJURY, V44, P1458, DOI 10.1016/j.injury.2012.10.009; Mayo JA, 2013, MIL MED, V178, P945, DOI 10.7205/MILMED-D-12-00527; Newcomer SR, 2011, AM J MANAG CARE, V17, pE324; Northwood M, 2018, J ADV NURS, V74, P45, DOI 10.1111/jan.13408; Reed AM, 2018, MIL MED, V183, pE304, DOI 10.1093/milmed/usx079; Rivera Jessica C, 2015, US Army Med Dep J, P74; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Salter M., 2014, TIME; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheppard C., 2007, WOMEN COMBAT; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilkinson C. W, 2018, FRONT NEUROL, V19, P2	43	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1049-3867	1878-4321		WOMEN HEALTH ISS	Womens Health Iss.	JUL-AUG	2021	31	4					392	398		10.1016/j.whi.2021.03.009			7	Public, Environmental & Occupational Health; Women's Studies	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Women's Studies	TG7AH	WOS:000671552500013	34059434				2022-02-07	
J	Maddux, AB; Sevick, C; Cox-Martin, M; Bennett, TD				Maddux, Aline B.; Sevick, Carter; Cox-Martin, Matthew; Bennett, Tellen D.			Novel Claims-Based Outcome Phenotypes in Survivors of Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; critical care; critical care outcomes; patient outcome assessment; pediatric; traumatic; wounds and injury	LATENT CLASS; CHILDREN; CARE; LIKELIHOOD; MORTALITY; EVENTS	Objective: For children hospitalized with acute traumatic brain injury (TBI), to use postdischarge insurance claims to identify: (1) healthcare utilization patterns representative of functional outcome phenotypes and (2) patient and hospitalization characteristics that predict outcome phenotype. Setting: Two pediatric trauma centers and a state-level insurance claim aggregator. Patients: A total of 289 children, who survived a hospitalization after TBI between 2009 and 2014, were in the hospital trauma registry, and had postdischarge insurance eligibility. Design: Retrospective cohort study. Main Measures: Unsupervised machine learning to identify phenotypes based on postdischarge insurance claims. Regression analyses to identify predictors of phenotype. Results: Median age 5 years (interquartile range 2-12), 29% (84/289) female. TBI severity: 30% severe, 14% moderate, and 60% mild. We identified 4 functional outcome phenotypes. Phenotypes 3 and 4 were the highest utilizers of resources. Morbidity burden was highest during the first 4 postdischarge months and subsequently decreased in all domains except respiratory. Severity and mechanism of injury, intracranial pressure monitor placement, seizures, and hospital and intensive care unit lengths of stay were phenotype predictors. Conclusions: Unsupervised machine learning identified postdischarge phenotypes at high risk for morbidities. Most phenotype predictors are available early in the hospitalization and can be used for prognostic enrichment of clinical trials targeting mitigation or treatment of domain-specific morbidities.	[Maddux, Aline B.] Univ Colorado, Sch Med, Sect Crit Care Med, Aurora, CO 80045 USA; [Maddux, Aline B.; Sevick, Carter; Cox-Martin, Matthew; Bennett, Tellen D.] Childrens Hosp Colorado, Aurora, CO USA; [Sevick, Carter; Cox-Martin, Matthew] Univ Colorado, Adult & Child Consortium Hlth Outcomes Res & Deli, Anschutz Med Campus, Aurora, CO 80045 USA; [Bennett, Tellen D.] Univ Colorado, Dept Pediat, Sect Informat & Data Sci, Sch Med, Aurora, CO 80045 USA; Denver Hlth Med Ctr, Denver, CO USA		Maddux, AB (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Pediat Crit Care, Educ 2 South,13121 East 17th Ave,MS 8414, Aurora, CO 80045 USA.	aline.maddux@childrenscolorado.org		Maddux, Aline/0000-0002-0949-4284	University of Colorado Data Science to Patient Value (D2V) program; Francis Family Foundation; Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD096018]	Dr Bennett has received a grant from the University of Colorado Data Science to Patient Value (D2V) program. Dr Maddux has received grants from the Francis Family Foundation and the Eunice Kennedy Shriver National Institute forChildHealth andHumanDevelopment (K23HD096018, Maddux).	Ahmed OZ, 2019, J TRAUMA ACUTE CARE, V86, P810, DOI 10.1097/TA.0000000000002120; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; [Anonymous], 1999, JAMA, V282, P974; Aspesberro F, 2016, PEDIATR CRIT CARE ME, V17, pE272, DOI 10.1097/PCC.0000000000000727; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bennett TD, 2017, PEDIATR CRIT CARE ME, V18, P442, DOI 10.1097/PCC.0000000000001120; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bhatraju PK, 2019, AM J RESP CRIT CARE, V199, P863, DOI 10.1164/rccm.201807-1346OC; Brown SM, 2017, THORAX, V72, P1094, DOI 10.1136/thoraxjnl-2017-210337; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Charrad M, 2014, J STAT SOFTW, V61, P1; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CIVHC. Low Value Care in Colorado, 2020, SEC LOW VAL CAR COL SEC LOW VAL CAR COL; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Faul M, 2010, TRAUMATIC BRAIN INJU; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Herridge MS, 2017, AM J RESP CRIT CARE, V196, P1380, DOI 10.1164/rccm.201704-0815ED; Herridge MS, 2016, AM J RESP CRIT CARE, V194, P831, DOI 10.1164/rccm.201512-2343OC; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kassambara A., 2017, PRACTICAL GUIDE CLUS, V1st, P15; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2020, J NEUROTRAUM, V37, P1512, DOI 10.1089/neu.2019.6874; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Lebart L, 2000, STAT EXPLORATOIRE MU; Maddux AB, 2020, CRIT CARE MED, V48, pE1313, DOI 10.1097/CCM.0000000000004595; Maddux AB, 2018, AM J RESP CRIT CARE, V197, P1378, DOI 10.1164/rccm.201801-0044ED; Maddux AB, 2018, PEDIATR CRIT CARE ME, V19, pE31, DOI 10.1097/PCC.0000000000001383; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Norwegian Institute of Public Health, 2018, ATC STRUCT PRINC ATC STRUCT PRINC; Papachristou N, 2018, J PAIN SYMPTOM MANAG, V55, P318, DOI 10.1016/j.jpainsymman.2017.08.020; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Porter J LD., 2019, ALL PAYER CLAIMS DAT; Puhr R, 2017, STAT MED, V36, P2302, DOI 10.1002/sim.7273; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rosario BL, 2018, PEDIATR CRIT CARE ME, V19, P957, DOI 10.1097/PCC.0000000000001676; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sinha P, 2018, INTENS CARE MED, V44, P1859, DOI 10.1007/s00134-018-5378-3; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; Watson RS, 2018, AM J RESP CRIT CARE, V197, P1457, DOI 10.1164/rccm.201708-1768OC; Williams JB, 2018, PEDIATR CRIT CARE ME, V19, P599, DOI 10.1097/PCC.0000000000001567; Zimmerman JJ, 2020, CRIT CARE MED, V48, P329, DOI 10.1097/CCM.0000000000004123	49	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		242	252		10.1097/HTR.0000000000000646			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100009	33656469	Green Accepted			2022-02-07	
J	Marquardt, CA; Pokorny, VJ; Kang, SS; Cuthbert, BN; Sponheim, SR				Marquardt, Craig A.; Pokorny, Victor J.; Kang, Seung Suk; Cuthbert, Bruce N.; Sponheim, Scott R.			Posttraumatic Stress Symptom Dimensions and Brain Responses to Startling Auditory Stimuli in Combat Veterans	JOURNAL OF ABNORMAL PSYCHOLOGY			English	Article						PTSD; mTBI; veterans; startle; EEG	EVENT-RELATED POTENTIALS; UNPREDICTABLE THREAT; ANXIETY SENSITIVITY; PTSD SYMPTOMS; DISORDER; ANTICIPATION; INJURY; ATTENTION; INTENSITY; EXPERIENCES	Posttraumatic stress disorder (PTSD) is marked by alterations in emotional functioning, physiological reactivity, and attention. Neural reactivity to acoustic startle stimuli can be used to understand brain functions related to these alterations. Investigations of startle reactivity in PTSD have yielded inconsistent findings, which may reflect the heterogeneity of the disorder. Furthermore, little is known of how the common co-occurrence of mild traumatic brain injury (mTBI; i.e., concussion) may influence neural reactivity. We examined the event-related potentials (ERPs) of combat veterans (n = 102) to acoustic startle probes delivered during viewing of pleasant, neutral, unpleasant, and combat-related pictures. Interview-based assessments yielded dimensional characterizations of PTSD and mTBI. The P3 ERP response to startle probes was reduced during all affective relative to neutral pictures but failed to be associated with a PTSD diagnosis. However, two separable domains of PTSD symptomatology were associated with startle ERPs regardless of the picture conditions. Maladaptive avoidance was associated with smaller N1, P2, and P3 amplitudes, while intrusive reexperiencing was associated with larger P2 amplitudes. There were no main effects of mTBI. Findings suggest that level of symptomatology rather than a formal diagnosis of PTSD better explains alterations in neural reactivity after traumatic events, while mild brain injuries have little impact. Avoidance symptoms of PTSD may dampen neural functions that facilitate reorientation to threat while intrusive reexperiencing of traumatic events appears to heighten sensory reactivity. Considering specific aspects of symptomatology provides insight into the neural basis of trauma-related psychopathology and may help guide individualization of clinical interventions.	[Marquardt, Craig A.; Sponheim, Scott R.] Univ Minnesota Twin Cities, Dept Psychiat & Behav Sci, Minneapolis, MN USA; [Marquardt, Craig A.; Pokorny, Victor J.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Res Serv 151,One Vet Dr, Minneapolis, MN 55417 USA; [Pokorny, Victor J.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA; [Kang, Seung Suk] Univ Missouri Kansas City, Dept Basic Med Sci, Kansas City, MO USA; [Cuthbert, Bruce N.] NIMH, Bethesda, MD 20892 USA		Sponheim, SR (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Res Serv 151,One Vet Dr, Minneapolis, MN 55417 USA.	sponh001@umn.edu	Sponheim, Scott/J-3857-2017	Sponheim, Scott/0000-0002-2782-0856; Pokorny, Victor/0000-0002-1003-0196; Marquardt, Craig/0000-0003-2714-6168			American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bakker Mirte J, 2009, J Psychiatry Neurosci, V34, P314; Benning SD, 2015, PSYCHOPHYSIOLOGY, V52, P1409, DOI 10.1111/psyp.12468; Benotsch EG, 2000, J ABNORM PSYCHOL, V109, P205, DOI 10.1037//0021-843X.109.2.205; Bernat EM, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13618; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bradford DE, 2017, SOC COGN AFFECT NEUR, V12, P1823, DOI 10.1093/scan/nsx095; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; BUCHSBAUM M, 1971, PSYCHOPHYSIOLOGY, V8, P600, DOI 10.1111/j.1469-8986.1971.tb00496.x; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Cuthbert BN, 1998, PSYCHOPHYSIOLOGY, V35, P344, DOI 10.1017/S0048577298970536; Cuthbert BN, 2005, J ABNORM PSYCHOL, V114, P565, DOI 10.1037/0021-843X.114.4.565; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Dien J, 2010, PSYCHOPHYSIOLOGY, V47, P170, DOI 10.1111/j.1469-8986.2009.00885.x; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Drislane LE, 2013, PSYCHOL MED, V43, P825, DOI 10.1017/S0033291712001547; Engelmann JM, 2011, PSYCHOPHYSIOLOGY, V48, P1656, DOI 10.1111/j.1469-8986.2011.01235.x; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Franken IHA, 2011, J PSYCHOPHYSIOL, V25, P32, DOI 10.1027/0269-8803/a000030; Gilmore CS, 2018, BEHAV BRAIN RES, V340, P174, DOI 10.1016/j.bbr.2016.12.002; GRAHAM FK, 1979, ORIENTING REFLEX HUM, P00137; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; GROVE WM, 1991, PSYCHOL REP, V69, P3; Grupe DW, 2016, PSYCHOL MED, V46, P1885, DOI 10.1017/S0033291716000374; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holand S, 1999, J HYPERTENS, V17, P1893, DOI 10.1097/00004872-199917121-00018; Iacono WG, 2003, INT J PSYCHOPHYSIOL, V48, P147, DOI 10.1016/S0167-8760(03)00052-7; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Kayser J, 2003, CLIN NEUROPHYSIOL, V114, P2307, DOI 10.1016/S1388-2457(03)00241-4; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Krause E, 2018, BIOL PSYCHIAT-COGN N, V3, P525, DOI 10.1016/j.bpsc.2017.12.002; Lang P. J., 2008, TECH REP A 8; Lang PJ, 2018, BIOL PSYCHIAT-COGN N, V3, P626, DOI 10.1016/j.bpsc.2017.07.006; Lewine JD, 2002, AM J PSYCHIAT, V159, P1689, DOI 10.1176/appi.ajp.159.10.1689; Lieberman L, 2017, J PSYCHIATR RES, V92, P55, DOI 10.1016/j.jpsychires.2017.04.002; Maguen S, 2006, J LOSS TRAUMA, V11, P373, DOI 10.1080/15325020600672004; Marquardt CA, 2018, J TRAUMA STRESS, V31, P114, DOI 10.1002/jts.22259; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; McPherson WB, 1997, INTEGR PHYS BEH SCI, V32, P31, DOI 10.1007/BF02688611; Metzger LJ, 2008, J REHABIL RES DEV, V45, P437, DOI 10.1682/JRRD.2007.07.0100; Metzger LJ, 2002, PSYCHOPHYSIOLOGY, V39, P49, DOI 10.1017/S0048577201020029; Miller MW, 2002, PSYCHOPHYSIOLOGY, V39, P519, DOI 10.1017/S0048577202394095; Moran JK, 2017, BIOL PSYCHOL, V129, P305, DOI 10.1016/j.biopsycho.2017.09.014; Nelson BD, 2017, PSYCHOPHYSIOLOGY, V54, P1180, DOI 10.1111/psyp.12869; Nelson BD, 2015, J ANXIETY DISORD, V33, P62, DOI 10.1016/j.janxdis.2015.05.003; Nelson BD, 2015, PSYCHOPHYSIOLOGY, V52, P887, DOI 10.1111/psyp.12418; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO, P449, DOI [10.1201/b18126-38, DOI 10.1201/B18126-38]; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; PAIGE SR, 1990, BIOL PSYCHIAT, V27, P419, DOI 10.1016/0006-3223(90)90552-D; Perkins ER, 2017, INT J PSYCHOPHYSIOL, V111, P145, DOI 10.1016/j.ijpsycho.2016.11.012; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; PRITCHARD WS, 1986, PSYCHOL BULL, V100, P43, DOI 10.1037/0033-2909.100.1.43; PUTNAM LE, 1990, PSYCHOPHYSIOLOGY, V27, P275, DOI 10.1111/j.1469-8986.1990.tb00383.x; ROTH WT, 1984, PSYCHOPHYSIOLOGY, V21, P466, DOI 10.1111/j.1469-8986.1984.tb00228.x; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Stevens ES, 2018, J ANXIETY DISORD, V54, P1, DOI 10.1016/j.janxdis.2017.12.001; STINE RA, 1995, AM STAT, V49, P53, DOI 10.2307/2684812; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Vaidyanathan U, 2014, PSYCHOPHYSIOLOGY, V51, P1285, DOI 10.1111/psyp.12348; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981	85	0	0	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0021-843X	1939-1846		J ABNORM PSYCHOL	J. Abnorm. Psychol.	JUL	2021	130	5					455	467		10.1037/abn0000552			13	Psychology, Clinical; Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology; Psychiatry	UL5IW	WOS:000692685500004	34472883				2022-02-07	
J	Massot-Tarrus, A; Yu, YJ; AlKhateeb, M; Mirsattari, SM				Massot-Tarrus, Andreu; Yu, Yeyao Joe; AlKhateeb, Mashael; Mirsattari, Seyed M.			Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit	EPILEPSY & BEHAVIOR			English	Article						Pseudoseizures; Prognosis; Dissociative disorder; Conversive disorder; Conversion disorder; Somatization	TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUGS; ETIOLOGY; ATTACKS	Objective: To identify predictors of Psychogenic NonEpileptic Seizure (PNES) improvement and anti seizure medication (ASM) discontinuation in patients with PNES only. Methods: This is a retrospective study of a consecutively enrolled cohort of 271 patients diagnosed with PNES by video-EEG (vEEG) telemetry in our Epilepsy Monitoring Unit (EMU) between May 2000 and February 2010. Patients with any possibility of past or present comorbid epilepsy based on clinical, EEG, and neuroimaging, or less than one year of follow-up after discharge were excluded. Results: A total of 109 subjects were included. The mean age at PNES onset was 33 (range 6-89), mean age at EMU admission was 38.3 (16-89.8), 70.6% were female mean video-EEG length was 6.1 days, and the median time of final follow-up 3.3 (CI 1.6-6.4) years. 51/108 patients (47.2%) reported a PNES decrease and 29 (26.8%) experienced PNES resolution. 59/73 (81.9%) subjects on ASM at the time of EMU admission were able to discontinue them by the final visit. On univariate analysis, patients whose PNES frequency improved were significantly younger at time of admission, more likely married or cohabiting, less likely unemployed, less likely to have migraine, and had a higher frequency of PNES. On hierarchical regression analysis, younger age and employment remained significant predictors of PNES improvement and resolution. Patients who achieved ASM discontinuation had significantly more children and subsequent EMU visits, were less likely to have history of minor head trauma immediately preceding PNES onset and structural brain lesions, experienced a greater reduction of ASMs during the EMU admission, and had a greater improvement of their PNES frequency at the final visit (p < 0.05). On hierarchical regression analysis, higher number of children, absence of structural brain lesions, fewer ASMs at EMU discharge, and improvement of PNES frequency remained significant predictors of ASM discontinuation. Conclusion: The outcome of PNES is positively correlated with earlier age of diagnosis in an EMU, especially in patients with better social resources. Furthermore, discontinuation of ASM is more likely if the process is initiated during the EMU stay and in the absence of structural brain lesions. (c) 2021 Elsevier Inc. All rights reserved.	[Massot-Tarrus, Andreu] Hosp Gen Univ Gregorio Maranon, Dept Neurol, Madrid, Spain; [Yu, Yeyao Joe; Mirsattari, Seyed M.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Mirsattari, Seyed M.] Western Univ, Psychol, London, ON, Canada; [AlKhateeb, Mashael] King Faisal Specialist Hosp Res Ctr, Neurol Sect, Dept Neurosci, Riyadh, Saudi Arabia		Massot-Tarrus, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Doctor Esquerdo 46, Madrid 28007, Spain.	andreu.massot@salud.madrid.org			London Health Sciences Foundation	This study was funded by London Health Sciences Foundation.	American Psychological Association (APA), 2013, DIAGNOSTIC STAT MANU, P1; Anzellotti F, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00461; Asadi-Pooya AA, 2019, EPILEPTIC DISORD, V21, P371, DOI 10.1684/epd.2019.1077; Asadi-Pooya AA, 2015, EPILEPSY BEHAV, V46, P60, DOI 10.1016/j.yebeh.2015.03.015; Baroni G, 2016, SEIZURE-EUR J EPILEP, V37, P35, DOI 10.1016/j.seizure.2016.02.003; Baslet G, 2016, PSYCHOSOMATICS, V57, P1, DOI 10.1016/j.psym.2015.10.004; Benbadis SR, 1999, EUR NEUROL, V41, P114, DOI 10.1159/000008015; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Bernard SK.Heather, 2020, CLIN EXP PEDIAT 1017; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Deleuran M, 2019, EPILEPSY BEHAV, V98, P195, DOI 10.1016/j.yebeh.2019.05.007; Derry PA, 1996, SEIZURE-EUR J EPILEP, V5, P35, DOI 10.1016/S1059-1311(96)80060-4; Doss RC, 2016, EPILEPTIC DISORD, V18, P337, DOI 10.1684/epd.2016.0873; Duncan R, 2016, SEIZURE-EUR J EPILEP, V36, P22, DOI 10.1016/j.seizure.2015.12.016; Duncan R, 2014, J NEUROL NEUROSUR PS, V85, P954, DOI 10.1136/jnnp-2013-306671; Duncan R, 2011, EPILEPSY BEHAV, V20, P308, DOI 10.1016/j.yebeh.2010.10.022; Durrant Joseph, 2011, Epilepsy Res Treat, V2011, P274736, DOI 10.1155/2011/274736; Flewelling KD, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107383; Kaemmer, 1989, MINNESOTA MULTIPHASI; Labiner DM, 2010, EPILEPSIA, V51, P2322, DOI 10.1111/j.1528-1167.2010.02648.x; Labudda K, 2020, EPILEPSY BEHAV, V106, DOI 10.1016/j.yebeh.2020.107029; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; Milan-Tomas A, 2018, CAN J NEUROL SCI, V45, P130, DOI 10.1017/cjn.2017.283; Nezadal T, 2011, NEUROL RES, V33, P694, DOI 10.1179/1743132811Y.0000000003; Oto M, 2010, EPILEPSIA, V51, P1994, DOI 10.1111/j.1528-1167.2010.02696.x; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Plecher H., 2021, UNEMPLOYMENT RATE CA; Popkirov S, 2019, EPILEPTIC DISORD, V21, P529, DOI 10.1684/epd.2019.1107; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Uppal S, 2017, INSIGHTS  CAN SOC YO; Walther K, 2019, EPILEPSIA, V60, P669, DOI 10.1111/epi.14682; Yadav A, 2015, EPILEPSY BEHAV, V53, P168, DOI 10.1016/j.yebeh.2015.10.017; Yon MI, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.106940	35	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2021	120								108004	10.1016/j.yebeh.2021.108004			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	SM2GS	WOS:000657428900002	33984657				2022-02-07	
J	Maurice, D; Giordani, L; Martin, SS; Yagai, B; Colizzi, V; Foti, C				Maurice, D.; Giordani, L.; Martin, S. Sobze; Yagai, B.; Colizzi, V; Foti, C.			The 2019 Cameroon University Games: Prevention Strategies for Musculoskeletal Injuries	MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL			English	Article						Injury; Cameroon University Games; epidemiology; trauma; musculoskeletal	OLYMPIC SUMMER GAMES; SPORTS INJURIES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; EPIDEMIOLOGY; ILLNESS; SURVEILLANCE; CONCUSSION; ZURICH	Background. The real burden of injuries among student athletes during the Cameroon University Games (CUG) is not yet known. The purpose of this study was to determine and analyze the incidence of musculoskeletal injuries among university athletes during the XXII CUG, hosted by Dschang University in May 2019. Methods. In this prospective cohort study, we recorded the daily number of injury occurrence among Olympic, Paralympic and fan's club university athletes from the reports of all the CUG 2019 medical teams. Injuries were analysed overall and according to age, gender, sports type, location, body region and mechanism. Associations were investigated by Chi Square or Fisher's exact test as appropriate, with P < 0.05 considered as statistically significant. Results. Out of the 2583 university athletes (1976 in Olympic, 97 in Paralympic and 510 in Fan's dub) of the 2019 CUG, a total of 235 musculoskeletal injuries (without any double starter), representing an overall incidence rate of 9.1 injury per 100 athletes was found. No injury was reported among the Paralympic athletes. The incidence among Olympic sports and Fan's club athletes were 10.4% and 5.9%, respectively. The sports with the top three highest injury incidence during the 7-day competition was wrestling (33.3%), judo (18.4%) and football (16.9%); while sprain (42.1%), contusion (18.7%) and skin injury (18.3%) were the injury type with the highest proportion. Even though no significant difference was observed between females and males' Olympic athletes in the overall injury incidence, a significantly higher difference was observed among males (13.7%) when compared to females (4.8%) handball players, P = 0.01. Lower limb was the most injured body region; while knee, ankle, leg and thigh the commonest location observed. Of note, there was up to 5.9% overall injury incidence among the fan's club, which are also considered as athletes in this competition, a peculiarity of the CUG. Lastly, a total number of 4 concussions was found. Conclusions. Overall, injury incidence in athletes was 9.1% during the 2019 CUG. However, there is a need to monitor the occurrence of injury rates over time in various disciplines and sports in order to best design effective prevention strategies.	[Maurice, D.; Giordani, L.; Foti, C.] Tor Vergata Univ Rome, Dept Clin Sci & Translat Med, Phys & Rehabil Med, Via Montpellier 1, I-00133 Rome, Italy; [Maurice, D.; Martin, S. Sobze] Univ Dschang, Dept Physiotherapy & Phys Med, Dschang, Cameroon; [Yagai, B.] Tor Vergata Univ Rome, Dept Expt Med, Rome, Italy; [Colizzi, V] Tor Vergata Univ Rome, Dept Biol, Rome, Italy		Maurice, D (corresponding author), Tor Vergata Univ Rome, Dept Clin Sci & Translat Med, Phys & Rehabil Med, Via Montpellier 1, I-00133 Rome, Italy.	douryangmaurice@gmail.com					Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Bizzini M, 2011, SCAND J MED SCI SPOR, V21, P42, DOI 10.1111/j.1600-0838.2009.01003.x; Diong J, 2014, BRIT J SPORT MED, V48, P1388, DOI 10.1136/bjsports-2013-092433; Douryang M, 2020, MED SPORT, V73, P712, DOI 10.23736/S0025-7826.20.03806-5; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Fiore DC, 2020, MUSCLES LIGAMENTS TE, V10, P179; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Gallo-Vallejo Miguel Angel, 2016, BMJ Open Sport Exerc Med, V2, pe000123, DOI 10.1136/bmjsem-2016-000123; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Lertwanich P., 2011, Siriraj Medical Journal, V63, P8; Malm C, 2019, SPORTS, V7, DOI 10.3390/sports7050127; Mascherini G, 2017, MLTJ-MUSCLE LIGAMENT, V7, P573, DOI 10.11138/mltj/2017.7.4.573; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Oberladstaetter J, 2009, ARCH ORTHOP TRAUM SU, V129, P359, DOI 10.1007/s00402-008-0658-y; Padulo J, 2018, MLTJ-MUSCLE LIGAMENT, V8, P305, DOI 10.11138/mltj/2018.8.3.305; Palmer-Green D, 2015, BRIT J SPORT MED, V49, P25, DOI 10.1136/bjsports-2014-094206; Pangrazio O, 2016, MLTJ-MUSCLE LIGAMENT, V6, P124, DOI 10.11138/mltj/2016.6.1.124; Park KJ, 2017, BRIT J SPORT MED, V51, P220, DOI 10.1136/bjsports-2016-096754; Pellicciari L, 2016, MED PROBL PERFORM AR, V31, P13, DOI 10.21091/mppa.2016.1003; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rasuli S., 2012, Advances in Environmental Biology, V6, P1801; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Steffen K, 2020, BRIT J SPORT MED, V54, P168, DOI 10.1136/bjsports-2019-101040; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Webborn N, 2014, PM&R, V6, pS18, DOI 10.1016/j.pmrj.2014.06.003	29	0	0	0	0	EDRA SPA	MILANO	VIA G SPADOLINI, 7, MILANO, 20141, ITALY	2240-4554			MLTJ-MUSCLE LIGAMENT	MLTJ-Muscles Ligaments Tendons J.	JUL-SEP	2021	11	3					475	483		10.32098/mltj.03.2021.12			9	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	YN4KG	WOS:000747228400012		Bronze			2022-02-07	
J	McDonald, AJ; Cook, S; Turner, NE; Ialomiteanu, AR; Mann, RE; Bondy, SJ; Roerecke, M; McCready, J; Millstone, D; Hamilton, HA; Elton-Marshall, T; Rehm, J; Kurdyak, P; Ilie, G; Vingilis, ER; Wickens, CM; van Der Maas, M; Cusimano, MD				McDonald, Andre J.; Cook, Steven; Turner, Nigel E.; Ialomiteanu, Anca R.; Mann, Robert E.; Bondy, Susan J.; Roerecke, Michael; McCready, John; Millstone, Dov; Hamilton, Hayley A.; Elton-Marshall, Tara; Rehm, Juergen; Kurdyak, Paul; Ilie, Gabriela; Vingilis, Evelyn R.; Wickens, Christine M.; van Der Maas, Mark; Cusimano, Michael D.			Adult attention-deficit hyperactivity disorder symptoms and psychological distress, hazardous drinking, and problem gambling: A population-based study	PSYCHIATRY RESEARCH			English	Article						Adult ADHD; Psychological distress; Mental health; Alcohol abuse; Problem gambling; Epidemiology	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; REPORT SCALE ASRS; DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; REPRESENTATIVE SAMPLE; SCREENING SCALES; MENTAL-ILLNESS; ADHD; PREVALENCE	Recognition of ADHD in the adult population is relatively recent. Epidemiological research examining the mental health impact of ADHD in adulthood is thus limited. The objective of this study was to examine whether adult ADHD symptoms are associated with psychological distress, hazardous drinking, and problem gambling, after controlling for traumatic brain injury and sociodemographic characteristics. We analyzed data from a population-based survey administered in 2015 and 2016 to adults aged 18 years and over in Ontario, Canada (N = 3,817). Logistic regression was used to construct unadjusted and multivariable models for each of the three focal relationships. In the unadjusted models, ADHD symptoms were significantly related to psychological distress (OR = 9.3; 95% CI:6.1, 14.0) and hazardous drinking (OR = 2.1; 95% CI: 1.3, 3.4), but not to problem gambling (OR = 1.5; 0.5, 4.3). After adjustment, ADHD symptoms were significantly related to psychological distress (OR = 7.1; 95% CI: 4.6, 11.1), but not hazardous drinking (OR = 1.4; 95% CI: 0.8, 2.5) or problem gambling (OR = 0.6; 95% CI: 0.2, 2.5). This study further highlights the importance of clinicians assessing for concomitant ADHD and psychological distress in adults.	[McDonald, Andre J.; Turner, Nigel E.; Ialomiteanu, Anca R.; Mann, Robert E.; Roerecke, Michael; McCready, John; Millstone, Dov; Hamilton, Hayley A.; Elton-Marshall, Tara; Rehm, Juergen; Kurdyak, Paul; Wickens, Christine M.; van Der Maas, Mark] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada; [McDonald, Andre J.; Turner, Nigel E.; Mann, Robert E.; Bondy, Susan J.; Roerecke, Michael; Hamilton, Hayley A.; Elton-Marshall, Tara; Rehm, Juergen; Wickens, Christine M.; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cook, Steven] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [McCready, John] Hlth Horizons Consulting, Toronto, ON, Canada; [Elton-Marshall, Tara; Vingilis, Evelyn R.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Dresden, Germany; [Kurdyak, Paul] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Vingilis, Evelyn R.] Western Univ, Dept Family Med, London, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON, Canada		McDonald, AJ (corresponding author), Ctr Addict & Mental Hlth, 33 Russell St, Toronto, ON M5S 2S1, Canada.	andre.mcdonald@mail.utoronto.ca	McDonald, Andre/AAZ-9353-2021; Bondy, Susan/C-6737-2014	McDonald, Andre/0000-0003-1734-5067; Wickens, Christine M./0000-0002-9865-850X; Cook, Steven/0000-0002-6363-2940; Bondy, Susan/0000-0002-6516-4159	Ministry of Health and LongTerm CareMinistry of Health and Long-Term Care, Ontario [3632]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation	The ideas expressed are those of the authors and do not necessarily reflect those of the Centre for Addiction and Mental Health, the University of Toronto, or the Ministry of Health and LongTerm Care. This project was supported by a grant from the Ministry of Health and LongTerm Care as Project No. 3632. Additional support was obtained from a STAIR Team Grant from the Canadian Institutes of Health Research (# TIR103946; MC, RM, MA, GI) and from the Ontario Neurotrauma Foundation. The project was subject to ethics review by the Centre for Addiction and Mental Health (CAMH) and approved as Protocol #305/200906, 2015. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments including informed consent and confidentiality of all personal information.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amstadter AB, 2012, J PSYCHIATR RES, V46, P87, DOI 10.1016/j.jpsychires.2011.09.017; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babor TF, 2001, AUDIT ALCOHOL USE DI; Beheshti A, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-2442-7; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 2010, AM J PSYCHIAT, V167, P409, DOI 10.1176/appi.ajp.2009.09050736; Breyer JL, 2009, J GAMBL STUD, V25, P227, DOI 10.1007/s10899-009-9126-z; Caye A, 2016, EUR CHILD ADOLES PSY, V25, P1151, DOI 10.1007/s00787-016-0831-8; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Dowling NA, 2017, CLIN PSYCHOL REV, V51, P109, DOI 10.1016/j.cpr.2016.10.008; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Faul M, 2010, TRAUMATIC BRAIN INJU; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Ferris J., 2001, CANADIAN PROBLEM GAM; Friedrichs B, 2012, J ATTEN DISORD, V16, P13, DOI 10.1177/1087054710376909; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Hamilton HA, 2019, J PSYCHIATR RES, V111, P89, DOI 10.1016/j.jpsychires.2019.01.008; Hansell NK, 2012, PSYCHOL MED, V42, P1249, DOI 10.1017/S0033291711002431; Hechtman LT, 1993, HYPERACTIVE CHILDREN; Hegerl U., 2019, AROUSAL REGULATION A; Hesson J, 2018, J ATTEN DISORD, V22, P191, DOI 10.1177/1087054715573992; Ialomiteanu AR, 2016, CAMH RES DOCUMENT SE, V45; Ilie G, 2017, PSYCHIAT RES, V258, P184, DOI 10.1016/j.psychres.2017.08.011; Ilie G, 2017, VIOLENCE VICTIMS, V32, P869, DOI 10.1891/0886-6708.VV-D-16-00027; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Kooij JJS, 2012, J ATTEN DISORD, V16, p3S, DOI 10.1177/1087054711435361; McGough JJ, 2016, AM J PSYCHIAT, V173, P960, DOI 10.1176/appi.ajp.2016.15091207; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okie S, 2006, NEW ENGL J MED, V354, P2637, DOI 10.1056/NEJMp068113; Pineiro-Dieguez B, 2016, J ATTEN DISORD, V20, P1066, DOI 10.1177/1087054713518240; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; SAS Institute Inc, 2016, SAS SOFTW VERS 9 4; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Theule J., 2016, J ATTEN DISORD, V20, P1; Turner N.E., 2008, INT GAMBL STUD, V8, P281, DOI [DOI 10.1080/14459790802405905, https://doi.org/10.1080/14459790802405905]; Turner NE, 2019, PSYCHIAT RES, V272, P692, DOI 10.1016/j.psychres.2018.12.170; van der Maas M, 2018, CRIM BEHAV MENT HEAL, V28, P120, DOI 10.1002/cbm.2045; Vingilis E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/982072; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Williams RJ, 2007, CAN PUBLIC POL, V33, P367, DOI 10.3138/cpp.33.3.367; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Yoshimasu K, 2018, J ATTEN DISORD, V22, P535, DOI 10.1177/1087054716676342	61	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781	1872-7123		PSYCHIAT RES	Psychiatry Res.	JUL	2021	301								113985	10.1016/j.psychres.2021.113985			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SR5YS	WOS:000661120000021	34023674				2022-02-07	
J	McDonald, CC; Jain, D; Storey, EP; Gonzalez, M; Master, CL; Arbogast, KB				McDonald, Catherine C.; Jain, Divya; Storey, Eileen P.; Gonzalez, Madeline; Master, Christina L.; Arbogast, Kristy B.			Changes in Driving Behaviors After Concussion in Adolescents	JOURNAL OF ADOLESCENT HEALTH			English	Article						Adolescent; Concussion; Driving; Mild traumatic brain injury; Motor vehicle crash	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; DRIVERS; SYMPTOMS; FITNESS; RATES	Purpose: Although return to learn, exercise, and sports have evidence-based guidelines, there is limited research investigating return to driving after concussion. The purpose was to characterize and compare adolescent driving behaviors after concussion. Methods: Using the Minds Matter Concussion Registry, we queried data of adolescents, aged 16-19 years, diagnosed with a concussion <= 28 days of injury and seen between January 31, 2017 and August 31, 2018 at the specialty care concussion program. Outcomes included patient report of: changes postinjury driving behaviors; Post-Concussion Symptom Inventory; return to school, and exercise and sports. Provider recommendations for return to school after initial clinical assessment were also examined. Descriptive statistics, analysis of covariance, and chi-square tests were performed. Results: Of the 332 drivers (46.1% female; mean age 17.5 years, 95% confidence interval [CI], 17.4-17.6), 46.9% had returned to driving since injury. Of those who returned to driving, 58.9% reported "Driving with No Changes." The Post-Concussion Symptom Inventory score was higher among "Driving with Changes" (48.7, 95% CI: 42.2-55.2) than "Driving with No Changes" (27.4, 95% CI: 22.3-32.5, p < .01) and "Has Not Driven Since Injury" (42.3, 95% CI: 38.4-46.3, p < .01). Among the 332 drivers, few had returned to exercise (15.4%) or organized sports (6.0%). Of those in school (n = 291), only 8.9% were provider recommended to return to full school days after clinical assessment. Conclusion: Many adolescents continued to drive after concussion, despite not yet having returned to exercise or sport. Nine of 10 were advised to return to school with accommodations to begin a gradual increase in cognitive activity, suggesting a gradual increase in driving may be justified. (C) 2020 Society for Adolescent Health and Medicine. All rights reserved.	[McDonald, Catherine C.] Univ Penn, Sch Nursing, Claire Fagin Hall 418 Curie Blvd,414, Philadelphia, PA 19104 USA; [McDonald, Catherine C.; Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [McDonald, Catherine C.; Jain, Divya; Storey, Eileen P.; Gonzalez, Madeline; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [McDonald, Catherine C.] Univ Penn, Penn Injury Sci Ctr, Philadelphia, PA 19104 USA; [Jain, Divya] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Div Orthoped, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA		McDonald, CC (corresponding author), Univ Penn, Sch Nursing, Claire Fagin Hall 418 Curie Blvd,414, Philadelphia, PA 19104 USA.	mcdonalc@nursing.upenn.edu		Gonzalez, Madeline/0000-0002-7697-8051; Jain, Divya/0000-0002-2255-8764; McDonald, Catherine/0000-0003-3856-8542	National Institute of Nursing Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR018425]; National Science FoundationNational Science Foundation (NSF) [EEC-1460927]	Research reported in this publication was supported by the National Institute of Nursing Research of the National Institutes of Health under Award Number R01NR018425. This material is also based upon work supported by the National Science Foundation under Grant Number EEC-1460927. The authors thank members of the Children's Hospital of Philadelphia Sports Medicine and Performance Center Team including Naomi Brown, MD, FAAP, CAQSM, Matthew Grady, MD, FAAP, CAQSM, Christopher Renjilian, MD, and Brian Vernau, MD, FAAP, CAQSM.	Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Bergdahl J, 2005, SOC SCI J, V42, P595, DOI 10.1016/j.soscij.2005.09.006; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, TEEN DRIV GET FACTS; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Curry AE, 2015, ACCIDENT ANAL PREV, V80, P243, DOI 10.1016/j.aap.2015.04.019; Foss Robert D., 2011, MEASURING CHANGES TE; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Hoffman NL, 2018, INT J ATHL THER TRAI, V23, P21, DOI 10.1123/ijatt.2017-0025; Insurance Institute for Highway Safety, TEEN OV; Klein TA, 2017, J PEDIATR HEALTH CAR, V31, P441, DOI 10.1016/j.pedhc.2016.11.004; Lucas JA, 2019, BRIT J SPORT MED, V53, P495, DOI 10.1136/bjsports-2018-099118; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mayhew DR, 2003, ACCIDENT ANAL PREV, V35, P407, DOI 10.1016/S0001-4575(02)00019-2; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidt JD, 2018, J NEUROTRAUM, V35, P2418, DOI 10.1089/neu.2018.5707; Schmidt JD, 2019, BRAIN INJURY, V33, P1652, DOI 10.1080/02699052.2019.1664765; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Williams AF, 2017, J SAFETY RES, V63, P29, DOI 10.1016/j.jsr.2017.08.010	32	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	JUL	2021	69	1					108	113		10.1016/j.jadohealth.2020.10.009			6	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	TB8QQ	WOS:000668211200018	33339732				2022-02-07	
J	Miles, SR; Silva, MA; Neumann, D; Dillahunt-Aspillaga, C; Corrigan, JD; Tang, XY; Eapen, BC; Nakase-Richardson, R				Miles, Shannon R.; Silva, Marc A.; Neumann, Dawn; Dillahunt-Aspillaga, Christina; Corrigan, John D.; Tang, Xinyu; Eapen, Blessen C.; Nakase-Richardson, Risa			Demographic and Mental Health Predictors of Arrests Up to 10 Years Post-Traumatic Brain Injury: A Veterans Affairs TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; arrest; brain injuries; criminal behavior; mental health; military personnel; traumatic; veterans	NATIONAL SAMPLE; PREVALENCE; VA; IRAQ; RELIABILITY; VALIDITY; CARE; 1ST	Objective: Examine rates and predictors of arrests in Veterans and Service Members (V/SM) who received inpatient rehabilitation for traumatic brain injury (TBI). Setting: Veterans Administration (VA) Polytrauma Rehabilitation Centers. Participants: A total of 948 V/SM drawn from the VA TBI Model Systems cohort with arrest data up to 10 years post-TBI. Design: Longitudinal cohort study; secondary analysis of pre-TBI characteristics predicting post-TBI arrests. Main Measures: Disclosure of arrests pre-TBI and up to10 years post-TBI. Results: Thirty-six percent of the sample had been arrested prior to their TBI; 7% were arrested post-TBI. When considering all variables simultaneously in a multivariate model, pre-TBI mental health treatment (adjusted odds ratio [aOR] = 4.30; 95% confidence interval [CI]: 2.03-9.14), pre-TBI heavy alcohol use (aOR = 3.04; CI: 1.08-8.55), and number of follow-up interviews (aOR = 2.05; CI: 1.39-4.50) were significant predictors of post-TBI arrest. Conclusion: Arrest rates of V/SM prior to TBI were consistent with rates of arrest for people of similar ages in the United States. Post-TBI rates were lower for V/SM than published rates of post-TBI arrests in civilians with TBI. As part of rehabilitation planning for V/SM with TBI, providers should assess for preinjury mental health services and alcohol misuse to (1) identify those who may be at risk for postinjury arrests and (2) provide relevant resources and/or supports.	[Miles, Shannon R.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Miles, Shannon R.; Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.; Nakase-Richardson, Risa] Univ S Florida, Div Pulm & Sleep Med, Dept Internal Med, Tampa, FL 33620 USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Neumann, Dawn] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Neumann, Dawn] Rehabil Hosp Indiana, Indianapolis, IN USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehabil & Mental Hlth Counseling Program, Tampa, FL 33620 USA; [Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Tang, Xinyu] Tampa VA Res & Educ Fdn Inc, Tampa, FL USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Miles, SR (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA.	shannon.miles@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015, HT0014-19-C-0004]; NIDILRRUnited States Department of Health & Human Services [90DPTB0001]; Indiana University [90DRTB0002]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded collaboration between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015; HT0014-19-C-0004) from theDefense and Veterans Brain Injury Center within the DefenseHealth Agency. The NIDILRR funding to The Ohio State University (90DPTB0001) and Indiana University (90DRTB0002) also supported the project. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy, or decision unless so designated by other official documentation. TheNIDILRR is a Center within theAdministration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this publication do not necessarily represent the policy ofNIDILRR, ACL, orHHS, and you should not assume endorsement by the Federal Government. The participating agencies' institutional review boards approved this study, and informed consent was obtained after the details of the study were thoroughly explained to participants.	Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barnes JC, 2015, AM J CRIM JUSTICE, V40, P457, DOI 10.1007/s12103-014-9273-3; Bonczar Thomas P., 2003, PREVALENCE IMPRISONM; Bushway S. D., 2004, J CONTEMP CRIM JUST, V20, P276, DOI DOI 10.1177/1043986204266890; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; De Luca SM, 2016, COMMUNITY MENT HLT J, V52, P174, DOI 10.1007/s10597-015-9964-3; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; (DVBIC) DaVBIC, 2019, DOD WORLDW TBI NUMB DOD WORLDW TBI NUMB; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Grossbard JR, 2013, PSYCHIAT SERV, V64, P547, DOI 10.1176/appi.ps.003002012; Hughes N, 2020, LANCET CHILD ADOLESC, V4, P163, DOI 10.1016/S2352-4642(19)30401-8; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Schiltz K., 2011, MINERVA PSICHIAT, V52, P187; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Tanielian TL., 2009, INVISIBLE SOUNDS WAR; Team RC, 2013, R FDN STAT COMP VIEN R FDN STAT COMP VIEN; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Sentencing Project, 2019, TRENDS US CORR FACT TRENDS US CORR FACT; Uniform Data System for Medical Rehabilitation, 2012, FIM INSTR ITS BACKGR; White MD, 2012, JUSTICE Q, V29, P258, DOI 10.1080/07418825.2011.560890; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wszalek JA, 2015, J HEAD TRAUMA REHAB, V30, P86, DOI 10.1097/HTR.0000000000000130	34	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E240	E248		10.1097/HTR.0000000000000640			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100008	33528175				2022-02-07	
J	Moore, M; Goldin, Y; Patel, H; Greenwald, BD				Moore, Matthew; Goldin, Yelena; Patel, Harsh; Greenwald, Brian D.			Low Vitamin D Level Is Associated with Acute Deep Venous Thrombosis in Patients with Traumatic Brain Injury	BRAIN SCIENCES			English	Article						deep venous thrombosis; traumatic brain injury; vitamin D	25-HYDROXYVITAMIN D DEFICIENCY; VEIN THROMBOSIS; LOWER-EXTREMITY; PREVALENCE; PROPHYLAXIS	Vitamin D and its association with venous thromboembolism (VTE) have been studied in common rehabilitation populations, such as spinal cord injury and ischemic stroke groups. This study explores the relationship between vitamin D levels and acute deep venous thrombosis (DVT) in the traumatic brain injury (TBI) population. This is a retrospective cohort study that analyzes the relationship between vitamin D levels and the prevalence of DVT during acute inpatient rehabilitation. In this population, 62% (117/190) of patients had low vitamin D levels upon admission to acute rehabilitation. Furthermore, 21% (24/117) of patients in the low vitamin D group had acute DVT during admission to acute rehabilitation. In contrast, only 8% (6/73) of patients in the normal vitamin D group had acute DVT during admission to acute rehabilitation. Fisher's exact tests revealed significant differences between individuals with low and normal vitamin D levels (p = 0.025). In conclusion, a vitamin D level below 30 ng/mL was associated with increased probability of the occurrence of acute DVT in individuals with moderate-severe TBI.	[Moore, Matthew; Goldin, Yelena; Greenwald, Brian D.] JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08820 USA; [Patel, Harsh] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA		Moore, M (corresponding author), JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08820 USA.	Matthew.Moore@hmhn.org; yelena.goldin@hmhn.org; h.h.pate119@gmail.com; Brian.Greenwald@HMHN.org					Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Anjum I, 2018, CUREUS, V10, DOI 10.7759/cureus.2960; Bell KR, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P810; Bendik I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00248; Boffa MC, 1998, LUPUS, V7, pS120, DOI 10.1177/096120339800700227; Chindamo Maria Chiara, 2019, J. vasc. bras., V18, pe20180107, DOI 10.1590/1677-5449.180107; Cross D., 2010, CLIN MED RES, V8, P202, DOI [10.3121/cmr.2010.943.c-b4-02, DOI 10.3121/CMR.2010.943.C-B4-02]; Dehghani K, 2019, BIOMED RES THER, V6, P3107, DOI 10.15419/bmrat.v6i4.535; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Ehsanian R, 2019, PM&R, V11, P125, DOI 10.1016/j.pmrj.2018.09.038; Fernandes MR, 2017, REV ASSOC MED BRAS, V63, P550, DOI 10.1590/1806-9282.63.06.550; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Intiso D, 2018, BRAIN INJURY, V32, P1817, DOI 10.1080/02699052.2018.1537512; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; Khademvatani K, 2014, INT J GEN MED, V7, P303, DOI 10.2147/IJGM.S64812; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; Lee JM, 2019, WORLD NEUROSURG, V126, pE1421, DOI 10.1016/j.wneu.2019.02.244; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Meehan Meghan, 2014, J Aging Gerontol, V2, P60; Mioc ML, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2141-4; Pellicane AJ, 2011, ARCH PHYS MED REHAB, V92, P705, DOI 10.1016/j.apmr.2010.12.028; Pellicane AJ, 2010, AM J PHYS MED REHAB, V89, P899, DOI 10.1097/PHM.0b013e3181f71112; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rethinasamy R, 2019, MALAYS J MED SCI, V26, P139, DOI 10.21315/mjms2019.26.5.13; Tang HL, 2015, BRAIN INJURY, V29, P1165, DOI 10.3109/02699052.2015.1035330; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wu WX, 2018, CLIN APPL THROMB-HEM, V24, p69S, DOI 10.1177/1076029618786574	31	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2021	11	7							849	10.3390/brainsci11070849			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TN9FQ	WOS:000676532100001	34202164	Green Published, gold			2022-02-07	
J	Mowbray, F; Arora, R; Shukla, M; Shihan, H; Kannikeswaran, N				Mowbray, Fabrice; Arora, Rajan; Shukla, Meghna; Shihan, Hadeel; Kannikeswaran, Nirupama			Factors associated with avoidable interhospital transfers for children with a minor head injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Minor head injury; Avoidable transfers; Risk factors; Children; Emergency department	PEDIATRIC TRAUMA; PATIENT TRANSFERS; DISCHARGE; CARE	Introduction: Children with minor head injuries (MHI) are routinely transferred to a pediatric trauma center for definitive care. Unwarranted transfers result in minimal benefit to the patient and add substantially to healthcare costs. The purpose of this study is to explore the factors associated with avoidable interhospital transfers of children with MHI. Methods: We conducted a retrospective cohort study of children <18 years of age transferred to our pediatric emergency department (PED) for MHI between January 2013 and December 2018. Patients transferred for non-accidental trauma, and those with a history of coagulopathies, underlying neurological conditions, intraventricular shunts and developmental delay were excluded. Transfers were categorized as avoidable if none of the following interventions were required at our PED: procedural sedation, anticonvulsant initiation, subspecialty consultation, intensive care unit admission or hospital admission for >= 2 nights, intubation or operative intervention. We collected demographics, injury mechanism, neuroimaging results, interventions performed and PED disposition. Binary logistic regression was conducted to provide adjusted associations between patient characteristics and the risk of avoidable interhospital transfers. Results: We analyzed 1078 transfers for MHI, of which 450 (42%) transfers were classified as avoidable. Children in the avoidable transfer group tended to be younger, less likely to have experienced loss of consciousness, and more likely to belong to the the group at lowest risk for a clinically important traumatic brain injury (ciTBI). Our multivariable model determined that children less than 2 years of age (OR = 1.75; 95% CI = 1.3-2.37), low-risk group for ciTBI (OR = 1.66; 95% CI = 1.22-0.1), and a positive head CT at the transferring hospital (OR = 0.06; 95% CI = 0.02-0.1) were all significantly associated with avoidable transfers. Conclusion: There is a high rate of avoidable transfers in children with MHI. Focused interventions targeting risk factors associated with avoidable transfers may reduce unwarranted interhospital transfers. (c) 2020 Elsevier Inc. All rights reserved.	[Mowbray, Fabrice] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St West, Hamilton, ON L8S 4L8, Canada; [Arora, Rajan; Shukla, Meghna; Kannikeswaran, Nirupama] Childrens Hosp Michigan, Dept Pediat, Div Pediat Emergency Med, 3901 Beaubien St, Detroit, MI 48201 USA; [Shihan, Hadeel] Childrens Hosp Michigan, Dept Pediat, 3901 Beaubien St, Detroit, MI 48201 USA		Kannikeswaran, N (corresponding author), Childrens Hosp Michigan, Dept Pediat, Div Pediat Emergency Med, 3901 Beaubien St, Detroit, MI 48201 USA.	mowbrayf@mcmaster.ca; rarora@dmc.org; mshukl@dmc.org; hshihan@dmc.org; nkannike@dmc.org					Eakins C, 2012, AM J ROENTGENOL, V199, P916, DOI 10.2214/AJR.11.7662; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Gattu RK, 2017, PEDIATR EMERG CARE, V33, P334, DOI 10.1097/PEC.0000000000000805; Gattu RK, 2014, PEDIATR EMERG CARE, V30, P26, DOI 10.1097/PEC.0000000000000061; Goldstein SD, 2015, J PEDIATR SURG, V50, P1028, DOI 10.1016/j.jpedsurg.2015.03.028; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Li J, 2012, PEDIATRICS, V130, P83, DOI 10.1542/peds.2011-1819; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Peebles ER, 2018, PEDIATR EMERG CARE, V34, P650, DOI 10.1097/PEC.0000000000001098; R Core Team, 2020, R LANG ENV STAT COMP; Simon HK, 1996, PEDIATR EMERG CARE, V12, P336, DOI 10.1097/00006565-199610000-00003; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; Soundappan SVS, 2007, J TRAUMA, V62, P1229, DOI 10.1097/01.ta.0000219893.99386.fc; Walls TA, 2015, PEDIATR EMERG CARE, V31, P10, DOI 10.1097/PEC.0000000000000326	18	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45						208	212		10.1016/j.ajem.2020.08.046			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XN7BD	WOS:000729654900007	33046290				2022-02-07	
J	Nagarajan, T; Prakash, P; Bhandari, SK				Nagarajan, Thiruvalluvan; Prakash, Poonam; Bhandari, Sujit Kumar			Multidimensional evaluation of prosthetically rehabilitated\cranial defects using key behavior change inventory	JOURNAL OF INDIAN PROSTHODONTIC SOCIETY			English	Article						Cranial defects; cranial prosthesis; key behavior change inventory; sunken skin flap syndrome; traumatic brain injury	IMPLANT	Defects of the cranial vault can result from the decompressive craniectomy secondary to trauma, cerebral infections, resection of intracranial processes, or bone invading skin tumors. Reconstruction of the cranial vault not only provides protection and esthetic reasons but also maintains and restores physiological circulatory system of the cerebrum essential for the regulation of intracranial pressure. This paper presents prosthetic rehabilitation of two patients, who suffered head injury resulting in extensive frontoparieto temporal defects that induced symptoms such as headache, fatigue, loss of concentration, loss of memory, and depression. Along with the physical dysfunction and disfigurement, the injury resulted in a deep psychological impact on overall well-being and self-esteem of the patient as well as the close family members. The patients were prosthetically rehabilitated with custom-made heat polymerized polymethyl methacrylate cranial prosthesis and the assessment of postrehabilitation outcome was done using a specific measurement tool; key behaviors change inventory (KBCI) a 64-item questionnaire that evaluates executive, interpersonal, and emotional functioning behaviors following traumatic brain injury. Rehabilitation resulted in the restoration of form, function, and esthetics along with the improvement in psychological status and general health as reflected in KBCI scores posttreatment. Based on the posttreatment scores obtained in the cases under study, it is suggested that KBCI may serve as an important prognostic tool for the assessment of treatment outcomes.	[Nagarajan, Thiruvalluvan] CMDC NC, Graded Specialist Prosthodont, Udhampur, Jammu & Kashmir, India; [Prakash, Poonam] AFMC, Div Prosthodont & Crown & Bridge, Dept Dent Surg & Oral Hlth Sci, Pune, Maharashtra, India; [Bhandari, Sujit Kumar] AFMC, Dept Dent Surg & Oral Hlth Sci, Pune, Maharashtra, India		Prakash, P (corresponding author), Armed Forces Med Coll, Div Prosthodont & Crown & Bridge, Departmen Dent Surg & Oral Hlth Sci, Pune, Maharashtra, India.	pnmprakash1977@gmail.com					AQUILINO SA, 1988, J PROSTHET DENT, V59, P68, DOI 10.1016/0022-3913(88)90111-4; Arpan Pavaiya, 2009, Journal of Indian Prosthodontic Society, V9, P109, DOI 10.4103/0972-4052.55256; Bandyopadhyay T K, 2005, Med J Armed Forces India, V61, P36, DOI 10.1016/S0377-1237(05)80116-9; BEUMER J, 1979, J PROSTHET DENT, V42, P67, DOI 10.1016/0022-3913(79)90332-9; JORDAN RD, 1978, J PROSTHET DENT, V40, P230, DOI 10.1016/0022-3913(78)90022-7; Joseph TM, 2018, J INDIAN PROSTHODONT, V18, P76, DOI 10.4103/jips.jips_136_17; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; MARTIN JW, 1984, J PROSTHET DENT, V52, P414, DOI 10.1016/0022-3913(84)90457-8; SCHUPPER N, 1968, J PROSTHET DENT, V19, P594, DOI 10.1016/0022-3913(68)90260-6; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	10	0	0	1	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	0972-4052	1998-4057		J INDIAN PROSTHODONT	J. Indian Prosthodont.	JUL-SEP	2021	21	3					311	315		10.4103/jips.jips_587_20			5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	UB1ID	WOS:000685603900015	34380821	gold			2022-02-07	
J	Amroodi, MN; Tabrizian, P; Mohammadpour, M				Nakhaei Amroodi, Morteza; Tabrizian, Pouria; Mohammadpour, Mehdi			Bilateral distal clavicular fracture in a patient with traumatic brain injury and decreased level of consciousness: a rare case report	CURRENT ORTHOPAEDIC PRACTICE			English	Article									[Nakhaei Amroodi, Morteza; Tabrizian, Pouria; Mohammadpour, Mehdi] Iran Univ Med Sci, Shafa Orthoped Hosp, Bone & Joint Reconstruct Res Ctr, Tehran, Iran; [Mohammadpour, Mehdi] Shafa Orthoped Hosp, Baharestan Sq, Tehran, Iran		Mohammadpour, M (corresponding author), Shafa Orthoped Hosp, Baharestan Sq, Tehran, Iran.	drmna@yahoo.com; tabrizian.pouria@gmail.com; mehdi.668491@gmail.com					Bajuri MY, 2018, MALAYS ORTHOP J, V12, P60, DOI 10.5704/MOJ.1803.015; Baumgarten KM, 2009, ORTHOPEDICS, V32, P713; Craig EV., 1988, SHOULDER, P428; Kim DW, 2020, CLIN ORTHOP SURG, V12, P135, DOI 10.4055/cios20010; Kulkarni Raghavendra S, 2011, J Orthop Case Rep, V1, P29; NEER CS, 1968, CLIN ORTHOP RELAT R, P43; Sambandam Balaji, 2014, J Clin Orthop Trauma, V5, P65, DOI 10.1016/j.jcot.2014.05.007; van den Bout HET, 2011, SA orthop. j., V10, P56	8	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1940-7041	1941-7551		CURR ORTHOP PRACT	Curr. Orthop. Pract.	JUL-AUG	2021	32	4					409	410					2	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	TG4KE	WOS:000671374900015					2022-02-07	
J	Nichols, E				Nichols, Emma		GBD 2019 Dementia Collaborators	The Burden of Dementia due to Down Syndrome, Parkinson's Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019	NEUROEPIDEMIOLOGY			English	Article						Dementia; Global health; Burden of disease; Meta-analysis; Public health	ALZHEIMERS-DISEASE; RISK-FACTORS; PATHOLOGIES; PREVALENCE	Background: In light of the increasing trend in the global number of individuals affected by dementia and the lack of any available disease-modifying therapies, it is necessary to fully understand and quantify the global burden of dementia. This work aimed to estimate the proportion of dementia due to Down syndrome, Parkinson's disease, clinical stroke, and traumatic brain injury (TBI), globally and by world region, in order to better understand the contribution of clinical diseases to dementia prevalence. Methods: Through literature review, we obtained data on the relative risk of dementia with each condition and estimated relative risks by age using a Bayesian meta-regression tool. We then calculated population attributable fractions (PAFs), or the proportion of dementia attributable to each condition, using the estimates of relative risk and prevalence estimates for each condition from the Global Burden of Disease Study 2019. Finally, we multiplied these estimates by dementia prevalence to calculate the number of dementia cases attributable to each condition. Findings: For each clinical condition, the relative risk of dementia decreased with age. Relative risks were highest for Down syndrome, followed by Parkinson's disease, stroke, and TBI. However, due to the high prevalence of stroke, the PAF for dementia due to stroke was highest. Together, Down syndrome, Parkinson's disease, stroke, and TBI explained 10.0% (95% UI: 6.0-16.5) of the global prevalence of dementia. Interpretation: Ten percent of dementia prevalence globally could be explained by Down syndrome, Parkinson's disease, stroke, and TBI. The quantification of the proportion of dementia attributable to these 4 conditions constitutes a small contribution to our overall understanding of what causes dementia. However, epidemiological research into modifiable risk factors as well as basic science research focused on elucidating intervention approaches to prevent or delay the neuropathological changes that commonly characterize dementia will be critically important in future efforts to prevent and treat disease.				eln1@uw.edu	Chu, Dinh Toi/I-7414-2019; Hay, Simon I/F-8967-2015; Ferrara, Pietro/AAF-4113-2019; Hankey, Graeme J/H-4968-2014; Hassan, Amr/AAP-3025-2021; Wang, Yuan Pang/A-4863-2008; KIM, YUN JIN/AAE-8281-2019; Mondello, Stefania/A-1813-2012; Diaz, Daniel/P-1916-2018	Chu, Dinh Toi/0000-0002-4596-2022; Hay, Simon I/0000-0002-0611-7272; Ferrara, Pietro/0000-0002-0349-3221; Hankey, Graeme J/0000-0002-6044-7328; Hassan, Amr/0000-0001-7374-7074; Wang, Yuan Pang/0000-0001-7076-8312; KIM, YUN JIN/0000-0001-8853-6587; Mondello, Stefania/0000-0002-8587-3614; Diaz, Daniel/0000-0003-2302-1982; Ayano, Getinet/0000-0002-9137-4141; Landires, Ivan/0000-0001-6323-1170; Araujo, Luis Fernando/0000-0002-0952-5052; Biswas, Atanu/0000-0001-5696-9839			Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Ballard C, 2016, LANCET NEUROL, V15, P622, DOI 10.1016/S1474-4422(16)00063-6; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Brayne C, 2009, J ALZHEIMERS DIS, V18, P645, DOI 10.3233/JAD-2009-1182; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Corraini P, 2017, STROKE, V48, P180, DOI 10.1161/STROKEAHA.116.015242; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kuzma E, 2018, ALZHEIMERS DEMENT, V14, P1416, DOI 10.1016/j.jalz.2018.06.3061; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Matthews KA, 2019, ALZHEIMERS DEMENT, V15, P17, DOI 10.1016/j.jalz.2018.06.3063; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Prince M, 2015, ALZHEIMERS DIS INT W; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Waite LM, 2015, AUST PRESCR, V38, P60, DOI 10.18773/austprescr.2015.018; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; World Health Organization, 1992, ICD 10 CLASSIFICATIO	39	0	0	4	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology	JUL	2021	55	4					286	296		10.1159/000515393			11	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	TM1PJ	WOS:000675325100005	34182555	Green Published, Green Accepted, hybrid			2022-02-07	
J	Noureldine, MHA; Hartnett, S; Zavadskiy, G; Pressman, E; Kim, JK; Davis, D; Ciesla, D; Bull, B; Agazzi, S				Noureldine, Mohammad Hassan A.; Hartnett, Sara; Zavadskiy, Gleb; Pressman, Elliot; Kim, Joon Kyung; Davis, Donald; Ciesla, David; Bull, Brooke; Agazzi, Siviero			Predicting neurosurgical clearance in the polytrauma patient with concomitant traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Polytrauma; Traumatic brain injury; Neurosurgical clearance model; ICP Score; Glasgow coma score; CT score; Injury severity score	INTENSIVE-CARE-UNIT; OUTCOMES; IMPACT	The goal of this study is to develop a model based on previously used prognostic predictors in traumatic brain injury (TBI) patients with polytrauma, which will facilitate the decision-making of whether to clear these patients for non-cranial surgery. Data of eligible patients was obtained from a trauma database at a Level I trauma and academic tertiary referral center in the United States. The number of days seen by the neurosurgical service prior to clearance, injury severity score (ISS), post-trauma day 0 (PTD 0) of Glasgow Coma Score (GCS), intracranial pressure (ICP) score and computed tomography (CT) score, as well as the changes in GCS, ICP score and CT score between PTD 0 and day of clearance were the variables used in developing the model. The Neurosurgical Clearance Model (NCM) was developed using data from 50 patients included in the study. Patients were cleared by neurosurgeons 1.6 days later than it would appear possible based on a retrospective review of the patients' clinical conditions. A single model equa-tion was developed, the ultimate result of which isa clearance probability value. The best cutoff clearance probability value was found to be 0.584 (or 58.4%) using Receiver Operator Characteristic curve analysis. Our data suggests that neurosurgeons are risk-averse in clearing polytrauma patients for non-cranial sur-gery. This pilot NCM, if reproduced and validated by other groups and in larger prospective studies, may become a useful tool to assist clinicians in this often-difficult decision-making process. (c) 2021 Elsevier Ltd. All rights reserved.	[Noureldine, Mohammad Hassan A.; Agazzi, Siviero] Univ S Florida, Dept Surg, Tampa, FL 33606 USA; [Hartnett, Sara; Pressman, Elliot] Univ S Florida, Dept Neurosurg & Brain Repair, 2 Tampa Gen Circle,Suite 7062, Tampa, FL 33606 USA; [Zavadskiy, Gleb] Univ S Florida, Muma Coll Business, Tampa, FL 33606 USA; [Kim, Joon Kyung] Univ S Florida, Morsani Coll Med, Tampa, FL 33606 USA; [Davis, Donald; Ciesla, David] Univ S Florida, Dept Surg, Div Trauma & Acute Care Surg, Tampa, FL 33606 USA; [Bull, Brooke] Tampa Gen Hosp, Dept Surg, Div Trauma & Acute Care Surg, Tampa, FL 33606 USA		Agazzi, S (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, 2 Tampa Gen Circle,Suite 7062, Tampa, FL 33606 USA.		Noureldine, Mohammad Hassan A/L-2847-2016	Noureldine, Mohammad Hassan A/0000-0001-6954-4207			Algarra NN, 2017, J NEUROSURG ANESTH, V29, P228, DOI 10.1097/ANA.0000000000000292; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Celi LA, 2008, CRIT CARE, V12, DOI 10.1186/cc7140; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mohamed M, 2015, COMMUNITY RES FORUM, P107304; Prognosis IMo, 2011, NEUROSURGERY, V70, P811; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; Young LB, 2011, ARCH INTERN MED, V171, P498, DOI 10.1001/archinternmed.2011.61	16	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2021	89						51	55		10.1016/j.jocn.2021.04.023			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SP8KR	WOS:000659912500009	34119294				2022-02-07	
J	Nye, M; Cacolice, PA				Nye, Megan; Cacolice, Paul A.			Mild Jugular Compression Reduces White Matter Alterations in High School-Aged Males Playing Collision Sports	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						brain injury; concussion; contact; neuroshield; prevention; q-collar	HEAD IMPACT EXPOSURE; BRAIN; CONCUSSION; MICROSTRUCTURE; WOODPECKER; MANAGEMENT; MARKERS; INJURY; COLLAR	Clinical question: Do mild jugular compression (MJC) devices reduce white matter alterations in high school-aged males playing collision sports? Clinical bottom line: There is moderate evidence at Strength of Recommendation B to support that MJC reduces WMAs in high school-aged males playing collision sports.	[Nye, Megan] Westfield State Univ, Westfield, MA 01086 USA; [Cacolice, Paul A.] Westfield State Univ, Movement Sci Sport & Leisure Studies Dept, Westfield, MA 01086 USA		Nye, M (corresponding author), Westfield State Univ, Westfield, MA 01086 USA.	megan.nye@uconn.edu					Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Mohamed AZ, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102136; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; OCEBM Levels of Evidence Working Group, 2011, OXFORD CTR EVIDENCE; PEDro, 1999, PEDRO SCAL ENGL PEDRO SCAL ENGL; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smoliga JM, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2018-099594; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	17	0	0	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JUL	2021	26	4					181	185		10.1123/ijatt.2020-0035			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TK2DS	WOS:000673976300001					2022-02-07	
J	Pesonen, A; Ben-Hamouda, N; Schneider, A				Pesonen, Anais; Ben-Hamouda, Nawfel; Schneider, Antoine			Acute kidney injury after brain injury: does it exist?	MINERVA ANESTESIOLOGICA			English	Article						Acute kidney injury; Brain injuries; traumatic; Review	INFLAMMATION; STROKE; RISK	Acute kidney injury (AKI) is frequent after cerebral insults, with an incidence close to 10% in both traumatic brain injury (TBI) and cerebrovascular disease. AKI in this context has substantial impact on mortality and neurological outcome. Numerous factors may play a role in the development of AKI after brain injury: intravascular volume depletion, raised-intra-abdominal pressure, rhabdomyolysis or sepsis in TBI; age, ischemic heart disease or arteriosclerotic disease in stroke. However, brain-kidney crosstalk mechanisms are complex and there remains a strong rationale for a causal relationship between brain and kidney injury. Cerebral lesions might alter renal function through a neuro-endocrine pathway combining sympathetic system, renin-angiotensin-aldosterone and glucocorticoid activation. Altogether these systems impair renal autoregulation ultimately leading to AKI. In addition, cerebral lesions might lead to a systemic inflammatory response making the kidney vulnerable for dysfunction. Indeed, inflammation and immune system activation are core mechanisms for the development of AKI. Last, direct lesions of specific area of the brain might lead to vasomotor changes and AKI. In this work, we reviewed the epidemiology of AKI after brain injury and examine potential mechanisms suggesting a causal relationship between these two entities.	[Pesonen, Anais] Ctr Hosp Univ Vaudois CHUV, Dept Anesthesia, Lausanne, Switzerland; [Pesonen, Anais; Ben-Hamouda, Nawfel; Schneider, Antoine] Ctr Hosp Univ Vaudois CHUV, Adult Intens Care Unit, Lausanne, Switzerland; [Ben-Hamouda, Nawfel; Schneider, Antoine] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland		Schneider, A (corresponding author), Univ Lausanne UNIL, Adult Intens Care Unit, Ctr Hosp Univ Vaudois CHUV, Fac Biol & Med, 46 Ave Bugnon, Lausanne, Switzerland.	antoine.schneider@chuv.ch	Ben-Hamouda, Nawfel/AAM-2416-2020	Ben-Hamouda, Nawfel/0000-0003-4428-5223	Fondation Leenaards, Lausanne, Switzerland	This study was funded by the Fondation Leenaards, Lausanne, Switzerland.	Arnold J, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1085-0; Audibert G, 2012, Ann Fr Anesth Reanim, V31, pe109, DOI 10.1016/j.annfar.2012.04.014; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Civiletti F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42147-4; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Haselton JR, 1998, AM J PHYSIOL-REG I, V275, pR1334, DOI 10.1152/ajpregu.1998.275.4.R1334; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Imig JD, 2013, COMPR PHYSIOL; Khalid F, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19517; Kim Y, 2016, J IND ENG CHEM, V33, P108, DOI 10.1016/j.jiec.2015.09.023; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Masson P, 2015, NEPHROL DIAL TRANSPL, V30, P1162, DOI 10.1093/ndt/gfv009; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Morariu AM, 2008, AM J TRANSPLANT, V8, P933, DOI 10.1111/j.1600-6143.2008.02166.x; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Nishi EE, 2015, EXP PHYSIOL, V100, P479, DOI 10.1113/expphysiol.2014.079889; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Pratschke Johann, 2004, Ann Transplant, V9, P78; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Sanchez-Fructuoso AI, 2004, TRANSPLANTATION, V78, P142, DOI 10.1097/01.TP.0000134769.65550.70; SCHRAMM LP, 1993, BRAIN RES, V616, P251, DOI 10.1016/0006-8993(93)90216-A; Smets P, 2010, GEN COMP ENDOCR, V169, P1, DOI 10.1016/j.ygcen.2010.07.004; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210; Zhao Q, 2020, J CEREBR BLOOD F MET, V40, P246, DOI 10.1177/0271678X19890931	31	0	0	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUL	2021	87	7					823	827		10.23736/S0375-9393.20.14991-5			5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	TQ9RU	WOS:000678613700012	33054019				2022-02-07	
J	Popovich, M; Almeida, A; Lorincz, M; Eckner, JT; Freeman, J; Streicher, N; Alsalaheen, B				Popovich, Michael; Almeida, Andrea; Lorincz, Matthew; Eckner, James T.; Freeman, Jeremiah; Streicher, Nicholas; Alsalaheen, Bara			Does Exercise Increase Vestibular and Ocular Motor Symptom Detection After Sport-Related Concussion?	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						mild traumatic brain injury; sport-related concussion; supervised exercise challenge; Vestibular; Ocular Motor Screening	PERFORMANCE; RECOVERY; REHABILITATION; RELIABILITY; DIZZINESS; EXERTION; THERAPY	Background and Purpose: Postconcussive vestibular and ocular motor symptoms are common and contribute to longer recovery. The Vestibular/Ocular Motor Screening (VOMS) is used to detect such symptoms, but a VOMS performed at rest may miss symptoms that are only provoked by exertion. Supervised exercise challenges (SECs) have been shown to detect concussion-related symptoms provoked by physical exertion. The purpose of this study was to determine whether athletes undergoing an SEC will exhibit greater symptom provocation with the VOMS compared to a VOMS performed at rest prior to an SEC. Methods: Thirty-six athletes (58.3% male) between ages 10 and 18 years and within 30 days of concussion were included. All participants completed VOMS assessments at rest and immediately after an SEC. VOMS total symptom score increases were calculated for both pre- and post-SEC assessments compared using Wilcoxon ranked sum tests. The frequencies of positive assessments for each VOMS item were compared using McNemar's test. Results: There were significant increases in post-SEC symptom provocation scores compared with pre-SEC scores for all VOMS items. The post-SEC VOMS identified 29 participants (80.6%) as positive in at least 1 VOMS item compared with 21 participants (58.3%) identified as positive pre-SEC (P = 0.008). For all VOMS items, the post-SEC VOMS identified participants who were previously negative on a pre-SEC VOMS but became positive after the SEC. Discussion and Conclusions: An SEC performed prior to a VOMS assessment may increase the detection of vestibular and ocular motor symptoms that may be missed if the VOMS was performed only at rest. Video Abstract available for more insight from the authors (see the Video Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A342).	[Popovich, Michael; Almeida, Andrea; Lorincz, Matthew; Streicher, Nicholas; Alsalaheen, Bara] Univ Michigan, Dept Neurol, Ann Arbor, MI 48105 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48105 USA; [Freeman, Jeremiah] Univ Michigan, Dept Sports Med & Phys Therapy, Ann Arbor, MI 48105 USA		Popovich, M (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48105 USA.	mipopovi@med.umich.edu			Inter-disciplinary research awards, College of Health Sciences, University of Michigan-Flint; The Research and Creative Activity (RCA) award, University of Michigan-Flint; Dr Ben F. Bryer Foundation Medical Research Fund	Dr Alsalaheen received grant support for the current study from Inter-disciplinary research awards, College of Health Sciences, University of Michigan-Flint, The Research and Creative Activity (RCA) award, University of Michigan-Flint and from Dr Ben F. Bryer Foundation Medical Research Fund.	Alsalaheen B, 2020, PEDIATR PHYS THER, V32, P331, DOI 10.1097/PEP.0000000000000729; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cameron Philip W, 2018, Int J Exerc Sci, V11, P462; Yong JPCP, 2020, CLIN J SPORT MED, V30, P353, DOI 10.1097/JSM.0000000000000605; Cohen J., 2013, STAT POWER ANAL BEHA; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Marshall CM, 2019, PHYSICIAN SPORTSMED, V47, P158, DOI 10.1080/00913847.2018.1542258; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Patterson JN, 2017, J AM ACAD AUDIOL, V28, P36, DOI 10.3766/jaaa.15110; Popovich M, 2021, J ATHL TRAINING, V56, P148, DOI 10.4085/1062-6050-0072.20; Popovich M, 2021, CLIN J SPORT MED, V31, P127, DOI 10.1097/JSM.0000000000000721; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Ratka J, 2020, BRAIN INJURY, V34, P110, DOI 10.1080/02699052.2019.1682194; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Rosenthal R., 1994, PARAMETRIC MEASURES; Samuel RD, 2017, J HUM KINET, V57, P85, DOI 10.1515/hukin-2017-0050; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sullivan SJ, 2011, BRIT J SPORT MED, V45, P46, DOI 10.1136/bjsm.2009.071225; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	39	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2021	45	3					214	220		10.1097/NPT.0000000000000356			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	SZ9GX	WOS:000666866500003	33782346				2022-02-07	
J	Pouladian, P; Yamauchi, T; Wakida, NM; Gomez-Godinez, V; Berns, MW; Preece, D				Pouladian, Pegah; Yamauchi, Toyohiko; Wakida, Nicole M.; Gomez-Godinez, Veronica; Berns, Michael W.; Preece, Daryl			Combining quantitative phase microscopy and laser-induced shockwave for the study of cell injury	BIOMEDICAL OPTICS EXPRESS			English	Article							WAVES	In this paper, we propose a new system for studying cellular injury. The system is a biophotonic work station that can generate Laser-Induced Shockwave (LIS) in the cell culture medium combined with a Quantitative Phase Microscope (QPM), enabling the real-time measurement of intracellular dynamics and quantitative changes in cellular thickness during the damage and recovery processes. In addition, the system is capable of Phase Contrast (PhC) and Differential Interference Contrast (DIC) microscopy. Our studies showed that QPM allows us to discern changes that otherwise would be unnoticeable or difficult to detect using phase or DIC imaging. As one application, this system enables the study of traumatic brain injury in vitro. Astrocytes are the most numerous cells in the central nervous system (CNS) and have been shown to play a role in the repair of damaged neuronal tissue. In this study, we use LIS to create a precise mechanical force in the culture medium at a controlled distance from astrocytes and measure the quantitative changes, in order of nanometers, in cell thickness. Experiments were performed in different cell culture media in order to evaluate the reproducibility of the experimental method. (c) 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Pouladian, Pegah; Wakida, Nicole M.; Berns, Michael W.; Preece, Daryl] Univ Calif Irvine, Beckman Laser Inst, Dept Biomed Engn, Irvine, CA 92617 USA; [Yamauchi, Toyohiko] Hamamatsu Photon KK, 5000 Hirakuchi, Shizuoka 4348601, Japan; [Gomez-Godinez, Veronica] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92093 USA		Pouladian, P (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Dept Biomed Engn, Irvine, CA 92617 USA.	ppouladi@uci.edu; dpreece@uci.edu					Berns MW, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00721; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Calabuig A, 2017, J BIOPHOTONICS, V10, P919, DOI 10.1002/jbio.201500340; Carmona C, 2017, PROC SPIE, V10347, DOI 10.1117/12.2274563; Delale CF., 2013, BUBBLE DYNAMICS SHOC, P67, DOI DOI 10.1007/978-3-642-34297-43; Doukas AG, 2004, AIP CONF PROC, V706, P1431; Godinez V. Gomez, FRONT BIOENG BIOTECH, V9, P97; Godinez VG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227849; Hayakawa T, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4971827; Hosokawa Y, 2004, APPL PHYS A-MATER, V79, P795, DOI 10.1007/s00339-004-2823-7; Hosokawa Y, 2019, JPN J APPL PHYS, V58, DOI 10.7567/1347-4065/ab4749; Hu CF, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2018.2869613; Hunt TP, 2006, BIOMED MICRODEVICES, V8, P227, DOI 10.1007/s10544-006-8170-z; Liang XJ, 2007, SENSOR ACTUAT A-PHYS, V133, P349, DOI 10.1016/j.sna.2006.06.045; Lokhandwalla M, 2001, PHYS MED BIOL, V46, P413, DOI 10.1088/0031-9155/46/2/310; Masters Barry R., 2012, Journal of Biomedical Optics, V17, DOI 10.1117/1.JBO.17.2.029901; Miccio L, 2011, BIOMED OPT EXPRESS, V2, P331, DOI 10.1364/BOE.2.000331; Mir M, 2012, PROG OPTICS, V57, P133, DOI 10.1016/B978-0-44-459422-8.00003-5; Mugnano M, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201800099; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Park Y, 2018, NAT PHOTONICS, V12, P578, DOI 10.1038/s41566-018-0253-x; Pavillon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030912; Pouladian P., 2020, OPTICAL TRAPPING OPT; Rau KR, 2006, BIOPHYS J, V91, P317, DOI 10.1529/biophysj.105.079921; Selfridge A, 2015, PROC SPIE, V9548, DOI 10.1117/12.2189724; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Tomura S, 2020, NEUROSCI LETT, V721, DOI 10.1016/j.neulet.2020.134827; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; Wakida NM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.596577; Wakida NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196153; Wakida NM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718920; Yamauchi T., 2018, QUANTITATIVE PHASE I, V10503; Yamauchi T, 2008, OPT EXPRESS, V16, P12227, DOI 10.1364/OE.16.012227; Yamauchi T, 2011, OPT EXPRESS, V19, P5536, DOI 10.1364/OE.19.005536; Yao CP, 2008, IEEE T NANOBIOSCI, V7, P111, DOI 10.1109/TNB.2008.2000742; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	37	0	0	3	3	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	JUL 1	2021	12	7					4020	4031		10.1364/BOE.427693			12	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	TE6IL	WOS:000670114300004	34457396	Green Published, gold			2022-02-07	
J	Powell, JR; Boltz, AJ; Robison, HJ; Morris, SN; Collins, CL; Chandran, A				Powell, Jacob R.; Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.; Chandran, Avinash			Epidemiology of Injuries in National Collegiate Athletic Association Men's Wrestling: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						NCAA wrestling; injury surveillance; descriptive epidemiology	SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY	Context: The first men's wrestling National Collegiate Athletic Association (NCAA) Championship was sponsored in 1928; since then, participation has increased. Background: Continued study of wrestling injury data is essential to identify areas for intervention based on emerging trends. Methods: Exposure and injury data collected in the NCAA Injury Surveillance Program during 2014-2015 through 2018-2019 were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics, and injury rate ratios (IRRs) were used to examine differential injury rates. Results: The overall injury rate was 8.82 per 1000 athlete exposures. The competition injury rate was significantly higher than practice injury rate (IRR = 4.11; 95% CI = 3.72, 4.55). The most commonly injured body parts were the knee (21.4%), shoulder (13.4%), and head/face (13.3%), and the most prevalently reported specific injury was concussion. Summary: These findings provide the most current update to injury incidence and outcomes in NCAA men's wrestling. We identify notable trends that warrant consideration in future research.	[Powell, Jacob R.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Powell, Jacob R.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA; [Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.; Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Powell, Jacob/0000-0002-3899-9433	NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA-ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAAISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate studentathletes.	Agel J, 2007, J ATHL TRAINING, V42, P241; [Anonymous], 2017-18 and 2018-19 major rules changes for wrestling; [Anonymous], Welcome to the ancient Olympic Games; [Anonymous], NCAA Wrestling 2015-16 and 2016-17 rules and interpretations; Barbee c, 2019, NCAA WRESTLING 2019; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P173; Hammer E, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120903699; Irick E., STUDENT ATHLETE PART; Jang TR, 2009, BIOMED ENG-APP BAS C, V21, P215, DOI 10.4015/S1016237209001271; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2018, J ATHL TRAINING, V53, P1143, DOI 10.4085/1062-6050-154-17; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Turocy PS, 2011, J ATHL TRAINING, V46, P322; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Zinder SM, 2010, J ATHL TRAINING, V45, P411, DOI 10.4085/1062-6050-45.4.411	18	0	0	2	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					727	733		10.4085/1062-6050-429-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700019	34280284	gold			2022-02-07	
J	Rakib, F; Al-Saad, K; Ustaoglu, SG; Ullah, E; Mall, R; Thompson, R; Abdelalim, EM; Ahmed, T; Severcan, F; Ali, MHM				Rakib, Fazle; Al-Saad, Khalid; Ustaoglu, Sebnem Garip; Ullah, Ehsan; Mall, Raghvendra; Thompson, Richard; Abdelalim, Essam M.; Ahmed, Tariq; Severcan, Feride; Ali, Mohamed H. M.			Fourier Transform Infrared Imaging-A Novel Approach to Monitor Bio Molecular Changes in Subacute Mild Traumatic Brain Injury	BRAIN SCIENCES			English	Article						fourier transform infrared; traumatic brain injury; biochemical analysis and immunohistochemistry	PENTYLENETETRAZOL-INDUCED SEIZURES; RAT-BRAIN; STRONGLY INTERACTS; LIPID-PEROXIDATION; MODEL MEMBRANES; FT-IR; SPECTROSCOPY; TISSUE; PATHOPHYSIOLOGY; PROTEIN	Traumatic brain injury (TBI) can be defined as a disorder in the function of the brain after a bump, blow, or jolt to the head, or penetrating head injury. Mild traumatic brain injury (mTBI) can cause devastating effects, such as the initiation of long-term neurodegeneration in brain tissue. In the current study, the effects of mTBI were investigated on rat brain regions; cortex (Co) and corpus callosum (CC) after 24 h (subacute trauma) by Fourier transform infrared (FTIR) imaging and immunohistochemistry (IHC). IHC studies showed the formation of amyloid-beta (A beta) plaques in the cortex brain region of mTBI rats. Moreover, staining of myelin basic protein presented the shearing of axons in CC region in the same group of animals. According to FTIR imaging results, total protein and lipid content significantly decreased in both Co and CC regions in mTBI group compared to the control. Due to this significant decrease in both lipid and protein content, remarkable consistency in lipid/protein band ratio in mTBI and control group, was observed. Significant decrease in methyl content and a significant increase in olefinic content were observed in Co and CC regions of mTBI rat brain tissues. Classification amongst distinguishable groups was performed using principal component analysis (PCA) and hierarchical clustering (HCA). This study established the prospective of FTIR imaging for assessing biochemical changes due to mTBI with high sensitivity, precision and high-resolution.	[Rakib, Fazle; Al-Saad, Khalid] Qatar Univ, Dept Chem & Earth Sci, POB 2713, Doha, Qatar; [Ustaoglu, Sebnem Garip] Altinbas Univ, Fac Med, Dept Med Biochem, TR-34218 Istanbul, Turkey; [Ullah, Ehsan; Mall, Raghvendra] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, POB 34110, Doha, Qatar; [Thompson, Richard; Ahmed, Tariq; Ali, Mohamed H. M.] Hamad Bin Khalifa Univ HBKU, Qatar Fdn QF, Qatar Biomed Res Inst QBRI, POB 34110, Doha, Qatar; [Abdelalim, Essam M.] Hamad Bin Khalifa Univ HBKU, Qatar Fdn QF, Qatar Biomed Res Inst QBRI, Diabet Res Ctr, POB 34110, Doha, Qatar; [Abdelalim, Essam M.] Suez Canal Univ, Fac Vet Med, Dept Cytol & Histol, Ismailia 41522, Egypt; [Severcan, Feride] Altinbas Univ, Fac Med, Dept Biophys, TR-34218 Istanbul, Turkey		Ali, MHM (corresponding author), Hamad Bin Khalifa Univ HBKU, Qatar Fdn QF, Qatar Biomed Res Inst QBRI, POB 34110, Doha, Qatar.; Severcan, F (corresponding author), Altinbas Univ, Fac Med, Dept Biophys, TR-34218 Istanbul, Turkey.	fazle@qsneoscience.com; kalsaad@qu.edu.qa; sebnem.garip@altinbas.edu.tr; eullah@hbku.edu.qa; rmall@hbku.edu.qa; ithompson@hbku.edu.qa; emohamed@hbku.edu.qa; taahmed@hbku.edu.qa; feride.severcan@altinbas.edu.tr; moaam@yahoo.com	Mall, Raghvendra/I-9470-2019; Thompson, I Richard/J-9900-2016	Mall, Raghvendra/0000-0003-1779-3150; Thompson, I Richard/0000-0002-9554-550X; Abdelalim, Essam/0000-0001-7764-6772	NPRP Award from the Qatar National Research Fund (a member of The Qatar Foundation) [7-1648-3-420-4]	This study was made possible by a NPRP Award [7-1648-3-420-4] from the Qatar National Research Fund (a member of The Qatar Foundation). The statements made herein are solely the responsibility of the authors.	Abbas S, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.10.105003; Abdelalim EM, 2008, NEUROSCIENCE, V155, P192, DOI 10.1016/j.neuroscience.2008.05.020; Abdelalim EM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00116; Aksoy C, 2019, METHODS MOL BIOL, V2045, P201, DOI 10.1007/7651_2018_119; Aksoy C, 2012, STEM CELLS DEV, V21, P2000, DOI 10.1089/scd.2011.0444; Ali MHM, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030109; Ali MHM, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122436; Ali MHM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00647; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Ariyannur PS, 2021, AGING DIS, V12, P983, DOI 10.14336/AD.2020.1015; Baker MJ, 2018, ANALYST, V143, P1735, DOI 10.1039/c7an01871a; Balbekova A, 2018, APPL SPECTROSC, V72, P241, DOI 10.1177/0003702817734618; Baloglu FK, 2015, ANALYST, V140, P2205, DOI [10.1039/c4an02008a, 10.1039/C4AN02008A]; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Caine S, 2016, NEUROBIOL DIS, V91, P132, DOI 10.1016/j.nbd.2016.03.006; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Depciuch J, 2018, SPECTROCHIM ACTA A, V204, P18, DOI 10.1016/j.saa.2018.06.010; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Ergun S, 2014, BBA-BIOMEMBRANES, V1838, P2798, DOI 10.1016/j.bbamem.2014.07.025; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Garip S, 2010, J PHARMACEUT BIOMED, V52, P580, DOI 10.1016/j.jpba.2010.01.044; Giorgini E, 2018, ANALYST, V143, P3317, DOI 10.1039/c8an00602d; Giorgini E, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.12.125003; Giorgini E, 2015, SPECTROCHIM ACTA A, V141, P99, DOI 10.1016/j.saa.2015.01.052; Goormaghtigh E, 2016, BIOMED SPECTROSC IMA, V5, P325, DOI 10.3233/BSI-160151; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mignolet A, 2016, BBA-PROTEINS PROTEOM, V1864, P85, DOI 10.1016/j.bbapap.2015.08.010; Notarstefano V, 2020, ANALYST, V145, P8038, DOI 10.1039/d0an01623c; Notarstefano V, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201960071; Notarstefano V, 2019, SPECTROCHIM ACTA A, V212, P206, DOI 10.1016/j.saa.2018.12.054; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rakib F, 2021, SPECTROCHIM ACTA A, V248, DOI 10.1016/j.saa.2020.119189; Rakib F, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110293; Rincon S, 2016, HAND CLINIC, V135, P447, DOI 10.1016/B978-0-444-53485-9.00022-2; Severcan F, 2005, ANAL BIOCHEM, V339, P36, DOI 10.1016/j.ab.2005.01.011; Severcan F, 2005, BBA-BIOMEMBRANES, V1668, P215, DOI 10.1016/j.bbamem.2004.12.009; Severcan F, 1997, BIOSCIENCE REP, V17, P231, DOI 10.1023/A:1027341731230; Sevinc A, 2015, BIOMED SPECTROSC IMA, V4, P341, DOI 10.3233/BSI-150123; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Sinke MRT, 2021, J NEUROTRAUM, V38, P1642, DOI 10.1089/neu.2020.7151; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Szczerbowska-Boruchowska M, 2007, ARCH BIOCHEM BIOPHYS, V459, P241, DOI 10.1016/j.abb.2006.12.027; Turker S, 2014, ANAL CHEM, V86, P1395, DOI 10.1021/ac402992j; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Ustaoglu SG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92015-3; Ustaoglu SG, 2018, APPL SPECTROSC, V72, P689, DOI 10.1177/0003702817734617; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wu O, 2006, BRAIN, V129, P2384, DOI 10.1093/brain/awl183; Yonar D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19303-3; Zaninotto ALC, 2018, NEUROMETHODS, V138, P105, DOI 10.1007/978-1-4939-7880-9_4; Zetterberg H., 2015, ANIMAL MODELS CONCUS; Zhang J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170720; Zhang J, 2015, J FORENSIC SCI, V60, P1488, DOI 10.1111/1556-4029.12871	67	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2021	11	7							918	10.3390/brainsci11070918			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TO2GR	WOS:000676737600001	34356152	gold, Green Published			2022-02-07	
J	Ramey, WL; Chapman, JR				Ramey, Wyatt L.; Chapman, Jens R.			Classification Systems What Is Available and a Proposed Alternative	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Spinal cord injury; Neurotrauma; ASIA classification scale; Spine trauma; Spinal cord	SPINAL-CORD-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; SEVERITY SCORE; RELIABILITY; PROGNOSIS; RECOVERY; OUTCOMES; MOTOR		[Ramey, Wyatt L.] Banner Univ Arizona, Dept Neurosurg, Med Ctr Tucson, POB 245070,1501 North Campbell Ave,Room 4303, Tucson, AZ 85724 USA; [Chapman, Jens R.] Swedish Neurosci Inst, Dept Neurosurg, 550 17th Ave, Seattle, WA 98122 USA		Ramey, WL (corresponding author), Banner Univ Arizona, Dept Neurosurg, Med Ctr Tucson, POB 245070,1501 North Campbell Ave,Room 4303, Tucson, AZ 85724 USA.	Wyattr12@email.arizona.edu					Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; American Spinal Injury Association, 2000, ISNCSCI WORKSH; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Burns AS, 2001, SPINE, V26, pS129, DOI 10.1097/00007632-200112151-00022; Burrell HL, 1935, ANN SURG, V42, P481; Catz A, 1997, SPINAL CORD, V35, P850, DOI 10.1038/sj.sc.3100504; Coleman William P, 2004, Spine J, V4, P373, DOI 10.1016/j.spinee.2003.12.006; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; CROZIER KS, 1992, PARAPLEGIA, V30, P762, DOI 10.1038/sc.1992.147; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Frankel H L, 1969, Paraplegia, V7, P179; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Harrop JS, 2009, SPINE, V34, P2525, DOI 10.1097/BRS.0b013e3181bd1402; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Kim CM, 2004, SPINAL CORD, V42, P156, DOI 10.1038/sj.sc.3101569; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Lee JY, 2005, J ORTHOP SCI, V10, P671, DOI 10.1007/s00776-005-0956-y; LONG C I I, 1955, Arch Phys Med Rehabil, V36, P249; Malterud K, 1997, SCAND J PRIM HEALTH, V15, P5, DOI 10.3109/02813439709043420; Marino RJ, 2008, J SPINAL CORD MED, V31, P166, DOI 10.1080/10790268.2008.11760707; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Savic G, 2007, SPINAL CORD, V45, P444, DOI 10.1038/sj.sc.3102044; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Vaccaro AR, 2005, J SPINAL DISORD TECH, V18, P209; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; van Middendorp JJ, 2010, EUR SPINE J, V19, P1238, DOI 10.1007/s00586-010-1415-9; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417	29	0	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2021	32	3			SI		333	340		10.1016/j.nec.2021.03.005			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SJ6RR	WOS:000655660300006	34053721				2022-02-07	
J	Ratajczak, M; Ptak, M; Kwiatkowski, A; Kubicki, K; Fernandes, FAO; Wilhelm, J; Dymek, M; Sawicki, M; Zolkiewski, S				Ratajczak, Monika; Ptak, Mariusz; Kwiatkowski, Artur; Kubicki, Konrad; Fernandes, Fabio A. O.; Wilhelm, Johannes; Dymek, Mateusz; Sawicki, Marek; Zolkiewski, Slawomir			Symmetry of the Human Head-Are Symmetrical Models More Applicable in Numerical Analysis?	SYMMETRY-BASEL			English	Article						finite element head model; symmetry; head biomechanics; brain; skull; human asymmetry	TRAUMATIC BRAIN-INJURY; ASYMMETRY; IMPACT; VALIDATION; COMPLEX; STENT	The study of symmetrical and non-symmetrical effects in physics, mathematics, mechanics, medicine, and numerical methods is a current topic due to the complexity of the experiments, calculations, and virtual simulations. However, there is a limited number of research publications in computational biomechanics focusing on the symmetry of numerical head models. The majority of the models in the researched literature are symmetrical. Thus, we stated a hypothesis wherever the symmetrical models might be more applicable in numerical analysis. We carried out in-depth studies about head symmetry through clinical data, medical images, materials models, and computer analysis. We concluded that the mapping of the entire geometry of the skull and brain is essential due to the significant differences that affect the results of numerical analyses and the possibility of misinterpretation of the tissue deformation under mechanical load results.	[Ratajczak, Monika] Univ Zielona Gora, Fac Mech Engn, Szafrana 4, PL-65516 Zielona Gora, Poland; [Ptak, Mariusz; Dymek, Mateusz; Sawicki, Marek] Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland; [Kwiatkowski, Artur] Prov Specialist Hosp Legnica, Dept Neurosurg, Iwaszkiewicza 5, PL-59220 Legnica, Poland; [Kubicki, Konrad] Wroclaw Med Univ, Dept Neurosurg, Ludwika Pasteura 1, PL-50367 Wroclaw, Poland; [Fernandes, Fabio A. O.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal; [Wilhelm, Johannes] CFturbo GmbH, Unterer Kreuzweg 1, D-01097 Dresden, Germany; [Zolkiewski, Slawomir] Silesian Tech Univ, Fac Mech Engn, Konarskiego 18a, PL-44100 Gliwice, Poland		Ptak, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland.	m.ratajczak@iimb.uz.zgora.pl; mariusz.ptak@pwr.edu.pl; artur.kwiatkowski@szpital.legnica.pl; konrad.kubicki@umed.wroc.pl; fabiofernandes@ua.pt; johannes.wilhelm@cfturbo.com; mateusz.dymek@pwr.edu.pl; sawicki.marek@pwr.edu.pl; slawomir.zolkiewski@polsl.pl	Dymek, Mateusz/AAY-3591-2021; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013	Dymek, Mateusz/0000-0001-7809-6848; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336; Kubicki, Konrad/0000-0002-6140-8363	National Centre for Research and Development, PolandNational Centre for Research & Development, Poland [LIDER/8/0051/L-8/16/NCBR/2017]; Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [CEECIND/01192/2017]	The publication was developed as part of project LIDER/8/0051/L-8/16/NCBR/2017 funded by the National Centre for Research and Development, Poland. Moreover, the researchers under grant CEECIND/01192/2017, acknowledge the support given by Fundacao para a Ciencia e a Tecnologia (FCT).	Arkusz K, 2019, COMPUT METHOD BIOMEC, V22, P313, DOI 10.1080/10255842.2018.1553238; Arkusz K, 2018, ACTA BIOENG BIOMECH, V20, P29, DOI 10.5277/ABB-00882-2017-02; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; Bukala J, 2016, BIOCYBERN BIOMED ENG, V36, P145, DOI 10.1016/j.bbe.2015.10.009; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Chovalopoulou ME, 2017, INT J LEGAL MED, V131, P803, DOI 10.1007/s00414-016-1430-4; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Distriquin Y, 2020, EUR RADIOL EXP, V4, DOI 10.1186/s41747-020-00194-x; Duboc V, 2015, ANNU REV GENET, V49, P647, DOI 10.1146/annurev-genet-112414-055322; Evans CS, 2000, PERCEPTION, V29, P31, DOI 10.1068/p2905; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8; Gaviglio, P 19 INT TECHN C ENH; Gawlikowska A, 2007, HOMO, V58, P159, DOI 10.1016/j.jchb.2006.10.001; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kayaert G, 2009, VISION RES, V49, P708, DOI 10.1016/j.visres.2009.01.002; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klekiel T, 2015, ARCH METALL MATER, V60, P2115, DOI 10.1515/amm-2015-0356; Klekiel T, 2020, J MATER RES TECHNOL, V9, P9004, DOI 10.1016/j.jmrt.2020.06.047; Kong XZ, 2018, P NATL ACAD SCI USA, V115, pE5154, DOI 10.1073/pnas.1718418115; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Li, 2012, INT J VEH SAF, V6, P91, DOI 10.1504/IJVS.2012.049024; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Luders E, 2006, CEREB CORTEX, V16, P1232, DOI 10.1093/cercor/bhj064; Mackiewicz A, 2016, CLIN BIOMECH, V32, P72, DOI 10.1016/j.clinbiomech.2015.11.016; Mackiewicz A, 2016, ACTA MECH AUTOMATICA, V10, P258, DOI 10.1515/ama-2016-0039; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Makin ADJ, 2012, NEUROPSYCHOLOGIA, V50, P3250, DOI 10.1016/j.neuropsychologia.2012.10.003; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MYSLOBODSKY MS, 1987, PERCEPT MOTOR SKILL, V65, P415, DOI 10.2466/pms.1987.65.2.415; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Palka L, 2020, INJURY, V51, P1527, DOI 10.1016/j.injury.2020.03.057; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Ptak M, 2017, LECT N MECH ENG, P431, DOI 10.1007/978-3-319-50938-9_45; Radosevic D, 2020, INT J MORPHOL, V38, P1566; Ratajczak M, 2019, MATERIALS, V12, DOI 10.3390/ma12020271; Roe J.M., 2020, ASYMMETRIC THINNING, DOI [10.1101/2020.06.18.158980, DOI 10.1101/2020.06.18.158980]; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sasaki Y, 2005, P NATL ACAD SCI USA, V102, P3159, DOI 10.1073/pnas.0500319102; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SEIDENWURM D, 1985, AM J NEURORADIOL, V6, P777; Sybilski K, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11041427; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Toma M, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25020022; Wade TJ, 2010, SYMMETRY-BASEL, V2, P1081, DOI 10.3390/sym2021081; Wilhelm J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10134467; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zilles K, 1996, NEUROSCI BIOBEHAV R, V20, P593, DOI 10.1016/0149-7634(95)00072-0; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	64	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-8994		SYMMETRY-BASEL	Symmetry-Basel	JUL	2021	13	7							1252	10.3390/sym13071252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TO6VB	WOS:000677045400001		gold			2022-02-07	
J	Richardson, NM; Lamson, AL				Richardson, Natalie M.; Lamson, Angela L.			Understanding Moral Injury: Military-Related Injuries of the Mind, Body, and Soul	SPIRITUALITY IN CLINICAL PRACTICE			English	Article; Early Access						moral injury; biopsychosocial-spiritual health; military; traumatic brain injury; posttraumatic stress	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SPIRITUAL STRUGGLES; VETERANS; SUICIDE; MODEL; SCALE; GUILT; DEPLOYMENT; SYMPTOMS	As research continues to expand our understanding of moral injury, much remains unknown about these invisible injuries of war, particularly in relation to other stress disorders commonly experienced by military populations. While some overlap in symptomology may exist between other military traumatic stress disorders, including posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI), less is known about the symptoms of moral injury and how those symptoms are unique from or interface with PTSD and TBI. The current review sought to highlight literature on moral injury in the context of military service members by differentiating moral injury and diagnostic symptomology of PTSD and TBI and providing historical context and theoretical exploration of the common injuries experienced by military personnel. The biopsychosocial-spiritual framework was introduced as an important foundation for better understanding the interconnected yet distinct differences between common military experiences that often lead to injuries of the mind (PTSD), body (TBI), and soul (moral injury) for our men and women in uniform. The authors concluded that while significant strides have been made for differentiating between diagnostic criteria for common trauma responses impacting service members and veterans since the 1980s, actions in delineating the deeper rooted morally injurious experiences of military service are needed. Key steps for addressing the gaps in our understanding of and empirically validated treatments for moral injury are also introduced.	[Richardson, Natalie M.; Lamson, Angela L.] East Carolina Univ, Coll Hlth & Human Performance, Dept Human Dev & Family Sci, Greenville, NC 27858 USA		Richardson, NM (corresponding author), East Carolina Univ, Coll Hlth & Human Performance, Dept Human Dev & Family Sci, Greenville, NC 27858 USA.	richardsonna17@students.ecu.edu		Lamson, Angela/0000-0002-9045-1475			American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; American Psychiatric Association (APA), 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association (APA), 2019, DSM HIST; Antal CJ, 2015, RELIG EDUC, V110, P382, DOI 10.1080/00344087.2015.1063962; Barnes HA, 2019, J NEUROPSYCH CLIN N, V31, P98, DOI 10.1176/appi.neuropsych.19020036; Braitman Abby L, 2018, Traumatology (Tallahass Fla), V24, P301, DOI 10.1037/trm0000158; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan A.O., 2014, TRAUMATOLOGY, V20, P154, DOI [10.1037/h0099852, DOI 10.1037/H0099852]; Bryan CJ, 2018, PSYCHOL TRAUMA-US, V10, P36, DOI 10.1037/tra0000290; Bryan CJ, 2016, ASSESSMENT, V23, P557, DOI 10.1177/1073191115590855; Carey LB, 2016, J RELIG HEALTH, V55, P1218, DOI 10.1007/s10943-016-0231-x; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Currier JM, 2019, J TRAUMA STRESS, V32, P393, DOI 10.1002/jts.22378; Currier JM, 2018, CLIN PSYCHOL PSYCHOT, V25, P474, DOI 10.1002/cpp.2170; Currier JM, 2015, CLIN PSYCHOL PSYCHOT, V22, P54, DOI 10.1002/cpp.1866; Dean, 2018, PHYS ARENT BURNING O; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD WORLDW NUMB TBI; Doss BD, 2012, BEHAV THER, V43, P216, DOI 10.1016/j.beth.2011.06.006; Drescher K, 2011, TRAUMATOLOGY, V17, P8, DOI DOI 10.1177/1534765610395615; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Exline JJ, 2014, PSYCHOL RELIG SPIRIT, V6, P208, DOI 10.1037/a0036465; Farnsworth JK, 2019, J TRAUMA STRESS, V32, P373, DOI 10.1002/jts.22356; Farnsworth JK, 2017, J CONTEXT BEHAV SCI, V6, P391, DOI 10.1016/j.jcbs.2017.07.003; Farnsworth JK, 2014, REV GEN PSYCHOL, V18, P249, DOI 10.1037/gpr0000018; Fontana A, 2004, J NERV MENT DIS, V192, P579, DOI 10.1097/01.nmd.0000138224.17375.55; Frankfurt S, 2016, MIL PSYCHOL, V28, P318, DOI 10.1037/mil0000132; Friedman, 2018, PTSD HIST OVERVIEW; FRIEDMAN MJ, 1981, PSYCHOSOMATICS, V22, P931; Fry ST, 2002, NURS ETHICS, V9, P373, DOI 10.1191/0969733002ne522oa; Gray MJ, 2017, COGN BEHAV PRACT, V24, P383, DOI 10.1016/j.cbpra.2017.03.001; Griffin BJ, 2019, J TRAUMA STRESS, V32, P350, DOI 10.1002/jts.22362; Haight W, 2016, CHILD YOUTH SERV REV, V70, P190, DOI 10.1016/j.childyouth.2016.09.026; Harris, 2016, SOCIAL WORK CHRISTIA, V43, P7; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Hepworth J., 2014, MED FAMILY THERAPY I, DOI [10.1037/14256-000, DOI 10.1037/14256-000]; Herman J.L., 1992, TRAUMA RECOVERY; Hodgson TJ, 2017, J RELIG HEALTH, V56, P1212, DOI 10.1007/s10943-017-0407-z; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; HOROWITZ MJ, 1980, ARCH GEN PSYCHIAT, V37, P85; Jansen D.J., 2013, POSTTRAUMATIC STRESS; Jinkerson JD., 2016, TRAUMATOLOGY, V22, P122, DOI [DOI 10.1037/TRM0000069, 10.1037/trm0000069]; Kelley ML, 2019, PSYCHOL TRAUMA-US, V11, P621, DOI 10.1037/tra0000447; Koenig HG, 2020, J NERV MENT DIS, V208, P7, DOI 10.1097/NMD.0000000000001077; Koenig HG, 2018, J RELIG HEALTH, V57, P249, DOI 10.1007/s10943-017-0531-9; Libin A.V., 2019, POSTTRAUMATIC STRESS; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Litz B, 2012, PTSD RES Q, V23, P1; Litz BT, 2019, J TRAUMA STRESS, V32, P341, DOI 10.1002/jts.22405; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Moon Z, 2019, PASTOR PSYCHOL, V68, P93, DOI 10.1007/s11089-017-0795-8; Murray E, 2018, ANN EMERG MED, V72, P322, DOI 10.1016/j.annemergmed.2018.03.040; Nash W, 2016, ADAPTIVE DISCLOSURE; Nash WP, 2013, CLIN CHILD FAM PSYCH, V16, P365, DOI 10.1007/s10567-013-0146-y; National Institute of Neurological Disorders and Stroke, 2017, TRAUMATIC BRAIN INJU; Nazarov A, 2015, ACTA PSYCHIAT SCAND, V132, P4, DOI 10.1111/acps.12406; Neria Y, 2019, J TRAUMA STRESS, V32, P459, DOI 10.1002/jts.22402; Nieuwsma JA, 2015, CURR PSYCHIATRY REV, V11, P193, DOI 10.2174/1573400511666150629105234; Pargament K. I., 2005, JUDEO CHRISTIAN PERS, P245, DOI [10.1037/10859-013, DOI 10.1037/10859-013]; Paul Lisa A, 2014, Am J Psychother, V68, P277; Prins A., 2015, PRIMARY CARE PTSD SC; Richardson NM, 2020, J TRAUMA STRESS, V33, P575, DOI 10.1002/jts.22553; Schorr Y, 2018, J CLIN PSYCHOL, V74, P2203, DOI 10.1002/jclp.22660; Scurfield, 1996, ETHNOCULTURAL ASPECT, DOI [10.1037/10555-000, DOI 10.1037/10555-000]; Shay J., 1994, ACHILLES VIETNAM COM; Shay J., 2002, ODYSSEUS AM COMBAT T; Shay J, 2014, PSYCHOANAL PSYCHOL, V31, P182, DOI 10.1037/a0036090; Smigelsky MA, 2019, J CLIN PSYCHOL, V75, P499, DOI 10.1002/jclp.22714; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Steenkamp MM, 2013, COGN BEHAV PRACT, V20, P471, DOI 10.1016/j.cbpra.2013.05.002; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; United States Department of Veterans Affairs (USDVA), 2018, VA NAT SUIC DAT REP; United States Department of Veterans Affaris (USDVA), 2019, VA DIS COMP PTSD; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wortmann JH, 2017, SPIRITUAL CLIN PRACT, V4, P249, DOI 10.1037/scp0000140; Wright L., 1996, BELIEFS HEART HEALIN; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yeterian JD, 2019, J TRAUMA STRESS, V32, P363, DOI 10.1002/jts.22380; Zerach G, 2018, J CLIN PSYCHOL, V74, P1526, DOI 10.1002/jclp.22598	82	0	0	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2326-4500	2326-4519		SPIRITUAL CLIN PRACT	Spiritual. Clin. Pract.												10.1037/scp0000270		JUL 2021	15	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	XT1OD	WOS:000733364000001					2022-02-07	
J	Rokos, A; Mah, R; Boshra, R; Harrison, A; Choy, TL; Blain-Moraes, S; Connolly, JF				Rokos, Alexander; Mah, Richard; Boshra, Rober; Harrison, Amabilis; Choy, Tsee Leng; Blain-Moraes, Stefanie; Connolly, John F.			Eliciting and Recording Event Related Potentials (ERPs) in Behaviourally Unresponsive Populations: A Retrospective Commentary on Critical Factors	BRAIN SCIENCES			English	Article						disorders of consciousness; electroencephalography; N400; P3b; event related potentials	MINIMALLY CONSCIOUS STATE; COMPLEX SOUND SEQUENCES; SUBJECTS OWN NAME; VEGETATIVE STATE; MISMATCH NEGATIVITY; RECEPTIVE VOCABULARY; REPLY REPLICABILITY; BRAIN POTENTIALS; LEXICAL DECISION; NEURAL RESPONSES	A consistent limitation when designing event-related potential paradigms and interpreting results is a lack of consideration of the multivariate factors that affect their elicitation and detection in behaviorally unresponsive individuals. This paper provides a retrospective commentary on three factors that influence the presence and morphology of long-latency event-related potentials-the P3b and N400. We analyze event-related potentials derived from electroencephalographic (EEG) data collected from small groups of healthy youth and healthy elderly to illustrate the effect of paradigm strength and subject age; we analyze ERPs collected from an individual with severe traumatic brain injury to illustrate the effect of stimulus presentation speed. Based on these critical factors, we support that: (1) the strongest paradigms should be used to elicit event-related potentials in unresponsive populations; (2) interpretation of event-related potential results should account for participant age; and (3) speed of stimulus presentation should be slower in unresponsive individuals. The application of these practices when eliciting and recording event-related potentials in unresponsive individuals will help to minimize result interpretation ambiguity, increase confidence in conclusions, and advance the understanding of the relationship between long-latency event-related potentials and states of consciousness.	[Rokos, Alexander] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3A 2B4, Canada; [Mah, Richard] McMaster Univ, Dept Linguist & Languages, Hamilton, ON L8S 4M2, Canada; [Boshra, Rober] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L8, Canada; [Harrison, Amabilis] St Josephs Healthcare Hamilton, Imaging Res Ctr, Hamilton, ON L8N 4A6, Canada; [Choy, Tsee Leng] McMaster Univ, McMaster Integrat Neurosci Discovery & Study MiND, Hamilton, ON L8S 4L8, Canada; [Blain-Moraes, Stefanie] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada; [Connolly, John F.] Ctr Adv Res Expt & Appl Linguist, Dept Psychol Neurosci & Behav, Hamilton, ON L8S 4K1, Canada		Blain-Moraes, S (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada.	alexander.rokos@mail.mcgill.ca; mahrl@mcmaster.ca; boshrar@mcmaster.ca; amabilis.harrison@gmail.com; tlchoy@hotmail.com; stefanie.blain-moraes@mcgill.ca; jfcnep@gmail.com		Connolly, John/0000-0001-8869-5369	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR [20889]; Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-03817]	J.F.C. was supported by an infrastructure grant from the Canada Foundation for Innovation (#20889); S.B.-M. was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (Discovery RGPIN-2016-03817).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Bernat JL, 2017, ANN NEUROL, V82, P863, DOI 10.1002/ana.25089; Blain-Moraes S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00248; Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; Connolly JF, 1999, ARCH PHYS MED REHAB, V80, P1309, DOI 10.1016/S0003-9993(99)90035-7; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; De Lucia M, 2016, BRAIN, V139, pE32, DOI 10.1093/brain/aww063; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Dhond RP, 2007, HUM BRAIN MAPP, V28, P355, DOI 10.1002/hbm.20282; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; EVANS EF, 1992, PHILOS T R SOC B, V336, P295, DOI 10.1098/rstb.1992.0062; Federmeier KD, 2005, PSYCHOPHYSIOLOGY, V42, P133, DOI 10.1111/j.1469-8986.2005.00274.x; Fins JJ, 2015, RIGHTS COME MIND BRA; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2008, CLIN NEUROPHYSIOL, V119, P2224, DOI 10.1016/j.clinph.2008.03.035; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Garrido MI, 2007, P NATL ACAD SCI USA, V104, P20961, DOI 10.1073/pnas.0706274105; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Harrison AH, 2013, NEUROSCI BIOBEHAV R, V37, P1403, DOI 10.1016/j.neubiorev.2013.05.004; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; JENNETT B, 1972, LANCET, V1, P734; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Kutas M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P406; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Luck S. J., 2011, OXFORD HDB EVENT REL; Lugo ZR, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00569; Mah RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200793; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1995, EAR HEARING, V16, P6; Naccache L, 2016, CORTEX, V85, P126, DOI 10.1016/j.cortex.2016.04.003; Naccache L, 2016, BRAIN, V139, pE31, DOI 10.1093/brain/aww060; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2013, ANNU REV PSYCHOL, V64, P109, DOI 10.1146/annurev-psych-113011-143729; Paszkiel S, 2020, STUD COMPUT INTELL, V852, P3, DOI 10.1007/978-3-030-30581-9_2; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Real RGL, 2016, CLIN NEUROPHYSIOL, V127, P1395, DOI 10.1016/j.clinph.2015.07.020; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Silverstein BH, 2015, CORTEX, V73, P216, DOI 10.1016/j.cortex.2015.09.004; SUGG MJ, 1995, BIOL PSYCHOL, V41, P255, DOI 10.1016/0301-0511(95)05136-8; Tzovara A, 2015, BRAIN, V138, pE396, DOI 10.1093/brain/awv186; Tzovara A, 2015, BRAIN, V138, P1160, DOI 10.1093/brain/awv041; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Ziegler JC, 1999, PSYCHOPHYSIOLOGY, V36, P775, DOI 10.1111/1469-8986.3660775	75	0	0	9	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2021	11	7							835	10.3390/brainsci11070835			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TO8YB	WOS:000677188400001	34202435	Green Published			2022-02-07	
J	Sander, AM; Ketchum, JM; Lequerica, AH; Pappadis, MR; Bushnik, T; Hammond, FM; Sevigny, M				Sander, Angelle M.; Ketchum, Jessica M.; Lequerica, Anthony H.; Pappadis, Monique R.; Bushnik, Tamara; Hammond, Flora M.; Sevigny, Mitch			Primary Language and Participation Outcomes in Hispanics With Traumatic Brain Injury: A Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community participation; disparities; primary language; traumatic brain injuries	COMMUNITY INTEGRATION; ETHNIC DISPARITIES; REHABILITATION; ACCULTURATION; RACE/ETHNICITY; PERFORMANCE; DISCHARGE; RACE	Objective: To examine the relationship between primary language and participation outcomes in English- and Spanish-speaking persons with complicated mild to severe traumatic brain injury (TBI) at 1 year post-injury. Setting: Community following discharge from inpatient rehabilitation. Participants: A total of 998 Hispanic participants with outcomes available at year 1 follow-up; 492 (49%) indicated English as their primary language and 506 (51%) indicated Spanish as their primary language. Design: Prospective, multicenter, cross-sectional, observational cohort study. Main Measures: Community participation at 1 year post-injury was assessed by 3 domains of the Participation Assessment with Recombined Tools-Objective (PART-O): Out and About, Productivity, and Social Relations. Results: Unadjusted group comparisons showed better participation outcomes for English versus Spanish speakers for all PART-O domains and for the Balanced Total score. After controlling for relevant covariates, English-speaking participants had significantly better PART-O Balanced Total scores and better scores on the Social Relations domain, although effect sizes were small. Conclusions: Hispanic persons with TBI whose primary language is Spanish may require greater assistance integrating socially back into their communities after TBI. However, potential cultural differences in value placed on various social activities must be considered. Potential cultural bias inherent in existing measures of participation should be investigated in future studies.	[Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.; Pappadis, Monique R.] TIRR Mem Herman, Brain Injury Res Ctr, Houston, TX USA; [Ketchum, Jessica M.; Sevigny, Mitch] Craig Hosp, Res Dept, Englewood, CO USA; [Lequerica, Anthony H.] Kessler Fdn, E Hanover, NJ USA; [Lequerica, Anthony H.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Pappadis, Monique R.] Univ Texas Med Branch Galveston, Sch Hlth Profess, Div Rehabil Sci, Galveston, TX USA; [Bushnik, Tamara] Rusk Rehabil, New York, NY USA; [Bushnik, Tamara] NYU Langone Hlth, New York, NY USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu		Bushnik, Tamara/0000-0003-3328-257X	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG024832, P30 AG059301] Funding Source: Medline; NIMHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [L60 MD009326] Funding Source: Medline; ACL HHS [90DPTB0010, 90DP0036, 90DPTB0016, 90DPTB0003, 90DPTB0007, 90DP0084, 90DPTB0002] Funding Source: Medline		Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Embretson S.E., 2013, ITEM RESPONSE THEORY; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Jamison L, 2012, BRAIN INJURY, V26, P805, DOI 10.3109/02699052.2012.655367; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Ketchum JM, 2020, J HEAD TRAUMA REHAB, V35, P254, DOI 10.1097/HTR.0000000000000566; Krch D, 2015, CLIN NEUROPSYCHOL, V29, P624, DOI 10.1080/13854046.2015.1063696; Lequerica AH, 2019, J HEAD TRAUMA REHAB, V34, pE46, DOI 10.1097/HTR.0000000000000398; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Okazaki S, 1995, PSYCHOL ASSESSMENT, V7, P367, DOI 10.1037/1040-3590.7.3.367; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Setodji CM, 2011, MED CARE, V49, P461, DOI 10.1097/MLR.0b013e318207edb5; Shen BJ, 2001, AM J COMMUN PSYCHOL, V29, P387, DOI 10.1023/A:1010338413293; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2019 TRAUM BRAIN INJ 2019 TRAUM BRAIN INJ; United States Census Bureau, 2020, DET LANG SPOK HOM AB DET LANG SPOK HOM AB; US Census Bureau, 2010, ANN EST RES POP SEX ANN EST RES POP SEX; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	32	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E218	E225		10.1097/HTR.0000000000000655			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100003	33656477	Green Accepted			2022-02-07	
J	Santo, AL; Reed, JM; Lynall, RC				Santo, Ashley L.; Reed, Julianna M.; Lynall, Robert C.			Tandem gait test performance in healthy, physically active adults: Clinical implications for concussion evaluation	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Balance; Postural control; Musculoskeletal equilibrium	DUAL-TASK; SINGLE-TASK; POSTURAL CONTROL; ASSOCIATIONS; STRATEGIES; BALANCE; VALUES	Objectives: To identify factors affecting performance on the tandem gait test in healthy, physically active adults. Design: Cross-sectional. Methods: Participants completed the tandem gait test according to Sport Concussion Assessment Tool 3 (SCAT3) guidelines. Dependent variables included time for best trial (initial 3 m, turn, final 3 m and total) and whether the trial was "pass" or "fail". Independent variables included sex, concussion history, foot length, height and total number of trials. Results: 55% (35/64) of participants passed the first trial of the tandem gait test; 19% (12/64) had a best time <14 s. Sex and concussion history did not affect performance (p > 0.05). There were no differences in turn times for those with and without a history of concussion (t = 0.26, p = 0.80). The number of trials was not significantly correlated with best time (& thorn; = & minus;0.04, p = 0.74). There were low (& thorn; = & minus;0.31) to negligible (& thorn; < 0.30) correlations between foot length, height and all portions of the test. There was more variability in times for the turn (COV = 27%) than during the straight portions (COV = 18%). Conclusions: Current recommendations for the tandem gait test led to a high false-positive rate in healthy, physically active adults. Sex, concussion history, number of trials and foot length had little to no influence on scores on the test. Turning times were more variable than times on the straight portions of the test. Clinicians may use these results as a guideline when interpreting performance on the tandem gait test in healthy physically active adults. (c) 2021 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Santo, Ashley L.; Reed, Julianna M.] Towson Univ, Dept Kinesiol, Towson, MD 21252 USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Santo, AL (corresponding author), Towson Univ, Dept Kinesiol, Towson, MD 21252 USA.	asanto@towson.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Bryk KN, 2020, J SCI MED SPORT; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Galea OA, 2019, MUSCULOSKEL SCI PRAC, V42, P166, DOI 10.1016/j.msksp.2019.04.006; Gray M, 2020, PHYS THER SPORT, V42, P68, DOI 10.1016/j.ptsp.2020.01.001; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Kaminski TW, 2017, SPORTS HEALTH, V379, P312; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Manaseer TS, 2020, INT J SPORTS PHYS TH, V15, P487, DOI 10.26603/ijspt20200487; Mayhew JL, 2010, J STRENGTH COND RES, V24, P447, DOI 10.1519/JSC.0b013e3181c08860; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Muehlbauer T, 2015, SPORTS MED, V45, P1671, DOI 10.1007/s40279-015-0390-z; Mukaka MM, 2012, MALAWI MED J, V24, P69; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Paillard T, 2006, J ATHL TRAINING, V41, P172; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; SCAT3, 2013, BRIT J SPORT MED, V47, p259L; Schatz P, 2017, BRIT J SPORT MED, V51, pA78; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Smela P., 2017, ACTA FAC ED PHYS U C, V57, P125, DOI https://doi.org/10.1515/afepuc-2017-0012; Strobach T, 2017, ADV COGN PSYCHOL, V13, P28, DOI 10.5709/acp-0204-7	34	0	0	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2021	24	7					622	626		10.1016/j.jsams.2021.01.005			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SL1PO	WOS:000656691600003	33551351				2022-02-07	
J	Sarmiento, K; Waltzman, D; Devine, O; Zhang, XJ; DePadilla, L; Kresnow, MJ; Borradaile, K; Hurwitz, A; Jones, D; Goyal, R; Breiding, MJ				Sarmiento, Kelly; Waltzman, Dana; Devine, Owen; Zhang, Xinjian; DePadilla, Lara; Kresnow, Marcie-Jo; Borradaile, Kelley; Hurwitz, Andrew; Jones, David; Goyal, Ravi; Breiding, Matthew J.			Differences in Head Impact Exposures Between Youth Tackle and Flag Football Games and Practices: Potential Implications for Prevention Strategies	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head impact; practice; game; football; concussion; sensor	EMERGENCY-DEPARTMENT VISITS; TRAUMATIC BRAIN-INJURIES; HIGH-SCHOOL; UNITED-STATES; PLAYERS; ACCELERATION; KINEMATICS; MAGNITUDE; CHILDREN	Background: Interventions designed to reduce the risk for head impacts and concussion in youth football have increased over the past decade; however, understanding of the role of regular game play on head impact exposure among youth tackle and flag football athletes is currently limited. Purpose: To explore head impact exposure among youth tackle and flag football athletes (age range, 6-14 years) during both practices and games. Study Design: Cohort study; Level of evidence, 2. Methods: Using the Vector MouthGuard sensor, the authors collected head impact data from 524 tackle and flag youth football athletes over the course of a football season. Quantities of interest were estimated from regression models using Bayesian methods. Results: For impacts >= 10g, a tackle football athlete had an estimated 17.55 (95% CI, 10.78-28.96) times more head impacts per practice compared with a flag football athlete (6.85 [95% CI, 6.05-7.76] and 0.39 [95% CI, 0.24-0.62] head impacts, respectively). Additionally, a tackle football athlete had an estimated 19.48 (95% CI, 12.74-29.98) times more head impacts per game compared with a flag football athlete (13.59 [95% CI, 11.97-15.41] and 0.70 [95% CI, 0.46-1.05] head impacts, respectively). Among tackle football athletes, the estimated average impact rate was 6.51 (95% CI, 5.75-7.37) head impacts during a practice and 12.97 (95% CI, 11.36-14.73) impacts during a game, resulting in 2.00 (95% CI, 1.74-2.29) times more >= 10g head impacts in games versus practices. Tackle football athletes had 2.06 (95% CI, 1.80-2.34) times more high-magnitude head impacts (>= 40g) during a game than during a practice. On average, flag football athletes experienced an estimated 0.37 (95% CI, 0.20-0.60) head impacts during a practice and 0.77 (95% CI, 0.53-1.06) impacts during a game, resulting in 2.06 (95% CI, 1.29-3.58) times more >= 10g head impacts in games versus practices. Because of model instability caused by a large number of zero impacts for flag football athletes, a comparison of high-magnitude head impacts is not reported for practices or games. Conclusion: This study provides a characterization of the head impact exposure of practices and games among a large population of youth tackle and flag football athletes aged 6 to 14 years. These findings suggest that a greater focus on game-based interventions, such as fair play interventions and strict officiating, may be beneficial to reduce head impact exposures for youth football athletes.	[Sarmiento, Kelly; Waltzman, Dana; Devine, Owen; Zhang, Xinjian; DePadilla, Lara; Kresnow, Marcie-Jo; Borradaile, Kelley; Hurwitz, Andrew; Jones, David; Goyal, Ravi; Breiding, Matthew J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Sarmiento, Kelly; Waltzman, Dana; Zhang, Xinjian; Kresnow, Marcie-Jo; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Hwy NE,MS S106-09, Atlanta, GA 30341 USA; [Devine, Owen] Premier Fed Inc, Atlanta, GA USA; [DePadilla, Lara] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Overdose Prevent, Atlanta, GA USA; [Borradaile, Kelley; Hurwitz, Andrew; Jones, David; Goyal, Ravi] Math Policy Inc, Princeton, NJ USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Prevent, 4770 Buford Hwy NE,MS S106-09, Atlanta, GA 30341 USA.	ksarmiento@cdc.gov			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [2016-N-17798]	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded by the Centers for Disease Control and Prevention, contract solicitation BAA#2016-N-17798. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bellamkonda S, 2018, J APPL BIOMECH, V34, P354, DOI 10.1123/jab.2017-0207; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Chinn NR., 2016, BMJ OPEN SPORT EXERC, V2; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Council on Sports Medicine and Fitness, 2015, PEDIATRICS, V136, P1430; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Higgins M, 2007, J ATHL TRAINING, V42, P5; Kercher K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237800; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kriz PK, 2019, AM J SPORT MED, V47, P438, DOI 10.1177/0363546518815886; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Lynall RC, 2017, J NEUROTRAUM, V34, P2684, DOI 10.1089/neu.2017.5032; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Pfaller AY, 2019, AM J SPORT MED, V47, P2294, DOI 10.1177/0363546519860120; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Santos MP, 2004, PEDIATR EXERC SCI, V16, P210, DOI 10.1123/pes.16.3.210; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Snyder D, 2016, VECTOR MOUTHGUARD DA; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; The Aspen Institute, STAT PLAY TRENDS DEV; Todd RA, 2019, INJURY PREV, V25, P211, DOI 10.1136/injuryprev-2016-042272; Waltzman D, 2021, SPORTS HEALTH, V13, P454, DOI 10.1177/1941738121992324; Waltzman D, 2020, MMWR-MORBID MORTAL W, V69, P870, DOI 10.15585/mmwr.mm6927a4; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Williams D, RETHINKING ROBUST ST; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	49	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2021	49	8					2218	2226		10.1177/03635465211011754			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TC4KN	WOS:000668609500033	33999722				2022-02-07	
J	Sarmiento, K; Daugherty, J; Haarbauer-Krupa, J				Sarmiento, Kelly; Daugherty, Jill; Haarbauer-Krupa, Juliet			Healthcare Providers' Self-Reported Pediatric Mild Traumatic Brain Injury Diagnosis, Prognosis, and Management Practices: Findings From the 2019 DocStyles Survey	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; guideline; mTBI; TBI	CONCUSSION CARE; DISCHARGE INSTRUCTIONS; EMERGENCY-DEPARTMENT; HEAD-INJURY; CHILDREN; GUIDELINES; IMPLEMENTATION; STRATEGIES; KNOWLEDGE; OUTCOMES	Objective: To assess adherence to 5 key recommendations in the Centers for Disease Control and Prevention evidence-based guideline on pediatric mild traumatic brain injury, this article presents results from the 2019 DocStyles survey. Study Design: Cross-sectional, web-based survey of 653 healthcare providers. Results: Most healthcare providers reported adhering to the recommendations regarding the use of computed tomography and providing education and reassurance to patients and their families. However, less than half reported routinely examining their patients with mild traumatic brain injury (mTBI) using age-appropriate, validated symptom scales, assessing for risk factors for prolonged recovery, and advising patients to return to noncontact, light aerobic activities within 2 to 3 days. Self-reported mTBI diagnosis, prognosis, and management practices varied by specialty. Only 3.8% of healthcare providers answered all 7 questions in a way that is most consistent with the 5 recommendations examined from the Centers for Disease Control and Prevention Pediatric mTBI Guideline. Conclusion: This study highlights several important information gaps regarding pediatric mTBI diagnosis and management. Further efforts to improve adoption of guideline recommendations may be beneficial to ensure optimal outcomes for children following an mTBI.	[Sarmiento, Kelly; Daugherty, Jill; Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE, Atlanta, GA 30341 USA		Sarmiento, K (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	KSarmiento@cdc.gov					[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Campanella P, 2016, EUR J PUBLIC HEALTH, V26, P60, DOI 10.1093/eurpub/ckv122; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Centers for Disease Control and Prevention, 2018, CDC PED MTBI GUID TA CDC PED MTBI GUID TA; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2017, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention and others, 2003, REP C MILD TRAUM BRA REP C MILD TRAUM BRA; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Donnell Z, 2018, J SAFETY RES, V67, P203, DOI 10.1016/j.jsr.2018.09.006; Echemendia RJ, 2018, HAND CLINIC, V158, P179, DOI 10.1016/B978-0-444-63954-7.00018-5; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Koval RR, 2020, ANN EMERG MED, V75, P483, DOI 10.1016/j.annemergmed.2019.08.419; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinlay Audrey, 2018, Concussion, V3, pCNC52, DOI 10.2217/cnc-2017-0017; Nelson LD, 2017, CLIN J SPORT MED, V27, P381, DOI 10.1097/JSM.0000000000000369; Newnham H, 2017, INT J QUAL HEALTH C, V29, P752, DOI 10.1093/intqhc/mzx121; Nigrovic LE, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1495; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Reisner A, 2017, J PEDIATR-US, V184, P26, DOI 10.1016/j.jpeds.2017.01.045; Sarmiento K, 2020, CLIN NEUROPSYCHOL, V34, P259, DOI 10.1080/13854046.2019.1660806; Sarmiento K, 2020, CLIN J SPORT MED, V30, P612, DOI 10.1097/JSM.0000000000000704; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	61	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		282	292		10.1097/HTR.0000000000000671			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100015	33656487	Green Accepted			2022-02-07	
J	Schijns, OEMG; Koehler, PJ				Schijns, Olaf E. M. G.; Koehler, Peter J.			On the Threshold of Scientific Medicine: Gerard van Swieten and His Perception of the Pathophysiology in Traumatic Brain Injury	EUROPEAN NEUROLOGY			English	Article						Gerard van Swieten; Traumatic brain injury		Gerard van Swieten (1700-1772), famous pupil of Professor Herman Boerhaave (1668-1738) of Leiden University and personal physician of Austrian Habsburg Empress Maria Theresa (1717-1780). Herman Boerhaave was a renowned Dutch physician inside and outside Europe in the 18th century. He was not only appointed professor in medicine, chemistry, and botany but also a chancellor of the Leiden University in 1714 and published his well-known Aphorismi de cognoscendis et curandis morbis in 1709. Gerard van Swieten commented upon Boerhaave's aphorisms and demonstrated actual knowledge, less well-known among the medical community, about the pathophysiology of traumatic brain injury which half a century later (19th century) became known as the Monro-Kellie doctrine. Using the original commentaries upon Boerhaave's aphorisms by van Swieten himself, we explored his way of formulating the pathophysiological concept of traumatic brain injury, which still is valid today.	[Schijns, Olaf E. M. G.] Maastricht Univ, Dept Neurosurg, Med Ctr MUMC, Maastricht, Netherlands; [Schijns, Olaf E. M. G.] Maastricht Univ, Acad Ctr Epileptol, Med Ctr MUMC, Maastricht, Netherlands; [Schijns, Olaf E. M. G.] Kempenhaeghe, Maastricht, Netherlands; [Schijns, Olaf E. M. G.] Univ Maastricht UM, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands; [Koehler, Peter J.] Univ Maastricht, Fac Hlth Med & Life Sci, Maastricht, Netherlands		Schijns, OEMG (corresponding author), Maastricht Univ, Dept Neurosurg, Med Ctr MUMC, Maastricht, Netherlands.; Schijns, OEMG (corresponding author), Maastricht Univ, Acad Ctr Epileptol, Med Ctr MUMC, Maastricht, Netherlands.; Schijns, OEMG (corresponding author), Kempenhaeghe, Maastricht, Netherlands.; Schijns, OEMG (corresponding author), Univ Maastricht UM, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands.	o.schijns@mumc.nl					Greenblatt, 2007, BRAIN, V130, P303; Haller, 1786, 1 LINES PHYSL, V1; Kellie G, 1824, T MED CHIR SOC EDIN, V1, P82; Kidd M, 2001, WORLD J SURG, V25, P444, DOI 10.1007/s002680020117; LESKY E, 1958, Gesnerus, V15, P120; Macintyre I, 2014, J MED BIOGR, V22, P93, DOI 10.1177/0967772013479271; Monro A., 1783, OBSERVATIONS STRUCTU; Neuburger M., 1897, HISTORISCHE ENTWICKL; Van Swieten G, 1759, COMMENTARIES BOERHAA, V2; Voogd Jan, 2018, Handb Clin Neurol, V154, P3, DOI 10.1016/B978-0-444-63956-1.00001-1; Willis T., 1664, CEREBRI ANATOME CUI	11	0	0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.	AUG	2021	84	5					393	398		10.1159/000517001		JUL 2021	6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UB9SD	WOS:000668963200001	34198304	hybrid			2022-02-07	
J	Seehusen, CN; Wilson, JC; Walker, GA; Reinking, SE; Howell, DR				Seehusen, Corrine N.; Wilson, Julie C.; Walker, Gregory A.; Reinking, Sarah E.; Howell, David R.			More Physical Activity after Concussion Is Associated with Faster Return to Play among Adolescents	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mild traumatic brain injury; pediatric; rehabilitation; exercise	STATEMENT; RECOVERY; CHILDREN; INJURY; RISK	Concussion management has evolved to de-emphasize rest in favor of early introduction of post-injury physical activity. However, the optimal quantity, frequency and intensity of physical activity are unclear. Our objective was to examine the association between objective physical activity metrics and clinical recovery after concussion. We prospectively enrolled a cohort of 32 youth athletes with concussion, evaluated within 14 days of injury and after return-to-play (RTP) clearance. For two weeks after enrollment, we quantified steps/day and exercise frequency, duration, and intensity via wrist-worn actigraphy. We grouped participants by RTP clearance timing (<28 days vs. >= 28 days). Seventeen (53%) participants required >= 28 days post-concussion for RTP clearance. Groups were similar in age (14.9 +/- 1.9 vs. 15.4 +/- 1.5 years; p = 0.38), proportion of females (47% vs. 40%; p = 0.69), and concussion history (59% vs. 47%; p = 0.49). During the study period, the RTP >= 28 days group took fewer steps/day (8158 +/- 651 vs. 11,147 +/- 4013; p = 0.02), exercised fewer days/week (2.9 +/- 2.4 vs. 5.0 +/- 1.9 days/week; p = 0.01), and exercised fewer total minutes/week (117 +/- 122 vs. 261 +/- 219 min/week; p = 0.03). Furthermore, we observed >= 10,251 average steps/day, >= 4 exercise sessions/week, and exercising >= 134 total minutes/week were optimal cutpoints to distinguish between groups. These findings support the benefit of physical activity during concussion recovery.	[Seehusen, Corrine N.; Wilson, Julie C.; Walker, Gregory A.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Wilson, Julie C.; Walker, Gregory A.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Reinking, Sarah E.] Childrens Hosp Colorado, Phys Therapy Dept, Aurora, CO 80045 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA.	corrine.seehusen@childrenscolorado.org; julie.wilson@childrenscolorado.org; gregory.walker@childrenscolorado.org; sarah.reinking@childrenscolorado.org; David.Howell@CUAnschutz.edu		Walker, Gregory/0000-0003-4919-4638; Howell, David/0000-0002-2955-0191	Children's Hospital Colorado Research Institute Pilot Grant Program	This research was funded by the Children's Hospital Colorado Research Institute Pilot Grant Program.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Fuller D, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/18694; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Howell DR, 2021, AM J SPORT MED, V49, P1912, DOI 10.1177/03635465211005761; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Huber DL, 2019, J ATHL TRAINING, V54, P929, DOI 10.4085/1062-6050-93-18; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Montes Jeffrey, 2020, Int J Exerc Sci, V13, P410; Pierpoint LA, 2021, CLIN SPORT MED, V40, P1, DOI 10.1016/j.csm.2020.08.013; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Silverberg ND, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00362; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-78; Varner CE, 2021, ACAD EMERG MED, V28, P493, DOI 10.1111/acem.14215; Wingerson Mathew J, 2020, J Athl Train, DOI 10.4085/323-20; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	27	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUL	2021	18	14							7373	10.3390/ijerph18147373			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	TO3RQ	WOS:000676833700001	34299824	Green Published, gold			2022-02-07	
J	Shafiee, S; Zali, A; Shafizad, M; Zeydi, AE; Ehteshami, S; Rezaii, F; Tafakhori, A; Ertiaei, A; Darvishi-Khezri, H; Khademloo, M; Khoshnood, RJ				Shafiee, Sajad; Zali, Alireza; Shafizad, Misagh; Zeydi, Amir Emami; Ehteshami, Saeid; Rezaii, Fatemeh; Tafakhori, Abbas; Ertiaei, Abolhasan; Darvishi-Khezri, Hadi; Khademloo, Mohammad; Khoshnood, Reza Jalili			The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial	ETHIOPIAN JOURNAL OF HEALTH SCIENCES			English	Article						Simvastatin; Brain Injuries; Traumatic; Glasgow Outcome Scale; Patient Outcome Assessment	STATIN USE; THERAPY; NEUROINFLAMMATION; CHOLESTEROL; INVOLVEMENT; SURVIVAL; SAFETY; RATS; CARE	BACKGROUND: Despite recent promising pharmacological and technological advances in neurosurgical intensive care, the overall TBI-related mortality and morbidity remain high and still pose a major clinical problem. The aim of this study was to evaluate the effect of oral simvastatin on the clinical outcome of patients with severe TBI. METHODS: In a double-blind placebo-controlled randomized clinical trial a total of 98 patients with severe TBI in Imam Khomeini Hospital in Sari, Iran, were evaluated Patients who meet the inclusion criteria were randomly allocated into two groups (n=49). In addition to supportive therapies, the intervention group received oral simvastatin (40 mg, daily) for 10 days, and the control group received the placebo (10 days). Patients' Glasgow coma scale (GCS) score, in hospital mortality, duration of mechanical ventilation and length of ICU and neurosurgery ward stay were evaluated during three-time intervals (T1: admission, T2: discharge and T3: one month after discharge). RESULTS: The percentage of conscious patients was 18.9% (7 cases) in the simvastatin group and 3.1% (1 case) in controls (P=0.06) at T2. One month after discharge (T3) the proportion of conscious patients significantly increased in the simvastatin group compared to control group (64.9 % versus 28.1 %; P=0.002). There was no significant difference for the mean of GCS score between the simvastatin group and control group at T1 (6.41 +/- 1.30 versus 6.41 +/- 1.28, respectively; P = 0.98). However, the mean score of GCS in patients who received simvastatin was significantly greater than controls at T2 and T3 (p<0.05). There was no significant differences between two group in-terms of length of mechanical ventilation, ICU and neurosurgery ward stay. CONCLUSION: According to the results of this study it seems that using simvastatin may be an effective and promising therapeutic modality for improving GCS score during TBI recovery.	[Shafiee, Sajad; Shafizad, Misagh; Ehteshami, Saeid] Mazandaran Univ Med Sci, Orthoped Res Ctr, Dept Neurosurg, Sari, Iran; [Zali, Alireza; Khoshnood, Reza Jalili] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohadaye Tajrish Neurosurg Ctr Excellence, Tehran, Iran; [Zeydi, Amir Emami] Mazandaran Univ Med Sci, Nasibeh Sch Nursing & Midwifery, Dept Med Surg Nursing, Sari, Iran; [Rezaii, Fatemeh] Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran; [Tafakhori, Abbas] Univ Tehran Med Sci, Iranian Ctr Neurol Res ICNR, Neurosci Inst, Tehran, Iran; [Ertiaei, Abolhasan] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurosurg, Tehran, Iran; [Darvishi-Khezri, Hadi] Mazandaran Univ Med Sci, Thalassemia Res Ctr TRC, Hemoglobinopathy Inst, Sari, Iran; [Khademloo, Mohammad] Mazandaran Univ Med Sci, Fac Med, Dept Community Med, Sari, Iran		Khoshnood, RJ (corresponding author), Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohadaye Tajrish Neurosurg Ctr Excellence, Tehran, Iran.	drkhoshnoud76@gmail.com		Zali, Alireza/0000-0002-2298-2290	Mazandaran University of Medical Sciences, Sari, Iran	Mazandaran University of Medical Sciences, Sari, Iran.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Anghinah R, 2018, ARQ NEURO-PSIQUIAT, V76, P100, DOI [10.1590/0004-282X20170196, 10.1590/0004-282x20170196]; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hoglund K, 2007, CNS DRUGS, V21, P449; Hu M, 2012, THER ADV DRUG SAF, V3, P133, DOI 10.1177/2042098612439884; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Jansen JO, 2013, CRIT CARE, V17, DOI 10.1186/cc12499; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Khokhar B, 2018, J HEAD TRAUMA REHAB, V33, pE68, DOI 10.1097/HTR.0000000000000369; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lokhandwala A, 2020, J SURG RES, V245, P367, DOI 10.1016/j.jss.2019.07.081; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Naghibi T, 2016, TURK J MED SCI, V46, P1, DOI 10.3906/sag-1404-125; Neilson SJ, 2016, BRAIN INJURY, V30, P993, DOI 10.3109/02699052.2016.1147599; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pedersen TR, 2004, EXPERT OPIN PHARMACO, V5, P2583, DOI 10.1517/14656566.5.12.2583; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Ramkumar S, 2016, ACTA CARDIOL SIN, V32, P631, DOI 10.6515/ACS20160611A; Robertson CS, 2017, J NEUROTRAUM, V34, P1394, DOI 10.1089/neu.2016.4717; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Vergouwen MDI, 2009, J CEREBR BLOOD F MET, V29, P1444, DOI 10.1038/jcbfm.2009.59; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang KW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/910260; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Whyte J, 2019, J NEUROTRAUM, V36, P118, DOI 10.1089/neu.2017.5545; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	41	0	0	0	0	JIMMA UNIV, ETHIOPIA	JIMMA	PO BOX 378, JIMMA, OROMIA 00000, ETHIOPIA	1029-1857	2413-7170		ETHIOP J HEALTH SCI	Ethiop. J. Health Sci.	JUL	2021	31	4					807	816		10.4314/ejhs.v31i4.15			10	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	XU6XW	WOS:000734406000015	34703180				2022-02-07	
J	Shahryari, M; Bibak, B; Khaksari, M; Keshavarzi, ZE; Salmani, N; Shirazpour, S; Alimandi, F				Shahryari, Marzieh; Bibak, Bahram; Khaksari, Mohammad; Keshavarzi, Zaki Eh; Salmani, Neda; Shirazpour, Sara; Alimandi, Fatemeh			Anti-edema effect of Aloe vera leaf extract following traumatic brain injury: Role of pro-inflammatory cytokines	AVICENNA JOURNAL OF PHYTOMEDICINE			English	Article						Aloe vera; Traumatic brain injury; Brain edema; IL-1 beta; TNF-alpha; TGF-beta	TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE-2; SEX STEROID-HORMONES; AXONAL INJURY; TNF-ALPHA; SERUM; EXPRESSION; INTERLEUKIN-1; SUPPRESSES; ADHESION	Objective: Based on anti-inflammatory effects of Aloe vera, the effect of aqueous extract of this plant on brain edema and changes in some pro-inflammatory cytokines was investigated after traumatic brain injury (TBI). Materials and Methods: In this study, adult male Wistar rats were divided into 5 groups: Sham, TBI, vehicle (Veh), and low dose (LA) and high dose (HA) Aloe vera. The vehicle and aqueous extract of Aloe vera were injected intraperitoneally 30 min after induction of diffuse TBI by Marmarou's method. Brain edema (brain water content), and transforming growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF alpha), interleukin 6 (IL-6) and IL-1 beta levels in serum and brain were measured 24 hr after TBI induction. Results: Increased brain edema by TBI was reduced by both LA and HA (p<0.01 and p<0.05, respectively). IL-6 increased in the brain of TBI group compared to sham, and which was inhibited by both Aloe vera doses compared to Veh (p<0.001). The differences in the IL-6 serum levels among Veh, LA and HA groups were not significant. Increases in serum and brain IL-1 beta levels were reduced only in the HA group (p<0.001). Although only in the brain, TNF-alpha level increased after trauma, but both LA and HA inhibited it in a dose-dependent manner (p<0.01 and p<0.05, respectively) . The amount of TGF-beta in the brain was reduced by both doses of the extract (p<0.001). Conclusion: These results indicated that Aloe vera has a neuroprotective effect induced by reducing brain edema. The probable mechanism particularly for HA is decreasing levels of pro-inflammatory cytokines such as TGF-beta, TNF-alpha, IL-6 and IL-1 beta.	[Shahryari, Marzieh] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Bibak, Bahram; Keshavarzi, Zaki Eh] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran; [Bibak, Bahram; Keshavarzi, Zaki Eh] North Khorasan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Bojnurd, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Salmani, Neda] Islamic Azad Univ, Genet Inst, Dept Psychol, Zarand Branch, Kerman, Iran; [Shirazpour, Sara; Alimandi, Fatemeh] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran		Bibak, B (corresponding author), North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran.; Bibak, B (corresponding author), North Khorasan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Bojnurd, Iran.; Khaksari, M (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran.	bibak44@googlemail.com; mkhaksari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281	Research Council of North Khorasan University of Medical Sciences and Kerman University of Medical Sciences	This study was financially supported by a grant from Research Council of North Khorasan University of Medical Sciences and Kerman University of Medical Sciences.	Abbas AK, 2014, CELLULAR MOL IMMUNOL, P1; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Benedi J, 2004, LIFE SCI, V75, P1263, DOI 10.1016/j.lfs.2004.05.001; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Bibak B, 2007, INT J PHARMACEUT, V5, P248; Bramlett HM, 2009, NEUROSCI LETT, V461, P49, DOI 10.1016/j.neulet.2009.05.071; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Devaraj A., 2011, INT RES J PHARM, V3, P103; Duansak D, 2003, CLIN HEMORHEOL MICRO, V29, P239; Eamlamnam K, 2006, WORLD J GASTROENTERO, V12, P2034, DOI 10.3748/wjg.v12.i13.2034; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habeeb F, 2007, METHODS, V42, P388, DOI 10.1016/j.ymeth.2007.03.005; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Intiso D, 2004, NEUROL SCI, V24, P390, DOI 10.1007/s10072-003-0194-z; Jafarzadeh H, 2014, J GORGAN UNI MED SCI, V16, P1; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Keshavarzi Z, 2014, AVICENNA J PHYTOMEDI, V4, P137; Keshavarzi Z, 2012, IRAN J BASIC MED SCI, V15, P1102; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2014, AVICENNA J PHYTOMEDI, V4, P118; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kovacs EJ, 2005, EXP GERONTOL, V40, P549, DOI 10.1016/j.exger.2005.04.009; Kumar S, 2007, BIOORGAN MED CHEM, V15, P2952, DOI 10.1016/j.bmc.2007.02.004; Langmead L, 2004, ALIMENT PHARM THER, V19, P521, DOI 10.1111/j.1365-2036.2004.01874.x; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Morganti-Kossmann C, 2010, ELSEV INSIGHT, P193, DOI 10.1016/B978-0-12-384691-4.00010-9; Park MY, 2011, LIFE SCI, V88, P486, DOI 10.1016/j.lfs.2011.01.010; Park MY, 2009, BIOSCI BIOTECH BIOCH, V73, P828, DOI 10.1271/bbb.80714; Prabjone R, 2006, CLIN HEMORHEOL MICRO, V35, P359; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sarkar D., 2005, Indian Journal of Pharmacology, V37, P371; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Valko T., 2004, DEMOGR RES, VS2, P305; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yun N, 2009, FOOD CHEM TOXICOL, V47, P1341, DOI 10.1016/j.fct.2009.03.013	54	0	0	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2228-7930	2228-7949		AVICENNA J PHYTOMEDI	Avicenna J. Phytomedicine	JUL-AUG	2021	11	4					380	393					14	Chemistry, Medicinal	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	ST1ZU	WOS:000662250400007	34290969				2022-02-07	
J	Shihan, HA; Arora, R; Mowbray, F; Shukla, M; Miranda, A; Kannikeswaran, N				Shihan, Hadeel A.; Arora, Rajan; Mowbray, Fabrice; Shukla, Meghna; Miranda, Alejandro; Kannikeswaran, Nirupama			Minor head injury transfers: Trends and outcomes	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Minor head injury; Children; Transfers; Outcome	COMPUTED-TOMOGRAPHY USE; EMERGENCY-DEPARTMENT; CHILDREN; DISCHARGE; TRAUMA	Background: Children with traumatic head injury are often transferred from community Emergency Departments (ED) to a Pediatric Emergency Department (PED). The primary objective of this study was to describe the outcomes of minor head injury (MHI) transfers to a PED. The secondary objective was to report Computed Tomography (CT) utilization rates for MHI. Methods: We conducted a retrospective study of children aged <= 18 years transferred to our PED for MHI from 2013 to 2018. Patients with Glasgow Coma Scale (GCS) < 14, coagulopathies, history of brain mass/shunt and suspected non-accidental trauma were excluded. Data collected included demographics, interventions performed, and disposition. MHI risk stratification and clinically important traumatic brain injury (ciTBI) were defined per the Pediatric Emergency Care Applied Research Network (PECARN) head injury guidelines. Descriptive statistics were reported using general measures of frequency and central tendency. Results: A total of 1078 children with MHI were analyzed based on eligibility criteria. The majority of patients were male (62%) and >= 2 years of age (69.3%). Subspecialist consultation (57.2%) and neuroimaging (27.4%) were the most commonly performed interventions in the PED. Only 14 children (1.3%) required neurosurgical intervention. One-third of the transferred patients required no additional work-up. Two-thirds of the patients (66.6%) were directly discharged from the PED. Though the total number of MHI transfers per year declined steadily during the study period (from 271/year to 119/year), CT head utilization remained relatively similar across the study years (60.3% to 70.8%). A higher proportion of children received CT in the ED when compared to the PED for low-risk (28.9% vs 15.8%) and intermediate-risk groups (42.8% vs 29.4%). Conclusions: The majority of pediatric MHI transfers are discharged home following a subspecialty consultation and/or neuroimaging. Despite guidelines and a low incidence of ciTBI, CT utilization remains high in the intermediate and low risk MHI groups, especially in the community settings. Targeted interventions are needed to reduce the potentially avoidable transfers and low-value performance of CT in children with MHI. (c) 2021 Elsevier Inc. All rights reserved.	[Shihan, Hadeel A.] Childrens Hosp Michigan, 3901 Beaubien St, Detroit, MI 48201 USA; [Arora, Rajan; Kannikeswaran, Nirupama] Cent Michigan Univ, Childrens Hosp Michigan, Detroit, MI USA; [Mowbray, Fabrice] McMaster Univ, Hamilton, ON, Canada; [Shukla, Meghna] Childrens Hosp Michigan, Emergency Dept, Detroit, MI 48201 USA; [Miranda, Alejandro] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA		Shihan, HA (corresponding author), Childrens Hosp Michigan, 3901 Beaubien St, Detroit, MI 48201 USA.	hshihan@dmc.org					Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Bourgeois FT, 2007, PEDIATR EMERG CARE, V23, P94, DOI 10.1097/PEC.0b013e3180302c22; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Franca UL, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1940; Franca UL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.1096; Gerber N, 2019, EMERG RADIOL, V26, P45, DOI 10.1007/s10140-018-1645-4; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kannikeswaran N, 2020, AM J EMERG MED; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Li J, 2019, PEDIATR EMERG CARE, V35, P38, DOI 10.1097/PEC.0000000000000848; Li J, 2020, PEDIATR EMERG CARE, V36, P95, DOI 10.1097/PEC.0000000000001116; Li J, 2012, PEDIATRICS, V130, P83, DOI 10.1542/peds.2011-1819; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Peebles ER, 2018, PEDIATR EMERG CARE, V34, P650, DOI 10.1097/PEC.0000000000001098; Puffenbarger MS, 2019, ACAD EMERG MED, V26, P784, DOI 10.1111/acem.13666; Rosenthal Jennifer L, 2016, Hosp Pediatr, V6, P345, DOI 10.1542/hpeds.2015-0211; Sawaya RD, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02328-x; Schappert Susan M, 2012, Natl Health Stat Report, P1; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Snyder CW, 2019, J TRAUMA ACUTE CARE, V86, P92, DOI 10.1097/TA.0000000000002087; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Taylor MA, 2020, J PEDIATR SURG; Walls TA, 2015, PEDIATR EMERG CARE, V31, P10, DOI 10.1097/PEC.0000000000000326	33	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45						80	85		10.1016/j.ajem.2021.02.046			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XN7FF	WOS:000729665500015	33676080				2022-02-07	
J	Shimony, N; Dailey, T; Barrow, D; Bui, A; Noureldine, MHA; Martinez-Sosa, M; Rodriguez, LF; Carey, CM; Tuite, GF; Jallo, GI				Shimony, Nir; Dailey, Travis; Barrow, David; Bui, Anh; Noureldine, Mohammad Hassan A.; Martinez-Sosa, Meleine; Rodriguez, Luis F.; Carey, Carolyn M.; Tuite, Gerald F.; Jallo, George, I			Pediatric mild head trauma: is outpatient follow-up imaging necessary or beneficial?	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						trauma; MRI; mild TBI; pediatric	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CHILDREN; VISITS	OBJECTIVE Pediatric traumatic brain injury (TBI) is the leading cause of death among children and is a significant cause of morbidity. However, the majority of injuries are mild (Glasgow Coma Scale score 13-15) without any need for neurosurgical intervention, and clinically significant neurological decline rarely occurs. Although the question of repeat imaging within the first 24 hours has been discussed in the past, the yield of short-term follow-up imaging has never been thoroughly described. In this paper, the authors focus on the yield of routine repeat imaging for pediatric mild TBI (mTBI) at the first clinic visit following hospital discharge. METHODS The authors conducted a retrospective review of patients with pediatric brain trauma who had been admitted to Johns Hopkins All Children's Hospital (JHACH). Patients with mTBI were identified, and their presentation, hospital course, and imaging results were reviewed. Those pediatric patients with mTBI who had undergone no procedure during their initial admission (only conservative treatment) were eligible for inclusion in the study. Two distinct groups were identified: patients who underwent repeated imaging at their follow-up clinic visit and those who underwent only clinical evaluation. Each case was assessed on whether the follow-up imaging had changed the follow-up course. RESULTS Between 2010 and 2015, 725 patients with TBI were admitted to JHACH. Of those, 548 patients qualified for analysis (i.e., those with mTBI who received conservative treatment without any procedure and were seen in the clinic for follow-up evaluation within 8 weeks after the trauma). A total of 392 patients had only clinic follow-up, without any diagnostic imaging study conducted as part of their clinic visit, whereas the other 156 patients underwent repeat MRI. Only 1 patient had a symptomatic change and was admitted after undergoing imaging. For 30 patients (19.2%), it was decided after imaging to continue the neurosurgical follow-up, which is a change from the institutional paradigm after mTBI. None of these patients had a change in neurological status, and all had a good functional status. All of these patients had one more follow-up in the clinic with new MRI, and none of them required further follow-up. CONCLUSIONS Children with mTBI are commonly followed up in the ambulatory clinic setting. The authors believe that for children with mTBI, normal clinical examination, and no new symptoms, there is no need for routine ambulatory imaging since the clinical yield of such is relatively low.	[Shimony, Nir; Noureldine, Mohammad Hassan A.; Rodriguez, Luis F.; Carey, Carolyn M.; Tuite, Gerald F.] Johns Hopkins All Childrens Hosp, Inst Brain Protect Sci, St Petersburg, FL USA; [Dailey, Travis; Barrow, David; Bui, Anh; Martinez-Sosa, Meleine] Morsani Coll Med, Dept Neurosurg, Tampa, FL USA; [Shimony, Nir; Jallo, George, I] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Shimony, Nir] Geisinger Commonwealth Sch Med, Dept Neurosurg, Danville, PA USA		Shimony, N (corresponding author), Geisinger Med Ctr, Danville, PA 17822 USA.	nshimony@geisinger.edu	Noureldine, Mohammad Hassan A/L-2847-2016	Noureldine, Mohammad Hassan A/0000-0001-6954-4207			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Sorantin E, 2013, EUR J PEDIATR SURG, V23, P444, DOI 10.1055/s-0033-1361924; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012	18	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2021	28	1					62	68		10.3171/2020.11.PEDS20588			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TH0TW	WOS:000671808900003	33962382				2022-02-07	
J	Shorer, M; Fennig, S; Apter, A; Peleg, TP				Shorer, Maayan; Fennig, Silvana; Apter, Alan; Peleg, Tammy Pilowsky			Involvement in litigation in children with PTSD following motor vehicle accident: Associations with emotional distress and treatment outcomes	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Post-traumatic stress disorder; Mild traumatic brain injury; Litigation; Intervention efficacy; Children	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSION SYNDROME; COMPENSATION-SEEKING; FINANCIAL COMPENSATION; PROLONGED EXPOSURE; MONEY MATTERS; HEAD-INJURY; ADOLESCENTS	Objectives: Litigation is common in the context of Post-traumatic Stress Disorder (PTSD) and mild Traumatic Brain Injury (mTBI), adding contradicting motivations to individuals' engagement in psychotherapeutic interventions. This study's main goal was to explore the relationship between litigation status and emotional distress among children with PTSD following motor vehicle accidents (MVAs). We also present preliminary findings from a pilot study on treatment efficacy for children with PTSD, with and without litigation. Methods: Participants included 76 children with PTSD following MVA and their main caregiving parent. The associations between litigation status (litigation involvement, litigation phase, and litigation's emotional impact) and children's global distress, PTSD, persistent post-concussion symptoms (PPCS), and sub-optimal effort, and parents' PTSD symptoms were assessed before and after intervention for PTSD. Comorbid mTBI was explored as a possible moderating factor. Results: Involvement in litigation was not related to children's and parents' pre-intervention distress, nor to the presence of mTBI or to children's effort. However, higher emotional impact of litigation on parents was associated with children's higher PPCS pre-intervention. A pilot study on intervention outcomes found an improvement both in children with and without litigation involvement. A greater decrease in PPCS following intervention was found in children of parents with higher emotional impact of litigation . Conclusions: The emotional impact of litigation on parents should be considered while addressing children in litigation context. However, this study's preliminary findings suggest that children with litigation involvement may benefit from treatment, thus litigation should not serve solely as an exclusion criterion for psychological intervention. A larger study should further explore this issue.	[Shorer, Maayan; Fennig, Silvana; Apter, Alan; Peleg, Tammy Pilowsky] Schneider Childrens Med Ctr Israel, Dept Psychol Med, Petah Tiqwa, Israel; [Shorer, Maayan; Apter, Alan] Ruppin Acad Ctr, Clin Psychol Program, Emek Hefer, Israel; [Fennig, Silvana; Apter, Alan] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Peleg, Tammy Pilowsky] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel		Shorer, M (corresponding author), Ruppin Acad Ctr, Clin Psychol Program, Emek Hefer, Israel.	maayans@ruppin.ac.il			Israel Insurance Association	This study was supported in part by a grant from the Israel Insurance Association. The funding source were not involved in determining the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the submission for publication.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bariola E, 2011, CLIN CHILD FAM PSYCH, V14, P198, DOI 10.1007/s10567-011-0092-5; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2003, J NERV MENT DIS, V191, P191, DOI 10.1097/00005053-200303000-00009; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Craig A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011993; DeViva JC, 2003, J TRAUMA STRESS, V16, P503, DOI 10.1023/A:1025766713188; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Ferguson R. J., 1995, SOURCEBOOK PSYCHOL T SOURCEBOOK PSYCHOL T, P615; Foa E.B., 2008, PROLONGED EXPOSURE T; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Fontana A, 1998, J NERV MENT DIS, V186, P223, DOI 10.1097/00005053-199804000-00004; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Frueh BC, 2003, PSYCHIATR SERV, V54, P84, DOI 10.1176/appi.ps.54.1.84; Gilboa-Schechtman E, 2010, J AM ACAD CHILD PSY, V49, P1034, DOI 10.1016/j.jaac.2010.07.014; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hickling E.J., 2005, DEPAUL LAW REV, V55, P617; Howe L. L. S., 2012, DETECTION MALINGERIN; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kirk JW, 2020, APPL NEUROPSYCH-CHIL, V9, P292, DOI 10.1080/21622965.2020.1750118; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W., 2015, VALIDITY TESTING CHI; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Kunst MJJ, 2015, J FORENSIC PSYCHI PS, V26, P309, DOI 10.1080/14789949.2015.1004636; Kunst M, 2010, J INTERPERS VIOLENCE, V25, P1631, DOI 10.1177/0886260509354591; Laor N, 2001, AM J PSYCHIAT, V158, P1020, DOI 10.1176/appi.ajp.158.7.1020; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Libow J. A., 2003, MALINGERING ILLNESS, P147; Matsuzawa YK, 2014, PSYCHOL INJ LAW, V7, P388, DOI 10.1007/s12207-014-9204-0; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; McDermott BM, 2000, AUST NZ J PSYCHIAT, V34, P446, DOI 10.1080/j.1440-1614.2000.00753.x; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ern.11.94, 10.1586/ERN.11.94]; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meiser-Stedman R, 2017, DEPRESS ANXIETY, V34, P348, DOI 10.1002/da.22602; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Murphy J. M., 2013, THESIS SAINT LOUIS U THESIS SAINT LOUIS U; Nixon RDV, 2013, PSYCHOL ASSESSMENT, V25, P1025, DOI 10.1037/a0033324; Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Perry Bruce D., 1999, Current Opinion in Pediatrics, V11, P310, DOI 10.1097/00008480-199908000-00008; Rambo PL, 2015, APPL NEUROPSYCH-CHIL, V4, P1, DOI 10.1080/21622965.2013.780238; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R., 2013, HDB PSYCHOL FORENSIC, V11, P517; Rogers R., 2003, MALINGERING ILLNESS, P71; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sayer N. A, 2007, PTSD RES Q, V18, P1; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Scott E, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00306; Shorer M., 2018, J TRAUMATIC STRESS D, V7, DOI [10.4172/2324-8947.1000-109, DOI 10.4172/2324-8947.1000-109]; Shorer M, 2020, J TRAUMA STRESS, V33, P330, DOI 10.1002/jts.22512; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spielberger CD, 1973, STATE TRAIT ANXIETY; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; WHO, 1998, WELLB MEAS PRIM HLTH; Williams A. D, 1997, CRIT ISS NE, P71; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	85	0	0	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527	1873-6386		INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	JUL-AUG	2021	77								101711	10.1016/j.ijlp.2021.101711			9	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	TP5KW	WOS:000677639200002	34010757				2022-02-07	
J	Singleton, JM; Bilello, LA; Greige, T; Balaji, L; Tibbles, CD; Edlow, JA; Stippler, M; Rosen, CL				Singleton, Jennifer M.; Bilello, Leslie A.; Greige, Tatiana; Balaji, Lakshman; Tibbles, Carrie D.; Edlow, Jonathan A.; Stippler, Martina; Rosen, Carlo L.			Outcomes of a novel ED observation pathway for mild traumatic brain injury and associated intracranial hemorrhage	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Intracranial hemorrhage; Emergency department observation	LOW-RISK; COMPUTED-TOMOGRAPHY; ADULT PATIENTS; DETERIORATION	Background: Recent studies have shown that the majority of non-anticoagulated patients with small subdural or subarachnoid intracranial hemorrhage (ICH) in the setting of mild traumatic brain injury do not experience clinical deterioration or require neurosurgical intervention. We implemented a novel ED observation pathway to reduce unnecessary admissions among patients with ICH in the setting of mild TBI (complicated mild TBI, cmTBI). Methods: Prospective, single-center study of ED patients presenting to a Level-1 Trauma Center, 4/2016-12/2018. Inclusion criteria: head injury with GCS >= 14, minor positive CT findings (i.e. subdural hematoma <1 cm). Exclusion criteria: GCS < 14, multi-system trauma procedural intervention or admission, epidural hematoma, skull fracture, seizure, anticoagulant/antiplatelet use beyond aspirin, physician discretion. Outcomes: pathway completion rate, ED length-of-stay (LOS), neurosurgical intervention, hospital LOS, 7-day return visits. Results: 138 patients met all pathway criteria and were included in analysis. 113/138 (81.9%) patients were discharged home after observation with mean ED LOS of 17.3 h (median 15.4 h, SD +/- 10.5) including 91/111 (81.9%) patients transferred from outside hospitals (median 18.1 h, SD +/- 11.0). Increased age and aspirin use were correlated with pathway non-completion requiring admission, but not due to hematoma expansion. Among admitted patients, none required neurosurgical intervention. Seven (5.1%) 7-day return visits occurred, 3 (2%) related to initial cmTBI; 1 (0.9%) was admitted for neurologic monitoring. Conclusions: ED observation for patients with cmTBI resulted in an 82% pathway completion rate, including outside hospital transfers. These results suggest that patients with cmTBI may be safely discharged from the ED after a brief period of observation. Our pathway protocol and implementation involved neurosurgical consultation and the ability to perform repeat neurologic exams in the ED. Future studies should examine the feasibility of non transfer protocols for appropriately selected patients and access to neurosurgical expertise in the community setting. (c) 2020 Elsevier Inc. All rights reserved.	[Singleton, Jennifer M.] Univ Colorado, Emergency Med, Sch Med, Leprino Bldg,7th Floor,Campus Box B-215,12401 E 1, Aurora, CO 80045 USA; [Bilello, Leslie A.; Greige, Tatiana; Balaji, Lakshman; Tibbles, Carrie D.; Edlow, Jonathan A.; Rosen, Carlo L.] Beth Israel Deaconess Med Ctr, Emergency Med, Harvard Med Sch, Boston, MA 02215 USA; [Stippler, Martina] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Neurosurg, Boston, MA 02215 USA		Singleton, JM (corresponding author), Univ Colorado, Emergency Med, Sch Med, Leprino Bldg,7th Floor,Campus Box B-215,12401 E 1, Aurora, CO 80045 USA.	Jennifer.singleton@cuanschutz.edu; lbilello@bidmc.harvard.edu; tgreige@bidmc.harvard.edu; lbalaji@bidmc.harvard.edu; ctibbles@bidmc.harvard.edu; jedlow@bidmc.harvard.edu; mstipple@bidmc.harvard.edu; Crosen2@bidmc.harvard.edu					Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Ashkenazi I, 2015, EMERG MED J, V32, P946, DOI 10.1136/emermed-2014-203930; Bardes JM, 2016, AM SURGEON, V82, P36; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Borczuk P, 2019, WEST J EMERG MED, V20, P307, DOI 10.5811/westjem.2018.12.39337; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Centers for Disease Control and Prevention, 2000, SURV REP TRAUM BRAIN; Head Trauma Guideline Task Force, 2017, GUIDELINES MANAGEMEN; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Olldashi F, 2019, WORLD NEUROSURG, V128, pE340, DOI 10.1016/j.wneu.2019.04.150; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Trauma System Planning Committee, 2007, GUID TRIAG TRIAG TRA	20	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2021	45						340	344		10.1016/j.ajem.2020.08.093			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XN7BD	WOS:000729654900029	33041142				2022-02-07	
J	Song, B; Lee, SJ; Kim, CH				Song, Bokyung; Lee, Sung-Joong; Kim, Chong-Hyun			Roles of Cytokines in the Temporal Changes of Microglial Membrane Currents and Neuronal Excitability and Synaptic Efficacy in ATP-Induced Cortical Injury Model	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						ATP injury; cortex; microglia; cytokine; excitability; purinergic receptor; potassium channel	K+ CURRENT; CNS; BRAIN; MACROPHAGES; ACTIVATION; INFLAMMATION; CHANNELS; RELEASE; IL-10; ALPHA	Cytokines are important neuroinflammatory modulators in neurodegenerative brain disorders including traumatic brain injury (TBI) and stroke. However, their temporal effects on the physiological properties of microglia and neurons during the recovery period have been unclear. Here, using an ATP-induced cortical injury model, we characterized selective effects of ATP injection compared to needle-control. In the damaged region, the fluorescent intensity of CX(3)CR1-GFP (+) cells, as well as the cell density, was increased and the maturation of newborn BrdU (+) cells continued until 28 day-post-injection (dpi) of ATP. The excitability and synaptic E/I balance of neurons and the inward and outward membrane currents of microglia were increased at 3 dpi, when expressions of tumor necrosis factor (TNF)-alpha/interleukin (IL)-1 beta and IL-10/IL-4 were also enhanced. These changes of both cells at 3 dpi were mostly decayed at 7 dpi and were suppressed by any of IL-10, IL-4, suramin (P2 receptor inhibitor) and 4-AP (K+ channel blocker). Acute ATP application alone induced only small effects from both naive neurons and microglial cells in brain slice. However, TNF-alpha alone effectively increased the excitability of naive neurons, which was blocked by suramin or 4-AP. TNF-alpha and IL-1 beta increased and decreased membrane currents of naive microglia, respectively. Our results suggest that ATP and TNF-alpha dominantly induce the physiological activities of 3 dpi neurons and microglia, and IL-10 effectively suppresses such changes of both activated cells in K+ channel- and P2 receptor-dependent manner, while IL-4 suppresses neurons preferentially.	[Song, Bokyung; Kim, Chong-Hyun] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul 02792, South Korea; [Song, Bokyung; Kim, Chong-Hyun] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul 02792, South Korea; [Lee, Sung-Joong] Seoul Natl Univ, Sch Dent, Dent Res Inst, Program Neurosci, Seoul 08826, South Korea		Kim, CH (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul 02792, South Korea.; Kim, CH (corresponding author), Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul 02792, South Korea.	h13003@kist.re.kr; sjlee87@snu.ac.kr; ckimya@kist.re.kr		Song, Bokyung/0000-0002-3803-0235; Kim, Chong-Hyun/0000-0002-0968-4176	National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Science, ICT & Future Planning [2016M3C7A1905119]; KIST Institutional ProgramKorea Institute of Science & Technology (KIST) [2E30190, 2E30762]	This research was funded by the Brain Research Program through the National Research Foundation of Korea (NRF) and the Ministry of Science, ICT & Future Planning (http://ernd.nrf.re.kr/index.do (accessed on 23 June 2021)) to C.-H.K. (Project No. 2016M3C7A1905119) and by the KIST Institutional Program (http://www.kist.re.kr/kist_web/main/(accessed on 23 June 2021)) to C.-H.K. (Project No. 2E30190 and 2E30762).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Anderson WD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00233; Andrejew R, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00124; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burnstock G, 2016, NEUROPHARMACOLOGY, V104, P4, DOI 10.1016/j.neuropharm.2015.05.031; Cai Q, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010150; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; de Bilbao F, 2009, J NEUROCHEM, V110, P12, DOI 10.1111/j.1471-4159.2009.06098.x; Deng Yi Yu, 2011, Front Biosci (Schol Ed), V3, P884; Di Lucente J, 2018, GLIA, V66, P1881, DOI 10.1002/glia.23457; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Dugue R., 2017, MECH NEUROINFLAMMATI, P211, DOI [DOI 10.5772/INTECHOPEN.70099, 10.5772/intechopen.70099]; Eder C, 2005, J NEUROSCI RES, V81, P314, DOI 10.1002/jnr.20476; Eder C, 2010, J NEUROIMMUNOL, V224, P51, DOI 10.1016/j.jneuroim.2010.05.008; Fiebich BL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00260; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Filippov AK, 2006, J NEUROSCI, V26, P9340, DOI 10.1523/JNEUROSCI.2635-06.2006; Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007; Fogal B, 2008, J NEUROCHEM, V106, P1, DOI 10.1111/j.1471-4159.2008.05315.x; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Franke H, 2006, PFLUG ARCH EUR J PHY, V452, P622, DOI 10.1007/s00424-006-0071-8; Frik J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745294; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Giuliani AL, 2019, IMMUNOL LETT, V205, P16, DOI 10.1016/j.imlet.2018.11.006; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832; Gustafson-Vickers SL, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-63; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Ikeda M, 2013, BBA-MOL CELL RES, V1833, P2573, DOI 10.1016/j.bbamcr.2013.06.022; Illes P, 2019, TRENDS NEUROSCI, V42, P885, DOI 10.1016/j.tins.2019.09.006; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Izquierdo P, 2019, TRENDS NEUROSCI, V42, P278, DOI 10.1016/j.tins.2018.12.007; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P308, DOI 10.5607/en.2013.22.4.308; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; KAUR C, 1987, J ANAT, V154, P215; Kawabori M, 2015, METAB BRAIN DIS, V30, P381, DOI 10.1007/s11011-014-9531-6; Kearney CJ, 2017, MOL CELL, V65, P965, DOI 10.1016/j.molcel.2017.02.024; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Luo LX, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104925; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; NAKAZAWA K, 1994, PFLUG ARCH EUR J PHY, V429, P143, DOI 10.1007/BF02584042; Nenov MN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133375; Nguyen HM, 2017, CHANNELS, V11, P305, DOI 10.1080/19336950.2017.1300738; Norris GT, 2019, J EXP MED, V216, P60, DOI 10.1084/jem.20180199; Ohsawa K, 2011, GLIA, V59, P1793, DOI 10.1002/glia.21238; Ponulak F, 2011, ACTA NEUROBIOL EXP, V71, P409; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Richter N, 2014, NEUROSCI LETT, V583, P130, DOI 10.1016/j.neulet.2014.09.035; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; SCHELPER RL, 1986, J NEUROPATH EXP NEUR, V45, P1, DOI 10.1097/00005072-198601000-00001; Seifert S, 2011, CELL CALCIUM, V49, P365, DOI 10.1016/j.ceca.2011.03.005; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; SRozsa K, 1997, GEN PHARMACOL-VASC S, V29, P73, DOI 10.1016/S0306-3623(96)00527-7; Stebbing MJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00497; Suryanarayanan A, 2016, NEUROPHARMACOLOGY, V107, P181, DOI 10.1016/j.neuropharm.2016.03.027; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Thei L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00676; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Zhan LH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000134; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	89	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUL	2021	22	13							6853	10.3390/ijms22136853			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	TF8FE	WOS:000670950400001	34202215	gold, Green Published			2022-02-07	
J	Surathi, P; Sher, J; Obaydou, N; Pergament, KM				Surathi, Pratibha; Sher, Jessica; Obaydou, Nadeem; Pergament, Kathleen Mangunay			Sepsis or sympathetics? Paroxysmal sympathetic hyperactivity after pontine stroke	BMJ CASE REPORTS			English	Article						stroke; long term care	TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA; MANAGEMENT	A 64-year-old man from nursing home with a pontine stroke 3 months ago, ventilator-dependent, presented with episodic fever, tachycardia and tachypnoea occurring several times a day. He was evaluated for sepsis and pulmonary embolism and was treated empirically with broad-spectrum antibiotics. But these episodes persisted. Due to the episodic nature and typical symptoms of sympathetic overactivity, in the setting of prior brain injury, paroxysmal sympathetic hyperactivity was considered. His antibiotics were discontinued, and he was treated symptomatically with baclofen and bromocriptine, which resulted in a partial reduction of these episodes.	[Surathi, Pratibha] Rutgers New Jersey Med Sch, Neurol, Newark, NJ 07103 USA; [Sher, Jessica; Obaydou, Nadeem; Pergament, Kathleen Mangunay] Rutgers New Jersey Med Sch, Internal Med, Newark, NJ USA		Surathi, P (corresponding author), Rutgers New Jersey Med Sch, Neurol, Newark, NJ 07103 USA.	pratibha.surathi@gmail.com		Pergament, Kathleen/0000-0001-5777-6174			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Peirs C, 2016, SCIENCE, V354, P578, DOI 10.1126/science.aaf8933; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabchevsky AG, 2006, PROG BRAIN RES, V152, P265, DOI 10.1016/S0079-6123(05)52017-X; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	19	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JUL	2021	14	7							e236873	10.1136/bcr-2020-236873			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS0TK	WOS:000679369100001	34301695				2022-02-07	
J	Talboom, JS; De Both, MD; Naymik, MA; Schmidt, AM; Lewis, CR; Jepsen, WM; Haberg, AK; Rundek, T; Levin, BE; Hoscheidt, S; Bolla, Y; Brinton, RD; Schork, NJ; Hay, M; Barnes, CA; Glisky, E; Ryan, L; Huentelman, MJ				Talboom, J. S.; De Both, M. D.; Naymik, M. A.; Schmidt, A. M.; Lewis, C. R.; Jepsen, W. M.; Haberg, A. K.; Rundek, T.; Levin, B. E.; Hoscheidt, S.; Bolla, Y.; Brinton, R. D.; Schork, N. J.; Hay, M.; Barnes, C. A.; Glisky, E.; Ryan, L.; Huentelman, M. J.			Two separate, large cohorts reveal potential modifiers of age-associated variation in visual reaction time performance	NPJ AGING AND MECHANISMS OF DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; COGNITIVE-ABILITY; MODEL SELECTION; MIDDLE-AGE; R PACKAGE; HEALTH; SPEED; LIFE; SEX	To identify potential factors influencing age-related cognitive decline and disease, we created MindCrowd. MindCrowd is a cross-sectional web-based assessment of simple visual (sv) reaction time (RT) and paired-associate learning (PAL). svRT and PAL results were combined with 22 survey questions. Analysis of svRT revealed education and stroke as potential modifiers of changes in processing speed and memory from younger to older ages (n(total) = 75,666, n(women) = 47,700, n(men) = 27,966; ages 18-85 years old, mean (M)(Age) = 46.54, standard deviation (SD)(Age) = 18.40). To complement this work, we evaluated complex visual recognition reaction time (cvrRT) in the UK Biobank (n(total) = 158,249 n(women) = 89,333 n(men) = 68,916; ages 40-70 years old, M-Age = 55.81, SDAge = 7.72). Similarities between the UK Biobank and MindCrowd were assessed using a subset of MindCrowd (UKBb MindCrowd) selected to mirror the UK Biobank demographics (n(total) = 39,795, n(women) = 29,640, n(men) = 10,155; ages 40-70 years old, M-Age = 56.59, SDAge = 8.16). An identical linear model (LM) was used to assess both cohorts. Analyses revealed similarities between MindCrowd and the UK Biobank across most results. Divergent findings from the UK Biobank included (1) a first-degree family history of Alzheimer's disease (FHAD) was associated with longer cvrRT. (2) Men with the least education were associated with longer cvrRTs comparable to women across all educational attainment levels. Divergent findings from UKBb MindCrowd included more education being associated with shorter svRTs and a history of smoking with longer svRTs from younger to older ages.	[Talboom, J. S.; De Both, M. D.; Naymik, M. A.; Schmidt, A. M.; Lewis, C. R.; Jepsen, W. M.; Schork, N. J.; Huentelman, M. J.] Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA; [Talboom, J. S.; De Both, M. D.; Naymik, M. A.; Schmidt, A. M.; Lewis, C. R.; Jepsen, W. M.; Hoscheidt, S.; Bolla, Y.; Brinton, R. D.; Hay, M.; Barnes, C. A.; Glisky, E.; Ryan, L.; Huentelman, M. J.] Arizona Alzheimers Consortium, Phoenix, AZ 85014 USA; [Haberg, A. K.] Norwegian Univ Sci & Technol, Trondheim, Norway; [Rundek, T.; Levin, B. E.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Rundek, T.; Levin, B. E.] Evelyn F McKnight Brain Inst, Miami, FL USA; [Hoscheidt, S.; Bolla, Y.; Brinton, R. D.; Hay, M.; Barnes, C. A.; Glisky, E.; Ryan, L.] Univ Arizona, Tucson, AZ USA; [Schork, N. J.] City Hope Natl Med Ctr, Duarte, CA 91010 USA		Huentelman, MJ (corresponding author), Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA.; Huentelman, MJ (corresponding author), Arizona Alzheimers Consortium, Phoenix, AZ 85014 USA.	mhuentelman@tgen.org			State of Arizona DHS of the Arizona Alzheimer's Consortium; Flinn Foundation; McKnight Brain Research Foundation; NIH-NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG049465, UH2 AG064706, U19 AG023122, U24 AG051129, U24 AG051129-04S1]	A substantial porting of this research was conducted using the generous data and resources provided by the UK Biobank (https://www.ukbiobank.ac.uk/publishedpapers).We acknowledge the Mueller Family Charitable Trust and Mike Mueller their significant donations. The State of Arizona DHS also supported this work in support of the Arizona Alzheimer's Consortium (PI; Eric Reiman), the Flinn Foundation (PI; Matt Huentelman), The McKnight Brain Research Foundation, NIH-NIA grant R01AG049465 (PI; Carol Barnes), and NIH-NIA grants UH2 AG064706, U19 AG023122, U24 AG051129, and U24 AG051129-04S1 (PI; Nicholas J. Schork). We also recognize the support of many anonymous donors and institutional support of TGen, the City of Hope, and the University of Arizona.	Balakrishnan G, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/301473; Barthelemy S, 2002, BEHAV BRAIN RES, V133, P109, DOI 10.1016/S0166-4328(01)00446-6; Barthelemy S, 2001, NEUROSCI LETT, V315, P41, DOI 10.1016/S0304-3940(01)02313-8; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; BLEECKER ML, 1987, DEV NEUROPSYCHOL, V3, P165, DOI 10.1080/87565648709540372; BLOUGH PM, 1987, PERCEPT PSYCHOPHYS, V41, P276, DOI 10.3758/BF03208225; Boisgontier MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090457; Bryan J, 1996, PSYCHOL AGING, V11, P3, DOI 10.1037/0882-7974.11.1.3; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Calcagno V, 2010, J STAT SOFTW, V34, P1; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x; Deary IJ, 2009, PSYCHOL AGING, V24, P40, DOI 10.1037/a0014442; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Elgar FJ, 2008, CAN J PUBLIC HEALTH, V99, P423, DOI 10.1007/BF03405254; EVARTS EV, 1981, BRAIN, V104, P167, DOI 10.1093/brain/104.1.167; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Galton F., 1890, J ANTHR I GREAT BR I, V19, P27, DOI [10.2307/2842529, DOI 10.2307/2842529]; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; GRIMBY A, 1995, GERONTOLOGY, V41, P286; Harrison Ewen, 2020, CRAN; Huentelman MJ, 2020, TRENDS NEUROSCI, V43, P17, DOI 10.1016/j.tins.2019.11.004; Ikeda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148297; JA L, 2019, INTERACTIONS COMPREH INTERACTIONS COMPREH; Jain Aditya, 2015, Int J Appl Basic Med Res, V5, P124, DOI 10.4103/2229-516X.157168; Johnson SC, 2006, J NEUROSCI, V26, P6069, DOI 10.1523/JNEUROSCI.0959-06.2006; Kaur P., 2006, INT J DIAB DEV CTRIE, V26, P112, DOI DOI 10.4103/0973-3930.32170; Kilander L, 1998, HYPERTENSION, V31, P780, DOI 10.1161/01.HYP.31.3.780; Kosinski RJ, 2008, CLEMSON U, V10, P337; Kraut R, 2004, AM PSYCHOL, V59, P105, DOI 10.1037/0003-066X.59.2.105; Krieg EF, 2001, NEUROTOXICOL TERATOL, V23, P569, DOI 10.1016/S0892-0362(01)00177-5; Lee JJ, 2013, PSYCHOL SCI, V24, P1226, DOI 10.1177/0956797612471540; Lenth RV., 2018, PACKAGE EMMEANS ESTI; LINDENBERGER U, 1993, PSYCHOL AGING, V8, P207, DOI 10.1037/0882-7974.8.2.207; Long J. A, 2017, PACKAGE JTOOLS V 2 0 PACKAGE JTOOLS V 2 0; LUPINACCI NS, 1993, RES Q EXERCISE SPORT, V64, P144, DOI 10.1080/02701367.1993.10608791; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Moradi A, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0612-0; Nettelbeck T., 1980, REACTION TIMES, P418; Patel MD, 2002, J AM GERIATR SOC, V50, P700, DOI 10.1046/j.1532-5415.2002.50165.x; Pearce SC, 2016, J CLIN EXP NEUROPSYC, V38, P1, DOI 10.1080/13803395.2015.1078295; R Development Core Team, 2012, R LANG ENV STAT COMP; Racine J. S, 2021, RSTUDIO PLATFORM IND; Rawle MJ, 2018, J AM GERIATR SOC, V66, P916, DOI 10.1111/jgs.15317; Reimers S, 2007, BEHAV RES METHODS, V39, P365, DOI 10.3758/BF03193004; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Ryan L, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00128; Sabia S, 2008, ARCH INTERN MED, V168, P1165, DOI 10.1001/archinte.168.11.1165; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Shields Margot, 2008, Health Rep, V19, P61; Sliwinski M, 1997, J GERONTOL B-PSYCHOL, V52, pP308, DOI 10.1093/geronb/52B.6.P308; Spierer DK, 2010, J STRENGTH COND RES, V24, P957, DOI 10.1519/JSC.0b013e3181c7c536; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; TAIMELA S, 1991, PERCEPT MOTOR SKILL, V73, P1195, DOI 10.2466/PMS.73.8.1195-1202; Talboom JS, 2019, ELIFE, V8, DOI 10.7554/eLife.46179; Tierney NJ, 2017, JOSS, V2, P355, DOI DOI 10.21105/JOSS.00355; Tonnessen E, 2013, J STRENGTH COND RES, V27, P885, DOI 10.1519/JSC.0b013e31826520c3; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WELFORD AT, 1988, ANN NY ACAD SCI, V515, P1, DOI 10.1111/j.1749-6632.1988.tb32958.x; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Yoon K, 2014, ARCH GERONTOL GERIAT, V59, P584, DOI 10.1016/j.archger.2014.08.008; Zeileis A., 2020, PACKAGESANDWICH V 3 PACKAGESANDWICH V 3	71	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2056-3973		NPJ AGING MECH DIS	npj Aging Mech. Dis.	JUL 1	2021	7	1							14	10.1038/s41514-021-00067-6			18	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	TH0VE	WOS:000671812900002	34210964	gold, Green Published			2022-02-07	
J	Tan, XG; Sajja, VSSS; D'Souza, MM; Gupta, RK; Long, JB; Singh, AK; Bagchi, A				Tan, X. Gary; Sajja, Venkata Siva Sai Sujith; D'Souza, Maria M.; Gupta, Raj K.; Long, Joseph B.; Singh, Ajay K.; Bagchi, Amit			A Methodology to Compare Biomechanical Simulations With Clinical Brain Imaging Analysis Utilizing Two Blunt Impact Cases	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury (TBI); computational; modeling and prediction; traffic accidents; magnetic resonance imaging (MRI); diffusion weighted imaging (DWI); apparent diffusion coefficient (ADC); injury assessment	APPARENT DIFFUSION-COEFFICIENT; INJURY; HEAD; CLASSIFICATION; FUTURE; VALUES; STATE; MRI	According to the US Defense and Veterans Brain Injury Center (DVBIC) and Centers for Disease Control and Prevention (CDC), mild traumatic brain injury (mTBI) is a common form of head injury. Medical imaging data provides clinical insight into tissue damage/injury and injury severity, and helps medical diagnosis. Computational modeling and simulation can predict the biomechanical characteristics of such injury, and are useful for development of protective equipment. Integration of techniques from computational biomechanics with medical data assessment modalities (e.g., magnetic resonance imaging or MRI) has not yet been used to predict injury, support early medical diagnosis, or assess effectiveness of personal protective equipment. This paper presents a methodology to map computational simulations with clinical data for interpreting blunt impact TBI utilizing two clinically different head injury case studies. MRI modalities, such as T1, T2, diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC), were used for simulation comparisons. The two clinical cases have been reconstructed using finite element analysis to predict head biomechanics based on medical reports documented by a clinician. The findings are mapped to simulation results using image-based clinical analyses of head impact injuries, and modalities that could capture simulation results have been identified. In case 1, the MRI results showed lesions in the brain with skull indentation, while case 2 had lesions in both coup and contrecoup sides with no skull deformation. Simulation data analyses show that different biomechanical measures and thresholds are needed to explain different blunt impact injury modalities; specifically, strain rate threshold corresponds well with brain injury with skull indentation, while minimum pressure threshold corresponds well with coup-contrecoup injury; and DWI has been found to be the most appropriate modality for MRI data interpretation. As the findings from these two cases are substantiated with additional clinical studies, this methodology can be broadly applied as a tool to support injury assessment in head trauma events and to improve countermeasures (e.g., diagnostics and protective equipment design) to mitigate these injuries.	[Tan, X. Gary; Bagchi, Amit] US Naval Res Lab, Washington, DC 20375 USA; [Sajja, Venkata Siva Sai Sujith; Long, Joseph B.] Walter Reed Army Inst Res, Silver Spring, MD USA; [D'Souza, Maria M.] Inst Nucl Med & Allied Sci, New Delhi, India; [Gupta, Raj K.] US Army Med Res & Dev Command, Ft Detrick, MD USA; [Singh, Ajay K.] Def Res & Dev Org DRDO, Life Sci Directorate, New Delhi, India		Tan, XG (corresponding author), US Naval Res Lab, Washington, DC 20375 USA.	gary.tan@nrl.navy.mil		Sajja, Sujith/0000-0002-1992-9501	Office of Naval Research (ONR) through NRL's Basic Research ProgramOffice of Naval Research; US Department of Defense (DOD)United States Department of Defense; Indian MOD/DRDO through the collaborative US-India Research Program PA [US-IN-A-16-0002]	Partial funding was provided by the Office of Naval Research (ONR) through NRL's Basic Research Program. It was also funded in part by the US Department of Defense (DOD) and the Indian MOD/DRDO through the collaborative US-India Research Program PA #US-IN-A-16-0002. This work was supported in part by a grant of computer time from the DOD High Performance Computing Modernization Program at the Army Research Laboratory, Air Force Research Laboratory, and Army Engineer Research Laboratory DOD Supercomputing Resource Centers.	Ahrens J., 2005, VISUALIZATION HDB; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bagchi, 2017, BIOMECHANICAL MODELI; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bonet J, 2001, INT J NUMER METH ENG, V50, P119, DOI 10.1002/1097-0207(20010110)50:1<119::AID-NME24>3.0.CO;2-C; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; CDC, 2020, US CTR DIS CONTR PRE, DOI [10.1007/s11831-019-09352-w, DOI 10.1007/S11831-019-09352-W]; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Hu JW, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P417, DOI 10.1016/B978-0-12-809831-8.00010-6; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jolivet Erwan, 2015, Stapp Car Crash J, V59, P337; Kang BK, 2001, KOREAN J RADIOL, V2, P183, DOI 10.3348/kjr.2001.2.4.183; Kang W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34085-4; Kazam J Jacob, 2015, Top Magn Reson Imaging, V24, P225, DOI 10.1097/RMR.0000000000000061; Li XG, 2021, BIOMECH MODEL MECHAN, V20, P403, DOI 10.1007/s10237-020-01391-8; Lu LY, 2014, NEUROL INDIA, V62, P487, DOI 10.4103/0028-3886.144434; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Merkle, 2012, DUKE REV MRI PRINCIP; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nelson F, 2008, MULT SCLER J, V14, P1214, DOI 10.1177/1352458508094644; Post A, 2015, ACCIDENT ANAL PREV, V79, P33, DOI 10.1016/j.aap.2015.03.017; Prabhu RK, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6020040; Qidwai, 2018, NRLMR63509807 DEF TE; Raj R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53889-6; Saunders RN, 2019, ANN BIOMED ENG, V47, P2005, DOI 10.1007/s10439-018-02157-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sener RN, 2001, COMPUT MED IMAG GRAP, V25, P299, DOI 10.1016/S0895-6111(00)00083-5; Shah N, 2004, AM J NEURORADIOL, V25, P157; Singh, 2020, J ENG SCI MED DIAGN, V3; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Tan X. Gary, 2011, International Journal of Human Factors Modelling and Simulation, V2, P85, DOI 10.1504/IJHFMS.2011.041639; Tan XG, 2020, MIL MED, V185, P214, DOI 10.1093/milmed/usz308; Teferra K, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3109; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vaswani Aneel Kumar, 2014, ISRN Radiol, V2014, P578986, DOI 10.1155/2014/578986; Viano, 2003, P ASME BIOENG C KEY; Whitley, 2005, 200512 USAARL DEF TE; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yang XX, 2019, INT J EXTREME MANUF, V1, DOI 10.1088/2631-7990/ab263f; Zhang K, 2017, J BIOMECH, V60, P253, DOI 10.1016/j.jbiomech.2017.06.015; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	56	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	JUL 1	2021	9								654677	10.3389/fbioe.2021.654677			17	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	TJ4OJ	WOS:000673462600001	34277581	Green Published, gold			2022-02-07	
J	Tapper, A; Gonzalez, D; Nouredanesh, M; Niechwiej-Szwedo, E				Tapper, Anthony; Gonzalez, David; Nouredanesh, Mina; Niechwiej-Szwedo, Ewa			Pupillometry provides a psychophysiological index of arousal level and cognitive effort during the performance of a visual-auditory dual-task in individuals with a history of concussion	VISION RESEARCH			English	Article						Traumatic brain injury; Divided attention; Working memory; Athletes; Pupil size	WORKING-MEMORY CAPACITY; PUPIL SIZE; LOCUS-COERULEUS; BRAIN ACTIVATION; ATTENTION; LOAD; INJURY; DIFFICULTY; RESPONSES; DIAMETER	Research shows that concussions cause long-term deficits in executive functions when tested using challenging tasks with high cognitive load. The neurophysiological mechanism(s) associated with executive dysfunction are not well understood. Pupillometry provides a non-invasive index of arousal and cognitive load; therefore, the current study investigated whether pupillometry could help explain the persistent deficits in dual-task performance in individuals with a history of concussion (n = 14) compared to controls (n = 13). Participants were tested using a computerized Corsi block task which increased in difficulty as a function of set size (i.e., number of blocks to be remembered) and task condition (i.e., performed alone and concurrently with an auditory task). Pupil size was measured during the initial fixation prior to the Corsi task to assess arousal level, and during the encoding phase to assess task evoked pupil response. Results showed that: 1) in contrast to the control group, pupil size was not modulated by task condition in the concussed group indicating that arousal level was similar in the single and dual task; 2) task evoked pupil dilation increased as a function of set size in the single task in both groups, 3) in contrast to the control group, those with a history of concussion had similar pupil size during the single and dual task conditions. One interpretation of these results is that individuals with a history of concussion exert greater effort when performing relatively easier tasks, and they reach capacity limits when the cognitive load is lower in comparison to non-concussed individuals. In conclusion, pupillometry may provide insight into persisting deficits in executive functions following concussion(s).	[Tapper, Anthony; Gonzalez, David; Niechwiej-Szwedo, Ewa] Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON, Canada; [Nouredanesh, Mina] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON, Canada		Niechwiej-Szwedo, E (corresponding author), Univ Waterloo, Dept Kinesiol, 200 Univ Ave W, Waterloo, ON, Canada.	atapper@uwaterloo.ca; eniechwiej@uwaterloo.ca			PROPEL Centre for Population Health Impact, University of Waterloo	This research was supported by funding from the PROPEL Centre for Population Health Impact, University of Waterloo.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Recarte MA, 2008, SPAN J PSYCHOL, V11, P374, DOI 10.1017/S1138741600004406; Arent SM, 2003, RES Q EXERCISE SPORT, V74, P436, DOI 10.1080/02701367.2003.10609113; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Ayala N, 2021, EXP BRAIN RES, V239, P245, DOI 10.1007/s00221-020-05967-9; Ayala N, 2020, J NEUROTRAUM, V37, P2558, DOI 10.1089/neu.2019.6865; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, V2, P142; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Ciuffreda Kenneth J, 2017, Concussion, V2, pCNC36, DOI 10.2217/cnc-2016-0029; Corsi P., 1972, THESIS MONTREAL QB; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eldar E, 2013, NAT NEUROSCI, V16, P1146, DOI 10.1038/nn.3428; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Grandchamp R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00031; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hayes TR, 2016, BEHAV RES METHODS, V48, P510, DOI 10.3758/s13428-015-0588-x; Heitz RP, 2008, PSYCHOPHYSIOLOGY, V45, P119, DOI 10.1111/j.1469-8986.2007.00605.x; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jainta Stephanie, 2011, Front Hum Neurosci, V5, P97, DOI 10.3389/fnhum.2011.00097; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Karatekin C, 2004, PSYCHOPHYSIOLOGY, V41, P175, DOI 10.1111/j.1469-8986.2004.00147.x; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Koelewijn T, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518811444; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; Miller AL, 2019, J MEM LANG, V104, P25, DOI 10.1016/j.jml.2018.09.005; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; PEAVLER WS, 1974, PSYCHOPHYSIOLOGY, V11, P559, DOI 10.1111/j.1469-8986.1974.tb01114.x; Peysakhovich V, 2015, PROCEDIA MANUF, V3, P5199, DOI 10.1016/j.promfg.2015.07.583; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Richard NM, 2018, NEUROPSYCHOLOGY, V32, P541, DOI 10.1037/neu0000442; Rowland DC, 2008, ANN NY ACAD SCI, V1129, P213, DOI 10.1196/annals.1417.014; Scharinger C, 2015, PSYCHOPHYSIOLOGY, V52, P1293, DOI 10.1111/psyp.12500; Siegle GJ, 2003, NEUROIMAGE, V20, P114, DOI 10.1016/S1053-8119(03)00298-2; SIMPSON HM, 1969, PERCEPT MOTOR SKILL, V29, P495, DOI 10.2466/pms.1969.29.2.495; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Tapper A., 2015, THESIS U WATERLOO; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Tsai YF, 2007, AVIAT SPACE ENVIR MD, V78, pB176; Tse KM., 2015, AM J ENG TECHNOLOGY, V1, P28; Tsukahara JS, 2016, COGNITIVE PSYCHOL, V91, P109, DOI 10.1016/j.cogpsych.2016.10.001; Unsworth N, 2018, J COGNITIVE NEUROSCI, V30, P1241, DOI 10.1162/jocn_a_01251; Unsworth N, 2017, J EXP PSYCHOL LEARN, V43, P1962, DOI 10.1037/xlm0000421; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; van der Wel P, 2018, PSYCHON B REV, V25, P2005, DOI 10.3758/s13423-018-1432-y; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; Wang CA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01029; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Winn MB, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518800869; Zekveld AA, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518777174	62	0	0	4	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	JUL	2021	184						43	51		10.1016/j.visres.2021.03.011			9	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Ophthalmology; Psychology	SE5KF	WOS:000652110300006	33866265				2022-02-07	
J	Tenney, JR; Gloss, D; Arya, R; Kaplan, PW; Lesser, R; Sexton, V; Nuwer, M				Tenney, Jeffrey R.; Gloss, David; Arya, Ravindra; Kaplan, Peter W.; Lesser, Ronald; Sexton, Vicki; Nuwer, Marc			Practice Guideline: Use of Quantitative EEG for the Diagnosis of Mild Traumatic Brain Injury: Report of the Guideline Committee of the American Clinical Neurophysiology Society	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						qEEG; mTBI; Diagnosis; Guideline	CONCUSSION	Despite many decades of research, controversy regarding the utility of quantitative EEG (qEEG) for the accurate diagnosis of mild traumatic brain injury (mTBI) remains. This guideline is meant to assist clinicians by providing an expert review of the clinical usefulness of qEEG techniques for the diagnosis of mTBI. This guideline addresses the following primary aim: For patients with or without posttraumatic symptoms (abnormal cognition or behavior), does qEEG either at the time of injury or remote from the injury, as compared with current clinical diagnostic criteria, accurately identify those patients with mTBI (i.e., concussion)? Secondary aims included differentiating between mTBI and other diagnoses, detecting mTBI in the presence of central nervous system medications, and pertinence of statistical methods for measurements of qEEG components. It was found that for patients with or without symptoms of abnormal cognition or behavior, current evidence does not support the clinical use of qEEG either at the time of the injury or remote from the injury to diagnose mTBI (level U). In addition, the evidence does not support the use of qEEG to differentiate mTBI from other diagnoses or detect mTBI in the presence of central nervous system medications, and suitable statistical methods do not exist when using qEEG to identify patients with mTBI. Based upon the current literature review, qEEG remains an investigational tool for mTBI diagnosis (class III evidence).	[Tenney, Jeffrey R.; Arya, Ravindra] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Tenney, Jeffrey R.; Arya, Ravindra] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Gloss, David] Charleston Area Med Ctr, Dept Neurol, Charleston, WV USA; [Kaplan, Peter W.; Lesser, Ronald] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sexton, Vicki] ASET Neurodiagnost Soc, Kansas City, MO USA; [Nuwer, Marc] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Nuwer, Marc] Ronald Reagan UCLA Med Ctr, Dept Clin Neurophysiol, Los Angeles, CA USA		Tenney, JR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA.	jeffrey.tenney@cchmc.org					Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Corradini PL, 2014, BRAIN INJURY, V28, P1317, DOI 10.3109/02699052.2014.916819; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Neurology) AAAo, 2011, CLIN PRACTICE GUIDEL; Niedermeyer's Electroencephalography, 2017, BASIC PRINCIPLES CLI, V7; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; NUWER M R, 1990, Brain Topography, V3, P103, DOI 10.1007/BF01128867; Nuwer MR, 2016, NEUROL-CLIN PRACT, V6, P543, DOI 10.1212/CPJ.0000000000000308; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450	19	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JUL	2021	38	4					287	292		10.1097/WNP.0000000000000853			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WN4OI	WOS:000711748700008	34038930	Bronze			2022-02-07	
J	Thomas, JM; Louca, I; Bolan, F; Sava, OR; Allan, SM; Lawrence, CB; Pinteaux, E				Thomas, Josephine M.; Louca, Irene; Bolan, Faye; Sava, Oana-Roxana; Allan, Stuart M.; Lawrence, Catherine B.; Pinteaux, Emmanuel			Regenerative Potential of Hydrogels for Intracerebral Hemorrhage: Lessons from Ischemic Stroke and Traumatic Brain Injury Research	ADVANCED HEALTHCARE MATERIALS			English	Article						acute brain injury; hydrogels; intracerebral hemorrhage; regenerative medicine; stroke	NEURAL PROGENITOR CELLS; FUNCTIONAL RECOVERY; STEM-CELLS; INFLAMMATORY RESPONSE; ANIMAL-MODELS; IRON OVERLOAD; RAT MODEL; NEUROGENESIS; ANGIOGENESIS; MECHANISMS	Intracerebral hemorrhage (ICH) is a deadly and debilitating type of stroke, caused by the rupture of cerebral blood vessels. To date, there are no restorative interventions approved for use in ICH patients, highlighting a critical unmet need. ICH shares some pathological features with other acute brain injuries such as ischemic stroke (IS) and traumatic brain injury (TBI), including the loss of brain tissue, disruption of the blood-brain barrier, and activation of a potent inflammatory response. New biomaterials such as hydrogels have been recently investigated for their therapeutic benefit in both experimental IS and TBI, owing to their provision of architectural support for damaged brain tissue and ability to deliver cellular and molecular therapies. Conversely, research on the use of hydrogels for ICH therapy is still in its infancy, with very few published reports investigating their therapeutic potential. Here, the published use of hydrogels in experimental ICH is commented upon and how approaches reported in the IS and TBI fields may be applied to ICH research to inform the design of future therapies is described. Unique aspects of ICH that are distinct from IS and TBI that should be considered when translating biomaterial-based therapies between disease models are also highlighted.	[Thomas, Josephine M.; Louca, Irene; Bolan, Faye; Sava, Oana-Roxana; Allan, Stuart M.; Lawrence, Catherine B.; Pinteaux, Emmanuel] Univ Manchester, Northern Care Alliance NHS Grp, Manchester Acad Hlth Sci Ctr, Geoffrey Jefferson Brain Res Ctr, Manchester M13 9PT, Lancs, England; [Thomas, Josephine M.; Louca, Irene; Bolan, Faye; Sava, Oana-Roxana; Allan, Stuart M.; Lawrence, Catherine B.; Pinteaux, Emmanuel] Univ Manchester, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Manchester M13 9PT, Lancs, England		Thomas, JM (corresponding author), Univ Manchester, Northern Care Alliance NHS Grp, Manchester Acad Hlth Sci Ctr, Geoffrey Jefferson Brain Res Ctr, Manchester M13 9PT, Lancs, England.; Thomas, JM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Manchester M13 9PT, Lancs, England.	josephine.thomas@manchester.ac.uk		Allan, Stuart/0000-0001-9646-4456; Lawrence, Catherine/0000-0002-2372-2968; Bolan, Faye/0000-0003-4182-544X; Thomas, Josephine/0000-0002-1787-1748; Pinteaux, Emmanuel/0000-0002-9986-4401; Sava, Roxana/0000-0002-4800-9077	Engineering and Physical Science Research Council (EPSRC, UK)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Medical Research Council (MRC, UK) Centre for Doctoral Training in Regenerative Medicine Studentship GrantUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [EP/L014904/1]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article. This work was supported by an Engineering and Physical Science Research Council (EPSRC, UK) and Medical Research Council (MRC, UK) Centre for Doctoral Training in Regenerative Medicine Studentship Grant [No. EP/L014904/1].	Agrawal H, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt532; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005; Ballios BG, 2015, STEM CELL REP, V4, P1031, DOI 10.1016/j.stemcr.2015.04.008; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bolan F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00924; Butcher K, 2016, STROKE, V47, P3065, DOI 10.1161/STROKEAHA.116.015060; Clausen F, 2014, BRAIN RES, V1588, P37, DOI 10.1016/j.brainres.2014.08.043; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Cui CM, 2017, MOL MED REP, V15, P2374, DOI 10.3892/mmr.2017.6223; Doll DN, 2014, AGING DIS, V5, P294, DOI 10.14336/AD.2014.0500294; Erning K, 2020, CURR OPIN BIOMED ENG, V14, P9, DOI 10.1016/j.cobme.2020.04.002; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Gong YH, 2020, J CONTROL RELEASE, V320, P381, DOI 10.1016/j.jconrel.2020.01.029; Greenberg David A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P321, DOI 10.2174/187152707783220901; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Han QQ, 2011, BIOMATERIALS, V32, P3244, DOI 10.1016/j.biomaterials.2011.01.039; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Hatakeyama M, 2020, NEURAL REGEN RES, V15, P16, DOI 10.4103/1673-5374.264442; Hettiaratchi MH, 2019, J CONTROL RELEASE, V297, P14, DOI 10.1016/j.jconrel.2019.01.033; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P9122, DOI 10.1007/s12035-018-1050-8; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kanazawa M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42582; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kornev VA, 2018, COMPUT STRUCT BIOTEC, V16, P488, DOI 10.1016/j.csbj.2018.10.011; Lei CY, 2016, BRAIN RES, V1632, P1, DOI 10.1016/j.brainres.2015.11.045; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Lim TC, 2020, TRANSL STROKE RES, V11, P412, DOI 10.1007/s12975-019-00721-y; Love CJ, 2019, STROKE, V50, P2278, DOI 10.1161/STROKEAHA.118.023721; Lu JJ, 2019, REGEN BIOMATER, V6, P325, DOI 10.1093/rb/rbz027; Luo TT, 2017, INT J PHARMACEUT, V534, P179, DOI 10.1016/j.ijpharm.2017.10.010; Ma XT, 2020, BIOACT MATER, V5, P124, DOI 10.1016/j.bioactmat.2020.01.005; MacLean FL, 2018, APL BIOENG, V2, DOI 10.1063/1.5023709; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; MacLellan CL, 2009, BEHAV BRAIN RES, V198, P321, DOI 10.1016/j.bbr.2008.11.004; Marquardt LM, 2016, CURR STEM CELL REP, V2, P207, DOI 10.1007/s40778-016-0058-0; Matsuse D, 2011, TISSUE ENG PT A, V17, P1993, DOI [10.1089/ten.tea.2010.0585, 10.1089/ten.TEA.2010.0585]; McCabe C, 2018, NEUROPHARMACOLOGY, V134, P169, DOI 10.1016/j.neuropharm.2017.09.022; Modo M, 2019, BRAIN RES BULL, V150, P136, DOI 10.1016/j.brainresbull.2019.05.013; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Nih LR, 2017, ADV MATER, V29, DOI 10.1002/adma.201606471; Nih LR, 2016, CURR OPIN BIOTECH, V40, P155, DOI 10.1016/j.copbio.2016.04.021; Otero L, 2012, HISTOL HISTOPATHOL, V27, P303, DOI 10.14670/HH-27.303; Otero-Ortega L, 2018, J CEREBR BLOOD F MET, V38, P767, DOI 10.1177/0271678X17708917; Pias-Peleteiro J, 2017, NEURAL REGEN RES, V12, P558, DOI 10.4103/1673-5374.205085; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Qin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129881; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Ruan LH, 2015, BRAIN RES, V1623, P166, DOI 10.1016/j.brainres.2015.02.042; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Sang LYH, 2015, NANOMED-NANOTECHNOL, V11, P611, DOI 10.1016/j.nano.2014.05.012; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Selim M, 2018, STROKE, V49, P1308, DOI 10.1161/STROKEAHA.117.019539; Selim M, 2011, STROKE, V42, P3067, DOI 10.1161/STROKEAHA.111.617589; Siaw-Debrah F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5135429; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song S, 2008, ACTA NEUROCHIR SUPPL, V105, P13; Sun YQ, 2016, ACS APPL MATER INTER, V8, P2348, DOI 10.1021/acsami.5b11473; Tan HX, 2020, ACTA BIOMATER, V102, P1, DOI 10.1016/j.actbio.2019.11.032; Terasaki Y, 2014, CURR MED CHEM, V21, P2035, DOI 10.2174/0929867321666131228223400; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Tschoe C, 2020, J STROKE, V22, P29, DOI 10.5853/jos.2019.02236; Turnbull MT, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0073-8; Wang GQ, 2016, MOL NEUROBIOL, V53, P3576, DOI 10.1007/s12035-015-9302-3; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang S, 2015, STEM CELLS, V33, P3315, DOI 10.1002/stem.2087; Wang ZZ, 2011, J CELL MOL MED, V15, P2624, DOI 10.1111/j.1582-4934.2011.01259.x; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu JK, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00785; Xu Z, 2018, BIOMATERIALS, V157, P125, DOI 10.1016/j.biomaterials.2017.12.010; Xue S, 2015, J NEUROTRAUM, V32, P506, DOI 10.1089/neu.2014.3480; Yao MH, 2019, BIOMATER SCI-UK, V7, P4088, DOI 10.1039/c9bm00749k; Yeatts SD, 2013, NEUROCRIT CARE, V19, P257, DOI 10.1007/s12028-013-9861-y; Yuan J, 2017, J SURG RES, V207, P85, DOI 10.1016/j.jss.2016.08.090; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang N, 2016, NANOMED-NANOTECHNOL, V12, P1205, DOI 10.1016/j.nano.2015.12.387; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2; Zhu Q, 2019, INT J PHARMACEUT, V566, P342, DOI 10.1016/j.ijpharm.2019.05.076	98	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	AUG	2021	10	16							2100455	10.1002/adhm.202100455		JUL 2021	11	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	UA8IZ	WOS:000668585900001	34197036	hybrid			2022-02-07	
J	Ul Haq, N; Ahmed, A; Ali, M; Ishaq, M; Ullah, S; Mehdi, W; Mehtaabudin				Ul Haq, Naeem; Ahmed, Adnan; Ali, Mukhtiyar; Ishaq, Muhammad; Ullah, Sana; Mehdi, Waqas; Mehtaabudin			Surgical Management of Traumatic Epidural Hematomas	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Epidural hematoma; Glasgow Outcome Scale		Aim: To find out predictive significance and impact on neurosurgical treatment in EDH patients Setting & duration of study: Neurosurgery unit, Mardan Medical Complex, Mardan, from Dec, 2017 to Dec, 2019 Sample size: 120 individuals with traumatic epidural hematoma were treated through surgical intervention. Result: Out of 120 cases, 74% were male, while 26% were female. Motor vehicle accidents caused 86% of the injuries, while falls and heavy hits caused 14% of the injuries. On well defined tomography imaging of the brain, 14% individuals exhibited the swirl sign. The epidural hematoma had a strong association with preoperative Glasgow score, preoperative mydriasis, time from injury to CT scan, and intraoperative hematoma volume. Conclusion: Epidural hematoma has an excellent outcome, if managed on time. The epidural hematoma may be linked with a cataclysmic result, with comparatively high rates of mortality and morbidity.	[Ul Haq, Naeem; Ishaq, Muhammad] Bacha Khan Med Coll Mardan Med Complex, Neurosurg, Mardan, Pakistan; [Ahmed, Adnan] Bacha Khan Med Coll Mardan Med Complex, Neurosurg Ward, Mardan, Pakistan; [Ali, Mukhtiyar] Bacha Khan Med Coll, Mardan Med Complex, Surg, Mardan, Pakistan; [Ullah, Sana; Mehdi, Waqas; Mehtaabudin] King Edward Med Univ, Mayo Hosp Lahore, Neurosurg Dept, Lahore, Pakistan		Ul Haq, N (corresponding author), Bacha Khan Med Coll Mardan Med Complex, Neurosurg, Mardan, Pakistan.						Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Brain Trauma Foundation American Association of Neurological Surgeons, 2017, GUIDELINES NEUROL SC, V38, P2111; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	9	0	0	0	0	LAHORE MEDICAL & DENTAL COLL	LAHORE	CANAL BANK N, TULSPURA, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	JUL	2021	15	7					1525	1526		10.53350/pjmhs211571525			2	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TS9ZM	WOS:000680011300023		Bronze			2022-02-07	
J	van den Broek, B; Spauwen, P; Ponds, R; van Heugten, C; Bus, B				van den Broek, Brenda; Spauwen, Peggy; Ponds, Rudolf; van Heugten, Caroline; Bus, Boudewijn			Exploring Perceived Interactions Between Consequences of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						clinicians; perceived causal relations network; symptomatology; traumatic brain injury	COMMUNICATION ABILITY; NETWORK STRUCTURE; PERSPECTIVES; ASSOCIATION; DISABILITY; FATIGUE; DOCTORS; SKILLS; WORK	Objective: To explore the perceived interactions between consequences of traumatic brain injury (TBI). Participants: Fifteen clinicians experienced in working with patients with TBI. Methods: Participating clinicians completed an online questionnaire in which they estimated the degree to which consequences of TBI (taken from the Brief ICF Core Set for Traumatic Brain Injury) causally relate to each other. Based on these perceived interactions, a visual network was constructed and centrality measures for this network were computed. Results: The resulting network demonstrates various strong perceived causal relations between the consequences of TBI. Impairments in consciousness were perceived to most strongly cause other TBI consequences in the network. Difficulties with acquiring, keeping, and terminating a job were perceived to be most strongly caused by other TBI consequences. Difficulties in partaking in complex interpersonal interactions were also perceived to play a central role in the network. Conclusion: In the perception of clinicians, consequences of TBI interact with each other and are thus not solely a direct result of the injury. While more research is needed to map the interactions between consequences of TBI, our results could have important implications for the way we understand and treat the problems patients are faced with after TBI.	[van den Broek, Brenda; Spauwen, Peggy; Bus, Boudewijn] GGZ Oost Brabant, Huize Padua Clin Ctr Brain Injury & Psychiat, Boekelo, Netherlands; [van den Broek, Brenda; Spauwen, Peggy; Ponds, Rudolf; van Heugten, Caroline; Bus, Boudewijn] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Ponds, Rudolf] Adelante Rehabil Ctr, Hoensbroek, Netherlands; [Ponds, Rudolf; van Heugten, Caroline] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Heugten, Caroline] Maastricht Univ, Dept Neuropsychol & Pychopharmacol, Maastricht, Netherlands		Bus, B (corresponding author), Huize Padua Clin Ctr Brain Injury & Psychiat, Kluisstr 2, NL-5427 EM Boekelo, Netherlands.	BAA.bus@ggzoostbrabant.nl		ponds, rudolf/0000-0002-9748-4659; van den Broek, Brenda/0000-0001-7952-7769			BEUTLER LE, 1995, AM PSYCHOL, V50, P984, DOI 10.1037/0003-066X.50.12.984; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Borsboom D, 2008, J CLIN PSYCHOL, V64, P1089, DOI 10.1002/jclp.20503; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bringmann LF, 2015, PSYCHOL MED, V45, P747, DOI 10.1017/S0033291714001809; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Dee C, 2005, J MED LIBR ASSOC, V93, P213; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Epskamp S, 2018, CLIN PSYCHOL SCI, V6, P416, DOI 10.1177/2167702617744325; Epskamp S, 2021, MULTIVAR BEHAV RES, V56, P314, DOI [10.1080/00273171.2018.1489771, 10.1080/00273171.2018.1454823]; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Etikan I., 2016, BIOMETRICS BIOSTATIS, V3, P55; Frewen PA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.20656; Frewen PA, 2012, ASSESSMENT, V19, P480, DOI 10.1177/1073191111418297; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Greene T, 2018, PSYCHOL MED, V48, P2409, DOI 10.1017/S0033291718000351; Isvoranu AM, 2017, SCHIZOPHRENIA BULL, V43, P187, DOI 10.1093/schbul/sbw055; Kim NS, 2002, J EXP PSYCHOL GEN, V131, P451, DOI 10.1037//0096-3445.131.4.451; Klippel A, 2018, SCHIZOPHRENIA BULL, V44, P328, DOI 10.1093/schbul/sbx037; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Lin K., 2018, RANCHOS AMIGOS; Marshall AP, 2013, J CLIN NURS, V22, P1424, DOI 10.1111/jocn.12070; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Oliveri RS, 2004, J EVAL CLIN PRACT, V10, P219, DOI 10.1111/j.1365-2753.2003.00477.x; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Spiller TR, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1318032; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079	42	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2021	36	4			SI		E209	E217		10.1097/HTR.0000000000000601			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ9HU	WOS:000673784100002	32898026	Green Published, hybrid			2022-02-07	
J	Veillard, KL; Boltz, AJ; Robison, HJ; Morris, SN; Collins, CL; Chandran, A				Veillard, Kevin L.; Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.; Chandran, Avinash			Epidemiology of Injuries in National Collegiate Athletic Association Women's Softball: 2014-2015 Through 2018-2019	JOURNAL OF ATHLETIC TRAINING			English	Article						collegiate; epidemiology; injury surveillance	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; 1ST DECADE; SPORTS; SHOULDER; SYSTEM	Context: Women's softball athletes account for approximately 9% of all female athletes competing within the National Collegiate Athletic Association (NCAA). Background: Routine surveillance of NCAA women's softball injuries is important for identifying the emerging injury patterns in this sport. Methods: Exposure and injury data collected during competitive seasons in the NCAA Injury Surveillance Program during 2014-2015 through 2018-2019 (5 years) academic years were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics; injury rate ratios (IRRs) were used to examine differential injury rates. Results: The overall injury rate was 3.92 per 1000 athlete exposures. Practice and preseason injury rates increased during 2015/16 through 2018/19. Most injuries were shoulder (15.2%), hand/wrist (11.8%), knee (11.2%), and head/face injuries (11.2%) and were classified as contusions (14.2%), sprains (14.1%), and inflammatory conditions (14.1%). Concussion (6.8%) was the most commonly reported injury, and concussion incidence fluctuated during 2014-2015 through 2018-2019. Summary: Results indicate an increasing trend in practice and preseason injury incidence. Findings also suggest that workload accumulation in the shoulder and the mechanisms of concussion warrant further attention in this population.	[Veillard, Kevin L.] George Washington Univ, Sch Publ Hlth, Dept Epidemiol, Milken Inst, Washington, DC USA; [Boltz, Adrian J.; Robison, Hannah J.; Morris, Sarah N.; Collins, Christy L.; Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46202 USA.	avinashc@datalyscenter.org		Boltz, Adrian/0000-0002-0168-4892	NCAA	The NCAA Injury Surveillance Program was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate student-athletes.	[Anonymous], 2020, NCAA sports sponsorship and participation rates database; Barrentine SW, 1998, J ORTHOP SPORT PHYS, V28, P405, DOI 10.2519/jospt.1998.28.6.405; Black GM, 2016, SPORTS MED, V46, P1503, DOI 10.1007/s40279-016-0529-6; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Dick R, 2007, J ATHL TRAINING, V42, P173; Fry KE, 2019, CLIN J SPORT MED, V29, P406, DOI 10.1097/JSM.0000000000000692; Gilmer GG, 2019, J SPORT REHABIL, V28, P196, DOI 10.1123/jsr.2017-0276; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Marshall SW, 2007, J ATHL TRAINING, V42, P286; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rojas IL, 2009, AM J SPORT MED, V37, P558, DOI 10.1177/0363546508328105; Shanley E, 2012, INT J SPORTS PHYS TH, V7, P548; Shanley E, 2011, J ATHL TRAINING, V46, P648; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Vetter RE, 2010, J STRENGTH COND RES, V24, P587, DOI 10.1519/JSC.0b013e3181c7c2eb; Wasserman EB, 2019, J ATHL TRAINING, V54, P198, DOI 10.4085/1062-6050-239-17; Wasserman EB, 2019, J ATHL TRAINING, V54, P212, DOI 10.4085/1062-6050-206-17; Wright K., BRIEF HIST GRAND SLA; Yang Justin S, 2016, HSS J, V12, P111, DOI 10.1007/s11420-016-9499-3	22	0	0	3	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2021	56	7					734	741		10.4085/1062-6050-668-20			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TL2DA	WOS:000674662700020	34280289	gold			2022-02-07	
J	Vilcinis, R; Bunevicius, A; Piliponis, L; Tamasauskas, A				Vilcinis, Rimantas; Bunevicius, Adomas; Piliponis, Lukas; Tamasauskas, Arimantas			Influence of Decompressive Craniectomy Post Evacuation of Epidural Hematoma in Comatose Patients	WORLD NEUROSURGERY			English	Article						Coma; Decompressive craniectomy; Epidural hematoma; Herniation; Outcome	TRAUMATIC BRAIN-INJURY; SUBDURAL-HEMATOMA; ZERO MORTALITY; CRANIOTOMY; CLASSIFICATION; PREDICTORS	-BACKGROUND: Epidural hematoma causing brain her-n iation is a major cause of mortality and morbidity after severe traumatic brain injury, even if surgical treatment is performed quickly. Decompression may be effective in decreasing intracranial pressure, but its effect on out-comes remains unclear. -METHODS: A retrospective analysis of deeply comatose patients (Glasgow Coma Scale score 3-5) who underwent surgical treatment during a 12-year period, either via osteoplastic craniotomy (OC) or decompressive craniec-tomy, was carried out. Patient groups were compared on the basis of demographics, admission clinical state, head computed tomography imaging characteristics, and discharge outcome. -RESULTS: A total of 60 patients were examined. The first group of 31 patients (52%) needed decompression during primary surgery. The second group of 29 patients (48%) u nderwent OC with evacuation of epidural hematoma without decompression. Both patient groups were similar according to age (40.9 +/- 13 vs. 40.6 +/- 12.5 years), Glasgow Coma Scale score before surgery (4 [3-5] vs. 4 [3-5]), hematoma thickness (based on computed tomography) (3.44 +/- 1 vs. 3.36 +/- 1.62 cm), and midline shift (1.42 +/- 0.83 vs. 1.36 +/- 0.9 cm). Mortality was more evident in the decom-pression group (45.2% vs. 13.8%; P = 0.008), and the Glasgow Outcome Score was also lower, 2.26 +/- 1.5 versus 3.45 +/- 1.5 (P = 0.003). -CONCLUSIONS: Decompressive craniectomy following the evacuation of an acute epidural hematoma in deeply comatose patients demonstrated inferior outcomes in comparison with OC. Brain injury in the decompressive craniectomy patient group was more severe (concomitant subdural hematoma, early brain ischemia, and early brain herniation), which may have influenced the outcome. Further prospective studies are needed.	[Vilcinis, Rimantas; Piliponis, Lukas; Tamasauskas, Arimantas] Lithuanian Univ Hlth Sci, Med Acad, Dept Neurosurg, Kaunas, Lithuania; [Bunevicius, Adomas; Tamasauskas, Arimantas] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania		Piliponis, L (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Dept Neurosurg, Kaunas, Lithuania.	luke.piliponis@gmail.com		Piliponis, Lukas/0000-0002-1853-8787			BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JENNETT B, 1975, LANCET, V1, P480; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kim NY, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000022074; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MAHONEY F I, 1965, Md State Med J, V14, P61; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P261, DOI 10.1007/978-3-211-98811-4_49; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Rosyidi RM, 2019, INTERDISCIP NEUROSUR, V17, P12, DOI 10.1016/j.inat.2019.01.021; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Wang JW, 2016, J CLIN NEUROSCI, V27, P1, DOI 10.1016/j.jocn.2015.06.037; Wang WH, 2014, J NEUROTRAUM, V31, P1444, DOI 10.1089/neu.2013.3142; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Yilmaz I, 2019, ULUS TRAVMA ACIL CER, V25, P147, DOI 10.5505/tjtes.2018.48079	33	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2021	151						E753	E759		10.1016/j.wneu.2021.04.109			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TE3HD	WOS:000669904000008	33945890				2022-02-07	
J	Vinogradsky, EI; Otallah, SI				Vinogradsky, Emillee, I; Otallah, Scott, I			Vanishing White Matter Disease Diagnosis After Athletic Concussion in an Adolescent Male Patient	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; leukoencephalopathy; vanishing white matter disease	LEUKOENCEPHALOPATHY	We report the recognition of a diagnosis of leukoencephalopathy with vanishing white matter, also known as vanishing white matter disease in an adolescent male patient after a sports-related concussion. The patient's atypical symptoms after the concussion led to imaging and subsequent neurological consultation. The objective of this clinical case is to highlight the importance of considering imaging in patients who present with atypical symptoms that may be present after a concussion and to raise awareness of this rare disorder which can present after head trauma.	[Vinogradsky, Emillee, I; Otallah, Scott, I] Wake Forest Baptist Hlth, Pediat Neurol Dept, Winston Salem, NC 27157 USA		Otallah, SI (corresponding author), Wake Forest Baptist Hlth, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sotallah@wakehealth.edu					Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Clark AJ, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11173; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Klingelhoefer L, 2014, PEDIATR NEUROL, V51, P157, DOI 10.1016/j.pediatrneurol.2014.03.008; Lee Bruce, 2005, NeuroRx, V2, P372; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Parikh S, 2015, MOL GENET METAB, V114, P501, DOI 10.1016/j.ymgme.2014.12.434; Proud CG, 2012, FUTUR NEUROL, V7, P81, DOI 10.2217/FNL.11.63; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Tyrakowski M, 2013, OPER TECHN SPORT MED, V21, P159, DOI 10.1053/j.otsm.2013.10.006; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9	13	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2021	31	4					E207	E209		10.1097/JSM.0000000000000783			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	WN3JX	WOS:000711669500005	31688083				2022-02-07	
J	von Steinbuechel, N; Rauen, K; Krenz, U; Wu, YJ; Covic, A; Plass, AM; Cunitz, K; Mueller, I; Bockhop, F; Polinder, S; Wilson, L; Steyerberg, EW; Maas, AIR; Menon, D; Zeldovich, M				von Steinbuechel, Nicole; Rauen, Katrin; Krenz, Ugne; Wu, Yi-Jhen; Covic, Amra; Plass, Anne Marie; Cunitz, Katrin; Mueller, Isabelle; Bockhop, Fabian; Polinder, Suzanne; Wilson, Lindsay; Steyerberg, Ewout W.; Maas, Andrew I. R.; Menon, David; Zeldovich, Marina		Linguistic Validation Grp CENTER	Translation and Linguistic Validation of Outcome Instruments for Traumatic Brain Injury Research and Clinical Practice: A Step-by-Step Approach within the Observational CENTER-TBI Study	JOURNAL OF CLINICAL MEDICINE			English	Article						translation; linguistic validation; outcome instruments; traumatic brain injury	QUALITY-OF-LIFE; CROSS-CULTURAL ADAPTATION; TASK-FORCE; SCALE; DISORDER; QOLIBRI; HEALTH; RECOMMENDATIONS; QUESTIONNAIRES; GUIDELINES	Assessing outcomes in multinational studies on traumatic brain injury (TBI) poses major challenges and requires relevant instruments in languages other than English. Of the 19 outcome instruments selected for use in the observational Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, 17 measures lacked translations in at least one target language. To fill this gap, we aimed to develop well-translated linguistically and psychometrically validated instruments. We performed translations and linguistic validations of patient-reported measures (PROMs), clinician-reported (ClinRO), and performance-based (PerfO) outcome instruments, using forward and backward translations, reconciliations, cognitive debriefings with up to 10 participants, iterative revisions, and international harmonization with input from over 150 international collaborators. In total, 237 translations and 211 linguistic validations were carried out in up to 20 languages. Translations were evaluated at the linguistic and cultural level by coding changes when the original versions are compared with subsequent translation steps, using the output of cognitive debriefings, and using comprehension rates. The average comprehension rate per instrument varied from 88% to 98%, indicating a good quality of the translations. These outcome instruments provide a solid basis for future TBI research and clinical practice and allow the aggregation and analysis of data across different countries and languages.	[von Steinbuechel, Nicole; Krenz, Ugne; Wu, Yi-Jhen; Covic, Amra; Plass, Anne Marie; Cunitz, Katrin; Mueller, Isabelle; Bockhop, Fabian; Zeldovich, Marina] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany; [Rauen, Katrin] Univ Zurich, Psychiat Hosp Zurich, Dept Geriatr Psychiat, Minervastr 145, CH-8032 Zurich, Switzerland; [Rauen, Katrin] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res ISD, Univ Hosp, Feodor Lynen Str 17, D-81377 Munich, Germany; [Polinder, Suzanne; Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LJ, Scotland; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, NL-2333 RC Leiden, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, B-2650 Edegem, Belgium; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 157, Cambridge CB2 0QQ, England		von Steinbuechel, N (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de; katrin.rauen@uzh.ch; ugne.krenz@med.uni-goettingen.de; yi-jhen.wu@med.uni-goettingen.de; amra.covic@med.uni-goettingen.de; annemarie.plass@med.uni-goettingen.de; katrin.cunitz@med.uni-goettingen.de; isabelle.mueller@med.uni-goettingen.de; fabian.bockhop@med.uni-goettingen.de; s.polinder@erasmusmc.nl; l.wilson@stir.ac.uk; e.steyerberg@erasmusmc.nl; andrew.maas@uza.be; dkm13@cam.ac.uk; marina.zeldovich@med.uni-goettingen.de	Cunitz, Katrin/AAS-8176-2020	Cunitz, Katrin/0000-0001-5530-8190; Mueller, Isabelle/0000-0001-7511-6647; Rauen, Katrin/0000-0003-4555-6697	European Union 7th Framework programme (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	CENTER-TBI was supported by the European Union 7th Framework programme (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Acquadro C., 2012, LINGUISTIC VALIDATIO; Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Alonso J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-210; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Fyndanis V, 2017, CLIN LINGUIST PHONET, V31, P697, DOI 10.1080/02699206.2017.1310299; Gorbunova A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072100; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hunt S, 2003, BRIT MED J, V327, P352, DOI 10.1136/bmj.327.7411.352; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McKown S, 2020, J PATIENT-REP OUTCOM, V4, DOI 10.1186/s41687-020-00248-z; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Perneger TV, 1999, J CLIN EPIDEMIOL, V52, P1037, DOI 10.1016/S0895-4356(99)00088-8; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Plass AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210138; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; von Steinbuechel N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10112396; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, P776; Strauss E., 2006, COMPENDIUM NEUROPSYC, P655; Strauss E., 2006, CANTAB COMPENDIUM NE, P415; Swaine-Verdier Angelo, 2004, Value Health, V7 Suppl 1, pS27, DOI 10.1111/j.1524-4733.2004.7s107.x; Teymoori A, 2020, J AFFECT DISORDERS, V262, P278, DOI 10.1016/j.jad.2019.10.035; Thomson HJ, 2013, EUR J CANCER, V49, P1018, DOI 10.1016/j.ejca.2012.09.021; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Van Praag DLG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231857; Victor T.L., 2013, MILD TRAUMATIC BRAIN, P269; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J.E., 2009, USER S MANUAL SF12V2; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Wild D, 2009, VALUE HEALTH, V12, P430, DOI 10.1111/j.1524-4733.2008.00471.x; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wu Y.-J., 2021, VALUE HEALTH	56	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUL	2021	10	13							2863	10.3390/jcm10132863			31	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG1OL	WOS:000671180500001	34203325	Green Published, gold			2022-02-07	
J	Walker, GA; Wilson, JC; Seehusen, CN; Provance, AJ; Howell, DR				Walker, Gregory A.; Wilson, Julie C.; Seehusen, Corrine N.; Provance, Aaron J.; Howell, David R.			Is near point of convergence associated with symptom profiles or recovery in adolescents after concussion?	VISION RESEARCH			English	Article						Vision; Mild traumatic brain injury; Vergence; Gait; Recovery; Adolescent	CHILDREN; INSUFFICIENCY; RELIABILITY; IMPAIRMENT; DURATION; BURDEN; RISK	Our purpose was to compare the clinical and injury characteristics of concussion patients with a receded near point of convergence (NPC) vs those without a receded NPC. Concussion patients were seen within 14 days of injury. We compared those with receded a NPC (>6 cm) break point distance and those with a normal NPC distance on symptom, behavioral, and clinical assessments. We also compared NPC break points between those who did/did not recover within 28 days of injury. 123 patients completed the assessment. 77/123 (63%) of participants demonstrated a receded NPC when tested within 14 days of injury. Those with receded a NPC break point (n = 77; mean = 14.9, SD = 1.5 years; 47% female) were significantly younger than those with a normal NPC break point (n = 46; mean = 15.7, SD = 1.7 years; 46% female). The receded NPC break point group had a significantly greater proportion of patients reporting headaches (86% vs. 61%), as well as significantly greater cognitive (mean = 13.4, SD = 8.7 vs. mean = 8.8, SD = 8.6), somatic (mean = 10.0, SD = 5.9 vs. mean = 6.9, SD = 6.6), and overall (mean = 23.7, SD = 13.6 vs. mean = 15.8, SD = 14.4) symptom severity. Our multivariable model indicated among all potential predictor variables, more severe somatic symptoms were significantly associated with a greater NPC break point (beta = 0.26; 95% CI = 0.01, 0.52). The group who went onto experience persistent symptoms had a significantly greater NPC break point at initial evaluation than those without persistent symptoms (mean = 9.7, SD = 7.5 cm vs. mean = 7.0, SD = 4.0 cm). Those with a receded NPC break point at initial evaluation showed an increased symptom burden, most notable with somatic symptoms, compared with those without a receded NPC break point.	[Walker, Gregory A.; Wilson, Julie C.; Seehusen, Corrine N.; Provance, Aaron J.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Walker, Gregory A.; Wilson, Julie C.; Provance, Aaron J.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Sports Med Ctr, Childrens Hosp Colorado, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@CUAnschutz.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); MINDSOURCE Colorado Brain Injury Network	Unrelated to this study, Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the National Institute of Neurological Disorders And Stroke, and MINDSOURCE Colorado Brain Injury Network.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barnhardt C, 2012, OPTOMETRY VISION SCI, V89, P1512, DOI 10.1097/OPX.0b013e318269c8f9; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Cooper J, 2012, OPTOMETRY, V83, P20; Cripps A, 2018, BRAIN INJURY, V32, P1566, DOI 10.1080/02699052.2018.1497812; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ernst N., 2020, J ATHL TRAINING; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Howell D. R., 2018, CLIN J SPORT MED OFF; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Koyama S, 2018, EUR J PHYSIOTHER, V20, P135, DOI 10.1080/21679169.2017.1414304; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Maples WC, 2007, OPTOMETRY VISION SCI, V84, P224, DOI 10.1097/OPX.0b013e3180339f44; Master CL, 2020, J PEDIATR-US, V223, P128, DOI 10.1016/j.jpeds.2020.04.001; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nunes AF, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1061-x; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Santo AL, 2020, J SPORT REHABIL, V29, P1179, DOI 10.1123/jsr.2019-0428; Schilling S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010351; Sherry N. S., 2019, CLIN J SPORT MED OFF; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Suleiman A, 2020, NEURO-OPHTHALMOLOGY, V44, P157, DOI 10.1080/01658107.2019.1653325; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Van Deventer KA, 2021, J SPORT HEALTH SCI, V10, P131, DOI 10.1016/j.jshs.2020.08.005; Worts P. R., 2018, AM J SPORTS MED, V46, pHTT; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	43	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	JUL	2021	184						52	57		10.1016/j.visres.2021.03.007			6	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	SE5KF	WOS:000652110300007	33866266				2022-02-07	
J	Wang, H; Liu, KL; Xiu, C; Liu, B; Zhao, WT; Liu, L; Pang, JF				Wang, He; Liu, Kaili; Xiu, Chao; Liu, Bin; Zhao, Wantao; Liu, Liang; Pang, Jinfeng			Dynamic Changes and Clinical Significance of White Blood Cells and Platelets in Patients with Traumatic Brain Injury	TOBACCO REGULATORY SCIENCE			English	Article						Traumatic Brain Injury; Patient White Blood Cells; Platelets; Dynamic Changes; C-reactive Protein	COGNITIVE IMPAIRMENT; PROTEIN; AGE	Traumatic brain injury (TBI) is becoming the main cause of death threatening human life because of its high disability rate, high mortality rate and great social harm. The purpose of this study was to investigate the dynamic changes and clinical significance of leukocytes (WBC) and platelets (PLT) in patients with traumatic brain injury. In the process of specimen collection, 4ml of peripheral venous blood was collected 24 hours, 4 days, 7 days, 14 days and 21 days after craniocerebral injury using sterile, non-heat source and non-endotoxin test tube. 2ml venous blood was added into EDTA anticoagulant blood collection vessel to detect the changes of peripheral blood leukocytes and platelets in patients with craniocerebral injury. In addition, 2 ml venous blood was added into the procoagulant blood collection vessel, and the serum was separated and frozen for the determination of CRP and TSP1. All patients were evaluated with Glasgow outcome score at discharge. When detecting PLT and WBC, Sysmex K4500 hematology analyzer was used to routinely measure the number of PLT and WBC in peripheral blood at different time points. In the process of CRP (C-reactive protein) measurement, adjust the pipette to 60 mu l, and add 50 mu l of developer a and developer B into the micropore respectively. Then it vibrates on a mini vibrator for 5 seconds to ensure mixing. Preheat the microplate reader for 30 minutes, place the microplate in the microplate reader, set the parameters and read the values. When measuring TSP1 (thrombin sensitive protein 1), adjust the micropipette to 50 mu l, then add 50 mu l termination solution into the micropore respectively, and then vibrate on the micro vibrator for 30 seconds to ensure full mixing. Further analysis showed that there was no difference between the non-infection group and the normal control group on the 4th day (P > 0.05). This study is helpful to the timely treatment of patients with traumatic brain injury.	[Wang, He; Pang, Jinfeng] BeiHua Univ, Affiliated Hosp, Dept Neurosurg, 12 Jiefang Zhong Rd, Jilin 132000, Jilin, Peoples R China; [Liu, Kaili] BeiHua Univ, Affiliated Hosp, Dept Lab, Jilin 132000, Jilin, Peoples R China; [Xiu, Chao] BeiHua Univ, Affiliated Hosp, Dept Presidents Off, Jilin 132000, Jilin, Peoples R China; [Liu, Bin] Daan First Peoples Hosp, Dept Ultrasonog, Daan 131300, Jilin, Peoples R China; [Zhao, Wantao] BeiHua Univ, Affiliated Hosp, Dept Med Examinat Ctr, Jilin 132000, Jilin, Peoples R China; [Liu, Liang] Jilin Peoples Hosp, Dept Internal Med Neurol, Jilin 132000, Jilin, Peoples R China		Pang, JF (corresponding author), BeiHua Univ, Affiliated Hosp, Dept Neurosurg, 12 Jiefang Zhong Rd, Jilin 132000, Jilin, Peoples R China.	pyneurosurgery@sina.com					Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Algarra NN, 2016, CURR ANESTHESIOL REP, V6, P193; Alghafri Rahab Marhoon, 1800, Rev Diabet Stud, V16, P35, DOI 10.1900/RDS.2020.16.35; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Bjugstad KB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6974257; el Barzouhi A, 2016, J NEUROSURG-SPINE, V24, P978, DOI 10.3171/2015.10.SPINE15858; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Mercier Eric, 2016, CMAJ Open, V4, pE371; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Reeves TM, 2016, EXP NEUROL, V283, P188, DOI 10.1016/j.expneurol.2016.06.011; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Wang G, 2016, NEURAL REGEN RES, V11, P771, DOI 10.4103/1673-5374.182704; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z	26	0	0	20	20	TOBACCO REGULATORY SCIENCE GROUP	OAK RIDGE	2205-K OAK RIDGE RIDGE, STE 115-TRS, OAK RIDGE, NC 27310 USA	2333-9748			TOB REGUL SCI	Tob. Regul. Sci.	JUL	2021	7	4					264	273		10.18001/TRS.7.4.3			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XA8NB	WOS:000720896200003					2022-02-07	
J	Wang, SH; Zhu, KX; Hou, XX; Hou, LJ				Wang, Shenhao; Zhu, Kaixin; Hou, Xiaoxiang; Hou, Lijun			The association of traumatic brain injury, gut microbiota and the corresponding metabolites in mice	BRAIN RESEARCH			English	Article						Brain injury; Intestinal flora; Metabolites; Controlled cortical impact; Non-target LC-MS		Background: Traumatic Brain Injury (TBI) present a significant burden to global health. Close association and mutual regulation exist between the brain and gut microbiota. In addition, metabolites may play an important role as intermediary mediators of the brain and gut microbiota. Consequently, the study sought to investigate the alterations in gut microbiota and metabolites after TBI and conducted a comprehensive analysis of the correlation between gut microbiota and metabolites after TBI in mice. Methods: Changes in intestinal microbiota and metabolites in mice after moderate or severe traumatic brain injury were detected through 16S rDNA sequencing and the non-target LC-MS technology. Additionally, Pearson correlation analysis was used to explore the association between the microbiota and metabolites. Results: TBI was able to change the composition of intestinal microbiota, resulting to a decrease in microbial diversity in the intestinal tract (sham vs sTBI: 8.35 +/- 0.12 vs 7.71 +/- 0.5, p < 0.01; sTBI vs mTBI: 7.71 +/- 0.5 vs 8.25 +/- 0.34, p < 0.05). The results also showed that TBI could change the types and abundance of metabolites (723 in mTBI and sham groups; 1221 in sTBI and sham groups; 324 in mTBI and sTBI groups). Moreover, some of the altered gut metabolites were significantly correlated with part of the altered gut microbes after TBI. Conclusions: TBI significantly changed intestinal microbiota as well as metabolites. Some of the altered microbiota and metabolites had a significant association. The results from this study provide information that paves way for future studies utilizing the brain gut axis theory in the diagnosis and treatment of TBI.	[Wang, Shenhao; Zhu, Kaixin; Hou, Xiaoxiang; Hou, Lijun] Naval Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China		Hou, LJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, 415 Fengyang Rd, Shanghai, Peoples R China.	lijunhoucz@126.com			Shanghai Changzheng Hospital under Pyramid Talent Project	This work was supported by Shanghai Changzheng Hospital under Pyramid Talent Project.	Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Batulu H, 2019, EXP THER MED, V17, P4109, DOI 10.3892/etm.2019.7423; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bordoni L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223238; Bravo TP, 2008, BRAIN RES, V1205, P100, DOI 10.1016/j.brainres.2008.01.102; Brenner LA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01015; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chen DL, 2020, AGING-US, V12, P260, DOI 10.18632/aging.102614; Chiu LS, 2017, MOL NEUROBIOL, V54, P7838, DOI 10.1007/s12035-016-0287-3; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Erny D, 2017, IMMUNOLOGY, V150, P7, DOI 10.1111/imm.12645; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Farr SA, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02009-7; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Houser MC, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-016-0002-0; Leigh SJ, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0734-9; Lima-Ojeda JM, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00153; Long-Smith C, 2020, ANNU REV PHARMACOL, V60, P477, DOI 10.1146/annurev-pharmtox-010919-023628; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahadevan S, 2008, ANAL CHEM, V80, P7562, DOI 10.1021/ac800954c; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; Portbury SD, 2018, METALLOMICS, V10, P846, DOI 10.1039/c8mt00068a; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; Rocks T, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2020.110201; Sarkar A, 2016, TRENDS NEUROSCI, V39, P763, DOI 10.1016/j.tins.2016.09.002; Serbanescu MA, 2019, ANESTH ANALG, V129, pE126, DOI 10.1213/ANE.0000000000003938; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tan AH, 2021, ANN NEUROL, V89, P546, DOI 10.1002/ana.25982; Torres-Fuentes C, 2017, LANCET GASTROENTEROL, V2, P747, DOI 10.1016/S2468-1253(17)30147-4; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; Wang T.J., TRAUMATIC BRAIN INJU, DOI [10.1089/neu.2020.7317, DOI 10.1089/NEU.2020.7317]; Wen L., 2019, J VISUAL EXPER JOVE, V151; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang C, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1735-9	48	0	0	4	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2021	1762								147450	10.1016/j.brainres.2021.147450			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL7MH	WOS:000639151900016	33773978				2022-02-07	
J	Weber, AM; Zhang, Y; Kames, C; Rauscher, A				Weber, A. M.; Zhang, Y.; Kames, C.; Rauscher, A.			Quantitative Susceptibility Mapping of Venous Vessels in Neonates with Perinatal Asphyxia	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEAR-INFRARED SPECTROSCOPY; NONINVASIVE MRI MEASUREMENTS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NEWBORN-INFANTS; PRETERM INFANTS; OXYGENATION; SATURATION; PERFUSION	BACKGROUND AND PURPOSE: Cerebral venous oxygen saturation can be used as an indirect measure of brain health, yet it often requires either an invasive procedure or a noninvasive technique with poor sensitivity. We aimed to test whether cerebral venous oxygen saturation could be measured using quantitative susceptibility mapping, an MR imaging technique, in 3 distinct groups: healthy term neonates, injured term neonates, and preterm neonates. MATERIALS AND METHODS: We acquired multiecho gradient-echo MR imaging data in 16 neonates with perinatal asphyxia and moderate or severe hypoxic-ischemic encephalopathy (8 term age: average, 40.0 [SD, 0.8] ?weeks? gestational age; 8 preterm, 33.5 [SD, 2.0] ?weeks? gestational age) and in 8 healthy term-age controls (39.3 [SD, 0.6]?weeks, for a total of n?=?24. Data were postprocessed as quantitative susceptibility mapping images, and magnetic susceptibility was measured in cerebral veins by thesholding out 99.95% of lower magnetic susceptibility values. RESULTS: The mean magnetic susceptibility value of the cerebral veins was found to be 0.36 (SD, 0.04)?ppm in healthy term neonates, 0.36 (SD, 0.06)?ppm in term injured neonates, and 0.29 (SD, 0.04)?ppm in preterm injured neonates. Correspondingly, the derived cerebral venous oxygen saturation values were 73.6% (SD, 2.8%), 71.5% (SD, 7.4%), and 72.2% (SD, 5.9%). There was no statistically significant difference in cerebral venous oxygen saturation among the 3 groups (P?=?.751). CONCLUSIONS: Quantitative susceptibility mapping?derived oxygen saturation values in preterm and term neonates agreed well with values in past literature. Cerebral venous oxygen saturation in preterm and term neonates with hypoxic-ischemic encephalopathy, however, was not found to be significantly different between neonates or healthy controls.	[Weber, A. M.; Rauscher, A.] Div Neurol, Vancouver, BC, Canada; [Weber, A. M.; Kames, C.; Rauscher, A.] Dept Pediat, Vancouver, BC, Canada; [Weber, A. M.; Kames, C.; Rauscher, A.] Univ British Columbia, MRI Res Ctr, Vancouver, BC, Canada; [Kames, C.; Rauscher, A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Rauscher, A.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Zhang, Y.] Chongqing Med Univ, Dept Radiol, Childrens Hosp, Chongqing, Peoples R China; [Zhang, Y.] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Zhang, Y.] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Zhang, Y.] China Chongqing Int Sci & Technol Cooperat Ctr Ch, Chongqing, Peoples R China		Weber, AM (corresponding author), BC Childrens Hosp, Res Inst, Variety Bldg,Room 370B,950 West 28th Ave, Vancouver, BC VSZ 4H4, Canada.	alex.weber@ubc.ca		Kames, Christian/0000-0002-7845-9124; Rauscher, Alexander/0000-0002-1961-8252			Albayram MS, 2020, AM J NEURORADIOL, V41, P331, DOI 10.3174/ajnr.A6371; Antonucci R, 2014, J PEDIATR NEONATAL I, V3, DOI 10.7363/030269; Azzopardi D, 2010, SEMIN FETAL NEONAT M, V15, P261, DOI 10.1016/j.siny.2010.03.001; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P1837; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Bosemani T, 2014, J MAGN RESON IMAGING, V40, P530, DOI 10.1002/jmri.24410; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buchvald FF, 1999, BIOL NEONATE, V75, P97, DOI 10.1159/000014084; Cainelli E, 2018, CLIN NEUROPHYSIOL, V129, P1300, DOI 10.1016/j.clinph.2018.03.043; Chai C, 2020, BRAIN IMAGING BEHAV, V14, P1339, DOI 10.1007/s11682-018-9999-5; Chai C, 2017, NEUROIMAGE-CLIN, V15, P625, DOI 10.1016/j.nicl.2017.06.008; Chalak LF, 2012, J PEDIATR-US, V160, P388, DOI 10.1016/j.jpeds.2011.09.001; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; De Vis JB, 2014, NEUROIMAGE, V95, P185, DOI 10.1016/j.neuroimage.2014.03.060; Deistung A, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3569; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Dolui S, 2016, J CEREBR BLOOD F MET, V36, P1244, DOI 10.1177/0271678X16646124; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Doucette J, 2019, NEUROIMAGE, V185, P198, DOI 10.1016/j.neuroimage.2018.10.035; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gopagondanahalli KR, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00114; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Kames C, 2018, NEUROIMAGE, V167, P276, DOI 10.1016/j.neuroimage.2017.11.018; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Laptook AR, 2016, CLIN PERINATOL, V43, P529, DOI 10.1016/j.clp.2016.04.010; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu PY, 2014, NMR BIOMED, V27, P332, DOI 10.1002/nbm.3067; Liu SF, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3552; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Neelavalli J, 2014, J MAGN RESON IMAGING, V39, P998, DOI 10.1002/jmri.24245; Portnoy S, 2018, MAGN RESON MED, V79, P3194, DOI 10.1002/mrm.26978; PRYDS O, 1990, J PEDIATR-US, V117, P119, DOI 10.1016/S0022-3476(05)72459-8; Rana L, 2018, EUR J RADIOL OPEN, V5, P215, DOI 10.1016/j.ejro.2018.08.001; Rescoe E, 2017, J THORAC CARDIOV SUR, V154, P1056, DOI 10.1016/j.jtcvs.2017.03.154; Salhab WA, 2005, PEDIATR NEUROL, V32, P25, DOI 10.1016/j.pediatrneurol.2004.06.016; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Shetty AN, 2019, PEDIATR RADIOL, V49, P224, DOI 10.1007/s00247-018-4283-9; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; SKOV L, 1993, PEDIATR RES, V33, P52, DOI 10.1203/00006450-199301000-00011; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Tortora D, 2016, AM J NEURORADIOL, V37, P2144, DOI 10.3174/ajnr.A4877; vanderHoeven MAHBM, 1996, ARCH DIS CHILD-FETAL, V74, pF177, DOI 10.1136/fn.74.3.F177; Wang Y, 2017, J MAGN RESON IMAGING, V46, P951, DOI 10.1002/jmri.25693; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Yadav BK, 2019, EUR RADIOL, V29, P2017, DOI 10.1007/s00330-018-5735-1; Yadav BK, 2018, EUR RADIOL, V28, P1884, DOI 10.1007/s00330-017-5160-x; Zhang Y, 2019, AM J NEURORADIOL, V40, P1221, DOI 10.3174/ajnr.A6114	60	0	0	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL	2021	42	7					1327	1333		10.3174/ajnr.A7086			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UB0SZ	WOS:000685564400029	34255732	hybrid			2022-02-07	
J	Weber, MW; Nie, JZ; Watson, VL; Nordmann, NJ; Bernard, J; Michael, AP; Wellman, E; Delfino, KR; Espinosa, JA				Weber, Matthew W.; Nie, Jeffrey Z.; Watson, Victoria L.; Nordmann, Nathan J.; Bernard, Joseph; Michael, Alex P.; Wellman, Elek; Delfino, Kristin R.; Espinosa, Jose A.			Utility of Head Computed Tomography Scans Before Outpatient Follow-up for Low-Risk Mild Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Costs and cost analysis; Follow-up studies; Head computed tomography; Intracranial hemorrhage; Management of traumatic brain injury; Mild traumatic brain injury; Outpatient	INTRACRANIAL HEMORRHAGE; CT; MANAGEMENT; SCORE	BACKGROUND: Neurosurgeons are frequently consulted for traumatic brain injuries (TBIs) resulting in intracranial hemorrhage (ICH). After inpatient confirmation of hemorrhage stability, outpatient head computed tomography (CT) is often performed to assess for hemorrhage resolution. Our objective was to assess the practice patterns and clinical utility of routine outpatient head CT scans for patients with mild TBI (mTBI). MATERIALS AND METHODS: A retrospective review was performed on all adult mTBI patients with ICH who presented to a level I trauma center over a 4-year period. A combination of the patient's initial clinical evaluation and CT findings was used to identify mTBI patients at low risk for neurologic deterioration and neurosurgical intervention. Findings from the outpatient follow-up clinical evaluation and head CT were assessed. Patients without outpatient follow-up within 3 months were excluded. RESULTS: Forty-nine patients met inclusion criteria for the study. Thirty-two had an outpatient head CT before their follow-up appointment. Twenty-one patients had at least 1 neurologic finding at the earliest follow-up appointment. All patients except those with a subdural hematoma (SDH) had smaller or resolving ICH on outpatient CT scans. Seven patients with an SDH had unchanged or expanded hemorrhage on outpatient imaging, 2 of whom had traumatic brain injuryLrelated hospitalizations and 1 of whom underwent neurosurgical intervention due to an enlarging SDH. CONCLUSIONS: Routine outpatient head CT scans before follow-up for low-risk mTBI patients without an SDH appears to have limited clinical utility. In low-risk mTBI patients with an SDH, obtaining an outpatient head CT is reasonable to monitor for resolution.	[Weber, Matthew W.; Nie, Jeffrey Z.; Watson, Victoria L.; Nordmann, Nathan J.; Bernard, Joseph; Michael, Alex P.; Wellman, Elek; Espinosa, Jose A.] Southern Illinois Univ, Sch Med, Div Neurosurg, Springfield, IL 62702 USA; [Delfino, Kristin R.] Southern Illinois Univ, Sch Med, Ctr Clin Res, Springfield, IL USA		Weber, MW (corresponding author), Southern Illinois Univ, Sch Med, Div Neurosurg, Springfield, IL 62702 USA.	mweber96@siumed.edu	Nie, Jeffrey/AAU-1475-2021	Nie, Jeffrey/0000-0001-5213-4252			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Arnold MR, 2020, AM J EMERG MED, V38, P1097, DOI 10.1016/j.ajem.2019.158379; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Befeler AR, 2016, J NEUROSURG, V124, P703, DOI 10.3171/2015.4.JNS141257; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Centers for Disease Control and Prevention, 2003, REP C MILD TRA INJ U; Centers for Disease Control and Prevention, 2015, REP C TRA BRA INJ US; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; LUND E, 1982, NEURORADIOLOGY, V22, P181, DOI 10.1007/BF00341246; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; Peterson AB, 2014, SURVEILLANCE REPORT; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Rubino S, 2014, J NEUROSURG, V121, P944, DOI 10.3171/2014.6.JNS132204; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Weber MW, 2021, CLIN NEUROL NEUROSUR, V202, DOI 10.1016/j.clineuro.2021.106518; World Health Organization Press, 2006, NEUR DIS PUBL HLTH C; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	37	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2021	151						E565	E570		10.1016/j.wneu.2021.04.087			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TE3HU	WOS:000669905700025	33940271				2022-02-07	
J	Wheatley, MA; Kapil, S; Lewis, A; O'Sullivan, JW; Armentrout, J; Moran, TP; Osborne, A; Moore, BL; Morse, B; Rhee, P; Ahmad, F; Atallah, H				Wheatley, Matthew A.; Kapil, Shikha; Lewis, Amanda; O'Sullivan, Jessica Walsh; Armentrout, Joshua; Moran, Tim P.; Osborne, Anwar; Moore, Brooks L.; Morse, Bryan; Rhee, Peter; Ahmad, Faiz; Atallah, Hany			Management of Minor Traumatic Brain Injury in an ED Observation Unit	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							DEPARTMENT OBSERVATION UNIT; SERIAL COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; LOW-RISK; SUBARACHNOID HEMORRHAGE; INTRACRANIAL HEMORRHAGE; DIAGNOSTIC PROTOCOL; RANDOMIZED-TRIAL; INPATIENT CARE; CLINICAL-TRIAL	Introduction: Traumatic intracranial hemorrhages (TIH) have traditionally been managed in the intensive care unit (ICU) setting with neurosurgery consultation and repeat head CT (HCT) for each patient. Recent publications indicate patients with small TIH and normal neurological examinations who are not on anticoagulation do not require ICU-level care, repeat HCT, or neurosurgical consultation. It has been suggested that these patients can be safely discharged home after a short period of observation in emergency department observation units (EDOU) provided their symptoms do not progress. Methods: This study is a retrospective cross-sectional evaluation of an EDOU protocol for minor traumatic brain injury (mTBI). It was conducted at a Level I trauma center. The protocol was developed by emergency medicine, neurosurgery and trauma surgery and modeled after the Brain Injury Guidelines (BIG). All patients were managed by attendings in the ED with discretionary neurosurgery and trauma surgery consultations. Patients were eligible for the mTBI protocol if they met BIG 1 or BIG 2 criteria (no intoxication, no anticoagulation, normal neurological examination, no or non-displaced skull fracture, subdural or intraparenchymal hematoma up to 7 millimeters, trace to localized subarachnoid hemorrhage), and had no other injuries or medical co-morbidities requiring admission. Protocol in the EDOU included routine neurological checks, symptom management, and repeat HCT for progression of symptoms. The EDOU group was compared with historical controls admitted with primary diagnosis of TIH over the 12 months prior to the initiation of the mTBI protocols. Primary outcome was reduction in EDOU length of stay (LOS) as compared to inpatient LOS. Secondary outcomes included rates of neurosurgical consultation, repeat HCT, conversion to inpatient admission, and need for emergent neurosurgical intervention. Results: There were 169 patients placed on the mTBI protocol between September 1, 2016 and August 31, 2019. The control group consisted of 53 inpatients. Median LOS (interquartile range [IQR]) for EDOU patients was 24.8 (IQR: 18.8 - 29.9) hours compared with a median LOS for the comparison group of 60.2 (IQR: 45.1 - 85.0) hours (P <.001). In the EDOU group 47 (27.8%) patients got a repeat HCT compared with 40 (75.5%) inpatients, and 106 (62.7%) had a neurosurgical consultation compared with 53 (100%) inpatients. Subdural hematoma was the most common type of hemorrhage. It was found in 60 (35.5%) patients, and subarachnoid hemorrhage was found in 56 cases (33.1%). Eleven patients had multicompartment hemorrhage of various classifications. Twelve (7.1%) patients required hospital admission from the EDOU. None of the EDOU patients required emergent neurosurgical intervention. Conclusion: Patients with minor TIH can be managed in an EDOU using an mTBI protocol and discretionary neurosurgical consults and repeat HCT. This is associated with a significant reduction in length of stay.	[Wheatley, Matthew A.; Lewis, Amanda; O'Sullivan, Jessica Walsh; Moran, Tim P.; Osborne, Anwar; Moore, Brooks L.] Emory Univ, Sch Med, Dept Emergency Med, 201 Dowman Dr, Atlanta, GA 30322 USA; [Kapil, Shikha] Georgetown Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Wheatley, Matthew A.; Lewis, Amanda; O'Sullivan, Jessica Walsh; Osborne, Anwar; Moore, Brooks L.] Grady Hlth Syst, Dept Emergency Med, Atlanta, GA USA; [Armentrout, Joshua] Atlanta Med Ctr, Dept Emergency Med, Atlanta, GA USA; [Morse, Bryan] Maine Med Ctr, Dept Surg & Surg Crit Care, Portland, ME 04102 USA; [Rhee, Peter] Westchester Med Ctr, Dept Surg Trauma Surg & Surg Crit Care, Valhalla, NY USA; [Ahmad, Faiz] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Atallah, Hany] Jackson Hlth Syst, Miami, FL USA		Wheatley, MA (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, 201 Dowman Dr, Atlanta, GA 30322 USA.	mwheatl@emory.edu					Baugh CW, 2015, ACAD EMERG MED, V22, P934, DOI 10.1111/acem.12720; Baugh CW, 2013, NEW ENGL J MED, V369, P302, DOI 10.1056/NEJMp1304493; Baugh CW, 2012, HEALTH AFFAIR, V31, P2314, DOI 10.1377/hlthaff.2011.0926; Baugh CW, 2011, HEALTH CARE MANAGE R, V36, P28, DOI 10.1097/HMR.0b013e3181f3c035; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Decker WW, 2008, ANN EMERG MED, V52, P322, DOI 10.1016/j.annemergmed.2007.12.015; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Gomez MA, 1996, J AM COLL CARDIOL, V28, P25, DOI 10.1016/0735-1097(96)00093-9; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; McDermott MF, 1997, ARCH INTERN MED, V157, P2055, DOI 10.1001/archinte.157.18.2055; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Roberts RR, 1997, JAMA-J AM MED ASSOC, V278, P1670, DOI 10.1001/jama.278.20.1670; Ross MA, 2007, ANN EMERG MED, V50, P109, DOI 10.1016/j.annemergmed.2007.03.008; Ross MA, 2013, HEALTH AFFAIR, V32, P2149, DOI 10.1377/hlthaff.2013.0662; Ross Michael A, 2012, Crit Pathw Cardiol, V11, P128; Rydman RJ, 1998, MED CARE, V36, P599, DOI 10.1097/00005650-199804000-00015; Schrager J, 2013, ACAD EMERG MED, V20, P554, DOI 10.1111/acem.12147; Schuur JD, 2012, NEW ENGL J MED, V367, P391, DOI 10.1056/NEJMp1204431; Shen WK, 2004, CIRCULATION, V110, P3636, DOI 10.1161/01.CIR.0000149236.92822.07; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sun BC, 2014, ANN EMERG MED, V64, P167, DOI 10.1016/j.annemergmed.2013.10.029; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wright B, 2018, ANN EMERG MED, V72, P166, DOI 10.1016/j.annemergmed.2018.02.005; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	37	0	0	2	2	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	JUL	2021	22	4					943	950		10.5811/westjem.2021.4.50442			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TU9NQ	WOS:000681356800019		gold, Green Published			2022-02-07	
J	Wiecek, EK; Roberts, TL; Shah, AS; Raghuram, A				Wiecek, Emily K.; Roberts, Tawna L.; Shah, Ankoor S.; Raghuram, Aparna			Vergence, accommodation, and visual tracking in children and adolescents evaluated in a multidisciplinary concussion clinic	VISION RESEARCH			English	Article						Concussion; Accommodation; Vergence; Visual tracking; Binocular vision	EMERGENCY-DEPARTMENT; VISITS; SYSTEM	Many patients with concussion experience visual symptoms following injury that lead to a diagnosis of convergence insufficiency, accommodative insufficiency, or saccadic dysfunction. However, these diagnostic categories are based on aggregates of clinical tests developed from a non-concussed population and therefore may not accurately describe visual deficits in the concussed population. Thus, we sought to understand individual metrics of visual dysfunction in chronically symptomatic post-concussion patients. This retrospective cross-sectional study included patients examined at the multidisciplinary concussion clinic (MDCC) at Boston Children's Hospital over four years. Patients aged 5-21 years who had a complete assessment of eye alignment, vergence, accommodation, and visual tracking, and had visual acuity better than or equal to 20/30 in each eye were included. Patients with history of amblyopia, strabismus, or ocular pathology were excluded. Chart review yielded 116 patients who met inclusion criteria (median age 15 years, 64% female). The majority of patients (52%) experienced a single concussion and most were sports-related (50%). Clinical data show vergence, accommodation, or visual tracking deficits in 95% of patients. A receded near point of convergence (NPC, 70/116) and reduced accommodative amplitude (63/116) were the most common deficits. Both NPC and accommodative amplitude were significantly correlated with one another (r = -0.5) and with measures of visual tracking (r = -0.34). Patients with chronic post-concussion symptoms show deficits in individual metrics of vergence, accommodation and visual tracking. The high incidence of these deficits, specifically NPC and accommodative amplitude, highlights the need for a detailed sensorimotor evaluation to guide personalized treatment following concussion.	[Wiecek, Emily K.; Shah, Ankoor S.; Raghuram, Aparna] Boston Childrens Hosp, Boston, MA 02115 USA; [Wiecek, Emily K.; Shah, Ankoor S.; Raghuram, Aparna] Harvard Med Sch, Boston, MA 02115 USA; [Roberts, Tawna L.] Stanford Univ, Spencer Ctr Vis Res, Byers Eye Inst, Palo Alto, CA 94303 USA		Wiecek, EK (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, Fegan 4,300 Longwood Ave, Boston, MA 02115 USA.	emily.wiecek@childrens.harvard.edu		Raghuram, Aparna/0000-0002-2913-6046	Boston Children's Hospital Ophthalmology Foundation Discovery Award; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [NEI P30-EY026877]; Christ Family Fund; Research to Prevent Blindness, Inc.Research to Prevent Blindness (RPB)	This work is supported by the Boston Children's Hospital Ophthalmology Foundation Discovery Award (AR, EW, AS), National Eye Institute (NEI P30-EY026877 (TLR)), The Christ Family Fund (AS), Research to Prevent Blindness, Inc. (TLR).	Agarwal M, 2016, EUR RADIOL, V26, P2193, DOI 10.1007/s00330-015-4004-9; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Ciuffreda K. J., 2017, CONCUSSION; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Feil M, 2017, GRAEF ARCH CLIN EXP, V255, P2247, DOI 10.1007/s00417-017-3770-2; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; HOLM S, 1979, SCAND J STAT, V6, P65; Kassambara A., 2017, GGPUBR GGPLOT2 BASED; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Langdon S., 2020, SPORTS MED, V50, P1829, DOI [10.1007/s40279-020-01321-9, DOI 10.1007/s40279-020-01321-9]; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Master CL, 2020, JAMA OPHTHALMOL, V138, P1135, DOI 10.1001/jamaophthalmol.2020.3466; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuseviciene G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018734; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; R Development Core Team, 2008, R LANG ENV STAT COMP; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Roberts TL, 2019, INVEST OPHTH VIS SCI, V60, P1527, DOI 10.1167/iovs.18-25256; Roberts TL, 2015, OPTOMETRY VISION SCI, V92, P1092, DOI 10.1097/OPX.0000000000000711; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; Seidemann A, 2003, VISION RES, V43, P419, DOI 10.1016/S0042-6989(02)00571-0; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x	39	0	0	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	JUL	2021	184						30	36		10.1016/j.visres.2021.03.002			7	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	SE5KF	WOS:000652110300004	33838503				2022-02-07	
J	Wood, TA; Tablerion, JM; Ballard, RA; Zimmerman, J; Sosnoff, JJ				Wood, Tyler A.; Tablerion, Jake M.; Ballard, Randy A.; Zimmerman, Jerrad; Sosnoff, Jacob J.			Linear Acceleration at Head Impact in Collegiate Divers: A Pilot Study	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						athletes; brain concussion; kinematics	FOOTBALL PLAYERS; CONCUSSION	There is minimal biomechanical research examining head impacts in noncollision sport, such as diving. This pilot study quantified the number of head impacts and magnitude of linear head acceleration in collegiate divers. Three participants wore instrumented swim caps for 10 practice sessions. A total of 1,271 dives were recorded and analyzed. Acceleration at impact ranged from 24.1g to 33.3g for 1-m dives and from 31.6g to 38.4g for 3-m dives. Simple main effects were observed for dive type (p>.001) and dive distance (p>.001). The current data suggest diving athletes experience considerable head acceleration, yet more research is needed to understand the potential implications.	[Wood, Tyler A.] Northern Illinois Univ, Coll Educ, Dept Kinesiol & Phys Educ, De Kalb, IL 60115 USA; [Tablerion, Jake M.; Sosnoff, Jacob J.] Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA; [Sosnoff, Jacob J.] Univ Kansas, Med Ctr, Sch Hlth Profess, Lawrence, KS 66045 USA; [Sosnoff, Jacob J.] Univ Kansas, Med Ctr, Dept Phys Therapy Rehabil Sci & Athlet Training, Lawrence, KS 66045 USA; [Ballard, Randy A.] Univ Illinois, Div Intercollegiate Athlet, Champaign, IL USA; [Zimmerman, Jerrad] Carle Fdn Hosp, Urbana, IL USA		Sosnoff, JJ (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA.; Sosnoff, JJ (corresponding author), Univ Kansas, Med Ctr, Sch Hlth Profess, Lawrence, KS 66045 USA.; Sosnoff, JJ (corresponding author), Univ Kansas, Med Ctr, Dept Phys Therapy Rehabil Sci & Athlet Training, Lawrence, KS 66045 USA.	jsosnoff@kumc.edu			Neal Research Award [12507]; Carle Foundation Hospital, Urbana, IL	This work was supported by the Neal Research Award (fund number: 12507) and Carle Foundation Hospital, Urbana, IL.	Bakrania K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164045; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Committee USO, 2018, TYP DIV TYP DIV; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Nguyen JVK, 2019, SPORTS MED, V49, P1575, DOI 10.1007/s40279-019-01135-4; OBrien R., 2003, SPRINGBOARD PLATFORM, V2nd; Pavey TG, 2016, J SCI MED SPORT, V19, P395, DOI 10.1016/j.jsams.2015.04.007; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	26	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JUL	2021	26	4					212	215		10.1123/ijatt.2020-0029			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	TK2DS	WOS:000673976300006					2022-02-07	
J	Xie, Y; Guo, ZD; Chen, FH; Xiao, C; Xu, JP; Bo, DZ				Xie, Yun; Guo, Zhidong; Chen, Fanghui; Xiao, Chen; Xu, Jianping; Bo, Dezhi			Serum netrin-1 as a potential biomarker for functional outcome of traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Netrin-1; Prognosis; Severity; Biomarkers	HEMORRHAGE	Background: Decreased serum netrin-1 concentrations have been found after acute brain injury. We investigated the role of serum netrin in prognosis of traumatic brain injury (TBI). Methods: In this prospective and observational study, enzyme-linked immunosorbent assay was used to detect serum netrin-1 concentrations in 50 mild TBI patients (Glasgow coma scale (GCS) score, 13-15), 83 moderate TBI patients (GCS score, 9-12), 69 severe TBI patients (GCS score, 3-8) and 50 healthy controls. Glasgow outcome scale score of 1-3 at 6 months after trauma was defined as poor outcome. Results: Serum netrin-1 concentrations were significantly lower in moderate or severe TBI patients than in controls and in severe TBI patients than in moderate TBI patients, while not in mild TBI patients than in controls. GCS score and Rotterdam computed tomography classification were closely correlated with serum netrin-1 concentrations among TBI patients. Forty-two (20.8%) patients had poor outcome. Receiver operating characteristic curve analysis revealed that serum netrin-1 concentrations could distinguish patients with poor outcome from the other remainders significantly. In addition, serum netrin-1 concentrations were independently associated with poor outcome. Conclusions: Serum netrin-1 might serve as a potential biomarker for prognosis of TBI.	[Xie, Yun; Guo, Zhidong; Chen, Fanghui; Xiao, Chen] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Emergency Med, Sch Med, 261 Huansha Rd, Hangzhou 310006, Peoples R China; [Xu, Jianping; Bo, Dezhi] Liangzhu Hosp Yuhang Dist Hangzhou City, 1657 Moganshan Rd, Hangzhou 311113, Peoples R China		Guo, ZD (corresponding author), Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Emergency Med, Sch Med, 261 Huansha Rd, Hangzhou 310006, Peoples R China.	HZguozd@126.com					Baba K, 2018, ELIFE, V7, DOI 10.7554/eLife.34593; Chen JL, 2019, CLIN CHIM ACTA, V495, P294, DOI 10.1016/j.cca.2019.04.080; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Guo DX, 2019, STROKE, V50, P845, DOI 10.1161/STROKEAHA.118.024631; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kang DS, 2018, EMBO REP, V19, DOI 10.15252/embr.201846250; Lin ZH, 2018, MOL IMMUNOL, V103, P166, DOI 10.1016/j.molimm.2018.08.021; Lou XH, 2020, CLIN CHIM ACTA, V508, P154, DOI 10.1016/j.cca.2020.05.032; Metin C, 1997, DEVELOPMENT, V124, P5063; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Wang J, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00432; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Xie ZY, 2018, BRAIN BEHAV IMMUN, V69, P190, DOI 10.1016/j.bbi.2017.11.012; Xie ZY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005198; Xie ZY, 2017, NEUROPHARMACOLOGY, V119, P123, DOI 10.1016/j.neuropharm.2017.03.025; Yu J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00700	17	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUL	2021	518						22	27		10.1016/j.cca.2021.03.008			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	SG8UV	WOS:000653717400004	33741358				2022-02-07	
J	Xu, F; Shu, X; Li, X; Tang, RL				Xu, Fan; Shu, Xin; Li, Xin; Tang, Ruoli			Health indicator construction for roller bearing based on an unsupervised deep belief network with a novel sigmoid zero local minimum point model	STRUCTURAL HEALTH MONITORING-AN INTERNATIONAL JOURNAL			English	Article						Health indicator; deep belief networks; sigmoid zero local minimum point model; roller bearings; monotonicity	FAULT-DIAGNOSIS METHOD; CLUSTERING-ALGORITHM; DECOMPOSITION; MANAGEMENT; STRATEGY	Extracting bearing degradation curves with good smoothness and monotonicity as a health indicator lays a solid foundation for predicting the bearing's remaining useful life. Traditional bearing health indicator construction methods generally have the following problems: (1) they require manual experience, such as manual labeling of data is burdensome when the amount of collected data is large, for feature extraction, selection, and fusion with other indicators and models because the methods rely on substantial expert experience and signal-processing technology; (2) deep belief networks in deep learning require engineering experts with rich experience to label the data, and because the degradation state of a bearing is constantly changing, it is difficult to rely on manual experience to distinguish and label it accurately; (3) owing to the noise in the data collected during the study, the extracted health indicator curve shows obvious oscillation and poor smoothness. In response to the above problems, this study proposes a model based on an unsupervised deep belief network and a new sigmoid zero local minimum point to eliminate health indicator curve oscillation and improve monotonicity. The main idea is that a deep belief network without a label output layer is used to extract the preliminary health indicator curve directly from the original signal, whereas the sigmoid zero local minimum point uses the average value based on a sigmoid function to reduce the weight of the current health indicator value to eliminate concussion, and then it uses the zero and local minimum points to further improve the monotonicity of the extracted health indicator without parameters. Finally, the superiority of the model proposed in this study (deep belief network-sigmoid zero local minimum point) is verified through a comparison of multiple bearing datasets and other models.	[Xu, Fan] City Univ Hong Kong, Sch Data Sci, Hong Kong, Peoples R China; [Shu, Xin] Wuhan Bridge Special Technol Co Ltd, China Railway Major Bridge Engn Grp, Wuhan, Peoples R China; [Shu, Xin] State Key Lab Hlth & Safety Bridge Struct, Wuhan, Peoples R China; [Li, Xin; Tang, Ruoli] Wuhan Univ Technol, Sch Energy & Power Engn, Wuhan, Peoples R China		Xu, F (corresponding author), City Univ Hong Kong, Sch Data Sci, Kowloon, Tat Chee Ave, Hong Kong 990777, Peoples R China.	fanxu8@cityu.edu.hk					Affonso C, 2017, EXPERT SYST APPL, V85, P114, DOI 10.1016/j.eswa.2017.05.039; Decelle A, 2018, J STAT PHYS, V172, P1576, DOI 10.1007/s10955-018-2105-y; Dong ZC, 2020, NONLINEAR DYNAM, V100, P2287, DOI 10.1007/s11071-020-05607-5; Fu Y, 2015, PROC CIRP, V31, P29, DOI 10.1016/j.procir.2015.03.016; Guan Z., 2019, SENSORS-BASEL, V19, P91; Guo JF, 2020, ENG APPL ARTIF INTEL, V88, DOI 10.1016/j.engappai.2019.103378; He Zhengjia, 2014, Journal of Mechanical Engineering, V50, P171, DOI 10.3901/JME.2014.02.171; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Kaur M, 2020, CLUSTER COMPUT, V23, P1439, DOI 10.1007/s10586-019-02999-x; Kosasih B, 2014, APPL MECH MATER, V493, P343, DOI 10.4028/www.scientific.net/AMM.493.343; Lai JG, 2020, IEEE T SMART GRID, V11, P2746, DOI 10.1109/TSG.2020.2966691; Lai JG, 2021, IEEE T IND INFORM, V17, P219, DOI 10.1109/TII.2020.2969458; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lei YG, 2016, IEEE T INSTRUM MEAS, V65, P2671, DOI 10.1109/TIM.2016.2601004; [李本威 Li Benwei], 2016, [推进技术, Journal of Propulsion Technology], V37, P2173; Li ZQ, 2019, NEURAL PROCESS LETT, V49, P305, DOI 10.1007/s11063-017-9751-y; Nectoux P., 2012, IEEE INT C PROGN HLT; Peng KX, 2019, NEUROCOMPUTING, V361, P19, DOI 10.1016/j.neucom.2019.07.075; Rai A, 2017, MECH SYST SIGNAL PR, V93, P16, DOI 10.1016/j.ymssp.2017.02.003; Shao HD, 2018, IEEE T IND ELECTRON, V65, P2727, DOI 10.1109/TIE.2017.2745473; Shao HD, 2018, MECH SYST SIGNAL PR, V100, P743, DOI 10.1016/j.ymssp.2017.08.002; Shen CQ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9163374; Shen Zhongjie, 2013, Journal of Mechanical Engineering, V49, P183, DOI 10.3901/JME.2013.02.183; Sun SN, 2017, NEUROCOMPUTING, V257, P79, DOI 10.1016/j.neucom.2016.11.063; Tamilselvan P, 2013, RELIAB ENG SYST SAFE, V115, P124, DOI 10.1016/j.ress.2013.02.022; Tang RL, 2020, APPL ENERG, V259, DOI 10.1016/j.apenergy.2019.114183; Tang RL, 2018, APPL ENERG, V228, P254, DOI 10.1016/j.apenergy.2018.06.092; Tse PW, 2017, J VIB CONTROL, V23, P1925, DOI 10.1177/1077546315604522; Wang D, 2018, IEEE ACCESS, V6, DOI 10.1109/ACCESS.2017.2774261; Wang XQ, 2017, J VIBROENG, V19, P4272, DOI 10.21595/jve.2017.18549; Xu F, 2020, APPL SOFT COMPUT, V89, DOI 10.1016/j.asoc.2020.106119; Xu F, 2020, MEASUREMENT, V152, DOI 10.1016/j.measurement.2019.107371; Xu F, 2019, J VIB CONTROL, V25, P473, DOI 10.1177/1077546318783886; Xu F, 2018, SHOCK VIB, V2018, DOI 10.1155/2018/3059230; Xu F, 2018, APPL SOFT COMPUT, V73, P898, DOI 10.1016/j.asoc.2018.09.037; Yan RQ, 2007, MECH SYST SIGNAL PR, V21, P824, DOI 10.1016/j.ymssp.2006.02.009; Yan RQ, 2012, MECH SYST SIGNAL PR, V29, P474, DOI 10.1016/j.ymssp.2011.11.022; Yu K, 2020, STRUCT HEALTH MONIT, V19, P240, DOI 10.1177/1475921719841690; Zhao HM, 2019, J MECH SCI TECHNOL, V33, P4165, DOI 10.1007/s12206-019-0811-2	39	0	0	10	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1475-9217	1741-3168		STRUCT HEALTH MONIT	Struct. Health Monit.	JUL	2021	20	4			SI		2110	2123		10.1177/1475921720963951			14	Engineering, Multidisciplinary; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Instruments & Instrumentation	TB2RY	WOS:000667797200044					2022-02-07	
J	Xu, JJ; Li, XQ; Hu, XM; Chen, MR; Chen, QL; Wu, WF; Quan, K				Xu, J. J.; Li, X. Q.; Hu, X. M.; Chen, M. R.; Chen, Q. L.; Wu, W. F.; Quan, K.			Pogostone attenuates traumatic brain injury-induced inflammatory response and neurological damage via regulating NF-kappa B and PPAR-gamma pathways	JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS			English	Article						traumatic brain injury (TBI); pogostone; PPAR-gamma; NF-kappa B; inflammatory response	ACTIVATED RECEPTOR-GAMMA; PROLIFERATION; MECHANISMS; MICROGLIA; TURNOVER	Neuroinflammation occurs after traumatic brain injury (TBI) and induces secondary brain injury. This study was aimed at probing the neuroprotective effects of pogostone on TBI-induced neurological damage and inflammatory response. The TBI model of mice was established with Feeney DM method. The neuroprotective effects of pogostone were determined using modified neurological severity scores (mNSS), rotarod test, brain water content detection, and HE staining. Microglial activation and expression of proinflammatory cytokines were also examined to evaluate the anti-inflammatory effects of pogostone. The expression levels of PPAR-gamma and NF-kappa B were quantified by Western blot and immunofluorescence. We demonstrated that the motor, learning, and memory functions of the mice in the TBI group, compared with those in the Sham group, were significantly decreased, accompanied by increased brain edema, neuronal apoptosis, and microglial activation. With pogostone treatment, the mice had lower mNSS scores and better motor scores compared with the mice in the TBI group. Furthermore, brain edema, neuronal apoptosis, microglial activation, expressions of inflammatory factors [including tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and iNOS] in brain tissue of the mice were inhibited by pogostone treatment, and NF-kappa B signaling was significantly suppressed. Moreover, PPAR-gamma expression in brain tissues of the mice was up-regulated after pogostone treatment. However, these effects of pogostone were significantly suppressed by PPAR-gamma inhibitor T0070907. In conclusion, pogostone can probably ameliorate traumatic brain injury-induced inflammatory response and neurological damage via regulating NF-kappa B and PPAR-gamma pathways, and it is a promising neuroprotective drug.	[Xu, J. J.] Wuhan Univ, Dept Med Equipment, Renmin Hosp, Wuhan, Peoples R China; [Li, X. Q.] Hubei Univ Sci & Technol, Dept Biomed Engn, Xianning Ave 88, Xianning 437100, Hubei, Peoples R China; [Hu, X. M.] Wuhan Univ Sci & Technol, Dept Pharm, Tianyou Hosp, Wuhan, Peoples R China; [Chen, M. R.; Chen, Q. L.; Quan, K.] Peoples Hosp Jiangbei Dist, Dept Neurosurg, Chongqing Red Cross Hosp, Chongqing, Peoples R China; [Wu, W. F.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Ctr Nucl & Cell Signaling, Houston, TX USA		Li, XQ (corresponding author), Hubei Univ Sci & Technol, Dept Biomed Engn, Xianning Ave 88, Xianning 437100, Hubei, Peoples R China.	lixiaoqing@hbust.edu.cn					Agarwal S, 2017, BIOCHEM BIOPH RES CO, V483, P1166, DOI 10.1016/j.bbrc.2016.08.043; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Boraschi D, 2018, IMMUNOL REV, V281, P197, DOI 10.1111/imr.12606; Borland MG, 2017, TOXICOL SCI, V159, P436, DOI 10.1093/toxsci/kfx147; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Campbell RA, 2019, PEDIATR RES, V86, P55, DOI 10.1038/s41390-019-0388-6; Chen XY, 2016, EXP BIOL MED, V241, P193, DOI 10.1177/1535370215600099; Sanchez EC, 2013, CRIT CARE NURS Q, V36, P290, DOI 10.1097/CNQ.0b013e318294e9e3; Ferret-Sena V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061639; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hong F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082189; Hu GY, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4850612; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mashhadizadeh S, 2017, IRAN J BASIC MED SCI, V20, P399, DOI 10.22038/IJBMS.2017.8581; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Shankaran M, 2007, J NEUROSCI RES, V85, P2374, DOI 10.1002/jnr.21389; Swamy MK, 2015, MOLECULES, V20, P8521, DOI 10.3390/molecules20058521; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang LM, 2014, BIOCHEM PHARMACOL, V92, P73, DOI 10.1016/j.bcp.2014.07.018	27	0	0	2	2	BIOLIFE SAS	SILVA MARINA (TE)	VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY	0393-974X	1724-6083		J BIOL REG HOMEOS AG	J. Biol. Regul. Homeost. Agents	JUL-AUG	2021	35	4					1245	1253					9	Endocrinology & Metabolism; Immunology; Medicine, Research & Experimental; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Research & Experimental Medicine; Physiology	UP3LJ	WOS:000695284600005					2022-02-07	
J	Yousef, N; Abdullahi, KO; Perveen, K; Khan, S				Yousef, Nazia; Abdullahi, Kabir Ozigi; Perveen, Kousar; Khan, Sadia			IMPACT OF EDUCATIONAL TRAINING ON NEUROLOGICAL ASSESSMENT SKILLS OF FEMALE NURSES IN EVALUATING TRAUMATIC BRAIN INJURY PATIENTS THROUGH GLASGOW COMA SCALE IN LAHORE GENERAL HOSPITAL, LAHORE, PAKISTAN	GOMAL JOURNAL OF MEDICAL SCIENCES			English	Article						Traumatic Brain Injury; Head Injuries; Brain Injuries; Neurological Assessment; Glasgow Coma Scale; Nursing Assessment; Skills; Nurses; Pakistan		Background: Traumatic Brain Injury (TBI) is a leading cause of death and disability worldwide. The objective of this study was to determine the impact of educational training on neurological assessment skill of female nurses in evaluating traumatic brain injury patients through Glasgow Coma Scale in Lahore General Hospital, Lahore, Pakistan. Material & Methods: This quasi-experimental one group pre-posttest design study was conducted at Lahore 2021 to May 15, 2021. Pre-test neurological assessment skill of 70 nurses was noted by an observer, two weeks educational training was given and four weeks later on, post-test score was noted. For neurological assessment skill, a 20 items observatory checklist was used. Age groups, marital status, job experience, work experience in recent department and work place were four demographic, while neurological assessment skill score was one research variable. Paired sample t test was used for hypothesis testing. Results: Out 70 nurses, 26 (37.1%) were in age group 25-30 years, 18 (25.7%) in 31-35, 16 (22.9%) in 36-40, six (8.6%) in 41-45 and four (5.7%) in 46-50 years. Marital status was; 36 (51.4%) single, 27 (38.6%) married, three (4.3%) divorced and four (5.7%) widow. Job experience was; eight (11.4%) had <2 years, 33 (47.1%) 2-5 years, 25 (35.7%) 6-10 years and four (5.7%) had >10 years. Work experience in recent department was; 16 (22.9%) had <1 year, 39 (55.7%) 1-3 years, 13 (18.6%) 4-5 years and two (2.9%) had >5 years. Work place was Trauma Unit in 12 (17.1%), neurosurgery ICUs in 38 (54.3%) and surgical units in 20 (28.6%) cases. Mean 16.89 +/- 2.52 posttest skills score was significantly higher than mean 12.56 +/- 2.67 pretest skills score (p=<.0001). Conclusion: Our study confirmed that the effect of educational training was significant in improving neurological assessment skills of nurses in evaluating traumatic brain injury patients through Glasgow Coma Scale in Lahore General Hospital, Lahore, Pakistan. Further studies are suggested with increased sample size and multiple research settings.	[Yousef, Nazia; Abdullahi, Kabir Ozigi; Perveen, Kousar; Khan, Sadia] Univ Lahore, Fac Allied Hlth & Sci, Lahore Sch Nursing, Dept Nursing, Lahore, Pakistan		Yousef, N (corresponding author), Univ Lahore, Fac Allied Hlth & Sci, Lahore Sch Nursing, Lahore, Pakistan.	naziayousif19@gmail.com	ABDULLAHI, KABIR OZIGI/J-6222-2018	ABDULLAHI, KABIR OZIGI/0000-0001-6708-1413			Arsh A, 2017, KHYBER MED U J, V9, P55; Bae KS, 2020, NURS HEALTH SCI, V22, P99, DOI 10.1111/nhs.12654; Catangui E., 2019, J NURS PRACT, V3, P109, DOI [10.36959/545/370, DOI 10.36959/545/370]; Cook NF, 2021, CRIT CARE NURS CLIN, V33, P89, DOI 10.1016/j.cnc.2020.10.005; Devi WA, 2018, INT J NURS ED, V10, P89, DOI [10.5958/0974-9357.2018.00048.X, DOI 10.5958/0974-9357.2018.00048.X]; Enriquez CM, 2019, J NEUROSCI NURS, V51, P142, DOI 10.1097/JNN.0000000000000448; Greenshields Sarah, 2019, Br J Nurs, V28, P1056, DOI 10.12968/bjon.2019.28.16.1056; Hien NT, 2011, PERSPECTIVES NUR SCI, V8, P54; Jones C, 2018, THESIS U ARIZONA; Kamothi A, 2016, INT J NOVEL RES HEAL, V3, P210; Khan TA, 2020, HOSP PRACT, V48, P145, DOI 10.1080/21548331.2020.1762366; Kotfis K, 2018, ARCH MED SCI, V14, P880, DOI 10.5114/aoms.2017.69752; Kumar S, 2015, INT J PHARM SCI REV, V35, P191; Maher AB, 2016, INT J ORTHOP TRAUMA, V22, P44, DOI 10.1016/j.ijotn.2016.01.002; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, NURS TIMES, V110, P12; Teles M, 2013, J KRISHNA INST MED S, V2; Vink P, 2018, J CLIN NURS, V27, P3913, DOI 10.1111/jocn.14614	18	0	0	0	0	GOMAL MEDICAL COLL	DERA ISMAIL KHAN	NORTH CIRCULAR RD, DERA ISMAIL KHAN, 00000, PAKISTAN	1819-7973	1997-2067		GOMAL J MED SCI	Gomal J. Med. Sci.	JUL-SEP	2021	19	3					105	110		10.46903/gjms/19.03.971			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XV9JU	WOS:000735249700005					2022-02-07	
J	Zhang, LM; Zhang, DX; Zheng, WC; Hu, JS; Fu, L; Li, Y; Xin, Y; Wang, XP				Zhang, Li-Min; Zhang, Dong-Xue; Zheng, Wei-Chao; Hu, Jin-Shu; Fu, Lan; Li, Yan; Xin, Yue; Wang, Xu-Peng			CORM-3 exerts a neuroprotective effect in a rodent model of traumatic brain injury via the bidirectional gut-brain interactions	EXPERIMENTAL NEUROLOGY			English	Article						Carbon monoxide; Neuroprotection; Pyroptosis; Jejunum; Traumatic brain injury	HEMORRHAGIC-SHOCK; CARBON-MONOXIDE; INTESTINAL PERMEABILITY; PREFRONTAL CORTEX; OXIDATIVE STRESS; MICROBIOTA; PYROPTOSIS; RESPONSES; PROTECTS; RATS	Objective: Traumatic brain injury (TBI) induced the gastrointestinal inflammation that is associated with TBIrelated morbidity and mortality. Carbon monoxide-releasing molecule (CORM)-3 is a water-soluble exogenous carbon monoxide that exerts protective effects against inflammation-induced pyroptosis. We investigated the gastrointestinal inflammation in a rodent model of traumatic brain injury (TBI) with subsequent hemorrhagic shock and resuscitation (HSR), as well as effects of CORM-3 using an intestinal injection on both gut and brain. Methods: Following exposure to TBI plus HSR, rats were administrated with CORM-3 (8 mg/kg) through an intestinal injection after resuscitation immediately. The pathological changes and pyroptosis in the gut were measured at 24 h and 30 day post-trauma. We also assessed the intestinal and cortical CO content, as well as IL1 beta and IL-18 levels in the serum within 48 h after trauma. We then explored pathological changes in the ventromedial prefrontal cortex (vmPFC) and neurological behavior deficits on 30 day post-trauma. Results: After TBI + HSR exposure, CORM-3-treated rats presented significantly decreased pyroptosis, more CO content in the jejunum, and lower IL-1 beta, IL-18 levels in the serum at 24 h after trauma. Moreover, the rats treated with CORM-3 exerted ameliorated jejunal and vmPFC injury, enhanced learning/memory ability and exploratory activity, improved anxiety-like behaviors than the TBI + HSR-treated rats on 30 day post-trauma. Conclusion: These experimental data demonstrated and bidirectional gut-brain interactions after TBI, antiinflammatory effects of CORM-3, which may improve late outcomes after brain injury.	[Zhang, Li-Min; Zheng, Wei-Chao; Li, Yan; Xin, Yue; Wang, Xu-Peng] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Zhang, Dong-Xue] Cangzhou Cent Hosp, Dept Gerontol, Cangzhou, Peoples R China; [Hu, Jin-Shu] Cangzhou Cent Hosp, Clin Lab, Cangzhou, Peoples R China; [Fu, Lan] Cangzhou Cent Hosp, Dept Radiodiag, Cangzhou, Peoples R China		Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701296]; Wu Jieping Medical Foundation [320.6750.17533]	The present study is supported by National Natural Science Foundation of China (81701296) and Wu Jieping Medical Foundation (320.6750.17533) .	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Basuroy S, 2013, AM J PHYSIOL-CELL PH, V304, pC1105, DOI 10.1152/ajpcell.00023.2013; Bertogliat MJ, 2020, NEUROCHEM INT, V133, DOI 10.1016/j.neuint.2019.104642; Bharwani A, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0771-7; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bittner B, 2018, BIODRUGS, V32, P425, DOI 10.1007/s40259-018-0295-0; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Chaves-Ferreira M, 2015, ANGEW CHEM INT EDIT, V54, P1172, DOI 10.1002/anie.201409344; Chen JX, 2020, BRAIN RES BULL, V162, P20, DOI 10.1016/j.brainresbull.2020.04.017; Cheng YY, 2017, CURR PHARM DESIGN, V23, P3884, DOI 10.2174/1381612823666170413122439; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; DeLano F.A., 2013, SCI TRANSL MED, V5; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Eroglua O, 2017, INJURY, V48, P2675, DOI 10.1016/j.injury.2017.09.032; Faizan M, 2019, MATERIALS, V12, DOI 10.3390/ma12101643; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fu L, 2020, INT J MOL MED, V45, P1176, DOI 10.3892/ijmm.2020.4493; Fujisaki N, 2016, MED GAS RES, V6, P122, DOI 10.4103/2045-9912.191357; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Geng FY, 2016, NEUROIMMUNOMODULAT, V23, P122, DOI 10.1159/000445689; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; He J, 2018, INT J MOL MED, V41, P709, DOI 10.3892/ijmm.2017.3287; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Joe Y, 2015, AM J PATHOL, V185, P2867, DOI 10.1016/j.ajpath.2015.07.002; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Lan YL, 2019, INFLAMM RES, V68, P311, DOI 10.1007/s00011-019-01217-z; Leibowitz A, 2019, EUR J TRAUMA EMERG S, V45, P263, DOI 10.1007/s00068-018-0908-9; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li Y, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104842; Liang YJ, 2018, SURG OBES RELAT DIS, V14, P821, DOI 10.1016/j.soard.2018.03.006; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu X, 2017, ADV IMMUNOL, V135, P81, DOI 10.1016/bs.ai.2017.02.002; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Ochner CN, 2012, NEUROSCI RES, V74, P138, DOI 10.1016/j.neures.2012.08.002; Onyiah JC, 2014, GUT MICROBES, V5, P220, DOI 10.4161/gmic.27290; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Patterson TT, 2019, SHOCK, V52, P318, DOI 10.1097/SHK.0000000000001278; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Schmidtner AK, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0556-9; Seno S, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-00571-7; Spalding KN, 2018, J NEUROSCI, V38, P3767, DOI 10.1523/JNEUROSCI.2501-17.2018; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Xia PP, 2018, CELL PHYSIOL BIOCHEM, V45, P2351, DOI 10.1159/000488183; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024; Zhang DX, 2020, NEUROCHEM INT, V139, DOI 10.1016/j.neuint.2020.104784; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zhang LM, 2019, FREE RADICAL BIO MED, V141, P299, DOI 10.1016/j.freeradbiomed.2019.06.031; Zhang LM, 2019, J SURG RES, V235, P591, DOI 10.1016/j.jss.2018.10.046; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898; Zheng G, 2019, EBIOMEDICINE, V40, P643, DOI 10.1016/j.ebiom.2018.12.059; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	66	0	0	5	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2021	341								113683	10.1016/j.expneurol.2021.113683			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SI7HH	WOS:000654996800005	33711325				2022-02-07	
J	Zhu, CY; Zhang, YF; Li, W; Li, QQ				Zhu, Chunying; Zhang, Yingfu; Li, Wei; Li, Qianqian			Clinical observation of individualized nutritional formula on inflammation index, immune status and gastrointestinal tolerance in patients with severe head injury	PAKISTAN JOURNAL OF MEDICAL SCIENCES			English	Article						individualized nutritional formula; severe head injury; inflammatory factors; immune status; gastrointestinal tolerance	TRAUMATIC BRAIN-INJURY; ENTERAL NUTRITION; GUIDELINES; MANAGEMENT	Objectives: To evaluate the clinical significance of individualized nutritional formulas on inflammatory factors, immune status and gastrointestinal tolerance in patients with severe head injury. Methods: A total of 80 patients with severe head injury who were hospitalized in Baoding No.1 Central Hospital from March 2017 to March 2020 were randomly divided into two groups with 40 cases in each group. Patients in both groups were given enteral nutrition (EN), the control group was given conventional enteral nutrition formula through nasointestinal tube, and the experimental group was given individualized nutrition formula. All patients were tested for tumor necrosis factor(TNF-alpha), C-reactive protein(CRP), interleukin 6(IL-6), IgA, IgM, IgG, serum intestinal fatty acid binding protein(I-FABP) and D-lactic acid concentration before and after enteral nutrition treatment. The incidence of adverse reactions such as abdominal distension, diarrhea, constipation, and gastric retention within seven days after treatment of two groups were compared and analyzed. Results: There was no significant difference in inflammatory factors such as TNF-a, CRP, IL-6, immunoglobulin levels, I-FABP and D-lactic acid concentration between the two groups before treatment (p 0.05). After treatment, the above indicators of the two groups of patients were better than before treatment, the difference was statistically significant (p<0.05), and the experimental group was significantly better than the control group (p<0.05). The experimental group had a gastrointestinal adverse reaction rate of 10%, and the control group had 27.5%, the difference was statistically significant (p=0.04). Conclusions: Individualized nutritional formula has more significant advantages than conventional nutritional formula for patients with severe head injury, which can reduce inflammatory response, increase the patient's immune level, improve the intestinal mucosal barrier function, have good gastrointestinal tolerance, and have a low incidence of adverse reactions.	[Zhu, Chunying; Li, Wei; Li, Qianqian] Baoding 1 Cent Hosp, Dept Neurosci, Crit Care Unit, Baoding 071000, Hebei, Peoples R China; [Zhang, Yingfu] Baoding 1 Cent Hosp, Endoscop Diag & Treatment Ctr, Baoding 071000, Hebei, Peoples R China		Zhu, CY (corresponding author), Baoding 1 Cent Hosp, Dept Neurosci, Crit Care Unit, Baoding 071000, Hebei, Peoples R China.	taksun66@163.com					Azim A, 2016, J TRAUMA ACUTE CARE, V81, P520, DOI 10.1097/TA.0000000000001089; Badjatia N, 2014, NEUROCRIT CARE, V21, P159, DOI 10.1007/s12028-014-0036-2; Balakrishnan B, 2019, NEUROCRIT CARE, V30, P193, DOI 10.1007/s12028-018-0597-6; Bernini A, 2020, J CEREBR BLOOD F MET, V40, P177, DOI 10.1177/0271678X18808947; Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chapple LA, 2018, JPEN-PARENTER ENTER, V42, P318, DOI 10.1177/0148607116687498; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Druyan ME, 2012, JPEN-PARENTER ENTER, V36, P77, DOI 10.1177/0148607111420157; Fan Ming-chao, 2016, Chinese Medical Sciences Journal, V31, P213; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Jain S, 2020, GLASGOW COMA SCALE G; Jiang HT, 2020, PAK J MED SCI, V36, P770, DOI 10.12669/pjms.36.4.2045; Kofler M, 2018, J CEREBR BLOOD F MET, V38, P518, DOI 10.1177/0271678X17700434; Lorenz Kai J, 2015, GMS Interdiscip Plast Reconstr Surg DGPW, V4, pDoc15, DOI 10.3205/iprs000074; Mazaherpur S, 2016, J CLIN DIAGN RES, V10, pJC1, DOI 10.7860/JCDR/2016/19271.8625; Painter TJ, 2015, INT J SURG, V21, P70, DOI 10.1016/j.ijsu.2015.07.008; Rai VRH, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0369-4; Rincon S, 2016, HAND CLINIC, V135, P447, DOI 10.1016/B978-0-444-53485-9.00022-2; Vieira LV, 2018, METAB BRAIN DIS, V33, P1755, DOI 10.1007/s11011-018-0287-2; Wan GH, 2019, J INT MED RES, DOI 10.1177/0300060519888112; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838	23	0	0	1	3	PROFESSIONAL MEDICAL PUBLICATIONS	SADDAR	PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN	1682-024X			PAK J MED SCI	Pak. J. Med. Sci.	JUL-AUG	2021	37	4					952	958		10.12669/pjms.37.4.3987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB0NL	WOS:000667639800006	34290765	Green Published, gold			2022-02-07	
J	Alderman, N; Williams, C; Wood, RL				Alderman, Nick; Williams, Claire; Wood, Rodger Llewellyn			Using the St Andrew's - Swansea Neurobehavioural Outcome Scale (SASNOS) to determine prevalence and predictors of neurobehavioural disability amongst survivors with traumatic brain injury in the community	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; Neurobehavioural disability; Outcomes; Outcome measurement; Inter-rater reliability	CHALLENGING BEHAVIOR; AGGRESSIVE-BEHAVIOR; INVENTORY-II; REHABILITATION; DISORDERS; VALIDITY; ADULTS; RECOMMENDATIONS; VALIDATION; SYMPTOMS	Studies using the St Andrew's - Swansea Neurobehavioural Outcome Scale (SASNOS) confirm neurobehavioural disability (NBD) is highly prevalent in inpatient Neurobehavioural Rehabilitation and Stroke samples. However, a recent study amongst a Danish community sample of acquired brain injury survivors found a relative paucity of NBD symptoms; and when symptoms were present, they tended to be of mild severity. The current observational study employed the SASNOS to explore prevalence of NBD in survivors with traumatic brain injury (TBI) living in the community, the extent of survivors' self-awareness of NBD symptoms, and constructed prediction models of NBD. A de-identified data set was compiled, comprising data for 97 TBI survivors (74.2% men, mean time since injury 2.8 years). In addition to SASNOS self- and proxy-ratings, various demographic, clinical and injury-related characteristics were captured. NBD was found to be highly characteristic, although severity varied depending on subtype. Statistical comparison of self- and proxy-ratings did not support reduced self awareness regarding NBD, whereas treating the problem as one of inter-rater reliability suggested this was an issue. Executive impairment, depressed mood and sex were especially prognostic of NBD. Reasons accounting for differences in NBD between the community samples are discussed and recommendations for future research made.	[Alderman, Nick; Williams, Claire] Avalon Ctr, Elysium Healthcare, Elysium Neurol Serv, Swindon, Wilts, England; [Alderman, Nick; Williams, Claire] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Wood, Rodger Llewellyn] Swansea Univ, Med Sch, Swansea, W Glam, Wales		Alderman, N (corresponding author), Avalon Ctr, Elysium Healthcare, Elysium Neurol Serv, Swindon, Wilts, England.	nick.alderman@elysiumhealthcare.co.uk		Williams, Claire/0000-0002-0791-744X; Alderman, Nick/0000-0002-8523-4142			Alderman N, 2001, BRAIN DAM B, P175; Alderman N, 2020, NEUROPSYCHOL REHABIL, V30, P1318, DOI 10.1080/09602011.2019.1582432; Alderman N, 2018, BRAIN INJURY, V32, P218, DOI 10.1080/02699052.2017.1406989; Alderman N, 2017, ARCH CLIN NEUROPSYCH, V32, P951, DOI 10.1093/arclin/acx026; Alderman N, 2013, BRAIN IMPAIR, V14, P5, DOI 10.1017/BrImp.2013.7; Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; All-Party Parliamentary Group on Acquired Brain Injury, 2018, ACQ BRAIN INJ NEUR T; Altman D.G., 1990, PRACTICAL STAT MED R; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burgess P.W., 1996, BEHAV ASSESSMENT DYS, P11; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chester V, 2018, PSYCHOL CRIME LAW, V24, P400, DOI 10.1080/1068316X.2017.1302583; Cohen J, 1998, STAT POWER ANAL BEHA; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; IBM Corp, 2019, IBM SPSS STAT WINDOW; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Mooney B, 2006, APPL NEUROPSYCHOL, V13, P12, DOI 10.1207/s15324826an1301_2; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; O'Callaghan J., 2014, MAIL ONLINE     0718; O'Connell EL, 2020, DISABIL REHABIL, V42, P2868, DOI 10.1080/09638288.2019.1572792; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Pek J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02104; Prigatano GP, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01569; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Shaw S, 2015, PSYCHOL ASSESSMENT, V27, P138, DOI 10.1037/a0038195; Soendergaard PL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00051; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stolwyk RJ, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1840637; Stolwyk RJ, 2018, TOP STROKE REHABIL, V25, P527, DOI 10.1080/10749357.2018.1499301; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Timmer ML, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00246; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; WechslerD, 2001, WECHSLER TEST ADULT; Williams C, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00119; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	60	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1946092		JUN 2021	28	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TA9JV	WOS:000667562400001	34180770				2022-02-07	
J	Laing, DG; Epps, A; Jinks, AL				Laing, David G.; Epps, Adrienne; Jinks, Anthony L.			Chemosensory Loss during a Traumatic Brain Injury Suggests a Central Pathway for the Rehabilitation of Anosmia	CHEMICAL SENSES			English	Article						anosmia; chemosensory tests; rehabilitation; search images	OLFACTORY-BULB; PREDICTIVE CODES; GRAY-MATTER; SMELL; PIRIFORM; IDENTIFICATION; CONVERGENCE; DYSFUNCTION; PERCEPTION; CHILDREN	Currently, no method has been developed for rehabilitating olfaction in anosmic patients following a traumatic brain injury (TBI). Here a method for rehabilitation is described which is based on a recent finding that the human posterior pyriform cortex (PPC) generates predictive odor "search images" in advance of an encounter with an olfactory stimulus. The search image enhances perceptual sensitivity and allows the odor it represents to be identified without input occurring from the olfactory receptors or bulbs. Furthermore, based on the finding here that anosmics with aTBI often have normal trigeminal and gustatory function, it is proposed that normality in these chemosensory systems may indicate that key cortical regions including the PPC are intact in anosmics and capable of processing olfactory information. In addition, the results of chemosensory tests of the olfactory, gustatory, and intranasal trigeminal systems of 18 patients with aTBI are given that identify which patients would most likely benefit from the rehabilitation procedure.	[Laing, David G.] Univ NSW Med, Sch Womens & Childrens Hlth, Discipline Paediat, Sydney Childrens Hosp, Level 3,High St, Randwick, NSW 2031, Australia; [Epps, Adrienne] Sydney Childrens Hosp, Rehab2Kids, High St, Randwick, NSW 2031, Australia; [Jinks, Anthony L.] Western Sydney Univ, Sch Psychol, Kingswood Campus,Second Ave, Kingswood, NSW 2747, Australia		Laing, DG (corresponding author), Univ NSW Med, Sch Womens & Childrens Hlth, Discipline Paediat, Sydney Childrens Hosp, Level 3,High St, Randwick, NSW 2031, Australia.	d.laing@unsw.edu.au					Abele M, 2003, J NEUROL, V250, P1453, DOI 10.1007/s00415-003-0248-4; Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Armstrong JE, 2010, PEDIATR NEPHROL, V25, P1497, DOI 10.1007/s00467-010-1529-7; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bitter T, 2010, CHEM SENSES, V35, P407, DOI 10.1093/chemse/bjq028; Connelly T, 2003, J NEUROL NEUROSUR PS, V74, P1435, DOI 10.1136/jnnp.74.10.1435; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doidge N., 2008, BRAIN CHANGES ITSELF, P15; FINGER TE, 1993, J COMP NEUROL, V334, P117, DOI 10.1002/cne.903340110; Flohr ELR, 2014, NEUROSCIENCE, V268, P118, DOI 10.1016/j.neuroscience.2014.03.018; Frasnelli J, 2007, CEREB CORTEX, V17, P370, DOI 10.1093/cercor/bhj154; Frasnelli J, 2011, NEUROSCIENCE, V189, P377, DOI 10.1016/j.neuroscience.2011.04.065; Frasnelli J, 2009, CHEM SENSES, V34, P139, DOI 10.1093/chemse/bjn068; Gottfried JA, 2014, HDB OLFACTION GUSTAT, P279; Gudziol H, 2001, ORL J OTO-RHINO-LARY, V63, P72, DOI 10.1159/000055713; Han PF, 2018, J NEUROTRAUM, V35, P2632, DOI 10.1089/neu.2017.5393; Howard JD, 2014, NEURON, V84, P857, DOI 10.1016/j.neuron.2014.10.012; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Hummel T, 1996, CHEM SENSES, V21, P75, DOI 10.1093/chemse/21.1.75; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kollndorfer K, 2015, NEUROSCIENCE, V310, P589, DOI 10.1016/j.neuroscience.2015.09.045; Laing DG, 2008, OTOLARYNG HEAD NECK, V139, P74, DOI 10.1016/j.otohns.2006.11.058; Laing DG, 2010, PEDIATR PULM, V45, P807, DOI 10.1002/ppul.21261; Leigh AD, 1943, LANCET, V1, P38; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; MCBRIDE RL, 1983, PERCEPT PSYCHOPHYS, V34, P77, DOI 10.3758/BF03205899; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nordin S, 1998, ACTA OTO-LARYNGOL, V118, P226; Philpott C, 2014, MANAGEMENT SMELL TAS, P91; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Royet JP, 2004, CHEM SENSES, V29, P731, DOI 10.1093/chemse/bjh067; Schaefer ML, 2002, J COMP NEUROL, V444, P221, DOI 10.1002/cne.10143; Small DM, 1997, J NEUROSCI, V17, P5136; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Tremblay C, 2018, CHEM SENSES, V43, P611, DOI 10.1093/chemse/bjy049; Zelano C, 2011, NEURON, V72, P178, DOI 10.1016/j.neuron.2011.08.010	42	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	JUN 30	2021	46						1	8		10.1093/chemse/bjab016			8	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	TH6YR	WOS:000672233400001	33893484				2022-02-07	
J	Latella, D; Maggio, MG; Andaloro, A; Marchese, D; Manuli, A; Calabro, RS				Latella, Desiree; Maggio, Maria Grazia; Andaloro, Adriana; Marchese, Domenicaroberta; Manuli, Alfredo; Calabro, Rocco Salvatore			Hypersexuality in neurological diseases: do we see only the tip of the iceberg?	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Sexual addiction; Hypersexuality; Neurological disorder; Pathophysiology	TRAUMATIC BRAIN-INJURY; KLUVER-BUCY-SYNDROME; KLEINE-LEVIN-SYNDROME; TEMPORAL-LOBE EPILEPSY; IMPULSE CONTROL DISORDERS; PARKINSONS-DISEASE; SEXUAL-BEHAVIOR; PSYCHOLOGICAL SYMPTOMS; VENTRAL STRIATUM; DEMENTIA	The purpose of this commentary is to investigate the pathophysiological mechanisms underlying hypersexuality and its manifestation in neurological diseases through a meta-analysis. Studies were identified by searching on PubMed, Web of Science and Cochrane databases. All results of each database between 2014 and 2020 were evaluated for possible inclusion. After an accurate revision of complete manuscripts, forty articles satisfied the inclusion/exclusion criteria. Data from our meta-analysis indicated hypersexuality to be a frequent sexual disorder in patients with neurological disorders, especially neurodegenerative ones. Hypersexuality could negatively affect a patient's management and outcomes. This commentary discusses studies that are often incomplete for evaluation measures or sample selection. In our opinion, it is necessary to consider hypersexuality with particular attention, so more extensive sample studies are needed to find the most appropriate treatment to improve the quality of life for both the patient and the caregiver.	[Latella, Desiree; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo SS 113, I-98124 Messina, Italy; [Maggio, Maria Grazia] Univ Catania, Dept Biomed & Biotechnol Sci, Via S Sofia 98, I-95123 Catania, CT, Italy; [Andaloro, Adriana; Marchese, Domenicaroberta] Tudio Riabilitaz Nutr & Cognit, Via St Agostino 14, I-98121 Messina, Italy; [Manuli, Alfredo] OU Policlin G Martino, Via Consolare Valeria 1, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it					Aalten P, 2007, DEMENT GERIATR COGN, V24, P457, DOI 10.1159/000110738; Ahmed RM, 2015, J ALZHEIMERS DIS, V46, P677, DOI 10.3233/JAD-150034; Alagiakrishnan K, 2005, POSTGRAD MED J, V81, P463, DOI 10.1136/pgmj.2004.028043; Althof SE, 2012, INT J IMPOT RES, V24, P131, DOI 10.1038/ijir.2012.2; ANSON JA, 1993, J NEUROL NEUROSUR PS, V56, P311, DOI 10.1136/jnnp.56.3.311; Antonini A, 2016, EUR J NEUROL, V23, P1556, DOI 10.1111/ene.13078; Arnulf I, 2018, REV NEUROL-FRANCE, V174, P216, DOI 10.1016/j.neurol.2018.03.005; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Arnulf I, 2015, SLEEP MED CLIN, V10, P151, DOI 10.1016/j.jsmc.2015.02.001; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Baird AD, 2002, EPILEPSY BEHAV, V3, P173, DOI 10.1006/ebeh.2002.0342; Bartlett R, 2015, DEMENTIA-LONDON, V14, P788, DOI 10.1177/1471301213512116; Batty GD, 2006, J EPIDEMIOL COMMUN H, V60, P872, DOI 10.1136/jech.2005.045039; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Bentivoglio AR, 2013, NEUROL SCI, V34, P1207, DOI 10.1007/s10072-012-1224-5; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; BLUMER D, 1967, ARCH NEUROL-CHICAGO, V16, P37, DOI 10.1001/archneur.1967.00470190041005; BLUMER D, 1970, AM J PSYCHIAT, V126, P1099; Bothe B, 2019, J SEX RES, V56, P180, DOI 10.1080/00224499.2018.1494262; Brand M, 2008, COGN PROCESS, V9, P159, DOI 10.1007/s10339-008-0204-4; BURNS A, 1990, BRIT J PSYCHIAT, V157, P86, DOI 10.1192/bjp.157.1.86; Calabro RS, 2019, FUNCT NEUROL, V34, P129; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carpenter BN, 2013, SEX ADDICT COMPULS, V20, P79, DOI 10.1080/10720162.2013.772873; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; Chou Chao-Liang, 2008, Acta Neurol Taiwan, V17, P199; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cilia R, 2011, MOVEMENT DISORD, V26, P225, DOI 10.1002/mds.23480; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Crowe SF, 1999, BRAIN INJURY, V13, P347; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Djamshidian A, 2012, MOVEMENT DISORD, V27, P1137, DOI 10.1002/mds.25105; Eikmeier G, 2013, PSYCHIAT PRAX, V40, P392, DOI 10.1055/s-0033-1343274; ELLISON JM, 1982, PSYCHOSOMATICS, V23, P499; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FREEMON FR, 1969, NEUROLOGY, V19, P87, DOI 10.1212/WNL.19.1.87; Garre-Olmo J, 2010, NEUROLOGY, V75, P1249, DOI 10.1212/WNL.0b013e3181f5d4c4; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Grandgenevre P, 2015, PRESSE MED, V44, pE51, DOI 10.1016/j.lpm.2014.06.037; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Higgins Agnes, 2004, Br J Nurs, V13, P1330; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; JENSEN I, 1979, J NEUROL NEUROSUR PS, V42, P256, DOI 10.1136/jnnp.42.3.256; Kafka Martin P, 2003, Sex Abuse, V15, P307, DOI 10.1023/A:1025000227956; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Kar SK, 2018, J PEDIATR NEUROSCI, V13, P523, DOI [10.4103/jpn.JPN_70_18, 10.4103/JPN.JPN_70_18]; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; Kesler A, 2000, SLEEP, V23, P563; Klos KJ, 2005, PARKINSONISM RELAT D, V11, P381, DOI 10.1016/j.parkreldis.2005.06.005; Kor A, 2013, SEX ADDICT COMPULS, V20, P27, DOI 10.1080/10720162.2013.768132; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kuhn S, 2016, INT REV NEUROBIOL, V129, P67, DOI 10.1016/bs.irn.2016.04.002; Kuzma JM, 2008, PSYCHIAT CLIN N AM, V31, P603, DOI 10.1016/j.psc.2008.06.005; Lanska Douglas J, 2018, Front Neurol Neurosci, V41, P77, DOI 10.1159/000475721; Latella D, 2019, J NEUROL SCI, V398, P101, DOI 10.1016/j.jns.2019.01.034; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Lavault S, 2015, ANN NEUROL, V77, P529, DOI 10.1002/ana.24350; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Maggio MG, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1753058; Maresca G, 2020, PSYCHOL HEALTH MED, V25, P10, DOI 10.1080/13548506.2019.1597977; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mendez MF, 2013, ARCH SEX BEHAV, V42, P501, DOI 10.1007/s10508-012-0042-4; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miglis MG, 2014, NAT SCI SLEEP, V6, P19, DOI 10.2147/NSS.S44750; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Morcos N, 2014, J NEUROPSYCH CLIN N, V26, pE10, DOI 10.1176/appi.neuropsych.13060132; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Mutarelli EG, 2006, ARQ NEURO-PSIQUIAT, V64, P146, DOI 10.1590/S0004-282X2006000100032; Olson DA, 2003, SOUTH MED J, V96, P323, DOI 10.1097/01.SMJ.0000061505.81880.96; Ornstein KA, 2013, INT PSYCHOGERIATR, V25, P1453, DOI 10.1017/S1041610213000768; Ozdemir H, 2007, TURK PSIKIYATR DERG, V18, P184; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Pujara MS, 2016, J NEUROSCI, V36, P5047, DOI 10.1523/JNEUROSCI.4236-15.2016; Reid RC, 2012, J BEHAV ADDICT, V1, P115, DOI 10.1556/JBA.1.2012.001; Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sharma A, 2015, ANN INDIAN ACAD NEUR, V18, P49, DOI 10.4103/0972-2327.144311; Shearer DL, 2002, PERSPECT SEX REPRO H, V34, P236, DOI 10.2307/3097822; SHUKLA GD, 1979, BRIT J PSYCHIAT, V135, P411, DOI 10.1192/bjp.135.5.411; Simpson G, 2001, J HEAD TRAUMA REHAB, V16, P556, DOI 10.1097/00001199-200112000-00004; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Spalletta G, 2010, AM J GERIAT PSYCHIAT, V18, P1026, DOI 10.1097/JGP.0b013e3181d6b68d; Stein DJ, 2016, J AFFECT DISORDERS, V190, P663, DOI 10.1016/j.jad.2015.10.061; Stein DJ, 2008, PSYCHIAT CLIN N AM, V31, P587, DOI 10.1016/j.psc.2008.06.007; Taylor A, 2011, AGE AGEING, V40, P538, DOI 10.1093/ageing/afr049; Thompson C, 2010, INT PSYCHOGERIATR, V22, P300, DOI 10.1017/S1041610209991220; Torrisi M, 2017, GERIATR GERONTOL INT, V17, P865, DOI 10.1111/ggi.12854; van Eimeren T, 2010, NEUROLOGY, V75, P1711, DOI 10.1212/WNL.0b013e3181fc27fa; Vitale C, 2013, BEHAV NEUROL, V27, P559, DOI [10.1155/2013/989757, 10.3233/BEN-129024]; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; von Wild K, 2012, J Med Life, V5, P3; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2017, INT REV NEUROBIOL, V133, P679, DOI [10.1016/bs.im.2017.04.006, 10.1016/bs.irn.2017.04.006]; Wick Jeannette Y, 2005, Consult Pharm, V20, P1006, DOI 10.4140/TCP.n.2005.1006; Wilson SJ, 2001, SEIZURE-EUR J EPILEP, V10, P165, DOI 10.1053/seiz.2000.0491; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	102	0	0	1	1	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	JUN 30	2021	20	2					477	487		10.31083/j.jin2002051			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI4XD	WOS:000672804800027	34258950	gold			2022-02-07	
J	Parry, K; White, AJ; Cleland, J; Hardwicke, J; Batten, J; Piggin, J; Howarth, N				Parry, Keith; White, Adam J.; Cleland, Jamie; Hardwicke, Jack; Batten, John; Piggin, Joe; Howarth, Nathan			Masculinities, Media and the Rugby Mind: An Analysis of Stakeholder Views on the Relationship Between Rugby Union, the Media, Masculine-Influenced Views on Injury, and Concussion	COMMUNICATION & SPORT			English	Article; Early Access						concussion; media; masculinities; sport sociology; rugby union	HIGH-SCHOOL RUGBY; HEGEMONIC MASCULINITY; FOOTBALL; SPORT; MANAGEMENT; TACKLE; GAME; BODY	Rugby union, alongside other collision and contact sports, faces ever mounting pressure from increased recognition of concussive injuries and the risks they present to athletes, both in the short-term and long-term. Here, the media is a central component of increasing pressure for cultural change. This research analysed data from 524 self-selected survey respondents to examine rugby union fans' and stakeholders' perceptions of media portrayal of concussion and how it might influence their own perceptions. We found evidence of a complex and heterogenous relationship between perceptions of masculinity, views and attitudes toward mass media, and degree of involvement in rugby union. Specifically, partisans of the sport generally saw mass media as hostile, with coverage biased against rugby, allowing them to manufacture doubt regarding risk information, as well as maintaining involvement in the sport. We conclude that critical commentaries from the media have the ability to challenge masculinities around concussion.	[Parry, Keith] Bournemouth Univ, Fern Barrow, England; [White, Adam J.; Howarth, Nathan] Oxford Brookes Univ, Headington, England; [Cleland, Jamie] Univ Winchester, Winchester, Hants, England; [Hardwicke, Jack; Batten, John] Univ South Australia, Adelaide, SA, Australia; [Piggin, Joe] Loughborough Univ, Loughborough, Leics, England; [Howarth, Nathan] Univ Warwick, Coventry, W Midlands, England		Howarth, N (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Headington Rd, Oxford OX3 0BP, England.	nhowarth@brookes.ac.uk	Batten, John/ABD-7384-2021; Cleland, Jamie/N-2815-2018	Cleland, Jamie/0000-0001-8852-2257; Howarth, Nathan/0000-0002-5049-6062; Batten, John/0000-0001-7499-7817; Parry, Keith D./0000-0001-9025-9101			Abernethy L, 2003, BRIT J SPORT MED, V37, P354, DOI 10.1136/bjsm.37.4.354; Adams A, 2010, J LANG SOC PSYCHOL, V29, P278, DOI 10.1177/0261927X10368833; Adams J., 1995, RISK; Adams ML, 2011, ARTISTIC IMPRESSIONS; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Anderson E, 2009, ROUTL RES GEND SOC, P1; Anderson E., 2017, SPORT THEORY SOCIAL, V2nd ed; Anderson E., 2020, CONVERSATION; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Association of Internet Researchers, 2019, INTERNET RESEARCH ET; Batten J., 2016, BRIT J SPORT MED, V50; Bell T. R., 2016, International Journal of Sport Communication, V9, P499, DOI 10.1123/IJSC.2016-0075; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Bourdieu Pierre, 1993, CULTURAL STUDIES REA, P427; Bowley B, 2013, AGENDA-EMPOWER WOMEN, V27, P87, DOI 10.1080/10130950.2013.843740; Bowman P, 2020, SPORT HIST, V40, P395, DOI 10.1080/17460263.2020.1756394; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Clayton B., 2009, SPORT SOCIAL IDENTIT, P132; Cleland J, 2014, J ETHN MIGR STUD, V40, P638, DOI 10.1080/1369183X.2013.777524; Cleland J, 2011, MEDIA CULT SOC, V33, P299, DOI 10.1177/0163443710393866; Coakley J., 2011, SPORTS SOC; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Connell R.W., 2005, MASCULINITIES; Connell R.W., 1995, MASCULINITIES; Connell R. W., 1987, GENDER POWER SOC; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Coupland C, 2015, ORGANIZATION, V22, P793, DOI 10.1177/1350508413517409; Cowan D, 2016, QUAL RES SPORT EXERC, V8, P505, DOI 10.1080/2159676X.2016.1206608; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Davis NW, 2009, J APPL SPORT PSYCHOL, V21, P116, DOI 10.1080/10413200802575700; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dunning, 1986, THEOR CULT SOC, V3, P79, DOI DOI 10.1177/0263276486003001007; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Griffin SA, 2021, BRIT J SPORT MED, V55, P319, DOI 10.1136/bjsports-2020-102085; Gunther AC, 2006, J COMMUN, V56, P449, DOI 10.1111/j.1460-2466.2006.00295.x; Hargreaves J, 1986, SPORT POWER CULTURE; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Lewis N, 2015, COMMUN SPORT, V3, P219, DOI 10.1177/2167479513508273; Light R, 2000, SPORT EDUC SOC, V5, P163, DOI 10.1080/713696032; Light R, 2007, QUEST, V59, P323, DOI 10.1080/00336297.2007.10483556; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Malcolm D, 2002, SOCIOL SPORT J, V19, P149, DOI 10.1123/ssj.19.2.149; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Messner M, 2013, COMMUN SPORT, V1, P113, DOI 10.1177/2167479512467977; Muir K., 2020, PALGRAVE HDB MASCULI, P323; Murray A, 2017, INT REV SOCIOL SPORT, V52, P536, DOI 10.1177/1012690215609786; Murray A, 2016, SOCIOL RES ONLINE, V21, DOI 10.5153/sro.4044; Nelson JL, 2018, NEW MEDIA SOC, V20, P3720, DOI 10.1177/1461444818758715; Park MK, 2015, COMMUN SPORT, V3, P367, DOI 10.1177/2167479513516854; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Piggin J., 2020, PHYS ACTIVITY POLITI; Pollock AM, 2017, BRIT J SPORT MED, V51, P1113, DOI 10.1136/bjsports-2016-096996; Pringle R, 2005, J SPORT SOC ISSUES, V29, P256, DOI 10.1177/0193723505276228; Proctor H, 2011, GENDER EDUC, V23, P843, DOI 10.1080/09540253.2010.549114; Pronger B., 1990, ARENA MASCULINITY SP; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sanderson J., 2019, Journal of Sports Media, V14, P1, DOI 10.1353/jsm.2019.0002; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Smith B., 2018, INT REV SPORT EXER P, V11, P101, DOI [DOI 10.1080/1750984X.2017.1317357, 10.1080/1750984X.2017.1317357]; Smith B, 2018, QUAL RES SPORT EXERC, V10, P137, DOI 10.1080/2159676X.2017.1393221; Sparkes AC., 2014, QUALITATIVE RES METH; Sport Collision Injury Collective, 2016, OP LETT PREV INJ CHI; St John W, 2000, J NURS SCHOLARSHIP, V32, P393; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Von Burg R, 2009, CRIT STUD MEDIA COMM, V26, P351, DOI 10.1080/15295030903176641; Whigham S, 2020, SPORT EDUC SOC, V25, P493, DOI 10.1080/13573322.2019.1619545; White A.J., 2017, RUGBY WORLD PROFESSI, P67; White A.J., 2019, INT REV SOCIOL SPORT, V54, P1020, DOI [10.1177/1012690219839909, DOI 10.1177/1012690219839909]; White A.J., 2020, ROUTLEDGE HDB ATHLET; White A, 2017, SPORT EDUC SOC, V22, P905, DOI 10.1080/13573322.2015.1112779; White AJ, 2020, COMMUN SPORT, DOI 10.1177/2167479520948048; White AJ, 2018, INJURY PREV, V24, P114, DOI 10.1136/injuryprev-2017-042672; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Workewych AM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720057; Wright J., 1999, International Review for the Sociology of Sport, V34, P227, DOI 10.1177/101269099034003001	84	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport											21674795211027292	10.1177/21674795211027292		JUN 2021	23	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	TD9ML	WOS:000669641400001		Green Accepted, Green Published, hybrid			2022-02-07	
J	Son, C; Tarasiewicz, I				Son, Colin; Tarasiewicz, Izabela			Short-Term Outcomes of Ethnic and Racial Minority Pediatric Patients Following Traumatic Brain Injury in the State of Texas	CUREUS			English	Article						pediatric trauma; traumatic brain injury; pediatric head trauma; racial disparity	UNITED-STATES; HEALTH-CARE; DISPARITIES; CHILDREN; EPIDEMIOLOGY; RACE; DISPOSITION; PREVENTION; MORTALITY; QUALITY	Background Pediatric traumatic brain injury represents a significant cause of morbidity and mortality. Broadly healthcare disparities exist for ethnic and racial minorities in the United States but it has not previously be evaluated how these disparities might influence outcomes in pediatric traumatic brain injury. Methods We sought all hospital admissions between the years 2006 and 2011 for patients aged 0-17 years admitted with traumatic brain injuries as identified by the International Classification of Diseases, 9th Revision (ICD9) code, from a statewide database of all civilian hospital admissions. Demographic information including race, ethnicity, insurance status and illness severity as calculated by All Patient Refined-Diagnosis Related Group (APR-DRG) were analysed versus the disposition at discharge. Results 14,087 pediatric traumatic brain injury patients were admitted between 2006 and 2011. Pediatric traumatic brain injury patients of ethnic or racial minority had higher rates of in-hospital mortality as compared to whites (4.2% versus 3.3%, p = 0.009) and were less likely to be discharged to inpatient rehabilitation (2.9% versus 4%, p < 0.001). These disparities persisted even when controlling for insurance status and illness severity. Conclusion Ethnic and racial minority children from the U.S. state of Texas suffer worse short-term outcomes following traumatic brain injury than their white counterparts. Strategies are needed for addressing this disparity.	[Son, Colin] Neurosurg Associates San Antonio, Neurosurg, San Antonio, TX 78229 USA; [Tarasiewicz, Izabela] Univ Texas Hlth Sci Ctr San Antonio, Neurosurg, San Antonio, TX 78229 USA		Son, C (corresponding author), Neurosurg Associates San Antonio, Neurosurg, San Antonio, TX 78229 USA.	colinson@gmail.com					3M Health Information Systems, 2003, ALL PATIENT REFINED; [Anonymous], 2015, TEXAS INPATIENT PUBL; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Centers for Medicare and Medicaid Services, 2010, LIST DIAGN REL GROUP LIST DIAGN REL GROUP; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Fiscella K, 2002, MED CARE, V40, P52, DOI 10.1097/00005650-200201000-00007; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Hamilton NA, 2010, SEMIN PEDIATR SURG, V19, P271, DOI 10.1053/j.sempedsurg.2010.06.005; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lehmkuhl DI, 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199308020-00010; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; National Center for Health Statistics, 2015, UND CAUS DEATH 1999 UND CAUS DEATH 1999; Ramirez R.R., 2011, OVERVIEW RACE HISPAN; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; World Health Organization, 1978, INT CLASS DIS	33	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 30	2021	13	6							e16050	10.7759/cureus.16050			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TK3TU	WOS:000674085800029	34336525	Green Published, gold			2022-02-07	
J	Yeo, J				Yeo, Jerrold			Emotional Disturbances After Traumatic Brain Injury: Prevalence, Assessment, and Treatment	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Traumatic brain injury; Depression; Anxiety; Trauma; Mood disturbance; Psychological treatment	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; PROLONGED EXPOSURE THERAPY; ETHNIC DISPARITIES; AMERICAN-INDIANS; MOOD DISORDERS; UNITED-STATES; DEPRESSION; OUTCOMES; ANXIETY	Purpose of Review Emotional disturbances are common after traumatic brain injury (TBI), and this review article examines the common mood difficulties, explores differential diagnoses, and suggests evidence-based treatment methods. Recent Findings A robust clinical interview and the utilization of standardized and validated measures are important to accurately diagnose certain mood disturbances and differentiate them from other brain-injury-related presentations. Accurate diagnosis can assist with efficient and effective treatment methods, and evidence-based treatment includes the use of cognitive behavioral therapy (CBT), motivational interviewing (MI), and other methods with modifications to account for the hallmark features of TBI. Pharmacologic intervention can assist with managing some of the symptoms of mood disturbances. Emotional disturbances are very common after TBI, and timely and targeted evidence-based treatment can help mitigate the negative effects on rehabilitation outcomes. Future research should also focus on comorbid mood disorders after TBI.	[Yeo, Jerrold] Univ Pittsburgh, Med Ctr, UPMC Mercy, UPMC Rehabil Inst, 1400 Locust St,Bldg E,Suite 6012, Pittsburgh, PA 15219 USA; [Yeo, Jerrold] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Kaufmann Med Bldg,Suite 910,3471 Fifth Ave, Pittsburgh, PA 15213 USA		Yeo, J (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Mercy, UPMC Rehabil Inst, 1400 Locust St,Bldg E,Suite 6012, Pittsburgh, PA 15219 USA.; Yeo, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Kaufmann Med Bldg,Suite 910,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	yeo@upmc.edu		Yeo, Jerrold/0000-0002-4339-1764			Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson ES, 2019, AM J EMERG MED, V37, P2028, DOI 10.1016/j.ajem.2019.02.030; [Anonymous], TRAUMATIC BRAIN INJU, P2021; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Auclair-Pilote J, 2021, DISABIL REHABIL, V43, P507, DOI 10.1080/09638288.2019.1630858; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Beadle EJ, 2020, DISABIL REHABIL, V42, P1414, DOI 10.1080/09638288.2018.1527954; Beck AT, 1993, BECK ANXIETY INVENTO; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu D, 2018, REHABIL TRAUMA BRAIN, P123; Cittolin-Santos Giordano F, 2017, Case Rep Psychiatry, V2017, P7541307, DOI 10.1155/2017/7541307; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Dismuke Clara E, 2015, Glob J Health Sci, V8, P260, DOI 10.5539/gjhs.v8n2p260; Driessen E, 2010, PSYCHIAT CLIN N AM, V33, P537, DOI 10.1016/j.psc.2010.04.005; Emery G, 1987, GUILFORD CLIN PSYCHO; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR., 2013, MANAG ADULTS TRAUMA, P195; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Holm K., 2019, BRAIN IMPAIR, P65; Jaffee, 2013, MANAG ADULTS TRAUMA, P167; Jain S, 2017, ASEAN J PSYCHIATR, V18, P95; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Leavitt RA, 2018, MMWR-MORBID MORTAL W, V67, P237, DOI 10.15585/mmwr.mm6708a1; Liu ZQ, 2018, J NEUROSURG SCI, V62, P24, DOI 10.23736/S0390-5616.17.03953-4; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mundluru J, 2021, J NEUROTRAUM, V38, P566, DOI 10.1089/neu.2020.7282; Murphy T, 2014, AM J PUBLIC HEALTH, V104, pS470, DOI 10.2105/AJPH.2013.301854; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Neurobehavioral MJ., 2000, CENT OUTCOME MEAS BR; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Ouellet MC, 2018, J NEUROTRAUM, V35, P1620, DOI 10.1089/neu.2017.5379; Peterson AB, 2019, SURVEILLANCE REPORT; Peterson AB, 2019, J SAFETY RES, V71, P315, DOI 10.1016/j.jsr.2019.09.017; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rabner J, 2016, AM J ADDICTION, V25, P91, DOI 10.1111/ajad.12338; Ragsdale KA, 2016, J TRAUMA STRESS, V29, P474, DOI 10.1002/jts.22130; Reichard AA, 2003, MMWR SURVEILL SUMM, V52, pL; Rivara FP., 2017, AM ACAD PEDIAT; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Tate R., 2007, PSYCHOL TREATMENT AN; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Yudofsky SC, 2011, TXB TRAUMA BRAIN INJ, P179; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoccolotti P., 2010, NEUROPSYCHOL REV SPR, P86	82	0	0	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	SEP	2021	9	3					85	92		10.1007/s40141-021-00311-w		JUN 2021	8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	UM0OZ	WOS:000681287500001					2022-02-07	
J	Zhang, WQ; Hong, J; Zheng, WC; Liu, AJ; Yang, Y				Zhang, Wenqian; Hong, Jun; Zheng, Wencheng; Liu, Aijun; Yang, Ying			High glucose exacerbates neuroinflammation and apoptosis at the intermediate stage after post-traumatic brain injury	AGING-US			English	Article						high glucose; traumatic brain injury; neuroinflammation; apoptosis	HYPERGLYCEMIA; ERK5; PATHWAY; PROTECTS; KINASES; CELLS; FLUID	Traumatic brain injury (TBI) is a highly lethal event with a poor prognosis. Recovering residual neuronal function in the intermediate stage of TBI is important for treatment; however, neuroinflammation and neuronal apoptosis impede residual neuronal repair processes. Considering that hyperglycemia influences inflammatory processes and neuronal survival, we examined the effects of high glucose on neuroinflammation and neuronal death during the intermediate phase of TBI. Rat models of type 2 diabetes mellitus and/or TBI were developed and behaviorally assessed. Neurological function and cognitive abilities were impaired in TBI rats and worsened by type 2 diabetes mellitus. Histopathological staining and analyses of serum and hippocampal mRNA and protein levels indicated that neuroinflammation and apoptosis were induced in TBI rats and exacerbated by hyperglycemia. Hyperglycemia inhibited hippocampal mitogen-activated protein kinase kinase 5 (MEK5) phosphorylation in TBI rats. In vitro assays were used to assess inflammatory factor expression, apoptotic protein levels and neuronal survival after MEK5 activation in TBI-and/or high-glucose treated neurons. MEK5/extracellular signal-regulated kinase 5 (ERK5) pathway activation reduced the inflammation, cleaved caspase-3 expression, Bax/Bcl-2 ratio and apoptosis of TBI neurons, even under high glucose conditions. Thus, high glucose exacerbated neuroinflammation and apoptosis in the intermediate stage post-TBI by inhibiting the MEK5/ERK5 pathway.	[Zhang, Wenqian; Hong, Jun; Liu, Aijun] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China; [Zhang, Wenqian; Hong, Jun; Liu, Aijun] Tangshan Gongren Hosp, Hebei Inst Head Trauma, Tangshan 063000, Hebei, Peoples R China; [Zheng, Wencheng] Tangshan Gongren Hosp, Dept Cardiol, Tangshan 063000, Hebei, Peoples R China; [Yang, Ying] Tangshan Gongren Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China		Hong, J (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China.; Hong, J (corresponding author), Tangshan Gongren Hosp, Hebei Inst Head Trauma, Tangshan 063000, Hebei, Peoples R China.; Yang, Y (corresponding author), Tangshan Gongren Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China.	2633955818@qq.com; yangying1115@126.com		, Ying Yang/0000-0002-1262-5492; , Wenqian Zhang/0000-0002-4757-5253	Medical Science Research Foundation of Hebei Province [20120913]; Provincial Natural Science Foundation of Hebei [H2021105003, H2021105004]	We thank Dr. Junichi Abe for his gift of CAMEK5. This work was supported by the Medical Science Research Foundation of Hebei Province (Grant no. 20120913) , Provincial Natural Science Foundation of Hebei (H2021105003, H2021105004) .	Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bahniwal M, 2017, CURR ALZHEIMER RES, V14, P731, DOI 10.2174/1567205014666170117104053; Boni-Schnetzler M, 2008, DIABETES OBES METAB, V10, P201, DOI 10.1111/j.1463-1326.2008.00950.x; Candeias E, 2018, MOL NEUROBIOL, V55, P4030, DOI 10.1007/s12035-017-0622-3; Chen CD, 2019, AGING-US, V11, P697, DOI 10.18632/aging.101770; Chen CD, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12410; Cui CM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9245702; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finegan KG, 2015, CANCER RES, V75, P742, DOI 10.1158/0008-5472.CAN-13-3043; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Ho N, 2013, NEUROSCI BIOBEHAV R, V37, P1346, DOI 10.1016/j.neubiorev.2013.03.010; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Hsieh CF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37215-0; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; Lan CCE, 2013, DIABETES, V62, P2530, DOI 10.2337/db12-1714; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; McCowen Karen C, 2002, N Engl J Med, V346, P1586; Nam DH, 2017, MOL CELLS, V40, P457, DOI 10.14348/molcells.2017.2296; National Research Council, 2011, GUIDE CARE USE LAB A; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rao HV, 2021, J ALZHEIMERS DIS, V79, P211, DOI 10.3233/JAD-200658; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Sanchez-Fdez A, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01327-2018; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Tatara Y, 2021, J NEUROTRAUM, V38, P886, DOI 10.1089/neu.2020.7118; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Wang H, 2021, J CELL BIOCHEM, V122, P1239, DOI 10.1002/jcb.29523; Wang KJ, 2020, MOL MED REP, V22, P5399, DOI 10.3892/mmr.2020.11618; Wang M, 2018, CLIN IMMUNOL, V197, P77, DOI 10.1016/j.clim.2018.09.005; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Yang Y, 2018, MOL MED REP, V18, P2449, DOI 10.3892/mmr.2018.9180; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhu H, 2014, J BIOL CHEM, V289, P6311, DOI 10.1074/jbc.M113.506584	54	0	0	2	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	JUN 30	2021	13	12					16088	16104					17	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	TD0CL	WOS:000669004100001	34176788	Green Published, gold			2022-02-07	
J	Belanger, HG; Toyinbo, P; Barrett, B; King, E; Sayer, NA				Belanger, Heather G.; Toyinbo, Peter; Barrett, Blake; King, Emily; Sayer, Nina A.			Concussion coach for postconcussive symptoms: a randomized, controlled trial of a smartphone application with Afghanistan and Iraq war Veterans	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						TBI; Veterans Health Administration; postconcussive; mobile application; smart phone; rehabilitation; Bayesian network	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; MINOR HEAD-INJURY; SOCIAL SUPPORT; SELF-EFFICACY; REHABILITATION; SCALE; PREDICTORS; FREEDOM	Objective: Investigate the effectiveness of Concussion Coach, an interactive smartphone application, as a treatment for residual neurobehavioral symptoms and distress in Veterans with a history of mild traumatic brain injury (mild TBI). Methods: Veterans with mild TBI were randomized to Concussion Coach (n = 238) or Treatment-as-Usual (TAU) (n = 241) in a 3-month randomized controlled trial. Primary outcome measures included postconcussive symptom (PCS) severity as measured by the Neurobehavioral Symptom Inventory (NSI), and psychological distress as measured by the Brief Symptom Inventory-18 (BSI-18). Measures of self-efficacy, social support, and comfort with technology were administered as potential moderators and mediators. An intention-to-treat (ITT) analysis was performed (N = 461: Concussion Coach = 231 and TAU = 230) using Bayesian Network (BN)modeling. Results: The probability of decreased PCS severity was significantly greater for those assigned to Concussion Coach, .35 [.32, .37], than for TAU, .29 (.27, .32), with an odds ratio (OR) of 1.29. Also, Concussion Coach showed a significantly greater probability of increased self-efficacy (.36 [.32,.39]) than did TAU (.28 [.25, .30], OR = 1.42). In turn, self-efficacy (increased vs. decreased) showed a significantly greater probability of decreased PCS severity (.51 [.47, .54] vs. .27 [.24, .30], OR = 2.71) and decreased psychological distress (.53 [.49, .56] vs. .32 [.29, .35], OR = 2.35), suggesting that self-efficacy may have mediated Concussion Coach effects. Conclusions: Concussion Coach is effective at reducing PCS severity and psychological distress. Increased self-efficacy/perception of self-management of symptoms may be key to successful treatment of residual symptoms in those with history of concussion.	[Belanger, Heather G.; Toyinbo, Peter; Barrett, Blake] James A Haley Vet Hosp, Res & Dev Serv, Tampa, FL 33612 USA; [Belanger, Heather G.] US Special Operat Command USSOCOM, Tampa, FL 33621 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol & Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.] St Michaels Inc, Tampa, FL USA; [King, Emily] Bay Pines VA, St Petersburg, FL USA; [Sayer, Nina A.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Ctr Care Delivery & Outcomes Res, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Sayer, Nina A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Belanger, HG (corresponding author), US Special Operat Command USSOCOM, Tampa, FL 33621 USA.	heather.belanger.ctr@socom.mil		Barrett, Blake/0000-0002-7895-8660	VA HSRD grant [IIR 13-196-1]; Department of Defense (DoD)United States Department of Defense; Department of Veterans Affairs, Veterans Health Administration (VHA)US Department of Veterans Affairs; St Michael's Inc.; 9Line LLC	The research reported here was funded by VA HSRD grant IIR 13-196-1, and further supported by the Department of Defense (DoD), and Department of Veterans Affairs, Veterans Health Administration (VHA). Further support was provided by 9Line LLC and St Michael's Inc. The views expressed herein are those of the authors and do not necessarily reflect the views of the DoD, VHA, or DVBIC. The first author was an employee of the VHA when this study was conducted.	Agtarap S, 2019, PSYCHOL ASSESSMENT, V31, P1340, DOI 10.1037/pas0000756; Aponte J, 2017, J CLIN NURS, V26, P2703, DOI 10.1111/jocn.13763; Belanger HG, 2020, NEUROPSYCHOL REHABIL, V30, P1190, DOI 10.1080/09602011.2019.1575245; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Biecek P., 2018, J MACHINE LEARNING R, V19, P1; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Brown CH, 2008, DRUG ALCOHOL DEPEN, V95, pS74, DOI 10.1016/j.drugalcdep.2007.11.013; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Deaton A, 2018, SOC SCI MED, V210, P2, DOI 10.1016/j.socscimed.2017.12.005; Denneson LM, 2019, ARCH SUICIDE RES, V23, P234, DOI 10.1080/13811118.2018.1456383; Department of Veterans Affairs, 2013, VHA HDB; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Derogatis LR, 2000, BSI 18 ADM SCORING P; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dorai-Raj S., 2014; Emsley R, 2010, STAT METHODS MED RES, V19, P237, DOI 10.1177/0962280209105014; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Ginsburg OM, 2014, ONCOLOGIST, V19, P177, DOI 10.1634/theoncologist.2013-0314; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Hullam G., 2012, P 6 EUR WORKSH PROB; Jaber AF, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.028993; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; KORB K, 2011, BAYESIAN ARTIFICIAL; Kuhn E, 2017, J CONSULT CLIN PSYCH, V85, P267, DOI 10.1037/ccp0000163; Lakshminarayanan K, 2018, CONTEMP CLIN TRIALS, V70, P24, DOI 10.1016/j.cct.2018.05.005; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Liew BXW, 2019, CLIN J PAIN, V35, P647, DOI 10.1097/AJP.0000000000000728; Lim K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7691-3; Lindley S, 2010, ANN NY ACAD SCI, V1208, P104, DOI 10.1111/j.1749-6632.2010.05692.x; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Madigan D., 1999, BAYESIAN GRAPHICAL M; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Miner A, 2016, PSYCHOL TRAUMA-US, V8, P384, DOI 10.1037/tra0000092; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Nagarajan R, 2013, BAYESIAN NETWORKS R; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pew Research Center, 2019, MOB FACT SHEET MOB T; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; R Core Team, 2014, R LANG ENV STAT COMP; RAND Corporation, 2008, INVISIBLE WOUNDS WAR; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Sabella SA, 2019, J HEAD TRAUMA REHAB, V34, P233, DOI 10.1097/HTR.0000000000000471; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schell T.L., 2008, SURVEY INDIVIDUALS P; Scutari M, 2013, ARTIF INTELL MED, V57, P207, DOI 10.1016/j.artmed.2012.12.006; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Sheese ALN, 2014, PROG NEUROL SURG, V28, P149, DOI 10.1159/000358775; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stuart E, 2008, PREV SCI, V9, P288, DOI 10.1007/s11121-008-0104-y; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Toyinbo PA, 2017, AM J EPIDEMIOL, V185, P135, DOI 10.1093/aje/kww074; Trinh LN, 2020, AM J SPORT MED, V48, P1516, DOI 10.1177/0363546519882626; Turan B, 2016, HEALTH PSYCHOL, V35, P1126, DOI 10.1037/hea0000356; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Xesfingi S, 2016, INTERACT J MED RES, V5, P81, DOI 10.2196/ijmr.4749; Yehene E, 2020, APPL NEUROPSYCH-ADUL, V27, P468, DOI 10.1080/23279095.2019.1569523; Zairina E, 2016, RESPIROLOGY, V21, P867, DOI 10.1111/resp.12773	88	0	0	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2021.1936188		JUN 2021	27	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TB6TX	WOS:000668079300001	34184976				2022-02-07	
J	Boele, HJ; Joung, S; Fil, JE; Mudd, AT; Fleming, SA; Koekkoek, SKE; Dilger, RN				Boele, Henk-Jan; Joung, Sangyun; Fil, Joanne E.; Mudd, Austin T.; Fleming, Stephen A.; Koekkoek, Sebastiaan K. E.; Dilger, Ryan N.			Young Domestic Pigs (Sus scrofa) Can Perform Pavlovian Eyeblink Conditioning	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						pig; eyeblink conditioning; cerebellar learning; associative learning; nutrition	NICTITATING-MEMBRANE RESPONSE; HEAD-INJURY; CEREBELLAR; TRACE; RABBIT; MEMORY; DELAY; LOCALIZATION; ACQUISITION; EXTINCTION	Introduction: Pigs have been an increasingly popular preclinical model in nutritional neuroscience, as their anatomy, physiology, and nutrition requirements are highly comparable to those of humans. Eyeblink conditioning is one of the most well-validated behavioral paradigms in neuroscience to study underlying mechanisms of learning and memory formation in the cerebellum. Eyeblink conditioning has been performed in many species but has never been done on young pigs. Therefore, our aim here was to develop and validate an eyeblink conditioning paradigm in young pigs. Method: Eighteen intact male pigs were artificially reared from postnatal day 2-30. The eyeblink conditioning setup consisted of a sound-damping box with a hammock that pigs were placed in, which allowed the pig to remain comfortable yet maintain a typical range of head motion. In a delay conditioning paradigm, the conditional stimulus (CS) was a 550 ms blue light-emitting diode (LED), the unconditional stimulus (US) was a 50 ms eye air-puff, the CS-US interval was 500 ms. Starting at postnatal day 14, pigs were habituated for 5 days to the eyeblink conditioning setup, followed by 5 daily sessions of acquisition training (40 paired CS-US trials each day). Results: The group-averaged amplitude of conditioned eyelid responses gradually increased over the course of the 5 days of training, indicating that pigs learned to make the association between the LED light CS and the air-puff US. A similar increase was found for the conditioned response (CR) probability: the group-averaged CR probability on session 1 was about 12% and reached a CR probability of 55% on day 5. The latency to CR peak time lacked a temporal preference in the first session but clearly showed preference from the moment that animals started to show more CRs in session 2 and onwards whereby the eyelid was maximally closed exactly at the moment that the US would be delivered. Conclusion: We concluded that 3-week-old pigs have the capability of performing in a cerebellar classical conditioning task, demonstrating for the first time that eyeblink conditioning in young pigs has the potential to be a valuable behavioral tool to measure neurodevelopment.	[Boele, Henk-Jan; Koekkoek, Sebastiaan K. E.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Boele, Henk-Jan] Princeton Neurosci Inst, Princeton, NJ USA; [Joung, Sangyun; Fil, Joanne E.; Mudd, Austin T.; Fleming, Stephen A.; Dilger, Ryan N.] Univ Illinois, Neurosci Program, Champaign, IL 61801 USA; [Dilger, Ryan N.] Univ Illinois, Dept Anim Sci, Champaign, IL 61801 USA; [Dilger, Ryan N.] Univ Illinois, Div Nutr Sci, Champaign, IL 61801 USA		Dilger, RN (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL 61801 USA.; Dilger, RN (corresponding author), Univ Illinois, Dept Anim Sci, Champaign, IL 61801 USA.; Dilger, RN (corresponding author), Univ Illinois, Div Nutr Sci, Champaign, IL 61801 USA.	rdilger2@illinois.edu			Netherlands Organization for Scientific Research-Veni ZonMW [91618112]; Erasmus MC Fellowship [106958]; United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [1009051]	This work was supported by Netherlands Organization for Scientific Research-Veni ZonMW, 91618112 (HJB) and Erasmus MC Fellowship 106958 (H-JB). This work was partially supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch project 1009051 (RD). The USDA funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Albergaria C, 2018, NAT NEUROSCI, V21, P725, DOI 10.1038/s41593-018-0129-x; Boele HJ, 2016, NEURONAL CODES OF THE CEREBELLUM, P53, DOI 10.1016/B978-0-12-801386-1.00003-4; Boele HJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9426; Boele HJ, 2010, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.019.2009; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Cason H, 1922, J EXP PSYCHOL, V5, P153, DOI 10.1037/h0074822; Chettih SN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00072; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dilger RN, 2010, BRAIN BEHAV IMMUN, V24, P1156, DOI 10.1016/j.bbi.2010.05.008; Fleming SA, 2019, NUTR NEUROSCI, V22, P499, DOI 10.1080/1028415X.2017.1415280; Fleming SA, 2017, BEHAV BRAIN RES, V321, P50, DOI 10.1016/j.bbr.2016.12.027; Freeman JH, 2011, LEARN MEMORY, V18, P666, DOI 10.1101/lm.2023011; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Goodman LK, 2018, JOVE-J VIS EXP, DOI 10.3791/58037; GORMEZANO I, 1962, SCIENCE, V138, P33, DOI 10.1126/science.138.3536.33; Grasselli G, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000596; Halverson HE, 2015, J NEUROSCI, V35, P7813, DOI 10.1523/JNEUROSCI.3663-14.2015; Heck DH, 2013, J NEUROSCI, V33, P17603, DOI 10.1523/JNEUROSCI.2759-13.2013; Heiney SA, 2014, J NEUROSCI, V34, P14845, DOI 10.1523/JNEUROSCI.2820-14.2014; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Herbert JS, 2003, BEHAV NEUROSCI, V117, P1196, DOI 10.1037/0735-7044.117.6.1196; Ivkovich D, 1999, PSYCHOL SCI, V10, P4, DOI 10.1111/1467-9280.00097; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Johansson F, 2015, CELL REP, V13, P1741, DOI 10.1016/j.celrep.2015.10.047; Johnson TB, 2008, BEHAV NEUROSCI, V122, P722, DOI 10.1037/0735-7044.122.3.722; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lintz L.M., 1967, PSYCHON SCI, V7, P405; Liu HN, 2014, J NUTR, V144, P1903, DOI 10.3945/jn.114.199828; Manns JR, 2000, HIPPOCAMPUS, V10, P181, DOI 10.1002/(SICI)1098-1063(2000)10:2<181::AID-HIPO7>3.0.CO;2-V; Manns JR, 2000, LEARN MEMORY, V7, P267, DOI 10.1101/lm.33400; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; McEchron MD, 2008, DEV NEUROSCI-BASEL, V30, P243, DOI 10.1159/000110502; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; Mudd AT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020135; Mudd AT, 2017, ADV NUTR, V8, P92, DOI 10.3945/an.116.013243; Mudd AT, 2016, NUTR NEUROSCI, V19, P425, DOI 10.1179/1476830515Y.0000000031; Mudd AT, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00004; Odle J, 2014, ANNU REV ANIM BIOSCI, V2, P419, DOI 10.1146/annurev-animal-022513-114158; Ohmae S, 2015, NAT NEUROSCI, V18, P1798, DOI 10.1038/nn.4167; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Rasmussen A., CER GORD RES C JUL 1 CER GORD RES C JUL 1; Rasmussen A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03343-2; Reeb-Sutherland BC, 2015, J AUTISM DEV DISORD, V45, P376, DOI 10.1007/s10803-013-1905-9; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434; Steinmetz AB, 2014, NEUROBIOL LEARN MEM, V114, P148, DOI 10.1016/j.nlm.2014.06.003; Strydis C., 2020, REAL TIME FACE LANDM REAL TIME FACE LANDM; Svensson P, 1997, LEARN MEMORY, V4, P105, DOI 10.1101/lm.4.1.105; Tanida H., 1993, ANIMAL SCI TECHNOL, V62, P1029; ten Brinke MM, 2015, CELL REP, V13, P1977, DOI 10.1016/j.celrep.2015.10.057; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thurling M, 2015, J NEUROSCI, V35, P1228, DOI 10.1523/JNEUROSCI.2492-14.2015; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; WELSH JP, 1989, J NEUROSCI, V9, P299; WOODY CD, 1969, J NEUROPHYSIOL, V32, P717, DOI 10.1152/jn.1969.32.5.717; YEO CH, 1985, EXP BRAIN RES, V60, P114, DOI 10.1007/BF00237024; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023	65	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 29	2021	15								690019	10.3389/fnbeh.2021.690019			14	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	TH5SD	WOS:000672148800001	34267630	gold, Green Published			2022-02-07	
J	Harrison, RT; DeBacker, JR; Trevino, M; Bielefeld, EC; Lobarinas, E				Harrison, Ryan T.; DeBacker, J. Riley; Trevino, Monica; Bielefeld, Eric C.; Lobarinas, Edward			Cochlear Preconditioning as a Modulator of Susceptibility to Hearing Loss	ANTIOXIDANTS & REDOX SIGNALING			English	Article; Early Access						sound conditioning; hearing loss; cochlea; antioxidants; noise; ototoxicity	NOISE-INDUCED HEARING; CISPLATIN-INDUCED OTOTOXICITY; OUTER HAIR CELL; AUGMENTED ACOUSTIC ENVIRONMENT; TEMPORARY THRESHOLD SHIFT; BRAIN-STEM RESPONSE; ACQUIRED-RESISTANCE; NITRIC-OXIDE; AMINOGLYCOSIDE OTOTOXICITY; CONDITIONING EXPOSURES	Significance: Acquired sensorineural hearing loss is a major public health problem worldwide. The leading causes of sensorineural hearing loss are noise, aging, and ototoxic medications, with the key underlying pathology being damage to the cochlea. The review focuses on the phenomenon of preconditioning, in which the susceptibility to cochlear injury is reduced by exposing the ear to a stressful stimulus. Recent Advances: Cochlear conditioning has focused on the use of mono-modal conditioning, specifically conditioning the cochlea with moderate noise exposures before a traumatic exposure that causes permanent hearing loss. Recently, cross-modal conditioning has been explored more thoroughly, to prevent not only noise-induced hearing loss, but also age-related and drug-induced hearing losses. Critical Issues: Noise exposures that cause only temporary threshold shifts (TTSs) can cause long-term synaptopathy, injury to the synapses between the inner hair cells and spiral ganglion cells. This discovery has the potential to significantly alter the field of cochlear preconditioning with noise. Further, cochlear preconditioning can be the gateway to the development of clinically deployable therapeutics. Therefore, understanding the underlying mechanisms of conditioning is crucial for optimizing clinical protection against sensorineural hearing loss. Future Directions: Before the discovery of synaptopathy, noise exposures that caused only TTSs were believed to be either harmless or potentially beneficial. Any considerations of preconditioning with noise must consider the potential for injury to the synapses. Further, the discovery of different methods to precondition the cochlea against injury will yield new avenues for protection against hearing loss in the vulnerable populations.	[Harrison, Ryan T.; DeBacker, J. Riley; Bielefeld, Eric C.] Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall 1070 Carmack Rd, Columbus, OH 43210 USA; [Trevino, Monica; Lobarinas, Edward] Univ Texas Dallas, Callier Ctr Commun Disorders, Sch Behav & Brain Sci, Dallas, TX USA		Bielefeld, EC (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall 1070 Carmack Rd, Columbus, OH 43210 USA.	bielefeld.6@osu.edu		Bielefeld, Eric/0000-0001-7174-1402; DeBacker, J. Riley/0000-0002-8217-9598			Alvarado JC, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00019; Bauer Carol A, 2007, Int Tinnitus J, V13, P21; Bielefeld EC, 2005, HEARING RES, V207, P35, DOI 10.1016/j.heares.2005.03.025; Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; Bing D, 2015, CELL PHYSIOL BIOCHEM, V35, P1905, DOI 10.1159/000374000; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; BOHNE BA, 1987, HEARING RES, V29, P251, DOI 10.1016/0378-5955(87)90172-9; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Breglio AM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01837-1; CAMPO P, 1991, HEARING RES, V55, P195, DOI 10.1016/0378-5955(91)90104-H; CANLON B, 1988, HEARING RES, V34, P197, DOI 10.1016/0378-5955(88)90107-4; Canlon B, 1998, NEUROREPORT, V9, P269, DOI 10.1097/00001756-199801260-00017; Chen YS, 2005, HEARING RES, V203, P94, DOI 10.1016/j.heares.2004.12.006; CLARK WW, 1987, J ACOUST SOC AM, V82, P1253, DOI 10.1121/1.395261; De Oliveira JAA, 2004, OTOLARYNG HEAD NECK, V131, P271, DOI 10.1016/j.otohns.2004.02.041; DeBacker JR, 2017, EAR HEARING, V38, P282, DOI 10.1097/AUD.0000000000000391; Dhukhwa A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00444; DIXON W, 1971, J ACOUST SOC AM, V49, P91; Fan LQ, 2020, FRONT SYST NEUROSCI, V14, DOI 10.3389/fnsys.2020.00025; Fernandez EA, 2010, JARO-J ASSOC RES OTO, V11, P235, DOI 10.1007/s10162-009-0204-9; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; FRANKLIN DJ, 1991, HEARING RES, V53, P185, DOI 10.1016/0378-5955(91)90053-C; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Goman AM, 2016, AM J PUBLIC HEALTH, V106, P1820, DOI 10.2105/AJPH.2016.303299; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Grinn SK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00465; Guest H, 2019, NEUROSCIENCE, V407, P75, DOI 10.1016/j.neuroscience.2018.12.019; Hamernik RP, 2008, HEARING RES, V239, P99, DOI 10.1016/j.heares.2008.02.001; Harris KC, 2006, HEARING RES, V213, P118, DOI 10.1016/j.heares.2005.11.012; Harrison RT, 2016, ANTI-CANCER DRUG, V27, P780, DOI 10.1097/CAD.0000000000000395; Harrison RT, 2015, LARYNGOSCOPE, V125, pE78, DOI 10.1002/lary.24948; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; HENDERSON D, 1994, HEARING RES, V74, P22, DOI 10.1016/0378-5955(94)90172-4; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HENSELMAN LW, 1994, HEARING RES, V78, P1, DOI 10.1016/0378-5955(94)90038-8; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Hight NG, 2003, HEARING RES, V179, P21, DOI 10.1016/S0378-5955(03)00067-4; Hu BH, 1997, HEARING RES, V113, P198, DOI 10.1016/S0378-5955(97)00143-3; Hu BH, 1997, HEARING RES, V110, P209, DOI 10.1016/S0378-5955(97)00075-0; International Organization for Standardization (ISO), 2013, ISO1999; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Kopke RD, 2000, HEARING RES, V149, P138, DOI 10.1016/S0378-5955(00)00176-3; Kopke RD, 2002, LARYNGOSCOPE, V112, P1515, DOI 10.1097/00005537-200209000-00001; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lanvers-Kaminsky C, 2017, CLIN PHARMACOL THER, V101, P491, DOI 10.1002/cpt.603; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Le Prell CG, 2018, EAR HEARING, V39, P1057, DOI 10.1097/AUD.0000000000000575; Li Y, 2004, EUR J CANCER, V40, P2445, DOI 10.1016/j.ejca.2003.08.009; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lobarinas E, 2017, HEARING RES, V349, P155, DOI 10.1016/j.heares.2016.12.009; Maudonnet EN, 2008, DRUG CHEM TOXICOL, V31, P11, DOI 10.1080/01480540701688287; McFadden SL, 1997, HEARING RES, V103, P142, DOI 10.1016/S0378-5955(96)00170-0; Meltser I, 2011, HEARING RES, V281, P47, DOI 10.1016/j.heares.2011.06.003; MILLER JD, 1974, J ACOUST SOC AM, V56, P729, DOI 10.1121/1.1903322; Miller JD., 1963, ACTA OTOLARYNGOL S, V176, P1; MIYAKITA T, 1992, HEARING RES, V60, P149, DOI 10.1016/0378-5955(92)90017-H; National Institute on Deafness and Other Communication Disorders, 2016, QUICK STAT HEAR; Niu X, 2002, J SOUND VIB, V250, P115, DOI 10.1006/jsvi.2001.3999; Niu XZ, 2003, NEUROREPORT, V14, P1025, DOI 10.1097/01.wnr.0000070830.57864.32; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 2011, HEARING RES, V280, P141, DOI 10.1016/j.heares.2011.05.007; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Pukkila M, 1997, ACTA OTO-LARYNGOL, P59; QUIRK WS, 1994, HEARING RES, V74, P217, DOI 10.1016/0378-5955(94)90189-9; RAJAN R, 1983, HEARING RES, V12, P185, DOI 10.1016/0378-5955(83)90105-3; Ramkumar V, 2004, HEARING RES, V188, P47, DOI 10.1016/S0378-5955(03)00344-7; RAVI R, 1995, PHARMACOL TOXICOL, V76, P386, DOI 10.1111/j.1600-0773.1995.tb00167.x; REDDEL RR, 1982, CANCER TREAT REP, V66, P19; Roy S, 2013, J CLIN INVEST, V123, P4945, DOI 10.1172/JCI71353; RYAN AF, 1994, HEARING RES, V72, P23, DOI 10.1016/0378-5955(94)90201-1; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; SEIDMAN MD, 1993, OTOLARYNG HEAD NECK, V109, P1052, DOI 10.1177/019459989310900613; Shi X, 2007, FREE RADICAL RES, V41, P1313, DOI 10.1080/10715760701687117; Shi XR, 2003, BRAIN RES, V967, P1, DOI 10.1016/S0006-8993(02)04090-8; SLEPECKY N, 1986, HEARING RES, V22, P307, DOI 10.1016/0378-5955(86)90107-3; SUBRAMANIAM M, 1991, HEARING RES, V52, P181, DOI 10.1016/0378-5955(91)90197-H; SUBRAMANIAM M, 1992, HEARING RES, V58, P57, DOI 10.1016/0378-5955(92)90008-B; SUBRAMANIAM M, 1991, HEARING RES, V56, P65, DOI 10.1016/0378-5955(91)90154-2; Suryadevara AC, 2009, LARYNGOSCOPE, V119, P1166, DOI 10.1002/lary.20145; Tahera Y, 2007, NEUROBIOL DIS, V25, P189, DOI 10.1016/j.nbd.2006.09.004; Tanaka C, 2009, LARYNGOSCOPE, V119, P1374, DOI 10.1002/lary.20244; TEPPER JM, 1980, BRAIN RES, V187, P81, DOI 10.1016/0006-8993(80)90496-5; Theneshkumar S, 2009, MED SCI MONITOR, V15, pBR173; Valderrama JT, 2018, HEARING RES, V365, P36, DOI 10.1016/j.heares.2018.06.003; VANZEIJL LGPM, 1984, ARCH OTO-RHINO-LARYN, V239, P255; VIALL J, 1977, T AM ACAD OPHTHALMOL, V84, P459; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Ward WD., 1976, EFFECTS NOISE HEARIN, P407; White DR, 1998, J ACOUST SOC AM, V103, P1566, DOI 10.1121/1.421303; Whitehorn H, 2014, SAMJ S AFR MED J, V104, P288, DOI 10.7196/SAMJ.7389; Willott JF, 1999, HEARING RES, V135, P78, DOI 10.1016/S0378-5955(99)00094-5; Wu WJ, 2002, AUDIOL NEURO-OTOL, V7, P171, DOI 10.1159/000058305; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Yamasoba T, 1999, HEARING RES, V127, P31, DOI 10.1016/S0378-5955(98)00178-6; Yamasoba T, 1999, BRAIN RES, V815, P317, DOI 10.1016/S0006-8993(98)01100-7; Yamasoba T, 1998, HEARING RES, V120, P143, DOI 10.1016/S0378-5955(98)00054-9; Yoshida N, 2000, HEARING RES, V148, P213, DOI 10.1016/S0378-5955(00)00161-1; Yoshida N, 1999, J NEUROSCI, V19, P10116; Zheng XY, 1997, HEARING RES, V104, P191, DOI 10.1016/S0378-5955(96)00187-6; Zhu GX, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/8823785; Zuo HY, 2008, J OCCUP HEALTH, V50, P373, DOI 10.1539/joh.L8032	106	0	0	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.												10.1089/ars.2021.0055		JUN 2021	14	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	TB9UX	WOS:000668290400001	34011160				2022-02-07	
J	Pulsipher, DT; Rettig, EK; Krapf, EM; Stanford, LD				Pulsipher, Dalin T.; Rettig, Eman K.; Krapf, Erica M.; Stanford, Lisa D.			A cross-sectional cohort study of post-concussive symptoms and their relationships with depressive symptoms in youth with and without concussion	BRAIN INJURY			English	Article						Concussion; post-concussive; nonspecific; depression	POSTCONCUSSION-LIKE SYMPTOMS; TRAUMATIC BRAIN-INJURY; LIFE-STYLE FACTORS; BASE RATES; HEAD-INJURY; STRESS; ANXIETY; LINE; TAU	Objectives: To evaluate the frequency and severity of post-concussive symptoms in youth with a history of concussion relative to youth without concussion who had another medical diagnosis, as well as compare the correlations between post-concussive and depressive symptoms between groups. We hypothesized comparable symptom reporting and correlations in each group. Methods: A total of 564 youth ages 8-18 years were assessed regarding post-concussive symptoms. A subset of youth (n = 360) were compared on correlations between post-concussive and depressive symptoms. Non-parametric statistics were used for most analyses. Results: Youth with concussion reported a comparable number of post-concussive and depressive symptoms as youth with another medical condition without concussion. However, those with concussion reported greater post-concussive symptom severity (but small effect sizes). Relationships between post-concussive and depressive symptoms were comparable for both groups, but for those who sustained a concussion, the correlation was significantly stronger for females than males. Conclusions: This study further demonstrates that post-concussive symptoms are nonspecific and provide little functional utility. Post-concussive and depressive symptoms are strongly correlated, particularly in females with concussion. Psychiatric comorbidities and other medical diagnoses should be assessed pre-injury because both affect interpretation of post-concussive symptom reports.	[Pulsipher, Dalin T.; Rettig, Eman K.; Krapf, Erica M.; Stanford, Lisa D.] Akron Childrens Hosp, Neurodev Sci Ctr, Div Neurobehav Hlth, Akron, OH USA		Pulsipher, DT (corresponding author), Univ Rochester, Dept Neurol, Med Ctr, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	neuro.pulsipher@gmail.com		Pulsipher, Dalin/0000-0002-1809-6288			Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Axelrod BN, 1998, ARCH CLIN NEUROPSYCH, V13, P543, DOI 10.1016/S0887-6177(97)00044-9; Balasundaram AP, 2017, SCAND J MED SCI SPOR, V27, P2002, DOI 10.1111/sms.12844; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Bauer RM, 2016, CLIN NEUROPSYCHOL, P1, DOI [10.1080/13854046.2016.1150413, DOI 10.1080/13854046.2016.1150413]; Bernard CO, 2020, J INT NEUROPSYCH SOC, V26, P451, DOI 10.1017/S1355617719001279; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Couch CM, 2011, ARCH CLIN NEUROPSYCH, V26, P349, DOI 10.1093/arclin/acr028; Cullum CM, 2019, ARCH CLIN NEUROPSYCH, V126, pE374; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; GILPIN AR, 1993, EDUC PSYCHOL MEAS, V53, P87, DOI 10.1177/0013164493053001007; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KOWALSKI CJ, 1972, J ROY STAT SOC C-APP, V21, P1; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Leathem J, 2016, J PEDIAT NEUROPSYCHO, V2, P1, DOI [10.1007/s40817-016-0022-z, DOI 10.1007/S40817-016-0022-Z]; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tomczak E, 2014, OVERVIEW SOME RECOMM, V1, P7; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Walker D.A., 2003, J MOD APPL STAT METH, P525, DOI DOI 10.22237/JMASM/1067646360; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	38	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					964	970		10.1080/02699052.2021.1942550		JUN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000668040800001	34184599				2022-02-07	
J	Yang, C; Huang, XJ; Feng, JF; Xie, L; Hui, JY; Li, WP; Jiang, JY				Yang, Chun; Huang, Xianjian; Feng, Junfeng; Xie, Li; Hui, Jiyuan; Li, Weiping; Jiang, Jiyao			Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma (PREDICT-AEDH): study protocol for a randomized controlled trial	TRIALS			English	Article						Acute epidural hematoma (AEDH); Herniation; Surgery; Decompressive craniectomy (DC); Craniotomy; Randomized controlled trial (RCT)	BRAIN-INJURY; CEREBRAL INFARCTION; MULTICENTER; GUIDELINES; SCALE; RISK	BackgroundThe expeditious surgical evacuation of acute epidural hematoma (AEDH) is an attainable gold standard and is often expected to have a good clinical outcome for patients with surgical indications. However, controversy exists on the optimal surgical options for AEDH, especially for patients with brain herniation. Neurosurgeons are confronted with the decision to evacuate the hematoma with decompressive craniectomy (DC) or craniotomy.Methods/designPatients of both sexes, age between 18 and 65 years, who presented to the emergency room with a clinical and radiological diagnosis of AEDH with herniation, were assessed against the inclusion and exclusion criteria to be enrolled in the study. Clinical and radiological information, including diagnosis of AEDH, treatment procedures, and follow-up data at 1, 3, and 6 months after injury, was collected from 120 eligible patients in 51 centers. The patients were randomized into groups of DC versus craniotomy in a 1:1 ratio. The primary outcome was the Glasgow Outcome Score-Extended (GOSE) at 6 months post-injury. Secondary outcomes included incidence of postoperative cerebral infarction, incidence of additional craniocerebral surgery, and other evaluation indicators within 6 months post-injury.DiscussionThis study is expected to support neurosurgeons in their decision to evacuate the epidural hematoma with or without a DC, especially in patients with brain herniation, and provide additional evidence to improve the knowledge in clinical practice.Trial registrationClinicalTrials.govNCT 04261673. Registered on 04 February 2020	[Yang, Chun; Feng, Junfeng; Hui, Jiyuan; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg,Brain Injury Ctr, 160 Pujian Rd, Shanghai, Peoples R China; [Yang, Chun; Feng, Junfeng; Hui, Jiyuan; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Huang, Xianjian; Li, Weiping] Shenzhen Univ, Dept Neurosurg, Affiliated Hosp 1, 3002 Sungang West Rd, Shenzhen, Guangdong, Peoples R China; [Xie, Li] Shanghai Jiao Tong Univ, Clin Res Inst, Sch Med, 227 Chongqing South Rd, Shanghai, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg,Brain Injury Ctr, 160 Pujian Rd, Shanghai, Peoples R China.; Jiang, JY (corresponding author), Shanghai Inst Head Trauma, Shanghai, Peoples R China.; Li, WP (corresponding author), Shenzhen Univ, Dept Neurosurg, Affiliated Hosp 1, 3002 Sungang West Rd, Shenzhen, Guangdong, Peoples R China.	Liweiping60@139.com; jiyaojiang@126.com					Bullock M Ross, 2006, Neurosurgery, V58, pS7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gurer B, 2017, TURK NEUROSURG, V27, P37, DOI 10.5137/1019-5149.JTN.14809-15.0; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lin H, 2016, J NEUROTRAUM, V33, P1023, DOI 10.1089/neu.2014.3656; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P261, DOI 10.1007/978-3-211-98811-4_49; Ruff LM, 2013, BRIT J NEUROSURG, V27, P19, DOI 10.3109/02688697.2012.709555; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Soon WC, 2016, BRIT J NEUROSURG, V30, P233, DOI 10.3109/02688697.2015.1119237; Wang WH, 2014, J NEUROTRAUM, V31, P1444, DOI 10.1089/neu.2013.3142; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang SJ, 2017, BRAIN INJURY, V31, P215, DOI 10.1080/02699052.2016.1227088	20	0	0	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUN 29	2021	22	1							421	10.1186/s13063-021-05359-6			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	TG1TS	WOS:000671194200003	34187537	Green Published, Green Submitted, gold			2022-02-07	
J	Clausen, AN; Bouchard, HC; Welsh-Bohmer, KA; Morey, RA				Clausen, Ashley N.; Bouchard, Heather C.; Welsh-Bohmer, Kathleen A.; Morey, Rajendra A.		VA Mid-Atlantic MIRECC Workgrp	Assessment of Neuropsychological Function in Veterans With Blast-Related Mild Traumatic Brain Injury and Subconcussive Blast Exposure	FRONTIERS IN PSYCHOLOGY			English	Article						subconcussive; traumatic brain injury; neuropsychological function; military; cognition; head injuries; blast concussion	POSTTRAUMATIC-STRESS-DISORDER; LOW-LEVEL BLAST; NIH TOOLBOX; POSTCONCUSSIVE SYMPTOMS; COGNITIVE DYSFUNCTION; OEF/OIF/OND VETERANS; TEST-PERFORMANCE; IRAQI FREEDOM; SOLDIERS; VALIDATION	Objective: The majority of combat-related head injuries are associated with blast exposure. While Veterans with mild traumatic brain injury (mTBI) report cognitive complaints and exhibit poorer neuropsychological performance, there is little evidence examining the effects of subconcussive blast exposure, which does not meet clinical symptom criteria for mTBI during the acute period following exposure. We compared chronic effects of combat-related blast mTBI and combat-related subconcussive blast exposure on neuropsychological performance in Veterans. Methods: Post-9/11 Veterans with combat-related subconcussive blast exposure (n = 33), combat-related blast mTBI (n = 26), and controls (n = 33) without combat-related blast exposure, completed neuropsychological assessments of intellectual and executive functioning, processing speed, and working memory via NIH toolbox, assessment of clinical psychopathology, a retrospective account of blast exposures and non-blast-related head injuries, and self-reported current medication. Huber Robust Regressions were employed to compare neuropsychological performance across groups. Results: Veterans with combat-related blast mTBI and subconcussive blast exposure displayed significantly slower processing speed compared with controls. After adjusting for post-traumatic stress disorder and depressive symptoms, those with combat-related mTBI exhibited slower processing speed than controls. Conclusion: Veterans in the combat-related blast mTBI group exhibited slower processing speed relative to controls even when controlling for PTSD and depression. Cognition did not significantly differ between subconcussive and control groups or subconcussive and combat-related blast mTBI groups. Results suggest neurocognitive assessment may not be sensitive enough to detect long-term effects of subconcussive blast exposure, or that psychiatric symptoms may better account for cognitive sequelae following combat-related subconcussive blast exposure or combat-related blast mTBI.	[Clausen, Ashley N.] Kansas City VA Med Ctr, Kansas City, MO 64128 USA; [Clausen, Ashley N.; Bouchard, Heather C.; Morey, Rajendra A.; VA Mid-Atlantic MIRECC Workgrp] Duke Univ, Duke Univ North Carolina Chapel Hill Brain Imagin, Durham, NC 27708 USA; [Clausen, Ashley N.; Bouchard, Heather C.; Morey, Rajendra A.] Durham Vet Affairs Healthcare Syst, VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC 27705 USA; [Welsh-Bohmer, Kathleen A.; Morey, Rajendra A.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Morey, Rajendra A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA		Clausen, AN (corresponding author), Kansas City VA Med Ctr, Kansas City, MO 64128 USA.; Clausen, AN (corresponding author), Duke Univ, Duke Univ North Carolina Chapel Hill Brain Imagin, Durham, NC 27708 USA.; Clausen, AN (corresponding author), Durham Vet Affairs Healthcare Syst, VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC 27705 USA.	ashley.n.clausen@gmail.com			U.S. Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) core funds of the Department of Veterans Affairs Office of Mental Health ServicesUS Department of Veterans Affairs; VA Office of Research and Development [5I01CX000748-01, 5I01CX00012002]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS08688501A1]; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research Service of the Durham VA Health Care System; Department of Veterans Affairs Mid-Atlantic MIRECCUS Department of Veterans Affairs	This research was supported by the U.S. Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC) core funds of the Department of Veterans Affairs Office of Mental Health Services. RM also received financial support from the VA Office of Research and Development (5I01CX000748-01, 5I01CX00012002). Additional financial support was provided by the National Institute for Neurological Disorders and Stroke (R01NS08688501A1). Writing of this manuscript was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Durham VA Health Care System, and the Department of Veterans Affairs Mid-Atlantic MIRECC.	Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder RM, 2019, CLIN NEUROPSYCHOL, V33, P220, DOI 10.1080/13854046.2018.1521993; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Clausen AN, 2020, NEUROPSYCHOPHARMACOL, V45, P491, DOI 10.1038/s41386-019-0539-9; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dunbar KE, 2019, CYBERPSYCH BEH SOC N, V22, P761, DOI 10.1089/cyber.2019.0296; First M.B., 1996, STRUCTURED CLIN INTE; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Greer N, 2016, PREVALENCE EPIDEMIOL; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Hodes RJ, 2013, NEUROLOGY, V80, pS1, DOI 10.1212/WNL.0b013e3182872e90; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Jorgensen-Wagers K, 2021, MIL MED, V186, P546, DOI 10.1093/milmed/usaa410; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; LaValle CR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00949; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nelson NW, 2020, NEUROPSYCHOLOGY, V34, P116, DOI 10.1037/neu0000594; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rao SM, 2017, MULT SCLER J, V23, P1929, DOI 10.1177/1352458516688955; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Trivedi MH, 2014, J AFFECT DISORDERS, V152, P19, DOI 10.1016/j.jad.2013.09.012; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Venegas J., 2011, ENCY CLIN NEUROPSYCH, P2693, DOI DOI 10.1007/978-0-387-79948-3_1500; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F., 2013, DIAGNOSTIC STAT MANU, V5th; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472	66	0	0	7	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JUN 28	2021	12								686330	10.3389/fpsyg.2021.686330			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TH0VV	WOS:000671814600001	34262512	gold, Green Published, Green Submitted			2022-02-07	
J	Estival, S; Laurier, V; Mourre, F; Postal, V				Estival, Severine; Laurier, Virginie; Mourre, Fabien; Postal, Virginie			Improvement of Planning Abilities in Adults with Prader-Willi Syndrome: A Randomized Controlled Trial	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Cognitive rehabilitation; executive functions; intellectual disability; metacognitive strategy training; planning; prader-willi syndrome	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; FRONTAL-LOBE; REHABILITATION; DEFICITS; INDIVIDUALS; VALIDITY; ORGANIZATION; OUTPATIENTS; EXPERIENCE	Prader-Willi Syndrome (PWS) is a neurodevelopmental genetic disorder with executive deficits. Planning is one of the impaired executive functions implied in the regulation of behavior and everyday actions. We aimed to explore the feasibility and the effectiveness of a metacognitive strategy training designed to improve planning in adults with PWS using a double-blind between-group (training versus usual care) randomized controlled trial, with computerized tests and paper-pencil ecological outcome measures targeting planning, other executive functions, and achievement of personalized goal. Results showed better performances in several executive tasks and in achievement of personalized goals after both interventions, but better improvement for the experimental group (n = 27) compared to control (n = 26) only on the task assessing planning abilities. Interviews with occupational therapists demonstrated the feasibility of this training with this population. Despite a small number of sessions, the metacognitive strategy training showed encouraging results on planning abilities of patients.	[Estival, Severine; Postal, Virginie] Univ Bordeaux, Lab Psychol LabPsy, EA4139, Bordeaux, France; [Laurier, Virginie; Mourre, Fabien] Unite Prader Willi, Hop Marin, AP HP, Hendaye, France		Estival, S (corresponding author), Lab Psychol, EA4139, 3 Ter Pl Victoire, F-33076 Bordeaux, France.	s.estival@live.fr		Estival, Severine/0000-0002-6400-0451	French Ministry of Higher Education and Research; Prader-Willi Association France	This study is funded by a 3-year PhD scholarship from the French Ministry of Higher Education and Research. We would like to thank the Prader-Willi Association France for financial support for travel expenses linked to the protocol.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Arrington CM, 2004, PSYCHOL SCI, V15, P610, DOI 10.1111/j.0956-7976.2004.00728.x; Benarroch F, 2007, CHILD ADOL PSYCH CL, V16, P695, DOI 10.1016/j.chc.2007.03.007; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bertens D, 2015, ARCH CLIN NEUROPSYCH, V30, P122, DOI 10.1093/arclin/acu093; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Butler MG, 2019, CURR PEDIATR REV, V15, P207, DOI 10.2174/1573396315666190716120925; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Cheval?re J., 2014, THESIS U BORDEAUX BO; Chevalere J, 2013, J Appl Res Intellect Disabil, V26, P309, DOI 10.1111/jar.12044; Chevalere J, 2015, AJIDD-AM J INTELLECT, V120, P215, DOI 10.1352/1944-7558-120.3.215; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Copet P, 2010, J INTELL DISABIL RES, V54, P204, DOI 10.1111/j.1365-2788.2010.01251.x; de Rotrou J, 2012, DEMENT GERIATR COGN, V33, P210, DOI 10.1159/000338232; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Estival S, 2019, DEV NEUROREHABIL, V22, P569, DOI 10.1080/17518423.2019.1642414; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Hart T, 2012, ARCH PHYS MED REHAB, V93, pS117, DOI 10.1016/j.apmr.2011.11.039; HOLM VA, 1993, PEDIATRICS, V91, P398; Jauregi J, 2007, J INTELL DISABIL RES, V51, P350, DOI 10.1111/j.1365-2788.2006.00883.x; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Krasny-Pacini A, 2016, ARCH PHYS MED REHAB, V97, P157, DOI 10.1016/j.apmr.2015.08.424; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Laurier V, 2015, J INTELL DISABIL RES, V59, P411, DOI 10.1111/jir.12140; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lewis BA, 2002, AM J SPEECH-LANG PAT, V11, P285, DOI 10.1044/1058-0360(2002/033); Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; Li SC, 2008, PSYCHOL AGING, V23, P731, DOI 10.1037/a0014343; Luria, 1996, HIGHER CORTICAL FUNC; Martin R., 1972, TEST COMMISSIONS EPR, V2nd; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Postal V, 2021, STUDY DEFICIT PLANNI; Rainville C, 2002, ARCH CLIN NEUROPSYCH, V17, P513, DOI 10.1016/S0887-6177(01)00132-9; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spillane V, 2007, J ADV NURS, V60, P343, DOI 10.1111/j.1365-2648.2007.04386.x; Tournier I, 2014, ARCH GERONTOL GERIAT, V59, P599, DOI 10.1016/j.archger.2014.07.016; Whittington J, 2004, J INTELL DISABIL RES, V48, P172, DOI 10.1111/j.1365-2788.2004.00556.x; Whittington J, 2017, NEUROSCI BIOBEHAV R, V72, P153, DOI 10.1016/j.neubiorev.2016.09.013; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woodcock KA, 2009, COGN NEUROPSYCHOL, V26, P172, DOI 10.1080/02643290802685921; Ylvisaker M, 2009, DEV NEUROREHABIL, V12, P370, DOI 10.3109/17518420903087533	55	0	0	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	OCT 3	2021	24	7					478	493		10.1080/17518423.2021.1915405		JUN 2021	16	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	UP5VS	WOS:000667992600001	34184596				2022-02-07	
J	Evans, E; Krebill, C; Gutman, R; Resnik, L; Zonfrillo, MR; Lueckel, SN; Zhang, WN; Kumar, RG; Dams-O'Connor, K; Thomas, KS				Evans, Emily; Krebill, Cicely; Gutman, Roee; Resnik, Linda; Zonfrillo, Mark R.; Lueckel, Stephanie N.; Zhang, Wenhan; Kumar, Raj G.; Dams-O'Connor, Kristen; Thomas, Kali S.			Functional motor improvement during inpatient rehabilitation among older adults with traumatic brain injury	PM&R			English	Article; Early Access							MINORITY STATUS; FILE LINKING; OUTCOMES; DISCHARGE; INSTITUTIONALIZATION; COMMUNITY; ASSOCIATION; DISPARITIES; PREDICTION; IMPACT	Background Older adults comprise an increasingly large proportion of patients with traumatic brain injury (TBI) receiving care in inpatient rehabilitation facilities (IRF). However, high rates of comorbidities and evidence of declining preinjury health among older adults who sustain TBI raise questions about their ability to benefit from IRF care. Objectives To describe the proportion of older adults with TBI who exhibited minimal detectable change (MDC) and a minimally clinically important difference (MCID) in motor function from IRF admission to discharge; and to identify characteristics associated with clinically meaningful improvement in motor function and better discharge functional status. Design This retrospective cohort study used Medicare administrative data probabilistically linked to the National Trauma Data Bank to estimate the proportion of patients whose motor function improved during inpatient rehabilitation and identify factors associated with meaningful improvement in motor function and motor function at discharge. Setting Inpatient rehabilitation facilities in the United States. Patients Fee-for-service Medicare beneficiaries with TBI. Main Outcome Measures Minimal Detectable Change (MDC) and Minimally Clinically Important Difference (MCID) in the Functional Independence Measure motor (FIM-M) score from admission to discharge, and FIM-M score at IRF discharge. Results From IRF admission to discharge 84% of patients achieved the MDC threshold, and 68% of patients achieved the MCID threshold for FIM-M scores. Factors associated with a higher probability of achieving the MCID for FIM-M scores included better admission motor and cognitive function, lower comorbidity burden, and a length of stay longer than 10 days but only among individuals with lower admission motor function. Older age was associated with a lower FIM-M discharge score, but not the probability of achieving the MCID in FIM-M score. Conclusion Older adults with TBI have the potential to improve their motor function with IRF care. Baseline functional status and comorbidity burden, rather than acute injury severity, should be used to guide care planning.	[Evans, Emily] Brown Univ, Sch Publ Hlth, Ctr Gerontol & Healthcare Res, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Krebill, Cicely] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Gutman, Roee] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Resnik, Linda; Thomas, Kali S.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Ctr Gerontol & Healthcare Res,VA Med Ctr, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Emergency Med, Warren Alpert Sch Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Pediat, Warren Alpert Sch Med, Providence, RI 02912 USA; [Lueckel, Stephanie N.] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, Div Acute Care Surg & Surg Crit Care, Providence, RI 02903 USA; [Zhang, Wenhan] Brown Univ, Sch Publ Hlth, Ctr Gerontol & Healthcare Res, Providence, RI 02912 USA; [Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Evans, E (corresponding author), Brown Univ, Sch Publ Hlth, Ctr Gerontol & Healthcare Res, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	emily_evans@brown.edu	Gutman, Roee/J-2355-2014	Gutman, Roee/0000-0001-7095-3016; Evans, Emily/0000-0002-1027-5441	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [5T32HS000011-33]; Center on Health Services Training and Research; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R21AG059120]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0009-01]; Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [PCORI/ME-2017C3-9241]; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [CDA 14-422]	Agency for Healthcare Research and Quality, Grant/Award Number: 5T32HS000011-33; Center on Health Services Training and Research; National Institute on Aging, Grant/Award Number: 1R21AG059120; National Institute on Disability, Independent Living, and Rehabilitation Research, Grant/Award Number: 90DPTB0009-01; Patient-Centered Outcomes Research Institute, Grant/Award Number: PCORI/ME-2017C3-9241; U.S. Department of Veterans Affairs, Grant/Award Number: CDA 14-422	Alcusky M, 2018, ARCH PHYS MED REHAB, V99, P1124, DOI 10.1016/j.apmr.2017.09.005; [Anonymous], 2014, MIMRGNS STATA MODULE; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Buntin MB., 2006, INPATIENT REHABILITA; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Medicare and Medicaid Services, 2014, INP REH FAC PAT ASS; Chambers R., 2009, 1809 U WOLLONGONG; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu CM, 2004, EUR RESPIR J, V23, P136, DOI 10.1183/09031936.03.00017803; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Evans E, 2021, J HEAD TRAUMA REHAB, V36, pE186, DOI 10.1097/HTR.0000000000000638; Everink IHJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0187-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Gutman R, 2016, STAT MED, V35, P115, DOI 10.1002/sim.6586; Gutman R, 2013, J AM STAT ASSOC, V108, P34, DOI 10.1080/01621459.2012.726889; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hashmi ZG, 2018, JAMA SURG, V153, P852, DOI 10.1001/jamasurg.2018.0483; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Kane RL, 2007, ARCH PHYS MED REHAB, V88, P1500, DOI 10.1016/j.apmr.2007.06.015; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Leland NE, 2015, MED CARE, V53, P879, DOI 10.1097/MLR.0000000000000419; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Malec JF, 2009, BRAIN INJURY, V23, P22, DOI 10.1080/02699050802590320; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Portelli R, 2005, CLIN REHABIL, V19, P97, DOI 10.1191/0269215505cr822oa; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Scheuren F, 1993, SURV METHODOL, V19, P39; Shan M., ARXIV200508549V12020; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403	55	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12644		JUN 2021	11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	TA5OJ	WOS:000667298000001	34018693				2022-02-07	
J	Jiang, LL; Wu, YJ; Zhang, Y; Lu, DH; Yan, KS; Gao, J				Jiang, Lulu; Wu, Yujuan; Zhang, Yang; Lu, Dahao; Yan, Keshi; Gao, Ju			Effects of intraoperative lung-protective ventilation on clinical outcomes in patients with traumatic brain injury: a randomized controlled trial	BMC ANESTHESIOLOGY			English	Article						Traumatic brain injury; Lung-protective ventilation; Postoperative pulmonary complications; Optic nerve sheath diameter; Glial fibrillary acidic protein; Ubiquitin carboxyl-terminal hydrolase isozyme L1	END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; INTRACRANIAL-PRESSURE; TIDAL-VOLUME; CARE; IMPROVE	Background Secondary lung injury is the most common non-neurological complication after traumatic brain injury (TBI). Lung-protective ventilation (LPV) has been proven to improve perioperative oxygenation and lung compliance in some critical patients. This study aimed to investigate whether intraoperative LPV could improve respiratory function and prevent postoperative complications in emergency TBI patients. Methods Ninety TBI patients were randomly allocated to three groups (1:1:1): Group A, conventional mechanical ventilation [tidal volume (VT) 10 mL/kg only]; Group B, small VT (8 mL/kg) + positive end-expiratory pressure (PEEP) (5 cmH(2)O); and Group C, small VT (8 mL/kg) + PEEP (5 cmH(2)O) + recruitment maneuvers (RMs). The primary outcome was the incidence of total postoperative pulmonary complications; Secondary outcomes were intraoperative respiratory mechanics parameters and serum levels of brain injury markers, and the incidence of each postoperative pulmonary and neurological complication. Results Seventy-nine patients completed the final analysis. The intraoperative PaO2 and dynamic pulmonary compliance of Groups B and C were higher than those of Group A (P = 0.028; P = 0.005), while their airway peak pressure and plateau pressure were lower than those of group A (P = 0.004; P = 0.005). Compared to Group A, Groups B and C had decreased 30-day postoperative incidences of total pulmonary complications, hypoxemia, pulmonary infection, and atelectasis (84.0 % vs. 57.1 % vs. 53.8 %, P = 0.047; 52.0 % vs. 14.3 % vs. 19.2 %, P = 0.005; 84.0 % vs. 50.0 % vs. 42.3 %, P = 0.006; 24.0 % vs. 3.6 % vs. 0.0 %, P = 0.004). Moreover, intraoperative hypotension was more frequent in Group C than in Groups A and B (P = 0.007). At the end of surgery, the serum levels of glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase isozyme L1 in Group B were lower than those in Groups A and C (P = 0.002; P < 0.001). The postoperative incidences of neurological complications among the three groups were comparable. Conclusions Continuous intraoperative administration of small VT + PEEP is beneficial to TBI patients. Additional RMs can be performed with caution to prevent disturbances in the stability of cerebral hemodynamics.	[Jiang, Lulu; Zhang, Yang] Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, 139 Renmin Cent Rd, Changsha 410011, Peoples R China; [Jiang, Lulu; Zhang, Yang; Lu, Dahao; Yan, Keshi; Gao, Ju] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Sch, Dept Anesthesiol, 98 Nantong West Rd, Yangzhou 225001, Jiangsu, Peoples R China; [Wu, Yujuan] Xiangtan Cent Hosp, Dept Anesthesiol, 120 Heping Rd, Xiangtan 411100, Peoples R China		Gao, J (corresponding author), Yangzhou Univ, Northern Jiangsu Peoples Hosp, Clin Med Sch, Dept Anesthesiol, 98 Nantong West Rd, Yangzhou 225001, Jiangsu, Peoples R China.	178201049@csu.edu.cn					Barnes T, 2018, CHEST, V154, P185, DOI 10.1016/j.chest.2017.11.010; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Boone MD, 2017, NEUROCRIT CARE, V26, P174, DOI 10.1007/s12028-016-0328-9; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Chan MC, 2015, RESP CARE, V60, P12, DOI 10.4187/respcare.03138; Chen H, 2019, CRIT CARE MED, V47, P254, DOI 10.1097/CCM.0000000000003558; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907; Finsterer J, 2019, EUR NEUROL, V81, P94, DOI 10.1159/000500139; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Hemmes SNT, 2017, EUR J ANAESTH, V34, P492, DOI 10.1097/EJA.0000000000000646; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Kerr N, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113080; Koutsoukou Antonia, 2016, World J Crit Care Med, V5, P65, DOI 10.5492/wjccm.v5.i1.65; Krebs J, 2014, CRIT CARE, V18, DOI 10.1186/cc13813; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Lopez-Aguilar J, 2010, INTENS CARE MED, V36, P347, DOI 10.1007/s00134-009-1695-x; Lyon M, 2018, J NEUROTRAUM, V35, P695, DOI 10.1089/neu.2017.5164; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marret E, 2018, EUR J ANAESTH, V35, P727, DOI 10.1097/EJA.0000000000000804; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Gara B, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3030; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Ruggieri F, 2018, J NEUROSURG ANESTH, V30, P246, DOI 10.1097/ANA.0000000000000442; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Whiteley JR, 2015, J NEUROSURG ANESTH, V27, P155, DOI 10.1097/ANA.0000000000000106; Xu, 2014, MED STAT, P573; Zelnick LR, 2014, J NEUROTRAUM, V31, P1029, DOI 10.1089/neu.2013.3122; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	36	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	JUN 28	2021	21	1							182	10.1186/s12871-021-01402-w			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	TD8UN	WOS:000669594800005	34182951	Green Submitted, gold, Green Published			2022-02-07	
J	Li, GY; Han, X; Gao, L; Tong, WS; Xue, Q; Gong, S; Song, Y; Chen, SY; Dong, Y				Li, Gaoyi; Han, Xi; Gao, Liang; Tong, Wusong; Xue, Qiang; Gong, Shun; Song, Yu; Chen, Songyu; Dong, Yan			Association of Anxiety and Depressive Symptoms with Memory Function following Traumatic Brain Injury	EUROPEAN NEUROLOGY			English	Article						Anxiety; Depression; Memory; Traumatic brain injury	MAJOR DEPRESSION; COGNITIVE IMPAIRMENT; DISORDERS; MILD; RECOVERY; SCALE; YOUNG	Introduction: Memory impairment and mood disorders are among the most troubling sequelae following traumatic brain injury (TBI). The relationships between comorbid psychiatric disorders and memory function have not been well illustrated. The aim of the study was to explore the relationships of comorbid anxiety and depressive symptoms with memory function following TBI. Methods: A total of 46 TBI participants across all levels of injury and 23 healthy controls were enrolled in this case-control study. Wechsler Memory Scale-Chinese Revision (WMS-CR) picture, recognition, associative learning, comprehension memory, and digit span were administered to evaluate several categories of memory capacity. The Hospital Anxiety and Depression Scale (HADS) was employed to evaluate the anxiety and depressive symptoms. Stepwise multiple linear regressions were conducted. Results: Compared to healthy controls, the participants with TBI reported more anxiety and depressive symptoms. In the meanwhile, they performed more poorly on memory tests, showing 1.84 SDs, 1.07 SDs, and 0.68 SDs below healthy participants on visuospatial memory, working memory, and verbal memory, respectively. A variety of variables, including HADS depression, HADS anxiety, age, GCS, and education were associated with posttraumatic memory function in the bivariate models. The stepwise multiple linear regressions demonstrated a negative association between HADS depression and posttraumatic memory function, especially performance on visuospatial and verbal memory and a positive association between education and posttraumatic memory function. Conclusion: More depressive symptoms rather than anxiety symptoms and less years of education are significant predictors for posttraumatic memory dysfunction.	[Li, Gaoyi; Tong, Wusong] Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Shanghai Hushan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Gao, Liang; Song, Yu; Chen, Songyu; Dong, Yan] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [Xue, Qiang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Gong, Shun] Gen Hosp Northern Theater Command, Dept Neurosurg, Shenyang, Peoples R China; [Dong, Yan] Shanghai Tenth Peoples Hosp, Clin Med Sci & Tech Innovat Pk, Shanghai, Peoples R China		Dong, Y (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.; Dong, Y (corresponding author), Shanghai Tenth Peoples Hosp, Clin Med Sci & Tech Innovat Pk, Shanghai, Peoples R China.	smmudongyan@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671227]	This work was supported by the National Natural Science Foundation of China (grants 81671227).	Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bin Abdullah MFIL, 2018, ASIAN J PSYCHIATR, V37, P67, DOI 10.1016/j.ajp.2018.08.017; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Gong Y., 1989, HDB WECHSLER MEMORY; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lindgren M, 2020, J AFFECT DISORDERS, V263, P221, DOI 10.1016/j.jad.2019.11.161; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McKenzie DP, 2018, J AFFECT DISORDERS, V236, P164, DOI 10.1016/j.jad.2018.04.092; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Polich G, 2019, HAND CLINIC, V165, P253, DOI 10.1016/B978-0-444-64012-3.00015-0; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Roberts CM, 2018, J INT NEUROPSYCH SOC, V24, P1064, DOI 10.1017/S1355617718000565; Rydon-Grange M, 2019, NEUROPSYCHOL REHABIL, V29, P214, DOI 10.1080/09602011.2016.1272469; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	33	0	0	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.	AUG	2021	84	5					340	347		10.1159/000513195		JUN 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UB9SD	WOS:000668954000001	34182550				2022-02-07	
J	Moreau, N; Tache, E; Champagne-Lavau, M				Moreau, Noemie; Tache, Emmanuelle; Champagne-Lavau, Maud			Speaking with virtual humans: Assessing social cognition in traumatic brain injury with a second-person perspective task	JOURNAL OF NEUROPSYCHOLOGY			English	Article; Early Access						executive functions; real social interactions; social cognition; traumatic brain injury; virtual humans	FACIAL AFFECT RECOGNITION; DIFFERENT MEDIA; IMPAIRMENT; EMOTION; COMMUNICATION; INFORMATION; CONTRIBUTE; BEHAVIOR; DEFICITS; PEOPLE	Objective This study is one of the first to investigate social cognition in participants with traumatic brain injury (TBI) using a task that actively engaged the participant in a real interaction with a partner. Previous results have reported altered social cognition in TBI patients, but social cognition was mostly assessed through traditional tasks involving conscious and deliberate reasoning about characters' mental states (i.e., a third-person perspective). Our goal was to present a new paradigm which allowed the assessment of social cognition in conditions closer to real life meaning that participants were actively engaged in an interaction (i.e., second-person perspective) in order to capture more implicit use of social cognition processes. Method This study used three tasks to evaluate social cognition. We designed a task, called EVICog, in which participants were engaged in real audio-visual conversations with two virtual humans who expressed emotions and produced speech content that required the participants to make inferences about the characters' mental states. The two other tasks are standard in the literature; they use photographs to test participants' recognition of emotions and short comic strips to test their attribution of intentions. Results Our results showed that TBI participants presented a significant deficit of social cognition compared to control participants. The ROC analysis showed that EVICog has a high discrimination power compared to the other tests. Conclusion These results further confirm that social cognition is altered in TBI participants even in real interactions and further support the use of ecological settings to investigate social cognition.	[Moreau, Noemie; Tache, Emmanuelle; Champagne-Lavau, Maud] Aix Marseille Univ, CNRS, LPL, Aix En Provence, France; [Moreau, Noemie] Ctr Hosp Intercommunal Aix Pertuis, Serv Neurol, Ave Tamaris, F-13616 Aix En Provence 1, France		Moreau, N (corresponding author), Ctr Hosp Intercommunal Aix Pertuis, Serv Neurol, Ave Tamaris, F-13616 Aix En Provence 1, France.	nmoreau@ch-aix.fr			Agence Nationale de la Recherche grantFrench National Research Agency (ANR) [ANR-11-BSH2006-01]	This research was supported by an Agence Nationale de la Recherche grant (ANR-11-BSH2006-01 MINDPROGEST) to MCL. We would like to thank the neuropsychologists of SAMSAH TC-CL, UEROS, and Centre Phocee, for their precious help in recruiting patients.	Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Apperly IA, 2010, Q J EXP PSYCHOL, V63, P1201, DOI 10.1080/17470210903281582; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bente G, 2001, J NONVERBAL BEHAV, V25, P151, DOI 10.1023/A:1010690525717; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Burgess P.W., 1997, HAYLING BRIXTON TEST; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Canty AL, 2017, NEUROPSYCHOL REHABIL, V27, P834, DOI 10.1080/09602011.2015.1052820; Champagne-Lavau M, 2013, PSYCHOL ASSESSMENT, V25, P1404, DOI 10.1037/a0033433; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; de Bruin L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00151; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Delis DC., 2001, DELIS KAPLAN EXECUTI; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; El Haj M, 2016, MEMORY, V24, P526, DOI 10.1080/09658211.2015.1021257; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fazaeli SM, 2018, TRAUMA MON, V23, DOI 10.5812/traumamon.22022; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 2012, PHILOS T R SOC B, V367, P2213, DOI 10.1098/rstb.2012.0123; Godefroy O., 2008, FONCTIONS EXECUTIVES; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; KELLEY JF, 1984, ACM T OFF INF SYST, V2, P26, DOI 10.1145/357417.357420; Kelly M, 2014, J CLIN EXP NEUROPSYC, V36, P897, DOI 10.1080/13803395.2014.955784; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Mutlu B, 2019, BRAIN INJURY, V33, P23, DOI 10.1080/02699052.2018.1531305; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Sarfati Y, 1997, SCHIZOPHR RES, V25, P199, DOI 10.1016/S0920-9964(97)00025-X; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Stone V.E., 2011, OXFORD HDB SOCIAL NE, P455; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wechsler D., 2011, ECHELLE INTELLIGENCE, V4th ed.; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Zupan B, 2016, JOVE-J VIS EXP, DOI 10.3791/53774; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	49	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.												10.1111/jnp.12257		JUN 2021	22	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TA8TG	WOS:000667518400001	34184396				2022-02-07	
J	Neice, RJ; Lurski, AJ; Bartsch, AJ; Plaisted, TA; Lowry, DS; Wetzel, ED				Neice, R. J.; Lurski, A. J.; Bartsch, A. J.; Plaisted, T. A.; Lowry, D. S.; Wetzel, E. D.			An Experimental Platform Generating Simulated Blunt Impacts to the Head Due to Rearward Falls	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Traumatic brain injury; Football; Anthropometric test dummy; Backfall	TRAUMATIC BRAIN-INJURY	Impacts to the back of the head due to rearward falls, also referred to as "backfall" events, represent a common source of TBI for athletes and soldiers. A new experimental apparatus is described for replicating the linear and rotational kinematics of the head during backfall events. An anthropomorphic test device (ATD) with a head-borne sensor suite was configured to fall backwards from a standing height, inducing contact between the rear of the head and a ground surface simulant. A pivoting swing arm and release strap were used to generate consistent and realistic head kinematics. Backfall experiments were performed with the ATD fitted with an American football helmet and the resulting linear and rotational head kinematics, as well as calculated injury metrics, compared favorably with those of football players undergoing similar impacts during games or play reconstructions. This test method complements existing blunt impact helmet performance experiments, such as drop tower and pneumatic ram test methods, which may not be able to fully reproduce head-neck-torso kinematics during a backfall event.	[Neice, R. J.; Lurski, A. J.; Plaisted, T. A.; Wetzel, E. D.] US Army, Res Lab, Mat & Mfg Sci Div, Aberdeen Proving Ground, MD 21005 USA; [Bartsch, A. J.] Prevent Biometr, Minneapolis, MN USA; [Lowry, D. S.] CCDC Data & Anal Ctr, Aberdeen Proving Ground, MD 21005 USA		Wetzel, ED (corresponding author), US Army, Res Lab, Mat & Mfg Sci Div, Aberdeen Proving Ground, MD 21005 USA.	eric.d.wetzel2.civ@mail.mil			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-17-1-0019]; National Football League through the Head Health Challenge II	This research was supported in part by an appointment to the Postgraduate Research Participation Program at the U.S. Army Research Laboratory administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USARL. The data analyzed from Reference  was funded by the Congressionally Directed Medical Research Program Award W81XWH-17-1-0019. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the DEVCOM Army Research Laboratory or the US Government. The authors also acknowledge funding from the National Football League through the Head Health Challenge II under which the backfall platform was originally developed. Joe Lee (SURVICE Engineering) is acknowledged for assistance in development of the backfall test apparatus, including installing and troubleshooting instrumentation.	ASTM International, 2016, 35516 ASTM INT; ASTM International, 2010, F193610 ASTM INT; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bartsch AJ, 2020, ANN BIOMED ENG, V48, P2667, DOI 10.1007/s10439-020-02640-8; Begonia M, 2019, MIL MED, V184, P237, DOI 10.1093/milmed/usy282; Biocore LLC, 2020, BIOC SIM TOOLS; Broglio Steven P, 2016, Concussion, V1, pCNC23, DOI 10.2217/cnc-2016-0007; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Corrales MA, 2020, ANN BIOMED ENG, V48, P121, DOI 10.1007/s10439-019-02359-1; Decker W, 2020, ANN BIOMED ENG, V48, P258, DOI 10.1007/s10439-019-02345-7; Defense and Veterans Brain Injury Center, 2020, TOT 2000 Q3 2019 DOD; Faul M, 2010, CDC TBI US REPORT TR; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gardner JM, 2018, P I MECH ENG P-J SPO, V232, P197, DOI 10.1177/1754337117723756; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Giudice JS, 2020, ANN BIOMED ENG, V48, P1524, DOI 10.1007/s10439-020-02472-6; Hayes WC, 2007, ANNU REV BIOMED ENG, V9, P55, DOI 10.1146/annurev.bioeng.9.060906.151946; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Kent R, 2020, ANN BIOMED ENG, V48, P2639, DOI 10.1007/s10439-020-02621-x; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; MacGillivray S. R., 2020, THESIS U ALBERTA; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McHenry B. G., 2004, HEAD INJURY CRITERIO, V29, P5; Newman J.A., 2000, STAPP CAR CRASH J; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2019, ND00217M19A NOCSAE; NOCSAE, 2020, ND08118AM20 NOCSAE; Ogle M. K., 2018, THESIS U ALBERTA; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu T., 2019, INTEGRATION INTERSPE	39	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2021	49	10			SI		2886	2900		10.1007/s10439-021-02809-9		JUN 2021	15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	WH8FD	WOS:000667581400002	34184145				2022-02-07	
J	Wilson, LD; Hildebrand, RA; Le, T; McKinney, BA				Wilson, Laura D.; Hildebrand, Rachel A.; Le, Trang; McKinney, Brett A.			Repetitive head impacts in a collegiate football season: Exposure and effects	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article; Early Access						American football; balance; cognition; concussion; reaction time	ESTIMATING PREMORBID ABILITY; SELF-REPORTED CONCUSSION; CLINICAL MEASURES; POSTURAL CONTROL; READING SUBTEST; SYMPTOMS; PLAYERS; MAGNITUDE; HISTORY; SPORT	This study describes exposure to repetitive head impacts (RHI) by player position and activity during a collegiate football season, and investigates the relationship between RHI and acute (i.e., daily and weekly) and short-term (i.e., pre- to post-season) changes in balance, reaction time, symptoms, and cognition. We recorded RHI exposure in twenty Division I collegiate American football players during a single season using the Riddell InSite system. Participants sustained 4,586 impacts (4.20% high impact, i.e., >63 g; 95.79% low impact, i.e., 20-63 g). Greatest exposure to RHI was observed in running backs and defensive ends during games, and tight ends and defensive ends during practices. Running plays and team drills placed players at greatest risk for exposure during practice. Cumulative RHI exposure across the season was associated with short-term declines in reaction time (p = 0.045), but not balance or cognition. Acute decline in balance was associated with the number of impacts sustained in the past week (p < 0.05), but not the past 24 hours (p > 0.05). Acute increase in total symptom score was also associated with the number of impacts sustained in the past week (p < 0.01), but not the past 24 hours (p > 0.05). Reaction time did not decline based on impact exposure in the past 24 hours or week. This study identifies activities and positions that may put players at risk for RHI exposure, and demonstrates that RHI sustained during the course of typical American football play by non-concussed individuals may result in small changes in balance, reaction time, and symptoms, but not cognition.	[Wilson, Laura D.] Univ Tulsa, Mary K Chapman Ctr, Oxley Coll Hlth Sci, Dept Commun Sci & Disorders, Tulsa, OK 74104 USA; [Hildebrand, Rachel A.] Univ Tulsa, Oxley Coll Hlth Sci, Dept Kinesiol & Rehabilitat Sci, Tulsa, OK 74104 USA; [Le, Trang; McKinney, Brett A.] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA; [Le, Trang] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [McKinney, Brett A.] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA		Wilson, LD (corresponding author), Univ Tulsa, Mary K Chapman Ctr 103, Oxley Coll Hlth Sci, Dept Commun Sci & Disorders, 800 S Tucker Dr, Tulsa, OK 74104 USA.	laura-wilson@utulsa.edu			American Athletic Conference Academic Consortium, Providence, RI; University of Tulsa, Tulsa, OK Wilson, Hildebrand)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research reported here was supported by the American Athletic Conference Academic Consortium, Providence, RI, through a grant to The University of Tulsa (Wilson, Hildebrand). The opinions expressed are those of the authors and do not represent the views of the American Athletic Conference Academic Consortium. Additional support was provided by The University of Tulsa, Tulsa, OK Wilson, Hildebrand). SWAY Medical, Inc. provided access to their iOS application at no cost to LDW and RAH for use in this study. For the remaining authors no competing financial or non-financial interests exist.	Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; [Anonymous], 2014, RIDDELL INSITE IT WO; Asken BM, 2020, CLIN NEUROPSYCHOL, V34, P919, DOI 10.1080/13854046.2019.1680735; Asken BM, 2019, ANN BIOMED ENG, V47, P2094, DOI 10.1007/s10439-018-2088-5; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Ball JD, 2007, CLIN NEUROPSYCHOL, V21, P422, DOI 10.1080/13854040600582577; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Burghart M, 2019, APPL NEUROPSYCH-ADUL, V26, P558, DOI 10.1080/23279095.2018.1469491; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Caccese JB., 2019, REPETITIVE SUBCONCUS; Champagne AA, 2019, MED SCI SPORT EXER, V51, P2366, DOI 10.1249/MSS.0000000000002046; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dabbs NC, 2017, J FUNCT MORPHOL KINE, V2, P26, DOI DOI 10.3390/JFMK2030026; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hoelzle JB, 2014, CLIN NEUROPSYCHO, V28, P371; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kaminski TW, 2020, RES SPORTS MED, V28, P217, DOI 10.1080/15438627.2019.1635130; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McDermott BP, 2017, J ATHL TRAINING, V52, P877, DOI 10.4085/1062-6050-52.9.02; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mullen CM, 2014, APPL NEUROPSYCH-ADUL, V21, P69, DOI 10.1080/09084282.2012.727111; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; R Core Team, 2020, R LANG ENV STAT COMP; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roth RM, 2005, BRIEF A BEHAV RATING; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Seifert K., 2018, ESPN; Shiflett E., 2015, EFFECTS SUBCONCUSSIV; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	65	0	0	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.											17479541211027277	10.1177/17479541211027277		JUN 2021	13	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	TD4XJ	WOS:000669330900001					2022-02-07	
J	Zynda, AJ; Petit, KM; Anderson, M; Tomczyk, CP; Covassin, T				Zynda, Aaron J.; Petit, Kyle M.; Anderson, Morgan; Tomczyk, Christopher P.; Covassin, Tracey			Removal From Activity After Sports- Related Concussion in Sex-Comparable Sports From the Michigan High School Athletic Association	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						sports-related concussion; removal from activity; adolescent; sex differences	STATES HIGH-SCHOOL; POSITION STATEMENT; GENDER-DIFFERENCES; INJURY; KNOWLEDGE; RATES; EPIDEMIOLOGY; MANAGEMENT; RISK; AGE	Background: Research has demonstrated that female athletes are more likely to report their sports-related concussion (SRC) symptoms compared with male athletes; however, it is unknown if these reporting behaviors correspond to immediate removal from activity in sex-comparable sports. Purpose: To compare the incidence of high school student-athletes removed and not removed from activity after SRC in sex-comparable sports in Michigan. Study Design: Descriptive epidemiology study. Methods: Participants included student-athletes diagnosed with SRC participating in Michigan High School Athletic Association-sponsored athletic activities (22 sex-comparable sports) between 2016 and 2019. All SRCs were recorded in the association's Head Injury Reporting System (HIRS) by certified athletic trainers, administrators, or coaches. Removal from activity indicated that the student-athlete was removed from play at the time of an injury event. If the student-athlete reported that his or her suspected injury event occurred earlier during activity or if symptom onset was delayed, "not removed from activity" was entered into the HIRS. Incidence proportions were calculated by dividing SRCs not removed by total SRCs in each sport. Risk ratios were calculated by dividing the incidence proportions of girls not removed by boys not removed in each sport. Results: A total of 4418 (2773 female, 1645 male) SRCs were reported, with the most occurring in female soccer players (n = 1023). Overall, 515 girls and 243 boys were not removed from activity, resulting in incidences of 0.19 (95% CI, 0.17-0.20) and 0.15 (95% CI, 0.13-0.17), respectively. Across all sports, girls were 1.26 (95% CI, 1.09-1.45) times as likely to not be removed from activity compared with boys. Of the sports with the most SRCs-soccer, basketball, baseball/softball, and lacrosse-girls had 1.37 (95% CI, 1.09-1.72), 1.15 (95% CI, 0.89-1.47), 1.19 (95% CI, 0.77-1.84), and 1.35 (95% CI, 0.94-1.95) times the risk of not being removed, respectively. Conclusion: Girls were at greater risk of not being removed from activity compared with boys in sex-comparable sports. Results from this study should be incorporated into SRC education in Michigan and potentially elsewhere to inform affiliated personnel of potential sex differences and protect female student-athletes from further harm.	[Zynda, Aaron J.; Petit, Kyle M.; Anderson, Morgan; Tomczyk, Christopher P.; Covassin, Tracey] Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA; [Petit, Kyle M.] Univ Mary, Bismarck, ND USA		Zynda, AJ (corresponding author), Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA.	zyndaaar@msu.edu	; Zynda, Aaron/P-5353-2018	Tomczyk, Christopher/0000-0003-3790-2385; Zynda, Aaron/0000-0003-0663-7320	Michigan High School Athletic Association (MHSAA)	This project was supported by the Michigan High School Athletic Association (MHSAA). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of the MHSAA. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bey T, 2009, WEST J EMERG MED, V10, P6; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2018, AM J SPORT MED, V46, P2270, DOI 10.1177/0363546518780225; Derose KP, 2001, J GEN INTERN MED, V16, P218, DOI 10.1046/j.1525-1497.2001.016004218.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Drummond JL, 2007, J ATHL TRAINING, V42, P106; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Esposito G, 1996, J NUCL MED, V37, P559; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Kahanov L, 2011, J ATHL TRAINING, V46, P424; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Olson A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00220; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zynda Aaron J, 2020, Int J Exerc Sci, V13, P87	42	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.											03635465211020007	10.1177/03635465211020007		JUN 2021	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TV0UA	WOS:000681442500001	34181487				2022-02-07	
J	Newton, J; Wuerch, E; Thomas, N; Seo, B; Lang, E; Manhas, KP				Newton, Janna; Wuerch, Emily; Thomas, Noel; Seo, Boogyung; Lang, Eddy; Manhas, Kiran Pohar			Developing a Mobile App for Concussion to aid Patient Empowerment and Symptom Management	CUREUS			English	Article						concussion applications; concussion symptom management; patient empowerment; healthcare technology; adult concussion recovery; mild traumatic brain injury; mtbi	PATHOPHYSIOLOGY	Despite the high prevalence of concussions each year in Canada, access to consistent and science-based information on how to self-manage these injuries remains a significant hurdle for many patients. Currently, available mobile applications (apps) focus mainly on supporting patients with sports-related concussions, although falls account for more traumatic brain injuries (TBI) than sports-related TBI's in Alberta. Patients from a broader demographic may be limited from accessing information on how to correctly manage and track their symptoms as they feel that currently available resources are not applicable to them. Through collaboration between health system leaders, expert consultations, patients, and university students, a mobile app was designed as a platform to help patients manage and track symptoms at home, as well as to clarify misleading information and misconceptions surrounding injury. The team engaged numerous physicians, patient advisors, and health system leaders to improve upon the features of currently-existing concussion apps such as symptom tracking, insight into concussion, and strategies for returning to work/school that are more inclusive to adult, non-sports related injuries. We believe that these features will advance recovery by alleviating the burden of uncertainty and confusion for patients and their family members.	[Newton, Janna; Wuerch, Emily; Thomas, Noel; Seo, Boogyung; Lang, Eddy] Univ Calgary, Emergency Med, Calgary, AB, Canada; [Manhas, Kiran Pohar] Alberta Hlth Serv, Neurosci, Calgary, AB, Canada		Newton, J (corresponding author), Univ Calgary, Emergency Med, Calgary, AB, Canada.	jannanewton4@gmail.com					[Anonymous], 2019, CONCUSSION RECOVERY; [Anonymous], 2019, TACKLING PROBLEM HEA; [Anonymous], 2018, GUIDELINE CONCUSSION; [Anonymous], 2017, WEBASSEMBLY CUT FIGM; [Anonymous], 2019, INTRO GIT WHAT IT IS; [Anonymous], 2019, TREAT CONCUSSION HIN; Bevilacqua Zachary W, 2019, Concussion, V4, pCNC63, DOI 10.2217/cnc-2019-0004; Cahill B, 2021, UI DESIGN IOS APP DE, DOI [10.1007/978-1-4842-6449-2, DOI 10.1007/978-1-4842-6449-2]; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Flocke SA, 2004, PREV MED, V38, P343, DOI 10.1016/j.ypmed.2003.11.004; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Shahaf DB, 2018, BRAIN INJURY, V32, P331, DOI 10.1080/02699052.2018.1425914; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Traumatic brain injuries in Alberta, 2017, HOSP ADM 2005 2014 E; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; Yiu V, 2019, CAN MED ASSOC J, V191, pS1, DOI 10.1503/cmaj.191232	19	0	0	1	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 27	2021	13	6							e15972	10.7759/cureus.15972			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TA6GA	WOS:000667345400023	34336464	gold, Green Published			2022-02-07	
J	Shankar, U; Soni, H; Komal, A				Shankar, Uma; Soni, Himanshu; Komal, Arpita			Access Leads to Success: Management of Gunshot Injury to Maxillofacial Region with Access Osteotomy for Bullet Retrieval	JOURNAL OF MAXILLOFACIAL & ORAL SURGERY			English	Article; Early Access								Head, face and neck are three highly separate frame area that behave in a different way in phrases of gunshot injuries. Interpersonal violence, assaults, accidents and suicide attempts being the most common reason in most developed and developing countries. Morbidity and mortality to this area depends on the type of weapon used,entry and exit path and the distance from where it is fired. The complexity of facial skeleton and its close association with important vital structure makes the management of these gunshot wounds challenging in terms of accessibility, visibility and wound management. Here we present a case of access osteotomy in the form of maxillary Lefort I osteotomy for bullet retrieval lodged in nasopharyngeal area following gunshot injury due to interpersonal violence.	[Shankar, Uma] Rajeshwar Hosp, Patna, Bihar, India; [Soni, Himanshu] Mahatma Gandhi Canc Hosp, Miraj, Maharashtra, India; [Komal, Arpita] Awadh Dent Coll, Jamsedhpur, Jharkhand, India		Soni, H (corresponding author), Mahatma Gandhi Canc Hosp, Miraj, Maharashtra, India.	himanshu.soni8@gmail.com		SONI, HIMANSHU/0000-0002-1662-0015; Komal, Arpita/0000-0003-1312-9367			Akinwande JA., 1998, J CLIN PRACT, V1, P9; Amato J J, 1974, Ann Thorac Surg, V18, P565; Bidra AS, 2010, J PROSTHET DENT, V104, P142, DOI 10.1016/S0022-3913(10)00120-4; DASANI BM, 1994, J CLIN GASTROENTEROL, V19, P296, DOI 10.1097/00004836-199412000-00007; FACKLER ML, 1984, J TRAUMA, V24, P35, DOI 10.1097/00005373-198401000-00005; Holmes JD., 2004, GUNSHOT INJURIES PET, V2nd, P511; Maki MH, 2009, J CRANIOFAC SURG, V20, P873, DOI 10.1097/SCS.0b013e3181a14d1d; Nemzek WR, 1996, AM J NEURORADIOL, V17, P161; Newgard K., 1992, WOUND BALLISTICS REV, V1, P12; Ongom Peter A, 2014, J Med Case Rep, V8, P29, DOI 10.1186/1752-1947-8-29	10	0	0	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-8279	0974-942X		J MAXILLOFAC ORAL SU	J. Maxillofac. Oral. Surg.												10.1007/s12663-021-01609-x		JUN 2021	7	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	TA3GS	WOS:000667139100001					2022-02-07	
J	Schmidt, J; Brown, KE; Feldman, SJ; Babul, S; Zwicker, JG; Boyd, LA				Schmidt, Julia; Brown, Katlyn E.; Feldman, Samantha J.; Babul, Shelina; Zwicker, Jill G.; Boyd, Lara A.			Evidence of altered interhemispheric communication after pediatric concussion	BRAIN INJURY			English	Article						Concussion; transcranial magnetic stimulation; interhemispheric communication; adolescents; upper limb function	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INHIBITION; ABNORMALITIES; CHILDREN; MEMORY; YOUTH; RESPONSES; SPORTS	OBJECTIVES: To investigate neurophysiological alterations within the typical symptomatic period after concussion (1-month) and throughout recovery (6-months) in adolescents; and (2) to examine relationships between neurophysiological and upper limb kinematic outcomes. METHODS: 18 adolescents with concussion were compared to 17 healthy controls. Transcranial magnetic stimulation (TMS) was used to assess neurophysiological differences between groups including: short- and long-interval intracortical inhibition, intracortical facilitation, short- and long-latency afferent inhibition, afferent facilitation, and transcallosal inhibition (TCI). Behavioral measures of upper limb kinematics were assessed with a robotic device. RESULTS: Mixed model analysis of neurophysiological data identified two key findings. First, participants with concussion demonstrated delayed onset of interhemispheric inhibition, as indexed by TCI, compared to healthy controls. Second, our exploratory analysis indicated that the magnitude of TCI onset delay in adolescents with concussion was related to upper limb kinematics. CONCLUSIONS: Our findings indicate that concussion in adolescence alters interhemispheric communication. We note relationships between neurophysiological and kinematic data, suggesting an affinity for individuals with less concussion-related physiological change to improve their motor behavior over time. These data serve as an important step in future development of assessments (neurobiological and clinical) and interventions for concussion.	[Schmidt, Julia; Zwicker, Jill G.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Brown, Katlyn E.] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Brown, Katlyn E.] Univ British Columbia, Grad Program Rehabil Sci, Vancouver, BC, Canada; [Feldman, Samantha J.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada; [Babul, Shelina; Zwicker, Jill G.] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Babul, Shelina; Boyd, Lara A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Babul, Shelina] BC Childrens Hosp, Dept Emergency Med, Vancouver, BC, Canada; [Babul, Shelina; Zwicker, Jill G.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Zwicker, Jill G.] BC Childrens Hosp, Sunny Hill Hlth Ctr, Vancouver, BC, Canada; [Boyd, Lara A.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada		Schmidt, J (corresponding author), Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada.	Julia.Schmidt@ubc.ca		Zwicker, Jill/0000-0002-2986-6938; Schmidt, Julia/0000-0003-2004-4871	Michael Smith Foundation for Health Research (MSFHR)Michael Smith Foundation for Health Research; Jakeway Family Neurorehabilitation Seed Fund; Natural Sciences and Engineering Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); MSFHRMichael Smith Foundation for Health Research; Canadian Child Health Clinician Scientist Program; BC Children's Hospital Research Institute; Sunny Hill Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	JS received scholarship funding from Michael Smith Foundation for Health Research (MSFHR). This work was funded by Jakeway Family Neurorehabilitation Seed Fund (awarded to LB and JS). KEB and SJF received funding from the Natural Sciences and Engineering Council of Canada. JGZ is funded by the MSFHR, Canadian Child Health Clinician Scientist Program, BC Children's Hospital Research Institute, Sunny Hill Foundation, and Canadian Institutes of Health Research;	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Babul, 2016, BURDEN CONCUSSION CH; Barlow KM, 2016, PEDIATRIC BRAIN STIMULATION: MAPPING AND MODULATING THE DEVELOPING BRAIN, P345, DOI 10.1016/B978-0-12-802001-2.00017-5; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Boyd, 2017, ORG HUM BRAIN MAPP A; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Brown KE, 2015, EXP BRAIN RES, V233, P927, DOI 10.1007/s00221-014-4168-6; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Davidson TW, 2016, CLIN NEUROPHYSIOL, V127, P3364, DOI 10.1016/j.clinph.2016.07.012; De Gennaro L, 2004, NEUROSCI RES, V48, P129, DOI 10.1016/j.neures.2003.10.004; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Garvey MA, 2001, J CHILD NEUROL, V16, P891, DOI 10.1177/088307380101601205; Garvey MA, 2008, CLIN NEUROPHYSIOL, V119, P973, DOI 10.1016/j.clinph.2007.11.048; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; King R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00451; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lao Y, 2015, PROC SPIE, V9287, DOI 10.1117/12.2072600; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Long J. D., 2012, LONGITUDINAL DATA AN; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Mang CS, 2019, J NEUROTRAUM, V36, P308, DOI 10.1089/neu.2017.5587; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meyer BU, 1998, ANN NEUROL, V43, P360, DOI 10.1002/ana.410430314; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; R Development Core Team, 2012, R LANG ENV STAT COMP; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sailer A, 2003, BRAIN, V126, P1883, DOI 10.1093/brain/awg183; Sailer A, 2002, J PHYSIOL-LONDON, V544, P617, DOI 10.1113/jphysiol.2002.028670; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Schmierer K, 2002, NEUROLOGY, V59, P1218, DOI 10.1212/WNL.59.8.1218; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Snijders TAB., 2012, MULTILEVEL ANAL INTR; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tokimura H, 1996, ELECTROMYOGR MOTOR C, V101, P263, DOI 10.1016/0924-980X(96)95664-7; VALLSSOLE J, 1992, ELECTROEN CLIN NEURO, V85, P355, DOI 10.1016/0168-5597(92)90048-G; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Walker, 2014, LME LINEAR MIXED EFF; Wassermann EM, 1996, EXP BRAIN RES, V109, P158; Wickham H., 2015, R PACKAGE VERSION; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	57	0	0	3	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2021	35	10					1143	1161		10.1080/02699052.2021.1929485		JUN 2021	19	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WA1IB	WOS:000684719800001	34384288				2022-02-07	
J	Dhillon, S; Sekely, A; Gujral, P; Joseph, S; Zakzanis, KK				Dhillon, Sonya; Sekely, Angela; Gujral, Preet; Joseph, Shaylyn; Zakzanis, Konstantine K.			Linguistic Interpretation of Acute Injury Characteristics That Define Mild Traumatic Brain Injury: an Exploratory Study of Native and Non-native English Speakers	PSYCHOLOGICAL INJURY & LAW			English	Article						Mild traumatic brain injury; Linguistic factors; Diagnostic terminology; Brain injury	ACUTE STRESS DISORDER; NEUROPSYCHOLOGY; SYMPTOMS; RECOMMENDATIONS; ACADEMY	In this study, we sought to explore if linguistic factors impact the diagnosis of mild traumatic brain injury (mTBI). More specifically, we examined if the meaning of acute injury characteristics that determine whether an mTBI was sustained systematically differed across linguistically diverse populations. A total of 296 participants (68% female; 33% of South Asian descent; 42% second generation Canadian) were administered an mTBI Criterion Questionnaire where they were asked to define the diagnostic terms "dazed," "disoriented," and "confused." These words were analyzed and placed into an appropriate validated word category scale (i.e., self-reference, social, positive emotion, negative emotion, and cognitive) using the Linguistic Inquiry and Word Count software program. There were no significant differences between native-English and limited English proficiency (i.e., non-native-English) speaker groups for the diagnostic terms "dazed" and "confused." However, there were significant differences between these language groups for the diagnostic term "disoriented." Our findings suggest that individuals that have limited English proficiency may be subject to additional distortions in symptom reporting. Clinicians should be particularly mindful of linguistic differences in patient interpretation of acute injury characteristics in the context of establishing a diagnosis of mTBI.	[Dhillon, Sonya; Sekely, Angela; Zakzanis, Konstantine K.] Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada; [Gujral, Preet; Joseph, Shaylyn; Zakzanis, Konstantine K.] Univ Toronto, Dept Psychol, Toronto, ON, Canada		Dhillon, S (corresponding author), Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada.	Sonya.dhillon@mail.utoronto.ca					Amer Psychological Assoc, 2016, AM PSYCHOL, V71, P900, DOI 10.1037/amp0000102; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cohen J, 1988, STAT POWER ANAL BEHA; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Harzing AW, 2006, INT J CROSS CULT MAN, V6, P243, DOI 10.1177/1470595806066332; Haslam N., 2001, TRANSCULT PSYCHIATRY, V38, P317, DOI [10.1177/136346150103800303, DOI 10.1177/136346150103800303]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; International Organization for Migration, 2020, WORLD MIGR REP; Iuliucci N., 2014, P INT S HUM FACT ERG, V3, P207, DOI [10.1177/2327857914031034, DOI 10.1177/2327857914031034]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Nijdam-Jones A, 2017, PSYCHOL ASSESSMENT, V29, P1321, DOI 10.1037/pas0000438; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Pennebaker J.W., 2015, LINGUISTIC INQUIRY W; Ponsford J, 2020, NEUROPSYCHOL REHABIL, V30, P85, DOI 10.1080/09602011.2018.1453367; Rogers R, 2008, CLIN ASSESSMENT MALI; Ruff RM, 2008, PSYCHOL INJ LAW, V1, P122, DOI 10.1007/s12207-008-9010-7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stern, 2018, HDB CLIN NEUROLOGY; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tsao J.W., 2012, TRAUMATIC BRAIN INJU; Weiss RA, 2012, PROF PSYCHOL-RES PR, V43, P234, DOI 10.1037/a0025850; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Young G, 2020, PSYCHOL INJ LAW, V13, P427, DOI 10.1007/s12207-020-09395-6; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	34	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	SEP	2021	14	3			SI		153	160		10.1007/s12207-021-09416-y		JUN 2021	8	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	WB9GE	WOS:000667016400001					2022-02-07	
J	Gutierrez-Quiceno, L; Dammer, EB; Johnson, AG; Webster, JA; Shah, R; Duong, D; Yin, LM; Seyfried, NT; Alvarez, VE; Stein, TD; McKee, AC; Hales, CM				Gutierrez-Quiceno, Laura; Dammer, Eric B.; Johnson, Ashlyn Grace; Webster, James A.; Shah, Rhythm; Duong, Duc; Yin, Luming; Seyfried, Nicholas T.; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.; Hales, Chadwick M.			A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy	MOLECULAR NEURODEGENERATION			English	Article						Chronic traumatic encephalopathy (CTE); Tandem mass tagged (TMT); Proteomics; Frontotemporal dementia (FTD); Immunoglobulin; Weighted gene co-expression network analysis (WGCNA); Astrocyte	ALZHEIMERS-DISEASE; TAU; PATHOLOGY; NEUROPATHOLOGY; TRANSCRIPTOME; TAUOPATHIES; DIAGNOSIS; SPECTRUM; INJURY	Background There is an association between repetitive head injury (RHI) and a pathologic diagnosis of chronic traumatic encephalopathy (CTE) characterized by the aggregation of proteins including tau. The underlying molecular events that cause these abnormal protein accumulations remain unclear. Here, we hypothesized that identifying the human brain proteome from serial CTE stages (CTE I-IV) would provide critical new insights into CTE pathogenesis. Brain samples from frontotemporal lobar degeneration due to microtubule associated protein tau (FTLD-MAPT) mutations were also included as a distinct tauopathy phenotype for comparison. Methods Isobaric tandem mass tagged labeling and mass spectrometry (TMT-MS) followed by integrated differential and co-expression analysis (i.e., weighted gene co-expression network analysis (WGCNA)) was used to define modules of highly correlated proteins associated with clinical and pathological phenotypes in control (n = 23), CTE (n = 43), and FTLD-MAPT (n = 12) post-mortem cortical tissues. We also compared these findings to network analysis of AD brain. Results We identified over 6000 unique proteins across all four CTE stages which sorted into 28 WGCNA modules. Consistent with Alzheimer's disease, specific modules demonstrated reduced neuronal protein levels, suggesting a neurodegeneration phenotype, while other modules were increased, including proteins associated with inflammation and glial cell proliferation. Notably, unique CTE-specific modules demonstrated prominent enrichment of immunoglobulins, including IGHM and IGLL5, and extracellular matrix (ECM) proteins as well as progressive protein changes with increasing CTE pathologic stage. Finally, aggregate cell subtype (i.e., neurons, microglia, astrocytes) protein abundance levels in CTE cases were similar in expression to AD, but at intermediate levels between controls and the more exaggerated phenotype of FTLD-MAPT, especially in astrocytes. Conclusions Overall, we identified thousands of protein changes in CTE postmortem brain and demonstrated that CTE has a pattern of neurodegeneration in neuronal-synaptic and inflammation modules similar to AD. We also identified unique CTE progressive changes, including the enrichment of immunoglobulins and ECM proteins even in early CTE stages. Early and sustained changes in astrocyte modules were also observed. Overall, the prominent overlap with FTLD-MAPT cases confirmed that CTE is on the tauopathy continuum and identified CTE stage specific molecular phenotypes that provide novel insights into disease pathogenesis.	[Gutierrez-Quiceno, Laura; Dammer, Eric B.; Johnson, Ashlyn Grace; Webster, James A.; Shah, Rhythm; Duong, Duc; Yin, Luming; Seyfried, Nicholas T.; Hales, Chadwick M.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, 615 Michael St,Off 505H, Atlanta, GA 30322 USA; [Gutierrez-Quiceno, Laura; Johnson, Ashlyn Grace; Webster, James A.; Shah, Rhythm; Hales, Chadwick M.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30329 USA; [Dammer, Eric B.; Duong, Duc; Yin, Luming; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 East Concord St, Boston, MA 02118 USA; [Alvarez, Victor E.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, 72 East Concord St, Boston, MA 02118 USA; [Stein, Thor D.; McKee, Ann C.] Boston Univ, Dept Pathol & Lab Med, Sch Med, 72 East Concord St, Boston, MA 02118 USA; [Stein, Thor D.; McKee, Ann C.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Stein, Thor D.; McKee, Ann C.] Dept Vet Affairs Med Ctr, 200 Springs Rd, Bedford, MA 01730 USA; [McKee, Ann C.] Boston Univ, Dept Anat & Neurobiol, Sch Med, 72 East Concord St, Boston, MA 02118 USA		Hales, CM (corresponding author), Emory Univ, Sch Med, Ctr Neurodegenerat Dis, 615 Michael St,Off 505H, Atlanta, GA 30322 USA.; Hales, CM (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30329 USA.	cmhales@emory.edu		Johnson, Ashlyn/0000-0001-6129-8267	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award [I01-CX001038]; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01NS086659-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP) [13267017]; Concussion Legacy Foundation; Emory Alzheimer's Disease Research Center [P50AG025688, P30AG066511]; Accelerating Medicine Partnership AD grant [U01AG046161]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS087121]; DoD-PRARP [AZ150143]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038) to TDS; Veterans Affairs Biorepository (CSP 501) to TDS and ACM; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C) to ACM; National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01) to VEA, TDS, and ACM; National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5) to TDS and ACM; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017) to ACM; Concussion Legacy Foundation to ACM, the Emory Alzheimer's Disease Research Center (P50AG025688, P30AG066511), Accelerating Medicine Partnership AD grant U01AG046161, NINDS K08NS087121 to CMH and DoDPRARP AZ150143 to CMH. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Abreha MH, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800108; Alosco ML, 2020, ACTA NEUROPATHOL, V140, P495, DOI 10.1007/s00401-020-02197-9; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Bi BB, 2019, EXP NEUROBIOL, V28, P362, DOI 10.5607/en.2019.28.3.362; Chen KL, 2010, NEUROBIOL DIS, V40, P378, DOI 10.1016/j.nbd.2010.06.013; Cherry JD, 2018, J NEUROPATH EXP NEUR, V77, P40, DOI 10.1093/jnen/nlx100; Cho H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65916-y; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Ferrer I, 2014, J NEUROPATH EXP NEUR, V73, P81, DOI 10.1097/NEN.0000000000000030; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Hales CM, 2016, PROTEOMICS, V16, P3042, DOI 10.1002/pmic.201600057; Higuchi M, 2002, NEURON, V35, P433, DOI 10.1016/S0896-6273(02)00789-4; Javidi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00686; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Johnson ECB, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0282-4; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin WL, 2003, AM J PATHOL, V162, P213, DOI 10.1016/S0002-9440(10)63812-6; Martini-Stoica H, 2018, J EXP MED, V215, P2355, DOI 10.1084/jem.20172158; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Umoh ME, 2018, EMBO MOL MED, V10, P48, DOI 10.15252/emmm.201708202; Veksler R, 2020, BRAIN, V143, P1826, DOI 10.1093/brain/awaa140; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhong Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-89	40	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1750-1326		MOL NEURODEGENER	Mol. Neurodegener.	JUN 25	2021	16	1							40	10.1186/s13024-021-00462-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC4CV	WOS:000668589500002	34172091	Green Published, gold			2022-02-07	
J	Hodoodi, F; Allah-Tavakoli, M; Tajik, F; Fatemi, I; Ahmadi, AM				Hodoodi, Fardin; Allah-Tavakoli, Mohammad; Tajik, Farzad; Fatemi, Iman; Ahmadi, Amir Moghadam			The effect of head cooling and remote ischemic conditioning on patients with traumatic brain injury	ISCIENCE			English	Article							MODERATE; PROTECTION; TOLERANCE; FLUID	Cerebral impairment caused by an external force to the head is known as traumatic brain injury (TBI). The aim of this study was to determine the role of local hypothermia and remote ischemic conditioning (RIC) on oxidative stress, inflammatory response after TBI, and other involved variables. The present study is a clinical trial on 84 patients with TBI who were divided into 4 groups. The head cooling for 1.5 to 6 hr was performed in the first three days after TBI. RIC intervention was performed within the golden time after TBI in the form of four 5-min cycles with full cuff and 5 min of emptying of cuff. The group receiving the head cooling technique recovered better than the group receiving the RIC technique. Generally, combination of the two interventions of head cooling and RIC techniques is more effective on the improvement of clinical status of patients than each separate technique.	[Hodoodi, Fardin; Allah-Tavakoli, Mohammad] Rafsanjan Univ Med Sci, Schoole Med, Dept Physiol & Pharmacol, Rafsanjan, Iran; [Allah-Tavakoli, Mohammad] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Rafsanjan, Iran; [Tajik, Farzad] Rafsanjan Univ Med Sci, Dept Clin Res Sci, Dept Med, Rafsanjan, Iran; [Tajik, Farzad; Ahmadi, Amir Moghadam] Rafsanjan Univ Med Sci, Dept Neurol, Dept Med, Rafsanjan, Iran; [Fatemi, Iman] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran; [Ahmadi, Amir Moghadam] Rafsanjan Univ Med Sci, Noncommunicable Dis Res Ctr, Rafsanjan, Iran		Ahmadi, AM (corresponding author), Rafsanjan Univ Med Sci, Dept Neurol, Dept Med, Rafsanjan, Iran.; Ahmadi, AM (corresponding author), Rafsanjan Univ Med Sci, Noncommunicable Dis Res Ctr, Rafsanjan, Iran.	a.moghadamahmadi@gmail.com	fatemi, iman/I-3054-2017	fatemi, iman/0000-0002-9666-9651	Rafsanja University of Medical Sciences	We thank all the patients and their families who participated in the present study research deputy of Rafsanja University of Medical Sciences for funding support, as well as the emergency department, ICU, laboratory, CT scan, and clinical studies center of Shahid Rahnemoun Hospital in Yazd.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Bian Y, 2015, ACTA NEUROL BELG, V115, P651, DOI 10.1007/s13760-014-0420-x; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gonzalez NR, 2014, NEUROSURGERY, V75, P590, DOI 10.1227/NEU.0000000000000514; Hess D.C., 2015, CELL THERAPY BRAIN I; Hu S, 2010, J NEUROSURG ANESTH, V22, P46, DOI 10.1097/ANA.0b013e3181c572bd; JENNETT B, 1975, LANCET, V1, P480; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Packer L., 2002, SUPEROXIDE DISMUTASE; Panagiotidou A., 2008, J VASC SURG, V47, P688; Ren CH, 2011, NEUROL RES, V33, P514, DOI 10.1179/016164111X13007856084241; Ribbons KA, 1997, EUR J PHARMACOL, V323, P245, DOI 10.1016/S0014-2999(97)00017-4; Rogler G., 2015, ANTITUMOR NECROSIS F; Saxena P, 2010, J CARDIAC SURG, V25, P127, DOI 10.1111/j.1540-8191.2009.00820.x; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; TEASDALE G, 1974, LANCET, V2, P81; Wang T, 2014, WORLD J GASTROENTERO, V20, P9519, DOI 10.3748/wjg.v20.i28.9519; Wang Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-15; Wei DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030892; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e	37	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2589-0042		ISCIENCE	iScience	JUN 25	2021	24	6							102472	10.1016/j.isci.2021.102472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TA5PU	WOS:000667301700011	34169235	Green Published			2022-02-07	
J	Lu, CC; Nyam, TTE; Kuo, JR; Lee, YL; Chio, CC; Wang, CC				Lu, Chung-Che; Nyam, Tee-Tau Eric; Kuo, Jinn-Rung; Lee, Yao-Lin; Chio, Chung-Ching; Wang, Che-Chuan			The neuroprotective effects of AMN082 on neuronal apoptosis in rats after traumatic brain injury	BMC NEUROSCIENCE			English	Article						AMN082; Traumatic brain injury; Nitrosative stress; Apoptosis; NMDA receptor	LATERAL FLUID-PERCUSSION; 7 ALLOSTERIC AGONIST; III ACTIVATORS; SH-SY5Y CELLS; RECEPTOR; PEROXYNITRITE; INHIBITION; PATHWAY	Background The aim of this study was to investigate whether AMN082 exerts its neuroprotective effect by attenuating glutamate receptor-associated neuronal apoptosis and improving functional outcomes after traumatic brain injury (TBI). Methods Anesthetized male Sprague-Dawley rats were divided into the sham-operated, TBI + vehicle, and TBI + AMN082 groups. AMN082 (10 mg/kg) was intraperitoneally injected 0, 24, or 48 h after TBI. In the 120 min after TBI, heart rate, mean arterial pressure, intracranial pressure (ICP), and cerebral perfusion pressure (CPP) were continuously measured. Motor function, the infarct volume, neuronal nitrosative stress-associated apoptosis, and N-methyl-d-aspartate receptor 2A (NR2A) and NR2B expression in the pericontusional cortex were measured on the 3rd day after TBI. Results The results showed that the AMN082-treated group had a lower ICP and higher CPP after TBI. TBI-induced motor deficits, the increase in infarct volume, neuronal apoptosis, and 3-nitrotyrosine and inducible nitric oxide synthase expression in the pericontusional cortex were significantly improved by AMN082 therapy. Simultaneously, AMN082 increased NR2A and NR2B expression in neuronal cells. Conclusions We concluded that intraperitoneal injection of AMN082 for 3 days may ameliorate TBI by attenuating glutamate receptor-associated nitrosative stress and neuronal apoptosis in the pericontusional cortex. We suggest that AMN082 administration in the acute stage may be a promising strategy for TBI.	[Lu, Chung-Che; Nyam, Tee-Tau Eric; Kuo, Jinn-Rung; Lee, Yao-Lin; Chio, Chung-Ching; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan		Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.; Wang, CC (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Wang, CC (corresponding author), Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan.	wangchechuan@gmail.com		Lee, Yaolin/0000-0001-7443-1514	Chi-Mei Medical Center [CMFHR10755]	This study was supported by Grants from Chi-Mei Medical Center, CMFHR10755.	Bradley SR, 2012, PHARMACOL BIOCHEM BE, V101, P35, DOI 10.1016/j.pbb.2011.11.006; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Brassai A, 2015, BRAIN RES BULL, V112, P1, DOI 10.1016/j.brainresbull.2014.12.007; Chong AJ, 2019, WORLD NEUROSURG, V132, pE99, DOI 10.1016/j.wneu.2019.08.250; Dingledine R, 1999, PHARMACOL REV, V51, P7; Domin H, 2015, NEUROCHEM INT, V88, P110, DOI 10.1016/j.neuint.2014.12.010; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; Gu ZL, 2012, J BIOL CHEM, V287, P10265, DOI 10.1074/jbc.M111.325175; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Jantas D, 2016, NEUROPHARMACOLOGY, V111, P195, DOI 10.1016/j.neuropharm.2016.09.003; Jantas D, 2015, NEUROCHEM INT, V88, P124, DOI 10.1016/j.neuint.2014.12.011; Jantas D, 2014, NEUROPHARMACOLOGY, V83, P36, DOI 10.1016/j.neuropharm.2014.03.019; Jantas D, 2018, NEUROPHARMACOLOGY, V141, P223, DOI 10.1016/j.neuropharm.2018.08.035; Jenda M, 2015, PROG NEURO-PSYCHOPH, V57, P166, DOI 10.1016/j.pnpbp.2014.11.004; Konieczny J, 2013, PHARMACOL REP, V65, P1194, DOI 10.1016/S1734-1140(13)71477-4; Kotlinska JH, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172512; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Marmarou A, 2003, ACT NEUR S, V86, P7; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Palazzo E, 2015, PAIN, V156, P1060, DOI 10.1097/j.pain.0000000000000150; Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2; Palucha-Poniewiera A, 2014, NEUROPHARMACOLOGY, V82, P59, DOI 10.1016/j.neuropharm.2014.03.001; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Podkowa K, 2018, NEUROPHARMACOLOGY, V141, P214, DOI 10.1016/j.neuropharm.2018.08.022; Rizzo SJS, 2011, J PHARMACOL EXP THER, V338, P345, DOI 10.1124/jpet.110.177378; Wang CC, 2018, EUR J PHARMACOL, V823, P11, DOI 10.1016/j.ejphar.2018.01.038; Wang CC, 2018, WORLD NEUROSURG, V112, pE719, DOI 10.1016/j.wneu.2018.01.140; Wang WY, 2012, NEUROSCIENCE, V205, P167, DOI 10.1016/j.neuroscience.2011.12.039; Wang Y, 1997, J NEUROSCI, V17, P4341; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	38	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	JUN 25	2021	22	1							44	10.1186/s12868-021-00649-w			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA0HC	WOS:000666935500001	34171999	gold, Green Published			2022-02-07	
J	Amery, B; Heinsberg, LW; Puccio, AM; Shaffer, JR; Okonkwo, DO; Beers, SR; Weeks, DE; Conley, YP				Treble-Barna, Amery; Heinsberg, Lacey W.; Puccio, Ava M.; Shaffer, John R.; Okonkwo, David O.; Beers, Sue R.; Weeks, Daniel E.; Conley, Yvette P.			Acute Brain-Derived Neurotrophic Factor DNA Methylation Trajectories in Cerebrospinal Fluid and Associations With Outcomes Following Severe Traumatic Brain Injury in Adults	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain-derived neurotrophic factor; clinical outcomes; DNA methylation; epigenetics; traumatic brain injury	BDNF GENE; VAL66MET POLYMORPHISM; COGNITIVE IMPAIRMENT; PROMOTER METHYLATION; SAS PROCEDURE; SERUM BDNF; CELL; EXPRESSION; DISEASE; IMPACT	Background. Epigenetic biomarkers have the potential to explain outcome heterogeneity following traumatic brain injury (TBI) but are largely unexplored. Objective. This exploratory pilot study characterized brain-derived neurotrophic factor (BDNF) DNA methylation trajectories following severe TBI. Methods. Brain-derived neurotrophic factor DNA methylation trajectories in cerebrospinal fluid (CSF) over the first 5 days following severe TBI in 112 adults were examined in association with 3- and 12-month outcomes. Results. Group-based trajectory analysis revealed low and high DNA methylation groups at two BDNF cytosine-phosphate-guanine (CpG) targets that showed suggestive associations (P < .05) with outcomes. Membership in the high DNA methylation groups was associated with better outcomes after controlling for age, sex, and injury severity. Associations of age x trajectory group interactions with outcomes at a third CpG site revealed a pattern of the same or better outcomes with higher ages in the high DNA methylation group and worse outcomes with higher ages in the low DNA methylation group. Conclusions. Although no observed associations met the empirical significance threshold after correcting for multiple comparisons, suggestive associations of the main effect models were consistent in their direction of effect and were observed across two CpG sites and two outcome time points. Results suggest that higher acute CSF BDNF DNA methylation may promote recovery following severe TBI in adults, and this effect may be more robust with higher age. While the results require replication in larger and racially diverse independent samples, BDNF DNA methylation may serve as an early postinjury biomarker helping to explain outcome heterogeneity following TBI.	[Treble-Barna, Amery] Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, 3471 Fifth Ave,KAU 910, Pittsburgh, PA 15213 USA; [Heinsberg, Lacey W.; Shaffer, John R.; Weeks, Daniel E.; Conley, Yvette P.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Heinsberg, Lacey W.] Univ Pittsburgh, Sch Med, Div Internal Med, Pittsburgh, PA USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Shaffer, John R.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA		Amery, B (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, 3471 Fifth Ave,KAU 910, Pittsburgh, PA 15213 USA.	amery.treble-barna@pitt.edu		Weeks, Daniel/0000-0001-9410-7228; Treble-Barna, Amery/0000-0003-3980-7293; Heinsberg, Lacey/0000-0002-7690-5485	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NR015142, P50NS030318, K01HD097030, F31NR017311, TL1TR001858]	The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Research reported in this publication was supported by the National Institutes of Health under Award Numbers R21NR015142 (YPC), P50NS030318 (DOO), K01HD097030 (ATB), F31NR017311 (LWH), and TL1TR001858 (LWH). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. No competing financial interests exist.	Arockiaraj AI, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00671; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bendinelli C, 2020, EUR J TRAUMA EMERG S, V46, P873, DOI 10.1007/s00068-019-01139-9; Brown DT, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040195; Carlberg L, 2014, J AFFECT DISORDERS, V168, P399, DOI 10.1016/j.jad.2014.07.022; Chang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110773; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Dell'Osso B, 2014, J AFFECT DISORDERS, V166, P330, DOI 10.1016/j.jad.2014.05.020; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Finan JD, 2018, J ALZHEIMERS DIS, V65, P1055, DOI 10.3233/JAD-180585; Fransquet PD, 2020, EPIGENOMICS-UK, V12, P2109, DOI 10.2217/epi-2020-0236; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Heinsberg LW, 2020, NEUROCRIT CARE, V32, P550, DOI 10.1007/s12028-019-00787-4; Hing B, 2018, AM J MED GENET B, V177, P143, DOI 10.1002/ajmg.b.32616; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Ikegame T, 2013, J HUM GENET, V58, P434, DOI 10.1038/jhg.2013.65; Islam F, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0794-6; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Kang HJ, 2015, PSYCHIAT INVEST, V12, P523, DOI 10.4306/pi.2015.12.4.523; Kertes DA, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0367-x; KhorshidAhmad T, 2016, MOL NEUROBIOL, V53, P1092, DOI 10.1007/s12035-014-9074-1; Kim JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033322; Klein KO, 2016, BIOINFORMATICS, V32, P593, DOI 10.1093/bioinformatics/btv615; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liu BL, 2010, NEURO-ONCOLOGY, V12, P540, DOI 10.1093/neuonc/nop064; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Na KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21089; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Prasher D, 2020, BIOCHEM CELL BIOL, V98, P12, DOI 10.1139/bcb-2019-0045; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Roy B, 2017, J PSYCHIATR RES, V89, P115, DOI 10.1016/j.jpsychires.2017.02.005; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Saito T, 2020, NEUROBIOL AGING, V94, P227, DOI 10.1016/j.neurobiolaging.2020.06.003; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Schuster AA, 2018, J NEUROTRAUM, V35, pA275; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Titus AJ, 2017, HUM MOL GENET, V26, pR216, DOI 10.1093/hmg/ddx275; Treble-Barna A, 2018, J NEUROTRAUM, V35, pA273; Ursini G, 2016, EPIGENETICS-US, V11, P11, DOI 10.1080/15592294.2015.1117736; Xie B, 2017, J ALZHEIMERS DIS, V58, P263, DOI 10.3233/JAD-170007; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv907; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	69	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	SEP	2021	35	9					790	800	15459683211028245	10.1177/15459683211028245		JUN 2021	11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UK7UB	WOS:000667897100001	34167372	Green Accepted			2022-02-07	
J	Krishna, ST; Roberts, S; Dardis, R				Trichinopoly Krishna, Sandhya; Roberts, Stuart; Dardis, Ronan			Electrically assisted pedal cycles: is new legislation required to mitigate increased head injury risk?	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Head protective devices; bicycling; brain injuries; traumatic; public health; risk	BICYCLE HELMET LEGISLATION; LIGHT RUNNING BEHAVIOR; BIKE RIDERS; CYCLISTS; SAFETY; CHINA	Objectives Electrically Assisted Pedal Cycles (EAPCs) are pedal bikes that are fitted with a motor that travel at higher speeds than conventional bicycles. Recent international data shows that there is an association with increased severity of injury, particularly in paediatric populations. Currently, EAPCs are subject to the same legislation regarding helmet use as pedal bikes in the UK and EU which does not mandate the use of a helmet. Here we examine safety concerns surrounding EAPCs in the context of existing EU and UK legislation to assess whether changes to these should be made by public health bodies to mitigate the increased risk of injury. Methods A retrospective international literature review looking at electric bicycle-related trauma and legislation was conducted using a systematic search of internet databases. Peer-reviewed articles and online resources were reviewed based on relevance to the above objective. Results EAPCS can travel at up to 17.5 mph, resulting in higher speeds of travel and collision. The use of EAPCs has been associated with increased severity of head injuries. Bicycle helmets have been shown to reduce the severity of head injury in accidents involving both EAPCs and pedal cycles. Healthcare providers should pay extra attention to the possibility of severe injuries when a patient had a bicycle accident with an EAPC, especially in paediatric populations. Conclusions Given that EAPCS have been associated internationally with increased severity of head injuries we propose that existing EU and UK legislation may not be fit for purpose with respects to increased EAPC usage and criteria for impact protection of existing helmets. Further research and audit with more accurate recording of data associated with EAPCs use and associated injuries would inform enhanced regulation regarding EAPC usage in the future.	[Trichinopoly Krishna, Sandhya; Roberts, Stuart; Dardis, Ronan] Univ Hosp Coventry & Warwickshire, Dept Neurosurg, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England		Krishna, ST (corresponding author), Univ Hosp Coventry & Warwickshire, Dept Neurosurg, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.	Sandhya.t.krishna@doctors.org.uk		Roberts, Stuart/0000-0002-6636-6326; Trichinopoly Krishna, Sandhya/0000-0002-4535-8896			[Anonymous], 2018, ROSPA FACTSHEET; [Anonymous], 2020, BBC NEWS 0915; [Anonymous], ROAD MAP ROAD SAFETY; [Anonymous], 2013, BSI STANDARDS PUBLIC; [Anonymous], 2010, PRESTO CYCLING POLIC; Baschera D, 2019, WORLD NEUROSURG, V126, pE1023, DOI 10.1016/j.wneu.2019.03.032; Bateman-House A, 2014, AM J PUBLIC HEALTH, V104, P986, DOI 10.2105/AJPH.2013.301810; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Capua T, 2019, RAMBAM MAIMONIDES ME, V10, DOI 10.5041/RMMJ.10370; Cherry C.R., 2010, J E ASIA SOC TRANSP, V8, P1424, DOI [10.11175/easts.8.1424, DOI 10.11175/EASTS.8.1424]; Davidse RJ, 2019, ACCIDENT ANAL PREV, V129, P334, DOI 10.1016/j.aap.2019.05.016; Du W, 2014, INJURY PREV, V20, P128, DOI 10.1136/injuryprev-2012-040618; Esmaeilikia M, 2018, J AUSTRALAS COLL ROA, V29, P30; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Grant D, 2004, J POLICY ANAL MANAG, V23, P595, DOI 10.1002/pam.20029; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Karepov Y, 2019, CHILD NERV SYST, V35, P1393, DOI 10.1007/s00381-019-04146-8; Lin S, 2008, TRANSPORT RES REC, P52, DOI 10.3141/2048-07; MacArthur J, 2014, TRANSPORT RES REC, P123, DOI 10.3141/2468-14; Olivier J, 2019, INT J EPIDEMIOL, V48, P1197, DOI 10.1093/ije/dyz003; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Olivier J, 2016, MED J AUSTRALIA, V205, P54, DOI 10.5694/mja16.00193; Papoutsi S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/850236; Poos H P A M, 2017, Ned Tijdschr Geneeskd, V161, pD1520; Sandberg M, 2018, COMPUT METHOD BIOMEC, V21, P684, DOI 10.1080/10255842.2018.1511775; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Schlaff CD, 2019, WORLD NEUROSURG, V132, P202, DOI 10.1016/j.wneu.2019.08.237; Smith A, 2019, J TRAUMA ACUTE CARE, V87, P76, DOI 10.1097/TA.0000000000002328; SWOV, 2017, SWOV FACT SHEET; Uff C., 2020, WERE ALREADY TREATIN; Wang Z, 2019, TRAFFIC INJ PREV, V20, P72, DOI 10.1080/15389588.2018.1511898; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Wu CX, 2012, ACCIDENT ANAL PREV, V49, P186, DOI 10.1016/j.aap.2011.06.001; Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003902; Yao L, 2012, TRANSPORT RES REC, P49, DOI 10.3141/2314-07; Zhang YQ, 2013, ACCIDENT ANAL PREV, V52, P210, DOI 10.1016/j.aap.2012.12.032	37	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	SEP 3	2021	35	5					629	632		10.1080/02688697.2021.1940846		JUN 2021	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YG0QL	WOS:000667084700001	34180330				2022-02-07	
J	Anand, SK; Sahu, MR; Mondal, AC				Anand, Surendra Kumar; Sahu, Manas Ranjan; Mondal, Amal Chandra			Induction of oxidative stress and apoptosis in the injured brain: potential relevance to brain regeneration in zebrafish	MOLECULAR BIOLOGY REPORTS			English	Article						Adult neurogenesis; Brain regeneration; Oxidative stress; Apoptosis; Zebrafish	NEUROTROPHIC FACTOR; MODEL; ACTIVATION	Recent findings suggest a significant role of the brain-derived neurotrophic factor (BDNF) as a mediator of brain regeneration following a stab injury in zebrafish. Since BDNF has been implicated in many physiological processes, we hypothesized that these processes are affected by brain injury in zebrafish. Hence, we examined the impact of stab injury on oxidative stress and apoptosis in the adult zebrafish brain. Stab wound injury (SWI) was induced in the right telencephalic hemisphere of the adult zebrafish brain and examined at different time points. The biochemical variables of oxidative stress insult and transcript levels of antioxidant genes were assessed to reflect upon the oxidative stress levels in the brain. Immunohistochemistry was performed to detect the levels of early apoptotic marker protein cleaved caspase-3, and the transcript levels of pro-apoptotic and anti-apoptotic genes were examined to determine the effect of SWI on apoptosis. The activity of antioxidant enzymes, the level of lipid peroxidation (LPO) and reduced glutathione (GSH) were significantly increased in the injured fish brain. SWI also enhanced the expression of cleaved caspase-3 protein and apoptosis-related gene transcripts. Our results indicate induction of oxidative stress and apoptosis in the telencephalon of adult zebrafish brain by SWI. These findings contribute to the overall understanding of the pathophysiology of traumatic brain injury and adult neurogenesis in the zebrafish model and raise new questions about the compensatory physiological mechanisms in response to traumatic brain injury in the adult zebrafish brain.	[Anand, Surendra Kumar; Sahu, Manas Ranjan; Mondal, Amal Chandra] Jawaharlal Nehru Univ, Sch Life Sci, Lab Cellular & Mol Neurobiol, New Mehrauli Rd, New Delhi 110067, India		Mondal, AC (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Cellular & Mol Neurobiol, New Mehrauli Rd, New Delhi 110067, India.	acmondal@mail.jnu.ac.in	Mondal, Amal/AAW-2938-2021	Mondal, Amal/0000-0003-0491-7804	DBT NER [BT/PR32907/MED/122/227/2019]; School of Life Sciences, Jawaharlal Nehru University, New Delhi, India; CSIR-HRDG, New Delhi	ACM highly acknowledges the financial supports from DBT NER (BT/PR32907/MED/122/227/2019), and School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. SKA acknowledges the financial support from CSIR-HRDG, New Delhi.	Anand SK, 2020, J NEUROSCI RES, V98, P754, DOI 10.1002/jnr.24536; Anand SK, 2018, NEUROSCI LETT, V672, P28, DOI 10.1016/j.neulet.2018.02.040; Anand SK, 2017, DEV NEUROBIOL, V77, P1188, DOI 10.1002/dneu.22508; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cacialli P, 2018, J COMP NEUROL, V526, P569, DOI 10.1002/cne.24352; Chen SD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030545; Clairborne A., 1985, CRC HDB METHODS OXYG, P283; Du DL, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5816837; Eckl J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186386; Fatima M, 2020, NEUROCHEM INT, V136, DOI 10.1016/j.neuint.2020.104730; Fatima M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38085-2; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Hock FJ., 2016, DRUG DISCOVERY EVALU, P4071, DOI [10.1007/978-3-319-05392-9_135, DOI 10.1007/978-3-319-05392-9_135]; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lutton EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00582; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; Miller AA, 2006, ANTIOXID REDOX SIGN, V8, P1113, DOI 10.1089/ars.2006.8.1113; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Numakawa T, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/405194; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sassen W. A., 2015, Advances in Genomics and Genetics, V5, P151; Schmidt R, 2014, JOVE-J VIS EXP, DOI 10.3791/51753; Srisutthisamphan K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22639-5; Srivastav S, 2020, ACS CHEM NEUROSCI, V11, P3772, DOI 10.1021/acschemneuro.0c00366; Srivastav S, 2018, NEUROCHEM INT, V121, P98, DOI 10.1016/j.neuint.2018.10.001; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Tukaj S, 2016, CELL STRESS CHAPERON, V21, P213, DOI 10.1007/s12192-016-0670-z; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Zagorac D, 2005, STROKE, V36, P2589, DOI 10.1161/01.STR.0000189997.84161.95; Zhuang SJ, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-020-03175-0	43	0	0	5	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	JUN	2021	48	6					5099	5108		10.1007/s11033-021-06506-7		JUN 2021	10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ9IP	WOS:000665717500003	34165768	Green Submitted			2022-02-07	
J	Begel, V; Bachrach, A; Dalla Bella, S; Laroche, J; Clement, S; Riquet, A; Dellacherie, D				Begel, Valentin; Bachrach, Asaf; Dalla Bella, Simone; Laroche, Julien; Clement, Sylvain; Riquet, Audrey; Dellacherie, Delphine			Dance Improves Motor, Cognitive, and Social Skills in Children With Developmental Cerebellar Anomalies	CEREBELLUM			English	Article; Early Access						Cerebellar anomalies; Sensorimotor synchronization; Rhythm; Rehabilitation; Dance	TRAUMATIC BRAIN-INJURY; SENSORIMOTOR SYNCHRONIZATION; RHYTHM DISCRIMINATION; NORMATIVE SAMPLE; BEAT PERCEPTION; BASAL GANGLIA; ADAPTED TANGO; BEHAVIOR; ATAXIA; ATTENTION	In this multiple single-cases study, we used dance to train sensorimotor synchronization (SMS), motor, and cognitive functions in children with developmental cerebellar anomalies (DCA). DCA are rare dysfunctions of the cerebellum that affect motor and cognitive skills. The cerebellum plays an important role in temporal cognition, including SMS, which is critical for motor and cognitive development. Dancing engages the SMS neuronal circuitry, composed of the cerebellum, the basal ganglia, and the motor cortices. Thus, we hypothesized that dance has a beneficial effect on SMS skills and associated motor and cognitive functions in children with DCA. Seven children (aged 7-11) with DCA participated in a 2-month dance training protocol (3 h/week). A test-retest design protocol with multiple baselines was used to assess children's SMS skills as well as motor, cognitive, and social abilities. SMS skills were impaired in DCA before the training. The training led to improvements in SMS (reduced variability in paced tapping), balance, and executive functioning (cognitive flexibility), as well as in social skills (social cognition). The beneficial effects of the dance training were visible in all participants. Notably, gains were maintained 2 months after the intervention. These effects are likely to be sustained by enhanced activity in SMS brain networks due to the dance training protocol.	[Begel, Valentin; Clement, Sylvain; Dellacherie, Delphine] Univ Lille, PSITEC Psychol Interact Temps Emot Cognit, ULR 4072, F-59000 Lille, France; [Begel, Valentin] McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Bachrach, Asaf] Univ Paris 08, CNRS, UMR 7023, 59-61 Rue Pouchet, F-75849 Paris, France; [Dalla Bella, Simone] Int Lab Brain Mus & Sound Res BRAMS, 1430 Blvd Mt Royal, Montreal, PQ H2V 2J2, Canada; [Dalla Bella, Simone] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Dalla Bella, Simone] McGill Univ, Ctr Res Brain Language & Mus CRBLM, Fac Med, 3640 Montagne, Montreal, PQ H3G 2A8, Canada; [Laroche, Julien] Univ Econ & Human Sci Warsaw, Dept Cognit Psychol, Okopowa 59, PL-01043 Warsaw, Poland; [Laroche, Julien] Univ Paris 08, Labex Arts H2H, 2 Rue Liberte, F-93526 St Denis, France; [Clement, Sylvain] Fdn Ist Italiano Tecnol IIT, Ctr Translat Neurophysiol Speech & Commun CTNSC, Via Fossato Mortara 17-19, I-44121 Ferrara, Italy; [Riquet, Audrey; Dellacherie, Delphine] Univ Hosp Lille, Dept Pediat Neurol, 2 Av Oscar Lambret, F-59037 Lille, France		Dellacherie, D (corresponding author), Univ Lille, PSITEC Psychol Interact Temps Emot Cognit, ULR 4072, F-59000 Lille, France.; Dellacherie, D (corresponding author), Univ Hosp Lille, Dept Pediat Neurol, 2 Av Oscar Lambret, F-59037 Lille, France.	delphine.dellacherie@univ-lille.fr	Begel, Valentin/O-3414-2015		"Fondation Maladies Rares" ("TEMDANCE" grant)	The research was supported by the "Fondation Maladies Rares" ("TEMDANCE" grant).	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Agostin TM, 1997, PSYCHOL SCHOOLS, V34, P219; Bachrach A, 2016, NEUROIMAGE, V124, P464, DOI 10.1016/j.neuroimage.2015.08.072; Bares M, 2019, CEREBELLUM, V18, P266, DOI 10.1007/s12311-018-0979-5; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Becker DR, 2014, EARLY CHILD RES Q, V29, P411, DOI 10.1016/j.ecresq.2014.04.014; Begel V, 2018, ANN PHYS REHABIL MED, V61, P395, DOI 10.1016/j.rehab.2018.04.001; Bella SD, 2017, BEHAV RES METHODS, V49, P1128, DOI 10.3758/s13428-016-0773-6; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Benoit CE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00494; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Bledsoe JC, 2011, J AM ACAD CHILD PSY, V50, P593, DOI 10.1016/j.jaac.2011.02.014; Bodranghien F, 2016, CEREBELLUM, V15, P369, DOI 10.1007/s12311-015-0687-3; Bolduc ME, 2009, DEV MED CHILD NEUROL, V51, P256, DOI 10.1111/j.1469-8749.2008.03224.x; Boltshauser E, 2004, AM J MED GENET A, V126A, P376, DOI 10.1002/ajmg.a.20662; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9721143X; Bramlett RK, 2000, SPECIAL SERVICES SCH, V16, P147, DOI [DOI 10.1300/J008V16N01, DOI 10.1300/J008V16N01_10]; Brenna V., 2014, PAEDIAT NEUROLOGICAL, V27, P221; Breska A, 2016, CURR OPIN BEHAV SCI, V8, P282, DOI 10.1016/j.cobeha.2016.02.034; Broersen R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162042; Brooks BL, 2010, CHILD NEUROPSYCHOL, V16, P80, DOI 10.1080/09297040903146966; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Brown T, 2013, ENCY AUTISM SPECTRUM, P1925, DOI [10.1007/978-1-4419-1698-3_1922, DOI 10.1007/978-1-4419-1698-3_1922]; Chauvigne LAS, 2019, HUM MOVEMENT SCI, V63, P199, DOI 10.1016/j.humov.2018.12.005; Chuang LY, 2015, EXP BRAIN RES, V233, P1181, DOI 10.1007/s00221-015-4196-x; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; Coubard OA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00013; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Crawford JR, 2007, COGN NEUROPSYCHOL, V24, P343, DOI 10.1080/02643290701290146; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Dalla Bella S, 2015, ANN NY ACAD SCI, V1337, P77, DOI 10.1111/nyas.12651; Damm L, 2020, NEUROSCI BIOBEHAV R, V112, P553, DOI 10.1016/j.neubiorev.2019.12.024; De Dreu CKW, 2011, SOC PSYCHOL PERS SCI, V2, P72, DOI 10.1177/1948550610381789; de Natale ER, 2017, NEUROREHABILITATION, V40, P141, DOI 10.3233/NRE-161399; De Smet HJ, 2013, BRAIN LANG, V127, P334, DOI 10.1016/j.bandl.2012.11.001; Deak GO, 2003, ADV CHILD DEV BEHAV, V31, P271; Delabary MD, 2018, AGING CLIN EXP RES, V30, P727, DOI 10.1007/s40520-017-0836-2; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Ebner TJ, 2011, CEREBELLUM, V10, P683, DOI 10.1007/s12311-010-0243-0; Fogel BL, 2012, J CHILD NEUROL, V27, P1138, DOI 10.1177/0883073812448231; Giacosa C, 2016, NEUROIMAGE, V135, P273, DOI 10.1016/j.neuroimage.2016.04.048; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, ANN NY ACAD SCI, V1169, P35, DOI 10.1111/j.1749-6632.2009.04553.x; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Gronlund E, 2005, AM J DANCE THER, V27, P63, DOI 10.1007/s10465-005-9000-1; Grube M, 2010, P NATL ACAD SCI USA, V107, P11597, DOI 10.1073/pnas.0910473107; Guell X, 2015, CEREBELLUM, V14, P50, DOI 10.1007/s12311-014-0630-z; Hackney Madeleine E, 2007, J Neurol Phys Ther, V31, P173, DOI 10.1097/NPT.0b013e31815ce78b; Hackney ME, 2015, J AM GERIATR SOC, V63, P2105, DOI 10.1111/jgs.13650; Hackney ME, 2011, NEUROREHAB NEURAL RE, V24, P384, DOI [10.1177/1545968309353329.Effects, DOI 10.1177/1545968309353329.EFFECTS]; Himberg T, 2018, BEHAV SCI, V8, DOI 10.3390/bs8020023; Himle MB, 2004, J APPL BEHAV ANAL, V37, P1, DOI 10.1901/jaba.2004.37-1; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Iversen JR, 2008, P 10 INT C MUS PERC; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Jeong YJ, 2005, INT J NEUROSCI, V115, P1711, DOI 10.1080/00207450590958574; Jin XH, 2019, EXP BRAIN RES, V237, P743, DOI 10.1007/s00221-018-5410-4; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Jones CRG, 2014, ADV EXP MED BIOL, V829, P265, DOI 10.1007/978-1-4939-1782-2_14; Joufflineau C, 2018, BEHAV SCI, V8, DOI 10.3390/bs8020024; Karpati FJ, 2016, EXP BRAIN RES, V234, P893, DOI 10.1007/s00221-015-4524-1; Karpati FJ, 2015, ANN NY ACAD SCI, V1337, P140, DOI 10.1111/nyas.12632; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SAE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00086; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Laland K, 2016, CURR BIOL, V26, pR5, DOI 10.1016/j.cub.2015.11.031; Lang EJ, 2017, CEREBELLUM, V16, P230, DOI 10.1007/s12311-016-0787-8; Li GJ, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/9693109; London J., 2012, HEARING TIME PSYCHOL, DOI [10.1093/acprof:oso/9780199744374.001.0001, DOI 10.1093/ACPROF:OSO/9780199744374.001.0001]; Lopez-Ortiz C, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116670926; Lopez-Ortiz Citlali, 2012, Arts Health, V4, P39; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marsden J, 2011, CLIN REHABIL, V25, P195, DOI 10.1177/0269215510382495; Marsden JF, 2018, HAND CLINIC, V159, P261, DOI 10.1016/B978-0-444-63916-5.00017-3; McKee KE, 2013, J MOTOR BEHAV, V45, P519, DOI 10.1080/00222895.2013.834288; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Molinari M, 2003, ANN NY ACAD SCI, V999, P313, DOI 10.1196/annals.1284.042; Molinari M, 2007, CEREBELLUM, V6, P18, DOI 10.1080/14734220601142886; Molinari M, 2008, CEREBELLUM, V7, P611, DOI 10.1007/s12311-008-0060-x; Morgan DL, 2008, SINGLE CASE RES METH, DOI [10.4135/9781483329697, DOI 10.4135/9781483329697]; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Musselman KE, 2014, NEUROLOGY, V82, P80, DOI 10.1212/01.wnl.0000438224.25600.6c; Nowak DA, 2007, CEREBELLUM, V6, P7, DOI 10.1080/14734220600776379; Nozaradan S, 2017, CORTEX, V95, P156, DOI 10.1016/j.cortex.2017.08.015; Paquette S, 2017, NEUROIMAGE, V163, P177, DOI 10.1016/j.neuroimage.2017.09.017; Poretti A, 2014, AM J MED GENET C, V166, P211, DOI 10.1002/ajmg.c.31398; Provasi J, 2014, RES DEV DISABIL, V35, P2053, DOI 10.1016/j.ridd.2014.04.024; Puyjarinet F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11295-w; Repp B.H., 2006, ADV COGN PSYCHOL, V2, P163, DOI [DOI 10.2478/V10053-008-0053-9, 10.2478/v10053-008-0053-9]; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; REYNOLDS CR, 1979, J PERS ASSESS, V43, P281, DOI 10.1207/s15327752jpa4303_9; Ryan MM, 2003, J CHILD NEUROL, V18, P309, DOI 10.1177/08830738030180050901; Sampaio Luciana Maria Malosa, 2016, J Vasc Interv Neurol, V9, P21; Sartor-Glittenberg C, 2014, PHYSIOTHER THEOR PR, V30, P138, DOI 10.3109/09593985.2013.819952; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2019, ANNU REV NEUROSCI, V42, P337, DOI 10.1146/annurev-neuro-070918-050258; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schwartze M, 2016, BEHAV BRAIN RES, V312, P285, DOI 10.1016/j.bbr.2016.06.040; Schwartze M, 2013, NEUROSCI BIOBEHAV R, V37, P2587, DOI 10.1016/j.neubiorev.2013.08.005; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shanahan J, 2015, ARCH PHYS MED REHAB, V96, P141, DOI 10.1016/j.apmr.2014.08.017; Shen Y, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.585598; SNOW JH, 1992, J LEARN DISABIL, V25, P265, DOI 10.1177/002221949202500408; Song YG, 2019, PHYSIOTHER THEOR PR, V35, P756, DOI 10.1080/09593985.2018.1457119; Soppelsa R, 2005, PSYMOTRICITE, P195; Surgent OJ, 2019, GAIT POSTURE, V71, P245, DOI 10.1016/j.gaitpost.2019.05.011; Teixeira-Machado L, 2017, AM J PHYS MED REHAB, V96, P424, DOI 10.1097/PHM.0000000000000646; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; Therrien AS, 2019, NEUROSCI LETT, V688, P37, DOI 10.1016/j.neulet.2018.06.055; Thier P, 2019, ANNU REV VIS SCI, V5, P247, DOI [10.1146/annurev-vision-091718-015000, 10.1146/annurev-vision-091718015000]; Tierney AT, 2013, BRAIN LANG, V124, P225, DOI 10.1016/j.bandl.2012.12.014; Timmann D, 1999, J NEUROPHYSIOL, V82, P103, DOI 10.1152/jn.1999.82.1.103; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Van Dooren W., 2007, ED CHILD PSYCHOL, V24, P16; Van Overwalle F, 2019, MED HYPOTHESES, V128, P33, DOI 10.1016/j.mehy.2019.05.014; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Watson MJ, 2009, CLIN REHABIL, V23, P764, DOI 10.1177/0269215509337272; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	131	0	0	3	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1473-4222	1473-4230		CEREBELLUM	Cerebellum												10.1007/s12311-021-01291-2		JUN 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SY2JB	WOS:000665717100001	34169400	Green Submitted			2022-02-07	
J	Deskit, P				Deskit, Padma			Case Series of Neurotrauma Managed by General Surgeon at Ladakh - The Highest Plateau State of India	INDIAN JOURNAL OF SURGERY			English	Article; Early Access						Neurotrauma; Rural and remote places; General surgeon; Ladakh	TRAUMATIC BRAIN-INJURY; NEUROSURGERY; TELEMEDICINE; HOSPITALS; ADOPTION; COUNTY; NEED	Trauma including neurotrauma is one of the major killers in the world. The health infrastructure in developing countries has a huge disparity, with super specialist care confined to big cities only. Adding to this problem is factors like poverty, poor road condition and no organised emergency evacuation system. The utopian scenario where specialist and infrastructure are made available in every village is a distant dream. So at present, the most feasible and cost-effective way to prevent death due to neurotrauma in rural and remote setting is putting the general surgeon working in remote area at the forefront. Our study is an effort in this direction and is reporting operative management of patients with neurotrauma in remote high-altitude Ladakh. So today, the need of hour is continuing skill enhancement training for capacity building of rural surgeon, where they are trained to do burr hole and craniotomy for reducing mortality and morbidity from neurotrauma.	[Deskit, Padma] SNM Hosp, Leh Ladakh 194101, India		Deskit, P (corresponding author), SNM Hosp, Leh Ladakh 194101, India.	drpadmadeskit@gmail.com					Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Campbell NA, 2011, ANZ J SURG, V81, P601, DOI 10.1111/j.1445-2197.2010.05593.x; Ellegala DB, 2014, J NEUROSURG, V121, P1526, DOI 10.3171/2014.7.JNS122153; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Ganapathy K, 2015, NEUROL INDIA, V63, P142, DOI 10.4103/0028-3886.156274; Ganapathy K, 2013, WORLD NEUROSURG, V79, P621, DOI 10.1016/j.wneu.2013.02.071; Ganapathy K, 2009, TELEMED J E-HEALTH, V15, P576, DOI 10.1089/tmj.2009.0066; Gbalipre FB, 2014, PALGO J MED MED SCI, V1, P1; Ghimire P., 2012, NEPAL J MED SCI, V1, P19, DOI [10.3126/njms.v1i1.5791, DOI 10.3126/NJMS.V1I1.5791]; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Head Trauma, 2018, ADV TRAUM LIF SUPP S, V10, P102; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Pandey P, 2019, INDIAN J NEUROTRAUM, V16, P87, DOI 10.1055/s-0039-3401897; Raj A, 2018, INT J ACAD MED, V4, P89, DOI 10.4103/IJAM.IJAM_67_17; Rattan A, 2019, INDIAN J NEUROTRAUM, V16, P82, DOI 10.1055/s-0039-3400331; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; SIMPSON D, 1984, AUST NZ J SURG, V54, P29, DOI 10.1111/j.1445-2197.1984.tb06681.x; Sinha M, 2016, INDIAN J NEUROTRAUM, V13, P177, DOI 10.1055/s-0036-1593762; Sinha Virendra Deo, 2012, Asian J Neurosurg, V7, P75, DOI 10.4103/1793-5482.98648; Upadhyayula PS, 2018, J NEUROSCI RURAL PRA, V9, P123, DOI 10.4103/jnrp.jnrp_273_17; Zanaboni P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1743-5	24	0	0	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg												10.1007/s12262-021-03002-x		JUN 2021	6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SY1XY	WOS:000665688200006	34188368	Bronze, Green Published			2022-02-07	
J	Inclan, PM; Chang, PS; Mack, CD; Solomon, GS; Brophy, RH; Hinton, RY; Spindler, KP; Sills, AK; Matava, MJ				Inclan, Paul M.; Chang, Peter S.; Mack, Christina D.; Solomon, Gary S.; Brophy, Robert H.; Hinton, Richard Y.; Spindler, Kurt P.; Sills, Allen K.; Matava, Matthew J.			Validity of Research Based on Public Data in Sports Medicine: A Quantitative Assessment of Anterior Cruciate Ligament Injuries in the National Football League	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						anterior cruciate ligament; National Football League; Internet; injury surveillance	PERFORMANCE-BASED OUTCOMES; CHRONIC TRAUMATIC ENCEPHALOPATHY; SYSTEMATIC REVIEWS; RETURN; PLAY; RECONSTRUCTION; SURGERY; CONCUSSION; IMPACT; EPIDEMIOLOGY	Background: Numerous researchers have leveraged publicly available Internet sources to publish publicly obtained data (POD) studies concerning various orthopaedic injuries in National Football League (NFL) players. Purpose: To provide a comprehensive systematic review of all POD studies regarding musculoskeletal injuries in NFL athletes and to use anterior cruciate ligament (ACL) injuries in NFL players to quantify the percentage of injuries identified by these studies. Study Design: Systematic review; Level of evidence, 4. Methods: A systematic review was conducted to identify all published studies utilizing POD regarding ACL injury in NFL athletes from 2000 to 2019. Data regarding player demographics were extracted from each publication. These results were compared with prospectively collected data reported by the teams' medical staff to the NFL Injury Surveillance System database linked to the League's electronic health record. An ACL "capture rate" for each article was calculated by dividing the number of ACL injuries in the POD study by the total number of ACL injuries in the NFL injury database occurring in the study period of interest. Results: A total of 42 studies were extracted that met the definition of a POD study: 28 evaluated a variety of injuries and 14 dealt specifically with ACL injuries, with 35 (83%) of the 42 studies published during or since 2015. POD studies captured a mean of 66% (range, 31%-90%) of ACL injuries reported by the teams' medical staff. This inability to capture all injury rates varied by position, with 86% capture of ACL injuries in skill athletes, 72% in midskill athletes, and 61% in linemen. POD studies captured 35% of injuries occurring during special teams play. Conclusion: The frequency of studies leveraging publicly obtained injury data in NFL players has rapidly increased since 2000. There is significant heterogeneity in the degree to which POD studies correctly identify ACL injuries from public reports. Sports medicine research relying solely on publicly obtained sources should be interpreted with an understanding of their inherent limitations and biases. These studies underreport the true incidence of injuries, with a bias toward capturing injuries in more popular players.	[Inclan, Paul M.; Chang, Peter S.; Mack, Christina D.; Solomon, Gary S.; Brophy, Robert H.; Hinton, Richard Y.; Spindler, Kurt P.; Sills, Allen K.; Matava, Matthew J.] Washington Univ St Louis, St Louis, MO USA; [Inclan, Paul M.; Chang, Peter S.; Brophy, Robert H.; Matava, Matthew J.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 14263 USA; [Mack, Christina D.] IQVIA, Res Triangle Pk, NC USA; [Solomon, Gary S.; Sills, Allen K.] Natl Football League, New York, NY 10017 USA; [Solomon, Gary S.; Sills, Allen K.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37208 USA; [Hinton, Richard Y.] MedStar Union Mem Orthoped, Baltimore, MD 21210 USA; [Spindler, Kurt P.] Cleveland Clin Sports Hlth, Cleveland, OH 44135 USA		Matava, MJ (corresponding author), Washington Univ St Louis, Dept Orthopaed, 14532 South Outer Forty Drive, Chesterfield, MO 63017 USA.	matavam@wustl.edu	Brophy, Robert H/AAX-8562-2021	Brophy, Robert H/0000-0002-2912-8265; Inclan, Paul/0000-0003-0819-0446			[Anonymous], 2014, SIGNIFICANT CHANGES; Baker HP, 2020, PHYSICIAN SPORTSMED, V48, P124, DOI [10.1080/00913847.2019.1676137, 10.1080/00913847.2019.1587565]; Baker HP, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118768446; Bakshi NK, 2018, SPORTS HEALTH, V10, P495, DOI 10.1177/1941738118768812; Bramer WM, 2016, J MED LIBR ASSOC, V104, P240, DOI 10.3163/1536-5050.104.3.014; Brophy RH, 2011, AM J SPORT MED, V39, P704, DOI 10.1177/0363546510382887; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; Carey JL, 2006, AM J SPORT MED, V34, P1911, DOI 10.1177/0363546506290186; Cinque ME, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117711681; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Dick R, 2007, J ATHL TRAINING, V42, P173; Dodson CC, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116631949; Dreyer NA, 2019, SPORTS HEALTH, V11, P440, DOI 10.1177/1941738119854759; Eisenstein ED, 2016, ORTHOP J SPORTS MED, V4, DOI DOI 10.1177/2325967116670117; Erickson BJ, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140728-59; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hsu WK, 2011, SPINE, V36, P800, DOI 10.1097/BRS.0b013e3181e50651; Hsu WK, 2011, SPINE J, V11, P180, DOI 10.1016/j.spinee.2010.12.009; Jack RA., 2017, ORTHOP J SPORTS MED, V5, P2325; Jack RA, 2017, FOOT ANKLE INT, V38, P1092, DOI 10.1177/1071100717718131; Jack RA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117699590; Jack RA, 2017, ORTHOPEDICS, V40, pE836, DOI 10.3928/01477447-20170719-03; Johnston JT, 2018, AM J SPORT MED, V46, P862, DOI 10.1177/0363546518756328; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kluczynski MA, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119864356; Kraeutler MJ, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117691941; Krill MK, 2018, PHYSICIAN SPORTSMED, V46, P342, DOI 10.1080/00913847.2018.1482188; Krill MK, 2017, PHYSICIAN SPORTSMED, V45, P259, DOI 10.1080/00913847.2017.1343652; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Maak TG, 2020, ARTHROSCOPY, V36, P2938, DOI 10.1016/j.arthro.2020.08.038; Mack C, 2020, CURR SPORT MED REP, V19, P168, DOI 10.1249/JSR.0000000000000711; Mack CD, 2019, J ATHL TRAINING, V54, P466, DOI 10.4085/1062-6050-18-19; Mai HT, 2018, CLIN SPINE SURG, V31, pE80, DOI 10.1097/BSD.0000000000000570; Mai HT, 2017, AM J SPORT MED, V45, P2226, DOI 10.1177/0363546517704834; Mai HT, 2016, SPINE, V41, P1785, DOI 10.1097/BRS.0000000000001868; Mai HT, 2016, AM J SPORT MED, V44, P2255, DOI 10.1177/0363546516651426; Makhni EC, 2015, PHYSICIAN SPORTSMED, V43, P300, DOI 10.1080/00913847.2015.1050952; Markowitz JS, 2016, J OCCUP ENVIRON MED, V58, pE15, DOI 10.1097/JOM.0000000000000633; McHale KJ, 2016, AM J SPORT MED, V44, P1810, DOI 10.1177/0363546516645082; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; National Collegiate Athletic Association, CHANG COLL KICK RUL CHANG COLL KICK RUL; National Football League, 2017, 2017 PERS INJ REP PO 2017 PERS INJ REP PO; Navarro SM., 2017, ORTHOP J SPORTS MED, V5; Okoroha KR, 2019, ARTHROSCOPY, V35, P158, DOI 10.1016/j.arthro.2018.08.007; Okoroha KR, 2018, J SHOULDER ELB SURG, V27, P17, DOI 10.1016/j.jse.2017.07.027; Okoroha KR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117698788; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parekh Selene G, 2009, Foot Ankle Spec, V2, P283, DOI 10.1177/1938640009351138; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Read CR, 2017, AM J SPORT MED, V45, P1815, DOI 10.1177/0363546517703361; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Savage JW, 2010, CLIN J SPORT MED, V20, P350, DOI 10.1097/JSM.0b013e3181efc259; Schallmo MS, 2018, AM J SPORT MED, V46, P1959, DOI 10.1177/0363546518773080; Schallmo MS, 2018, KNEE, V25, P692, DOI 10.1016/j.knee.2018.04.008; Secrist ES., 2016, ORTHOP J SPORTS MED, V4, P2325; Singh SK, 2018, ORTHOPEDICS, V41, pE479, DOI 10.3928/01477447-20180424-03; Singh SK, 2018, SPORTS HEALTH, V10, P70, DOI 10.1177/1941738117729660; Sochacki Kyle R, 2019, Hand (N Y), V14, P487, DOI 10.1177/1558944718760001; Trofa DP, 2017, AM J SPORT MED, V45, P2864, DOI 10.1177/0363546517713001; Vora D, 2019, CLIN J SPORT MED, V29, P459, DOI 10.1097/JSM.0000000000000548; Weistroffer JK, 2011, AM J SPORT MED, V39, P632, DOI 10.1177/0363546510388901; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Yang J., 2017, Orthop J Sports Med, V5; Yang J, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119830139; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	70	0	0	5	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.											03635465211015435	10.1177/03635465211015435		JUN 2021	10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TV2IJ	WOS:000681548600001	34166138				2022-02-07	
J	Santos, JPL; Kontos, AP; Mailliard, S; Eagle, SR; Holland, CL; Suss, SJ; Abdul-waalee, H; Stiffler, RS; Bitzer, HB; Blaney, NA; Colorito, AT; Santucci, CG; Brown, A; Kim, T; Iyengar, S; Skeba, A; Diler, RS; Ladouceur, CD; Phillips, ML; Brent, D; Collins, MW; Versace, A				Lima Santos, Joao Paulo; Kontos, Anthony P.; Mailliard, Sarrah; Eagle, Shawn R.; Holland, Cynthia L.; Suss, Stephen J., Jr.; Abdul-waalee, Halimah; Stiffler, Richelle S.; Bitzer, Hannah B.; Blaney, Nicholas A.; Colorito, Adam T.; Santucci, Christopher G.; Brown, Allison; Kim, Tae; Iyengar, Satish; Skeba, Alexander; Diler, Rasim S.; Ladouceur, Cecile D.; Phillips, Mary L.; Brent, David; Collins, Michael W.; Versace, Amelia			White Matter Abnormalities Associated With Prolonged Recovery in Adolescents Following Concussion	FRONTIERS IN NEUROLOGY			English	Article						adolescence; concussion; predictors; recovery; diffusion MRI	SUPERIOR LONGITUDINAL FASCICULUS; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; DIFFUSION MRI; BRAIN-INJURY; PREDICTORS; PERFORMANCE; MATURATION; DISORDERS	Background: Concussion symptoms in adolescents typically resolve within 4 weeks. However, 20 - 30% of adolescents experience a prolonged recovery. Abnormalities in tracts implicated in visuospatial attention and emotional regulation (i.e., inferior longitudinal fasciculus, ILF; inferior fronto-occipital fasciculus, IFOF; uncinate fasciculus; UF) have been consistently reported in concussion; yet, to date, there are no objective markers of prolonged recovery in adolescents. Here, we evaluated the utility of diffusion MRI in outcome prediction. Forty-two adolescents (12.1 - 17.9 years; female: 44.0%) underwent a diffusion Magnetic Resonance Imaging (dMRI) protocol within the first 10 days of concussion. Based on days of injury until medical clearance, adolescents were then categorized into SHORT (N = 21) or LONG (>28 days; N = 21) recovery time. Fractional anisotropy (FA) in the ILF, IFOF, UF, and/or concussion symptoms were used as predictors of recovery time (SHORT, LONG). Forty-two age- and sex-matched healthy controls served as reference. Higher FA in the ILF (left: adjusted odds ratio; AOR = 0.36, 95% CI = 0.15 - 0.91, P = 0.030; right: AOR = 0.28, 95% CI = 0.10 - 0.83, P = 0.021), IFOF (left: AOR = 0.21, 95% CI = 0.07 - 0.66, P = 0.008; right: AOR = 0.30, 95% CI = 0.11 - 0.83, P = 0.020), and UF (left: AOR = 0.26, 95% CI = 0.09 - 0.74, P = 0.011; right: AOR = 0.28, 95% CI = 0.10 - 0.73, P = 0.010) was associated with SHORT recovery. In additional analyses, while adolescents with SHORT recovery did not differ from HC, those with LONG recovery showed lower FA in the ILF and IFOF (P < 0.014). Notably, inclusion of dMRI findings increased the sensitivity and specificity (AUC = 0.93) of a prediction model including clinical variables only (AUC = 0.75). Our findings indicate that higher FA in long associative tracts (especially ILF) might inform a more objective and accurate prognosis for recovery time in adolescents following concussion.	[Lima Santos, Joao Paulo; Mailliard, Sarrah; Suss, Stephen J., Jr.; Abdul-waalee, Halimah; Stiffler, Richelle S.; Brown, Allison; Iyengar, Satish; Skeba, Alexander; Diler, Rasim S.; Ladouceur, Cecile D.; Phillips, Mary L.; Brent, David; Versace, Amelia] Univ Pittsburgh, Western Psychiat Hosp, Dept Psychiat, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Eagle, Shawn R.; Holland, Cynthia L.; Bitzer, Hannah B.; Blaney, Nicholas A.; Colorito, Adam T.; Santucci, Christopher G.; Collins, Michael W.] Univ Pittsburgh, Med Ctr UPMC, Dept Orthopaed Surg, Sports Concuss Program, Pittsburgh, PA USA; [Kim, Tae; Versace, Amelia] Univ Pittsburgh, Magnet Resonance Res Ctr, Dept Radiol, Pittsburgh, PA USA		Santos, JPL (corresponding author), Univ Pittsburgh, Western Psychiat Hosp, Dept Psychiat, Pittsburgh, PA 15260 USA.	santosjp@upmc.edu	Versace, Amelia/G-1772-2018	Versace, Amelia/0000-0001-9925-5203; Lima Santos, Joao Paulo/0000-0003-0676-8515	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH114881, R01MH111600]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10OD023405-01]; Chuck Noll Foundation for Brain Injury Research [FP00004146]	The present study was supported by the National Institute of Mental Health (R01MH114881, PIs: Versace, Kontos; R01MH111600, PIs: Ladouceur, Diler), National Institute of Health (1S10OD023405-01; PI: Hetherington), and the Chuck Noll Foundation for Brain Injury Research (FP00004146). These funding agencies were not involved in the design or conduct of the study, the collection, management, analysis, or interpretation of the data, or the preparation, review, or approval of the manuscript.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Cubon VA, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1165; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fong AK, 2021, J NEUROTRAUM, V38, P44, DOI 10.1089/neu.2020.7100; Gerson AC, 1996, PSYCHIAT RES, V65, P189, DOI 10.1016/S0165-1781(96)02851-X; Herbet G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00077; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; King R, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101842; Klarborg B, 2013, HUM BRAIN MAPP, V34, P3216, DOI 10.1002/hbm.22139; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kowalczyk CL, 2020, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2020.1774376; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Lynch KM, 2020, NEUROIMAGE, V212, DOI 10.1016/j.neuroimage.2020.116672; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinnon ET, 2017, ANN NEUROL, V82, P147, DOI 10.1002/ana.24983; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Poznanski E, 1996, CHILDRENS DEPRESSION; R Core Team, 2020, R LANG ENV STAT COMP; Ralph MAL, 2010, BRAIN, V133, P3243, DOI 10.1093/brain/awq264; Rice GE, 2015, ANN NY ACAD SCI, V1359, P84, DOI 10.1111/nyas.12951; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schilling S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010351; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Urger SE, 2015, J CHILD NEUROL, V30, P9, DOI 10.1177/0883073813520503; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wasserthal J, 2018, LECT NOTES COMPUT SC, V11072, P36, DOI 10.1007/978-3-030-00931-1_5; Wasserthal J, 2018, NEUROIMAGE, V183, P239, DOI 10.1016/j.neuroimage.2018.07.070; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930; Wu YP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00088; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	76	0	0	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 24	2021	12								681467	10.3389/fneur.2021.681467			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF2QQ	WOS:000670557100001	34248824	Green Published, gold			2022-02-07	
J	Walston, L; Martin, C; Walston, Z; Yake, D				Walston, Lindsay; Martin, Cara; Walston, Zach; Yake, Dale			An irritability-based approach to whiplash-associated concussion rehabilitation: a case series	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Concussion; whiplash; physical therapy; irritability	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION; PSYCHOMETRIC PROPERTIES; PROGNOSTIC-FACTORS; DISORDERS; EXERCISE; INDIVIDUALS; DIZZINESS; SYMPTOMS; HEADACHE	Background: An estimated 45% of concussions are reported to be related to motor vehicle collisions (MVC). However, limited research exists involving the treatment of MVC-related concussion, especially when combined with whiplash-associated disorders (WAD). Purpose: The purpose of this case series is to examine the patient response to an irritability-based approach to the physiological, cervical, and vestibulo-ocular trajectories in patients with diagnosed concussion and WAD disorder following an MVC. Case Description: Three patients clinically diagnosed by a neurologist with WAD and concussion following a rear-end MVC were evaluated and treated in an outpatient physical therapy setting. Each individual was progressed through an irritability-based treatment approach based on individual symptom presentation. Outcomes: Following therapy, 2 of 3 patients reported full resolution of subjective symptoms with a negative Vestibular Oculo-motor Screening All patients exceeded their predicted goals based on Focus on Therapeutic Outcomes score. Conclusion: This case series demonstrated successful treatment of all three individuals with concussion and concurrent WAD. Two of three individuals demonstrated full resolution of subjective symptoms and objective impairments at the end of treatment. Further research is warranted into the effectiveness of a multi-factorial approach to address the highly variable symptom profile of individuals with concussion and WAD.	[Walston, Lindsay; Martin, Cara; Walston, Zach; Yake, Dale] PT Solut Phys Therapy, Atlanta, GA 30318 USA		Walston, L (corresponding author), PT Solut Phys Therapy, Atlanta, GA 30318 USA.	walstonlw@gmail.com					Ahadi Mohsen, 2019, Int Tinnitus J, V23, P42, DOI 10.5935/0946-5448.20190008; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Balla J, 1987, Clin Exp Neurol, V23, P179; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Boyles R, 2011, J MAN MANIP THER, V19, P135, DOI 10.1179/2042618611Y.0000000011; Celenay ST, 2016, J ORTHOP SPORT PHYS, V46, P44, DOI 10.2519/jospt.2016.5979; Centers for Disease Control and Prevention, 2011, COMPL CONC; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Cullen KE, 2011, EXP BRAIN RES, V210, P377, DOI 10.1007/s00221-011-2555-9; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haas M, 2010, SPINE J, V10, P117, DOI 10.1016/j.spinee.2009.09.002; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Hart D.L., 2001, Work, V16, P39; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee KC, 2006, CLIN REHABIL, V20, P909, DOI 10.1177/026921550506072186; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Mergner T, 2001, EXP BRAIN RES, V141, P33, DOI 10.1007/s002210100826; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Posadzki P, 2011, HEADACHE, V51, P1132, DOI 10.1111/j.1526-4610.2011.01932.x; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Ritchie C, 2016, J ORTHOP SPORT PHYS, V46, P851, DOI 10.2519/jospt.2016.6918; RUBIN AM, 1995, AM J OTOL, V16, P216; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith A, 2017, SCAND J PAIN, V15, P14, DOI 10.1016/j.sjpain.2016.11.007; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; van Ettekoven H, 2006, CEPHALALGIA, V26, P983, DOI 10.1111/j.1468-2982.2006.01163.x; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Ylinen J, 2010, J REHABIL MED, V42, P344, DOI 10.2340/16501977-0527	45	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2021.1938306		JUN 2021	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	TA0GS	WOS:000666934500001	34167435				2022-02-07	
J	Gomez, AD; Bayly, PV; Butman, JA; Pham, DL; Prince, JL; Knutsen, AK				Gomez, Arnold D.; Bayly, Philip V.; Butman, John A.; Pham, Dzung L.; Prince, Jerry L.; Knutsen, Andrew K.			Group characterization of impact-induced, in vivo human brain kinematics	JOURNAL OF THE ROYAL SOCIETY INTERFACE			English	Article						traumatic brain injury; dynamic magnetic resonance imaging; head impact; finite strain	MECHANICAL-PROPERTIES; FOOTBALL PLAYERS; HEAD KINEMATICS; CONCUSSION; RESONANCE; STRAIN; MOTION; REGISTRATION; DEFORMATION; TISSUE	Brain movement during an impact can elicit a traumatic brain injury, but tissue kinematics vary from person to person and knowledge regarding this variability is limited. This study examines spatio-temporal brain-skull displacement and brain tissue deformation across groups of subjects during a mild impact in vivo. The heads of two groups of participants were imaged while subjected to a mild (less than 350 rad s(-2)) impact during neck extension (NE, n = 10) and neck rotation (NR, n = 9). A kinematic atlas of displacement and strain fields averaged across all participants was constructed and compared against individual participant data. The atlas-derived mean displacement magnitude was 0.26 +/- 0.13 mm for NE and 0.40 +/- 0.26 mm for NR, which is comparable to the displacement magnitudes from individual participants. The strain tensor from the atlas displacement field exhibited maximum shear strain (MSS) of 0.011 +/- 0.006 for NE and 0.017 +/- 0.009 for NR and was lower than the individual MSS averaged across participants. The atlas illustrates common patterns, containing some blurring but visible relationships between anatomy and kinematics. Conversely, the direction of the impact, brain size, and fluid motion appear to underlie kinematic variability. These findings demonstrate the biomechanical roles of key anatomical features and illustrate common features of brain response for model evaluation.	[Gomez, Arnold D.] Johns Hopkins Univ, Sch Med, Dept Neurol, 600 North Wolfe St,200 Carnegie Hall, Baltimore, MD 21218 USA; [Bayly, Philip V.] Washington Univ St Louis, Dept Mech Engn & Mat Sci, 1 Brookings Dr,Box 1185, St Louis, MI 63130 USA; [Butman, John A.] Natl Inst Hlth, Clin Ctr, Bethesda, MD USA; [Pham, Dzung L.; Knutsen, Andrew K.] Henry M Jackson Fdn Adv Mil Med Inc, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Prince, Jerry L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA		Gomez, AD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 North Wolfe St,200 Carnegie Hall, Baltimore, MD 21218 USA.	adgomez@jhu.edu	; Butman, John/J-2780-2013	Knutsen, Andrew/0000-0002-1340-654X; Butman, John/0000-0002-1547-9195; Bayly, Philip/0000-0003-4303-0704	US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01/R56-NS055951, U01 NS112120]; US Department of Defence in the Center for Neuroscience and Regenerative Medicine; Intramural Research Program of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Funding was provided by the US National Institute of Neurological Disorders and Stroke (grant nos. R01/R56-NS055951 and U01 NS112120), the US Department of Defence in the Center for Neuroscience and Regenerative Medicine, and the Intramural Research Program of the US National Institutes of Health.	Abney TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022063; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dinh HQ, 2008, LECT NOTES COMPUT SC, V5342, P187, DOI 10.1007/978-3-540-89689-0_23; Eskandari F, 2020, CLIN BIOMECH, V75, DOI 10.1016/j.clinbiomech.2020.105000; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gehre C., 2009, 21 ESV C STUTTG, V1, P09; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Gomez AD., 2019, COMPUTATIONAL BIOMEC, P3, DOI [10.1007/978-3-319-75589-2_2, DOI 10.1007/978-3-319-75589-2_2]; Gomez AD, 2018, LECT NOTES COMPUT SC, V11071, P428, DOI 10.1007/978-3-030-00934-2_48; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Gomez Arnold David, 2017, Comput Biomech Med Algorithms Models Appl (2017), V2017, P81, DOI 10.1007/978-3-319-54481-6_7; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guttman MA, 1997, IEEE COMPUT GRAPH, V17, P30, DOI 10.1109/38.576854; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Helms G, 2009, J MAGN RESON IMAGING, V29, P198, DOI 10.1002/jmri.21629; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Huo Y, 2016, NEUROIMAGE, V138, P197, DOI 10.1016/j.neuroimage.2016.05.030; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Knutsen Andrew K, 2020, Brain Multiphys, V1, DOI 10.1016/j.brain.2020.100015; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Monea AG, 2012, J NEUROTRAUM, V29, P2305, DOI 10.1089/neu.2011.2271; NELSON WH, 1980, J MAGN RESON, V38, P71, DOI 10.1016/0022-2364(80)90178-X; Ng LJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00269; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Osman NF, 1999, MAGN RESON MED, V42, P1048; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Prange MT., 1999, PROC 43 STAPP CAR CR, DOI [10.4271/99SC23, DOI 10.4271/99SC23]; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Rougon N, 2004, PROC SPIE, V5370, P253, DOI 10.1117/12.535609; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Spencer AJM., 1985, CONTINUUM MECH; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Teferra K, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3109; Terrell TR, 2018, BRIT J SPORT MED, V52, P192, DOI 10.1136/bjsports-2016-097419; Veress AI, 2005, J BIOMECH ENG-T ASME, V127, P1195, DOI 10.1115/1.2073677; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; WELFORD BP, 1962, TECHNOMETRICS, V4, P419, DOI 10.2307/1266577; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xing FX, 2017, PROC SPIE, V10133, DOI 10.1117/12.2254363; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	67	0	0	0	0	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1742-5689	1742-5662		J R SOC INTERFACE	J. R. Soc. Interface	JUN 23	2021	18	179							20210251	10.1098/rsif.2021.0251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX2NQ	WOS:000665047600001	34157896	Bronze			2022-02-07	
J	Polopalli, S; Yetukuri, AR; Danduga, RCSR; Kola, PK				Polopalli, Subramanyam; Yetukuri, Amulya Rani; Danduga, Ravi Chandra Sekhara Reddy; Kola, Phani Kumar			A prognostic study on the effect of post-traumatic stress disorder on cerebral ischaemia reperfusion-induced stroke	WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY			English	Article; Early Access						Post-traumatic stress disorder; single prolonged stress; bilateral common carotid artery occlusion; histopathology; brain lesion area measurement	SINGLE-PROLONGED STRESS; INDUCED HUNTINGTONS-DISEASE; ANXIETY-LIKE BEHAVIORS; OXIDATIVE STRESS; RAT MODEL; COGNITIVE IMPAIRMENT; MEMORY IMPAIRMENT; ACID; SYMPTOMS; NEURONS	Objectives Previous studies have been established that persons who experienced a stroke are soon likely to develop several anxiety disorders. In which one of the major anxiety disorders is Post-traumatic Stress Disorder (PTSD). Yet, the likelihood of PTSD in conjunction with cerebral stroke has not been well described. Hence, we evaluated the impact of PTSD on cerebral stroke in rodents subjected to single prolonged stress (SPS) and bilateral common carotid artery occlusion (BCCAo), respectively. Methods The relation between PTSD and cerebral stroke is evaluated by performing behavioural, biochemical, histopathological, and brain lesion area measurement studies. Results Interestingly, SPS + BCCAo induction increased behavioural abnormalities like cognitive impairment and anxiety-like behaviour compared to SPS and BCCAo groups alone. Motor impairment was also observed in SPS + BCCAo rats compared to SPS rats, whereas no change with BCCAo rats. Furthermore, increased brain tissue MDA, acetylcholinesterase, and decreased SOD, catalase, and GSH were observed in SPS + BCCAo subjected rats compared to SPS and BCCAo rats alone. Additionally, SPS + BCCAo induction considerably increased the plasma corticosterone levels and caused severe neurotransmitter alterations. The SPS + BCCAo exposure significantly increased the brain lesion area in comparison with BCCAo rats. Moreover, severe histopathological alterations were observed in the hippocampus (CA1) of SPS + BCCAo rats compared to SPS and BCCAo rats alone. Conclusions In conclusion, our study results suggested that SPS-induced PTSD may aggravate the BCCAo induced cerebral ischaemia-reperfusion injury.	[Polopalli, Subramanyam] Vishnu Inst Pharmaceut Educ & Res, Dept Pharmacol, Narsapur, Medak, India; [Polopalli, Subramanyam; Yetukuri, Amulya Rani; Danduga, Ravi Chandra Sekhara Reddy; Kola, Phani Kumar] Acharya Nagarjuna Univ, Univ Coll Pharmaceut Sci, Dept Pharmacol, Nagarjuna Nagar, Andhra Pradesh, India		Danduga, RCSR (corresponding author), Acharya Nagarjuna Univ, Coll Pharmaceut Sci, Dept Pharmacol, Guntur 522510, Andhra Pradesh, India.	ravichandra.pharma2262@gmail.com	Polopalli, Subramanyam/ABA-2363-2021	kola, phanI kumar/0000-0002-1833-7811; Danduga, Ravi Chandra Sekhara Reddy/0000-0003-2159-9596; Polopalli, Subramanyam/0000-0001-5541-5324	University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, and Guntur, India	The work was supported by the University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, and Guntur, India. The authors are thankful to Prof. A Prameela Rani, University College of Pharmaceutical Sciences, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, for their kind cooperation.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Alzoubi KH, 2018, PSYCHIAT RES, V270, P430, DOI 10.1016/j.psychres.2018.10.008; Aschbacher K, 2013, PSYCHONEUROENDOCRINO, V38, P1698, DOI 10.1016/j.psyneuen.2013.02.004; Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; Aytac E, 2006, PROSTAG LEUKOTR ESS, V74, P373, DOI 10.1016/j.plefa.2006.03.006; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Cheng W, 2019, J AFFECT DISORDERS, V246, P682, DOI 10.1016/j.jad.2018.12.084; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Danduga RCSR, 2018, BIOMED PHARMACOTHER, V105, P1254, DOI 10.1016/j.biopha.2018.06.079; de Souza CP, 2019, BEHAV BRAIN RES, V359, P749, DOI 10.1016/j.bbr.2018.09.008; Dhadde SB, 2016, BIOMED PHARMACOTHER, V77, P52, DOI 10.1016/j.biopha.2015.11.009; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fang Q, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00387; Fernandez C, 2009, BIOL RES, V42, P57, DOI [10.4067/S0716-97602009000100006, /S0716-97602009000100006]; Gaur Vaibhav, 2011, Inflammopharmacology, V19, P205, DOI 10.1007/s10787-010-0068-y; Gaur V, 2009, EUR J PHARMACOL, V616, P147, DOI 10.1016/j.ejphar.2009.06.056; Goble, 2009, ACETYLCHOLINE POST T; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; Ivasenko T., 2012, NATURAL EXACT APPL S, V66, P242; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jun HJ, 2015, J PHYS THER SCI, V27, P781, DOI 10.1589/jpts.27.781; Kaundal M, 2018, EUR J PHARMACOL, V832, P56, DOI 10.1016/j.ejphar.2018.05.015; Keller SM, 2015, BEHAV BRAIN RES, V287, P182, DOI 10.1016/j.bbr.2015.03.043; Khoshnam SE, 2018, METAB BRAIN DIS, V33, P785, DOI 10.1007/s11011-018-0187-5; Koinig H, 2001, BRAIN RES, V898, P297, DOI 10.1016/S0006-8993(01)02204-1; Kola PK, 2017, EPILEPSY BEHAV, V75, P114, DOI 10.1016/j.yebeh.2017.07.011; Kumar A, 2016, BRAIN RES BULL, V122, P35, DOI 10.1016/j.brainresbull.2016.02.016; Kurinami H, 2014, STROKE, V45, P1131, DOI 10.1161/STROKEAHA.113.003577; Kwon HM, 2014, STROKE, V45, P871, DOI 10.1161/STROKEAHA.113.004099; Lee B, 2018, KOREAN J PHYSIOL PHA, V22, P525, DOI 10.4196/kjpp.2018.22.5.525; Lee B, 2014, BIOMOL THER, V22, P213, DOI 10.4062/biomolther.2014.032; Lee BK, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1683-4; Lee H., 2018, EVID-BASED COMPL ALT, V2018, P1, DOI DOI 10.1155/2018/9041309; Lisieski MJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00196; Magdaleno-Madrigal VM, 2019, BEHAV BRAIN RES, V361, P26, DOI 10.1016/j.bbr.2018.12.037; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patki G, 2014, PHYSIOL BEHAV, V130, P47, DOI 10.1016/j.physbeh.2014.03.016; Perrine SA, 2016, BEHAV BRAIN RES, V303, P228, DOI 10.1016/j.bbr.2016.01.056; Poustchi F, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202001571; Ramagiri S, 2017, EUR J PHARMACOL, V803, P84, DOI 10.1016/j.ejphar.2017.03.028; Salehi M, 2021, J AFFECT DISORDERS, V282, P527, DOI 10.1016/j.jad.2020.12.188; Santos R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/730581; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Singh DP, 2013, EUR J PHARMACOL, V720, P98, DOI 10.1016/j.ejphar.2013.10.043; Soares LM, 2013, BEHAV BRAIN RES, V249, P28, DOI 10.1016/j.bbr.2013.04.010; Sohn E, 2019, MOLECULES, V24, DOI 10.3390/molecules24020343; Souza RR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00615; Tang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/497842; Tillmann S, 2019, BEHAV BRAIN RES, V359, P755, DOI 10.1016/j.bbr.2018.08.025; Umukoro Solomon, 2019, Pathophysiology, V26, P77, DOI 10.1016/j.pathophys.2018.10.002; Vasudevan M, 2007, PHARM BIOL, V45, P267, DOI 10.1080/13880200701214631; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Wahul AB, 2018, J CHEM NEUROANAT, V92, P1, DOI 10.1016/j.jchemneu.2018.04.006; Wang JG, 2017, J MOL NEUROSCI, V63, P28, DOI 10.1007/s12031-017-0953-6; Wen LL, 2017, APOPTOSIS, V22, P753, DOI 10.1007/s10495-017-1371-5; WRIGHT F, 2017, STROKE RES TREATMENT, V2017, P1; Wu ZM, 2017, PSYCHIAT RES, V255, P287, DOI 10.1016/j.psychres.2017.05.051; Zhao RR, 2015, NEUROSCI LETT, V587, P113, DOI 10.1016/j.neulet.2014.12.037	62	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1562-2975	1814-1412		WORLD J BIOL PSYCHIA	World J. Biol. Psychiatry												10.1080/15622975.2021.1935318		JUN 2021	15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	SY2BT	WOS:000665698100001	34165039				2022-02-07	
J	Sivandzade, F; Alqahtani, F; Cucullo, L				Sivandzade, Farzane; Alqahtani, Faleh; Cucullo, Luca			Impact of chronic smoking on traumatic brain microvascular injury: An in vitro study	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						alternative; blood-brain barrier; endothelium; in vitro; inflammation; Nrf2; oxidative stress; smoking; TBI; traumatic injury	OXIDATIVE STRESS; DENICOTINIZED CIGARETTES; PROVIDES NEUROPROTECTION; CEREBROVASCULAR SYSTEM; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; BARRIER; ACTIVATION; PROTECTS; NRF2-ARE	Traumatic brain injury (TBI) is a major reason of cerebrovascular and neurological damage. Premorbid conditions such as tobacco smoking (TS) can worsen post-TBI injuries by promoting vascular endothelial impairments. Indeed, TS-induced oxidative stress (OS) and inflammation can hamper the blood-brain barrier (BBB) endothelium. This study evaluated the subsequence of chronic TS exposure on BBB endothelial cells in an established in vitro model of traumatic cell injury. Experiments were conducted on confluent TS-exposed mouse brain microvascular endothelial cells (mBMEC-P5) following scratch injury. The expression of BBB integrity-associated tight junction (TJ) proteins was assessed by immunofluorescence imaging (IF), Western blotting (WB) and quantitative RT-PCR. We evaluated reactive oxygen species (ROS) generation, the nuclear factor 2-related (Nrf2) with its downstream effectors and several inflammatory markers. Thrombomodulin expression was used to assess the endothelial haemostatic response to injury and TS exposure. Our results show that TS significantly decreased Nrf2, thrombomodulin and TJ expression in the BBB endothelium injury models while increased OS and inflammation compared to parallel TS-free cultures. These data suggest that chronic TS exposure exacerbates traumatic endothelial injury and abrogates the protective antioxidative cell responses. The downstream effect was a more significant decline of BBB endothelial viability, which could aggravate subsequent neurological impairments.	[Sivandzade, Farzane] Oakland Univ, Dept Biol Sci, Rochester, MI 48063 USA; [Sivandzade, Farzane; Cucullo, Luca] Oakland Univ, William Beaumont Sch Med, Dept Fdn Med Studies, 586 Pioneer Dr,460 ODowd Hall, Rochester, MI 48309 USA; [Alqahtani, Faleh] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia		Cucullo, L (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Fdn Med Studies, 586 Pioneer Dr,460 ODowd Hall, Rochester, MI 48309 USA.	lcucullo@oakland.edu		Sivandzade, Farzane/0000-0001-8649-3712; Alqahtani, Faleh/0000-0003-3924-593X	National Institutes of Health/National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [2R01--DA029121, 1R01-DA049737]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01-NS117906]	This work was supported by the National Institutes of Health/National Institute on Drug Abuse 2R01--DA029121 and 1R01-DA049737 and the National Institute of Neurological Disorders and Stroke 1R01-NS117906 to Dr Luca Cucullo.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Archie SR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113916; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Benardais K, 2013, NEUROSCI LETT, V555, P165, DOI 10.1016/j.neulet.2013.09.038; Bhalerao A, 2020, J PUBLIC HEALTH-HEID, V28, P259, DOI 10.1007/s10389-019-01062-8; Carvalho C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00806; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Cojocaru Inimioara Mihaela, 2013, Rom J Intern Med, V51, P97; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Enciu AM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297512; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; He YX, 2019, NEUROREPORT, V30, P344, DOI 10.1097/WNR.0000000000001205; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Kaisar MA, 2017, REDOX BIOL, V13, P353, DOI 10.1016/j.redox.2017.06.006; Khan NM, 2017, FREE RADICAL BIO MED, V112, P191, DOI 10.1016/j.freeradbiomed.2017.10.300; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li ZZ, 2018, BIOMED PHARMACOTHER, V106, P349, DOI 10.1016/j.biopha.2018.06.041; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Lutton EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00582; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Naik P, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0173-3; Naik P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-51; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Prasad S, 2017, REDOX BIOL, V12, P58, DOI 10.1016/j.redox.2017.02.007; Prasad S, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0014-x; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sajja RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31137-7; Sajja RK, 2015, NEUROSCI LETT, V598, P59, DOI 10.1016/j.neulet.2015.05.015; Sajja RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122358; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Sivandzade F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174225; Sivandzade F, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0497-5; Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Takeno A, 2015, BONE, V77, P135, DOI 10.1016/j.bone.2015.04.025; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/314082; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang X, 2011, TOXICOL IN VITRO, V25, P839, DOI 10.1016/j.tiv.2011.02.004; Wang X, 2014, ANAL METHODS-UK, V6, P3019, DOI 10.1039/c4ay00288a; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang YY, 2015, INFLAMMATION, V38, P756, DOI 10.1007/s10753-014-9986-y; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou Y, 2019, INT J NEUROSCI, V129, P801, DOI 10.1080/00207454.2019.1569652	68	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2021	25	15					7122	7134		10.1111/jcmm.16741		JUN 2021	13	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	TU3TW	WOS:000664647600001	34160882	Green Published, gold			2022-02-07	
J	Cajani, S; Fischer, H; Pietsch, U				Cajani, S.; Fischer, H.; Pietsch, U.			Emergency service care of mountain bike elite races Rescue concept and analysis of 5 years of world cup elite cross-country/downhill and marathon stage races	ANAESTHESIST			German	Article						Mountain bike injury; Downhill; Cross-country; Mountain rescue; Rescue concept; Endurance events	INJURY	Background Despite the ever-gaining popularity of mountain bike sports, the number of studies in regards to injury patterns and organizational aspects of rescue services is rather sparse. To efficiently support mass events such as the Union Cycliste Internationale (UCI) World Cup and UCI Championship, the World Championships and Swiss Epic Marathon, efficient rescue concepts are crucial. Challenges include high risk of injury in disciplines such as Downhill as well as the need to cover events in remote and often rough terrain in the Swiss Alps during the Swiss Epic Marathon, providing medical services not only for participants but also for spectators. We analysed the number of injuries sustained by participants as well as the different challenges for rescue services at these events. Methods Retrospective analysis of emergencies at the Swiss Epic from 2016-2020, the UCI World Cup Races from 2015-2017 and 2019, as well as the UCI Championship 2018. Summary of the organizational aspects of the attending rescue services and special requirements and track concepts used at the events analysed. Results Significantly higher probability of injury in Downhill disciplines vs. Cross-Country. In particular traumatic brain injury and extremity fractures. More severe injuries (NACA III to IV) were more common in Downhill compared to other disciplines (p < 0,01). Conclusion Mass events require rescue concepts tailored to the competition's sport as well as it's terrain. The number of injuries was low but their severity necessitates highly qualified personnel and efficient rescue logistics to be planned beforehand. GPS-tracking and central disposition of mobile rescue resources is essential for marathon races while track competitions benefit from a mix of stationary posts and mobile units.	[Cajani, S.; Fischer, H.; Pietsch, U.] Kantonsspital St Gallen, Klin Anasthesiol Intens Med Rettungsmed & Schmerz, St Gallen, Switzerland; [Pietsch, U.] Univsitatsspital Bern, Univ Notfallzentrum, Inselspital, Bern, Switzerland		Pietsch, U (corresponding author), Univsitatsspital Bern, Univ Notfallzentrum, Inselspital, Bern, Switzerland.	urs.pietsch@kssg.ch					Ansari M, 2017, CURR SPORT MED REP, V16, P404, DOI 10.1249/JSR.0000000000000429; Chow TK, 2002, WILD ENVIRON MED, V13, P27, DOI 10.1580/1080-6032(2002)013[0027:MOIICO]2.0.CO;2; Clark G, 2021, CLIN J SPORT MED, V31, pE414, DOI 10.1097/JSM.0000000000000819; Pietsch Urs, 2016, Air Med J, V35, P301, DOI 10.1016/j.amj.2016.05.006; Yanturali S, 2015, PHYSICIAN SPORTSMED, V43, P348, DOI 10.1080/00913847.2015.1096182	5	0	0	5	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JAN	2022	71	1			SI		59	64		10.1007/s00101-021-00999-4		JUN 2021	6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	YI0HM	WOS:000664426600001	34159413				2022-02-07	
J	Ilyas, CMA; Rehm, M; Nasrollahi, K; Madadi, Y; Moeslund, TB; Seydi, V				Ilyas, Chaudhary Muhammad Aqdus; Rehm, Matthias; Nasrollahi, Kamal; Madadi, Yeganeh; Moeslund, Thomas B.; Seydi, Vahid			Deep transfer learning in human-robot interaction for cognitive and physical rehabilitation purposes	PATTERN ANALYSIS AND APPLICATIONS			English	Article; Early Access						Deep transfer learning; Emotion recognition; Traumatic brain injury (TBI); TBI patients database; Cognitive; social; and physical therapy; Rehabilitation strategies; Human-robot interaction; Assistive care; Assessment and monitoring; Augmentative and Assistive Technology (AAT)	FACIAL EXPRESSION RECOGNITION; CARE; IMPAIRMENT; STRATEGIES; NETWORK	This paper presents the extraction of the emotional signals from traumatic brain-injured (TBI) patients through the analysis of facial features and implementation of the effective emotion-recognition model through the Pepper robot to assist in the rehabilitation process. The identification of emotional cues from TBI patients is very challenging due to unique and diverse psychological, physiological, and behavioral challenges such as non-cooperation, facial/body paralysis, upper or lower limb impairments, cognitive, motor, and hearing skills inhibition. It is essential to read subtle changes in the emotional cues of TBI patients for effective communication and the development of affect-based systems. To analyze the variations of the emotional signal in TBI patients, a new database is collected in a natural and unconstrained environment from eleven residents of a neurological center in three different modalities, RGB, thermal and depth in three specified scenarios performing physical, cognitive and social communication rehabilitation activities. Due to the lack of labeled data, a deep transfer learning method is applied to efficiently classify emotions. The emotion classification model is tested through closed-field study and installment of a Pepper robot equipped with the trained model. Our deep trained and fine-tuned emotional recognition model composed of CNN-LSTM has improved the performance by 1.47% on MMI, and 4.96% on FER2013 validation data set. In addition, use of temporal information and transfer learning techniques to overcome TBI-data limitations has increased the performance efficacy on challenging dataset of neurologically impaired people. Findings that emerged from the study illustrate the noticeable effectiveness of SoftBank Pepper robot equipped with deep trained emotion recognition model in developing rehabilitation strategies by monitoring the TBI patient's emotions. This research article presents the technical solution for real therapeutic robot interaction to rehabilitate patients with standard monitoring, assessment, and feedback in the neuro centers.	[Ilyas, Chaudhary Muhammad Aqdus; Nasrollahi, Kamal; Madadi, Yeganeh; Moeslund, Thomas B.] Aalborg Univ, Visual Anal & Percept VAP Lab, Aalborg, Denmark; [Ilyas, Chaudhary Muhammad Aqdus; Rehm, Matthias] Aalborg Univ, Human Robot Interact HRI Lab, Aalborg, Denmark; [Madadi, Yeganeh; Seydi, Vahid] Islamic Azad Univ, South Tehran Branch, Fac Tech & Engn, Dept Comp Engn, Tehran, Iran; [Nasrollahi, Kamal] Milestone Syst AS, Res Dept, Copenhagen, Denmark		Ilyas, CMA (corresponding author), Aalborg Univ, Visual Anal & Percept VAP Lab, Aalborg, Denmark.; Ilyas, CMA (corresponding author), Aalborg Univ, Human Robot Interact HRI Lab, Aalborg, Denmark.	cmai@create.aau.dk	Ilyas, Chaudhary Muhammad Aqdus/G-2308-2017	Ilyas, Chaudhary Muhammad Aqdus/0000-0002-0766-3531; Moeslund, Thomas B./0000-0001-7584-5209			Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Corneanu CA, 2016, IEEE T PATTERN ANAL, V38, P1548, DOI 10.1109/TPAMI.2016.2515606; Albiol A, 2008, PATTERN RECOGN LETT, V29, P1537, DOI 10.1016/j.patrec.2008.03.017; Albuquerque VHC, 2017, BRAIN COMPUTER INTER; Alharbi S, 2017, IEEE IPCCC; Balconi M., 2012, NEUROPSYCHOL TRENDS, V11, P19; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bellantonio M., 2017, SPATIOTEMPORAL PAIN, P151; Bemelmans R, 2012, J AM MED DIR ASSOC, V13, P114, DOI 10.1016/j.jamda.2010.10.002; Berretti S, 2011, VISUAL COMPUT, V27, P1021, DOI 10.1007/s00371-011-0611-x; Breuer R., 2017, ARXIV PREPRINT ARXIV; Burgner-Kahrs J, 2015, IEEE T ROBOT, V31, P1261, DOI 10.1109/TRO.2015.2489500; Cabibihan JJ, 2013, INT J SOC ROBOT, V5, P593, DOI 10.1007/s12369-013-0202-2; Calvaresi D, 2017, J AMB INTEL HUM COMP, V8, P239, DOI 10.1007/s12652-016-0374-3; Chen LF, 2018, INFORM SCIENCES, V428, P49, DOI 10.1016/j.ins.2017.10.044; Deng W., 2020, IEEE T AFFECT COMPUT; Dhall A., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P2106, DOI 10.1109/ICCVW.2011.6130508; Dhall A, 2011, TRCS1121 AUSTR NAT U; Dhall A, 2017, P 19 ACM INT C MULT, P524, DOI DOI 10.1145/3136755.3143004; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Ekman P., 2013, EMOTION HUMAN FACE G; Elaklouk AM, 2015, J KING SAUD UNIV-COM, V27, P160, DOI 10.1016/j.jksuci.2014.03.019; Fan Y, 2016, ICMI'16: PROCEEDINGS OF THE 18TH ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P445, DOI 10.1145/2993148.2997632; Friesen W. V., 1983, U CALIFORNIA SAN FRA, V2, P1; Goodfellow IJ, 2015, NEURAL NETWORKS, V64, P59, DOI 10.1016/j.neunet.2014.09.005; Guo JZ, 2018, IEEE ACCESS, V6, P26391, DOI 10.1109/ACCESS.2018.2831927; Hassner T, 2015, PROC CVPR IEEE, P4295, DOI 10.1109/CVPR.2015.7299058; Ng HW, 2015, ICMI'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P443, DOI 10.1145/2818346.2830593; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Ilyas CMA, 2019, IEEE ROMAN; Ilyas CMA, 2018, IEEE IMAGE PROC, P2291, DOI 10.1109/ICIP.2018.8451223; Ilyas CMA, 2018, INT JOINT C COMP VIS, P369; Jones M, 2003, MITSUBISHI ELECT RES, V3, P2; Kahou SE, 2013, ICMI'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P543, DOI 10.1145/2522848.2531745; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kaya H, 2015, ICMI'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P459, DOI 10.1145/2818346.2830588; Kim BK, 2016, IEEE COMPUT SOC CONF, P1499, DOI 10.1109/CVPRW.2016.187; Kim Y, 2017, ARXIV PREPRINT ARXIV; King DE, 2009, J MACH LEARN RES, V10, P1755; Krishna NM, 2019, IEEE ACCESS, V7, P77905, DOI 10.1109/ACCESS.2019.2922047; Kulkarni K, 2021, IEEE T AFFECT COMPUT, V12, P377, DOI 10.1109/TAFFC.2018.2874996; Kuo CM, 2018, IEEE COMPUT SOC CONF, P2202, DOI 10.1109/CVPRW.2018.00286; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Li S, 2017, PROC CVPR IEEE, P2584, DOI 10.1109/CVPR.2017.277; Liu M., 2014, P 16 INT C MULT INT, P494, DOI DOI 10.1145/2663204.2666274; Liu P, 2014, PROC CVPR IEEE, P1805, DOI 10.1109/CVPR.2014.233; Liu XF, 2017, IEEE COMPUT SOC CONF, P522, DOI 10.1109/CVPRW.2017.79; Lucey P., 2010, P COMP SOC C COMP VI, V2010, P94, DOI DOI 10.1109/CVPRW.2010.5543262; Lyons M.J., 1998, P 3 INT C AUT FAC GE, P14, DOI DOI 10.5281/ZENODO.3451524; Maskeliunas R, 2019, FUTURE INTERNET, V11, DOI 10.3390/fi11120259; Mavadati M, 2016, P IEEE C COMP VIS PA, P1; Mavadati SM, 2013, IEEE T AFFECT COMPUT, V4, P151, DOI 10.1109/T-AFFC.2013.4; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Meng ZB, 2017, IEEE INT CONF AUTOMA, P558, DOI 10.1109/FG.2017.140; Mohammadi MR, 2014, J VIS COMMUN IMAGE R, V25, P1082, DOI 10.1016/j.jvcir.2014.03.006; Muri RM, 2016, J COMP NEUROL, V524, P1578, DOI 10.1002/cne.23908; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Otberdout N, 2019, IEEE T NEUR NET LEAR; Pantic M, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO (ICME), VOLS 1 AND 2, P317, DOI 10.1109/ICME.2005.1521424; Perry JC, 2011, HDB RES IMPROVING LE, P683; Rapple L, 2008, FOCUS J RESP CARE SL, P36; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Robinson H, 2014, INT J SOC ROBOT, V6, P575, DOI 10.1007/s12369-014-0242-2; Rodil K, 2018, NORDICHI'18: PROCEEDINGS OF THE 10TH NORDIC CONFERENCE ON HUMAN-COMPUTER INTERACTION, P686, DOI 10.1145/3240167.3240253; Rudovic O, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aao6760; Salkevicius J, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8091039; Sariyanidi E, 2015, IEEE T PATTERN ANAL, V37, P1113, DOI 10.1109/TPAMI.2014.2366127; Shan CF, 2009, IMAGE VISION COMPUT, V27, P803, DOI 10.1016/j.imavis.2008.08.005; Shapii A, 2015, BIOMED RES INT 2015; Simonyan K, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.8; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sun N, 2019, PATTERN RECOGN LETT, V119, P49, DOI 10.1016/j.patrec.2017.10.022; Sutton M, 2012, ASHA LEADER, V17, P32; Tang Y, 2013, ABS13060239 CORR; Taylor RH, 2016, SPRINGER HANDBOOK OF ROBOTICS, P1657; Tian YI, 2001, IEEE T PATTERN ANAL, V23, P97, DOI 10.1109/34.908962; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Uddin MZ, 2017, IEEE ACCESS, V5, P4525, DOI 10.1109/ACCESS.2017.2676238; Valstar M, 2010, P INT WORKSH EMOTION, P65; Wan J, 2017, IEEE INT CONF COMP V, P3189, DOI 10.1109/ICCVW.2017.377; Yan JW, 2018, NEUROCOMPUTING, V309, P27, DOI 10.1016/j.neucom.2018.03.068; Yao AB, 2016, ICMI'16: PROCEEDINGS OF THE 18TH ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P472, DOI 10.1145/2993148.2997639; Yao AB, 2015, ICMI'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P451, DOI 10.1145/2818346.2830585; Yin LJ, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P211; Yu ZB, 2018, VISUAL COMPUT, V34, P1691, DOI 10.1007/s00371-017-1443-0; Yu ZD, 2015, ICMI'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P435; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; Zhang KH, 2017, IEEE T IMAGE PROCESS, V26, P4193, DOI 10.1109/TIP.2017.2689999; Zhang KP, 2016, IEEE SIGNAL PROC LET, V23, P1499, DOI 10.1109/LSP.2016.2603342; [张醒 Zhang Xing], 2013, [火工品, Initiators & Pyrotechnics], P1; Zhang ZP, 2018, INT J COMPUT VISION, V126, P550, DOI 10.1007/s11263-017-1055-1; Zhao XY, 2016, LECT NOTES COMPUT SC, V9906, P425, DOI 10.1007/978-3-319-46475-6_27; Zhao XM, 2011, SENSORS-BASEL, V11, P9573, DOI 10.3390/s111009573	93	0	0	9	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1433-7541	1433-755X		PATTERN ANAL APPL	Pattern Anal. Appl.												10.1007/s10044-021-00988-8		JUN 2021	25	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	SW5LY	WOS:000664557900001					2022-02-07	
J	Karthigeyan, M; Gupta, SK; Salunke, P; Dhandapani, S; Wankhede, LS; Kumar, A; Singh, A; Sahoo, SK; Tripathi, M; Gendle, C; Singla, R; Aggarwal, A; Singla, N; Mohanty, M; Mohindra, S; Chhabra, R; Tewari, MK; Jain, K				Karthigeyan, Madhivanan; Gupta, Sunil Kumar; Salunke, Pravin; Dhandapani, Sivashanmugam; Wankhede, Lomesh Shankarrao; Kumar, Anurodh; Singh, Apinderpreet; Sahoo, Sushanta Kumar; Tripathi, Manjul; Gendle, Chandrashekhar; Singla, Raghav; Aggarwal, Ashish; Singla, Navneet; Mohanty, Manju; Mohindra, Sandeep; Chhabra, Rajesh; Tewari, Manoj Kumar; Jain, Kajal			Head injury care in a low- and middle-income country tertiary trauma center: epidemiology, systemic lacunae, and possible leads	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Neurotrauma; Registry; Tertiary; Trauma; Lower-middle-income countries; Hub and spoke; Task sharing	BRAIN-INJURY; MANAGEMENT; OUTCOMES; TIME	Background Although head injury (HI) from low- and middle-income countries (LMIC) heavily contributes to the global disease burden, studies are disproportionately less from this part of the world. Knowing the different epidemiological characteristics from high-income nations can target appropriate prevention strategies. This study aims to provide a comprehensive overview of the clinico-epidemiological data of HI patients, focusing on the existing challenges with possible solutions from a developing nation's perspective. Methods This is a prospective, registry-based, observational study of HI in an Indian tertiary trauma-care center over 4 years. Various clinico-epidemiological parameters, risk factors, and imaging spectrum were analyzed in a multivariate model to identify the challenges faced by LMIC and discuss pragmatic solutions. Results The study included a large-volume cohort of 14,888 patients. Notably, half of these patients belonged to mild HI, despite most were referred (90.3%) cases. Only one-third (30.8%) had severe HI. Less than a third reached us within 6 h of injury. Road traffic accidents (RTA) accounted for most injuries (61.1%), especially in the young (70.9%). Higher age, males, RTA, helmet non-usage, drunken driving, systemic injuries, and specific imaging features had an independent association with injury severity. Conclusions The study represents the much-needed, large-volume, epidemiological profile of HI from an LMIC, highlighting the suboptimal utilization of peripheral healthcare systems. Strengthening and integrating these facilities with the tertiary centers in a hub and enhanced spoke model, task sharing design, and efficient back-referrals promise effective neurotrauma care while avoiding overburden in the tertiary centers. Better implementation of road safety laws also has the potential to reduce the burden of HI.	[Karthigeyan, Madhivanan; Gupta, Sunil Kumar; Salunke, Pravin; Dhandapani, Sivashanmugam; Wankhede, Lomesh Shankarrao; Kumar, Anurodh; Singh, Apinderpreet; Sahoo, Sushanta Kumar; Tripathi, Manjul; Gendle, Chandrashekhar; Singla, Raghav; Aggarwal, Ashish; Singla, Navneet; Mohanty, Manju; Mohindra, Sandeep; Chhabra, Rajesh; Tewari, Manoj Kumar] Postgrad Inst Med Educ & Res PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India; [Jain, Kajal] Postgrad Inst Med Educ & Res PGIMER, Dept Anesthesia, Sect 12, Chandigarh 160012, India		Gupta, SK (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India.	drguptasunil@gmail.com		Singla, Raghav/0000-0003-4426-5089			Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Agrawal A, 2018, NEUROL INDIA, V66, P976, DOI 10.4103/0028-3886.237027; Al-Hajj S, 2021, NEUROEPIDEMIOLOGY, V55, P20, DOI 10.1159/000511554; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], ADOLESCENT HLTH S E; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burton Adrian, 2016, Lancet Neurol, V15, P1011, DOI 10.1016/S1474-4422(16)30131-4; Chaitanya K, 2018, CHILD NERV SYST, V34, P1119, DOI 10.1007/s00381-018-3784-z; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Devi BI, 2019, WORLD NEUROSURG, V123, pE588, DOI 10.1016/j.wneu.2018.11.227; Devi Y, 2020, J NEUROSCI RURAL PRA, V11, P629, DOI 10.1055/s-0040-1716777; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dhandapani S S, 2012, Asian J Neurosurg, V7, P17, DOI 10.4103/1793-5482.95690; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2341-x; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; GBD, 2016, LANCET NEUROL, V18, P56; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; John T J, 1999, Indian Pediatr, V36, P461; Karthigeyan M, 2021, ACTA NEUROCHIR, V163, P1053, DOI 10.1007/s00701-021-04723-4; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2017, NEUROL INDIA, V65, P257, DOI 10.4103/0028-3886.201848; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Morisse E, 2014, BRAIN INJURY, V28, P1436, DOI 10.3109/02699052.2014.919526; Mukherjee KK, 2015, ACTA NEUROCHIR, V157, P305, DOI 10.1007/s00701-014-2296-1; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Robertson Faith C, 2020, World Neurosurg X, V6, P100058, DOI 10.1016/j.wnsx.2019.100058; Robertson Faith C, 2020, World Neurosurg X, V6, P100060, DOI 10.1016/j.wnsx.2019.100060; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; United Nations, 2017, WORLD POP AG; World Health Organization, 2006, HELM ROAD SAF DEC MA; World Health Organization, 2018, GLOBAL STATUS REPORT; WorldHealth Organization, 2004, WORLD REPORT ROAD TR	52	0	0	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2021	163	10					2919	2930		10.1007/s00701-021-04908-x		JUN 2021	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UW6OM	WOS:000664420500002	34159448				2022-02-07	
J	Stone, JE; Fung, TS; Machan, M; Campbell, C; Shan, RLP; Debert, CT				Stone, Jacqueline E.; Fung, Tak S.; Machan, Matthew; Campbell, Christina; Shan, Rodney Li Pi; Debert, Chantel T.			Ultrasound-guided platelet-rich plasma injections for post-traumatic greater occipital neuralgia: study protocol for a pilot randomized controlled trial	PILOT AND FEASIBILITY STUDIES			English	Article						Greater occipital neuralgia; Post-traumatic headaches; Concussion; Traumatic brain injury; Platelet-rich plasma; Corticosteroids; Ultrasound guidance; Randomized controlled trial	CARPAL-TUNNEL-SYNDROME; NERVE REGENERATION; HEADACHE IMPACT; INJURIES; CONCUSSION; EFFICACY	Background: Post-traumatic headaches (PTH) are a common sequelae of traumatic brain injury (TBI) and greatly impact patient function and quality of life. Post-traumatic greater occipital neuralgia (GON) is a type of post-traumatic headache. Conventional treatment includes steroid/anesthetic injections which typically alleviate pain but have a short duration of effect. Platelet-rich plasma (PRP) is an emerging biological treatment for numerous degenerative disorders, including peripheral nerve disorders. The primary aim of this pilot study is to evaluate whether a randomized control trial of PRP for the treatment of GON in patients with post-traumatic headaches is feasible in regard to recruitment, adherence, retention, and adherence and adverse events. Exploratory aims include improvement in pain, function, and quality of life in patients with post-traumatic GON receiving PRP compared to steroid/anesthetic and normal saline injections. Methods: Thirty adults (over 18 years of age) with post-traumatic GON will be randomized into one of three groups: (1) autologous PRP injection, (2) steroid/anesthetic injection (standard care), or (3) placebo injection with normal saline. Injections will be performed to the greater occipital nerve under ultrasound guidance by a trained physician. Daily headache intensity and frequency data will be collected pre-injection and for the duration of the study period. Feasibility will be defined as greater than 30% recruitment, 70% completion of intervention, 70% retention, and less than 2 minor adverse events. Exploratory outcomes will be explored using the Headache Impact Test-6 (HIT-6, a valid and reliable 6-item questionnaire for assessment of the impact of headaches across different diagnostic groups of headaches) and the quality of life in following brain injury questionnaire (QOILIBRI). Discussion: This pilot study will be the first to evaluate the feasibility of PRP as a potential treatment of GON in patients with post-traumatic headache.	[Stone, Jacqueline E.; Machan, Matthew; Campbell, Christina; Shan, Rodney Li Pi; Debert, Chantel T.] Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, 1403 29 St NW, Calgary, AB T2N 2T9, Canada; [Fung, Tak S.] Univ Calgary, Informat Technol, Calgary, AB, Canada		Stone, JE (corresponding author), Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.	jestone@ucalgary.ca		Stone, Jacqueline/0000-0003-0737-522X	Hotchkiss Brain Institute PFUN award	This study is funded by the Hotchkiss Brain Institute PFUN award; this is a peer reviewed grant. None of the study's funding sources had a role in study design or implementation. Funding agencies will not have a role in study execution, analysis, results interpretation, manuscript drafting, or future publication of results.	Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; Anjayani S, 2014, INT J DERMATOL, V53, P109, DOI 10.1111/ijd.12162; ANTHONY M, 1992, CLIN NEUROL NEUROSUR, V94, P297, DOI 10.1016/0303-8467(92)90177-5; Chalela JA, 2018, AEROSP MED HUM PERF, V89, P409, DOI 10.3357/AMHP.5020.2018; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Choi I, 2016, J KOREAN MED SCI, V31, P479, DOI 10.3346/jkms.2016.31.4.479; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ding XG, 2009, ASIAN J ANDROL, V11, P215, DOI 10.1038/aja.2008.37; Dougherty C, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0411-x; Ducic I, 2015, MICROSURG, V35, P603, DOI 10.1002/micr.22503; Farrag TY, 2007, LARYNGOSCOPE, V117, P157, DOI 10.1097/01.mlg.0000249726.98801.77; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Giannessi E, 2014, J RECONSTR MICROSURG, V30, P617, DOI 10.1055/s-0034-1372483; Hammond S R, 1978, Clin Exp Neurol, V15, P258; Hassanien M, 2020, PAIN MED, V21, P757, DOI 10.1093/pm/pnz140; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnston PC, 2015, ENDOCRINE, V48, P410, DOI 10.1007/s12020-014-0409-5; Juskys Raimondas, 2018, Acta Med Litu, V25, P53, DOI 10.6001/actamedica.v25i2.3757; Kim JY, 2014, NEURAL REGEN RES, V9, P1351, DOI 10.4103/1673-5374.137587; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kuhn Walter F., 1997, Journal of Orofacial Pain, V11, P158; Laver L, 2017, CARTILAGE, V8, P341, DOI 10.1177/1947603516670709; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacMahon PJ, 2009, RADIOLOGY, V252, P647, DOI 10.1148/radiol.2523081929; Malahias MA, 2015, NEURAL REGEN RES, V10, P1856, DOI 10.4103/1673-5374.165322; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; Park GY, 2014, MUSCLE NERVE, V49, P56, DOI 10.1002/mus.23863; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Raeissadat SA, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1963-4; Sampson S, 2008, CURR REV MUSCULOSKE, V1, P165, DOI 10.1007/s12178-008-9032-5; Sanchez M, 2014, KNEE SURG SPORT TR A, V22, P1084, DOI 10.1007/s00167-013-2479-y; Sanchez M, 2017, NEURAL REGEN RES, V12, P47, DOI 10.4103/1673-5374.198973; Sanchez M, 2017, J TISSUE ENG REGEN M, V11, P1619, DOI 10.1002/term.2079; Sariguney Y, 2008, J RECONSTR MICROSURG, V24, P159, DOI 10.1055/s-2008-1076752; Shim JH, 2011, KOREAN J ANESTHESIOL, V61, P50, DOI 10.4097/kjae.2011.61.1.50; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Uzun H, 2017, J PLAST SURG HAND SU, V51, P301, DOI 10.1080/2000656X.2016.1260025; Ward JB, 2003, SEMIN NEUROL, V23, P59; Wu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00224-6; Zaremski JL, 2015, CURR SPORT MED REP, V14, P16, DOI 10.1249/JSR.0000000000000121; Zheng CB, 2016, J TISSUE ENG REGEN M, V10, P428, DOI 10.1002/term.1756; Zhu Y, 2020, LID, V21, P2057	43	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2055-5784		PILOT FEASIBILITY ST	Pilot Feasibility Stud.	JUN 22	2021	7	1							130	10.1186/s40814-021-00867-3			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	SX2RN	WOS:000665057700002	34158124	Green Published, gold			2022-02-07	
J	Amir, J; Nair, JKR; Del Carpio-O'Donovan, R; Ptito, A; Chen, JK; Chankowsky, J; Tinawi, S; Lunkova, E; Saluja, RS				Amir, Joelle; Nair, Jay Kumar Raghavan; Del Carpio-O'Donovan, Raquel; Ptito, Alain; Chen, Jen-Kai; Chankowsky, Jeffrey; Tinawi, Simon; Lunkova, Ekaterina; Saluja, Rajeet Singh			Atypical resting state functional connectivity in mild traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						functional magnetic resonance imaging; intrinsic functional connectivity networks; mild traumatic brain injury; postconcussive symptoms; resting state	DEFAULT-MODE NETWORK; SCALE; DYSFUNCTION; RECOVERY; FMRI	Objectives This study aimed to investigate changes in three intrinsic functional connectivity networks (IFCNs; default mode network [DMN], salience network [SN], and task-positive network [TPN]) in individuals who had sustained a mild traumatic brain injury (mTBI). Methods Resting-state functional magnetic resonance imaging (rs-fMRI) data were acquired from 27 mTBI patients with persistent postconcussive symptoms, along with 26 age- and sex-matched controls. These individuals were recruited from a Level-1 trauma center, at least 3 months after a traumatic episode. IFCNs were established based on seed-to-voxel, region-of-interest (ROI) to ROI, and independent component analyses (ICA). Subsequently, we analyzed the relationship between functional connectivity and postconcussive symptoms. Results Seed-to-voxel analysis of rs-fMRI demonstrated decreased functional connectivity in the right lateral parietal lobe, part of the DMN, and increased functional connectivity in the supramarginal gyrus, part of the SN. Our TPN showed both hypo- and hyperconnectivity dependent on seed location. Within network hypoconnectivity was observed in the visual network also using group comparison. Using an ICA, we identified altered network functional connectivity in regions within four IFCNs (sensorimotor, visual, DMN, and dorsal attentional). A significant negative correlation between dorsal attentional network connectivity and behavioral symptoms score was also found. Conclusions Our findings indicate that rs-fMRI may be of use clinically in order to assess disrupted functional connectivity among IFCNs in mTBI patients. Improved mTBI diagnostic and prognostic information could be especially relevant for athletes looking to safely return to play, as well for individuals from the general population with persistent postconcussive symptoms months after injury, who hope to resume activity.	[Amir, Joelle; Ptito, Alain; Chen, Jen-Kai; Lunkova, Ekaterina] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Nair, Jay Kumar Raghavan; Del Carpio-O'Donovan, Raquel; Chankowsky, Jeffrey; Saluja, Rajeet Singh] McGill Univ, Hlth Ctr, Dept Radiol, Montreal, PQ, Canada; [Tinawi, Simon] McGill Univ, Hlth Ctr, Dept Rehabil Med, Montreal, PQ, Canada; [Ptito, Alain; Saluja, Rajeet Singh] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		Saluja, RS (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada.	rajeet.saluja@mcgill.ca		Amir, Joelle/0000-0002-1783-1586	Fonds de recherche du Quebec -SanteFonds de la Recherche en Sante du Quebec [33299]	the Fonds de recherche du Quebec -Sante, Grant/Award Number: (33299)	Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chong CD, 2018, HEADACHE, V58, P827, DOI 10.1111/head.13269; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; D'Souza MM, 2020, NEURORADIOL J, V33, P186, DOI 10.1177/1971400920901706; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Di X, 2015, J NEUROPHYSIOL, V114, P2785, DOI 10.1152/jn.00893.2014; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kornelsen J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00048; Li FF, 2020, CNS NEUROSCI THER, V26, P1083, DOI 10.1111/cns.13430; Li FF, 2019, AGING-US, V11, P10684, DOI 10.18632/aging.102484; Lu LY, 2020, BRAIN IMAGING BEHAV, V14, P941, DOI 10.1007/s11682-020-00288-5; Lu LY, 2019, EUR J RADIOL, V114, P69, DOI 10.1016/j.ejrad.2019.03.002; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2001, J ATHL TRAINING, V36, P274; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nieto-Castanon A., 2020, HDB FUNCTIONAL CONNE; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Puig J, 2020, J NEUROTRAUM, V37, P1761, DOI 10.1089/neu.2019.6623; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rosenthal S, 2018, NEUROIMAG CLIN N AM, V28, P107, DOI 10.1016/j.nic.2017.09.008; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smitha KA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917697342; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Storti SF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00072; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yan Y, 2017, J CLIN NEUROSCI, V44, P114, DOI 10.1016/j.jocn.2017.05.010; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2021	11	8								10.1002/brb3.2261		JUN 2021	12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WK0YR	WOS:000663852700001	34152089	Green Submitted, gold, Green Published			2022-02-07	
J	Ashton, C; Laffan, M; Hutchinson, PJ; Lecky, F; Ralhan, S; Smith, JE; Coles, JP; Stanworth, S; Curry, N				Ashton, Catherine; Laffan, M.; Hutchinson, P. J.; Lecky, Fiona; Ralhan, S.; Smith, Jason E.; Coles, Jonathan P.; Stanworth, Simon; Curry, Nicola			Survey evaluating clinical equipoise around platelet transfusion after head injury and traumatic intracranial haemorrhage (ICH) in patients on antiplatelet medications	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						trauma; head; accidental falls; emergency department; haematology; geriatrics	ASPIRIN	Introduction Patients aged 60 or over account for over half of the severely injured trauma patients and a traumatic brain injury is the most common injury sustained. Many of these patients are taking antiplatelet medications but there is clinical equipoise about the role of platelet transfusion in patients with traumatic intracranial haemorrhage (ICH) taking prior antiplatelet medications. Method A prepiloted survey was designed to explore a range of clinical issues in managing patients taking antiplatelet medications admitted with a traumatic brain injury. This was sent via email to consultants and specialty registrar members of a variety of relevant UK societies and working groups in the fields of emergency medicine, critical care, neurosurgery and haematology. Results 193 responses were received, mostly from colleagues in emergency medicine, neurosurgery, anaesthesia and haematology. Respondents indicated that there is a lack of evidence to support the use of platelet transfusion in this patient population but also lack of evidence of harm. Results also demonstrate uncertainties as to whether platelets should be given to all or some patients and doubt regarding the value of viscoelastic testing. Discussion Our survey demonstrates equipoise in current practice with regards to platelet transfusion in patients with a traumatic ICH who are taking antiplatelet medication. There is support for additional trials to investigate the effect of platelet transfusion in this rising population of older, high-risk patients, in order to provide a better evidence-base for guideline development.	[Ashton, Catherine; Ralhan, S.] Oxford Univ Hosp NHS Fdn Trust, Dept Geratol, Oxford, England; [Laffan, M.] Imperial Coll London, Dept Immunol & Inflammat, London, England; [Hutchinson, P. J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Lecky, Fiona] Univ Sheffield, Hlth Serv Res, Sheffield, S Yorkshire, England; [Lecky, Fiona] Salford Royal Hosp NHS Fdn Trust, Emergency Dept TARN, Salford, Lancs, England; [Smith, Jason E.] Univ Hosp Plymouth NHS Trust, Emergency Dept, Plymouth, Devon, England; [Smith, Jason E.] Royal Ctr Def Med, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England; [Coles, Jonathan P.] Univ Cambridge, Anaesthesia, Cambridge, England; [Stanworth, Simon] NHS Blood & Transplant Organ Donat & Transplantat, Transfus, Bristol, Avon, England; [Curry, Nicola] Univ Oxford, Haematol, Radcliffe Dept Med, Oxford, England		Ashton, C (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Geratol, Oxford, England.	catherine.ashton@ouh.nhs.uk	; Smith, Jason/H-9380-2013	Coles, Jonathan/0000-0003-4013-679X; Lecky, Fiona/0000-0001-6806-0921; Laffan, Michael/0000-0002-8268-3268; Ashton, Catherine/0000-0003-4044-5293; Smith, Jason/0000-0002-6143-0421	NIHRNational Institute for Health Research (NIHR); Royal College of Surgeons of England; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR)	PJH is supported by the NIHR and the Royal College of Surgeons of England. JPC is supported by the NIHR Cambridge Biomedical Research Centre.	Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Baksaas-Aasen K, 2021, INTENS CARE MED, V47, P49, DOI 10.1007/s00134-020-06266-1; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Trauma Audit and Research Network (TARN), 2017, MAJOR TRAUMA OLDER P; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005	9	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2021-211189		JUN 2021	4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XL6WO	WOS:000728284400001	34158388	Green Submitted			2022-02-07	
J	Khosroshahi, SF; Yin, XZ; Donat, CK; McGarry, A; Lopez, MY; Baxan, N; Sharp, DJ; Sastre, M; Ghajari, M				Khosroshahi, Siamak Farajzadeh; Yin, Xianzhen; Donat, Cornelius K.; McGarry, Aisling; Lopez, Maria Yanez; Baxan, Nicoleta; Sharp, David J.; Sastre, Magdalena; Ghajari, Mazdak			Multiscale modelling of cerebrovascular injury reveals the role of vascular anatomy and parenchymal shear stresses	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BARRIER; IMPACT; DISRUPTION; INFLAMMATION; DEFORMATION; NEUROTRAUMA; CORTEX; DAMAGE	Neurovascular injury is often observed in traumatic brain injury (TBI). However, the relationship between mechanical forces and vascular injury is still unclear. A key question is whether the complex anatomy of vasculature plays a role in increasing forces in cerebral vessels and producing damage. We developed a high-fidelity multiscale finite element model of the rat brain featuring a detailed definition of the angioarchitecture. Controlled cortical impacts were performed experimentally and in-silico. The model was able to predict the pattern of blood-brain barrier damage. We found strong correlation between the area of fibrinogen extravasation and the brain area where axial strain in vessels exceeds 0.14. Our results showed that adjacent vessels can sustain profoundly different axial stresses depending on their alignment with the principal direction of stress in parenchyma, with a better alignment leading to larger stresses in vessels. We also found a strong correlation between axial stress in vessels and the shearing component of the stress wave in parenchyma. Our multiscale computational approach explains the unrecognised role of the vascular anatomy and shear stresses in producing distinct distribution of large forces in vasculature. This new understanding can contribute to improving TBI diagnosis and prevention.	[Khosroshahi, Siamak Farajzadeh; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London, England; [Yin, Xianzhen] Shanghai Inst Mat Med, Shanghai, Peoples R China; [Donat, Cornelius K.; McGarry, Aisling; Lopez, Maria Yanez; Sharp, David J.; Sastre, Magdalena] Imperial Coll London, Dept Brain Sci, London, England; [Baxan, Nicoleta] Imperial Coll London, Biol Imaging Ctr, London, England; [Donat, Cornelius K.] Imperial Coll London, Ctr Blast Injury Studies, London, England		Khosroshahi, SF (corresponding author), Imperial Coll London, Dyson Sch Design Engn, London, England.	s.f.khosroshahi@imperial.ac.uk	Lopez, Maria Yanez/AAB-6740-2019	Lopez, Maria Yanez/0000-0001-5187-2501; McGarry, Aisling/0000-0002-7203-1258; Farajzadeh Khosroshahi, Siamak/0000-0003-4476-2579	Wellcome TrustWellcome TrustEuropean Commission [212430/Z/18/Z]; Wellcome Trust Networks of Excellence; Royal British Legion Centre for Blast Injury Studies, Imperial College London	This study was funded through Wellcome Trust, Seed Award in Science Grant No. 212430/Z/18/Z, Wellcome Trust Networks of Excellence and the Royal British Legion Centre for Blast Injury Studies, Imperial College London.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Al-Sarraj S, 2016, DIAGNOSTIC HISTOPATH, V22, P318, DOI [10.1016/j.mpdhp.2016.08.005, DOI 10.1016/J.MPDHP.2016.08.005]; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chanda B., 2011, DIGITAL IMAGE PROCES; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Donat CK, 2021, BRAIN, V144, P70, DOI 10.1093/brain/awaa336; Donat CK, 2016, NEUROMOL MED, V18, P158, DOI 10.1007/s12017-016-8385-y; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; LSTC, 2014, LS DYNA KEYWORD USER; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Menon DK., 2015, NAT REV GASTRO HEPAT, V12, P57; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Omori K., 2000, ASME APPL MECH DIV, V246, P167; Pasquesi SA, 2020, J MECH BEHAV BIOMED, V106, DOI 10.1016/j.jmbbm.2020.103740; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI., 1997, SAE T, V106, P3792; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Todorov MI, 2020, NAT METHODS, V17, P442, DOI 10.1038/s41592-020-0792-1; Toth A, 2019, J NEUROTRAUM, V36, P1670, DOI 10.1089/neu.2018.6004; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Nguyen VP, 2011, J MULTISCALE MODEL, V3, P229, DOI 10.1142/S1756973711000509; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08311; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732	51	0	0	3	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 21	2021	11	1							12927	10.1038/s41598-021-92371-0			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TA5AS	WOS:000667261900015	34155289	Green Published, gold			2022-02-07	
J	Montivero, AJ; Ghersi, MS; Silvero, MJ; de la Villarmois, EA; Catalan-Figueroa, J; Herrera, M; Becerra, MC; Herenu, CB; Perez, MF				Montivero, Agustin. J.; Ghersi, Marisa. S.; Silvero C, M. Jazmin; Artur de la Villarmois, Emilce; Catalan-Figueroa, Johanna; Herrera, Macarena; Becerra, Maria Cecilia; Herenu, Claudia. B.; Perez, Mariela. F.			Early IGF-1 Gene Therapy Prevented Oxidative Stress and Cognitive Deficits Induced by Traumatic Brain Injury	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; neuroinflammation; secondary injury; cognitive deficits; IGF-1 gene therapy	GROWTH-FACTOR-I; WORKING-MEMORY; ANTERIOR-PITUITARY; RATS; SERUM; PATHOPHYSIOLOGY; HIPPOCAMPUS; MANAGEMENT; MICROGLIA; RECOVERY	Traumatic Brain Injury (TBI) remains a leading cause of morbidity and mortality in adults under 40 years old. Once primary injury occurs after TBI, neuroinflammation and oxidative stress (OS) are triggered, contributing to the development of many TBI-induced neurological deficits, and reducing the probability of critical trauma patients ' survival. Regardless the research investment on the development of anti-inflammatory and neuroprotective treatments, most pre-clinical studies have failed to report significant effects, probably because of the limited blood brain barrier permeability of no-steroidal or steroidal anti-inflammatory drugs. Lately, neurotrophic factors, such as the insulin-like growth factor 1 (IGF-1), are considered attractive therapeutic alternatives for diverse neurological pathologies, as they are neuromodulators linked to neuroprotection and anti-inflammatory effects. Considering this background, the aim of the present investigation is to test early IGF-1 gene therapy in both OS markers and cognitive deficits induced by TBI. Male Wistar rats were injected via Cisterna Magna with recombinant adenoviral vectors containing the IGF-1 gene cDNA 15 min post-TBI. Animals were sacrificed after 60 min, 24 h or 7 days to study the advanced oxidation protein products (AOPP) and malondialdehyde (MDA) levels, to recognize the protein oxidation damage and lipid peroxidation respectively, in the TBI neighboring brain areas. Cognitive deficits were assessed by evaluating working memory 7 days after TBI. The results reported significant increases of AOPP and MDA levels at 60 min, 24 h, and 7 days after TBI in the prefrontal cortex, motor cortex and hippocampus. In addition, at day 7, TBI also reduced working memory performance. Interestingly, AOPP, and MDA levels in the studied brain areas were significantly reduced after IGF-1 gene therapy that in turn prevented cognitive deficits, restoring TBI-animals working memory performance to similar values regarding control. In conclusion, early IGF-1 gene therapy could be considered a novel therapeutic approach to targeting neuroinflammation as well as to preventing some behavioral deficits related to TBI.	[Montivero, Agustin. J.; Ghersi, Marisa. S.; Artur de la Villarmois, Emilce; Catalan-Figueroa, Johanna; Herrera, Macarena; Herenu, Claudia. B.; Perez, Mariela. F.] Univ Nacl Cordoba, Inst Farmacol Expt Cordoba IFEC CONICET, Fac Ciencias Quim, Dept Farmacol, Cordoba, Argentina; [Silvero C, M. Jazmin; Becerra, Maria Cecilia] Univ Nacl, Inst Multidisciplinario Biol Vegetal IMBIV CONICE, Fac Ciencias Quim, Dept Ciencias Farmace prime uticas, Cordoba, Argentina; [Catalan-Figueroa, Johanna] Univ Catol Maule, Fac Med, Escuela Quim Farm, Talca, Chile		Perez, MF (corresponding author), Univ Nacl Cordoba, Inst Farmacol Expt Cordoba IFEC CONICET, Fac Ciencias Quim, Dept Farmacol, Cordoba, Argentina.	mfperez@unc.edu.ar		Becerra, Maria Cecilia/0000-0003-2853-4437	CONSOLIDAR SECyT-UNC 2018; PRIMAR SECyT-UNC 2019; IFEC-CONICET Institutional grant 2019	This study was supported by the grants from CONSOLIDAR SECyT-UNC 2018 and PRIMAR SECyT-UNC 2019 to Perez, IFEC-CONICET Institutional grant 2019, and CONSOLIDAR SECyT-UNC 2018 to Becerra.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Alain BBN, 2008, CHIN J TRAUMATOL, V11, P114; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ayabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102469; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2019, SEXUALLY TRANSMITTED, P24; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Deakin IH, 2012, CEREB CORTEX, V22, P1520, DOI 10.1093/cercor/bhr223; Dillon GM, 2008, NEUROBIOL LEARN MEM, V90, P426, DOI 10.1016/j.nlm.2008.05.008; Dubiel R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00520; Falomir-Lockhart E, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00048; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Hatton J., 1997, FOC, V2, pE9, DOI [10.3171/foc.1997.2.5.9, DOI 10.3171/FOC.1997.2.5.9]; Herenu CB, 2007, GENE THER, V14, P237, DOI 10.1038/sj.gt.3302870; Herenu CB, 2009, NEUROSCIENCE, V163, P442, DOI 10.1016/j.neuroscience.2009.06.024; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Impellizzeri D, 2019, FASEB J, V33, P11364, DOI 10.1096/fj.201900538R; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Katerji M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1279250; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Krishnamurthy K., 2016, CELLULAR MOL MECH SE; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lara AH, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00173; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Madathil S.K., 2015, IGF 1 IGF R SIGNALIN; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Montivero A.J., 2021, PSYCHIAT NEUROSCIENC; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Nishida F, 2011, NEUROSCIENCE, V177, P195, DOI 10.1016/j.neuroscience.2011.01.013; Nishida F, 2020, EUR J NEUROSCI, V52, P3339, DOI 10.1111/ejn.14876; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Occhieppo VB, 2021, EUR J NEUROSCI, V54, P5705, DOI 10.1111/ejn.14756; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Pardo J, 2018, J GERONTOL A-BIOL, V73, P459, DOI 10.1093/gerona/glx125; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Polli JE, 1997, J PHARM SCI, V86, P690, DOI 10.1021/js960473x; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Robles JF, 2009, INT J ENDOCRINOL MET, V7, P72; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Serhan A, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00349; Silva DD, 2011, ACTA CIR BRAS, V26, P94, DOI 10.1590/S0102-86502011000200004; Siracusa R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090824; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tian J, 2017, MOL NEUROBIOL, V54, P3976, DOI 10.1007/s12035-016-9956-5; Trejo JL, 2004, GROWTH HORM IGF RES, V14, pS39, DOI 10.1016/j.ghir.2004.03.010; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Whitaker-Lea WA, 2017, PHYS MED REH CLIN N, V28, P227, DOI 10.1016/j.pmr.2016.12.002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zgaljardic DJ, 2011, CLIN ENDOCRINOL, V74, P365, DOI 10.1111/j.1365-2265.2010.03935.x; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261	82	0	0	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUN 21	2021	12								672392	10.3389/fphar.2021.672392			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TD7BS	WOS:000669478200001	34234671	Green Published, gold			2022-02-07	
J	Pham, TL; Chrousos, GP; Merkenschlager, A; Petrowski, K; Ullmann, E				Pham, Thuylinh L.; Chrousos, George P.; Merkenschlager, Andreas; Petrowski, Katja; Ullmann, Enrico			Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report	FRONTIERS IN PSYCHIATRY			English	Article						Post-traumatic stress disorder; lamotrigine; inflammation; self-harm behavior; obesity	PTSD	The SARS-CoV-2 pandemic has been a worldwide chronic, stress-inducing natural catastrophe associated with increased emotional challenging. Patients with Post-traumatic stress disorder (PTSD), self-injury behavior, and obesity are predisposed to aggravation of their symptoms at this time, requiring new therapeutic approaches to balance their disrupted neuro-hormonal stress axis. Here we present our observations of an off-label treatment with lamotrigine in an adolescent girl with PTSD, self-injury behavior, and obesity. Lamotrigine was an efficacious pharmaceutical intervention that helped the patient deal with chronic stress and associated anxiety. The results are discussed based on our previous basic research outcomes in animals and humans that focused on the glutamate-cortisol circuits within the limbic brain.	[Pham, Thuylinh L.; Ullmann, Enrico] Univ Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, Leipzig, Germany; [Chrousos, George P.] Natl & Kapodistrian Univ Athens, Univ Res Inst Maternal & Child Hlth & Precis Med, Athens, Greece; [Chrousos, George P.; Ullmann, Enrico] South Ural State Univ, Sch Med Biol, Chelyabinsk, Russia; [Merkenschlager, Andreas] Univ Leipzig, Dept Neuropediat, Leipzig, Germany; [Petrowski, Katja] Univ Med Mainz, Dept Med Psychol & Med Sociol, Clin & Policlin Psychosomat Med & Psychotherapy, Mainz, Germany; [Ullmann, Enrico] Tech Univ Dresden, Dept Internal Med, Dresden, Germany		Ullmann, E (corresponding author), Univ Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, Leipzig, Germany.; Ullmann, E (corresponding author), South Ural State Univ, Sch Med Biol, Chelyabinsk, Russia.; Ullmann, E (corresponding author), Tech Univ Dresden, Dept Internal Med, Dresden, Germany.	enrico.ullmann@uniklinikum-dresden.de					Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; Baumeister D, 2016, MOL PSYCHIATR, V21, P642, DOI 10.1038/mp.2015.67; Bowden CL, 2006, AM J PSYCHIAT, V163, P1199, DOI 10.1176/appi.ajp.163.7.1199; Brewin CR, 2017, CLIN PSYCHOL REV, V58, P1, DOI 10.1016/j.cpr.2017.09.001; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Cloitre M, 2011, J TRAUMA STRESS, V24, P615, DOI 10.1002/jts.20697; Crawford MJ, 2018, AM J PSYCHIAT, V175, P756, DOI 10.1176/appi.ajp.2018.17091006; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Herhaus B, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0729-6; Hertzberg MA, 1999, BIOL PSYCHIAT, V45, P1226, DOI 10.1016/S0006-3223(99)00011-6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Sar V, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.5622; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tang WJ, 2020, J AFFECT DISORDERS, V274, P1, DOI 10.1016/j.jad.2020.05.009; Ullmann E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207440; Ullmann E, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00047; Weathers F.W., 2013, PTSD CHECKLIST DSM 5	19	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	JUN 21	2021	12								655079	10.3389/fpsyt.2021.655079			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	TD6ZW	WOS:000669473400001	34234698	Green Published, gold			2022-02-07	
J	Huang, JH; Wang, TJ; Wu, SF; Liu, CY; Fan, JY				Huang, Jui-Hsia; Wang, Tsae-Jyy; Wu, Shu-Fang; Liu, Chieh-Yu; Fan, Jun-Yu			Post-craniotomy fever and its associated factors in patients with traumatic brain injury	NURSING IN CRITICAL CARE			English	Article; Early Access						infection; post-craniotomy fever; traumatic brain injury	VENTILATOR-ASSOCIATED PNEUMONIA; SEVERITY SCORE; STATISTICAL POWER; RISK-FACTORS; MANAGEMENT; MULTICENTER; INFECTIONS	Background Fever frequently occurs in patients with traumatic brain injury and can cause secondary damage to the brain. Critical care nurses play essential roles in assessing and managing fever in these patients. Aim The study aimed to (a) examine the fever causes in and condition of neurosurgical patients with traumatic brain injury in intensive care, (b) identify the factors associated with fever, and (c) determine the effects of fever on hospital stay and prognosis. Study design This study is a retrospective observational design. Methods Data were collected through chart reviews of 93 traumatic brain injury patients admitted to a teaching hospital's intensive care unit for postoperative care. Fever was defined as at least one episode of body temperature >38 degrees C. Results Of the 93 patients, 76 developed a fever within 1-week post-craniotomy. Of these, 49 were infection-related and 27 were unexplained. Results of logistic regression showed that the preoperative Glasgow coma scale score (ss = -.323; P = .013) and length of intubation (ss = .480; P = .005) were the key predictors of unexplained post-craniotomy fever, and these two variables (ss = -.494; P < .001 and ss = .479; P = .006, respectively) were also the key predictors of infection-related fever. Conclusion A significant portion of patients developed a fever during the first post-craniotomy week. Patients with a lower pre-craniotomy Glasgow coma scale score and a longer intubation length were at a greater risk for both infection-related fever and unexplained fever. Patients with fever had a bad outcome score. Relevance to clinical practice Critical care nurses should closely monitor traumatic brain injury patients' body temperatures and employ evidence-based infection prevention and control measures to minimize their infection risks. Respiratory care and intensive care unit Liberation Bundle should be reinforced to liberate these patients from mechanical ventilation and its associated complications.	[Huang, Jui-Hsia] Ten Chan Gen Hosp, Dept Nursing, Intens Care Unit, Taoyuan, Taiwan; [Wang, Tsae-Jyy; Wu, Shu-Fang] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, 365 Ming Rd, Taipei 11219, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan; [Fan, Jun-Yu] Chang Gung Univ Sci & Technol, Dept Nursing, Linkou Campus, Taoyuan, Taiwan		Wang, TJ (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, 365 Ming Rd, Taipei 11219, Taiwan.	tsaejyy@ntunhs.edu.tw					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balas MC, 2019, CRIT CARE NURSE, V39, P46, DOI 10.4037/ccn2019927; Banerjee D., 2016, GEN MED, V4, P274, DOI [10.4172/2327-5146.1000274, DOI 10.4172/2327-5146.1000274]; Bengualid V, 2015, AM J CRIT CARE, V24, pE1, DOI 10.4037/ajcc2015856; Busl KM, 2018, NEUROSURG CLIN N AM, V29, P299, DOI 10.1016/j.nec.2017.11.008; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Delgado-Lopez PD, 2009, NEUROCIRUGIA, V20, P124; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goyal Keshav, 2020, Journal of Neurocritical Care, V13, P19, DOI 10.18700/jnc.190090; Hinson HE, 2018, J TRAUMA ACUTE CARE, V84, P19, DOI 10.1097/TA.0000000000001627; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; JENNETT B, 1975, LANCET, V1, P480; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; Lopez GA, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0393-6; Lovett ME, 2018, J NEUROSURG-PEDIATR, V21, P164, DOI 10.3171/2017.8.PEDS17104; Mazandarani PD, 2016, EMERGENCY, V4, P88; O'Leary RA, 2018, J NEUROSURG SCI, V62, P542, DOI 10.23736/S0390-5616.18.04501-0; Park DW, 2016, J KOREAN MED SCI, V31, P2033, DOI 10.3346/jkms.2016.31.12.2033; Pecoraro V, 2021, INTERN EMERG MED, V16, P1071, DOI 10.1007/s11739-020-02556-0; POLIT DF, 1990, NURS RES, V39, P365; Pun BT, 2019, CRIT CARE MED, V47, P3, DOI 10.1097/CCM.0000000000003482; Rakhit S, 2021, SEMIN RESP CRIT CARE, V42, P127, DOI 10.1055/s-0040-1716493; Reaven Nancy L, 2009, J Intensive Care Med, V24, P131, DOI 10.1177/0885066608330211; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Robba C, 2020, CHEST, V158, P2292, DOI 10.1016/j.chest.2020.06.064; Sun YL, 2020, J INT MED RES, V48, DOI 10.1177/0300060520942113; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	36	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1362-1017	1478-5153		NURS CRIT CARE	Nurs. Crit. Care												10.1111/nicc.12640		JUN 2021	10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	SU7JR	WOS:000663309300001	34145947				2022-02-07	
J	Furtado, ABV; Goncalves, DF; Hartmann, DD; Courtes, AA; Cassol, G; Nunez-Figueredo, Y; Argolo, DS; do Nascimento, RP; Costa, SL; da Silva, VDA; Royes, LFF; Soares, FAA				Vieira Furtado, Andrezza Bond; Goncalves, Debora Farina; Hartmann, Diane Duarte; Courtes, Aline Alves; Cassol, Gustavo; Nunez-Figueredo, Yanier; Argolo, Deivison Silva; do Nascimento, Ravena Pereira; Costa, Silvia Lima; Amaral da Silva, Victor Diogenes; Freire Royes, Luiz Fernando; Antunes Soares, Felix Alexandre			JM-20 Treatment After Mild Traumatic Brain Injury Reduces Glial Cell Pro-inflammatory Signaling and Behavioral and Cognitive Deficits by Increasing Neurotrophin Expression	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						JM-20; Neuroprotection; Neuroinflammation; Multi-target; Astrocytes; Microglia	NERVE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; NEURONAL LOSS; NITRIC-OXIDE; GDNF; NEUROINFLAMMATION; INVOLVEMENT; IMPAIRMENTS; MICROGLIA	Traumatic brain injury (TBI) is considered a public health problem and is often related to motor and cognitive disabilities, besides behavioral and emotional changes that may remain for the rest of the subject's life. Resident astrocytes and microglia are the first cell types to start the inflammatory cascades following TBI. It is widely known that continuous or excessive neuroinflammation may trigger many neuropathologies. Despite the large numbers of TBI cases, there is no effective pharmacological treatment available. This study aimed to investigate the effects of the new hybrid molecule 3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro1H-pyrido[2,3-b][1,5]benzodiazepine (JM-20) on TBI outcomes. Male Wistar rats were submitted to a weight drop model of mild TBI and treated with a single dose of JM-20 (8 mg/kg). Twenty-four hours after TBI, JM-20-treated animals showed improvements on locomotor and exploratory activities, and short-term memory deficits induced by TBI improved as well. Brain edema was present in TBI animals and the JM-20 treatment was able to prevent this change. JM-20 was also able to attenuate neuroinflammation cascades by preventing glial cells-microglia and astrocytes-from exacerbated activation, consequently reducing pro-inflammatory cytokine levels (TNF-alpha and IL-1 beta). BDNF mRNA level was decreased 24 h after TBI because of neuroinflammation cascades; however, JM-20 restored the levels. JM-20 also increased GDNF and NGF levels. These results support the JM-20 neuroprotective role to treat mild TBI by reducing the initial damage and limiting long-term secondary degeneration after TBI.	[Vieira Furtado, Andrezza Bond; Goncalves, Debora Farina; Hartmann, Diane Duarte; Courtes, Aline Alves; Freire Royes, Luiz Fernando; Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil; [Hartmann, Diane Duarte] Univ Reg Noroeste Estado Rio Grande do Sul, Dept Fisioterapia, Ijui, RS, Brazil; [Cassol, Gustavo] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [Nunez-Figueredo, Yanier] Ctr Invest & Desarrollo Medicamentos, Havana, Cuba; [Argolo, Deivison Silva; do Nascimento, Ravena Pereira; Costa, Silvia Lima; Amaral da Silva, Victor Diogenes] Univ Fed Bahia, Dept Bioquim & Biofis, Lab Neuroquim & Biol Celular, Salvador, BA, Brazil; [Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Dept Bioquim & Biol Mol, CCNE, BR-97105900 Santa Maria, RS, Brazil		Soares, FAA (corresponding author), Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil.; Soares, FAA (corresponding author), Univ Fed Santa Maria, Dept Bioquim & Biol Mol, CCNE, BR-97105900 Santa Maria, RS, Brazil.	felix@ufsm.br		Cassol, Gustavo/0000-0003-1343-7001; Farina Goncalves, Debora/0000-0003-2356-2922	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88882.182135/201801, 0737/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos Emergentes (PRONEM) [16/2551-0000248-7]; Foundation for Research Support of the State of Bahia (FAPESB) [INT 0016/2016]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PROEX Process Number: 88882.182135/201801 financial support number: 0737/2018), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Programa de Apoio a Nucleos Emergentes (PRONEM) [grant number16/2551-0000248-7], Foundation for Research Support of the State of Bahia (FAPESB, Process number INT 0016/2016).	Aarse J, 2016, HIPPOCAMPUS, V26, P739, DOI 10.1002/hipo.22555; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Arsenijevic D, 2007, EUR CYTOKINE NETW, V18, P93, DOI 10.1684/ecn.2007.0091; Fonseca-Fonseca LA, 2019, NEUROSCI LETT, V690, P29, DOI 10.1016/j.neulet.2018.10.008; Bawa P, 2016, DRUG DISCOV TODAY, V21, P1886, DOI 10.1016/j.drudis.2016.08.001; Baxter MG, 2010, BEHAV NEUROSCI, V124, P706, DOI 10.1037/a0021029; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bonafina A, 2019, CELL REP, V29, P4308, DOI 10.1016/j.celrep.2019.11.100; Budni J, 2015, AGING DIS, V6, P331, DOI 10.14336/AD.2015.0825; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cattaruzza M, 2000, BRIT J PHARMACOL, V129, P1155, DOI 10.1038/sj.bjp.0703192; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; Collier TJ, 1999, DRUG AGING, V14, P261, DOI 10.2165/00002512-199914040-00003; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Hart Tessa, 2017, Arch Phys Med Rehabil, V98, P407, DOI 10.1016/j.apmr.2016.09.112; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Komoda H, 2010, CLIN EXP HYPERTENS, V32, P121, DOI 10.3109/10641960903254414; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Liu GX, 2014, INT IMMUNOPHARMACOL, V19, P145, DOI 10.1016/j.intimp.2014.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lopez NE, 2014, J SURG RES, V187, P230, DOI 10.1016/j.jss.2013.09.030; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGee J, 2016, NEUROL CLIN, V34, P55, DOI 10.1016/j.ncl.2015.08.004; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Figueredo YN, 2013, NEUROL RES, V35, P804, DOI 10.1179/1743132813Y.0000000216; Nunez-Figueredo Y, 2018, PHARMACOL REP, V70, P699, DOI 10.1016/j.pharep.2018.02.013; Nunez-Figueredo Y, 2014, NEUROPHARMACOLOGY, V85, P517, DOI 10.1016/j.neuropharm.2014.06.009; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; PECHAN PA, 1995, NEUROREPORT, V6, P669, DOI 10.1097/00001756-199503000-00021; Petukhova EO, 2019, J ALZHEIMERS DIS, V69, P443, DOI 10.3233/JAD-190150; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Radiske A, 2017, NEUROBIOL LEARN MEM, V142, P79, DOI 10.1016/j.nlm.2017.02.018; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Ramirez-Sanchez J, 2019, MOL NEUROBIOL, V56, P502, DOI 10.1007/s12035-018-1087-8; Rocha SM, 2012, NEUROBIOL DIS, V47, P407, DOI 10.1016/j.nbd.2012.04.014; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Voss JL, 2017, TRENDS COGN SCI, V21, P577, DOI 10.1016/j.tics.2017.05.008; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Weissmiller AM, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-14; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong-Guerra M, 2019, NEUROL RES, V41, P385, DOI 10.1080/01616412.2019.1573285; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	92	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02436-4		JUN 2021	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SV0CX	WOS:000663496800002	34148214				2022-02-07	
J	Chadwick, L; Roth, E; Minich, NM; Taylor, HG; Bigler, ED; Cohen, DM; Bacevice, A; Mihalov, LK; Bangert, BA; Zumberge, NA; Yeates, KO				Chadwick, Leah; Roth, Elizabeth; Minich, Nori M.; Taylor, H. Gerry; Bigler, Erin D.; Cohen, Daniel M.; Bacevice, Ann; Mihalov, Leslie K.; Bangert, Barbara A.; Zumberge, Nicholas A.; Yeates, Keith Owen			Cognitive Outcomes in Children with Mild Traumatic Brain Injury: An Examination Using the National Institutes of Health Toolbox Cognition Battery	JOURNAL OF NEUROTRAUMA			English	Article						cognitive assessment; crystalized cognition; fluid cognition; pediatric; traumatic brain injury	NIH TOOLBOX; HEAD-INJURY; PERFORMANCE; VALIDITY; CB; ADOLESCENTS; CONSISTENCY; CONCUSSION; SYMPTOMS	This study is the first to examine cognitive outcomes after pediatric mild TBI using the National Institutes of Health Toolbox Cognition Battery (NIHTB-CB), a computerized cognitive test battery. The NIHTB-CB includes two complex measures of attention and executive function that allow differentiation of accuracy and response speed. We compared performance on the NIHTB-CB among children 8-16 years of age with mild TBI (n = 143) versus children with orthopedic injuries (OIs; n = 74) recruited in emergency departments and followed for 6 months post-injury. Mixed-model analyses showed that the mild TBI group showed significantly lower Fluid Cognition composite scores than the OI group at 10 days (group intercept, p = 0.018); the magnitude of group differences declined modestly over time (group x time interaction, p = 0.055). Effect sizes were d = 0.34 at 10 days post-injury, d = 0.27 at 3 months, and d = 0.10 at 6 months. No significant effects of group or time were found for the Crystallized Cognition composite. Analyses of Fluid Cognition subtests indicated that children with mild TBI displayed deficits for as long as 3 months on measures of attention and executive function (e.g., cognitive flexibility, inhibitory control), but not on measures of explicit memory, working memory, or processing speed. The poorer performance of the mild TBI group on measures of attention and executive function was attributable largely to slowed reaction time, not decreased accuracy. The findings suggest that children with mild TBI demonstrate persistent deficits in fluid cognition that are most apparent on tasks that combine demands for both speed and executive function.	[Chadwick, Leah; Yeates, Keith Owen] Univ Calgary, Dept Psychol, 2500 Univ Dr Northwest, Calgary, AB T2N 1N4, Canada; [Chadwick, Leah; Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Roth, Elizabeth; Minich, Nori M.; Bacevice, Ann] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Cohen, Daniel M.; Mihalov, Leslie K.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry; Cohen, Daniel M.; Mihalov, Leslie K.; Zumberge, Nicholas A.] Nationwide Childrens Hosp, Columbus, OH USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bacevice, Ann] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Bangert, Barbara A.] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara A.] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA		Chadwick, L (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr Northwest, Calgary, AB T2N 1N4, Canada.; Chadwick, L (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.	leah.chadwick@ucalgary.ca			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD076885]	This work was supported by the National Institutes of Health grant R01HD076885.	Akshoomoff N, 2013, MONOGR SOC RES CHILD, V78, P119, DOI 10.1111/mono.12038; American Association for Automotive Medicine, 1990, ABBR INJ SCAL AIS 19, pIL; Anderson V, 2020, J NEUROTRAUM, V37, P1392, DOI 10.1089/neu.2019.6683; [Anonymous], SAS 9 4; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P34, DOI 10.1111/mono.12033; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control., 2019, SURVEILLANCE REPORT; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Green, 2004, GREENS EDMONTON ALBE; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; IBM Corp, 2016, IBM SPSS STAT WINDOW; Kirkwood M. W., 2015, VALIDITY TESTING CHI, P3; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Mayer AR, 2020, NEUROLOGY, V94, pE241, DOI 10.1212/WNL.0000000000008488; McWhirter L, 2020, J NEUROL NEUROSUR PS, V91, P945, DOI 10.1136/jnnp-2020-323776; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; Watson W, 2020, REHABIL PSYCHOL, V65, P22, DOI 10.1037/rep0000309; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	43	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2590	2599		10.1089/neu.2020.7513		JUN 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000663071100001	33906429				2022-02-07	
J	Cho, MJ; Yi, KS; Choi, CH; Yum, KS; Cha, SH; Kim, Y; Lee, J				Cho, Min Jai; Yi, Kyung Sik; Choi, Chi-Hoon; Yum, Kyu Sun; Cha, Sang-Hoon; Kim, Yook; Lee, Jisun			Sphenoid sinus pseudoaneurysm with carotid cavernous fistula presenting with delayed subarachnoid hemorrhage A case report	MEDICINE			English	Article						carotid-cavernous fistula; embolization; head trauma; sphenoid sinus pseudoaneurysm; subarachnoid hemorrhage	TRAUMATIC PSEUDOANEURYSM; ENDOVASCULAR TREATMENT; DIAGNOSIS; ARTERY	Rationale: Sphenoid sinus pseudoaneurysm arising from the cavernous segment of the internal carotid artery (ICA) caused by traumatic vessel injury is rare, and rarer is a concomitant carotid-cavernous fistula (CCF). In particular, delayed subarachnoid hemorrhage (SAH) due to pseudoaneurysm rupture has not been reported to-date in literature. Here, we report a case of sphenoid sinus pseudoaneurysm with CCF presenting with delayed SAH. Patient concerns: A 73-year-old man presented with traumatic brain injury due to motorcycle accident. Diagnoses: Twenty-four days after admission, the patient's neurological status suddenly deteriorated. Brain computed tomography (CT) showed acute SAH along interhemispheric cisterns and suprasellar intracerebral hematoma. Brain CT angiography and digital subtraction angiography revealed giant sphenoid sinus pseudoaneurysm with CCF and the daughter sac of the pseudoaneurysm extended to the intracranial part via fracture in the superior wall of the sphenoid sinus. Interventions: As the sphenoid sinus pseudoaneurysm and CCF shared one rupture point, endovascular treatment with intraarterial approach using coil and liquid embolic material by balloon assisted technique was performed simultaneously. Outcomes: The origin of the pseudoaneurysmal sac and CCF was sufficiently blocked after injection of liquid embolic material and the lesions completely resolved immediately after endovascular treatment. Lessons: Sphenoid sinus pseudoaneurysm and CCF rarely occur following head trauma through a series of processes involving fracture of the lateral wall of the sphenoid sinus and ICA cavernous segment injury. Sphenoid sinus pseudoaneurysm may present as SAH through intracranial rupture with concomitant superior wall fracture of the sphenoid sinus. Therefore, early diagnosis using CT or magnetic resonance angiography and appropriate treatment through understanding the disease mechanism is necessary.	[Cho, Min Jai; Yi, Kyung Sik; Choi, Chi-Hoon; Yum, Kyu Sun; Cha, Sang-Hoon; Kim, Yook; Lee, Jisun] Chungbuk Natl Univ, Dept Radiol, Cheongju, South Korea; [Cho, Min Jai] Chungbuk Natl Univ, Dept Neurosurg, Cheongju, South Korea; [Yum, Kyu Sun] Chungbuk Natl Univ, Dept Neurol, Cheongju, South Korea; [Choi, Chi-Hoon; Cha, Sang-Hoon; Lee, Jisun] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Choi, Chi-Hoon; Cha, Sang-Hoon; Lee, Jisun] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea		Yi, KS (corresponding author), Chungbuk Natl Univ Hosp, Dept Radiol, 776,1Sunhwan Ro, Cheongju 28644, South Korea.	yiksyi@gmail.com			Chungbuk National University Hospital	This work was supported by the research grant of the Chungbuk National University Hospital, 2021.	Chen DS, 1998, LARYNGOSCOPE, V108, P326, DOI 10.1097/00005537-199803000-00004; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Deng D, 2019, AM J OTOLARYNG, V40, P106, DOI 10.1016/j.amjoto.2018.09.014; Fabian TS, 1999, J TRAUMA, V47, P275, DOI 10.1097/00005373-199908000-00009; FUJII K, 1979, J NEUROSURG, V50, P31, DOI 10.3171/jns.1979.50.1.0031; Huai RC, 2008, INTERV NEURORADIOL, V14, P59, DOI 10.1177/159101990801400108; Ikram, 2012, BMJ CASE REP, V2012; Koekkoek Johan A F, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-009013; Liang Wen, 2007, J Trauma, V63, P1014; Pelliccia P, 2016, ACTA OTORHINOLARYNGO, V36, P149, DOI 10.14639/0392-100X-192913; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; Saket RR, 2012, CLIN RADIOL, V67, P815, DOI 10.1016/j.crad.2011.12.009; Zhang CW, 2010, KOREAN J RADIOL, V11, P603, DOI 10.3348/kjr.2010.11.6.603	13	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUN 18	2021	100	24							e26383	10.1097/MD.0000000000026383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS3EX	WOS:000661624000059	34128900	Green Published, gold			2022-02-07	
J	Hasler, RM; Rauer, T; Pape, HC; Zwahlen, M				Hasler, Rebecca M.; Rauer, Thomas; Pape, Hans-Christoph; Zwahlen, Marcel			Inter-hospital transfer of polytrauma and severe traumatic brain injury patients: Retrospective nationwide cohort study using data from the Swiss Trauma Register	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; PREHOSPITAL TRIAGE; CENTER CARE; INCREASED MORTALITY; FIELD TRIAGE; 110 MMHG; OVERTRIAGE; AGE; PROTOCOLS; SYSTEMS	Introduction Polytrauma and traumatic brain injury (TBI) patients are among the most vulnerable patients in trauma care and exhibit increased morbidity and mortality. Timely care is essential for their outcome. Severe TBI with initially high scores on the Glasgow Coma (GCS) scores is difficult to recognise on scene and referral to a Major Trauma Center (MTC) might be delayed. Therefore, we examined current referral practice, injury patterns and mortality in these patients. Materials and methods Retrospective, nationwide cohort study with Swiss Trauma Register (STR) data between 01/012015 and 31/12/2018. STR includes patients >= 16 years with an Injury Severity Score (ISS) >15 and/or an Abbreviated Injury Scale (AIS) for head >2. We performed Cox proportional hazard models with injury type as the primary outcome and mortality as the dependent variable. Secondary outcomes were inter-hospital transfer and age. Results 9,595 patients were included. Mortality was 12%. 2,800 patients suffered from isolated TBI. 69% were men. Median age was 61 years and median ISS 21. Two thirds of TBI patients had a GCS of 13-15 on admission to the Emergency Department (ED). 26% of patients were secondarily transferred to an MTC. Patients with isolated TBI and those aged >= 65 years were transferred more often. Crude analysis showed a significantly elevated hazard for death of 1.48 (95%CI 1.28-1.70) for polytrauma patients with severe TBI and a hazard ratio (HR) of 1.82 (95%CI 1.58-2.09) for isolated severe TBI, compared to polytrauma patients without TBI. Patients directly admitted to the MTC had a significantly elevated HR for death of 1.63 (95%CI 1.40-1.89), compared to those with secondary transfer. Conclusions A high initial GCS does not exclude the presence of severe TBI and triage to an MTC should be seriously considered for elderly TBI patients.	[Hasler, Rebecca M.; Rauer, Thomas; Pape, Hans-Christoph] Univ Hosp Zurich, Dept Traumatol, Zurich, Switzerland; [Hasler, Rebecca M.; Zwahlen, Marcel] Bern Univ, Inst Social & Prevent Med ISPM, Bern, Switzerland		Hasler, RM (corresponding author), Univ Hosp Zurich, Dept Traumatol, Zurich, Switzerland.; Hasler, RM (corresponding author), Bern Univ, Inst Social & Prevent Med ISPM, Bern, Switzerland.	rebecca.hasler@usz.ch		Zwahlen, Marcel/0000-0002-6772-6346; Pape, Hans-Christoph/0000-0002-2059-4980; Hasler, Rebecca Maria/0000-0002-0616-2313	Furstlicher Kommerzienrat Guido Feger Foundation	RMH has received funding from the Furstlicher Kommerzienrat Guido Feger Foundation.	AAAM AAAM, 2008, C ISA ADV AUT MED AB C ISA ADV AUT MED AB; [Anonymous], 2011, GUIDELINES FIELD TRI; [Anonymous], 2014, REGIONAL TRAUMA SYST; Brown J, 2017, SURG CLIN N AM, V97, P961, DOI 10.1016/j.suc.2017.06.007; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Follin A, 2016, INJURY, V47, P1555, DOI 10.1016/j.injury.2016.04.024; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Gupta R, 2010, J TRAUMA, V69, P253, DOI 10.1097/TA.0b013e3181e4d579; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Hasler R., 2012, EUR SPINE J, V21, P2384; Hasler RM, 2014, J TRAUMA ACUTE CARE, V77, P757, DOI 10.1097/TA.0000000000000452; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Jensen KO., 2020, EUR J TRAUMA EMERG S; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Rogers A, 2012, AM SURGEON, V78, P711; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Ruge T, 2020, UPSALA J MED SCI, V125, P58, DOI 10.1080/03009734.2019.1706674; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; TEASDALE G, 1974, LANCET, V2, P81; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; van Rein EAJ, 2017, J TRAUMA ACUTE CARE, V83, P328, DOI 10.1097/TA.0000000000001516	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253504	10.1371/journal.pone.0253504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	WOS:000671690700030	34143842	Green Published, Green Accepted, gold			2022-02-07	
J	Mehta, NK; Siegel, J; Cowan, B; Johnson, J; Hojjat, H; Chung, MT; Carron, MA				Mehta, Neil K.; Siegel, Justin; Cowan, Brandon; Johnson, Jared; Hojjat, Houmehr; Chung, Michael T.; Carron, Michael A.			Head and Neck Injury Patterns among American Football Players	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article; Early Access						tackle-football; football trauma; football injuries; head and neck; head and neck trauma	HIGH-SCHOOL; UNITED-STATES; EPIDEMIOLOGY; CONCUSSION; CHILDREN; SPORTS	Importance: American football is a popular high-impact sport, leading to 2.7 million injuries in the United States annually. Recent evidence in football-related neurological damage has spurred national interest in player-safety. Football players injure their head and neck in up to 26% of total injuries. Variation in injury patterns between age groups and correlated hospitalizations for football-related head and neck injury has yet to be characterized. Objective: Our aim is to evaluate injury patterns among American-football related head and neck trauma. Methods: A retrospective cohort study of patients with football-related head and neck injury in the National Electronic Injury Surveillance System (NEISS). Results: Nearly 100 000 ED visits for football-related head and neck injuries occur annually. Males comprised 95% of patients, with a median age of 13. The head comprised 70% of injuries followed by the face (13%). The most common diagnoses were concussions (39%), internal organ injury (26%), and lacerations (11%). Pediatric patients were more likely to sustain concussions while adults experienced more lacerations (P < .05%). Fractures and nerve damage were rare injuries but caused a disproportionate share of hospitalizations. Conclusion: Pediatric males are most likely to present for emergency care from football-related injury to the head and neck. Evaluating physicians can anticipate concussions, internal organ injury, and lacerations among presenting patients. Concussions, facial fractures, and nerve damage are injuries most likely to lead to hospitalization.	[Mehta, Neil K.; Siegel, Justin; Cowan, Brandon; Johnson, Jared; Hojjat, Houmehr; Chung, Michael T.; Carron, Michael A.] Wayne State Univ, Dept Otolaryngol, Div Facial Plast Surg, Detroit, MI 48201 USA		Chung, MT (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, Div Facial Plast Surg, 5E UHC,4201 St Antoine, Detroit, MI 48201 USA.	michael.chung@wayne.edu		Mehta, Neil/0000-0003-3393-0506			ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; [Anonymous], 2018, NEISS ONLINE DATABAS; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Billock RM, 2017, CLIN PEDIATR, V56, P535, DOI 10.1177/0009922816664063; Bresler AY, 2019, AM J OTOLARYNG, V40, P662, DOI 10.1016/j.amjoto.2019.05.023; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Chorney SR, 2017, LARYNGOSCOPE, V127, P1296, DOI 10.1002/lary.26441; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; DeFroda Steven F, 2019, J Clin Orthop Trauma, V10, P954, DOI 10.1016/j.jcot.2019.01.019; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Graham R, SPORTS RELATED CONCU; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; League NF., 2021, YOUTH FOOTBALL SAFET YOUTH FOOTBALL SAFET; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McGinity MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195827; Mortensen JD, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109411; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Scheffler P, 2019, INT J PEDIATR OTORHI, V121, P6, DOI 10.1016/j.ijporl.2019.02.036; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shields WC, 2015, INJURY PREV, V21, P296, DOI 10.1136/injuryprev-2015-041559; Smart BJ, 2016, AM J EMERG MED, V34, P1198, DOI 10.1016/j.ajem.2016.02.057; Smith PJ, 2018, J PEDIATR ORTHOPED, V38, pE57, DOI 10.1097/BPO.0000000000001101; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439	28	0	0	2	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.											00034894211026478	10.1177/00034894211026478		JUN 2021	8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	TS6EF	WOS:000679740200001	34142563				2022-02-07	
J	Pinasco, C; Oviedo, M; Goldfeder, M; Bruno, D; Lischinsky, A; Torralva, T; Roca, M				Pinasco, Clara; Oviedo, Mercedes; Goldfeder, Maria; Bruno, Diana; Lischinsky, Alicia; Torralva, Teresa; Roca, Maria			Sensitivity and specificity of the INECO frontal screening (IFS) in the detection of patients with traumatic brain injury presenting executive deficits	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Executive functions; INECO frontal screening; neuropsychological assessment; TBI	MONTREAL COGNITIVE ASSESSMENT; MENTAL-STATE-EXAMINATION; ASSESSMENT BATTERY; FRONTOTEMPORAL DEMENTIA; DYSFUNCTION; VALIDITY; TOOL; REHABILITATION; IMPAIRMENT; OUTCOMES	Executive dysfunction (EF) is a common feature of adult traumatic brain injury (TBI), especially in moderate to severe cases. Assessing EF usually requires the administration of an extensive neuropsychological battery, which is time consuming and expensive. The INECO frontal screening (IFS) is a brief, easy-to-administer screening test which has previously shown to be useful in the detection of executive deficits in different psychiatric and neurological populations. The aim of the present study was to assess the usefulness of the IFS in the detection of executive dysfunction in TBI patients. Twenty-eight TBI patients and thirty-two healthy controls were assessed with a battery that included classical executive tests and the IFS. Our results indicated that with a cutoff score of 26.25 points, the IFS showed good sensitivity and specificity in the detection of executive impairments in TBI patients. It also showed good positive and negative predicted values. Our results suggest that the IFS can be considered a useful tool for identifying executive dysfunction in patients with TBI.	[Pinasco, Clara; Oviedo, Mercedes; Goldfeder, Maria; Bruno, Diana; Lischinsky, Alicia; Torralva, Teresa; Roca, Maria] Favaloro Univ, CONICET, Natl Sci & Tech Res Council, Inst Cognit & Translat Neurosci INCyT,INECO Fdn, Marcelo T Alvear 1632,C1060AAF, Buenos Aires, DF, Argentina; [Pinasco, Clara] Univ Catolica Argentina, Fac Psicol & Psicopedag, Buenos Aires, DF, Argentina; [Oviedo, Mercedes] Neurociencias INECO Orono, Rosario, Argentina; [Bruno, Diana] Univ Catolica Cuyo, Fac Filosofia & Humanidades, Inst Invest Psicol Basica & Aplicada IIPBA, San Juan, Argentina; [Lischinsky, Alicia] Univ Favaloro, Fac Med, Dept Salud Mental & Psiquiat, Buenos Aires, DF, Argentina		Roca, M (corresponding author), Favaloro Univ, CONICET, Natl Sci & Tech Res Council, Inst Cognit & Translat Neurosci INCyT,INECO Fdn, Marcelo T Alvear 1632,C1060AAF, Buenos Aires, DF, Argentina.	mroca@ineco.org.ar		Bruno, Diana/0000-0003-3581-1666; Lischinsky, Alicia/0000-0002-2610-3492			Baez S, 2014, PSYCHIAT RES, V216, P269, DOI 10.1016/j.psychres.2014.01.020; Bezdicek O, 2017, J INT NEUROPSYCH SOC, V23, P675, DOI 10.1017/S1355617717000522; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Broche-Pérez Yunier, 2019, Dement. neuropsychol., V13, P394, DOI 10.1590/1980-57642018dn13-040005; Bruno D, 2015, NEUROL SCI, V36, P2035, DOI 10.1007/s10072-015-2299-6; Buoli M, 2014, COMPR PSYCHIAT, V55, P1561, DOI 10.1016/j.comppsych.2014.06.001; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Butman J, 2000, MEDICINA-BUENOS AIRE, V60, P561; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; de Guise E, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1862118; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; de Guise E, 2011, APPL NEUROPSYCHOL, V18, P179, DOI 10.1080/09084282.2011.595444; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaber TAZK, 2008, BRAIN INJURY, V22, P589, DOI 10.1080/02699050802132461; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Golden CJ, 1978, STROOP COLOR WORD TE; Han M, 2020, ANN REHABIL MED-ARM, V44, P261, DOI 10.5535/arm.19111; Hazan E, 2017, BRAIN INJURY, V31, P1501, DOI 10.1080/02699052.2017.1376763; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hodges J. R., 1994, COGNITIVE ASSESSMENT; Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Luria A., 1966, HIGH ORDER HIGHER CO; Lutkenhoff ES, 2020, NEUROLOGY, V95, pE2398, DOI 10.1212/WNL.0000000000010825; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marchio PS, 2006, NEUROCIRUGIA, V17, P14; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nieuwenhuis-Mark RE, 2010, J GERIATR PSYCH NEUR, V23, P151, DOI 10.1177/0891988710363714; Ostberg A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00832; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Peterson A., 2019, SURVEILLANCE REPORT, V24; Poncet F, 2017, NEUROPSYCHOL REHABIL, V27, P618, DOI 10.1080/09602011.2016.1268171; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rojas N, 2019, APPL NEUROPSYCH-ADUL, V26, P319, DOI 10.1080/23279095.2017.1422506; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Moghaddam HS, 2020, BEHAV NEUROL, V2020, DOI 10.1155/2020/8710373; Schultz R, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2021.1882507; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Sigurdardottir S, 2020, J INT NEUROPSYCH SOC, V26, P654, DOI 10.1017/S1355617720000193; Silva T, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.22; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Soble JR, 2013, APPL NEUROPSYCH-ADUL, V20, P257, DOI 10.1080/09084282.2012.713056; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Gils A, 2020, PRACT NEUROL, V20, P213, DOI 10.1136/practneurol-2018-002087; Wallace EJ, 2020, NEUROPSYCHOLOGY, V34, P881, DOI 10.1037/neu0000690; Weschler D., 2007, WESCHLER ADULT INTEL, VThird; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321	69	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1937170		JUN 2021	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SW2VS	WOS:000664378200001	34156897				2022-02-07	
J	Qafiti, FN; Rubay, D; Shin, R; Lottenberg, L; Borrego, R				Qafiti, Fred N.; Rubay, David; Shin, Rebecca; Lottenberg, Lawrence; Borrego, Robert			Therapeutic Hypothermia With Progesterone Improves Neurologic Outcomes in Ventricular Fibrillation Cardiac Arrest After Electric Shock	CUREUS			English	Article						hypothermia; out-of-hospital cardiac arrest; progesterone; anoxic brain injury; electric shock	TRAUMATIC BRAIN-INJURY; ALLOPREGNANOLONE; METAANALYSIS	Trauma by electricity imposes mechanical, electrical, and thermal forces on the human body. Often, the delicate cardiac electrophysiology is disrupted causing dysrhythmia and subsequent cardiac arrest. Anoxic brain injury (ABI) is the most severe consequence and the main cause of mortality following cardiac arrest. Establishing a working protocol to treat patients who are at risk for ABI after suffering a cardiac arrest is of paramount importance. There has yet to be sufficient exploration of combination therapy of therapeutic hypothermia (TH) and progesterone as a neuroprotective strategy in patients who have suffered cardiac arrest after electric shock. The protocol required TH initiation upon transfer to the ICU with a target core body temperature of 33 degrees C for 18 hours. This was achieved through a combination of cooling blankets, ice packs, chilled IV fluids, nasogastric lavage with iced saline, and intravascular cooling devices. Progesterone therapy at 80-100 mg intramuscularly every 12 hours for 72 hours was initiated shortly after admission to the ICU. We present a case series of three patients (mean age = 29.3 years, mean presenting Glasgow Coma Score = 3) who suffered ventricular fibrillation (VF) cardiac arrest from non-lightning electric shock, and who had considerably improved outcomes following the TH-progesterone combination therapy protocol. The average length of stay was 13.7 days. The cases presented suggest that there may be a role for neuroprotective combination therapy in post-resuscitation care of VF cardiac arrest. While TH is well documented as a neuroprotective measure, progesterone administration is a safe therapy with promising, albeit currently inconclusive, neuroprotective effect. Future protocols involving TH and progesterone combination therapy in these patients should be further explored.	[Qafiti, Fred N.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Gen Surg, Boca Raton, FL 33431 USA; [Rubay, David] Univ Florida, Coll Med, Trauma & Surg Crit Care, Gainesville, FL 32611 USA; [Shin, Rebecca] Florida Atlantic Univ, Charles E Schmidt Coll Med, Surg, Boca Raton, FL 33431 USA; [Lottenberg, Lawrence] Florida Atlantic Univ, St Marys Med Ctr, Surg, W Palm Beach, FL USA; [Borrego, Robert] St Marys Hosp, Surg, W Palm Beach, FL USA		Rubay, D (corresponding author), Univ Florida, Coll Med, Trauma & Surg Crit Care, Gainesville, FL 32611 USA.	davidrubay79@gmail.com					Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Fox JL, 2010, CAN J EMERG MED, V12, P355; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Holzer M, 2002, NEW ENGL J MED, V346, P549; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Schenone AL, 2016, RESUSCITATION, V108, P102, DOI 10.1016/j.resuscitation.2016.07.238; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8	20	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 18	2021	13	6							e15749	10.7759/cureus.15749			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SU8IR	WOS:000663374900019	34290928	gold, Green Published			2022-02-07	
J	You, YW; Wang, DZ; Wang, YN; Li, ZP; Ma, XD				You, Yanwei; Wang, Dizhi; Wang, Yuning; Li, Zhipeng; Ma, Xindong			A Bird's-Eye View of Exercise Intervention in Treating Depression Among Teenagers in the Last 20 Years: A Bibliometric Study and Visualization Analysis	FRONTIERS IN PSYCHIATRY			English	Article						exercise intervention; depression; teenagers; bibliometric; visualization analysis	PHYSICAL-ACTIVITY; HIGH-SCHOOL; SPORTS PARTICIPATION; EMERGING TRENDS; REGENERATIVE MEDICINE; SUICIDAL-BEHAVIOR; EARLY ADOLESCENCE; PROTECTIVE FACTOR; MENTAL TOUGHNESS; TAI CHI	Background: Exercise is medicine. Multiple studies on the effects and mechanisms of exercise in treating depression among teenagers and adolescents have been widely reported. However, literature involving scientometric analysis of this topic is sparse. Here, we endeavored to conduct a bibliometric study and visualization analysis to give a bird's-eye view of publications between 2000 and 2020 on exercise therapy treating depression. Methods: Relevant original publications were obtained from the Science Citation Index Expanded in the Web of Science Core Collection (WoSCC) database between 2000 and 2020. CiteSpace (5.7.R 5) and VOSviewer (1.6.16) software were used to perform bibliometric analysis of countries, institutions, categories, journals, authors, references, and keywords involved in this topic. Results: A total number of 975 articles on this field were retrieved from the WoSCC database and we identified an overall increase in the amount of publications over the past two decades, with the United States and Harvard University leading the field. Most related publications were published in the journals with a focus on sport, medicine, rehabilitation, psychology, and health, as represented by the dual-map overlay. A series of authors and co-cited authors were identified as main contributors in the exercise-depression-teenager domain. Three major clusters were explored based on the reference co-citation analysis: "exercise," "suicide," and "concussion". Conclusions: Current concerns and hotspots of exercise intervention in depression treatments were summarized by "individual level," "social level," "role of exercise," and "research quality." We considered that the following four directions were potential future perspectives: "research on the effect of specific exercise intervention," "research on the essence of exercise and sports," "research on the combination mode of 'exercise + X'," and "research on the micro and molecular level," which should receive more attention.	[You, Yanwei; Wang, Dizhi; Wang, Yuning; Li, Zhipeng; Ma, Xindong] Tsinghua Univ, Div Sport Sci & Phys Educ, Beijing, Peoples R China		Ma, XD (corresponding author), Tsinghua Univ, Div Sport Sci & Phys Educ, Beijing, Peoples R China.	maxd@mail.tsinghua.edu.cn			National Social Science Fund of China [16BTY065]; Leading Talents of Independent Research Program of Tsinghua University [2016THZWLJ12]	This work was supported by the National Social Science Fund of China under grant number 16BTY065; and the Leading Talents of Independent Research Program of Tsinghua University under grant number 2016THZWLJ12.	Alghadir AH, 2016, BIOL TRACE ELEM RES, V172, P299, DOI 10.1007/s12011-015-0601-3; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Ansseau M, 2004, J AFFECT DISORDERS, V78, P49, DOI 10.1016/S0165-0327(02)00219-7; Archer T, 2014, CNS NEUROL DISORD-DR, V13, P1640; Audrain-McGovern J, 2006, ARCH GEN PSYCHIAT, V63, P433, DOI 10.1001/archpsyc.63.4.433; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Bailey AP, 2018, PSYCHOL MED, V48, P1068, DOI 10.1017/S0033291717002653; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Biddle SJH, 2019, PSYCHOL SPORT EXERC, V42, P146, DOI 10.1016/j.psychsport.2018.08.011; Boone EM, 2006, J RES ADOLESCENCE, V16, P79, DOI 10.1111/j.1532-7795.2006.00122.x; Boone SD, 2016, SUICIDE LIFE-THREAT, V46, P625, DOI 10.1111/sltb.12240; Bornmann L, 2014, EMBO REP, V15, P1228, DOI 10.15252/embr.201439608; Brailovskaia J, 2020, CURR PSYCHOL, DOI 10.1007/s12144-020-01152-x; Brand S, 2017, J SPORT SCI, V35, P426, DOI 10.1080/02640414.2016.1167936; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Brown DR, 2007, MED SCI SPORT EXER, V39, P2248, DOI 10.1249/mss.0b013e31815793a3; Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c; Chen CM, 2014, EXPERT OPIN BIOL TH, V14, P1295, DOI 10.1517/14712598.2014.920813; Chen CM, 2012, EXPERT OPIN BIOL TH, V12, P593, DOI 10.1517/14712598.2012.674507; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P67, DOI 10.1109/INFVIS.2003.1249010; Chioqueta Andrea P, 2007, Arch Suicide Res, V11, P375, DOI 10.1080/13811110600897143; Cooper J, 2002, SOC PSYCH PSYCH EPID, V37, P271, DOI 10.1007/s001270200019; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; Davidson CL, 2013, SUICIDE LIFE-THREAT, V43, P279, DOI 10.1111/sltb.12014; Dishman RK, 1997, MED SCI SPORT EXER, V29, P63, DOI 10.1097/00005768-199701000-00010; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dopp RR., 2012, DEPRESS RES TREAT, V2012, P257472, DOI [10.1155/2012/257472, DOI 10.1155/2012/257472]; Ellegaard O, 2015, SCIENTOMETRICS, V105, P1809, DOI 10.1007/s11192-015-1645-z; Fan JC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00477; Ferenchick EK, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l794; Fornaro M, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00294; Friedman RA, 2007, NEW ENGL J MED, V356, P2343, DOI 10.1056/NEJMp078015; Gaggero G, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.611489; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gao Y, 2019, ENVIRON SCI POLLUT R, V26, P17809, DOI 10.1007/s11356-019-05071-8; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Gu DX, 2017, INT J MED INFORM, V98, P22, DOI 10.1016/j.ijmedinf.2016.11.006; Gucciardi DF, 2012, J SPORT EXERCISE PSY, V34, P16, DOI 10.1123/jsep.34.1.16; Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002; HODGMAN CH, 1992, HOSP PRACT, V27, P73; HOLLIDAY SM, 1995, DRUGS, V49, P280, DOI 10.2165/00003495-199549020-00010; Isaksson J, 2020, J AFFECT DISORDERS, V277, P825, DOI 10.1016/j.jad.2020.09.008; Jones G, 2007, SPORT PSYCHOL, V21, P243, DOI 10.1123/tsp.21.2.243; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Kim HJ, 2016, NEUROIMAGE, V139, P149, DOI 10.1016/j.neuroimage.2016.06.029; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Korczak DJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2266; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Krogh J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014820; Kvam S, 2016, J AFFECT DISORDERS, V202, P67, DOI 10.1016/j.jad.2016.03.063; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066996; Lee JS, 2019, MENT HEALTH PHYS ACT, V17, DOI 10.1016/j.mhpa.2019.100298; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Liang YD, 2017, J PAIN RES, V10, P951, DOI 10.2147/JPR.S132808; Liao HC, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010166; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu S, 2019, NEURAL REGEN RES, V14, P1643, DOI 10.4103/1673-5374.255995; Mackenzie S, 2011, AM J ORTHOPSYCHIAT, V81, P101, DOI 10.1111/j.1939-0025.2010.01077.x; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; May R, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0140-z; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Mikkelsen K, 2017, MATURITAS, V106, P48, DOI 10.1016/j.maturitas.2017.09.003; Millan MJ, 2009, NEUROTHERAPEUTICS, V6, P53, DOI 10.1016/j.nurt.2008.10.039; Miller KE, 2009, SOCIOL SPORT J, V26, P335, DOI 10.1123/ssj.26.2.335; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mowbray CT, 2006, AM J ORTHOPSYCHIAT, V76, P226, DOI 10.1037/0002-9432.76.2.226; Beserra AHN, 2018, TRENDS PSYCHIATR PSY, V40, P360, DOI 10.1590/2237-6089-2017-0155; Nemeroff CB, 2001, ANN NY ACAD SCI, V932, P1; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Oelrich B, 2007, EUR UROL, V52, P1238, DOI 10.1016/j.eururo.2007.06.050; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Panza MJ, 2020, J SPORT EXERCISE PSY, V42, P201, DOI 10.1123/jsep.2019-0235; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Qiu YY, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0534-5; Rehm J, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-0997-0; Robertson-Wilson J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01603; Sabiston CM, 2013, PREV MED, V56, P95, DOI 10.1016/j.ypmed.2012.11.013; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Schoeman JC, 2017, BEHAV BRAIN RES, V323, P86, DOI 10.1016/j.bbr.2017.01.043; Schwartz LM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01887; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Steyn SF, 2020, EUR J NEUROSCI, V52, P3979, DOI 10.1111/ejn.14757; Taliaferro LA, 2010, RES Q EXERCISE SPORT, V81, P328; Taliaferro LA, 2009, J AM COLL HEALTH, V57, P427, DOI 10.3200/JACH.57.4.427-436; Tao FB, 2007, J PAEDIATR CHILD H, V43, P762, DOI 10.1111/j.1440-1754.2007.01217.x; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Tomson LM, 2003, J SPORT EXERCISE PSY, V25, P419, DOI 10.1123/jsep.25.4.419; Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299; van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Wang F, 2014, INT J BEHAV MED, V21, P605, DOI 10.1007/s12529-013-9351-9; Wang Q, 2014, SCI TOTAL ENVIRON, V473, P483, DOI 10.1016/j.scitotenv.2013.12.066; Wegner M, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00081; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; Wichers M, 2002, INT J NEUROPSYCHOPH, V5, P375, DOI 10.1017/S1461145702003103; Xu Y, 2005, PHARMACOL BIOCHEM BE, V82, P200, DOI 10.1016/j.pbb.2005.08.009; Yan WW, 2020, NEUROIMAGE, V220, DOI 10.1016/j.neuroimage.2020.117121; Zhang JY, 2018, NEUROPSYCH DIS TREAT, V14, P2313, DOI 10.2147/NDT.S173255	112	0	0	35	44	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	JUN 18	2021	12								661108	10.3389/fpsyt.2021.661108			17	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	TC9EI	WOS:000668939800001	34220574	gold, Green Published			2022-02-07	
J	Biggs, AT; Hirsch, DA				Biggs, Adam T.; Hirsch, Dale A.			Using Monte Carlo simulations to translate military and law enforcement training results to operational metrics	JOURNAL OF DEFENSE MODELING AND SIMULATION-APPLICATIONS METHODOLOGY TECHNOLOGY-JDMS			English	Article; Early Access						Military; law enforcement; Monte Carlo; translational; applied research	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; EXERCISE-INDUCED FATIGUE; TRAUMATIC BRAIN-INJURY; POLICE OFFICERS; SITUATIONAL AWARENESS; COGNITIVE PERFORMANCE; SHOOTING PERFORMANCE; STRESS; MARKSMANSHIP; ANXIETY	There are numerous challenges comparing research initiatives due to methodological differences and scenario-specific problems. Military and law enforcement issues present an extreme variant of this challenge. Specifically, assessment and training scenarios strive for realism, but operators cannot engage one another with live rounds or induce the full spectrum of environmental stressors for obvious safety reasons. Instead, particular factors are evaluated in a given scenario via experimental statistics despite the inherent difficulty in communicating inferential statistics to the intended audience of military and law enforcement professionals. The current investigation explores how Monte Carlo simulations can use probabilistic distribution sampling to convert statistical inferences into concrete operational outcomes. Using this type of distribution sampling, statistical inferences can be translated into operational metrics such as the probability of winning a gunfight. Describing these statistical values and effect sizes in terms of survival provides a more appreciable operational metric that military and law enforcement personnel can use when evaluating the advantages of various training platforms or equipment. Several approaches are examined that each accomplish this general goal, including circumstances outside of marksmanship and lethal force decision-making.	[Biggs, Adam T.] Naval Med Res Unit Dayton, 2624 Q St,Bldg 851,Area B, Wright Patterson AFB, OH 45433 USA; [Hirsch, Dale A.] Naval Hlth Res Ctr, San Diego, CA USA		Biggs, AT (corresponding author), Naval Med Res Unit Dayton, 2624 Q St,Bldg 851,Area B, Wright Patterson AFB, OH 45433 USA.	adam.t.biggs.mil@socom.mil			Office of Naval ResearchOffice of Naval Research [N0001418WX00247]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Office of Naval Research (grant number N0001418WX00247).	Alexander A. L., 2005, DARWARS TRAINING IMP, V5, P1; Biggs A, 2019, MILITARY MED, V184, P611; Biggs AT, 2015, PSYCHOL SCI, V26, P1164, DOI 10.1177/0956797615579274; Blacker KJ, 2021, HUM FACTORS, V63, P1141, DOI 10.1177/0018720820916975; Blacker KJ, 2019, J COGN ENHANCE, V3, P30, DOI 10.1007/s41465-018-0076-1; BLUM M, 1986, COMBINATORICA, V6, P97, DOI 10.1007/BF02579167; Brown SA., P HUM FACT ERG SOC A, V61, P2020; Charles M. T., 2003, INT J POLICE SCI MAN, V5, P16, DOI DOI 10.1350/IJPS.5.1.16.11245; Chusilp P, 2014, INT J APPL PHYS MATH, V4, P280, DOI 10.7763/IJAPM.2014.V4.299.; Clark K, 2012, INFLUENCE ATTENTION; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Getty TJ, MODELING VIRTUAL ENV; Hamilton JA, 2019, AM J PSYCHOL, V132, P179, DOI 10.5406/amerjpsyc.132.2.0179; Harris KR, 2017, ERGONOMICS, V60, P1112, DOI 10.1080/00140139.2016.1260165; Hope L, 2016, J APPL RES MEM COGN, V5, P239; Hu XJ, 2013, APPL MECH MATER, V397-400, P2459, DOI 10.4028/www.scientific.net/AMM.397-400.2459; Jensen T, 2012, NAVAL MARKSMANSHIP T; Landman A, 2016, ERGONOMICS, V59, P950, DOI 10.1080/00140139.2015.1107625; Landman A, 2016, ANXIETY STRESS COPIN, V29, P570, DOI 10.1080/10615806.2015.1070834; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Lim J, 2017, ERGONOMICS, V60, P824, DOI 10.1080/00140139.2016.1222001; Markham AE., 2016, INT C SER GAM INT SI, P99; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; McNamara JA., P HUM FACT ERG SOC A, V60, P2043; Mihaylov DG, 2017, J DEF MODEL SIMUL-AP, V14, P465, DOI 10.1177/1548512916688566; Min BJ, 2016, J KOREAN PHYS SOC, V69, P1139, DOI 10.3938/jkps.69.1139; MORRISON GB, 1998, POLICING, V0021; Nibbeling N, 2014, ERGONOMICS, V57, P1366, DOI 10.1080/00140139.2014.924572; Nibbeling N, 2013, ERGONOMICS, V56, P1877, DOI 10.1080/00140139.2013.847213; Nieuwenhuys A, 2012, APPL COGNITIVE PSYCH, V26, P608, DOI 10.1002/acp.2838; Nieuwenhuys A, 2012, EMOTION, V12, P827, DOI 10.1037/a0025699; Nieuwenhuys A, 2011, COGN PROCESS, V12, P277, DOI 10.1007/s10339-011-0396-x; Oudejans RRD, 2008, ERGONOMICS, V51, P261, DOI 10.1080/00140130701577435; Pae SI, 2005, PROCEEDINGS OF THE SIXTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1079; Palmer CJ, 2013, ERGONOMICS, V56, P1708, DOI 10.1080/00140139.2013.832805; Proctor SP, 2015, MIL MED, V180, P660, DOI 10.7205/MILMED-D-14-00298; Renden PG, 2017, ERGONOMICS, V60, P669, DOI 10.1080/00140139.2016.1205222; Renden PG, 2015, ERGONOMICS, V58, P1496, DOI 10.1080/00140139.2015.1013578; Rose LT, 2011, MEAS-INTERDISCIP RES, V9, P222, DOI 10.1080/15366367.2011.632338; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rubinstein R., 2016, SIMULATION MONTE CAR; Saus ER, 2006, MIL PSYCHOL, V18, pS3, DOI 10.1207/s15327876mp1803s_2; Saus ER, 2012, COMPUT HUM BEHAV, V28, P1262, DOI 10.1016/j.chb.2012.02.009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Spaulding D, 2003, POLICE LAW ENFORCEM, V27, P22; Suss J, 2019, J POLICE CRIM PSYCHO, V34, P292, DOI 10.1007/s11896-019-09329-2; Taverniers J, 2014, HUM FACTORS, V56, P403, DOI 10.1177/0018720813489148; Tharion WJ, 2003, AVIAT SPACE ENVIR MD, V74, P309; United States Marine Corps, 2019, REV TABL 2 BCM TRAIN; Vickers JN, 2012, HUMAN MOVEMENT SCI, V31; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wang HY, 2016, AM J OPERATIONS RES, V6, P450, DOI 10.4236/ajor.2016.66042; Wilson K., P HUM FACT ERG SOC A, V57, P1244; Wilson KM, P HUM FACT ERG SOC A, V58, P1204; Wilson KM, 2015, HUM FACTORS, V57, P1219, DOI 10.1177/0018720815605703; Worden BP, 2012, NAVAL POSTGRADUATE S; Yates WW, 2004, NAVAL POSTGRADUATE S	59	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1548-5129	1557-380X		J DEF MODEL SIMUL-AP	J. Def. Model. Simul.-Appl. Methodol. Technol.-JDMS											15485129211021159	10.1177/15485129211021159		JUN 2021	13	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	SX5FO	WOS:000665231000001					2022-02-07	
J	Lin, JC; Mueller, C; Campbell, KA; Thannickal, HH; Daredia, AF; Sheriff, S; Maudsley, AA; Brunner, RC; Younger, JW				Lin, Joanne C.; Mueller, Christina; Campbell, Kelsey A.; Thannickal, Halle H.; Daredia, Altamish F.; Sheriff, Sulaiman; Maudsley, Andrew A.; Brunner, Robert C.; Younger, Jarred W.			Investigating whole-brain metabolite abnormalities in the chronic stages of moderate or severe traumatic brain injury	PM&R			English	Article; Early Access							MAGNETIC-RESONANCE-SPECTROSCOPY; LONG-TERM DISABILITY; UNITED-STATES; DIFFUSION; FATIGUE; ACTIVATION; BIOMARKER; NEURODEGENERATION; DISTRIBUTIONS; CONNECTIVITY	Background Evidence suggests that neurometabolic abnormalities can persist after traumatic brain injury (TBI) and drive clinical symptoms such as fatigue and cognitive disruption. Magnetic resonance spectroscopy has been used to investigate metabolite abnormalities following TBI, but few studies have obtained data beyond the subacute stage or over large brain regions. Objective To measure whole-brain metabolites in chronic stages of TBI. Design Observational study. Setting University. Participants Eleven men with a moderate or severe TBI more than 12 months prior and 10 age-matched healthy controls completed whole-brain spectroscopic imaging. Main Measures Ratios of N-acetylaspartate (NAA), choline (CHO), and myo-inositol (MI) to creatine (CR) were measured in whole-brain gray and white matter as well as 64 brain regions of interest. Arterial spin labeling (ASL) data were also collected to investigate whether metabolite abnormalities were accompanied by differences in cerebral perfusion. Results There were no differences in metabolite ratios within whole-brain gray and white matter regions of interest (ROIs). Linear regression showed lower NAA/CR in the white matter of the left occipital lobe but higher NAA/CR in the gray matter of the left parietal lobe. Metabolite abnormalities were observed in several brain regions in the TBI group including the corpus callosum, putamen, and posterior cingulate. However, none of the findings survived correction for multiple comparison. There were no differences in cerebral blood flow between patients and controls. Conclusion Higher MI/CR may indicate ongoing gliosis, and it has been suggested that low CHO/CR at chronic time points may indicate cell death or lack of healthy turnover and repair. However, with the small sample size of this study, we caution against the overinterpretation of our results. None of the findings within ROIs survived correction for multiple comparison. Thus, they may be considered possible avenues for future research in this area.	[Lin, Joanne C.; Mueller, Christina; Campbell, Kelsey A.; Daredia, Altamish F.; Younger, Jarred W.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Thannickal, Halle H.] Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA; [Sheriff, Sulaiman; Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Brunner, Robert C.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Lin, JC (corresponding author), Univ Auckland, Sch Pharm, Fac Med & Hlth Sci, Auckland, New Zealand.	joanne.lin@auckland.ac.nz		Lin, Joanne/0000-0001-5551-2263	National Institute of Biomedial Imaging and Bioengineering [R01EB016064]; University of Alabama at Birmingham; Functional Neurorecovery Collaborative Pilot Grant	National Institute of Biomedial Imaging and Bioengineering, Grant/Award Number: R01EB016064; University of Alabama at Birmingham, Grant/Award Number: Functional Neurorecovery Collaborative Pilot Grant	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Centers for Disease Control and Prevention, 2014, REP C TRA BRA INJ US; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Ebel A, 2003, MAGN RESON IMAGING, V21, P113, DOI 10.1016/S0730-725X(02)00645-8; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Haley AP, 2011, BRAIN IMAGING IN BEHAVIORAL MEDICINE AND CLINICAL NEUROSCIENCE, P83, DOI 10.1007/978-1-4419-6373-4_6; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2017, J NEUROIMAGING, V27, P562, DOI 10.1111/jon.12463; Maudsley AA, 2017, NEUROIMAGE, V146, P1093, DOI 10.1016/j.neuroimage.2016.09.062; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Mueller C, 2020, BRAIN IMAGING BEHAV, V14, P562, DOI 10.1007/s11682-018-0029-4; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sheth C, 2020, J NEUROPHYSIOL, V123, P1619, DOI 10.1152/jn.00765.2019; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12623		JUN 2021	14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ST2PS	WOS:000662292600001	33930238				2022-02-07	
J	Murali, S; Alam, F; Kroeker, J; Ginsberg, J; Oberg, E; Woodruff, P; Moore, AN; Raimonde, AJ; Novakovic, R; Buderer, NM; Stausmire, JM; Leskovan, JJ; Afaneh, A				Murali, Shyam; Alam, Farjana; Kroeker, Jenna; Ginsberg, Jennifer; Oberg, Erin; Woodruff, Phillip; Moore, Aaron N.; Raimonde, Anthony Jay; Novakovic, Rachel; Buderer, Nancy M.; Stausmire, Julie M.; Leskovan, John J.; Afaneh, Amer			Retrospective analysis of small intracranial hemorrhage in trauma: Is acute care surgery team management alone safe?	BRAIN INJURY			English	Article						Brain Injury Guidelines; Intracranial hemorrhages; Traumatic brain injury; Neurosurgery; Acute care surgery	BRAIN-INJURY GUIDELINES; NEUROSURGEONS CRITICAL ROLE; PATIENT; UTILITY; BIG	Background: The Brain Injury Guidelines (BIG) provide a validated framework for categorizing patients with small intracranial haemorrhages (ICH) who could be managed by acute care surgery without neurosurgical consultation or repeat head computed tomography in the absence of neurological deterioration. This replication study retrospectively applied BIG criteria to ICH subjects and only included BIG1 and BIG2 subjects. Methods: The trauma registry was queried from 2014 to 2019 for subjects with a traumatic ICH <1 cm, Glasgow Coma Scale score of 14/15 and not on anticoagulation therapy. Patients were then categorized under BIG 1 or BIG2 and outcomes were evaluated. Results: Two hundred fourteen subjects were reviewed (88 BIG1 and 126 BIG2). Twenty-three subjects had worse repeat imaging, but only one had worsening exam that resolved spontaneously. None required neurosurgical intervention. One died of non-neurological causes. Conclusions: Retrospective analysis supported our hypothesis that patients categorized as BIG1 or BIG2 could have been safely managed by acute care surgeons without neurosurgical consultation or repeat head imaging. A review of minor worsening on repeat imaging without changes in neurological exams and no need for neurosurgical interventions supports this evidence-based approach to the management of small intracranial haemorrhages.	[Murali, Shyam] Mercy Hlth St Vincent Med Ctr, Dept Emergency Med, Toledo, OH USA; [Alam, Farjana; Kroeker, Jenna; Ginsberg, Jennifer; Oberg, Erin; Woodruff, Phillip; Stausmire, Julie M.] Mercy Hlth St Vincent Med Ctr, Dept Acad Affairs, Toledo, OH USA; [Alam, Farjana] Northeast Ohio Med Univ, Rootstown, OH USA; [Kroeker, Jenna; Ginsberg, Jennifer; Oberg, Erin; Woodruff, Phillip] St Georges Univ, Sch Med, Great River, NY USA; [Kroeker, Jenna] Maimonides Hosp, Dept Gen Surg, Residency Program, Brooklyn, NY 11219 USA; [Moore, Aaron N.; Raimonde, Anthony Jay; Leskovan, John J.; Afaneh, Amer] Mercy Hlth St Vincent Med Ctr, Dept Trauma & Crit Care Surg, Toledo, OH USA; [Novakovic, Rachel] Mercy Hlth St Vincent Med Ctr, Dept Trauma & Crit Care Surg, Burn Ctr, Toledo, OH USA; [Buderer, Nancy M.] Nancy Buderer Consulting LLC, Dept Acad Affairs, Oak Harbor, OH USA		Stausmire, JM (corresponding author), Mercy Hlth St Vincent Med Ctr, Acad Res, Toledo, OH 43608 USA.	Julie_Stausmire1@mercy.com		Murali, Shyam/0000-0002-5621-6121			Azim A, 2017, J TRAUMA ACUTE CARE, V83, P1200, DOI 10.1097/TA.0000000000001611; Capron GK, 2017, AM J SURG, V214, P1182, DOI 10.1016/j.amjsurg.2017.09.002; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Traumatic Brain Injury  Concussion Data and Statistics, 2019, NAT CTR INJ PREV CON; Devulapalli KK, 2018, AM J NEURORADIOL, V39, P654, DOI 10.3174/ajnr.A5557; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2016, JAMA SURG, V151, P200, DOI 10.1001/jamasurg.2015.3645; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Khalayleh H, 2019, WORLD J SURG, V43, P497, DOI 10.1007/s00268-018-4821-5; Khan AD, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000483; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Tang AL, 2010, SCAND J SURG, V99, P61, DOI 10.1177/145749691009900202; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Ullman JS, 2016, JAMA SURG, V151, P199, DOI 10.1001/jamasurg.2015.3642; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	19	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					886	892		10.1080/02699052.2021.1920052		JUN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000662087700001	34133258				2022-02-07	
J	Riccardi, JS; Eagan-Johnson, B; Vaccaro, M; Ciccia, AH				Riccardi, Jessica Salley; Eagan-Johnson, Brenda; Vaccaro, Monica; Ciccia, Angela H.			Academic and post-secondary participation of students with ABI after the BrainSTEPS program	BRAIN IMPAIRMENT			English	Article; Early Access						childhood brain injury; education; special education; vocation; independent living	INJURY; EDUCATION; OUTCOMES; YOUTH	Purpose: To describe and analyze educational and post-high school participation of individuals who sustained an acquired brain injury (ABI) during childhood and participated in a state-wide school-based brain injury support program, BrainSTEPS in Pennsylvania (BrainSTEPS). Method: Retrospective analysis of programmatic information and data collected through electronic and phone surveys during a follow-up survey for a statewide, school-based, school consultation program for students with ABI. Participants: Caregivers reported on 190 individuals with ABI who participated in Pennsylvania's BrainSTEPS Program. Results: Individuals post-ABI who participated in the BrainSTEPS were most likely to have experienced a mild ABI in high school due to sports. Post-injury, students were most likely to be enrolled in regular education, have graduated high school, pursued four-year college education and be attending post-secondary education and living with family. Additional significant relationships were not reported within the concussion or moderate-severe traumatic brain injury subgroups. Significant relationships for educational outcomes included higher likelihood of regular educational placement at the time of referral given an older grade at injury and regular educational placement before injury. For post-high school outcomes, a younger age at survey was associated with current attendance in post-secondary education, compared to other vocational options. Conclusions: Individuals with a history of ABI before school age and during primary and secondary education present with heterogeneous educational and post-high school outcomes. A greater breadth of measures of formal and informal educational and vocational supports and post-high school attainment should be implemented to accurately capture the needs and outcomes of these students to inform supports and services.	[Riccardi, Jessica Salley] Case Western Reserve Univ, Commun Sci, Dept Psychol Sci, Cleveland, OH 44106 USA; [Eagan-Johnson, Brenda] Brain Injury Assoc Penn, Chambursburg, PA USA; [Vaccaro, Monica] Brain Injury Assoc Penn, Programs, Chambursburg, PA USA; [Ciccia, Angela H.] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA		Riccardi, JS (corresponding author), Case Western Reserve Univ, Commun Sci, Dept Psychol Sci, Cleveland, OH 44106 USA.	jxs1654@case.edu			PA Department of Health, Bureau of Special Education via the PaTTAN network; PA Department of Education, Bureau of Special Education via the PaTTAN network	BrainSTEPS was created in 2007 by the Pennsylvania Department of Health. The program is jointly funded by the PA Department of Health and PA Department of Education, Bureau of Special Education via the PaTTAN network. BrainSTEPS is implemented by the Brain Injury Association of Pennsylvania. Conflicts of Interest. Brenda Eagan-Johnson is the Project Director of BrainSTEPS	Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; De Netto RK, 2020, DISABIL REHABIL, V42, P2444, DOI 10.1080/09638288.2019.1637948; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; JASP Team, 2020, JASP VERS 0 13 1 COM; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; Myers R.K., 2017, CLIN PEDIATR, P1; Nybo T, 2005, ACTA NEUROL SCAND, V112, P338, DOI 10.1111/j.1600-0404.2005.00489.x; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tucker MS, 2017, REHABIL COUNS BULL, V60, P215, DOI 10.1177/0034355216660279; U.S. Bureau of Labor and Statistics, 2020, COLL ENROLLMENT WORK; U.S. Department of Education N. C. for E. S., 2018, 2017094 NCES US DEP; Venville A, 2016, INT J DISABIL DEV ED, V63, P571, DOI 10.1080/1034912X.2016.1153050; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	23	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000103	10.1017/BrImp.2021.10		JUN 2021	16	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YI3TO	WOS:000743774200001					2022-02-07	
J	Johnson, ED; Oak, S; Griswold, DP; Olaya, S; Puyana, JC; Rubiano, AM				Johnson, Erica D.; Oak, Sangki; Griswold, Dylan P.; Olaya, Sandra; Puyana, Juan C.; Rubiano, Andres M.			Neurotrauma Registry Implementation in Colombia: A Qualitative Assessment	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injury; LMICS; trauma registry; neurotrauma	THEORETICAL DOMAINS FRAMEWORK; TRAUMATIC BRAIN-INJURY; BEHAVIOR-CHANGE; GLOBAL BURDEN; MORTALITY; CARE; CHALLENGES	Objectives Latin America is among several regions of the world that lacks robust data on injuries due to neurotrauma. This research project sought to investigate a multi-institution brain injury registry in Colombia, South America, by conducting a qualitative study to identify factors affecting the creation and implementation of a multi-institution TBI registry in Colombia before the establishment of the current registry. Methods Key informant interviews and participant observation identified barriers and facilitators to the creation of a TBI registry at three health care institutions in this upper-middle-income country in South America. Results The study identified barriers to implementation involving incomplete clinical data, limited resources, lack of information and technology (IT) support, time constraints, and difficulties with ethical approval. These barriers mirrored similar results from other studies of registry implementation in low- and middle-income countries (LMICs). Ease of use and integration of data collection into the clinical workflow, local support for the registry, personal motivation, and the potential future uses of the registry to improve care and guide research were identified as facilitators to implementation. Stakeholders identified local champions and support from the administration at each institution as essential to the success of the project. Conclusion Barriers for implementation of a neurotrauma registry in Colombia include incomplete clinical data, limited resources and lack of IT support. Some factors for improving the implementation process include local support, personal motivation and potential uses of the registry data to improve care locally. Information from this study may help to guide future efforts to establish neurotrauma registries in Latin America and in LMICs.	[Johnson, Erica D.] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh, PA USA; [Oak, Sangki] Brigham & Womens Hosp, Dept Gen Surg, 75 Francis St, Boston, MA 02115 USA; [Griswold, Dylan P.] Stanford Sch Med, Stanford, CA 94305 USA; [Olaya, Sandra] Javeriana Univ, Meditech Fdn, Emergency Med Program, Cali, Colombia; [Puyana, Juan C.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Rubiano, Andres M.] INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia; [Rubiano, Andres M.] Univ El Bosque, Bogota, Colombia; [Rubiano, Andres M.] Meditech Fdn, Valle Salud Clin, Cali, Colombia		Rubiano, AM (corresponding author), INUB MEDITECH Res Grp, Neurosci Inst, Bogota, Colombia.; Rubiano, AM (corresponding author), Univ El Bosque, Bogota, Colombia.; Rubiano, AM (corresponding author), Meditech Fdn, Valle Salud Clin, Cali, Colombia.	andresrubiano@aol.com	Griswold, Dylan/ABC-7890-2021	Griswold, Dylan/0000-0003-0291-8360			Assan A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024845; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Bommakanti K, 2018, J SURG RES, V223, P72, DOI 10.1016/j.jss.2017.09.039; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Dasari M, 2016, WORLD J SURG, V40, P2840, DOI 10.1007/s00268-016-3654-3; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Fetterman David.M., 2009, ETHNOGRAPHY STEP BY, V17; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Leavy MB, MULTINATIONAL REGIST; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mirbaha F, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0302-5; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Patton MQ., 2014, QUALITATIVE RES EVAL; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; St-Louis E, 2018, INJURY, V49, P2100, DOI 10.1016/j.injury.2018.10.007; Takian A, 2013, FAM PRACT, V30, P551, DOI 10.1093/fampra/cmt025	20	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2021	12	03					518	523		10.1055/s-0041-1727577		JUN 2021	6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TK9DX	WOS:000662018900005	34295106	Green Published, gold			2022-02-07	
J	Trbovich, AM; Preszler, J; Emami, K; Cohen, P; Eagle, S; Collins, MW; Kontos, AP				Trbovich, Alicia M.; Preszler, Jonathan; Emami, Kouros; Cohen, Paul; Eagle, Shawn; Collins, Michael W.; Kontos, Anthony P.			Is Overparenting Associated with Adolescent/Young Adult Emotional Functioning and Clinical Outcomes Following Concussion?	CHILD PSYCHIATRY & HUMAN DEVELOPMENT			English	Article; Early Access						Concussion recovery; Helicopter parenting; Overparenting; Emotional distress; Clinical outcomes	ANXIETY STRESS SCALES; SPORT-RELATED CONCUSSION; DASS-21 FACTOR STRUCTURE; TRAUMATIC BRAIN-INJURY; CONSTRUCT-VALIDITY; NORMATIVE DATA; HIGH-SCHOOL; DEPRESSION; SYMPTOMS; CHILD	Overparenting (O-P), or "helicopter" parenting, has warranted increased attention across the past decade. It is characterized as being overly involved, protective, and low on granting autonomy, and is associated with deleterious psychosocial outcomes outside of the concussion literature. This study examined the association of overparenting and patient emotional distress and clinical outcomes (i.e., symptoms, neurocognitive test scores, recovery time) post-concussion. Adolescents/young adult concussion patients (injury < 30 days) and parents (N = 101 child-parent dyads) participated. Patient participants completed measures of depression, anxiety, stress, and concussion clinical outcomes while parents concurrently completed an overparenting measure. Results of a general linear model found that overparenting was associated with higher anxiety and stress report of the child. Overparenting had a significant positive correlation with concussion recovery, although of a small magnitude. Emotional distress level, but not overparenting, was moderately associated with worse performance on clinical outcomes, including neurocognitive testing, vestibular/ocular motor dysfunction, and concussion symptom severity.	[Trbovich, Alicia M.; Preszler, Jonathan; Emami, Kouros; Eagle, Shawn; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr UPMC, Dept Orthopaed Surg, Sports Med Concuss Program, 3200 S Water St Pittsburgh, Pittsburgh, PA 15203 USA; [Cohen, Paul] WakeMed Hlth & Hosp, WakeMed Concuss Program, 3000 New Bern Ave, Raleigh, NC 27610 USA		Trbovich, AM (corresponding author), Univ Pittsburgh, Med Ctr UPMC, Dept Orthopaed Surg, Sports Med Concuss Program, 3200 S Water St Pittsburgh, Pittsburgh, PA 15203 USA.	trbovicham@upmc.edu		Trbovich, Alicia/0000-0003-4539-7120			Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Dressing M., 2020, J CLIN SPORT PSYCHOL, V1, P1, DOI [10.1123/jcsp.2019-0077, DOI 10.1123/JCSP.2019-0077]; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Hansen BH, 2016, NORD J PSYCHIAT, V70, P133, DOI 10.3109/08039488.2015.1061053; Hatfield E., 2011, EMOTIONAL CONTAGION; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hixson KM, 2017, J SPORT REHABIL, V26, P588, DOI 10.1123/jsr.2016-0122; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; LeMoyne T, 2011, SOCIOL SPECTRUM, V31, P399, DOI 10.1080/02732173.2011.574038; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McElroy MK, 2018, THESIS; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Padilla-Walker LM, 2012, J ADOLESCENCE, V35, P1177, DOI 10.1016/j.adolescence.2012.03.007; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Rapson R., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Riegler KE, 2020, NEUROPSYCHOLOGY, V34, P63, DOI 10.1037/neu0000582; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Saman Yougan, 2012, Front Neurol, V3, P116, DOI 10.3389/fneur.2012.00116; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schiffrin HH, 2014, J CHILD FAM STUD, V23, P548, DOI 10.1007/s10826-013-9716-3; Segrin C, 2015, J CHILD FAM STUD, V24, P470, DOI 10.1007/s10826-013-9858-3; Segrin C, 2013, J SOC CLIN PSYCHOL, V32, P569, DOI 10.1521/jscp.2013.32.6.569; Segrin C, 2012, FAM RELAT, V61, P237, DOI 10.1111/j.1741-3729.2011.00689.x; Shaffer M, 2020, ARCH CLIN NEUROPSYCH, V35, P635, DOI 10.1093/arclin/acaa036.39; Shoup R., 2009, 49 ANN FOR ASS I RES; Sommerfeldt SL, 2016, J CLIN CHILD ADOLESC, V45, P69, DOI 10.1080/15374416.2015.1072823; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220	55	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0009-398X	1573-3327		CHILD PSYCHIAT HUM D	Child Psychiat. Hum. Dev.												10.1007/s10578-021-01204-8		JUN 2021	9	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	ST0AK	WOS:000662113800002	34136979				2022-02-07	
J	Lempke, LB; Lynall, RC; Anderson, MN; McCrea, MA; McAllister, TW; Broglio, SP; Schmidt, JD				Lempke, Landon B.; Lynall, Robert C.; Anderson, Melissa N.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.; Schmidt, Julianne D.		CARE Consortium Investigators	Optimizing Order of Administration for Concussion Baseline Assessment Among NCAA Student-Athletes and Military Cadets	SPORTS MEDICINE			English	Article							MENTAL FATIGUE; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; SPORT CONCUSSION; KING-DEVICK; PERFORMANCE; COLLEGIATE; SENSITIVITY; SYMPTOMS; IMPACT	Background Concussion pre-injury (i.e., baseline) assessments serve as a benchmark comparison point in the event an individual sustains a concussion and allows clinicians to compare to post-injury measures. However, baseline assessments must reflect the individual's true and most optimized performance to serve as a useful comparison. Mental fatigue and motivation throughout baseline testing may alter individual assessment performance, indicating an order of administration (OoA) may play an influential role in assessment outcomes. Objective To examine the influence concussion baseline battery OoA has on symptom, postural stability, cognitive screening, and computerized neurocognitive test outcomes. Methods We employed a retrospective observational cohort study to examine healthy collegiate student-athletes and military cadets (n = 2898, 19.0 +/- 1.4 years, 66.1% male, 75.6% white, 54.4% Division-I) baseline assessment performance on the Sport Concussion Assessment Tool (SCAT; total symptom number and severity), Balance Error Scoring System (BESS; total error scores), Standardized Assessment of Concussion (SAC; total score), and Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) domain scores (verbal and visual memory, visual-motor speed, reaction time). Assessments were binned to beginning, middle, or end tertiles based upon OoA. We used one-way ANOVAs with Tukey post-hoc t tests, 95% confidence intervals (CI), and Cohen's d effect sizes for significant models (alpha = 0.05). Results SCAT total symptom number (mean difference = 2.23; 95% CI 1.76-2.70; d = 0.49, p < 0.001) and severity (mean difference = 5.58; 95% CI 4.42-6.74; d = 0.50; p < 0.001) were lower when completed at the end of baseline testing compared to the middle. Total BESS errors were 1.06 lower when completed at the middle relative to the end (95% CI 0.43-1.69; d = 0.17; p = 0.001). Total SAC scores were better at the beginning relative to middle (mean difference = 0.58; 95% CI 0.25-0.90; d = 0.33; p < 0.001) and end (mean difference = 0.44; 95% CI 0.16-0.73; d = 0.24; p = 0.001). Verbal memory, visual memory, and reaction time performance were highest at the beginning (p <= 0.002), while visual-motor speed performance was highest at the middle (p = 0.001). Conclusion Completing baseline assessments in the order of (1) ImPACT, (2) SAC, (3) BESS, and (4) SCAT symptom checklist may improve performance across assessments collectively. Clinicians and researchers should consider completing baseline assessments in this order when possible to potentially aid in optimizing concussion baseline assessment performance and maximize post-concussion comparisons.	[Lempke, Landon B.; Lynall, Robert C.; Anderson, Melissa N.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Ramsey Student Ctr, 330 River Rd, Athens, GA 30606 USA; [Lempke, Landon B.] Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Lempke, Landon B.] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [McCrea, Michael A.] Dept Neurosurg & Neurol, Milwaukee, WI USA; [McAllister, Thomas W.] Sch Med, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Lempke, LB (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Ramsey Student Ctr, 330 River Rd, Athens, GA 30606 USA.; Lempke, LB (corresponding author), Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA.; Lempke, LB (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	lblempke@uga.edu	Lempke, Landon/C-4800-2018	Lempke, Landon/0000-0003-0007-1362	Grand Alliance Concussion Assessment, Research, and Education Consortium - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This study was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education Consortium, funded by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Anderson MN, 2020, BRAIN INJURY, V34, P369, DOI 10.1080/02699052.2020.1724332; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; BRANDON AD, 1985, INT J CLIN NEUROPSYC, V7, P152; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2020, J ATHL TRAINING, V55, P601, DOI 10.4085/1062-6050-164-19; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cohen J., 1988, STAT POWER ANAL BEHA; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; FRANZEN MD, 1993, ARCH CLIN NEUROPSYCH, V8, P105, DOI 10.1016/0887-6177(93)90028-Y; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lloyd KP, 2012, APPL NEUROPSYCH-ADUL, V19, P299, DOI 10.1080/09084282.2012.670153; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Medicine BPGL and BA of S and E, 2013, BRIT J SPORT MED, V47, P259; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; RStudio Team, 2016, RSTUDIO INT DEV ENV; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Van der Vaart A.W., 2000, ASYMPTOTIC STAT; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Walton SR, 2020, ARCH CLIN NEUROPSYCH, V35, P275, DOI 10.1093/arclin/acz068; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Womack C, 2008, YB SPORTS MED, V2008, P10, DOI [10.1016/S0162-0908(08)79111-6, DOI 10.1016/S0162-0908(08)79111-6]	51	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	JAN	2022	52	1					165	176		10.1007/s40279-021-01493-y		JUN 2021	12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YH1FL	WOS:000661788600001	34129221				2022-02-07	
J	Sagir, D				Sagir, Dilek			Dose-dependent effects of prenatal exposure of pioglitazone, the PPAR gamma agonist, on the hippocampus development and learning and memory performance of rat offspring	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Pioglitazone; PPAR gamma; Hippocampus; Neurotoxicity; Glial fibrillar acidic protein (GFAP); Learning and memory	ACTIVATED-RECEPTOR-GAMMA; STEM-CELL PROLIFERATION; TRAUMATIC BRAIN-INJURY; ALPHA AGONIST; COGNITIVE DEFICITS; INSULIN-RESISTANCE; FENOFIBRATE; ROSIGLITAZONE; DAMAGE; MODEL	It is known that pioglitazone, defined as a PPAR gamma agonist, has neuron-protective properties in nervous system disorders. The aim of this study is to investigate the effects of pioglitazone administration at different doses during prenatal period on the neurons, glial cells and learning-memory levels in the hippocampus of rat offspring. Pregnant rats were divided into three groups; Low-Dose Pioglitazone (LDP), High-Dose Pioglitazone (HDP) and control (C) (n = 3). Pregnant rats in the HDP and LDP groups were given pioglitazone at 30 mg/kg and 5 mg/ kg doses, respectively, by gavage once a day during their pregnancy. No procedure was applied to the rats in the control group. Morris water tank test was applied to offspring obtained from postnatal 24th to 28th day. The offspring were sacrificed on the 29th postal day and their brain tissues removed. Stereological, histopathological and immunohistochemical techniques were used to analyze brain tissues. As a result of the analysis, it was observed that there were delays in learning and memory, the number of pyramidal neurons decreased, and the density of cells stained with glial fibrillar acidic protein (GFAP) positive increased in the HDP group compared to the other groups (p < 0.05). No significant difference was found between the LDP and control groups in terms of these parameters (p > 0.05). Our results showed that pioglitazone administered in the prenatal period had an effect on the hippocampus development and learning and memory performance of rats, depending on the dose.	[Sagir, Dilek] Sinop Univ, Fac Hlth Sci, TR-57000 Sinop, Turkey		Sagir, D (corresponding author), Sinop Univ, Fac Hlth Sci, TR-57000 Sinop, Turkey.	bio_dilek@hotmail.com					Baghcheghi Y, 2019, INT J NEUROSCI, V129, P1024, DOI 10.1080/00207454.2019.1632843; Baghcheghi Y, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/1952561; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chinnam Pushpalatha, 2012, Toxicol Int, V19, P250, DOI 10.4103/0971-6580.103660; Cippitelli A, 2017, BRAIN BEHAV IMMUN, V64, P320, DOI 10.1016/j.bbi.2017.02.001; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Elshama SS, 2016, IRAN J BASIC MED SCI, V19, P712; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Grover S, 2013, PHARMACOL BIOCHEM BE, V111, P17, DOI 10.1016/j.pbb.2013.08.001; Han Y, 2020, BRAIN BEHAV IMMUN, V87, P568, DOI 10.1016/j.bbi.2020.02.002; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Jahangiri Z, 2019, METAB BRAIN DIS, V34, P1157, DOI 10.1007/s11011-019-00410-7; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Khoshnam SE, 2018, LIFE SCI, V211, P126, DOI 10.1016/j.lfs.2018.08.065; Kirsten TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197060; Lamtai M, 2021, BIOL TRACE ELEM RES, V199, P1445, DOI 10.1007/s12011-020-02247-z; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Lee CH, 2010, BRAIN RES, V1329, P30, DOI 10.1016/j.brainres.2010.03.027; Liao L, 2017, INT IMMUNOPHARMACOL, V49, P178, DOI 10.1016/j.intimp.2017.05.036; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Liu WC, 2018, BBA-MOL BASIS DIS, V1864, P274, DOI 10.1016/j.bbadis.2017.10.017; Mandrekar-Colucci S, 2013, ASN NEURO, V5, DOI 10.1042/AN20130030; Mehrabadi AR, 2015, IRAN J PHARM RES, V14, P825; Merlob Paul, 2002, Paediatr Drugs, V4, P755, DOI 10.2165/00148581-200204110-00007; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morales-Garcia JA, 2011, GLIA, V59, P293, DOI 10.1002/glia.21101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Sagir D, 2018, HUM EXP TOXICOL, V37, P827, DOI 10.1177/0960327117730883; Sain H, 2011, NEUROSCIENCE, V192, P322, DOI 10.1016/j.neuroscience.2011.07.002; Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10; Schernthaner G, 2013, DIABETES CARE, V36, pS155, DOI 10.2337/dcS13-2031; Schuler F, 2001, BBA-BIOENERGETICS, V1506, P79, DOI 10.1016/S0005-2728(01)00183-9; Seok H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40736-x; Sevillano J, 2005, BIOCHEM J, V389, P913, DOI 10.1042/BJ20041837; Seydi E, 2020, DRUG RES, V70, P112, DOI 10.1055/a-1085-2542; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; Soria A, 2002, J LIPID RES, V43, P74; Sundararajan S, 2006, NEUROCHEM INT, V49, P136, DOI 10.1016/j.neuint.2006.03.020; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yuan Y, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110543; Zhao QY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0728-y	50	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	JUN 15	2021	421								115544	10.1016/j.taap.2021.115544			7	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	SF3LF	WOS:000652660100005	33894214				2022-02-07	
J	Shirvani, S; Davoudi, M; Shirvani, M; Koleini, P; Panah, SH; Shoshtari, F; Omidi, A				Shirvani, Sheida; Davoudi, Mohammadreza; Shirvani, Masoud; Koleini, Peiman; Panah, Safora Hojat; Shoshtari, Fatemeh; Omidi, Abdollah			Comparison of the effects of transcranial direct current stimulation and mindfulness-based stress reduction on mental fatigue, quality of life and aggression in mild traumatic brain injury patients: a randomized clinical trial	ANNALS OF GENERAL PSYCHIATRY			English	Article						Traumatic brain injuries; Mindfulness-based stress reduction; Transcranial direct current stimulation	ATTENTION; TDCS	Background The rate of traumatic brain injuries (TBIs) due to the accidents is high around the world. Patients with mild TBIs may suffer from some psychological disorders, including aggression, and mental fatigue, and thus their quality of life decreased. Among different treatments for TBI, two treatments, namely transcranial direct current stimulation (tDCS), and mindfulness-based stress reduction (MBSR) have shown to be effective. Therefore, this study aimed to compare the effects of these two treatments on mental fatigue, aggression and quality of life in mTBI patients. Materials and methods This randomized controlled trial study was conducted on 48 TBI patients referred to emergency and neurosurgery departments of Shahid Beheshti Hospital, Kashan, Iran. They were selected using the convenience sampling method. Data were collected using the mental fatigue scale, the World Health Organization Quality of Life-BREF (short version), and the Buss-Perry Aggression Questionnaires. Then, the data were analyzed using a Mixed Repeated Measures ANOVAs, and the Levene and Kolmogorov-Smirnov tests by SPSS-23 software. Results The mean age of patients in the three groups of MBSR, tDCS and control were 69.38 + 6.11 (25% male), 25.40 + 12.11 (25% male) and 69.37 + 0.2 (18.8% male), respectively. There was no significant difference between the three groups in terms of mental fatigue, quality of life and aggression (P < 0.05). In addition, the results showed that there was a significant difference between the main effect of time and the interaction between time and group (P < 0.001). Conclusions Both MBSR and tDCS methods are effective in reducing the mental fatigue and aggression and increasing quality of life of mTBI patients; MBSR treatment, as indicated in the present study, can be more effective than tDCS in patients with mTBI. Trial registration : Thailand Registry of Clinical Trials, TCTR20180827003 Registered on August 24, 2018.	[Shirvani, Sheida; Omidi, Abdollah] Kashan Univ Med Sci, Sch Med, Dept Clin Psychol, Kashan, Iran; [Davoudi, Mohammadreza] Univ Social Welf & Rehabil Sci, Dept Clin Psychol, Tehran, Iran; [Shirvani, Masoud] Milad Hosp, Dept Neurosurg, Tehran, Iran; [Koleini, Peiman] Islamic Azad Univ, Sch Dent, Dept Dent Surg, Isfahan Khorasgan Branch, Esfahan, Iran; [Panah, Safora Hojat; Shoshtari, Fatemeh] Univ Najaf Abad, Dept Clin Psychol, Esfahan, Iran		Omidi, A (corresponding author), Kashan Univ Med Sci, Sch Med, Dept Clin Psychol, Kashan, Iran.	Ab.omidi20@yahoo.com					Acler M, 2013, RESTOR NEUROL NEUROS, V31, P661, DOI 10.3233/RNN-130321; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Del Vecchio T, 2004, CLIN PSYCHOL REV, V24, P15, DOI 10.1016/j.cpr.2003.09.006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Didonna, 2009, CLIN HDB MINDFULNESS, DOI [10.1007/978-0-387-09593-6, DOI 10.1007/978-0-387-09593-6]; Farzandipour M, 2007, EPIDEMIOLOGICAL STUD; Faul M, 2010, TRAUMATIC BRAIN INJU, P2010; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kekic M, 2014, APPETITE, V78, P55, DOI 10.1016/j.appet.2014.03.010; Kilpatrick LA, 2011, NEUROIMAGE, V56, P290, DOI 10.1016/j.neuroimage.2011.02.034; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lao SA, 2016, CONSCIOUS COGN, V45, P109, DOI 10.1016/j.concog.2016.08.017; Mehdizadeh Kashi Abolfazl, 2018, Obstet Gynecol Sci, V61, P598, DOI 10.5468/ogs.2018.61.5.598; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Shirvani S, 2020, ARCH TRAUMA RES, V9, P41, DOI 10.4103/atr.atr_67_18; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Wang BF, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.648354; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Zhang QX, 2019, SUPPORT CARE CANCER, V27, P771, DOI 10.1007/s00520-018-4570-x	32	0	0	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1744-859X		ANN GEN PSYCHIATR	Ann. Gen. Psychiatr.	JUN 15	2021	20	1							33	10.1186/s12991-021-00355-1			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SS6ZZ	WOS:000661905200001	34130721	Green Submitted, Green Published, gold			2022-02-07	
J	Breeze, J; Fryer, RN; Russell, J				Breeze, John; Fryer, R. N.; Russell, J.			Comparing the medical coverage provided by four contemporary military combat helmets against penetrating traumatic brain injury	BMJ MILITARY HEALTH			English	Article; Early Access						trauma management; neuroradiology; oral & maxillofacial surgery	BODY ARMOR; HEAD; WOUNDS	Introduction Modern military combat helmets vary in their shapes and features, but all are designed to protect the head from traumatic brain injury. Recent recommendations for protection against energised projectiles that are characteristic of secondary blast injury is to ensure coverage of both the brain and brainstem. Method Graphical representations of essential coverage of the head (cerebral hemispheres, cerebellum and brainstem) within an anthropometrically sized model were superimposed over two standard coverage helmets (VIRTUS helmet, Advanced Combat Helmet (ACH)) and two 'high-cut' helmets (a Dismounted Combat Helmet (DCH)) and Combat Vehicle Crewman (CVC) helmet), both of which are designed to be worn with communications devices. Objective shotline coverage from representative directions of projectile travel (-30 to +30 degrees) was determined using the Coverage of Armour Tool (COAT). Results VIRTUS and ACH demonstrated similar overall coverage (68.7% and 69.5%, respectively), reflecting their similar shell shapes. ACH has improved coverage from below compared with VIRTUS (23.3% vs 21.7%) due to its decreased standoff from the scalp. The 'high-cut' helmets (DCH and CVC) had reduced overall coverage (57.9% and 52.1%), which was most pronounced from the side. Conclusions Both the VIRTUS and ACH helmets provide excellent overall coverage of the brain and brainstem against ballistic threats. Coverage of both would be improved at the rear by using a nape protector and the front using a visor. This is demonstrated with the analysis of the addition of the nape protector in the VIRTUS system. High-cut helmets provide significantly reduced coverage from the side of the head, as the communication devices they are worn with are not designed to provide protection from ballistic threats. Unless absolutely necessary, it is therefore recommended that high-cut helmets be worn only by those users with defined specific requirements, or where the risk of injury from secondary blast is low.	[Breeze, John] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham B15 2WB, W Midlands, England; [Breeze, John] Imperial Coll London, Dept Bioengn, London, England; [Fryer, R. N.] Dstl, Platform Syst Div, Fareham, Hampshire, England; [Russell, J.] Dstl, Platform Syst Div, Salisbury, Wilts, England		Breeze, J (corresponding author), Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham B15 2WB, W Midlands, England.	johno.breeze@gmail.com		Breeze, John/0000-0002-2352-1365; Russell, Jonathan/0000-0001-6855-2950	Dstl [DSTL/CP121059]; Royal Centre for Defence Medicine [RCDM/Res/Audit/1036.19.0514, CC1-20200040]	Approval for undertaking and publishing this study was obtained from Dstl (Ref: DSTL/CP121059) and the Royal Centre for Defence Medicine (Ref: RCDM/Res/Audit/1036.19.0514 and CC1-20200040). Content includes material subject to (c) Crown copyright (2019), UK Ministry of Defence. This material is licensed under the terms of the Open Government License. Approval to publish was granted by Defence Equipment and Support.	Bailey KV., 1940, J ROY ARMY MED CORPS, V75, P160; Breeze J, 2017, BRIT J ORAL MAX SURG, V55, P173, DOI 10.1016/j.bjoms.2016.10.018; Breeze J, 2015, INJURY, V46, P629, DOI 10.1016/j.injury.2015.01.045; Breeze J, 2015, BRIT J ORAL MAX SURG, V53, P3, DOI 10.1016/j.bjoms.2014.04.017; Breeze J, 2012, INJURY, V43, P1856, DOI 10.1016/j.injury.2011.07.001; Breeze J, 2016, J ROY ARMY MED CORPS, V162, P284, DOI 10.1136/jramc-2015-000431; Breeze J, 2015, J ROY ARMY MED CORPS, V161, P9, DOI 10.1136/jramc-2013-000108; Breeze J, 2015, J ROY ARMY MED CORPS, V161, P36, DOI 10.1136/jramc-2014-000249; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; Carr D, 2014, TEXT RES J, V84, P655, DOI 10.1177/0040517513499436; Carr DJ, 2020, BMJ MILITARY HEALTH, V166, P342, DOI 10.1136/jramc-2018-001123; Carr DJ, 2017, J ROY ARMY MED CORPS, V163, P13, DOI 10.1136/jramc-2015-000600; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Eberius N., 2010, SURVIVABILITY ANAL E; Gofrit ON, 1996, INJURY, V27, P577, DOI 10.1016/S0020-1383(96)00072-1; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Kulkarni SG, 2012, INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION - 2012, VOL 8, P567; Lewis EA, 2018, P PERS ARM SYST S 01 P PERS ARM SYST S 20, P1; Mahoney PF, 2017, INT J LEGAL MED, V131, P1765, DOI 10.1007/s00414-017-1665-8; NATO Standardization Office, 2019, AEP2902 NATO STAND O; Rafaels KA, 2015, J FORENSIC SCI, V60, P219, DOI 10.1111/1556-4029.12570; Ran Y, 2010, J TRAUMA, V69, P541, DOI 10.1097/TA.0b013e3181e4ec69; Wilson S., 2016, DISMOUNTED ANTHROPOM, P705	24	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2633-3767	2633-3775		BMJ MILITARY HEALTH	BMJ Military Health												10.1136/bmjmilitary-2021-001833		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XK9BE	WOS:000727750700001	34131065				2022-02-07	
J	Edwards, S; Tahu, T; Buchanan, M; Tucker, R; Fuller, G; Gardner, AJ				Edwards, Suzi; Tahu, Timana; Buchanan, Matthew; Tucker, Ross; Fuller, Gordon; Gardner, Andrew J.			Three-dimensional mechanics of the rugby tackle, does the ball carrier alter their movement into contact in response to the tackler's position?	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article; Early Access						Biomechanics; injury risk factors; kinematics; motion analysis	VIDEO ANALYSIS; WORLD CUP; UNION; CONCUSSION; HEAD; INJURIES; RELIABILITY; KINEMATICS	In rugby league and rugby union, the ball carrier is vulnerable to injury during a tackle. The height of the tackle has been associated with injury risk. The extent to which a ball carrier may alter their approach entering a tackle in response the tackler's body height is unknown. This exploratory study aimed to identify if, when and how, the ball carrier modified their motion when being tackled in response to tackling instructions given to the tackler. Three-dimensional analysis was completed on 15 adult male rugby union/league players performing a front-on, one-on-one tackle at differing tackle heights. Repeated measure factorial analyses of variance were used to test for differences (P < 0.05). The ball carrier used two movement strategies: (1) increasing their stability by flexing their trunk, knee, and hips more when entering mid/high torso tackles; (2) offloading the ball or performing an evasive movement strategy by positioning themselves in a more upright body position when being tackled at a lower torso tackle height. This preliminary evidence suggests it may be beneficial for a coach to provide different instructions to the ball carrier to modify their movement strategies when being tackled in response to the height of the tackler to improve their performance and decrease their potential injury risk.	[Edwards, Suzi; Tahu, Timana; Buchanan, Matthew] Univ Newcastle, Sch Environm & Life Sci, 10 Chittaway Rd, Ourimbah, NSW 2258, Australia; [Edwards, Suzi; Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Edwards, Suzi] Univ Newcastle, Prior Res Ctr Phys Act & Nutr, Callaghan, NSW, Australia; [Tucker, Ross] World Rugby Pty Ltd, Dublin, Ireland; [Fuller, Gordon] Univ Sheffield, Sch Hlth & Related Res, Emergency Med Res Sheffield Grp, Sheffield, S Yorkshire, England; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia		Edwards, S (corresponding author), Univ Newcastle, Sch Environm & Life Sci, 10 Chittaway Rd, Ourimbah, NSW 2258, Australia.	Suzi.Edwards@newcastle.edu.au	Edwards, Suzi/E-8841-2016	Edwards, Suzi/0000-0002-5790-0232; Gardner, Andrew/0000-0001-5031-5586	National Rugby League (NRL) Rugby League Research Committee (RLRC)	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Research support was provided for this project from the National Rugby League (NRL) Rugby League Research Committee (RLRC).	Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Davidow D, 2018, J SCI MED SPORT, V21, P1025, DOI 10.1016/j.jsams.2018.04.003; den Hollander S, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0142-3; Edwards S, 2021, SPORTS MED-OPEN, V7, DOI 10.1186/s40798-021-00322-w; Edwards S, 2021, INT J SPORTS SCI COA, V16, P944, DOI 10.1177/1747954121996946; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Den Hollander S, 2021, INT J SPORTS SCI COA, V16, P421, DOI 10.1177/1747954120976943; Kawasaki T, 2018, AM J SPORT MED, V46, P2514, DOI 10.1177/0363546518781808; League, 2019, NATL RUGBY LEAGUE CO; League NR., 2018, TACKLE SAFE PROGRAM; McLean SG, 2005, BRIT J SPORT MED, V39, P355, DOI 10.1136/bjsm.2005.018598; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Savage TN, 2017, J SPORT SCI, V35, P449, DOI 10.1080/02640414.2016.1172722; Schaefer A, 2018, J SPORT SCI, V36, P679, DOI 10.1080/02640414.2017.1330548; Seminati E, 2017, SPORT BIOMECH, V16, P58, DOI 10.1080/14763141.2016.1194453; Stokes KA, 2021, BRIT J SPORT MED, V55, P220, DOI [10.1136/bjsports-2019-101557, 10.1136/bjsports-2020-101983]; Tanabe Y, 2018, J SHOULDER ELB SURG, V46, P2514; Tierney GJ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040726; Tierney GJ, 2019, J SPORT SCI, V37, P262, DOI 10.1080/02640414.2018.1494952; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Wheeler K, 2009, INT J SPORTS SCI COA, V4, P535, DOI 10.1260/174795409790291420; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Winer BJ., 1971, STAT PRINCIPLES EXPT; Winter DA., 2009, BIOMECHANICS MOTOR C, DOI [10.1002/9780470549148, DOI 10.1002/9780470549148]	39	0	0	1	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.											17479541211024022	10.1177/17479541211024022		JUN 2021	11	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	SW1KE	WOS:000664275500001					2022-02-07	
J	Gousias, K; Pleger, B; Markou, M; Grozinger, M; Sedaghat, S; Pintea, B; Schildhauer, TA; Martinez, R; Hamsen, U				Gousias, Konstantinos; Pleger, Burkhard; Markou, Markella; Groezinger, Martin; Sedaghat, Sam; Pintea, Bogdan; Schildhauer, Thomas A.; Martinez, Ramon; Hamsen, Uwe			Distinct Behavior of Traumatic versus Nontraumatic Intracerebral Hematomas: Different Biology or Impact of Age?	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article; Early Access						intracerebral hematoma; elderly; novel oral anticoagulants; hematoma expansion; traumatic brain injury	INITIAL CONSERVATIVE TREATMENT; ORAL ANTICOAGULANTS; EARLY SURGERY; RADIOLOGICAL COURSE; BLOOD-PRESSURE; BRAIN-INJURY; HEMORRHAGE; MANAGEMENT; COAGULOPATHY; GUIDELINES	Background and Study Aims Patients with large intracerebral hematomas (ICH) may demonstrate different demographics and underlying brain and systemic diseases, as well as different radiologic courses and distinct outcomes. It remains unclear whether their different behavior attributes to a different biology of the ICH or to the asymmetric characteristics of the two populations. To analyze and adjust for potential sources of selection and treatment bias, our study compared age-matched patients with traumatic and nontraumatic ICH in a single cohort diagnosed and treated in the same surgical department. Material and Methods We analyzed 135 consecutive patients with traumatic ( n =90) or spontaneous ICH ( n =45) undergoing treatment at a surgical intensive care unit of an urban university hospital. We documented their differences before and after adjustment for age in terms of demographics, the therapies applied, their radiologic (i.e., volume and rate of ICH expansion [HE]) and clinical (patients' outcome at 30 days) course, the length of hospital and ICU stay, as well as the hospital costs. Results Patients with traumatic ICH demonstrated more favorable clinical and radiologic characteristics at admission, that is, higher Glasgow Coma Scale score ( p <0.001), less frequently dilated pupil ( p =0.028), lower Charlson Comorbidity Index ( p <0.001), smaller ICH volume ( p <0.001), noneloquent ( p <0.001) or nonintraventricular ( p =0.003) ICH locations, as well as underwent fewer neurosurgical interventions ( p <0.001) and showed a better outcome ( p =0.041), defined as Glasgow Outcome Scale 4 and 5. After adjustment for age, no different outcomes were observed. Of note, elderly patients on novel oral anticoagulants (NOACs) were more likely to develop an HE compared with those on vitamin K antagonists (VKAs, p =0.05) after traumatic brain injury (TBI) but not after spontaneous ICH. Conclusion Our data reveal a significant heterogeneity within the traumatic series. Whereas younger patients show an excellent outcome, the elderly population of the traumatic cases demonstrates a poor outcome similar to that of the nontraumatic cohort. HE under NOACs rather than under VKAs is more likely in the elderly after TBI. Larger prospective trials are warranted to elucidate the potential individual underlying molecular mechanisms for the development of an ICH and HE in these diseases.	[Gousias, Konstantinos; Pintea, Bogdan; Martinez, Ramon] BG Bergmannsheil Univ Hosp Bochum, Dept Neurosurg & Neurotraumatol, Bochum, Germany; [Gousias, Konstantinos] Univ Munster, St Marien Acad Hosp Lunen, Dept Neurosurg, Altstadtstr 23, D-44534 Lunen, Germany; [Pleger, Burkhard] BG Bergmannsheil Univ Hosp Bochum, Dept Neurol, Bochum, Germany; [Markou, Markella] BG Hosp Duisburg, Dept Neurol & Psychotraumatol, Duisburg, Germany; [Groezinger, Martin; Sedaghat, Sam] BG Bergmannsheil Univ Hosp Bochum, Dept Radiol, Bochum, Germany; [Schildhauer, Thomas A.; Hamsen, Uwe] BG Bergmannsheil Univ Hosp Bochum, Dept Gen & Trauma Surg, Bochum, Germany		Gousias, K (corresponding author), Univ Munster, St Marien Acad Hosp Lunen, Dept Neurosurg, Altstadtstr 23, D-44534 Lunen, Germany.	gousias.konstantinos@klinikum-luenen.de		Schildhauer, Thomas/0000-0002-3232-9869			Adachi T, 2017, CEREBROVASC DIS EXTR, V7, P62, DOI 10.1159/000462985; Bhatia K, 2018, CURR CARDIOL REP, V20, DOI 10.1007/s11886-018-1078-4; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Choo YS, 2016, J NEUROSURG, V125, P1242, DOI 10.3171/2015.10.JNS151643; Coleman CI, 2017, STROKE, V48, P2142, DOI 10.1161/STROKEAHA.117.017474; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fiebach JB, 2009, NERVENARZT, V80, P205, DOI 10.1007/s00115-008-2607-y; Francis R, 2015, BRIT J NEUROSURG, V29, P655, DOI 10.3109/02688697.2015.1054349; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Fu CH, 2019, WORLD NEUROSURG, V122, pE995, DOI 10.1016/j.wneu.2018.10.192; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hill MD, 2013, STROKE, V44, P2951, DOI 10.1161/STROKEAHA.113.002790; Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Krishnamurthi RV, 2014, GLOB HEART, V9, P101, DOI 10.1016/j.gheart.2014.01.003; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Krishnan K, 2018, INT J STROKE, V13, P362, DOI 10.1177/1747493017744463; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Markou M, 2021, EUR J TRAUMA EMERG S, V47, P565, DOI 10.1007/s00068-019-01228-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Morgan TC, 2013, STROKE, V44, P635, DOI 10.1161/STROKEAHA.112.670653; Purrucker JC, 2016, JAMA NEUROL, V73, P169, DOI 10.1001/jamaneurol.2015.3682; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Ting HW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121548; Tsivgoulis G, 2017, NEUROLOGY, V89, P1142, DOI 10.1212/WNL.0000000000004362; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; von der Brelie C, 2017, ACTA NEUROCHIR, V159, P101, DOI 10.1007/s00701-016-3026-7; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	46	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A												10.1055/s-0041-1728764		JUN 2021	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SR7HA	WOS:000661212300004	34126640				2022-02-07	
J	Kuo, CW; Chang, MY; Liu, HH; He, XK; Chan, SY; Huang, YZ; Peng, CW; Chang, PK; Pan, CY; Hsieh, TH				Kuo, Chi-Wei; Chang, Ming-Yuan; Liu, Hui-Hua; He, Xiao-Kuo; Chan, Shu-Yen; Huang, Ying-Zu; Peng, Chih-Wei; Chang, Pi-Kai; Pan, Chien-Yuan; Hsieh, Tsung-Hsun			Cortical Electrical Stimulation Ameliorates Traumatic Brain Injury-Induced Sensorimotor and Cognitive Deficits in Rats	FRONTIERS IN NEURAL CIRCUITS			English	Article						traumatic brain injury (TBI); cortical electrical stimulation; neuromodulation; sensorimotor impairment; cognitive dysfunction	MOTOR CORTEX STIMULATION; MODEL; PLASTICITY; NEURONS; PAIN; PATHOPHYSIOLOGY; ASTROGLIOSIS; EXCITABILITY; EXPRESSION; ISCHEMIA	Objective: Individuals with different severities of traumatic brain injury (TBI) often suffer long-lasting motor, sensory, neurological, or cognitive disturbances. To date, no neuromodulation-based therapies have been used to manage the functional deficits associated with TBI. Cortical electrical stimulation (CES) has been increasingly developed for modulating brain plasticity and is considered to have therapeutic potential in TBI. However, the therapeutic value of such a technique for TBI is still unclear. Accordingly, an animal model of this disease would be helpful for mechanistic insight into using CES as a novel treatment approach in TBI. The current study aims to apply a novel CES scheme with a theta-burst stimulation (TBS) protocol to identify the therapeutic potential of CES in a weight drop-induced rat model of TBI. Methods: TBI rats were divided into the sham CES treatment group and CES treatment group. Following early and long-term CES intervention (starting 24 h after TBI, 1 session/day, 5 days/week) in awake TBI animals for a total of 4 weeks, the effects of CES on the modified neurological severity score (mNSS), sensorimotor and cognitive behaviors and neuroinflammatory changes were identified. Results: We found that the 4-week CES intervention significantly alleviated the TBI-induced neurological, sensorimotor, and cognitive deficits in locomotor activity, sensory and recognition memory. Immunohistochemically, we found that CES mitigated the glial fibrillary acidic protein (GFAP) activation in the hippocampus. Conclusion: These findings suggest that CES has significant benefits in alleviating TBI-related symptoms and represents a promising treatment for TBI.	[Kuo, Chi-Wei; Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Kuo, Chi-Wei; Hsieh, Tsung-Hsun] Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan; [Kuo, Chi-Wei; Hsieh, Tsung-Hsun] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Chang, Ming-Yuan] Min Sheng Gen Hosp, Dept Surg, Div Neurosurg, Taoyuan, Taiwan; [Chang, Ming-Yuan] Chung Chou Univ Sci & Technol, Dept Early Childhood & Family Educare, Yuanlin, Taiwan; [Liu, Hui-Hua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China; [Liu, Hui-Hua] Fifth Hosp Xiamen, Xiamen, Peoples R China; [He, Xiao-Kuo] Fujian Univ Tradit Chinese Med, Fuzhou, Peoples R China; [Chan, Shu-Yen] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Chan, Shu-Yen] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Huang, Ying-Zu] Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Huang, Ying-Zu] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Ying-Zu; Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Sch Biomed Engn, Taipei, Taiwan; [Chang, Pi-Kai] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan		Hsieh, TH (corresponding author), Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan.; Hsieh, TH (corresponding author), Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan.; Hsieh, TH (corresponding author), Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan.; Hsieh, TH (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.	hsiehth@mail.cgu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 109-2314-B-182-029-MY3, MOST 108-2314-B-182-015-MY3, MOST 109-2221-E-038-005-MY3]; Chang Gung Medical Foundation, Taiwan [CMRPD1H0463, CMRPD1K0671]; Industry-Academy Cooperation Project of Chang Gung University [QCRPD657, SCRPD1H0061, SCRPD1K0351, SCRPD1K0611]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81902286]; MinSheng General Hospital [1090003, 2020003]	This study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 109-2314-B-182-029-MY3, MOST 108-2314-B-182-015-MY3 to T-HH and MOST 109-2221-E-038-005-MY3 to C-WP), Chang Gung Medical Foundation, Taiwan (CMRPD1H0463 and CMRPD1K0671 to T-HH), Industry-Academy Cooperation Project of Chang Gung University (QCRPD657, SCRPD1H0061, SCRPD1K0351 and SCRPD1K0611 to T-HH), National Natural Science Foundation of China (Grant number 81902286 to H-HL) and MinSheng General Hospital (Grant number 1090003 and 2020003 to M-YC).	Adkins D.L., 2015, BRAIN NEUROTRAUMA MO; Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2006, EXP NEUROL, V200, P356, DOI 10.1016/j.expneurol.2006.02.131; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Albertsmeier M, 2007, RESUSCITATION, V74, P552, DOI 10.1016/j.resuscitation.2007.01.040; Alm PA, 2013, J PAIN RES, V6, P479, DOI 10.2147/JPR.S44648; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asan AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203727; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown JA, 2005, NEUROSURGERY, V56, P290, DOI 10.1227/01.neu.0000148905.75845.98; Cavinato M, 2012, CLIN NEUROPHYSIOL, V123, P1893, DOI 10.1016/j.clinph.2012.02.066; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cikriklar HI, 2016, TURK NEUROSURG, V26, P878, DOI 10.5137/1019-5149.JTN.13946-15.2; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fagundes-Pereyra WJ, 2010, ARQ NEURO-PSIQUIAT, V68, P923, DOI 10.1590/S0004-282X2010000600018; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng XJ, 2020, BRAIN STIMUL, V13, P655, DOI 10.1016/j.brs.2020.02.002; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Hsieh TH, 2015, CEREB CORTEX, V25, P1806, DOI 10.1093/cercor/bht421; Hsieh TH, 2015, J MED BIOL ENG, V35, P62, DOI 10.1007/s40846-015-0006-y; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Kamble N, 2014, PARKINSONISM RELAT D, V20, P695, DOI 10.1016/j.parkreldis.2014.03.018; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Khedr EM, 2007, CLIN NEUROPHYSIOL, V118, P140, DOI 10.1016/j.clinph.2006.09.006; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Pink AE, 2021, NEUROPSYCHOL REHABIL, V31, P479, DOI 10.1080/09602011.2019.1706585; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Sokal P, 2019, J PAIN RES, V12, P1863, DOI 10.2147/JPR.S195867; Son BC, 2006, PAIN, V123, P210, DOI 10.1016/j.pain.2006.02.028; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wakasa S, 2009, J THORAC CARDIOV SUR, V137, P983, DOI 10.1016/j.jtcvs.2008.10.002; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Yu KP, 2018, ANN REHABIL MED-ARM, V42, P502, DOI 10.5535/arm.2018.42.4.502; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Zaninotto Ana Luiza, 2019, Dement. neuropsychol., V13, P172, DOI 10.1590/1980-57642018dn13-020005; Zhang YL, 2019, J NEUROTRAUM, V36, P589, DOI 10.1089/neu.2018.5790	56	0	0	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5110		FRONT NEURAL CIRCUIT	Front. Neural Circuits	JUN 14	2021	15								693073	10.3389/fncir.2021.693073			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA1UX	WOS:000667040800001	34194304	Green Published, gold			2022-02-07	
J	Rogan, A; Patel, V; Birdling, J; Lockett, J; Simmonds, H; McQuade, D; Larsen, P				Rogan, Alice; Patel, Vimal; Birdling, Jane; Lockett, Jessica; Simmonds, Harnah; McQuade, David; Larsen, Peter			Acute traumatic brain injury and the use of head computed tomography scans in the emergency department	TRAUMA-ENGLAND			English	Article; Early Access						Traumatic brain injury; computed tomography head scan; guideline adherence; computed tomography head use; clinical guidelines	NEW-ZEALAND; VALIDATION; MANAGEMENT; MILD; CT	Introduction The use of CT head scanning for traumatic brain injury (TBI) is a vital diagnostic tool, guided by risk stratification tools. This study aims to review the use of CT head scans and adherence to guidelines for TBI in two New Zealand emergency departments (EDs). Methods Retrospective observational study of patients referred for head CT from EDs to exclude a significant intracranial injury between 1st September 2018 and 31st August 2019. Clinical data were collected regarding presenting patterns, identification of injuries on CT scan and adherence to National Institute of Clinical Excellence (NICE) CT head guidelines. Results Out of 425 included cases, 41 (10%) patients had an intracranial injury seen on their CT head scan. Patients who reported loss (32% vs 20%, p < 0.05) or possible loss of consciousness (34% vs 22%, p < 0.05) and had a Glasgow Coma Score (GCS) <13 (17% vs 8%, p < 0.05) or focal neurology (10% vs 3%, p < 0.05) were more likely to have an intracranial injury on CT. Interestingly, 17 (41%) patients with CT diagnosed injuries had a GCS 15 and no focal neurology. NICE guidelines were adhered to in 364 (86%) of CT requests. In the 14% of cases that did not meet guideline criteria, all CT head scans were negative. Conclusion CT head scans are a valuable tool in TBI, and guidelines successfully identify those with significant intracranial injuries. However, the rate of significant injury for the total population requiring head CT remains low, with over 90% of head CTs in the population normal, despite high guideline compliance, perhaps identifying a role for novel objective tests in ED guidelines internationally.	[Rogan, Alice; Larsen, Peter] Univ Otago, Dept Surg & Anaesthesia, Wellington, New Zealand; [Patel, Vimal] Hutt Valley Hosp, Hutt Valley Emergency Dept, Lower Hutt, New Zealand; [Birdling, Jane; Lockett, Jessica; Simmonds, Harnah; McQuade, David] Wellington Reg Hosp, Wellington Emergency Dept, Wellington, New Zealand		Rogan, A (corresponding author), Univ Otago, Sch Med & Hlth Sci, Dept Surg & Anaesthesia, Mein Str,POB 7343, Wellington 6242, New Zealand.	alice.rogan@otago.ac.nz		Rogan, Alice/0000-0003-1305-0325; Lockett, Jessica/0000-0003-3242-1486	CCDHB; HVDHB; University of Otago (Wellington) Department of Surgery and Anaesthesia	The authors would like to thank Hutt and Wellington Emergency Departments for their data contributions; the research offices at CCDHB and HVDHB for their local approval and support; the RAG-M and University of Otago Health Committees for their approval and the University of Otago (Wellington) Department of Surgery and Anaesthesia for their expertise and support.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Australasian College of Emergency Medicine, 2019, TESTS TREATMENTS PRO; Baloescu C, 2018, ANN EMERG MED, V72, P637, DOI 10.1016/j.annemergmed.2018.06.034; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Fayngersh V, 2009, LUNG, V187, P143, DOI 10.1007/s00408-009-9143-9; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Howkins J., 2017, CLIN RADIOL, V72, pS15, DOI [10.1016/j.crad.2017.06.017, DOI 10.1016/J.CRAD.2017.06.017]; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kelly AM, 2000, EMERG MED AUSTRALASI, V12, P50, DOI 10.1046/j.1442-2026.2000.00083.x23; King D, 2019, J NEUROL SCI, V399, P61, DOI 10.1016/j.jns.2019.01.049; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; National Institute for Health and Care Excellence, 2014, HEAD INJ CLIN GUID; Pozzato I, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034494; Seidel J, 2019, CAN ASSOC RADIOL J, V70, P13, DOI 10.1016/j.carj.2018.10.004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Xiao QJ., 2015, AUSTIN EMERG MED, V1, P1003	23	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma											14604086211023646	10.1177/14604086211023646		JUN 2021	10	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	SW6BI	WOS:000664598600001					2022-02-07	
J	Turk, KW; Marin, A; Schiloski, KA; Vives-Rodriguez, AL; Uppal, P; Suh, C; Dwyer, B; Palumbo, R; Budson, AE				Turk, Katherine W.; Marin, Anna; Schiloski, Kylie A.; Vives-Rodriguez, Ana L.; Uppal, Prayerna; Suh, Cheongmin; Dwyer, Brigid; Palumbo, Rocco; Budson, Andrew E.			Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; repetitive head impacts; event relate potential; chronic traumatic encephalopathy; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; AUDITORY-EVOKED-RESPONSES; ALZHEIMERS-DISEASE; REACTION-TIME; TARGET DETECTION; MIDDLE-LATENCY; RISK; DEMENTIA; ASSOCIATION	Objective: Traumatic brain injury (TBI) and repetitive head impacts (RHI) related to blasts or contact sports are commonly reported among military service members. However, the clinical implications of remote TBI and RHI in veterans remains a challenge when evaluating older veterans at risk of neurodegenerative conditions including Alzheimer's disease (AD) and Chronic Traumatic Encephalopathy (CTE). This study aimed to test the hypothesis that veterans in a memory disorders clinic with remote head injury would be more likely to have neurodegenerative clinical diagnoses, increased rates of amyloid PET positivity, higher prevalence of cavum septum pellucidi/vergae, and alterations in event-related potential (ERP) middle latency auditory evoked potentials (MLAEPs) and long latency ERP responses compared to those without head injuries. Methods: Older veterans aged 50-100 were recruited from a memory disorders clinic at VA Boston Healthcare system with a history of head injury (n = 72) and without head injury history (n = 52). Patients were classified as reporting prior head injury including TBI and/or RHI exposure based on self-report and chart review. Participants underwent MRI to determine presence/absence of cavum and an ERP auditory oddball protocol. Results: The head injury group was equally likely to have a positive amyloid PET compared to the non-head injury group. Additionally, the head injury group were less likely to have a diagnosis of a neurodegenerative condition than those without head injury. P200 target amplitude and MLAEP amplitudes for standard and target tones were decreased in the head injury group compared to the non-head injury group while P3b amplitude did not differ. Conclusions: Veterans with reported remote head injury evaluated in a memory disorders clinic were not more likely to have a neurodegenerative diagnosis or imaging markers of neurodegeneration than those without head injury. Decreased P200 target and MLAEP target and standard tone amplitudes in the head injury group may be relevant as potential diagnostic markers of remote head injury.	[Turk, Katherine W.; Marin, Anna; Schiloski, Kylie A.; Vives-Rodriguez, Ana L.; Uppal, Prayerna; Suh, Cheongmin; Palumbo, Rocco; Budson, Andrew E.] VA Boston Healthcare Syst, Ctr Translat Cognit Neurosci, Boston, MA 02130 USA; [Turk, Katherine W.; Dwyer, Brigid; Palumbo, Rocco; Budson, Andrew E.] Boston Univ, Alzheimer Dis Res Ctr, Boston, MA 02215 USA; [Marin, Anna] Boston Univ, Dept Neurosci, Boston, MA 02215 USA; [Palumbo, Rocco] D Annunzio Univ Chieti Pescara, Dept Psychol Hlth & Terr Sci, Chieti, Italy		Turk, KW (corresponding author), VA Boston Healthcare Syst, Ctr Translat Cognit Neurosci, Boston, MA 02130 USA.; Turk, KW (corresponding author), Boston Univ, Alzheimer Dis Res Ctr, Boston, MA 02215 USA.	katherine.turk3@va.gov	Palumbo, Rocco/H-7375-2014	Palumbo, Rocco/0000-0002-2385-5840	Alzheimer's Association Clinical Fellowship Research Award [AACF-16-443347]; VA Career Development Award-2 [IK2 CX002065]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 (AG13846)]; VA Merit AwardUS Department of Veterans Affairs [CX001698]; False Memories in Alzheimer's Disease	This study was supported the Alzheimer's Association Clinical Fellowship Research Award (AACF-16-443347 to KT). VA Career Development Award-2 (IK2 CX002065 to KT). NIH/NIA P30 (AG13846) (The principal investigator is Neil W. Kowall, MD and AB was a co-investigator). VA Merit Award (CX001698). The title of the grant is False Memories in Alzheimer's Disease. The principal investigator was AB.	Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Benedetti A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-026598; Bourisly AK, 2018, TRANSL NEUROSCI, V9, P61, DOI 10.1515/tnsci-2018-0011; Cecchi Marco, 2015, Alzheimers Dement (Amst), V1, P387, DOI 10.1016/j.dadm.2015.08.004; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Cummings J L, 1989, J Neuropsychiatry Clin Neurosci, V1, P236; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Defense UDoVAaDo, 2016, CLIN PRACT GUID MAN; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Drake M E Jr, 1996, Electromyogr Clin Neurophysiol, V36, P457; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Golob EJ, 2009, NEUROLOGY, V73, P1649, DOI 10.1212/WNL.0b013e3181c1de77; Golob EJ, 2007, BRAIN, V130, P740, DOI 10.1093/brain/awl375; Golob EJ, 2000, CLIN NEUROPHYSIOL, V111, P1438, DOI 10.1016/S1388-2457(00)00332-1; Golob EJ, 2002, CLIN NEUROPHYSIOL, V113, P151, DOI 10.1016/S1388-2457(01)00713-1; Grasset L, 2020, ALZHEIMERS DEMENT, V16, P853, DOI 10.1002/alz.12080; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Graves RE, 2004, J CLIN EXP NEUROPSYC, V26, P891, DOI 10.1080/13803390490510716; Hamilton HK, 2019, JAMA PSYCHIAT, V76, P1187, DOI 10.1001/jamapsychiatry.2019.2135; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Irimajiri R, 2005, CLIN NEUROPHYSIOL, V116, P1918, DOI 10.1016/j.clinph.2005.04.010; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Kappenman ES, 2010, PSYCHOPHYSIOLOGY, V47, P888, DOI 10.1111/j.1469-8986.2010.01009.x; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KILENY P, 1987, ELECTROEN CLIN NEURO, V66, P108, DOI 10.1016/0013-4694(87)90180-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kornblith E, 2020, NEUROLOGY, V95, pE1768, DOI 10.1212/WNL.0000000000010617; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Leyhe T, 2009, NEUROPSYCHOLOGIA, V47, P2464, DOI 10.1016/j.neuropsychologia.2009.04.018; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Moser JS, 2008, EMOTION, V8, P693, DOI 10.1037/a0013173; NOVAK GP, 1990, ELECTROEN CLIN NEURO, V75, P255, DOI 10.1016/0013-4694(90)90105-S; Pachana NA, 2007, INT PSYCHOGERIATR, V19, P103, DOI 10.1017/S1041610206003504; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2005, Current Alzheimer Research, V2, P515, DOI 10.2174/156720505774932214; Qureshi KL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-021675; Reinhart RMG, 2011, INT J PSYCHOPHYSIOL, V79, P16, DOI 10.1016/j.ijpsycho.2010.08.009; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Teng E, 2007, DEMENT GERIATR COGN, V24, P253, DOI 10.1159/000107100; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Washnik NJ, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519840094; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3	71	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 14	2021	12								626767	10.3389/fneur.2021.626767			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA1VO	WOS:000667042500001	34194379	gold, Green Published			2022-02-07	
J	Yasuda, I; Katsuki, M; Narita, N				Yasuda, Iori; Katsuki, Masahito; Narita, Norio			A Case of Traumatic Cerebrospinal Fluid Rhinorrhea Successfully Treated Using Intravenous Factor XIII Administration	CUREUS			English	Article						blood coagulation factor xiii; cerebrospinal fluid leakage; neurotrauma; lumbar spinal drainage; traumatic cerebrospinal fluid rhinorrhea		Traumatic cerebrospinal fluid (CSF) rhinorrhea occurs around 2% of severe head trauma. We should find the fistula and surgically seal it or perform conservative therapy with bed rest with/without lumbar spinal CSF drainage. However, the fistula may not be identified, and treatment may sometimes be challenging. Blood coagulation factor XIII (factor XIII) is one of the blood coagulation factors. It also promotes fibroblast proliferation during the wound healing process. We herein reported a traumatic CSF rhinorrhea patient who was successfully treated using intravenous (IV) factor XIII administration. This report would contribute to the effectiveness of factor XIII administration in the treatment of traumatic CSF rhinorrhea. A 58-year-old man fell from a height of 1.5 meters and hit his forehead. He presented with numbness in both upper limbs but no paresis. Neck magnetic resonance imaging (MRI) revealed cervical spinal cord injury without a cervical vertebral or cranial fracture. He was conservatively treated and discharged after three months. He had been aware of rhinorrhea since the trauma but was treated as allergic rhinitis. A year after the trauma, he was diagnosed with traumatic CSF rhinorrhea. We confirmed a bit of rhinorrhea despite the seven-day bedrest, so we intravenously administered 240 international units of factor XIII every day for 10 days. After 10 days, there was no rhinorrhea at all, and the patient was discharged on the 28th day. He has had no recurrence of rhinorrhea after a three-month follow-up. Factor XIII administration might be useful to treat traumatic CSF rhinorrhea.	[Yasuda, Iori; Katsuki, Masahito; Narita, Norio] Kesennuma City Hosp, Dept Neurosurg, Kesennuma, Miyagi, Japan; [Katsuki, Masahito] Itoigawa Gen Hosp, Dept Neurosurg, Itoigawa, Japan		Narita, N (corresponding author), Kesennuma City Hosp, Dept Neurosurg, Kesennuma, Miyagi, Japan.	naritanorio1111@gmail.com	Katsuki, Masahito/AAA-1036-2022	Katsuki, Masahito/0000-0002-0192-5430			Gerlach R, 2002, STROKE, V33, P1618, DOI 10.1161/01.STR.0000017219.83330.FF; GRAF CJ, 1981, J NEUROSURG, V54, P392, DOI 10.3171/jns.1981.54.3.0392; Hussein Mohamed, 2019, Asian J Neurosurg, V14, P473, DOI 10.4103/ajns.AJNS_265_18; Kawahara N, 2016, NEUROSURGERY; Kawamura A, 1997, NEUROL SURG TOKYO, V25, P53; LAKI K, 1948, SCIENCE, V108, P280, DOI 10.1126/science.108.2802.280; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; Matsuwaki Y, 2010, J OTOLARYNG JAP, V53, P300, DOI [10.11453/orltokyo.53.300, DOI 10.11453/ORLTOKYO.53.300]; Mayfrank L, 1996, ACTA NEUROCHIR, V138, P245, DOI 10.1007/BF01411734; Nakano M, 2020, JAPANESE J STROKE, V42, P196, DOI [10.3995/jstroke.10720, DOI 10.3995/JSTROKE.10720]; Uozumi Y, 2017, SPINAL SURG, V31, P135, DOI [10.2531/spinalsurg.31.135, DOI 10.2531/SPINALSURG.31.135]	11	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 14	2021	13	6							e15633	10.7759/cureus.15633			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	ST1QQ	WOS:000662225600003	34306845	gold, Green Published			2022-02-07	
J	Cranmer, G; Rey, R; Tallapragada, M				Cranmer, Gregory; Rey, Rikishi; Tallapragada, Meghnaa			Exploring the role of parents' sport orientations in the efficacy of concussion intervention materials	COMMUNICATION RESEARCH REPORTS			English	Article						Concussion; experiment; sports orientations; sports communication	SCHOOL FOOTBALL PLAYERS; ARGUMENT STRENGTH; MESSAGES; ATTITUDE; EDUCATION; CHILDREN; SMOKING; CUES	Investigations into parents' role as health referents in the management of sport-related concussion (SRC) are on the rise. This study contributes to these efforts by exploring the efficacy of concussion intervention materials to promote conversational intentions because of parents' orientations toward football and SRC management. Data collected from 600 parents of middle and high school football players offered support for an indirect effect of family sport orientations on SRC conversation intentions after reading concussion intervention material via perceptions of argument strength and self-efficacy, sequentially (i.e., serial mediation). These results underscore the importance of recognizing the characteristics and belief systems of parents when involving them in SRC management efforts.	[Cranmer, Gregory] Clemson Univ, Dept Commun, Sport Commun, Clemson, SC 29631 USA; [Rey, Rikishi] Chapman Univ, Sch Commun, Orange, CA USA; [Tallapragada, Meghnaa] Klein Coll Media & Commun, Publ Relat, Philadelphia, PA USA		Cranmer, G (corresponding author), 408 Strode Tower, Clemson, SC 29634 USA.	gcranme@clemson.edu		Tallapragada, Meghnaa/0000-0003-1472-9129			Akhtar O, 2013, PERS SOC PSYCHOL B, V39, P1214, DOI 10.1177/0146167213492430; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Boneau RD, 2020, COMMUN SPORT, V8, P26, DOI 10.1177/2167479518816104; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cappella JN, 2006, J COMMUN, V56, pS265, DOI 10.1111/j.1460-2466.2006.00293.x; Cote J, 1999, SPORT PSYCHOL, V13, P395, DOI 10.1123/tsp.13.4.395; Cranmer GA, 2021, J FAM COMMUN, V21, P70, DOI 10.1080/15267431.2020.1856852; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fishbein M, 2003, COMMUN THEOR, V13, P164, DOI 10.1111/j.1468-2885.2003.tb00287.x; Fontana J, 2021, HEALTH COMMUN, DOI 10.1080/10410236.2021.1876326; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HAYES AF, 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hyman M., 2009, IT HURTS AMERICAS OB; Hyman N, 2012, MOST EXPENSIVE GAME; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Lee S, 2013, NICOTINE TOB RES, V15, P527, DOI 10.1093/ntr/nts171; Lee S, 2011, NICOTINE TOB RES, V13, P282, DOI 10.1093/ntr/ntq255; Lyons BA, 2019, PUBLIC UNDERST SCI, V28, P320, DOI 10.1177/0963662518821017; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGlynn J, 2020, J SPORT SOC ISSUES, V44, P261, DOI 10.1177/0193723520903226; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Nussbaum JF, 2017, DEFINING SPORT COMMUNICATION, P178; Park HS, 2007, HUM COMMUN RES, V33, P81, DOI 10.1111/j.1468-2958.2007.00290.x; Petty R., 1986, COMMUNICATION PERSUA, DOI DOI 10.1016/S0065-2601(08)60214-2; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Slater MD, 2002, COMMUN THEOR, V12, P173, DOI 10.1111/j.1468-2885.2002.tb00265.x; Slater MD, 1996, COMMUN RES, V23, P210, DOI 10.1177/009365096023002003; Starcher SC, 2015, COMMUN Q, V63, P204, DOI 10.1080/01463373.2015.1012221; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tallapragada M, 2020, COMMUN SPORT, DOI 10.1177/2167479520944549; Turman PD, 2007, COMMUN EDUC, V56, P333, DOI 10.1080/03634520701199999; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; Wells GL, 1999, PERS SOC PSYCHOL B, V25, P1115, DOI 10.1177/01461672992512005; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Witte K, 1996, J Health Commun, V1, P317, DOI 10.1080/108107396127988; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Young, 2004, SPORTING BODIES DAMA, P59; Zhao XQ, 2011, COMMUN METHODS MEAS, V5, P48, DOI 10.1080/19312458.2010.547822	44	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0882-4096	1746-4099		COMMUN RES REP	Commun. Res. Rep.	AUG 8	2021	38	4					250	261		10.1080/08824096.2021.1936480		JUN 2021	12	Communication	Emerging Sources Citation Index (ESCI)	Communication	US5JD	WOS:000661579300001					2022-02-07	
J	Khaled, M; Fadle, AA; Attia, AK; Sami, A; Hafez, A; Oyoun, NA				Khaled, Mohamed; Fadle, Amr A.; Attia, Ahmed Khalil; Sami, Andrew; Hafez, Abdelkhalek; Abol Oyoun, Nariman			Single-bone versus both-bone plating of unstable paediatric both-bone forearm fractures. A randomized controlled clinical trial	INTERNATIONAL ORTHOPAEDICS			English	Article						Single-bone fixation; Both-bone fixation; Ulna ORIF; Pediatric forearm fractures	INTRAMEDULLARY FIXATION; CHILDREN; RADIUS	Purpose This clinical trial compares the functional and radiological outcomes of single-bone fixation to both-bone fixation of unstable paediatric both-bone forearm fractures. Methods This individually randomized two-group parallel clinical trial was performed following the Consolidated Standards of Reporting Trials (CONSORT) statement at a single academic tertiary medical centre with an established paediatric orthopaedics unit. All children aged between nine and 15 years who presented to the emergency department at Assiut university with unstable diaphyseal, both-bone forearm fractures requiring surgical intervention between November 1, 2018, and February 28, 2020, were screened for eligibility against the inclusion and exclusion criteria. Inclusion criteria were diaphyseal unstable fractures defined as shaft fractures between the distal and proximal metaphyses with an angulation of > 10 degrees, and/or malrotation of > 30 degrees, and/or displacement > 10 mm after attempted closed reduction. Exclusion criteria included open fractures, Galeazzi fractures, Monteggia fractures, radial head fractures, and associated neurovascular injuries. Patients who met the inclusion criteria were randomized to either the single-bone fixation group (intervention) or the both-bone fixation group (control). Primary outcomes were forearm range of motion and fracture union, while secondary outcomes were forearm function (price criteria), radius re-angulation, wrist and elbow range of motion, and surgical time Results A total of 50 children were included. Out of these 50 children, 25 were randomized to either arm of the study. All children in either group received the treatment assigned by randomization. Fifty (100%) children were available for final follow-up at six months post-operatively. The mean age of single-bone and both-bone fixation groups was 11.48 +/- 1.93 and 13 +/- 1.75 years, respectively, with a statistically significant difference (p = 0.006). There were no statistically significant differences in gender, laterality, affection of the dominant hand, or mode of trauma between single-bone and both-bone fixation groups. All patients in both groups achieved fracture union. There mean radius re-angulation of the single-bone fixation groups was 5.36 +/- 4.39 (0-20) degrees, while there was no radius re-angulation in the both-bone fixation group, with a statistically significant difference (p < 0.001). The time to union in the single-bone group was 6.28 +/- 1.51 weeks, while the time to union in the both-bone fixation group was 6.64 +/- 1.75 weeks, with no statistically significant difference (p = 0.44). There were no infections or refractures in either group. In the single-bone fixation group, 24 (96%) patients have regained their full forearm ROM (loss of ROM < 15 degrees), while only one (4%) patient lost between 15 and 30 degrees of ROM. In the both-bone fixation group, 23 (92%) patients have regained their full forearm ROM (loss of ROM < 15 degrees), while only two (8%) patients lost between 15 and 30 degrees of ROM. There was no statistically significant difference between groups in loss of forearm ROM (p = 0.55). All patients in both groups regained full ROM of their elbow and wrist joints. On price grading, 24 (96%) and 23 (92%) patients who underwent single bone fixation and both-bone fixation scored excellent, respectively. Only one (4%) patient in the single-bone fixation group and two (8%) patients in the both-bone fixation group scored good, with no statistically significant difference in price score between groups (p = 0.49). The majority of the patients from both groups had no pain on the numerical pain scale; 22 (88%) patients in the single-bone fixation group and 21 (84%) patients in the both-bone fixation groups, with no statistically significant difference between groups (p = 0.38). The single-bone fixation group had a significantly shorter mean operative time in comparison to both-bones plating (43.60 +/- 6.21 vs. 88.60 +/- 10.56 (min); p < 0.001). Conclusion Single-bone ulna open reduction and plate fixation and casting are safe and had a significantly shorter operative time than both-bone fixation. However, single-bone ORIF had a higher risk radius re-angulation, alas clinically acceptable. Both groups had equally excellent functional outcomes, forearm ROM, and union rates with no complications or refractures. Long-term studies are required.	[Khaled, Mohamed; Fadle, Amr A.; Sami, Andrew; Hafez, Abdelkhalek; Abol Oyoun, Nariman] Assiut Univ, Orthoped Dept 1, Assiut, Egypt; [Attia, Ahmed Khalil] Hamad Med Corp, Dept Orthoped Surg, POB 3050, Doha, Qatar		Attia, AK (corresponding author), Hamad Med Corp, Dept Orthoped Surg, POB 3050, Doha, Qatar.	mohamed.khaled@aun.edu.eg; Amr.a.mohamed@aun.edu.eg; Dr.ahmed.khalil.85@gmail.com; Andrewsami3030@gmail.com; AbdelkhalekHafezortho@gmail.com; n.aboloyoun@aeun.edu.eg		Mohammed, Amr A. Fadle/0000-0002-4032-6254; Attia, Ahmed/0000-0003-0762-8434	Qatar National Library	Open access funding provided by the Qatar National Library.	Ali Ayman Mohamed, 2010, J Orthop Surg (Hong Kong), V18, P328; Alnaib M, 2011, ACTA ORTHOP BELG, V77, P458; Bhaskar AR, 2001, J BONE JOINT SURG BR, V83B, P253, DOI 10.1302/0301-620X.83B2.10955; Colaris J, 2013, ARCH ORTHOP TRAUM SU, V133, P1079, DOI 10.1007/s00402-013-1763-0; Colaris J, 2010, INJURY, V41, P643, DOI 10.1016/j.injury.2010.02.007; Cullen MC, 1998, J PEDIATR ORTHOPED, V18, P14, DOI 10.1097/00004694-199801000-00004; Dietz JF, 2010, J PEDIATR ORTHOPED, V30, P420, DOI 10.1097/BPO.0b013e3181e00c44; Flynn JM, 1996, J PEDIATR ORTHOPED, V16, P655, DOI 10.1097/01241398-199609000-00020; Hammad A, 2007, ACTA ORTHOP BELG, V73, P588; Houshian S, 2005, INJURY, V36, P1421, DOI 10.1016/j.injury.2005.09.002; JONES DJ, 1995, J ORTHOP TRAUMA, V9, P198, DOI 10.1097/00005131-199506000-00004; Kirkos JM, 2000, INJURY, V31, P591, DOI 10.1016/S0020-1383(00)00057-7; Lee S, 2002, CLIN ORTHOP RELAT R, P245; McGinley JC, 2001, CLIN ORTHOP RELAT R, P108, DOI 10.1097/00003086-200102000-00013; Meier R, 2004, ARCH ORTHOP TRAUM SU, V124, P1, DOI 10.1007/s00402-003-0585-x; Price CT, 2010, J PEDIATR ORTHOPED, V30, pS82, DOI 10.1097/BPO.0b013e3181bbf1b4; PRICE CT, 1990, J PEDIATR ORTHOPED, V10, P705, DOI 10.1097/01241398-199011000-00001; Prommersberger KJ, 2004, J HAND SURG-AM, V29A, P110, DOI 10.1016/j.jhsa.2003.09.014; Reinhardt KR, 2008, J PEDIATR ORTHOPED, V28, P403, DOI 10.1097/BPO.0b013e31816d71f2; Richard MJ, 2007, HAND CLIN, V23, P235, DOI 10.1016/j.hcl.2007.02.005; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shoemaker SD, 1999, J PEDIATR ORTHOPED, V19, P329, DOI 10.1097/00004694-199905000-00009; Sinikumpu JJ, 2012, INJURY, V43, P362, DOI 10.1016/j.injury.2011.11.006; Smith VA, 2005, J PEDIATR ORTHOPED, V25, P309, DOI 10.1097/01.bpo.0000153943.45396.22; THOMPSON GH, 1984, CLIN ORTHOP RELAT R, P10; VITTAS D, 1991, CLIN ORTHOP RELAT R, P261; Yong BC, 2018, INDIAN J ORTHOP, V52, P529, DOI 10.4103/ortho.IJOrtho_125_17; YOUNGER ASE, 1994, J PEDIATR ORTHOPED, V14, P200, DOI 10.1097/01241398-199403000-00013; Yung PSH, 2004, J PEDIATR ORTHOPED, V24, P7, DOI 10.1097/01241398-200401000-00002	29	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JAN	2022	46	1			SI		105	114		10.1007/s00264-021-05097-z		JUN 2021	10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	YE9FX	WOS:000660822000001	34120195	hybrid, Green Accepted			2022-02-07	
J	Souesme, G; Voyer, M; Gagnon, E; Terreau, P; Fournier-St-Amand, G; Lacroix, N; Gravel, K; Vaillant, MC; Gagne, ME; Ouellet, MC				Souesme, Guillaume; Voyer, Manon; Gagnon, Eric; Terreau, Paule; Fournier-St-Amand, Genevieve; Lacroix, Nadine; Gravel, Kristina; Vaillant, Marie-Claude; Gagne, Marie-Eve; Ouellet, Marie-Christine			Barriers and facilitators linked to discharge destination following inpatient rehabilitation after traumatic brain injury in older adults: a qualitative study	DISABILITY AND REHABILITATION			English	Article; Early Access						Barriers and facilitators; discharge; older adults; qualitative study; traumatic brain injury	ELDERLY-PATIENTS; HEALTH-CARE; RESIDENTIAL SATISFACTION; ETHNIC-DIFFERENCES; DECISION-MAKING; HOME ASSESSMENT; SELF-AWARENESS; OUTCOMES; CAREGIVERS; TRANSITION	Purpose To identify facilitators and barriers associated with returning home for older adults having received inpatient rehabilitation after traumatic brain injury (TBI). Methods A qualitative design was used. Five older patients with TBI and four family caregivers were interviewed and six healthcare professionals participated in a focus group. Results Main facilitators to returning home highlighted by all participants were: (1) Patient's adequate health condition and functional status, (2) Access to health and other services at home, (3) Availability of help from a family caregiver. Conversely, if one of these factors was not met, it represented a barrier. Other facilitators identified were (4) Attachment to one's home, (5) Feeling of commitment toward a loved one, (6) Having the possibility of going through a transitional phase, (7) United front between the patient and the family caregiver towards a return home. Additional barriers to returning home included: (8) Incongruent perspectives, and (9) Unclear knowledge about available health and other services at home. Conclusion The results of this study could be translated into a practical tool to guide patients, families and professionals in the decision about returning home or exploring an alternative option after inpatient rehabilitation for TBI in older adults.	[Souesme, Guillaume; Fournier-St-Amand, Genevieve; Gravel, Kristina; Vaillant, Marie-Claude; Gagne, Marie-Eve; Ouellet, Marie-Christine] Interdisciplinary Ctr Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Souesme, Guillaume; Fournier-St-Amand, Genevieve; Gravel, Kristina; Vaillant, Marie-Claude; Gagne, Marie-Eve; Ouellet, Marie-Christine] Laval Univ, Sch Psychol, Quebec City, PQ, Canada; [Voyer, Manon; Terreau, Paule; Lacroix, Nadine] Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Inst Readaptat Deficience Phys Quebec, Quebec City, PQ, Canada; [Gagnon, Eric] Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Gagnon, Eric] Laval Univ, Sociol Dept, Quebec City, PQ, Canada		Ouellet, MC (corresponding author), Interdisciplinary Ctr Res Rehabil & Social Integr, Inst Readaptat Deficience Phys Quebec, 525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada.	marie-christine.ouellet@psy.ulaval.ca		Ouellet, Marie-Christine/0000-0003-3477-1893	Institut de readaptation en deficience physique de Quebec	This work was supported by the Institut de readaptation en deficience physique de Quebec.	Albrecht JS, 2019, J AM GERIATR SOC, V67, P2382, DOI 10.1111/jgs.16098; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Berges IM, 2008, AM J PHYS MED REHAB, V87, P567, DOI 10.1097/PHM.0b013e31817c143a; Bivona U, 2019, BRAIN INJURY, V33, P1245, DOI 10.1080/02699052.2019.1641225; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Blanchet A., 2010, SERIE ENQUETE SES ME; Branco BC., 2019, PANAM J TRAUMA CRIT, V8, P91; Braun V., 2013, SUCCESSFUL QUALITATI, P382; Burholt V, 2006, ENVIRON PLANN A, V38, P1095, DOI 10.1068/a3767; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chapman DW, 2006, URBAN AFF REV, V41, P769, DOI 10.1177/1078087406287164; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chin Raymond P. H., 2008, Hong Kong Medical Journal, V14, P209; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Dekker K, 2011, HOUSING STUD, V26, P479, DOI 10.1080/02673037.2011.559751; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Everink IHJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0187-4; Fisher F, 2012, J HUNTINGTONS DIS, V1, P187, DOI 10.3233/JHD-120022; Gagnon E., 2017, SERV SOCIAL, V62, P49; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Harding R, 2015, J PAIN SYMPTOM MANAG, V50, P445, DOI 10.1016/j.jpainsymman.2015.04.005; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Holm AL, 2016, OPEN J NURS, V6, P170, DOI 10.4236/ojn.2016.63018%5Cn; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Johnston K, 2010, J EVAL CLIN PRACT, V16, P1333, DOI 10.1111/j.1365-2753.2009.01339.x; Jordan JL, 2002, POSTGRAD MED J, V78, P383, DOI 10.1136/pmj.78.921.383; Kahana E, 2003, ENVIRON BEHAV, V35, P434, DOI 10.1177/0013916503035003007; Kim DY, 2019, INT J REHABIL RES, V42, P256, DOI 10.1097/MRR.0000000000000353; Kinsella GJ, 2011, BRAIN IMPAIR, V12, P71, DOI 10.1375/brim.12.1.71; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kurichi JE, 2013, PM&R, V5, P408, DOI 10.1016/j.pmrj.2012.09.578; Lannin NA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-42; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Lockwood KJ, 2015, J REHABIL MED, V47, P289, DOI 10.2340/16501977-1942; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Meijer R, 2003, CLIN REHABIL, V17, P512, DOI 10.1191/0269215503cr644oa; Mihaljcic T, 2017, ARCH GERONTOL GERIAT, V69, P38, DOI 10.1016/j.archger.2016.11.003; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Peace S., 2007, AGEING SOC EUROPEAN, V3rd ed; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rigon J, 2017, RESTOR NEUROL NEUROS, V35, P115, DOI 10.3233/RNN-150538; Sander AM, 2019, ARCH PHYS MED REHAB, V100, pS58, DOI 10.1016/j.apmr.2018.08.193; Schreier M., 2012, QUALITATIVE CONTENT, P272; Siebens HC, 2012, PM&R, V4, P548, DOI 10.1016/j.pmrj.2012.05.001; Suppes A, 2013, BRAIN INJURY, V27, P1141, DOI 10.3109/02699052.2013.804201; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2020, J NEUROSCI NURS, V52, P46, DOI 10.1097/JNN.0000000000000498; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; van Almenkerk S, 2013, DISABIL REHABIL, V35, P1774, DOI 10.3109/09638288.2012.756941; Walker A. C., 2004, GROWING OLDER QUALIT, P60; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Yan K, 2013, INT J THER REHABIL, V20, P361, DOI 10.12968/ijtr.2013.20.7.361; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	65	0	0	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1919212		JUN 2021	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SR9PV	WOS:000661376800001	34126821				2022-02-07	
J	An, LL; Chopp, M; Zacharek, A; Shen, Y; Chen, ZL; Qian, Y; Li, W; Landschoot-Ward, J; Liu, ZW; Venkat, P				An, Lulu; Chopp, Michael; Zacharek, Alex; Shen, Yi; Chen, Zhili; Qian, Yu; Li, Wei; Landschoot-Ward, Julie; Liu, Zhongwu; Venkat, Poornima			Cardiac Dysfunction in a Mouse Vascular Dementia Model of Bilateral Common Carotid Artery Stenosis	FRONTIERS IN CARDIOVASCULAR MEDICINE			English	Article						bilateral common carotid artery stenosis; brain-heart interaction; cardiac dysfunction; inflammation; oxidative stress	BRAIN-HEART INTERACTION; CARDIOVASCULAR-DISEASE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; MURINE MODEL; THROMBIN; ACTIVATION; RECEPTOR; FIBROSIS; IL-6	Background: Cardiac function is associated with cognitive function. Previously, we found that stroke and traumatic brain injury evoke cardiac dysfunction in mice. In this study, we investigate whether bilateral common carotid artery stenosis (BCAS), a model that induces vascular dementia (VaD) in mice, induces cardiac dysfunction. Methods: Late-adult (6-8 months) C57BL/6J mice were subjected to sham surgery (n = 6) or BCAS (n = 8). BCAS was performed by applying microcoils (0.16 mm internal diameter) around both common carotid arteries. Cerebral blood flow and cognitive function tests were performed 21-28 days post-BCAS. Echocardiography was conducted in conscious mice 29 days after BCAS. Mice were sacrificed 30 days after BCAS. Heart tissues were isolated for immunohistochemical evaluation and real-time PCR assay. Results: Compared to sham mice, BCAS in mice significantly induced cerebral hypoperfusion and cognitive dysfunction, increased cardiac hypertrophy, as indicated by the increased heart weight and the ratio of heart weight/body weight, and induced cardiac dysfunction and left ventricular (LV) enlargement, indicated by a decreased LV ejection fraction (LVEF) and LV fractional shortening (LVFS), increased LV dimension (LVD), and increased LV mass. Cognitive deficits significantly correlated with cardiac deficits. BCAS mice also exhibited significantly increased cardiac fibrosis, increased oxidative stress, as indicated by 4-hydroxynonenal and NADPH oxidase-2, increased leukocyte and macrophage infiltration into the heart, and increased cardiac interleukin-6 and thrombin gene expression. Conclusions: BCAS in mice without primary cardiac disease provokes cardiac dysfunction, which, in part, may be mediated by increased inflammation and oxidative stress.	[An, Lulu; Chopp, Michael; Zacharek, Alex; Shen, Yi; Chen, Zhili; Qian, Yu; Li, Wei; Landschoot-Ward, Julie; Liu, Zhongwu; Venkat, Poornima] Henry Ford Hosp, Dept Neurol, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Venkat, P (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI USA.	pvenkat3@hfhs.org		An, Lulu/0000-0002-3036-1689			Ahn SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28646; Akbar H, 2018, J THROMB HAEMOST, V16, P2083, DOI 10.1111/jth.14240; Akbar H., 2015, ARTERIOSCL THROMB VA, V35, DOI [10.1161/atvb.35.suppl_1.58, DOI 10.1161/ATVB.35.SUPPL_1.58]; BARCLAY LL, 1988, J AM GERIATR SOC, V36, P22, DOI 10.1111/j.1532-5415.1988.tb03429.x; Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Braunersreuther V, 2013, J MOL CELL CARDIOL, V64, P99, DOI 10.1016/j.yjmcc.2013.09.007; Carrim N, 2015, REDOX BIOL, V6, P640, DOI 10.1016/j.redox.2015.10.009; Chen JL, 2017, TRANSL STROKE RES, V8, P374, DOI 10.1007/s12975-017-0520-z; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cikes M, 2016, EUR HEART J, V37, P1642, DOI 10.1093/eurheartj/ehv510; Coltman R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.09.005; Cosarderelioglu C, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.586314; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dong AP, 2017, THROMB RES, V159, P58, DOI 10.1016/j.thromres.2017.09.016; Dupuis M, 2012, SEIZURE-EUR J EPILEP, V21, P51, DOI 10.1016/j.seizure.2011.09.006; Elkins JS, 2005, NEUROLOGY, V64, P1750, DOI 10.1212/01.WNL.0000161850.01792.77; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Freeman JG, 2001, J NEUROIMMUNOL, V119, P231, DOI 10.1016/S0165-5728(01)00384-8; Fuentes E, 2018, TRENDS CARDIOVAS MED, V28, P429, DOI 10.1016/j.tcm.2018.03.001; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Higaki A, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008121; Higaki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191708; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Ihara Masafumi, 2011, J Aging Res, V2011, P978761, DOI 10.4061/2011/978761; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Iwanami J, 2015, J AM SOC HYPERTENS, V9, P250, DOI 10.1016/j.jash.2015.01.010; JAFRI SM, 1993, EUR HEART J, V14, P205, DOI 10.1093/eurheartj/14.2.205; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jia GH, 2018, HYPERTENSION, V72, P537, DOI 10.1161/HYPERTENSIONAHA.118.11065; Jumeau Celine, 2016, JACC Basic Transl Sci, V1, P328; Justin B Ng, 2013, Clin Epidemiol, V5, P135, DOI 10.2147/CLEP.S30621; Khan MB, 2015, TRANSL STROKE RES, V6, P69, DOI 10.1007/s12975-014-0374-6; Komamura K, 2014, WORLD J CARDIOL, V6, P602, DOI 10.4330/wjc.v6.i7.602; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kuller LH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005353; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lee ES, 2019, J CEREBR BLOOD F MET, V39, P44, DOI 10.1177/0271678X17736963; Li R, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113093; Li W, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113209; Li W, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00965; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P10908; Lopez-Zambrano M, 2020, THROMB HAEMOSTASIS, V120, P658, DOI 10.1055/s-0040-1703007; Lu L, 2017, CLIN EXP PHARMACOL P, V44, P55, DOI 10.1111/1440-1681.12753; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Mewhort HEM, 2016, AM J PHYSIOL-HEART C, V310, pH716, DOI 10.1152/ajpheart.00309.2015; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Poh L., 2020, AIM2 INFLAMMASOME ME, DOI [10.1101/2020.06.05.135228, DOI 10.1101/2020.06.05.135228]; RAAB W, 1961, AM J CARDIOL, V8, P203, DOI 10.1016/0002-9149(61)90207-7; Reitz C, 2007, AM J GERIATR CARDIOL, V16, P183, DOI 10.1111/j.1076-7460.2007.06511.x; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; SCHOMIG A, 1990, CIRCULATION, V82, P13; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; SOWER LE, 1995, J IMMUNOL, V155, P895; Spinetta MJ, 2008, PSYCHOPHARMACOLOGY, V201, P361, DOI 10.1007/s00213-008-1294-5; Srinivasan VJ, 2015, J CEREBR BLOOD F MET, V35, P1552, DOI 10.1038/jcbfm.2015.175; Stephan BCM, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0898-y; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Ueland T, 2015, CLIN CHIM ACTA, V443, P71, DOI 10.1016/j.cca.2014.09.001; Usberti M, 2002, NEPHRON, V91, P25, DOI 10.1159/000057601; Venkat P, 2015, EXP NEUROL, V272, P97, DOI 10.1016/j.expneurol.2015.05.006; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Wu QJ, 2017, CELL DEATH DIFFER, V24, P1632, DOI 10.1038/cdd.2017.91; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yan T, 2020, J CEREBR BLOOD F MET, V40, P1213, DOI 10.1177/0271678X18813317; Yan T, 2014, CNS NEUROSCI THER, V20, P935, DOI 10.1111/cns.12307; Yang MJ, 2020, ACTA BIOCH BIOPH SIN, V52, P1, DOI 10.1093/abbs/gmz115; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Yang Y, 2016, NEUROCHEM INT, V94, P90, DOI 10.1016/j.neuint.2016.02.012; Yildiz M, 2020, PROG CARDIOVASC DIS, V63, P10, DOI 10.1016/j.pcad.2019.11.009; Yu P, 2019, J CEREBR BLOOD F MET, V39, P2497, DOI 10.1177/0271678X18800593; Zhao Q, 2020, J CEREBR BLOOD F MET, V40, P246, DOI 10.1177/0271678X19890931; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	87	0	0	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2297-055X			FRONT CARDIOVASC MED	Front. Cardiovasc. Med.	JUN 11	2021	8								681572	10.3389/fcvm.2021.681572			12	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	SX9YN	WOS:000665552800001	34179145	gold, Green Published			2022-02-07	
J	Gaudet, CE				Gaudet, Charles E.			Multivariate Base Rates and Concussion Detection: A Comparative Study	ASSESSMENT			English	Article; Early Access						concussion; ImPACT; multivariate base rates; validity; classification accuracy	LOW SCORES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; MANAGEMENT; CHILDREN; HEALTHY; SPORT; ADOLESCENTS; VARIABILITY; PATTERNS	Recent research has yielded multivariate base rates (MBRs) of low scores in healthy populations using a widely adopted concussion screening measure, Immediate Postconcussion and Cognitive Testing (ImPACT). However, the extent to which individuals with concussion obtain reliable changes at divergent frequencies relative to healthy individuals is largely unknown. The present study examined whether MBRs of reliable change accurately discriminated between those with and without concussion. This archival review consisted of 129 healthy individuals and 81 individuals with concussion. MBRs of reliable change scores were examined at varying cutoffs and frequencies between those with and without concussion. Composites showed small to medium effect sizes in differentiating between those with and without concussion. MBRs of reliable change scores on ImPACT provided limited discriminative utility in isolation. Computations of posttest probabilities using Bayes' Theorem yielded evidence for incremental gains when utilizing MBRs of reliable change under certain constraints.	[Gaudet, Charles E.] Brown Univ, Providence, RI 02906 USA; [Gaudet, Charles E.] Univ Rhode Isl, Kingston, RI 02881 USA		Gaudet, CE (corresponding author), Brown Univ, Dept Psychiat & Human Behavio, Warren Alpert Med Sch, 345 Blackstone Blvd, Providence, RI 02906 USA.	charles_gaudet@brown.edu	Gaudet, Charles/AAV-1607-2021				Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2013, APPL NEUROPSYCH-CHIL, V2, P70, DOI 10.1080/21622965.2012.742792; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cook NE, 2019, CHILD NEUROPSYCHOL, V25, P836, DOI 10.1080/09297049.2018.1543389; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Czerniak LL, 2021, SPORTS MED, V51, P351, DOI 10.1007/s40279-020-01393-7; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Gaudet CE, 2021, ARCH CLIN NEUROPSYCH, V36, P561, DOI 10.1093/arclin/acaa074; Gaudet CE, 2019, APPL NEUROPSYCH-CHIL, V8, P163, DOI 10.1080/21622965.2017.1417126; Gavett BE, 2015, J INT NEUROPSYCH SOC, V21, P249, DOI 10.1017/S1355617715000168; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 1991, COMPREHENSIVE NORMS; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hinton-Bayre AD, 2016, ARCH CLIN NEUROPSYCH, V31, P754, DOI 10.1093/arclin/acw064; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Karr JE, 2017, ARCH CLIN NEUROPSYCH, V32, P297, DOI 10.1093/arclin/acw105; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Labarge AS, 2003, ARCH CLIN NEUROPSYCH, V18, P165, DOI 10.1016/S0887-6177(01)00193-7; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	38	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment											10731911211022840	10.1177/10731911211022840		JUN 2021	11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	SV9NE	WOS:000664144300001	34116607				2022-02-07	
J	Morrissey, PJ; Zhou, JJ; Shah, NV; Torre, BB; Dekis, JC; Newman, JM; Connors, KM; Urban, WP				Morrissey, Patrick J.; Zhou, Jack J.; Shah, Neil V.; Torre, Barrett B.; Dekis, Joanne C.; Newman, Jared M.; Connors, Katherine M.; Urban, William P.			Epidemiology of female youth ice hockey injuries presenting to United States emergency departments from 2002 to 2019	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Traumatic brain injury; ice hockey; concussion; sports injury; epidemiology; female athlete	SEX-DIFFERENCES; RISK-FACTORS; RATES; CONCUSSION; SURVEILLANCE; ASSOCIATION; MECHANISMS; CONTACT; MENS	Background: This study documented injury types, rates and mechanisms for female youth ice hockey players reporting to US emergency departments to inform safety measures and sideline medical preparedness. Methods: The National Electronic Injury Surveillance System (NEISS) database was queried for ice hockey injuries (product code 1279) from 1 January 2002 to 31 December 2019. Incidence rate ratios (IRR) were calculated using OpenEpi and compared between age divisions. Spearman's rank correlation was utilized to evaluate the correlation between age and injury incidence. USA Hockey membership statistics were used to establish the population at risk and calculate incidence rates (IR). Results: An estimated 20,384 ice hockey injuries presented to participating United States emergency departments. The number of female youth ice hockey players increased significantly from 36,258 in 2002 to 65,072 in 2019 (p < 0.01). The most commonly injured body parts were the head (n = 5,519, IR = 62.1 [95%CI 54.3-70.0 per 10,000 athletes), trunk (n = 2,364, IR = 26.6 [95%CI 21.2-32.0] per 10,000 athletes), and wrist (n = 1,824, IR = 20.5 [95%CI 15.7-25.4] per 10,000 athletes). The most commonly reported mechanisms of injury were player-to-player collision (n = 4,746, IR = 53.4 [95%CI 46.4-60.5] per 10,000 athletes) and falls (n = 4,585, IR = 51.6 [95%CI 44.1-59.1] per 10,000 athletes). The most common diagnoses were traumatic brain injury (n = 5,333, IR = 60.0 [95%CI 52.3-67.8] per 10,000 athletes), contusion (n = 4,204, IR = 47.3 [95%CI 40.3-54.4] per 10,000 athletes) and strain/sprain (n = 3,601, IR = 40.5 [95%CI 34.1-47.0] per 10,000 athletes). A positive correlation was found between age and injury incidence, as well as increasing age and injuries from player-to-player collision and TBI's. Conclusions: Though body checking is illegal at all levels of women's ice hockey, player-to-player collision prevailed as the leading mechanism on injury. Hopefully this study informs players, parents, coaches, trainers and clinicians about the impact of player-to-player collisions on overall injury burden in the older age divisions of youth female hockey.	[Morrissey, Patrick J.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed Surg, 593 Eddy St, Providence, RI 02912 USA; [Zhou, Jack J.; Shah, Neil V.; Torre, Barrett B.; Dekis, Joanne C.; Newman, Jared M.; Connors, Katherine M.; Urban, William P.] Suny Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, Brooklyn, NY 11203 USA		Morrissey, PJ (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Orthopaed Surg, 593 Eddy St, Providence, RI 02912 USA.	patmorrissey3@gmail.com		Shah, Neil/0000-0002-3439-3071			Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Brust J, 1998, MED J ALLINA, V7, P27229; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Eckner JT, 2018, AM J SPORT MED, V46, P2253, DOI 10.1177/0363546518777244; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Gilenstam K, 2008, SCAND J MED SCI SPOR, V18, P235, DOI 10.1111/j.1600-0838.2007.00665.x; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hill DE, 2011, CLIN SPORT MED, V30, P841, DOI 10.1016/j.csm.2011.07.003; Hockey U, US HOCK NAT REG REP; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Poonai N, 2017, Paediatr Child Health, V19, P418; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Smith AM, IC HOCK SUMM ACT CON, P1; Stead TS, 2016, CUREUS, V8, DOI 10.7759/cureus.755; Thompson MC, 2014, BRAIN INJURY, V28, P431, DOI 10.3109/02699052.2014.887146; Trofa DP, 2017, ORTHOP J SPORT MED, V5, P4; USA Hockey's Risk Management and Member, 2021, SUMMARY INSURANCE CO; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	34	0	0	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1932635		JUN 2021	6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	SO9YW	WOS:000659330800001	34030578				2022-02-07	
J	Simchick, G; Scheulin, KM; Sun, WW; Sneed, SE; Fagan, MM; Cheek, SR; West, FD; Zhao, Q				Simchick, Gregory; Scheulin, Kelly M.; Sun, Wenwu; Sneed, Sydney E.; Fagan, Madison M.; Cheek, Savannah R.; West, Franklin D.; Zhao, Qun			Detecting functional connectivity disruptions in a translational pediatric traumatic brain injury porcine model using resting-state and task-based fMRI	SCIENTIFIC REPORTS			English	Article							COGNITIVE REHABILITATION THERAPY; INDIVIDUAL-DIFFERENCES; GYRENCEPHALIC BRAIN; PREFRONTAL CORTEX; MINIATURE PIG; HEAD-INJURY; MOTOR; CHILDREN; DEFICITS; NETWORK	Functional magnetic resonance imaging (fMRI) has significant potential to evaluate changes in brain network activity after traumatic brain injury (TBI) and enable early prognosis of potential functional (e.g., motor, cognitive, behavior) deficits. In this study, resting-state and task-based fMRI (rs- and tb-fMRI) were utilized to examine network changes in a pediatric porcine TBI model that has increased predictive potential in the development of novel therapies. rs- and tb-fMRI were performed one day post-TBI in piglets. Activation maps were generated using group independent component analysis (ICA) and sparse dictionary learning (sDL). Activation maps were compared to pig reference functional connectivity atlases and evaluated using Pearson spatial correlation coefficients and mean ratios. Nonparametric permutation analyses were used to determine significantly different activation areas between the TBI and healthy control groups. Significantly lower Pearson values and mean ratios were observed in the visual, executive control, and sensorimotor networks for TBI piglets compared to controls. Significant differences were also observed within several specific individual anatomical structures within each network. In conclusion, both rs- and tb-fMRI demonstrate the ability to detect functional connectivity disruptions in a translational TBI piglet model, and these disruptions can be traced to specific affected anatomical structures.	[Simchick, Gregory; Sun, Wenwu; Zhao, Qun] Univ Georgia, Franklin Coll Arts & Sci, Dept Phys & Astron, 500 DW Brooks Dr Rm 119, Athens, GA 30602 USA; [Simchick, Gregory; Scheulin, Kelly M.; Sun, Wenwu; Sneed, Sydney E.; Fagan, Madison M.; West, Franklin D.; Zhao, Qun] Univ Georgia, Regenerat Biosci Ctr, 425 River Rd Rm 316, Athens, GA 30602 USA; [Scheulin, Kelly M.; Fagan, Madison M.; West, Franklin D.] Univ Georgia, Biomed & Hlth Sci Inst, Neurosci Program, Athens, GA 30602 USA; [Scheulin, Kelly M.; Sneed, Sydney E.; Fagan, Madison M.; Cheek, Savannah R.; West, Franklin D.] Univ Georgia, Coll Agr & Environm Sci, Dept Anim & Dairy Sci, Athens, GA 30602 USA		Zhao, Q (corresponding author), Univ Georgia, Franklin Coll Arts & Sci, Dept Phys & Astron, 500 DW Brooks Dr Rm 119, Athens, GA 30602 USA.; West, FD; Zhao, Q (corresponding author), Univ Georgia, Regenerat Biosci Ctr, 425 River Rd Rm 316, Athens, GA 30602 USA.; West, FD (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Neurosci Program, Athens, GA 30602 USA.; West, FD (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	westf@uga.edu; qunzhao@uga.edu		Simchick, Gregory/0000-0001-9326-7203; Sneed, Sydney/0000-0002-4839-9693	Franklin Foundation for Neuroimaging; College of Agricultural and Environmental Sciences, University of Georgia	This work was supported by the Franklin Foundation for Neuroimaging and the College of Agricultural and Environmental Sciences, University of Georgia.	Antognini JF, 1997, LIFE SCI, V61, pPL349, DOI 10.1016/S0024-3205(97)00960-0; Ashburner J., 2016, SPM12 MANUAL; Augustine G., 2001, NEUROSCIENCE; Baker EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206481; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Borich MR, 2015, NEUROPSYCHOLOGIA, V79, P246, DOI 10.1016/j.neuropsychologia.2015.07.007; Brett M, 2003, HUMAN BRAIN FUNCT, V2, P2; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chan MY, 2017, J NEUROSCI, V37, P2734, DOI 10.1523/JNEUROSCI.2406-16.2017; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cole MW, 2016, NAT NEUROSCI, V19, P1718, DOI 10.1038/nn.4406; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; D'Souza A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00353; Elliott ML, 2019, NEUROIMAGE, V189, P516, DOI 10.1016/j.neuroimage.2019.01.068; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Faul M, 2010, TRAUMATIC BRAIN INJU; Finn ES, 2017, NEUROIMAGE, V160, P140, DOI 10.1016/j.neuroimage.2017.03.064; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Green C, 2018, J NEUROSCI, V38, P1648, DOI 10.1523/JNEUROSCI.2715-17.2018; Greene AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04920-3; Hamilton C, 2017, BRAIN STRUCT FUNCT, V222, P3205, DOI 10.1007/s00429-017-1396-0; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hua SE, 1997, LEARN MEMORY, V4, P63, DOI 10.1101/lm.4.1.63; Iandolo R, 2018, HUM BRAIN MAPP, V39, P1929, DOI 10.1002/hbm.23972; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Jaber SM, 2015, DEV NEUROPSYCHOL, V40, P34, DOI 10.1080/87565641.2014.969733; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kantak SS, 2012, NEUROREHAB NEURAL RE, V26, P282, DOI 10.1177/1545968311420845; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kilteni K, 2020, J NEUROSCI, V40, P894, DOI 10.1523/JNEUROSCI.1732-19.2019; Kinder H. A., 2019, J NEUROTRAUMA; Kinder HA, 2019, J NEUROTRAUM, V36, P2930, DOI 10.1089/neu.2018.6303; Kinder HA, 2019, J NEUROTRAUM, V36, P2810, DOI 10.1089/neu.2019.6405; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kuluz JW, 2007, STROKE, V38, P1932, DOI 10.1161/STROKEAHA.106.475244; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Laatsch LK, 2004, BRAIN INJURY, V18, P957, DOI 10.1080/02699050410001672369; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; LYNN B, 1995, EUR J NEUROSCI, V7, P431, DOI 10.1111/j.1460-9568.1995.tb00339.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Mairal J, 2010, J MACH LEARN RES, V11, P19; Mastrovito D, 2013, J NEUROSCI, V33, P12912, DOI 10.1523/JNEUROSCI.2580-13.2013; MATTSSON JL, 1978, AM J VET RES, V39, P1279; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; Mushiake H, 2009, INT REV NEUROBIOL, V85, P1, DOI 10.1016/S0074-7742(09)85001-0; Nakamura M, 2009, J NEUROSURG-PEDIATR, V3, P488, DOI 10.3171/2008.6.PEDS0834; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; PARKER DB, 2019, SCI REP-UK, V9, P2, DOI DOI 10.1038/s41598-018-37676-3; Peterson AB, 2014, SURVEILLANCE REPORT; Rachakonda S., 2020, GROUP ICA FMRI TOOLB; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shirai T., 2019, J AM ASS LAB ANIMAL; Simchick G., 2019, BRAIN CONNECTIVITY; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tanaka Y, 2008, STROKE, V39, P205, DOI 10.1161/STROKEAHA.107.489906; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yin T., 2019, P 27 ANN M ISMRM MON; Zhang S, 2016, BRAIN IMAGING BEHAV, V10, P21, DOI 10.1007/s11682-015-9359-7	88	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 11	2021	11	1							12406	10.1038/s41598-021-91853-5			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SV4GJ	WOS:000663778500027	34117318	Green Published, gold			2022-02-07	
J	Thanjavur, K; Babul, A; Foran, B; Bielecki, M; Gilchrist, A; Hristopulos, DT; Brucar, LR; Virji-Babul, N				Thanjavur, Karun; Babul, Arif; Foran, Brandon; Bielecki, Maya; Gilchrist, Adam; Hristopulos, Dionissios T.; Brucar, Leyla R.; Virji-Babul, Naznin			Recurrent neural network-based acute concussion classifier using raw resting state EEG data	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; FEATURE-SELECTION; NON-STATIONARITY; CONNECTIVITY; EPIDEMIOLOGY; ADOLESCENTS; PERFORMANCE; ARTIFACTS; DIAGNOSIS	Concussion is a global health concern. Despite its high prevalence, a sound understanding of the mechanisms underlying this type of diffuse brain injury remains elusive. It is, however, well established that concussions cause significant functional deficits; that children and youths are disproportionately affected and have longer recovery time than adults; and that individuals suffering from a concussion are more prone to experience additional concussions, with each successive injury increasing the risk of long term neurological and mental health complications. Currently, the most significant challenge in concussion management is the lack of objective, clinically- accepted, brain-based approaches for determining whether an athlete has suffered a concussion. Here, we report on our efforts to address this challenge. Specifically, we introduce a deep learning long short-term memory (LSTM)-based recurrent neural network that is able to distinguish between non-concussed and acute post-concussed adolescent athletes using only short (i.e. 90 s long) samples of resting state EEG data as input. The athletes were neither required to perform a specific task nor expected to respond to a stimulus during data collection. The acquired EEG data were neither filtered, cleaned of artefacts, nor subjected to explicit feature extraction. The LSTM network was trained and validated using data from 27 male, adolescent athletes with sports related concussion, benchmarked against 35 non-concussed adolescent athletes. During rigorous testing, the classifier consistently identified concussions with an accuracy of > 90% and achieved an ensemble median Area Under the Receiver Operating Characteristic Curve (ROC/AUC) equal to 0.971. This is the first instance of a high-performing classifier that relies only on easy-to-acquire resting state, raw EEG data. Our concussion classifier represents a promising first step towards the development of an easy-to-use, objective, brain-based, automatic classification of concussion at an individual level.	[Thanjavur, Karun; Babul, Arif] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Foran, Brandon; Bielecki, Maya; Gilchrist, Adam] Western Univ, Middlesex Coll, Dept Comp Sci, London, ON N6A 5B7, Canada; [Hristopulos, Dionissios T.] Tech Univ Crete, Sch Elect & Comp Engn, Khania 73100, Greece; [Brucar, Leyla R.; Virji-Babul, Naznin] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada; [Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada		Thanjavur, K (corresponding author), Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada.	karun@uvic.ca	Babul, Arif/E-2730-2010	Babul, Arif/0000-0003-1746-9529; Brucar, Leyla/0000-0002-5852-3088	WestGrid; Compute Canada	Firstly, we thank Nazim Madhavji (Computer Science, Western University) and Kwang Moo Yi (Computer Science, University of British Columbia) for valuable advice and discussions that informed the present study. We also thank the anonymous reviewers for their insightful comments and suggestions. Finally, we acknowledge all the athletes from Seafair Minor Hockey Association and Richmond Football Club who participated in this study. This research was enabled in part by support provided by WestGrid (www.westgrid.ca) and Compute Canada (www.computecanada.ca).	[Anonymous], 2020, MATLAB 9 7 0 1190202; [Anonymous], 2018, RSNA STATEMENT TRAUM; [Anonymous], 2015, NET STATION FILE FOR; Balkan O, 2015, IEEE ENG MED BIO, P4053, DOI 10.1109/EMBC.2015.7319284; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bishop CM., 2006, PATTERN RECOGN; Bono Valentina, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P5864, DOI 10.1109/ICASSP.2014.6854728; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chung AW, 2019, SCI REP-UK, V9, P1; Churchill NW, 2020, HUM BRAIN MAPP, V41, P2567, DOI 10.1002/hbm.24962; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Concussion Ontario, 2017, CHAR ACC CONC CAR ON; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; Daly I, 2012, IEEE ENG MED BIO, P3963, DOI 10.1109/EMBC.2012.6346834; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Das A., 2020, ELECTROPHYSIOLOGICAL, DOI [10.1101/2020.07.24.220566, DOI 10.1101/2020.07.24.220566]; Davatzikos C, 2019, NEUROIMAGE, V197, P652, DOI 10.1016/j.neuroimage.2018.10.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunkley BT, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00280; Fan Jerome, 2006, CJEM, V8, P19; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fichtinger G., 2020, HDB MED IMAGE COMPUT, P379; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garg S., 2015, 37 ANN INT C IEE ENG; Gu X., 2020, ARXIV PREPRINT ARXIV; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735; Hristopulos DT, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00419; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Islam MK, 2016, NEUROPHYSIOL CLIN, V46, P287, DOI 10.1016/j.neucli.2016.07.002; Ivarsson E, 2020, IFMBE PROC, V76, P1064, DOI 10.1007/978-3-030-31635-8_129; Jiang X, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19050987; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Keshavarz-Hedayati B., 2015, 37 ANN INT C IEE ENG; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Klonowski Wlodzimierz, 2009, Nonlinear Biomed Phys, V3, P2, DOI 10.1186/1753-4631-3-2; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Krawczuk J, 2016, ARTIF INTELL MED, V66, P63, DOI 10.1016/j.artmed.2015.11.001; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manning KY, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101627; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Masters D., 2018, 180407612 ARXIV; MATLAB (R2020a), DEEP LEARN TOOLB SEQ; MATLAB (R2020a), 2020, DEEP LEARNING TOOLBO; MATLAB (R2020a), DEEP LEARN TOOLB LON; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meisler SL, 2019, J NEUROSCI METH, V328, DOI 10.1016/j.jneumeth.2019.108421; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Muller AM, 2018, ASN NEURO, V10, DOI 10.1177/1759091417753802; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Munia TTK, 2016, IEEE ENG MED BIO, P41, DOI 10.1109/EMBC.2016.7590635; Munson NA, 2009, LECT NOTES ARTIF INT, V5782, P144; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Neumann U, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0114-4; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Porter S, 2017, Heliyon, V3, pe00373, DOI 10.1016/j.heliyon.2017.e00373; Pratiher S, 2018, IEEE GLOB CONF SIG, P499, DOI 10.1109/GlobalSIP.2018.8646518; Raza H, 2019, NEUROCOMPUTING, V343, P154, DOI 10.1016/j.neucom.2018.04.087; Rotem-Kohavi N, 2017, NEUROSCI LETT, V650, P118, DOI 10.1016/j.neulet.2017.04.031; Rotem-Kohavi N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00209; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahiner B, 2000, MED PHYS, V27, P1509, DOI 10.1118/1.599017; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Shen YW, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00366; Sherstinsky A, 2020, PHYSICA D, V404, DOI 10.1016/j.physd.2019.132306; Singh A, 2016, PROCEEDINGS OF THE 10TH INDIACOM - 2016 3RD INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT, P1310; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Solomon GS, 2008, J NEUROPSYCHIATRY CL, V20, P504, DOI [10.1176/jnp.2008.20.4.504, DOI 10.1176/JNP.2008.20.4.504]; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Thomas AW, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01321; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wakuya H, 2001, NEURAL NETWORKS, V14, P1307, DOI 10.1016/S0893-6080(01)00087-9; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	100	0	0	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 11	2021	11	1							12353	10.1038/s41598-021-91614-4			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SV4GD	WOS:000663777900009	34117309	Green Submitted, Green Published, gold			2022-02-07	
J	Todd, J; Bharadwaj, VN; Nellenbach, K; Nandi, S; Mihalko, E; Copeland, C; Brown, AC; Stabenfeldt, SE				Todd, Jordan; Bharadwaj, Vimala N.; Nellenbach, Kimberly; Nandi, Seema; Mihalko, Emily; Copeland, Connor; Brown, Ashley C.; Stabenfeldt, Sarah E.			Platelet-like particles reduce coagulopathy-related and neuroinflammatory pathologies post-experimental traumatic brain injury	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						blood-brain barrier; coagulopathy; neuroinflammation; permeability; platelet-like particles; traumatic brain injury	CORTICAL CONTUSION; TIME-COURSE; COAGULATION; BARRIER; IMPACT; MODEL; FIBRINOGEN; ASTROGLIOSIS; TRANSFUSION; DYSFUNCTION	Coagulopathy may occur following traumatic brain injury (TBI), thereby negatively affecting patient outcomes. Here, we investigate the use of platelet-like particles (PLPs), poly(N-isopropylacrylamide-co-acrylic-acid) microgels conjugated with a fibrin-specific antibody, to improve hemostasis post-TBI. The objective of this study was to diminish coagulopathy in a mouse TBI model (controlled cortical impact) via PLP treatment, and subsequently decrease blood-brain barrier (BBB) permeability and neuroinflammation. Following an acute intravenous injection of PLPs post-TBI, we analyzed BBB permeability, ex vivo coagulation parameters, and neuroinflammation at 24 hr and 7 days post-TBI. Both PLP-treatment and control particle-treatment had significantly decreased BBB permeability and improved clot structure 24 hr post-injury. Additionally, no significant change in tissue sparing was observed between 24 hr and 7 days for PLP-treated cohorts compared to that observed in untreated cohorts. Only PLP-treatment resulted in significant reduction of astrocyte expression at 7 days and percent difference from 24 hr to 7 days. Finally, PLP-treatment significantly reduced the percent difference from 24 hr to 7 days in microglia/macrophage density compared to the untreated control. These results suggest that PLP-treatment addressed acute hypocoagulation and decreased BBB permeability followed by decreased neuroinflammation and fold-change tissue loss by 7 days post-injury. These promising results indicate that PLPs could be a potential therapeutic modality for TBI.	[Todd, Jordan; Bharadwaj, Vimala N.; Copeland, Connor; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Nellenbach, Kimberly; Nandi, Seema; Mihalko, Emily; Brown, Ashley C.] North Carolina State Univ & Univ North Carolina C, Joint Dept Biomed Engn, Raleigh, NC 27606 USA; [Nellenbach, Kimberly; Nandi, Seema; Mihalko, Emily; Brown, Ashley C.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.; Brown, AC (corresponding author), North Carolina State Univ & Univ North Carolina C, Joint Dept Biomed Engn, Raleigh, NC 27606 USA.	aecarso2@ncsu.edu; sarah.stabenfeldt@asu.edu	Bharadwaj, Vimala/AAV-1040-2021	Bharadwaj, Vimala/0000-0002-6243-0861	American Heart AssociationAmerican Heart Association [18PRE33990338]; National Science Foundation, Division of Materials ResearchNational Science Foundation (NSF) [CAREER 1847488]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL130918]	American Heart Association, Grant/Award Number: 18PRE33990338; National Science Foundation, Division of Materials Research, Grant/Award Number: CAREER 1847488; Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: DP2HD084067; National Heart, Lung, and Blood Institute, Grant/Award Number: R01HL130918	Adelson PD, 1998, ACT NEUR S, V71, P104; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bachman H, 2015, SOFT MATTER, V11, P2018, DOI 10.1039/c5sm00047e; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bharadwaj VN, 2020, TISSUE ENG PT A, V26, P688, DOI 10.1089/ten.tea.2020.0040; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown AC, 2019, BIOCONJUGATE CHEM, V30, P1951, DOI 10.1021/acs.bioconjchem.9b00360; Brown AC, 2014, NAT MATER, V13, P1108, DOI [10.1038/NMAT4066, 10.1038/nmat4066]; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Mihalko E, 2020, SEMIN THROMB HEMOST, V46, P96, DOI 10.1055/s-0039-1696944; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Nandi S, 2020, J COLLOID INTERF SCI, V577, P406, DOI 10.1016/j.jcis.2020.05.088; Nandi S, 2020, ACS BIOMATER SCI ENG, V6, P3026, DOI 10.1021/acsbiomaterials.9b01976; Nandi S, 2019, BIOMATER SCI-UK, V7, P669, DOI 10.1039/c8bm01201f; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Park J, 2019, P NATL ACAD SCI USA, V116, P14947, DOI 10.1073/pnas.1820276116; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor G, 2013, J TRAUMA ACUTE CARE, V74, P1367, DOI 10.1097/TA.0b013e31828cca61; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang Y, 2015, BRAIN RES, V1594, P267, DOI 10.1016/j.brainres.2014.10.035	58	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	DEC	2021	109	12					2268	2278		10.1002/jbm.b.34888		JUN 2021	11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	WA7HX	WOS:000660246500001	34117693				2022-02-07	
J	Borde, P; Kumar, S; Sahana, D; Rathore, L; Jain, A; Tawari, M; Sahu, R				Borde, Praveen; Kumar, Sanjeev; Sahana, Debabrata; Rathore, Lavlesh; Jain, Amit; Tawari, Manish; Sahu, Rajiv			Management Challenges and Outcomes of Traumatic Brain Injury due to Bear Maul in Tribal Areas of Chhattisgarh, India-Man versus Wild	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						bear maul; traumatic brain injury; TBI; man versus wild; head injury		Objectives Neurosurgeons working in the vicinity of tribal areas face traumatic brain injury (TBI) cases due to bear maul which is on the rise in Chhattisgarh. Most of the literature is focused on the management of maxillofacial injuries. This study intends to describe the challenges in management and outcomes of TBI due to bear maul. Materials and Methods A retrospective review was conducted from May 2018 to April 2020. The patients without TBI were excluded. The variables studied were age, gender, timing and mode of conflict, Glasgow coma scale (GCS) at arrival, injury spectrum, hospital stay, the modified Rankin score (MRS), mini mental status examination (MMSE), and surgical site infections (SSI). Results Twenty-eight patients were eligible for analysis. The mean age of presentation was 40.67 +/- 13.99 years. There were 23 males (82.15%). Most common time of attack was during dawn (n = 11, 39.28%) followed by dusk (n = 9, 32.14%) and day (n = 8, 28.57%) time. Provoked conflicts were seen in 64.28%. The mean preoperative GCS was 11.07 +/- 3.54 and hospital stay was 18.71 +/- 9.51 days. Skull fractures were found in 24/28 (85.71%). The mean MRS was 1.67 +/- 1.38 at a mean follow-up of 14.53 +/- 6.59 months. Favorable outcome (MRS = 2) was seen in 64.28% of patients. The mean MMSE score was 22.28 +/- 5.36. Eight patients developed SSI (28.57%). Conclusion Outcomes of TBI due to bear maul depend on preoperative GCS. There are higher incidences of skull fractures and SSI. Humans need to avoid infiltration in wildlife territory to reduce the number of conflicts.	[Borde, Praveen; Kumar, Sanjeev; Sahana, Debabrata; Rathore, Lavlesh; Jain, Amit; Tawari, Manish; Sahu, Rajiv] DKS Postgrad Inst & Res Ctr, Dept Neurosurg, Raipur 492001, Madhya Pradesh, India		Kumar, S (corresponding author), DKS Postgrad Inst & Res Ctr, Dept Neurosurg, Raipur 492001, Madhya Pradesh, India.	ksanjeev79@gmail.com		Kumar, Sanjeev/0000-0003-3071-3063			[Anonymous], TIMES INDIA; Bargali HS, 2005, URSUS, V16, P263, DOI 10.2192/1537-6176(2005)016[0263:COSBAA]2.0.CO;2; Bashir SA, 2013, J CRANIOFAC SURG, V24, pE2, DOI 10.1097/SCS.0b013e3182636c9e; Crowcroft NS, 2007, PEDIATR ANESTH, V17, P1216, DOI 10.1111/j.1460-9592.2007.02360.x; FESCHAREK R, 1994, VACCINE, V12, P12, DOI 10.1016/0264-410X(94)90004-3; Floyd T, 1999, WILD ENVIRON MED, V10, P75, DOI 10.1580/1080-6032(1999)010[0075:BIHIAF]2.3.CO;2; Forest and Climate Change Department Government of Chhattisgarh, INTRODUCTION; Ghezta NK, 2019, J ORAL MAXIL SURG, V77, DOI 10.1016/j.joms.2018.12.029; Gupta S., 2019, TRAUMAXILLA, V1, P22; Iqbal A., 2015, J DENT RES DEV, V5, P11; Kunimoto D, 2004, J CLIN MICROBIOL, V42, P3374, DOI 10.1128/JCM.42.7.3374-3376.2004; Mamtani, 2017, INT J BIOMED RES, V8, P694; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Moir D M, 1891, Ind Med Gaz, V26, P74; Nabi DG, 2009, INJURY, V40, P87, DOI 10.1016/j.injury.2008.06.042; Prasad SC, 2013, CASE REP OTOLARYNGOL, V2013, DOI 10.1155/2013/957251; Pukar M, 2014, INT J MED RES HEALTH, V3, P503, DOI 10.5958/j.2319-5886.3.2.108; Rajpurohit KS, 2000, WILDLIFE SOC B, V28, P393; Ram R, 2011, J MAXILLOFAC ORAL SU, V10, P85, DOI 10.1007/s12663-010-0126-4; Rasool A, 2010, INJURY, V41, P116, DOI 10.1016/j.injury.2009.07.077; Roka YB, 2012, EMERG MED AUSTRALAS, V24, P677, DOI 10.1111/1742-6723.12007; Shah Ajaz A, 2010, Natl J Maxillofac Surg, V1, P96, DOI 10.4103/0975-5950.79208; Short JA, 2006, PEDIATR ANESTH, V16, P514, DOI 10.1111/j.1460-9592.2006.01897.x; Siddharth RK., 2020, J EVID BASED MED HEA, V7, P34; Thomas N, 2011, EXPERT REV ANTI-INFE, V9, P215, DOI [10.1586/eri.10.162, 10.1586/ERI.10.162]; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P22, DOI 10.1097/00000433-199303000-00005; Wani Mohd Lateef, 2011, J Emerg Trauma Shock, V4, P20, DOI 10.4103/0974-2700.76827; Zine KU., 2014, J FORENSIC MEDSCI LA, V23, P1	28	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2021	12	03					504	511		10.1055/s-0041-1727580		JUN 2021	8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TK9DX	WOS:000659553900001	34295104	gold, Green Published			2022-02-07	
J	Elahi, C; Adil, SM; Sakita, F; Mmbaga, BT; Rocha, TAH; Fuller, A; Haglund, MM; Vissoci, JRN; Staton, C				Elahi, Cyrus; Adil, Syed M.; Sakita, Francis; Mmbaga, Blandina T.; Rocha, Thiago Augusto Hernandes; Fuller, Anthony; Haglund, Michael M.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine			Corticosteroid Randomization after Significant Head Injury and International Mission for Prognosis and Clinical Trialsin Traumatic Brain Injury Models Compared with a Machine Learning-Based Predictive Model from Tanzania	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						artificial intelligence; global neurosurgery; machine learning; predictive modeling; traumatic brain injury		Hospitals in low- and middle-income countries (LMICs) could benefit from decision support technologies to reduce time to triage, diagnosis, and surgery for patients with traumatic brain injury (TBI). Corticosteroid Randomization after Significant Head Injury (CRASH) and International Mission for Prognosis and Clinical Trials in Traumatic Brain Injury (IMPACT) are robust examples of TBI prognostic models, although they have yet to be validated in Sub-Saharan Africa (SSA). Moreover, machine learning and improved data quality in LMICs provide an opportunity to develop context-specific, and potentially more accurate, prognostic models. We aim to externally validate CRASH and IMPACT on our TBI registry and compare their performances to that of the locally derived model (from the Kilimanjaro Christian Medical Center [KCMC]). We developed a machine learning-based prognostic model from a TBI registry collected at a regional referral hospital in Moshi, Tanzania. We also used the core CRASH and IMPACT online risk calculators to generate risk scores for each patient. We compared the discrimination (area under the curve [AUC]) and calibration before and after Platt scaling (Brier, Hosmer-Lemeshow Test, and calibration plots) for CRASH, IMPACT, and the KCMC model. The outcome of interest was unfavorable in-hospital outcome defined as a Glasgow Outcome Scale score of 1-3. There were 2972 patients included in the TBI registry, of whom 11% had an unfavorable outcome. The AUCs for the KCMC model, CRASH, and IMPACT were 0.919, 0.876, and 0.821, respectively. Prior to Platt scaling, CRASH was the best calibrated model (chi(2) = 68.1) followed by IMPACT (chi(2) = 380.9) and KCMC (chi(2) = 1025.6). We provide the first SSA validation of the core CRASH and IMPACT models. The KCMC model had better discrimination than either of these. CRASH had the best calibration, although all model predictions could be successfully calibrated. The top performing models, KCMC and CRASH, were both developed using LMIC data, suggesting that locally derived models may outperform imported ones from different contexts of care. Further work is needed to externally validate the KCMC model.	[Elahi, Cyrus] Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Elahi, Cyrus; Adil, Syed M.; Fuller, Anthony; Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Div Neurosurg & Neurol, Durham, NC USA; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Sakita, Francis] Kilimanjaro Christian Med Ctr, Emergency Dept, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Rocha, Thiago Augusto Hernandes] WHO, Pan Amer Hlth Org, Brasilia, DF, Brazil; [Fuller, Anthony; Haglund, Michael M.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC USA		Elahi, C (corresponding author), Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	cyrusweal@gmail.com					Adil SM, 2021, J NEUROTRAUM, V38, P928, DOI 10.1089/neu.2020.7262; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Assel Melissa, 2017, Diagn Progn Res, V1, P19, DOI 10.1186/s41512-017-0020-3; Connolly B, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1736-3; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Elahi C., 2020, J NEUROSURG; Elahi C, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.7.FOCUS19316; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Core Team, R LANG ENV STAT COMP; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; van Calster B, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1466-7; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168	22	0	0	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7483		JUN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SQ1IT	WOS:000660114000001	33980030				2022-02-07	
J	Trevino, LR; Roberge, P; Auer, ME; Morales, A; Torres-Reveron, A				Trevino, Lisa R.; Roberge, Peter; Auer, Michael E.; Morales, Angela; Torres-Reveron, Annelyn			Predictors of Functional Outcome in a Cohort of Hispanic Patients Using Exoskeleton Rehabilitation for Cerebrovascular Accidents and Traumatic Brain Injury	FRONTIERS IN NEUROROBOTICS			English	Article						trauma; injury; minorities; gait; diabetes	GAIT REHABILITATION; SUPPORTED TREADMILL; BODY-WEIGHT; STROKE; RISK; EPIDEMIOLOGY; IMPROVEMENT; TECHNOLOGY; ROBOTICS; THERAPY	Traumatic brain injury (TBI) and cerebrovascular accidents (CVA) are two of the leading causes of disability in the United States. Robotic exoskeletons (RE) have been approved for rehabilitation by the Federal Drug Administration (FDA) for use after a CVA, and recently received approval for use in patients with TBI. The aim of the study was to determine which factors predict the improvement in functional independence measure (FIM) score after using RE rehabilitation in a population of patients with CVA or TBI. We carried out a retrospective chart-review analysis of the use of the RE (Ekso (R) GT) in the rehabilitation of patients with TBI and CVA using data from a single, private rehabilitation hospital for patients admitted and discharged between 01/01/2017 and 04/30/2020. From the medical records, we collected presentation date, Glasgow Coma Scale score (GCS) on the date of injury, rehabilitation start date, age, diabetes status on presentation (Yes or No), injury category (TBI or CVA), and both admission and discharge FIM scores. Matching algorithms resulted in one TBI patient matched to three CVA patients resulting in a sample size of 36. The diabetic and non-diabetic populations showed significant differences between age and days from injury to the start of rehabilitation. A multivariate linear regression assessed predictors for discharge motor FIM and found admission motor FIM score and total RE steps to be statistically significant predictors. For each point scored higher on the admission motor FIM the discharge FIM was increased by 1.19 FIM points, and for each 1,000 steps taken in the RE, the discharge motor FIM increased by three points. The type of acquired brain injury (CVA or TBI) was not found to affect functional outcome. The presented results show that key clinic-biologic factors including diabetic status, together with start to rehabilitation play key roles in discharge FIM scores for patients using RE.	[Trevino, Lisa R.; Roberge, Peter; Torres-Reveron, Annelyn] DHR Hlth Inst Res & Dev, Edinburg, TX 78539 USA; [Auer, Michael E.; Morales, Angela] DHR Hlth Rehabil Hosp, Edinburg, TX USA		Torres-Reveron, A (corresponding author), DHR Hlth Inst Res & Dev, Edinburg, TX 78539 USA.	anne.torres@dhr-rgv.com					[Anonymous], 2015, C TRAUM BRAIN INJ US; Asselin PK, 2016, JOVE-J VIS EXP, DOI 10.3791/54071; Berger A, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00172; Blackwell D.L., 2018, NATL CENT HLTH STAT; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; Bruni MF, 2018, J CLIN NEUROSCI, V48, P11, DOI 10.1016/j.jocn.2017.10.048; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chen R, 2016, AM J MED SCI, V351, P380, DOI 10.1016/j.amjms.2016.01.011; Dijkers MP, 2021, ARCH PHYS MED REHAB, V102, P300, DOI 10.1016/j.apmr.2019.01.025; DIJKERS MP, 1991, J REHABIL RES DEV, V28, P33, DOI 10.1682/JRRD.1991.04.0033; DiRocco P.J., 1995, FITNESS PROGRAMMING, V1st; Esquenazi A, 2017, PM&R, V9, P839, DOI 10.1016/j.pmrj.2016.12.010; Esquenazi A, 2013, PM&R, V5, P280, DOI 10.1016/j.pmrj.2012.10.009; Fasoli SE, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01088; Gempeler A, 2020, NEUROCRIT CARE, V33, P718, DOI 10.1007/s12028-020-00955-x; Giles GM, 2010, AM J OCCUP THER, V64, P182, DOI 10.5014/ajot.64.1.182; Globe Newswire, 2020, EKS BION REC FDA CLE; Hesse S, 2009, BRAIN RES BULL, V78, P26, DOI 10.1016/j.brainresbull.2008.06.004; Karunakaran KK, 2020, IEEE ENG MED BIO, P3224, DOI 10.1109/EMBC44109.2020.9175764; Khoury JC, 2013, STROKE, V44, P1500, DOI 10.1161/STROKEAHA.113.001318; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lapitskaya N, 2011, BRAIN INJURY, V25, P1070, DOI 10.3109/02699052.2011.607782; Lee M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3564; Leeper T.J., 2018, MARGINS MARGINAL EFF; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Logan LM, 2018, J HEAD TRAUMA REHAB, V33, pE61, DOI 10.1097/HTR.0000000000000349; Louie DR, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-1617-7; Maggio MG, 2020, INT J NEUROSCI, V130, P117, DOI 10.1080/00207454.2019.1664519; Mehrholz J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub4; Millard AV, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00135; National Spinal Cord Injury Statistical Center, 2019, FACTS FIG GLANC; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nolan KJ, 2020, FRONT NEUROROBOTICS, V14, DOI 10.3389/fnbot.2020.581815; Nolan Karen J, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2809, DOI 10.1109/EMBC.2018.8512745; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Palermo AE, 2017, TOP SPINAL CORD INJ, V23, P234, DOI 10.1310/sci2303-234; Parrington L, 2020, PHYS THER, V100, P687, DOI 10.1093/ptj/pzaa007; Permenter C.M., 2020, POSTCONCUSSIVE SYNDR; R Core Team, 2020, R LANG ENV STAT COMP; Tatara Y, 2021, J NEUROTRAUM, V38, P886, DOI 10.1089/neu.2020.7118; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Thorpe ER, 2018, J NEUROL PHYS THER, V42, P2, DOI 10.1097/NPT.0000000000000211; Tomida K, 2019, J STROKE CEREBROVASC, V28, P2421, DOI 10.1016/j.jstrokecerebrovasdis.2019.06.030; Tziomalos K, 2014, WORLD J DIABETES, V5, P939, DOI 10.4239/wjd.v5.i6.939; UT Health-School of Public Health Brownsville, 2018, RHP 5 COMM NEEDS ASS; Wang YH, 2014, J CHIN MED ASSOC, V77, P469, DOI 10.1016/j.jcma.2014.03.006; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE13, DOI 10.1097/HTR.0000000000000038	51	0	0	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5218			FRONT NEUROROBOTICS	Front. Neurorobotics	JUN 10	2021	15								682156	10.3389/fnbot.2021.682156			10	Computer Science, Artificial Intelligence; Robotics; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Robotics; Neurosciences & Neurology	SX1BM	WOS:000664946700001	34177511	gold, Green Published			2022-02-07	
J	Xu, LD; Ware, JB; Kim, JJ; Shahim, P; Silverman, E; Magdamo, B; Dabrowski, C; Wesley, L; Le, MD; Morrison, J; Zamore, H; Lynch, CE; Petrov, D; Chen, HI; Schuster, J; Diaz-Arrastia, R; Sandsmark, DK				Xu, Linda; Ware, Jeffrey B.; Kim, Junghoon J.; Shahim, Pashtun; Silverman, Erika; Magdamo, Brigid; Dabrowski, Cian; Wesley, Leroy; Le, My Duyen; Morrison, Justin; Zamore, Hannah; Lynch, Cillian E.; Petrov, Dmitriy; Chen, H. Isaac; Schuster, James; Diaz-Arrastia, Ramon; Sandsmark, Danielle K.			Arterial Spin Labeling Reveals Elevated Cerebral Blood Flow with Distinct Clusters of Hypo- and Hyperperfusion after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; cerebral blood flow; cerebrovascular; perfusion; traumatic brain injury	HEAD-INJURY; PERFUSION; SYMPTOMS; MRI	Imaging detection of brain perfusion alterations after traumatic brain injury (TBI) may provide prognostic insights. In this study, we used arterial spin labeling (ASL) to quantify cross-sectional and longitudinal changes in cerebral blood flow (CBF) after TBI and correlated changes with clinical outcome. We analyzed magnetic resonance imaging scans from adult participants with TBI requiring hospitalization in the acute (2 weeks post-injury, n = 33) and chronic (6 months post-injury, n = 16) phases, with 13 participants scanned longitudinally at both time points. We also analyzed 18 age- and sex-matched healthy controls. Whole-brain CBF maps were derived using a three-dimensional pseudo-continuous arterial spin label technique. Mean CBF across tissue-based regions (whole brain, gray matter, and white matter) was compared cross-sectionally and longitudinally. In addition, individual-level clusters of abnormal perfusion were identified using voxel-based z-score analysis of relative CBF maps, and number and volume of abnormally hypo- and hyperperfused clusters were assessed cross-sectionally and longitudinally. Finally, all CBF measures were correlated with clinical outcome measures. Mean global and gray matter CBF were significantly elevated in acute and chronic TBI participants compared to controls. Participants with better outcome at 6 months post-injury tended to have higher CBF in the acute phase compared to those with poorer outcome. Acute TBI participants had a significantly greater volume of hypo- and hyperperfused brain tissue compared to controls, with these regions partially normalizing by the chronic phase. Our findings demonstrate global elevation of CBF with focal hypo- and hyperperfusion in the early post-injury period and suggest a reparative role for acute elevation in CBF post-TBI.	[Xu, Linda; Ware, Jeffrey B.; Silverman, Erika; Magdamo, Brigid; Dabrowski, Cian; Wesley, Leroy; Le, My Duyen; Morrison, Justin; Zamore, Hannah; Lynch, Cillian E.; Petrov, Dmitriy; Chen, H. Isaac; Schuster, James; Diaz-Arrastia, Ramon; Sandsmark, Danielle K.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, Junghoon J.] CUNY, Sch Med, City Coll New York, New York, NY 10031 USA; [Shahim, Pashtun] NIH, Bldg 10, Bethesda, MD 20892 USA		Sandsmark, DK (corresponding author), Univ Penn, 51 North 39th St,Med Off Bldg,Suite 205, Philadelphia, PA 19104 USA.	danielle.sandsmark@pennmedicine.upenn.edu			Pennsylvania Department of Health; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086090, K23-NS104239-03]; DoDUnited States Department of Defense [W81XWH-14-2-0176, W81XWH-19-2-0002]	Work in the authors' laboratory was supported by the Pennsylvania Department of Health. This work was also funded by NINDS U01 NS086090, DoD W81XWH-14-2-0176, W81XWH-19-2-0002, and NINDS K23-NS104239-03.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Clark AL, 2021, J CEREBR BLOOD F MET, V41, P431, DOI 10.1177/0271678X19897443; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu AA, 2011, NEUROLOGY, V77, P1518, DOI 10.1212/WNL.0b013e318233b229; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stampfer E., 2014, JACKKNIFE RESAMPLING; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Ware JB, 2020, J NEUROTRAUM, V37, P2180, DOI 10.1089/neu.2020.7031; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	38	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2538	2548		10.1089/neu.2020.7553		JUN 2021	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000660114900001	34115539				2022-02-07	
J	Lu, LH; Steinman, J; Sled, JG; Mao, HJ				Lu, Lihong; Steinman, Joe; Sled, John G.; Mao, Haojie			Brain microvascular damage linked to a moderate level of strain induced by controlled cortical impact	JOURNAL OF BIOMECHANICS			English	Article						Microvascular damage; Vessel density; Brain strain; Controlled cortical impact	HEAD-INJURY	Cerebral blood vessels play an important role in brain metabolic activity in general and following traumatic brain injury (TBI) in particular. However, the extent to which TBI alters microvessel structure is not well understood. Specifically, how intracranial mechanical responses produced during impacts relate to vascular damage needs to be better studied. Therefore, the objective of this study was to investigate the biomechanical mechanisms and thresholds of brain microvascular injury. Detailed microvascular damage of mouse brain was quantified using Arterial Spin Labeling (ASL) magnetic resonance imaging (MRI) and ex vivo Serial Two-Photon Tomography (STPT) in seven mice that had undergone controlled cortical impact. Mechanical strains were investigated through finite element (FE) modeling of the mouse brain. We then compared the post-injury vessel density map with FE-predicted strain and found a moderate correlation between the vessel length density and the predicted peak maximum principal strains (MPS) (R-2 = 0.52). High MPS was observed at the impact regions with low vessel length density, supporting the mechanism of strain-triggered microvascular damage. Using logistic regression, the MPS corresponding to a 50% probability of injury was found to be 0.17. Given the literature reporting MPS of over 0.2 in the human brain for mild TBI/concussion cases, it is highly recommended to consider microvascular damage when investigating mild TBI/concussion in the future. (C) 2021 Elsevier Ltd. All rights reserved.	[Lu, Lihong; Mao, Haojie] Western Univ, Mech & Mat Engn, London, ON, Canada; [Steinman, Joe; Sled, John G.] Univ Toronto, Med Biophys, Toronto, ON, Canada; [Steinman, Joe; Sled, John G.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada; [Mao, Haojie] Western Univ, Biomed Engn, London, ON, Canada		Mao, HJ (corresponding author), 1151 Richmond St, London, ON N6A 3K7, Canada.	haojie.mao@uwo.ca	; Mao, Haojie/Q-7514-2018; Sled, John G/D-8268-2012	Steinman, Joe/0000-0002-1354-4221; Mao, Haojie/0000-0002-7563-9234; Sled, John G/0000-0002-4461-283X	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs programCanada Research Chairs; Canadian Institutes of Health Research GrantCanadian Institutes of Health Research (CIHR) [FRN - 152961]	We acknowledge NSERC and the Canada Research Chairs program as well as the Canadian Institutes of Health Research Grant FRN - 152961.	Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Bell ED, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00002; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Dorr A, 2017, J CEREBR BLOOD F MET, V37, P1046, DOI 10.1177/0271678X16669514; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Kleiven S., 2007, SAE TECH PAP; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu L., 2019, J NEUROTRAUMA; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Price L., 2016, TRANSLATIONAL RES TR, P85; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/NMETH.1854, 10.1038/nmeth.1854]; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Shreiber DI., 1997, SAE T, V106, P3792; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	28	0	0	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUN 9	2021	122								110452	10.1016/j.jbiomech.2021.110452			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	SF3IP	WOS:000652653100028	33901935				2022-02-07	
J	Robbins, GT; Goldstein, R; Siddiqui, S; Huang, DS; Zafonte, R; Schneider, JC				Robbins, Gregory T.; Goldstein, Richard; Siddiqui, Sameer; Huang, Donna S.; Zafonte, Ross; Schneider, Jeffrey C.			Capture rates of comorbidity measures at inpatient rehabilitation facilities after a stroke or brain injury	PM&R			English	Article; Early Access							OLDER-ADULTS; ISCHEMIC-STROKE; INDEX; FRAILTY; VALIDATION; MORTALITY; OUTCOMES; DISABILITY; INSTITUTE; ICD-9-CM	Background Comorbidity indices have been used to represent the overall medical complexity of patient populations in clinical research; however, it is not known how well they capture the comorbidities of patients with a stroke or brain injury admitted to inpatient rehabilitation facilities (IRFs). Objective To determine how well commonly used comorbidity indices capture the comorbidities of patients admitted to IRFs after a stroke or brain injury. Design Cross-sectional, retrospective study. Setting IRFs nationwide. Participants Adults from four impairment groups: (1) hemorrhagic stroke, (2) ischemic stroke, (3) nontraumatic brain injury (NTBI), and (4) traumatic brain injury (TBI). Main Outcome Measures International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes were extracted from the Uniform Data System for Medical Rehabilitation (UDSMR) for IRF discharges from October 1, 2015 to December 31, 2017. The percentage of discharges captured by Deyo-Charlson, Elixhauser, and Centers for Medicare and Medicaid Services (CMS) tiers was determined, as was the percentage of comorbidities captured. These measures were also compared with respect to their ability to capture chronic medical complexity by examining the percentage of codes captured after removal of codes deemed to represent hospital complications or sequela of the admission diagnosis. Results The percentage of discharges without at least one ICD-10-CM code captured by any index ranged from 0.3%-3.8%. The percentage of comorbidities with a prevalence exceeding 1% captured by at least one index ranged from 37.1%-43.6%. Chronic comorbidities were most likely to be captured by Elixhauser (40.7%-44.4%), followed by Deyo-Charlson (7.8%-9.6%), then CMS tiers (4.5%-6.9%). Existing comorbidity measures capture most IRF discharges related to a brain injury or stroke, whereas most medical comorbidities escape representation. Several common, functionally relevant diagnoses were not captured. Conclusion The use of comorbidity indices in the IRF neurologic injury population should account for the fact that these measures miss several common, important comorbidities.	[Robbins, Gregory T.; Goldstein, Richard; Siddiqui, Sameer; Huang, Donna S.; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA		Robbins, GT (corresponding author), Wake Forest Baptist Hlth, Dept Orthoped & Rehabil, 8th Floor,Janeway Tower,Med Ctr Blvd, Winston Salem, NC 27157 USA.	grobbins@wakehealth.edu		Huang, Donna/0000-0001-8620-639X			[Anonymous], 2014, SURVEILLANCE REPORT; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Berg GD, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022935; Bhavnani SP, 2013, ANN NONINVAS ELECTRO, V18, P379, DOI 10.1111/anec.12045; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Braun KF, 2012, DIABETES RES CLIN PR, V98, P164, DOI 10.1016/j.diabres.2012.04.016; Carter GM., 2005, PRELIMINARY ANALYSES; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferriero G, 2006, Eura Medicophys, V42, P91; Flint AC, 2010, AM J NEURORADIOL, V31, P1192, DOI 10.3174/ajnr.A2050; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallacher Katie I, 2018, J Comorb, V8, P1, DOI 10.15256/joc.2018.8.129; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Graham JE, 2009, ARCH PHYS MED REHAB, V90, P1110, DOI 10.1016/j.apmr.2009.01.014; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Huang D, 2020, ARCH PHYS MED REHAB, V101, P1731, DOI 10.1016/j.apmr.2020.04.025; Hwang F, 2019, CUREUS, V11, DOI 10.7759/cureus.6154; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Kabboord AD, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.028; Kawryshanker S., 2014, CURR GERONTOL GERIAT, V2014; Kiely DK, 2009, J AM GERIATR SOC, V57, P1532, DOI 10.1111/j.1532-5415.2009.02394.x; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Ladha KS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008990; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Lim JH, 2015, J PHYS THER SCI, V27, P799, DOI 10.1589/jpts.27.799; Liu MG, 1997, ARCH PHYS MED REHAB, V78, P166, DOI 10.1016/S0003-9993(97)90259-8; Liu MG, 1999, AM J PHYS MED REHAB, V78, P416, DOI 10.1097/00002060-199909000-00004; (MedPAC) MPAC, 2018, REPORT C MEDICARE PA; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Phan TG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00192; Piernik-Yoder B, 2013, ARCH PHYS MED REHAB, V94, P1508, DOI 10.1016/j.apmr.2013.04.014; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Shih SL, 2015, J GEN INTERN MED, V30, P1688, DOI 10.1007/s11606-015-3350-2; Slocum CS, 2015, AM J PHYS MED REHAB, V94, P373, DOI 10.1097/PHM.0000000000000180; Tam AKH, 2018, DISABIL REHABIL, V40, P1842, DOI 10.1080/09638288.2017.1309465; Tocchi C, 2014, J NURS MEAS, V22, P223, DOI 10.1891/1061-3749.22.2.223; Valkova M, 2012, J IMAB, V18, P298, DOI 10.5272/jimab.2012183.298; Waller M, 2017, EMERG THEMES EPIDEMI, V14, P1, DOI 10.1186/s12982-017-0057-3; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Xia WS, 2019, INJURY, V50, P1565, DOI 10.1016/j.injury.2019.07.001; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	49	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12589		JUN 2021	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	SO8BL	WOS:000659199800001	33728804				2022-02-07	
J	Brazdzionis, J; Patchana, T; Savla, P; Podkovik, S; Browne, J; Ohno, A; Taka, TM; Modi, A; Wacker, MR; Cortez, V; Miulli, DE				Brazdzionis, James; Patchana, Tye; Savla, Paras; Podkovik, Stacey; Browne, Jonathan; Ohno, Ai; Taka, Taha M.; Modi, Arnav; Wacker, Margaret Rose; Cortez, Vladimir; Miulli, Dan E.			Medical Comorbidities Associated With Outcomes in Patients With Traumatic Epidural Hematomas	CUREUS			English	Article						comorbid disease; epidural hematoma; traumatic brain injury; length of stay; comorbidity	BRAIN-INJURY; SUBSTANCE-ABUSE; RECOVERY; SMOKING	Background Traumatic brain injury (TBI) is a frequently encountered neurosurgical pathology with significant morbidity and mortality. One such subtype is the epidural hematoma. Literature regarding the effects of comorbidities in TBI and epidural hematomas is limited. Methodology This was a single-center retrospective review of 50 consecutive patients admitted to a level two trauma center with epidural hematomas. Patients were identified using an internal trauma database. Patients were included if they were 18 years of age with a diagnosed epidural hematoma. Outcome variables of Glasgow coma scale (GCS), length of stay in the intensive care unit (ICU) and hospital, and requirement of a neurosurgical procedure were analyzed. Identification of the presence of diagnosed comorbidities was performed including common comorbidities such as obesity, diabetes, hypertension, hyperlipidemia, drug use, tobacco use, cancer, psychiatric disease, and renal disease. Correlations were evaluated using two-sided bivariate analysis (p < 0.05). Results A total of 50 patients were included for analysis. Significant correlations with a p-value less of than 0.05 were noted in initial GCS and cancer (r = -0.357, p = 0.011), requirements of an intracranial procedure with a history of gastrointestinal disease (r = 0.377, p = 0.007), and younger age (r = -0.306, p = 0.031). Increased ICU length of stay was related to a history of cancer (r = 0.494, p < 0.001), a history of respiratory disease (r = 0.427, p = 0.002), and a history of psychiatric disease (r = 0.297, p = 0.036). Increased hospital length of stay was related to psychiatric disorders (r = 0.285, p = 0.045). Discharge GCS was negatively associated with a history of hypertension (r = -0.374, p = 0.008), tobacco use (r = -0.417, p = 0.003), drug use (r = -0.294, p = 0.037), and history of cancer (r = -0.303, p = 0.032). Discussion and Conclusions In our 50 consecutive patient subset, selected comorbidities demonstrated significant relationships with outcome measures of GCS, need for a procedure, and lengths of stay in the hospital and ICU. Obtaining comorbidity information when available from families can better allow the clinician to optimize treatment and educate loved ones about the potential effects of these comorbidities on the overall health of the patient. Understanding these correlations may allow for a better understanding of the systemic effects of the pathophysiology of injury in epidural hematomas.	[Brazdzionis, James; Patchana, Tye; Savla, Paras; Podkovik, Stacey] Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA; [Browne, Jonathan; Ohno, Ai; Modi, Arnav] Calif Univ Sci & Med, Neurosurg, Colton, CA USA; [Taka, Taha M.] Univ Calif Riverside, Neurosurg, Riverside, CA 92521 USA; [Wacker, Margaret Rose; Miulli, Dan E.] Arrowhead Reg Med Ctr, Neurosurg, Colton, CA USA; [Cortez, Vladimir] Desert Reg Med Ctr, Neurosurg, Palm Springs, CA USA		Brazdzionis, J (corresponding author), Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA.	jbrazdzionis@une.edu		Browne, Jonathan/0000-0002-6233-2997; Ohno, Ai/0000-0002-5577-480X			Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dahdah Marie N, 2016, Proc (Bayl Univ Med Cent), V29, P271; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Kulesza B, 2021, EUR J TRAUMA EMERG S, V47, P1517, DOI 10.1007/s00068-020-01460-8; Kumar S, 2013, Lung India, V30, P178, DOI 10.4103/0970-2113.116238; Lehmkuhl DI, 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199308020-00010; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Montorfano L, 2020, SURGERY, V167, P478, DOI 10.1016/j.surg.2019.10.006; Ostberg A, 2014, BRAIN INJURY, V28, P155, DOI 10.3109/02699052.2013.860468; Raghupathi W, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030431; Siddiqui N, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3316-2; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Zimering Mark B, 1800, J Endocrinol Diabetes, V6, DOI 10.15226/2374-6890/6/3/001137	20	0	0	1	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 8	2021	13	6							e15514	10.7759/cureus.15514			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SR7CY	WOS:000661200500004	34277158	Green Published, gold			2022-02-07	
J	Khan, A; Bellio, MA; Schulman, IH; Levi, AD; Longsomboon, B; Brooks, A; Valasaki, K; DiFede, DL; Pujol, MV; Yavagal, DR; Bates, KE; Si, MS; Kaushal, S; Green, BA; Anderson, KD; Guest, JD; Burks, SS; Silvera, R; Santamaria, AJ; Lalwani, A; Dietrich, WD; Hare, JM				Khan, Aisha; Bellio, Michael A.; Schulman, Ivonne H.; Levi, Allan D.; Longsomboon, Bangon; Brooks, Adriana; Valasaki, Krystalenia; DiFede, Darcy L.; Pujol, Marietsy V.; Yavagal, Dileep R.; Bates, Karen E.; Si, Ming-Sing; Kaushal, Sunjay; Green, Barth A.; Anderson, Kimberly D.; Guest, James D.; Burks, Stephen Shelby; Silvera, Risset; Santamaria, Andrea J.; Lalwani, Anil; Dietrich, W. Dalton; Hare, Joshua M.			The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						mesenchymal stem cells; clinical investigation; expanded access IND; schwann cell; single patient IND	NERVE GROWTH-FACTOR; AUTOLOGOUS SCHWANN-CELLS; ISCHEMIC CARDIOMYOPATHY; SCIATIC-NERVE; CLINICAL-TRIALS; REPAIR; REGENERATION; EXPERIENCE; SAFETY; DEATH	The U.S. Food and Drug Administration (FDA) provides guidance for expanded access to experimental therapies, which in turn plays an important role in the Twenty-first Century Cures Act mandate to advance cell-based therapy. In cases of incurable diseases where there is a lack of alternative treatment options, many patients seek access to cell-based therapies for the possibility of treatment responses demonstrated in clinical trials. Here, we describe the use of the FDA's expanded access to investigational new drug (IND) to address rare and emergency conditions that include stiff-person syndrome, spinal cord injury, traumatic brain stem injury, complex congenital heart disease, ischemic stroke, and peripheral nerve injury. We have administered both allogeneic bone marrow-derived mesenchymal stem cell (MSC) and autologous Schwann cell (SC) therapy to patients upon emergency request using Single Patient Expanded Access (SPEA) INDs approved by the FDA. In this report, we present our experience with 10 completed SPEA protocols.	[Khan, Aisha; Bellio, Michael A.; Schulman, Ivonne H.; Longsomboon, Bangon; Brooks, Adriana; Valasaki, Krystalenia; DiFede, Darcy L.; Pujol, Marietsy V.; Yavagal, Dileep R.; Silvera, Risset; Hare, Joshua M.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Khan, Aisha; Schulman, Ivonne H.; Brooks, Adriana; Green, Barth A.; Guest, James D.; Silvera, Risset; Santamaria, Andrea J.; Dietrich, W. Dalton] Univ Miami, Leonard M Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Schulman, Ivonne H.] Univ Miami, Leonard M Miller Sch Med, Katz Family Div Nephrol & Hypertens, Miami, FL USA; [Levi, Allan D.; Green, Barth A.; Guest, James D.; Burks, Stephen Shelby; Dietrich, W. Dalton] Univ Miami, Leonard M Miller Sch Med, Dept Neurol Surg, Miami, FL USA; [Yavagal, Dileep R.; Bates, Karen E.] Univ Miami, Leonard M Miller Sch Med, Dept Clin Neurol & Neurosurg, Miami, FL USA; [Si, Ming-Sing] CS Mott Childrens Hosp, Michigan Med, Dept Cardiac Surg, Sect Pediat Cardiovasc Surg, Ann Arbor, MI USA; [Kaushal, Sunjay] Univ Maryland, Sch Med, Div Cardiac Surg, Baltimore, MD 21201 USA; [Anderson, Kimberly D.] Case Western Reserve Univ Sch, Cleveland, OH USA; [Lalwani, Anil] Medtron ST Neurosurg, Louisville, CO USA; [Hare, Joshua M.] Univ Miami, Dept Med, Div Cardiol, Leonard M Miller Sch Med, Miami, FL USA		Khan, A (corresponding author), Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.; Khan, A (corresponding author), Univ Miami, Leonard M Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	akhan@med.miami.edu			ISCI	We would like to thank the ISCI for the support in this work.	Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Baizabal-Carvallo JF, 2015, J NEUROL NEUROSUR PS, V86, P840, DOI 10.1136/jnnp-2014-309201; Barker RA, 1998, J NEUROL NEUROSUR PS, V65, P633, DOI 10.1136/jnnp.65.5.633; Berrocal YA, 2013, J NEUROSURG, V119, P720, DOI 10.3171/2013.4.JNS121189; Bhatti AB, 2015, CUREUS, V7, DOI 10.7759/cureus.427; Brunet MC, 2019, WORLD NEUROSURG, V128, P573, DOI 10.1016/j.wneu.2019.04.055; Chang TS, 2013, JAMA NEUROL, V70, P1140, DOI 10.1001/jamaneurol.2013.3499; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Duddy ME, 2009, FRONT NEUROL NEUROSC, V26, P147, DOI 10.1159/000212375; Florea V, 2017, CIRC RES, V121, P1279, DOI 10.1161/CIRCRESAHA.117.311827; Folkers KM, 2018, THER INNOV REGUL SCI, V52, P285, DOI 10.1177/2168479018759661; Fontaine MJ, 2016, TRANSFUS MED REV, V30, P37, DOI 10.1016/j.tmrv.2015.11.004; Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004; Gersey ZC, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2016.12.FOCUS16474; Gershanik OS, 2009, PARKINSONISM RELAT D, V15, pS130, DOI 10.1016/S1353-8020(09)70799-0; Glassberg MK, 2017, CHEST, V151, P971, DOI 10.1016/j.chest.2016.10.061; GUENARD V, 1992, J NEUROSCI, V12, P3310; Hare JM, 2017, J AM COLL CARDIOL, V69, P526, DOI 10.1016/j.jacc.2016.11.009; Hare JM, 2013, CIRCULATION, V127, P1630, DOI 10.1161/CIRCULATIONAHA.112.000779; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Hogan M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0586-6; Jarow JP, 2017, THER INNOV REGUL SCI, V51, P246, DOI 10.1177/2168479016679214; Jarow JP, 2016, THER INNOV REGUL SCI, V50, P705, DOI 10.1177/2168479016656030; Jerusalem G, 2016, ANN ONCOL, V27, P1719, DOI 10.1093/annonc/mdw249; Jin S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.73.4186; Knoepfler PS, 2015, ADV DRUG DELIVER REV, V82-83, P192, DOI 10.1016/j.addr.2014.12.001; Levi AD, 2016, CELL TRANSPLANT, V25, P1395, DOI 10.3727/096368915X690198; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; OTTO D, 1987, NEUROSCI LETT, V83, P156, DOI 10.1016/0304-3940(87)90233-3; Pagano MB, 2014, TRANSFUSION, V54, P1851, DOI 10.1111/trf.12573; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Pittenger MF, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/280572; Premer C, 2015, EBIOMEDICINE, V2, P467, DOI 10.1016/j.ebiom.2015.03.020; Puthumana J, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0283; RICH KM, 1987, J NEUROCYTOL, V16, P261, DOI 10.1007/BF01795309; RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5; Rieger AC, 2019, EBIOMEDICINE, V48, P377, DOI 10.1016/j.ebiom.2019.09.043; Santamaria AJ, 2019, J NEUROTRAUM, V36, P500, DOI 10.1089/neu.2018.5716; Schulman I.H., 2018, MANAGEMENT CLIN TRIA; Schulman I.H., 2018, STROMAL CELLS; Schulman IH, 2018, CIRC RES, V123, P1030, DOI 10.1161/CIRCRESAHA.118.310426	43	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	JUN 8	2021	9								675738	10.3389/fcell.2021.675738			11	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	SV8GV	WOS:000664057000001	34169074	Green Published, gold			2022-02-07	
J	Vahdat, M; Hosseini, SA; Soltani, F; Cheraghian, B; Namjoonia, M				Vahdat, Mahsa; Hosseini, Seyed Ahmad; Soltani, Farhad; Cheraghian, Bahman; Namjoonia, Masih			The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial	NUTRITION JOURNAL			English	Article						Traumatic brain injury; Inflammation; Taurine; Clinical outcome; TBI	CRITICALLY-ILL PATIENTS; OXIDATIVE STRESS; NERVOUS-SYSTEM; NITRIC-OXIDE; NEUROINFLAMMATION; CHLORAMINE; PLASMA; PATHOPHYSIOLOGY; IMMUNONUTRITION; NEUTROPHILS	Background: Traumatic brain injury is a public health concern and is the main cause of death among various types of trauma. The inflammatory conditions due to TBI are associated with unfavorable clinical outcomes. Taurine has been reported to have immune-modulatory effects. Thus, the aim of this study was to survey the effect of taurine supplementation in TBI patients. Methods: In this study, 32 patients with TBI were randomized into two groups. The treatment group received 30 mg/kg/day of taurine in addition to the Standard Entera Meal and the control group received Standard Entera Meal for 14 days. Prior to and following the intervention, the patients were investigated in terms of serum levels of IL-6, IL-10, hs-CRP and TNF-alpha as well as APACHEII, SOFA and NUTRIC scores, Glasgow coma scale and weight. In addition, the length of Intensive Care Unit stay, days of dependence on ventilator and 30-day mortality were studied. SPSS software (version 13.0) was used for data analysis. Results: Taurine significantly decreased the serum levels of IL-6 (p = 0.04) and marginally APACHEII score (p = 0.05). In addition, weight loss was significantly lower in taurine group (p = 0.03). Furthermore, taurine significantly increased the GCS (p = 0.03). The groups were not different significantly in terms of levels of IL-10, hs-CRP, and TNF-alpha, SOFA and NUTRIC scores, 30-day mortality, length of ICU stay and days of dependence on ventilator. Conclusion: According to the results of the present study, taurine supplementation can reduce the IL-6 levels as one of the important inflammatory markers in these patients; and enhances the clinical outcomes too.	[Vahdat, Mahsa; Hosseini, Seyed Ahmad] Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz, Iran; [Vahdat, Mahsa; Hosseini, Seyed Ahmad; Namjoonia, Masih] Ahvaz Jundishapur Univ Med Sci, Sch Allied Med Sci, Dept Nutr, Ahvaz, Iran; [Soltani, Farhad] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Anaesthesiol & Crit Care, Ahvaz, Iran; [Cheraghian, Bahman] Ahvaz Jundishapur Univ Med Sci, Sch Publ Hlth, Dept Stat & Epidemiol, Ahvaz, Iran		Hosseini, SA (corresponding author), Ahvaz Jundishapur Univ Med Sci, Nutr & Metab Dis Res Ctr, Ahvaz, Iran.; Hosseini, SA (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Allied Med Sci, Dept Nutr, Ahvaz, Iran.	seyedahmadhosseini@yahoo.com		namjoonia, masih/0000-0002-5317-6785	Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [NRC-9630]	This study was supported by the Vice Chancellor for research affairs of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (NRC-9630).	Abd El-Twab SM, 2016, CAN J PHYSIOL PHARM, V94, P651, DOI 10.1139/cjpp-2015-0503; Aguilar F, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1327; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; [Anonymous], 2000, J Neurotrauma, V17, P563; Barua M, 2001, J IMMUNOL, V167, P2275, DOI 10.4049/jimmunol.167.4.2275; Boelens PG, 2003, AM J CLIN NUTR, V77, P250, DOI 10.1093/ajcn/77.1.250; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Cruzat VF, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0061-8; Das J, 2012, TOXICOL APPL PHARM, V258, P296, DOI 10.1016/j.taap.2011.11.009; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Elmokadem EM, 2015, INT J PHARM SCI RES, V6, P3544, DOI 10.13040/IJPSR.0975-8232.6(8).3544-53; Engel JM, 2006, AMINO ACIDS, V30, P87, DOI 10.1007/s00726-005-0238-1; Furst P, 2000, NUTRITION, V16, P603, DOI 10.1016/S0899-9007(00)00321-X; Gad MA, 2012, N AM J MED SCI, V4, P129, DOI 10.4103/1947-2714.93889; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Kato H, 2000, BRAIN PATHOL, V10, P137; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lak S, 2015, ADV PHARM BULL, V5, P531, DOI 10.15171/apb.2015.072; Lin S, 2013, MOL NUTR FOOD RES, V57, P2155, DOI 10.1002/mnfr.201300150; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marcinkiewicz J, 1995, J LEUKOCYTE BIOL, V58, P667, DOI 10.1002/jlb.58.6.667; McGuire MF, 2019, PERSP TRANS CELL BIO, V4, P221, DOI 10.1016/B978-0-12-813832-8.00012-1; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; PAAUW JD, 1990, AM J CLIN NUTR, V52, P657, DOI 10.1093/ajcn/52.4.657; Pei P, 2019, FOOD CHEM TOXICOL, V125, P392, DOI 10.1016/j.fct.2019.01.015; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Slotwinski R, 2007, J PANCREAS, V8, P759; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Van Stijn MFM, 2015, INT J MOL SCI, V16, P12288, DOI 10.3390/ijms160612288; Vanitha MK, 2015, INT J PHARM RES HLTH, V3, P680; Vaughan LE, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1384-1; Vermeulen MAR, 2016, JPEN-PARENTER ENTER, V40, P264, DOI 10.1177/0148607114567199; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu GH, 2001, WORLD J GASTROENTERO, V7, P357; Wu JY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S1; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	60	0	0	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1475-2891		NUTR J	Nutr. J.	JUN 8	2021	20	1							53	10.1186/s12937-021-00712-6			9	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	SO7WJ	WOS:000659186100001	34103066	gold, Green Published			2022-02-07	
J	Fiems, CL; Bales, M; Ganley, S; Michel, D; Rice, K; Silverman, K				Fiems, Connie L.; Bales, Megan; Ganley, Stephanie; Michel, Dylan; Rice, Kallee; Silverman, Kayla			Reliability of a recumbent stepper submaximal exercise test after traumatic brain injury	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Submaximal exercise test; cardiorespiratory fitness; recumbent stepper; traumatic brain injury	TEST-RETEST RELIABILITY; PHYSICAL-ACTIVITY; VALIDITY; RECOMMENDATIONS; INDIVIDUALS; FITNESS; STROKE	Purpose: To determine the test-retest reliability of a total body recumbent stepper (TBRS) sub-maximal exercise test and to examine its relationship with other measures throughout the International Classification of Functioning that are indicative of overall health in individuals with traumatic brain injury (TBI). Methods: Twenty-three ambulatory individuals with severe, chronic (>6 mos) TBI completed a TBRS submaximal exercise test, 6-minute walk test (6MWT), and Mayo Portland Adaptability Inventory (MPAI-4) at initial testing. A repeat TBRS submaximal exercise test was conducted 4-7 days later. Estimated peak oxygen consumption (VO2) was calculated from the TBRS submaximal exercise test using the VO2 prediction equation. Average daily step count was collected by an activity monitor for the 4-7-day period between tests. Results: Test-retest reliability was good (ICC3,1 = 0.79, p < .001). The difference between the tests was 0.46 ml.kg(-1).min(-1) which was not statistically different. Neither the 6MWT distance nor gait speed are related to the TBRS-estimated peak VO2. The MPAI-4 total score and adjustment subscale each had a fair relationship with the TBRS-estimated peak VO2 (r = -0.41, p = .05; rs = -0.41, p = .05, respectively). Conclusion: These data suggest that the TBRS submaximal exercise test may be a reliable measure to estimate peak VO2 in ambulatory adults with chronic severe TBI.	[Fiems, Connie L.; Bales, Megan; Ganley, Stephanie; Michel, Dylan; Rice, Kallee; Silverman, Kayla] Univ Indianapolis, Krannert Sch Phys Therapy, 1400 East Hanna Ave, Indianapolis, IN 46227 USA		Fiems, CL (corresponding author), Univ Indianapolis, Krannert Sch Phys Therapy, 1400 East Hanna Ave, Indianapolis, IN 46227 USA.	Fiemsc@uindy.edu		FIEMS, CONNIE/0000-0003-4491-531X	University of Indianapolis In Query Grant [525017]	This work was supported by the University of Indianapolis In Query Grant [Index #525017].	Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Billinger SA, 2008, PHYS THER, V88, P1188, DOI 10.2522/ptj.20080072; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Billinger SA, 2012, MED SCI SPORT EXER, V44, P1539, DOI 10.1249/MSS.0b013e31824f5be4; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chong D., 2020, UMPHREDS NEUROLOGICA, V7, P641; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dalleck LC, 2011, PERCEPT MOTOR SKILL, V112, P183, DOI 10.2466/06.15.27.PMS.112.1.183-192; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Herda AA, 2014, PHYS THER, V94, P722, DOI 10.2522/ptj.20130307; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lezak, 2008, MANUAL MAYO PORTLAND; Mendelsohn ME, 2008, PHYS THER, V88, P747, DOI 10.2522/ptj.20070161; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Mudge S, 2008, CLIN REHABIL, V22, P871, DOI 10.1177/0269215508092822; Pilutti LA, 2015, J NEUROL PHYS THER, V39, P241, DOI 10.1097/NPT.0000000000000099; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Riebe D., 2018, ACSMS GUIDELINES EXE; Riebe D, 2015, MED SCI SPORT EXER, V47, P2473, DOI 10.1249/MSS.0000000000000664; Santa Clara Valley Medical Center, 2006, CTR OUTC MEAS BRAIN; Wilson DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172294	27	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2021.1934923		JUN 2021	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	SR3TL	WOS:000660965000001	34112064				2022-02-07	
J	Biscardi, M; Shafi, R; Cullen, N; Einstein, G; Colantonio, A				Biscardi, Melissa; Shafi, Reema; Cullen, Nora; Einstein, Gillian; Colantonio, Angela			Menopause, anti-Mullerian hormone and cognition in a cohort of women with persistent symptoms following TBI: a case for future research	BRAIN INJURY			English	Article						TBI; hormones; menopause; cognition; distress; long-term outcomes	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL STATUS RBANS; PITUITARY DYSFUNCTION; LONG-TERM; REPEATABLE BATTERY; REPRODUCTIVE-AGE; CLINICAL UTILITY; HYPOPITUITARISM; OUTCOMES; ASSOCIATION	Objectives: Primary: To explore anti-Mullerian Hormone (AMH) levels in community dwelling women following TBI. Secondary: To explore the relation of AMH to menstrual cycle, cognition, distress and symptoms of menopause. Setting: Large adult TBI outpatient clinic in Toronto Canada. Research design: Prospective study of 10 women with persistent symptoms who were one or more years post TBI. Methods: Consenting participants provided a serum sample for AMH levels, and completed the Menopause Rating Scale (MRS), Symptom Checklist-90 r (SCL-90 r), Repeatable Battery for the Assessment of Neurological Status (RBANS) and a health questionnaire. Main outcomes and results: This study found lower than expected levels of AMH in 50% of participants relative to age matched norms and 50% of participants experienced new onset of menstrual changes. Also notable were findings of lower-than-expected cognitive scores in women over 35 and reports of menopause-related symptoms across all ages groups. Conclusions: As our understanding of the role of AMH grows, examining changes in this novel biomarker in the long-term post-TBI is warranted. Future research should be sufficiently powered to expand on and validate the study's findings.	[Biscardi, Melissa; Shafi, Reema; Colantonio, Angela] Rehabil Sci Bldg,500 Univ Ave,Rm 260, Toronto, ON M5G 1V7, Canada; [Cullen, Nora] West Pk Healthcare Ctr, Toronto, ON, Canada; [Einstein, Gillian] Univ Toronto, Dept Psychol, Toronto, ON, Canada		Biscardi, M (corresponding author), Rehabil Sci Bldg,500 Univ Ave,Rm 260, Toronto, ON M5G 1V7, Canada.	melissa.biscardi@utoronto.ca		Einstein, Gillian/0000-0002-0770-5471; Shafi, Reema/0000-0002-1034-980X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CWG-126580]	This work was supported by the Canadian Institutes of Health Research [CWG-126580].	Aggarwal CC, 2016, OUTLIER ANAL, V2nd; Avis Nancy E, 2005, Am J Med, V118 Suppl 12B, P37, DOI 10.1016/j.amjmed.2005.09.057; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Colantonio A, 2011, J NEUROSCI NURS, V43, P141, DOI 10.1097/JNN.0b013e3182135b13; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Cuesta M, 2016, CLIN ENDOCRINOL, V84, P92, DOI 10.1111/cen.12874; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Derogatis LR., 1973, PSYCHOPHARMACOL BULL, V9; Dong YZ, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0271-4; Edwards H, 2019, MENOPAUSE, V26, P45, DOI 10.1097/GME.0000000000001171; Fourman LT, 2015, J CLIN ENDOCR METAB, V100, P812, DOI 10.1210/jc.2014-3344; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Glynn N, 2019, PITUITARY, V22, P249, DOI 10.1007/s11102-019-00938-y; Greendale GA, 2011, OBSTET GYN CLIN N AM, V38, P519, DOI 10.1016/j.ogc.2011.05.007; Harlow Sioban D, 2017, Womens Midlife Health, V3, DOI 10.1186/s40695-017-0021-y; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; Izzo G, 2016, INT J SURG, V28, pS103, DOI 10.1016/j.ijsu.2015.05.056; Jehan S, 2017, SLEEP SCI, V10, P11, DOI 10.5935/1984-0063.20170003; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kim Soo Ah, 2015, J Menopausal Med, V21, P19, DOI 10.6118/jmm.2015.21.1.19; Kline J, 2016, MATURITAS, V92, P115, DOI 10.1016/j.maturitas.2016.07.010; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Kruszynska A, 2017, MENOPAUSE REV, V16, P47, DOI 10.5114/pm.2017.68591; Ledger WL, 2010, J CLIN ENDOCR METAB, V95, P5144, DOI 10.1210/jc.2010-0701; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Moslehi N., 2018, MENOPAUSE, V1; Nakayama M., 2014, FERTILITY STERILITY, V102; Podfigurna A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100374; Potthoff P, 2000, Zentralbl Gynakol, V122, P280; Preuper HRS, 2011, SPINE, V36, P969, DOI 10.1097/BRS.0b013e3181e8af83; Public Health Agency of Canada, 2020, INJ REV 2020 ED SPOT; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rocca WA, 2014, MOL CELL ENDOCRINOL, V389, P7, DOI 10.1016/j.mce.2014.01.020; Rossler W, 2016, WORLD PSYCHIATRY, V15, P146, DOI 10.1002/wps.20319; Silva MSB, 2021, CELL MOL LIFE SCI, V78, P1, DOI 10.1007/s00018-020-03576-x; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Simoes-Pereira J, 2018, ENDOCRINE, V61, P144, DOI 10.1007/s12020-018-1555-y; Sliwinski JR, 2014, INTEGR MED INSIGHTS, V9, DOI 10.4137/IMI.S15682; Smith RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155079; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Sutton M., 2018, J WOMENS HLTH; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Weidner K, 2017, J PSYCHOSOM OBST GYN, V38, P170, DOI 10.1080/0167482X.2017.1291624; White AJ, 2016, FERTIL STERIL, V106, P723, DOI 10.1016/j.fertnstert.2016.05.015; Woods Nancy Fugate, 2016, Womens Midlife Health, V2, P6, DOI 10.1186/s40695-016-0019-x; Woods NF, 2005, AM J MED, V118, P1405, DOI 10.1016/j.amjmed.2005.10.008; Yang W., 2016, SCI REP-UK, V6; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	60	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					934	942		10.1080/02699052.2021.1929487		JUN 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000658196900001	34096423				2022-02-07	
J	Novack, TA; Zhang, Y; Kennedy, R; Rapport, LJ; Marwitz, J; Dreer, LE; Goldin, Y; Niemeier, JP; Bombardier, C; Bergquist, T; Watanabe, TK; Tefertiller, C; Brunner, R				Novack, Thomas A.; Zhang, Yue; Kennedy, Richard; Rapport, Lisa J.; Marwitz, Jennifer; Dreer, Laura E.; Goldin, Yelena; Niemeier, Janet P.; Bombardier, Charles; Bergquist, Thomas; Watanabe, Thomas K.; Tefertiller, Candice; Brunner, Robert			Driving patterns, confidence, and perception of abilities following moderate to severe traumatic brain injury: a TBI model system study	BRAIN INJURY			English	Article						Transportation; traumatic brain injury; social reintegration	COMMUNITY INTEGRATION; PREDICTORS; AWARENESS; BEHAVIOR; EXPOSURE; DEFICITS; RETURN	Objective: Describe driving patterns following moderate-to-severe traumatic brain injury (TBI). Participants: Adults (N = 438) with TBI that required inpatient acute rehabilitation who had resumed driving. Design: Cross-sectional, observational design. Setting: Eight TBI Model System sites. Main Measures: A driving survey was completed at phone follow-up. Results: Most respondents reported driving daily, although 41% reported driving less than before their injury. Driving patterns were primarily associated with employment, family income, sex, residence, and time since injury, but not injury severity. Confidence in driving was high for most participants and was associated with a perception that the TBI had not diminished driving ability. Lower confidence and perceived loss of ability were associated with altered driving patterns. Conclusion: Most people with moderate-to-severe TBI resume driving but perhaps not at pre-injury or normal levels compared to healthy drivers. Some driving situations are restricted. The relationship between low confidence/perceived loss of ability and driving patterns/restrictions suggests people with TBI are exhibiting some degree of caution consistent with those perceptions. Careful assessment of driving skills and monitoring during early stages of RTD is warranted, particularly for younger, male, and/or single drivers who express higher levels of confidence.	[Novack, Thomas A.; Niemeier, Janet P.; Brunner, Robert] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Zhang, Yue; Kennedy, Richard] Univ Alabama Birmingham, Integrat Ctr Aging Res, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Rapport, Lisa J.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Marwitz, Jennifer] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Goldin, Yelena] JFK Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ USA; [Bombardier, Charles] Univ Washington, Dept Phys Med & Rehabil, Seattle, WA 98195 USA; [Bergquist, Thomas] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Watanabe, Thomas K.] Elkins Pk Einstein Healthcare Network, Moss Rehabil, Dept Phys Med & Rehabil, Elkins Pk, PA USA; [Tefertiller, Candice] Craig Hosp, Res Dept, Englewood, CO USA		Novack, TA (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, Spain Rehabil Ctr 530, 1717 6th Ave S, Birmingham, AL 35249 USA.	tnovack@uabmc.edu	Bombardier, Charles H./AAZ-3260-2021; Kennedy, Richard/K-1525-2018	Bombardier, Charles H./0000-0003-4758-6283; Kennedy, Richard/0000-0003-4638-126X; Rapport, Lisa/0000-0001-8014-9523	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDIRLRR), Administration of Community Living [90DPTB0015, 90DPTB0006, 90DPTB0004, 90DPTB00070, 90DPTB0014, 90DPTB0008, 90DPTB0005, 90DPTB0012]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDIRLRR), Administration of Community Living [grant nos. 90DPTB0015, 90DPTB0006, 90DPTB0004, 90DPTB00070, 90DPTB0014, 90DPTB0008, 90DPTB0005, 90DPTB0012].	Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Enriquez J., 2019, SEAT BELT USE 2018 O; Fisk GD, 1998, BRAIN INJURY, V12, P683; George S, 2007, CLIN REHABIL, V21, P56, DOI 10.1177/0269215506071284; Gooden JR, 2019, NEUROPSYCHOL REHABIL, V29, P92, DOI 10.1080/09602011.2016.1261716; Gooden JR, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000212; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Highway Statistics 2018, 2019, DEP TRANSP FED HIGHW; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Mcguckin N., 2018, SUMMARY TRAVEL TREND; McKerral M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00144; Novack TA, 2021, ARCH PHYS MED REHAB, V102, P1568, DOI 10.1016/j.apmr.2021.02.006; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Ross P, 2016, DISABIL REHABIL, V38, P994, DOI 10.3109/09638288.2015.1074293; Santos A., 2011, SUMMARY TRAVEL TREND; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	24	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					863	870		10.1080/02699052.2021.1934730		JUN 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000658201900001	34096418				2022-02-07	
J	Thor, JA; Mazlan, M; Waran, V				Thor, Ju An; Mazlan, Mazlina; Waran, Vicknes			Employment status after traumatic brain injury and the effect of concomitant injuries on return to work	BRAIN INJURY			English	Article						Employment; traumatic brain injury; concomitant injury; return to work	MODERATE; REHABILITATION; POPULATION; STABILITY; DISCHARGE	Purpose: This study aims to describe the employment status and pattern among survivors of traumatic brain injury after motor vehicle accidents, and to explore the effects of demographic, injury variables and concomitant injuries on the employment status . Method: A retrospective analyses of 370 medical reports written for patients who sustained traumatic brain injury from motor vehicle accidents was conducted. To establish the employment pattern, the pre-injury employment history was compared to the latest employment status documented. Types and severity of concomitant injuries were rated according to Abbreviated Injury Scale criteria. All significant variables were further analyzed using logistic regression to explore predictors of employment. Results: Up to 87% of the patients sustained concomitant injuries, with more than two-thirds (72%) scoring <= 2 on the Abbreviated Injury Scale. One hundred and eighty-two patients (49.2%) successfully returned to work. Among those who returned to work, 34% returned to former employment with pre-injury job description. Severity of traumatic brain injury, length of acute hospital stay, ambulation status and cognitive status were found to be significant predictive factors for employment status post traumatic brain injury. Presence of concomitant extremity injuries was found to influence the employment pattern among traumatic brain injury survivors. Conclusion: The return to work rate was somewhat low and was not influenced by presence of concomitant injuries. .	[Thor, Ju An; Mazlan, Mazlina] Univ Malaya, Dept Rehabil Med, Fac Med, Kuala Lumpur, Malaysia; [Thor, Ju An] Hosp Queen Elizabeth, Dept Rehabil Med, Kota Kinabalu, Sabah, Malaysia; [Waran, Vicknes] Univ Malaya, Dept Surg, Div Neurosurg, Fac Med, Kuala Lumpur, Malaysia		Mazlan, M (corresponding author), Univ Malaya, Med Ctr, Dept Rehabil Med, 12th Floor, Kuala Lumpur 50603, Malaysia.	drmazlina@gmail.com	Mazlan, Mazlina/A-1015-2011; Mathaneswaran, Vickneswaran/E-5180-2010	Mazlan, Mazlina/0000-0002-4012-1873; 			Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; [Anonymous], MAL EMPL LEG, P53981; Association for the Advancement of Automotive Medicine, 1998, ABBREVIATED INJURY S; Autret K, 2015, ANN PHYS REHABIL MED, V58, P308, DOI 10.1016/j.rehab.2015.06.001; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Geneva: World Health Organization, 2002, PROJ MORT BURD DIS 2; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; ILO, ICSE93 ILO; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; McLean R, 2007, ANN ACAD MED SINGAP, V36, P18; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Yu JH, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/274326	41	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					949	956		10.1080/02699052.2021.1934729		JUN 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000658195400001	34096426				2022-02-07	
J	Guo, GN; Gou, YJ; Jiang, XY; Wang, SH; Wang, RL; Liang, CQ; Yang, G; Wang, TG; Yu, AY; Zhu, GY				Guo, Guoning; Gou, Yajun; Jiang, Xingyu; Wang, Shuhong; Wang, Ruilie; Liang, Changqiang; Yang, Guang; Wang, Tinggang; Yu, Anyong; Zhu, Guoyan			Long Non-coding RNAs in Traumatic Brain Injury Accelerated Fracture Healing	FRONTIERS IN SURGERY			English	Article						traumatic brain injury; fracture; long non-coding RNAs; immune cells; endothelia cells	STEM-CELLS; R-PACKAGE; BONE; ANGIOGENESIS; OSTEOGENESIS; LANDSCAPES; EXPRESSION; REGULATORS; REPAIR; ROLES	It is commonly observed that patients with bone fracture concomitant with traumatic brain injury (TBI) had significantly increased fracture healing, but the underlying mechanisms were not fully revealed. Long non-coding RNAs (lncRNAs) are known to play complicated roles in bone homeostasis, but their role in TBI accelerated fracture was rarely reported. The present study was designed to determine the role of lncRNAs in TBI accelerated fracture via transcriptome sequencing and further bioinformatics analyses. Blood samples from three fracture-only patients, three fracture concomitant with TBI patients, and three healthy controls were harvested and were subsequently subjected to transcriptome lncRNA sequencing. Differentially expressed genes were identified, and pathway enrichment was performed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. High-dimensional data visualization by self-organizing map (SOM) machine learning was applied to further interpret the data. An xCell method was then used to predict cellular behavior in all samples based on gene expression profiles, and an lncRNA-cell interaction network was generated. A total of 874 differentially expressed genes were identified, of which about 26% were lncRNAs. Those identified lncRNAs were mainly enriched on TBI-related and damage repair-related pathways. SOM analyses revealed that those differentially expressed lncRNAs could be divided into three major module implications and were mainly enriched on transcriptional regulation and immune-related signal pathways, which promote us to further explore cellular behaviors based on differentially expressed lncRNAs. We have predicted that basophils, CD8+ T effector memory cells, B cells, and naive B cells were significantly downregulated, while microvascular endothelial cells were predicted to be significantly upregulated in the Fr/TBI group, was the lowest and highest, respectively. ENSG00000278905, ENSG00000240980, ENSG00000255670, and ENSG00000196634 were the most differentially expressed lncRNAs related to all changes of cellular behavior. The present study has revealed for the first time that several critical lncRNAs may participate in TBI accelerated fracture potentially via regulating cellular behaviors of basophils, cytotoxic T cells, B cells, and endothelial cells.	[Guo, Guoning; Jiang, Xingyu; Wang, Shuhong; Wang, Ruilie; Liang, Changqiang; Yang, Guang; Wang, Tinggang; Yu, Anyong] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Guizhou, Peoples R China; [Gou, Yajun] Shapingba Dist Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zhu, Guoyan] Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Dept Hlth Management, Chongqing, Peoples R China		Wang, TG; Yu, AY (corresponding author), Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Guizhou, Peoples R China.; Zhu, GY (corresponding author), Third Mil Med Univ, Army Med Univ, Xinqiao Hosp, Dept Hlth Management, Chongqing, Peoples R China.	huyangshu2007@126.com; 2360298076@qq.com; gyone@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471862]; Science and Technology Bureau of Zunyi [HZ-2020-259]	This study was funded in part by the National Natural Science Foundation of China, grant number #81471862, and by the Science and Technology Bureau of Zunyi, grant number #HZ-2020-259.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; ANDREW JG, 1994, ACTA ORTHOP SCAND, V65, P462, DOI 10.3109/17453679408995493; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bernhardsson M, 2019, J ORTHOP RES, V37, P805, DOI 10.1002/jor.24246; Chen W, 2017, LANCET GLOB HEALTH, V5, pE807, DOI 10.1016/S2214-109X(17)30222-X; Chung R, 2006, J LEUKOCYTE BIOL, V80, P1272, DOI 10.1189/jlb.0606365; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cottrell J, 2010, PHARMACEUTICALS, V3, P1668, DOI 10.3390/ph3051668; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Goerke SM, 2015, MICROVASC RES, V98, P40, DOI 10.1016/j.mvr.2014.12.001; GOKTURK E, 1995, ACTA ORTHOP SCAND, V66, P473; Hadjiargyrou M, 2014, J BONE MINER RES, V29, P2307, DOI 10.1002/jbmr.2373; Hassan MQ, 2015, BONE, V81, P746, DOI 10.1016/j.bone.2015.05.026; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Li D, 2019, J CELL PHYSIOL, V234, P21316, DOI 10.1002/jcp.28736; Liu YB, 2019, J CELL MOL MED, V23, P3855, DOI 10.1111/jcmm.14229; Liu ZC, 2019, EUR REV MED PHARMACO, V23, P60, DOI 10.26355/eurrev_201908_18629; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Loeffler-Wirth H, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03806-w; Loffler-Wirth H, 2015, BIOINFORMATICS, V31, P3225, DOI 10.1093/bioinformatics/btv342; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Nam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040044; Ni S, 2021, J CELL BIOCHEM, V122, P1003, DOI 10.1002/jcb.29637; Qiu M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.203; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Salhotra A, 2020, NAT REV MOL CELL BIO, V21, P696, DOI 10.1038/s41580-020-00279-w; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Sikora M, 2020, MOL THER-NUCL ACIDS, V21, P792, DOI 10.1016/j.omtn.2020.07.017; Song W, 2020, DNA CELL BIOL, V39, P926, DOI 10.1089/dna.2020.5391; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Weitzmann MN, 2017, TOXICOL PATHOL, V45, P911, DOI 10.1177/0192623317735316; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Xu WW, 2020, EUR REV MED PHARMACO, V24, P4070, DOI 10.26355/eurrev_202004_20983; Yang SF, 2015, APMIS, V123, P975, DOI 10.1111/apm.12439; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang JL, 2018, INT J MOL MED, V41, P213, DOI 10.3892/ijmm.2017.3215; Zhao Xiao-gang, 2007, Chin J Traumatol, V10, P376; Zhou P, 2019, J CELL PHYSIOL, V234, P13799, DOI 10.1002/jcp.28060	41	0	0	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	JUN 4	2021	8								663377	10.3389/fsurg.2021.663377			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ST8IJ	WOS:000662681200001	34150839	Green Published, gold			2022-02-07	
J	Spikman, JM; van der Horn, HJ; Scheenen, ME; de Koning, ME; Savas, M; Langerak, T; van Rossum, EFC; van der Naalt, J				Spikman, Jacoba M.; van der Horn, Harm J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Savas, Mesut; Langerak, Thomas; van Rossum, Elisabeth F. C.; van der Naalt, Joukje			Coping with stress before and after mild traumatic brain injury: a pilot hair cortisol study	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); pre-morbid characteristics; hair cortisol; coping style; post-traumatic stress	HOSPITAL ANXIETY; DEPRESSION; COMPLAINTS; INDIVIDUALS; PREDICTORS; STABILITY; BIOMARKER; SCALE; SYMPTOMS; DISORDER	Background: Cortisol is a crucial hormone for adaptation to challenging and stressful situations. Hair cortisol measurement is used to determine chronic stress; the growth rate of hair allows to determine averaged cortisol levels for a longer period. Objective: Pre- and post-injury measures of hair cortisol were compared in patients with mild traumatic brain injury (mTBI), and related to their coping styles. Methods: For 46 patients with mTBI, 3 cm scalp hair samples were collected 4-6 weeks post-injury, resulting in two 1 cm segments, pre- and post-injury. Hair samples were also collected for 11 healthy controls. Hair cortisol was quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Complaints, anxiety, depression and coping style were measured two weeks post-injury and long term (six-twelve months), added with measures for post-traumatic stress and functional outcome. Results: There were no differences between patients' pre- and post-injury cortisol levels, nor between cortisol levels of patients and controls. However, pre- and post-injury cortisol levels of patients were negatively correlated with both passive and an avoidant coping style. Conclusions: Our findings suggest that mTBI has no separate impact on chronic long-term cortisol levels, possibility indicating that variability in cortisol levels reflects individuals' premorbid characteristics determining coping with stress in general.	[Spikman, Jacoba M.; van der Horn, Harm J.; Scheenen, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1,Poortweg 4,Postbus 30-001 AB51, NL-9700 RB Groningen, Netherlands; [de Koning, Myrthe E.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Savas, Mesut; Langerak, Thomas; van Rossum, Elisabeth F. C.] Univ Med Ctr Rotterdam, Dept Internal Med, Div Endocrinol, Erasmus MC, Rotterdam, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1,Poortweg 4,Postbus 30-001 AB51, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418	Nederlandse Hersenstichting (Dutch Brain Foundation) [PS2012-06]	This work is supported by the Nederlandse Hersenstichting (Dutch Brain Foundation) under Grant number PS2012-06.	Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Colledge F, 2017, NEUROPSYCHOBIOLOGY, V75, P12, DOI 10.1159/000477966; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2012.654479, 10.3109/10253890.2011.619239]; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Gerritsen L, 2019, PSYCHONEUROENDOCRINO, V101, P246, DOI 10.1016/j.psyneuen.2018.11.019; Geyer S, 2015, SOC SCI MED, V135, P92, DOI 10.1016/j.socscimed.2015.04.027; Gregorio GW, 2016, J NEUROTRAUM, V33, P696, DOI 10.1089/neu.2015.3900; Joseph S, 2000, J TRAUMA STRESS, V13, P101, DOI 10.1023/A:1007777032063; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; LeBeau MA, 2011, FORENSIC SCI INT, V210, P110, DOI 10.1016/j.forsciint.2011.02.015; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Savas M, 2019, NEUROENDOCRINOLOGY, V109, P171, DOI 10.1159/000498886; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Sorbo A, 2020, ACTA NEUROL SCAND, V141, P342, DOI 10.1111/ane.13212; Stalder T, 2017, PSYCHONEUROENDOCRINO, V77, P261, DOI 10.1016/j.psyneuen.2016.12.017; Stalder T, 2010, BIOL PSYCHOL, V85, P357, DOI 10.1016/j.biopsycho.2010.08.005; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steudte S, 2011, PSYCHIAT RES, V186, P310, DOI 10.1016/j.psychres.2010.09.002; Steudte-Schmiedgen S, 2017, J PSYCHIATR RES, V84, P184, DOI 10.1016/j.jpsychires.2016.09.024; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Tafet GE, 2005, COGN AFFECT BEHAV NE, V5, P37, DOI 10.3758/CABN.5.1.37; TEASDALE G, 1974, LANCET, V2, P81; Tellegen B., 1988, UTRECHTSE COPING LIJ; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Van Der Naalt, 2016, J NEUROTRAUM; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Wester VL, 2015, EUR J ENDOCRINOL, V173, pM1, DOI 10.1530/EJE-15-0313; Wester VL, 2014, CURR OPIN ENDOCRINOL, V21, P306, DOI 10.1097/MED.0000000000000077; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2021	35	8					871	879		10.1080/02699052.2021.1901143		JUN 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TS9JB	WOS:000658215100001	34096416	hybrid			2022-02-07	
J	Travis, E; Thornton, C; Scott-Bell, A				Travis, Eleanor; Thornton, Claire; Scott-Bell, Andrea			Concussion Reporting and Safeguarding Policy Development in British American Football: An Essential Agenda	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						American Football; British Universities and Colleges Sport; player welfare; medical provision; British American Football	HIGH-SCHOOL; SPORTS-MEDICINE; EPIDEMIOLOGY; INJURIES; PAIN	The objective of this study was to examine concussion reporting and safeguarding policy in British American Football (BAF). Data were collected via an online survey tool. The data presented are part of a broader study that examined injury profiles, concussion reporting behaviors, and medical provision in BAF. Concussion-like symptoms were found in over half (58.8%) of the participants. Of those, 36.4% reported they had previously been formally diagnosed with a concussion while playing BAF. Just under half of the participants (44.7%) had suspected they had had a concussion, although it was not formally diagnosed, and 23.5% of the participants had previously hidden concussion symptoms. Fifty-eight percent of the teams reported they did not have a regular game-day medic, with a range of hired medical personnel who attended the games. Prominent barriers to hiring a medic included budget, institutional support shortfall, and lack of medic reliability and game knowledge. BAF is a developing sport with a clear vision for growth of participation. Yet, the current concussion and medical provision policies do not address the sport's welfare needs. Through discussion of these policies in the context of this study's findings, we highlight vital areas of concern in policy and practice that the British American Football Association needs to address in their medical and concussion policies.	[Travis, Eleanor] Hartpury Univ, Dept HE Sport, Gloucester, England; [Thornton, Claire; Scott-Bell, Andrea] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England		Travis, E (corresponding author), Hartpury Univ, Dept HE Sport, Gloucester, England.	eleanor.travis@hartpury.ac.uk		Scott-Bell, Andrea/0000-0002-1022-9023; Thornton, Claire/0000-0002-5032-1836	 [HRKE010521]	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors. Funding for publication was granted by the lead authors institution (No. HRKE010521).	Atkinson Michael, 2010, SEXUAL SPORTS RHETOR, P15; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; BAFA, 2020, BAFAS 10 YEAR VIS; Battista J., 2020, NFL REVEALS 2019 INJ; Bayram JM, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120960206; BUCS, 2021, AM FOOTB; Channon A, 2021, INT REV SOCIOL SPORT, V56, P578, DOI 10.1177/1012690220927338; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; Crawford R., 2016, LONG HIST AM FOOTBAL; Dillon R., 2011, NEWCASTLE HERAL 0329, P56; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; Edwards T, 2018, SPORTS MED, V48, P45, DOI 10.1007/s40279-017-0783-2; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; Follmer B, 2020, PHYSICIAN SPORTSMED, V48, P417, DOI 10.1080/00913847.2020.1729668; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kaplan Y, 2013, CLIN J SPORT MED, V23, P39, DOI 10.1097/JSM.0b013e3182694870; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Maguire JA, 2011, SPORT SOC, V14, P950, DOI 10.1080/17430437.2011.603551; Malcolm D, 2002, SOCIOL SPORT J, V19, P149, DOI 10.1123/ssj.19.2.149; Malcolm D., 2019, CONCUSSION CRISIS SP, DOI [10.4324/9780429028175-2, DOI 10.4324/9780429028175-2]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDaniel M., 2019, BU WELL, V4, P7; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; NCAA, 2021, CONC SAF PROT MAN; Needham A., FOOTBALL UK; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Pielke R., 2020, DECLINE FOOTBALL IS; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Statista, 2021, NFL AV TOT REG SEAS; Statista, 2021, NUMB PART TACKL FOOT; The National Federation of State High School Associations, 2019, HIGH SCH PART SURV A; Ward PA, 2018, J STRENGTH COND RES, V32, P2072, DOI 10.1519/JSC.0000000000002294; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	41	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUN 4	2021	3								671876	10.3389/fspor.2021.671876			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SV4BD	WOS:000663764800001	34151261	Green Accepted, Green Published, gold			2022-02-07	
J	Liang, F; Kang, N; Li, PP; Liu, XH; Li, G; Yang, J				Liang, Fang; Kang, Nan; Li, Pinpin; Liu, Xuehua; Li, Ge; Yang, Jing			Effect of Hyperbaric Oxygen Therapy on Polarization Phenotype of Rat Microglia After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						hyperbaric oxygen; traumatic brain injury; microglia; polarization phenotype; neurological function	IMPAIRMENT; EXPRESSION; ISCHEMIA; SURVIVAL; IMPACT; CELLS	Background: The neurological defect caused by secondary damage following traumatic brain injury (TBI) is considered critical for the management of TBI. Microglia (MG) are a resident brain macrophage that could differentiate into M1 type or M2 type in response to injury and repair. It is known that the MG transition from M1 phenotype to anti-inflammatory M2 phenotype might reduce secondary injury of TBI. So, a TBI animal model was established and we compared biomarkers of M1 and M2MG between the controls and experimental animals receiving hyperbaric oxygen therapy (HBOT). This study aimed to explore whether HBOT was an effective method to improve neural functional recovery via promoting the polarization of MG into M2 after TBI. Methods: The rats were randomly divided into four groups: SH (Sham-operated), SH + HBO (hyperbaric oxygen), TBI, and TBI + HBO. Each group included 42 rats, and each of these were divided into the following groups: 1, 6, 12, 24, 72 h, 7, and 14 days. The expression of M1 biomarker inducible nitric oxide synthase (iNOS), M2 biomarker arginase 1 (Arg1), associated cytokine tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta 1 (TGF-beta 1) was evaluated after the observation time. Results: TBI significantly increased the expression levels of M1 marker iNOS and M2 markers Arg1 at different time points. The increased expression of iNOS was suppressed, while the expression level of Arg1 was enhanced by HBOT. Moreover, HBOT suppressed the pro-inflammatory TNF-alpha secreted by M1, and promoting the anti-inflammatory TGF-1 beta. Conclusions: In the present study, HBOT showed the effects on shift of M1 toward M2 phenotype with increased expression of M2 biomarkers and decreased expression of M1 biomarkers in the early stage after TBI.	[Liang, Fang; Li, Pinpin; Liu, Xuehua; Li, Ge; Yang, Jing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China; [Kang, Nan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Orthoped, Beijing, Peoples R China		Yang, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China.	JYang1068@163.com					Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bastos GN, 2008, NEUROSCIENCE, V155, P454, DOI 10.1016/j.neuroscience.2008.06.020; Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Buras JA, 2007, NEUROL RES, V29, P127, DOI 10.1179/016164107X174147; Caso JR, 2020, PROG NEURO-PSYCHOPH, V96, DOI 10.1016/j.pnpbp.2019.109727; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Farag E, 2017, J CLIN NEUROSCI, V46, P1, DOI 10.1016/j.jocn.2017.08.055; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goretsky T, 2012, AM J PATHOL, V181, P1306, DOI 10.1016/j.ajpath.2012.06.016; Hadanny A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023387; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Lanfranco MF, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2608; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Wada K, 2000, ACT NEUR S, V76, P285; Wang M, 2019, CNS NEUROSCI THER, V25, P1126, DOI 10.1111/cns.13208; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Zingler P, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0405-8	35	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 3	2021	12								640816	10.3389/fneur.2021.640816			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ST1IB	WOS:000662202800001	34149591	gold, Green Published			2022-02-07	
J	Olah, E; Poto, L; Rumbus, Z; Pakai, E; Romanovsky, AA; Hegyi, P; Garami, A				Olah, Emoke; Poto, Laszlo; Rumbus, Zoltan; Pakai, Eszter; Romanovsky, Andrej A.; Hegyi, Peter; Garami, Andras			POLAR Study Revisited: Therapeutic Hypothermia in Severe Brain Trauma Should Not Be Abandoned	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						cooling index; induced hypothermia; meta-analysis; mortality; thermoregulation; traumatic brain injury	MILD HYPOTHERMIA; PROPHYLACTIC HYPOTHERMIA; FOLLOW-UP; INJURY; PUBLICATION; BIAS	The benefits of therapeutic hypothermia (TH) in severe traumatic brain injury (sTBI) have been long debated. In 2018, the POLAR study, a high-quality international trial, appeared to end the debate by showing that TH did not improve mortality in sTBI. However, the POLAR-based recommendation to abandon TH was challenged by different investigators. In our recent meta-analysis, we introduced the cooling index (COIN) to assess the extent of cooling and showed that TH is beneficial in sTBI, but only when the COIN is sufficiently high. In the present study, we calculated the COIN for the POLAR study and ran a new meta-analysis, which included the POLAR data and accounted for the cooling extent. The POLAR study targeted a high cooling extent (COIN of 276 degrees C x h; calculated for 72 h), but the achieved cooling was much lower (COIN of 193 degrees C x h)-because of deviations from the protocol. When the POLAR data were included in the COIN-based meta-analysis, TH had an overall effect of reducing death (odds rate of 0.686; p = 0.007). Among the subgroups with different COIN levels, the only significantly decreased odds rate (i.e., beneficial effect of TH) was observed in the subgroup with high COIN (0.470; p = 0.013). We conclude that, because of deviations from the targeted cooling protocol, the overall cooling extent was not sufficiently high in the POLAR study, thus masking the beneficial effects of TH. The current analysis shows that TH is beneficial in sTBI, but only when the COIN is high. Abandoning the use of TH in sTBI may be premature.	[Olah, Emoke; Rumbus, Zoltan; Pakai, Eszter; Hegyi, Peter; Garami, Andras] Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary; [Poto, Laszlo] Univ Pecs, Med Sch, Inst Bioanal, Pecs, Hungary; [Romanovsky, Andrej A.] Univ Arizona, Sch Mol Sci, Tempe, AZ USA		Garami, A (corresponding author), Univ Pecs, Med Sch, Inst Translat Med, Dept Thermophysiol, 12 Szigeti Str, H-7624 Pecs, Hungary.	andras.garami@aok.pte.hu	Garami, Andras/AAF-8588-2020	Garami, Andras/0000-0003-2493-0571; Romanovsky, Andrej/0000-0003-3772-8575	Hungarian National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [FK 124483]; New National Excellence Program of the Hungarian Ministry for Innovation and Technology [UNKP-20-3-II-PTE-877, UNKP-20-5-PTE736]; Janos Bolyai Research Scholarship of the Hungarian Academy of SciencesHungarian Academy of Sciences	This work was supported by the Hungarian National Research, Development and Innovation Office (grant FK 124483), the New National Excellence Program of the Hungarian Ministry for Innovation and Technology (grants UNKP-20-3-II-PTE-877 and UNKP-20-5-PTE736), and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; Bouzat P, 2019, ANAESTH CRIT CARE PA, V38, P95, DOI 10.1016/j.accpm.2019.01.008; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chin SM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00344; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engrand N, 2019, JAMA-J AM MED ASSOC, V321, P1725, DOI 10.1001/jama.2019.1534; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moore L, 2020, J NEUROTRAUM, V37, P2605, DOI 10.1089/neu.2020.7044; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smrcka M, 2005, ACT NEUR S, V95, P273; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	27	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7509		JUN 2021	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SM8LY	WOS:000657851500001	34002636	hybrid, Green Accepted			2022-02-07	
J	Wang, HL; Chen, JW; Yang, SH; Lo, YC; Pan, HC; Liang, YW; Wang, CF; Yang, Y; Kuo, YT; Lin, YC; Chou, CY; Lin, SH; Chen, YY				Wang, Han-Lin; Chen, Jia-Wei; Yang, Shih-Hung; Lo, Yu-Chun; Pan, Han-Chi; Liang, Yao-Wen; Wang, Ching-Fu; Yang, Yi; Kuo, Yun-Ting; Lin, Yi-Chen; Chou, Chin-Yu; Lin, Sheng-Huang; Chen, You-Yin			Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						multimodal optical imaging system; AUDA; neovascularization; cranial window; ischemic stroke; penumbra	SOLUBLE EPOXIDE HYDROLASE; CEREBRAL-ARTERY OCCLUSION; WAVELENGTH LASER SPECKLE; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; BLOOD-FLOW; EPOXYEICOSATRIENOIC ACIDS; NEUROPROTECTIVE AGENT; GLYCINE ANTAGONIST; METABOLIC-RATE	Administration of 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) has been demonstrated to alleviate infarction following ischemic stroke. Reportedly, the main effect of AUDA is exerting anti-inflammation and neovascularization via the inhibition of soluble epoxide hydrolase. However, the major contribution of this anti-inflammation and neovascularization effect in the acute phase of stroke is not completely elucidated. To investigate the neuroprotective effects of AUDA in acute ischemic stroke, we combined laser speckle contrast imaging and optical intrinsic signal imaging techniques with the implantation of a lab-designed cranial window. Forepaw stimulation was applied to assess the functional changes via measuring cerebral metabolic rate of oxygen (CMRO2) that accompany neural activity. The rats that received AUDA in the acute phase of photothrombotic ischemia stroke showed a 30.5 +/- 8.1% reduction in the ischemic core, 42.3 +/- 15.1% reduction in the ischemic penumbra (p < 0.05), and 42.1 +/- 4.6% increase of CMRO2 in response to forepaw stimulation at post-stroke day 1 (p < 0.05) compared with the control group (N = 10 for each group). Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 +/- 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% +/- 16.4% increase of astrocytes (p < 0.01), 30.0 +/- 10.9% increase of neurons (p < 0.01), and 65.5 +/- 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). These results suggested that AUDA affects the anti-inflammation at the beginning of ischemic injury and restores neuronal metabolic rate of O-2 and tissue viability. The neovascularization triggered by AUDA restored CBF and may contribute to ischemic infarction reduction at post-stroke day 3. Moreover, for long-term neuroprotection, astrocytes in the penumbra region may play an important role in protecting neurons from apoptotic injury.	[Wang, Han-Lin; Chen, Jia-Wei; Liang, Yao-Wen; Wang, Ching-Fu; Yang, Yi; Kuo, Yun-Ting; Lin, Yi-Chen; Chou, Chin-Yu; Chen, You-Yin] Natl Yang Ming Chiao Tung Univ, Dept Biomed Engn, Taipei, Taiwan; [Yang, Shih-Hung] Natl Cheng Kung Univ, Dept Mech Engn, Tainan, Taiwan; [Lo, Yu-Chun; Chen, You-Yin] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Pan, Han-Chi] Natl Lab Anim Ctr, Taipei, Taiwan; [Lin, Sheng-Huang] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurol, Hualien, Taiwan; [Lin, Sheng-Huang] Tzu Chi Univ, Sch Med, Dept Neurol, Hualien, Taiwan		Chen, YY (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Biomed Engn, Taipei, Taiwan.; Chen, YY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.; Lin, SH (corresponding author), Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurol, Hualien, Taiwan.; Lin, SH (corresponding author), Tzu Chi Univ, Sch Med, Dept Neurol, Hualien, Taiwan.	shlin355@gmail.com; irradiance@so-net.net.tw		Yang, Shih-Hung/0000-0001-5893-6299	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 110-2321-B-010-006, 109-2221-E-010-004-MY2, 109-2314-B-303-016, 109-2636-E-006-010, 108-2321-B-010-008-MY2]	This work is financially supported by Ministry of Science and Technology of Taiwan under Contract numbers of MOST 110-2321-B-010-006, 109-2221-E-010-004-MY2, 109-2314-B-303-016, and 109-2636-E-006-010 (Young Scholar Fellowship Program), and 108-2321-B-010-008-MY2.	Alexandrova M, 2004, J CLIN NEUROSCI, V11, P501, DOI 10.1016/j.jocn.2003.10.015; Ambrus R, 2016, EUR SURG RES, V56, P87, DOI 10.1159/000442790; Autio J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024056; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Bortel A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00832; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Chang LH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18558-6; Chen XJ, 2016, MOL NEUROBIOL, V53, P1565, DOI 10.1007/s12035-015-9118-1; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; Chong SP, 2015, BIOMED OPT EXPRESS, V6, P3941, DOI 10.1364/BOE.6.003941; Clark TA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39092-7; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Culver JP, 2003, J CEREBR BLOOD F MET, V23, P911, DOI 10.1097/01.WCB.0000076703.71231.BB; Dai N, 2019, EXP THER MED, V17, P3580, DOI 10.3892/etm.2019.7396; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/S0304-3940(96)13116-5; Dehghani H, 2009, PHILOS T R SOC A, V367, P3073, DOI 10.1098/rsta.2009.0090; Dorand RD., 2014, INTRAVITAL, DOI [10.4161/intv.29728, DOI 10.4161/INTV.29728]; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Du CW, 2011, REV NEUROSCIENCE, V22, P695, DOI 10.1515/RNS.2011.053; Fordsmann JC, 2019, GLIA, V67, P37, DOI 10.1002/glia.23506; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Geng HX, 2017, NEUROCHEM RES, V42, P2841, DOI 10.1007/s11064-017-2297-6; Ghijsen M, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.3.036013; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Ginsberg MD, 2013, LANCET NEUROL, V12, P1049, DOI 10.1016/S1474-4422(13)70223-0; Goldey GJ, 2014, NAT PROTOC, V9, P2515, DOI 10.1038/nprot.2014.165; GRAY CW, 1992, BRAIN RES, V574, P257, DOI 10.1016/0006-8993(92)90825-T; Gulke E, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774254; He HY, 2017, NEUROSCI LETT, V643, P45, DOI 10.1016/j.neulet.2017.02.009; Heo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27818; Hung TH, 2017, ONCOTARGET, V8, P103236, DOI 10.18632/oncotarget.21139; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Imig JD, 2006, CARDIOVASC DRUG REV, V24, P169, DOI 10.1111/j.1527-3466.2006.00169.x; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jeon MT, 2020, BRIT J PHARMACOL, V177, P668, DOI 10.1111/bph.14882; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; KAWAMURA S, 1990, INT J MICROCIRC, V9, P369; Kazmi SMS, 2015, J CEREBR BLOOD F MET, V35, P1076, DOI 10.1038/jcbfm.2015.84; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Kirkpatrick SJ, 2008, OPT LETT, V33, P2886, DOI 10.1364/OL.33.002886; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Li H, 2014, OPT EXPRESS, V22, P21079, DOI 10.1364/OE.22.021079; Li SJ, 2012, MOLECULES, V17, P13403, DOI 10.3390/molecules171113403; Li YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113658; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Liu Y, 2016, J MOL NEUROSCI, V58, P254, DOI 10.1007/s12031-015-0670-y; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lu HDD, 2017, NEUROIMAGE, V148, P160, DOI 10.1016/j.neuroimage.2017.01.006; MARAGOS PA, 1986, IEEE T ACOUST SPEECH, V34, P1228, DOI 10.1109/TASSP.1986.1164959; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morone KA, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.031220; Nam JH, 2015, BRAIN, V138, P3610, DOI 10.1093/brain/awv297; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Nishiyama N, 2014, J NEUROPHYSIOL, V111, P208, DOI 10.1152/jn.00588.2013; Pan HC, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.035003; Park K, 2015, QUANT IMAGING MED SU, V5, P97, DOI 10.3978/j.issn.2223-4292.2014.11.31; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Poyhonen S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00486; Qin J, 2012, BIOMED OPT EXPRESS, V3, P455, DOI 10.1364/BOE.3.000455; Qu YY, 2015, NEUROCHEM RES, V40, P1, DOI 10.1007/s11064-014-1456-2; Razmara A, 2017, SPR SER TRANSL STROK, P133, DOI 10.1007/978-3-319-45345-3_5; Reif R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052041; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; Sato T, 2017, ADV BIOMED ENG, V6, P68, DOI 10.14326/abe.6.68; Schellinger PD, 2012, EXPERT REV NEUROTHER, V12, P169, DOI [10.1586/ern.11.198, 10.1586/ERN.11.198]; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Sigal I, 2014, BIOMED OPT EXPRESS, V5, P123, DOI 10.1364/BOE.5.000123; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Takuwa H, 2014, J NEUROSCI METH, V237, P9, DOI 10.1016/j.jneumeth.2014.08.022; Terashvili M, 2008, J PHARMACOL EXP THER, V326, P614, DOI 10.1124/jpet.108.136739; Tromberg B.J., 2019, HIGH SPEED QUANTITAT, DOI [10.1101/786244, DOI 10.1101/786244]; Tu RR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23504-1; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WAHL M, 1970, PFLUG ARCH EUR J PHY, V316, P152, DOI 10.1007/BF00586483; Wang JKT, 2006, P NATL ACAD SCI USA, V103, P10461, DOI 10.1073/pnas.0600930103; Wang J, 2013, OPT LETT, V38, P3690, DOI 10.1364/OL.38.003690; White SM, 2011, MICROVASC RES, V82, P92, DOI 10.1016/j.mvr.2011.03.006; Whiteley WN, 2016, LANCET NEUROL, V15, P925, DOI [10.1016/S1474-4422(16)30076-X, 10.1016/s1474-4422(16)30076-X]; Winchester LW, 2004, P ANN INT IEEE EMBS, V26, P1252; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Wu CH, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1005-4; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Yeh CF, 2019, NEUROPSYCH DIS TREAT, V15, P2927, DOI 10.2147/NDT.S210403; Yeh CF, 2019, NEUROREPORT, V30, P567, DOI 10.1097/WNR.0000000000001248; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Yuan L, 2016, NEUROPATH APPL NEURO, V42, P607, DOI 10.1111/nan.12291; Zapeda A, 2004, J NEUROSCI METH, V136, P1, DOI 10.1016/j.jneumeth.2004.02.025; Zhang L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5026984; Zhang PY, 2017, BIOMED PHARMACOTHER, V90, P69, DOI 10.1016/j.biopha.2017.03.039; Zhang PY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-43; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhang ZJ, 2012, BRAIN RES BULL, V87, P193, DOI 10.1016/j.brainresbull.2011.11.002; Zuluaga-Ramirez V, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0021-y	110	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 3	2021	15								655305	10.3389/fncel.2021.655305			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ST1JG	WOS:000662205900001	34149359	gold, Green Published			2022-02-07	
J	Aravich, D; Troxell, L				Aravich, Dana; Troxell, Laura			Clinical Practice Guidelines for Occupational Therapists in the Evaluation and Treatment of Oculomotor Impairment Following Traumatic Brain Injury	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Traumatic brain injury (TBI); Mild traumatic brain injury (mTBI); Oculomotor; Oculomotor impairment; Oculomotor dysfunction; Vision exercise; Occupational therapy; Occupational therapist; Optometry; Optometrist; Vision; Low vision; Interdisciplinary	VISUAL DYSFUNCTION; BINOCULAR DIPLOPIA; REHABILITATION; VISION; PLASTICITY	Purpose of review Currently, a lack of guidelines exists regarding best practices for occupational therapists (OTs) in the treatment and evaluation of oculomotor dysfunction following traumatic brain injury (TBI). Furthermore, individuals with TBI would benefit significantly from collaboration between OTs and optometrists during inpatient rehab. Recent findings Although few articles examine interdisciplinary models of inpatient rehab care that include optometry, a recent pilot study is explored. Emerging evidence from the field of optometry supports the use of restorative approaches for oculomotor impairment in mild TBI; however, cases with moderate to severe TBI are not addressed. We describe an interdisciplinary approach involving collaboration between optometry and occupational therapy, yielding a comprehensive model to effectively evaluate and treat oculomotor impairments in those with TBI and facilitate improved performance in daily activities. We also provide guidelines useful for OTs working in settings where collaboration with optometry is not feasible.	[Aravich, Dana; Troxell, Laura] Univ Pittsburgh Med Ctr UPMC, Ctr Rehab Serv CRS, UPMC Eye Ctr Eye & Ear Inst, Low Vis Occupat Therapy Dept, 7th Floor,Room 745,203 Lothrop St, Pittsburgh, PA 15213 USA		Troxell, L (corresponding author), Univ Pittsburgh Med Ctr UPMC, Ctr Rehab Serv CRS, UPMC Eye Ctr Eye & Ear Inst, Low Vis Occupat Therapy Dept, 7th Floor,Room 745,203 Lothrop St, Pittsburgh, PA 15213 USA.	mariottil@upmc.edu		, Laura/0000-0002-3228-6598			American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; [Anonymous], 2015, Am J Occup Ther, V69 Suppl 3, p6913410030p1, DOI 10.5014/ajot.2015.696S03; Barstow, 2011, OCCUPATIONAL THERAPY, P75; Barstow EA, 2011, OCCUPATIONAL THERAPY, P359; Berger S, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020875; Berryman A, 2020, AM J OCCUP THER, V74, DOI 10.5014/ajot.2020.026880; Berthold-Lindstedt M, 2017, J REHABIL MED, V49, P327, DOI 10.2340/16501977-2218; Bertone A, 2007, J CLIN EXP NEUROPSYC, V29, P467, DOI 10.1080/13803390600770793; Blanchard S., 2016, OPTOM VIS PERFORM, V4; Bogner J, 2019, ARCH PHYS MED REHAB, V100, P1810, DOI 10.1016/j.apmr.2018.12.037; Bowers Alex R, 2001, Clin Exp Optom, V84, P139; Burgess G, 2018, NEUROREHABILITATION, V42, P223, DOI 10.3233/NRE-172263; Calabrese A, 2016, JAMA OPHTHALMOL, V134, P398, DOI 10.1001/jamaophthalmol.2015.6097; Carey L, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5232374; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Clark J, 2017, J ATHL TRAINING, V52, P725, DOI 10.4085/1062-6050-52.4.04; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Flanders M, 1999, CAN J OPHTHALMOL, V34, P335; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Gilbert M., 2011, OCCUPATIONAL THERAPY, P227; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hardgrave N, 2012, OPTOMETRY VISION SCI, V89, P1611, DOI 10.1097/OPX.0b013e31826ab10a; Hatt SR, 2014, AM J OPHTHALMOL, V157, P1209, DOI 10.1016/j.ajo.2014.02.033; Herron S, 2016, TOP STROKE REHABIL, V23, P1, DOI 10.1179/1074935715Z.00000000065; Hollestelle, 2017, NZ J OCCUPATIONAL TH, V64, P32; Horton JC, 2017, GRAEF ARCH CLIN EXP, V255, P435, DOI 10.1007/s00417-016-3580-y; Houston KE, 2017, OPTOMETRY VISION SCI, V94, P120, DOI 10.1097/OPX.0000000000000976; Jacobson S, 2011, NEUROANATOMY FOR THE NEUROSCIENTIST, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9653-4; Johansson J, 2021, BRAIN INJURY, V35, P82, DOI 10.1080/02699052.2020.1858495; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Lotery AJ, 2000, AGE AGEING, V29, P221, DOI 10.1093/ageing/29.3.221; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Merabet, 2020, ARCH REHABIL RES CLI, V3; Mogk L., 2011, OCCUPATIONAL THERAPY, P27; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; Peters M, 2015, OPTOMETRY VISUAL PER, V3, P126; Politzer TA, 1996, NEUROREHABILITATION, V6, P213, DOI 10.3233/NRE-1996-6307; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rowe F, 2010, EYE, V24, P682, DOI 10.1038/eye.2009.138; Rucker JC, 2005, NEUROLOGIST, V11, P98, DOI 10.1097/01.nrl.0000156318.80903.b1; Schultz-Krohn W, 2018, PEDRETTIS OCCUPATION, P594; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Singman EL., 2013, MED INSTRUM, V1; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Warren, 1998, BRAIN INJURY VISUAL; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; Warren M., 2013, PEDRETTIS OCCUPATION, P590; Watabe T, 2019, BRAIN INJURY, V33, P1592, DOI 10.1080/02699052.2019.1658225; World Health Organization, 2003, CONS DEV STAND CHAR; Yoo PY, 2020, CAN J OCCUP THER, V87, P117, DOI 10.1177/0008417419892393	54	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	SEP	2021	9	3					93	99		10.1007/s40141-021-00310-x		JUN 2021	7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	UM0OZ	WOS:000681487800001	34094719	Green Published, Bronze			2022-02-07	
J	Barker-Haliski, M; Knox, K; Zierath, D; Koneval, Z; Metcalf, C; Wilcox, KS; White, HS				Barker-Haliski, Melissa; Knox, Kevin; Zierath, Dannielle; Koneval, Zachery; Metcalf, Cameron; Wilcox, Karen S.; White, H. Steve			Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital	EPILEPSIA			English	Article						antiepileptogenesis; EEG; everolimus; kainic acid; phenobarbital	SPONTANEOUS MOTOR SEIZURES; TUBEROUS SCLEROSIS; KAINIC ACID; STATUS EPILEPTICUS; MAMMALIAN TARGET; RAT MODEL; RAPAMYCIN; EPILEPSY; KAINATE; EPILEPTOGENESIS	Objective The kainic acid (KA)-induced status epilepticus (SE) model in rats is a well-defined model of epileptogenesis. This model closely recapitulates many of the clinical and pathological characteristics of human temporal lobe epilepsy (TLE) that arise following SE or another neurological insult. Spontaneous recurrent seizures (SRS) in TLE can present after a latent period following a neurological insult (traumatic brain injury, SE event, viral infection, etc.). Moreover, this model is suitable for preclinical studies to evaluate the long-term process of epileptogenesis and screen putative disease-modifying/antiepileptogenic agents. The burden of human TLE is highly variable, similar to the post-KA SE rat model. In this regard, this model may have broad translational relevance. This report thus details the pharmacological characterization and methodological refinement of a moderate-throughput drug screening program using the post-KA-induced SE model of epileptogenesis in male Sprague Dawley rats to identify potential agents that may prevent or modify the burden of SRS. Specifically, we sought to demonstrate whether our protocol could prevent the development of SRS or lead to a reduced frequency/severity of SRS. Methods Rats were administered either everolimus (2-3 mg/kg po) beginning 1, 2, or 24 h after SE onset, or phenobarbital (60 mg/kg ip) beginning 1 h after SE onset. All treatments were administered once/day for 5-7 days. Rats in all studies (n = 12/treatment dose/study) were then monitored intermittently by video-electroencephalography (2 weeks on, 2 weeks off, 2 weeks on epochs) to determine latency to onset of SRS and disease burden. Results Although no adverse side effects were observed in our studies, no treatment significantly modified disease or prevented the presentation of SRS by 6 weeks after SE onset. Significance Neither phenobarbital nor everolimus administered at several time points after SE onset prevented the development of SRS. Nonetheless, we demonstrate a practical and moderate-throughput screen for potential antiepileptogenic agents in a rat model of TLE.	[Barker-Haliski, Melissa; Knox, Kevin; Zierath, Dannielle; Koneval, Zachery; White, H. Steve] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Metcalf, Cameron; Wilcox, Karen S.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA		Barker-Haliski, M (corresponding author), Univ Washington, Dept Pharm, Seattle, WA 98195 USA.	mhaliski@uw.edu		Wilcox, Karen/0000-0003-2660-8826	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN271201600048C]	National Institute of Neurological Disorders and Stroke, Grant/Award Number: HHSN271201600048C	Abraham J, 2012, NEUROBIOL DIS, V46, P425, DOI 10.1016/j.nbd.2012.02.006; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Barker-Haliski M, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107750; Barker-Haliski M, 2014, NEURON, V84, P582, DOI 10.1016/j.neuron.2014.10.029; Barker-Haliski ML, 2015, DRUGS, V75, P749, DOI 10.1007/s40265-015-0395-9; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bertoglio D, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00588; Bolanos AR, 1998, NEUROLOGY, V51, P41, DOI 10.1212/WNL.51.1.41; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Clement EV, 2020, PEDIATR DRUGS, V22, P73, DOI 10.1007/s40272-019-00376-0; Cook AM, 2012, NEUROCRIT CARE, V17, P24, DOI 10.1007/s12028-012-9711-3; Crino PB, 2019, EPILEPSY BEHAV, V101, DOI 10.1016/j.yebeh.2019.106550; Curatolo P, 2018, EXPERT REV NEUROTHER, V18, P185, DOI 10.1080/14737175.2018.1428562; Drion CM, 2016, EPILEPSIA, V57, P688, DOI 10.1111/epi.13345; Grabenstatter HL, 2019, EPILEPSIA, V60, P636, DOI 10.1111/epi.14680; Grabenstatter HL, 2005, EPILEPSIA, V46, P8, DOI 10.1111/j.0013-9580.2005.13404.x; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Henske EP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.35; Huang X, 2012, NEUROSCIENCE, V215, P90, DOI 10.1016/j.neuroscience.2012.04.011; Kehne JH, 2017, NEUROCHEM RES, V42, P1894, DOI 10.1007/s11064-017-2275-z; Leary S., 2013, J AM VET MED ASSOC, V2013; Lechuga L, 2019, EXPERT REV NEUROTHER, V19, P913, DOI 10.1080/14737175.2019.1635457; Lefebvre KA, 2010, TOXICON, V56, P218, DOI 10.1016/j.toxicon.2009.05.034; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Mizuno S, 2021, EPILEPSIA OPEN, V6, P431, DOI 10.1002/epi4.12485; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; MURRI L, 1980, ITAL J NEUROL SCI, V1, P225; National Advisory Neurological Disorders and Stroke (NANDS) Council, 2020, REP NINDS EP THER SC; Patel DC, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0105-17.2017; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Prasad A, 2002, ANN NEUROL, V51, P175, DOI 10.1002/ana.10085; Sasongko TH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011272.pub2; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; STAFSTROM CE, 1993, EPILEPSIA, V34, P420, DOI 10.1111/j.1528-1157.1993.tb02582.x; SUTULA T, 1992, J NEUROSCI, V12, P4173; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Theilmann W, 2020, NEUROPHARMACOLOGY, V180, DOI 10.1016/j.neuropharm.2020.108297; Thomson KE, 2020, EPILEPSIA, V61, P1301, DOI 10.1111/epi.16531; Thomson KE, 2014, J NEUROSCI METH, V238, P105, DOI 10.1016/j.jneumeth.2014.09.019; Vargas JR, 2013, J NEUROPATH EXP NEUR, V72, P919, DOI 10.1097/NEN.0b013e3182a4b266; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Yang MT, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0797-6; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	49	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUL	2021	62	7					1677	1688		10.1111/epi.16955		JUN 2021	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TD9FG	WOS:000657142400001	34080183	Green Submitted, hybrid, Green Published			2022-02-07	
J	De Jesus, O; Fernandez-de Thomas, RJ				De Jesus, Orlando; Fernandez-de Thomas, Ricardo J.			Bone Fragment Granuloma Mimicking a Brain Tumor Following Placement of an Intracranial Pressure Monitoring System	CUREUS			English	Article						foreign body; granuloma; icp monitoring; neoplasm; neuroradiology; traumatic brain injury	FOREIGN-BODY GRANULOMA; NEUROENDOSCOPY; MIGRATION; REMOVAL	The placement of intracranial pressure (ICP) monitoring system requires drilling an orifice in the skull. Bone fragments can accidentally be inserted into the brain parenchyma while introducing the ICP monitoring system during the procedure. An intracranial granuloma can be subsequently formed if a non-specific reaction is induced and maintained by the inserted hone fragment in the brain parenchyma. These intracranial granulomas may eventually be confused with brain masses on follow-up imaging studies. We present the case of a 65-year-old male who underwent cranial surgery secondary to a severe traumatic brain injury (TM). An intracranial bolt was initially placed contralaterally to measure the ICP. Eleven years later, a granuloma from a retained bone fragment secondary to the intracranial bolt placement was suspected. The clinical course, radiological investigations, and differential diagnosis are presented.	[De Jesus, Orlando; Fernandez-de Thomas, Ricardo J.] Univ Puerto Rico, Neurosurg, Med Sci Campus, San Juan, PR 00936 USA		De Jesus, O (corresponding author), Univ Puerto Rico, Neurosurg, Med Sci Campus, San Juan, PR 00936 USA.	drodejesus@aol.com					Akhaddar A, 2018, WORLD NEUROSURG, V120, P457, DOI 10.1016/j.wneu.2018.09.143; Akhaddar A, 2008, J NEUROSURG, V108, P820, DOI 10.3171/JNS/2008/108/4/0820; Al-Afif S, 2018, ACTA NEUROCHIR, V160, P2069, DOI 10.1007/s00701-018-3663-0; Alorainy IA, 2001, EUR J RADIOL, V40, P218, DOI 10.1016/S0720-048X(01)00385-0; Choi Tae-Min, 2016, Korean J Neurotrauma, V12, P118, DOI 10.13004/kjnt.2016.12.2.118; Cunliffe CH, 2009, ARCH PATHOL LAB MED, V133, P101, DOI 10.1043/1543-2165-133.1.101; Dinesh SK, 2008, J CLIN NEUROSCI, V15, P463, DOI 10.1016/j.jocn.2006.11.022; El Ahmadieh TY, 2018, J NEUROSURG-PEDIATR, V22, P578, DOI 10.3171/2018.5.PEDS18152; Feldman RP, 1999, NEUROSURGERY, V44, P855, DOI 10.1097/00006123-199904000-00091; Foreman B, 2018, NEUROCRIT CARE, V29, P469, DOI 10.1007/s12028-018-0551-7; Huisman Thierry A G M, 2009, Cancer Imaging, V9 Spec No A, pS10, DOI 10.1102/1470-7330.2009.9003; Jang SW, 2010, KOREAN J RADIOL, V11, P359, DOI 10.3348/kjr.2010.11.3.359; Ji C, 2010, J KOREAN NEUROSURG S, V47, P158, DOI 10.3340/jkns.2010.47.2.158; Kafadar A, 2010, NEUROSURGERY, V67, pE503, DOI 10.1227/01.NEU.0000371975.21566.7D; Thomson S, 2003, J NEUROSURG, V98, P186, DOI 10.3171/jns.2003.98.1.0186; Turhan T, 2011, CHILD NERV SYST, V27, P719, DOI 10.1007/s00381-010-1339-z; Vishteh SG, 1998, J NEUROSURG, V88, P928; Wang K, 2019, WORLD NEUROSURG, V127, P629, DOI 10.1016/j.wneu.2019.01.286; Winter SF, 2021, ONCOLOGIST, V26, pE893, DOI 10.1002/onco.13766	19	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 2	2021	13	6							e15394	10.7759/cureus.15394			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SM8IL	WOS:000657842100013	34249544	gold, Green Published			2022-02-07	
J	Gryffydd, L; Mitra, B; Wright, BJ; Kinsella, GJ				Gryffydd, Lei; Mitra, Biswadev; Wright, Bradley J.; Kinsella, Glynda J.			Cognitive performance in older adults at three months following mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Cognition; prospective memory; older adults; mild traumatic brain injury; augmented reality	PROSPECTIVE MEMORY; SEVERITY SCORE; MORTALITY; VALIDITY; TRAIL; NEUROPSYCHOLOGY; REHABILITATION; PREDICTORS; RECOVERY	Introduction: In the context of limited research assessing outcomes following mild traumatic brain injury (mTBI) in older adults, this study evaluated cognitive outcomes through prospective memory, and expected that performance of an older mTBI group (>= 65 years) would be lower compared to orthopedic and community controls. The study also explored whether cognitive resources (retrospective memory, executive function) moderated any association between presenting Glasgow Coma Scale (GCS) and prospective memory. Method: At three-months post-injury, a mTBI group (n = 39), an orthopedic control group (n = 63), and a community control group (n = 46) completed a neuropsychological assessment, including (i) prospective memory, using a standardized paper-and-pencil task (Cambridge Prospective Memory Test), an augmented reality task and a naturalistic task, and (ii) standardized measures of retrospective memory (Hopkins Verbal Learning Test) and executive function (Trail Making Test). Group performances were compared, and bootstrapped moderation analyses evaluated the role of cognitive resources in the relationship between GCS and prospective memory outcome. Results: The mTBI group, as compared to community controls, performed significantly lower on the augmented reality task (d = -0.64 to d = -0.79), and there was a small-moderate but non-significant effect (d = -0.45) on the naturalistic task. There were no differences between the mTBI group and orthopedic controls. Retrospective memory was a unique predictor of the augmented reality task (B = 1.83) and moderated the relationship between presenting GCS and the naturalistic task (B = -5.60). Executive function moderated the association between presenting GCS and augmented reality (B = -1.13) and naturalistic task (B = -1.57). Conclusions: At three-months post-mTBI, older adults are at risk of poor cognitive performance; and the relationship between GCS and prospective memory can be moderated by cognitive resources. Further follow-up is indicated to determine whether impairments resolve or persist over time.	[Gryffydd, Lei; Wright, Bradley J.; Kinsella, Glynda J.] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic 3086, Australia; [Mitra, Biswadev] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Mitra, Biswadev; Kinsella, Glynda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Mitra, Biswadev] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Kinsella, Glynda J.] Caulfield Hosp, Dept Psychol, Caulfield, Australia		Kinsella, GJ (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Mitra, Biswadev/AAC-3724-2019; Kinsella, Glynda/O-6347-2017	Mitra, Biswadev/0000-0002-0508-2450; Wright, Bradley/0000-0002-6428-9128; Kinsella, Glynda/0000-0002-5859-0934; Gryffydd, Lei/0000-0001-5854-0745	Commonwealth Research Training Scheme award	This work was supported by a Commonwealth Research Training Scheme award to L.G.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Australian Bureau of Statistics, 2009, AUSTR NZ CLASS OCC; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bedard M, 2020, J CLIN EXP NEUROPSYC, V42, P344, DOI 10.1080/13803395.2020.1714552; Benedict, 2001, HOPKINS VERBAL LEARN; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; Cohen J., 2003, APPL MULTIPLE CORREL, V3rd; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cusimano MD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20520; De Luca R, 2020, APPL NEUROPSYCH-CHIL, V9, P282, DOI 10.1080/21622965.2019.1576525; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delprado J, 2013, PSYCHOL AGING, V28, P322, DOI 10.1037/a0029785; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eglit GML, 2020, CLIN NEUROPSYCHOL, V34, P332, DOI 10.1080/13854046.2019.1643923; Farrimond S, 2006, APPL COGNITIVE PSYCH, V20, P533, DOI 10.1002/acp.1202; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Gatz M, 1995, Int Psychogeriatr, V7, P429, DOI 10.1017/S1041610295002171; Gennarelli TA., 2008, ABBREVIATED INJURY S; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Gryffydd L, 2022, AGING NEUROPSYCHOL C, V29, P104, DOI 10.1080/13825585.2020.1857327; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Hayes A.F., 2017, INTRO MEDIATION MODE; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; Karr JE, 2020, ACTA NEUROL SCAND, V141, P183, DOI 10.1111/ane.13190; Karr JE, 2020, BRAIN INJURY, V34, P26, DOI 10.1080/02699052.2019.1669825; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kinsella G., 2014, UNDERSTANDING TRAUMA, P356; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kourtesis P, 2021, J INT NEUROPSYCH SOC, V27, P181, DOI 10.1017/S1355617720000764; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee SD, 2018, J CLIN EXP NEUROPSYC, V40, P183, DOI 10.1080/13803395.2017.1326465; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Parsons TD, 2017, J ALZHEIMERS DIS, V59, P1227, DOI 10.3233/JAD-170295; Piefke M., 2017, PSYCHOL NEUROSCI, V10, P345, DOI [DOI 10.1037/pne0000102, 10.1037/pne0000102, DOI 10.1037/PNE0000102]; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Raskin SA, 2018, CLIN NEUROPSYCHOL, V32, P741, DOI 10.1080/13854046.2018.1484519; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Robinson A, 2021, PERS INDIV DIFFER, V172, DOI 10.1016/j.paid.2020.110563; Robinson CD., 2013, MULTIPLE LINEAR REGR, V39, P16; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rose NS, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00592; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Scullin MK, 2013, COGNITIVE PSYCHOL, V67, P55, DOI 10.1016/j.cogpsych.2013.07.001; Sheppard DP, 2020, CLIN NEUROPSYCHOL, V34, P755, DOI 10.1080/13854046.2019.1637461; Siddiqui T.G., 2020, BMJ OPEN, V10, P038432, DOI [10.1136/bmjopen-2020-038432, DOI 10.1136/bmjopen-2020-038432]; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sullivan KL, 2018, J CLIN EXP NEUROPSYC, V40, P733, DOI 10.1080/13803395.2018.1432571; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Sutin AR, 2018, J ALZHEIMERS DIS, V65, P1041, DOI 10.3233/JAD-180119; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Toth L, 2021, GEROSCIENCE, V43, P125, DOI 10.1007/s11357-020-00280-3; van der Leeuw G, 2018, J PAIN, V19, P1435, DOI 10.1016/j.jpain.2018.06.009; Wan C.K., 1990, INTERACTION EFFECTS; West S. G., 1991, MULTIPLE REGRESSION; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Xu W, 2020, J NEUROL NEUROSUR PS, V91, P236, DOI 10.1136/jnnp-2019-321896	84	0	0	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 28	2021	43	5					481	496		10.1080/13803395.2021.1933915		JUN 2021	16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	UC2DQ	WOS:000657723100001	34078223				2022-02-07	
J	Kissinger-Knox, AM; Eagle, SR; Jennings, S; Collins, MW; Kontos, AP				Kissinger-Knox, Alicia M.; Eagle, Shawn R.; Jennings, Sabrina; Collins, Michael W.; Kontos, Anthony P.			Does time since concussion alter the factor structure of a multidomain assessment in adolescents?	CHILD NEUROPSYCHOLOGY			English	Article						Adolescents; concussion; factor analysis; oculomotor; vestibular	SYMPTOMS QUESTIONNAIRE; HEALTH-CARE; SPORT; IMPACT; PREDICTORS; STATEMENT; VALIDITY	The utilization of principal component analysis (PCA) approaches to concussion is beneficial to inform the interpretation of clinical outcome data in adolescent patients. While researchers have identified factors using post-concussive symptom scales and cognitive testing, there has yet to be a PCA that incorporates vestibular or oculomotor outcomes, or that focuses exclusively on adolescents. Moreover, the role of time since injury has not been examined in relation to concussion factors in this at-risk population. PCA methods were applied to two independent samples of 237 adolescents who presented to an outpatient concussion clinic: 1) <= 7 days (n = 145), and 2) 8 days-1 month (n = 92). The two separate PCAs included nine clinical assessments comprised of: a) four symptoms factors (cognitive/fatigue/migraine, affective, somatic, sleep), b) memory and speeded cognitive performance, c) near point of convergence (NPC), d) oculomotor, and e) vestibular outcomes. A three-component model including 1) symptoms, 2) cognitive, and 3) vestibular/oculomotor factors that accounted for 69.2% of the variance was supported for the <= 7 days sample. All items except somatic symptoms loaded. A different three-component model was supported for the 8 days-1 month sample, including 1) vestibulo-ocular migraine, 2) visuo-cognitive, and 3) affective-sleep that accounted for 72.1% of the variance, with all items loading. The findings supported two different concussion factor models that highlight the influence of time since injury and importance of considering vestibular and oculomotor outcomes in adolescents. Clinicians should evaluate these different factors using a comprehensive, multi domain approach to better inform assessment and monitor recovery in adolescent patients following concussion.	[Kissinger-Knox, Alicia M.; Jennings, Sabrina; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Concuss Program, Pittsburgh, PA 15203 USA; [Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, 3850 S Water St, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu					Bailey C, 2019, J HEAD TRAUMA REHAB, V34, P375, DOI 10.1097/HTR.0000000000000527; Brustman K, 2020, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2020.1788563; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caldwell JT, 2016, AM J PUBLIC HEALTH, V106, P1463, DOI 10.2105/AJPH.2016.303212; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Hair J. F., 2010, MULTIVARIATE DATA AN; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kesavayuth D, 2020, ECON MODEL, V86, P227, DOI 10.1016/j.econmod.2019.06.014; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kowalczyk CL, 2020, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2020.1774376; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nonzee NJ, 2015, J WOMENS HEALTH, V24, P506, DOI 10.1089/jwh.2014.4998; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pizer SD, 2011, J GEN INTERN MED, V26, pS676, DOI 10.1007/s11606-011-1819-1; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055	38	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 17	2021	27	8					1104	1116		10.1080/09297049.2021.1936475		JUN 2021	13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY1DA	WOS:000658924200001	34098854				2022-02-07	
J	Meyers, JE; Miller, RM				Meyers, John E.; Miller, Ronald M.			Objective methods for matching neuropsychological patterns: Formulas and comparisons	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Comparative; computer applications; tests	PROFILES; DISEASE	Introduction Objective neuropsychology test score pattern matching methods can help to identify data similarities and differences with comparison groups which can help the clinician in diagnosis and in identifying treatment options. Materials and methods The current study examines five methods of matching a data set: Correlation, Configuration, Kullback-Leibler (KL) Divergence, Pooled Effect Size (Cohen's d), and a new method called MNB (Meyers Neuropsychological Battery) Code. Thirty data sets diagnosed with Traumatic Brain Injury (TBI) were compared with four Comparison Group data sets consisting of TBI, Depression, Anxiety and Attention Deficit/Hyperactivity Disorder. Results The Correlation Method was correct 90% (27/30) and Configuration was correct 86% (26/30). The KL Divergence was correct 76% (23/30) and the MNB Code was correct 73% (22/30). The Effect Size Method was correct 70% (21/30). When using a simple majority of all the matching methods, the classification rate was 90+ percent. Conclusions The results of this study demonstrate that there are statistical methods that can identify patterns of cognitive strengths and weaknesses. Multiple matching methods and a simple majority of agreement between the different comparisons suggests the best matching profile for diagnosis. In some cases, more than one pattern may be present.	[Meyers, John E.] Meyers Neuropsychol Serv, Nokomis, FL 34275 USA; [Miller, Ronald M.] Utah Valley Univ, Woodbury Sch Business Strateg Management & Opera, Orem, UT USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, Nokomis, FL 34275 USA.	jmeyersneuro@yahoo.com					Al-Labadi L, 2021, J KOREAN STAT SOC, V50, P272, DOI 10.1007/s42952-020-00072-7; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; BRIGGS G G, 1975, Cortex, V11, P230; Buscema M, 2004, NEUROINFORMATICS, V2, P399, DOI 10.1385/NI:2:4:399; CLAESON LE, 1971, CLAESON DAHL LEARNIN; Clim A, 2018, PROCEDIA COMPUT SCI, V141, P448, DOI 10.1016/j.procs.2018.10.144; Cohen J., 2013, STAT POWER ANAL BEHA; Conners C. K., 2000, CONNERS CONTINUOUS P; Delis DC., 2001, DELIS KAPLAN EXECUTI; Kertesz A., 1983, W APHASIA BATTERY; Kullback S., 1959, INFORM THEORY STAT; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; MACK WJ, 1992, J GERONTOL, V47, pP154, DOI 10.1093/geronj/47.3.P154; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 1995, PSYCHOL ASSESSMENT R; Meyers JE, 2020, APPL NEUROPSYCH-ADUL, V27, P364, DOI 10.1080/23279095.2018.1550412; Meyers JE, 2020, APPL NEUROPSYCH-ADUL, V27, P279, DOI 10.1080/23279095.2018.1535435; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P60, DOI 10.1080/09084282.2012.737881; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nelson H.E., 1982, NATL ADULT READING T; Perez M.L., 2003, APLICACIONES REDES N; Ramirez-Gomez L, 2017, DEMENT GERIATR COGN, V44, P1, DOI 10.1159/000477344; Reitan R, 1985, HALSTEAD REITAN NEUR; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Salarvan S, 2019, INT J BIPOLAR DISORD, V7, DOI 10.1186/s40345-019-0149-9; Smith A., 1991, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Weigl E, 1941, J ABNORM SOC PSYCH, V36, P3, DOI 10.1037/h0055544	34	0	0	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1929986		JUN 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SM7CV	WOS:000657759600001	34081873				2022-02-07	
J	Richie, EA; Nugent, JG; Raslan, AM				Richie, Emma A.; Nugent, Joseph G.; Raslan, Ahmed M.			Racial and Ethnic Inequities in Mortality During Hospitalization for Traumatic Brain Injury: A Call to Action	FRONTIERS IN SURGERY			English	Article						mortality; disparities; inequities; TBI; neurotrauma; race	STRUCTURAL RACISM; PROPENSITY SCORE; UNITED-STATES; DISPARITIES; RACE; ASSOCIATION; DISCHARGE; OUTCOMES; CARE	The health disparities which drive inequities in health outcomes have long plagued our already worn healthcare system and are often dismissed as being a result of social determinants of health. Herein, we explore the nature of these inequities by comparing outcomes for racial and ethnic minorities patients suffering from traumatic brain injury (TBI). We retrospectively reviewed all patients enrolled in the Trauma One Database at the Oregon Health & Science University Hospital from 2006 to October 2017 with an abbreviated injury scale (AIS) for the head or neck >2. Racial and ethnic minority patients were defined as non-White or Hispanic. A total of 6,352 patients were included in our analysis with 1,504 in the racial and ethnic minority cohort vs. 4,848 in the non-minority cohort. A propensity score (PS) model was generated to account for differences in baseline characteristics between these cohorts to generate 1,500 matched pairs. The adjusted hazard ratio for in-hospital mortality for minority patients was 2.21 [95% Confidence Interval (CI) 1.43-3.41, p < 0.001] using injury type, probability of survival, and operative status as covariates. Overall, this study is the first to specifically look at racial and ethnic disparities in the field of neurosurgical trauma. This research has demonstrated significant inequities in the mortality of TBI patients based on race and ethnicity and indicates a substantive need to reshape the current healthcare system and advocate for safer and more supportive pre-hospital social systems to prevent these life-threatening sequelae.	[Richie, Emma A.; Nugent, Joseph G.; Raslan, Ahmed M.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA		Richie, EA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA.	richie@ohsu.edu					Bailey ZD, 2021, NEW ENGL J MED, V384, P768, DOI 10.1056/NEJMms2025396; Bhangu A, 2016, BRIT J SURG, V103, P971, DOI 10.1002/bjs.10151; Branch CL, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18367; Brenner EK, 2020, BRAIN INJURY, V34, P801, DOI 10.1080/02699052.2020.1741033; Chiu RG, 2020, WORLD NEUROSURG, V140, pE175, DOI 10.1016/j.wneu.2020.04.231; Churchwell K, 2020, CIRCULATION, V142, pE454, DOI 10.1161/CIR.0000000000000936; Clark David E, 2018, Inj Epidemiol, V5, P11, DOI 10.1186/s40621-018-0149-8; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Egede LE, 2006, J GEN INTERN MED, V21, P667, DOI 10.1111/j.1525-1497.2006.0512.x; Fuentes A, 2019, REHABIL PSYCHOL, V64, P229, DOI 10.1037/rep0000260; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Genevieve LD, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-0457-8; Haider AH, 2013, ANN SURG, V258, P572, DOI 10.1097/SLA.0b013e3182a50148; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Ho DE, 2011, J STAT SOFTW, V42; Homo RL., 2020, AM SURGEON, DOI [10.1177/0003134820983187, DOI 10.1177/0003134820983187]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kowalski RG, 2021, JAMA NEUROL, V78, P548, DOI 10.1001/jamaneurol.2021.0084; Krivo LJ, 2009, AM J SOCIOL, V114, P1765, DOI 10.1086/597285; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Lane SD, 2017, J HEALTH CARE POOR U, V28, P446, DOI 10.1353/hpu.2017.0033; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Martin MJ, 2011, J RES ADOLESCENCE, V21, P662, DOI 10.1111/j.1532-7795.2010.00699.x; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Meloni M., 2017, WILEY BLACKWELL ENCY, P1; Mesic A, 2018, J NATL MED ASSOC, V110, P106, DOI 10.1016/j.jnma.2017.12.002; Montgomery JR, 2019, JAMA-J AM MED ASSOC, V321, P2129, DOI 10.1001/jama.2019.1146; Nazroo JY, 2020, SOCIOL HEALTH ILL, V42, P262, DOI 10.1111/1467-9566.13001; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Phelan JC, 2013, AM SOCIOL REV, V78, P167, DOI 10.1177/0003122413476034; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Smedley A, 2005, AM PSYCHOL, V60, P16, DOI 10.1037/0003-066X.60.1.16; Udyavar R, 2018, CURR TRAUMA REP, V4, P25, DOI 10.1007/s40719-018-0114-6; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; VONELM E, 2007, LANCET, V370, P1453, DOI DOI 10.1016/S0140-6736(07)61602-X; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Zhu TH, 2018, ACAD EMERG MED, V25, P44, DOI 10.1111/acem.13307	44	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	JUN 2	2021	8								690971	10.3389/fsurg.2021.690971			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	SS7HB	WOS:000661924400001	34150842	Green Submitted, Green Published, gold			2022-02-07	
J	Rivera, K; Truckner, R; Furiato, A; Martinez, S				Rivera, Kevin; Truckner, Robert; Furiato, Anthony; Martinez, Sergio			The Diagnostic Challenge of the Pediatric Brain Abscess	CUREUS			English	Article						altered mental status; pediatric; traumatic brain injury; increased intracranial pressure; intracranial abscess		Pediatric brain abscess (PBA) is a rare condition that portends a high mortality rate if not recognized and treated early. The spectrum of clinical manifestations of this disease process is wide and can often be vague, making it difficult for timely diagnosis in the emergency department. We detail the presentation of a four-year-old male with autism and a four-day history of decreased activity after a fall with a critical and rapidly worsening clinical course. Subsequent operative intervention revealed a diagnosis of PBA. This case highlights the clinical challenges of diagnosing altered mental status in a developmentally challenged pediatric patient.	[Rivera, Kevin; Furiato, Anthony; Martinez, Sergio] Univ S Florida, HCA Healthcare, Emergency Med, Morsani Coll Med,Grad Med Educ Consortium,Brandon, Brandon, FL 33511 USA; [Truckner, Robert] Univ S Florida, HCA Healthcare, Pediat Emergency Med, Morsani Coll Med,Grad Med Educ Consortium,Brandon, Brandon, FL USA		Rivera, K (corresponding author), Univ S Florida, HCA Healthcare, Emergency Med, Morsani Coll Med,Grad Med Educ Consortium,Brandon, Brandon, FL 33511 USA.	kevin.riverarodriguez@hcahealthcare.com					Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Giannoni CM, 1997, LARYNGOSCOPE, V107, P863, DOI 10.1097/00005537-199707000-00005; Mameli C, 2019, CHILD NERV SYST, V35, P1117, DOI 10.1007/s00381-019-04182-4; SEYDOUX C, 1992, CLIN INFECT DIS, V15, P394, DOI 10.1093/clind/15.3.394; Shachor-Meyouhas Y, 2010, ACTA PAEDIATR, V99, P1163, DOI 10.1111/j.1651-2227.2010.01780.x; Weinberg GA, 2018, PEDIATR REV, V39, P270, DOI 10.1542/pir.2017-0147; Xiao FR, 2005, SURG NEUROL, V63, P442, DOI 10.1016/j.surneu.2004.08.093	7	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 2	2021	13	6							e15402	10.7759/cureus.15402			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SM8IL	WOS:000657842100021	34104611				2022-02-07	
J	Sargolzaei, S; Kaushik, A; Soltani, S; Amini, MH; Khalghani, MR; Khoshavi, N; Sargolzaei, A				Sargolzaei, Saman; Kaushik, Ajeet; Soltani, Seyed; Amini, M. Hadi; Khalghani, Mohammad Reza; Khoshavi, Navid; Sargolzaei, Arman			Preclinical Western Blot in the Era of Digital Transformation and Reproducible Research, an Eastern Perspective	INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES			English	Article						Computational science; Digital transformation; Interdisciplinary; Online database; Reproducible research; Western blot	TRAUMATIC BRAIN-INJURY; HARM-BENEFIT ANALYSIS; EXPRESSION; INHIBITION; HIPPOCAMPUS; HYPOTHERMIA; HOMEOSTASIS; MANAGEMENT; AUTOPHAGY; BIOMARKER	The current research is an interdisciplinary endeavor to develop a necessary tool in preclinical protein studies of diseases or disorders through western blotting. In the era of digital transformation and open access principles, an interactive cloudbased database called East-West Blot (https://rancs-lab.shinyapps.io/WesternBlots) is designed and developed. The online interactive subject-specific database built on the R shiny platform facilitates a systematic literature search on the specific subject matter, here set to western blot studies of protein regulation in the preclinical model of TBI. The tool summarizes the existing publicly available knowledge through a data visualization technique and easy access to the critical data elements and links to the study itself. The application compiled a relational database of PubMed-indexed western blot studies labeled under HHS public access, reporting downstream protein regulations presented by fluid percussion injury model of traumatic brain injury. The promises of the developed tool include progressing toward implementing the principles of 3Rs (replacement, reduction, and refinement) for humane experiments, cultivating the prerequisites of reproducible research in terms of reporting characteristics, paving the ways for a more collaborative experimental design in basic science, and rendering an up- to-date and summarized perspective of current publicly available knowledge.	[Sargolzaei, Saman] Univ Tennessee, Dept Engn, Martin, TN 38238 USA; [Kaushik, Ajeet] Florida Polytech Univ, Dept Nat Sci, Lakeland, FL USA; [Soltani, Seyed] Florida Polytech Univ, Mech Engn Dept, Lakeland, FL USA; [Amini, M. Hadi] Florida Int Univ, Sch Comp & Informat Sci, Miami, FL 33199 USA; [Khoshavi, Navid] Florida Polytech Univ, Comp Sci Dept, Lakeland, Lakeland, FL USA; [Khalghani, Mohammad Reza] Florida Polytech Univ, Elect & Comp Engn Dept, Lakeland, FL USA; [Sargolzaei, Arman] Tennessee Technol Univ, Dept Mech Engn, Cookeville, TN 38505 USA		Sargolzaei, S (corresponding author), Univ Tennessee, Dept Engn, Martin, TN 38238 USA.	saman@utm.edu	Sargolzaei, Saman/AAE-2482-2019; Amini, M. Hadi/H-4881-2016	Sargolzaei, Saman/0000-0001-6114-5113; Amini, M. Hadi/0000-0002-2768-3601			Abad-Segura E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052107; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bronstad A, 2016, LAB ANIM-UK, V50, P1, DOI 10.1177/0023677216642398; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen W, 2018, J NEUROPHYSIOL, V119, P305, DOI 10.1152/jn.00654.2017; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Ding J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080429; Duclos C, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0709-x; Eakin K, 2015, BRAIN NEUROTRAUMA MO; Gilda JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135392; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Griffiths DR, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1767; Guzzi PH, 2013, INTERDISCIP SCI, V5, P187, DOI 10.1007/s12539-013-0173-x; Hekman RM, 2020, MOL CELL, V80, P1104, DOI 10.1016/j.molcel.2020.11.028; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Huang YJ, 2020, AM J CANCER RES, V10, P2337; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaushik AC., 2019, INTERDISCIP SCI COMP, DOI [10.1371/journal.pone.0135392, DOI 10.1371/JOURNAL.PONE.0135392]; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Li L, 2019, NEURAL REGEN RES, V14, P1573, DOI 10.4103/1673-5374.255972; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Maria NSS, 2019, EXP NEUROL, V318, P78, DOI 10.1016/j.expneurol.2019.04.016; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Martins-de-Souza D, 2011, INT REV NEUROBIOL, V101, P65, DOI 10.1016/B978-0-12-387718-5.00004-3; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Moher David, 2009, Open Med, V3, pe123; Moritz CP, 2020, J PROTEOMICS, V212, DOI 10.1016/j.jprot.2019.103575; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; RENART J, 1979, P NATL ACAD SCI USA, V76, P3116, DOI 10.1073/pnas.76.7.3116; RStudio Inc., 2013, EAS WEB APPL R; RStudio Team, 2020, RSTUDIO INT DEV ENV; Russell NH, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146466; Sargolzaei Saman, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P652, DOI 10.1109/EMBC.2018.8512402; Sargolzaei Saman, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5414, DOI 10.1109/EMBC.2018.8513500; Sargolzaei Saman, 2018, IEEE EMBS Int Conf Biomed Health Inform, V2018, P381, DOI 10.1109/BHI.2018.8333448; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Skovira JW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0769-2; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Takeuchi S, 2013, TURK NEUROSURG, V23, P349, DOI 10.5137/1019-5149.JTN.7023-12.1; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Truettner JS, 2018, J NEUROTRAUM, V35, P940, DOI 10.1089/neu.2017.5303; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vazquez N, 2018, INTERDISCIP SCI, V10, P24, DOI 10.1007/s12539-018-0282-7; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Wurbel H, 2017, LAB ANIMAL, V46, P164, DOI 10.1038/laban.1220	62	0	0	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1913-2751	1867-1462		INTERDISCIP SCI	Interdiscip. Sci.	SEP	2021	13	3					490	499		10.1007/s12539-021-00442-7		JUN 2021	10	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	UC5QS	WOS:000657224500002	34080131				2022-02-07	
J	Solvang, PK; Heiaas, I; Romsland, G; Soberg, HL				Solvang, Per Koren; Heiaas, Ida; Romsland, Grace; Soberg, Helene Lundgaard			The unexpected other: Challenges and strategies after acquired impairment	HEALTH			English	Article; Early Access						chronic illness and disability; experiencing illness and narratives; illness behaviour	TRAUMATIC BRAIN-INJURY; DISABILITY; CAREGIVERS; IMPACT; LIFE	People experiencing traumatic brain injury or multitrauma will often live with problems in functioning for a profound period in life. A situation of great complexity emerges involving both the experience of an impaired body and the experience of a changed social position. This article addresses the intricate relations between the altered body, personal ambitions, and social surroundings in the first 2-3 years after an injury. The conceptual framework centers around the process of change, applying concepts such as the unexpected other and biographical reconstruction. Twenty-one people of working age were interviewed two times. All interviewees had experienced traumatic brain injury or multitrauma. A thematic narrative analysis was applied. Consequences of the injury took place at a carnal level where fatigue is something completely different from becoming exhausted and where elimination of body waste takes place through practices novel to the injured person. Living with impairment also took place at the level of social interaction. Here, family relations, shame, and establishing a new identity seemed profoundly important. This article makes two novel contributions. First, it emphasizes more than previous studies do that the daily management of altered body functions is more important for independence and wellbeing. Second, the article identifies the narrative about the accident as an important issue for injured people to settle.	[Solvang, Per Koren; Soberg, Helene Lundgaard] Oslo Metropolitan Univ, Dept Physiotherapy, POB 4, N-0130 Oslo, Norway; [Heiaas, Ida] Oslo Metropolitan Univ, Dept Physiotherapy, Hlth Sci, Oslo, Norway; [Heiaas, Ida] Norwegian Womens Publ Hlth Assoc, Dept Res & Dev, Oslo, Norway; [Romsland, Grace] Sunnaas Rehabil Hosp, Nesodden, Norway; [Soberg, Helene Lundgaard] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway		Solvang, PK (corresponding author), Oslo Metropolitan Univ, Dept Physiotherapy, POB 4, N-0130 Oslo, Norway.	persol@oslomet.no		Koren Solvang, Per/0000-0002-6494-3417	Research Council of NorwayResearch Council of Norway [229082]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by The Research Council of Norway (Grant No. 229082).	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Abonie US, 2020, J SPORT SCI, V38, P590, DOI 10.1080/02640414.2020.1721254; Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Braaf S, 2020, DISABIL REHABIL, V42, P2707, DOI 10.1080/09638288.2019.1571116; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Buetow SA, 2019, DISABIL REHABIL, V41, P740, DOI 10.1080/09638288.2017.1406997; Bury M, 2001, SOCIOL HEALTH ILL, V23, P263, DOI 10.1111/1467-9566.00252; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CORKER M, 1999, DISABILITY DISCOURSE; Douglas J., 2015, RETHINKING REHABILIT, P163; Fadyl JK., 2017, NEUROPSYCHOL REHABIL, V29, P1095; Frank A. W., 2013, WOUNDED STORYTELLER; Grue J, 2016, SOCIOL HEALTH ILL, V38, P957, DOI 10.1111/1467-9566.12417; Hammell K.W., 2006, PERSPECTIVES DISABIL; Hammell KW, 2015, RETHINKING REHABILIT; Hartog I, 2020, J HEALTH PSYCHOL, V25, P738, DOI 10.1177/1359105317731823; Harvey J, 2018, DISABIL SOC, V33, P78, DOI 10.1080/09687599.2017.1382322; Hutchinson K, 2018, DISABIL SOC, V33, P175, DOI 10.1080/09687599.2017.1392931; Kleinman Arthur, 1988, ILLNESS NARRATIVES S; Kralik D, 2006, J ADV NURS, V55, P320, DOI 10.1111/j.1365-2648.2006.03899.x; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Locock L, 2009, SOCIOL HEALTH ILL, V31, P1043, DOI 10.1111/j.1467-9566.2009.01176.x; Loy BD, 2017, J PSYCHOSOM RES, V100, P1, DOI 10.1016/j.jpsychores.2017.06.017; Lynch J, 2017, SPINAL CORD, V55, P964, DOI 10.1038/sc.2017.56; Malabou C., 2012, ONTOLOGY ACCIDENT ES; Mik-Meyer N, 2016, HUM RELAT, V69, P1341, DOI 10.1177/0018726715618454; Poku BA, 2020, QUAL HEALTH RES, V30, P1431, DOI 10.1177/1049732320916464; Riessman K. C., 2008, NARRATIVE METHODS HU; Romsland Grace Inga, 2019, Res Involv Engagem, V5, P18, DOI 10.1186/s40900-019-0153-3; Rosenberg G., 2020, TRAUMA SURG ACUTE CA, V5; Sherry M, 2016, DISABIL SOC, V31, P729, DOI 10.1080/09687599.2016.1203290; Siebers T., 2006, DISABILITY STUDIES R; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Solomon P, 2020, DISABIL REHABIL, V42, P3566, DOI 10.1080/09638288.2019.1602850; Villa D, 2021, DISABIL REHABIL, V43, P3298, DOI 10.1080/09638288.2020.1743773	37	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1363-4593	1461-7196		HEALTH-LONDON	Health											13634593211021482	10.1177/13634593211021482		JUN 2021	17	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	SN0QS	WOS:000658003400001	34075795				2022-02-07	
J	Arain, SH; Shaikh, MA; Narejo, MA; Ansari, NS; Mari, AR				Arain, Safdar Hussain; Shaikh, Muhammad Aslam; Narejo, Mumtaz Ali; Ansari, Najmus Saqib; Mari, Abdul Razaque			Management of Depressed Skull Fractures: Selective Conservative Management of Non Missile Injuries	PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES			English	Article						Depressed skull fracture; Non-missile injuries; Cerebrospinal fluid	HEAD-INJURY; HEMATOMA; NEED	Objective: To determine the outcomes of management of depressed skull fractures. Study Design: Descriptive Study Place and Duration of Study: Department of Neurosurgeries, Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences Gambat and Chandka Medical College Hospital, Larkana from 1st March 2020 to 28th February 2021. Methodology: Eighty patients of both sexes were enrolled in this study. Patients were aged between 12-70 years of age. Patient's detailed demographics age, sex and body mass index were recorded. Diagnosis of skull fractures from closed head injury patients were undergone for CT scan Depressed fracture of more than 5 mm, cosmetically disfiguring fractures and fracture over the sinuses were operated. All the patients were given prophylactic antibiotics and anticonvulsants. Patients were followed for 4-months. Outcomes were assessed by Glasgow Coma Scale (GCS). Results: Fifty five (68.8%) patients were males and thirty five (31.2%) were females with mean age was 18.21 +/- 7.32 years and mean body mass index was 20.04 +/- 3.14 kg/m(2). Road traffic accident (56.25%) was the most common cause of the injury followed by fall from the height 25 (31.25%). The compound fractures have 48 (60%) and simple fractures were 32 (40%). Surgery was done among 70 (87.5%) cases and 10 (12.5%) patients were conservatively treated. Among these 50 (62.5%) patients were completely recovered. Cerebrospinal fluid leak was the most common complication and was found in 13 (16.25%) cases. Conclusion: The use of antibiotics and anticonvulsants had effective results during peri-operative periods to avoid infection and epilepsy. The initial stage of operation is particularly necessary when the fracture is larger than 5mm. Cerebrospinal fluid leaks occur after surgery as the most common complication.	[Arain, Safdar Hussain; Narejo, Mumtaz Ali] Pir Abdul Qadir Shah Jeelani Inst Med Sci, Dept Neurosurg, Gambat, Pakistan; [Shaikh, Muhammad Aslam] Shaheed Mohtarma Benazir Bhutto Med Univ, Chandka Med Coll, Dept Neurosurg, Larkana, Pakistan; [Ansari, Najmus Saqib] Ghulam Muhammad Mahar Med Coll Sukkur, Dept Neurosurg, Sukkur, Sindh, Pakistan; [Mari, Abdul Razaque] Peoples Univ Med & Hlth Sci, Dept Neurosurg, Nawabshah, Pakistan		Arain, SH (corresponding author), Pir Abdul Qadir Shah Jeelani Inst Med Sci, Dept Neurosurg, Gambat, Pakistan.	drsafdararain@gmail.com					Al-Haddad SA, 2002, ANN ROY COLL SURG, V84, P196; Ali L, 2021, J SAIDU MED COLL SWA, V11, P30; Ali M, 2003, J POSTGRAD MED I, V17, P116; Asif M, 2017, PAK J NEUROL SURG, V21, P144; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Dhandapani S, 2015, WORLD NEUROSURG, V84, P1244, DOI 10.1016/j.wneu.2015.05.058; Ebtehaj M, 2012, IRISH J MED SCI, V181, P77, DOI 10.1007/s11845-011-0768-3; HEARY RF, 1993, J TRAUMA, V35, P441, DOI 10.1097/00005373-199309000-00018; Khan IU, 2008, RAWAL MED J, V33, P228; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Mendelow A D, 1983, J R Coll Surg Edinb, V28, P80; Mossop D, 2005, ANN ROY COLL SURG, V87, P188, DOI 10.1308/1478708051630; Muhammad G, 2020, PJNS, V24, P350; Mukherjee KK, 2015, ACTA NEUROCHIR, V157, P305, DOI 10.1007/s00701-014-2296-1; Mushtaq A, 2010, PAK J NEUROL SURG, V14, P11; Nnadi M O N, 2014, Niger Postgrad Med J, V21, P311; Rehman L, 2007, JCPSP-J COLL PHYSICI, V17, P140; Rolekar Nikita G, 2014, IJMHS, V3, DOI [10.5455/ijmsph.2014.271020141, DOI 10.5455/IJMSPH.2014.271020141]; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186	21	0	0	0	0	LAHORE MEDICAL & DENTAL COLL	LAHORE	CANAL BANK N, TULSPURA, LAHORE, 00000, PAKISTAN	1996-7195			PAK J MED HEALTH SCI	Pak. J. Med. Health Sci.	JUN	2021	15	6					1484	1486		10.53350/pjmhs211561484			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TT0KE	WOS:000680039800083		Bronze			2022-02-07	
J	Bae, S; Song, SW; Kim, WJ; Kang, Y; Kang, KW; Park, CB; Kang, JH; Bu, JH; Lee, SK; Ko, SY				Bae, SooJin; Song, Sung Wook; Kim, Woo Jeong; Kang, YoungJoon; Kang, Kyeong Won; Park, Chang Bae; Kang, Jeong Ho; Bu, Ji Hwan; Lee, Sung Kgun; Ko, Seo Young			Traumatic brain injury in patients aged >= 65 years versus patients aged >= 80 years: a multicenter prospective study of mortality and medical resource utilization	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Geriatrics; Brain injuries; traumatic; Mortality	OLDER-ADULTS; GERIATRIC TRAUMA; CARE; OUTCOMES; RESUSCITATION; DISCHARGE; ORDERS	Objective This study aimed to determine whether there is a difference in mortality and medical resource utilization between geriatric (aged >= 65 years) and super-geriatric patients (aged >= 80 years) with traumatic brain injury (TBI). Methods We obtained comprehensive data (demographics, injury characteristics, injury severities, and outcomes) of geriatric and super-geriatric TBI patients from an emergency departmentbased injury surveillance system database from 2011 to 2016. Multivariate logistic regression analysis was performed to compare the mortality and nonroutine discharge (NRDC) status between both groups. Results Among 442,533 TBI patients, 48,624 were older than 65 years. A total of 48,446 patients (37,140 geriatric and 11,306 super-geriatric) without exclusion criteria were included in the final analysis. Both overall in-hospital mortality (adjusted odds ratio, 1.88; 95% confidence interval [CI], 1.28 to 2.74; P = 0.001) and NRDC (adjusted odds ratio, 1.35; 95% CI, 1.07 to 1.71; P = 0.011) were significantly higher in the super-geriatric group. In the stratified analysis, there were no significant differences in NRDC rate for all stratifications of treatment timing (emergency department vs. ward admission), but mortality remained to be significant for all stratifications. Conclusion Super-geriatric TBI patients showed a significantly higher risk-adjusted overall mortality and more inadequate medical resource utilization than did geriatric TBI patients. However, super-geriatric patients were more likely to undergo NRDC after admission; thus, further research about age-related health inequalities is needed in the treatment of super-geriatric patients.	[Bae, SooJin; Park, Chang Bae; Bu, Ji Hwan; Ko, Seo Young] Jeju Natl Univ Hosp, Dept Emergency Med, Jeju, South Korea; [Song, Sung Wook; Kim, Woo Jeong; Kang, Kyeong Won; Kang, Jeong Ho; Lee, Sung Kgun] Jeju Natl Univ, Dept Emergency Med, Sch Med, 15 Aran 13 Gil, Jeju 63241, South Korea; [Kang, YoungJoon] Jeju Natl Univ, Dept Med Educ, Sch Med, Jeju, South Korea		Song, SW (corresponding author), Jeju Natl Univ, Dept Emergency Med, Sch Med, 15 Aran 13 Gil, Jeju 63241, South Korea.	sungwook78@jejunu.ac.kr			Research of Korea Centers for Disease Control and Prevention	This research was supported by the Research of Korea Centers for Disease Control and Prevention.	Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Dean D, 2015, ACAD EMERG MED, V22, P54, DOI 10.1111/acem.12555; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hanson CW, 1999, CRIT CARE MED, V27, P270, DOI 10.1097/00003246-199902000-00030; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McKevitt EC, 2003, CAN J SURG, V46, P211; McKinley BA, 2000, ARCH SURG-CHICAGO, V135, P688, DOI 10.1001/archsurg.135.6.688; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; Statistics Korea, 2019, POP STAT PROSP WORLD; Statistics Korea, 2019, POPULATION PROJECTIO; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	24	0	0	0	0	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	JUN	2021	8	2					94	102		10.15441/ceem.20.045			9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	TC5CL	WOS:000668656300004	34237814	Green Published, gold			2022-02-07	
J	Baghel, A; Keshav, K; Kumar, A; Sharma, P				Baghel, Anurag; Keshav, Kumar; Kumar, Amit; Sharma, Pulak			Clinicoradiological Outcome of Concomitant Fractures of Proximal Femur and Femoral Shaft Treated With Second-Generation Cephalomedullary Nailing	CUREUS			English	Article						ipsilateral; concomitant; hip; femoral shaft; femoral neck; intertrochanteric; fracture; cephalomedullary nail; proximal femoral nail; pfn	CONCURRENT IPSILATERAL FRACTURES; HIP; NECK; FIXATION	Background The ideal modality of treatment of concomitant fractures of the hip (intertrochanteric/femoral neck) and the femoral shaft is still evolving. The aim of our retrospective study was to assess the clinicoradiological outcome of such fractures managed by closed second-generation cephalomedullary nailing. Methodology The study was conducted among skeletally mature patients presenting within one week of injury who underwent closed second-generation cephalomedullary nailing (proximal femoral nail). Those presenting beyond one week or those who had pathological fractures, incomplete follow-ups, or other modes of fixation were excluded. Functional results were evaluated according to Friedman and Wyman's clinical assessment system. Time required for fracture healing and the presence of any complications were also noted. Results A total of 10 patients with the ipsilateral hip (five intertrochanteric and five femoral neck) and femoral shaft fractures were included in the study. Associated injuries found included fractures of the ipsilateral tibia/fibula at varying levels in three patients; hand and wrist injuries in two patients; and contralateral femoral shaft fracture, ipsilateral patella, bilateral crush injury of the foot, and head and chest injury with brachial plexus injury in one patient each. Four patients were diagnosed with intra-articular knee injuries (ligamentous and meniscal injuries) postoperatively. At the final follow-up, the functional outcome results were good in four, fair in one, and poor in five patients. All femoral neck fractures united at a mean of 15.2 weeks (range: 12.0-18.0 weeks) and intertrochanteric fractures at a mean of 14.0 weeks (range: 12.0-22.0 weeks). However, there was residual varus malunion in two intertrochanteric fractures. Eight femoral shaft fractures were infra-isthmic; of these, four resulted in nonunion (two of hypertrophic and two of atrophic type) and two were found to be in the delayed union, which eventually united by 24 weeks. Conclusions Second-generation cephalomedullary nail is an acceptable, cost-effective, and minimally invasive alternative for the management of concomitant ipsilateral fractures of the hip and supra-isthmic or isthmic femoral shaft fractures. For infra-isthmic fractures, retrograde femoral nail or distal femoral plate along with a separate implant for addressing the hip fracture (either cannulated cancellous screw or dynamic hip screw, preferably in a rendezvous/overlapping manner) are better options.	[Baghel, Anurag; Keshav, Kumar; Kumar, Amit; Sharma, Pulak] Sanjay Gandhi Postgrad Inst Med Sci, Orthopaed, Lucknow, Uttar Pradesh, India		Keshav, K (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Orthopaed, Lucknow, Uttar Pradesh, India.	keshav4700@yahoo.co.in	KESHAV, KUMAR/AAX-2960-2020	KESHAV, KUMAR/0000-0002-2164-0029			Alho A, 1996, ACTA ORTHOP SCAND, V67, P19, DOI 10.3109/17453679608995603; Alho A, 1997, ANN CHIR GYNAECOL FE, V86, P326; Angelini Andrea, 2021, Eur J Orthop Surg Traumatol, V31, P1345, DOI 10.1007/s00590-021-02873-w; Bali K, 2013, CHIN J TRAUMATOL, V16, P40, DOI 10.3760/cma.j.issn.1008-1275.2013.01.008; Bedi A, 2009, J ORTHOP TRAUMA, V23, P249, DOI 10.1097/BOT.0b013e3181a03675; Boulton CL, 2015, INJURY, V46, P478, DOI 10.1016/j.injury.2014.11.021; CASEY MJ, 1979, J BONE JOINT SURG AM, V61, P503, DOI 10.2106/00004623-197961040-00003; Dahuja A, 2018, INT J RES ORTHOP, V4, P384, DOI [10.18203/issn.2455, DOI 10.18203/ISSN.2455]; FRIEDMAN RJ, 1986, CLIN ORTHOP RELAT R, P188; Gadegone WM, 2013, INDIAN J ORTHOP, V47, P272, DOI 10.4103/0019-5413.109441; Harewood Seun, 2020, Trauma Case Rep, V29, P100346, DOI 10.1016/j.tcr.2020.100346; Jain P, 2004, INJURY, V35, P1031, DOI 10.1016/j.injury.2003.09.039; Kang LQ, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01929-7; Kesemenli Cumhur Cevdet, 2012, Musculoskelet Surg, V96, P117, DOI 10.1007/s12306-012-0206-3; Lambiris E, 2003, ORTHOPEDICS, V26, P305, DOI 10.3928/0147-7447-20030301-10; Lawson E, 2017, CHIN J TRAUMATOL, V20, P155, DOI 10.1016/j.cjtee.2016.07.002; LEUNG KS, 1993, INJURY, V24, P41, DOI 10.1016/0020-1383(93)90082-H; Mohapatra NC, 2017, J ORTHOP TRAUMATOL R, V9, P17; Oh CW, 2006, ARCH ORTHOP TRAUM SU, V126, P448, DOI 10.1007/s00402-006-0161-2; Ostrum RF, 2014, CLIN ORTHOP RELAT R, V472, P2751, DOI 10.1007/s11999-013-3271-5; Seong Yoon Jae, 2019, Hip Pelvis, V31, P190, DOI 10.5371/hp.2019.31.4.190; Shetty MS, 2007, INT ORTHOP, V31, P77, DOI 10.1007/s00264-006-0143-6; Singh R, 2008, J ORTHOP TRAUMATOL, V9, P141, DOI 10.1007/s10195-008-0025-3; Tornetta P, 2007, J BONE JOINT SURG AM, V89A, P39, DOI 10.2106/JBJS.F.00297; Wang Wen-yue, 2012, Orthop Surg, V4, P41, DOI 10.1111/j.1757-7861.2011.00166.x; Wei YP, 2021, MEDICINE, V100; Weinlein JC, 2017, CAMPBELLS OPERATIVE, P2817; Weinlein JC, 2017, CAMPBELLS OPERATIVE, P3081; Wu KT, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-019-1524-z	29	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUN 1	2021	13	6							e15381	10.7759/cureus.15381			12	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SM8HM	WOS:000657839600019	34249534	Green Published, gold			2022-02-07	
J	Bernstein, JPK; Rich, T; McKnight, S; Mehr, J; Ferguson, J; Hughes, A				Bernstein, John P. K.; Rich, Tonya; McKnight, Stefanie; Mehr, Julie; Ferguson, John; Hughes, Adriana			On-road driving test performance in veterans: Effects of age, clinical diagnosis and cognitive measures	JOURNAL OF SAFETY RESEARCH			English	Article						Driving; Older adults; Cognition; Processing speed; Attention	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; DEMENTIA; PREDICTORS; ABILITY; IMPAIRMENT; PREVALENCE; DRIVERS; SAFETY; ADULTS	Introduction: Veterans are at heightened risk of being in a motor-vehicle crash and many fail on-road driving evaluations, particularly as they age. This may be due in part to the high prevalence of age associated conditions impacting cognition in this population, including neurodegenerative diseases (e.g., Alzheimer's Disease) and acquired neurological conditions (e.g., cerebrovascular accident). However, understanding of the impact of referral diagnosis, age and cognition on Veterans' on-road driving performance is limited. Methods: 109 Veterans were referred for a driving evaluation (mean age = 72.0, SD = 11.5) at a driving assessment clinic at the Minneapolis Veterans Affairs Healthcare System. Of the 109 Veterans enrolled, 44 were referred due to a neurodegenerative disease, 37 due to an acquired neurological condition, and 28 due to a non-neurological condition (e.g., vision loss). Veterans completed collection of health history information and administration of cognitive tests assessing visual attention, processing speed, and executive functioning, as well as a standardized, on-road driving evaluation. Results: A total of 17.9% of Veterans failed the on-road evaluation. Clinical diagnostic group was not associated with failure rate. Age was not associated with failure rates in the full sample or within diagnostic groups. After controlling for age, poorer processing speed and selective/divided attention were associated with higher failure rates in the full sample. No cognitive tests were associated with failure rates within diagnostic groups. Conclusion: Referral diagnosis and age alone are not reliable predictors of Veterans' driving performance. Cognitive performance, specifically speed of processing and attention, may be helpful in screening Veterans' driving safety. Practical Applications: Clinicians tasked with assessing Veterans' driving safety should take into account cognitive performance, particularly processing speed and attention, when making decisions regarding driving safety. Age and referral diagnosis, while helpful information, are insufficient to predict outcomes on driving evaluations. (c) 2021 National Safety Council and Elsevier Ltd. All rights reserved.	[Bernstein, John P. K.] Louisiana State Univ, Dept Clin Psychol, Baton Rouge, LA 70803 USA; [Bernstein, John P. K.; Rich, Tonya; McKnight, Stefanie; Mehr, Julie; Ferguson, John; Hughes, Adriana] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Hughes, Adriana] Oregon Ctr Aging & Technol, Portland, OR USA; [Ferguson, John] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Hughes, Adriana] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Bernstein, JPK (corresponding author), Louisiana State Univ, Dept Clin Psychol, Baton Rouge, LA 70803 USA.	jberns16@u.rochester.edu		Rich, Tonya/0000-0002-9419-7259; Bernstein, John/0000-0002-4621-0666			Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Berndt A, 2008, AUSTRALAS J AGEING, V27, P157, DOI 10.1111/j.1741-6612.2008.00300.x; Bernstein JPK, 2019, CLIN NEUROPSYCHOL, V33, P971, DOI 10.1080/13854046.2018.1518490; Bernthal JC, 2020, ROUTL INTERD PERSP, P1, DOI 10.1080/23279095.2020.1769098; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Boulias C, 2006, ARCH PHYS MED REHAB, V87, P1183, DOI 10.1016/j.apmr.2006.06.001; Bowers AR, 2013, ACCIDENT ANAL PREV, V59, P537, DOI 10.1016/j.aap.2013.06.037; Brown LB, 2004, J GERIATR PSYCH NEUR, V17, P232, DOI 10.1177/0891988704269825; FITTEN LJ, 1995, JAMA-J AM MED ASSOC, V273, P1360, DOI 10.1001/jama.273.17.1360; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Frittelli C, 2009, INT J GERIATR PSYCH, V24, P232, DOI 10.1002/gps.2095; Kawano N, 2012, AGING CLIN EXP RES, V24, P285, DOI 10.1007/BF03325260; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Krahl PL, 2010, AM J PREV MED, V38, pS189, DOI 10.1016/j.amepre.2009.10.024; Krull MAR, 2004, MIL MED, V169, P926, DOI 10.7205/MILMED.169.11.926; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lincoln Andrew E, 2006, Traffic Inj Prev, V7, P31, DOI 10.1080/15389580500412028; Lincoln NB, 2006, INT J GERIATR PSYCH, V21, P1044, DOI 10.1002/gps.1604; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; Niewoehner PM, 2012, J AM GERIATR SOC, V60, P2070, DOI 10.1111/j.1532-5415.2012.04201.x; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Pope CN, 2017, ACCIDENT ANAL PREV, V98, P123, DOI 10.1016/j.aap.2016.09.030; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Seelye A, 2017, J ALZHEIMERS DIS, V59, P1427, DOI 10.3233/JAD-170116; SEKULER R, 1986, J OPT SOC AM A, V3, P864, DOI 10.1364/JOSAA.3.000864; Sibener L, 2014, ALZHEIMERS DEMENT, V10, pS105, DOI 10.1016/j.jalz.2014.04.011; Silva MT, 2009, REV ASSOC MED BRAS, V55, P484, DOI 10.1590/S0104-42302009000400027; Strayer DL, 2004, HUM FACTORS, V46, P640, DOI 10.1518/hfes.46.4.640.56806; US Bureau of Labor, 2016, BLS NEWS RELEASE; Verster JC, 2005, CURR PSYCHIATRY REV, V1, P215, DOI 10.2174/1573400054065613; Wickens CM, 2008, ACCIDENT ANAL PREV, V40, P1223, DOI 10.1016/j.aap.2008.01.006; Woodall KA, 2014, AM J PREV MED, V46, P350, DOI 10.1016/j.amepre.2013.11.015	39	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	JUN	2021	77						40	45		10.1016/j.jsr.2021.01.005			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	SO4VT	WOS:000658972700005	34092326				2022-02-07	
J	Betthauser, LM; Forster, JE; Bortz, A; Penzenik, M; Hernandez, TD; Bahraini, N; Brenner, LA				Betthauser, Lisa M.; Forster, Jeri E.; Bortz, Ann; Penzenik, Molly; Hernandez, Theresa D.; Bahraini, Nazanin; Brenner, Lisa A.			Strength and awareness in action: Feasibility of a yoga-based intervention for post-acute mild TBI headaches among veterans	CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS			English	Article						Yoga; Post-concussive headaches; mTBI; Veterans	HEALTH; CARE	Background: Mild traumatic brain injury (mTBI) is a signature injury sustained by Veterans during recent conflicts. For some, mTBI/concussion is associated with disabling symptoms, including post-concussive headaches (PCH). However, there are limited evidence-based treatments for persistent PCH. Objective: Investigators assessed the feasibility of design elements of a yoga-based interventional trial for PCH among Veterans, as well as the acceptability of the intervention. Methods: This randomized controlled acceptability and feasibility trial was implemented using a waitlist-control design. Design elements of interest included: an exercise run-in class; recruitment and retention strategies; and, ecological momentary assessment (EMA) modalities to track headaches and yoga practice. Veteran satisfaction regarding the intervention was also evaluated. A descriptive analysis was conducted on candidate outcomes including PCH, post-concussive symptoms, pain, and daily functioning. Results: Twenty-seven participants (out of 70 consented and eligible after Study Visit 1) completed each evaluation timepoint and regularly attended yoga sessions, with 89% of these Veterans reporting moderate to high levels of satisfaction with the intervention at study completion. Qualitatively, participants endorsed improvements in headaches, chronic pain, and mood. Feasibility results were mixed. Initial feasibility criterion regarding yoga attendance was not met; however, modifications, such as expansion to an additional clinic site and reduction of in-person yoga sessions with increased encouragement to use study-created online yoga videos improved feasibility of the study design. Participants most frequently used mobile and web-based EMA modalities to track yoga practice. Conclusions: Although challenges with feasibility of the study design elements were noted, results suggested acceptability of the yoga-based intervention for Veterans with persistent PCH. Additional exploration regarding the frequency and modality of yoga delivery (e.g., in-person, telehealth) is warranted. Impact: Veterans found the yoga-based intervention acceptable, however exploration of novel modalities of intervention delivery will likely be necessary to enhance the feasibility of intervention implementation during future trials.	[Betthauser, Lisa M.; Forster, Jeri E.; Bortz, Ann; Penzenik, Molly; Hernandez, Theresa D.; Bahraini, Nazanin; Brenner, Lisa A.] Rocky Mt Reg VA, Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 N Wheeling St, Aurora, CO 80045 USA; [Betthauser, Lisa M.; Forster, Jeri E.; Bortz, Ann; Hernandez, Theresa D.; Bahraini, Nazanin; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Anschutz Med Campus,12631 E 17th Ave,Rm1201G, Aurora, CO 80045 USA; [Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Muenzinger D244,345 UCD, Boulder, CO 80309 USA; [Bahraini, Nazanin; Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus,13001 E 17th Pl,Q20-C2000, Aurora, CO 80045 USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus,13001 E 17th Pl,Q20-C2000, Aurora, CO 80045 USA		Betthauser, LM (corresponding author), Rocky Mt Reg VA, Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 N Wheeling St, Aurora, CO 80045 USA.	Lisa.Betthauser@va.gov; Jeri.Forster@cuanschutz.edu; annbortz@yahoo.com; Molly.Penzenik@va.gov; Theres.hernandez@colorado.edu; Nazanin.Bahraini@va.gov; Lisa.Brenner@v.gov			Colorado Traumatic Brain Injury Trust Fund [10 13 74]	This study was funded by the Colorado Traumatic Brain Injury Trust Fund (part of the MINDSOURCE Brain Injury Network) , Contract IHEA #10 13 74 .	Anheyer D, 2020, J GEN INTERN MED, V35, P846, DOI 10.1007/s11606-019-05413-9; Arean P. A., 2013, HIGH QUALITY PSYCHOT; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Chang Douglas G, 2016, J Orthop Rheumatol, V3, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Da vi s D. M, 2011, PSYCHOTHERAPY, V48, P208; Digre KB, 2019, HEADACHE, V59, P1, DOI 10.1111/head.13456; Elwy AR, 2014, AM J PREV MED, V47, P220, DOI 10.1016/j.amepre.2014.03.012; Fe el ey N, CAN J NURS RES, V41, P85; First M., 2015, STRUCTURED CLIN INTE; Flegal K. E., 2007, BMC COMPLEM ALTERN M, V7, P37, DOI [DOI 10.1186/1472-6882-7-37, 10.1186/1472-6882-7-37]; Fraser F, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0624-x; Ga la nt in o M. L, 2004, ALTERNATIVE THER HLT, V10, P56; Groessl EJ, 2008, J ALTERN COMPLEM MED, V14, P1123, DOI 10.1089/acm.2008.0020; Has on-Ohayon I., 2006, PSYCHOL SERV, V3, P262; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Mahoney L., 2017, BMC COMPL ALTERNATIV, V17, P198; Mathersul Danielle C, 2018, Glob Adv Health Med, V7, p2164956118766011, DOI 10.1177/2164956118766011; Miller CJ, 2016, TELEMED E-HEALTH, V22, P847, DOI 10.1089/tmj.2015.0190; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Park CL, 2014, COMPLEMENT THER MED, V22, P920, DOI 10.1016/j.ctim.2014.08.008; Patwardhan AR, 2017, J PRIM CARE COMMUNIT, V8, P31, DOI 10.1177/2150131916664682; Pew Research Center, 2019, INTERNET TECHNOLOGY; Proudfoot J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1475; Ro ss A, 2012, EVID BASED COMPLEMEN, V2012; Saper RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/658030; Se lm an L, 2015, BMC COMPL ALTERNATIV, V15, P21; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Snowden Austyn, 2011, Br J Nurs, V20, P220; Ta ss or el li C, 2018, CEPHALALGIA, V38, P815; Te rr io H, 2009, J HEAD TRAUMA REHAB, V24, P14; Th ee le r B. J, 2009, HEADACHE, V49, P529; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tilbrook HE, 2011, ANN INTERN MED, V155, P569, DOI 10.7326/0003-4819-155-9-201111010-00003; To ro us J, 2014, JMIR MHEALTH UHEALTH, V2; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Williams K, 2009, SPINE, V34, P2066, DOI 10.1097/BRS.0b013e3181b315cc	40	0	0	1	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA		2451-8654		CONT CLIN TRIAL COMM	Contemp. Clin. Trials Commun.	JUN	2021	22								100762	10.1016/j.conctc.2021.100762			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	SY2XJ	WOS:000665755200009	34013090	gold, Green Published			2022-02-07	
J	Bourdillon, A; Salehi, PP; Steren, B; Pei, KY; Lee, YH				Bourdillon, Alexandra; Salehi, Parsa P.; Steren, Benjamin; Pei, Kevin Y.; Lee, Yan Ho			Characterizing Epidemiology and Associated-Factors of Adolescent Sports-Related Traumas Using Trauma Quality Improvement Program	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Firearms; law enforcement; legal intervention; trauma	CRANIOFACIAL FRACTURES; INJURIES; OUTCOMES	Sports-related injuries contribute to a considerable proportion of pediatric and adolescent craniofacial trauma, which can have severe and longstanding consequences on physical and mental health. The growing popularity of sports within this at-risk group warrants further characterization of such injuries in order to enhance management and prevention strategies. In this study, the authors summarized key trends in 1452 sports-related injuries among individuals aged 16 to 19 using the American College of Surgeon's Trauma Quality Improvement Program database from 2014 to 2016. The authors observed a preponderance of injuries associated with skateboarding, snowboarding, and skiing, with significantly higher percentages of traumatic brain injuries among skateboarding-related traumas. Notably, we observed that traumatic brain injurie rates were slightly higher among subjects who wore helmets. Intensive care unit durations and hospital stays appeared to vary by sport and craniofacial fracture. Altogether, this study contributes to the adolescent sports-related injuries and craniofacial trauma literature.	[Bourdillon, Alexandra; Steren, Benjamin] Yale Sch Med, New Haven, CT USA; [Salehi, Parsa P.; Lee, Yan Ho] Yale Sch Med, Div Otolaryngol, Dept Surg, New Haven, CT USA; [Pei, Kevin Y.] Parkview Hlth, Dept Surg, Ft Wayne, IN USA		Lee, YH (corresponding author), Yale Sch Med, Otolaryngol, 47 Coll Pl,2nd Floor, New Haven, CT 06510 USA.	yan.lee@yale.edu	Pei, Kevin/AAU-2584-2021	Steren, Benjamin/0000-0003-0598-3467			Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; [Anonymous], 2019, SPORTS SAFETY CHILD; [Anonymous], WHAT ARE POSSIBLE EF; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Esquivel AO, 2015, SPORTS HEALTH, V7, P366, DOI 10.1177/1941738115579854; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Hornor MA, 2018, CURR TRAUMA REP, V4, P160, DOI 10.1007/s40719-018-0127-1; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Madigan DJ, 2018, J SPORT SCI, V36, P545, DOI 10.1080/02640414.2017.1322709; Meehan WP, 2013, PEDIATR EMERG CARE, V29, P624, DOI 10.1097/PEC.0b013e31828e9cea; Michaud P A, 2001, Inj Prev, V7, P41, DOI 10.1136/ip.7.1.41; Salehi PP, 2020, LARYNGOSCOPE, V130, pE824, DOI 10.1002/lary.28690; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Singh DJ, 2004, CLIN PLAST SURG, V31, P499, DOI 10.1016/j.cps.2004.03.012; Torabi SJ, 2020, J CRANIOFAC SURG, V31, P1232, DOI 10.1097/SCS.0000000000006425; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Witt PA, 2018, J PARK RECREAT ADM, V36, P191, DOI 10.18666/JPRA-2018-V36-I3-8618; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023; YAMAMOTO L G, 1991, Pediatric Emergency Care, V7, P267, DOI 10.1097/00006565-199110000-00002	24	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUN	2021	32	4					1618	1621		10.1097/SCS.0000000000007619			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	SS2TX	WOS:000661595100122	33741887				2022-02-07	
J	Buttner, F; Howell, DR; Iverson, GL; Doherty, C; Blake, C; Ryan, J; Delahunt, E				Buttner, Fionn; Howell, David R.; Iverson, Grant L.; Doherty, Cailbhe; Blake, Catherine; Ryan, John; Delahunt, Eamonn			Participation in pre-injury level sport one-year following sport-related concussion: A prospective, matched cohort study	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Sports; Wounds and injuries; Return to sport; Psychology	HIGH-SCHOOL; RETURN; TIME; SUPPORT; ANXIETY; IMPACT; RISK	Objectives: To estimate the times taken to receive clearance to return to sporting activity and to return to pre-injury level of sport competition following sport-related concussion, and to estimate the proportion of athletes who were participating at their pre-injury level of sport competition six months and one-year following sport-related concussion. Design: Prospective cohort study. Methods: Amateur, adult athletes (16-38 years old) were diagnosed with sport-related concussion at a university-affiliated hospital emergency department. Participants were assessed within one-week, upon medical clearance to return to sporting activity, two weeks following return to sporting activity, six months, and 12 months following sport-related concussion. We assessed sex-, age-, and activity matched non-injured, control participants at matched time-points. Participants were asked during each study assessment whether they were participating in any sport, in a different sport than before their sport-related concussion, in the same sport but at a lower level of competition than before their sport related concussion, or in the same sport at the same level of competition than before their sport-related concussion. Results: Fifty concussed participants and 50 non-injured, control participants completed the study. The median times taken to receive clearance to return to sporting activity and to return to pre-injury level of sport competition following sport-related concussion were 13 days (95%CI = 12,16) and 31 days (95%CI = 28,32), respectively. One-year following sport-related concussion, 52% of participants reported that they were no longer participating in the same sport and at the same level of competition as they were before their sport-related concussion, compared with only 24% of participants in the non-injured, control group (p = 0.003). Conclusions: A greater percentage of athletes in the concussion group were not participating at their perceived pre-injury level of sport competition one-year following sport-related concussion compared with a non-injured control group. Factors that explain the lower proportion of amateur athletes participating at their pre-injury level of sport competition one-year after sport-related concussion are likely multifaceted and should be considered in future investigations. (c) 2021 Sports Medicine Australia. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Buttner, Fionn; Doherty, Cailbhe; Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Ryan, John] St Vincents Univ Hosp, Emergency Dept, Dublin, Ireland; [Blake, Catherine; Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin, Ireland		Buttner, F (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland.	fionn.cleirigh-buttner@ucdconnect.ie		Doherty, Cailbhe/0000-0002-5284-856X	Government of Ireland Postgraduate Research Scholarship by the Irish Research Council; ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.); National Football League	Fionn Buttner is the recipient of a Government of Ireland Postgraduate Research Scholarship awarded by the Irish Research Council, which funded the current research study. Grant Iverson, Ph.D. serves as a scientific advisor for BioDirection, Inc., Sway Operations, LLC, and Highmark, Inc. He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.) . He has an independent practice in forensic neuropsychology, including expert testimony, in matters relating to mild TBI. He has received research funding as a principal investigator from the National Football League, and salary support as a collaborator from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. He acknowledges unrestricted philanthropic support from the MooneyReed Charitable Foundation, Heinz Family Foundation, ImPAC (R) Applications, Inc., and Spaulding Research Institute.	Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ardern CL, 2014, BRIT J SPORT MED, V48, P1543, DOI 10.1136/bjsports-2013-093398; Ardern CL, 2014, BRIT J SPORT MED, V48, P1613, DOI 10.1136/bjsports-2014-093842; Ardern CL, 2013, AM J SPORT MED, V41, P1549, DOI 10.1177/0363546513489284; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Cross M, 2015, BR J SPORTS MED; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Navarro SM, 2017, ORTHOP J SPORTS MED, V5; Ramkumar PN, 2018, ORTHOP J SPORTS MED, V6; Ramkumar PN, 2019, AM J SPORT MED, V47, P2287, DOI 10.1177/0363546519859542; Reiman MP, 2018, BRIT J SPORT MED, V52, P972, DOI 10.1136/bjsports-2017-098696; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wayment HA, 2020, J AM COLL HEALTH, V68, P438, DOI 10.1080/07448481.2019.1577863; Worner T, 2018, BRIT J SPORT MED, V52, P1475, DOI 10.1136/bjsports-2018-099154	30	0	0	6	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUN	2021	24	6					561	566		10.1016/j.jsams.2020.12.014			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SD8QU	WOS:000651641700010	33495041	hybrid			2022-02-07	
J	Cheradame, J; Piscione, J; Carling, C; Guinoiseau, JP; Dufour, B; Jacqmin-Gadda, H; Decq, P				Cheradame, Jeremy; Piscione, Julien; Carling, Christopher; Guinoiseau, Jean-Pierre; Dufour, Bernard; Jacqmin-Gadda, Helene; Decq, Philippe			Incidence and Risk Factors in Concussion Events: A 5-Season Study in the French Top 14 Rugby Union Championship	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; rugby; epidemiology; longitudinal study; incidence; multivariate analysis	INJURY RISK; EPIDEMIOLOGY	Background: Concussions are a source of major concern in rugby, and a limited number of studies have attempted to identify risk factors for these injuries. Purpose: To investigate the incidence of match concussion and associated risk factors, including individual workload, anthropometric variables, playing position, and season phase, in elite rugby union players. Study Design: Case-control study; Level of evidence 3. Methods: All concussions and explanatory variables were collected for every match over 5 consecutive seasons (2014-2018) in 1334 professional players participating in the French Top 14 championship. Concussion risk was estimated using mixed effects Poisson regression. Results: Mean match concussion incidence equated to 10.4 (95% CI, 9.3-11.5) concussions for 1000 hours of game exposure. A peak was reached in the 2016-2017 season (13.7; 95% CI, 11.0-16.5). A greater risk was observed in the playoffs as compared with the first phase of the season (incidence rate ratio, 3.96; 95% CI, 2.10-7.35). In comparison with other positions, half-backs incurred the highest rate of concussion events (incidence, 16.1; 95% CI, 11.8-20.3). Irrespective of playing position, those with greater height and lower body mass reported a higher risk of concussions (P = .02), especially during tackling actions for lighter players (P = .01) and during other match events for taller players (P = .03). When adjusted for season phase, players who had accumulated a higher amount of playing time since the beginning of the season demonstrated a lower risk of concussion (P = .005). Conclusion: Inter- and intraseasonal variations in concussion rates were observed. Within positional groups, lighter and taller players were more at risk, with the highest incidence generally observed in half-backs. Workload was measured by the number of matches played before a concussion event, and it appeared to have a protective rather than deleterious effect on concussion risk.	[Cheradame, Jeremy; Piscione, Julien; Carling, Christopher; Guinoiseau, Jean-Pierre; Dufour, Bernard; Jacqmin-Gadda, Helene; Decq, Philippe] French Rugby Federat, Marcoussis, France; [Cheradame, Jeremy; Piscione, Julien; Carling, Christopher] French Rugby Union Federat, Res Dept, 3-5 Rue Jean Montaigu, F-91460 Marcoussis, France; [Guinoiseau, Jean-Pierre] French Rugby Union Federat, Med Dept, Marcoussis, France; [Dufour, Bernard] French Natl Rugby League, Med Dept, Paris, France; [Jacqmin-Gadda, Helene] Univ Bordeaux, ISPED, Bordeaux Populat Hlth U1219, INSERM, Bordeaux, France; [Decq, Philippe] Arts & M Tiers ParisTech, Inst Biomecan Humaine Georges Charpak, Clichy, France; [Decq, Philippe] Univ Paris, Hop Beaujon, Assistance Publ Hop Paris, Neurochirurg, Clichy, France		Cheradame, J (corresponding author), French Rugby Union Federat, Res Dept, 3-5 Rue Jean Montaigu, F-91460 Marcoussis, France.	jeremy.cheradame@ffr.fr					Akinwande M.O., 2015, OPEN J STAT, V5, P754, DOI [DOI 10.4236/OJS.2015.57075, 10.4236/ojs.2015.57075]; Anstiss T., 2019, ENGLAND PROFESSIONAL; Brooks JHM, 2011, BRIT J SPORT MED, V45, P765, DOI 10.1136/bjsm.2009.066985; Burger N., LONG TERM EFFECTS CO; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Cross MJ, 2016, INT J SPORT PHYSIOL, V11, P350, DOI 10.1123/ijspp.2015-0187; Davidow D, 2020, J SCI MED SPORT, V23, P1105, DOI 10.1016/j.jsams.2020.04.005; Davidow D, 2018, J SCI MED SPORT, V21, P1025, DOI 10.1016/j.jsams.2018.04.003; Fuller CW, 2020, SA J. Sports Med., V32, P1, DOI [10.17159/2078-516x/2020/v32i1a8062, 10.17159/2078-516X/2020/v32i1a8062]; Fuller CW, 2017, BRIT J SPORT MED, V51, P51, DOI 10.1136/bjsports-2016-096275; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Rafferty J, 2019, BRIT J SPORT MED, V53, P969, DOI 10.1136/bjsports-2017-098417; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Williams S, 2017, SPORTS MED, V47, P2395, DOI 10.1007/s40279-017-0721-3; Williams S, 2017, BRIT J SPORT MED, V51, P209, DOI 10.1136/bjsports-2016-096589	22	0	0	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2021	49	7					1921	1928		10.1177/03635465211006480			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	SN0FI	WOS:000657972800027	33861663				2022-02-07	
J	Chiappini, A; Greuter, L; Mariani, L; Guzman, R; Soleman, J				Chiappini, Alessio; Greuter, Ladina; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda			Mortality and Outcome in Patients Older Than 80 Years of Age Undergoing Burr-Hole Drainage of Chronic Subdural Hematoma	WORLD NEUROSURGERY			English	Article						Burr-hole drainage; Chronic subdural hematoma; Elderly; Geriatric neurosurgery; Mortality; Outcome; Traumatic brain injury	LOW-DOSE ASPIRIN; ANTITHROMBOTIC AGENTS; RECURRENCE; EVACUATION; RESUMPTION; SURGERY	OBJECTIVE: Chronic subdural hematoma is frequently seen within the elderly population and neurosurgeons are confronted with patients older than 80 years presenting with symptomatic chronic subdural hematoma. However, data on surgical outcome are scarce. The aim of this study is to analyze the mortality and outcome after burr-hole drainage in patients older than 80 years. METHODS: This is a single-center retrospective study including patients who underwent burr-hole drainage of chronic subdural hematoma between the years 2016 and 2019. The cohort was divided into 3 age groups (80e84 years; 85-89 years; >90 years). Primary outcome was 30-day and overall mortality, whereas secondary outcome measures were recurrence rates, postoperative bleeding rates, and outcome measured by the modified ranking scale. Uni- and multivariate analysis was conducted to assess for potential risk factors for mortality, recurrence and postoperative bleeding rates. RESULTS: In total, 107 patients with a mean age of 85.5 +/- 3.9 years were included. Mortality rate was less than 10% in each group, showing no significant difference between them (P = 0.455). No significant difference in recurrence and postoperative bleeding rates was seen (P = 0.491 and P = 0.532). Modified Ranking scale score differed significantly at release, whereas at follow-up no difference was seen. After uni- and multivariate analysis, age was not correlated with higher recurrence, postoperative bleeding, or mortality rates. Preoperative midline shift was found to be an independent risk factor for recurrence. CONCLUSIONS: In patients older than 80 years undergoing burr-hole drainage for chronic subdural hematoma, age was not directly correlated with higher recurrence, postoperative bleeding, or mortality rates.	[Chiappini, Alessio; Greuter, Ladina; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda] Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland; [Chiappini, Alessio; Mariani, Luigi; Guzman, Raphael; Soleman, Jehuda] Univ Basel, Fac Med, Basel, Switzerland		Chiappini, A (corresponding author), Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland.; Chiappini, A (corresponding author), Univ Basel, Fac Med, Basel, Switzerland.	alessio.chiappini@icloud.com	Chiappini, Alessio/ABC-7435-2020	Chiappini, Alessio/0000-0002-3573-7032			Adhiyaman V, 2017, QJM-INT J MED, V110, P375, DOI [10.1093/qjmed/hcw231, 10.1093/qjmed/hcx143]; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Christopher E, 2019, NEUROSURG REV, V42, P427, DOI 10.1007/s10143-018-0979-4; De Bonis P, 2018, CLIN NEUROL NEUROSUR, V170, P88, DOI 10.1016/j.clineuro.2018.05.002; Dumont TM, 2013, WORLD NEUROSURG, V80, P889, DOI 10.1016/j.wneu.2012.06.026; Eaton J, 2018, WORLD J SURG, V42, P1248, DOI 10.1007/s00268-017-4285-z; FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457; Fornebo I, 2017, ACTA NEUROCHIR, V159, P2045, DOI 10.1007/s00701-017-3330-x; Fukui S, 1993, No To Shinkei, V45, P449; Greuter L, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20489; He C, 2021, NEUROSURG REV, V44, P479, DOI 10.1007/s10143-019-01218-w; Kamenova M, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3064-y; Kamenova M, 2017, WORLD NEUROSURG, V100, P594, DOI 10.1016/j.wneu.2017.01.065; Kamenova M, 2016, NEUROSURGERY, V79, P715, DOI 10.1227/NEU.0000000000001393; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Kuhn EN, 2018, WORLD NEUROSURG, V119, pE374, DOI 10.1016/j.wneu.2018.07.168; Lee L, 2016, J NEUROSURG, V124, P546, DOI 10.3171/2014.12.JNS142053; Licci M, 2018, CRIT CARE MED, V46, pE26, DOI 10.1097/CCM.0000000000002804; Martinez-Perez R, NEUROSURG REV; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Phan K, 2018, WORLD NEUROSURG, V109, pE792, DOI 10.1016/j.wneu.2017.10.091; Pilitsis J, 2013, CLIN NEUROL NEUROSUR, V115, P1429, DOI 10.1016/j.clineuro.2013.01.017; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schucht P, 2019, NEW ENGL J MED, V380, P1186, DOI 10.1056/NEJMc1812507; Soleman J, 2019, NEUROSURGERY, V85, pE825, DOI 10.1093/neuros/nyz095; Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398; Stanisic M, 2017, NEUROSURGERY, V81, P752, DOI 10.1093/neuros/nyx090; Stippler M, 2013, NEUROL RES, V35, P243, DOI 10.1179/1743132813Y.0000000163; Surve RM, 2017, J NEUROSURG ANESTH, V29, P274, DOI 10.1097/ANA.0000000000000305; Todeschi J, 2020, NEUROCHIRURGIE, V66, P195, DOI 10.1016/j.neuchi.2020.04.136; Uno M, 2017, NEUROL MED-CHIR, V57, P402, DOI 10.2176/nmc.ra.2016-0337; Wang YS, 2017, J CLIN NEUROSCI, V38, P79, DOI 10.1016/j.jocn.2016.12.001; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1	36	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2021	150						E337	E346		10.1016/j.wneu.2021.03.002			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SM8GR	WOS:000657837500035	33706018				2022-02-07	
J	Chitrala, KN; Nagarkatti, P; Nagarkatti, M				Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi			Computational analysis of deleterious single nucleotide polymorphisms in catechol O-Methyltransferase conferring risk to post-traumatic stress disorder	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						(COMT); Molecular dynamic simulations (MD; simulations); Single nucleotide polymorphism (SNP); Molecular modelling; Mutation	ACCESSIBLE SURFACE-AREA; GENETIC-VARIATION; RECEPTOR GENE; BRAIN-INJURY; DRUG DESIGN; ASSOCIATION; COMT; SYMPTOMS; PROTEIN; ENZYME	Post-traumatic stress disorder (PTSD) is one of the prevalent neurological disorder which is drawing increased attention over the past few decades. Major risk factors for PTSD can be categorized into environmental and genetic factors. Among the genetic risk factors, polymorphisms in the catechol-O-methyltransferase (COMT) gene is known to be associated with the risk for PTSD. In the present study, we analysed the impact of deleterious single nucleotide polymorphisms (SNPs) in the COMT gene conferring risk to PTSD using computational based approaches followed by molecular dynamic simulations. The data on COMT gene associated with PTSD were collected from several databases including Online Mendelian Inheritance in Man (OMIM) search. Datasets related to SNP were downloaded from the dbSNP database. To study the structural and dynamic effects of COMT wild type and mutant forms, we performed molecular dynamics simulations (MD simulations) at a time scale of 300 ns. Results from screening the SNPs using the computational tools SIFT and Polyphen-2 demonstrated that the SNP rs4680 (V158M) in COMT has a deleterious effect with phenotype in PTSD. Results from the MD simulations showed that there is some major fluctuations in the structural features including root mean square deviation (RMSD), radius of gyration (Rg), root mean square fluctuation (RMSF) and secondary structural elements including alpha-helices, sheets and turns between wild-type (WT) and mutant forms of COMT protein. In conclusion, our study provides novel insights into the deleterious effects and impact of V158M mutation on COMT protein structure which plays a key role in PTSD.	[Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Chitrala, Kumaraswamy Naidu] Temple Univ, Fels Canc Inst Personalized Med, Lewis Katz Sch Med, Philadelphia, PA 19140 USA		Chitrala, KN (corresponding author), Temple Univ, Fels Canc Inst Personalized Med, Lewis Katz Sch Med, Philadelphia, PA 19140 USA.	tul53710@temple.edu		Chitrala, Kumaraswamy naidu/0000-0003-0663-9529	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI129788]; TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership; National Cancer Institute of National Institutes of Health (NCI/NIH) [U54 CA221704(5)]	The present study was supported in part by NIH grant R01AI129788, TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704(5) from the National Cancer Institute of National Institutes of Health (NCI/NIH).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amstadter AB, 2011, DIS MARKERS, V30, P89, DOI [10.1155/2011/928497, 10.3233/DMA-2011-0761]; Amstadter AB, 2009, J ANXIETY DISORD, V23, P369, DOI 10.1016/j.janxdis.2008.12.005; Badour CL, 2015, J ANXIETY DISORD, V36, P78, DOI 10.1016/j.janxdis.2015.09.009; Bam M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.185; Bam M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31209; Bam M, 2016, J NEUROIMMUNE PHARM, V11, P168, DOI 10.1007/s11481-015-9643-8; Berhanu WM, 2012, PROTEIN SCI, V21, P1837, DOI 10.1002/pro.2164; Cao Y, 2014, J PHYS CHEM B, V118, P470, DOI 10.1021/jp410296s; Castro-Vale I, 2016, NEUROSCI BIOBEHAV R, V63, P143, DOI 10.1016/j.neubiorev.2016.02.005; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chitrala KN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168404; Cote Y, 2010, P NATL ACAD SCI USA, V107, P19844, DOI 10.1073/pnas.1013674107; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Deslauriers J, 2018, DEPRESS ANXIETY, V35, P32, DOI 10.1002/da.22678; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Donaldson ZR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.226; Duan ZX, 2015, J AFFECT DISORDERS, V188, P210, DOI 10.1016/j.jad.2015.08.066; El-Solh A.A., 2018, SLEEP DISORDERS PATI; Fani N, 2016, DEPRESS ANXIETY, V33, P300, DOI 10.1002/da.22483; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Gasparyan AY, 2013, J KOREAN MED SCI, V28, P1270, DOI 10.3346/jkms.2013.28.9.1270; Gerlt JA, 1997, CHEM BIOL, V4, P259, DOI 10.1016/S1074-5521(97)90069-7; Govindasamy H, 2020, J BIOMOL STRUCT DYN, V38, P5307, DOI 10.1080/07391102.2019.1699446; Gupta MK, 2020, PHYTOCHEMISTRY, V175, DOI 10.1016/j.phytochem.2020.112365; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Hu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r9; Junaid M, 2021, J BIOMOL STRUCT DYN, V39, P3172, DOI 10.1080/07391102.2020.1761879; Kanaan N, 2008, CHEM COMMUN, P6114, DOI 10.1039/b814212b; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kanasaki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08513-w; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kimbrel NA, 2015, PSYCHIAT RES, V229, P326, DOI 10.1016/j.psychres.2015.07.002; Li Y, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa050; Liberzon I, 2014, JAMA PSYCHIAT, V71, P1174, DOI 10.1001/jamapsychiatry.2014.999; Lin LY, 2016, DEPRESS ANXIETY, V33, P323, DOI 10.1002/da.22466; Liu Yutao, 2013, J Depress Anxiety, V2, pS4001; Ma ZG, 2014, BRIT J CLIN PHARMACO, V77, P410, DOI 10.1111/bcp.12169; Magarkar A, 2018, CHEM COMMUN, V54, P3440, DOI 10.1039/c8cc00221e; Michopoulos V, 2015, AM J PSYCHIAT, V172, P353, DOI 10.1176/appi.ajp.2014.14020263; Miller MW, 2015, PSYCHONEUROENDOCRINO, V62, P359, DOI 10.1016/j.psyneuen.2015.09.003; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Murzyn K, 2013, J PHYS CHEM B, V117, P16388, DOI 10.1021/jp408162d; Nagasundaram N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30106; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nissinen E, 2010, INT REV NEUROBIOL, V95, P73, DOI [10.1016/B978-0-12-381326-8-00005-3, 10.1016/B978-0-12-381326-8.00005-3]; Orlowski A, 2011, J PHYS CHEM B, V115, P13541, DOI 10.1021/jp207177p; Pal LR, 2015, J MOL BIOL, V427, P2271, DOI 10.1016/j.jmb.2015.04.014; Patel CN, 2018, J BIOMOL STRUCT DYN, V36, P3938, DOI 10.1080/07391102.2017.1404931; Patra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161868; Pietrzak RH, 2015, J CLIN PSYCHIAT, V76, pE537, DOI 10.4088/JCP.14l09346; Powers A, 2016, J PSYCHIATR RES, V83, P195, DOI 10.1016/j.jpsychires.2016.09.006; Rakofsky JJ, 2012, MOL PSYCHIATR, V17, P22, DOI 10.1038/mp.2011.121; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; Rutherford K, 2009, BIOCHEMISTRY-US, V48, P6450, DOI 10.1021/bi900174v; Sadeh N, 2016, DEPRESS ANXIETY, V33, P308, DOI 10.1002/da.22480; Sak K, 2017, DRUG METAB REV, V49, P56, DOI 10.1080/03602532.2016.1258075; Schacht JP, 2016, PHARMACOGENOMICS J, V16, P430, DOI 10.1038/tpj.2016.43; Scheuer S, 2016, J PSYCHIATR RES, V72, P30, DOI 10.1016/j.jpsychires.2015.10.009; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; SLADEKCHELGREN S, 1981, BIOCHEM GENET, V19, P1037, DOI 10.1007/BF00484563; Solovieff N, 2014, NEUROPSYCHOPHARMACOL, V39, P1872, DOI 10.1038/npp.2014.34; Spagnolo PA, 2016, ALCOHOL CLIN EXP RES, V40, P2426, DOI 10.1111/acer.13210; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Street AG, 1998, FOLD DES, V3, P253, DOI 10.1016/S1359-0278(98)00036-4; Stubelius A, 2012, IMMUNOBIOLOGY, V217, P751, DOI 10.1016/j.imbio.2012.04.010; Tai CH, 2002, ACTA MED OKAYAMA, V56, P1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wei S, 2017, J COMPUT CHEM, V38, P1270, DOI 10.1002/jcc.24709; Wingo AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10106; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Wolf EJ, 2014, J TRAUMA STRESS, V27, P379, DOI 10.1002/jts.21937; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Wu Q, 2019, TOXICOL APPL PHARM, V367, P12, DOI 10.1016/j.taap.2019.01.016; Xuan WJ, 2007, BIOINFORMATICS, V23, P2477, DOI 10.1093/bioinformatics/btm375; Yang ZY, 2019, REACT CHEM ENG, V4, P298, DOI [10.1039/c8re00213d, 10.1039/C8RE00213D]; Zhang JM, 2014, J ANXIETY DISORD, V28, P902, DOI 10.1016/j.janxdis.2014.09.013; Zhou JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094075; J PSYCHIATR NEUROSCI; TRANSL PSYCHIAT	89	0	0	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JUN	2021	138						207	218		10.1016/j.jpsychires.2021.03.048			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	SN8MF	WOS:000658539800007	33865170				2022-02-07	
J	Crasta, JE; Raja, AE; Caffo, BS; Hluchan, CM; Suskauer, SJ				Crasta, Jewel E.; Raja, Altamash E.; Caffo, Brian S.; Hluchan, Christine M.; Suskauer, Stacy J.			The Effect of Age and Competition Level on Subtle Motor Performance in Adolescents Medically Cleared Postconcussion Preliminary Findings	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Concussion; Physical and Neurological Examination of Subtle Signs (PANESS); Motor; Competition Level	NEUROLOGICAL EXAMINATION; POSTURAL STABILITY; SPORT CONCUSSION; RECOVERY; INJURY; BRAIN; SIGNS; SYMPTOMS; CHILDREN; RETURN	Objective The aim of this study was to examine the effect of age and level of competition on subtle motor performance in adolescents who have recently been medically cleared postconcussion and never-injured controls. Design Thirty adolescents who were recently medically cleared postconcussion (12-18 yrs) and 30 never-concussed, typically developing controls were examined using the Revised Physical and Neurological Examination of Subtle Signs (PANESS) and the Immediate Post-Concussion Assessment and Cognitive Testing. Results Older age was associated with better Immediate Post-Concussion Assessment and Cognitive Testing scores in both groups, whereas only the control group showed improved motor performance on the PANESS with increasing age. Adolescents across both groups participating at a higher level of competition (school or travel level) had better motor performance on the PANESS than those participating at a lower level of competition (recreational level or no sports participation). Adolescents medically cleared postconcussion had greater motor deficits on the PANESS than controls did. Conclusion After medical clearance, adolescents with a history of recent concussion demonstrate alterations in the relationship between motor function and age. The PANESS merits further exploration as a measure that is sensitive to factors affecting motor performance, such as age and level of athletic competition, as well as to persistent subtle motor deficits in adolescents medically cleared postconcussion.	[Crasta, Jewel E.; Suskauer, Stacy J.] Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA; [Crasta, Jewel E.] Ohio State Univ, Div Occupat Therapy, Columbus, OH 43210 USA; [Raja, Altamash E.; Hluchan, Christine M.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Caffo, Brian S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA.		Crasta, Jewel/AAV-4936-2021	Crasta, Jewel/0000-0002-5397-6336	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD080378, R01HD090266]; Kennedy Krieger Institute/Johns Hopkins University Intellectual & Developmental Disabilities Research Center (IDDRC) [U54 HD079123]	Supported by the National Institutes of Health (S. J. Suskauer: R21HD080378 and R01HD090266) and the Kennedy Krieger Institute/Johns Hopkins University Intellectual & Developmental Disabilities Research Center (IDDRC) (U54 HD079123).	Barnett LM, 2016, SPORTS MED, V46, P1663, DOI 10.1007/s40279-016-0495-z; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Cole WR, 2008, NEUROLOGY, V71, P1514, DOI 10.1212/01.wnl.0000334275.57734.5f; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crasta JE, 2019, AM J PHYS MED REHAB, V98, P737, DOI 10.1097/PHM.0000000000001110; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; FELDT LS, 1958, PSYCHOMETRIKA, V23, P335, DOI 10.1007/BF02289783; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jadczak L, 2019, J STRENGTH COND RES, V33, P3384, DOI 10.1519/JSC.0000000000002476; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Largo RH, 2003, SWISS MED WKLY, V133, P193; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckay D, 2016, PEDIATR EXERC SCI, V28, P488, DOI 10.1123/pes.2016-0021; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Opstoel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126282; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Russell K, 2019, J NEUROSURG-PEDIATR, V23, P455, DOI 10.3171/2018.8.PEDS18356; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Stephens JA, 2020, J MOTOR BEHAV, V52, P13, DOI 10.1080/00222895.2019.1570908; Stephens JA, 2018, AM J PHYS MED REHAB, V97, P456, DOI 10.1097/PHM.0000000000000906; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Vandorpe B, 2012, J SCI MED SPORT, V15, P220, DOI 10.1016/j.jsams.2011.09.006	37	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	2021	100	6					563	569		10.1097/PHM.0000000000001589			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	SE6BS	WOS:000652156300013	32932362				2022-02-07	
J	Cyr, K; Greene, H; Buckley, R				Cyr, Kayla; Greene, Helena; Buckley, Richard			C3 geriatric distal femoral fracture-ORIF or replace with a distal femoral replacement (DFR)	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							FEMUR FRACTURES; FIXATION	History: A 83yo female tripped on a rug at home. She fell onto her left knee. She had immediate left knee pain. She had never hurt her left knee before. Past Medical History: She takes medication for her blood pressure and has no allergies. She has had prior successful bilateral total hip arthroplasties 5 years ago. Her BMI is in the normal range. She has had no problems with her bilateral total hip arthroplasties. Social History: She lives alone, but her daughter is close by to help her with activities like heavy cleaning. This woman is still driving and doing her own shopping and uses no walking aids. She is a retired secretary. Physical Exam: Distal function is good in the leg. She has no other injuries. Her neck and head are uninjured. Xray and CT: There is a C3 left sided comminuted distal femoral fracture. The bilateral total hip arthroplasties are in good position and appear normal (Fig. 1). (C) 2021 Elsevier Ltd. All rights reserved.	[Cyr, Kayla] Univ Alberta, Dept Orthoped Surg, Edmonton, AB, Canada; [Greene, Helena] Mem Univ, Hlth Sci Ctr, Div Orthoped Surg, St John, NF, Canada; [Buckley, Richard] Univ Calgary, Dept Surg, 3134 Hosp Dr NW, Calgary, AB T2N 5A1, Canada; [Buckley, Richard] Foothills Prov Gen Hosp, 0490 McCaig Tower,3134 Hosp Dr NW, Calgary, AB T2N 5A1, Canada		Buckley, R (corresponding author), Univ Calgary, Dept Surg, 3134 Hosp Dr NW, Calgary, AB T2N 5A1, Canada.; Buckley, R (corresponding author), Foothills Prov Gen Hosp, 0490 McCaig Tower,3134 Hosp Dr NW, Calgary, AB T2N 5A1, Canada.	buckclin@ucalgary.ca					Beeres FJP, 2020, OPER ORTHOP TRAUMATO, V32, P545, DOI 10.1007/s00064-020-00664-w; Bettin CC, 2016, J ORTHOP TRAUMA, V30, P503, DOI 10.1097/BOT.0000000000000600; Consigliere P, 2019, EUR J ORTHOP SURG TR, V29, P1789, DOI 10.1007/s00590-019-02486-4; Gangavalli AK, 2016, ORTHOP CLIN N AM, V47, P85, DOI 10.1016/j.ocl.2015.08.011; Gwathmey FW, 2010, J AM ACAD ORTHOP SUR, V18, P597; Hake ME, 2019, J AM ACAD ORTHOP SUR, V27, pE867, DOI 10.5435/JAAOS-D-17-00706; Hart GP, 2017, J ARTHROPLASTY, V32, P202, DOI 10.1016/j.arth.2016.06.006; Lieder CM, 2021, J ORTHOP TRAUMA, V35, P49, DOI 10.1097/BOT.0000000000001882; Salazar BP, 2021, J ORTHOP TRAUMA, V35, P2, DOI 10.1097/BOT.0000000000001867	9	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUN	2021	52	6					1260	1262		10.1016/j.injury.2021.03.009			3	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	SJ0XL	WOS:000655253400004	33715844				2022-02-07	
J	Dag, U; Deveci, E				Dag, Umut; Deveci, Engin			Protective Effect of Losartan, an Angiotensin Type 1 Receptor Blocker, on Retinal Damage Caused by Traumatic Brain Injury	ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY			English	Article						angiotensin II type 1 receptors blockage; blood brain barrier; brain injury; immunohistochemistry; losartan; neuroinflammation; optic nerve injuries; retina; retinal damage; retinal ganglion cells; traumatic brain injury	INDEPENDENT PHOTORECEPTOR APOPTOSIS; PROGRAMMED CELL-DEATH; GROWTH-FACTORS; EXPRESSION; MOUSE; CASPASE-3; APAF1; MODEL	OBJECTIVE: To observe the changes in retina after traumatic brain injury (TBI), and the effect of Losartan, an angiotensin II receptor antagonist, which inhibits the vasoconstrictor and platelet aggregation. STUDY DESIGN: Male Sprague Dawley rats (n=30) were divided into 3 groups of 10: Control (isotonic sa-line solution given intragastrically for 7 days), Trauma (craniectomy under anesthesia, saline solution administered intragastrically, sacrificed after 7 days), and Trauma+ Losartan (after craniotomy, 30 mg/kg losartan administered for 7 days, sacrificed at the end of the 7th day). Retina and blood samples were taken. MDA, GSH-Px, and MPO were used as biochemical markers. Tissues were fixed in a 10% formalin solution and embedded in paraffin blocks for histopathologic examination; 5-mu m-thick sections were obtained and stained with H-E. RESULTS: MPO activity significantly decreased in the Trauma group after TBI as compared with Controls (p< 0.001). The MDA level was low in the Losartan group (p< 0.001). GSH-Px levels in the Trauma group were lower than levels in Controls (p< 0.001). Hypertrophy and intense chromatin were observed in some of the photoreceptors in the Trauma group. Dilation and endothelial hyperplasia were observed in the vessels towards the ganglion layer. In the Trauma+ Losartan group a significant improvement was observed in the nuclei of the photoreceptors, and edema between the membranes disappeared. VEGF expression in the Trauma group was increased in pigment epithelium cells. In the Trauma+ Losartan group VEGF expression was evident in the inner and outer limiting membranes in the pigment epithelium and ganglion cells. In the Control group there was negative expression in the distribution of APAF in the nuclei of the photoreceptors. In the Trauma group APAF-1 positive expression in the limiting membrane with degenerative photoreceptors and an increase in APAF-1 expression was observed. In the Trauma+ Losartan group, APAF-1 expression was negative in ganglion cells. CONCLUSION: Losartan plays a role in the development of mitotic activity and decrease of apoptotic process in preventing cell damage, and as it induces angiogenic development it can be an important prophylactic agent in vascular remodeling.	[Dag, Umut] Gazi Yasargil Educ & Res Hosp, Dept Ophthalmol, Diyarbakir, Turkey; [Deveci, Engin] Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey		Deveci, E (corresponding author), Dicle Univ, Med Fac, Dept Histol & Embryol, Diyarbakir, Turkey.	engindeveci64@gmail.com					Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; Baloglu M, 2019, FOLIA MORPHOL, V78, P17, DOI 10.5603/FM.a2018.0050; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bull ND, 2011, INVEST OPHTH VIS SCI, V52, P3309, DOI 10.1167/iovs.10-6873; CAGLIERO E, 1991, DIABETES, V40, P102, DOI 10.2337/diabetes.40.1.102; Cecconi F, 2004, DEVELOPMENT, V131, P2125, DOI 10.1242/dev.01082; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; Doonan F, 2003, J NEUROSCI, V23, P5723; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Friedman A, 2014, EXPERT REV NEUROTHER, V14, P1365, DOI 10.1586/14737175.2014.972945; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Li P, 1998, J CARDIOVASC PHARM, V32, P198, DOI 10.1097/00005344-199808000-00005; Lo MW, 1995, CLIN PHARMACOL THER, V58, P641, DOI 10.1016/0009-9236(95)90020-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Morrison DG, 2007, INVEST OPHTHALMOL VI, V48, P1735; Muller M, 2005, DEV DYNAM, V234, P215, DOI 10.1002/dvdy.20534; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xiong JH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00992; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang Y, 2011, INT J OPHTHALMOL-CHI, V4, P259, DOI 10.3980/j.issn.2222-3959.2011.03.09; Zhang TL, 2012, CNS NEUROSCI THER, V18, P981, DOI 10.1111/cns.12015	28	0	0	1	1	SCI PRINTERS & PUBL INC	ST LOUIS	PO DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA	0884-6812			ANAL QUANT CYTOPATHO	Anal. Quant. Cytopathol. Histopathol.	JUN	2021	43	3					121	128					8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	UK1YF	WOS:000691771000003					2022-02-07	
J	Tran, D; Chu, HT; Le, TD; Le, TA; Duong, HD; Dong, HV				Dat Tran; Hung Thanh Chu; Tam Duc Le; Tuan Anh Le; Ha Dai Duong; He Van Dong			Spontaneous cranial bone regeneration following craniectomy for traumatic brain injury in a pregnant woman: A case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Spontaneous bone regeneration; Craniectomy; Traumatic brain injury; Epidural hematoma; Pregnancy; Case report	OSSIFICATION; OSTEOGENESIS; PERICRANIUM; DEFECTS; DURA	Introduction and importance: Spontaneous bone formation following craniectomy is an extremely rare in adult. As in the medical literature, this is the first case report on total spontaneous ossification following craniectomy in a pregnant woman. Case presentation: In this paper, we reported a 20-year-old female currently in the 30th week of her pregnancy suffered from head trauma following motorcycle accident. On admission to our hospital, her GCS score was 3 points. She was treated with emergency extradural hematoma evacuation with craniectomy and Caesarean section with uterine artery ligation. 3 weeks post-operation, the patient and her daughter were discharged from the hospital. At follow-up, spontaneous cranial bone generation was observed. Clinical discussion: The presentation, diagnosis and strategy of treatments were discussed. Conclusion: Diagnostic imaging in traumatic pregnant patient is often postponed for the concern of fetus exposure to radiation. Traumatic pregnant patient with possible head trauma should be transferred to a center with expertise in neurotrauma and obstetrical care. Spontaneous cranial bone regeneration following craniectomy in adult is rare. Surgery techniques and hormones in pregnancy contribute to bone formation.	[Hung Thanh Chu; Tam Duc Le; Tuan Anh Le; Ha Dai Duong] Hanoi Med Univ, Dept Surg, Hanoi, Vietnam; [Dat Tran; Tuan Anh Le; Ha Dai Duong; He Van Dong] Viet Duc Univ Hosp, Dept Neurosurg 1, Hanoi, Vietnam; [Tam Duc Le] Hanoi Med Univ Hosp, Dept Neurosurg & Spine Surg, Hanoi, Vietnam		Chu, HT (corresponding author), Hanoi Med Univ, Dept Surg, Hanoi, Vietnam.	hungchu94@hmu.edu.vn; duongdaiha@hmu.edu.vn	Le, Tam/AAR-5083-2021; Le, Tam/AAX-6024-2021; Chu, Hung Thanh/AAQ-1978-2021	Le, Tam/0000-0002-9409-8525; Chu, Hung Thanh/0000-0002-3698-5855; Duong, Ha/0000-0003-0850-664X			Agha RA, 2020, INT J SURG, V84, P226, DOI 10.1016/j.ijsu.2020.10.034; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Gonzalez-Bonet LG, 2021, WORLD NEUROSURG, V147, P67, DOI 10.1016/j.wneu.2020.12.056; Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51; Gosain AK, 2011, PLAST RECONSTR SURG, V128, P85, DOI 10.1097/PRS.0b013e31821740cc; HAMMERLE CHF, 1995, J ORAL MAXIL SURG, V53, P167, DOI 10.1016/0278-2391(95)90396-8; Hoover DA, 2001, J NEUROSURG, V95, P350, DOI 10.3171/jns.2001.95.2.0350; Jain V, 2015, J OBSTET GYNAECOL CA, V37, P553, DOI 10.1016/S1701-2163(15)30232-2; Jiang QH, 2020, EUR NEUROL, V83, P121, DOI 10.1159/000507190; Kohlhepp LM, 2018, ANAESTHESIST, V67, P383, DOI 10.1007/s00101-018-0437-2; Mathew J, 2008, TURK NEUROSURG, V18, P407; Prasad G Lakshmi, 2021, Surg Neurol Int, V12, P46, DOI 10.25259/SNI_756_2020; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Schulze-Spate U, 2016, CLIN ORAL IMPLAN RES, V27, P701, DOI 10.1111/clr.12641; Szpalski C, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10201; Tatar M, 2008, EUR RESPIR J, V31, P385, DOI 10.1183/09031936.00063507; Themes UFO, 2016, REC SCALP; Thim T, 2012, INT J GEN MED, V5, P117, DOI 10.2147/IJGM.S28478; Thombre BD, 2018, CHILD NERV SYST, V34, P1449, DOI 10.1007/s00381-018-3863-1; Vaananen HK, 1996, MATURITAS, V23, pS65	20	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.	JUN	2021	83								105993	10.1016/j.ijscr.2021.105993			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	TC5PE	WOS:000668692600024	34049177	Green Published, gold			2022-02-07	
J	Dell, KC; Grossner, EC; Staph, J; Schatz, P; Hillary, FG				Dell, Kristine C.; Grossner, Emily C.; Staph, Jason; Schatz, Philip; Hillary, Frank G.			A Population-Based Study of Pre-Existing Health Conditions in Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						cluster analysis; pre-existing conditions; traumatic brain injury	NATIONAL INSTITUTE; OUTCOMES; OLDER; REHABILITATION; EPIDEMIOLOGY; MORTALITY; PEOPLE; ADULTS; PROGESTERONE; TRAJECTORIES	Health factors impacting both the occurrence of, and recovery from traumatic brain injury (TBI) vary in complexity, and present genuine challenges to researchers and healthcare professionals seeking to characterize injury consequences and determine prognosis. However, attempts to clarify causal links between injury characteristics and clinical outcomes (including mortality) often compel researchers to exclude pre-existing health conditions (PECs) in their samples, including psychiatric history, medication usage, and other comorbid conditions. In this pre-registered population-based study (total starting n = 939,123 patients), we examined trends in PEC incidence over 22 years in the state of Pennsylvania (1997-2019) in individuals sustaining TBI (n = 169,452) and individuals with orthopedic injury (n = 87,637). The goal was to determine how PECs interact with age and injury severity to influence short-term outcomes. A further goal was to determine whether number of PECs, or specific PEC clusters contributed to worse outcomes within the TBI cohort, compared with orthopedic injury alone. Primary findings indicate that PECs significantly influenced mortality within the TBI cohort; patients having four or more PECs were associated with approximately a two times greater likelihood of dying in acute care (odds ratio [OR] 1.9). Additionally, cluster analyses revealed four distinct PEC clusters that are age and TBI severity dependent. Overall, the likelihood of zero PECs hovers at similar to 25%, which is critical to consider in TBI outcomes work and could potentially contribute to the challenges facing intervention science with regard to reproducibility of findings.	[Dell, Kristine C.; Grossner, Emily C.; Staph, Jason; Hillary, Frank G.] Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16802 USA; [Dell, Kristine C.; Grossner, Emily C.; Hillary, Frank G.] Penn State Univ, Social & Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu			Pennsylvania Department of Health (PA-DOH SAP) [4100077082]	This project is funded, in part, under a Grant with the Pennsylvania Department of Health (PA-DOH SAP# 4100077082). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.	Albrecht J.S., 2020, J NEUROTRAUM, V37, P1; Albrecht JS, 2020, J HEAD TRAUMA REHAB, V35, pE352, DOI 10.1097/HTR.0000000000000551; [Anonymous], 2020, ALZHEIMERS DEMENT, V16, P391, DOI 10.1002/alz.12068; [Anonymous], 2018, OP MAN DAT COLL SYST; [Anonymous], 2020, LOGSTASH COMPUTER SO; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Atsumi H, 2019, WORLD NEUROSURG, V122, pE924, DOI 10.1016/j.wneu.2018.10.176; Bannon SM, 2021, J HEAD TRAUMA REHAB, V36, pE50, DOI 10.1097/HTR.0000000000000586; Bauman M., 2017, MULTIPLE CHRONIC CON; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015; Bertisch H, 2017, ARCH PHYS MED REHAB, V98, P2288, DOI 10.1016/j.apmr.2017.04.006; Bliemel C, 2017, INT ORTHOP, V41, P1995, DOI 10.1007/s00264-017-3591-2; Bobeff EJ, 2019, WORLD NEUROSURG, V128, pE129, DOI 10.1016/j.wneu.2019.04.060; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Brenner EK, 2020, BRAIN INJURY, V34, P801, DOI 10.1080/02699052.2020.1741033; Brown K, 2017, INJURY PREV, V23, P403, DOI 10.1136/injuryprev-2016-042192; Calvo RY, 2016, INJURY, V47, P677, DOI 10.1016/j.injury.2015.10.055; Centers for Disease Control and Prevention, 2020, CHRON DIS NAT CTR CH; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Chang Jonathan, 2019, AMIA Jt Summits Transl Sci Proc, V2019, P305; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Germolec D., 2018, MARKERS INFLAMMATION, V2nd; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Hamel RN, 2019, SPORTS MED, V49, P1183, DOI 10.1007/s40279-019-01122-9; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hayward RD, 2018, BRAIN INJURY, V32, P1373, DOI 10.1080/02699052.2018.1487584; Hillary FG, 2020, INT J PSYCHOPHYSIOL, V154, P3, DOI 10.1016/j.ijpsycho.2019.05.006; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Kumar RG, 2020, J HEAD TRAUMA REHAB, V35, pE372, DOI 10.1097/HTR.0000000000000572; Kumar RG, 2020, J TRAUMA ACUTE CARE, V88, P491, DOI 10.1097/TA.0000000000002562; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Marklund N, 2019, J INTERN MED, V285, P608, DOI 10.1111/joim.12900; Miller A.H., 2017, NAT REV IMMUNOL, V16, P22; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Python, 2020, PYTH LANG INT COMP S; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Sammy I, 2016, INJURY, V47, P1170, DOI 10.1016/j.injury.2016.02.027; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Trivedi RB, 2015, CONTEMP CLIN TRIALS, V44, P20, DOI 10.1016/j.cct.2015.07.009; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Ware JB, 2020, J NEUROTRAUM, V37, P2180, DOI 10.1089/neu.2020.7031; Weihs C, 2005, ST CLASS DAT ANAL, P335; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yeates KO, 2017, J INT NEUROPSYCH SOC, V23, P806, DOI 10.1017/S1355617717000686; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	79	0	0	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JUN 1	2021	2	1					255	269		10.1089/neur.2020.0065			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XI5ZQ	WOS:000726189700001	34223556	gold, Green Published			2022-02-07	
J	Derrett, S; Wyeth, EH; Richardson, A; Davie, G; Samaranayaka, A; Lilley, R; Harcombe, H				Derrett, Sarah; Wyeth, Emma H.; Richardson, Amy; Davie, Gabrielle; Samaranayaka, Ari; Lilley, Rebbecca; Harcombe, Helen			Prospective Outcomes of Injury Study 10 Years on (POIS-10): An Observational Cohort Study	METHODS AND PROTOCOLS			English	Article						injury; injury outcomes; longitudinal cohort study; Maori health; indigenous health; disability; wellbeing; person-reported outcomes	TRAUMATIC BRAIN-INJURY; NEW-ZEALAND; HEALTH; WORKERS; TRENDS; SCALES; MAORI	Injury is a leading cause of disability and is costly. This prospective cohort study extension aims to improve disability, health, and wellbeing outcomes for injured New Zealanders, including for Maori. We will identify predictors and modifiable risk factors of long-term outcomes (positive and negative), and develop an Injury Early Care Tool (INJECT) to inform the implementation of effective interventions to improve outcomes. In the Prospective Outcomes of Injury Study (POIS), 2856 people participated following an injury (occurring between 2007 and 2009) registered with New Zealand's no-fault accident compensation scheme (ACC). POIS-10 will invite 2121 people (including 358 Maori) who completed a 24-month POIS interview and agreed to follow-up, anticipating 75% participation (n = 1591). Interviews will collect sociodemographic characteristics, life events, comorbidities, and new injuries since participants' 24-month interview, as well as key disability, health, and wellbeing outcomes 12 years post-injury. Injury-related data will be collected from ACC and hospitalisation records 12 years post-injury. Regression models for the main outcomes will examine the direct effects of predictor variables after adjustment for a wide range of confounders. POIS-10 is enhanced by our partnership with ACC, and expert advisors and will benefit injured people, including Maori, through increased understanding of mechanisms and interventions to improve long-term post-injury outcomes.	[Derrett, Sarah; Richardson, Amy; Davie, Gabrielle; Lilley, Rebbecca; Harcombe, Helen] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 56, Dunedin 9054, New Zealand; [Wyeth, Emma H.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Ngai Tahu Maori Hlth Res Unit, POB 56, Dunedin 9054, New Zealand; [Samaranayaka, Ari] Univ Otago, Biostat Ctr, Div Hlth Sci, POB 56, Dunedin 9054, New Zealand		Derrett, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 56, Dunedin 9054, New Zealand.	sarah.derrett@otago.ac.nz; emma.wyeth@otago.ac.nz; amy.richardson110@gmail.com; gabrielle.davie@otago.ac.nz; ari.samaranayaka@otago.ac.nz; rebbecca.lilley@otago.ac.nz; helen.harcombe@otago.ac.nz		Samaranayaka, Ari/0000-0003-4933-9569; Lilley, Rebbecca/0000-0002-3901-2880; Derrett, Sarah/0000-0003-2867-0498; Wyeth, Emma/0000-0002-6869-5190	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC19/344]	This research was funded by the Health Research Council of New Zealand, Grant Number HRC19/344.	Accident Compensation Corporation, 2019, ANN REP 2019; [Anonymous], 2001, NZ STAND CLASS OCC; Ballantyne PJ, 2016, CRIT PUBLIC HEALTH, V26, P173, DOI 10.1080/09581596.2015.1010485; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Casey R, 2017, J OCCUP ENVIRON MED, V59, P486, DOI 10.1097/JOM.0000000000000998; Davie G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193019; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558, 10.1136/ip.2009.022558a]; Derrett S, 2017, INJURY PREV, V23, P429, DOI 10.1136/injuryprev-2016-042193; Derrett S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080194; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Derrett S, 2012, INJURY PREV, V18, P343, DOI 10.1136/injuryprev-2011-040266; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Dowd MD, 1996, AM J PUBLIC HEALTH, V86, P929, DOI 10.2105/AJPH.86.7.929; Falkenberg L, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0282-9; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fransen M, 2006, OCCUP ENVIRON MED, V63, P352, DOI 10.1136/oem.2005.024398; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2016, B WORLD HEALTH ORGAN, V94, P806, DOI 10.2471/BLT.16.172155; Geraerds AJLM, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01412-1; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harcombe H., 2014, P EUROQOL GROUPS 31; Harcombe H, 2018, INJURY PREV, V24, P437, DOI 10.1136/injuryprev-2017-042467; Harcombe H, 2015, INJURY, V46, P1275, DOI 10.1016/j.injury.2015.04.004; Hepp U, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-53; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hone L, 2014, SOC INDIC RES, V119, P1031, DOI 10.1007/s11205-013-0501-x; Humphrey G., 2003, NZ MED J ONLINE, V116, P1168; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kieser J, 2002, INT J ORAL MAX SURG, V31, P206, DOI 10.1054/ijom.2002.0208; Langley J, 2014, NEW ZEAL MED J, V127, P53; Langley J, 2013, ARCH PHYS MED REHAB, V94, P1277, DOI 10.1016/j.apmr.2013.02.012; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lilley R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017390; Lilley R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-995; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; Maclennan B, 2014, AUST NZ J PUBL HEAL, V38, P227, DOI 10.1111/1753-6405.12228; Maclennan B, 2013, NEW ZEAL MED J, V126, P39; McAllister S., 2014, INT J WELLBEING, V4, P19, DOI [10.5502/ijw.v4i2.2, DOI 10.5502/IJW.V4I2.2]; [Ministry of Health Health Mo], 2017, CONT GUID 2016 17 NZ; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Narduzzi S, 2014, EPIDEMIOL PREV, V38, P335; O'Hagan FT, 2012, CAN J PUBLIC HEALTH, V103, pE303, DOI 10.1007/BF03404240; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Scuffham PA, 1997, ACCIDENT ANAL PREV, V29, P1, DOI 10.1016/S0001-4575(96)00054-1; SPARC, 2004, NZ PHYS ACT QUEST; Spittal MJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020803; Statistics New Zealand, KEY FIND 2013 NZ DIS; Statistics New Zealand, 2006 CENS QUEST; Statistics New Zealand, HOUS EC SURV 2006 20; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sullivan M, 2010, INJURY PREV, V16, DOI 10.1136/ip.2010.028134; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ware J., 2000, SF 36 HLTH SURVEY MA; Wilson R, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-21; Wilson SJ, 2018, QUAL LIFE RES, V27, P3167, DOI 10.1007/s11136-018-1970-9; Wilson SJ, 2017, QUAL LIFE RES, V26, P1831, DOI 10.1007/s11136-017-1521-9; Wilson Suzanne J, 2014, Inj Prev, V20, P57, DOI 10.1136/injuryprev-2012-040690; World Health Organization, 2007, INT CLASS FUNCT DIS; Wyeth EH, 2019, PUBLIC HEALTH, V176, P118, DOI 10.1016/j.puhe.2018.08.014; Wyeth EH, 2018, ARCH ENVIRON OCCUP H, V73, P79, DOI 10.1080/19338244.2017.1329698; Wyeth EH, 2017, AUST NZ J PUBL HEAL, V41, P262, DOI 10.1111/1753-6405.12657; Wyeth EH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-120; Wyeth EH, 2010, ETHNIC HEALTH, V15, P303, DOI 10.1080/13557851003721194; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	73	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2409-9279		METHOD PROTOCOL	Methods Protoc.	JUN	2021	4	2							35	10.3390/mps4020035			11	Biochemical Research Methods	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	TB8DB	WOS:000668175600001	34067618	Green Published, gold			2022-02-07	
J	Frozandeh, F; Shahrokhi, N; Khaksari, M; Amiresmaili, S; AsadiKaram, G; Shahrokhi, N; Iranpour, M				Frozandeh, Forouzan; Shahrokhi, Nader; Khaksari, Mohammad; Amiresmaili, Sedigheh; AsadiKaram, Gholamreza; Shahrokhi, Nava; Iranpour, Maryam			Evaluation of the protective effect curcumin on encephalopathy caused by intrahepatic and extrahepatic damage in male rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Acetaminophen; Brain edema; Curcumin; Hepatic damage; Hepatic encephalopathy; Intracranial pressure	TRAUMATIC BRAIN-INJURY; ACUTE LIVER-FAILURE; ACETAMINOPHEN-INDUCED HEPATOTOXICITY; HEPATIC-ENCEPHALOPATHY; INTRACRANIAL-PRESSURE; OXIDATIVE STRESS; EDEMA; MODEL; HEMORRHAGE; MANAGEMENT	Objective(s): Along with increased intracranial pressure (ICP) and brain damage, brain edema is the most common cause of death in patients with hepatic encephalopathy. Curcumin can pass the bloodbrain barrier and possesses anti-inflammatory and antioxidant properties. This study focuses on the curcumin protective effect on intrahepatic and extrahepatic damage in the brain. Materials and Methods: One hundred and forty-four male Albino N-Mary rats were randomly divided into 2 main groups: intrahepatic injury group and extrahepatic cholestasis group. In intra-hepatic injury group intrahepatic damage was induced by intraperitoneal (IP) injection of acetaminophen (500 mg/kg) [19] and included four subgroups: 1. Sham, 2. Acetaminophen (APAP), 3. Normal saline (Veh) which was used as curcumin solvent, and 4. Curcumin (CMN). In extrahepatic cholestasis group intrahepatic damage was caused by common bile duct litigation (BDL) and included four subgroups: 1. Sham, 2. BDL, 3. Vehicle (Veh), and 4. Curcumin (CMN). In both groups, 72 hr after induction of cholestasis, brain water content, blood-brain barrier permeability, serum ammonia, and histopathological indicators were examined and ICP was measured every 24 hr for three days. Results: The results showed that curcumin reduced brain edema, ICP, serum ammonia, and blood-brain barrier permeability after extrahepatic and intrahepatic damage. The maximum effect of curcumin on ICP was observed 72 hr after the injection. Conclusion: According to our findings, it seems that curcumin is an effective therapeutic intervention for treating encephalopathy caused by extrahepatic and intrahepatic damage.	[Frozandeh, Forouzan] Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Khaksari, Mohammad; AsadiKaram, Gholamreza] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Amiresmaili, Sedigheh] Bam Univ Med Sci, Dept Physiol, Bam, Iran; [Shahrokhi, Nava] Kerman Univ Med Sci, Sch Med, Kerman, Iran; [Iranpour, Maryam] Kerman Univ Med Sci, Pathol & Stem Cell Res Ctr, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Kerman, Iran.	nshahrokhi@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; IRANPOUR, MARYAM/AAH-7467-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; IRANPOUR, MARYAM/0000-0001-8749-8080	Physiology Research Centre, Kerman University of Medical Sciences, Kerman, Iran	The present study was financially supported by the Physiology Research Centre, Deputy for Research and Technology, Kerman University of Medical Sciences, Kerman, Iran.	Amiresmaili S, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114044; Badria FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134156; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Cai SY, 2013, HEPATOLOGY, V57, P2418, DOI 10.1002/hep.26161; Cichoz-Lach H, 2013, WORLD J GASTROENTERO, V19, P26, DOI 10.3748/wjg.v19.i1.26; Dairam A, 2008, J AGR FOOD CHEM, V56, P3350, DOI 10.1021/jf0734931; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Dhanda S, 2015, BEHAV BRAIN RES, V286, P222, DOI 10.1016/j.bbr.2015.01.042; Fan Z, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/191624; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Jayakumar AR, 2014, TRANSL STROKE RES, V5, P28, DOI 10.1007/s12975-014-0328-z; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Kawai H, 2012, J TOXICOL SCI, V37, P1165, DOI 10.2131/jts.37.1165; Kawaratani H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/495156; King MD, 2011, J NEUROSURG, V115, P116, DOI 10.3171/2011.2.JNS10784; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Monfort P, 2009, NEUROCHEM INT, V55, P106, DOI 10.1016/j.neuint.2009.01.021; Mpabanzi L, 2012, NEUROCHEM INT, V60, P736, DOI 10.1016/j.neuint.2011.10.014; Nguyen KD, 2014, WORLD J GASTROENTERO, V20, P9418, DOI 10.3748/wjg.v20.i28.9418; Olteanu D, 2012, ACTA PHYSIOL HUNG, V99, P61, DOI 10.1556/APhysiol.99.2012.1.7; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Qi ZH, 2017, NEUROSCI LETT, V637, P120, DOI 10.1016/j.neulet.2016.11.038; Rao KVR, 2014, METAB BRAIN DIS, V29, P927, DOI 10.1007/s11011-014-9502-y; Romero-Gomez M, 2015, J HEPATOL, V62, P437, DOI 10.1016/j.jhep.2014.09.005; Sepehrinezhad A, 2020, METAB BRAIN DIS, V35, P559, DOI 10.1007/s11011-020-00549-8; Shapiro H, 2006, J GASTROEN HEPATOL, V21, P358, DOI 10.1111/j.1440-1746.2005.03984.x; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thebaut A, 2018, CLIN RES HEPATOL GAS, V42, P103, DOI 10.1016/j.clinre.2017.08.007; Tokac M, 2013, FOOD CHEM TOXICOL, V61, P28, DOI 10.1016/j.fct.2013.01.015; Tripodi V, 2012, ANN HEPATOL, V11, P930, DOI 10.1016/S1665-2681(19)31420-6; Varatharajalu R, 2016, OXID MED CELL LONGEV, V2016; Wang L, 2018, INT IMMUNOPHARMACOL, V61, P20, DOI 10.1016/j.intimp.2018.05.011; Wright G, 2007, METAB BRAIN DIS, V22, P375, DOI 10.1007/s11011-007-9071-4; Yoon E, 2016, J CLIN TRANSL HEPATO, V4, P131, DOI 10.14218/JCTH.2015.00052; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Yuan J, 2017, J SURG RES, V207, P85, DOI 10.1016/j.jss.2016.08.090; Zhang JF, 2014, J NUTR, V144, P1211, DOI 10.3945/jn.114.193573; Zhang ZY, 2017, MOL NEUROBIOL, V54, P1, DOI 10.1007/s12035-015-9635-y; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	44	0	0	2	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUN	2021	24	6					760	766		10.22038/ijbms.2021.53171.11976			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	SM2HA	WOS:000657429800007	34630953				2022-02-07	
J	Galgano, AC; Cohn, JE; Licata, JJ; Othman, S; Stucker, FJ; Bundrick, P				Galgano, Alissa C.; Cohn, Jason E.; Licata, Jordan J.; Othman, Sammy; Stucker, Fred J.; Bundrick, Paige			Slippery Slopes: Skiing-Related Facial Trauma in Adults	CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION			English	Article; Early Access						skiing; maxillofacial trauma; craniofacial trauma; sports injuries; NEISS; otolaryngology	HEAD-INJURIES; HELMET USE; DATABASE; SKIERS; SPORTS; SAFETY; RISK	Design: Retrospective, observational, cross-sectional study. Objective: To determine the incidence of skiing-related facial trauma and to identify their patterns in terms of potential risk factors, mechanism of injury, anatomical location, and degree of severity. Methods: Data was collected using the National Electronic Injury Surveillance System and included snow skiing-related incidents during the years 2009 to 2018. Specifically, injuries limited to the facial region including the head, face, eye(s), mouth, neck or ear(s) were reported. Patients with fractures were further classified by the study variables. Descriptive statistics were used to classify continuous variables while chi-square analysis was used to compare categorical variables. Results: A total of 514 (n = 514) patients met the inclusion criteria within the study period. The majority of injuries were due to concussions (59%), followed by lacerations (18%), fractures (11%), contusions (11%) and dental injuries (1%). Of the fractures seen, the majority were nasal (30%) and cervical spine (30%), followed by midface (27%), mandible (9%) and skull (4%). In our population, head injuries were more common in females (80%) than in males (60%), whereas, mouth injuries were more common in males (8%) than females (1%) [chi(2) = 30.2, p < 0.001]. Conclusions: Skiing-related craniofacial trauma remains a significant mechanism of injury. Our data illustrates a need to correlate these injuries to the use of personal protective equipment. Furthermore, this data calls for the strict implementation of such equipment and the development of safety protocols to further prevent deleterious injury.	[Galgano, Alissa C.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Cohn, Jason E.; Stucker, Fred J.; Bundrick, Paige] LSU Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, Div Facial Plast Reconstruct Surg, Shreveport, LA USA; [Licata, Jordan J.] Philadelphia Coll Osteopath Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA USA; [Othman, Sammy] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA		Cohn, JE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, Div Facial Plast Reconstruct Surg, 1501 Kings Highway, Shreveport, LA 71103 USA.	jcohnmed2729@gmail.com		Galgano, Alissa/0000-0002-2894-2660			Bailly N, 2018, WILD ENVIRON MED, V29, P151, DOI 10.1016/j.wem.2017.11.007; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Exadaktylos AK, 2004, BRIT J SPORT MED, V38, P750, DOI 10.1136/bjsm.2003.008581; Gassner R, 2000, ENDOD DENT TRAUMATOL, V16, P122; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Kanwar R, 2015, EMERG MED CLIN N AM, V33, P241, DOI 10.1016/j.emc.2014.12.002; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Polites SF, 2018, J PEDIATR SURG, V53, P1024, DOI 10.1016/j.jpedsurg.2018.02.044; Provance AJ, 2018, RES SPORTS MED, V26, P150, DOI 10.1080/15438627.2018.1438282; Ruzic L, 2011, WILD ENVIRON MED, V22, P291, DOI 10.1016/j.wem.2011.09.001; Shealy JE., 2015, SKIING TRAUMA SAFETY, V20th Volume, P22, DOI DOI 10.1520/STP158220140079; Stuart CA, 2020, CLIN BIOMECH, V73, P122, DOI 10.1016/j.clinbiomech.2020.01.011; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Svider PF, 2016, INT J PEDIATR OTORHI, V87, P78, DOI 10.1016/j.ijporl.2016.05.025; Tuli T, 2010, J ORAL MAXIL SURG, V68, P293, DOI 10.1016/j.joms.2009.09.072; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Weber CD, 2016, EUR J TRAUMA EMERG S, V42, P741, DOI 10.1007/s00068-015-0596-7; Weinstein S, 2019, CURR SPORT MED REP, V18, P394, DOI 10.1249/JSR.0000000000000651; Willick SE, 2019, CLIN J SPORT MED, V29, P329, DOI 10.1097/JSM.0000000000000527	19	0	0	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1943-3875	1943-3883		CRANIOMAX TRAUM REC	Craniomaxillofacial Trauma Reconstr.											19433875211020933	10.1177/19433875211020933		JUN 2021	6	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	SQ7XN	WOS:000660564500001					2022-02-07	
J	Garcia-Perez, D; Panero-Perez, I; Fernandez, CE; Moreno-Gomez, LM; Esteban-Sinovas, O; Navarro-Main, B; Lopez, PAG; Castano-Leon, AM; Lagares, A				Garcia-Perez, Daniel; Panero-Perez, Irene; Eiriz Fernandez, Carla; Miguel Moreno-Gomez, Luis; Esteban-Sinovas, Olga; Navarro-Main, Blanca; Gomez Lopez, Pedro A.; Castano-Leon, Ana M.; Lagares, Alfonso			Densitometric analysis of brain computed tomography as a new prognostic factor in patients with acute subdural hematoma	JOURNAL OF NEUROSURGERY			English	Article						acute subdural hematoma; surgery; outcome; densitometric analysis; Hounsfield units; trauma; traumatic brain injury	HEAD-INJURY; SURGICAL-MANAGEMENT; OUTCOME PREDICTION; WHITE-MATTER; CLASSIFICATION; MORTALITY; TRAUMA; MODELS; ADULTS; EDEMA	OBJECTIVE Acute subdural hematoma (ASDH) is a major cause of mortality and morbidity after traumatic brain injury (TBI). Surgical evacuation is the mainstay of treatment in patients with altered neurological status or significant mass effect. Nevertheless, concerns regarding surgical indication still persist. Given that clinicians often make therapeutic decisions on the basis of their prognosis assessment, to accurately evaluate the prognosis is of great significance. Unfortunately, there is a lack of specific and reliable prognostic models. In addition, the interdependence of certain well-known predictive variables usually employed to guide surgical decision-making in ASDH has been proven. Because gray matter and white matter are highly susceptible to secondary insults during the early phase after TBI, the authors aimed to assess the extent of these secondary insults with a brain parenchyma densitometric quantitative CT analysis and to evaluate its prognostic capacity. METHODS The authors performed a retrospective analysis among their prospectively collected cohort of patients with moderate to severe TBI. Patients with surgically evacuated, isolated, unilateral ASDH admitted between 2010 and 2017 were selected. Thirty-nine patients were included. For each patient, brain parenchyma density in Hounsfield units (HUs) was measured in 10 selected slices from the supratentorial region. In each slice, different regions of interest (ROIs), including and excluding the cortical parenchyma, were defined. The injured hemisphere, the contralateral hemisphere, and the absolute differences between them were analyzed. The outcome was evaluated using the Glasgow Outcome Scale-Extended at 1 year after TBI. RESULTS Fifteen patients (38.5%) had a favorable outcome. Collected demographic, clinical, and radiographic data did not show significant differences between favorable and unfavorable outcomes. In contrast, the densitometric analysis demonstrated that greater absolute differences between both hemispheres were associated with poor outcome. These differences were detected along the supratentorial region, but were greater at the high convexity level. Moreover, these HU differences were far more marked at the cortical parenchyma. It was also detected that these differences were more prone to ischemic and/or edematous insults than to hyperemic changes. Age was significantly correlated with the side to-side HU differences in patients with unfavorable outcome. CONCLUSIONS The densitometric analysis is a promising prognostic tool in patients diagnosed with ASDH. The supplementary prognostic information provided by the densitometric analysis should be evaluated in future studies. https://thejns.org/doi/abs/10.3171/2020.4.JNS193445	[Garcia-Perez, Daniel; Panero-Perez, Irene; Eiriz Fernandez, Carla; Miguel Moreno-Gomez, Luis; Esteban-Sinovas, Olga; Navarro-Main, Blanca; Gomez Lopez, Pedro A.; Castano-Leon, Ana M.; Lagares, Alfonso] Univ Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain		Garcia-Perez, D (corresponding author), Univ Hosp 12 Octubre, Madrid, Spain.	dgp.neurosurgery@gmail.com	Lagares, Alfonso/B-2969-2011; Castano-Leon, Ana M/ABF-6322-2020; Gomez, Pedro/E-2411-2014	Lagares, Alfonso/0000-0003-3996-0554; Castano-Leon, Ana M/0000-0002-7918-5049; Gomez, Pedro/0000-0002-4185-5238; , DANIEL/0000-0002-0298-5283	ISCIII European institution [PI18/01387]; FEDER European institution [PI18/01387]	This research was jointly funded by the ISCIII and FEDER European institutions, with FIS project no. PI18/01387. The sponsor had no role in the design or conduct of this research.	Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chieregato A, 2009, NEUROSURGERY, V64, P705, DOI 10.1227/01.NEU.0000341872.17024.44; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gentsch A, 2015, CLIN NEURORADIOL, V25, P49, DOI 10.1007/s00062-013-0281-3; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jin XQ, 2019, WORLD NEUROSURG, V124, pE266, DOI 10.1016/j.wneu.2018.12.081; Jin XQ, 2018, WORLD NEUROSURG, V116, pE759, DOI 10.1016/j.wneu.2018.05.086; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kim H, 2019, J NEUROSURG, V131, P1243, DOI 10.3171/2018.5.JNS172711; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kotwica Z, 1993, Acta Neurochir (Wien), V121, P95; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; Wajima D, 2017, BRAIN RES, V1670, P165, DOI 10.1016/j.brainres.2017.06.017; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	42	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2021	134	6					1940	1950		10.3171/2020.4.JNS193445			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SP1YS	WOS:000659469900004	32736362	Bronze			2022-02-07	
J	Garcia-Rudolph, A; Garcia-Molina, A				Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto			Functional recovery of working-age patients with traumatic brain injury stratified in 30-day periods since head trauma to rehabilitation admission	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						independent living; rehabilitation; traumatic brain injury	OUTCOMES; TIME	We stratified 213 patients with traumatic brain injury according to their time to rehabilitation admission in three groups (0-30 days, 31-60 and 61-90) in order to (1) compare total Functional Independence Measure efficiency and effectiveness between groups; (2) analyze time to admission as predictor of TFIM at discharge. After adjusting for age, Glasgow Coma Scale (GCS), Disability Rating Scale (DRS) and sex, 0-30 had the highest TFIM efficiency compared with 31-60 (P < 0.001) and 61-90 (P < 0.001), 31-60 was quasi-significantly (P = 0.051) higher than 61-90. After adjusting for age, GCS, DRS and sex, 0-30 had the highest TFIM mean effectiveness when compared with 31-60 (P = 0.004) and 61-90 (P < 0.001). Thirty-one to 60 was significantly higher (P = 0.041) than 61-90. Almost half of the variance was explained by regression models containing time to admission as predictor of TFIM at discharge. Time to admission was key to obtain significant differences in TFIM efficiency, effectiveness and in predicting TFIM at discharge.	[Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto] Univ Barcelona, Inst Guttmann, Dept Res & Innovat, Univ Inst Attached Autonomous, Barcelona, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto] Autonomous Univ Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Rudolph, Alejandro; Garcia-Molina, Alberto] Germans Trias & Pujol Fdn, Hlth Sci Res Inst, Barcelona, Spain		Garcia-Rudolph, A (corresponding author), Hosp Neurorehabil, Inst Guttmann, Dept Res & Innovat, Cami Can Ruti S-N, Barcelona 08916, Spain.	alejandropablogarcia@gmail.com					Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P449, DOI 10.1097/HTR.0b013e31826674d6; Braine ME, 2017, J CLIN NURS, V26, P280, DOI 10.1111/jocn.13390; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Vidmar G, 2011, ZDRAV VARST, V50, P24, DOI 10.2478/v10152-010-0025-6; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	9	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2021	44	2					189	192		10.1097/MRR.0000000000000456			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RZ6PE	WOS:000648722300017	33481456				2022-02-07	
J	Grover, PJ; Harris, L; Qureshi, AM; Rennie, A; Robertson, F; James, G				Grover, Patrick J.; Harris, Lauren; Qureshi, Ayman M.; Rennie, Adam; Robertson, Fergus; James, Greg			Occult posterior inferior cerebellar artery dissection requiring endovascular treatment following pediatric head trauma: case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						trauma; posterior inferior cerebellar artery; PICA; dissection; aneurysm; pediatrics; vascular disorders	SUBARACHNOID HEMORRHAGE; INTRACRANIAL ANEURYSMS; VERTEBRAL ARTERY; CASE SERIES; CHILDREN	This is the eighth case report of a pediatric dissecting posterior inferior cerebellar artery aneurysm. The authors present the case of a 13-year-old boy who presented with posttraumatic posterior fossa subdural, subarachnoid, and intraventricular hemorrhage with hydrocephalus. Initial vascular imaging findings were negative; however, a high level of suspicion is necessary. The aneurysm was identified on day 20, after recurrence of hydrocephalus, and was treated with endo- vascular vessel sacrifice. The patient made a good recovery. It is important to consider arterial dissection in pediatric traumatic brain injury, especially with suspicious findings on initial CT scan and clinical presentation out of proportion to the mechanism of vascular is for	[Grover, Patrick J.; Harris, Lauren; Qureshi, Ayman M.] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London, England; [Rennie, Adam; Robertson, Fergus; James, Greg] Great Ormond St Hosp Sick Children, Dept Neurosurg, London, England		Grover, PJ (corresponding author), Natl Hosp Neurol & Neurosurg, London, England.	p.grover@nhs.net		James, Greg/0000-0003-3014-7428			Anami H, 2014, CHILD NERV SYST, V30, P2003, DOI 10.1007/s00381-014-2551-z; Binning MJ, 2009, ACTA NEUROCHIR, V151, P1647, DOI 10.1007/s00701-009-0323-4; BOSTROM K, 1992, FORENSIC SCI INT, V53, P61, DOI 10.1016/0379-0738(92)90133-H; Burger IM, 2006, STROKE, V37, P2535, DOI 10.1161/01.STR.0000239697.56147.77; deSouza RM, 2016, ACTA NEUROCHIR, V158, P1731, DOI 10.1007/s00701-016-2865-6; Fulkerson DH, 2010, CHILD NERV SYST, V26, P613, DOI 10.1007/s00381-010-1104-3; Griauzde J, 2014, J NEUROINTERV SURG, V6, DOI 10.1136/neurintsurg-2012-010573.rep; Hossain M, 2002, SPINAL CORD, V40, P307, DOI 10.1038/sj.sc.3101290; Kneyber MCJ, 2005, NEUROLOGY, V65, P1663, DOI 10.1212/01.wnl.0000184515.35205.10; Krings T, 2010, CHILD NERV SYST, V26, P1309, DOI 10.1007/s00381-009-1054-9; Lasjaunias P, 2005, CHILD NERV SYST, V21, P437, DOI 10.1007/s00381-004-1125-x; Loevner LA, 1998, AM J NEURORADIOL, V19, P386; Mizutani T, 1999, NEUROSURGERY, V45, P253, DOI 10.1097/00006123-199908000-00010; MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P231, DOI 10.3171/jns.2005.102.2.0231; Ong CK, 2010, J CLIN NEUROSCI, V17, P515, DOI 10.1016/j.jocn.2009.06.041; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Purgina B, 2015, FORENSIC SCI INT, V247, pE1, DOI 10.1016/j.forsciint.2014.11.003; Salehi MG, 2012, NEURORADIOL J, V25, P563, DOI 10.1177/197140091202500509; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; Su TM, 2014, J NEUROSURG-PEDIATR, V13, P503, DOI 10.3171/2014.1.PEDS13412; Sujijantarat N, 2017, WORLD NEUROSURG, V108, DOI 10.1016/j.wneu.2017.08.144; Sure U, 1999, CHILD NERV SYST, V15, P354, DOI 10.1007/s003810050411; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	26	0	0	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2021	27	6					643	648		10.3171/2020.11.PEDS18324			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	SO2HN	WOS:000658798500004	33836497				2022-02-07	
J	Grzesiak, M; Carender, W; Basura, GJ				Grzesiak, Melissa; Carender, Wendy; Basura, Gregory J.			Posttraumatic Dizziness: Navigating the Maze Towards Accurate Vestibular Diagnosis and Treatment	OTOLOGY & NEUROTOLOGY			English	Article						Benign paroxysmal positional vertigo; Canalith repositioning maneuver; Vestibular therapy	CANALITH REPOSITIONING PROCEDURE; BALANCE; REHABILITATION; MANAGEMENT; DISORDERS; MANEUVER	Objective: Highlight the importance of establishing a differential diagnosis to identify and treat multiple origins of dizziness in a patient following traumatic brain injury (TBI). Patient: 73-year-old man with TBI and temporal bone fracture developed posttraumatic bilateral multiple canal benign paroxysmal positional vertigo (BPPV). Intervention: Multi-disciplinary diagnostic evaluation and vestibular rehabilitation (VR) treatment focused on canalith repositioning maneuvers (CRMs) and central adaptation. Main Outcome Measures: Diagnostic imaging, audiometric testing, clinical evaluation including video recordings of patterns of nystagmus, Dizziness Handicap Inventory (DHI). Results: Systematic clinical examination identified multiple semicircular canal BPPV in addition to a suspected underlying unilateral hypofunction. Treatment focused on the appropriate CRMs and adaptation exercises. DHI scores improved significantly and patient returned to work and recreational activities. Conclusion: This Clinical Capsule Report highlights the importance of a comprehensive clinical evaluation of the TBI patient with dizziness when making an accurate diagnosis and treatment plan. Due to the complexity of differentiating between multiple canal BPPV in addition to other central and vestibular disorders, it is imperative for the clinician to have a clear understanding of nystagmus patterns for multicanal BPPV as well as other vestibular pathology.	[Grzesiak, Melissa; Carender, Wendy] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Michigan Balance Vestibular Testing & Rehabil, Ann Arbor, MT 48109 USA; [Grzesiak, Melissa; Carender, Wendy; Basura, Gregory J.] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Div Otol Neurotol Skull Base Surg, Michigan Med, Ann Arbor, MI 48109 USA		Basura, GJ (corresponding author), Univ Michigan, Otolaryngol Head & Neck Surg, Div Otol Neurotol & Skull Base Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	gbasura@umich.edu			NIH, HHMIHoward Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Funding support from NIH, HHMI, or others: None.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Asawavichiangianda S, 1999, ACTA OTO-LARYNGOL, P27; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Cohen HS, 2004, OTOL NEUROTOL, V25, P130, DOI 10.1097/00129492-200403000-00008; Curthoys IS., 2014, VESTIBULAR REHABILIT, VFourth ed., P121; Dannenbaum E, 2009, OTOL NEUROTOL, V30, P368, DOI 10.1097/MAO.0b013e31819bda35; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Fife TD, 1998, AM J OTOL, V19, P345; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Foster CA, 2012, AUDIOLOGY NEUROTOL E, V2, P16, DOI 10.1159/000337947; Gordon CR, 2004, ACTA NEUROL SCAND, V110, P166, DOI 10.1111/j.1600-0404.2004.00296.x; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Haripriya GR, 2018, INDIAN J OTOLARYNGOL, V70, P337, DOI 10.1007/s12070-018-1329-0; Helminski JO, 2014, PHYS THER, V94, P1373, DOI 10.2522/ptj.20130239; Helminski JO, 2010, PHYS THER, V90, P663, DOI 10.2522/ptj.20090071; Herdman SJ., 2014, VESTIBULAR REHABILIT, V4 th, P394; Herdman SJ., 2014, Vestibular Rehabilitation, VFourth, P324; Hillier SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub3; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kim SH, 2012, AURIS NASUS LARYNX, V39, P163, DOI 10.1016/j.anl.2011.03.008; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Lan D., 2019, DIAGNOSIS TREATMENT, P301; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Lueck CJ, 2005, PRACT NEUROL, V5, P288; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Nuti D, 1998, ACTA OTO-LARYNGOL, V118, P455, DOI 10.1080/00016489850154559; Piromchai P, 2019, OTOL NEUROTOL, V40, P951, DOI 10.1097/MAO.0000000000002310; Radtke A, 2004, NEUROLOGY, V63, P150, DOI 10.1212/01.WNL.0000130250.62842.C9; ROBINSON DA, 1984, ANN NEUROL, V16, P714, DOI 10.1002/ana.410160614; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Soto-Varela A, 2013, EUR ARCH OTO-RHINO-L, V270, P817, DOI 10.1007/s00405-012-2043-2; Strupp M, 2014, J NEUROL, V261, pS542, DOI 10.1007/s00415-014-7385-9; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553; Whitney SL, 2005, OTOL NEUROTOL, V26, P1027, DOI 10.1097/01.mao.0000185066.04834.4e; Yacovino DA, 2009, J NEUROL, V256, P1851, DOI 10.1007/s00415-009-5208-1; Zhu RT, 2019, ANN OTO RHINOL LARYN, V128, P869, DOI 10.1177/0003489419845014	40	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUN	2021	42	5					E573	E578		10.1097/MAO.0000000000003035			6	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	SS7ME	WOS:000661937800009	33967250				2022-02-07	
J	Hannah, TC; Li, AY; Spiera, Z; Kuohn, L; Dai, J; McAuley, F; Au, M; Durbin, JR; Dreher, N; Marayati, NF; Lovell, M; Choudhri, T				Hannah, Theodore C.; Li, Adam Y.; Spiera, Zachary; Kuohn, Lindsey; Dai, Jennifer; McAuley, Fiona; Au, Muhammad; Durbin, John R.; Dreher, Nickolas; Marayati, Naoum Fares; Lovell, Mark; Choudhri, Tanvir			Sex-Related Differences in the Incidence, Severity, and Recovery of Concussion in Adolescent Student-Athletes Between 2009 and 2019	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; female athletes; ImPACT; Severity Index	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; GENDER-DIFFERENCES; RISK-FACTORS; NEUROPSYCHOLOGICAL FUNCTION; NEUROCOGNITIVE PERFORMANCE; SYMPTOMS; DEPRESSION; IMPACT	Background: The sex of an athlete is thought to modulate concussion incidence; however, the effects of sex on concussion severity and recovery are less clear. Purpose: To evaluate sex differences in concussion severity and recovery using a large, heterogeneous sample of young student-athletes with the goal of understanding how sex affects concussion outcomes in young athletes. Study Design: Cohort study; Level of evidence, 3. Methods: The Immediate Post-Concussion Assessment and Cognitive Testing results of 11,563 baseline and 5216 postinjury tests were used to calculate the incidence of concussion of adolescent male and female student-athletes ages 12 to 22 years (median, 15 years). The postinjury tests of 3465 male and 1751 female student-athletes evaluated for concussion or head trauma were used to assess differences in the Severity Index (SI) and recovery. Chi-square tests and t tests were used to compare differences in demographic characteristics, incidence, and SI between the 2 cohorts. Multivariable linear, logistic, and Cox proportional hazards regressions were used to control for differences between cohorts in analyses of incidence, SI, and recovery. Results: When we controlled for demographic differences, female participants had higher odds of concussion (odds ratio, 1.62; 95% CI, 1.40-1.86; P < .0001) and higher SI after concussion (beta = 0.67; 95% CI, 0.02-1.32; P = .04). This discrepancy in SI was a result of differences in Symptom (2.40 vs 2.94; P < .0001) and Processing Speed (0.91 vs 1.06; P = .01) composite scores between male and female participants, respectively. We found no effect of sex on time to recovery when controlling for initial concussion SI (hazard ratio, 0.94; 95% CI, 0.78-1.12; P = .48). Conclusion: Using large, multisport cohorts, this study provides evidence that female athletes are at higher risk for more concussions and these concussions are more severe, but male and female athletes have similar recovery times when the analysis controls for initial concussion SI.	[Hannah, Theodore C.; Li, Adam Y.; Spiera, Zachary; Kuohn, Lindsey; Dai, Jennifer; McAuley, Fiona; Au, Muhammad; Durbin, John R.; Dreher, Nickolas; Marayati, Naoum Fares; Lovell, Mark; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, New York, NY 10029 USA		Hannah, TC (corresponding author), Dept Neurosurg, Annenberg Bldg,Floor 8,Room 88,1468 Madison Ave, New York, NY 10029 USA.	theodore.hannah@icahn.mssm.edu	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Hannah, Theodore/0000-0001-6527-9725			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P216, DOI 10.1093/arclin/acx059; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Centers for Disease Control and Prevention, PRINC EP PUBL HLTH P; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Faltus J, 2016, INT J SPORTS PHYS TH, V11, P498; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; National Federation of State High School Associations Advisory Committee, 2018 2019 HIGH SCH A; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shao MH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00878; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wang S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00107; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Zuckerman SL, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0909-4	50	0	0	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2021	49	7					1929	1937		10.1177/03635465211008596			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	SN0FI	WOS:000657972800028	33955795				2022-02-07	
J	Harper, MM; Boehme, N; Dutca, LM; Anderson, MG				Harper, Matthew M.; Boehme, Nickolas; Dutca, Laura M.; Anderson, Michael G.			The Retinal Ganglion Cell Response to Blast-Mediated Traumatic Brain Injury Is Genetic Background Dependent	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						blast; vision; retinal ganglion cells; traumatic brain injury; neurotrauma; pattern electroretinogram; genetic variation	COLLABORATIVE CROSS; DAMAGE; DEGENERATION; PREVENTION; RECOVERY; MODEL; EYE	PURPOSE. The purpose of this study was to examine the influence of genetic background on the retinal ganglion cell (RGC) response to blast-mediated traumatic brain injury (TBI) in Jackson Diversity Outbred (J:DO), C57BL/6J and BALB/cByJ mice. METHODS. Mice were subject to one blast injury of 137 kPa. RGC structure was analyzed by optical coherence tomography (OCT), function by the pattern electroretinogram (PERG), and histologically using BRN3A antibody staining. RESULTS. Comparison of the change in each group from baseline for OCT and PERG was performed. There was a significant difference in the J:DO Delta OCT compared to C57BL/6J mice (P = 0.004), but not compared to BALB/cByJ (P = 0.21). There was a significant difference in the variance of the Delta OCT in J:DO compared to both C57BL/6J and BALB/cByJ mice. The baseline PERG amplitude was 20.33 +/- 9.32 mu V, which decreased an average of -4.14 +/- 12.46 mu V following TBI. Baseline RGC complex + RNFL thickness was 70.92 +/- 4.52 mu m, which decreased an average of -1.43 +/- 2.88 mu m following blast exposure. There was not a significant difference in the Delta PERG between J:DO and C57BL/6J (P = 0.13), although the variances of the groups were significantly different. Blast exposure in J:DO mice results in a density change of 558.6 +/- 440.5 BRN3A-positive RGCs/mm(2) (mean +/- SD). CONCLUSIONS. The changes in retinal outcomes had greater variance in outbred mice than what has been reported, and largely replicated herein, for inbred mice. These results demonstrate that the RGC response to blast injury is highly dependent upon genetic background.	[Harper, Matthew M.; Boehme, Nickolas; Dutca, Laura M.; Anderson, Michael G.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Harper, Matthew M.; Boehme, Nickolas; Dutca, Laura M.; Anderson, Michael G.] Iowa City VA Healthcare Syst, Ctr Prevent & Treatment Visual Loss, Dept Vet Affairs, Iowa City, IA USA; [Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA USA		Harper, MM (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, VA Ctr Prevent & Treatment Visual Loss, 601 Hwy 6 W, Iowa City, IA 52242 USA.	matthew-harper@uiowa.edu	Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105	Department of Veterans Affairs Center for the Prevention and Treatment of Visual LossUS Department of Veterans Affairs; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583]; U.S. Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1 I01 RX003389, 1 I21 RX003325, IK2-RX002003]	Supported by the Department of Veterans Affairs Center for the Prevention and Treatment of Visual Loss, the Department of Defense (W81XWH-14-1-0583), and the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service awards 1 I01 RX003389 (MMH), 1 I21 RX003325 (MMH), and IK2-RX002003 (LMD). The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs, Department of Defense, or the U.S. Government.	Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P2469, DOI 10.1167/iovs.14-13943; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Evans LP, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.12.7; Evans LP, 2020, J NEUROTRAUM, V37, P1463, DOI 10.1089/neu.2019.6725; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; GUILLERY RW, 1974, SCI AM, V230, P44, DOI 10.1038/scientificamerican0574-44; Harper MM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03374; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Hedberg-Buenz A, 2016, EXP EYE RES, V146, P386, DOI 10.1016/j.exer.2015.07.020; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Lucas-Ruiz F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225733; Mao M, 2011, INVEST OPHTH VIS SCI, V52, P2679, DOI 10.1167/iovs.10-5993; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McDevitt Jane, 2017, Concussion, V2, pCNC26, DOI 10.2217/cnc-2016-0020; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohan K, 2012, VET OPHTHALMOL, V15, P94, DOI 10.1111/j.1463-5224.2012.01034.x; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Popescu C, 2015, J Med Life, V8, P272; Reynolds Mark E, 2019, MSMR, V26, P13; Saul MC, 2019, TRENDS GENET, V35, P501, DOI 10.1016/j.tig.2019.04.003; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Struebing FL, 2018, J NEUROTRAUM, V35, P118, DOI 10.1089/neu.2017.5104; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; van der Heide CJ, BIOLOGICAL CORRELATI; Weaver SM, 2014, CURR PHARM DESIGN, V20, P4275; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Williams RW, 1996, J NEUROSCI, V16, P7193; Woods LCS, 2014, PHYSIOL GENOMICS, V46, P81, DOI 10.1152/physiolgenomics.00127.2013; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	47	0	0	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JUN	2021	62	7							13	10.1167/iovs.62.7.13			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	UA5JI	WOS:000685197200005	34106210	Green Published, gold			2022-02-07	
J	Henky, J; Faried, A				Henky, Jefri; Faried, Ahmad			Correlation between Head. Computed Tomography Scan, Pre-operative Blood Lactate, and Pre-operative Glucose Level in Acute Traumatic Subdural Hematoma	MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL			English	Article						Acute traumatic subdural hematoma; blood lactate; blood glucose; head computer tomography scan	BRAIN	Acute traumatic subdural hematoma (SDH) is a focal brain injury resulting in alteration of cerebral perfusion and glucose metabolism, which would also results in hyperglicemia-induced-hyperlactatemia. A cross-sectional study was performed to analyze acute traumatic SDH patients by head CT scan and observe the effect on pre-operative blood lactate and blood glucose levels in 40 acute traumatic SDH patients at Dr. Hasan Sadikin Hospital Bandung, Indonesia during the period of July-September 2013. Somers' D correlation were used in the analysis with a p-value of .0.05 considered as significant with 95% confidence interval. The mean values of pre-operative blood lactate and blood glucose levels were 3.16 +/- 1.49 mmol/L and 155.85 +/- 32.95 mg/dL, respectively with a strong positive correlation between the hematoma thickness and the increase in blood lactate (r=0.656; p=0.021) and a moderate positive correlation with increased blood glucose (r=0.556; p=0.025). In addition, the compressed cistern also had a very weak positive correlation with increase in blood lactate (r=0.156; p=0.043) and very weak positive correlation with increase in blood glucose (r=0.139; p=0.056) while the midline shift had a weak positive correlation with increased blood lactate (r=0.353; p=0.041) and a weak positive correlation with increased blood glucose (r=0.333; p=0.046). In conclusion, increased hematoma thickness, compressed cistern, and midline shift seen on head CT scan correlate with increasing blood lactate and glucose levels in acute traumatic SDH. Head CT scan, blood lactate level, and blood glucose level can be considered as one of the routine examinations to determine acute traumatic SDH severity at the macroscopic and cellular level.	[Henky, Jefri] Baiturrahmah Univ, Dept Neurosurg, Fac Med, Semen Padang Hosp Padang, Jl Pass KM 15, Kota Padang, West Sumatra, Indonesia; [Faried, Ahmad] Univ Padjadjaran, Dept Neurosurg, Fac Med, Dr Hasan Sadikin Gen Hosp Bandung, Bandung, Indonesia		Henky, J (corresponding author), Baiturrahmah Univ, Dept Neurosurg, Fac Med, Semen Padang Hosp Padang, Jl Pass KM 15, Kota Padang, West Sumatra, Indonesia.	neurosurg_henky@yahoo.co.id					Brooks GA, 2020, J SPORT HEALTH SCI, V9, P446, DOI 10.1016/j.jshs.2020.02.006; Bullock M, 2011, YOUMANS WINN NEUROLO, P3267; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Fischbach F, 2015, MANUAL LAB DIAGNOSTI, V9th, P53, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; Grevfors N, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.610192; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jiang C, 2019, IEEE INT C BIOINFORM, P1083, DOI [10.1109/BIBM47256.2019.8983159, 10.1109/bibm47256.2019.8983159]; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Popescu C, 2015, J Med Life, V8, P272; Robertson C, 2011, YOUMANS WINN NEUROLO, P3397; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Shahlaie K, 2011, YOUMANS WINN NEUROLO, P3362; Sharma R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105180; Yu LY, 2015, CHINESE MED J-PEKING, V128, P976, DOI 10.4103/0366-6999.154323; Zacko J, 2011, YOUMANS WINN NEUROLO, P3424; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231	20	0	0	1	1	UNIV PADJADJARAN, FAKULTAS KEDOKTERAN, GEDUNG RUMAH SAKIT PENDIDIKAN	BANDUNG	RUANG MAJALAH KEDOKTERAN BANDUNG LANTAI 3, JL PROF DR EIJKMAN NO 38, BANDUNG, 40161, INDONESIA	0126-074X	2338-6223		MAJ KEDOKT BDG-MKB	Maj. Kedokt. Bdg.-MKB	JUN	2021	53	2					87	95		10.15395/mkb.v53n2.2364			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TP3AH	WOS:000677465800006		gold			2022-02-07	
J	Heredia, M; Sanchez-Robledo, V; Gomez, I; Criado, JM; de la Fuente, A; Devesa, J; Devesa, P; Riolobos, AS				Heredia, Margarita; Sanchez-Robledo, Virginia; Gomez, Ines; Criado, Jose Maria; de la Fuente, Antonio; Devesa, Jesus; Devesa, Pablo; Riolobos, Adelaida Sanchez			Cell Proliferation in the Piriform Cortex of Rats with Motor Cortex Ablation Treated with Growth Hormone and Rehabilitation	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						motor ablation; growth hormone; rehabilitation; cell proliferation; piriform cortex; brain injury	TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; ADULT NEUROGENESIS; GH TREATMENT; EXPRESSION; PLASTICITY; NEURONS; NEUROPROTECTION; LESION; PATHOPHYSIOLOGY	Traumatic brain injury represents one of the main health problems in developed countries. Growth hormone (GH) and rehabilitation have been claimed to significantly contribute to the recovery of lost motor function after acquired brain injury, but the mechanisms by which this occurs are not well understood. In this work, we have investigated cell proliferation in the piriform cortex (PC) of adult rats with ablation of the frontal motor cortex treated with GH and rehabilitation, in order to evaluate if this region of the brain, related to the sense of smell, could be involved in benefits of GH treatment. Male rats were either ablated the frontal motor cortex in the dominant hemisphere or sham-operated and treated with GH or vehicle at 35 days post-injury (dpi) for five days. At 36 dpi, all rats received daily injections of bromodeoxyuridine (BrdU) for four days. We assessed motor function through the paw-reaching-for-food task. GH treatment and rehabilitation at 35 dpi significantly improved the motor deficit caused by the injury and promoted an increase of cell proliferation in the PC ipsilateral to the injury, which could be involved in the improvement observed. Cortical ablation promoted a greater number of BrdU+ cells in the piriform cortex that was maintained long-term, which could be involved in the compensatory mechanisms of the brain after injury.	[Heredia, Margarita; Sanchez-Robledo, Virginia; Gomez, Ines; Criado, Jose Maria; de la Fuente, Antonio; Riolobos, Adelaida Sanchez] Univ Salamanca, Inst Neurosci Castilla & Leon INCyL, Dept Physiol & Pharmacol, Ave Alfonso X El Sabio S-N, Salamanca 37007, Spain; [Devesa, Jesus] Med Ctr Foltra, Sci Direct, Travesia Montouto 24, Teo 15894, Spain; [Devesa, Pablo] Univ Valle, Sch Med, Coordinat & Res, Cochabamba 1408, Bolivia		Heredia, M (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon INCyL, Dept Physiol & Pharmacol, Ave Alfonso X El Sabio S-N, Salamanca 37007, Spain.; Devesa, J (corresponding author), Med Ctr Foltra, Sci Direct, Travesia Montouto 24, Teo 15894, Spain.	mheredia@usal.es; robledo@usal.es; inesgomez_@usal.es; jmcriado@usal.es; jfuente@usal.es; jesus.devesa@usc.es; pdevesap@gmail.com; asriolob@usal.es	Devesa, Jesus/C-4910-2018	Devesa, Jesus/0000-0002-4153-2543			Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Aberg ND, 2010, GROWTH HORM IGF RES, V20, P264, DOI 10.1016/j.ghir.2009.12.003; Aberg ND, 2009, J ENDOCRINOL, V201, P141, DOI 10.1677/JOE-08-0495; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Bartkowska K, 2010, BRAIN BEHAV EVOLUT, V76, P128, DOI 10.1159/000320944; Basu A, 2017, HORM BEHAV, V93, P18, DOI 10.1016/j.yhbeh.2017.04.001; Benedetti B, 2020, CEREB CORTEX, V30, P1499, DOI 10.1093/cercor/bhz181; Butler T, 2019, EPILEPSY BEHAV, V94, P297, DOI 10.1016/j.yebeh.2019.01.022; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chennaoui M, 2020, SLEEP MED REV, V49, DOI 10.1016/j.smrv.2019.101223; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Datiche F, 1996, BRAIN RES BULL, V41, P391, DOI 10.1016/S0361-9230(96)00082-2; Devesa J, 2010, MED CLIN-BARCELONA, V135, P665, DOI 10.1016/j.medcli.2009.10.017; Devesa P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-100; Devesa P, 2011, BRAIN INJURY, V25, P503, DOI 10.3109/02699052.2011.559611; Feeney C, 2017, ANN NEUROL, V82, P30, DOI 10.1002/ana.24971; Figueiredo TH, 2018, EPILEPSIA, V59, P92, DOI 10.1111/epi.14500; Furigo IC, 2017, BRAIN STRUCT FUNCT, V222, P341, DOI 10.1007/s00429-016-1221-1; Harvey S, 2002, J MOL NEUROSCI, V18, P89, DOI 10.1385/JMN:18:1-2:89; He X, 2014, NEUROSCIENCE, V259, P101, DOI 10.1016/j.neuroscience.2013.11.056; Heredia M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225770; Heredia M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6125901; Heredia M, 2013, BEHAV BRAIN RES, V247, P48, DOI 10.1016/j.bbr.2013.03.012; Hogan MK, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00271; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Jia YB, 2021, INT J BIOL SCI, V17, P368, DOI 10.7150/ijbs.52169; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Jurkowski MP, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.576444; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Liu JT, 2020, WORLD J CLIN CASES, V8, P5773, DOI 10.12998/wjcc.v8.i22.5773; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Martinez-Moreno CG, 2020, VITAM HORM, V114, P91, DOI 10.1016/bs.vh.2020.04.001; Mascaro ALA, 2019, CELL REP, V28, P3474, DOI 10.1016/j.celrep.2019.08.062; Studzinski ALM, 2015, BEHAV BRAIN RES, V294, P36, DOI 10.1016/j.bbr.2015.07.054; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; NEAFSEY EJ, 1986, BRAIN RES, V377, P261, DOI 10.1016/0006-8993(86)90867-X; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; O'Leary RA, 2018, J NEUROSURG SCI, V62, P542, DOI 10.23736/S0390-5616.18.04501-0; Ong LK, 2018, STROKE, V49, P1257, DOI 10.1161/STROKEAHA.117.020557; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; Patzke N, 2013, NEUROSCIENCE, V238, P270, DOI 10.1016/j.neuroscience.2013.02.025; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Rolls ET, 2019, HAND CLINIC, V164, P97, DOI 10.1016/B978-0-444-63855-7.00007-1; Rossi SL, 2014, NEUROREPORT, V25, P1006, DOI 10.1097/WNR.0000000000000203; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rotheneichner P, 2018, CEREB CORTEX, V28, P2610, DOI 10.1093/cercor/bhy087; Sanchez-Bezanilla S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124563; Sanchez-Bezanilla S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020606; Santos-Torres J, 2009, J NEUROTRAUM, V26, P1593, DOI 10.1089/neu.2008.0702; Sarma AA, 2011, CEREB CORTEX, V21, P1231, DOI 10.1093/cercor/bhq199; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Shin DH, 2004, NEUROSCI LETT, V354, P64, DOI 10.1016/j.neulet.2003.09.070; Strauch C, 2020, CEREB CORTEX, V30, P135, DOI 10.1093/cercor/bhz077; Vadodaria KC, 2017, NEUROSCI LETT, V644, P76, DOI 10.1016/j.neulet.2017.02.060; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang DJ, 2020, P NATL ACAD SCI USA, V117, P3239, DOI 10.1073/pnas.1913922117; Ware JB, 2020, J NEUROTRAUM, V37, P2180, DOI 10.1089/neu.2020.7031; Wasinski F, 2019, ARCH ENDOCRIN METAB, V63, P549, DOI 10.20945/2359-3997000000184; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yuan TF, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00079; Yuan TF, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00167; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108518; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; Zhao JJ, 2019, NEUROSCI LETT, V708, DOI 10.1016/j.neulet.2019.134335	80	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN	2021	22	11							5440	10.3390/ijms22115440			21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	SQ2HI	WOS:000660178400001	34064044	Green Published, gold			2022-02-07	
J	Hifumi, T; Nakamura, K; Kuroda, Y; Kawakita, K; Fujita, M; Yamashita, S; Dohi, K; Kobata, H; Suehiro, E; Maekawa, T				Hifumi, Toru; Nakamura, Kentaro; Kuroda, Yasuhiro; Kawakita, Kenya; Fujita, Motoki; Yamashita, Susumu; Dohi, Kenji; Kobata, Hitoshi; Suehiro, Eiichi; Maekawa, Tsuyoshi		Brain Hypothermia B-HYPO Study	High early phase hemoglobin level is associated with favorable neurological outcome in patients with severe traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Hemoglobin; Traumatic brain injury; Glasgow Outcome Scale	MILD THERAPEUTIC HYPOTHERMIA; GLASGOW COMA SCALE; FEVER CONTROL; MANAGEMENT; MORTALITY; GUIDELINES	Background: The appropriate hemoglobin (Hb) level threshold for the early phase (i.e. from Emergency Department to ICU admission) in patients with severe traumatic brain injury (TBI) is still unknown. Therefore, we aimed to examine the association between Hb levels during the early phase and neurological outcomes in patients with severe TBI using data from the Brain Hypothermia (B-HYPO) Study Group. Methods: We performed a post-hoc analysis of the B-HYPO study (a prospective, multicenter, randomized controlled trial on patients with severe TBI who received either mild therapeutic hypothermia [MTH; 32.0 degrees C- 34.0 degrees C] or fever control [35.5 degrees C-37.0 degrees C]). We calculated Hb levels during early phase by the formula: (admission Hb + Hb on day 1) / 2. The primary outcome was the association between during early phase Hb levels and 6-month neurological outcome after the TBI based on the Glasgow Outcome Scale scores (a measure of functional recovery defined as moderate disability or good recovery). Results: We reviewed data from 130 patients and found favorable neurological outcomes in 48.5% of them. We found significant differences between the favorable and unfavorable neurological outcome groups in terms of their Hb levels on admission and on day 1. But, we found no Hb level differences after day 3 (including 1 day after rewarming). Our multivariable analysis showed that Hb levels during early phase were significantly associated with favorable neurological outcomes (odds ratio, 1.387; 95% confidence interval, 1.057-1.858; P = 0.018). Conclusions: High early phase Hb levels are associated with favorable neurological outcomes after severe TBI . (c) 2020 Elsevier Inc. All rights reserved.	[Hifumi, Toru] St Lukes Int Hosp, Emergency & Crit Care Med, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan; [Hifumi, Toru; Nakamura, Kentaro; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, 1750-1 Ikenobe, Kita, Kagawa 7610793, Japan; [Fujita, Motoki; Suehiro, Eiichi] Yamaguchi Univ, Sch Med, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, 1-1 Kouda, Yamaguchi 7458522, Japan; [Dohi, Kenji] Showa Univ, Dept Emergency Disaster & Crit Care Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, 11-1 Minamiakutagawacho, Takatsuki, Osaka 5691124, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Univ, 3-2-1 Sakurabatake, Yamaguchi, Yamaguchi 7538502, Japan		Hifumi, T (corresponding author), St Lukes Int Hosp, Emergency & Crit Care Med, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; East JM, 2018, CURR OPIN ANESTHESIO, V31, P219, DOI 10.1097/ACO.0000000000000566; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fujita M, 2017, J NEUROTRAUM, V34, P1565, DOI 10.1089/neu.2016.4753; Gobatto ALN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2273-9; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170	20	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2021	44						373	377		10.1016/j.ajem.2020.04.065			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SP0HO	WOS:000659354100002	32507479				2022-02-07	
J	Huang, YK; Lin, CK; Wang, CC; Kuo, JR; Lai, CF; Chen, CW; Lin, BS				Huang, Yao-Kuang; Lin, Chin-Kuo; Wang, Che-Chuan; Kuo, Jinn-Rung; Lai, Chien-Fu; Chen, Chien-Wei; Lin, Bor-Shyh			A novel wireless optical technique for quantitative evaluation of cerebral perfusion pressure in a fluid percussion animal model of traumatic brain injury	QUANTITATIVE IMAGING IN MEDICINE AND SURGERY			English	Article						Near-infrared spectroscopy (NIRS); oxy-hemoglobin (HbO(2)); deoxy-hemoglobin; total-hemoglobin (HbT); cerebral perfusion pressure (CPP); traumatic brain injury (TBI)		Background: Cerebral perfusion pressure (CPP) calculated by mean arterial pressure (MAP) minus intracranial pressure (ICP) is related to blood flow into the brain and reflects cerebral ischemia and oxygenation indirectly. Near-infrared spectroscopy (NIRS) can assess cerebral ischemia and hypoxia non invasively and has been widely used in neuroscience. However, the correlation between CPP and NIRS, and its potential application in traumatic brain injury, has seldom been investigated. Methods: We used a novel wireless NIRS system and commercial ICP and MAP devices to assess the trauma to rat brains using different impact intensity. The relationship between CPP and NIRS parameters with increasing impact strength were investigated. Results: The results showed that changes in CPP (Delta CPP), oxy-hemoglobin {Delta[HbO(2)]}, total-hemoglobin {Delta[HbT]}, and deoxy-hemoglobin were inversely proportional to the increase in impact intensity, and the correlations between Delta CPP, NIRS parameters {Delta[HbO(2)], and Delta[HbT]} were significant. Conclusions: The NIRS system can assess cerebral ischemia and oxygenation non-invasively and changes of HbO(2) and HbT may be used as reference parameters to assess the level of CPP in an animal model of traumatic brain injury.	[Huang, Yao-Kuang; Chen, Chien-Wei] Chiayi Chang Gung Mem Hosp, Div Cardiovasc Surg & Radiol, Putz, Chiayi, Taiwan; [Huang, Yao-Kuang; Lin, Chin-Kuo; Chen, Chien-Wei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Chin-Kuo] Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Pulm Infect & Crit Care, Putz, Chiayi, Taiwan; [Wang, Che-Chuan; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Surg, Div Neurosurg, Tainan, Taiwan; [Lai, Chien-Fu; Lin, Bor-Shyh] Natl Yang Ming Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan, Taiwan		Lin, BS (corresponding author), Natl Chiao Tung Univ, Inst Imaging & Biomed Photon, Tainan, Taiwan.	borshyhlin@gmail.com		Huang, Yao-Kuang/0000-0003-2699-2207; /0000-0002-5085-9919	Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan [MOST 108-2221-E-009-054-MY2]; Higher Education Sprout Project of the National Chiao Tung University; Ministry of Education (MOE), Taiwan	This research was partly supported by the Ministry of Science and Technology in Taiwan, under grants MOST 108-2221-E-009-054-MY2. This research was also partly supported by the Higher Education Sprout Project of the National Chiao Tung University and Ministry of Education (MOE), Taiwan.	Adjedj J, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0204-3; Barazangi N, 2008, NEUROL INDIA, V56, P405; Carlson BE, 2008, AM J PHYSIOL-HEART C, V295, pH1572, DOI 10.1152/ajpheart.00262.2008; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Fantini S, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031411; Ferrari M, 2006, J APPL PHYSIOL, V100, P1426, DOI 10.1152/japplphysiol.01207.2005; FERRARI M, 1985, ADV EXP MED BIOL, V191, P873; Forcione M, 2020, QUANT IMAG MED SURG, V10, P2085, DOI 10.21037/qims-20-742; Forcione M, 2020, J CEREBR BLOOD F MET, V40, P1586, DOI 10.1177/0271678X20921973; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Ganau M, 2020, QUANT IMAG MED SURG, V10, P2081, DOI 10.21037/qims-20-905; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; Gupta A K, 2002, J Postgrad Med, V48, P218; Hasan S, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/9101235; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; KOBARI M, 1988, STROKE, V19, P991, DOI 10.1161/01.STR.19.8.991; Kuo JR, 2014, IEEE J BIOMED HEALTH, V18, P167, DOI 10.1109/JBHI.2013.2261310; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Shepelytskyi Y, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090630; Stocchetti N, 1998, ACT NEUR S, V71, P162; Syrmos N, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/209750; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	29	0	0	0	2	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2223-4292	2223-4306		QUANT IMAG MED SURG	Quant. Imaging Med. Surg.	JUN	2021	11	6					2388	U72		10.21037/qims-20-777			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	RN2VR	WOS:000640210000015	34079709	Green Published, gold			2022-02-07	
J	Iaccarino, C; Lippa, L; Munari, M; Castioni, CA; Robba, C; Caricato, A; Pompucci, A; Signoretti, S; Zona, G; Rasulo, FA				Iaccarino, Corrado; Lippa, Laura; Munari, Marina; Castioni, Carlo A.; Robba, Chiara; Caricato, Anselmo; Pompucci, Angelo; Signoretti, Stefano; Zona, Gianluigi; Rasulo, Frank A.		Italian Soc Anesthesia Analgesia R	Management of intracranial hypertension following traumatic brain injury: a best clinical practice adoption proposal for intracranial pressure monitoring and decompressive craniectomy Joint statements by the Traumatic Brain Injury Section of the Italian Society of Neurosurgery (SINch) and the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Traumatic brain injuries; Decompressive craniectomy; Consensus development conference; Guideline	CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN; TRANSCRANIAL DOPPLER; CEREBROVASCULAR AUTOREGULATION; CONSENSUS STATEMENT; CONTINUOUS EEG; REACTIVITY; CISTERNOSTOMY; ULTRASOUND; INDEX	No robust evidence is provided by literature regarding the management of intracranial hypertension following severe traumatic brain injury (TBI). This is mostly due to the lack of prospective randomized controlled trials (RCTs), the presence of studies containing extreme heterogeneously collected populations and controversial considerations about chosen outcome. A scientific society should provide guidelines for care management and scientific support for those areas for which evidence-based medicine has not been identified. However, RCTs in severe TBI have failed to establish intervention effectiveness, arising the need to make greater use of tools such as Consensus Conferences between experts, which have the advantage of providing recommendations based on experience, on the analysis of updated literature data and on the direct comparison of different logistic realities. The Italian scientific societies should provide guidelines following the national laws ruling the best medical practice. However, many limitations do not allow the collection of data supporting high levels of evidence for intracranial pressure (ICP) monitoring and decompressive craniectomy (DC) in patients with severe TBI. This intersociety document proposes best practice guidelines for this subsetting of patients to be adopted on a national Italian level, along with joint statements from "TBI Section" of the Italian Society of Neurosurgery (SINch) endorsed by the Neuroanesthesia and Neurocritical Care Study Group of the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI). Presented here is a recap of recommendations on management of ICP and DC supported a high level of available evidence and rate of agreement expressed by the assemblies during the more recent consensus conferences, where members of both groups have had a role of active participants and supporters. The listed recommendations have been sent to a panel of experts consisting of the 107 members of the "TBI Section" of the SINch and the 111 members of the Neuroanesthesia and Neurocritical Care Study Group of the SIAARTI. The aim of the survey was to test a preliminary evaluation of the grade of predictable future adherence of the recommendations following this intersociety proposal. The following recommendations are suggested as representing best clinical practice, nevertheless, adoption of local multidisciplinary protocols regarding thresholds of ICP values, drug therapies, hemostasis management and perioperative care of decompressed patients is strongly recommended to improve treatment efficiency, to increase the quality of data collection and to provide more powerful evidence with future studies. Thus, for this future perspective a rapid overview of the role of the multimodal neuromonitoring in the optimal severe TBI management is also provided in this document. It is reasonable to assume that the recommendations reported in this paper will in future be updated by new observations arising from future trials. They are not binding, and this document should be offered as a guidance for clinical practice through an intersociety agreement, taking in consideration the low level of evidence.	[Iaccarino, Corrado] Univ Modena & Reggio Emilia, Modena Univ Hosp, Dept Biomed Metab & Neural Sci, Div Neurosurg, Modena, Italy; [Lippa, Laura] Osped Riuniti Livorno, Dept Neurosurg, Viale Vittorio Alfieri 36, I-57124 Livorno, Italy; [Munari, Marina] Padua Univ Hosp, Dept Anesthesia & Intens Care, Padua, Italy; [Castioni, Carlo A.] IRCCS Ist Sci Neurol Bellaria Hosp, Dept Anesthesia & Intens Care, Bologna, Italy; [Robba, Chiara] IRCCS San Martino Univ Hosp, Dept Anesthesia & Intens Care, Genoa, Italy; [Caricato, Anselmo] IRCCS A Gemelli Univ Polyclin Fdn, Dept Anesthesia & Crit Care, Rome, Italy; [Pompucci, Angelo] S Maria Goretti Hosp, Dept Neurosurg, Latina, Italy; [Signoretti, Stefano] S Eugenio Hosp, Div Emergency Urgency, Unit Neurosurg, Rome, Italy; [Zona, Gianluigi] IRCCS San Martino Univ Hosp, Dept Neurosurg, Genoa, Italy; [Zona, Gianluigi] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Rasulo, Frank A.] Spedali Civili Univ Hosp, Dept Anesthesiol Intens Care & Emergency Med, Brescia, Italy; [Rasulo, Frank A.] Univ Brescia, Dept Surg & Med Specialties Radiol Sci & Publ Hlt, Brescia, Italy		Lippa, L (corresponding author), Osped Riuniti Livorno, Dept Neurosurg, Viale Vittorio Alfieri 36, I-57124 Livorno, Italy.	laura.lippa@gmail.com	Daniela, Alampi/T-2811-2019; Magnoni, Sandra/AAC-7479-2022; Signoretti, stefano/AAL-5631-2020; aspide, raffaele/Q-2565-2019	Daniela, Alampi/0000-0003-2466-8593; Magnoni, Sandra/0000-0002-1723-0844; Signoretti, stefano/0000-0002-8086-1622; aspide, raffaele/0000-0003-4256-9812; D'AVELLA, Domenico/0000-0001-9077-412X; Alessandri, Francesco/0000-0003-3989-4964			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bailey RL, 2019, WORLD NEUROSURG, V130, pE62, DOI 10.1016/j.wneu.2019.05.195; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bartels E, 2012, PERSPECTIVES MED, V1; Behrens A, 2011, NEUROSURGERY, V69, pE1033, DOI 10.1227/NEU.0b013e31822999b7; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Ben-Hamouda N, 2014, CHEST, V146, P1375, DOI 10.1378/chest.14-0523; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Bertuetti R, 2020, MINERVA ANESTESIOL, V86, P327, DOI 10.23736/S0375-9393.19.13852-7; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Cherian I, 2019, INDONESIAN J NEUROSU, V2, P55, DOI DOI 10.15562/IJN.V2I3.58; Cherian I, 2019, WORLD NEUROSURG, V131, P385, DOI 10.1016/j.wneu.2019.07.082; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dengl M, 2012, Acta Neurochir Suppl, V114, P165, DOI 10.1007/978-3-7091-0956-4_31; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Guiza F, INTENSIVE CARE MED INTENSIVE CARE MED; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hall CA, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8010019; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; ISRCTN Registry, RAND EV SURG CRAN PA RAND EV SURG CRAN PA; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P537, DOI 10.1016/j.anclin.2016.04.007; Levi V, 2018, WORLD NEUROSURG, V117, P471, DOI 10.1016/j.wneu.2018.05.231; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mallucci CL, 2019, LANCET, V394, P1530, DOI 10.1016/S0140-6736(19)31603-4; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Morelli P, 2019, MINERVA ANESTESIOL, V85, P995, DOI 10.23736/S0375-9393.19.13437-2; Motuel J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0676-9; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Patchana T, 2020, CUREUS, P4; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Pou JAL, 2004, INTENS CARE MED, V30, P1672, DOI 10.1007/s00134-004-2348-8; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Rasulo Frank A, 2002, Curr Opin Anaesthesiol, V15, P483, DOI 10.1097/00001503-200210000-00002; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Robba C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03105-z; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robba C, 2018, ACTA NEUROCHIR SUPPL, V126, P69, DOI 10.1007/978-3-319-65798-1_15; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Rossini Z, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00458; Rubiano AM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01063; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Sekhon MS, 2015, INTENS CARE MED, V41, P177, DOI 10.1007/s00134-014-3560-9; Servadei F, 2020, ACTA NEUROCHIR, V162, P481, DOI 10.1007/s00701-020-04224-w; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Stocker RA, 2019, MED SCI BASEL, V7, pE37; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; Wijayatilake DS, 2015, J NEUROSURG ANESTH, V27, P241, DOI 10.1097/ANA.0000000000000143; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zoerle T, 2020, NEUROCRIT CARE, V33, P857, DOI 10.1007/s12028-020-01000-7	106	0	0	3	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	JUN	2021	65	3					219	238		10.23736/S0390-5616.21.05383-2			20	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TK1ND	WOS:000673933200001	34184860	hybrid, Green Published			2022-02-07	
J	Johnstone, MR; Bradyz, RD; Church, JE; Orr, D; McDonald, SJ; Grills, BL				Johnstone, Maddison R.; Bradyz, Rhys D.; Church, Jarrod E.; Orr, David; McDonald, Stuart J.; Grills, Brian L.			The TrkB agonist, 7,8-dihydroxyflavone, impairs fracture healing in mice	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						7,8-DHF; BDNF; Bone; Fracture; TrkB Agonist	NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; INTENSITY PULSED ULTRASOUND; NEUROTROPHIC FACTOR; RECEPTOR ANTAGONIST; ENDOTHELIAL-CELLS; GAMBOGIC AMIDE; BONE VOLUME; MOUSE MODEL; SNAP 37889	Objectives: To study the effects of the selective TrkB agonist, 7,8-dihydroxyflavone (7,8-DHF), on fracture healing in mice and on an osteoprogenitor cell line, Kusa4b10, in vitro. Methods: Mice received unilateral closed mid-shaft tibial fractures and treated for two weeks with vehicle or 5 mg/kg/day DHF and euthanised at 28 days post-fracture. Calluses were analysed by micro-computed tomography (mu CT) and three-point bending biomechanical test. Kusa4b10 cells were cultured with 50nM of 7,8-DHF or vehicle for 3-, 7-, 14-days for RT-PCR, and 21 days for mineralization. Results: mu CT found 7,8-DHF calluses had decreased tissue volume (p=0.042), mean polar moment of inertia (p=0.004), and mean cross-sectional area (p=0.042) compared to controls. At 28 days biomechanical analyses showed 7,8-DHF treatment decreased peak force (p=0.011) and stiffness per unit area (p=0.012). 7,8-DHF treatment did not change Kusa4b10 gene expression of Runx2 and alkaline phosphatase at all time points, nor mineralization. Conclusions: 7,8-DHF treatment had a negative impact on fracture healing at 28 days post-fracture via an unknown mechanism. 7,8-DHF may have had a central role in impairing fracture healing.	[Johnstone, Maddison R.; Church, Jarrod E.; Orr, David; McDonald, Stuart J.; Grills, Brian L.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Bradyz, Rhys D.; McDonald, Stuart J.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia		Grills, BL (corresponding author), La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia.	brian.grills@latrobe.edu.au		Church, Jarrod/0000-0001-8266-4043			Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Aiga A, 2006, ACTA MED OKAYAMA, V60, P267; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Beamer B., 2010, HSS J, V6, P85, DOI [10.1007/s11420-009-9129-4, DOI 10.1007/S11420-009-9129-4]; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.ne.18.030195.001255; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Camerino C, 2012, ENDOCRINOLOGY, V153, P5394, DOI 10.1210/en.2012-1378; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Doblare Manuel, 2003, Acta Cientifica Venezolana, V54, P58; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Ghiasi Mohammad S, 2017, Bone Rep, V6, P87, DOI 10.1016/j.bonr.2017.03.002; Grills BL, 1997, J ORTHOPAED RES, V15, P235, DOI 10.1002/jor.1100150212; Gupta VK, 2013, J MOL NEUROSCI, V49, P96, DOI 10.1007/s12031-012-9899-x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ida-Yonemochi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169201; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Johnstone MR, 2019, J MUSCULOSKEL NEURON, V19, P94; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kauschke V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113531; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Khosla S, 2002, ENDOCRINOLOGY, V143, P4161, DOI 10.1210/en.2002-220843; Kilian O, 2014, ANN ANAT, V196, P286, DOI 10.1016/j.aanat.2014.06.001; Leighton R, 2017, INJURY, V48, P1339, DOI 10.1016/j.injury.2017.05.016; Lin CY, 2014, BIOCHEM PHARMACOL, V91, P522, DOI 10.1016/j.bcp.2014.08.008; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Mills LA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002276; NAKANISHI T, 1994, BIOCHEM BIOPH RES CO, V198, P891, DOI 10.1006/bbrc.1994.1127; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Onan D, 2009, ENDOCRINOLOGY, V150, P2244, DOI 10.1210/en.2008-1597; Pilakka-Kanthikeel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062241; Pounder NM, 2008, ULTRASONICS, V48, P330, DOI 10.1016/j.ultras.2008.02.005; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Scheller KJ, 2017, NEUROPHARMACOLOGY, V118, P1, DOI 10.1016/j.neuropharm.2017.03.004; Scheller KJ, 2014, METHODSX, V1, P212, DOI 10.1016/j.mex.2014.09.003; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Upadhyay J, 2015, METABOLISM, V64, P105, DOI 10.1016/j.metabol.2014.10.021; Wang L, 2006, J ORTHOP RES, V24, P2238, DOI 10.1002/jor.20269; Warden SJ, 2000, CALCIFIED TISSUE INT, V66, P157, DOI 10.1007/s002230010031; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zhao S, 2016, J NEUROTRAUM, V33, P2055, DOI 10.1089/neu.2015.4036; Zura R, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2775	67	0	0	0	0	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	JUN	2021	21	2					263	271					9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	SO7RD	WOS:000659171800008	34059571				2022-02-07	
J	Julian-Villaverde, FJ; Ochoa-Callejero, L; Siles, E; Martinez-Lara, E; Martinez, A				Julian-Villaverde, Francisco J.; Ochoa-Callejero, Laura; Siles, Eva; Martinez-Lara, Esther; Martinez, Alfredo			Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage	CURRENT ISSUES IN MOLECULAR BIOLOGY			English	Article						adrenomedullin; acute hemorrhagic stroke; circulating levels; diagnostic biomarker; prognostic biomarker	ISCHEMIC NEUROLOGICAL DEFICITS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; COMPLEMENT FACTOR-H; PLASMA ADRENOMEDULLIN; CEREBROSPINAL-FLUID; RISK-FACTORS; PANCREATIC-CANCER; NITRIC-OXIDE; CELL-LINES	Hemorrhagic stroke remains an important health challenge. Adrenomedullin (AM) is a vasoactive peptide with an important role in cardiovascular diseases, including stroke. Serum AM and nitrate-nitrite and 5-nitroso compounds (NOx) levels were measured and compared between healthy volunteers (n = 50) and acute hemorrhagic stroke patients (n = 64). Blood samples were taken at admission (d0), 24 h later (d1), and after 7 days or at the time of hospital discharge (d7). Neurological severity (NIHSS) and functional prognosis (mRankin) were measured as clinical outcomes. AM levels were higher in stroke patients at all times when compared with healthy controls (p < 0.0001). A receiving operating characteristic curve analysis identified that AM levels at admission > 69.0 pg/mL had a great value as a diagnostic biomarker (area under the curve = 0.89, sensitivity = 80.0%, specificity = 100%). Furthermore, patients with a favorable outcome (NIHSS <= 3; mRankin <= 2) experienced an increase in AM levels from d0 to d1, and a decrease from d1 to d7, whereas patients with unfavorable outcome had no significant changes over time. NOx levels were lower in patients at d0 (p = 0.04) and d1 (p < 0.001) than in healthy controls. In conclusion, AM levels may constitute a new diagnostic and prognostic biomarker for this disease, and identify AM as a positive mediator for hemorrhagic stroke resolution.	[Julian-Villaverde, Francisco J.] Hosp San Pedro, Neurol Serv, Stroke Unit, Logrono 26006, Spain; [Ochoa-Callejero, Laura; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Angiogenesis Grp, Oncol Area, Logrono 26006, Spain; [Siles, Eva; Martinez-Lara, Esther] Univ Jaen, Expt Biol Dept, Jaen 23071, Spain		Martinez, A (corresponding author), Ctr Biomed Res La Rioja CIBIR, Angiogenesis Grp, Oncol Area, Logrono 26006, Spain.	fjulian@riojasalud.es; locallejero@riojasalud.es; esiles@ujaen.es; elara@ujaen.es; amartinezr@riojasalud.es	Ochoa, Laura/AAU-3807-2021; Martinez, Alfredo/A-3077-2013; Ochoa-Callejero, Laura/K-2560-2012	Martinez, Alfredo/0000-0003-4882-4044; Ochoa-Callejero, Laura/0000-0001-5366-6613; Siles Rivas, Eva/0000-0003-4192-7008	Fundacion Rioja Salud	This study was funded by Fundacion Rioja Salud.	Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Bonnard T, 2019, STROKE, V50, P1318, DOI 10.1161/STROKEAHA.118.022744; Chauhan G, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0804-z; Chen TJ, 2014, PEPTIDES, V56, P146, DOI 10.1016/j.peptides.2014.04.005; Chiu D, 2010, J STROKE CEREBROVASC, V19, P225, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.002; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Hurtado O, 2010, NEUROSCIENCE, V171, P885, DOI 10.1016/j.neuroscience.2010.09.021; Iring A, 2019, J CLIN INVEST, V129, P2775, DOI 10.1172/JCI123825; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; Kitago Tomoko, 2017, F1000Res, V6, P2044, DOI 10.12688/f1000research.11913.1; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kubo Y, 2008, CEREBROVASC DIS, V25, P164, DOI 10.1159/000113734; Kubo Y, 2013, NEUROL RES, V35, P713, DOI 10.1179/1743132813Y.0000000222; Larrayoz IM, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00384; Lenz IJ, 2021, J CEREBR BLOOD F MET, V41, P1669, DOI 10.1177/0271678X20973787; Li FJ, 2020, NEURAL REGEN RES, V15, P1199, DOI 10.4103/1673-5374.272567; Liu J, 2014, INT J NEUROSCI, V124, P271, DOI 10.3109/00207454.2013.837462; Lopez J, 2002, INT REV CYTOL, V221, P1; Makris K, 2018, CRIT REV CL LAB SCI, V55, P294, DOI 10.1080/10408363.2018.1461190; Martinez A, 1999, PEPTIDES, V20, P1471, DOI 10.1016/S0196-9781(99)00158-8; Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626; Martinez A, 2004, ENDOCRINOLOGY, V145, P3858, DOI 10.1210/en.2003-1251; MARTINEZ A, 1995, ENDOCRINOLOGY, V136, P4099, DOI 10.1210/en.136.9.4099; Morotti A, 2016, EMERG MED CLIN N AM, V34, P883, DOI 10.1016/j.emc.2016.06.010; Nishida H, 2008, PEPTIDES, V29, P599, DOI 10.1016/j.peptides.2007.12.006; Ochoa-Callejero L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33495; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; Paspalj D, 2015, MOL CELL BIOCHEM, V406, P75, DOI 10.1007/s11010-015-2425-z; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; Poorthuis MHF, 2017, JAMA NEUROL, V74, P75, DOI 10.1001/jamaneurol.2016.3482; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Serrano J, 2002, NEUROSCIENCE, V109, P717, DOI 10.1016/S0306-4522(01)00532-2; Serrano J, 2000, BRAIN RES, V853, P245, DOI 10.1016/S0006-8993(99)02273-8; Serrano J, 2008, BRAIN PATHOL, V18, P434, DOI 10.1111/j.1750-3639.2008.00142.x; Serrano-Ponz M, 2016, MOL MED REP, V13, P3724, DOI 10.3892/mmr.2016.5001; Simpkins AN, 2020, TRANSL STROKE RES, V11, P615, DOI 10.1007/s12975-019-00762-3; Somay G, 2007, NEUROSCIENCES, V12, P351; Terpolilli NA, 2016, J CEREBR BLOOD F MET, V36, P2096, DOI 10.1177/0271678X15605848; Turnbull MT, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0073-8; Waheed S, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/9206948; Wang CL, 2014, PEPTIDES, V54, P27, DOI 10.1016/j.peptides.2014.01.005; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; Watanabe K, 2001, ACTA NEUROCHIR, V143, P1157, DOI 10.1007/s007010100007; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; World Health Organization, 2021, TOP 10 CAUS DEATH; Xia CF, 2006, EXP NEUROL, V197, P521, DOI 10.1016/j.expneurol.2005.10.027; Yin JJ, 2021, PHARM STAT, V20, P657, DOI 10.1002/pst.2099; Zhang H, 2014, PEPTIDES, V52, P44, DOI 10.1016/j.peptides.2013.11.025	58	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1467-3037	1467-3045		CURR ISSUES MOL BIOL	Curr. Issues Mol. Biol.	JUN	2021	43	1					324	334		10.3390/cimb43010027			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TB1YA	WOS:000667739800027	34208106				2022-02-07	
J	Keating, CE; Browne, KD; Cullen, DK				Keating, Carolyn E.; Browne, Kevin D.; Cullen, D. Kacy			Dietary manipulation of vulnerability to traumatic brain injury-induced neuronal plasma membrane permeability	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Plasma membrane; Permeability; Mechanoporation; Lipid; Diet; Fish oil; High fat	HIGH-FAT DIET; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; COGNITIVE FUNCTION; LIPID-COMPOSITION; SUPPLEMENTATION; STRAIN; DEFORMATION; CALCIUM; MODEL	Traumatic brain injury (TBI) can produce physical disruptions in the plasma membranes of neurons, referred to as mechanoporation, which lead to increased cell permeability. We suspect that such trauma-induced membrane disruptions may be influenced by the physical properties of the plasma membrane, such as elasticity or rigidity. These membrane properties are influenced by lipid composition, which can be modulated via diet, leading to the intriguing possibility of prophylactically altering diet to confer resiliency to this mechanism of acute neuronal damage in TBI. In this proof-of-concept study, we used three different diets-one high in polyunsaturated fatty acids suggested to increase elasticity (Fish Oil), one high in saturated fatty acids and cholesterol suggested to increase rigidity (High Fat), and one standard rat chow (Control)-to alter brain plasma membrane lipid composition before subjecting rats to lateral fluid percussion injury (FPI). Lipid analysis (n = 12 rats) confirmed that diets altered brain fatty acid composition after 4 weeks of feeding, with the Fish Oil diet increasing unsaturated fatty acids, and interestingly, the High Fat diet increasing omega-6 docosapentaenoic acid. One cohort of animals (n = 34 rats) was assessed immediately after FPI or sham injury for acute changes in neuronal membrane permeability in the injury-adjacent cortex. Surprisingly, sham animals fed Fish Oil had increased membrane permeability, suggesting altered passive membrane properties. In contrast, injured animals fed the High Fat diet displayed less intense uptake of permeability marker, suggesting a reduced extent of injury-induced plasma membrane disruption, although the density of affected cells matched the other diet groups. In a separate cohort survived for 7 days after FPI (n = 48 rats), animals fed the High Fat diet exhibited a reduced lesion area. At both time points there were no statistically significant differences in inflammation. Unexpectedly, these results indicate that the High Fat diet, as opposed to the Fish Oil diet, beneficially modulated acute plasma membrane permeability and resulted in a smaller lesion size at 7 days post-injury. Additional studies are necessary to determine the impact of these various diets on behavioral outcomes post-TBI. Further investigation is also needed to understand the physical properties in neuronal plasma membranes that may underlie increased resiliency to trauma-induced disruptions and, importantly, to understand how these properties may be influenced by targeted dietary modifications for vulnerable populations.	[Keating, Carolyn E.; Browne, Kevin D.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Keating, Carolyn E.; Browne, Kevin D.; Cullen, D. Kacy] Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), 105 Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.	ckea@pennmedicine.upenn.edu; kbrowne@pennmedicine.upenn.edu; dkacy@pennmedicine.upenn.edu			Department of Veterans Affairs (BLRD Merit Review)US Department of Veterans Affairs [I01-BX005017, I01-BX003748]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03-NS116301]; Department of Health of the Commonwealth of Pennsylvania (PA Consortium on TBI: PACT)	We would like to thank Cassidy Fetterman and Alan Jinich for technical assistance. Financial support was provided by the Department of Veterans Affairs (BLR&D Merit Review I01-BX005017 & BLR&D Merit Review I01-BX003748), the National Institutes of Health (R03-NS116301), and the Department of Health of the Commonwealth of Pennsylvania (PA Consortium on TBI: PACT).	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Bailes JE, 2020, J NEUROSURG, V133, P598, DOI 10.3171/2020.3.JNS20183; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Boothe DL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00236; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; CLANDININ MT, 1992, ADV EXP MED BIOL, V318, P197; Contarini G, 2013, INT J MOL SCI, V14, P2808, DOI 10.3390/ijms14022808; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dangi B, 2009, J BIOL CHEM, V284, P14744, DOI 10.1074/jbc.M809014200; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; EHRINGER W, 1990, CHEM PHYS LIPIDS, V54, P79, DOI 10.1016/0009-3084(90)90063-W; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Emmerich T., 2016, NEUROMOLECULAR MED, P1; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Figueroa JD, 2013, J NEUROTRAUM, V30, P853, DOI 10.1089/neu.2012.2718; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gross BW, 2017, J TRAUMA NURS, V24, P15, DOI 10.1097/JTN.0000000000000256; Guo S, 2017, SCI REP-UK, V7; Hals PA, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0414-9; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Ibarguren M, 2014, BBA-BIOMEMBRANES, V1838, P1518, DOI 10.1016/j.bbamem.2013.12.021; Jeansen S, 2018, CLIN NUTR, V37, P948, DOI 10.1016/j.clnu.2017.03.027; Keating CE, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105210; Keating CE, 2020, J NEUROTRAUM, V37, P1918, DOI 10.1089/neu.2019.6738; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Levant B, 2013, LIPIDS, V48, P939, DOI 10.1007/s11745-013-3817-z; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Meaney D.F., 2016, YOUMANS WINNS NEUROL, V7th, P2755; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916x693842, 10.3727/096368916X693842]; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Saeedimasine M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44318-9; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Sears Barry, 2013, PharmaNutrition, V1, P86, DOI 10.1016/j.phanu.2013.04.002; Shaito A, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102829; Sharma S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00431; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Thau-Zuchman O, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6420; Trojian TH, 2017, CURR SPORT MED REP, V16, P247, DOI 10.1249/JSR.0000000000000387; Vanschoonbeek K, 2004, ARTERIOSCL THROM VAS, V24, P1734, DOI 10.1161/01.ATV.0000137119.28893.0b; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Weylandt KH, 2016, EUR J PHARMACOL, V785, P108, DOI 10.1016/j.ejphar.2015.11.002; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yang DY, 2007, NEUROTOXICOLOGY, V28, P1220, DOI 10.1016/j.neuro.2007.08.003; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; Zhu W, 2017, EXP THER MED, V14, P4411, DOI 10.3892/etm.2017.5054	73	0	0	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2021	340								113649	10.1016/j.expneurol.2021.113649			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SB1BR	WOS:000649737600002	33600812				2022-02-07	
J	Kim, JS; Carlucci, M				Kim, Jessica S.; Carlucci, Melissa			Reducing Unnecessary Head Computed Tomographic Scans in an Adult Emergency Department	JNP-JOURNAL FOR NURSE PRACTITIONERS			English	Article						Canadian CT Head Rule; emergency department; head computed tomographic scan; minor head injury	TRAUMATIC BRAIN-INJURY; CLINICAL DECISION-SUPPORT; NEW-ORLEANS CRITERIA; RULE; MANAGEMENT; TIME	A computed tomographic (CT) scan of the head is commonly used in the emergency department for patients who present with minor head injury. Frequent use of CT imaging contributes to health care costs, radiation exposure, and emergency department length of stay. The objective of this project was to decrease unnecessary head CT scans for patients presenting with minor head injury. A clinical decision pathway using the Canadian CT Head Rule was implemented. There was a 12% decrease in head CT use over 8 weeks, and no brain injuries were missed. These outcomes support the implementation of a clinical pathway using the Canadian CT Head Rule on a larger scale. (c) 2020 Elsevier Inc. All rights reserved.	[Kim, Jessica S.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Carlucci, Melissa] Univ Illinois, Coll Nusing, Dept Biobehav Nursing Sci, Chicago, IL USA		Kim, JS (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.	kim.jessica.s@gmail.com					American Board of Internal Medicine Foundation, OUR MISS CHOOS WIS; American College of Emergency Physicians, 2013, 10 THINGS PHYS PAT S; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Gimbel RW, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0602-1; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Michelson EA, 2018, WEST J EMERG MED, V19, P635, DOI 10.5811/westjem.2018.5.37293; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Niska R, NATL HOSP AMBULATORY; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rui PKK, NATL HOSP AMBULATORY; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Vedin T, 2017, QUAL MANAG HEALTH CA, V26, P190, DOI 10.1097/QMH.0000000000000151; Zakhari R, 2016, J AM ASSOC NURSE PRA, V28, P659, DOI 10.1002/2327-6924.12402	21	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1555-4155	1878-058X		JNP-J NURSE PRACT	JNP-J. Nurse Pract.	JUN	2021	17	6					749	752		10.1016/j.nurpra.2020.12.017			4	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	SQ1LO	WOS:000660121400026					2022-02-07	
